Citrus Sinensis ID: 042539
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 412 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LSF1 | 421 | Serine/threonine-protein | no | no | 0.813 | 0.795 | 0.455 | 1e-83 | |
| A2YBX5 | 589 | Protein kinase G11A OS=Or | N/A | no | 0.822 | 0.575 | 0.396 | 8e-67 | |
| Q0DCT8 | 589 | Protein kinase G11A OS=Or | no | no | 0.822 | 0.575 | 0.396 | 9e-67 | |
| Q9LFA2 | 934 | Serine/threonine-protein | no | no | 0.820 | 0.361 | 0.403 | 5e-66 | |
| Q64FQ2 | 525 | Protein kinase PINOID 2 O | no | no | 0.844 | 0.662 | 0.372 | 2e-65 | |
| O64682 | 438 | Protein kinase PINOID OS= | no | no | 0.813 | 0.764 | 0.410 | 5e-64 | |
| Q2RBR1 | 921 | Phototropin-1B OS=Oryza s | no | no | 0.771 | 0.345 | 0.384 | 9e-64 | |
| Q2QYY8 | 921 | Phototropin-1A OS=Oryza s | no | no | 0.771 | 0.345 | 0.384 | 1e-63 | |
| P15792 | 609 | Protein kinase PVPK-1 OS= | N/A | no | 0.873 | 0.591 | 0.383 | 7e-63 | |
| Q05999 | 578 | Serine/threonine-protein | no | no | 0.788 | 0.562 | 0.373 | 2e-62 |
| >sp|Q9LSF1|OXI1_ARATH Serine/threonine-protein kinase OXI1 OS=Arabidopsis thaliana GN=OXI1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 310 bits (794), Expect = 1e-83, Method: Compositional matrix adjust.
Identities = 165/362 (45%), Positives = 227/362 (62%), Gaps = 27/362 (7%)
Query: 10 QTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAE-- 67
+ + +LD + L+ L +LG+GA G VFLV D A ALKV+ K + K +
Sbjct: 7 KQSRALDFNRLEVLSLLGRGAKGVVFLVRDDDAKL-----LALKVILKEAIEKKKKGRES 61
Query: 68 -----RRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVF 122
+R +E VLSR HP P L G L TD+ + +A+ YCPG +LN LR Q++ +F
Sbjct: 62 EDDEYKRVSFEQGVLSRFDHPLFPSLHGVLATDKVIGYAIDYCPGQNLNSLRKMQSESMF 121
Query: 123 SPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFE 182
S +IRFY +E++ A+++LHN GI YRDLKP+N++I+++GH+ L DFDLS NL +T
Sbjct: 122 SDEIIRFYAAELVLALDYLHNQGIVYRDLKPDNVMIQENGHLMLIDFDLSTNLAPRTPQP 181
Query: 183 KQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNG 242
SL+ + KR +R+ R+ +G+ +S V S S +G
Sbjct: 182 SPSLSKPSPTM-------KRKKRLF-RFTSFC---NSGISPQESISVHSSSTLAVSDSSG 230
Query: 243 ERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLM 302
E+SNSFVGTEEYV+PEV+ GDGH+FAVDWW+LG++ YEMLYG TPFRG NRKETF +L
Sbjct: 231 EKSNSFVGTEEYVAPEVISGDGHDFAVDWWSLGVVLYEMLYGATPFRGSNRKETFYRILS 290
Query: 303 KTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFI 362
K P G+ T+L DLI+RLLEKDP +R+ EIK H FF+GV W+ + V RPP+I
Sbjct: 291 KPPNLTGETTSLRDLIRRLLEKDPSRRI----NVEEIKGHDFFRGVDWEKVILVSRPPYI 346
Query: 363 PS 364
P+
Sbjct: 347 PA 348
|
Involved in oxidative burst-mediated signaling. Required for basal resistance to P.parasitica infection and root hair growth. Partly required for the activation of MPK3 and MPK6 by hydrogen peroxide and cellulase elicitor. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|A2YBX5|G11A_ORYSI Protein kinase G11A OS=Oryza sativa subsp. indica GN=OsI_021818 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 254 bits (649), Expect = 8e-67, Method: Compositional matrix adjust.
Identities = 147/371 (39%), Positives = 215/371 (57%), Gaps = 32/371 (8%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
L L + K LK LG G +G+V+L + FA+KV+DK++L ++ + RA+ E
Sbjct: 190 LGLSHFKLLKKLGCGDIGSVYLSELNGT----KSYFAMKVMDKASLASRKKL-LRAQTEK 244
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEI 134
+L L HPFLP L ETD+F + +CPGGDL+ LR +Q + F ++FY++EI
Sbjct: 245 EILQCLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQRGKYFPEQAVKFYVAEI 304
Query: 135 ICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR------NLVKKTAFEKQSL-- 186
+ A+E+LH +GI YRDLKPEN+L+R+ GH+ L+DFDLS L++ + + ++L
Sbjct: 305 LLAMEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIRSSNPDAEALRK 364
Query: 187 NNNKFPVLPVTENPKRHRRILTRWLHALPENKTG---LKKTKSAR------VSPVSRRQQ 237
NN + V P P + + A P G K+K R V+ VS +
Sbjct: 365 NNQAYCVQPACVEPS----CMIQPSCATPTTCFGPRFFSKSKKDRKPKPEVVNQVSPWPE 420
Query: 238 SFD--NGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKE 295
+ RS SFVGT EY++PE+++G+GH AVDWW GI YE+L+G TPF+G +
Sbjct: 421 LIAEPSDARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRA 480
Query: 296 TFRNVL---MKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDL 352
T NV+ ++ PE+ + DLI+ LL K+P +RLG RGA EIK+H FF+GV W L
Sbjct: 481 TLFNVIGQPLRFPEYPVVSFSARDLIRGLLVKEPQQRLGCKRGATEIKQHPFFEGVNWAL 540
Query: 353 LTDVLRPPFIP 363
+ PP +P
Sbjct: 541 IR-CASPPEVP 550
|
May play a role in the regulation of metabolism and signal transduction processes. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0DCT8|G11A_ORYSJ Protein kinase G11A OS=Oryza sativa subsp. japonica GN=Os06g0291600 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 254 bits (649), Expect = 9e-67, Method: Compositional matrix adjust.
Identities = 147/371 (39%), Positives = 215/371 (57%), Gaps = 32/371 (8%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
L L + K LK LG G +G+V+L + FA+KV+DK++L ++ + RA+ E
Sbjct: 190 LGLSHFKLLKKLGCGDIGSVYLSELSGT----KSYFAMKVMDKASLASRKKL-LRAQTEK 244
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEI 134
+L L HPFLP L ETD+F + +CPGGDL+ LR +Q + F ++FY++EI
Sbjct: 245 EILQCLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQRGKYFPEQAVKFYVAEI 304
Query: 135 ICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR------NLVKKTAFEKQSL-- 186
+ A+E+LH +GI YRDLKPEN+L+R+ GH+ L+DFDLS L++ + + ++L
Sbjct: 305 LLAMEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIRSSNPDAEALRK 364
Query: 187 NNNKFPVLPVTENPKRHRRILTRWLHALPENKTG---LKKTKSAR------VSPVSRRQQ 237
NN + V P P + + A P G K+K R V+ VS +
Sbjct: 365 NNQAYCVQPACVEPS----CMIQPSCATPTTCFGPRFFSKSKKDRKPKPEVVNQVSPWPE 420
Query: 238 SFD--NGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKE 295
+ RS SFVGT EY++PE+++G+GH AVDWW GI YE+L+G TPF+G +
Sbjct: 421 LIAEPSDARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRA 480
Query: 296 TFRNVL---MKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDL 352
T NV+ ++ PE+ + DLI+ LL K+P +RLG RGA EIK+H FF+GV W L
Sbjct: 481 TLFNVIGQPLRFPEYPVVSFSARDLIRGLLVKEPQQRLGCKRGATEIKQHPFFEGVNWAL 540
Query: 353 LTDVLRPPFIP 363
+ PP +P
Sbjct: 541 IR-CASPPEVP 550
|
May play a role in the regulation of metabolism and signal transduction processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFA2|KIPK_ARATH Serine/threonine-protein kinase KIPK OS=Arabidopsis thaliana GN=KIPK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 251 bits (642), Expect = 5e-66, Method: Compositional matrix adjust.
Identities = 152/377 (40%), Positives = 206/377 (54%), Gaps = 39/377 (10%)
Query: 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWE 73
SL L + LK LG G +GTV+L + C FA+KV+D L A+ + RA+ E
Sbjct: 532 SLGLRHFNLLKKLGCGDIGTVYLAELIGTN----CLFAIKVMDNEFL-ARRKKSPRAQAE 586
Query: 74 IRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSE 133
+L L HPFLP L +D + YCPGGDL+VLR KQ R F RFY++E
Sbjct: 587 REILKMLDHPFLPTLYAQFTSDNLSCLVMEYCPGGDLHVLRQKQLGRCFPEPAARFYVAE 646
Query: 134 IICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS-RNLVKKTAFEKQS------- 185
I+ A+E+LH +GI YRDLKPENIL+R+ GH+ LTDFDLS R V T S
Sbjct: 647 ILLALEYLHMLGIIYRDLKPENILVREDGHIMLTDFDLSLRCAVNPTLVRSNSPPGKDPA 706
Query: 186 ------LNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSF 239
+N +TE + ++ + L N+ +K K R +S+ QQ
Sbjct: 707 RISGPYNTSNCIQPFCITEPSCQ----VSCFSPRLSSNQQQGRKPK--RGDHLSKTQQHL 760
Query: 240 DNG----------ERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFR 289
RSNSFVGT EY++PE+++G+GH AVDWW G+L YE+LYG TPF+
Sbjct: 761 SRSLPQLVAEPTEARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGVLLYELLYGKTPFK 820
Query: 290 GKNRKETFRNVLMKTPEFVGQ---RTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
G N ET NV+++ +F DLI+ LL K+P RLG +G+ EIK H FF+
Sbjct: 821 GYNNDETLANVVLQNLKFPDSPLVSFQAKDLIRGLLVKEPENRLGSEKGSVEIKRHPFFE 880
Query: 347 GVRWDLLTDVLRPPFIP 363
G+ W L+ + PP +P
Sbjct: 881 GLNWALIRCAI-PPELP 896
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q64FQ2|PID2_ARATH Protein kinase PINOID 2 OS=Arabidopsis thaliana GN=PID2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 249 bits (637), Expect = 2e-65, Method: Compositional matrix adjust.
Identities = 157/422 (37%), Positives = 220/422 (52%), Gaps = 74/422 (17%)
Query: 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWE 73
++ L++ + LK LG G +G+V+L R + TA +A+KVVDK + K + R A E
Sbjct: 81 AVGLEHFRLLKRLGSGDIGSVYLCQIRGSPETAF--YAMKVVDKEAVAVKKKLGR-AEME 137
Query: 74 IRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSE 133
++L L HPF P L + E + + YCPGGDL +R +Q + F+ S RFY +E
Sbjct: 138 KKILGMLDHPFCPTLYAAFEASHYSFLVMEYCPGGDLYAVRLRQPSKRFTISSTRFYAAE 197
Query: 134 IICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNK--- 190
+ A+E+LH MGI YRDLKPEN+LIR+ GHV L+DFDLS K Q L++N
Sbjct: 198 TLVALEYLHMMGIVYRDLKPENVLIREDGHVMLSDFDLSF----KCDVVPQFLSDNDRDR 253
Query: 191 ----------------------FPVLPV------TENPKRHRRILTRWLHALPENKTGLK 222
P+ PV T + +R + ++T +H EN G
Sbjct: 254 GHQEDDDDISIRRKCSTPSCTTTPLNPVISCFSPTSSRRRKKNVVTTTIH---ENAAGTS 310
Query: 223 KT-KSARVSPVSRRQQS----FDNG-----------------ERSNSFVGTEEYVSPEVV 260
+ KS VS R S NG RS SFVGT EY++PEV+
Sbjct: 311 DSVKSNDVSRTFSRSPSSCSRVSNGLRDISGGCPSIFAEPINARSKSFVGTHEYLAPEVI 370
Query: 261 RGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL----------MKTPEFVGQ 310
G GH AVDWW GI YEM++G TPF+G N ++T N+L + +P+
Sbjct: 371 SGQGHGSAVDWWTYGIFLYEMIFGRTPFKGDNNEKTLVNILKAPLTFPKVIVNSPKEYED 430
Query: 311 RTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREENDL 370
DLI +LL K+P KRLG L+G+ EIK H FF+GV W L+ + +PP++P E +
Sbjct: 431 MVNAQDLIIKLLVKNPKKRLGSLKGSIEIKRHEFFEGVNWALIRSI-KPPWVPKEETSHK 489
Query: 371 TE 372
T+
Sbjct: 490 TK 491
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. Plays a minor role in the regulation of cellular auxin efflux and cotyledon organogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64682|PID_ARATH Protein kinase PINOID OS=Arabidopsis thaliana GN=PID PE=1 SV=1 | Back alignment and function description |
|---|
Score = 245 bits (625), Expect = 5e-64, Method: Compositional matrix adjust.
Identities = 147/358 (41%), Positives = 191/358 (53%), Gaps = 23/358 (6%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCP-FALKVVDKSTLHAKHEAERRARWE 73
L + + ++ +G G +GTV+L + +R FA+KVVDK L K + R A E
Sbjct: 70 LTFRDFRLMRRIGAGDIGTVYLCRLAGDEEESRSSYFAMKVVDKEALALKKKMHR-AEME 128
Query: 74 IRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSE 133
+L L HPFLP L E F + YC GGDL+ LR++Q R FS S RFY +E
Sbjct: 129 KTILKMLDHPFLPTLYAEFEASHFSCIVMEYCSGGDLHSLRHRQPHRRFSLSSARFYAAE 188
Query: 134 IICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPV 193
++ A+E+LH +GI YRDLKPENIL+R GH+ L+DFDLS A E S + P
Sbjct: 189 VLVALEYLHMLGIIYRDLKPENILVRSDGHIMLSDFDLSLCSDSIAAVESSSSS----PE 244
Query: 194 LPVTENPKRHRRILTRWLHALPENKT-GLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252
+P+R R+ + L K L+ T+ PV+ RS SFVGT
Sbjct: 245 NQQLRSPRRFTRLARLFQRVLRSKKVQTLEPTRLFVAEPVT---------ARSGSFVGTH 295
Query: 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVGQRT 312
EYV+PEV G H AVDWWA G+ YEM+YG TPF RN++ + F
Sbjct: 296 EYVAPEVASGGSHGNAVDWWAFGVFLYEMIYGKTPFVAPTNDVILRNIVKRQLSFPTDSP 355
Query: 313 ALT------DLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPS 364
A +LI LL KDP KRLG RGA E+K H FFKG+ + L+ L PP IPS
Sbjct: 356 ATMFELHARNLISGLLNKDPTKRLGSRRGAAEVKVHPFFKGLNFALIR-TLTPPEIPS 412
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. Acts as a positive regulator of cellular auxin efflux and regulates organ development by enhancing polar auxin transport. Phosphorylates conserved serine residues in the PIN auxin efflux carriers. Phosphorylation of PIN proteins is required and sufficient for apical-basal PIN polarity that enables directional intercellular auxin fluxes, which mediate differential growth, tissue patterning and organogenesis. Acts in association with PIN1 to control the establishment of bilateral symmetry and promotion of cotyledon outgrowth. Regulates root gravitropism through modulation of PIN2-dependent basipetal auxin transport. Required for polarization of PIN3-dependent auxin transport for hypocotyl gravitropic response. The protein kinase activity of PID is essential for its auxin efflux regulatory function. PID kinase and PP2A phosphatase activities antagonistically regulate phosphorylation of PIN proteins, affecting PIN sorting. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2RBR1|PHT1B_ORYSJ Phototropin-1B OS=Oryza sativa subsp. japonica GN=PHOT1B PE=1 SV=2 | Back alignment and function description |
|---|
Score = 244 bits (623), Expect = 9e-64, Method: Compositional matrix adjust.
Identities = 145/377 (38%), Positives = 197/377 (52%), Gaps = 59/377 (15%)
Query: 10 QTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERR 69
++ S+ L + + +K LG G G+V LV FA+K +DKS + +++ R
Sbjct: 584 ESGESIGLKHFRPVKPLGSGDTGSVHLVELLNTGEY----FAMKAMDKSIMLNRNKVHR- 638
Query: 70 ARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRF 129
A E ++L L HPFLP L S +T + YCPGG+L VL Q +V +RF
Sbjct: 639 ATAERQILDLLDHPFLPTLYASFQTKTHICLITDYCPGGELFVLLDNQPLKVLHEDAVRF 698
Query: 130 YLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS-------RNLVKKTAFE 182
Y +E++ A+E+LH GI YRDLKPENIL+ + GH++LTDFDLS + + + A E
Sbjct: 699 YAAEVVVALEYLHCQGIIYRDLKPENILLHRDGHISLTDFDLSCLTSCRPQVFLPEDADE 758
Query: 183 KQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNG 242
K+ N +P+ P R
Sbjct: 759 KKGRKNGSYPIF--FAEPMRA--------------------------------------- 777
Query: 243 ERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLM 302
SNSFVGTEEY++PE++ G GH AVDWWALGIL YEMLYG TPFRGK R+ TF N+L
Sbjct: 778 --SNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQRTFANILH 835
Query: 303 KT---PEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRP 359
K P + A L+ RLL +DP RLG GA EIK H FF+G+ W L+ P
Sbjct: 836 KDIRFPASISVSLAARQLMYRLLHRDPANRLGSYEGANEIKGHPFFRGINWPLIRATAPP 895
Query: 360 PF-IPSREENDLTEKAM 375
IP ++D+ +K +
Sbjct: 896 KLEIPLFSKDDMEKKGL 912
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for phototropic responses. Regulates a wide range of physiological activities in plants that maximize the efficiency of photosynthesis, such as chloroplast relocations, stomata opening, and leaf expansion. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2QYY8|PHT1A_ORYSJ Phototropin-1A OS=Oryza sativa subsp. japonica GN=PHOT1A PE=1 SV=2 | Back alignment and function description |
|---|
Score = 244 bits (623), Expect = 1e-63, Method: Compositional matrix adjust.
Identities = 145/377 (38%), Positives = 197/377 (52%), Gaps = 59/377 (15%)
Query: 10 QTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERR 69
++ S+ L + + +K LG G G+V LV FA+K +DKS + +++ R
Sbjct: 584 ESGESIGLKHFRPVKPLGSGDTGSVHLVELLNTGEY----FAMKAMDKSIMLNRNKVHR- 638
Query: 70 ARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRF 129
A E ++L L HPFLP L S +T + YCPGG+L VL Q +V +RF
Sbjct: 639 ATAERQILDLLDHPFLPTLYASFQTKTHICLITDYCPGGELFVLLDNQPLKVLHEDAVRF 698
Query: 130 YLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS-------RNLVKKTAFE 182
Y +E++ A+E+LH GI YRDLKPENIL+ + GH++LTDFDLS + + + A E
Sbjct: 699 YAAEVVVALEYLHCQGIIYRDLKPENILLHRDGHISLTDFDLSCLTSCRPQVFLPEDADE 758
Query: 183 KQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNG 242
K+ N +P+ P R
Sbjct: 759 KKGRKNGSYPIF--FAEPMRA--------------------------------------- 777
Query: 243 ERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLM 302
SNSFVGTEEY++PE++ G GH AVDWWALGIL YEMLYG TPFRGK R+ TF N+L
Sbjct: 778 --SNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQRTFANILH 835
Query: 303 KT---PEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRP 359
K P + A L+ RLL +DP RLG GA EIK H FF+G+ W L+ P
Sbjct: 836 KDIRFPASISVSLAARQLMYRLLHRDPANRLGSYEGANEIKGHPFFRGINWPLIRATAPP 895
Query: 360 PF-IPSREENDLTEKAM 375
IP ++D+ +K +
Sbjct: 896 KLEIPLFSKDDMEKKGL 912
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for phototropic responses. Regulates a wide range of physiological activities in plants that maximize the efficiency of photosynthesis, such as chloroplast relocations, stomata opening, and leaf expansion. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P15792|KPK1_PHAVU Protein kinase PVPK-1 OS=Phaseolus vulgaris PE=2 SV=1 | Back alignment and function description |
|---|
Score = 241 bits (615), Expect = 7e-63, Method: Compositional matrix adjust.
Identities = 150/391 (38%), Positives = 214/391 (54%), Gaps = 31/391 (7%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
L++ + + LK LG G +G+V+L A R FA+KV++K+ L A + RA+ E
Sbjct: 224 LEMRHFRLLKKLGCGDIGSVYL----AELSGTRTSFAMKVMNKTEL-ANRKKLLRAQTER 278
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEI 134
+L L HPFLP L ET+ F + +CPGGDL+ LR +Q + FS +RFY++E+
Sbjct: 279 EILQSLDHPFLPTLYTHFETEIFSCLVMEFCPGGDLHALRQRQPGKYFSEHAVRFYVAEV 338
Query: 135 ICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLN----NNK 190
+ ++E+LH +GI YRDLKPEN+L+R+ GH+ L+DFDLS K S N ++
Sbjct: 339 LLSLEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCSVSPTLVKSSNNLQTKSSG 398
Query: 191 FPVLPVTENPK--------RHRRILTRWLHALPENKTGLKKTKSA--RVSPVSRRQQSFD 240
+ V P P + R+L + K +V+P+
Sbjct: 399 YCVQPSCIEPTCVMQPDCIKPSCFTPRFLSGKSKKDKKSKPKNDMHNQVTPLPELIAEPT 458
Query: 241 NGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNV 300
N RS SFVGT EY++PE+++G+GH AVDWW GI YE+L+G TPF+G + T NV
Sbjct: 459 NA-RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGRTPFKGSANRATLFNV 517
Query: 301 L---MKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVL 357
+ ++ PE A DLI+ LL K+P RL Y RGA EIK+H FF+ V W L+
Sbjct: 518 IGQPLRFPESPTVSFAARDLIRGLLVKEPQHRLAYRRGATEIKQHPFFQNVNWALIR-CA 576
Query: 358 RPPFIPS------REENDLTEKAMSGGGVDI 382
PP +P + E DL K SG +DI
Sbjct: 577 TPPEVPRQVINLPQTEKDLGVKP-SGNYLDI 606
|
Phaseolus vulgaris (taxid: 3885) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q05999|KPK7_ARATH Serine/threonine-protein kinase AtPK7 OS=Arabidopsis thaliana GN=PK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 239 bits (611), Expect = 2e-62, Method: Compositional matrix adjust.
Identities = 143/383 (37%), Positives = 204/383 (53%), Gaps = 58/383 (15%)
Query: 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWE 73
SL+ + K +K LG G +G V+L + FA+KV++K+ + A+ + R A+ E
Sbjct: 176 SLEAKDFKLIKKLGGGDIGNVYLAELIGTGVS----FAVKVMEKAAIAARKKLVR-AQTE 230
Query: 74 IRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSE 133
+L L HPFLP L ET+ + +CPGGDL+ LR KQ + F RFY++E
Sbjct: 231 KEILQSLDHPFLPTLYSHFETEMNSCLVMEFCPGGDLHSLRQKQRGKYFPEQAARFYVAE 290
Query: 134 IICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL---------------------- 171
++ A+E+LH +GI YRDLKPEN+L+R+ GH+ L+DFDL
Sbjct: 291 VLLAMEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLVRFAAITLESKS 350
Query: 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPK-----RHRRI---LTRWLHALPENKTGLKK 223
S ++ T ++ S + PV P+ +HR+ ++R + LPE
Sbjct: 351 SSYCIQPTCVDQSSCIVQPDCIQPVCFTPRFLSKGKHRKKSNDMSRQIRPLPE------- 403
Query: 224 TKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY 283
P S RS SFVGT EY++PE+++G+GH AVDWW GI YE+L+
Sbjct: 404 ---LIAEPTS---------ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF 451
Query: 284 GTTPFRGKNRKETFRNVL---MKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIK 340
G TPFRG + + T NV+ ++ PE A DLI+ LL K+P RL Y RGA EIK
Sbjct: 452 GITPFRGGDNRATLFNVVGQPLRFPEHPNVSFAARDLIRGLLVKEPQHRLAYRRGATEIK 511
Query: 341 EHVFFKGVRWDLLTDVLRPPFIP 363
+H FF+ V W L+ PP IP
Sbjct: 512 QHPFFQSVNWALIR-CTSPPQIP 533
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 412 | ||||||
| 255544806 | 440 | serine/threonine protein kinase, putativ | 0.922 | 0.863 | 0.738 | 1e-165 | |
| 359478402 | 400 | PREDICTED: serine/threonine-protein kina | 0.949 | 0.977 | 0.710 | 1e-158 | |
| 147784010 | 400 | hypothetical protein VITISV_023824 [Viti | 0.944 | 0.972 | 0.713 | 1e-158 | |
| 224075780 | 442 | predicted protein [Populus trichocarpa] | 0.917 | 0.855 | 0.701 | 1e-157 | |
| 449448750 | 421 | PREDICTED: serine/threonine-protein kina | 0.902 | 0.883 | 0.699 | 1e-152 | |
| 449503598 | 421 | PREDICTED: serine/threonine-protein kina | 0.902 | 0.883 | 0.699 | 1e-152 | |
| 356541914 | 419 | PREDICTED: serine/threonine-protein kina | 0.956 | 0.940 | 0.667 | 1e-150 | |
| 224053366 | 377 | predicted protein [Populus trichocarpa] | 0.868 | 0.949 | 0.700 | 1e-149 | |
| 357472907 | 408 | Cyclin-dependent kinase-like protein [Me | 0.859 | 0.867 | 0.672 | 1e-141 | |
| 356541183 | 411 | PREDICTED: serine/threonine-protein kina | 0.881 | 0.883 | 0.656 | 1e-139 |
| >gi|255544806|ref|XP_002513464.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223547372|gb|EEF48867.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 586 bits (1511), Expect = e-165, Method: Compositional matrix adjust.
Identities = 291/394 (73%), Positives = 332/394 (84%), Gaps = 14/394 (3%)
Query: 8 QPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAE 67
+P + P L+ DNL+A+K+LGKGAMGTVFLVHDRAADP A+ P+ALKVV+KSTLH K EA+
Sbjct: 28 EPPSLPELNFDNLRAIKVLGKGAMGTVFLVHDRAADPGAKNPYALKVVEKSTLHTKFEAD 87
Query: 68 RRARWEIRVLSRLS----HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFS 123
RRARWEI+VL +LS HPFLP L+ SLET EFLAWAVP+CPGGDLNVLRY+QNDRVFS
Sbjct: 88 RRARWEIQVLKKLSGKNSHPFLPHLISSLETPEFLAWAVPFCPGGDLNVLRYRQNDRVFS 147
Query: 124 PSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEK 183
+V+RFYL+EI+CA++HLH+MGI YRDLKPENIL++QSGHVTLTDFDLSR L K T K
Sbjct: 148 SAVVRFYLAEIVCALQHLHDMGIVYRDLKPENILVQQSGHVTLTDFDLSRTLTKPTV--K 205
Query: 184 QSLNNNKFPVLPVTENPKRHRRILTRWLHALP--ENKTGLKKTKSARVSPVSR-RQQSFD 240
L++ L + + P HRR LTRWL +P K GL+K KSARVSPVSR R+ SF
Sbjct: 206 SILSSC---ALQLQKKPNHHRRNLTRWLPMIPLHNEKNGLRKAKSARVSPVSRTRKLSFS 262
Query: 241 NGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNV 300
NGERSNSFVGTEEYVSPEVVRGDGHEF+VDWWALGILTYEMLYGTTPF+GKNRKETFRN+
Sbjct: 263 NGERSNSFVGTEEYVSPEVVRGDGHEFSVDWWALGILTYEMLYGTTPFKGKNRKETFRNI 322
Query: 301 LMKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPP 360
L K PEFVG+R LTDLI+RLLEKDP KRLGY RGACEIKEHVFFKGVRWDLLT+VLRPP
Sbjct: 323 LYKKPEFVGRRNELTDLIERLLEKDPTKRLGYQRGACEIKEHVFFKGVRWDLLTEVLRPP 382
Query: 361 FIPSREE-NDLTEKAMSGG-GVDIREYFENLRAP 392
FIP+R+E N LTE SG G+DIREYFE+LR P
Sbjct: 383 FIPARDETNSLTETVTSGSDGMDIREYFEDLRVP 416
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359478402|ref|XP_002282983.2| PREDICTED: serine/threonine-protein kinase OXI1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 565 bits (1455), Expect = e-158, Method: Compositional matrix adjust.
Identities = 287/404 (71%), Positives = 331/404 (81%), Gaps = 13/404 (3%)
Query: 10 QTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERR 69
+P L LD+L A+++LGKGAMGTVFLVHDR ADP+A PFALKVVDK + H K +A+RR
Sbjct: 3 NASPELHLDDLPAIQVLGKGAMGTVFLVHDRLADPSALSPFALKVVDKFSHHTKLDADRR 62
Query: 70 ARWEIRVLSRLS---HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSV 126
ARWEI VL RLS HPFLP L+GSLET EFLAWAVP+CPGGDLNVLRY Q DRVFSPSV
Sbjct: 63 ARWEISVLKRLSNPEHPFLPTLIGSLETPEFLAWAVPFCPGGDLNVLRYHQTDRVFSPSV 122
Query: 127 IRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSL 186
IRFY++EIICA+EHLH+MGIAYRDLKPEN+LI+QSGHVTLTDFDLSR+L +T K +
Sbjct: 123 IRFYVAEIICALEHLHSMGIAYRDLKPENVLIQQSGHVTLTDFDLSRSLKPRTV--KTLI 180
Query: 187 NNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSN 246
++ + P E +RHRR LTR L + +K GLKK KSARVSPVSRR+QSF NGERSN
Sbjct: 181 TSDPIELDP-PEIRQRHRRNLTR-LVTIVSDKGGLKKAKSARVSPVSRRKQSFSNGERSN 238
Query: 247 SFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE 306
SFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPF+GKNRKETFRNVLMKTPE
Sbjct: 239 SFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFKGKNRKETFRNVLMKTPE 298
Query: 307 FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSRE 366
F+G+RTALTDLI RLLEKDP KRLGY RGA EIK+HVFF+G++WD LT+VLRPPF+PS +
Sbjct: 299 FIGKRTALTDLIGRLLEKDPTKRLGYNRGASEIKQHVFFRGLQWDKLTEVLRPPFLPSMD 358
Query: 367 ENDLTEKAMSGGGVDIREYFENLRAPPPSMPPSPLPSPSHRSFA 410
+ LTE ++ DIREYF+ + + PS PS S RS +
Sbjct: 359 DELLTEN-ITADEFDIREYFQKTK-----VKPSLTPSTSSRSVS 396
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147784010|emb|CAN67877.1| hypothetical protein VITISV_023824 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 564 bits (1454), Expect = e-158, Method: Compositional matrix adjust.
Identities = 287/402 (71%), Positives = 330/402 (82%), Gaps = 13/402 (3%)
Query: 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRAR 71
+P L LD+L A+++LGKGAMGTVFLVHDR ADP+A PFALKVVDK + H K +A+RRAR
Sbjct: 5 SPELHLDDLPAIQVLGKGAMGTVFLVHDRLADPSALSPFALKVVDKFSHHTKLDADRRAR 64
Query: 72 WEIRVLSRLS---HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIR 128
WEI VL RLS HPFLP L+GSLET EFLAWAVP+CPGGDLNVLRY Q DRVFSPSVIR
Sbjct: 65 WEISVLKRLSNPEHPFLPTLIGSLETPEFLAWAVPFCPGGDLNVLRYHQTDRVFSPSVIR 124
Query: 129 FYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNN 188
FY++EIICA+EHLH+MGIAYRDLKPEN+LI+QSGHVTLTDFDLSR+L +T K + +
Sbjct: 125 FYVAEIICALEHLHSMGIAYRDLKPENVLIQQSGHVTLTDFDLSRSLKPRTV--KTLITS 182
Query: 189 NKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248
+ + P E +RHRR LTR L + +K GLKK KSARVSPVSRR+QSF NGERSNSF
Sbjct: 183 DPIELDP-PEIRQRHRRNLTR-LVTIVSDKGGLKKAKSARVSPVSRRKQSFSNGERSNSF 240
Query: 249 VGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV 308
VGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPF+GKNRKETFRNVLMKTPEF+
Sbjct: 241 VGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFKGKNRKETFRNVLMKTPEFI 300
Query: 309 GQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREEN 368
G+RTALTDLI RLLEKDP KRLGY RGA EIK+HVFF+G++WD LT VLRPPF+PS ++
Sbjct: 301 GKRTALTDLIGRLLEKDPTKRLGYNRGASEIKQHVFFRGLQWDKLTQVLRPPFLPSMDDE 360
Query: 369 DLTEKAMSGGGVDIREYFENLRAPPPSMPPSPLPSPSHRSFA 410
LTE ++ DIREYF+ + + PS PS S RS +
Sbjct: 361 LLTEN-ITADEFDIREYFQKTK-----VKPSLTPSTSSRSVS 396
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224075780|ref|XP_002304764.1| predicted protein [Populus trichocarpa] gi|222842196|gb|EEE79743.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 560 bits (1444), Expect = e-157, Method: Compositional matrix adjust.
Identities = 279/398 (70%), Positives = 326/398 (81%), Gaps = 20/398 (5%)
Query: 10 QTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERR 69
Q L D+++A+K+LGKGAMGTVFLVH++ DPTA+ PFALKVV+KSTLH K +AERR
Sbjct: 29 QHQKDLVFDSIRAIKVLGKGAMGTVFLVHNQETDPTAKNPFALKVVEKSTLHTKFDAERR 88
Query: 70 ARWEIRVLSRLS-----HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSP 124
ARWEI+VL++LS HPFLP L+ S+ET EFLAWAVP+CPGGDLNVLR++QND VFSP
Sbjct: 89 ARWEIQVLNQLSTPKTAHPFLPHLISSVETQEFLAWAVPFCPGGDLNVLRHRQNDHVFSP 148
Query: 125 SVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQ 184
+VIRFYL+EI+CA++HLH MGI +RDLKPENILI+ SGHVTLTDFDLSR L +KT
Sbjct: 149 AVIRFYLAEIVCALDHLHEMGIVFRDLKPENILIQHSGHVTLTDFDLSRTLTRKTV-RNL 207
Query: 185 SLNNNKFPVLPVTEN---------PKRHRRILTRW--LHALPENKTGLKKTKSARVSPVS 233
N +T N ++HRR LTRW ++ + K GLKK KSARVSPVS
Sbjct: 208 ICNAAASGCHLITGNRIEQPQKKQQQQHRRNLTRWWFVNDNQQKKNGLKKAKSARVSPVS 267
Query: 234 RRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNR 293
RR+ SF+NGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGIL+YEMLYGTTPF+GKNR
Sbjct: 268 RRKLSFNNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILSYEMLYGTTPFKGKNR 327
Query: 294 KETFRNVLMKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLL 353
KETFRNVL+K PEFVG+R LTDLI+RLLEKDP +RLGY RGACEIKEH FFKGVRWDLL
Sbjct: 328 KETFRNVLLKKPEFVGKRNDLTDLIERLLEKDPTQRLGYQRGACEIKEHGFFKGVRWDLL 387
Query: 354 TDVLRPPFIPSREENDLTEKAMSGGGVDIREYFENLRA 391
T+VLRPPFIPSRE+ +LT ++ GGVDIR+YFE+LRA
Sbjct: 388 TEVLRPPFIPSREDGELT---VTTGGVDIRKYFEDLRA 422
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449448750|ref|XP_004142128.1| PREDICTED: serine/threonine-protein kinase OXI1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 544 bits (1402), Expect = e-152, Method: Compositional matrix adjust.
Identities = 268/383 (69%), Positives = 310/383 (80%), Gaps = 11/383 (2%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
LDL L+ +K+LGKGAMGTVFLVHDR +D +A PFALKVV+KS+ +K +AERRARWEI
Sbjct: 13 LDLHTLRPIKVLGKGAMGTVFLVHDRISDESAHFPFALKVVEKSSFASKVDAERRARWEI 72
Query: 75 RVLSRLS-----HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRF 129
+VLSRLS HPFLP ++GS E+DEFL WAVPYCPGGDLNVLRY+Q DRVFSP+VIRF
Sbjct: 73 QVLSRLSFPKPPHPFLPDIVGSFESDEFLGWAVPYCPGGDLNVLRYRQLDRVFSPAVIRF 132
Query: 130 YLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNN- 188
YL+EI+CA++HLH+MGI YRDLKPEN+LI+QSGHVTLTDFDLSR L ++T + SL N
Sbjct: 133 YLAEIVCALDHLHSMGIVYRDLKPENVLIQQSGHVTLTDFDLSRTLTRRTVKDVVSLENT 192
Query: 189 -NKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNS 247
++ P + V P R+ LTRW+ A K GLKK KSARVSPVSRR+ SF NGERSNS
Sbjct: 193 GHEKPPIAVRRKPGRN---LTRWIMATSNVKNGLKKAKSARVSPVSRRKSSFTNGERSNS 249
Query: 248 FVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF 307
FVGTEEYVSPEVV+GDGHEFAVDWWALGILTYEMLYGTTPF+GKNRKETFRNVL+K PE
Sbjct: 250 FVGTEEYVSPEVVKGDGHEFAVDWWALGILTYEMLYGTTPFKGKNRKETFRNVLVKAPEL 309
Query: 308 VGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREE 367
+G+R+ LTDLI+RLL KDP KRLGY GACEIKEH FF GV+WDLLT+V RPPF+P REE
Sbjct: 310 IGKRSDLTDLIERLLVKDPTKRLGYAGGACEIKEHAFFNGVKWDLLTEVTRPPFLPQREE 369
Query: 368 NDLTEKAMSGGGVDIREYFENLR 390
+ T G V I EYF R
Sbjct: 370 TEWTGNVQL-GCVSITEYFHKER 391
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449503598|ref|XP_004162082.1| PREDICTED: serine/threonine-protein kinase OXI1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 544 bits (1401), Expect = e-152, Method: Compositional matrix adjust.
Identities = 268/383 (69%), Positives = 310/383 (80%), Gaps = 11/383 (2%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
LDL L+ +K+LGKGAMGTVFLVHDR +D +A PFALKVV+KS+ +K +AERRARWEI
Sbjct: 13 LDLHTLRPIKVLGKGAMGTVFLVHDRISDESAHFPFALKVVEKSSFASKVDAERRARWEI 72
Query: 75 RVLSRLS-----HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRF 129
+VLSRLS HPFLP ++GS E+DEFL WAVPYCPGGDLNVLRY+Q DRVFSP+VIRF
Sbjct: 73 QVLSRLSFPKPPHPFLPDIVGSFESDEFLGWAVPYCPGGDLNVLRYRQLDRVFSPAVIRF 132
Query: 130 YLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNN- 188
YL+EI+CA++HLH+MGI YRDLKPEN+LI+QSGHVTLTDFDLSR L ++T + SL N
Sbjct: 133 YLAEIVCALDHLHSMGIVYRDLKPENVLIQQSGHVTLTDFDLSRTLTRRTVKDVVSLENT 192
Query: 189 -NKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNS 247
++ P + V P R+ LTRW+ A K GLKK KSARVSPVSRR+ SF NGERSNS
Sbjct: 193 GHEKPPIAVRRKPGRN---LTRWIMATSNVKNGLKKAKSARVSPVSRRKSSFTNGERSNS 249
Query: 248 FVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF 307
FVGTEEYVSPEVV+GDGHEFAVDWWALGILTYEMLYGTTPF+GKNRKETFRNVL+K PE
Sbjct: 250 FVGTEEYVSPEVVKGDGHEFAVDWWALGILTYEMLYGTTPFKGKNRKETFRNVLVKAPEL 309
Query: 308 VGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREE 367
+G+R+ LTDLI+RLL KDP KRLGY GACEIKEH FF GV+WDLLT+V RPPF+P REE
Sbjct: 310 IGKRSDLTDLIERLLVKDPTKRLGYAGGACEIKEHAFFNGVKWDLLTEVTRPPFLPQREE 369
Query: 368 NDLTEKAMSGGGVDIREYFENLR 390
+ T G V I EYF R
Sbjct: 370 TEWTGNGQL-GCVSITEYFHKER 391
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356541914|ref|XP_003539417.1| PREDICTED: serine/threonine-protein kinase OXI1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 538 bits (1387), Expect = e-150, Method: Compositional matrix adjust.
Identities = 277/415 (66%), Positives = 328/415 (79%), Gaps = 21/415 (5%)
Query: 3 ATPPPQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHA 62
PPP + LDLD+LK LK+LGKG MGTVFLV +AA+ T FALKVVDK+ +HA
Sbjct: 6 TAPPPWQE----LDLDSLKPLKVLGKGGMGTVFLV--QAANNTR---FALKVVDKTCVHA 56
Query: 63 KHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVF 122
K +AERRARWEI+VLS LSHPFLP L+G+ E+ +FLAWA+PYCPGGDLNVLRY+Q DR F
Sbjct: 57 KLDAERRARWEIQVLSTLSHPFLPSLMGTFESPQFLAWALPYCPGGDLNVLRYRQTDRAF 116
Query: 123 SPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFE 182
SP+VIRFY++EI+CA++HLH+MGIAYRDLKPEN+L++ +GH+TLTDFDLSR L K
Sbjct: 117 SPAVIRFYVAEILCALDHLHSMGIAYRDLKPENVLVQNTGHITLTDFDLSRKLNPKPKPN 176
Query: 183 KQSLNNNKFPVLPVTENPKRHRRILTRWLHALP-------ENKTGLKKTKSARVSPVSRR 235
Q + + P V E ++HRR +RW+ P NK GLKK KSARVSPVSRR
Sbjct: 177 PQ-VPSIPLPNSNVPEPRRKHRRNFSRWISLFPPDGTHHNNNKNGLKKAKSARVSPVSRR 235
Query: 236 QQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKE 295
+ SF NGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGIL YEMLYGTTPF+GKNRKE
Sbjct: 236 KPSFSNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILIYEMLYGTTPFKGKNRKE 295
Query: 296 TFRNVLMKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTD 355
TFRNV+ K P FVG+RTALTDLI++LLEKDP KRLGY RGA EIKEH FF+GVRW+LLT+
Sbjct: 296 TFRNVITKPPVFVGKRTALTDLIEKLLEKDPTKRLGYTRGAVEIKEHEFFRGVRWELLTE 355
Query: 356 VLRPPFIPSREE--NDLTEKAMS-GGGVDIREYFENLRAPPPSMPPSPLPSPSHR 407
V+RPPFIP+R++ D T++ G DIR YF NL++ PS+P SPLPSPS R
Sbjct: 356 VVRPPFIPTRDDGAGDSTDRISDRNCGFDIRGYFLNLKS-SPSLPGSPLPSPSCR 409
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224053366|ref|XP_002297784.1| predicted protein [Populus trichocarpa] gi|222845042|gb|EEE82589.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 533 bits (1373), Expect = e-149, Method: Compositional matrix adjust.
Identities = 262/374 (70%), Positives = 306/374 (81%), Gaps = 16/374 (4%)
Query: 10 QTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERR 69
Q LD D+++A+K+LGKGAMGTVFLVH++ D TA+ FALKVV+KSTLH K +AERR
Sbjct: 3 QHQKDLDFDSIRAIKVLGKGAMGTVFLVHNQETDSTAKNRFALKVVEKSTLHTKFDAERR 62
Query: 70 ARWEIRVLSRLS-----HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSP 124
ARWEI+VL++LS HPFLP L+ S+ET EFLAW+VP+CPGGDLNVLR++QND VFSP
Sbjct: 63 ARWEIQVLNQLSTPKTTHPFLPNLISSIETQEFLAWSVPFCPGGDLNVLRHRQNDHVFSP 122
Query: 125 SVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFE-- 182
+VIRFYL+EI+CA++HLH MGI YRDLKPENILI+ SGHVTLTDFDLSR L +KT
Sbjct: 123 AVIRFYLAEIVCALDHLHQMGIVYRDLKPENILIQHSGHVTLTDFDLSRTLTRKTVRNLV 182
Query: 183 ---KQSLNN----NKFPVLPVTENPKRHRRILTRW--LHALPENKTGLKKTKSARVSPVS 233
S NN ++ P + + H R LTRW ++ + K GLKK KSARVSPVS
Sbjct: 183 PNAAASCNNLITVSEIEQQPQKKQQQHHIRNLTRWWFVNDVQHKKNGLKKAKSARVSPVS 242
Query: 234 RRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNR 293
RR+ SF+NGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGIL++EMLYGTTPF GKNR
Sbjct: 243 RRKLSFNNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILSFEMLYGTTPFVGKNR 302
Query: 294 KETFRNVLMKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLL 353
KETFRNVL K PEF+G+R LTDLI+RLLEKDP +RLGY RGACEIKEHVFFKGVRWDLL
Sbjct: 303 KETFRNVLAKKPEFIGKRNELTDLIERLLEKDPTQRLGYQRGACEIKEHVFFKGVRWDLL 362
Query: 354 TDVLRPPFIPSREE 367
T+VLRPPFIPSR++
Sbjct: 363 TEVLRPPFIPSRDD 376
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357472907|ref|XP_003606738.1| Cyclin-dependent kinase-like protein [Medicago truncatula] gi|355507793|gb|AES88935.1| Cyclin-dependent kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 508 bits (1309), Expect = e-141, Method: Compositional matrix adjust.
Identities = 255/379 (67%), Positives = 306/379 (80%), Gaps = 25/379 (6%)
Query: 31 MGTVFLVHD--RAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKL 88
MGTVFLVH+ T FALKVVDK+++HAK +AERRARWEI+VLS LSHPFLP +
Sbjct: 1 MGTVFLVHNPTTTTTTTNTTLFALKVVDKTSIHAKLDAERRARWEIQVLSTLSHPFLPSI 60
Query: 89 LGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAY 148
LG+ E+ +FLAWA+PYCPGGDLNVLRY+QNDRVFSPSV+RFYL+EI+CA++HLH+MGI Y
Sbjct: 61 LGTYESPQFLAWALPYCPGGDLNVLRYRQNDRVFSPSVVRFYLAEILCALDHLHSMGIVY 120
Query: 149 RDLKPENILIRQSGHVTLTDFDLSRNLVKKT-----AFEKQSLNNNKFPVLPVTENPKRH 203
RDLKPEN+LI+ SGHVTLTDFDLSR L +T A L ++KFP E+ ++H
Sbjct: 121 RDLKPENVLIQHSGHVTLTDFDLSRKLNPRTFKTVVATPPPPLPDSKFP-----ESSRKH 175
Query: 204 RRILTRWLHALPENKT---------GLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254
RR +RW+ LP + LKK KSARVSPVSRR+ SF NGERSNSFVGTEEY
Sbjct: 176 RRNFSRWIPLLPTESSHNHNRLHALNLKKAKSARVSPVSRRKLSFSNGERSNSFVGTEEY 235
Query: 255 VSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVGQRTAL 314
VSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPF+GKNRKETF+NVLMK+PEFVG+RT L
Sbjct: 236 VSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFKGKNRKETFKNVLMKSPEFVGKRTEL 295
Query: 315 TDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREEND---LT 371
TDLI++LLEKDP KRLGY RGA EIKEH FF+GVRW++LT+V+RPPF+P+R ++ +
Sbjct: 296 TDLIEKLLEKDPKKRLGYSRGAVEIKEHAFFRGVRWEILTEVIRPPFLPARYDDAGEFSS 355
Query: 372 EKAMSG-GGVDIREYFENL 389
EK +G GGVDI++YF+ +
Sbjct: 356 EKLSNGTGGVDIKDYFQRM 374
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356541183|ref|XP_003539060.1| PREDICTED: serine/threonine-protein kinase OXI1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 502 bits (1292), Expect = e-139, Method: Compositional matrix adjust.
Identities = 250/381 (65%), Positives = 304/381 (79%), Gaps = 18/381 (4%)
Query: 25 ILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPF 84
+LGKGAMGTVFLV D T PFALKVVDK+ +HAK +AERRARWEI+VLS LSHPF
Sbjct: 24 VLGKGAMGTVFLVQD-----TTNTPFALKVVDKTCVHAKLDAERRARWEIQVLSTLSHPF 78
Query: 85 LPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNM 144
LP L+G+LE+ +FLAWA+PYCPGGDLN LRY+Q DR FSP+VIRFY++EI+CA++HLH+M
Sbjct: 79 LPSLMGTLESPQFLAWALPYCPGGDLNFLRYRQTDRSFSPAVIRFYVAEILCALDHLHSM 138
Query: 145 GIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENP---K 201
GIAYRDLKPEN+L++ +GHVTLTDFDLSR L K + P LP + P +
Sbjct: 139 GIAYRDLKPENVLVQNTGHVTLTDFDLSRKLNPKPKPNPNPVIVPSIP-LPNSNVPQPRR 197
Query: 202 RHRRILTRWLHALPENKTGLKKTK------SARVSPVSRRQQSFDNGERSNSFVGTEEYV 255
+HRR L+RW+ P + T SA+VSPVSRR+ SF +GERSNSFVGTEEYV
Sbjct: 198 KHRRNLSRWISFFPPDGTNNNNKNGLKKAKSAQVSPVSRRKPSFSSGERSNSFVGTEEYV 257
Query: 256 SPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVGQRTALT 315
SPEVVRGDGHEFAVDWWALGIL YEMLYG TPF+G+NRKETFRNV+MK PEFVG+RTALT
Sbjct: 258 SPEVVRGDGHEFAVDWWALGILIYEMLYGKTPFKGRNRKETFRNVIMKPPEFVGKRTALT 317
Query: 316 DLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREE--NDLTEK 373
+LI+RLLEKDP KRLGY RGA EIKEH FF+GV+W+LLT+V+RPPFIPS ++ ++TE+
Sbjct: 318 NLIERLLEKDPTKRLGYTRGAAEIKEHEFFRGVQWELLTEVVRPPFIPSGDDGAGEMTER 377
Query: 374 -AMSGGGVDIREYFENLRAPP 393
+ GV+IR+YF+NL++ P
Sbjct: 378 FSDRNCGVNIRDYFQNLKSSP 398
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 412 | ||||||
| TAIR|locus:2008331 | 404 | UCN "UNICORN" [Arabidopsis tha | 0.885 | 0.903 | 0.633 | 4.3e-125 | |
| TAIR|locus:2091881 | 408 | UCNL "UNICORN-like" [Arabidops | 0.873 | 0.882 | 0.641 | 1.7e-123 | |
| TAIR|locus:2090310 | 421 | AGC2-1 [Arabidopsis thaliana ( | 0.810 | 0.793 | 0.465 | 8.7e-79 | |
| TAIR|locus:2123191 | 372 | AT4G13000 [Arabidopsis thalian | 0.735 | 0.814 | 0.469 | 5.7e-75 | |
| TAIR|locus:2087785 | 577 | AGC1.5 "AGC kinase 1.5" [Arabi | 0.825 | 0.589 | 0.426 | 3.1e-67 | |
| TAIR|locus:2098120 | 451 | AT3G44610 [Arabidopsis thalian | 0.844 | 0.771 | 0.421 | 4e-67 | |
| TAIR|locus:2055017 | 765 | AT2G44830 [Arabidopsis thalian | 0.868 | 0.467 | 0.414 | 9.4e-66 | |
| TAIR|locus:2160922 | 586 | D6PKL2 "D6 protein kinase like | 0.839 | 0.590 | 0.405 | 8.5e-65 | |
| UNIPROTKB|Q5I6E9 | 700 | Adi3 "AvrPto-dependent Pto-int | 0.856 | 0.504 | 0.409 | 3.7e-64 | |
| TAIR|locus:2049485 | 949 | AT2G36350 [Arabidopsis thalian | 0.871 | 0.378 | 0.408 | 5.3e-64 |
| TAIR|locus:2008331 UCN "UNICORN" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1229 (437.7 bits), Expect = 4.3e-125, P = 4.3e-125
Identities = 242/382 (63%), Positives = 297/382 (77%)
Query: 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWE 73
+L+LD LK LK+LGKGA GTVFLVHD +D + PFALK+VDKS+ + RRARWE
Sbjct: 16 NLNLDRLKVLKLLGKGATGTVFLVHDSVSDSSVSSPFALKLVDKSSASSL----RRARWE 71
Query: 74 IRVLSRLS-----HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIR 128
I++L RLS +PFLPKLL S E+ EF+AWA+PYC GGDLNVLR +QND VFS SVI+
Sbjct: 72 IQILRRLSDDTNPNPFLPKLLASSESSEFIAWALPYCSGGDLNVLRQRQNDGVFSSSVIK 131
Query: 129 FYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNN 188
FYL+EI+CA++HLH MGIAYRDLKPENIL+++SGHVTLTDFDLS +L K T E L++
Sbjct: 132 FYLAEIVCALDHLHTMGIAYRDLKPENILLQESGHVTLTDFDLSCSLNKPTRPEFYHLSD 191
Query: 189 NKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248
+ P P E+ H + + L + K KKTKSARV+P++RR+ SF GERSNSF
Sbjct: 192 PE-PD-PNPESNLSHNK---KSLRIFRQKK---KKTKSARVNPITRRRLSFSGGERSNSF 243
Query: 249 VGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV 308
VGT+EY+SPEV+RGDGH+FAVDWWALG+LTYEM+YG TPF+G+N+KETFRNVL+K PEF
Sbjct: 244 VGTDEYISPEVIRGDGHDFAVDWWALGVLTYEMMYGETPFKGRNKKETFRNVLVKEPEFA 303
Query: 309 GQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREEN 368
G+ + LTDLI+RLL KDP KR G+ RGA EIKEH FFKGVRW+LLT+VLRPPFIP R++
Sbjct: 304 GKPSDLTDLIRRLLVKDPTKRFGFWRGAAEIKEHAFFKGVRWELLTEVLRPPFIPLRDDG 363
Query: 369 DLTEKAMSGGGVDIREYFENLR 390
DLT K G I+EYFE L+
Sbjct: 364 DLTGKVTEESGFGIKEYFEKLK 385
|
|
| TAIR|locus:2091881 UCNL "UNICORN-like" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1214 (432.4 bits), Expect = 1.7e-123, P = 1.7e-123
Identities = 245/382 (64%), Positives = 295/382 (77%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
LDLD++KALKILGKGA GTVFL HD + ++ PFA+K+V KS+ + RRARWEI
Sbjct: 16 LDLDSIKALKILGKGATGTVFLAHDVVSTSSSSSPFAVKLVPKSSASSL----RRARWEI 71
Query: 75 RVLSRLS-----HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRF 129
VL RLS +PFLP+LL S E+ E+ AWAVPYC GGDLNVL ++QND VFS SVIRF
Sbjct: 72 EVLRRLSVDSNQNPFLPRLLASFESPEYFAWAVPYCSGGDLNVLLHRQNDGVFSSSVIRF 131
Query: 130 YLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNN 189
Y++EI+CA+EHLH MGIAYRDLKPENILI+QSGHVTLTDFDLSR+L K+ L +
Sbjct: 132 YVAEIVCALEHLHTMGIAYRDLKPENILIQQSGHVTLTDFDLSRSL-------KKPLRPH 184
Query: 190 KFPVLPVTENPKRHRRILTRWLHALPE-NKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248
+ P ++ R +R + E NKTGLKKT+SARV+P++RR+ SF +GERSNSF
Sbjct: 185 FYQPDPELIIDRKKSRSFSRLISPTAEKNKTGLKKTRSARVNPINRRKTSFSSGERSNSF 244
Query: 249 VGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV 308
VGT+EYVSPEV+RGDGH+FAVDWWALG+LTYEM+YG TPF+GK++KETFRNVLMK PEF
Sbjct: 245 VGTDEYVSPEVIRGDGHDFAVDWWALGVLTYEMMYGETPFKGKSKKETFRNVLMKEPEFA 304
Query: 309 GQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREEN 368
G+ LTDLI+RLL KDP +RLG RGA EIKE FF GVRWDLLT+VLRPPFIP R++
Sbjct: 305 GKPNDLTDLIRRLLVKDPNRRLGCHRGAAEIKELAFFAGVRWDLLTEVLRPPFIPLRDDG 364
Query: 369 DLTEKAMSGGGVDIREYFENLR 390
+LT GG DIRE+FE LR
Sbjct: 365 ELTV-----GGFDIREHFEKLR 381
|
|
| TAIR|locus:2090310 AGC2-1 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 792 (283.9 bits), Expect = 8.7e-79, P = 8.7e-79
Identities = 168/361 (46%), Positives = 230/361 (63%)
Query: 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAK---HEAE--- 67
+LD + L+ L +LG+GA G VFLV D A ALKV+ K + K E+E
Sbjct: 11 ALDFNRLEVLSLLGRGAKGVVFLVRDDDAKL-----LALKVILKEAIEKKKKGRESEDDE 65
Query: 68 -RRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSV 126
+R +E VLSR HP P L G L TD+ + +A+ YCPG +LN LR Q++ +FS +
Sbjct: 66 YKRVSFEQGVLSRFDHPLFPSLHGVLATDKVIGYAIDYCPGQNLNSLRKMQSESMFSDEI 125
Query: 127 IRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSL 186
IRFY +E++ A+++LHN GI YRDLKP+N++I+++GH+ L DFDLS NL +T SL
Sbjct: 126 IRFYAAELVLALDYLHNQGIVYRDLKPDNVMIQENGHLMLIDFDLSTNLAPRTPQPSPSL 185
Query: 187 NNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSN 246
+ P + KR +R+ R+ +G+ +S V S S +GE+SN
Sbjct: 186 SKPS-PTM------KRKKRLF-RFTSFC---NSGISPQESISVHSSSTLAVSDSSGEKSN 234
Query: 247 SFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE 306
SFVGTEEYV+PEV+ GDGH+FAVDWW+LG++ YEMLYG TPFRG NRKETF +L K P
Sbjct: 235 SFVGTEEYVAPEVISGDGHDFAVDWWSLGVVLYEMLYGATPFRGSNRKETFYRILSKPPN 294
Query: 307 FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSRE 366
G+ T+L DLI+RLLEKDP +R+ EIK H FF+GV W+ + V RPP+IP+ +
Sbjct: 295 LTGETTSLRDLIRRLLEKDPSRRINVE----EIKGHDFFRGVDWEKVILVSRPPYIPAPD 350
Query: 367 E 367
+
Sbjct: 351 D 351
|
|
| TAIR|locus:2123191 AT4G13000 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 756 (271.2 bits), Expect = 5.7e-75, P = 5.7e-75
Identities = 152/324 (46%), Positives = 218/324 (67%)
Query: 51 ALKVVDKSTLHAKHEAE--RRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGG 108
ALKV+ + ++ +K + +R +E VLSR HP P+L G + TD+ + +A+ YCPG
Sbjct: 45 ALKVILRESIESKKAKDEYKRISFEQGVLSRFDHPLFPRLHGVISTDKVIGYAIDYCPGR 104
Query: 109 DLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTD 168
DLN LR KQ++ +FS +IRFY +E++ A+E+LHN GI YRDLKP+N++I+++GH+ L D
Sbjct: 105 DLNSLRKKQSEEMFSDEIIRFYAAELVIALEYLHNQGIVYRDLKPDNVMIQENGHLMLVD 164
Query: 169 FDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSAR 228
FDLS NL +T + S +++ P L K+ R I +GL + +
Sbjct: 165 FDLSTNLPPRTP--QSSFSSS--PRLSTAT--KKERSIFAF---------SGLCNSGISP 209
Query: 229 VSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPF 288
VSR +S +GE+SNSFVGTEEYV+PEV+ G GH+FAVDWW+LG++ YEMLYG TPF
Sbjct: 210 DDSVSRSSESEFSGEKSNSFVGTEEYVAPEVITGSGHDFAVDWWSLGVVLYEMLYGATPF 269
Query: 289 RGKNRKETFRNVLMKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGV 348
RG NRKETF +L + P VG+ T+L DL+++LLEKDP +R+ + G IK H FFKG+
Sbjct: 270 RGSNRKETFLKILTEPPSLVGETTSLRDLVRKLLEKDPSRRIN-VEG---IKGHDFFKGL 325
Query: 349 RWDLLTDVLRPPFIPSREENDLTE 372
WDL+ V RPP+IP+ E ++++
Sbjct: 326 DWDLVLKVSRPPYIPAPENYEISK 349
|
|
| TAIR|locus:2087785 AGC1.5 "AGC kinase 1.5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 683 (245.5 bits), Expect = 3.1e-67, P = 3.1e-67
Identities = 152/356 (42%), Positives = 213/356 (59%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
+ LDN + LK LG G +G+V+L R + FA+KV+DK++L ++++ RA+ E
Sbjct: 180 IGLDNFRLLKRLGYGDIGSVYLADLRGTNAV----FAMKVMDKASLASRNKL-LRAQTER 234
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEI 134
+LS L HPFLP L ETD+F + +C GG+L+ LR KQ R F+ RFY SE+
Sbjct: 235 EILSLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQPSRRFTEEAARFYASEV 294
Query: 135 ICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS-RNLVKKTAFEKQSLNNNKFPV 193
+ A+E+LH +G+ YRDLKPENIL+R GH+ L+DFDLS R T + S+ + +
Sbjct: 295 LLALEYLHMLGVVYRDLKPENILVRDEGHIMLSDFDLSLRCTFNPTLVKSSSVCSGGGAI 354
Query: 194 L--PVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGE-RSNSFVG 250
L N H L LP KT K+ S + +S + + + RS SFVG
Sbjct: 355 LNEEFAVNGCMHPSAFLPRL--LPSKKTRKAKSDSG-LGGLSMPELMAEPTDVRSMSFVG 411
Query: 251 TEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL---MKTPEF 307
T EY++PE++RG+GH AVDWW GI YE+L+GTTPF+G+ + T NV+ +K P+
Sbjct: 412 THEYLAPEIIRGEGHGSAVDWWTFGIFLYELLHGTTPFKGQGNRATLHNVVGQPLKFPDT 471
Query: 308 VGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIP 363
+A DLI+ LL KDP +R+ Y RGA EIK+H FF+GV W L+ PP IP
Sbjct: 472 PHVSSAARDLIRGLLVKDPHRRIAYTRGATEIKQHPFFEGVNWALVRSAA-PPHIP 526
|
|
| TAIR|locus:2098120 AT3G44610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 682 (245.1 bits), Expect = 4.0e-67, P = 4.0e-67
Identities = 156/370 (42%), Positives = 210/370 (56%)
Query: 14 SLDLDNLKALKILGKGAMGTVFLVHDRA----ADPTA-RCPF-ALKVVDKSTLHAKHEAE 67
SL L +L+ LG G +G+VFL ++ + TA + P A KV+DK L A E
Sbjct: 63 SLSLSDLRFRLRLGSGDIGSVFLAEFKSLTAVTETTAVKLPLLAAKVMDKKEL-ASRSKE 121
Query: 68 RRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVI 127
RA+ E +L L HPFLP L ++++ ++L +CPGGDL+VLR KQ + F S +
Sbjct: 122 GRAKTEREILESLDHPFLPTLYAAIDSPKWLCLLTEFCPGGDLHVLRQKQTHKRFHESAV 181
Query: 128 RFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLN 187
RFY+SE+I AIE+LH +GI YRDLKPEN+L+R GH+ LTDFDLS + T+ + LN
Sbjct: 182 RFYVSEVIVAIEYLHMLGIVYRDLKPENVLVRSDGHIMLTDFDLSLKCDESTSTPQIVLN 241
Query: 188 NNKFP--VLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGE-- 243
N P EN R T +P R+ ++ +NG
Sbjct: 242 RNNLPNGSSDQNENQGMDHRQTTSSSCMIPNCIVPAVSCFHPRIRRRKKKTDHRNNGPEL 301
Query: 244 -------RSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKET 296
RS SFVGT EY++PE+V G+GH AVDWW LGI +E+ YGTTPF+G + + T
Sbjct: 302 VAEPVDVRSMSFVGTHEYLAPEIVSGEGHGSAVDWWTLGIFMFELFYGTTPFKGMDHELT 361
Query: 297 FRNVLMKTPEFVGQRT---ALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLL 353
N++ + EF + T A DLI +LL KDP +RLG GA +K H FF+GV W LL
Sbjct: 362 LANIVARALEFPKEPTIPSAAKDLISQLLAKDPSRRLGSSLGATAVKRHPFFQGVNWALL 421
Query: 354 TDVLRPPFIP 363
RPPF+P
Sbjct: 422 M-CTRPPFLP 430
|
|
| TAIR|locus:2055017 AT2G44830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 669 (240.6 bits), Expect = 9.4e-66, P = 9.4e-66
Identities = 158/381 (41%), Positives = 212/381 (55%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
L + + K LK LG G +G+V+L A RC FA+KV+DK++L + + R A+ E
Sbjct: 358 LGMSHFKLLKRLGCGDIGSVYL----AELSGTRCHFAVKVMDKASLEDRKKLNR-AQTER 412
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEI 134
+L L HPFLP L ETD F + YCPGGDL+ LR +Q + FS RFY +E+
Sbjct: 413 DILQLLDHPFLPTLYTHFETDRFSCLVMEYCPGGDLHTLRQRQPGKHFSEYAARFYAAEV 472
Query: 135 ICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS-RNLVKKT---AFEKQSLNNNK 190
+ A+E+LH +G+ YRDLKPEN+L+R GH+ L+DFDLS R V T F+
Sbjct: 473 LLALEYLHMLGVVYRDLKPENVLVRDDGHIMLSDFDLSLRCAVSPTLIKTFDSDPSRRGA 532
Query: 191 FPVLPVTENPKRHRRI-----LTRWLHALPENKTGLKKTKSA--RVSPVSRRQQSFDNGE 243
F V P P I L R + K +KT++ + S + +
Sbjct: 533 FCVQPACMEPTSACIIQPSCFLPRSIFPNKNKKNKSRKTQADFFKSHSGSLPELVAEPNT 592
Query: 244 RSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL-- 301
RS SFVGT EY++PE+++G+GH AVDWW GI +E+LYG TPF+G + T NV+
Sbjct: 593 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFVHELLYGKTPFKGSGNRATLFNVVGE 652
Query: 302 -MKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPP 360
+K PE A DLIQ LL KDP RLG RGA EIK+H FF+GV W L+ PP
Sbjct: 653 QLKFPESPATSYAGRDLIQALLVKDPKNRLGTKRGATEIKQHPFFEGVNWALIR-CSTPP 711
Query: 361 FIPSREENDLTEKAMSGGGVD 381
+P + E TE G +D
Sbjct: 712 EVPRQME---TEPPPKYGPID 729
|
|
| TAIR|locus:2160922 D6PKL2 "D6 protein kinase like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 660 (237.4 bits), Expect = 8.5e-65, P = 8.5e-65
Identities = 150/370 (40%), Positives = 211/370 (57%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
L L + + LK LG G +G+V+L +C FA+KV+DK++L A + RA+ E
Sbjct: 186 LGLSHFRLLKRLGCGDIGSVYLSELSGT----KCYFAMKVMDKTSL-ASRKKLLRAQTER 240
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEI 134
+L L HPFLP L ET++F + +CPGGDL+ LR +Q + FS ++FY++E
Sbjct: 241 EILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQRQPGKHFSEQAVKFYIAES 300
Query: 135 ICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN------LVKKTAFEKQSLNN 188
+ A+E+LH +GI YRDLKPEN+L+R+ GH+ L+DFDLS LVK A E L
Sbjct: 301 LLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCLVSPTLVKSAAIESDPLRK 360
Query: 189 NKFPVLPVTENPKRHRRILT-------RWLHALPENKTGLKKTKSA-RVSPVSRRQQSFD 240
N + V P P + T L + K K +A +V P+
Sbjct: 361 NVYCVQPACIEPSCIQPSCTVPTTCFSPRLFSSKSKKDRKPKNDTANQVRPLPELVAE-P 419
Query: 241 NGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNV 300
RS SFVGT EY++PE+++G+GH AVDWW GI YE+L+G TPF+G ++T NV
Sbjct: 420 TDARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGRTPFKGSGNRQTLFNV 479
Query: 301 L---MKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVL 357
+ ++ PE A DLI+ LL K+P +RLG+ RGA E+K+H FF+GV W L+
Sbjct: 480 VGQPLRFPETPVVSFAARDLIRGLLMKEPQQRLGFKRGATEVKQHPFFEGVNWALIR-CA 538
Query: 358 RPPFIPSREE 367
PP IP E
Sbjct: 539 TPPEIPKPVE 548
|
|
| UNIPROTKB|Q5I6E9 Adi3 "AvrPto-dependent Pto-interacting protein 3" [Solanum lycopersicum (taxid:4081)] | Back alignment and assigned GO terms |
|---|
Score = 654 (235.3 bits), Expect = 3.7e-64, P = 3.7e-64
Identities = 152/371 (40%), Positives = 205/371 (55%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
L + + K LK LG G +G+V+L RC FA+KV+DK++L A + RA+ E
Sbjct: 303 LGMSHFKLLKRLGCGDIGSVYLSELSGT----RCYFAMKVMDKASL-ASRKKLTRAQTER 357
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEI 134
+L L HPFLP L ETD F + YCPGGDL+ LR +Q + FS RFY +E+
Sbjct: 358 EILQLLDHPFLPTLYTHFETDRFSCLVMEYCPGGDLHTLRQRQPGKHFSEYAARFYAAEV 417
Query: 135 ICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS-RNLVKKTAFEKQSLNNNK--- 190
+ A+E+LH +G+ YRDLKPEN+L+R GH+ L+DFDLS R V T S + +K
Sbjct: 418 LLALEYLHMLGVVYRDLKPENVLVRDDGHIMLSDFDLSLRCAVSPTLIRISSDDPSKRGA 477
Query: 191 -FPVLPVTENPK----RHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERS 245
F V P P + L R + KT + S + + RS
Sbjct: 478 AFCVQPACIEPTTVCMQPACFLPRLFPQKSKKKTPKPRADSGFQANSMPELVAEPTSARS 537
Query: 246 NSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL---M 302
SFVGT EY++PE+++G+GH AVDWW GI +E+LYG TPF+G + T NV+ +
Sbjct: 538 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLHELLYGKTPFKGSGNRATLFNVVGQQL 597
Query: 303 KTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFI 362
K P+ A DLI+ LL K+P RLG RGA EIK+H FF+GV W L+ PP +
Sbjct: 598 KFPDSPATSYASRDLIRGLLVKEPQNRLGVKRGATEIKQHPFFEGVNWALIR-CSTPPEV 656
Query: 363 PSREENDLTEK 373
P E D K
Sbjct: 657 PRPVEPDYPAK 667
|
|
| TAIR|locus:2049485 AT2G36350 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 655 (235.6 bits), Expect = 5.3e-64, P = 5.3e-64
Identities = 157/384 (40%), Positives = 214/384 (55%)
Query: 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWE 73
SL L + LK LG G +GTV+L A C FA+KV+D L A+ + RA+ E
Sbjct: 553 SLGLRHFNLLKKLGCGDIGTVYL----AELVGTNCLFAIKVMDNEFL-ARRKKTPRAQAE 607
Query: 74 IRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSE 133
+L L HPFLP L +D + YCPGGDL+VLR KQ R FS RFY++E
Sbjct: 608 RAILKMLDHPFLPTLYAQFTSDNLSCLVMEYCPGGDLHVLRQKQLSRCFSEPATRFYVAE 667
Query: 134 IICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN------LVKKTAFEKQSLN 187
I+ A+E+LH +G+ YRDLKPENIL+R+ GH+ LTDFDLS L++ T+ ++
Sbjct: 668 ILLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCAVNPTLLRSTSPPEKDPA 727
Query: 188 NNKFP------VLPVTENPK-RHRRILTRWLHALPENKTGLKKTKSARVSPVSRR--QQS 238
P + P+ P R R L N+ K + ++ R Q
Sbjct: 728 RMSGPYSTSNCIQPLCIEPSCRVPCFSPRLLSTQARNQKPRKPKRPDLLTQQFRSLPQLV 787
Query: 239 FDNGE-RSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETF 297
+ E RSNSFVGT EY++PE+++G+GH AVDWW G+L YE+LYG TPF+G + +ET
Sbjct: 788 AEPTEARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGVLLYELLYGKTPFKGYDNEETL 847
Query: 298 RNVL---MKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLT 354
NV+ +K P+ +LI+RLL KDP RLG +GA EIK H FF+G+ W L+
Sbjct: 848 SNVVYQNLKFPDSPLVSFQAKELIRRLLVKDPESRLGSEKGAAEIKRHPFFEGLNWALIR 907
Query: 355 DVLRPPFIPSREENDLTEKAMSGG 378
+ PP +P +N TE G
Sbjct: 908 CAI-PPELPDIYDNGATEATSPEG 930
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 412 | |||
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-144 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-68 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-67 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-66 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-56 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-52 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-48 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-46 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-45 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-45 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-40 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-40 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-39 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-38 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-37 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-36 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-35 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-35 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-35 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-34 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-34 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-33 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-31 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-30 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-29 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-29 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-29 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-29 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-29 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-28 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-28 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-28 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-28 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-28 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-27 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-27 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-27 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-27 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-27 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-27 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-27 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-26 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-26 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-26 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-26 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-26 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-26 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-25 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-25 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-25 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-25 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-25 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-25 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-25 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-24 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-24 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-24 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-24 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-24 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-24 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-24 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-23 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-23 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-23 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-22 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-22 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-22 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-22 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-22 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 7e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-22 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-22 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-21 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-21 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-21 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-21 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-20 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-20 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-20 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-20 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-20 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-20 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-20 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-20 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-20 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-20 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-20 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-20 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-20 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-20 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-19 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-19 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-19 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-19 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-19 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-19 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-18 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-18 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-18 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-18 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-18 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-18 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-17 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-17 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-17 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-17 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-17 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-17 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-17 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-17 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-17 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-17 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-16 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-16 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-16 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-16 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-16 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-16 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-16 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-15 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-15 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-15 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-15 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-15 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-15 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-15 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-14 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-14 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-14 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-14 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 9e-14 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-13 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-13 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-12 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-11 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-10 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-10 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-10 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-09 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-09 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-09 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-09 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-09 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-09 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-09 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-09 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-09 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-09 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-08 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-08 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-08 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-08 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-08 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-08 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-08 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-07 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-07 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-07 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-07 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-07 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-07 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-07 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-06 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-06 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-06 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-06 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-06 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-06 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-06 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-06 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-06 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-06 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-06 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-06 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-06 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-06 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-06 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-06 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-06 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-06 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-06 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-06 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-06 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-05 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-05 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-05 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-05 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-05 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-05 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-05 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-05 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-05 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-05 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-05 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-05 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-05 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-05 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-05 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-05 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-05 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-05 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-05 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 7e-05 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-05 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-05 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-05 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-04 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-04 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-04 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-04 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-04 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-04 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-04 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-04 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-04 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-04 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-04 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-04 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-04 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-04 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-04 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-04 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-04 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-04 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-04 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-04 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-04 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-04 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-04 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-04 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-04 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-04 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-04 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-04 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-04 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-04 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-04 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-04 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 0.001 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 0.001 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 0.001 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 0.001 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 0.001 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 0.001 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 0.001 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 0.001 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 0.001 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 0.002 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 0.002 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 0.002 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.002 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 0.002 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 0.002 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 0.003 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 0.003 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 0.004 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 411 bits (1058), Expect = e-144
Identities = 150/355 (42%), Positives = 204/355 (57%), Gaps = 43/355 (12%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVL 77
+ K +K+LGKG +G VFLV + FALKV+DK + +++ +R E +L
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGK----LFALKVLDKKEMIKRNKV-KRVLTEQEIL 55
Query: 78 SRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICA 137
+ L HPFLP L S +T+ +L + YCPGG+L L +Q + S V RFY +E++ A
Sbjct: 56 ATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA 115
Query: 138 IEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVT 197
+E+LH +GI YRDLKPENIL+ +SGH+ L+DFDLS+ + ++L
Sbjct: 116 LEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKAL----------- 164
Query: 198 ENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257
K ++ + V+ + S + RSNSFVGTEEY++P
Sbjct: 165 -----------------------RKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAP 201
Query: 258 EVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF---VGQRTAL 314
EV+ GDGH AVDWW LGIL YEMLYGTTPF+G NR ETF N+L K F ++
Sbjct: 202 EVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSA 261
Query: 315 TDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREEND 369
DLI++LL KDP KRLG RGA EIK+H FF+GV W L+ PP IP ++
Sbjct: 262 RDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHT-TPPIIPRPDDGI 315
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 220 bits (563), Expect = 1e-68
Identities = 114/349 (32%), Positives = 173/349 (49%), Gaps = 57/349 (16%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAK-HEAERRARWEIRVLSRLS 81
+K++G+GA G V+LV D+ +A+KV+ KS + + A RA E +L+
Sbjct: 6 IKVIGRGAFGEVWLVRDKDT----GQVYAMKVLRKSDMIKRNQIAHVRA--ERDILADAD 59
Query: 82 HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHL 141
P++ KL S + +E L + Y PGGDL L +++ VF RFY++E++ A++ +
Sbjct: 60 SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSV 117
Query: 142 HNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL--VKKTAFEKQSLNNNKFPVLPVTEN 199
H +G +RD+KP+NILI GH+ L DF L + + K + +N F +N
Sbjct: 118 HKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR-----DN 172
Query: 200 PKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEV 259
RR + R+NS VGT +Y++PEV
Sbjct: 173 VLVRRRDHKQRRV-------------------------------RANSTVGTPDYIAPEV 201
Query: 260 VRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL-----MKTPEFVGQRTAL 314
+RG + DWW+LG++ YEMLYG PF +ET+ ++ ++ P
Sbjct: 202 LRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEA 261
Query: 315 TDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIP 363
DLI RLL DP RLG EIK H FFKG+ W+ L + +PPF+P
Sbjct: 262 IDLICRLL-CDPEDRLGSFE---EIKSHPFFKGIDWENLRE-TKPPFVP 305
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 215 bits (551), Expect = 1e-67
Identities = 106/327 (32%), Positives = 155/327 (47%), Gaps = 58/327 (17%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-H 82
KI+G+G+ TV L ++ + +A+K++DK L K + + + E VL+RL+ H
Sbjct: 7 KIIGEGSFSTVVLAKEKETNK----EYAIKILDKRQL-IKEKKVKYVKIEKEVLTRLNGH 61
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYLSEIICAIEHL 141
P + KL + + +E L + + Y P G+L +R + RFY +EI+ A+E+L
Sbjct: 62 PGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS---LDEKCTRFYAAEILLALEYL 118
Query: 142 HNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPK 201
H+ GI +RDLKPENIL+ + H+ +TDF TA
Sbjct: 119 HSKGIIHRDLKPENILLDKDMHIKITDFG--------TA--------------------- 149
Query: 202 RHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVR 261
++L P + K + + Q N R SFVGT EYVSPE++
Sbjct: 150 ---KVLD------PNSSPESNKGDA-----TNIDSQIEKNRRRFASFVGTAEYVSPELLN 195
Query: 262 GDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL---MKTPEFVGQRTALTDLI 318
+ D WALG + Y+ML G PFRG N TF+ +L P DLI
Sbjct: 196 EKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPPNFPPDAK--DLI 253
Query: 319 QRLLEKDPVKRLGYLRGACEIKEHVFF 345
++LL DP RLG G E+K H FF
Sbjct: 254 EKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 210 bits (537), Expect = 7e-66
Identities = 113/329 (34%), Positives = 159/329 (48%), Gaps = 68/329 (20%)
Query: 26 LGKGAMGTVFLV-HDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPF 84
+ KGA G VFL D +A+KV+ K+ + K++ ++ E +LS+ P+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDI-----YAIKVIKKADMIRKNQVDQ-VLTERDILSQAQSPY 54
Query: 85 LPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNM 144
+ KL S + + L + Y PGGDL L +N V R Y++EI+ A+E+LH+
Sbjct: 55 VVKLYYSFQGKKNLYLVMEYLPGGDLASLL--ENVGSLDEDVARIYIAEIVLALEYLHSN 112
Query: 145 GIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHR 204
GI +RDLKP+NILI +GH+ LTDF LS K ++ +N N + K +
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLS-----KVGLVRRQINLND--------DEKEDK 159
Query: 205 RILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDG 264
RI VGT +Y++PEV+ G G
Sbjct: 160 RI------------------------------------------VGTPDYIAPEVILGQG 177
Query: 265 HEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT---PEFVGQRTALTDLIQRL 321
H VDWW+LG + YE L G PF G+ +E F+N+L PE V DLI +L
Sbjct: 178 HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKL 237
Query: 322 LEKDPVKRLGYLRGACEIKEHVFFKGVRW 350
L DP KRLG + EIK H FFKG+ W
Sbjct: 238 LVPDPEKRLGA-KSIEEIKNHPFFKGIDW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 189 bits (483), Expect = 1e-56
Identities = 112/354 (31%), Positives = 177/354 (50%), Gaps = 46/354 (12%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVL 77
D+ +++K++G+GA G V LV + +A+K + KS + K + R E +L
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHI----YAMKKLRKSEMLEKEQVAH-VRAERDIL 55
Query: 78 SRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICA 137
+ +P++ KL S + + +L + Y PGGD+ L K++ F+ RFY++E I A
Sbjct: 56 AEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILA 113
Query: 138 IEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVT 197
I+ +H +G +RD+KP+N+L+ GH+ L+DF L T +
Sbjct: 114 IDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLC------TGLK--------------- 152
Query: 198 ENPKRHRRILTR-WLHALPENKTGLKKTKSARVSPVSRRQQSFDNGER--SNSFVGTEEY 254
K HR R HALP N + R+ +++ R + S VGT +Y
Sbjct: 153 ---KSHRTEFYRILSHALPSNFLDFISKPMSS----KRKAETWKRNRRALAYSTVGTPDY 205
Query: 255 VSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL-----MKTPEFVG 309
++PEV G+ DWW+LG++ YEML G PF N +ET+R ++ ++ P+ V
Sbjct: 206 IAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVP 265
Query: 310 QRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIP 363
DLI+RL + +RLG G EIK H FFKGV W+ + + P IP
Sbjct: 266 LSPEAKDLIKRLC-CEAERRLGN-NGVNEIKSHPFFKGVDWEHIRER-PAPIIP 316
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 1e-52
Identities = 116/360 (32%), Positives = 179/360 (49%), Gaps = 49/360 (13%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHE-AERRARWEIRV 76
++ +K++GKGA G V LV + +A+K + KS + K + A +A E V
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKI----YAMKTLLKSEMFKKDQLAHVKA--ERDV 54
Query: 77 LSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIIC 136
L+ P++ L S + ++L + + PGGDL + K + FS V RFY++E +
Sbjct: 55 LAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVL 112
Query: 137 AIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPV 196
AIE +H +G +RD+KP+NILI + GH+ L+DF LS T F KQ +
Sbjct: 113 AIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS------TGFHKQHDSAY------- 159
Query: 197 TENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFD--NGERSN------SF 248
++++L NK + S V ++ S D + N S
Sbjct: 160 ------YQKLLQG-----KSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYST 208
Query: 249 VGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL-----MK 303
VGT +Y++PE+ G+ DWW+LG + +E L G PF +N ET+R ++ +
Sbjct: 209 VGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLY 268
Query: 304 TPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIP 363
P+ + DLI+RL+ + RLG GA EIK H FF+GV WD + + R PFIP
Sbjct: 269 FPDDIHLSVEAEDLIRRLI-TNAENRLGR-GGAHEIKSHPFFRGVDWDTIRQI-RAPFIP 325
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 2e-48
Identities = 105/358 (29%), Positives = 165/358 (46%), Gaps = 85/358 (23%)
Query: 25 ILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPF 84
++G+G G V +V ++A +A+KV+ KS L A+ E E +LS + P+
Sbjct: 8 LVGRGHFGEVQVVREKATGDI----YAMKVMKKSVLLAQ-ETVSFFEEERDILSISNSPW 62
Query: 85 LPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNM 144
+P+L + + + L + Y PGGDL L + D+ F + +FYL+E++ AI +H M
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQ-FDEDMAQFYLAELVLAIHSVHQM 121
Query: 145 GIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHR 204
G +RD+KPEN+LI ++GH+ L DF + L + N LPV
Sbjct: 122 GYVHRDIKPENVLIDRTGHIKLADFGSAARL---------TANKMVNSKLPV-------- 164
Query: 205 RILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEV---VR 261
GT +Y++PEV +
Sbjct: 165 ---------------------------------------------GTPDYIAPEVLTTMN 179
Query: 262 GDG---HEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL-----MKTPEFVGQRTA 313
GDG + DWW+LG++ YEM+YG +PF +T+ N++ +K PE +
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239
Query: 314 LTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREENDLT 371
DLIQ LL +RLGY C H FF + W+ + + L PPF+P+ + +D T
Sbjct: 240 FLDLIQSLL-CGQKERLGYEGLCC----HPFFSKIDWNNIRNSL-PPFVPTLKSDDDT 291
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 5e-46
Identities = 111/349 (31%), Positives = 172/349 (49%), Gaps = 36/349 (10%)
Query: 21 KALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL 80
+K +G GA G V LV R D A +A+K + K+ + +++A + E +L+
Sbjct: 4 VKIKTIGIGAFGEVCLV--RKVDTNAL--YAMKTLRKADVLMRNQAAH-VKAERDILAEA 58
Query: 81 SHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEH 140
+ ++ KL S + + L + + Y PGGD+ L + +F + RFY++E+ CAIE
Sbjct: 59 DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIES 116
Query: 141 LHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENP 200
+H MG +RD+KP+NILI + GH+ LTDF L T F + +++K+
Sbjct: 117 VHKMGFIHRDIKPDNILIDRDGHIKLTDFGLC------TGF--RWTHDSKY------YQK 162
Query: 201 KRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVV 260
H R + E + R+ P+ RR++ ++S VGT Y++PEV+
Sbjct: 163 GDHHRQDS---MEPSEE---WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVL 216
Query: 261 RGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKET------FRNVLMKTPEFVGQRTAL 314
G+ DWW++G++ YEML G PF ET + L + R A
Sbjct: 217 LRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREA- 275
Query: 315 TDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIP 363
+DLI RL RLG GA EIK H FFKG+ + L + P+IP
Sbjct: 276 SDLILRLC-CGAEDRLGK-NGADEIKAHPFFKGIDFASLIRRQKAPYIP 322
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 6e-45
Identities = 113/348 (32%), Positives = 156/348 (44%), Gaps = 81/348 (23%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHE-----AERRARWEIRVLS 78
K++GKG+ G V L R +D + +A+KV+ K T+ K E AER +L
Sbjct: 1 KVIGKGSFGKVLLA-KRKSDGSF---YAVKVLQKKTILKKKEQNHIMAERNV-----LLK 51
Query: 79 RLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAI 138
L HPFL L S +T E L + + Y GG+L + Q +R F RFY +E+ AI
Sbjct: 52 NLKHPFLVGLHYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAEVASAI 109
Query: 139 EHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTE 198
+LH++ I YRDLKPENIL+ GHV LTDF L + V+
Sbjct: 110 GYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--------------------- 148
Query: 199 NPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPE 258
PE T ++P R++ +D
Sbjct: 149 ----------------PEETTSTFCGTPEYLAPEVLRKEPYDR----------------- 175
Query: 259 VVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVGQRT-ALTDL 317
VDWW LG + YEMLYG PF ++ + + N+L K + G +T A DL
Sbjct: 176 ---------TVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDL 226
Query: 318 IQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRW-DLLTDVLRPPFIPS 364
+ LL KD +RLG EIK HVFF + W DL + PP+ P+
Sbjct: 227 LVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKRITPPYNPN 274
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 8e-45
Identities = 61/156 (39%), Positives = 91/156 (58%), Gaps = 7/156 (4%)
Query: 26 LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFL 85
LGKG+ G V LV + +A+KV+ K + K + E +LSR++HPF+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKL----YAMKVLKKKKII-KRKEVEHTLTERNILSRINHPFI 55
Query: 86 PKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMG 145
KL + +T+E L + Y PGG+L + + FS RFY +EI+ A+E+LH++G
Sbjct: 56 VKLHYAFQTEEKLYLVLEYAPGGEL--FSHLSKEGRFSEERARFYAAEIVLALEYLHSLG 113
Query: 146 IAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAF 181
I YRDLKPENIL+ GH+ LTDF L++ L + +
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR 149
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 4e-43
Identities = 60/153 (39%), Positives = 87/153 (56%), Gaps = 9/153 (5%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
L+ LG+G+ G V+L D+ T + A+KV+ K + E R EI++L +L H
Sbjct: 4 LEKLGEGSFGKVYLARDK---KTGK-LVAIKVIKKKKIKKDRERILR---EIKILKKLKH 56
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLH 142
P + +L E ++ L + YC GGDL + S RFYL +I+ A+E+LH
Sbjct: 57 PNIVRLYDVFEDEDKLYLVMEYCEGGDL--FDLLKKRGRLSEDEARFYLRQILSALEYLH 114
Query: 143 NMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
+ GI +RDLKPENIL+ + GHV L DF L+R L
Sbjct: 115 SKGIVHRDLKPENILLDEDGHVKLADFGLARQL 147
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 1e-40
Identities = 55/156 (35%), Positives = 86/156 (55%), Gaps = 8/156 (5%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
L+ LG G+ GTV+ + A+K++ K K + ++ AR EIR+L RLSH
Sbjct: 4 LRKLGSGSFGTVYKAKHKGT----GKIVAVKILKKR--SEKSKKDQTARREIRILRRLSH 57
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLH 142
P + +L+ + E + L + YC GGDL Y S + +I+ +E+LH
Sbjct: 58 PNIVRLIDAFEDKDHLYLVMEYCEGGDLF--DYLSRGGPLSEDEAKKIALQILRGLEYLH 115
Query: 143 NMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178
+ GI +RDLKPENIL+ ++G V + DF L++ L+K
Sbjct: 116 SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKS 151
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 3e-40
Identities = 55/109 (50%), Positives = 71/109 (65%), Gaps = 6/109 (5%)
Query: 240 DNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRN 299
G R+N+F GT EY++PEV+ G G+ AVDWW+LG+L YEML G PF ++RKE +
Sbjct: 145 SEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEK 204
Query: 300 VL---MKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345
+L ++ PEF+ DLI LL+KDP KRLG GA EIK H FF
Sbjct: 205 ILKDPLRFPEFLSPEAR--DLISGLLQKDPTKRLGSG-GAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 2e-39
Identities = 107/354 (30%), Positives = 166/354 (46%), Gaps = 50/354 (14%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVL 77
D+ ++LK++G+GA G V LV + +A+K++ K+ + K + R E +L
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHI----YAMKILRKADMLEKEQVAH-IRAERDIL 55
Query: 78 SRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICA 137
++ K+ S + L + + PGGD+ L K++ S +FY++E + A
Sbjct: 56 VEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLA 113
Query: 138 IEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVT 197
I+ +H +G +RD+KP+N+L+ GHV L+DF L L
Sbjct: 114 IDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL---------------------- 151
Query: 198 ENPKRHRRILTRWLHALPENKTGLKKTKSARVSPV---SRRQQSFDNGERSNSFVGTEEY 254
K HR R L P + + S R + +RRQ ++ S VGT +Y
Sbjct: 152 --KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAY-------STVGTPDY 202
Query: 255 VSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL-----MKTPEFVG 309
++PEV G+ DWW+LG++ YEML G PF + +ET+R V+ + P V
Sbjct: 203 IAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVP 262
Query: 310 QRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIP 363
DLI R D R+G G EIK H FF+GV W + + RP IP
Sbjct: 263 ISEKAKDLILRFC-TDSENRIGS-NGVEEIKSHPFFEGVDWGHIRE--RPAAIP 312
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 4e-38
Identities = 106/354 (29%), Positives = 170/354 (48%), Gaps = 50/354 (14%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVL 77
++ ++LK++G+GA G V LV + +A+K++ K+ + K E R E +L
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHV----YAMKILRKADMLEK-EQVGHIRAERDIL 55
Query: 78 SRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICA 137
++ K+ S + L + + PGGD+ L K++ + +FY++E + A
Sbjct: 56 VEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLA 113
Query: 138 IEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVT 197
I+ +H +G +RD+KP+N+L+ GHV L+DF L L
Sbjct: 114 IDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL---------------------- 151
Query: 198 ENPKRHRRILTRWL-HALPENKT--GLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254
K HR R L H+LP + T + + A +RRQ +F S VGT +Y
Sbjct: 152 --KKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAF-------STVGTPDY 202
Query: 255 VSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL-----MKTPEFVG 309
++PEV G+ DWW+LG++ YEML G PF + +ET++ V+ + P V
Sbjct: 203 IAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVP 262
Query: 310 QRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIP 363
DLI R + R+G G EIK + FF+GV W+ + + RP IP
Sbjct: 263 ISEKAKDLILRFCCEWE-HRIG-APGVEEIKTNPFFEGVDWEHIRE--RPAAIP 312
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 5e-37
Identities = 55/162 (33%), Positives = 91/162 (56%), Gaps = 7/162 (4%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVL 77
D+ + +K LG G+ G V LV + + +ALK++ K+ + + E E R+L
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGK----YYALKILSKAKIVKLKQVEHVLN-EKRIL 55
Query: 78 SRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICA 137
+ HPFL L GS + D L + Y PGG+L + + F V RFY ++++ A
Sbjct: 56 QSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGEL--FSHLRKSGRFPEPVARFYAAQVVLA 113
Query: 138 IEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKT 179
+E+LH++ I YRDLKPEN+L+ G++ +TDF ++ + +T
Sbjct: 114 LEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT 155
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 4e-36
Identities = 96/349 (27%), Positives = 149/349 (42%), Gaps = 81/349 (23%)
Query: 26 LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFL 85
LGKG G V RA +A K ++K L K + A E R+L+++ F+
Sbjct: 1 LGKGGFGEVSACQMRATGKL----YACKKLNKKRLK-KRKGYEGAMVEKRILAKVHSRFI 55
Query: 86 PKLLGSLETDEFLAWAVPYCPGGDL--NVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN 143
L + +T L + GGDL ++ + + F FY ++II +EHLH
Sbjct: 56 VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ 115
Query: 144 MGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRH 203
I YRDLKPEN+L+ G+V ++D L+ L
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLAVEL---------------------------- 147
Query: 204 RRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGD 263
K G KTK + GT +++PE+++G+
Sbjct: 148 --------------KDGQSKTK---------------------GYAGTPGFMAPELLQGE 172
Query: 264 GHEFAVDWWALGILTYEMLYGTTPFRGK----NRKETFRNVL---MKTPEFVGQRTALTD 316
++F+VD++ALG+ YEM+ PFR + KE + +L + P+ A
Sbjct: 173 EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSP--ASKS 230
Query: 317 LIQRLLEKDPVKRLGYLRGAC-EIKEHVFFKGVRW-DLLTDVLRPPFIP 363
+ LL KDP KRLG+ G C ++ H F+ + W L +L PPF+P
Sbjct: 231 FCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPFVP 279
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 2e-35
Identities = 64/132 (48%), Positives = 83/132 (62%), Gaps = 9/132 (6%)
Query: 240 DNGERSNSFVGTEEYVSPEVVRG--DGHEFAVDWWALGILTYEMLYGTTPFR---GKN-R 293
+ ER+ SF GT EY++PEV+RG GH+ AVDWW+LG+LT+E+L G +PF +N +
Sbjct: 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ 217
Query: 294 KETFRNVLMKTPEFVGQRTALT-DLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD- 351
E R +L P F +A D IQ+LLEKDP KRLG GA EIK H FF+G+ WD
Sbjct: 218 SEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGA-NGADEIKNHPFFQGIDWDD 276
Query: 352 LLTDVLRPPFIP 363
L + PF P
Sbjct: 277 LAAKRIPAPFKP 288
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 108/351 (30%), Positives = 175/351 (49%), Gaps = 38/351 (10%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
+K LG GA G V L R D A +A+K + K + +++ + E +L+ +
Sbjct: 6 IKTLGIGAFGEVCLA--RKVDTKAL--YAMKTLRKKDVLLRNQVAH-VKAERDILAEADN 60
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLH 142
++ +L S + + L + + Y PGGD+ L + +F + RFY++E+ CA+E +H
Sbjct: 61 EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVH 118
Query: 143 NMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKR 202
MG +RD+KP+NILI + GH+ LTDF L T F + +++K+ ++ ++
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLC------TGF--RWTHDSKY--YQSGDHVRQ 168
Query: 203 HRRILT-RWLHALPEN-KTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVV 260
+ W P N + G R+ P+ RR ++S VGT Y++PEV+
Sbjct: 169 DSMDFSNEW--GDPANCRCG------DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL 220
Query: 261 RGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL-----MKTPEFVGQRTALT 315
G+ DWW++G++ YEML G PF + ET V+ + P +
Sbjct: 221 LRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEAS 280
Query: 316 DLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLR--PPFIPS 364
DLI +L + P RLG GA EIK H FFK + D +D+ + P+IP
Sbjct: 281 DLIIKLC-RGPEDRLGK-NGADEIKAHPFFKTI--DFSSDLRQQSAPYIPK 327
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 5e-35
Identities = 67/169 (39%), Positives = 92/169 (54%), Gaps = 21/169 (12%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVD-------KSTLHAKHEAERRA 70
D+L+ +K +G G G V LV DR + +ALKV+ K H +E
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDR----ISEHYYALKVMAIPEVIRLKQEQHVHNEK---- 52
Query: 71 RWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFY 130
RVL +SHPF+ +L + FL + Y PGG+L Y +N FS S FY
Sbjct: 53 ----RVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFY 106
Query: 131 LSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKT 179
SEI+CA+E+LH+ I YRDLKPENIL+ + GH+ LTDF ++ L +T
Sbjct: 107 ASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-34
Identities = 56/151 (37%), Positives = 79/151 (52%), Gaps = 9/151 (5%)
Query: 26 LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFL 85
LG+G GTV+L D+ A+K++ K EI +L +L+HP +
Sbjct: 1 LGEGGFGTVYLARDKKTG----KKVAIKIIKKED---SSSLLEELLREIEILKKLNHPNI 53
Query: 86 PKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMG 145
KL G E + L + YC GG L L K+N+ S I L +I+ +E+LH+ G
Sbjct: 54 VKLYGVFEDENHLYLVMEYCEGGSLKDL-LKENEGKLSEDEILRILLQILEGLEYLHSNG 112
Query: 146 IAYRDLKPENILI-RQSGHVTLTDFDLSRNL 175
I +RDLKPENIL+ +G V L DF LS+ L
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLL 143
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 4e-34
Identities = 53/126 (42%), Positives = 72/126 (57%), Gaps = 7/126 (5%)
Query: 243 ERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL- 301
R+ + GT EY++PE++ G+ AVDWWALGIL YEML G PF N + + +L
Sbjct: 153 GRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE 212
Query: 302 --MKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLR-GACEIKEHVFFKGVRWD-LLTDVL 357
++ P F DLI+ LL+ D KRLG L+ G +IK H +F G+ W LL +
Sbjct: 213 GKVRFPSFFSPD--AKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKI 270
Query: 358 RPPFIP 363
PFIP
Sbjct: 271 EAPFIP 276
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 8e-34
Identities = 93/375 (24%), Positives = 142/375 (37%), Gaps = 84/375 (22%)
Query: 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLS 78
+ + L+ LG+G+ G V+L DR ALKV+ K L +K + R EI++L+
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK-------LVALKVLAKK-LESKSKEVERFLREIQILA 52
Query: 79 RLSHP-FLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYLSEIIC 136
L+HP + KL + + L + Y GG L ++L+ S S F L++I+
Sbjct: 53 SLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112
Query: 137 AIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPV 196
A+E+LH+ GI +RD+KPENIL+ D +VK F
Sbjct: 113 ALEYLHSKGIIHRDIKPENILL-----------DRDGRVVKLIDF--------------- 146
Query: 197 TENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256
GL K + + ++ VGT Y++
Sbjct: 147 -----------------------GLAKL-------LPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 257 PEVVRGDGHE---FAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVGQR-- 311
PEV+ G + D W+LGI YE+L G PF G+ L E
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236
Query: 312 ------------TALTDLIQRLLEKDPVKRLGYLRGAC-EIKEHVFFKGVRWDLLTDVLR 358
A +DL+++LL KDP RL ++ H+ K L
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDD 296
Query: 359 PPFIPSREENDLTEK 373
+ L
Sbjct: 297 SAPLRLSLPPSLEAL 311
|
Length = 384 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 5e-33
Identities = 48/126 (38%), Positives = 73/126 (57%), Gaps = 3/126 (2%)
Query: 241 NGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNV 300
G +++F GT +Y++PE++ + AVDWWALG+L YEML G +PF G + E F+++
Sbjct: 149 GGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI 208
Query: 301 LMKTPEF-VGQRTALTDLIQRLLEKDPVKRLGYLR-GACEIKEHVFFKGVRWDLLTDV-L 357
L + +++ L K+P KRLG L G +IK H FF+ + WD L +
Sbjct: 209 LEDEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEI 268
Query: 358 RPPFIP 363
+PPF P
Sbjct: 269 KPPFKP 274
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-31
Identities = 57/154 (37%), Positives = 88/154 (57%), Gaps = 9/154 (5%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
L+++GKGA G V +V R + FA+K ++K K R E R+L L+H
Sbjct: 5 LRVIGKGAFGKVCIVQKR----DTKKMFAMKYMNKQKCVEKGSV-RNVLNERRILQELNH 59
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYK-QNDRVFSPSVIRFYLSEIICAIEHL 141
PFL L S + +E + V GGDL RY FS ++F++ EI+ A+E+L
Sbjct: 60 PFLVNLWYSFQDEENMYLVVDLLLGGDL---RYHLSQKVKFSEEQVKFWICEIVLALEYL 116
Query: 142 HNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
H+ GI +RD+KP+NIL+ + GHV +TDF+++ +
Sbjct: 117 HSKGIIHRDIKPDNILLDEQGHVHITDFNIATKV 150
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 4e-30
Identities = 104/349 (29%), Positives = 165/349 (47%), Gaps = 34/349 (9%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
+K LG GA G V L D A +A+K + K + +++ + E +L+ +
Sbjct: 6 IKTLGIGAFGEVCLA--CKVDTHAL--YAMKTLRKKDVLNRNQVAH-VKAERDILAEADN 60
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLH 142
++ KL S + + L + + Y PGGD+ L + VF + RFY++E+ AIE +H
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVH 118
Query: 143 NMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKR 202
MG +RD+KP+NILI GH+ LTDF L T F + +N+K+
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGLC------TGF--RWTHNSKY------YQKGS 164
Query: 203 HRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRG 262
H R + L ++ + + R+ + +R ++S VGT Y++PEV+
Sbjct: 165 HIRQDSMEPSDLWDDVSNCR--CGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR 222
Query: 263 DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL-----MKTPEFVGQRTALTDL 317
G+ DWW++G++ +EML G PF ET V+ + P V DL
Sbjct: 223 KGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDL 282
Query: 318 IQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLR--PPFIPS 364
I +L +RLG GA +IK H FF V D +D+ P++P
Sbjct: 283 ITKLCCSAE-ERLGR-NGADDIKAHPFFSEV--DFSSDIRTQPAPYVPK 327
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 76/178 (42%), Positives = 94/178 (52%), Gaps = 20/178 (11%)
Query: 243 ERSNSFVGTEEYVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRK----ETF 297
ER+ SF GT EY++PE++RG GH AVDWW+LGIL +E+L G +PF + + E
Sbjct: 161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS 220
Query: 298 RNVLMKTPEFVGQRTALT-DLIQRLLEKDPVKRLGY-LRGACEIKEHVFFKGVRW-DLLT 354
R +L P F DL+ +LL KDP KRLG +GA EIKEH FFKG+ W L
Sbjct: 221 RRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALAL 280
Query: 355 DVLRPPFIPS-REENDLTEKAMSGGGVDIREYFENLRA--PPPSMPPSPLPSPSHRSF 409
+ PPF PS R E D+ A E F NL P PPS SF
Sbjct: 281 RKVNPPFRPSIRNELDVGNFA---------EEFTNLEPVYSPAGTPPSGARVFQGYSF 329
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 64/153 (41%), Positives = 87/153 (56%), Gaps = 7/153 (4%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTL--HAKHEAERRARWEIRVLSRL 80
LK+LGKG G VF V T + FA+KV+ K+T+ + K A +A E +L +
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKI-FAMKVLKKATIVRNQKDTAHTKA--ERNILEAV 57
Query: 81 SHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEH 140
HPF+ L+ + +T L + Y GG+L + + + +F FYLSEI A+EH
Sbjct: 58 KHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSEISLALEH 115
Query: 141 LHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
LH GI YRDLKPENIL+ GHV LTDF L +
Sbjct: 116 LHQQGIIYRDLKPENILLDAQGHVKLTDFGLCK 148
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 44/120 (36%), Positives = 77/120 (64%), Gaps = 10/120 (8%)
Query: 241 NGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRK--ETFR 298
+G+++ +F GT EYV+PE++ G++F+VD+W+LGIL YE+L G PF + E +
Sbjct: 145 SGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYN 204
Query: 299 NVL-----MKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLR-GACEIKEHVFFKGVRWDL 352
++L ++ P ++ + DLI++LL ++P +RLG L+ G +IK+H +F G W+
Sbjct: 205 DILKGNGKLEFPNYIDKAA--KDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWEG 262
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 62/159 (38%), Positives = 92/159 (57%), Gaps = 4/159 (2%)
Query: 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLS 78
N + L++LG GA G VFLV + +A+KV+ K+T+ K + R E +VL
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKL-YAMKVLKKATIVQKAKTAEHTRTERQVLE 59
Query: 79 RL-SHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICA 137
+ PFL L + +TD L + Y GG+L Y++ F+ S +R Y++EI+ A
Sbjct: 60 AVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH--FTESEVRVYIAEIVLA 117
Query: 138 IEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176
++HLH +GI YRD+K ENIL+ GHV LTDF LS+ +
Sbjct: 118 LDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 5e-29
Identities = 60/133 (45%), Positives = 82/133 (61%), Gaps = 9/133 (6%)
Query: 240 DNGERSNSFVGTEEYVSPEVVRG--DGHEFAVDWWALGILTYEMLYGTTPF----RGKNR 293
D ER+ SF GT EY++P++VRG GH+ AVDWW++G+L YE+L G +PF ++
Sbjct: 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ 217
Query: 294 KETFRNVLMKTPEFVGQRTALT-DLIQRLLEKDPVKRLGY-LRGACEIKEHVFFKGVRW- 350
E R +L P + + +AL D+IQRLL KDP KRLG A EIK+H FF+ + W
Sbjct: 218 AEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWD 277
Query: 351 DLLTDVLRPPFIP 363
DL + PF P
Sbjct: 278 DLAAKKVPAPFKP 290
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 1e-28
Identities = 62/151 (41%), Positives = 97/151 (64%), Gaps = 5/151 (3%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
LK+LG+G+ G VFLV + P A +A+KV+ K+TL + R + E +L+ ++H
Sbjct: 1 LKVLGQGSFGKVFLVR-KITGPDAGQLYAMKVLKKATLKVRDRV--RTKMERDILAEVNH 57
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLH 142
PF+ KL + +T+ L + + GGDL K+ +F+ ++FYL+E+ A++HLH
Sbjct: 58 PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLH 115
Query: 143 NMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
++GI YRDLKPENIL+ + GH+ LTDF LS+
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSK 146
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 1e-28
Identities = 55/141 (39%), Positives = 84/141 (59%), Gaps = 7/141 (4%)
Query: 236 QQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKE 295
++S D+ +++ SF GT EY++PEVV GH + DWW+ G+L +EML G+ PF+GK+RKE
Sbjct: 146 KESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE 205
Query: 296 TFRNVL---MKTPEFVGQRTALTDLIQRLLEKDPVKRLGY-LRGACEIKEHVFFKGVRWD 351
T +L + P+F+ L++ L +++P RLG G EIK H FF + W+
Sbjct: 206 TMTMILKAKLGMPQFLSPEA--QSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWN 263
Query: 352 -LLTDVLRPPFIPSREENDLT 371
L ++PPF P+ D T
Sbjct: 264 KLYRREIKPPFKPAVGRPDDT 284
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 1e-28
Identities = 61/153 (39%), Positives = 83/153 (54%), Gaps = 7/153 (4%)
Query: 26 LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFL 85
+G+G G VFL + D ALK + KS L +E R E +L+ +L
Sbjct: 9 VGQGGYGQVFLAKKK--DTGEIV--ALKRMKKSLLFKLNEV-RHVLTERDILTTTKSEWL 63
Query: 86 PKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMG 145
KLL + + DE+L A+ Y PGGD L N V S RFY++E+ A++ LH +G
Sbjct: 64 VKLLYAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFEAVDALHELG 121
Query: 146 IAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178
+RDLKPEN LI SGH+ LTDF LS+ +V
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY 154
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 1e-28
Identities = 48/128 (37%), Positives = 84/128 (65%), Gaps = 7/128 (5%)
Query: 242 GERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL 301
G+R+++F GT E+++PEV+ + AVDWW LG+L YEML G +PF G + +E F +++
Sbjct: 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV 214
Query: 302 ---MKTPEFVGQRTALTDLIQRLLEKDPVKRLGY-LRGACEIKEHVFFKGVRWD-LLTDV 356
++ P F+ + +++RLL ++P +RLG + A ++K+ FF+ + WD LL
Sbjct: 215 NDEVRYPRFLSREAIS--IMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARK 272
Query: 357 LRPPFIPS 364
++PPF+P+
Sbjct: 273 IKPPFVPT 280
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 9e-28
Identities = 46/112 (41%), Positives = 63/112 (56%), Gaps = 9/112 (8%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGK-NRKETF 297
D GE+ +FVGT EY++PEV+ G G+ AVD W+LG++ YE+L G PF G E F
Sbjct: 147 LDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELF 206
Query: 298 RNVLMKTPEFVGQRTALT----DLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345
+ + P F ++ DLI++LL KDP KRL E +H FF
Sbjct: 207 KKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAE----EALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 54/137 (39%), Positives = 82/137 (59%), Gaps = 15/137 (10%)
Query: 243 ERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL- 301
+NS VG+ +Y++PEV+RG G++F VD+W+LG + YE L G PF G ET+ N+
Sbjct: 153 TYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY 212
Query: 302 ----MKTPEFVGQRTALT----DLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLL 353
++ P + R L+ DLI +L+ DP +R G L +IK H FFK V W+ L
Sbjct: 213 WKETLQRPVYDDPRFNLSDEAWDLITKLIN-DPSRRFGSLE---DIKNHPFFKEVDWNEL 268
Query: 354 TDVLRPPFIPSREENDL 370
+ L+PPF+P E+++
Sbjct: 269 RE-LKPPFVP-ELESEI 283
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 50/126 (39%), Positives = 81/126 (64%), Gaps = 6/126 (4%)
Query: 241 NGE-RSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRN 299
NGE ++++F GT +Y++PE+++G + +VDWW+ G+L YEML G +PF G++ E F +
Sbjct: 148 NGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDS 207
Query: 300 VLMKTPEFVGQRTA-LTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTD-VL 357
+L P F + D + +L E+DP KRLG + G +I++H FF+G+ W+ L +
Sbjct: 208 ILNDRPHFPRWISKEAKDCLSKLFERDPTKRLG-VDG--DIRQHPFFRGIDWERLEKREI 264
Query: 358 RPPFIP 363
PPF P
Sbjct: 265 PPPFKP 270
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 64/161 (39%), Positives = 91/161 (56%), Gaps = 4/161 (2%)
Query: 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLS 78
N + LK+LG GA G VFLV + +A+KV+ K+ L K + R E VL
Sbjct: 1 NFELLKVLGTGAYGKVFLVR-KVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLE 59
Query: 79 RLSH-PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICA 137
+ PFL L + +T+ L + Y GG++ Y++++ FS +RFY EII A
Sbjct: 60 HVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDN--FSEDEVRFYSGEIILA 117
Query: 138 IEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178
+EHLH +GI YRD+K ENIL+ GHV LTDF LS+ + +
Sbjct: 118 LEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 52/155 (33%), Positives = 78/155 (50%), Gaps = 12/155 (7%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKH-EAERRARWEIRVLSRLSH 82
++LG+G+ G+V+L D+ A+K V+ S + EA R EIR+LS L H
Sbjct: 6 ELLGRGSFGSVYLALDKDTGEL----MAVKSVELSGDSEEELEALER---EIRILSSLQH 58
Query: 83 PFLPKLLGSLETDEFLAWAVP--YCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEH 140
P + + GS +E + Y GG L+ L K VIR Y +I+ + +
Sbjct: 59 PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAY 116
Query: 141 LHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
LH+ GI +RD+K NIL+ G V L DF ++ L
Sbjct: 117 LHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRL 151
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 56/143 (39%), Positives = 87/143 (60%), Gaps = 8/143 (5%)
Query: 236 QQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKE 295
++S G +++F GT EY++PE++ GH AVDWW+LG L Y+ML G PF +NRK+
Sbjct: 148 KESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK 207
Query: 296 TFRNVL---MKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRG-ACEIKEHVFFKGVRW- 350
T +L + P ++ DL+++LL+++P RLG G A E++ H FF+ V W
Sbjct: 208 TIDKILKGKLNLPPYLTPEA--RDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWD 265
Query: 351 DLLTDVLRPPFIPS-REENDLTE 372
DLL + PPF P + E D+++
Sbjct: 266 DLLARKVEPPFKPLLQSEEDVSQ 288
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 6e-27
Identities = 63/159 (39%), Positives = 90/159 (56%), Gaps = 4/159 (2%)
Query: 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLS 78
N + LK+LG GA G VFLV + + + +A+KV+ K+T+ K + R E +VL
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKL-YAMKVLKKATIVQKAKTTEHTRTERQVLE 59
Query: 79 RLSH-PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICA 137
+ PFL L + +TD L + Y GG+L Q +R F ++ Y EI+ A
Sbjct: 60 HIRQSPFLVTLHYAFQTDTKLHLILDYINGGEL-FTHLSQRER-FKEQEVQIYSGEIVLA 117
Query: 138 IEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176
+EHLH +GI YRD+K ENIL+ +GHV LTDF LS+
Sbjct: 118 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 7e-27
Identities = 53/124 (42%), Positives = 73/124 (58%), Gaps = 3/124 (2%)
Query: 243 ERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLM 302
+R+ + GT EY++PEV++ GH AVDWWALGIL YEML G PF N + +L
Sbjct: 153 DRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA 212
Query: 303 KTPEFVGQ-RTALTDLIQRLLEKDPVKRLGYLR-GACEIKEHVFFKGVRWDLLTDV-LRP 359
EF DLI++LL D +RLG ++ GA ++K H +FK V WD + L+P
Sbjct: 213 GKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKP 272
Query: 360 PFIP 363
P +P
Sbjct: 273 PIVP 276
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 48/122 (39%), Positives = 77/122 (63%), Gaps = 5/122 (4%)
Query: 244 RSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK 303
R+++F GT +Y++PE+++G + F+VDWW+ G+L YEML G +PF G + E F ++ +
Sbjct: 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD 211
Query: 304 TPEFVGQRTALT-DLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTD-VLRPPF 361
TP + T + D++++L E+DP +RLG + I+ H FFK + W L L PPF
Sbjct: 212 TPHYPRWITKESKDILEKLFERDPTRRLGVVG---NIRGHPFFKTINWTALEKRELDPPF 268
Query: 362 IP 363
P
Sbjct: 269 KP 270
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 50/121 (41%), Positives = 71/121 (58%), Gaps = 2/121 (1%)
Query: 245 SNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT 304
+++F GT EY++PEV+R ++ VDWW LG + YEMLYG PF ++ E + N+L K
Sbjct: 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP 212
Query: 305 PEFVGQRT-ALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRW-DLLTDVLRPPFI 362
+ + L++ LL+KD KRLG EIK HVFF + W DL+ + PPF
Sbjct: 213 LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPPFN 272
Query: 363 P 363
P
Sbjct: 273 P 273
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 48/131 (36%), Positives = 70/131 (53%), Gaps = 6/131 (4%)
Query: 243 ERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL- 301
+R+ + GT EY++PEV++ GH AVDWW +G+L YE + G PF + +L
Sbjct: 170 DRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA 229
Query: 302 --MKTPEFVGQRTALTDLIQRLLEKDPVKRLGYL-RGACEIKEHVFFKGVRWDLLTDVLR 358
+K P + R DL++ LL+ D KRLG L G ++K H +F G WD L
Sbjct: 230 GRLKFPNWFDGRA--RDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYY 287
Query: 359 PPFIPSREEND 369
P IP R ++
Sbjct: 288 PAPIPVRVKSP 298
|
Length = 329 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 3e-26
Identities = 92/354 (25%), Positives = 160/354 (45%), Gaps = 85/354 (24%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIR-V 76
++ + +K++G+GA G V LV + + R +A+K++ K + + ++ WE R +
Sbjct: 43 EDYEVVKVIGRGAFGEVQLVRHK----STRKVYAMKLLSKFEMIKRSDSA--FFWEERDI 96
Query: 77 LSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIIC 136
++ + P++ +L + + D +L + Y PGGDL L ++ RFY +E++
Sbjct: 97 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNL---MSNYDVPEKWARFYTAEVVL 153
Query: 137 AIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPV 196
A++ +H+MG +RD+KP+N+L+ +SGH+ L DF +
Sbjct: 154 ALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM--------------------- 192
Query: 197 TENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256
NK G+ + +A +P +Y+S
Sbjct: 193 --------------------NKEGMVRCDTAVGTP---------------------DYIS 211
Query: 257 PEVVR---GDGHE-FAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL-----MKTPEF 307
PEV++ GDG+ DWW++G+ YEML G TPF + T+ ++ + P+
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD 271
Query: 308 VGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR--WDLLTDVLRP 359
+LI L V RLG G EIK H+FFK + W+ L D + P
Sbjct: 272 NDISKEAKNLICAFLTDREV-RLGR-NGVEEIKRHLFFKNDQWAWETLRDTVAP 323
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-26
Identities = 56/128 (43%), Positives = 78/128 (60%), Gaps = 3/128 (2%)
Query: 241 NGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNV 300
+ +++N+F GT EY++PE++ G G+ AVDWW LG+L YEML G PF +N E +R +
Sbjct: 146 DDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKI 205
Query: 301 LMKTPEFV-GQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD-LLTDVLR 358
L + F G DL+ LL +DP +RLGY GA EIK H FF + W LL ++
Sbjct: 206 LQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGY-NGAQEIKNHPFFSQLSWKKLLMKGIQ 264
Query: 359 PPFIPSRE 366
PPF P+
Sbjct: 265 PPFKPAVS 272
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 5e-26
Identities = 58/150 (38%), Positives = 87/150 (58%), Gaps = 7/150 (4%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP 83
K+LGKG G V LV ++A T + +A+K++ K + AK E E RVL HP
Sbjct: 1 KLLGKGTFGKVILVREKA---TGKY-YAMKILKKEVIIAKDEVAHTLT-ESRVLQNTRHP 55
Query: 84 FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN 143
FL L S +T + L + + Y GG+L + +RVFS RFY +EI+ A+ +LH+
Sbjct: 56 FLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALGYLHS 113
Query: 144 MGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+ YRDLK EN+++ + GH+ +TDF L +
Sbjct: 114 CDVVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-25
Identities = 60/155 (38%), Positives = 84/155 (54%), Gaps = 16/155 (10%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHE-----AERRARWEIRVLS 78
K++GKG+ G V L +A +A+KV+ K + K E AER +L
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKF----YAVKVLQKKAILKKKEQKHIMAERNV-----LLK 51
Query: 79 RLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAI 138
+ HPFL L S +T + L + + Y GG+L + Q +R F RFY +EI A+
Sbjct: 52 NVKHPFLVGLHYSFQTADKLYFVLDYVNGGEL--FFHLQRERSFPEPRARFYAAEIASAL 109
Query: 139 EHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+LH++ I YRDLKPENIL+ GHV LTDF L +
Sbjct: 110 GYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 49/116 (42%), Positives = 63/116 (54%), Gaps = 6/116 (5%)
Query: 241 NGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNV 300
NG + FVGT +Y++PE + G G + DWW+LG + +E L+G PF + F N+
Sbjct: 146 NGLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI 205
Query: 301 LMKT---PEFV--GQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351
L + PE V DLI RLL DP KRLG G EIK H FFK + WD
Sbjct: 206 LSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLG-ANGYQEIKSHPFFKSINWD 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 45/147 (30%), Positives = 71/147 (48%), Gaps = 9/147 (6%)
Query: 26 LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFL 85
+GKG G V+ + A+KV+ + K + EI++L + HP +
Sbjct: 8 IGKGGFGEVYKARHKRT----GKEVAIKVIKLESKEKKEKIIN----EIQILKKCKHPNI 59
Query: 86 PKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMG 145
K GS + L + +C GG L L K ++ + S I + E++ +E+LH+ G
Sbjct: 60 VKYYGSYLKKDELWIVMEFCSGGSLKDL-LKSTNQTLTESQIAYVCKELLKGLEYLHSNG 118
Query: 146 IAYRDLKPENILIRQSGHVTLTDFDLS 172
I +RD+K NIL+ G V L DF LS
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLS 145
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-25
Identities = 58/162 (35%), Positives = 88/162 (54%), Gaps = 17/162 (10%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHE-----AERRARWEIRVL 77
LK + KGA G+V+L R+ FA+KV+ KS + AK++ AER ++
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDY----FAIKVLKKSDMIAKNQVTNVKAERAI-----MM 51
Query: 78 SRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICA 137
+ P++ KL S ++ ++L + Y GGD L + Y++E++
Sbjct: 52 IQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLG 109
Query: 138 IEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN-LVKK 178
+E LH GI +RD+KPEN+LI Q+GH+ LTDF LSRN L K
Sbjct: 110 VEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 6e-25
Identities = 51/129 (39%), Positives = 73/129 (56%), Gaps = 2/129 (1%)
Query: 243 ERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLM 302
+ + +F GT EY++PEV+R ++ VDWW LG + YEMLYG PF ++ E + N+L
Sbjct: 151 DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH 210
Query: 303 KTPEF-VGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRW-DLLTDVLRPP 360
K G +++ LLEKD +RLG EI+EH FF+ + W DL + PP
Sbjct: 211 KPLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPP 270
Query: 361 FIPSREEND 369
F P+ E D
Sbjct: 271 FNPNVEGPD 279
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 7e-25
Identities = 50/156 (32%), Positives = 84/156 (53%), Gaps = 10/156 (6%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERR-ARWEIRVLSRLS 81
+K +GKG+ G V+LV ++ + LK +D L E ER A E+++L +L+
Sbjct: 5 IKQIGKGSFGKVYLVRRKSDGK----LYVLKEID---LSNMSEKEREDALNEVKILKKLN 57
Query: 82 HPFLPKLLGSLETDEFLAWAVPYCPGGDLN--VLRYKQNDRVFSPSVIRFYLSEIICAIE 139
HP + K S E L + Y GGDL+ + + K+ + F I + ++ A++
Sbjct: 58 HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK 117
Query: 140 HLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
+LH+ I +RD+KP+NI + +G V L DF +S+ L
Sbjct: 118 YLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVL 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 8e-25
Identities = 56/152 (36%), Positives = 83/152 (54%), Gaps = 11/152 (7%)
Query: 26 LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFL 85
LG G G V LV ++ + T FALK V K + + E +L +HPF+
Sbjct: 1 LGVGGFGRVELVKVKSKNRT----FALKCVKKRHIVET-GQQEHIFSEKEILEECNHPFI 55
Query: 86 PKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRV-FSPSVIRFYLSEIICAIEHLHN 143
KL + + +++ + YC GG+L +LR DR F RFY++ ++ A E+LHN
Sbjct: 56 VKLYRTFKDKKYIYMLMEYCLGGELWTILR----DRGLFDEYTARFYIACVVLAFEYLHN 111
Query: 144 MGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
GI YRDLKPEN+L+ +G+V L DF ++ L
Sbjct: 112 RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL 143
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 96/347 (27%), Positives = 142/347 (40%), Gaps = 76/347 (21%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP 83
++LGKG G V RA +A K ++K + + E A E ++L +++
Sbjct: 6 RVLGKGGFGEVCACQVRATGKM----YACKKLEKKRIKKRK-GEAMALNEKQILEKVNSR 60
Query: 84 FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN 143
F+ L + ET + L + GGDL +F H++N
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDL-----------------KF----------HIYN 93
Query: 144 MGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRH 203
MG D E + + +T DL R
Sbjct: 94 MGNPGFD---EERAVFYAAEITCGLEDLHR------------------------------ 120
Query: 204 RRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGD 263
RI+ R L PEN L R+S + + GE VGT Y++PEVV+ +
Sbjct: 121 ERIVYRDLK--PENIL-LDDYGHIRISDLGLAVE-IPEGETIRGRVGTVGYMAPEVVKNE 176
Query: 264 GHEFAVDWWALGILTYEMLYGTTPFRGK----NRKETFRNVLMKTPEFVGQRT-ALTDLI 318
+ F+ DWW LG L YEM+ G +PFR + R+E R V E+ + + A +
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236
Query: 319 QRLLEKDPVKRLGYLR-GACEIKEHVFFKGVRWDLL-TDVLRPPFIP 363
++LL KDP RLG GA E+K H FF+ + L +L PPF P
Sbjct: 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCP 283
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-24
Identities = 51/132 (38%), Positives = 76/132 (57%), Gaps = 7/132 (5%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFR----GKNRK 294
G++ GT Y++PEV++G+ ++F+VDW+ALG YEM+ G +PFR ++
Sbjct: 145 LKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE 204
Query: 295 ETFRNVLMKTPEFVGQRT-ALTDLIQRLLEKDPVKRLGYLRGAC-EIKEHVFFKGVRWDL 352
E R L E+ + + DL + LL+KDP KRLG G+ E++EH FK + W
Sbjct: 205 ELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRR 264
Query: 353 L-TDVLRPPFIP 363
L +L PPFIP
Sbjct: 265 LEAGMLEPPFIP 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 55/128 (42%), Positives = 72/128 (56%), Gaps = 10/128 (7%)
Query: 250 GTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVG 309
GT EY++PEV+ G+ VDWWA+GI+ YE L G PF G +E F V+ E+
Sbjct: 178 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237
Query: 310 QRTAL----TDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLR--PPFIP 363
AL DLI RLL ++P++RLG GA E+K+H FF G+ W +LR FIP
Sbjct: 238 GDEALPADAQDLISRLLRQNPLERLG-TGGAFEVKQHRFFLGLDW---NGLLRQKAEFIP 293
Query: 364 SREENDLT 371
E D T
Sbjct: 294 QLESEDDT 301
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 6e-24
Identities = 41/114 (35%), Positives = 59/114 (51%), Gaps = 13/114 (11%)
Query: 241 NGERSNSFVGTEEYVSPEVVR-GDGHEFAVDWWALGILTYEMLYGTTPFRGKNR---KET 296
+ +FVGT Y++PEV+ G+G+ VD W+LG++ YE+L G PF G+N +
Sbjct: 151 SSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQL 210
Query: 297 FRNVLMKTPEFVGQ-----RTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345
R +L EF DLI++ L KDP KR A EI +H +F
Sbjct: 211 IRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRP----TAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 6e-24
Identities = 53/154 (34%), Positives = 77/154 (50%), Gaps = 5/154 (3%)
Query: 26 LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFL 85
LGKG G V +A +A K +DK L K + E+ A E ++L ++S F+
Sbjct: 1 LGKGGFGEVCACQVKATGKM----YACKKLDKKRLK-KRKGEQMALNEKKILEKVSSRFI 55
Query: 86 PKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMG 145
L + ET + L + GGDL Y + F + FY ++IIC +EHLH
Sbjct: 56 VSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR 115
Query: 146 IAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKT 179
I YRDLKPEN+L+ G+V ++D L+ L
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 7e-24
Identities = 60/160 (37%), Positives = 90/160 (56%), Gaps = 7/160 (4%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP 83
K+LGKG G V LV ++A+ +A+K++ K + AK E E RVL HP
Sbjct: 1 KLLGKGTFGKVILVREKASGKY----YAMKILKKEVIIAKDEVAHTLT-ESRVLKNTRHP 55
Query: 84 FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN 143
FL L S +T + L + + Y GG+L + +RVFS RFY +EI+ A+++LH+
Sbjct: 56 FLTSLKYSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRFYGAEIVSALDYLHS 113
Query: 144 MGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEK 183
I YRDLK EN+++ + GH+ +TDF L + + A K
Sbjct: 114 GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMK 153
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 9e-24
Identities = 53/156 (33%), Positives = 86/156 (55%), Gaps = 7/156 (4%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVL 77
++ + +K++ GA G V+LV + R FA+K ++K L +++ ++ E +L
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHK----ETRQRFAMKKINKQNLILRNQIQQ-VFVERDIL 55
Query: 78 SRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICA 137
+ +PF+ + S ET L + Y GGD L +N + R Y +E + A
Sbjct: 56 TFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLL--KNIGALPVDMARMYFAETVLA 113
Query: 138 IEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+E+LHN GI +RDLKP+N+LI GH+ LTDF LS+
Sbjct: 114 LEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSK 149
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 2e-23
Identities = 57/150 (38%), Positives = 88/150 (58%), Gaps = 7/150 (4%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP 83
K+LGKG G V LV ++A T R +A+K++ K + AK E E RVL HP
Sbjct: 1 KLLGKGTFGKVILVREKA---TGRY-YAMKILRKEVIIAKDEVAHTVT-ESRVLQNTRHP 55
Query: 84 FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN 143
FL L + +T + L + + Y GG+L + +RVF+ RFY +EI+ A+E+LH+
Sbjct: 56 FLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLHS 113
Query: 144 MGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+ YRD+K EN+++ + GH+ +TDF L +
Sbjct: 114 RDVVYRDIKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 2e-23
Identities = 50/131 (38%), Positives = 77/131 (58%), Gaps = 2/131 (1%)
Query: 236 QQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKE 295
+++ ++ +++F GT EY++PEV+ ++ VDWW LG + YEMLYG PF +N E
Sbjct: 144 KENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 203
Query: 296 TFRNVLMKTPEFVGQRT-ALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRW-DLL 353
+ N+L K + T + L++ LL+KD KRLG EIK H+FF + W DL+
Sbjct: 204 MYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLI 263
Query: 354 TDVLRPPFIPS 364
+ PPF P+
Sbjct: 264 NKKITPPFNPN 274
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 5e-23
Identities = 39/108 (36%), Positives = 55/108 (50%), Gaps = 6/108 (5%)
Query: 242 GERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRK--ETFRN 299
+ S GT Y++PEV+ G+ AVDWW+LG+ YE L G P+RG +R + R
Sbjct: 153 DTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA 212
Query: 300 V-LMKTPEF-VGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345
+ T D I +LLE+DP KRLG ++K H +F
Sbjct: 213 KQETADVLYPATWSTEAIDAINKLLERDPQKRLGD--NLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 6e-23
Identities = 52/151 (34%), Positives = 79/151 (52%), Gaps = 8/151 (5%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-H 82
K+LGKG+ G V L + D +A+KV+ K + + E E RVL+ H
Sbjct: 1 KVLGKGSFGKVLLAELKGTDEL----YAVKVLKKDVILQDDDVECTMT-EKRVLALAGKH 55
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLH 142
PFL +L +T + L + + Y GGDL + + Q F RFY +EI+ ++ LH
Sbjct: 56 PFLTQLHSCFQTKDRLFFVMEYVNGGDL--MFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113
Query: 143 NMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
GI YRDLK +N+L+ GH+ + DF + +
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 1e-22
Identities = 62/161 (38%), Positives = 92/161 (57%), Gaps = 8/161 (4%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP 83
K+LGKG G V LV ++A T R +A+K++ K + AK E E RVL HP
Sbjct: 1 KLLGKGTFGKVILVKEKA---TGRY-YAMKILKKEVIVAKDEVAHTLT-ENRVLQNSRHP 55
Query: 84 FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN 143
FL L S +T + L + + Y GG+L + +RVFS RFY +EI+ A+++LH+
Sbjct: 56 FLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHS 113
Query: 144 -MGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEK 183
+ YRDLK EN+++ + GH+ +TDF L + +K A K
Sbjct: 114 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 154
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 4e-22
Identities = 63/155 (40%), Positives = 85/155 (54%), Gaps = 9/155 (5%)
Query: 26 LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHE-AERRARWEIRVLSRLSH-P 83
+GKG G V+ V R D T R +A+KV+ K + AK E A I V + L P
Sbjct: 1 IGKGTFGQVYQV--RKKD-TRRI-YAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESP 56
Query: 84 FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN 143
F+ L S +TD L Y GG+L + Q + FS +FY++E++ A+EHLH
Sbjct: 57 FIVGLKFSFQTDSDLYLVTDYMSGGEL--FWHLQKEGRFSEDRAKFYIAELVLALEHLHK 114
Query: 144 MGIAYRDLKPENILIRQSGHVTLTDFDLSR-NLVK 177
I YRDLKPENIL+ +GH+ L DF LS+ NL
Sbjct: 115 YDIVYRDLKPENILLDATGHIALCDFGLSKANLTD 149
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 6e-22
Identities = 43/123 (34%), Positives = 77/123 (62%), Gaps = 5/123 (4%)
Query: 244 RSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK 303
++ +F GT +Y++PE++ G + +VDWW+ G+L YEML G +PF G + +E F+++ M
Sbjct: 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD 211
Query: 304 TPEFVGQRTA-LTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTD-VLRPPF 361
P + T D++ +L ++P +RLG ++G +I++H FF+ + W L + + PPF
Sbjct: 212 NPCYPRWLTREAKDILVKLFVREPERRLG-VKG--DIRQHPFFREIDWSALEEREIEPPF 268
Query: 362 IPS 364
P
Sbjct: 269 KPK 271
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 6e-22
Identities = 49/136 (36%), Positives = 78/136 (57%), Gaps = 11/136 (8%)
Query: 241 NGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNV 300
NG+ +++F GT +Y++PE+++ + +VDWWA+G+L YEML G PF +N + F +
Sbjct: 149 NGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI 208
Query: 301 L---MKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLR--GACEIKEHVFFKGVRWDLLTD 355
L + P ++ Q D+++ + K+P RLG L G I H FFK + W+ L
Sbjct: 209 LNDEVVYPTWLSQDA--VDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNR 266
Query: 356 -VLRPPFIP---SREE 367
+ PPF P SRE+
Sbjct: 267 RQIEPPFRPRIKSRED 282
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 7e-22
Identities = 56/150 (37%), Positives = 83/150 (55%), Gaps = 6/150 (4%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP 83
K++GKG+ G V L +A + +A+KV+ K + K E + +L + HP
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKF----YAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 56
Query: 84 FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN 143
FL L S +T + L + + Y GG+L + Q +R F RFY +EI A+ +LH+
Sbjct: 57 FLVGLHFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAEIASALGYLHS 114
Query: 144 MGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+ I YRDLKPENIL+ GH+ LTDF L +
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 7e-22
Identities = 51/146 (34%), Positives = 85/146 (58%), Gaps = 18/146 (12%)
Query: 242 GERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPF--------RGKNR 293
G+ +++F GT Y++PE++RG+ + F+VDWWALG+L +EM+ G +PF +N
Sbjct: 150 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNT 209
Query: 294 KE-TFRNVLMKT---PEFVGQRTALTDLIQRLLEKDPVKRLGYLR--GACEIKEHVFFKG 347
++ F+ +L K P + + + +++ L KDP +RLG G +IK H FF+
Sbjct: 210 EDYLFQVILEKQIRIPRSLSVKAS--SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267
Query: 348 VRWDLL-TDVLRPPFIPSRE-ENDLT 371
+ WDLL + PP+ P+ E + DL
Sbjct: 268 IDWDLLEQKQVLPPYKPNIESDRDLD 293
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 7e-22
Identities = 80/310 (25%), Positives = 119/310 (38%), Gaps = 73/310 (23%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERR-ARWEIRVLSRLS 81
+++LGKGA G L + R D + L V + L E ERR A EI +LS L
Sbjct: 5 IRVLGKGAFGEATL-YRRTEDDS------LVVWKEVNLTRLSEKERRDALNEIVILSLLQ 57
Query: 82 HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHL 141
HP + D L + Y GG L +Q ++F ++ +YL +I+ A+ ++
Sbjct: 58 HPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYI 117
Query: 142 HNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPK 201
H GI +RD+K TL F L+K F
Sbjct: 118 HKAGILHRDIK------------TLNIFLTKAGLIKLGDF-------------------- 145
Query: 202 RHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVR 261
G+ K + S + + VGT Y+SPE+ +
Sbjct: 146 ------------------GISKILGSEYS-------------MAETVVGTPYYMSPELCQ 174
Query: 262 GDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK--TPEFVGQRTALTDLIQ 319
G + F D WALG + YE+L F N ++ TP + L L+
Sbjct: 175 GVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVH 234
Query: 320 RLLEKDPVKR 329
LL++DP KR
Sbjct: 235 SLLQQDPEKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 8e-22
Identities = 48/125 (38%), Positives = 76/125 (60%), Gaps = 8/125 (6%)
Query: 245 SNSFVGTEEYVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK 303
+N+F GT EY++PEV+ + G+ VD+W+LG+L +EM G +PF ++ ++ +RN+
Sbjct: 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG 212
Query: 304 TPEFVGQRTALTD----LIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLT-DVLR 358
F + L+D ++ LL ++P RLG R A E+KEH FF + WDLL+ +
Sbjct: 213 KVRF--PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQIT 270
Query: 359 PPFIP 363
PPF P
Sbjct: 271 PPFKP 275
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 3e-21
Identities = 58/186 (31%), Positives = 88/186 (47%), Gaps = 25/186 (13%)
Query: 240 DNGERSNSFVGTEEYVSPEVVR----GDGHEFA-VDWWALGILTYEMLYGTTPFRGKNRK 294
D +SN VGT +Y+SPE+++ G G DWW+LG+ YEMLYG TPF ++
Sbjct: 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
Query: 295 ETF------RNVLMKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGV 348
ET+ + P+ DLI+RL+ P RLG G + K+H FF+G+
Sbjct: 215 ETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICS-PETRLGR-NGLQDFKDHPFFEGI 272
Query: 349 RWDLLTDVLRPPFIPSREENDLTEKAMSGGGVDIREYFENLRAPPPSMPPSPLPSPS--H 406
WD + + P++P D+ + ++LR S+PPS + S H
Sbjct: 273 DWDNIRN-STAPYVPE------VSSPTDTSNFDVDD--DDLRN-TESLPPSSHGAFSGNH 322
Query: 407 RSFAEY 412
F +
Sbjct: 323 LPFVGF 328
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 5e-21
Identities = 47/133 (35%), Positives = 80/133 (60%), Gaps = 11/133 (8%)
Query: 242 GERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFR------GKNRKE 295
G+ +++F GT Y++PE++RG+ + F+VDWWALG+L +EM+ G +PF N ++
Sbjct: 150 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTED 209
Query: 296 TFRNVLMKTPEFVGQRTAL--TDLIQRLLEKDPVKRLG--YLRGACEIKEHVFFKGVRWD 351
V+++ P + + ++ + +++ L KDP +RLG G +IK H FF+ + WD
Sbjct: 210 YLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD 269
Query: 352 LLTD-VLRPPFIP 363
LL + PPF P
Sbjct: 270 LLEKKQVTPPFKP 282
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 6e-21
Identities = 45/127 (35%), Positives = 75/127 (59%), Gaps = 5/127 (3%)
Query: 242 GERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL 301
G+ + +F GT +Y++PE++ + +VDWWA G+L YEML G PF G++ E F++++
Sbjct: 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM 214
Query: 302 MKTPEFVG--QRTALTDLIQRLLEKDPVKRLGY-LRGACEIKEHVFFKGVRWDLLTDV-L 357
+ + A++ + + LL K P KRLG G +I+EH FF+ + W+ L +
Sbjct: 215 EHNVSYPKSLSKEAVS-ICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREI 273
Query: 358 RPPFIPS 364
+PPF P
Sbjct: 274 QPPFKPK 280
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 8e-21
Identities = 58/150 (38%), Positives = 84/150 (56%), Gaps = 6/150 (4%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP 83
K++GKG+ G V L R D +C +A+KV+ K + + E + +L + HP
Sbjct: 1 KVIGKGSFGKVLLA-KRKLD--GKC-YAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHP 56
Query: 84 FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN 143
FL L S +T E L + + + GG+L + Q +R F RFY +EI A+ +LH+
Sbjct: 57 FLVGLHYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYAAEIASALGYLHS 114
Query: 144 MGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+ I YRDLKPENIL+ GHV LTDF L +
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 53/171 (30%), Positives = 89/171 (52%), Gaps = 18/171 (10%)
Query: 236 QQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKE 295
++ +G + +F GT +Y++PE++ + +VDWWA G+L YEML G PF G++ E
Sbjct: 149 KEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208
Query: 296 TFRNVL---MKTPEFVGQRTALTDLIQRLLEKDPVKRLGY-LRGACEIKEHVFFKGVRWD 351
F++++ + P+ + + + + L+ K P KRLG G +I+EH FF+ + WD
Sbjct: 209 LFQSIMEHNVSYPKSLSKEA--VSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWD 266
Query: 352 LLTD-VLRPPFIPSREENDLTEKAMSGGGVDIREYFENLRAPPPSMPPSPL 401
L + ++PPF P K G + ++F R P PP L
Sbjct: 267 KLENREIQPPFKP---------KVCGKGAENFDKFFT--RGQPVLTPPDQL 306
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 1e-20
Identities = 77/343 (22%), Positives = 121/343 (35%), Gaps = 105/343 (30%)
Query: 21 KALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL 80
+ L +G+G G V+ D+ A+K + + A EI++L L
Sbjct: 2 QKLGKIGEGTYGVVYKARDKLTGEI----VAIKKIKLRFESEGIP--KTALREIKLLKEL 55
Query: 81 SHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRY-KQNDRVFSPSVIRFYLSEIICAIE 139
+HP + KLL L + D ++ + K R S+I+ YL +++ +
Sbjct: 56 NHPNIIKLLDVFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLA 112
Query: 140 HLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTEN 199
H+ GI +RDLKPEN+LI G + L DF L+R+ PV P T
Sbjct: 113 FCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGS--------------PVRPYTH- 157
Query: 200 PKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEV 259
++TRW Y +PE+
Sbjct: 158 -----YVVTRW-------------------------------------------YRAPEL 169
Query: 260 VRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNR----------------------KET 296
+ GD G+ VD W++G + E+L F GK+
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL 229
Query: 297 FRNVLMKTPEFVGQRTALT---------DLIQRLLEKDPVKRL 330
RN P+ G DL+ ++L DP KR+
Sbjct: 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRI 272
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-20
Identities = 54/151 (35%), Positives = 82/151 (54%), Gaps = 8/151 (5%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-H 82
K+LGKG+ G V L + + FA+K + K + + E E RVL+ H
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEF----FAIKALKKDVVLEDDDVEC-TMVERRVLALAWEH 55
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLH 142
PFL L + +T E L + + Y GGDL + + Q+ F + RFY +EIIC ++ LH
Sbjct: 56 PFLTHLFCTFQTKEHLFFVMEYLNGGDL--MFHIQSSGRFDEARARFYAAEIICGLQFLH 113
Query: 143 NMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
GI YRDLK +N+L+ + GH+ + DF + +
Sbjct: 114 KKGIIYRDLKLDNVLLDKDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 55/154 (35%), Positives = 85/154 (55%), Gaps = 7/154 (4%)
Query: 26 LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFL 85
+GKG+ G V V R T R +ALK + K+ + ++ E E VL++++ PF+
Sbjct: 1 IGKGSFGKVMQVRKR---DTQRI-YALKTIRKAHIVSRSEVTHTLA-ERTVLAQVNCPFI 55
Query: 86 PKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMG 145
L S ++ E L + + GG+L + Q + F S RFY +E++CA+E+LH
Sbjct: 56 VPLKFSFQSPEKLYLVLAFINGGEL--FHHLQREGRFDLSRARFYTAELLCALENLHKFN 113
Query: 146 IAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKT 179
+ YRDLKPENIL+ GH+ L DF L + +K
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD 147
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-20
Identities = 49/126 (38%), Positives = 71/126 (56%), Gaps = 3/126 (2%)
Query: 242 GERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL 301
G +F GT EY++PEV+ + + AVDWW LG++ YEM+ G PF ++ ++ F +L
Sbjct: 149 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 208
Query: 302 MKTPEFVGQRT-ALTDLIQRLLEKDPVKRL-GYLRGACEIKEHVFFKGVRW-DLLTDVLR 358
M+ F + L+ LL+KDP +RL G A EI EH FF + W D++ L
Sbjct: 209 MEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLE 268
Query: 359 PPFIPS 364
PPF P
Sbjct: 269 PPFKPQ 274
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 3e-20
Identities = 53/148 (35%), Positives = 80/148 (54%), Gaps = 7/148 (4%)
Query: 221 LKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYE 280
L K +++ ++ +G +F GT EY++PEV+ + + AVDWW LG++ YE
Sbjct: 129 LDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 188
Query: 281 MLYGTTPFRGKNRKETFRNVLMKTPEFVGQRT---ALTDLIQRLLEKDPVKRL-GYLRGA 336
M+ G PF ++ ++ F +LM+ F RT L+ LL+KDP +RL G A
Sbjct: 189 MMCGRLPFYNQDHEKLFELILMEEIRF--PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDA 246
Query: 337 CEIKEHVFFKGVRW-DLLTDVLRPPFIP 363
EI +H FF G+ W D+ L PPF P
Sbjct: 247 KEIMQHKFFAGIVWQDVYEKKLVPPFKP 274
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 3e-20
Identities = 52/151 (34%), Positives = 76/151 (50%), Gaps = 8/151 (5%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLS-RLSH 82
K+LGKG+ G V L + D +A+KV+ K + + + E R+L+ H
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEV----YAIKVLKKDVILQDDDVDCTMT-EKRILALAAKH 55
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLH 142
PFL L +T + L + + Y GGDL + Q R F RFY +E+ A+ LH
Sbjct: 56 PFLTALHCCFQTKDRLFFVMEYVNGGDL--MFQIQRSRKFDEPRSRFYAAEVTLALMFLH 113
Query: 143 NMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
G+ YRDLK +NIL+ GH L DF + +
Sbjct: 114 RHGVIYRDLKLDNILLDAEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 4e-20
Identities = 47/152 (30%), Positives = 75/152 (49%), Gaps = 11/152 (7%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVL---SR 79
L +LG+G G V L + +A+K + K + A+ E E E R+ +
Sbjct: 4 LAVLGRGHFGKVLLAEYK----KTGELYAIKALKKGDIIARDEVES-LMCEKRIFETANS 58
Query: 80 LSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIE 139
HPFL L +T++ + + + Y GGDL + + D VFS FY + ++ ++
Sbjct: 59 ERHPFLVNLFACFQTEDHVCFVMEYAAGGDL--MMHIHTD-VFSEPRAVFYAACVVLGLQ 115
Query: 140 HLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171
+LH I YRDLK +N+L+ G V + DF L
Sbjct: 116 YLHENKIVYRDLKLDNLLLDTEGFVKIADFGL 147
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 4e-20
Identities = 46/130 (35%), Positives = 74/130 (56%), Gaps = 9/130 (6%)
Query: 241 NGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNV 300
NG + +F GT +Y++PE+++ + +VDWWALG+L YEM+ G PF N + F ++
Sbjct: 149 NGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI 208
Query: 301 LMKT---PEFVGQRTALTDLIQRLLEKDPVKRLGYL---RGACEIKEHVFFKGVRWDLL- 353
L P ++ + +++ + K+P KRLG + G IK+H FFK + W LL
Sbjct: 209 LHDDVLYPVWLSKEA--VSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLE 266
Query: 354 TDVLRPPFIP 363
++PPF P
Sbjct: 267 QRKIKPPFKP 276
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 5e-20
Identities = 55/148 (37%), Positives = 79/148 (53%), Gaps = 7/148 (4%)
Query: 221 LKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYE 280
L K +++ ++ + +F GT EY++PEV+ + + AVDWW LG++ YE
Sbjct: 128 LDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 187
Query: 281 MLYGTTPFRGKNRKETFRNVLMKTPEFVGQRTALTD---LIQRLLEKDPVKRL-GYLRGA 336
M+ G PF ++ ++ F +LM+ +F RT D L+ LL KDP KRL G A
Sbjct: 188 MMCGRLPFYNQDHEKLFELILMEDIKF--PRTLSADAKSLLSGLLIKDPNKRLGGGPDDA 245
Query: 337 CEIKEHVFFKGVRW-DLLTDVLRPPFIP 363
EI H FF GV W D+ L PPF P
Sbjct: 246 KEIMRHSFFTGVNWQDVYDKKLVPPFKP 273
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (222), Expect = 5e-20
Identities = 83/363 (22%), Positives = 138/363 (38%), Gaps = 124/363 (34%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAER--------RARWEI 74
L+ LG+G G V+ +A D ALK + + + E R EI
Sbjct: 4 LEKLGEGTYGVVY----KARDKKTGEIVALKKI-------RLDNEEEGIPSTALR---EI 49
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRY-KQNDRVFSPSVIRFYLSE 133
+L L HP + KLL + T+ L YC D+++ +Y + SP++I+ + +
Sbjct: 50 SLLKELKHPNIVKLLDVIHTERKLYLVFEYC---DMDLKKYLDKRPGPLSPNLIKSIMYQ 106
Query: 134 IICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPV 193
++ + + H+ I +RDLKP+NILI + G + L DF L+R AF P+
Sbjct: 107 LLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLAR------AFG--------IPL 152
Query: 194 LPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253
T ++T W
Sbjct: 153 RTYTHE------VVTLW------------------------------------------- 163
Query: 254 YVSPEVVRGDGH-EFAVDWWALGILTYEMLYGTTPFRGKNR---------------KETF 297
Y +PE++ G H AVD W++G + EM+ G F G + +E++
Sbjct: 164 YRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESW 223
Query: 298 RNV------LMKTPEFVGQR---------TALTDLIQRLLEKDPVKRLGYLRGACEIKEH 342
V P+F + DL+ ++L+ +P KR+ A E +H
Sbjct: 224 PGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRI----SAKEALKH 279
Query: 343 VFF 345
+F
Sbjct: 280 PYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 6e-20
Identities = 50/133 (37%), Positives = 75/133 (56%), Gaps = 7/133 (5%)
Query: 236 QQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKE 295
++ +G +F GT EY++PEV+ + + AVDWW LG++ YEM+ G PF ++ +
Sbjct: 143 KEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 202
Query: 296 TFRNVLMKTPEFVGQRTALTD---LIQRLLEKDPVKRL-GYLRGACEIKEHVFFKGVRW- 350
F +LM+ F RT + L+ LL+KDP +RL G A E+ EH FF + W
Sbjct: 203 LFELILMEEIRF--PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 260
Query: 351 DLLTDVLRPPFIP 363
D++ L PPF P
Sbjct: 261 DVVQKKLLPPFKP 273
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 6e-20
Identities = 56/151 (37%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLS-RLSH 82
K+LGKG+ G VFL + + FA+K + K + + E E RVLS H
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQF----FAIKALKKDVVLMDDDVEC-TMVEKRVLSLAWEH 55
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLH 142
PFL L + +T E L + + Y GGDL + + Q+ F FY +EIIC ++ LH
Sbjct: 56 PFLTHLYCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGLQFLH 113
Query: 143 NMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+ GI YRDLK +NIL+ GH+ + DF + +
Sbjct: 114 SKGIVYRDLKLDNILLDTDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (220), Expect = 6e-20
Identities = 65/316 (20%), Positives = 116/316 (36%), Gaps = 74/316 (23%)
Query: 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSR 79
L+ K LG+GA G V+ + A+K + + + E E ++ +
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLE---EASIMKK 57
Query: 80 LSHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYLSEIICAI 138
LSHP + +LLG E L Y PGGDL + LR ++ + + +I +
Sbjct: 58 LSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLR--KHGEKLTLKDLLQMALQIAKGM 115
Query: 139 EHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTE 198
E+L + +RDL N L+ ++ V ++DF LSR++ + + K+ K P+
Sbjct: 116 EYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG--GGKLPI----- 168
Query: 199 NPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPE 258
+W+ +PE
Sbjct: 169 ----------KWM--------------------------------------------APE 174
Query: 259 VVRGDGHEFAVDWWALGILTYEML-YGTTPFRGKNRKETFRNV----LMKTPEFVGQRTA 313
++ D W+ G+L +E+ G P+ G + +E + + PE
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDE-- 232
Query: 314 LTDLIQRLLEKDPVKR 329
L +L+ + DP R
Sbjct: 233 LYELMLQCWAYDPEDR 248
|
Length = 258 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 6e-20
Identities = 48/122 (39%), Positives = 71/122 (58%), Gaps = 7/122 (5%)
Query: 249 VGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRK---ETFRNVLMKTP 305
VGT Y++PEVV+ + + F+ DWWALG L YEM+ G +PF+ + +K E ++ +
Sbjct: 162 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ 221
Query: 306 EFVGQRTA--LTDLIQRLLEKDPVKRLGYL-RGACEIKEHVFFKGVRWDLL-TDVLRPPF 361
E ++ + L + LL KDP +RLG GA E+KEH FK + + L +L PPF
Sbjct: 222 EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPF 281
Query: 362 IP 363
P
Sbjct: 282 KP 283
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 6e-20
Identities = 52/163 (31%), Positives = 86/163 (52%), Gaps = 18/163 (11%)
Query: 241 NGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNV 300
+G + +F GT +Y++PE++ + +VDWWA G+L YEML G PF G++ E F+++
Sbjct: 154 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 213
Query: 301 L---MKTPEFVGQRTALTDLIQRLLEKDPVKRLGY-LRGACEIKEHVFFKGVRWDLLT-D 355
+ + P+ + + + + L+ K P KRLG G +IKEH FF+ + W+ L
Sbjct: 214 MEHNVAYPKSMSKEAVA--ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERK 271
Query: 356 VLRPPFIPSREENDLTEKAMSGGGVDIREYFENLRAPPPSMPP 398
++PP+ P KA + ++F R PP PP
Sbjct: 272 EVQPPYKP---------KACGRDAENFDKFFT--RHPPVLTPP 303
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 1e-19
Identities = 47/138 (34%), Positives = 80/138 (57%), Gaps = 17/138 (12%)
Query: 242 GERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFR--------GKNR 293
G+ +++F GT Y++PE++RG+ + F+VDWWALG+L +EM+ G +PF +N
Sbjct: 150 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 209
Query: 294 KETFRNVLM----KTPEFVGQRTALTDLIQRLLEKDPVKRLGYL--RGACEIKEHVFFKG 347
++ V++ + P + + A +++ L KDP +RLG G +I+ H FF+
Sbjct: 210 EDYLFQVILEKQIRIPRSLSVKAA--SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267
Query: 348 VRWDLLTD-VLRPPFIPS 364
V WDL+ + PPF P+
Sbjct: 268 VDWDLMEQKQVVPPFKPN 285
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 2e-19
Identities = 47/129 (36%), Positives = 70/129 (54%), Gaps = 7/129 (5%)
Query: 242 GERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGK----NRKETF 297
GE VGT Y++PEV+ + + F+ DWW LG L YEM+ G +PFR + R+E
Sbjct: 155 GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD 214
Query: 298 RNVLMKTPEFVGQRTA-LTDLIQRLLEKDPVKRLGYL-RGACEIKEHVFFKGVRWDLL-T 354
R V E+ + + + + LL K+P +RLG GA +K+H FK + + L
Sbjct: 215 RRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEA 274
Query: 355 DVLRPPFIP 363
++L PPF P
Sbjct: 275 NMLEPPFCP 283
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 3e-19
Identities = 52/151 (34%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLS-RLSH 82
++LGKG+ G V L + + +A+KV+ K + + E E R+LS +H
Sbjct: 1 RVLGKGSFGKVMLARLKESGRL----YAVKVLKKDVILQDDDVECTMT-EKRILSLARNH 55
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLH 142
PFL +L +T + L + + + GGDL + + Q R F + RFY +EI A+ LH
Sbjct: 56 PFLTQLYCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITSALMFLH 113
Query: 143 NMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+ GI YRDLK +N+L+ GH L DF + +
Sbjct: 114 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 4e-19
Identities = 68/269 (25%), Positives = 114/269 (42%), Gaps = 68/269 (25%)
Query: 25 ILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRA-----RWEIRVLSR 79
++G G+ G+V+L + ++ A+K V+ ++ A + +R+ EI +L
Sbjct: 7 LIGSGSFGSVYL----GMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKE 62
Query: 80 LSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIE 139
L H + + LGS + L + Y PGG + L N F +++R ++ +I+ +
Sbjct: 63 LQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALL--NNYGAFEETLVRNFVRQILKGLN 120
Query: 140 HLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTEN 199
+LHN GI +RD+K NIL+ G + ++DF +S+ L E SL+
Sbjct: 121 YLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKL------EANSLST----------- 163
Query: 200 PKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEV 259
KT AR S G+ +++PEV
Sbjct: 164 -----------------------KTNGARPS-----------------LQGSVFWMAPEV 183
Query: 260 VRGDGHEFAVDWWALGILTYEMLYGTTPF 288
V+ + D W+LG L EML G PF
Sbjct: 184 VKQTSYTRKADIWSLGCLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 6e-19
Identities = 47/150 (31%), Positives = 70/150 (46%), Gaps = 12/150 (8%)
Query: 26 LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAK--HEAERRARWEIRVLSRLSHP 83
+G+GA G VF DR T ALK V L ++A R EI+ L HP
Sbjct: 8 IGEGAHGIVFKAKDRETGETV----ALKKVALRRLEGGIPNQALR----EIKALQACQHP 59
Query: 84 FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN 143
++ KLL + Y P VLR +R + ++ Y+ ++ + ++H
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYMPSDLSEVLR--DEERPLPEAQVKSYMRMLLKGVAYMHA 117
Query: 144 MGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
GI +RDLKP N+LI G + + DF L+R
Sbjct: 118 NGIMHRDLKPANLLISADGVLKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 6e-19
Identities = 57/157 (36%), Positives = 89/157 (56%), Gaps = 10/157 (6%)
Query: 25 ILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH-- 82
I+G+G G V+ R AD T + +A+K +DK + K + E A E +LS +S
Sbjct: 1 IIGRGGFGEVYGC--RKAD-TGKM-YAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGD 55
Query: 83 -PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHL 141
PF+ + + T + L++ + GGDL+ + VFS + +RFY +EII +EH+
Sbjct: 56 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHY--HLSQHGVFSEAEMRFYAAEIILGLEHM 113
Query: 142 HNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178
HN + YRDLKP NIL+ + GHV ++D L+ + KK
Sbjct: 114 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 150
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 7e-19
Identities = 63/283 (22%), Positives = 107/283 (37%), Gaps = 68/283 (24%)
Query: 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSR 79
L K LG+GA G V+ + A+K + + + E R E R++ +
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLR---EARIMRK 57
Query: 80 LSHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYLSEIICAI 138
L HP + KLLG +E L + Y PGGDL + LR + + S S + + +I +
Sbjct: 58 LDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP-KELSLSDLLSFALQIARGM 116
Query: 139 EHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTE 198
E+L + +RDL N L+ ++ V ++DF LSR+L ++ + K P+
Sbjct: 117 EYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG---KLPI----- 168
Query: 199 NPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPE 258
RW+ +PE
Sbjct: 169 ----------RWM--------------------------------------------APE 174
Query: 259 VVRGDGHEFAVDWWALGILTYEML-YGTTPFRGKNRKETFRNV 300
++ D W+ G+L +E+ G P+ G + E +
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYL 217
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 7e-19
Identities = 49/153 (32%), Positives = 75/153 (49%), Gaps = 5/153 (3%)
Query: 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSR 79
+ ++LGKG G V RA +A K ++K + K + E A E ++L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKM----YACKRLEKKRIK-KRKGESMALNEKQILEK 56
Query: 80 LSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIE 139
++ F+ L + ET + L + GGDL Y + F FY +EI+C +E
Sbjct: 57 VNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLE 116
Query: 140 HLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172
LH YRDLKPENIL+ GH+ ++D L+
Sbjct: 117 DLHRENTVYRDLKPENILLDDYGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 49/168 (29%), Positives = 87/168 (51%), Gaps = 7/168 (4%)
Query: 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRAR 71
T S L + + + LG G+ G V + + A+K + K + + + A+
Sbjct: 12 TSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYY----AIKCLKKREILKMKQVQHVAQ 67
Query: 72 WEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYL 131
E +L LSHPF+ ++ S + + + + + + GG+L + + F V +FY
Sbjct: 68 -EKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGEL--FTHLRKAGRFPNDVAKFYH 124
Query: 132 SEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKT 179
+E++ A E+LH+ I YRDLKPEN+L+ GHV +TDF ++ + +T
Sbjct: 125 AELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172
|
Length = 329 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 1e-18
Identities = 49/129 (37%), Positives = 70/129 (54%), Gaps = 7/129 (5%)
Query: 242 GERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGK----NRKETF 297
GE VGT Y++PEV+ + + D+W LG L YEM+ G +PFRG+ R+E
Sbjct: 155 GESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD 214
Query: 298 RNVLMKTPEFVGQRTALTDLI-QRLLEKDPVKRLG-YLRGACEIKEHVFFKGVRWDLL-T 354
R VL + + + I + LL KDP +RLG GA E+K H FF+ + + L
Sbjct: 215 RRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEA 274
Query: 355 DVLRPPFIP 363
+L PPF+P
Sbjct: 275 GMLDPPFVP 283
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 1e-18
Identities = 70/316 (22%), Positives = 118/316 (37%), Gaps = 75/316 (23%)
Query: 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSR 79
L K LG+GA G V+ + + A+K + + + E E R++ +
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA-SEQQIEEFLR--EARIMRK 57
Query: 80 LSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRY-KQNDRVFSPSVIRFYLSEIICAI 138
L HP + KLLG +E L + Y GGDL L Y ++N S S + + +I +
Sbjct: 58 LDHPNVVKLLGVCTEEEPLYIVMEYMEGGDL--LSYLRKNRPKLSLSDLLSFALQIARGM 115
Query: 139 EHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTE 198
E+L + +RDL N L+ ++ V ++DF LSR+L + K+ K P+
Sbjct: 116 EYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG---KLPI----- 167
Query: 199 NPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPE 258
RW+ +PE
Sbjct: 168 ----------RWM--------------------------------------------APE 173
Query: 259 VVRGDGHEFAVDWWALGILTYEML-YGTTPFRGKNRKETFRNV----LMKTPEFVGQRTA 313
++ D W+ G+L +E+ G P+ G + +E + + P
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPP--NCPPE 231
Query: 314 LTDLIQRLLEKDPVKR 329
L DL+ + +DP R
Sbjct: 232 LYDLMLQCWAEDPEDR 247
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 2e-18
Identities = 44/151 (29%), Positives = 76/151 (50%), Gaps = 8/151 (5%)
Query: 25 ILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPF 84
++G+GA G V+ + + A+K + + K EA + EI +L L HP
Sbjct: 7 LIGRGAFGVVY----KGLNLETGDFVAIKQISLEKI--KEEALKSIMQEIDLLKNLKHPN 60
Query: 85 LPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNM 144
+ K +GS+ET + L + Y G L + K+ F S++ Y+ +++ + +LH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQI-IKKFGP-FPESLVAVYVYQVLQGLAYLHEQ 118
Query: 145 GIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
G+ +RD+K NIL + G V L DF ++ L
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKL 149
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 3e-18
Identities = 49/134 (36%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 234 RRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNR 293
RR + GER +GT +Y++PE++ G H AVDWWALG+ +E L G PF +
Sbjct: 529 RRGAAPVEGER---ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETP 585
Query: 294 KETFRNVLMKTPEFVGQRTALTD----LIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349
++ F+N+L + + L+ I+ LL DP KR G E+K+H F GV
Sbjct: 586 QQVFQNILNRDIPWPEGEEKLSVNAQNAIEILLTMDPTKR----AGLKELKQHPLFHGVD 641
Query: 350 WDLLTDVLRPPFIP 363
W+ L + PFIP
Sbjct: 642 WENLQNQ-TMPFIP 654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 4e-18
Identities = 50/157 (31%), Positives = 85/157 (54%), Gaps = 16/157 (10%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRA-----RW 72
D+ + LK++G+GA G V +V + +A+K+++K E +RA R
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQV----YAMKILNK------WEMLKRAETACFRE 50
Query: 73 EIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLS 132
E VL ++ L + + + L + Y GGDL L K DR+ + RFYL+
Sbjct: 51 ERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL-PEDMARFYLA 109
Query: 133 EIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169
E++ AI+ +H +G +RD+KP+N+L+ ++GH+ L DF
Sbjct: 110 EMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADF 146
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 6e-18
Identities = 45/164 (27%), Positives = 80/164 (48%), Gaps = 9/164 (5%)
Query: 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERR-ARWEIRVL 77
+ ++++G+GA G V L +A L ++ + + + ER A+ E +VL
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQ-------KLVIIKQIPVEQMTKDERLAAQNECQVL 53
Query: 78 SRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICA 137
LSHP + + + D+ L + Y PGG L K+ + + I + +I+ A
Sbjct: 54 KLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA 113
Query: 138 IEHLHNMGIAYRDLKPENILI-RQSGHVTLTDFDLSRNLVKKTA 180
+ H+H I +RDLK +NIL+ + V + DF +S+ L K+
Sbjct: 114 LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 9e-18
Identities = 50/153 (32%), Positives = 75/153 (49%), Gaps = 5/153 (3%)
Query: 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSR 79
+ ++LGKG G V RA +A K ++K + K + E A E ++L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKM----YACKKLEKKRIK-KRKGESMALNEKQILEK 56
Query: 80 LSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIE 139
++ F+ L + ET + L + GGDL Y + F FY +EI C +E
Sbjct: 57 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLE 116
Query: 140 HLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172
LH I YRDLKPENIL+ GH+ ++D L+
Sbjct: 117 DLHQERIVYRDLKPENILLDDHGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-17
Identities = 50/130 (38%), Positives = 78/130 (60%), Gaps = 7/130 (5%)
Query: 243 ERSNSFVGTEEYVSPEVV-RGDGHEFAVDWWALGILTYEMLYGTTPFR---GKNRKETFR 298
++ ++ VGT Y++PEV+ +G ++ + DW++LG + +++L G +PFR K++ E R
Sbjct: 150 KKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 209
Query: 299 NVLMKTPEFVGQRTA-LTDLIQRLLEKDPVKRLGYL-RGACEIKEHVFFKGVRWD-LLTD 355
L E + L L++ LL++D KRLG L RGA E+KEHVFFKG+ W +
Sbjct: 210 MTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQ 269
Query: 356 VLRPPFIPSR 365
PP IP R
Sbjct: 270 KYPPPLIPPR 279
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 14/159 (8%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARW---EIRVLSRL 80
+++G+G+ V LV + +A+KV+ K ++ + + W E V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRI----YAMKVIKKELVNDDEDID----WVQTEKHVFETA 52
Query: 81 S-HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIE 139
S HPFL L +T+ L + + + GGDL + + Q R RFY +EI A+
Sbjct: 53 SNHPFLVGLHSCFQTESRLFFVIEFVSGGDL--MFHMQRQRKLPEEHARFYSAEISLALN 110
Query: 140 HLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178
LH GI YRDLK +N+L+ GH+ LTD+ + + ++
Sbjct: 111 FLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP 149
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-17
Identities = 57/157 (36%), Positives = 87/157 (55%), Gaps = 10/157 (6%)
Query: 25 ILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH-- 82
I+G+G G V+ R AD T + +A+K +DK + K + E A E +LS +S
Sbjct: 1 IIGRGGFGEVYGC--RKAD-TGKM-YAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGD 55
Query: 83 -PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHL 141
PF+ + + T + L + + GGDL+ + VFS +RFY +EII +EH+
Sbjct: 56 CPFIVCMTYAFHTPDKLCFILDLMNGGDLHY--HLSQHGVFSEKEMRFYATEIILGLEHM 113
Query: 142 HNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178
HN + YRDLKP NIL+ + GHV ++D L+ + KK
Sbjct: 114 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 150
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 2e-17
Identities = 66/320 (20%), Positives = 118/320 (36%), Gaps = 83/320 (25%)
Query: 24 KILGKGAMGTVFL--VHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS 81
K LG+GA G V+ + + A+K + + + + + E RV+ +L
Sbjct: 1 KKLGEGAFGEVYKGKLKGK---DGKTTEVAVKTLKEDASEEERKDFLK---EARVMKKLG 54
Query: 82 HPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVF------SPSVIRFYLSEI 134
HP + +LLG +E L + Y GGDL + LR + S + + +I
Sbjct: 55 HPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQI 114
Query: 135 ICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVL 194
+E+L + +RDL N L+ + V ++DF LSR++ + K++ K P+
Sbjct: 115 AKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT--GGKLPI- 171
Query: 195 PVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254
RW+
Sbjct: 172 --------------RWM------------------------------------------- 174
Query: 255 VSPEVVRGDGHEFAVDWWALGILTYEML-YGTTPFRGKNRKETFRNVL----MKTPEFVG 309
+PE ++ D W+ G+L +E+ G TP+ G + +E + + PE+
Sbjct: 175 -APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCP 233
Query: 310 QRTALTDLIQRLLEKDPVKR 329
L +L+ + DP R
Sbjct: 234 DE--LYELMLSCWQLDPEDR 251
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 3e-17
Identities = 49/147 (33%), Positives = 72/147 (48%), Gaps = 5/147 (3%)
Query: 26 LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFL 85
LGKG G V V + +A K +DK L K E+ A E +L +++ PF+
Sbjct: 1 LGKGGFGEVCAVQVKNTGKM----YACKKLDKKRLK-KKSGEKMALLEKEILEKVNSPFI 55
Query: 86 PKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMG 145
L + E+ L + GGDL Y +R + Y ++I C I HLH+M
Sbjct: 56 VNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD 115
Query: 146 IAYRDLKPENILIRQSGHVTLTDFDLS 172
I YRD+KPEN+L+ G+ L+D L+
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 4e-17
Identities = 53/156 (33%), Positives = 83/156 (53%), Gaps = 17/156 (10%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKH-----EAERRARWEIRVL 77
+K + +GA G V+L + +A+KVV K+ + K+ +AER A L
Sbjct: 9 VKPISRGAFGKVYLGRKKNNSKL----YAVKVVKKADMINKNMVHQVQAERDAL----AL 60
Query: 78 SRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICA 137
S+ PF+ L SL++ + + Y GGD+ L + F + Y+SE+ A
Sbjct: 61 SK--SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALA 116
Query: 138 IEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+++LH GI +RDLKP+N+LI GH+ LTDF LS+
Sbjct: 117 LDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 5e-17
Identities = 46/140 (32%), Positives = 67/140 (47%), Gaps = 16/140 (11%)
Query: 244 RSNSFVGTEEYVSPEVVRGDGH--EFA--VDWWALGILTYEMLYGTTPFRGKNRKETFRN 299
R ++ VGT +Y+SPEV++ G + DWW++G+ YEML G TPF + T+
Sbjct: 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK 258
Query: 300 VL-----MKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLT 354
++ + P+ + DLI L V RLG G EIK H FFK +W
Sbjct: 259 IMDHKNSLTFPDDIEISKQAKDLICAFLTDREV-RLGR-NGVDEIKSHPFFKNDQWTF-- 314
Query: 355 DVLR---PPFIPSREENDLT 371
D +R P +P + T
Sbjct: 315 DNIRETVAPVVPELSSDIDT 334
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 6e-17
Identities = 45/161 (27%), Positives = 78/161 (48%), Gaps = 14/161 (8%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERR--ARWEIR 75
+L+ +K+LG+G+ G V+ V + PT +ALK + H + E R E++
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHK---PTG-KIYALKKI-----HVDGDEEFRKQLLRELK 51
Query: 76 VLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEII 135
L P++ K G+ + ++ + Y GG L L K V+ + +I+
Sbjct: 52 TLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKK--VGKIPEPVLAYIARQIL 109
Query: 136 CAIEHLHNM-GIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
+++LH I +RD+KP N+LI G V + DF +S+ L
Sbjct: 110 KGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 7e-17
Identities = 45/122 (36%), Positives = 71/122 (58%), Gaps = 7/122 (5%)
Query: 249 VGTEEYVSPEVV-RGDGHEFAVDWWALGILTYEMLYGTTPFRG---KNRKETFRNVLMKT 304
VGT Y++PEV+ +G ++ + DW++LG + +++L G +PFR K++ E R L
Sbjct: 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 215
Query: 305 PEFVGQ-RTALTDLIQRLLEKDPVKRLGYL-RGACEIKEHVFFKGVRWDLL-TDVLRPPF 361
E L L++ LL++D +RLG L RGA E+KEH FF+ + W ++ PP
Sbjct: 216 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPPPL 275
Query: 362 IP 363
IP
Sbjct: 276 IP 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 7e-17
Identities = 48/135 (35%), Positives = 76/135 (56%), Gaps = 14/135 (10%)
Query: 240 DNGERSNSFVGTEEYVSPEVVRG--DG---HEFAVDWWALGILTYEMLYGTTPFRGKNRK 294
D +S+ VGT +Y+SPE+++ DG + DWW+LG+ YEMLYG TPF ++
Sbjct: 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
Query: 295 ETFRNVL-----MKTPEFVGQRT-ALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGV 348
ET+ ++ + P + + DLIQRL+ +RLG G + K+H FF+G+
Sbjct: 215 ETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRE-RRLGQ-NGIEDFKKHAFFEGI 272
Query: 349 RWDLLTDVLRPPFIP 363
W+ + + L P+IP
Sbjct: 273 DWENIRN-LEAPYIP 286
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 8e-17
Identities = 50/152 (32%), Positives = 85/152 (55%), Gaps = 6/152 (3%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVL 77
++ + LK++G+GA G V +V + AD FA+K+++K + + E R E VL
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKV----FAMKILNKWEMLKRAETAC-FREERDVL 55
Query: 78 SRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICA 137
+ ++ L + + + L + Y GGDL L K DR+ + RFYL+E++ A
Sbjct: 56 VNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL-PEDMARFYLAEMVIA 114
Query: 138 IEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169
I+ +H + +RD+KP+NIL+ +GH+ L DF
Sbjct: 115 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADF 146
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 49/151 (32%), Positives = 80/151 (52%), Gaps = 8/151 (5%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-H 82
+++G+G+ V LV + + +A+KVV K ++ + + + E V + S H
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERI----YAMKVVKKELVNDDEDIDW-VQTEKHVFEQASNH 55
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLH 142
PFL L +T+ L + + Y GGDL + + Q R RFY +EI A+ +LH
Sbjct: 56 PFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLH 113
Query: 143 NMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
GI YRDLK +N+L+ GH+ LTD+ + +
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 46/172 (26%), Positives = 91/172 (52%), Gaps = 6/172 (3%)
Query: 8 QPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAE 67
+P+ + ++ ++ LG G+ G V L + D P A+K +KS + + + +
Sbjct: 20 EPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFP---PVAIKRFEKSKIIKQKQVD 76
Query: 68 RRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVI 127
E ++L+ ++HPF L GS + + +L + + GG+ + + ++ F V
Sbjct: 77 HVFS-ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEF--FTFLRRNKRFPNDVG 133
Query: 128 RFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKT 179
FY ++I+ E+L ++ I YRDLKPEN+L+ + G + +TDF ++ + +T
Sbjct: 134 CFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT 185
|
Length = 340 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 44/156 (28%), Positives = 91/156 (58%), Gaps = 10/156 (6%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
+ ++ +K++G+GA G V LV + +++ +A+K++ K + + ++ WE
Sbjct: 40 MKAEDFDVIKVIGRGAFGEVQLVRHK----SSKQVYAMKLLSKFEMIKR--SDSAFFWEE 93
Query: 75 R-VLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSE 133
R +++ + ++ +L + + D++L + Y PGGDL L ++ RFY +E
Sbjct: 94 RDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNL---MSNYDIPEKWARFYTAE 150
Query: 134 IICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169
++ A++ +H+MG +RD+KP+N+L+ +SGH+ L DF
Sbjct: 151 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADF 186
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 44/125 (35%), Positives = 66/125 (52%), Gaps = 7/125 (5%)
Query: 244 RSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL-- 301
R+ + GT EY++PE++ GH A DWW LGI YE+L G PF ++ +L
Sbjct: 184 RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG 243
Query: 302 -MKTPEFVGQRTALTDLIQRLLEKDPVKRLGYL-RGACEIKEHVFFKGVRW-DLLTDVLR 358
+ P+F+ L+++LL D KR G L +GA +KEH +F + W LL +
Sbjct: 244 IIYFPKFLD--NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVE 301
Query: 359 PPFIP 363
P+ P
Sbjct: 302 VPYKP 306
|
Length = 340 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 50/151 (33%), Positives = 77/151 (50%), Gaps = 8/151 (5%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-H 82
+++G+G+ V LV + D +A+KVV K +H + + + E V + S +
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQI----YAMKVVKKELVHDDEDIDW-VQTEKHVFEQASSN 55
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLH 142
PFL L +T L + Y GGDL + + Q R RFY +EI A+ LH
Sbjct: 56 PFLVGLHSCFQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPEEHARFYAAEICIALNFLH 113
Query: 143 NMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
GI YRDLK +N+L+ GH+ LTD+ + +
Sbjct: 114 ERGIIYRDLKLDNVLLDADGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 48/152 (31%), Positives = 77/152 (50%), Gaps = 8/152 (5%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
L +LGKG+ G V L + D +A+K++ K + + E E RVL+
Sbjct: 5 LMVLGKGSFGKVMLAERKGTDEL----YAIKILKKDVIIQDDDVEC-TMVEKRVLALPGK 59
Query: 83 P-FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHL 141
P FL +L +T + L + + Y GGDL + +Q + F FY +EI + L
Sbjct: 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDL-MYHIQQVGK-FKEPHAVFYAAEIAIGLFFL 117
Query: 142 HNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
H+ GI YRDLK +N+++ GH+ + DF + +
Sbjct: 118 HSKGIIYRDLKLDNVMLDAEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 4e-16
Identities = 49/149 (32%), Positives = 73/149 (48%), Gaps = 5/149 (3%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP 83
++LGKG G V RA +A K ++K + K + E A E R+L +++
Sbjct: 6 RVLGKGGFGEVCACQVRATGKM----YACKKLEKKRIK-KRKGEAMALNEKRILEKVNSR 60
Query: 84 FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN 143
F+ L + ET + L + GGDL Y + F FY +E+ C +E L
Sbjct: 61 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 144 MGIAYRDLKPENILIRQSGHVTLTDFDLS 172
I YRDLKPENIL+ GH+ ++D L+
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 43/153 (28%), Positives = 89/153 (58%), Gaps = 10/153 (6%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIR-V 76
++ +K++G+GA G V LV +++ +A+K++ K + + ++ WE R +
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKV----YAMKLLSKFEMIKRSDSA--FFWEERDI 96
Query: 77 LSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIIC 136
++ + P++ +L + + D++L + Y PGGDL L + +FY +E++
Sbjct: 97 MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD---VPEKWAKFYTAEVVL 153
Query: 137 AIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169
A++ +H+MG+ +RD+KP+N+L+ + GH+ L DF
Sbjct: 154 ALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADF 186
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 49/151 (32%), Positives = 80/151 (52%), Gaps = 8/151 (5%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLS-RLSH 82
K+LGKG+ G V L + FA+K + K + + E E RVL+ +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEY----FAVKALKKDVVLIDDDVEC-TMVEKRVLALAWEN 55
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLH 142
PFL L + +T E L + + + GGDL + + Q+ F FY +EI+C ++ LH
Sbjct: 56 PFLTHLYCTFQTKEHLFFVMEFLNGGDL--MFHIQDKGRFDLYRATFYAAEIVCGLQFLH 113
Query: 143 NMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+ GI YRDLK +N+++ + GH+ + DF + +
Sbjct: 114 SKGIIYRDLKLDNVMLDRDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (188), Expect = 1e-15
Identities = 27/86 (31%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 246 NSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP 305
+ VGT Y+SPE+ + + + D W+LG + YE+ PF G+N E +L
Sbjct: 161 KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY 220
Query: 306 EFVGQR--TALTDLIQRLLEKDPVKR 329
+ + + L +L+ LL+KDP +R
Sbjct: 221 PPIPSQYSSELRNLVSSLLQKDPEER 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 40/153 (26%), Positives = 71/153 (46%), Gaps = 12/153 (7%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVL 77
+ K L+ +G+GA G V+ DRA A+K + + + + EI ++
Sbjct: 19 ELYKNLEKIGEGASGEVYKATDRATG----KEVAIKKMR-----LRKQNKELIINEILIM 69
Query: 78 SRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYLSEIIC 136
HP + S + L + Y GG L +++ QN + I + E++
Sbjct: 70 KDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIIT--QNFVRMNEPQIAYVCREVLQ 127
Query: 137 AIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169
+E+LH+ + +RD+K +NIL+ + G V L DF
Sbjct: 128 GLEYLHSQNVIHRDIKSDNILLSKDGSVKLADF 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-15
Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 7/159 (4%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
L+++G+G+ G LV +D +A+K + L A +R E +L+++ H
Sbjct: 5 LRVVGEGSFGRALLVQHVNSDQK----YAMKEI---RLPKSSSAVEDSRKEAVLLAKMKH 57
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLH 142
P + S E D L + YC GGDL Q ++F I + ++ ++H+H
Sbjct: 58 PNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH 117
Query: 143 NMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAF 181
+ +RD+K +NI + Q+G V L DF +R L A+
Sbjct: 118 EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (188), Expect = 2e-15
Identities = 72/350 (20%), Positives = 125/350 (35%), Gaps = 119/350 (34%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAE---RRARWEIRVLSR 79
+ +G+G G V+ +A + ALK + +E E A EI++L +
Sbjct: 4 IAQIGEGTYGQVY----KARNKKTGELVALKKIRME-----NEKEGFPITAIREIKLLQK 54
Query: 80 LSHPFLPKL----LGSLETDEFLAWAVPYCPGGDLN-VLRYKQNDRVFSPSVIRFYLSEI 134
L HP + +L + ++ + Y DL +L + F+ S I+ Y+ ++
Sbjct: 55 LRHPNIVRLKEIVTSKGKGSIYMVF--EYMDH-DLTGLLDSPEVK--FTESQIKCYMKQL 109
Query: 135 ICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVL 194
+ +++LH+ GI +RD+K NILI G + L DF L+R K+ N
Sbjct: 110 LEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKR---NSADYTN------ 160
Query: 195 PVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254
R++T W Y
Sbjct: 161 ----------RVITLW-------------------------------------------Y 167
Query: 255 VSPEVVRGDGH-EFAVDWWALGILTYEMLYGTTPFRGKN--------------------- 292
PE++ G VD W++G + E+ G F+G
Sbjct: 168 RPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP 227
Query: 293 ------------RKETFRNVLMKTPEFVGQRTALTDLIQRLLEKDPVKRL 330
K+ ++ L + + + +AL DL+ +LL DP KR+
Sbjct: 228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSAL-DLLDKLLTLDPKKRI 276
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 2e-15
Identities = 45/153 (29%), Positives = 77/153 (50%), Gaps = 6/153 (3%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
+K +G+G+ G LV + + +K ++ S + K E +R E+ VLS + H
Sbjct: 5 VKKIGEGSFGKAILVKSK----EDGKQYVIKEINISKMSPKEREE--SRKEVAVLSNMKH 58
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLH 142
P + + S E + L + YC GGDL Q +F I + +I A++H+H
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH 118
Query: 143 NMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
+ I +RD+K +NI + + G + L DF ++R L
Sbjct: 119 DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 50/163 (30%), Positives = 81/163 (49%), Gaps = 26/163 (15%)
Query: 26 LGKGAMGTVFLVHDRAADPTARCPFALKVVDK---------STLHAKHEAERRARWEIRV 76
LGKG+ GTV+LV D+ A R LKV+ + T+ A EA+ +
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEER----LKVLKEIPVGELNPNETVQANQEAQ--------L 55
Query: 77 LSRLSHPFLPKLLGS-LETDEFLAWAVPYCPGGDLN--VLRYKQNDRVFSPSVIRFYLSE 133
LS+L HP + K S LE D F YC G DL+ + K + S + + + +
Sbjct: 56 LSKLDHPAIVKFHASFLERDAFCI-ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQ 114
Query: 134 IICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176
++ + ++H I +RDLK +NI ++ + + + DF +SR L+
Sbjct: 115 LLLGVHYMHQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLM 156
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 8/164 (4%)
Query: 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLS 78
+ K LK LGKG+ G+V+ V R +D +ALK VD ++ K + A EIR+L+
Sbjct: 1 DFKVLKKLGKGSYGSVYKV-KRLSDNQF---YALKEVDLGSMSQKERED--AVNEIRILA 54
Query: 79 RLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLN--VLRYKQNDRVFSPSVIRFYLSEIIC 136
++HP + + L + Y P GDL+ + + K+ ++ I +++
Sbjct: 55 SVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLR 114
Query: 137 AIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTA 180
++ LH I +RDLK NIL+ + V + D +S+ L K A
Sbjct: 115 GLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA 158
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 3e-15
Identities = 74/350 (21%), Positives = 120/350 (34%), Gaps = 110/350 (31%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAE---RRARWEI 74
+ + L ++G+GA G V ++A T +V + E + A E+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKA---TGE------IVAIKKFKESEDDEDVKKTALREV 51
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEI 134
+VL +L H + L + L Y L +L P +R Y+ ++
Sbjct: 52 KVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGG--LPPDAVRSYIWQL 109
Query: 135 ICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVL 194
+ AI + H+ I +RD+KPENIL+ +SG + L DF +R L + A
Sbjct: 110 LQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-------------S 156
Query: 195 PVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254
P+T+ + TRW Y
Sbjct: 157 PLTD------YVATRW-------------------------------------------Y 167
Query: 255 VSPEVVRGDG-HEFAVDWWALGILTYEMLYGTTPFRGKN--------------------- 292
+PE++ GD + VD WA+G + E+L G F G +
Sbjct: 168 RAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQE 227
Query: 293 ------RKETFRNVLMKTPEFVGQRTA------LTDLIQRLLEKDPVKRL 330
R PE + +R D ++ L DP +RL
Sbjct: 228 LFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL 277
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 4e-15
Identities = 44/165 (26%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARC-----PFALKVVDKSTLHAKHEAERRARW 72
D+ + ++++G GA V+ A C A+K +D + R+
Sbjct: 1 DDYELIEVIGVGATAVVY---------AAICLPNNEKVAIKRIDLEKCQTSVDELRK--- 48
Query: 73 EIRVLSRLSHPFLPKLLGSLETDEFLAWAV-PYCPGGD-LNVLRYKQNDRVFSPSVIRFY 130
E++ +S+ +HP + K S + L W V PY GG L++++ ++I
Sbjct: 49 EVQAMSQCNHPNVVKYYTSFVVGDEL-WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATV 107
Query: 131 LSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
L E++ +E+LH+ G +RD+K NIL+ + G V + DF +S +L
Sbjct: 108 LKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASL 152
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 5e-15
Identities = 49/158 (31%), Positives = 78/158 (49%), Gaps = 17/158 (10%)
Query: 21 KALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAER-RARWEIRVLSR 79
K +K LG G G+V+L ++ A+K + K ++ E R E++ L +
Sbjct: 2 KVIKQLGDGTFGSVYLARNKETGEL----VAIKKM-KKKFYSWEECMNLR---EVKSLRK 53
Query: 80 L-SHPFLPKLLGS-LETDEFLAWAVPYCPGGDLNVLRY--KQNDRVFSPSVIRFYLSEII 135
L HP + KL E DE L + Y + N+ + + + FS SVIR + +I+
Sbjct: 54 LNEHPNIVKLKEVFRENDE-LYFVFEYM---EGNLYQLMKDRKGKPFSESVIRSIIYQIL 109
Query: 136 CAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+ H+H G +RDLKPEN+L+ V + DF L+R
Sbjct: 110 QGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 6e-15
Identities = 49/135 (36%), Positives = 75/135 (55%), Gaps = 14/135 (10%)
Query: 240 DNGERSNSFVGTEEYVSPEVVRG--DG---HEFAVDWWALGILTYEMLYGTTPFRGKNRK 294
D +S+ VGT +Y+SPE+++ DG + DWW+LG+ YEMLYG TPF ++
Sbjct: 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
Query: 295 ETFRNVLMKTP--EFVGQRTALT----DLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGV 348
ET+ ++ +F Q T ++ DLI+RL+ RLG G + K+H FF G+
Sbjct: 215 ETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSRE-HRLGQ-NGIEDFKQHPFFTGI 272
Query: 349 RWDLLTDVLRPPFIP 363
WD + + P+IP
Sbjct: 273 DWDNIRNC-EAPYIP 286
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 6e-15
Identities = 55/159 (34%), Positives = 82/159 (51%), Gaps = 9/159 (5%)
Query: 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVV--DKSTLHAKHEAERRARWEIRV 76
N + K+LG+GA G V+L +D D T R A+K V D + K E EI++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYD--VD-TGR-ELAVKQVPFDPDSPETKKEV-NALECEIQL 57
Query: 77 LSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIIC 136
L L H + + G L DE L+ + Y PGG +V + + +V R Y +I+
Sbjct: 58 LKNLQHERIVQYYGCLRDDETLSIFMEYMPGG--SVKDQLKAYGALTETVTRKYTRQILE 115
Query: 137 AIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
+E+LH+ I +RD+K NIL +G+V L DF S+ L
Sbjct: 116 GVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 8e-15
Identities = 45/152 (29%), Positives = 83/152 (54%), Gaps = 6/152 (3%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVL 77
D+ + +K++G+GA G V +V + + +A+K+++K + + E R E VL
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERI----YAMKILNKWEMLKRAETAC-FREERNVL 55
Query: 78 SRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICA 137
++ L + + + +L + Y GGDL L K DR+ + RFY++E++ A
Sbjct: 56 VNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRL-PEDMARFYIAEMVLA 114
Query: 138 IEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169
I +H + +RD+KP+N+L+ +GH+ L DF
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADF 146
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 46/152 (30%), Positives = 69/152 (45%), Gaps = 7/152 (4%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTL-HAKHEAERRARWEIRVLSRLS 81
K LG+G V+ D+ T R A+K + AK A EI++L L
Sbjct: 5 GKKLGEGTYAVVYKARDKE---TGRI-VAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 82 HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHL 141
HP + LL + + DL + K V +P+ I+ Y+ + +E+L
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMET-DLEKV-IKDKSIVLTPADIKSYMLMTLRGLEYL 118
Query: 142 HNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
H+ I +RDLKP N+LI G + L DF L+R
Sbjct: 119 HSNWILHRDLKPNNLLIASDGVLKLADFGLAR 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 1e-14
Identities = 48/159 (30%), Positives = 82/159 (51%), Gaps = 15/159 (9%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVV-----DKSTLHAKHEAERRARWEIRVLS 78
++LG G+ G+V+ + FA+K V ++ A + E+ EI +LS
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDF----FAVKEVSLADDGQTGQEAVKQLEQ----EIALLS 57
Query: 79 RLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAI 138
+L HP + + LG+ ++ L + PGG L L K+ P VIR Y +I+ +
Sbjct: 58 KLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKL-LKKYGSFPEP-VIRLYTRQILLGL 115
Query: 139 EHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177
E+LH+ +RD+K NIL+ +G V L DF +++ +V+
Sbjct: 116 EYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-14
Identities = 43/165 (26%), Positives = 84/165 (50%), Gaps = 9/165 (5%)
Query: 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKH-EAERRARWEIRVL 77
+ +K +G+G+ G ++L ++ + C +K +D + + K EA ++ E+ +L
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKS--DSEHC--VIKEIDLTKMPVKEKEASKK---EVILL 53
Query: 78 SRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICA 137
+++ HP + S + + L + YC GGDL +Q +FS I + +I
Sbjct: 54 AKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLG 113
Query: 138 IEHLHNMGIAYRDLKPENILIRQSGHVT-LTDFDLSRNLVKKTAF 181
++H+H+ I +RD+K +NI + ++G V L DF ++R L
Sbjct: 114 LKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL 158
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 49/152 (32%), Positives = 79/152 (51%), Gaps = 8/152 (5%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
L +LGKG+ G V L + D +A+K++ K + + E E RVL+
Sbjct: 5 LMVLGKGSFGKVMLAERKGTDEL----YAIKILKKDVVIQDDDVEC-TMVEKRVLALSGK 59
Query: 83 P-FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHL 141
P FL +L +T + L + + Y GGDL + + +Q R P + FY +EI + L
Sbjct: 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDL-MYQIQQVGRFKEPHAV-FYAAEIAIGLFFL 117
Query: 142 HNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
H+ GI YRDLK +N+++ GH+ + DF + +
Sbjct: 118 HSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 52/166 (31%), Positives = 81/166 (48%), Gaps = 16/166 (9%)
Query: 21 KALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL 80
L+ +GKG+ G V+ +A D A+KV+D A+ E E + EI+ LS+
Sbjct: 4 TLLECIGKGSFGEVY----KAIDKRTNQVVAIKVIDLE--EAEDEIEDIQQ-EIQFLSQC 56
Query: 81 SHPFLPKLLGSLETDEFLAWAVPYCPGGD-LNVLRYKQNDRVFSPSVIRFYLSEIICAIE 139
P++ K GS L + YC GG L++L+ + I F L E++ +E
Sbjct: 57 RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP----GKLDETYIAFILREVLLGLE 112
Query: 140 HLHNMGIAYRDLKPENILIRQSGHVTLTDF----DLSRNLVKKTAF 181
+LH G +RD+K NIL+ + G V L DF L+ + K+ F
Sbjct: 113 YLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF 158
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 3e-14
Identities = 46/163 (28%), Positives = 72/163 (44%), Gaps = 20/163 (12%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVV-----DKSTLHAKHEAERRARWEIRVL 77
+G G G V+ A + A+K + D T+ + E++VL
Sbjct: 5 GNKIGGGTFGKVY----TAVNLDTGELMAVKEIRIQDNDPKTIKEIAD-------EMKVL 53
Query: 78 SRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYLSEIIC 136
L HP L K G E + + YC GG L +L + R+ VIR Y +++
Sbjct: 54 ELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHG---RILDEHVIRVYTLQLLE 110
Query: 137 AIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKT 179
+ +LH+ GI +RD+KP NI + +G + L DF + L T
Sbjct: 111 GLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 4e-14
Identities = 45/163 (27%), Positives = 71/163 (43%), Gaps = 13/163 (7%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
++ +G G G V+ D A A+KV+ L + E + EI +L H
Sbjct: 8 IQRIGSGTYGDVYKARDIATGELV----AIKVI---KLEPGDDFEI-IQQEISMLKECRH 59
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLH 142
P + GS + L + YC GG L + Y+ S I + E + + +LH
Sbjct: 60 PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDI-YQVTRGPLSELQIAYVCRETLKGLAYLH 118
Query: 143 NMGIAYRDLKPENILIRQSGHVTLTDF----DLSRNLVKKTAF 181
G +RD+K NIL+ + G V L DF L+ + K+ +F
Sbjct: 119 ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSF 161
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 4e-14
Identities = 41/160 (25%), Positives = 74/160 (46%), Gaps = 9/160 (5%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVL 77
D+L+ L LG G G V V R PT + A+K + L +++ E+ +L
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHR---PTGKI-MAVKTI---RLEINEAIQKQILRELDIL 53
Query: 78 SRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICA 137
+ + P++ G+ + ++ + Y GG L+ + K+ ++ ++
Sbjct: 54 HKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKI-LKEVQGRIPERILGKIAVAVLKG 112
Query: 138 IEHLHN-MGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176
+ +LH I +RD+KP NIL+ G + L DF +S LV
Sbjct: 113 LTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 49/153 (32%), Positives = 80/153 (52%), Gaps = 11/153 (7%)
Query: 26 LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARW-EIRVLSRLSHPF 84
LG GA G V+ ++ A A KV++ K E E EI +L+ +HP+
Sbjct: 20 LGDGAFGKVYKAKNKETGALA----AAKVIE-----TKSEEELEDYMVEIEILATCNHPY 70
Query: 85 LPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNM 144
+ KLLG+ D L + +CPGG ++ + + DR + I+ +++ A+++LH+M
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSM 129
Query: 145 GIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177
I +RDLK N+L+ G + L DF +S VK
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK 162
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 5e-14
Identities = 46/156 (29%), Positives = 85/156 (54%), Gaps = 12/156 (7%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVD-KSTLHAKHEAERRA-----RWEIRVL 77
+++GKG G V+L A + T A+K V+ +T+ +H++ ++ R EI L
Sbjct: 7 ELIGKGTYGRVYL----ALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62
Query: 78 SRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICA 137
L H + + LG T+E+L+ + Y PGG + + R F ++RF+ +++
Sbjct: 63 KDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSC-LRTYGR-FEEQLVRFFTEQVLEG 120
Query: 138 IEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+ +LH+ GI +RDLK +N+L+ G ++DF +S+
Sbjct: 121 LAYLHSKGILHRDLKADNLLVDADGICKISDFGISK 156
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 48/152 (31%), Positives = 77/152 (50%), Gaps = 8/152 (5%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
L +LGKG+ G V L + D +A+K++ K + + E E RVL+
Sbjct: 5 LMVLGKGSFGKVMLAERKGTDEL----YAIKILKKDVVIQDDDVEC-TMVEKRVLALQDK 59
Query: 83 P-FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHL 141
P FL +L +T + L + + Y GGDL + +Q + P + FY +EI + L
Sbjct: 60 PPFLTQLHSCFQTVDRLYFVMEYVNGGDL-MYHIQQVGKFKEPQAV-FYAAEISVGLFFL 117
Query: 142 HNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
H GI YRDLK +N+++ GH+ + DF + +
Sbjct: 118 HRRGIIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 6e-14
Identities = 38/130 (29%), Positives = 65/130 (50%), Gaps = 7/130 (5%)
Query: 241 NGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNV 300
+G+ GT Y++PE+++ + + + VDW+A+G YEM+ G TPF+ K +
Sbjct: 147 DGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL 206
Query: 301 LMKT--PEFVGQRTALT----DLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLL- 353
+T E + T D+ + L K P RLG + ++H FFK + + L
Sbjct: 207 KRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLE 266
Query: 354 TDVLRPPFIP 363
++ PPF+P
Sbjct: 267 AGLIPPPFVP 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 8e-14
Identities = 50/165 (30%), Positives = 75/165 (45%), Gaps = 7/165 (4%)
Query: 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRV 76
L N K K +GKG V+ +A ALK V + +A + EI +
Sbjct: 1 LGNFKIEKKIGKGQFSVVY----KAICLLDGRVVALKKVQIFEMMDA-KARQDCLKEIDL 55
Query: 77 LSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVL--RYKQNDRVFSPSVIRFYLSEI 134
L +L HP + K L S + L + GDL+ + +K+ R+ I Y ++
Sbjct: 56 LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115
Query: 135 ICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKT 179
A+EH+H+ I +RD+KP N+ I +G V L D L R KT
Sbjct: 116 CSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 9e-14
Identities = 80/322 (24%), Positives = 139/322 (43%), Gaps = 67/322 (20%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
++++GKG MG V+L +D P ALK + + +R R E ++ + L H
Sbjct: 7 IRLIGKGGMGEVYLAYD----PVCSRRVALKKIREDLSENPLLKKRFLR-EAKIAADLIH 61
Query: 83 P-FLPKLLGSLETD-EFLAWAVPYCPGGDLNVL--RYKQNDRVFSP-----SVIRFY--L 131
P +P + S+ +D + + + +PY G L L Q + + SV F
Sbjct: 62 PGIVP--VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 132 SEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKF 191
+I IE++H+ G+ +RDLKP+NIL+ G V + D+ + + KK E++ L +
Sbjct: 120 HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA--IFKKL--EEEDLLDIDV 175
Query: 192 PVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251
N T ++ VGT
Sbjct: 176 DE----RNICYSSM------------------TIPGKI-------------------VGT 194
Query: 252 EEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKN-RKETFRNVLMKTPEFVGQ 310
+Y++PE + G + D +ALG++ Y+ML + P+R K RK ++R+V++ E
Sbjct: 195 PDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPY 254
Query: 311 R---TALTDLIQRLLEKDPVKR 329
R L+ + + L DP +R
Sbjct: 255 REIPPFLSQIAMKALAVDPAER 276
|
Length = 932 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-13
Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 8/162 (4%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
L +GKG+ G VF V R AD +A+K +D S ++ + E A E RVL++L
Sbjct: 5 LNKIGKGSFGVVFKVV-RKADKRV---YAMKQIDLSKMNRREREE--AIDEARVLAKLDS 58
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVI-RFYLSEIICAIEHL 141
++ + S L + Y GDL+ L Q R + RF++ +I+ + HL
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI-QILLGLAHL 117
Query: 142 HNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEK 183
H+ I +RD+K N+ + +V + D +++ L T F
Sbjct: 118 HSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN 159
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 38/163 (23%), Positives = 71/163 (43%), Gaps = 20/163 (12%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS- 81
++++G+G G V+ + A+K+ + + E + E +L + S
Sbjct: 11 VEVIGEGTYGKVYKARHKKTGQLV----AIKI-----MDIIEDEEEEIKEEYNILRKYSN 61
Query: 82 HPFLPKLLG-----SLETDEFLAWAV-PYCPGG---DLNVLRYKQNDRVFSPSVIRFYLS 132
HP + G + ++ W V C GG DL V ++ + I + L
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDL-VKGLRKKGKRLKEEWIAYILR 120
Query: 133 EIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
E + + +LH + +RD+K +NIL+ ++ V L DF +S L
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL 163
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 3e-13
Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 17/173 (9%)
Query: 21 KALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARW-EIRVLSR 79
+ L+ +GKG+ GTV V ++ K +D + E E++ E+ +L
Sbjct: 3 EVLETIGKGSFGTVRKVRRKSDGKI----LVWKEIDYGNMT---EKEKQQLVSEVNILRE 55
Query: 80 LSHPFLPKLLGSL--ETDEFLAWAVPYCPGGDLNVL--RYKQNDRVFSPSVIRFYLSEII 135
L HP + + + +++ L + YC GGDL L + K+ + I L++++
Sbjct: 56 LKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLL 115
Query: 136 CAIEHLHN-----MGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEK 183
A+ HN + +RDLKP NI + + +V L DF L++ L ++F K
Sbjct: 116 LALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAK 168
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 4e-13
Identities = 42/147 (28%), Positives = 70/147 (47%), Gaps = 9/147 (6%)
Query: 26 LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFL 85
LG GA G V+ + A A K++ + ++ E E EI +LS HP +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFA----AAKIIQ---IESEEELEDFMV-EIDILSECKHPNI 64
Query: 86 PKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMG 145
L + + L + +C GG L+ + + +R + IR+ +++ A+ LH+
Sbjct: 65 VGLYEAYFYENKLWILIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHK 123
Query: 146 IAYRDLKPENILIRQSGHVTLTDFDLS 172
+ +RDLK NIL+ G V L DF +S
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 52/166 (31%), Positives = 79/166 (47%), Gaps = 9/166 (5%)
Query: 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDK-STLHAKHEAERRARWEIR 75
L N + K +G+G V+ RA R P ALK V + AK A + EI
Sbjct: 1 LANFQIEKKIGRGQFSEVY----RATCLLDRKPVALKKVQIFEMMDAK--ARQDCVKEID 54
Query: 76 VLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLN--VLRYKQNDRVFSPSVIRFYLSE 133
+L +L+HP + K L S D L + GDL+ + +K+ R+ + Y +
Sbjct: 55 LLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQ 114
Query: 134 IICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKT 179
+ A+EH+H+ + +RD+KP N+ I +G V L D L R KT
Sbjct: 115 LCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 46/160 (28%), Positives = 68/160 (42%), Gaps = 10/160 (6%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRA-RWEIRV 76
+LK +K LG+G G V L DP V KS H+ E R EI +
Sbjct: 4 RHLKFIKQLGEGHFGKVELCR---YDPLGDNTGEQVAV-KSLNHSGEEQHRSDFEREIEI 59
Query: 77 LSRLSHPFLPKLLGSLETDEF--LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEI 134
L L H + K G E L + Y P G L + D++ ++ F S
Sbjct: 60 LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLF--SSQ 117
Query: 135 IC-AIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
IC +++L + +RDL NIL+ V ++DF L++
Sbjct: 118 ICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 43/117 (36%), Positives = 63/117 (53%), Gaps = 11/117 (9%)
Query: 244 RSNSFVGTEEYVSPEVVR---GDGHE-FAVDWWALGILTYEMLYGTTPFRGKNRKETFRN 299
R ++ VGT +Y+SPEV++ GDG+ DWW++G+ +EML G TPF + T+
Sbjct: 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSK 258
Query: 300 VL-----MKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351
++ + PE V +LI L V RLG G EIK+H FFK +W+
Sbjct: 259 IMDHKNSLNFPEDVEISKHAKNLICAFLTDREV-RLGR-NGVEEIKQHPFFKNDQWN 313
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 71/288 (24%), Positives = 110/288 (38%), Gaps = 70/288 (24%)
Query: 51 ALKVVDKSTLHAKHEAER-RARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAV-PYCPGG 108
A+K++ T + E +R R R E + +RL HP + LL S E L +AV Y PG
Sbjct: 7 AIKLL--RTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGR 64
Query: 109 DL-NVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG---HV 164
L VL D + +++ A+ HN GI +RDLKP+NI++ Q+G H
Sbjct: 65 TLREVL---AADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 165 TLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKT 224
+ DF + +LP + LTR
Sbjct: 122 KVLDFGIG-------------------TLLPGVRDADVAT--LTR--------------- 145
Query: 225 KSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYG 284
+ +GT Y +PE +RG+ D +A G++ E L G
Sbjct: 146 --------------------TTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTG 185
Query: 285 TTPFRGKNRKETFRNVLMKTPEFVGQRTA---LTDLIQRLLEKDPVKR 329
+G + E L + A L ++++ L KDP +R
Sbjct: 186 QRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 11/167 (6%)
Query: 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARW--EI 74
L N + K +G+G V+ RA P ALK V L +A+ RA EI
Sbjct: 1 LANFRIEKKIGRGQFSEVY----RATCLLDGVPVALKKVQIFDLM---DAKARADCIKEI 53
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLN--VLRYKQNDRVFSPSVIRFYLS 132
+L +L+HP + K S D L + GDL+ + +K+ R+ + Y
Sbjct: 54 DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV 113
Query: 133 EIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKT 179
++ A+EH+H+ + +RD+KP N+ I +G V L D L R KT
Sbjct: 114 QLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 47/169 (27%), Positives = 77/169 (45%), Gaps = 15/169 (8%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVL 77
+ + L LG+GA G+V + T FALK + + R E+ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLK---NTGMI-FALKTITTDPNPDLQKQILR---ELEIN 53
Query: 78 SRLSHPFLPKLLGS--LETDEFLAWAVPYCPGGDLNVLRYK----QNDRVFSPSVIRFYL 131
P++ K G+ E+ + A+ YC GG L+ + YK + R+ V+
Sbjct: 54 KSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSI-YKKVKKRGGRI-GEKVLGKIA 111
Query: 132 SEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTA 180
++ + +LH+ I +RD+KP NIL+ + G V L DF +S LV A
Sbjct: 112 ESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 2e-11
Identities = 45/168 (26%), Positives = 74/168 (44%), Gaps = 34/168 (20%)
Query: 21 KALKILGKGAMGTVFLVHDRAADPTARCPFALKV---VDKSTLHAKHEAERRARWEIRVL 77
+ LK +G GA G V D+ A+K V + AK R EI++L
Sbjct: 3 ELLKPIGSGAYGVVCSAVDKRTGR----KVAIKKISNVFDDLIDAK-----RILREIKLL 53
Query: 78 SRLSHPFLPKL---LGSLETDEFLAWAVPYCPGGDLN-VLRYKQND--RVF-SPSV---- 126
L H + L L ++F D+ V + D +V SP
Sbjct: 54 RHLRHENIIGLLDILRPPSPEDF----------NDVYIVTELMETDLHKVIKSPQPLTDD 103
Query: 127 -IRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
I+++L +I+ +++LH+ + +RDLKP NIL+ + + + DF L+R
Sbjct: 104 HIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 80/326 (24%), Positives = 125/326 (38%), Gaps = 95/326 (29%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAER-RARWEIRVL----- 77
++LG GA GTV L R +D PFA+KVVD + EA++ RA+ E+ L
Sbjct: 38 RVLGSGATGTV-LCAKRVSDGE---PFAVKVVD---MEGMSEADKNRAQAEVCCLLNCDF 90
Query: 78 ---SRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDL--NVLRYKQNDRVFSPSVIRFYLS 132
+ F K + E +A + Y GDL + + +R F
Sbjct: 91 FSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFI 150
Query: 133 EIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFP 192
+++ A+ H+H+ + +RD+K NIL+ +G V L DF
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF----------------------- 187
Query: 193 VLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252
G K +A VS + +F GT
Sbjct: 188 ---------------------------GFSKMYAATVS-----------DDVGRTFCGTP 209
Query: 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK--------- 303
YV+PE+ R + D ++LG+L YE+L PF G+N +E L
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSI 269
Query: 304 TPEFVGQRTALTDLIQRLLEKDPVKR 329
+PE + +++ LL DP +R
Sbjct: 270 SPE-------MQEIVTALLSSDPKRR 288
|
Length = 496 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 49/165 (29%), Positives = 79/165 (47%), Gaps = 16/165 (9%)
Query: 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVV---DKSTLHAKHEAERRARW 72
+ D +LGKG G V+ A D + + A+K + D + HE
Sbjct: 6 EYDENGERVVLGKGTYGIVY----AARDLSTQVRIAIKEIPERDSRYVQPLHE------- 54
Query: 73 EIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLN-VLRYKQNDRVFSPSVIRFYL 131
EI + S L H + + LGS + F + PGG L+ +LR K + I FY
Sbjct: 55 EIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYT 114
Query: 132 SEIICAIEHLHNMGIAYRDLKPENILIRQ-SGHVTLTDFDLSRNL 175
+I+ +++LH+ I +RD+K +N+L+ SG V ++DF S+ L
Sbjct: 115 KQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 49/167 (29%), Positives = 70/167 (41%), Gaps = 31/167 (18%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVD---------KSTLHAKHEAERRARWE 73
L +G+GA GTV+ +A D ALK V STL E
Sbjct: 4 LAEIGEGAYGTVY----KARDLNTGRFVALKKVRVPLSEEGIPLSTLR-----------E 48
Query: 74 IRVLSRL---SHPFLPKLL----GSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSV 126
I +L +L HP + +LL G E V DL K P
Sbjct: 49 IALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPET 108
Query: 127 IRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
I+ + +++ ++ LH+ I +RDLKP+NIL+ G V + DF L+R
Sbjct: 109 IKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLAR 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 9e-11
Identities = 30/117 (25%), Positives = 52/117 (44%), Gaps = 22/117 (18%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFR--------- 289
+ + N+ VGT +++PEV+ G +++ D W+LGI E+ G P+
Sbjct: 148 LSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF 207
Query: 290 --GKNRKETFRNVLMKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVF 344
N RN + EF D +++ L+K+P KR A ++ +H F
Sbjct: 208 KIATNGPPGLRNPEKWSDEFK-------DFLKKCLQKNPEKRP----TAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 1e-10
Identities = 34/106 (32%), Positives = 53/106 (50%), Gaps = 16/106 (15%)
Query: 250 GTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFR-NVLM----KT 304
GT +Y SPE ++G ++ + DWWA+G+LTYE+L G PF+ ++ E L+ K
Sbjct: 168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFK-EDEDEELDLESLLKRQQKK 226
Query: 305 PEFVGQR-TALTDLIQRLLEKDPVKRLGYLRGAC---EIKEHVFFK 346
F+ D +Q +L+ + RL EI +H F K
Sbjct: 227 LPFIKNVSKNANDFVQSMLKYNINYRL------TNYNEIIKHPFLK 266
|
Length = 267 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 49/167 (29%), Positives = 78/167 (46%), Gaps = 19/167 (11%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVL 77
D + ++ +GKG G VF V ++ A A+K++D H+ + E +L
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKA----AVKILDPI-----HDIDEEIEAEYNIL 68
Query: 78 SRLS-HPFLPKLLG-----SLETDEFLAWAVPYCPGG---DLNVLRYKQNDRVFSPSVIR 128
LS HP + K G ++ + L + C GG DL K+ +R+ P +I
Sbjct: 69 KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEP-IIA 127
Query: 129 FYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
+ L E + ++HLH +RD+K NIL+ G V L DF +S L
Sbjct: 128 YILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL 174
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 41/162 (25%), Positives = 79/162 (48%), Gaps = 13/162 (8%)
Query: 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLS 78
+++ +ILG G GTV+ +A R A+KV+ L E +++ E+ +L
Sbjct: 2 DIQYQEILGHGNGGTVY----KAYHLLTRRILAVKVI---PLDITVELQKQIMSELEILY 54
Query: 79 RLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAI 138
+ P++ G+ + ++ + GG L+V R ++ + R ++ ++ +
Sbjct: 55 KCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR-----KIPEHVLGRIAVA-VVKGL 108
Query: 139 EHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTA 180
+L ++ I +RD+KP N+L+ G V L DF +S LV A
Sbjct: 109 TYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA 150
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 55/186 (29%), Positives = 84/186 (45%), Gaps = 30/186 (16%)
Query: 5 PPPQPQTTPS-------------LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFA 51
PPP ++ S L L+ + +G GA GTV+ V R PT R +A
Sbjct: 48 PPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHR---PTGR-LYA 103
Query: 52 LKVVDKSTLHAKHE--AERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGD 109
LKV ++ HE R+ EI +L ++HP + K + + + + + GG
Sbjct: 104 LKV-----IYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS 158
Query: 110 LNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169
L D F V R +I+ I +LH I +RD+KP N+LI + +V + DF
Sbjct: 159 LEGTHI--ADEQFLADVAR----QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADF 212
Query: 170 DLSRNL 175
+SR L
Sbjct: 213 GVSRIL 218
|
Length = 353 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 43/155 (27%), Positives = 78/155 (50%), Gaps = 9/155 (5%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRA-RWEIRVLSRLS 81
++++GKG+ G V LV R V+ K L ER+A E ++LS+L
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQY-------VIKKLNLRNASRRERKAAEQEAQLLSQLK 57
Query: 82 HPFLPKLLGSLETDEFLAWAV-PYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEH 140
HP + S E ++ L + V +C GGDL +Q ++ + + + +I A+++
Sbjct: 58 HPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQY 117
Query: 141 LHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
LH I +RDLK +N+ + ++ + + D ++R L
Sbjct: 118 LHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 1e-10
Identities = 54/225 (24%), Positives = 85/225 (37%), Gaps = 73/225 (32%)
Query: 73 EIRVLSRLS-HPFLPKLLGSL--ETDEFLAWAVPYCPGGDLNVLRYKQNDR-VFSPSVIR 128
EI+ L RLS HP + +L+ L LA D+N+ + + ++
Sbjct: 47 EIQALRRLSPHPNILRLIEVLFDRKTGRLALV---FELMDMNLYELIKGRKRPLPEKRVK 103
Query: 129 FYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNN 188
Y+ +++ +++H+H GI +RD+KPENILI+ + L DF R + K
Sbjct: 104 SYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCR-----GIYSKP---- 153
Query: 189 NKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248
P TE I TRW
Sbjct: 154 ------PYTE------YISTRW-------------------------------------- 163
Query: 249 VGTEEYVSPEVVRGDG-HEFAVDWWALGILTYEMLYGTTPFRGKN 292
Y +PE + DG + +D WA+G + +E+L F G N
Sbjct: 164 -----YRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN 203
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 2e-10
Identities = 26/88 (29%), Positives = 45/88 (51%), Gaps = 6/88 (6%)
Query: 246 NSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP 305
++VGT Y+SPE + ++ D W+LG L YE+ + PF +N+ + + K
Sbjct: 168 KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI--KEG 225
Query: 306 EF----VGQRTALTDLIQRLLEKDPVKR 329
+F + L ++I+ +L DP KR
Sbjct: 226 KFRRIPYRYSSELNEVIKSMLNVDPDKR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 64/326 (19%), Positives = 119/326 (36%), Gaps = 89/326 (27%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALK-VVDKSTLHAKHEAERRARWEIRV 76
K ++ +G GA G V A D + A+K + + A+R R E+++
Sbjct: 5 SRYKPIENIGSGAYGVVC----SAIDTRSGKKVAIKKIPHAFDVPTL--AKRTLR-ELKI 57
Query: 77 LSRLSHP--------FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIR 128
L H P G+ D ++ V DL+ + + + IR
Sbjct: 58 LRHFKHDNIIAIRDILRPP--GADFKDVYV---VMDLMESDLHHIIHSDQP--LTEEHIR 110
Query: 129 FYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNN 188
++L +++ ++++H+ + +RDLKP N+L+ + + + DF ++R L
Sbjct: 111 YFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS---------- 160
Query: 189 NKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248
P H+ +T +
Sbjct: 161 -----------PTEHKYFMT--------------------------------------EY 171
Query: 249 VGTEEYVSPEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL----MK 303
V T Y +PE++ + A+D W++G + EML F GKN + +L
Sbjct: 172 VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSP 231
Query: 304 TPEFVGQRTA--LTDLIQRLLEKDPV 327
+ E + + + + IQ L K PV
Sbjct: 232 SEEVLNRIGSDRVRKYIQNLPRKQPV 257
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 5e-10
Identities = 46/158 (29%), Positives = 84/158 (53%), Gaps = 9/158 (5%)
Query: 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSR 79
LK +K+LG GA GTV+ + P A+KV+ ++T +A + E V++
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT---SPKANKEILDEAYVMAG 65
Query: 80 LSHPFLPKLLGSLETD--EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICA 137
+ P++ +LLG T + + +PY G L+ +R + DR+ S ++ + + +I
Sbjct: 66 VGSPYVCRLLGICLTSTVQLVTQLMPY--GCLLDYVR-ENKDRIGSQDLLNWCV-QIAKG 121
Query: 138 IEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
+ +L + + +RDL N+L++ HV +TDF L+R L
Sbjct: 122 MSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 6e-10
Identities = 46/173 (26%), Positives = 75/173 (43%), Gaps = 28/173 (16%)
Query: 26 LGKGAMGTV----------FLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRAR---- 71
LG+G G V F+ D + D + P + V L +A + AR
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAV---KMLRE--DANKNARNDFL 67
Query: 72 WEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVL---------RYKQNDRVF 122
EI+++SRL P + +LL T + L Y GDLN K +
Sbjct: 68 KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127
Query: 123 SPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
S S + F ++I +++L ++ +RDL N L+ ++ + + DF +SRNL
Sbjct: 128 SYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 6e-10
Identities = 43/149 (28%), Positives = 73/149 (48%), Gaps = 9/149 (6%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVD--KSTLHAKHEAERRARWEIRVLSRLS 81
+ LG GA + + A D A+K V ++T + E R EIR+++RL+
Sbjct: 6 QQLGTGAFSSCYQ----ARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN 61
Query: 82 HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHL 141
HP + ++LG+ D V + GG ++ L K F +VI Y +++ + +L
Sbjct: 62 HPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYL 119
Query: 142 HNMGIAYRDLKPENILIRQSGH-VTLTDF 169
H I +RD+K N+LI +G + + DF
Sbjct: 120 HENQIIHRDVKGANLLIDSTGQRLRIADF 148
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 7e-10
Identities = 47/161 (29%), Positives = 75/161 (46%), Gaps = 15/161 (9%)
Query: 26 LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARW-EIRVLSRLSHPF 84
LG GA G V+ ++ A A KV+D K E E EI +L+ HP
Sbjct: 13 LGDGAFGKVYKAQNKETGVLA----AAKVID-----TKSEEELEDYMVEIDILASCDHPN 63
Query: 85 LPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNM 144
+ KLL + + L + +C GG ++ + + +R + IR + + A+ +LH
Sbjct: 64 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHEN 122
Query: 145 GIAYRDLKPENILIRQSGHVTLTDFDLS----RNLVKKTAF 181
I +RDLK NIL G + L DF +S R + ++ +F
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF 163
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 31/89 (34%), Positives = 41/89 (46%), Gaps = 5/89 (5%)
Query: 247 SFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGK--NRKETFRNVLM-K 303
S VGT Y+SPE + +G+ F D W+LG L YEM +PF G N + +
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD 224
Query: 304 TPEFVGQR--TALTDLIQRLLEKDPVKRL 330
P L DL+ R + DP KR
Sbjct: 225 YPPLPADHYSEELRDLVSRCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 44/170 (25%), Positives = 76/170 (44%), Gaps = 24/170 (14%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARC-----PFALKVVDKSTLHAKHEAERRARWEIRVL 77
L+ LG+G+ G+V+ A A+KVV E + EI +L
Sbjct: 8 LEKLGEGSYGSVY---------KAIHKETGQVVAIKVV--PVEEDLQEIIK----EISIL 52
Query: 78 SRLSHPFLPKLLGSLETDEFLAWAV-PYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIIC 136
+ P++ K GS + L W V YC G ++ + K ++ + I L + +
Sbjct: 53 KQCDSPYIVKYYGSYFKNTDL-WIVMEYCGAGSVSDI-MKITNKTLTEEEIAAILYQTLK 110
Query: 137 AIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSL 186
+E+LH+ +RD+K NIL+ + G L DF +S L T ++ ++
Sbjct: 111 GLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLT-DTMAKRNTV 159
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 43/158 (27%), Positives = 70/158 (44%), Gaps = 13/158 (8%)
Query: 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLS 78
N K L+ LG+G TV+ +R ALK + L A+ A EI ++
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIV----ALKEIH---LDAEEGTPSTAIREISLMK 53
Query: 79 RLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQ---NDRVFSPSVIRFYLSEII 135
L H + +L + T+ L Y DL +Y P+ ++ + +++
Sbjct: 54 ELKHENIVRLHDVIHTENKLMLVFEYMDK-DLK--KYMDTHGVRGALDPNTVKSFTYQLL 110
Query: 136 CAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
I H + +RDLKP+N+LI + G + L DF L+R
Sbjct: 111 KGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 90/370 (24%), Positives = 136/370 (36%), Gaps = 156/370 (42%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALK-VVD---KSTLHAKHEAERRARWEIRVLS 78
L+ LGKGA G V+ +A D + ALK + D +T +A+R R EI L
Sbjct: 12 LQKLGKGAYGIVW----KAIDRRTKEVVALKKIFDAFRNAT-----DAQRTFR-EIMFLQ 61
Query: 79 RLS-HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDR----VFS------PSVI 127
L HP + KLL NV++ +ND+ VF +VI
Sbjct: 62 ELGDHPNIVKLL---------------------NVIK-AENDKDIYLVFEYMETDLHAVI 99
Query: 128 R----------FYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177
R + + +++ A++++H+ + +RDLKP NIL+ V L DF L+R+L
Sbjct: 100 RANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSL-- 157
Query: 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQ 237
+ N + PVL T+ + TRW
Sbjct: 158 -----SELEENPENPVL--TD------YVATRW--------------------------- 177
Query: 238 SFDNGERSNSFVGTEEYVSPEVVRGDGH-EFAVDWWALGILTYEMLYGTTPFRGKNRKET 296
Y +PE++ G VD W++G + EML G F G + T
Sbjct: 178 ----------------YRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTS---T 218
Query: 297 FRNVLMKTPEFVGQRTAL------------------------------------TDLIQR 320
N L K E +G +A DL+++
Sbjct: 219 L-NQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKK 277
Query: 321 LLEKDPVKRL 330
LL +P KRL
Sbjct: 278 LLVFNPNKRL 287
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 26/51 (50%), Positives = 34/51 (66%)
Query: 125 SVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
S +R YL +I+ IE H+ I +RD+KPENIL+ QSG V L DF +R L
Sbjct: 100 SRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 52/277 (18%), Positives = 95/277 (34%), Gaps = 99/277 (35%)
Query: 122 FSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAF 181
I F L +++ A++++H+ G +R +K +IL+ G V L+ S +++K
Sbjct: 98 LPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHG-- 155
Query: 182 EKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDN 241
KR R + H P++ S + P
Sbjct: 156 -------------------KRQRVV-----HDFPKS--------SVKNLP---------- 173
Query: 242 GERSNSFVGTEEYVSPEVVRGD--GHEFAVDWWALGILTYEMLYGTTPF----------- 288
++SPEV++ + G+ D +++GI E+ G PF
Sbjct: 174 ------------WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE 221
Query: 289 --RG-------------------KNRKETFRNVLMKTPEFVGQRT---ALTDLIQRLLEK 324
RG ++R + + RT ++ L++
Sbjct: 222 KVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQR 281
Query: 325 DPVKRLGYLRGACEIKEHVFFKGVRW--DLLTDVLRP 359
DP R A ++ H FFK + L D+L+P
Sbjct: 282 DPESR----PSASQLLNHSFFKQCKRRNTSLLDLLKP 314
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 3e-09
Identities = 29/96 (30%), Positives = 46/96 (47%), Gaps = 6/96 (6%)
Query: 240 DNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETF-- 297
+ ++ N+FVGT Y+SPE ++G+ + +A D W+LG+ E G PF + F
Sbjct: 152 NTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL 211
Query: 298 -RNVLMKTPEFVGQRTA---LTDLIQRLLEKDPVKR 329
+ + P + D I L+KDP KR
Sbjct: 212 MQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKR 247
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 62/313 (19%), Positives = 110/313 (35%), Gaps = 104/313 (33%)
Query: 73 EIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNV--------LRYKQNDRV-FS 123
E+++++ + H + L+ V Y G +N+ L+ + ++ +
Sbjct: 70 ELKIMNEIKHENIMGLV-----------DV-YVEGDFINLVMDIMASDLKKVVDRKIRLT 117
Query: 124 PSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEK 183
S ++ L +I+ + LH +RDL P NI I G + DF L+R
Sbjct: 118 ESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYG------- 170
Query: 184 QSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGE 243
L E +R + ++
Sbjct: 171 ---YPPYSDTLSKDETMQRREEMTSK---------------------------------- 193
Query: 244 RSNSFVGTEEYVSPEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNV-- 300
V T Y +PE++ G + + FAVD W++G + E+L G F G+N + +
Sbjct: 194 -----VVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFE 248
Query: 301 LMKTPEFVGQRTALT---------------------------DLIQRLLEKDPVKRLGYL 333
L+ TP A DL+Q LL+ +P++R+
Sbjct: 249 LLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERI--- 305
Query: 334 RGACEIKEHVFFK 346
A E +H +FK
Sbjct: 306 -SAKEALKHEYFK 317
|
Length = 335 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 4e-09
Identities = 41/155 (26%), Positives = 74/155 (47%), Gaps = 11/155 (7%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP 83
++LGKGA GTV+ A L D S + A + + + E+ +L L H
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVEL---DTSNVLAAEKEYEKLQEEVDLLKSLKHV 62
Query: 84 FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSP---SVIRFYLSEIICAIEH 140
+ + LG+ D ++ + + PGG ++ + + F P V Y +I+ + +
Sbjct: 63 NIVQYLGTCLDDNTISIFMEFVPGGSISSILNR-----FGPLPEPVFCKYTKQILDGVAY 117
Query: 141 LHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
LHN + +RD+K N+++ +G + L DF +R L
Sbjct: 118 LHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-09
Identities = 34/97 (35%), Positives = 49/97 (50%), Gaps = 12/97 (12%)
Query: 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFR----GKNRKETFRNVLMKTPEFVG 309
Y +PEV A DWW+LG + +E+L G T G N T + PE+V
Sbjct: 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTT-----LNIPEWVS 202
Query: 310 QRTALTDLIQRLLEKDPVKRLGY-LRGACEIKEHVFF 345
+ L+Q+LL+ +P +RLG + G +IK H FF
Sbjct: 203 EEAR--SLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-09
Identities = 48/170 (28%), Positives = 84/170 (49%), Gaps = 21/170 (12%)
Query: 21 KALKILGKGAMGTVFL-VHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSR 79
+ L+++G+GA G V+ H PT R ALK+++ T +R E+ +LS+
Sbjct: 4 QRLELIGRGAYGAVYRGKHV----PTGRV-VALKIINLDTPDDDVSDIQR---EVALLSQ 55
Query: 80 LSH---PFLPKLLGSLETDEFLAWAVPYCPGGDLNVL-RYKQNDRVFSPSVIRFYLSEII 135
L P + K GS L + Y GG + L + + +IR E++
Sbjct: 56 LRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR----EVL 111
Query: 136 CAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV----KKTAF 181
A++++H +G+ +RD+K NIL+ +G+V L DF ++ L K++ F
Sbjct: 112 VALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF 161
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 6e-09
Identities = 30/108 (27%), Positives = 45/108 (41%), Gaps = 35/108 (32%)
Query: 236 QQSFDNGERSNSFVGTEEYVSPEVVRGDGH-EFAVDWWALGILTYEMLYGTTPFRGKNRK 294
+ + + VGT Y++PEV+ G G+ D W+LG++ YE+
Sbjct: 141 KLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------- 187
Query: 295 ETFRNVLMKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEH 342
PE DLI+++L+KDP KR EI EH
Sbjct: 188 ----------PELK-------DLIRKMLQKDPEKRPSAK----EILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 7e-09
Identities = 47/164 (28%), Positives = 80/164 (48%), Gaps = 16/164 (9%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
L+ +GKG+ G VF + D + A+K++D L + + EI VLS+
Sbjct: 9 LEKIGKGSFGEVF----KGIDNRTQKVVAIKIID---LEEAEDEIEDIQQEITVLSQCDS 61
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGD-LNVLRYKQNDRVFSPSVIRFYLSEIICAIEHL 141
P++ K GS D L + Y GG L++L D +++R EI+ +++L
Sbjct: 62 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR----EILKGLDYL 117
Query: 142 HNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL----VKKTAF 181
H+ +RD+K N+L+ + G V L DF ++ L +K+ F
Sbjct: 118 HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF 161
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 8e-09
Identities = 43/156 (27%), Positives = 78/156 (50%), Gaps = 5/156 (3%)
Query: 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSR 79
LK +K+LG GA GTV+ T + P A+K+++++T +A E +++
Sbjct: 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT---GPKANVEFMDEALIMAS 65
Query: 80 LSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIE 139
+ HP L +LLG + + P G L ++ D + S ++ + + +I +
Sbjct: 66 MDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCV-QIAKGMM 123
Query: 140 HLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
+L + +RDL N+L++ HV +TDF L+R L
Sbjct: 124 YLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 8e-09
Identities = 50/167 (29%), Positives = 80/167 (47%), Gaps = 36/167 (21%)
Query: 21 KALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHE-----AERRARWEIR 75
K KI G+G G V+ D+ ALK K L + E A R EI
Sbjct: 3 KVEKI-GEGTYGVVYKARDKLTGEIV----ALK---KIRLETEDEGVPSTAIR----EIS 50
Query: 76 VLSRLSHPFLPKLLGSLETD-------EFLAWAVPYCPGGDLNVLRYKQNDRVFS--PSV 126
+L L+HP + +LL + ++ EFL DL++ +Y + + P +
Sbjct: 51 LLKELNHPNIVRLLDVVHSENKLYLVFEFL----------DLDLKKYMDSSPLTGLDPPL 100
Query: 127 IRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
I+ YL +++ I + H+ + +RDLKP+N+LI + G + L DF L+R
Sbjct: 101 IKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 9e-09
Identities = 42/158 (26%), Positives = 77/158 (48%), Gaps = 9/158 (5%)
Query: 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSR 79
L+ +K+LG GA GTV+ + P A+KV+ + T ++ E V++
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILD---EAYVMAS 65
Query: 80 LSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRY-KQN-DRVFSPSVIRFYLSEIICA 137
+ HP + +LLG + + P G L L Y + + D + S ++ + + +I
Sbjct: 66 VDHPHVVRLLG-ICLSSQVQLITQLMPLGCL--LDYVRNHKDNIGSQYLLNWCV-QIAKG 121
Query: 138 IEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
+ +L + +RDL N+L++ HV +TDF L++ L
Sbjct: 122 MSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 9e-09
Identities = 43/152 (28%), Positives = 74/152 (48%), Gaps = 14/152 (9%)
Query: 26 LGKGAMGTVFLVHDRAADPTARCPFALKVV--DKSTLHAKHEAERRARWEIRVLSRLSHP 83
+G+G GTVF +A + ALK V D A R EI +L L H
Sbjct: 8 IGEGTYGTVF----KAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKELKHK 59
Query: 84 FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDR-VFSPSVIRFYLSEIICAIEHLH 142
+ +L L +D+ L YC D ++ +Y + P +++ ++ +++ + H
Sbjct: 60 NIVRLYDVLHSDKKLTLVFEYC---DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH 116
Query: 143 NMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174
+ + +RDLKP+N+LI ++G + L DF L+R
Sbjct: 117 SHNVLHRDLKPQNLLINKNGELKLADFGLARA 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 9e-09
Identities = 52/163 (31%), Positives = 82/163 (50%), Gaps = 15/163 (9%)
Query: 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRA-RWEIRVL 77
N + K+LG+GA G V+L +D AD T R A+K V + E A EI++L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYD--AD-TGR-ELAVKQVPFDPDSQETSKEVNALECEIQLL 58
Query: 78 SRLSHPFLPKLLGSLE--TDEFLAWAVPYCPGGDLNVLRYKQNDRVF---SPSVIRFYLS 132
L H + + G L ++ L+ V Y PGG + K + + + +V R Y
Sbjct: 59 KNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSI-----KDQLKAYGALTENVTRRYTR 113
Query: 133 EIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
+I+ + +LH+ I +RD+K NIL +G+V L DF S+ +
Sbjct: 114 QILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRI 156
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 25/85 (29%), Positives = 41/85 (48%), Gaps = 2/85 (2%)
Query: 249 VGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLM-KTPEF 307
+GT Y++PEV +G + + D W+LG L YEM PF ++ ++ V K P
Sbjct: 162 IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPI 221
Query: 308 VGQRTA-LTDLIQRLLEKDPVKRLG 331
+ L + I+ +L+ P R
Sbjct: 222 PPIYSQDLQNFIRSMLQVKPKLRPN 246
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 35/111 (31%), Positives = 48/111 (43%), Gaps = 12/111 (10%)
Query: 242 GERSNSFVGTEEYVSPEVVRG---DGHEFAVDWWALGILTYEMLYGTTPFRG-KNRKETF 297
GE S GT Y++PEV+ G GH A D W+LG + EM G P+ N +
Sbjct: 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM 216
Query: 298 RNVLMKTPEFVGQRTALTDL----IQRLLEKDPVKRLGYLRGACEIKEHVF 344
+V + L+ + R LE DP KR A E+ +H F
Sbjct: 217 FHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRP----TASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 13/174 (7%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
L+ +GKG+ G VF + D + A+K++D A+ E E + EI VLS+
Sbjct: 9 LERIGKGSFGEVF----KGIDNRTQQVVAIKIIDLE--EAEDEIED-IQQEITVLSQCDS 61
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGD-LNVLRYKQNDRVFSPSVIRFYLSEIICAIEHL 141
P++ K GS L + Y GG L++LR F I L EI+ +++L
Sbjct: 62 PYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP----FDEFQIATMLKEILKGLDYL 117
Query: 142 HNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLP 195
H+ +RD+K N+L+ + G V L DF ++ L T ++ + F + P
Sbjct: 118 HSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAP 170
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 17/167 (10%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEA-ERRARWEIRV 76
D + L+ +G+G G V+ D+ T + ALK K+ L E A EI +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKN---TGKL-VALK---KTRLEMDEEGIPPTALREISL 53
Query: 77 LSRLSH-PFLPKLLGSLETDEFLAWAVPYCP----GGDLN---VLRYKQNDRVFSPSVIR 128
L LS ++ +LL +E Y DL + R I+
Sbjct: 54 LQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIK 113
Query: 129 FYLSEIICAIEHLHNMGIAYRDLKPENILI-RQSGHVTLTDFDLSRN 174
++ +++ + H H G+ +RDLKP+N+L+ +Q G + + D L R
Sbjct: 114 SFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 44/167 (26%), Positives = 84/167 (50%), Gaps = 12/167 (7%)
Query: 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSR 79
K +K+LG GA GTV+ + P A+K + ++T +A + E V++
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMAS 65
Query: 80 LSHPFLPKLLGSLETD--EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICA 137
+ +P + +LLG T + + +P+ G L+ +R + D + S ++ + + +I
Sbjct: 66 VDNPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREHK-DNIGSQYLLNWCV-QIAKG 121
Query: 138 IEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQ 184
+ +L + +RDL N+L++ HV +TDF L++ L A EK+
Sbjct: 122 MNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL---GADEKE 165
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 50/160 (31%), Positives = 79/160 (49%), Gaps = 9/160 (5%)
Query: 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRA-RWEIRVL 77
N + K+LG+GA G V+L +D AD T R A+K V + E A EI++L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYD--AD-TGR-ELAVKQVQFDPESPETSKEVNALECEIQLL 58
Query: 78 SRLSHPFLPKLLGSLE--TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEII 135
L H + + G L + L+ + + PGG + ++ + +V R Y +I+
Sbjct: 59 KNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIK--DQLKSYGALTENVTRKYTRQIL 116
Query: 136 CAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
+ +LH+ I +RD+K NIL G+V L DF S+ L
Sbjct: 117 EGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRL 156
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 5e-08
Identities = 35/113 (30%), Positives = 60/113 (53%), Gaps = 10/113 (8%)
Query: 73 EIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNV-LRYKQNDRVFS-----PSV 126
EI+++SRL +P + +LLG +D+ L Y GDLN L ++ + F+ PSV
Sbjct: 67 EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSV 126
Query: 127 IR---FYLS-EIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
Y++ +I +++L ++ +RDL N L+ + + DF +SRNL
Sbjct: 127 SIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL 179
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 38/136 (27%), Positives = 69/136 (50%), Gaps = 14/136 (10%)
Query: 50 FALKVV-DKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGG 108
A+KV+ ++ +A+ + + E+++LSRLS P + +LLG D L + Y G
Sbjct: 49 VAVKVLRPDASDNAREDFLK----EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENG 104
Query: 109 DLN-VLRYKQ--------NDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIR 159
DLN L+ N + S S + + ++I + +L ++ +RDL N L+
Sbjct: 105 DLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG 164
Query: 160 QSGHVTLTDFDLSRNL 175
++ + + DF +SRNL
Sbjct: 165 KNYTIKIADFGMSRNL 180
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 6e-08
Identities = 34/122 (27%), Positives = 55/122 (45%), Gaps = 18/122 (14%)
Query: 233 SRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKN 292
++R + GE + S GT +++PEV+RG+ + A D W+LG EM G P+ +
Sbjct: 148 AKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPW---S 204
Query: 293 RKETFRNVLMKT---------PEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHV 343
L K PE + + D +++ L +DP KR A E+ +H
Sbjct: 205 ELGNPMAALYKIGSSGEPPEIPEHLSE--EAKDFLRKCLRRDPKKRP----TADELLQHP 258
Query: 344 FF 345
F
Sbjct: 259 FL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 6e-08
Identities = 30/92 (32%), Positives = 42/92 (45%), Gaps = 2/92 (2%)
Query: 240 DNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRN 299
DN +N+ VGT Y+SPE+ + D WALG++ YE G PF N+
Sbjct: 153 DNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK 212
Query: 300 VLMKTPEFVGQR--TALTDLIQRLLEKDPVKR 329
++ V Q L LI + L KD +R
Sbjct: 213 IIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 6e-08
Identities = 48/164 (29%), Positives = 76/164 (46%), Gaps = 31/164 (18%)
Query: 23 LKILGKGAMGTVFLVHD-----RAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVL 77
LK +G GA G V +D A PF ++ HAK RA E+ ++
Sbjct: 21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF------QNVTHAK-----RAYRELVLM 69
Query: 78 SRLSHPFLPKLLG------SLET--DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRF 129
++H + LL SLE D +L + D N+ + Q D + +
Sbjct: 70 KLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELM-----DANLCQVIQMD--LDHERMSY 122
Query: 130 YLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
L +++C I+HLH+ GI +RDLKP NI+++ + + DF L+R
Sbjct: 123 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 7e-08
Identities = 33/119 (27%), Positives = 53/119 (44%), Gaps = 16/119 (13%)
Query: 239 FDNGERS----NSFVGTEEYVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNR 293
D G+R+ +FVGT +++PEV+ G++F D W+ GI E+ G P+
Sbjct: 153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP 212
Query: 294 KETFRNVLMKTP-------EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345
+ L P ++ + +I L+KDP KR A E+ +H FF
Sbjct: 213 MKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKR----PTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 86/372 (23%), Positives = 129/372 (34%), Gaps = 110/372 (29%)
Query: 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLH-AKHEAERRARWEIR 75
L + + L LG+G G V+ +A ALK K +H K A EI+
Sbjct: 7 LRDYEILGKLGEGTFGEVY----KARQIKTGRVVALK---KILMHNEKDGFPITALREIK 59
Query: 76 VLSRLSHPFLPKLL--------GSLETDEFLAWAVPYCPGGDLNVLRYKQNDRV-FSPSV 126
+L +L HP + L+ S + PY DL+ L +N V + S
Sbjct: 60 ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLL--ENPSVKLTESQ 116
Query: 127 IRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSL 186
I+ Y+ +++ I +LH I +RD+K NILI G + + DF L+R
Sbjct: 117 IKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR------------- 163
Query: 187 NNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSN 246
P P P K G +
Sbjct: 164 --------PYDGPP--------------PNPKGG-----------------GGGGTRKYT 184
Query: 247 SFVGTEEYVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKN------------- 292
+ V T Y PE++ G+ + AVD W +G + EM +GK+
Sbjct: 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244
Query: 293 --RKETFRNVLMKTPEFVGQRTALT-----------------DLIQRLLEKDPVKRLGYL 333
+ET+ P G + DL+ +LL DP KRL
Sbjct: 245 TPTEETWPG-WRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRL--- 300
Query: 334 RGACEIKEHVFF 345
A + EH +F
Sbjct: 301 -TASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 8e-08
Identities = 44/163 (26%), Positives = 75/163 (46%), Gaps = 17/163 (10%)
Query: 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRV 76
L + LK +G GA G V A D A+K + + + H +RA E+ +
Sbjct: 20 LKRYQQLKPIGSGAQGIVC----AAFDTVLGINVAVKKLSRPFQNQTHA--KRAYRELVL 73
Query: 77 LSRLSHPFLPKLLG------SLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFY 130
L ++H + LL SLE + + + V+ + + S +
Sbjct: 74 LKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMS-----YL 128
Query: 131 LSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
L +++C I+HLH+ GI +RDLKP NI+++ + + DF L+R
Sbjct: 129 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 8e-08
Identities = 50/155 (32%), Positives = 75/155 (48%), Gaps = 9/155 (5%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRA-RWEIRVLSRLSH 82
K+LG+GA G V+L +D T R A K V + E A EI++L L H
Sbjct: 8 KLLGQGAFGRVYLCYDV---DTGR-ELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 83 PFLPKLLGSLE--TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEH 140
+ + G L ++ L + Y PGG +V + + SV R Y +I+ + +
Sbjct: 64 ERIVQYYGCLRDRAEKTLTIFMEYMPGG--SVKDQLKAYGALTESVTRKYTRQILEGMSY 121
Query: 141 LHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
LH+ I +RD+K NIL +G+V L DF S+ L
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL 156
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 28/97 (28%), Positives = 49/97 (50%), Gaps = 10/97 (10%)
Query: 241 NGERSNSFVGTEEYVSPEVVR-GDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRN 299
N + ++FVGT +++PEV+ G ++ D W+LGI YEM G P+ + FR
Sbjct: 154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD---VDAFRA 210
Query: 300 VLM----KTPEFVGQR--TALTDLIQRLLEKDPVKRL 330
+++ K P L + + L+++P +RL
Sbjct: 211 MMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERL 247
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 11/157 (7%)
Query: 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVV--DKSTLHAKHEAERRARWEIRV 76
N + ++ +G+G G V+ ++ ALK + D T A R EI +
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVV----ALKKIRLDTETEGVPSTAIR----EISL 52
Query: 77 LSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIIC 136
L L+HP + KLL + T+ L + DL +I+ YL +++
Sbjct: 53 LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQ 111
Query: 137 AIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+ H+ + +RDLKP+N+LI G + L DF L+R
Sbjct: 112 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 45/167 (26%), Positives = 74/167 (44%), Gaps = 13/167 (7%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVL 77
D ++ L LGKG G+V+ V R T A+K + +K + E+ +L
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVT----MAMKEIRLELDESKF---NQIIMELDIL 53
Query: 78 SRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSP-SVIRFYLSEIIC 136
+ P++ G+ + + + Y G L+ L P V+R ++
Sbjct: 54 HKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVK 113
Query: 137 AIEHL---HNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTA 180
++ L HN I +RD+KP N+L+ +G V L DF +S NLV A
Sbjct: 114 GLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA 158
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-07
Identities = 43/164 (26%), Positives = 81/164 (49%), Gaps = 16/164 (9%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
L+ +GKG+ G V+ + D + A+K++D L + + EI VLS+
Sbjct: 9 LERIGKGSFGEVY----KGIDNRTKEVVAIKIID---LEEAEDEIEDIQQEITVLSQCDS 61
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGD-LNVLRYKQNDRVFSPSVIRFYLSEIICAIEHL 141
P++ + GS L + Y GG L++L+ + + +++R EI+ +++L
Sbjct: 62 PYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR----EILKGLDYL 117
Query: 142 HNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL----VKKTAF 181
H+ +RD+K N+L+ + G V L DF ++ L +K+ F
Sbjct: 118 HSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 161
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 54/192 (28%), Positives = 80/192 (41%), Gaps = 25/192 (13%)
Query: 20 LKALKILGKGAMGTVFLV-HDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLS 78
LK ++ LGKG G+V L +D D T V K H+ E R EI +L
Sbjct: 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEV-----VAVKKLQHSTAEHLRDFEREIEILK 60
Query: 79 RLSHPFLPKLLG---SLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEII 135
L H + K G S L + Y P G L K +R+ ++ Y S+I
Sbjct: 61 SLQHDNIVKYKGVCYSAGRRN-LRLVMEYLPYGSLRDYLQKHRERLDHRKLL-LYASQIC 118
Query: 136 CAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL--------VKKTA------F 181
+E+L + +RDL NIL+ V + DF L++ L V++ +
Sbjct: 119 KGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY 178
Query: 182 EKQSLNNNKFPV 193
+SL +KF V
Sbjct: 179 APESLTESKFSV 190
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 41/153 (26%), Positives = 69/153 (45%), Gaps = 16/153 (10%)
Query: 245 SNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT 304
++SF GT Y++PE+ + D W+LG++ YE+L PF+G +++E + VL
Sbjct: 228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGK 287
Query: 305 --PEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFI 362
P + + L+ LL K+P R ++ F K V +L D++R
Sbjct: 288 YDPFPCPVSSGMKALLDPLLSKNPALR----PTTQQLLHTEFLKYVA-NLFQDIVRHSET 342
Query: 363 PSREENDLTEKAMSGGGVDIREYFENLRAPPPS 395
S + + + + G RAPPPS
Sbjct: 343 ISPHDREEILRQLQESGE---------RAPPPS 366
|
Length = 478 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 46/161 (28%), Positives = 83/161 (51%), Gaps = 14/161 (8%)
Query: 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEA-ERRARWEIR 75
+D + ++ +G+G G V+ DR + T ALK K L + E A EI
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNET----IALK---KIRLEQEDEGVPSTAIREIS 53
Query: 76 VLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFS--PSVIRFYLSE 133
+L + H + +L + +++ L Y DL++ ++ + F+ P +I+ YL +
Sbjct: 54 LLKEMQHGNIVRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQ 110
Query: 134 IICAIEHLHNMGIAYRDLKPENILI-RQSGHVTLTDFDLSR 173
I+ I + H+ + +RDLKP+N+LI R++ + L DF L+R
Sbjct: 111 ILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
|
Length = 294 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 35/103 (33%), Positives = 51/103 (49%), Gaps = 2/103 (1%)
Query: 73 EIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLS 132
EIR+L +L HP L L+ L YC LN L ++N R +I+ +
Sbjct: 50 EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNEL--EKNPRGVPEHLIKKIIW 107
Query: 133 EIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
+ + A+ H +RD+KPENILI + G + L DF +R L
Sbjct: 108 QTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARIL 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 46/167 (27%), Positives = 75/167 (44%), Gaps = 19/167 (11%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVL 77
D + ++ +GKG G V+ V ++ A A+K++D + + + E +L
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLA----AVKILDPIS-----DVDEEIEAEYNIL 72
Query: 78 SRLS-HPFLPKLLGSL-ETDEFLA---WAV-PYCPGGDLNVL---RYKQNDRVFSPSVIR 128
L HP + K G + D+ + W V C GG + L R+ +I
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEA-MIS 131
Query: 129 FYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
+ L + ++HLHN I +RD+K NIL+ G V L DF +S L
Sbjct: 132 YILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 46/165 (27%), Positives = 79/165 (47%), Gaps = 21/165 (12%)
Query: 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRV 76
L + LK +G GA G V +D D A+K + + + H +RA E+ +
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNV----AIKKLSRPFQNQTHA--KRAYRELVL 69
Query: 77 LSRLSHPFLPKLLG------SLE--TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIR 128
+ ++H + LL SLE D +L + D N+ + Q + +
Sbjct: 70 MKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-----DANLCQVIQME--LDHERMS 122
Query: 129 FYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+ L +++C I+HLH+ GI +RDLKP NI+++ + + DF L+R
Sbjct: 123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 44/160 (27%), Positives = 74/160 (46%), Gaps = 22/160 (13%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDK---STLHAKHEAERRARWEIRVLSR 79
L +G GA G V D A+K + + S +HAK R E+R+L
Sbjct: 20 LSPVGSGAYGQVCSAFDTKTGRK----VAIKKLSRPFQSAIHAK-----RTYRELRLLKH 70
Query: 80 LSHPFLPKLLGSLETDEFL-----AWAVPYCPGGDLN-VLRYKQNDRVFSPSVIRFYLSE 133
+ H + LL L + V + G DLN +++ + S I+F + +
Sbjct: 71 MDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQ----KLSDDHIQFLVYQ 126
Query: 134 IICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
I+ ++++H+ GI +RDLKP NI + + + + DF L+R
Sbjct: 127 ILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 37/157 (23%), Positives = 65/157 (41%), Gaps = 21/157 (13%)
Query: 26 LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARW--EIRVLSRLSHP 83
LG G G+V A+K TL +H A + + E V+++L HP
Sbjct: 3 LGHGNFGSVVKGVYLMKS-GKEVEVAVK-----TLKQEHIAAGKKEFLREASVMAQLDHP 56
Query: 84 FLPKLLGSLETDEF-----LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAI 138
+ +L+G + + LA P G L +Y + R S ++ ++ +
Sbjct: 57 CIVRLIGVCKGEPLMLVMELA------PLGPLL--KYLKKRREIPVSDLKELAHQVAMGM 108
Query: 139 EHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
+L + +RDL N+L+ ++DF +SR L
Sbjct: 109 AYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRAL 145
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 80/339 (23%), Positives = 135/339 (39%), Gaps = 78/339 (23%)
Query: 17 LDNLKALKILGKGAMGTVFLV-HDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIR 75
L+ + +K +G G G VFLV H R + F K + L K + + E+
Sbjct: 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEF-----FCWKAISYRGL--KEREKSQLVIEVN 64
Query: 76 VLSRLSHPFLPKLLGSL--ETDEFLAWAVPYCPGGDL--NVLR-YKQNDRVFSPSVIRFY 130
V+ L H + + + + ++ L + +C GDL N+ + YK ++ +++
Sbjct: 65 VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDI- 123
Query: 131 LSEIICAIEHLHNMG-------IAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEK 183
+++ A+ + HN+ + +RDLKP+NI + R++ K TA
Sbjct: 124 TRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTG----------IRHIGKITA--- 170
Query: 184 QSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGE 243
Q+ N N P+ + + GL K
Sbjct: 171 QANNLNGRPIAKIGD--------------------FGLSKNIGIE--------------S 196
Query: 244 RSNSFVGTEEYVSPEVVRGDGHEF--AVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL 301
++S VGT Y SPE++ + + D WALG + YE+ G TPF N + L
Sbjct: 197 MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISEL 256
Query: 302 MKTPEF--VGQRTALTDLIQRLLEKDPVKR------LGY 332
+ P+ G+ L LI+ LL +R LGY
Sbjct: 257 KRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295
|
Length = 1021 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 49/187 (26%), Positives = 84/187 (44%), Gaps = 27/187 (14%)
Query: 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARW 72
P L+ +++K ++G+G G V + R R A+K + + +A + R
Sbjct: 2 PVLEWNDIKFQDVIGEGNFGQV--LKARIKKDGLRMDAAIKRMKE---YASKDDHRDFAG 56
Query: 73 EIRVLSRLS-HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVF--------- 122
E+ VL +L HP + LLG+ E +L A+ Y P G N+L + + RV
Sbjct: 57 ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG--NLLDFLRKSRVLETDPAFAIA 114
Query: 123 -------SPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN- 174
S + + +++ +++L +RDL NIL+ ++ + DF LSR
Sbjct: 115 NSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ 174
Query: 175 --LVKKT 179
VKKT
Sbjct: 175 EVYVKKT 181
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 4e-07
Identities = 44/145 (30%), Positives = 65/145 (44%), Gaps = 13/145 (8%)
Query: 26 LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFL 85
+G+GA GTV+ A D A+K ++ K EI V+ HP +
Sbjct: 27 IGQGASGTVYT----AIDVATGQEVAIKQMNLQQQPKKELIIN----EILVMRENKHPNI 78
Query: 86 PKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNM 144
L S + L + Y GG L +V+ D +V R E + A+E LH+
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR----ECLQALEFLHSN 134
Query: 145 GIAYRDLKPENILIRQSGHVTLTDF 169
+ +RD+K +NIL+ G V LTDF
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDF 159
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 32/111 (28%), Positives = 51/111 (45%), Gaps = 2/111 (1%)
Query: 73 EIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLS 132
EI ++ H + GS + L + +C GG L + + S S I +
Sbjct: 56 EIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP--LSESQIAYVSR 113
Query: 133 EIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEK 183
E + + +LH+ G +RD+K NIL+ +GHV L DF +S + A K
Sbjct: 114 ETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK 164
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 42/154 (27%), Positives = 71/154 (46%), Gaps = 15/154 (9%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHE--AERRARWEIRVLSRL 80
L+ LG+G TVF R +V + +HE A A E+ +L L
Sbjct: 11 LEKLGEGTYATVF---------KGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL 61
Query: 81 SHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQN-DRVFSPSVIRFYLSEIICAIE 139
H + L + TD+ L Y D ++ +Y + + S ++ +L +I+ +
Sbjct: 62 KHANIVTLHDIVHTDKSLTLVFEYL---DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLA 118
Query: 140 HLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+ H + +RDLKP+N+LI + G + L DF L+R
Sbjct: 119 YCHRRKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 8e-07
Identities = 48/178 (26%), Positives = 77/178 (43%), Gaps = 30/178 (16%)
Query: 26 LGKGAMGTVFL--VHDRAADPTARCPFALK-----VVDKSTLHAKHEAERRAR----WEI 74
LG+G G V L V + PT + PF ++ +V L +A + AR E+
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRP--DANKNARNDFLKEV 70
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLN-VLRYKQNDR------------- 120
++LSRL P + +LLG ++ L Y GDLN L D
Sbjct: 71 KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAH 130
Query: 121 ---VFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
S S + +I +++L ++ +RDL N L+ ++ + + DF +SRNL
Sbjct: 131 CLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 9e-07
Identities = 65/359 (18%), Positives = 125/359 (34%), Gaps = 120/359 (33%)
Query: 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLS 78
+ +K LG+GA G V + A+K + + + +K +RA E+++L
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETV--AIKKI--TNVFSKKILAKRALRELKLLR 56
Query: 79 RL-SHPFLPKLLGSLETDEFLAWAVPY-----------CPGGDLN-VLRYKQNDRVFSPS 125
H + L D + + + DL+ ++R Q + +
Sbjct: 57 HFRGHKNITCLY-----DMDIVFPGNFNELYLYEELMEA---DLHQIIRSGQP---LTDA 105
Query: 126 VIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQS 185
+ ++ +I+C ++++H+ + +RDLKP N+L+ + + DF L+R
Sbjct: 106 HFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARG----------- 154
Query: 186 LNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERS 245
F P + TRW
Sbjct: 155 -----FSENPGENAGFMTEYVATRW----------------------------------- 174
Query: 246 NSFVGTEEYVSPEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL--M 302
Y +PE++ + A+D W++G + E+L F+GK+ + +L +
Sbjct: 175 --------YRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVL 226
Query: 303 KTPE-----FVGQRTALT-------------------------DLIQRLLEKDPVKRLG 331
TP+ +G A DL+++LL DP KR+
Sbjct: 227 GTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS 285
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 1e-06
Identities = 28/88 (31%), Positives = 39/88 (44%), Gaps = 4/88 (4%)
Query: 246 NSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTP-FRGKNRKETFRNVLMKT 304
NS VGT +++PEV++ + VD W+LGI+ EM G P R + F
Sbjct: 174 NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI 233
Query: 305 PEFVGQR---TALTDLIQRLLEKDPVKR 329
P D + + L KDP KR
Sbjct: 234 PPLKNPEKWSPEFKDFLNKCLVKDPEKR 261
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 1e-06
Identities = 17/44 (38%), Positives = 28/44 (63%)
Query: 244 RSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTP 287
+ N+FVGT +++PEV++ G++ D W+LGI E+ G P
Sbjct: 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 37/143 (25%), Positives = 62/143 (43%), Gaps = 19/143 (13%)
Query: 29 GAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKL 88
G + V LV D T F LK + KS E R E + P + L
Sbjct: 4 GVIDKVLLVMDTRTQQT----FILKGLRKS-----SEYSR----ERLTIIPHCVPNMVCL 50
Query: 89 LGSLETDEFLAWAVPYCPGGDL--NVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGI 146
+ +++ + + + GG L ++ ++ ++ + +E++ A++ LH GI
Sbjct: 51 HKYIVSEDSVFLVLQHAEGGKLWSHISKFLN----IPEECVKRWAAEMVVALDALHREGI 106
Query: 147 AYRDLKPENILIRQSGHVTLTDF 169
RDL P NIL+ GH+ LT F
Sbjct: 107 VCRDLNPNNILLDDRGHIQLTYF 129
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 39/151 (25%), Positives = 69/151 (45%), Gaps = 9/151 (5%)
Query: 25 ILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPF 84
++G+ F V R +DP KVV K + AR E+ L+ H
Sbjct: 74 LVGRNPTTAAF-VATRGSDP------KEKVVAKFVMLNDERQAAYARSELHCLAACDHFG 126
Query: 85 LPKLLGSLETDEFLAWAVPYCPGGDLN-VLRYKQNDRV-FSPSVIRFYLSEIICAIEHLH 142
+ K ++D+ L + Y GGDLN ++ + + + F + +I+ A++ +H
Sbjct: 127 IVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH 186
Query: 143 NMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+ + +RDLK NI + +G + L DF S+
Sbjct: 187 SRKMMHRDLKSANIFLMPTGIIKLGDFGFSK 217
|
Length = 478 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 31/111 (27%), Positives = 52/111 (46%), Gaps = 20/111 (18%)
Query: 73 EIRVLSRLSHPFLPKLLGSLETD-------EFLAWAVPYCPGGDLNVLRYKQN---DRVF 122
EI +L L HP + L L + EFL +++ +Y + +
Sbjct: 49 EISLLKELQHPNIVCLQDVLMQESRLYLIFEFL----------SMDLKKYLDSLPKGQYM 98
Query: 123 SPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+++ YL +I+ I H+ + +RDLKP+N+LI G + L DF L+R
Sbjct: 99 DAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 48/155 (30%), Positives = 68/155 (43%), Gaps = 13/155 (8%)
Query: 26 LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS---H 82
+G GA GTV+ +A DP + ALK V T + E+ +L RL H
Sbjct: 8 IGVGAYGTVY----KARDPHSGHFVALKSVRVQT--NEDGLPLSTVREVALLKRLEAFDH 61
Query: 83 PFLPKLL---GSLETD-EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAI 138
P + +L+ + TD E V DL K I+ + + + +
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 139 EHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+ LH I +RDLKPENIL+ G V L DF L+R
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 72/330 (21%), Positives = 117/330 (35%), Gaps = 87/330 (26%)
Query: 24 KILGKGAMGTVF--LVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS 81
LG GA G V+ D + A+K + K A + ++ E ++S +
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG---ATDQEKKEFLKEAHLMSNFN 57
Query: 82 HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEI--IC--- 136
HP + KLLG +E + GGDL L Y ++ RV L E+ IC
Sbjct: 58 HPNIVKLLGVCLLNEPQYIIMELMEGGDL--LSYLRDARVERFGPPLLTLKELLDICLDV 115
Query: 137 --AIEHLHNMGIAYRDLKPENILIRQSGH-----VTLTDFDLSRNLVKKTAFEKQSLNNN 189
+L M +RDL N L+ + G+ V + DF L+R++ K + K+
Sbjct: 116 AKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG--EG 173
Query: 190 KFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249
PV RW+ +P S F
Sbjct: 174 LLPV---------------RWM------------------APESLLDGKFTTQS------ 194
Query: 250 GTEEYVSPEVVRGDGHEFAVDWWALGILTYEML-YGTTPFRGKNRKETFRNVL----MKT 304
D W+ G+L +E+L G P+ N +E ++V ++
Sbjct: 195 --------------------DVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQK 234
Query: 305 PEFVGQRTALTDLIQRLLEKDPVKRLGYLR 334
PE + + L+ +DP +R + R
Sbjct: 235 PENCPDK--IYQLMTNCWAQDPSERPTFDR 262
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 29/161 (18%)
Query: 23 LKILGKGAMGTV-----FLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVL 77
L+ +G GA G V L A PF+ V+ K T E+++L
Sbjct: 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-----------ELKLL 63
Query: 78 SRLSHPFLPKLLGSLETDEFLA-----WAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLS 132
L H + L +D F++ + V G DL+ L R I+++L
Sbjct: 64 KHLRHENIISL-----SDIFISPLEDIYFVTELLGTDLHRL---LTSRPLEKQFIQYFLY 115
Query: 133 EIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+I+ ++++H+ G+ +RDLKP NILI ++ + + DF L+R
Sbjct: 116 QILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 42/163 (25%), Positives = 77/163 (47%), Gaps = 17/163 (10%)
Query: 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRV 76
L + LK +G GA G V +D + A+K + + + H +RA E+ +
Sbjct: 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNV----AIKKLSRPFQNQTHA--KRAYRELVL 76
Query: 77 LSRLSHPFLPKLLG------SLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFY 130
+ ++H + LL SLE + + + V++ + + S +
Sbjct: 77 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS-----YL 131
Query: 131 LSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
L +++C I+HLH+ GI +RDLKP NI+++ + + DF L+R
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 41/172 (23%), Positives = 72/172 (41%), Gaps = 18/172 (10%)
Query: 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARC-PFALKVVDKSTLHAKHEAERRARWEIR 75
L ++ L+ LG+GA G V+ + A+K + ++ + R+ E
Sbjct: 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQ---EAE 60
Query: 76 VLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLN--VLRYKQNDRVFSPSVIRFYLS- 132
++S L HP + LLG ++ Y GDL+ ++R + V + S S
Sbjct: 61 LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120
Query: 133 -----------EIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+I +E+L + +RDL N L+ + V ++DF LSR
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 65/293 (22%), Positives = 105/293 (35%), Gaps = 94/293 (32%)
Query: 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRA----- 70
+ + L +G+G G V+ RA D T+ ALK V + + ER
Sbjct: 5 SVTEFEKLNRIGEGTYGIVY----RARDTTSGEIVALKKV-------RMDNERDGIPISS 53
Query: 71 -RWEIRVLSRLSHPFLPKLL----GSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPS 125
R EI +L L HP + +L G FL + YC DL L FS S
Sbjct: 54 LR-EITLLLNLRHPNIVELKEVVVGKHLDSIFLV--MEYCEQ-DLASLLD-NMPTPFSES 108
Query: 126 VIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQS 185
++ + +++ +++LH I +RDLK N+L+ G + + DF L+R
Sbjct: 109 QVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLART----------- 157
Query: 186 LNNNKFPVLPVTENPKRHR--RILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGE 243
P + +++T W
Sbjct: 158 -----------YGLPAKPMTPKVVTLW--------------------------------- 173
Query: 244 RSNSFVGTEEYVSPEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKE 295
Y +PE++ G + A+D WA+G + E+L GK+ E
Sbjct: 174 ----------YRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 20/162 (12%)
Query: 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDK---STLHAKHEAERRARWEIRV 76
+ L +G GA G+V A D R A+K + + S +HA RR E+R+
Sbjct: 17 YQNLTPVGSGAYGSV----CSAYDTRLRQKVAVKKLSRPFQSLIHA-----RRTYRELRL 67
Query: 77 LSRLSHPFLPKLLG----SLETDEF-LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYL 131
L + H + LL + + F + V G DLN + Q S ++F +
Sbjct: 68 LKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK---LSDEHVQFLI 124
Query: 132 SEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+++ ++++H+ GI +RDLKP N+ + + + + DF L+R
Sbjct: 125 YQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 14/93 (15%)
Query: 245 SNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT 304
+ +F GT Y+SPE ++ G++ D W+LG + YEM F G+N F +V+++
Sbjct: 162 ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN----FLSVVLRI 217
Query: 305 PEFVGQRTALTD--------LIQRLLEKDPVKR 329
E G +L + ++Q +L KDP R
Sbjct: 218 VE--GPTPSLPETYSRQLNSIMQSMLNKDPSLR 248
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 48/180 (26%), Positives = 81/180 (45%), Gaps = 16/180 (8%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
++ L +K LG G G V L RA + A+K +++ + + E E
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRA-----QIKVAIKAINEGAMSEEDFIE-----EA 50
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYLSE 133
+V+ +LSHP L +L G + L + G L N LR +Q S ++ +
Sbjct: 51 KVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQG--KLSKDMLLSMCQD 108
Query: 134 IICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPV 193
+ +E+L +RDL N L+ +G V ++DF ++R ++ E S + KFPV
Sbjct: 109 VCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD---EYTSSSGAKFPV 165
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 29/110 (26%), Positives = 48/110 (43%), Gaps = 8/110 (7%)
Query: 244 RSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK 303
R S VGT +++PEV+ + VD W+LGI+ EM+ G P+ + + + +
Sbjct: 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN 230
Query: 304 TPEFVGQ----RTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349
P + L + R+L +DP +R A E+ H F
Sbjct: 231 LPPKLKNLHKVSPRLRSFLDRMLVRDPAQRA----TAAELLNHPFLAKAG 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 42/160 (26%), Positives = 71/160 (44%), Gaps = 15/160 (9%)
Query: 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHE--AERRARWEI 74
L+ L LG+G TVF R +V + +HE A A E+
Sbjct: 4 LETYVKLDKLGEGTYATVF---------KGRSKLTENLVALKEIRLEHEEGAPCTAIREV 54
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQN-DRVFSPSVIRFYLSE 133
+L L H + L + T+ L Y D ++ +Y N + S ++ ++ +
Sbjct: 55 SLLKNLKHANIVTLHDIIHTERCLTLVFEYL---DSDLKQYLDNCGNLMSMHNVKIFMFQ 111
Query: 134 IICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
++ + + H I +RDLKP+N+LI + G + L DF L+R
Sbjct: 112 LLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 44/167 (26%), Positives = 78/167 (46%), Gaps = 24/167 (14%)
Query: 18 DNLKALKILGKGAMGTVFLVHD-----RAADPTARCPFALKVVDKSTLHAKHEAERRARW 72
+ + L +G GA G+V D R A PF +S +HAK R
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF------QSIIHAK-----RTYR 65
Query: 73 EIRVLSRLSHPFLPKLLG----SLETDEFL-AWAVPYCPGGDLNVLRYKQNDRVFSPSVI 127
E+R+L + H + LL + +EF + V + G DLN + Q + +
Sbjct: 66 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHV 122
Query: 128 RFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174
+F + +I+ ++++H+ I +RDLKP N+ + + + + DF L+R+
Sbjct: 123 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 169
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 4e-06
Identities = 41/165 (24%), Positives = 65/165 (39%), Gaps = 19/165 (11%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKS---TLHAKHEAERRARWEIRVLSRL 80
KILG+G G+V D + LKV K+ +H E E E +
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQ-----LKVAVKTMKLDIHTYSEIEEFLS-EAACMKDF 58
Query: 81 SHPFLPKLLG-SLETDEFLAWA-----VPYCPGGDLNVL----RYKQNDRVFSPSVIRFY 130
HP + KL+G E +P+ GDL+ R + +
Sbjct: 59 DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF 118
Query: 131 LSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
+ +I +E+L N +RDL N ++R+ V + DF LS+ +
Sbjct: 119 MVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKI 163
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 21/48 (43%), Positives = 32/48 (66%), Gaps = 1/48 (2%)
Query: 134 IICAIEHLH-NMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTA 180
I+ A+E+LH + + +RD+KP N+LI ++G V L DF +S LV A
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA 159
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 4e-06
Identities = 38/167 (22%), Positives = 75/167 (44%), Gaps = 10/167 (5%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
L ++L+ + LG G G+V V A KVV + AK ++ E+
Sbjct: 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTV----MAKKVV---HIGAKSSVRKQILREL 54
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEI 134
+++ P++ G+ + + + + G L+ + YK+ + ++ +
Sbjct: 55 QIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRI-YKKGGPI-PVEILGKIAVAV 112
Query: 135 ICAIEHLHNM-GIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTA 180
+ + +L+N+ I +RD+KP NIL+ G + L DF +S L+ A
Sbjct: 113 VEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA 159
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 4e-06
Identities = 28/99 (28%), Positives = 44/99 (44%), Gaps = 14/99 (14%)
Query: 245 SNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT 304
+++FVGT Y+SPE ++G + D W+LGI E+ G PF N + ++ M
Sbjct: 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGI 218
Query: 305 PEFVGQ--------------RTALTDLIQRLLEKDPVKR 329
+ + Q L D + L KDP +R
Sbjct: 219 LDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTER 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 4e-06
Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 11/157 (7%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVL 77
D+ + L+ LG+G+ TV+ + ALKV+ L + A E +L
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLV----ALKVI---RLQEEEGTPFTAIREASLL 57
Query: 78 SRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRY-KQNDRVFSPSVIRFYLSEIIC 136
L H + L + T E L Y ++ +Y ++ P ++ +L +++
Sbjct: 58 KGLKHANIVLLHDIIHTKETLTLVFEYV---HTDLCQYMDKHPGGLHPENVKLFLFQLLR 114
Query: 137 AIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+ ++H I +RDLKP+N+LI +G + L DF L+R
Sbjct: 115 GLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 47/165 (28%), Positives = 76/165 (46%), Gaps = 22/165 (13%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAE---RRARWEI 74
D + LK +G GA GTV DR KV K L+ ++E +RA E+
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRT--------GAKVAIKK-LYRPFQSELFAKRAYREL 65
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLA------WAVPYCPGGDLNVLRYKQNDRVFSPSVIR 128
R+L + H + LL D L +P+ G DL L + S I+
Sbjct: 66 RLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEK---LSEDRIQ 121
Query: 129 FYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
F + +++ ++++H GI +RDLKP N+ + + + + DF L+R
Sbjct: 122 FLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 28/105 (26%), Positives = 45/105 (42%), Gaps = 18/105 (17%)
Query: 236 QQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRG----- 290
Q D + N+ +GT +++PEV++ G+ D W+LGI EM G P+
Sbjct: 147 GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR 206
Query: 291 ------KNRKETFRNVLMKTPEFVGQRTALTDLIQRLLEKDPVKR 329
T + +PEF D +++ L KDP +R
Sbjct: 207 AIFMIPNKPPPTLSDPEKWSPEF-------NDFVKKCLVKDPEER 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 5e-06
Identities = 33/107 (30%), Positives = 50/107 (46%), Gaps = 8/107 (7%)
Query: 244 RSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNR-KETFRNVLM 302
+ ++ VGT +++PEVV + VD W+LGI+ EM+ G P+ +N + +
Sbjct: 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN 230
Query: 303 KTPEFVG---QRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
TPE D + R LE D KR A E+ +H F K
Sbjct: 231 GTPELQNPEKLSAIFRDFLNRCLEMDVEKRG----SAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 5e-06
Identities = 44/145 (30%), Positives = 64/145 (44%), Gaps = 13/145 (8%)
Query: 26 LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFL 85
+G+GA GTVF D A +V K K + EI V+ L +P +
Sbjct: 27 IGQGASGTVFTAIDVA--------TGQEVAIKQINLQKQPKKELIINEILVMKELKNPNI 78
Query: 86 PKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNM 144
L S + L + Y GG L +V+ D +V R E + A+E LH
Sbjct: 79 VNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCR----ECLQALEFLHAN 134
Query: 145 GIAYRDLKPENILIRQSGHVTLTDF 169
+ +RD+K +N+L+ G V LTDF
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDF 159
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 5e-06
Identities = 42/177 (23%), Positives = 77/177 (43%), Gaps = 20/177 (11%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRA--RW 72
++L ++ ++ LG+ G V+ H P + + V TL K E R +
Sbjct: 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQT----QAVAIKTLKDKAEGPLREEFKH 57
Query: 73 EIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLN---VLRYKQND---------- 119
E + SRL HP + LLG + ++ L+ YC DL+ V+R +D
Sbjct: 58 EAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117
Query: 120 -RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
P+ +++I +E L + + ++DL N+L+ +V ++D L R +
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREV 174
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 21/46 (45%), Positives = 29/46 (63%)
Query: 245 SNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRG 290
++S VGT Y+SPE + +G+ F D W+LG L YEM +PF G
Sbjct: 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 21/46 (45%), Positives = 29/46 (63%)
Query: 245 SNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRG 290
++S VGT Y+SPE + +G+ F D W+LG L YEM +PF G
Sbjct: 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 7e-06
Identities = 37/150 (24%), Positives = 69/150 (46%), Gaps = 9/150 (6%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP 83
++LGKG G VF + P A+K + E + + E R+L + HP
Sbjct: 1 ELLGKGNFGEVF-----KGTLKDKTPVAVKTCKEDL---PQELKIKFLSEARILKQYDHP 52
Query: 84 FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN 143
+ KL+G + + + PGGD K+ D + + +++F L + + +L +
Sbjct: 53 NIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFAL-DAAAGMAYLES 111
Query: 144 MGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+RDL N L+ ++ + ++DF +SR
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 7e-06
Identities = 29/104 (27%), Positives = 48/104 (46%), Gaps = 17/104 (16%)
Query: 73 EIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLS 132
E +L ++HP + +L G+ ++F +P RYK + + + +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILP----------RYKTDLYCYLAAKRNIAIC 182
Query: 133 EIIC-------AIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169
+I+ AI++LH I +RD+K ENI I G V L DF
Sbjct: 183 DILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDF 226
|
Length = 391 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 8e-06
Identities = 39/162 (24%), Positives = 67/162 (41%), Gaps = 20/162 (12%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
++++G G G V+ A A+KV+D + E + EI +L + SH
Sbjct: 21 VEVVGNGTYGQVYKGRHVKTGQLA----AIKVMD-----VTEDEEEEIKLEINMLKKYSH 71
Query: 83 ---------PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSE 133
F+ K D+ L + +C G + L I + E
Sbjct: 72 HRNIATYYGAFIKK--SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICRE 129
Query: 134 IICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
I+ + HLH + +RD+K +N+L+ ++ V L DF +S L
Sbjct: 130 ILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 8e-06
Identities = 44/164 (26%), Positives = 75/164 (45%), Gaps = 11/164 (6%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTAR-CPFALKVVDKSTLHAKHEAERRARW- 72
+D +K K++G G G V R P R P A+K TL A + ++R +
Sbjct: 1 IDASCIKIEKVIGAGEFGEV--CSGRLKLPGKREIPVAIK-----TLKAGYTEKQRRDFL 53
Query: 73 -EIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYL 131
E ++ + HP + L G + + + Y G L+ +++D F+ + L
Sbjct: 54 SEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAF-LRKHDGQFTVIQLVGML 112
Query: 132 SEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
I +++L +MG +RDL NIL+ + ++DF LSR L
Sbjct: 113 RGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 27/95 (28%), Positives = 45/95 (47%), Gaps = 2/95 (2%)
Query: 237 QSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKET 296
Q D + N+FVGT +++PEV++ ++F D W+LGI E+ G P +
Sbjct: 150 QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV 209
Query: 297 FRNVLMKT-PEFVGQRTA-LTDLIQRLLEKDPVKR 329
+ + P GQ + + ++ L KDP R
Sbjct: 210 LFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFR 244
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 53/213 (24%), Positives = 83/213 (38%), Gaps = 41/213 (19%)
Query: 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIR 75
++ + L +G+G G VF + ALK V + K A EI+
Sbjct: 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQI----VALKKV--LMENEKEGFPITALREIK 63
Query: 76 VLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQND--RVFSPSVIRFYLSE 133
+L L H + L+ E A G V + ++D + S ++F LSE
Sbjct: 64 ILQLLKHENVVNLI---EICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSE 120
Query: 134 IICAIEHL-------HNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSL 186
I ++ L H I +RD+K NILI + G + L DF L+R
Sbjct: 121 IKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFS---------- 170
Query: 187 NNNKFPVLPVTENPKRHR---RILTRWLHALPE 216
+++N K +R R++T W PE
Sbjct: 171 ---------LSKNSKPNRYTNRVVTLWYRP-PE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 49/203 (24%), Positives = 90/203 (44%), Gaps = 38/203 (18%)
Query: 19 NLKALKILGKGAMGTV-----FLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARW- 72
NL K LG+G G V F + RA T A+K++ ++ +E R
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTV----AVKMLKENA----SSSELRDLLS 52
Query: 73 EIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLR--------------YKQ 117
E +L +++HP + KL G+ D L V Y G L + LR +
Sbjct: 53 EFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRN 112
Query: 118 NDRVFSPSVIRFYLSEIIC-------AIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFD 170
+ + +P + ++I +++L M + +RDL N+L+ + + ++DF
Sbjct: 113 SSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFG 172
Query: 171 LSRNLVKKTAFEKQSLNNNKFPV 193
LSR++ ++ ++ K+S + PV
Sbjct: 173 LSRDVYEEDSYVKRS--KGRIPV 193
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 22/56 (39%), Positives = 34/56 (60%)
Query: 124 PSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKT 179
P +R Y+ ++I AI H I +RD+KPEN+LI + + L DF +RNL + +
Sbjct: 99 PEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 46.3 bits (109), Expect = 1e-05
Identities = 34/107 (31%), Positives = 50/107 (46%), Gaps = 8/107 (7%)
Query: 244 RSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK 303
+ ++ VGT +++PEVV + VD W+LGI+ EM+ G P+ +N +
Sbjct: 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN 230
Query: 304 -TPEFVGQR---TALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
TPE D + R LE D V R G A E+ +H F K
Sbjct: 231 GTPELQNPERLSAVFRDFLNRCLEMD-VDRRG---SAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-05
Identities = 32/151 (21%), Positives = 68/151 (45%), Gaps = 16/151 (10%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
+K+L G V+L+ + D + LK+ A E E +++L+R
Sbjct: 3 IKLLKGGLTNRVYLLGTKDED------YVLKINPSREKGADREREVAI---LQLLARKGL 53
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLH 142
P +PK+L S E+D + + + G L+ + ++ + + L+E++ + L
Sbjct: 54 P-VPKVLASGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQ------LAELLAKLHQLP 106
Query: 143 NMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+ + + DL P NIL+ + + D++ +
Sbjct: 107 LLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 27/87 (31%), Positives = 41/87 (47%), Gaps = 2/87 (2%)
Query: 245 SNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKE-TFRNVLMK 303
+++ +GT Y+SPE+ + + D WALG YEM F K+ +R + K
Sbjct: 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK 218
Query: 304 TPEFVGQRTA-LTDLIQRLLEKDPVKR 329
P + L +LI +L K P KR
Sbjct: 219 LPPMPKDYSPELGELIATMLSKRPEKR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 45.9 bits (108), Expect = 2e-05
Identities = 33/107 (30%), Positives = 49/107 (45%), Gaps = 8/107 (7%)
Query: 244 RSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK 303
+ ++ VGT +++PEVV + VD W+LGI+ EM+ G P+ +N +
Sbjct: 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN 230
Query: 304 -TPEFVGQRT---ALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
TPE D + R LE D KR A E+ +H F K
Sbjct: 231 GTPELQNPEKLSPIFRDFLNRCLEMDVEKR----GSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 44/163 (26%), Positives = 77/163 (47%), Gaps = 25/163 (15%)
Query: 22 ALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAE---RRARWEIRVLS 78
+LK +G GA G+V A D A+K L ++E +RA E+ +L
Sbjct: 19 SLKQVGSGAYGSVC----SAIDKRTGEKVAIK-----KLSRPFQSEIFAKRAYRELTLLK 69
Query: 79 RLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLN-VLRYKQND------RVFSPSVIRFYL 131
+ H + LL D F + AV D V+ Y Q D S +++ +
Sbjct: 70 HMQHENVIGLL-----DVFTS-AVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLV 123
Query: 132 SEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174
+++C ++++H+ GI +RDLKP N+ + + + + DF L+R+
Sbjct: 124 YQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARH 166
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 41/152 (26%), Positives = 71/152 (46%), Gaps = 11/152 (7%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
L+ LG+G+ TV+ R ALKV+ ++ + A E +L L H
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLV----ALKVI---SMKTEEGVPFTAIREASLLKGLKH 62
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRY-KQNDRVFSPSVIRFYLSEIICAIEHL 141
+ L + T E L + Y ++ +Y Q+ P +R ++ +++ + ++
Sbjct: 63 ANIVLLHDIIHTKETLTFVFEYM---HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI 119
Query: 142 HNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
H I +RDLKP+N+LI G + L DF L+R
Sbjct: 120 HGQHILHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 42/174 (24%), Positives = 67/174 (38%), Gaps = 16/174 (9%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPF-ALKVVDKSTLHAKHEAERRARWE 73
+ D + + LG+GA G VFL +P A+K + ++ + + R E
Sbjct: 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFER---E 58
Query: 74 IRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLN-VLRYKQNDRVF--SPSVIRFY 130
+L+ H + K G + Y GDLN LR D F SP
Sbjct: 59 AELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE 118
Query: 131 LSE---------IICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
L+ I + +L + +RDL N L+ V + DF +SR++
Sbjct: 119 LTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV 172
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 7/161 (4%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARW-EIRV 76
+NL K LG GA G V + A ++ +KV K H +ER A E+++
Sbjct: 35 NNLSFGKTLGAGAFGKVV---EATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKI 91
Query: 77 LSRL-SHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYLSEI 134
+S L +H + LLG+ + YC GDL N LR K+ + ++ F ++
Sbjct: 92 MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFS-YQV 150
Query: 135 ICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
+ L + +RDL N+L+ V + DF L+R++
Sbjct: 151 AKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDI 191
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 42/159 (26%), Positives = 73/159 (45%), Gaps = 14/159 (8%)
Query: 20 LKALKILGKGAMGTVFLV-HDRAADPTARCPFALKVVDKSTLHAKHEAERRARW--EIRV 76
LK +++LG+G G V L +D A D T ++V TL + + + W EI +
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTG------EMVAVKTLKRECGQQNTSGWKKEINI 59
Query: 77 LSRLSHPFLPKLLG--SLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEI 134
L L H + K G S + + L + Y P G L Y ++ + + + + +I
Sbjct: 60 LKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSL--RDYLPKHKL-NLAQLLLFAQQI 116
Query: 135 ICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+ +LH+ +RDL N+L+ V + DF L++
Sbjct: 117 CEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 42/169 (24%), Positives = 71/169 (42%), Gaps = 22/169 (13%)
Query: 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAER---RARWE 73
+D + +G+G G V+ D+ ALK V +E E A E
Sbjct: 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELV----ALKKV-----RLDNEKEGFPITAIRE 56
Query: 74 IRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRV---------FSP 124
I++L +L+H + L + TD+ A G V Y +D + FS
Sbjct: 57 IKILRQLNHRNIVNLK-EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE 115
Query: 125 SVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
I+ ++ +++ + + H +RD+K NIL+ G + L DF L+R
Sbjct: 116 DHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 38/155 (24%), Positives = 69/155 (44%), Gaps = 11/155 (7%)
Query: 27 GKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLP 86
G+G G V+ + +A+K ++ R EI +L L H +
Sbjct: 9 GRGTYGRVYKAKRKNGKDGK--EYAIKKFKGDKEQYTGISQSACR-EIALLRELKHENVV 65
Query: 87 KLLGS-LETDEFLAW-AVPYCPGGDLNVLRY-KQNDRV-FSPSVIRFYLSEIICAIEHLH 142
L+ LE + + Y ++++ +Q RV PS+++ L +I+ + +LH
Sbjct: 66 SLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH 125
Query: 143 NMGIAYRDLKPENILI----RQSGHVTLTDFDLSR 173
+ + +RDLKP NIL+ + G V + D L+R
Sbjct: 126 SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 42/158 (26%), Positives = 71/158 (44%), Gaps = 11/158 (6%)
Query: 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRV 76
L+ K L LG+G+ TV+ + ALK + L + A A E +
Sbjct: 4 LETYKKLDKLGEGSYATVY----KGRSKLTGQLVALKEI---RLEHEEGAPFTAIREASL 56
Query: 77 LSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQN-DRVFSPSVIRFYLSEII 135
L L H + L + T + L Y D ++ +Y + S +R +L +++
Sbjct: 57 LKDLKHANIVTLHDIIHTKKTLTLVFEYL---DTDLKQYMDDCGGGLSMHNVRLFLFQLL 113
Query: 136 CAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+ + H + +RDLKP+N+LI + G + L DF L+R
Sbjct: 114 RGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 21/65 (32%), Positives = 36/65 (55%)
Query: 109 DLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTD 168
DL K + I+ + +++ ++ LH+ + +RDLKP+NIL+ SG + L D
Sbjct: 94 DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD 153
Query: 169 FDLSR 173
F L+R
Sbjct: 154 FGLAR 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 3e-05
Identities = 17/52 (32%), Positives = 31/52 (59%)
Query: 122 FSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
F S ++ + +++ + HLH+ I +RDLK N+L+ G + + DF L+R
Sbjct: 103 FLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 28/106 (26%), Positives = 50/106 (47%), Gaps = 8/106 (7%)
Query: 244 RSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK 303
+ S VGT +++PEV+ + VD W+LGI+ EM+ G P+ + + + +
Sbjct: 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS 232
Query: 304 TP----EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345
P L D ++R+L ++P +R A E+ +H F
Sbjct: 233 PPPKLKNAHKISPVLRDFLERMLTREPQER----ATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 3e-05
Identities = 39/162 (24%), Positives = 69/162 (42%), Gaps = 20/162 (12%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
++++G G G V+ A A+KV+D + + E + EI +L + SH
Sbjct: 11 VELVGNGTYGQVYKGRHVKTGQLA----AIKVMDVTG-----DEEEEIKQEINMLKKYSH 61
Query: 83 ---------PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSE 133
F+ K + D+ L + +C G + L I + E
Sbjct: 62 HRNIATYYGAFIKKNPPGM--DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 119
Query: 134 IICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
I+ + HLH + +RD+K +N+L+ ++ V L DF +S L
Sbjct: 120 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 3e-05
Identities = 32/107 (29%), Positives = 49/107 (45%), Gaps = 8/107 (7%)
Query: 244 RSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK 303
+ ++ VGT +++PEVV + VD W+LGI+ EM+ G P+ +N +
Sbjct: 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231
Query: 304 -TPEFVGQR---TALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
TPE D + R L+ D KR A E+ +H F K
Sbjct: 232 GTPELQNPEKLSAIFRDFLNRCLDMDVEKR----GSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 4e-05
Identities = 30/92 (32%), Positives = 41/92 (44%), Gaps = 2/92 (2%)
Query: 240 DNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKET-FR 298
D + S VGT +++PEV+ G A D W+LG E+L G P+ N FR
Sbjct: 151 DVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFR 210
Query: 299 NVLMKTPEF-VGQRTALTDLIQRLLEKDPVKR 329
V P G L D + + +KDP R
Sbjct: 211 IVQDDHPPLPEGISPELKDFLMQCFQKDPNLR 242
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 4e-05
Identities = 49/180 (27%), Positives = 78/180 (43%), Gaps = 16/180 (8%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
+D +L LK LG G G V R + A+K++ + ++ +E E
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRG-----QYDVAIKMIKEGSM-----SEDEFIEEA 50
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYLSE 133
+V+ +LSH L +L G + Y G L N LR + F PS + +
Sbjct: 51 KVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHG--KRFQPSQLLEMCKD 108
Query: 134 IICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPV 193
+ + +L + +RDL N L+ G V ++DF LSR ++ E S +KFPV
Sbjct: 109 VCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD---EYTSSVGSKFPV 165
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 43/163 (26%), Positives = 75/163 (46%), Gaps = 17/163 (10%)
Query: 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARW- 72
+L++ LK L+ +GKG G V L R +C K++A +A
Sbjct: 2 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKC-------------IKNDATAQAFLA 48
Query: 73 EIRVLSRLSHPFLPKLLGSL-ETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFY 130
E V+++L H L +LLG + E L Y G L + LR + + +++F
Sbjct: 49 EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 108
Query: 131 LSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
L ++ A+E+L +RDL N+L+ + ++DF L++
Sbjct: 109 L-DVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 5e-05
Identities = 30/112 (26%), Positives = 47/112 (41%), Gaps = 12/112 (10%)
Query: 246 NSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETF------RN 299
+FVGT Y++PE ++G+ + D W+LG+ E+ G P+ +N
Sbjct: 157 KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI 216
Query: 300 VLMKTPEFVGQRTA--LTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349
V P + + D + L KDP +R Y E+ EH F K
Sbjct: 217 VNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYK----ELLEHPFIKKYE 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 5e-05
Identities = 45/163 (27%), Positives = 67/163 (41%), Gaps = 39/163 (23%)
Query: 23 LKILGKGAMGTVFLVHD-RAADPTARCPFALKVVDKSTLHAKHEAERRARW-----EIRV 76
L+ +G G+ G V+ D R + A + K + K E+ W E++
Sbjct: 30 LREIGHGSFGAVYFARDVRTNEVVA--------IKKMSYSGKQSNEK---WQDIIKEVKF 78
Query: 77 LSRLSHPFLPKLLGSLETDEFLAWAV-PYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEI- 134
L R+ HP + G E AW V YC G ++L + L E+
Sbjct: 79 LQRIKHPNSIEYKGCY-LREHTAWLVMEYCLGSASDLLEVHKKP-----------LQEVE 126
Query: 135 ICAIEH--------LHNMGIAYRDLKPENILIRQSGHVTLTDF 169
I AI H LH+ + +RD+K NIL+ + G V L DF
Sbjct: 127 IAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADF 169
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 44/182 (24%), Positives = 78/182 (42%), Gaps = 26/182 (14%)
Query: 15 LDLDNLKALKILGKGAMGTVF---LVHDRAADPTARCPFALKVVDKSTLHAKHEAERRAR 71
L+L L +I+G+G G V + A +C V ++ L
Sbjct: 3 LNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKC----DVTAQAFLE---------- 48
Query: 72 WEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYL 131
E V+++L H L +LLG + + G +N LR + V +++F L
Sbjct: 49 -ETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL 107
Query: 132 SEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKF 191
++ +E+L + + +RDL NIL+ + G ++DF L+R ++N+K
Sbjct: 108 -DVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLAR-------VGSMGVDNSKL 159
Query: 192 PV 193
PV
Sbjct: 160 PV 161
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 6e-05
Identities = 50/178 (28%), Positives = 84/178 (47%), Gaps = 20/178 (11%)
Query: 24 KILGKGAMGTVFLVHDRAADPTAR---CPFALKVVDKSTLHAKHEAERRARWEIRVLSRL 80
+++GKG G V+ H D + C A+K +++ T E E+ + E ++
Sbjct: 1 RVIGKGHFGCVY--HGTLIDSDGQKIHC--AVKSLNRIT--DLEEVEQFLK-EGIIMKDF 53
Query: 81 SHPFLPKLLGSLETDEFLAWAV-PYCPGGDL-NVLRYKQNDRVFSPSV---IRFYLSEII 135
SHP + LLG E V PY GDL N +R + ++ P+V I F L ++
Sbjct: 54 SHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHN----PTVKDLIGFGL-QVA 108
Query: 136 CAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPV 193
+E+L + +RDL N ++ +S V + DF L+R++ K + + K PV
Sbjct: 109 KGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV 166
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 7e-05
Identities = 17/45 (37%), Positives = 30/45 (66%)
Query: 125 SVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169
+VI+ + +++ + LH +GI +RD+KPEN+L+ G V + DF
Sbjct: 309 NVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDF 353
|
Length = 507 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 42/165 (25%), Positives = 71/165 (43%), Gaps = 13/165 (7%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARC-PFALKVVDKSTLHAKHEAERRARW- 72
+D + K++G G G V + P + A+K TL A ++R +
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKL--PGKKEIDVAIK-----TLKAGSSDKQRLDFL 53
Query: 73 -EIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLN-VLRYKQNDRVFSPSVIRFY 130
E ++ + HP + +L G + + Y G L+ LR +ND F+ +
Sbjct: 54 TEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLR--ENDGKFTVGQLVGM 111
Query: 131 LSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
L I +++L M +RDL NIL+ + ++DF LSR L
Sbjct: 112 LRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 8e-05
Identities = 45/165 (27%), Positives = 69/165 (41%), Gaps = 19/165 (11%)
Query: 26 LGKGAMGTVFLVHDRAADPTA-RCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPF 84
LG+GA G VFL PT + A+K + TL A+ + +R A +L+ L H
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAE----LLTNLQHEH 68
Query: 85 LPKLLGSLETDEFLAWAVPYCPGGDLN-VLRY-------------KQNDRVFSPSVIRFY 130
+ K G + L Y GDLN LR +Q S +
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 131 LSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
S+I + +L + +RDL N L+ + V + DF +SR++
Sbjct: 129 ASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV 173
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 9e-05
Identities = 34/123 (27%), Positives = 59/123 (47%), Gaps = 7/123 (5%)
Query: 73 EIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRY-KQNDRVFSPSVIRFYL 131
E V+ + HP L +LLG + + G N+L Y ++ +R +V+ Y+
Sbjct: 52 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG--NLLDYLRECNRQEVNAVVLLYM 109
Query: 132 -SEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNK 190
++I A+E+L +RDL N L+ ++ V + DF LSR L+ + + K
Sbjct: 110 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHA--GAK 166
Query: 191 FPV 193
FP+
Sbjct: 167 FPI 169
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 27/88 (30%), Positives = 40/88 (45%), Gaps = 2/88 (2%)
Query: 244 RSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK 303
++ + VGT Y+SPE+ G + D WALG + YE+ F N ++
Sbjct: 157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG 216
Query: 304 TPEFVGQRTA--LTDLIQRLLEKDPVKR 329
T + R + L LI +L DP KR
Sbjct: 217 TFAPISDRYSPDLRQLILSMLNLDPSKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 28/105 (26%), Positives = 41/105 (39%), Gaps = 29/105 (27%)
Query: 244 RSNSFVGTEEYVSPEVV---RGDGHEFAVDWWALGILTYEM------LYGTTPFRGKNRK 294
+ SF+GT +++PEV R G++ D WALGI E+ ++ P R
Sbjct: 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR----- 211
Query: 295 ETFRNVLMKTPEFVGQRTALTD----------LIQRLLEKDPVKR 329
L + L D I++ L KDP KR
Sbjct: 212 -----ALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKR 251
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 39/140 (27%), Positives = 63/140 (45%), Gaps = 24/140 (17%)
Query: 61 HAKHEAERRARWEIRVLSRLSH-PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQND 119
+A + R E+ VL +L H P + LLG+ E +L A+ Y P G N+L + +
Sbjct: 33 YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG--NLLDFLRKS 90
Query: 120 RVF-----------------SPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG 162
RV S ++ F +++ +++L +RDL NIL+ ++
Sbjct: 91 RVLETDPAFAIANSTASTLSSQQLLHF-AADVARGMDYLSQKQFIHRDLAARNILVGENY 149
Query: 163 HVTLTDFDLSRN---LVKKT 179
+ DF LSR VKKT
Sbjct: 150 VAKIADFGLSRGQEVYVKKT 169
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 44/166 (26%), Positives = 72/166 (43%), Gaps = 27/166 (16%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
L+ LG G+ G VF A D A+K + + + A R EI+++ RL H
Sbjct: 10 LRPLGCGSNGLVF----SAVDSDCDKRVAVKKIVLTDPQSVKHALR----EIKIIRRLDH 61
Query: 83 PFLPKL---LGSLETD---------EF-LAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIR 128
+ K+ LG +D E + V DL NVL S R
Sbjct: 62 DNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP----LSEEHAR 117
Query: 129 FYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHV-TLTDFDLSR 173
++ +++ ++++H+ + +RDLKP N+ I V + DF L+R
Sbjct: 118 LFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLAR 163
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 41/163 (25%), Positives = 73/163 (44%), Gaps = 17/163 (10%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVV------DKSTLHAKHEAERRARWEIRV 76
L+ LG GA G V+ V + ALK + + ++ E+ +
Sbjct: 5 LEHLGSGAFGCVYKVRKKNNGQNL---LALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 77 L-SRLSHPFLPKLLGS-LETDEF--LAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYL 131
+ +L HP + + + LE D + + P G+ N L+ K+ F+ I
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQR--FTEERIWNIF 119
Query: 132 SEIICAIEHLHN-MGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+++ A+ +LH I +RDL P NI++ + VT+TDF L++
Sbjct: 120 VQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK 162
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 37/128 (28%), Positives = 60/128 (46%), Gaps = 24/128 (18%)
Query: 73 EIRVLSRLS-HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVF--------- 122
E+ VL +L HP + LLG+ E +L A+ Y P G N+L + + RV
Sbjct: 52 ELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYG--NLLDFLRKSRVLETDPAFAKE 109
Query: 123 --------SPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174
S +++F S++ +++L +RDL N+L+ ++ + DF LSR
Sbjct: 110 HGTASTLTSQQLLQF-ASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRG 168
Query: 175 ---LVKKT 179
VKKT
Sbjct: 169 EEVYVKKT 176
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 39/158 (24%), Positives = 68/158 (43%), Gaps = 15/158 (9%)
Query: 20 LKALKILGKGAMGTVFLVHDRAADP---TARCPFALKVV-DKSTLHAKHEAERRARWEIR 75
L+ LK+LG G GTV H P + + P A+K + D+S E +
Sbjct: 9 LRKLKLLGSGVFGTV---HKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITD----HML 61
Query: 76 VLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRY-KQNDRVFSPSVIRFYLSEI 134
+ L H ++ +LLG + L P G L L + +Q+ P + + +I
Sbjct: 62 AMGSLDHAYIVRLLG-ICPGASLQLVTQLSPLGSL--LDHVRQHRDSLDPQRLLNWCVQI 118
Query: 135 ICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172
+ +L + +R+L NIL++ V + DF ++
Sbjct: 119 AKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVA 156
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 40/158 (25%), Positives = 72/158 (45%), Gaps = 11/158 (6%)
Query: 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRV 76
L+ L LG+G TV+ + D ALK + L + A A E+ +
Sbjct: 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLV----ALKEI---RLEHEEGAPCTAIREVSL 57
Query: 77 LSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQN-DRVFSPSVIRFYLSEII 135
L L H + L + T++ L Y D ++ +Y + + ++ +L +++
Sbjct: 58 LKDLKHANIVTLHDIIHTEKSLTLVFEYL---DKDLKQYLDDCGNSINMHNVKLFLFQLL 114
Query: 136 CAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+ + H + +RDLKP+N+LI + G + L DF L+R
Sbjct: 115 RGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 21/51 (41%), Positives = 29/51 (56%)
Query: 245 SNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKE 295
+NSFVGT Y+SPE ++G + D W+LG+ EM G P + KE
Sbjct: 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE 205
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 28/114 (24%), Positives = 49/114 (42%), Gaps = 16/114 (14%)
Query: 242 GERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL 301
GE +GT +++PEV+RG+ + + D W++G + EM P+ + ++
Sbjct: 162 GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA-LI 220
Query: 302 MK---------TPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
K PE + L D+ R LE P R + E+ +H F+
Sbjct: 221 FKIASATTAPSIPEHLSP--GLRDVTLRCLELQPEDR----PPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 29/99 (29%), Positives = 44/99 (44%), Gaps = 10/99 (10%)
Query: 237 QSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKET 296
Q D + N+FVGT +++PEV++ ++ D W+LGI E+ G P N
Sbjct: 150 QLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP----NSDMH 205
Query: 297 FRNVLMKTPEF-----VGQRT-ALTDLIQRLLEKDPVKR 329
VL P+ G+ + + I L KDP R
Sbjct: 206 PMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFR 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 45/157 (28%), Positives = 66/157 (42%), Gaps = 38/157 (24%)
Query: 248 FVGTEEYVSPEVVRGDGH-EFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT-- 304
+V T Y +PEV+ H VD W++G + EML G T F+GK+ + +L T
Sbjct: 174 YVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV 233
Query: 305 --PEFVGQ-----------------RTALT-----------DLIQRLLEKDPVKRLGYLR 334
PEFV + R + DL++++LE D KRL
Sbjct: 234 PGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRL---- 289
Query: 335 GACEIKEHVFFKGVRWDLLTDVLRPPFIPSREENDLT 371
A E EH +F R D + + P+ S E L+
Sbjct: 290 TATEALEHPYFDSFR-DADEETEQQPYDDSLENEKLS 325
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 41/158 (25%), Positives = 62/158 (39%), Gaps = 10/158 (6%)
Query: 25 ILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP- 83
+L +G G +F P +K V HA E +L LSH
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTV---KDHASEIQVTLLLQESCLLYGLSHQN 69
Query: 84 FLPKLLGSLETDEFLAWAVPYCPGGDLNV------LRYKQNDRVFSPSVIRFYLSEIICA 137
LP L +E E PY G+L + L N + S + +I C
Sbjct: 70 ILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACG 129
Query: 138 IEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
+ +LH G+ ++D+ N +I + V +TD LSR+L
Sbjct: 130 MSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDL 167
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 31/111 (27%), Positives = 50/111 (45%), Gaps = 2/111 (1%)
Query: 73 EIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLS 132
EI ++ H + GS + E L + YC GG L + + S I +
Sbjct: 56 EIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGP--LSELQIAYVCR 113
Query: 133 EIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEK 183
E + + +LH+ G +RD+K NIL+ +G V L DF ++ + A K
Sbjct: 114 ETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK 164
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 18/48 (37%), Positives = 30/48 (62%), Gaps = 1/48 (2%)
Query: 134 IICAIEHLHN-MGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTA 180
+ A+ +L + I +RD+KP NIL+ ++G++ L DF +S LV A
Sbjct: 116 TVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 43/183 (23%), Positives = 78/183 (42%), Gaps = 18/183 (9%)
Query: 13 PSLDLDNLKALKILGKGAMGTVF--LVHDRAADPTARCPFALKVVDKSTLHAKHEAERRA 70
P + D++ L+ LG GA G V+ L R D A+K + +S + E
Sbjct: 1 PEVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVEL-QVAVKTLPES---CSEQDESDF 56
Query: 71 RWEIRVLSRLSHPFLPKLLG-SLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIR 128
E ++S+ +H + +L+G S E + GGDL + LR + R PS +
Sbjct: 57 LMEALIMSKFNHQNIVRLIGVSFERLPRFI-LLELMAGGDLKSFLRENRP-RPERPSSLT 114
Query: 129 -----FYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGH---VTLTDFDLSRNLVKKTA 180
F ++ ++L +RD+ N L+ G + DF ++R++ + +
Sbjct: 115 MKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASY 174
Query: 181 FEK 183
+ K
Sbjct: 175 YRK 177
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 31/122 (25%), Positives = 53/122 (43%), Gaps = 9/122 (7%)
Query: 73 EIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYL 131
E V++ L HP L +LLG + L Y G L + LR + + + F L
Sbjct: 50 EASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFAL 109
Query: 132 SEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKF 191
++ +E+L +RDL N+L+ + ++DF L++ Q ++ K
Sbjct: 110 -DVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKE-------ASQGQDSGKL 161
Query: 192 PV 193
PV
Sbjct: 162 PV 163
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 45/209 (21%), Positives = 71/209 (33%), Gaps = 74/209 (35%)
Query: 134 IICAIEHL-HNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFP 192
I+ A+ +L G+ +RD+KP NIL+ SG+V L DF +S LV A
Sbjct: 123 IVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA------------ 170
Query: 193 VLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252
KT+SA G
Sbjct: 171 ------------------------------KTRSA----------------------GCA 178
Query: 253 EYVSPEVV----RGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRK-ETFRNVLMKTPEF 307
Y++PE + ++ D W+LGI E+ G P++ + E +L + P
Sbjct: 179 AYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPS 238
Query: 308 VGQRTALTDLIQRLLE----KDPVKRLGY 332
+ + ++ KD KR Y
Sbjct: 239 LPPNEGFSPDFCSFVDLCLTKDHRKRPKY 267
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 20/63 (31%), Positives = 39/63 (61%), Gaps = 1/63 (1%)
Query: 115 YKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGH-VTLTDFDLSR 173
Y +N+ +++ Y ++ A+ ++H+ I +RDLKP+N+LI + H + L DF ++
Sbjct: 160 YARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219
Query: 174 NLV 176
NL+
Sbjct: 220 NLL 222
|
Length = 440 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 3e-04
Identities = 42/145 (28%), Positives = 65/145 (44%), Gaps = 13/145 (8%)
Query: 26 LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFL 85
+G+GA GTV+ D A + + L + + E EI V+ +P +
Sbjct: 28 IGQGASGTVYTAMDVATGQEV-------AIRQMNLQQQPKKELIIN-EILVMRENKNPNI 79
Query: 86 PKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNM 144
L S + L + Y GG L +V+ D +V R E + A+E LH+
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR----ECLQALEFLHSN 135
Query: 145 GIAYRDLKPENILIRQSGHVTLTDF 169
+ +RD+K +NIL+ G V LTDF
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDF 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 20/51 (39%), Positives = 29/51 (56%)
Query: 245 SNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKE 295
+NSFVGT Y+SPE ++G + D W++G+ EM G P + KE
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE 209
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 45/183 (24%), Positives = 72/183 (39%), Gaps = 14/183 (7%)
Query: 19 NLKALKILGKGAMGTVFLVHDRAADPT-ARCPFALKVVDKSTLHAKHEAERRARWEIRVL 77
NL+ + LG+G G VFL + + +K + K+ RR E+ +
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRR---ELDMF 62
Query: 78 SRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLN--VLRYKQNDRVFSP----SVIRFYL 131
+LSH + +LLG E + Y GDL + K D P + + L
Sbjct: 63 RKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVAL 122
Query: 132 SEIIC-AIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNK 190
I ++HL N +RDL N L+ V ++ LS+++ E L N
Sbjct: 123 CTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS---EYYKLRNAL 179
Query: 191 FPV 193
P+
Sbjct: 180 IPL 182
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 28/117 (23%), Positives = 58/117 (49%), Gaps = 6/117 (5%)
Query: 63 KHEAERRARWEI----RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQN 118
K+E E+ R E+ ++ +L +P++ +++G E E L + GG LN +
Sbjct: 31 KNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSGKK 89
Query: 119 DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
D + +V+ + ++ +++L +RDL N+L+ + ++DF LS+ L
Sbjct: 90 DEITVSNVVEL-MHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKAL 145
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 31/104 (29%), Positives = 44/104 (42%), Gaps = 3/104 (2%)
Query: 73 EIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYL 131
E ++ L H L +L G + T L P G L + LR K F S + Y
Sbjct: 46 EAAIMHSLDHENLIRLYGVVLTHP-LMMVTELAPLGSLLDRLR-KDALGHFLISTLCDYA 103
Query: 132 SEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
+I + +L + +RDL NIL+ V + DF L R L
Sbjct: 104 VQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRAL 147
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 3e-04
Identities = 45/163 (27%), Positives = 67/163 (41%), Gaps = 18/163 (11%)
Query: 26 LGKGAMGTVFLVHDRAADPTARCPFALK--VVDKSTLHAKHEAERRARWEIRVLSRLSHP 83
LG+GA G VFL A+ CP K V K+ A A + E +L+ L H
Sbjct: 13 LGEGAFGKVFL-----AECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHE 67
Query: 84 FLPKLLGSLETDEFLAWAVPYCPGGDLN-VLRYKQNDRVF----------SPSVIRFYLS 132
+ K G + L Y GDLN LR D V + S +
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 133 EIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
+I + +L + +RDL N L+ ++ V + DF +SR++
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDV 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 32/109 (29%), Positives = 47/109 (43%), Gaps = 22/109 (20%)
Query: 247 SFVGTEEYVSPEVV-RGDGHEFAVDWWALGILTYEMLYGTTP----------FRGKNRKE 295
SF G+ +++PEV+ + G+ A D W+LG EM G P F+ KE
Sbjct: 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE 219
Query: 296 TFRNVLMKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVF 344
L P+ + D I + L++DP R A E+ EH F
Sbjct: 220 -----LPPIPDHLSDE--AKDFILKCLQRDPSLRP----TAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 44/165 (26%), Positives = 75/165 (45%), Gaps = 24/165 (14%)
Query: 10 QTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERR 69
P LDN KI G+G+ G V + D++ A+K +D + +RR
Sbjct: 14 PGDPRSYLDNFV--KI-GEGSTGIVCIATDKSTGRQV----AVKKMDLR------KQQRR 60
Query: 70 ARW--EIRVLSRLSHPFLPKLLGS-LETDEFLAWAV-PYCPGGDL-NVLRYKQNDRVFSP 124
E+ ++ HP + ++ S L DE W V + GG L +++ + + +
Sbjct: 61 ELLFNEVVIMRDYQHPNIVEMYSSYLVGDEL--WVVMEFLEGGALTDIVTHTRMNEEQIA 118
Query: 125 SVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169
+V L A+ LH G+ +RD+K ++IL+ G V L+DF
Sbjct: 119 TVCLAVLK----ALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDF 159
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 4e-04
Identities = 43/162 (26%), Positives = 64/162 (39%), Gaps = 37/162 (22%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARW-----EIRVL 77
L+ +G G+ G V+ D + K + K E+ W E+R L
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVV-------AIKKMSYSGKQSNEK---WQDIIKEVRFL 69
Query: 78 SRLSHPFLPKLLGSLETDEFLAWAV-PYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEI-I 135
+L HP + G E AW V YC G ++L + L E+ I
Sbjct: 70 QKLRHPNTIQYRGCY-LREHTAWLVMEYCLGSASDLLEVHKKP-----------LQEVEI 117
Query: 136 CAIEH--------LHNMGIAYRDLKPENILIRQSGHVTLTDF 169
A+ H LH+ + +RD+K NIL+ + G V L DF
Sbjct: 118 AAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDF 159
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 49/180 (27%), Positives = 77/180 (42%), Gaps = 16/180 (8%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
+D L LK LG G G V L R A +K++ + + +E E
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVA-----IKMIREGAM-----SEDDFIEEA 50
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYLSE 133
+V+ +LSHP L +L G + Y G L N LR + + S+
Sbjct: 51 KVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLR--ERKGKLGTEWLLDMCSD 108
Query: 134 IICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPV 193
+ A+E+L + G +RDL N L+ + V ++DF L+R ++ + S KFPV
Sbjct: 109 VCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD---QYTSSQGTKFPV 165
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 4e-04
Identities = 27/103 (26%), Positives = 49/103 (47%)
Query: 244 RSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK 303
+ S VGT +++PEV+ + VD W+LGI+ EM+ G P+ + + R +
Sbjct: 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN 233
Query: 304 TPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
P V ++ +++ L+ V+ A E+ +H F K
Sbjct: 234 LPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 4e-04
Identities = 43/181 (23%), Positives = 86/181 (47%), Gaps = 17/181 (9%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP 83
++LGKG G+V ++ D + + A+K++ K+ + + + E R E + HP
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQ-KVAVKML-KADIFSSSDIEEFLR-EAACMKEFDHP 61
Query: 84 FLPKLLG-SLETDEFLAWAVP-----YCPGGDLN--VLRYKQNDRVFSPSV---IRFYLS 132
+ KL+G SL + +P + GDL+ +L + + F+ + +RF +
Sbjct: 62 NVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI- 120
Query: 133 EIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFP 192
+I +E+L + +RDL N ++ ++ V + DF LS+ + + + +K P
Sbjct: 121 DIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA--SKLP 178
Query: 193 V 193
V
Sbjct: 179 V 179
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 34/121 (28%), Positives = 45/121 (37%), Gaps = 33/121 (27%)
Query: 242 GERSNSFVGTEEYVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGK--------- 291
GE +V T Y +PE++ GD + AVD WA+G L EML G F G
Sbjct: 154 GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHI 213
Query: 292 -----NRKETFRNVLMKTPEFVGQRTA------------------LTDLIQRLLEKDPVK 328
N + + K P F G R + DL ++ L DP
Sbjct: 214 IKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDD 273
Query: 329 R 329
R
Sbjct: 274 R 274
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 6e-04
Identities = 44/165 (26%), Positives = 77/165 (46%), Gaps = 12/165 (7%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVL 77
D+ + + LG G G VF V + P+ A K++ L K + E++VL
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHK---PSGLI-MARKLIH---LEIKPAIRNQIIRELQVL 57
Query: 78 SRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLS-EIIC 136
+ P++ G+ +D ++ + + GG L+ + K+ R+ P I +S +I
Sbjct: 58 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV-LKKAGRI--PEQILGKVSIAVIK 114
Query: 137 AIEHL-HNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTA 180
+ +L I +RD+KP NIL+ G + L DF +S L+ A
Sbjct: 115 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 159
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 6e-04
Identities = 17/51 (33%), Positives = 34/51 (66%)
Query: 123 SPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
S ++ +L +I+ +++LH+ GI +RD+KP N+L+ + + + DF L+R
Sbjct: 101 SSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 6e-04
Identities = 38/149 (25%), Positives = 70/149 (46%), Gaps = 11/149 (7%)
Query: 26 LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFL 85
+GKG G V+ A+K +STL + +R+ E +L + HP +
Sbjct: 3 IGKGNFGDVY-----KGVLKGNTEVAVKTC-RSTLPP--DLKRKFLQEAEILKQYDHPNI 54
Query: 86 PKLLGSLETDEFLAWAVPYCPGGD-LNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNM 144
KL+G + + + PGG L LR K+ +R+ +++ L + +E+L +
Sbjct: 55 VKLIGVCVQKQPIYIVMELVPGGSLLTFLR-KKKNRLTVKKLLQMSL-DAAAGMEYLESK 112
Query: 145 GIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+RDL N L+ ++ + ++DF +SR
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 42/164 (25%), Positives = 68/164 (41%), Gaps = 18/164 (10%)
Query: 26 LGKGAMGTVFLVHDRAADPTA-RCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPF 84
LG+GA G VFL P + A+K + +++ A+ + +R A +L+ L H
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAE----LLTVLQHQH 68
Query: 85 LPKLLGSLETDEFLAWAVPYCPGGDLN-VLRY---------KQNDRVFSPSVIRFYL--- 131
+ + G L Y GDLN LR D + L
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 132 SEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
S+I + +L ++ +RDL N L+ Q V + DF +SR++
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI 172
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 7e-04
Identities = 39/155 (25%), Positives = 68/155 (43%), Gaps = 11/155 (7%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARW--EIRVLSRLS 81
K++G G G VF + A+K TL + ++R + E ++ + S
Sbjct: 11 KVIGAGEFGEVFRGILKMPG-RKEVAVAIK-----TLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 82 HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRY-KQNDRVFSPSVIRFYLSEIICAIEH 140
H + +L G + + Y G L+ +Y + +D FS + L I +++
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALD--KYLRDHDGEFSSYQLVGMLRGIAAGMKY 122
Query: 141 LHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
L +M +RDL NIL+ + ++DF LSR L
Sbjct: 123 LSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 7e-04
Identities = 39/148 (26%), Positives = 68/148 (45%), Gaps = 8/148 (5%)
Query: 26 LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFL 85
+G+G G VF RA D T P A+K + TL +A + E R+L + SHP +
Sbjct: 3 IGRGNFGEVFSGRLRA-DNT---PVAVKSC-RETLPPDLKA--KFLQEARILKQYSHPNI 55
Query: 86 PKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMG 145
+L+G + + + GGD + R+ +I+ + +E+L +
Sbjct: 56 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQM-VENAAAGMEYLESKH 114
Query: 146 IAYRDLKPENILIRQSGHVTLTDFDLSR 173
+RDL N L+ + + ++DF +SR
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 7e-04
Identities = 46/185 (24%), Positives = 75/185 (40%), Gaps = 32/185 (17%)
Query: 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVV----DKSTLHAKHEAERRAR 71
+N++ ++ +G+GA G VF RA PF + V ++++ + + +R A
Sbjct: 3 PRNNIEYVRDIGQGAFGRVF--QARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60
Query: 72 WEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLN-VLR----YKQNDRVFSPSV 126
+++ HP + KLLG + + Y GDLN LR Q S S
Sbjct: 61 ----LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSS 116
Query: 127 IRFYLSEIICAIEHLHNM--------GIAY--------RDLKPENILIRQSGHVTLTDFD 170
R + + G+AY RDL N L+ ++ V + DF
Sbjct: 117 ARKC-GLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFG 175
Query: 171 LSRNL 175
LSRN+
Sbjct: 176 LSRNI 180
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 8e-04
Identities = 35/155 (22%), Positives = 64/155 (41%), Gaps = 16/155 (10%)
Query: 24 KILGKGAMGTVF--LVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARW--EIRVLSR 79
+ +G+G G V+ + + + A+K T R ++ E ++ +
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENE---KIAVAVKTCKNCT-----SPSVREKFLQEAYIMRQ 63
Query: 80 LSHPFLPKLLGSLETDEFLAWAV-PYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAI 138
HP + KL+G + + W V P G+L + S+I Y ++ A+
Sbjct: 64 FDHPHIVKLIGVITENP--VWIVMELAPLGELRSYLQVNKYSLDLASLI-LYSYQLSTAL 120
Query: 139 EHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+L + +RD+ N+L+ V L DF LSR
Sbjct: 121 AYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 31/91 (34%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 245 SNSFVGTEEYVSPEVV-RG-DGHEFAVDWWALGILTYEMLYGTTPFR--GKNRKETFRNV 300
+ +F GT +Y++PEV+ +G G+ D W+LG EM G PF G+ + F+
Sbjct: 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG 225
Query: 301 LMKT-PEFVGQRTA-LTDLIQRLLEKDPVKR 329
+ K PE +A + I R E DP KR
Sbjct: 226 MFKIHPEIPESLSAEAKNFILRCFEPDPDKR 256
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.001
Identities = 41/145 (28%), Positives = 65/145 (44%), Gaps = 13/145 (8%)
Query: 26 LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFL 85
+G+GA GTV+ D A + + L + + E EI V+ +P +
Sbjct: 27 IGQGASGTVYTAIDIATGQEV-------AIKQMNLQQQPKKELIIN-EILVMRENKNPNI 78
Query: 86 PKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNM 144
L S + L + Y GG L +V+ D +V R E + A++ LH+
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR----ECLQALDFLHSN 134
Query: 145 GIAYRDLKPENILIRQSGHVTLTDF 169
+ +RD+K +NIL+ G V LTDF
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDF 159
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.001
Identities = 19/50 (38%), Positives = 28/50 (56%), Gaps = 5/50 (10%)
Query: 244 RSNSFVGTEEYVSPEVVRGD-----GHEFAVDWWALGILTYEMLYGTTPF 288
R N+F+GT +++PEV+ D ++F D W+LGI EM G P
Sbjct: 167 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 46/169 (27%), Positives = 75/169 (44%), Gaps = 20/169 (11%)
Query: 18 DNLKALKILGKGAMGTVFLV-HDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRV 76
D+ + L LG G G V V H + AR K++ L K + E++V
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMAR-----KLIH---LEIKPAIRNQIIRELKV 52
Query: 77 LSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEI-I 135
L + P++ G+ +D ++ + + GG L+ + K+ R+ P I L +I I
Sbjct: 53 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV-LKKAGRI--PENI---LGKISI 106
Query: 136 CAIEHL----HNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTA 180
+ L I +RD+KP NIL+ G + L DF +S L+ A
Sbjct: 107 AVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 155
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.001
Identities = 67/343 (19%), Positives = 128/343 (37%), Gaps = 100/343 (29%)
Query: 15 LDLDNLKALKILGKGAMGTVFL-VHDRAADPTARCPFALK-VVDKSTLHAKHEAERRARW 72
L + + ++ LG+G+ G V+ + A+K V + +++ ER
Sbjct: 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMR-----ERIEFL 57
Query: 73 -EIRVLSRLSHPFLPKLLGSLETD-------EFLAWAVPYCPGGDL-NVLRYK-----QN 118
E V+ + + +LLG + T E +A GDL + LR + N
Sbjct: 58 NEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAK-------GDLKSYLRSRRPEAENN 110
Query: 119 DRVFSPSVIRFYL--SEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176
+ P++ +F +EI + +L +RDL N ++ + V + DF ++R++
Sbjct: 111 PGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY 170
Query: 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPEN-KTGLKKTKSARVSPVSRR 235
+ + K +LPV RW+ PE+ K G+ TKS
Sbjct: 171 ETDYYRKGGKG-----LLPV------------RWMA--PESLKDGVFTTKS--------- 202
Query: 236 QQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEML-YGTTPFRGKNRK 294
D W+ G++ +EM P++G + +
Sbjct: 203 ----------------------------------DVWSFGVVLWEMATLAEQPYQGLSNE 228
Query: 295 ETFRNVL----MKTPEFVGQRTALTDLIQRLLEKDPVKRLGYL 333
E + V+ + PE + L +L++ + +P R +L
Sbjct: 229 EVLKFVIDGGHLDLPENCPDK--LLELMRMCWQYNPKMRPTFL 269
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 32/107 (29%), Positives = 49/107 (45%), Gaps = 8/107 (7%)
Query: 243 ERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRG----KNRKETFR 298
R S VGT +++PE++ + VD W+LGI+ EM+ G P+ K K
Sbjct: 171 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD 230
Query: 299 NVLMKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345
N+ K +L + RLL +DP +R A E+ +H F
Sbjct: 231 NLPPKLKNLHKVSPSLKGFLDRLLVRDPAQR----ATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 45/162 (27%), Positives = 67/162 (41%), Gaps = 37/162 (22%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARW-----EIRVL 77
L+ +G G+ G V+ D + A+K K + K E+ W E+R L
Sbjct: 20 LREIGHGSFGAVYFARDVRTNEVV----AIK---KMSYSGKQSNEK---WQDIIKEVRFL 69
Query: 78 SRLSHPFLPKLLGSLETDEFLAWAV-PYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEI-- 134
+L HP + G E AW V YC G ++L V + L E+
Sbjct: 70 QQLRHPNTIEYKGCY-LREHTAWLVMEYCLGSASDIL-----------EVHKKPLQEVEI 117
Query: 135 --IC-----AIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169
IC + +LH+ +RD+K NIL+ + G V L DF
Sbjct: 118 AAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADF 159
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 19/51 (37%), Positives = 29/51 (56%)
Query: 245 SNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKE 295
+NSFVGT Y+SPE ++G + D W++G+ E+ G P + KE
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE 209
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.001
Identities = 42/167 (25%), Positives = 74/167 (44%), Gaps = 36/167 (21%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVV---DKSTLHAKHEAERRARWEIRVLSR 79
L +G+GA G V + PT A+K + + T +R R EI++L R
Sbjct: 10 LSYIGEGAYGMVCSATHK---PT-GVKVAIKKISPFEHQTF-----CQRTLR-EIKILRR 59
Query: 80 LSHPFLPKLL-----GSLET-------DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVI 127
H + +L S E+ E + DL L Q+ S I
Sbjct: 60 FKHENIIGILDIIRPPSFESFNDVYIVQELME--------TDLYKLIKTQH---LSNDHI 108
Query: 128 RFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174
+++L +I+ ++++H+ + +RDLKP N+L+ + + + DF L+R
Sbjct: 109 QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 20/57 (35%), Positives = 31/57 (54%), Gaps = 1/57 (1%)
Query: 233 SRRQQSF-DNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPF 288
S+R Q+ +G S GT ++SPEV+ G+G+ D W++G EML P+
Sbjct: 151 SKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPW 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 27/89 (30%), Positives = 44/89 (49%), Gaps = 2/89 (2%)
Query: 204 RRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGD 263
R+IL R + + +N K A++ +Q D+ E + + VGT Y+SPE+ +
Sbjct: 120 RKILHRDIKS--QNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNR 177
Query: 264 GHEFAVDWWALGILTYEMLYGTTPFRGKN 292
+ D W+LG + YE+ PF G N
Sbjct: 178 PYNNKTDIWSLGCVLYELCTLKHPFEGNN 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 24/83 (28%), Positives = 45/83 (54%), Gaps = 7/83 (8%)
Query: 248 FVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL--MKTP 305
+V T Y +PEV+ G G++ VD W++G + E++ G+ F+G + + + V+ + TP
Sbjct: 182 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTP 241
Query: 306 --EFVGQRTALTDLIQRLLEKDP 326
EF+ L ++ +E P
Sbjct: 242 SAEFM---NRLQPTVRNYVENRP 261
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 45/157 (28%), Positives = 79/157 (50%), Gaps = 12/157 (7%)
Query: 21 KALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL 80
K +++GKG+ G V A D A+K ++ H +A R R EI++L L
Sbjct: 3 KIQEVIGKGSYGVVC----SAIDTHTGEKVAIKKINDVFEHVS-DATRILR-EIKLLRLL 56
Query: 81 SHPFLPKLLGSL---ETDEFL-AWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIIC 136
HP + ++ + EF + V DL+ + K ND + +P +F+L +++
Sbjct: 57 RHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQV-IKANDDL-TPEHHQFFLYQLLR 114
Query: 137 AIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
A++++H + +RDLKP+NIL + + DF L+R
Sbjct: 115 ALKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 38/164 (23%), Positives = 63/164 (38%), Gaps = 18/164 (10%)
Query: 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDK-STLHAKHEAERRARWEIRVL 77
+K L G+ G VF+ A P P LK+ K +TL E +L
Sbjct: 67 GYTVIKTLTPGSEGRVFV----ATKPGQPDPVVLKIGQKGTTL-----------IEAMLL 111
Query: 78 SRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICA 137
++HP + ++ +L + +P+ L + R +I+
Sbjct: 112 QNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYL--TKRSRPLPIDQALIIEKQILEG 169
Query: 138 IEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAF 181
+ +LH I +RD+K ENI I V + D ++ V AF
Sbjct: 170 LRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF 213
|
Length = 357 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 11/164 (6%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTAR-CPFALKVVDKSTLHAKHEAERRARW- 72
+D+ +K +++G G G V R P R A+K TL + + ++R +
Sbjct: 1 IDVSCVKIEEVIGAGEFGEVC--RGRLKLPGKREIFVAIK-----TLKSGYTEKQRRDFL 53
Query: 73 -EIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYL 131
E ++ + HP + L G + + + G L+ +QND F+ + L
Sbjct: 54 SEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSF-LRQNDGQFTVIQLVGML 112
Query: 132 SEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
I +++L M +RDL NIL+ + ++DF LSR L
Sbjct: 113 RGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.003
Identities = 18/51 (35%), Positives = 29/51 (56%)
Query: 237 QSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTP 287
Q D + N+FVGT +++PEV++ ++ D W+LGI E+ G P
Sbjct: 150 QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.003
Identities = 41/165 (24%), Positives = 75/165 (45%), Gaps = 12/165 (7%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVL 77
D+ + + LG G G V V + + A K++ L K + E++VL
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPS----GLIMARKLIH---LEIKPAIRNQIIRELQVL 57
Query: 78 SRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLS-EIIC 136
+ P++ G+ +D ++ + + GG L+ + K+ R+ P I +S ++
Sbjct: 58 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV-LKEAKRI--PEEILGKVSIAVLR 114
Query: 137 AIEHL-HNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTA 180
+ +L I +RD+KP NIL+ G + L DF +S L+ A
Sbjct: 115 GLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 159
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.004
Identities = 24/105 (22%), Positives = 47/105 (44%), Gaps = 12/105 (11%)
Query: 250 GTEEYVSPEVVRGD----GHEFAVDWWALGILTYEMLYGTTPF-RGKNRKETFRNVLMKT 304
G + Y++PE + + G++ D W+LGI E+ G P+ K + + V+ +
Sbjct: 165 GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP 224
Query: 305 PEFVGQRT---ALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
+ D + + L+K+ +R Y E+ +H FF+
Sbjct: 225 SPQLPAEKFSPEFQDFVNKCLKKNYKERPNYP----ELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.004
Identities = 42/154 (27%), Positives = 64/154 (41%), Gaps = 27/154 (17%)
Query: 26 LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFL 85
+G G+ G V+ A + A+K + S +E + E++ L +L HP
Sbjct: 29 IGHGSFGAVYF----ATNSHTNEVVAVKKMSYSGKQT-NEKWQDIIKEVKFLQQLKHPNT 83
Query: 86 PKLLGSLETDEFLAWAV-PYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEI-ICAIEH--- 140
+ G E AW V YC G ++L + L E+ I AI H
Sbjct: 84 IEYKGCY-LKEHTAWLVMEYCLGSASDLLEVHKKP-----------LQEVEIAAITHGAL 131
Query: 141 -----LHNMGIAYRDLKPENILIRQSGHVTLTDF 169
LH+ + +RD+K NIL+ + G V L DF
Sbjct: 132 QGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADF 165
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 412 | |||
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.98 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.97 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.88 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.86 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.85 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.83 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.81 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.8 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.79 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.75 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.74 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.72 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.67 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.63 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.58 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.53 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.48 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.47 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.46 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.45 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.38 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.28 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.25 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.21 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.21 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.13 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.08 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.04 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.87 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.79 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.7 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.69 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.62 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.6 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.56 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.48 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.45 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.43 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.38 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.34 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.24 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.17 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.16 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.11 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.09 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.94 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.84 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.67 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.66 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.57 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.53 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.48 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.46 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.38 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.31 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.26 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.21 | |
| PLN02236 | 344 | choline kinase | 96.98 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.95 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.94 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.83 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.78 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.7 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.57 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.19 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.94 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.74 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.72 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.61 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 94.84 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 94.74 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.39 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.1 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 93.59 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 93.36 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 93.32 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 93.29 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.29 |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-70 Score=508.39 Aligned_cols=287 Identities=41% Similarity=0.737 Sum_probs=259.3
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
.....++|+++++||+|+||+||+|+.+.++ +.||+|+++|..+..+ .....+..|..||.+++||+||+++..|
T Consensus 20 ~~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~----kiYAmKvl~K~~iv~~-~e~~~~~~Er~IL~~v~hPFiv~l~ysF 94 (357)
T KOG0598|consen 20 EMVGPDDFEILKVIGKGSFGKVFQVRKKDTG----KIYAMKVLKKKKIVEK-KEVRHTKAERNILSKIKHPFIVKLIYSF 94 (357)
T ss_pred ccCChhheeeeeeeeccCCceEEEEEEcccC----ceeehhhhhhhHhhhh-hhHHHHHHHHHHHHhCCCCcEeeeEEec
Confidence 4678999999999999999999999998654 4599999999887544 4567788899999999999999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
|+.+.+|||+||+.||+|...+.++ +.|+|..+++|+++|+.||.|||++|||||||||+|||+|..|+++|+|||||
T Consensus 95 Qt~~kLylVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~ 172 (357)
T KOG0598|consen 95 QTEEKLYLVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLC 172 (357)
T ss_pred ccCCeEEEEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccc
Confidence 9999999999999999997766654 45999999999999999999999999999999999999999999999999999
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+... ..+..+.++|||+
T Consensus 173 k~~~---------------------------------------------------------------~~~~~t~tfcGT~ 189 (357)
T KOG0598|consen 173 KEDL---------------------------------------------------------------KDGDATRTFCGTP 189 (357)
T ss_pred hhcc---------------------------------------------------------------cCCCccccccCCc
Confidence 8542 3445667899999
Q ss_pred CCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-CCCCC-CChHHHHHHHHhhhhCCCccC
Q 042539 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT-PEFVG-QRTALTDLIQRLLEKDPVKRL 330 (412)
Q Consensus 253 ~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~~~-~~~~~~dli~~~L~~dP~~R~ 330 (412)
.|||||++.+.+|+.++||||||+++|||++|.+||.+.+...++.+|.... +..+. .+.+++|||+++|.+||++|+
T Consensus 190 eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 190 EYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred cccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 9999999999999999999999999999999999999999999999999887 66666 789999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCchhh-cccCCCCCCCCCCCch
Q 042539 331 GYLRGACEIKEHVFFKGVRWDLL-TDVLRPPFIPSREEND 369 (412)
Q Consensus 331 ~~~~~~~e~l~h~ff~~~~~~~~-~~~~~pp~~p~~~~~~ 369 (412)
+...++.++.+||||.+++|+.+ .....|||.|......
T Consensus 270 g~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~~~ 309 (357)
T KOG0598|consen 270 GGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTGLE 309 (357)
T ss_pred CCCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCCCcc
Confidence 76668999999999999999855 5577899999876654
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-69 Score=522.73 Aligned_cols=332 Identities=36% Similarity=0.610 Sum_probs=265.8
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
...+.++||+++++||+|+||.||+|+.+.++.. ||||+++|+.+... .....++.|..+|....+++||+||+.
T Consensus 135 R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~i----yAmK~LkKS~M~~~-~Qv~hV~aERdiL~~~ds~~vVKLyYs 209 (550)
T KOG0605|consen 135 RTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEI----YAMKILKKSEMLKK-NQVEHVRAERDILAEVDSPWVVKLYYS 209 (550)
T ss_pred cccCCcccchhheeeccccceeEEEEEEccCCcE----EeeecccHHHHHhh-hhHHHHHHHHHHhhhcCCCcEEEEEEE
Confidence 3477899999999999999999999999997766 99999999988654 446778889999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
|++.+++||||||++|||+..++... +.|+++++++|+++++.||+.||++|+|||||||+|+|||..||+||+||||
T Consensus 210 FQD~~~LYLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGL 287 (550)
T KOG0605|consen 210 FQDKEYLYLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGL 287 (550)
T ss_pred ecCCCeeEEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccc
Confidence 99999999999999999998888765 4599999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhc----ccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcc
Q 042539 172 SRNLVKKTAFEKQS----LNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNS 247 (412)
Q Consensus 172 a~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (412)
|..+.......... .+.......+...... .......+.+.....+ .-..-....+
T Consensus 288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~w---~~nrr~~a~S 347 (550)
T KOG0605|consen 288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKF-----------------NTPRSTMSRREQLQTW---KRNRRQLAYS 347 (550)
T ss_pred cchhhhhhhhhhhcchhhhhhhhccCCCcccccc-----------------ccccchhhHHHHHHHH---Hhhhhhhhhc
Confidence 98775443221100 0000000000000000 0000000000000000 0012234567
Q ss_pred cccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-----CCCCCCChHHHHHHHHhh
Q 042539 248 FVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT-----PEFVGQRTALTDLIQRLL 322 (412)
Q Consensus 248 ~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-----~~~~~~~~~~~dli~~~L 322 (412)
.+|||.|||||++.+.+|+..+||||||||+||||.|.+||.+.+..+++++|+... |.-..++++++|||.+||
T Consensus 348 tVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll 427 (550)
T KOG0605|consen 348 TVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLL 427 (550)
T ss_pred ccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHh
Confidence 999999999999999999999999999999999999999999999999999998754 444556799999999999
Q ss_pred hhCCCccCCCCCChhhhhcCCCCCCCCchhhcccCCCCCCCCCCCchhhhh
Q 042539 323 EKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREENDLTEK 373 (412)
Q Consensus 323 ~~dP~~R~~~~~~~~e~l~h~ff~~~~~~~~~~~~~pp~~p~~~~~~~~~~ 373 (412)
. ||++|++ ..+++||++||||++++|+.+.+.. |||+|...+...+.+
T Consensus 428 ~-d~~~RLG-~~G~~EIK~HPfF~~v~W~~l~~~~-apfvP~v~~~~DT~y 475 (550)
T KOG0605|consen 428 C-DPENRLG-SKGAEEIKKHPFFKGVDWDHLREMP-APFVPQVNSELDTQY 475 (550)
T ss_pred c-CHHHhcC-cccHHHHhcCCccccCCcchhhcCC-CCCCCCCCCcccccc
Confidence 8 9999998 5689999999999999999998865 999999888765543
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-67 Score=492.44 Aligned_cols=347 Identities=48% Similarity=0.782 Sum_probs=277.4
Q ss_pred CCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceee
Q 042539 10 QTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLL 89 (412)
Q Consensus 10 ~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~ 89 (412)
.....+.+++|++++.||.|.-|+||+|+.+.++ +.+||||+.|..+.. .....++..|.+||+.++||++++||
T Consensus 69 ~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~----~~fAmKVmdK~~l~~-rkKl~Ra~tE~eIL~~lDHPFlPTLY 143 (459)
T KOG0610|consen 69 SKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTN----CLFAMKVMDKESLAS-RKKLKRAQTEREILSLLDHPFLPTLY 143 (459)
T ss_pred cCCCccCHHHHHHHHHcCCCCceeEEEEEecCCC----ceEEEEEecHHHHhh-hhHHHHHHHHHHHHHhcCCCccchhh
Confidence 3456889999999999999999999999998865 559999999988754 45577888899999999999999999
Q ss_pred eeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccc
Q 042539 90 GSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169 (412)
Q Consensus 90 ~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DF 169 (412)
..|++++.+|+|||||.||+|..+++.+..+.|+++.|++|+++++.||+|||-.|||+||||||||||.++|++.|+||
T Consensus 144 a~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDF 223 (459)
T KOG0610|consen 144 ASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDF 223 (459)
T ss_pred heeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeec
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhcc-CCCCccccccccccCCCCccccccccCCCCCCccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHA-LPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (412)
-|+....-.......+. .+. ....+......+...... ....+.+-+...+.. .+...-.....+.++++|
T Consensus 224 DLS~~~~~~Pt~~~s~~----~~~--~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~--~~~p~~~aep~~~RSnSF 295 (459)
T KOG0610|consen 224 DLSLRCPVSPTLVKSSS----PRS--SGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESAS--RSLPELVAEPTGARSNSF 295 (459)
T ss_pred cccccCCCCCeeeccCC----CCC--CCCCcccccccccccccchhcccccccccccccc--ccchhhhcCCCCcccccc
Confidence 99987632222111000 000 000000000000000000 000000000011111 111112234556788999
Q ss_pred ccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCC---hHHHHHHHHhhhhC
Q 042539 249 VGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVGQR---TALTDLIQRLLEKD 325 (412)
Q Consensus 249 ~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~---~~~~dli~~~L~~d 325 (412)
+||-.|+|||++.|.+++.++|||+||+.+|||++|..||.|.+..+++.+|+.....++..+ ..++|||+++|.+|
T Consensus 296 VGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 296 VGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred ccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccC
Confidence 999999999999999999999999999999999999999999999999999999888777654 89999999999999
Q ss_pred CCccCCCCCChhhhhcCCCCCCCCchhhcccCCCCCCCCCCCchh
Q 042539 326 PVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREENDL 370 (412)
Q Consensus 326 P~~R~~~~~~~~e~l~h~ff~~~~~~~~~~~~~pp~~p~~~~~~~ 370 (412)
|.+|+++.++|.||++||||++++|. +-...+||++|...+...
T Consensus 376 P~kRlg~~rGA~eIK~HpFF~gVnWa-Lir~~~PP~iP~~~d~~~ 419 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEIKRHPFFEGVNWA-LIRCARPPEIPKPVDGGL 419 (459)
T ss_pred hhhhhccccchHHhhcCccccCCChh-heeccCCCcCCCccccCc
Confidence 99999999999999999999999999 556789999999876654
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-66 Score=471.86 Aligned_cols=277 Identities=40% Similarity=0.744 Sum_probs=255.1
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
...+++|+++++||.|+||+|.+++++.++.. ||+|++++..+. +....++..+|.++|+.+.||++++|++.|.
T Consensus 40 ~~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~y----YAmKvL~k~~vV-klKQveH~~nEk~vL~~v~~PFlv~l~~t~~ 114 (355)
T KOG0616|consen 40 PYSLQDFERLKTLGTGSFGRVHLVREKHSGNY----YAMKVLDKQKVV-KLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK 114 (355)
T ss_pred CcchhhhhheeeeccCccceEEEEEEccCCce----eehhhcCHHHHH-HHHHHHHHhhHHHHHhhccCceeEEEEEeec
Confidence 38999999999999999999999999987666 999999988763 3445677888999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
+.+++|+||||++||.|.++++..+ +|++..+++|++||+.||+|||+++|++|||||||||+|++|++||+|||+|+
T Consensus 115 d~~~lymvmeyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK 192 (355)
T KOG0616|consen 115 DNSNLYMVMEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAK 192 (355)
T ss_pred cCCeEEEEEeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceE
Confidence 9999999999999999998887654 59999999999999999999999999999999999999999999999999998
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
... .++.++||||.
T Consensus 193 ~v~------------------------------------------------------------------~rT~TlCGTPe 206 (355)
T KOG0616|consen 193 RVS------------------------------------------------------------------GRTWTLCGTPE 206 (355)
T ss_pred Eec------------------------------------------------------------------CcEEEecCCcc
Confidence 652 34668999999
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC-CChHHHHHHHHhhhhCCCccCCC
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVG-QRTALTDLIQRLLEKDPVKRLGY 332 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~dli~~~L~~dP~~R~~~ 332 (412)
|+|||+++..+|++++|||||||++|||+.|.+||.+.+...++.+|+.+...+|. .+.+++|||.++|++|-++|++.
T Consensus 207 YLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R~gn 286 (355)
T KOG0616|consen 207 YLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKLLQVDLTKRFGN 286 (355)
T ss_pred ccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHHHHhhhhHhhhcC
Confidence 99999999999999999999999999999999999999999999999999988887 48999999999999999999887
Q ss_pred CC-ChhhhhcCCCCCCCCchhh-cccCCCCCCC
Q 042539 333 LR-GACEIKEHVFFKGVRWDLL-TDVLRPPFIP 363 (412)
Q Consensus 333 ~~-~~~e~l~h~ff~~~~~~~~-~~~~~pp~~p 363 (412)
.. +.++++.||||++++|..+ +....+|+.|
T Consensus 287 lknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~p 319 (355)
T KOG0616|consen 287 LKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEP 319 (355)
T ss_pred cCCCccccccCcccccccHHHHhhccccCCCCC
Confidence 64 8999999999999999855 4567889988
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-66 Score=512.12 Aligned_cols=304 Identities=35% Similarity=0.709 Sum_probs=269.8
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeee
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGS 91 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~ 91 (412)
..+.+++|.++++||+|+||+|++|..+.++.. ||||+++|..+-.+. ....++.|.+|+.... ||+++.|+.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~----yAIK~LKK~~Il~~d-~Ve~~~~EkrI~~la~~HPFL~~L~~~ 437 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEY----YAIKVLKKGDILQRD-EVESLMCEKRIFELANRHPFLVNLFSC 437 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcE----EEEEEeeccceeccc-cHHHHHHHHHHHHHhccCCeEeecccc
Confidence 478999999999999999999999999986655 999999999875544 4566778999999996 9999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
|++.+++|+||||+.|||+... +..+.|++..+++|+++|+.||+|||++||||||||.+|||+|..|++||+|||+
T Consensus 438 fQT~~~l~fvmey~~Ggdm~~~---~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGl 514 (694)
T KOG0694|consen 438 FQTKEHLFFVMEYVAGGDLMHH---IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGL 514 (694)
T ss_pred cccCCeEEEEEEecCCCcEEEE---EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccc
Confidence 9999999999999999996433 3335699999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
++... ..+.+++|||||
T Consensus 515 cKe~m---------------------------------------------------------------~~g~~TsTfCGT 531 (694)
T KOG0694|consen 515 CKEGM---------------------------------------------------------------GQGDRTSTFCGT 531 (694)
T ss_pred ccccC---------------------------------------------------------------CCCCccccccCC
Confidence 98642 345678899999
Q ss_pred CCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC-CChHHHHHHHHhhhhCCCccC
Q 042539 252 EEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVG-QRTALTDLIQRLLEKDPVKRL 330 (412)
Q Consensus 252 ~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~dli~~~L~~dP~~R~ 330 (412)
|.|||||++.+..|+.++|||||||+|||||.|+.||.|.++++++..|+...+.+|. ++.++.+++++||.+||++|+
T Consensus 532 pey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRL 611 (694)
T KOG0694|consen 532 PEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRL 611 (694)
T ss_pred hhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHHHHhccCccccc
Confidence 9999999999999999999999999999999999999999999999999998888775 689999999999999999999
Q ss_pred CC-CCChhhhhcCCCCCCCCchhhc-ccCCCCCCCCCCCchhhhhhhcCCCCChhhhhhccCCCCCCCCC
Q 042539 331 GY-LRGACEIKEHVFFKGVRWDLLT-DVLRPPFIPSREENDLTEKAMSGGGVDIREYFENLRAPPPSMPP 398 (412)
Q Consensus 331 ~~-~~~~~e~l~h~ff~~~~~~~~~-~~~~pp~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (412)
++ .++++++++||||+.++|+.+. ...+|||+|...++. |.+++-+.+....|...|
T Consensus 612 G~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~-----------D~snFd~eFt~e~p~Lt~ 670 (694)
T KOG0694|consen 612 GSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPE-----------DVSNFDEEFTSEKPALTP 670 (694)
T ss_pred CCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChh-----------hhcccchhhhcCCCccCC
Confidence 97 3569999999999999998664 477999999976654 445555666666666666
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-64 Score=485.20 Aligned_cols=286 Identities=38% Similarity=0.607 Sum_probs=249.9
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeeeeE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLGSL 92 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 92 (412)
.-...||++++.||+|+|++|++|+++.++.. |||||+.|..+ .++...+.+.+|..+|.+| .||.|++||.+|
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~ke----YAiKVl~K~~I-ike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF 143 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKE----YAIKVLDKRYI-IKEKKVKYVTREKEALTQLSGHPGIVKLYFTF 143 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCce----eeHhhhhHHHH-HhhcccchhhHHHHHHHHhhCCCCeEEEEEEe
Confidence 56788999999999999999999999986655 99999999887 3455667788899999999 699999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
+++..+|+|+||+++|+|..++...+ .|++..+++|++||+.||+|||++|||||||||||||+|.+|++||+|||.|
T Consensus 144 QD~~sLYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 144 QDEESLYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred ecccceEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeecccc
Confidence 99999999999999999988887764 5999999999999999999999999999999999999999999999999999
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+.+........ .| .. ......+..+||||.
T Consensus 222 K~l~~~~~~~~-------~~---~~----------------------------------------~~~a~s~~~SFVGTA 251 (604)
T KOG0592|consen 222 KILSPSQKSQE-------NP---VD----------------------------------------PNQASSRRSSFVGTA 251 (604)
T ss_pred ccCChhhcccc-------Cc---cC----------------------------------------cccccCcccceeeee
Confidence 98743211000 00 00 001112246899999
Q ss_pred CCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCccCC
Q 042539 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKRLG 331 (412)
Q Consensus 253 ~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R~~ 331 (412)
.|.+||+|.+...+..+|+||||||||+|+.|.+||.+.++..+|++|+.....++ +.++.++|||.++|..||.+|+
T Consensus 252 eYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rl- 330 (604)
T KOG0592|consen 252 EYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRL- 330 (604)
T ss_pred cccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCCCCHHHHHHHHHHHccCccccc-
Confidence 99999999999999999999999999999999999999999999999998887775 5689999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCchhhcccCCCC
Q 042539 332 YLRGACEIKEHVFFKGVRWDLLTDVLRPP 360 (412)
Q Consensus 332 ~~~~~~e~l~h~ff~~~~~~~~~~~~~pp 360 (412)
|+++|++||||.+++|+.+.....|+
T Consensus 331 ---t~~qIk~HpFF~~Vdw~nlw~~~PP~ 356 (604)
T KOG0592|consen 331 ---TSQQIKAHPFFEGVDWENLWQQTPPK 356 (604)
T ss_pred ---cHHHHhhCcccccCChhhhhhcCCCc
Confidence 68999999999999999887765554
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-61 Score=472.72 Aligned_cols=265 Identities=30% Similarity=0.529 Sum_probs=239.1
Q ss_pred CCCCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccce
Q 042539 8 QPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPK 87 (412)
Q Consensus 8 ~~~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~ 87 (412)
.|...-...-.+|+..+.||+|||++||.+++..++.. ||+|+|.|..+. +.....++.+||+|.++|+|||||+
T Consensus 8 ip~~i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~----~A~KvVpk~~l~-k~~~reKv~~EIeIHr~L~HpnIV~ 82 (592)
T KOG0575|consen 8 IPEVIEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEV----VAVKVVPKKLLK-KPKQREKVLNEIEIHRSLKHPNIVQ 82 (592)
T ss_pred CCCeeecCCcceeeeeeeeccCcceEEEEEEEcCCCcE----EEEEEeehHHhc-CcchHHHHHHHHHHHHhcCCCcEEe
Confidence 33333344447899999999999999999999886655 999999987763 4456778888999999999999999
Q ss_pred eeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEc
Q 042539 88 LLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLT 167 (412)
Q Consensus 88 l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~ 167 (412)
+|++|++.+++|||+|+|..++|..++..+ +.++|.+|+.++.||+.||.|||+++|||||||..|||++.+-+|||+
T Consensus 83 f~~~FEDs~nVYivLELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIg 160 (592)
T KOG0575|consen 83 FYHFFEDSNNVYIVLELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIG 160 (592)
T ss_pred eeeEeecCCceEEEEEecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEec
Confidence 999999999999999999999998887744 459999999999999999999999999999999999999999999999
Q ss_pred cccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcc
Q 042539 168 DFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNS 247 (412)
Q Consensus 168 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (412)
|||||..+. .++++..+
T Consensus 161 DFGLAt~le---------------------------------------------------------------~~~Erk~T 177 (592)
T KOG0575|consen 161 DFGLATQLE---------------------------------------------------------------YDGERKKT 177 (592)
T ss_pred ccceeeeec---------------------------------------------------------------Ccccccce
Confidence 999998763 34567789
Q ss_pred cccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCC
Q 042539 248 FVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDP 326 (412)
Q Consensus 248 ~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP 326 (412)
+||||.|+|||++...++++.+||||+||++|.||+|+|||...+-.+++.+|......+| ..+.+++|||++||..||
T Consensus 178 lCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P 257 (592)
T KOG0575|consen 178 LCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPNP 257 (592)
T ss_pred ecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhcCCc
Confidence 9999999999999999999999999999999999999999999999999999998877665 468999999999999999
Q ss_pred CccCCCCCChhhhhcCCCCC
Q 042539 327 VKRLGYLRGACEIKEHVFFK 346 (412)
Q Consensus 327 ~~R~~~~~~~~e~l~h~ff~ 346 (412)
.+|| ++++++.|+||+
T Consensus 258 ~~Rp----sl~~vL~h~Ff~ 273 (592)
T KOG0575|consen 258 SERP----SLDEVLDHPFFK 273 (592)
T ss_pred ccCC----CHHHHhcCHhhh
Confidence 9999 699999999993
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-61 Score=455.94 Aligned_cols=263 Identities=28% Similarity=0.425 Sum_probs=226.9
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhh---HHHHHHHHHHHHHHhhcCCCccceee
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAK---HEAERRARWEIRVLSRLSHPFLPKLL 89 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~ 89 (412)
+....+.|.+.+.||+|+||.|-+|..+.++.. ||||++.+...... ......+.+|++||++|+|||||+++
T Consensus 167 pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~----vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~ 242 (475)
T KOG0615|consen 167 PKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQ----VAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIK 242 (475)
T ss_pred cchhcceeEeeeeecCCceeEEEEEEEcccCcE----EEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEe
Confidence 345678899999999999999999999986655 99999988765321 11234467899999999999999999
Q ss_pred eeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccC---CCEEE
Q 042539 90 GSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQS---GHVTL 166 (412)
Q Consensus 90 ~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~---g~vkL 166 (412)
++|+..+..|+||||+.||+|.+.+-... .+.+...+.++.|++.||.|||+.||+||||||+|||+..+ ..+||
T Consensus 243 d~f~~~ds~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKI 320 (475)
T KOG0615|consen 243 DFFEVPDSSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKI 320 (475)
T ss_pred eeeecCCceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEe
Confidence 99999999999999999999987766544 48999999999999999999999999999999999999877 67999
Q ss_pred ccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCc
Q 042539 167 TDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSN 246 (412)
Q Consensus 167 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (412)
+|||+|+... .+....
T Consensus 321 tDFGlAK~~g----------------------------------------------------------------~~sfm~ 336 (475)
T KOG0615|consen 321 TDFGLAKVSG----------------------------------------------------------------EGSFMK 336 (475)
T ss_pred cccchhhccc----------------------------------------------------------------cceehh
Confidence 9999998652 345567
Q ss_pred ccccCCCCccceeecCCCC---CchhhHHHHHHHHHHHhhCCCCCCCCCHHH-HHHHHhcCCC-----CCCCCChHHHHH
Q 042539 247 SFVGTEEYVSPEVVRGDGH---EFAVDWWALGILTYEMLYGTTPFRGKNRKE-TFRNVLMKTP-----EFVGQRTALTDL 317 (412)
Q Consensus 247 ~~~gt~~Y~APE~l~~~~~---~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-~~~~i~~~~~-----~~~~~~~~~~dl 317 (412)
++||||.|.|||++.+.++ ..++|+|||||+||.+|+|.+||.+..... ..++|..+.. .+..++.++.+|
T Consensus 337 TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dl 416 (475)
T KOG0615|consen 337 TLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDL 416 (475)
T ss_pred hhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHH
Confidence 9999999999999988764 458899999999999999999999866555 6677776553 344678999999
Q ss_pred HHHhhhhCCCccCCCCCChhhhhcCCCCCCCC
Q 042539 318 IQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 318 i~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~ 349 (412)
|++||..||++|+ +++|+|+||||+.+.
T Consensus 417 I~~mL~VdP~~R~----s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 417 INWMLVVDPENRP----SADEALNHPWFKDAP 444 (475)
T ss_pred HHHhhEeCcccCc----CHHHHhcChhhhccc
Confidence 9999999999999 699999999999765
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-59 Score=430.28 Aligned_cols=292 Identities=37% Similarity=0.670 Sum_probs=262.1
Q ss_pred CCCCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccce
Q 042539 8 QPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPK 87 (412)
Q Consensus 8 ~~~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~ 87 (412)
....+..+++++|..+++||+|.||+|-+|+.++++.. ||||+++|+.+-.+.+ ....+.|-++|+..+||++..
T Consensus 158 ~~~~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~----YAiKIlkKeviiakdE-VAHTlTE~RVL~~~~HPFLt~ 232 (516)
T KOG0690|consen 158 EAKRKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKL----YAIKILKKEVIIAKDE-VAHTLTENRVLQNCRHPFLTS 232 (516)
T ss_pred cccccceeccchhhHHHHhcCCccceEEEEeecccCce----eehhhhhhhheeehHH-hhhhhhHHHHHHhccCcHHHH
Confidence 44556788999999999999999999999999997766 9999999987766544 456677999999999999999
Q ss_pred eeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEc
Q 042539 88 LLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLT 167 (412)
Q Consensus 88 l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~ 167 (412)
|-..|++++++|+||||++||+|.-.+.. .+.|+|..+++|-++|+.||.|||+.+||+||||.+|+|+|++|++||+
T Consensus 233 LKYsFQt~drlCFVMeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKit 310 (516)
T KOG0690|consen 233 LKYSFQTQDRLCFVMEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKIT 310 (516)
T ss_pred hhhhhccCceEEEEEEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEee
Confidence 99999999999999999999999655544 4569999999999999999999999999999999999999999999999
Q ss_pred cccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcc
Q 042539 168 DFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNS 247 (412)
Q Consensus 168 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (412)
|||+++.-. ..+....+
T Consensus 311 DFGLCKE~I---------------------------------------------------------------~~g~t~kT 327 (516)
T KOG0690|consen 311 DFGLCKEEI---------------------------------------------------------------KYGDTTKT 327 (516)
T ss_pred ecccchhcc---------------------------------------------------------------cccceecc
Confidence 999998642 34556679
Q ss_pred cccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC-CChHHHHHHHHhhhhCC
Q 042539 248 FVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVG-QRTALTDLIQRLLEKDP 326 (412)
Q Consensus 248 ~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~dli~~~L~~dP 326 (412)
|||||.|.|||++....|+.++|||.+||++|||++|+.||...+...++.-|+.....++. ++++++.|+..+|.+||
T Consensus 328 FCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsGLL~kdP 407 (516)
T KOG0690|consen 328 FCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSGLLKKDP 407 (516)
T ss_pred ccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHHHHhhcCh
Confidence 99999999999999999999999999999999999999999999999999999998888876 68999999999999999
Q ss_pred CccCCCC-CChhhhhcCCCCCCCCch-hhcccCCCCCCCCCCCch
Q 042539 327 VKRLGYL-RGACEIKEHVFFKGVRWD-LLTDVLRPPFIPSREEND 369 (412)
Q Consensus 327 ~~R~~~~-~~~~e~l~h~ff~~~~~~-~~~~~~~pp~~p~~~~~~ 369 (412)
.+|++-. .++.|+..|+||.+++|. ....-..|||.|...++.
T Consensus 408 ~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtSet 452 (516)
T KOG0690|consen 408 KKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTSET 452 (516)
T ss_pred HhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCccccc
Confidence 9999864 359999999999999997 456678999999876654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-59 Score=434.52 Aligned_cols=257 Identities=26% Similarity=0.475 Sum_probs=230.4
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
.+.+++++.++.||+|..|+||+|+++.++.. +|+|+|.. ..+....+++.+|+++++.++|||||++|++|.
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i----~AlK~I~~---~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~ 147 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKI----YALKVILL---NIDPALQKQILRELEILRSCQSPYIVGFYGAFY 147 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeE----EEEEeecc---cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence 45667999999999999999999999986665 99999933 345677888999999999999999999999999
Q ss_pred eCCe-EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeeCCCCceEEccCCCEEEccccc
Q 042539 94 TDEF-LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN-MGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 94 ~~~~-~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
.+.. ++|+||||+||+|+.++... ++++|.....++.+++.||.|||+ ++||||||||+|||++..|.|||||||.
T Consensus 148 ~~~~~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 148 SNGEEISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred eCCceEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccc
Confidence 9984 99999999999999887654 459999999999999999999995 9999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
++.+.++ .+++++||
T Consensus 226 S~~lvnS-----------------------------------------------------------------~a~tfvGT 240 (364)
T KOG0581|consen 226 SGILVNS-----------------------------------------------------------------IANTFVGT 240 (364)
T ss_pred cHHhhhh-----------------------------------------------------------------hccccccc
Confidence 9887432 45689999
Q ss_pred CCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCC-----CHHHHHHHHhcCC-CCCCC--CChHHHHHHHHhhh
Q 042539 252 EEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGK-----NRKETFRNVLMKT-PEFVG--QRTALTDLIQRLLE 323 (412)
Q Consensus 252 ~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~-----~~~~~~~~i~~~~-~~~~~--~~~~~~dli~~~L~ 323 (412)
..|||||.+.+..|+.++||||||++++|+++|+.||... +..+++..|+.+. |.++. +++++++||..||+
T Consensus 241 ~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~ 320 (364)
T KOG0581|consen 241 SAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLR 320 (364)
T ss_pred ccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhc
Confidence 9999999999999999999999999999999999999874 6678888888854 44443 78999999999999
Q ss_pred hCCCccCCCCCChhhhhcCCCCCCC
Q 042539 324 KDPVKRLGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 324 ~dP~~R~~~~~~~~e~l~h~ff~~~ 348 (412)
+||.+|+ ++.++++|||+++.
T Consensus 321 Kdp~~R~----s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 321 KDPSERP----SAKQLLQHPFIKKF 341 (364)
T ss_pred CCcccCC----CHHHHhcCHHHhhc
Confidence 9999999 79999999999853
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-56 Score=421.76 Aligned_cols=259 Identities=25% Similarity=0.491 Sum_probs=226.9
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
.-.+++|.+.+.||+|+||+||+++++.++.. ||||.|.+..+. .+....+..|+.+|+.++|||||+|+++..
T Consensus 6 ~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~----VAIK~i~~~~l~--~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~ 79 (429)
T KOG0595|consen 6 MRVVGDYELSREIGSGSFAVVYKGRHKKSGTE----VAIKCIAKKKLN--KKLVELLLSEIKILKELKHPNIVRLLDCIE 79 (429)
T ss_pred ccccccceehhhccCcceEEEEEeEeccCCce----EEeeeehhhccC--HHHHHHHHHHHHHHHhcCCcceeeEEEEEe
Confidence 34578999999999999999999999886544 999999888763 345667788999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccC------CCEEEc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQS------GHVTLT 167 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~------g~vkL~ 167 (412)
+++.+|||||||.||||..+++.++ .++|..++.++.||+.||++||+++||||||||+||||+.. -.+||+
T Consensus 80 ~~~~i~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIA 157 (429)
T KOG0595|consen 80 DDDFIYLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIA 157 (429)
T ss_pred cCCeEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEec
Confidence 9999999999999999999988765 59999999999999999999999999999999999999875 358999
Q ss_pred cccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcc
Q 042539 168 DFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNS 247 (412)
Q Consensus 168 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (412)
|||+|+.+. .+....+
T Consensus 158 DFGfAR~L~----------------------------------------------------------------~~~~a~t 173 (429)
T KOG0595|consen 158 DFGFARFLQ----------------------------------------------------------------PGSMAET 173 (429)
T ss_pred ccchhhhCC----------------------------------------------------------------chhHHHH
Confidence 999999763 3445668
Q ss_pred cccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC----CCChHHHHHHHHhhh
Q 042539 248 FVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV----GQRTALTDLIQRLLE 323 (412)
Q Consensus 248 ~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~dli~~~L~ 323 (412)
.||+|.|||||++....|+.|+|+||+|+|+|+|++|++||...+..+.+..+..+....+ ..+..+.+|+..+|.
T Consensus 174 lcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~ 253 (429)
T KOG0595|consen 174 LCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQ 253 (429)
T ss_pred hhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhhhHHHh
Confidence 8999999999999999999999999999999999999999999999999887765543222 235677899999999
Q ss_pred hCCCccCCCCCChhhhhcCCCCCCC
Q 042539 324 KDPVKRLGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 324 ~dP~~R~~~~~~~~e~l~h~ff~~~ 348 (412)
.++..|.+ .++...|+|....
T Consensus 254 ~~~~~~~~----~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 254 RNPKDRIS----FEDFFDHPFLAAN 274 (429)
T ss_pred cCccccCc----hHHhhhhhhcccC
Confidence 99999984 6777888887653
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-57 Score=411.29 Aligned_cols=256 Identities=28% Similarity=0.469 Sum_probs=221.3
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
++.|+.+.++|+|+||+||+|+++.++.. ||||.+..+. ......+.++|||++|++++|+|+|.|+++|....
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqI----VAIKkF~Ese--dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkr 74 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQI----VAIKKFVESE--DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKR 74 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccE----EEEEeeccCC--ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcc
Confidence 57899999999999999999999986655 9999996554 34567888999999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
.+++|+|||+..-|..+-.. ...++++.++.|++|++.|+.|+|+++||||||||+||||+.+|.+||||||+|+.+.
T Consensus 75 klhLVFE~~dhTvL~eLe~~--p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~ 152 (396)
T KOG0593|consen 75 KLHLVFEYCDHTVLHELERY--PNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLS 152 (396)
T ss_pred eeEEEeeecchHHHHHHHhc--cCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhc
Confidence 99999999988777665433 3459999999999999999999999999999999999999999999999999998763
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
. .+...+.++.|.+|+|
T Consensus 153 ~---------------------------------------------------------------pgd~YTDYVATRWYRa 169 (396)
T KOG0593|consen 153 A---------------------------------------------------------------PGDNYTDYVATRWYRA 169 (396)
T ss_pred C---------------------------------------------------------------CcchhhhhhhhhhccC
Confidence 1 2233446789999999
Q ss_pred ceeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--------------CC----------------
Q 042539 257 PEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK--------------TP---------------- 305 (412)
Q Consensus 257 PE~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--------------~~---------------- 305 (412)
||.+.| ..|+.++||||+||++.||++|.+.|+|.++.+++..|... .+
T Consensus 170 PELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epL 249 (396)
T KOG0593|consen 170 PELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPL 249 (396)
T ss_pred hhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccch
Confidence 999998 57999999999999999999999999999988877665421 11
Q ss_pred --CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCC
Q 042539 306 --EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 306 --~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
.++..+.-+.||+.+||..||.+|+ +.++++.|+||.+
T Consensus 250 e~k~p~~s~~~ld~~k~cL~~dP~~R~----sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 250 ERKYPKISNVLLDLLKKCLKMDPDDRL----SCEQLLHHPYFDG 289 (396)
T ss_pred hhhcccchHHHHHHHHHHhcCCccccc----cHHHHhcChHHHH
Confidence 1234556788999999999999999 5799999999964
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-56 Score=425.77 Aligned_cols=286 Identities=38% Similarity=0.679 Sum_probs=254.6
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
..++.+.|..-++||+||||.||-|+.+.++.- ||+|.+.|..+..+ ......+.|.+||.+++.++||.|-++|
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKM----YAcKkL~KKRiKkr-~ge~maLnEk~iL~kV~s~FiVslaYAf 254 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKM----YACKKLDKKRIKKR-KGETMALNEKQILEKVSSPFIVSLAYAF 254 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhh----HHHHHHHHHHHHHh-hhhHHhhHHHHHHHHhccCcEEEEeeee
Confidence 467788999999999999999999999886655 99999988887543 4566778899999999999999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
++.+.+|+||..|+||||.-.+++.++..|+++.+++|++||++||++||+.+||+|||||+|||+|+.|+++|+|+|||
T Consensus 255 eTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLA 334 (591)
T KOG0986|consen 255 ETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLA 334 (591)
T ss_pred cCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceE
Confidence 99999999999999999998899988888999999999999999999999999999999999999999999999999999
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
..+ ..+......+||.
T Consensus 335 vei----------------------------------------------------------------~~g~~~~~rvGT~ 350 (591)
T KOG0986|consen 335 VEI----------------------------------------------------------------PEGKPIRGRVGTV 350 (591)
T ss_pred Eec----------------------------------------------------------------CCCCccccccCcc
Confidence 876 3445556669999
Q ss_pred CCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCC----CHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCC
Q 042539 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGK----NRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPV 327 (412)
Q Consensus 253 ~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~----~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~ 327 (412)
+|||||++.+..|+...|||||||+||||+.|+.||... ..+++.+.++.....++ ..+++++++++.+|++||+
T Consensus 351 GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~ 430 (591)
T KOG0986|consen 351 GYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPE 430 (591)
T ss_pred cccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHH
Confidence 999999999999999999999999999999999999764 34456666666554443 5789999999999999999
Q ss_pred ccCCCC-CChhhhhcCCCCCCCCchhhcc-cCCCCCCCCCCC
Q 042539 328 KRLGYL-RGACEIKEHVFFKGVRWDLLTD-VLRPPFIPSREE 367 (412)
Q Consensus 328 ~R~~~~-~~~~e~l~h~ff~~~~~~~~~~-~~~pp~~p~~~~ 367 (412)
+|+++. .+++++++||||++++|..+.. ...|||+|.+..
T Consensus 431 ~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~a 472 (591)
T KOG0986|consen 431 KRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGA 472 (591)
T ss_pred HhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCccc
Confidence 999996 5799999999999999997755 779999987643
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-56 Score=464.55 Aligned_cols=287 Identities=34% Similarity=0.631 Sum_probs=250.4
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
..+..+||.|+++||+|+||.|.+|+.+.++.. ||+|++.|-... +...-..|+.|..||..-+.++||+|+.+|
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~V----YAMK~lnK~eMl-Kr~~tA~F~EERDimv~~ns~Wiv~LhyAF 144 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKV----YAMKILNKWEML-KRAETACFREERDIMVFGNSEWIVQLHYAF 144 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccc----hhHHHhhHHHHh-hchhHHHHHHHhHHHHcCCcHHHHHHHHHh
Confidence 457789999999999999999999999987766 999999875542 233456677899999999999999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
++++++|+||||++||||-.++.... ++++..|++|+++|+.||..||+.|+|||||||+|||||..||+||+|||.|
T Consensus 145 QD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 145 QDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred cCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhH
Confidence 99999999999999999988887655 6999999999999999999999999999999999999999999999999988
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
-.+.. +...++.+.+|||
T Consensus 223 lkm~~--------------------------------------------------------------dG~V~s~~aVGTP 240 (1317)
T KOG0612|consen 223 LKMDA--------------------------------------------------------------DGTVRSSVAVGTP 240 (1317)
T ss_pred HhcCC--------------------------------------------------------------CCcEEeccccCCC
Confidence 76531 1223455779999
Q ss_pred CCccceeecC-----CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-----CCCCCCCChHHHHHHHHhh
Q 042539 253 EYVSPEVVRG-----DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK-----TPEFVGQRTALTDLIQRLL 322 (412)
Q Consensus 253 ~Y~APE~l~~-----~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~-----~~~~~~~~~~~~dli~~~L 322 (412)
.|++||+++. ..|+..+||||+||++|||++|..||...+..+++.+|+.. .|....+|.+++|||.++|
T Consensus 241 DYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll 320 (1317)
T KOG0612|consen 241 DYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALL 320 (1317)
T ss_pred CccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHh
Confidence 9999999963 34789999999999999999999999999999999999864 3444567899999999988
Q ss_pred hhCCCccCCCCCChhhhhcCCCCCCCCchhhcccCCCCCCCCCCCchhh
Q 042539 323 EKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREENDLT 371 (412)
Q Consensus 323 ~~dP~~R~~~~~~~~e~l~h~ff~~~~~~~~~~~~~pp~~p~~~~~~~~ 371 (412)
.+|+.|++= +++++++.||||.+++|+.+.+ ..|||+|...+++.+
T Consensus 321 -~~~e~RLgr-ngiedik~HpFF~g~~W~~iR~-~~pP~vPevssd~DT 366 (1317)
T KOG0612|consen 321 -CDREVRLGR-NGIEDIKNHPFFEGIDWDNIRE-SVPPVVPEVSSDDDT 366 (1317)
T ss_pred -cChhhhccc-ccHHHHHhCccccCCChhhhhh-cCCCCCCcCCCCCcc
Confidence 788999962 4699999999999999998877 568999998887654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-55 Score=429.99 Aligned_cols=261 Identities=31% Similarity=0.537 Sum_probs=232.9
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhh-HHHHHHHHHHHHHHhhcC-CCccceeeee
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAK-HEAERRARWEIRVLSRLS-HPFLPKLLGS 91 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~~~Ei~il~~l~-hpnIv~l~~~ 91 (412)
....+.|++.+.||+|+||+|++|++..++. .||+|++++...... ......+.+|+.+++.+. ||||++++++
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~----~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev 88 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGE----KVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEV 88 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCC----eEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEE
Confidence 4678899999999999999999999988664 499998877643212 245666778999999999 9999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccC-CCEEEcccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQS-GHVTLTDFD 170 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~-g~vkL~DFG 170 (412)
+.+...+|+|||||.||+|.+++.. .+++.|.+++.++.|++.||+|||++||+||||||+|||++.+ +++||+|||
T Consensus 89 ~~t~~~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 89 FATPTKIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred EecCCeEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 9999999999999999999988876 4569999999999999999999999999999999999999999 999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
++.... .......++||
T Consensus 167 ~s~~~~---------------------------------------------------------------~~~~~l~t~cG 183 (370)
T KOG0583|consen 167 LSAISP---------------------------------------------------------------GEDGLLKTFCG 183 (370)
T ss_pred cccccC---------------------------------------------------------------CCCCcccCCCC
Confidence 997541 12345568899
Q ss_pred CCCCccceeecCCC-C-CchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCC--ChHHHHHHHHhhhhCC
Q 042539 251 TEEYVSPEVVRGDG-H-EFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVGQ--RTALTDLIQRLLEKDP 326 (412)
Q Consensus 251 t~~Y~APE~l~~~~-~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~dli~~~L~~dP 326 (412)
|+.|+|||++.+.. | +.++||||+||+||.|++|+.||...+...++..|..+...++.. +.++++||.+||..||
T Consensus 184 sp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P 263 (370)
T KOG0583|consen 184 SPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEARSLIEKMLVPDP 263 (370)
T ss_pred CcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHHHHHHHHHcCCCc
Confidence 99999999999988 8 599999999999999999999999999999999998887766654 9999999999999999
Q ss_pred CccCCCCCChhhhhcCCCCCC
Q 042539 327 VKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 327 ~~R~~~~~~~~e~l~h~ff~~ 347 (412)
.+|+ ++.++++|+||+.
T Consensus 264 ~~R~----t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 264 STRI----TLLEILEHPWFQK 280 (370)
T ss_pred ccCC----CHHHHhhChhhcc
Confidence 9999 7999999999996
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-54 Score=420.81 Aligned_cols=281 Identities=32% Similarity=0.613 Sum_probs=240.0
Q ss_pred CCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceee
Q 042539 10 QTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLL 89 (412)
Q Consensus 10 ~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~ 89 (412)
..+....+++|++.+.||+|+||+||+|+++.++. .||+|++++..... ......+.+|+.+++.++||||++++
T Consensus 10 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~ 84 (329)
T PTZ00263 10 PDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGE----YYAIKCLKKREILK-MKQVQHVAQEKSILMELSHPFIVNMM 84 (329)
T ss_pred cccCCCCchheEEEEEEEecCCeEEEEEEECCCCC----EEEEEEEEHHHHhh-hhhHHHHHHHHHHHHhCCCCCCCcEE
Confidence 35677789999999999999999999999987554 49999997765422 23456678899999999999999999
Q ss_pred eeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccc
Q 042539 90 GSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169 (412)
Q Consensus 90 ~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DF 169 (412)
+++.+++.+|+|||||.||+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+||
T Consensus 85 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Df 162 (329)
T PTZ00263 85 CSFQDENRVYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDF 162 (329)
T ss_pred EEEEcCCEEEEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeec
Confidence 9999999999999999999998777654 35899999999999999999999999999999999999999999999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|+++.... ...+.+
T Consensus 163 g~~~~~~~------------------------------------------------------------------~~~~~~ 176 (329)
T PTZ00263 163 GFAKKVPD------------------------------------------------------------------RTFTLC 176 (329)
T ss_pred cCceEcCC------------------------------------------------------------------Ccceec
Confidence 99864311 112457
Q ss_pred cCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC-CChHHHHHHHHhhhhCCCc
Q 042539 250 GTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVG-QRTALTDLIQRLLEKDPVK 328 (412)
Q Consensus 250 gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~dli~~~L~~dP~~ 328 (412)
||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......++. .+..+++||.+||+.||.+
T Consensus 177 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 256 (329)
T PTZ00263 177 GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTDHTK 256 (329)
T ss_pred CChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHHhhcCHHH
Confidence 999999999999999999999999999999999999999998888888888776655544 6788999999999999999
Q ss_pred cCCCC-CChhhhhcCCCCCCCCchhhccc-CCCCCCC
Q 042539 329 RLGYL-RGACEIKEHVFFKGVRWDLLTDV-LRPPFIP 363 (412)
Q Consensus 329 R~~~~-~~~~e~l~h~ff~~~~~~~~~~~-~~pp~~p 363 (412)
|++.. .++++++.||||++++|+.+... ..+|+.+
T Consensus 257 R~~~~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~ 293 (329)
T PTZ00263 257 RLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIPV 293 (329)
T ss_pred cCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCcCC
Confidence 99642 35899999999999999866442 3344443
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-55 Score=412.98 Aligned_cols=286 Identities=32% Similarity=0.610 Sum_probs=252.4
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLG 90 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~ 90 (412)
...+.+.+|.++.+||+|+||+|.++..+.+. +.||||+++|+.+-+. +.....+.|.++|+... -|++++|+.
T Consensus 343 ~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtd----ELyAiKiLkKDViiQd-DDvectm~EKrvLAL~~kppFL~qlHS 417 (683)
T KOG0696|consen 343 RDRIKATDFNFLMVLGKGSFGKVLLAERKGTD----ELYAIKILKKDVIIQD-DDVECTMVEKRVLALPGKPPFLVQLHS 417 (683)
T ss_pred ccceeecccceEEEeccCccceeeeecccCcc----hhhhhhhhccceeeec-CcccceehhhhheecCCCCchHHHHHH
Confidence 44778889999999999999999999887755 4599999998876443 34556667999999885 689999999
Q ss_pred eEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccc
Q 042539 91 SLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 91 ~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
+|++-+.+|+||||++||||-..+.+ -+.|.|.+|.+|+++|+-||-+||++|||+||||.+|+|++..|++||+|||
T Consensus 418 cFQTmDRLyFVMEyvnGGDLMyhiQQ--~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFG 495 (683)
T KOG0696|consen 418 CFQTMDRLYFVMEYVNGGDLMYHIQQ--VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFG 495 (683)
T ss_pred HhhhhhheeeEEEEecCchhhhHHHH--hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecc
Confidence 99999999999999999999544444 4569999999999999999999999999999999999999999999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+++.-. ..+..+.++||
T Consensus 496 mcKEni---------------------------------------------------------------~~~~TTkTFCG 512 (683)
T KOG0696|consen 496 MCKENI---------------------------------------------------------------FDGVTTKTFCG 512 (683)
T ss_pred cccccc---------------------------------------------------------------cCCcceeeecC
Confidence 997532 34556779999
Q ss_pred CCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCcc
Q 042539 251 TEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKR 329 (412)
Q Consensus 251 t~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R 329 (412)
||.|+|||++..++|+.++||||+||+||||+.|++||.|.+..++++.|......++ ..|.++.+++..+|.+.|.+|
T Consensus 513 TPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ickg~ltK~P~kR 592 (683)
T KOG0696|consen 513 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAICKGLLTKHPGKR 592 (683)
T ss_pred CCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHHHHHhhcCCccc
Confidence 9999999999999999999999999999999999999999999999999998776665 578999999999999999999
Q ss_pred CCCCC-ChhhhhcCCCCCCCCchhhcc-cCCCCCCCCCCC
Q 042539 330 LGYLR-GACEIKEHVFFKGVRWDLLTD-VLRPPFIPSREE 367 (412)
Q Consensus 330 ~~~~~-~~~e~l~h~ff~~~~~~~~~~-~~~pp~~p~~~~ 367 (412)
+++.+ +-.++.+||||+.++|+.++. ...|||.|...-
T Consensus 593 LGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k~ 632 (683)
T KOG0696|consen 593 LGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIKC 632 (683)
T ss_pred cCCCCccccchhhCcchhhccHHHHhhccCCCCCCCcccc
Confidence 99854 467899999999999997766 568999998643
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-56 Score=398.01 Aligned_cols=250 Identities=30% Similarity=0.480 Sum_probs=219.1
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeee-e
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLG-S 91 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~-~ 91 (412)
....+.+|+++++||+|+||+||+|.+..++.. ||.|.|....+. ....+.+..|+.+|++|+|||||++|+ .
T Consensus 14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l----~a~K~i~f~~md--~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~ 87 (375)
T KOG0591|consen 14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKL----VALKKIQFGMMD--AKARQDCVKEISLLKQLNHPNIVQYYAHS 87 (375)
T ss_pred CcccHHHHHHHHHHcCCcchheEEeeeccCcch----hhhhhcchhhcc--HHHHHHHHHHHHHHHhcCCchHHHHHHHh
Confidence 467788999999999999999999999886554 999999866553 445677888999999999999999999 5
Q ss_pred EEeCC-eEEEEeeccCCCCchhHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHH--cC--ceeeeCCCCceEEccCCCE
Q 042539 92 LETDE-FLAWAVPYCPGGDLNVLRYK--QNDRVFSPSVIRFYLSEIICAIEHLHN--MG--IAYRDLKPENILIRQSGHV 164 (412)
Q Consensus 92 ~~~~~-~~~lv~e~~~gg~L~~~~~~--~~~~~l~~~~~~~~~~qi~~aL~yLH~--~~--iiHrDlKp~NiLl~~~g~v 164 (412)
|..+. -++||||||.+|||..++.. .....++|..++.++.|+|.||..+|+ .+ |+||||||.||+++.+|.|
T Consensus 88 f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvv 167 (375)
T KOG0591|consen 88 FIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVV 167 (375)
T ss_pred hhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCce
Confidence 55554 49999999999999988654 345679999999999999999999999 45 9999999999999999999
Q ss_pred EEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCC
Q 042539 165 TLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGER 244 (412)
Q Consensus 165 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (412)
||+||||++.+.+.. ..
T Consensus 168 KLGDfGL~r~l~s~~---------------------------------------------------------------tf 184 (375)
T KOG0591|consen 168 KLGDFGLGRFLSSKT---------------------------------------------------------------TF 184 (375)
T ss_pred eeccchhHhHhcchh---------------------------------------------------------------HH
Confidence 999999999875332 23
Q ss_pred CcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC-CC--CCChHHHHHHHHh
Q 042539 245 SNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE-FV--GQRTALTDLIQRL 321 (412)
Q Consensus 245 ~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~-~~--~~~~~~~dli~~~ 321 (412)
+.+++|||.||+||.+.+.+|+++||||||||++|||+.-++||.|.+..++.++|..+... .+ -.|.++..+|+.|
T Consensus 185 A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~c 264 (375)
T KOG0591|consen 185 AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTDLRELINMC 264 (375)
T ss_pred HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHH
Confidence 45889999999999999999999999999999999999999999999999999999877543 44 2578999999999
Q ss_pred hhhCCCccCC
Q 042539 322 LEKDPVKRLG 331 (412)
Q Consensus 322 L~~dP~~R~~ 331 (412)
+..||+.||+
T Consensus 265 i~vd~~~RP~ 274 (375)
T KOG0591|consen 265 IAVDPEQRPD 274 (375)
T ss_pred ccCCcccCCC
Confidence 9999999996
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-54 Score=428.80 Aligned_cols=270 Identities=26% Similarity=0.432 Sum_probs=237.0
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
+++-|++.+.||+|+-|.|-+|++..||+ .+|||+|.+..- ..+.....+.+||-||+.+.||||++||++|+++
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGq----laaiKii~k~~~-~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~ 84 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQ----LAAIKIIPKRSE-LSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENK 84 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccc----eeEEEeeccccc-cccccccchhhhhHHHHHhcCCCeeeeeeeeccC
Confidence 45679999999999999999998877554 599999987631 2234456778899999999999999999999999
Q ss_pred CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchh
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
.++|+|+||+.||.|.+++..++ .+++.+++.+++||+.|+.|||..+|+||||||+|+|+|.++++||+|||+|..-
T Consensus 85 ~~lylvlEyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe 162 (786)
T KOG0588|consen 85 QHLYLVLEYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE 162 (786)
T ss_pred ceEEEEEEecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc
Confidence 99999999999999988877654 5999999999999999999999999999999999999999999999999999643
Q ss_pred hchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCc
Q 042539 176 VKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYV 255 (412)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 255 (412)
..+....+.||+|+|.
T Consensus 163 ----------------------------------------------------------------~~gklLeTSCGSPHYA 178 (786)
T KOG0588|consen 163 ----------------------------------------------------------------VPGKLLETSCGSPHYA 178 (786)
T ss_pred ----------------------------------------------------------------cCCccccccCCCcccC
Confidence 2344556789999999
Q ss_pred cceeecCCCC-CchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCccCCCC
Q 042539 256 SPEVVRGDGH-EFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKRLGYL 333 (412)
Q Consensus 256 APE~l~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R~~~~ 333 (412)
|||++.|.+| +.++||||.|||||.||+|+.||++.+...++.++..+....+ .++.++.|||++||..||++|+
T Consensus 179 ~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~Ri--- 255 (786)
T KOG0588|consen 179 APEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRI--- 255 (786)
T ss_pred CchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccc---
Confidence 9999999999 7999999999999999999999999999999999988876665 4689999999999999999999
Q ss_pred CChhhhhcCCCCCCCCchhhcccCCCC
Q 042539 334 RGACEIKEHVFFKGVRWDLLTDVLRPP 360 (412)
Q Consensus 334 ~~~~e~l~h~ff~~~~~~~~~~~~~pp 360 (412)
|.+|+++|||+.+..-.......++|
T Consensus 256 -T~~eI~kHP~l~g~~~~~~~~~~~~~ 281 (786)
T KOG0588|consen 256 -TTEEILKHPFLSGYTSLPSSKSLRPP 281 (786)
T ss_pred -cHHHHhhCchhhcCCCCChhhhcCCC
Confidence 78999999999987654444334433
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-53 Score=411.82 Aligned_cols=274 Identities=38% Similarity=0.681 Sum_probs=231.2
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEEEee
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVP 103 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~e 103 (412)
+.||+|+||+||+|+++.++. .||||++++..... ......+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGK----YYAMKILKKEVIIA-KDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCC----EEEEEEEEHHHhhh-hHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEe
Confidence 479999999999999877554 49999998765432 2334566789999999999999999999999999999999
Q ss_pred ccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhhh
Q 042539 104 YCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEK 183 (412)
Q Consensus 104 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~ 183 (412)
|+.||+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 76 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~------ 147 (323)
T cd05571 76 YANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS------ 147 (323)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc------
Confidence 99999998776543 4589999999999999999999999999999999999999999999999999864310
Q ss_pred hcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecCC
Q 042539 184 QSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGD 263 (412)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~ 263 (412)
........+||+.|+|||++.+.
T Consensus 148 ---------------------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~ 170 (323)
T cd05571 148 ---------------------------------------------------------DGATMKTFCGTPEYLAPEVLEDN 170 (323)
T ss_pred ---------------------------------------------------------CCCcccceecCccccChhhhcCC
Confidence 11122356899999999999999
Q ss_pred CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCccCCCCC-Chhhhhc
Q 042539 264 GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKRLGYLR-GACEIKE 341 (412)
Q Consensus 264 ~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R~~~~~-~~~e~l~ 341 (412)
.++.++|||||||++|||++|..||.+.+....+..+......++ ..++++.+||.+||+.||++|++... ++.++++
T Consensus 171 ~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 999999999999999999999999999888888887776665544 46789999999999999999996432 6999999
Q ss_pred CCCCCCCCchhhcc-cCCCCCCCCCCC
Q 042539 342 HVFFKGVRWDLLTD-VLRPPFIPSREE 367 (412)
Q Consensus 342 h~ff~~~~~~~~~~-~~~pp~~p~~~~ 367 (412)
|+||.+++|..+.. ...||+.|....
T Consensus 251 h~~f~~~~~~~~~~~~~~~~~~~~~~~ 277 (323)
T cd05571 251 HRFFASINWQDVVQKKLEPPFKPQVTS 277 (323)
T ss_pred CCCcCCCCHHHHHhCCCCCCcCCCCCC
Confidence 99999999986654 445666655433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-55 Score=422.58 Aligned_cols=256 Identities=29% Similarity=0.502 Sum_probs=229.0
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
+++|.+.+.||+|+||+||+++.+.+.. .||||.+.|..- .+...+.+.+|++|++.++|||||.++++|++..
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~----~vAik~i~K~gr--~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~ 74 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQ----VVAIKFIDKSGR--NEKELKNLRQEVRILRSLKHPNIVEMLESFETSA 74 (808)
T ss_pred CcchhHHHHhcCCccceeeeccccccee----EEEEEEehhcCC--chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccc
Confidence 5789999999999999999988776554 499999988753 3445778889999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
++|+|+|||.| +|..++... +.++|++++.++.+++.||.|||+++|+|||+||+|||+..+|++|+||||+|+-+.
T Consensus 75 ~~~vVte~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~ 151 (808)
T KOG0597|consen 75 HLWVVTEYAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMS 151 (808)
T ss_pred eEEEEehhhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcc
Confidence 99999999988 898777654 459999999999999999999999999999999999999999999999999998663
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
.+....+++.|||.|||
T Consensus 152 ---------------------------------------------------------------~~t~vltsikGtPlYmA 168 (808)
T KOG0597|consen 152 ---------------------------------------------------------------TNTSVLTSIKGTPLYMA 168 (808)
T ss_pred ---------------------------------------------------------------cCceeeeeccCcccccC
Confidence 23344567789999999
Q ss_pred ceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC-CChHHHHHHHHhhhhCCCccCCCCCC
Q 042539 257 PEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVG-QRTALTDLIQRLLEKDPVKRLGYLRG 335 (412)
Q Consensus 257 PE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~dli~~~L~~dP~~R~~~~~~ 335 (412)
||++.+.+|+..+|+||||||+|||++|++||-..+..+..+.|......++. .+..+++|++.+|++||.+|++
T Consensus 169 PElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~Rlt---- 244 (808)
T KOG0597|consen 169 PELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLT---- 244 (808)
T ss_pred HHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhcChhhccc----
Confidence 99999999999999999999999999999999999989999999887766654 5789999999999999999995
Q ss_pred hhhhhcCCCCCCC
Q 042539 336 ACEIKEHVFFKGV 348 (412)
Q Consensus 336 ~~e~l~h~ff~~~ 348 (412)
-.+++.|||.++.
T Consensus 245 W~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 245 WTDLLGHPFWKGK 257 (808)
T ss_pred HHHHhcChHHhhh
Confidence 5899999998763
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-52 Score=409.43 Aligned_cols=318 Identities=42% Similarity=0.729 Sum_probs=246.7
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEEeCCe
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLETDEF 97 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 97 (412)
+|++++.||+|+||+||+|++.. +..+++.||+|++.+............+.+|+.+++.+. |+||+++++++..++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVT-GHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK 79 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcc-cCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE
Confidence 68999999999999999998743 223566799999987655444445667788999999995 8999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+|+|||||.||+|..++.... .+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 80 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 999999999999988776543 499999999999999999999999999999999999999999999999999875421
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
. .......++||+.|+||
T Consensus 158 ~--------------------------------------------------------------~~~~~~~~~gt~~y~aP 175 (332)
T cd05614 158 E--------------------------------------------------------------EKERTYSFCGTIEYMAP 175 (332)
T ss_pred c--------------------------------------------------------------CCCccccccCCccccCH
Confidence 0 11122356799999999
Q ss_pred eeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCC----CHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCccCC
Q 042539 258 EVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGK----NRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKRLG 331 (412)
Q Consensus 258 E~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~----~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R~~ 331 (412)
|++.+. .++.++|||||||++|||++|..||... ........+....+.++ ..++.+.+||.+||+.||++|++
T Consensus 176 E~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~ 255 (332)
T cd05614 176 EIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLG 255 (332)
T ss_pred HHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCC
Confidence 999875 4788999999999999999999999653 23344445555444443 46789999999999999999996
Q ss_pred CC-CChhhhhcCCCCCCCCchhhcc-cCCCCCCCCCCCchhhhhhhcCCCCChhhhhhccCCCCCCCCCCCCCCCCCCCc
Q 042539 332 YL-RGACEIKEHVFFKGVRWDLLTD-VLRPPFIPSREENDLTEKAMSGGGVDIREYFENLRAPPPSMPPSPLPSPSHRSF 409 (412)
Q Consensus 332 ~~-~~~~e~l~h~ff~~~~~~~~~~-~~~pp~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 409 (412)
.. .+++++++||||++.+|..... ...+++.|...... +...+.+......|...|++.|++..+.|
T Consensus 256 ~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (332)
T cd05614 256 AGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNEL-----------DVGNFAEEFTNLEPVYSPAGTPPSGARVF 324 (332)
T ss_pred CCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcc-----------hhhhcCcccccCCcccCCCCCCccccccc
Confidence 42 2588999999999999976544 34566766644332 22223333333334444555555566666
Q ss_pred cCC
Q 042539 410 AEY 412 (412)
Q Consensus 410 ~~~ 412 (412)
.+|
T Consensus 325 ~~~ 327 (332)
T cd05614 325 QGY 327 (332)
T ss_pred CCc
Confidence 665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-54 Score=381.47 Aligned_cols=266 Identities=31% Similarity=0.538 Sum_probs=242.5
Q ss_pred CCCCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccce
Q 042539 8 QPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPK 87 (412)
Q Consensus 8 ~~~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~ 87 (412)
+...+....+++|++.+.||+|.||.||+|+.+.++-. ||+||+-|+.+. .....+.+.||++|-..|+||||++
T Consensus 12 ~~~~~~~~~l~dfeigr~LgkgkFG~vYlarekks~~I----valKVlfKsqi~-~~~v~~qlrREiEIqs~L~hpnilr 86 (281)
T KOG0580|consen 12 GSRATKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFI----VALKVLFKSQIL-KTQVEHQLRREIEIQSHLRHPNILR 86 (281)
T ss_pred ccccccccchhhccccccccCCccccEeEeeeccCCcE----EEEeeeeHHHHH-HhcchhhhhheeEeecccCCccHHh
Confidence 34556789999999999999999999999999886665 999999998863 4567788999999999999999999
Q ss_pred eeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEc
Q 042539 88 LLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLT 167 (412)
Q Consensus 88 l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~ 167 (412)
+|++|.+...+||++||..+|+|...+.......|++..+..|+.|++.||.|+|.+++|||||||+|+|++..|.+||+
T Consensus 87 lY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiA 166 (281)
T KOG0580|consen 87 LYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIA 166 (281)
T ss_pred hhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeecc
Confidence 99999999999999999999999888886677789999999999999999999999999999999999999999999999
Q ss_pred cccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcc
Q 042539 168 DFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNS 247 (412)
Q Consensus 168 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (412)
|||.+... ...+..+
T Consensus 167 dfGwsV~~-----------------------------------------------------------------p~~kR~t 181 (281)
T KOG0580|consen 167 DFGWSVHA-----------------------------------------------------------------PSNKRKT 181 (281)
T ss_pred CCCceeec-----------------------------------------------------------------CCCCcee
Confidence 99988542 2345668
Q ss_pred cccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCC
Q 042539 248 FVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDP 326 (412)
Q Consensus 248 ~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP 326 (412)
.|||..|.+||...+..++..+|+|++|++.||++.|.+||...+..+++++|......++ .++.+++|||.+||.++|
T Consensus 182 lcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI~~ll~~~p 261 (281)
T KOG0580|consen 182 LCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLISRLLVKNP 261 (281)
T ss_pred eecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHHHHHhccCc
Confidence 9999999999999999999999999999999999999999999999999999987766555 468999999999999999
Q ss_pred CccCCCCCChhhhhcCCCCCC
Q 042539 327 VKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 327 ~~R~~~~~~~~e~l~h~ff~~ 347 (412)
.+|+ ...|++.|||+..
T Consensus 262 ~~r~----~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 262 IERL----ALTEVMDHPWIVA 278 (281)
T ss_pred cccc----cHHHHhhhHHHHh
Confidence 9999 6899999999864
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-52 Score=412.85 Aligned_cols=313 Identities=35% Similarity=0.619 Sum_probs=236.5
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
++|++++.||+|+||+||+|+++.++. .||||++++..... ......+.+|+.+++.++|+||++++++|.+++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGH----IYAMKKLRKSEMLE-KEQVAHVRAERDILAEADNPWVVKLYYSFQDENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCC----EEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCe
Confidence 589999999999999999999987554 49999997765422 2345667789999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+|+|||||.||+|..++... +.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.+..
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred EEEEECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999998887654 3599999999999999999999999999999999999999999999999999976532
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCcccccccc--CCCCCCcccccCCCCc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSF--DNGERSNSFVGTEEYV 255 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~gt~~Y~ 255 (412)
......... .....+. .. ......... ......+. .......+.+||+.|+
T Consensus 154 ~~~~~~~~~---~~~~~~~--------------------~~---~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~gt~~y~ 206 (364)
T cd05599 154 SHRTEFYRI---LSHALPS--------------------NF---LDFISKPMS-SKRKAETWKRNRRALAYSTVGTPDYI 206 (364)
T ss_pred ccccccccc---ccccccc--------------------cc---ccccccccc-ccccccchhhcccccccccccCcccc
Confidence 110000000 0000000 00 000000000 00000000 0011223568999999
Q ss_pred cceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-----CCCCCChHHHHHHHHhhhhCCCccC
Q 042539 256 SPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP-----EFVGQRTALTDLIQRLLEKDPVKRL 330 (412)
Q Consensus 256 APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-----~~~~~~~~~~dli~~~L~~dP~~R~ 330 (412)
|||++.+..++.++|||||||++|||++|.+||.+.+..+.+..++.... .....++++++||.+||. +|.+|+
T Consensus 207 aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~ 285 (364)
T cd05599 207 APEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRL 285 (364)
T ss_pred CHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcC
Confidence 99999999999999999999999999999999999988888777765332 222457899999999996 999999
Q ss_pred CCCCChhhhhcCCCCCCCCchhhcccCCCCCCCCCCC
Q 042539 331 GYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREE 367 (412)
Q Consensus 331 ~~~~~~~e~l~h~ff~~~~~~~~~~~~~pp~~p~~~~ 367 (412)
+. ++++++++||||++++|+.+.. ..++++|....
T Consensus 286 ~~-~~~~~ll~h~~~~~~~~~~~~~-~~~~~~~~~~~ 320 (364)
T cd05599 286 GN-NGVNEIKSHPFFKGVDWEHIRE-RPAPIIPELKS 320 (364)
T ss_pred CC-CCHHHHhcCCCcCCCCHHHHhh-cCCCCCCCCCC
Confidence 54 4699999999999999987654 34566665443
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-52 Score=410.27 Aligned_cols=288 Identities=30% Similarity=0.588 Sum_probs=245.1
Q ss_pred CCCCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccce
Q 042539 8 QPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPK 87 (412)
Q Consensus 8 ~~~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~ 87 (412)
.+.....+..++|++++.||+|+||.||+|.++..+ ...||+|++.+..... ......+.+|+.+++.++||||++
T Consensus 20 ~~~~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~---~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~Iv~ 95 (340)
T PTZ00426 20 EPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNED---FPPVAIKRFEKSKIIK-QKQVDHVFSERKILNYINHPFCVN 95 (340)
T ss_pred ccccCCCCChhhcEEEEEEeecCCeEEEEEEEECCC---CeEEEEEEEEHHHhhh-hhhHHHHHHHHHHHHhCCCCCCcc
Confidence 456678899999999999999999999999876543 2359999997765422 234556778999999999999999
Q ss_pred eeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEc
Q 042539 88 LLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLT 167 (412)
Q Consensus 88 l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~ 167 (412)
+++++.+++.+|+|||||.||+|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+
T Consensus 96 ~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~ 173 (340)
T PTZ00426 96 LYGSFKDESYLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMT 173 (340)
T ss_pred eEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEe
Confidence 9999999999999999999999988876543 59999999999999999999999999999999999999999999999
Q ss_pred cccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcc
Q 042539 168 DFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNS 247 (412)
Q Consensus 168 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (412)
|||+++.+.. ...+
T Consensus 174 DFG~a~~~~~------------------------------------------------------------------~~~~ 187 (340)
T PTZ00426 174 DFGFAKVVDT------------------------------------------------------------------RTYT 187 (340)
T ss_pred cCCCCeecCC------------------------------------------------------------------Ccce
Confidence 9999864310 1124
Q ss_pred cccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCC
Q 042539 248 FVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDP 326 (412)
Q Consensus 248 ~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP 326 (412)
.+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+....+..+......++ ..++.+.++|++||+.||
T Consensus 188 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~dp 267 (340)
T PTZ00426 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSHDL 267 (340)
T ss_pred ecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCH
Confidence 5799999999999998899999999999999999999999999988888888877655443 457899999999999999
Q ss_pred CccCCC-CCChhhhhcCCCCCCCCchhhc-ccCCCCCCCCCCC
Q 042539 327 VKRLGY-LRGACEIKEHVFFKGVRWDLLT-DVLRPPFIPSREE 367 (412)
Q Consensus 327 ~~R~~~-~~~~~e~l~h~ff~~~~~~~~~-~~~~pp~~p~~~~ 367 (412)
++|++. ..+++++++||||++++|.... ....+|+.|....
T Consensus 268 ~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~~ 310 (340)
T PTZ00426 268 TKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKN 310 (340)
T ss_pred HHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCC
Confidence 999853 2479999999999999997543 3456778877544
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-52 Score=415.74 Aligned_cols=320 Identities=33% Similarity=0.596 Sum_probs=235.9
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
++|.+++.||+|+||+||+|+++.++. .||||++.+..... ......+.+|+++++.++||||++++++|.+++.
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGK----IYAMKTLLKSEMFK-KDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCC----EEEEEEEEHHHHHH-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCe
Confidence 589999999999999999999887554 49999997654422 3345677889999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+|+|||||.||+|..++... +.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.+..
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999998877643 4599999999999999999999999999999999999999999999999999975432
Q ss_pred hhhh--hhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCcccccccc--CCCCCCcccccCCC
Q 042539 178 KTAF--EKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSF--DNGERSNSFVGTEE 253 (412)
Q Consensus 178 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~gt~~ 253 (412)
.... ..+...... ...+. ....+................... .......+.+||+.
T Consensus 154 ~~~~~~~~~~~~~~~-~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 213 (377)
T cd05629 154 QHDSAYYQKLLQGKS-NKNRI-------------------DNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPD 213 (377)
T ss_pred ccccccccccccccc-ccccc-------------------ccccccccccccccccchhhhhhhhhcccccccccCCCcc
Confidence 1100 000000000 00000 000000000000000000000000 00111235689999
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--CCC---CCCChHHHHHHHHhhhhCCCc
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT--PEF---VGQRTALTDLIQRLLEKDPVK 328 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~---~~~~~~~~dli~~~L~~dP~~ 328 (412)
|+|||++.+..++.++|||||||++|||++|.+||.+.+..+.+..+.... ..+ ...+.++++||.+||. +|.+
T Consensus 214 y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~ 292 (377)
T cd05629 214 YIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAEN 292 (377)
T ss_pred ccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhh
Confidence 999999999999999999999999999999999999988888777776422 222 2467899999999997 8888
Q ss_pred cCCCCCChhhhhcCCCCCCCCchhhcccCCCCCCCCCCC
Q 042539 329 RLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREE 367 (412)
Q Consensus 329 R~~~~~~~~e~l~h~ff~~~~~~~~~~~~~pp~~p~~~~ 367 (412)
|++- .++.+++.||||++++|+.+.. ..+|++|....
T Consensus 293 r~~r-~~~~~~l~hp~~~~~~~~~~~~-~~~~~~~~~~~ 329 (377)
T cd05629 293 RLGR-GGAHEIKSHPFFRGVDWDTIRQ-IRAPFIPQLKS 329 (377)
T ss_pred cCCC-CCHHHHhcCCCcCCCCHHHHcc-CCCCcccCCCC
Confidence 7642 3799999999999999988854 45677776543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-54 Score=414.95 Aligned_cols=287 Identities=35% Similarity=0.656 Sum_probs=257.8
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
..++.+.+++++..||-||||.|=+++.+.... .+|+|+++|.++... ....++..|.+||..++.|+||+||.+
T Consensus 414 ~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~----~fAlKilkK~hIVdt-kQqeHv~sEr~Im~~~~s~fIvrLYrT 488 (732)
T KOG0614|consen 414 FAQVKLSDLKRIATLGVGGFGRVELVKVNSQKA----TFALKILKKKHIVDT-KQQEHVFSERNIMMECRSDFIVRLYRT 488 (732)
T ss_pred hcccchhhhhhhhhcccCccceEEEEEecccch----HHHHHHHhHhhccch-hHHHHHHhHHHHHHhcCchHHHHHHHH
Confidence 457889999999999999999999998776443 399999999887443 446677889999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
|.++..+|++||-|-||+|+..+..++ .|++..+++|++.++.|++|||++|||+|||||+|+|++.+|-+||.|||+
T Consensus 489 frd~kyvYmLmEaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGF 566 (732)
T KOG0614|consen 489 FRDSKYVYMLMEACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGF 566 (732)
T ss_pred hccchhhhhhHHhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhh
Confidence 999999999999999999998887654 599999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
|+.+ ..+..+.+||||
T Consensus 567 AKki----------------------------------------------------------------~~g~KTwTFcGT 582 (732)
T KOG0614|consen 567 AKKI----------------------------------------------------------------GSGRKTWTFCGT 582 (732)
T ss_pred HHHh----------------------------------------------------------------ccCCceeeecCC
Confidence 9977 345677899999
Q ss_pred CCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--CCCC-CCChHHHHHHHHhhhhCCCc
Q 042539 252 EEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT--PEFV-GQRTALTDLIQRLLEKDPVK 328 (412)
Q Consensus 252 ~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~~-~~~~~~~dli~~~L~~dP~~ 328 (412)
|.|.|||++.+.+++.++|.||||+++|||++|.+||.+.+...++..|+.+. ..+| .+++.+.+||.++...+|.+
T Consensus 583 pEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~E 662 (732)
T KOG0614|consen 583 PEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTE 662 (732)
T ss_pred cccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHh
Confidence 99999999999999999999999999999999999999999999999998764 3344 35688999999999999999
Q ss_pred cCCCC-CChhhhhcCCCCCCCCchhhcc-cCCCCCCCCCCCch
Q 042539 329 RLGYL-RGACEIKEHVFFKGVRWDLLTD-VLRPPFIPSREEND 369 (412)
Q Consensus 329 R~~~~-~~~~e~l~h~ff~~~~~~~~~~-~~~pp~~p~~~~~~ 369 (412)
|+++. .++.+|++|.||.+.+|+-+.. ...||++|+.....
T Consensus 663 RLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~pt 705 (732)
T KOG0614|consen 663 RLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPT 705 (732)
T ss_pred hhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcc
Confidence 99973 5799999999999999997755 67999999977664
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-52 Score=404.13 Aligned_cols=277 Identities=32% Similarity=0.665 Sum_probs=231.2
Q ss_pred ceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHH---hhcCCCccceeeeeEEeCC
Q 042539 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVL---SRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 20 y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il---~~l~hpnIv~l~~~~~~~~ 96 (412)
|++++.||+|+||.||+|+++.++.. ||||++++...... .....+.+|++++ +.++||||+++++++.+++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~----~aiK~~~~~~~~~~-~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGEL----YAIKALKKGDIIAR-DEVESLMCEKRIFETANSERHPFLVNLFACFQTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCE----EEEEEEEHHHhhhh-hHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC
Confidence 78999999999999999998875544 99999987653222 2344566676665 4567999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
.+|+|||||.||+|..++.. ..+++.++..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 99999999999999766543 359999999999999999999999999999999999999999999999999986431
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
. ......+.+||+.|+|
T Consensus 153 ~---------------------------------------------------------------~~~~~~~~~g~~~y~a 169 (324)
T cd05589 153 G---------------------------------------------------------------FGDRTSTFCGTPEFLA 169 (324)
T ss_pred C---------------------------------------------------------------CCCcccccccCccccC
Confidence 0 1112235689999999
Q ss_pred ceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCccCCCC-C
Q 042539 257 PEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKRLGYL-R 334 (412)
Q Consensus 257 PE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R~~~~-~ 334 (412)
||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.++ ..++.+.+||.+||+.||.+|++.. .
T Consensus 170 PE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~ 249 (324)
T cd05589 170 PEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPERRLGSGEK 249 (324)
T ss_pred HhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCC
Confidence 9999999899999999999999999999999999988888888877655544 4678999999999999999999753 3
Q ss_pred ChhhhhcCCCCCCCCchhhc-ccCCCCCCCCCCC
Q 042539 335 GACEIKEHVFFKGVRWDLLT-DVLRPPFIPSREE 367 (412)
Q Consensus 335 ~~~e~l~h~ff~~~~~~~~~-~~~~pp~~p~~~~ 367 (412)
++.++++|+||++++|.... ....||+.|....
T Consensus 250 ~~~~l~~~~~f~~~~~~~~~~~~~~~~~~~~~~~ 283 (324)
T cd05589 250 DAEDVKKQPFFRDINWDDLLARKIKPPFVPTIKG 283 (324)
T ss_pred CHHHHhhCCCcCCCCHHHHHhCCCCcCccCCCCC
Confidence 69999999999999998543 3456777766443
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-52 Score=409.76 Aligned_cols=301 Identities=32% Similarity=0.545 Sum_probs=229.9
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
++|++++.||+|+||+||+|+++.++. .||||++.+..... ......+.+|+.++..++|+||+++++.++++..
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~-~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGH----VYAMKILRKADMLE-KEQVGHIRAERDILVEADSLWVVKMFYSFQDKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCC----EEEEEEEEHHHHHH-hhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCe
Confidence 589999999999999999999877544 49999997765422 3345667789999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+|+|||||.||+|..++... +.+++.+++.++.|++.||+|||++||+||||||+|||++.+|++||+|||+++.+..
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999998887654 3599999999999999999999999999999999999999999999999999986532
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
............ ..+....-.... +..... ...........+.+||+.|+||
T Consensus 154 ~~~~~~~~~~~~-----------------------~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~Gt~~Y~aP 205 (363)
T cd05628 154 AHRTEFYRNLNH-----------------------SLPSDFTFQNMN-SKRKAE----TWKRNRRQLAFSTVGTPDYIAP 205 (363)
T ss_pred cccccccccccc-----------------------cccccccccccc-cccccc----hhhhccccccccccCCccccCH
Confidence 111000000000 000000000000 000000 0000011223467899999999
Q ss_pred eeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-----CCCCCCChHHHHHHHHhhhhCCCccCCC
Q 042539 258 EVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT-----PEFVGQRTALTDLIQRLLEKDPVKRLGY 332 (412)
Q Consensus 258 E~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-----~~~~~~~~~~~dli~~~L~~dP~~R~~~ 332 (412)
|++.+..++.++|||||||++|||++|+.||.+.+..+.+.++.... +.....++++++||.+|+. +|.+|++-
T Consensus 206 E~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r 284 (363)
T cd05628 206 EVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGA 284 (363)
T ss_pred HHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCC
Confidence 99999999999999999999999999999999998888888887532 2223467899999999885 67766531
Q ss_pred CCChhhhhcCCCCCCCCchhhcc
Q 042539 333 LRGACEIKEHVFFKGVRWDLLTD 355 (412)
Q Consensus 333 ~~~~~e~l~h~ff~~~~~~~~~~ 355 (412)
++++++++||||++++|+.+..
T Consensus 285 -~~~~ei~~hp~f~~~~~~~~~~ 306 (363)
T cd05628 285 -PGVEEIKTNPFFEGVDWEHIRE 306 (363)
T ss_pred -CCHHHHhCCCCCCCCCHHHHHh
Confidence 3799999999999999998755
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-52 Score=399.81 Aligned_cols=274 Identities=42% Similarity=0.737 Sum_probs=234.0
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
++|++++.||+|+||+||+|+++.++. .||+|++.+..... ......+.+|+.+++.++||||+++++++.+++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEH----YYALKVMAIPEVIR-LKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCC----EEEEEEEEHHHHhh-hHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCe
Confidence 589999999999999999999887554 49999997654322 2334567789999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+|+||||+.||+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999998877654 3589999999999999999999999999999999999999999999999999865411
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
.....+||+.|+||
T Consensus 154 ------------------------------------------------------------------~~~~~~gt~~y~aP 167 (291)
T cd05612 154 ------------------------------------------------------------------RTWTLCGTPEYLAP 167 (291)
T ss_pred ------------------------------------------------------------------CcccccCChhhcCH
Confidence 11235799999999
Q ss_pred eeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC-CChHHHHHHHHhhhhCCCccCCCC-CC
Q 042539 258 EVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVG-QRTALTDLIQRLLEKDPVKRLGYL-RG 335 (412)
Q Consensus 258 E~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~dli~~~L~~dP~~R~~~~-~~ 335 (412)
|++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+......++. .+..+++||.+||+.||.+|++.. .+
T Consensus 168 E~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~ 247 (291)
T cd05612 168 EVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNG 247 (291)
T ss_pred HHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcCCCHHHccCCccCC
Confidence 9999999999999999999999999999999999888888888877665543 578999999999999999999643 36
Q ss_pred hhhhhcCCCCCCCCchhhcc-cCCCCCCCC
Q 042539 336 ACEIKEHVFFKGVRWDLLTD-VLRPPFIPS 364 (412)
Q Consensus 336 ~~e~l~h~ff~~~~~~~~~~-~~~pp~~p~ 364 (412)
+++++.|+||+.++|..... ...|++.|.
T Consensus 248 ~~~~l~h~~~~~~~~~~~~~~~~~~~~~p~ 277 (291)
T cd05612 248 ADDVKNHRWFKSVDWDDVPQRKLKPPIVPK 277 (291)
T ss_pred HHHHhcCccccCCCHHHHhcCCCCCCEeCC
Confidence 99999999999999985544 234444444
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-53 Score=408.80 Aligned_cols=260 Identities=29% Similarity=0.465 Sum_probs=222.9
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeee
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGS 91 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~ 91 (412)
.-+.+++|.++++||.|+||.||+|+.+.++.. ||||.+++.... -++. .-+||++.|++|+ |||||+|.++
T Consensus 5 ~~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~----VAIK~MK~Kf~s-~ee~--~nLREvksL~kln~hpniikL~Ev 77 (538)
T KOG0661|consen 5 QVIFMDRYTVIRKLGDGTFGSVYLAKSKETGEL----VAIKKMKKKFYS-WEEC--MNLREVKSLRKLNPHPNIIKLKEV 77 (538)
T ss_pred ehhHHHHHHHHHHhcCCcceeEEEeeecCCCce----eeHHHHHhhhcc-HHHH--HHHHHHHHHHhcCCCCcchhhHHH
Confidence 345679999999999999999999998886665 999999776543 2222 2346999999999 9999999999
Q ss_pred EEeCC-eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccc
Q 042539 92 LETDE-FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 92 ~~~~~-~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
+.+++ .+|+|||||+ ..|+.++..+ +..|++..++.|+.||+.||+|+|.+|+.|||+||||||+..+..+||+|||
T Consensus 78 i~d~~~~L~fVfE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFG 155 (538)
T KOG0661|consen 78 IRDNDRILYFVFEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFG 155 (538)
T ss_pred hhccCceEeeeHHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccc
Confidence 99888 9999999995 5787787776 6789999999999999999999999999999999999999989999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+||.+.+.. ..+.++.
T Consensus 156 LARev~Skp----------------------------------------------------------------PYTeYVS 171 (538)
T KOG0661|consen 156 LAREVRSKP----------------------------------------------------------------PYTEYVS 171 (538)
T ss_pred cccccccCC----------------------------------------------------------------Ccchhhh
Confidence 999874332 2345688
Q ss_pred CCCCccceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhc--CCCC---------------------
Q 042539 251 TEEYVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLM--KTPE--------------------- 306 (412)
Q Consensus 251 t~~Y~APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~--~~~~--------------------- 306 (412)
|++|+|||++... -|+.++||||+|||++|+++-++.|+|.++.+++.+|+. +.|.
T Consensus 172 TRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~ 251 (538)
T KOG0661|consen 172 TRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQV 251 (538)
T ss_pred cccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcC
Confidence 9999999998765 479999999999999999999999999999888877762 2111
Q ss_pred --------CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCC
Q 042539 307 --------FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 307 --------~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~ 349 (412)
++..+.++.+||.+||.+||.+|| ||.++++||||+...
T Consensus 252 ~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRp----TA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 252 KPSPLKDLLPNASSEAASLIERLLAWDPDKRP----TASQALQHPFFQVGR 298 (538)
T ss_pred CCCChHHhCcccCHHHHHHHHHHhcCCCccCc----cHHHHhcCccccccc
Confidence 124568899999999999999999 799999999998543
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-53 Score=399.35 Aligned_cols=254 Identities=28% Similarity=0.482 Sum_probs=232.7
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
-+|++.+.||+|+||+|-+|.++..+. .||||.|+|+.+... ....+++|||+||..|+||||+++|++|++.+.
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR----~VAiKsIrKdkIkde-qDlvhIRREIeIMSsLNHPhII~IyEVFENkdK 127 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGR----EVAIKSIRKDKIKDE-QDLVHIRREIEIMSSLNHPHIIQIYEVFENKDK 127 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCc----EeehhhhhhhhcccH-HHHHHHHHHHHHHhhcCCCceeehhhhhcCCce
Confidence 489999999999999999988876554 499999999988654 456788999999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+.|||||..||+|++++...+ .++|.+++.+++||+.|+.|+|.++++|||||.+|||+|.++++||+||||+..+
T Consensus 128 IvivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly-- 203 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLY-- 203 (668)
T ss_pred EEEEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhh--
Confidence 999999999999998887655 4999999999999999999999999999999999999999999999999999765
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
.++....+|||+|-|.+|
T Consensus 204 --------------------------------------------------------------~~~kfLqTFCGSPLYASP 221 (668)
T KOG0611|consen 204 --------------------------------------------------------------ADKKFLQTFCGSPLYASP 221 (668)
T ss_pred --------------------------------------------------------------ccccHHHHhcCCcccCCc
Confidence 234455689999999999
Q ss_pred eeecCCCC-CchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCChHHHHHHHHhhhhCCCccCCCCCCh
Q 042539 258 EVVRGDGH-EFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGA 336 (412)
Q Consensus 258 E~l~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~ 336 (412)
|++.|.+| +..+|.|||||+||-|++|.+||.|.+...+.++|-.+.+.-+..+.++.-||+.||..||++|. |+
T Consensus 222 EIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~PSdA~gLIRwmLmVNP~RRA----Ti 297 (668)
T KOG0611|consen 222 EIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETPSDASGLIRWMLMVNPERRA----TI 297 (668)
T ss_pred cccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCCchHHHHHHHHHhcCcccch----hH
Confidence 99999999 78999999999999999999999999999999999988877777788899999999999999998 79
Q ss_pred hhhhcCCCCC
Q 042539 337 CEIKEHVFFK 346 (412)
Q Consensus 337 ~e~l~h~ff~ 346 (412)
+++..|-|.+
T Consensus 298 eDiAsHWWvN 307 (668)
T KOG0611|consen 298 EDIASHWWVN 307 (668)
T ss_pred HHHhhhheee
Confidence 9999999974
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-52 Score=385.39 Aligned_cols=263 Identities=25% Similarity=0.394 Sum_probs=223.1
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
..--.+++|+++..|++|+||.||+|+++.++.. ||+|.++.+. .+...-...+|||.+|.+++|||||.+-.+
T Consensus 70 ~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eI----VALKr~kmek--ek~GFPItsLREIniLl~~~H~NIV~vkEV 143 (419)
T KOG0663|consen 70 GGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEI----VALKRLKMEK--EKEGFPITSLREINILLKARHPNIVEVKEV 143 (419)
T ss_pred cCcccHHHHHHHhhcccCcceeEEEeccCCccee----EEeeeccccc--ccCCCcchhHHHHHHHHhcCCCCeeeeEEE
Confidence 3345678999999999999999999999987665 9999997664 344455667789999999999999999998
Q ss_pred EEeC--CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccc
Q 042539 92 LETD--EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169 (412)
Q Consensus 92 ~~~~--~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DF 169 (412)
..-. +.+|+|||||+. ||..++.... ..|.+.+++.++.|++.||+|||++.|+|||||++|+|++..|.+||+||
T Consensus 144 VvG~~~d~iy~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDF 221 (419)
T KOG0663|consen 144 VVGSNMDKIYIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADF 221 (419)
T ss_pred EeccccceeeeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEeccc
Confidence 8643 579999999966 7777777655 46999999999999999999999999999999999999999999999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|+|+.+.+. ....+..+
T Consensus 222 GLAR~ygsp---------------------------------------------------------------~k~~T~lV 238 (419)
T KOG0663|consen 222 GLAREYGSP---------------------------------------------------------------LKPYTPLV 238 (419)
T ss_pred chhhhhcCC---------------------------------------------------------------cccCcceE
Confidence 999987421 12234567
Q ss_pred cCCCCccceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhc--CCCC--------------------
Q 042539 250 GTEEYVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLM--KTPE-------------------- 306 (412)
Q Consensus 250 gt~~Y~APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~--~~~~-------------------- 306 (412)
-|.+|+|||++.|. .|+.++|+||+|||+.||+++.+.|.|.+..+++.+|.. +.|.
T Consensus 239 VTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~ 318 (419)
T KOG0663|consen 239 VTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSE 318 (419)
T ss_pred EEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCC
Confidence 89999999999986 589999999999999999999999999999888887763 1110
Q ss_pred ---------CCC--CChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCC
Q 042539 307 ---------FVG--QRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 307 ---------~~~--~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~ 349 (412)
|.. .++...||++.+|.+||.+|+ ||+++|+|.||.+..
T Consensus 319 ~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~----tA~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 319 HPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRI----TAEDGLKHEYFRETP 368 (419)
T ss_pred CCchhhhhhccccccchhHHHHHHHHhccCccccc----cHHHhhcccccccCC
Confidence 111 346788999999999999999 799999999999743
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-52 Score=395.46 Aligned_cols=277 Identities=34% Similarity=0.619 Sum_probs=229.5
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeE
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFL 98 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 98 (412)
.|++++.||+|+||+||+|.+..++.. ||+|++.+...... .....+.+|+++++.++|+||+++++++.+++.+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~----~avK~~~~~~~~~~-~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKM----YACKKLEKKRIKKR-KGEAMALNEKRILEKVNSRFVVSLAYAYETKDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCce----EEEEEeeHhhhhhh-hhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeE
Confidence 488999999999999999998875544 99999977654322 2344567799999999999999999999999999
Q ss_pred EEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhch
Q 042539 99 AWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~ 178 (412)
|+|||||.||+|..++.......+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~- 154 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE- 154 (285)
T ss_pred EEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC-
Confidence 9999999999998777655545699999999999999999999999999999999999999999999999999865311
Q ss_pred hhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccce
Q 042539 179 TAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPE 258 (412)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 258 (412)
.......+||+.|+|||
T Consensus 155 ---------------------------------------------------------------~~~~~~~~g~~~y~aPE 171 (285)
T cd05631 155 ---------------------------------------------------------------GETVRGRVGTVGYMAPE 171 (285)
T ss_pred ---------------------------------------------------------------CCeecCCCCCCCccCHh
Confidence 11112347899999999
Q ss_pred eecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHH----HHHHHhcCCCCC-CCCChHHHHHHHHhhhhCCCccCCCC
Q 042539 259 VVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKE----TFRNVLMKTPEF-VGQRTALTDLIQRLLEKDPVKRLGYL 333 (412)
Q Consensus 259 ~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~----~~~~i~~~~~~~-~~~~~~~~dli~~~L~~dP~~R~~~~ 333 (412)
++.+..++.++|||||||++|+|++|+.||.+.+... ....+......+ ...+.++.+||++||+.||.+|++..
T Consensus 172 ~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05631 172 VINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCR 251 (285)
T ss_pred hhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCC
Confidence 9999999999999999999999999999998765322 222222222222 34678999999999999999999642
Q ss_pred -CChhhhhcCCCCCCCCchhhcc-cCCCCCCCC
Q 042539 334 -RGACEIKEHVFFKGVRWDLLTD-VLRPPFIPS 364 (412)
Q Consensus 334 -~~~~e~l~h~ff~~~~~~~~~~-~~~pp~~p~ 364 (412)
.+++++++||||.+++|+.+.. ...|||.|.
T Consensus 252 ~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05631 252 GNGAAGVKQHPIFKNINFKRLEANMLEPPFCPD 284 (285)
T ss_pred CCCHHHHhcCHhhcCCCHHHHHhCcCCcCCCCC
Confidence 3589999999999999986655 568888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-52 Score=374.67 Aligned_cols=255 Identities=28% Similarity=0.470 Sum_probs=220.1
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
++|..++.||+|.||.||+|++..++.. ||||.|+.... ++.....+.|||+.|+.++|+||+.|+++|.+.+.
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~----VAIKKIkl~~~--kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~ 75 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKR----VAIKKIKLGNA--KDGINRTALREIKLLQELKHPNIIELIDVFPHKSN 75 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcE----EEEEEeecccc--ccCccHHHHHHHHHHHHccCcchhhhhhhccCCCc
Confidence 6899999999999999999999886554 99999987753 34556778899999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+.||+||++ .||...+... ...++..+++.|+.+++.||+|||++.|+||||||.|+||+.+|.+||+|||+|+.+..
T Consensus 76 l~lVfEfm~-tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 76 LSLVFEFMP-TDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred eEEEEEecc-ccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 999999994 5887776654 45799999999999999999999999999999999999999999999999999998742
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
.. ......+-|.+|+||
T Consensus 154 p~---------------------------------------------------------------~~~~~~V~TRWYRAP 170 (318)
T KOG0659|consen 154 PN---------------------------------------------------------------RIQTHQVVTRWYRAP 170 (318)
T ss_pred CC---------------------------------------------------------------cccccceeeeeccCh
Confidence 21 111122778999999
Q ss_pred eeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CC---------------------------CC
Q 042539 258 EVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK--TP---------------------------EF 307 (412)
Q Consensus 258 E~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~~---------------------------~~ 307 (412)
|++.|. .|+..+||||.|||+.||+-|.+-|.|.++-+++..|... .| -+
T Consensus 171 ELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf 250 (318)
T KOG0659|consen 171 ELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLF 250 (318)
T ss_pred HHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCcccccc
Confidence 999885 5899999999999999999999999999999888777631 11 12
Q ss_pred CCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCC
Q 042539 308 VGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 308 ~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
+..+.++.||+.+||.+||.+|+ ++.|+++|+||+.
T Consensus 251 ~aas~d~ldLl~~m~~ynP~~Ri----ta~qaL~~~yf~~ 286 (318)
T KOG0659|consen 251 PAASSDALDLLSKMLTYNPKKRI----TASQALKHPYFKS 286 (318)
T ss_pred ccccHHHHHHHHhhhccCchhcc----cHHHHhcchhhhc
Confidence 34567889999999999999999 6999999999985
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-51 Score=408.60 Aligned_cols=324 Identities=28% Similarity=0.475 Sum_probs=234.3
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
.+|++++.||+|+||+||+|+++.++. .||||++.+..... ......+.+|+.+++.++|+||+++++++.+++.
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~----~~aiK~i~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~ 75 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHA----LYAMKTLRKKDVLN-RNQVAHVKAERDILAEADNEWVVKLYYSFQDKDN 75 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCC----EEEEEEEEHHHhhh-hHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCE
Confidence 369999999999999999999887554 49999997765432 2345678889999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+|+|||||.||+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.+..
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~ 153 (381)
T cd05626 76 LYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW 153 (381)
T ss_pred EEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence 99999999999998887654 3599999999999999999999999999999999999999999999999999875421
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
..... ....+. ........ .. .+....+.+.- .....................+++||+.|+||
T Consensus 154 ~~~~~--~~~~~~-~~~~~~~~-------~~----~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aP 217 (381)
T cd05626 154 THNSK--YYQKGS-HIRQDSME-------PS----DLWDDVSNCRC--GDRLKTLEQRATKQHQRCLAHSLVGTPNYIAP 217 (381)
T ss_pred ccccc--cccccc-cccccccC-------cc----ccccccccccc--ccccchhhccccccccccccccccCCccccCH
Confidence 11000 000000 00000000 00 00000000000 00000000000000111223567899999999
Q ss_pred eeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-----CCCCCCChHHHHHHHHhhhh--CCCccC
Q 042539 258 EVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT-----PEFVGQRTALTDLIQRLLEK--DPVKRL 330 (412)
Q Consensus 258 E~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-----~~~~~~~~~~~dli~~~L~~--dP~~R~ 330 (412)
|++.+..++.++|||||||++|||++|.+||.+.+..+....+.... +.....++++++||.+||.. ++..|+
T Consensus 218 E~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~ 297 (381)
T cd05626 218 EVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRN 297 (381)
T ss_pred HHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCC
Confidence 99999999999999999999999999999999888777666665322 22335689999999997654 444588
Q ss_pred CCCCChhhhhcCCCCCCCCchhhcccCCCCCCCCCCCc
Q 042539 331 GYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREEN 368 (412)
Q Consensus 331 ~~~~~~~e~l~h~ff~~~~~~~~~~~~~pp~~p~~~~~ 368 (412)
+++++++||||.+++|........+|+.|.....
T Consensus 298 ----~~~~~l~hp~f~~~~~~~~~~~~~~~~~p~~~~~ 331 (381)
T cd05626 298 ----GADDIKAHPFFSEVDFSSDIRTQPAPYVPKISHP 331 (381)
T ss_pred ----CHHHHhcCcccCCCChhHHhhcCCCCccCcCCCc
Confidence 7999999999999999865555667777765443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-51 Score=398.72 Aligned_cols=277 Identities=40% Similarity=0.703 Sum_probs=230.9
Q ss_pred eeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEEEe
Q 042539 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAV 102 (412)
Q Consensus 23 ~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 102 (412)
++.||+|+||.||+|++... ...++.||+|++++............+.+|+.+++.++||||++++++|.+++.+|+||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTG-ADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred CceeeecCCeEEEEEEEccc-CCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEE
Confidence 47899999999999987432 23566799999987655433344556778999999999999999999999999999999
Q ss_pred eccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhh
Q 042539 103 PYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFE 182 (412)
Q Consensus 103 e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~ 182 (412)
||+.||+|..++... +.+.+..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~----- 152 (323)
T cd05584 80 EYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH----- 152 (323)
T ss_pred eCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc-----
Confidence 999999998776543 4589999999999999999999999999999999999999999999999999864311
Q ss_pred hhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecC
Q 042539 183 KQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRG 262 (412)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~ 262 (412)
........+||+.|+|||++.+
T Consensus 153 ----------------------------------------------------------~~~~~~~~~gt~~y~aPE~~~~ 174 (323)
T cd05584 153 ----------------------------------------------------------EGTVTHTFCGTIEYMAPEILMR 174 (323)
T ss_pred ----------------------------------------------------------CCCcccccCCCccccChhhccC
Confidence 1112234679999999999999
Q ss_pred CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCccCCC-CCChhhhh
Q 042539 263 DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKRLGY-LRGACEIK 340 (412)
Q Consensus 263 ~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R~~~-~~~~~e~l 340 (412)
..++.++|||||||++|||++|+.||.+.+.......+.......+ ..++++.+||.+||++||++|++. ..++++++
T Consensus 175 ~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~ 254 (323)
T cd05584 175 SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQ 254 (323)
T ss_pred CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHh
Confidence 8899999999999999999999999999988888888877655443 457899999999999999999954 23699999
Q ss_pred cCCCCCCCCchhhc-ccCCCCCCCCC
Q 042539 341 EHVFFKGVRWDLLT-DVLRPPFIPSR 365 (412)
Q Consensus 341 ~h~ff~~~~~~~~~-~~~~pp~~p~~ 365 (412)
+||||+...|.... ....+|+.+..
T Consensus 255 ~h~~~~~~~~~~~~~~~~~~~~~~~~ 280 (323)
T cd05584 255 SHPFFRHVNWDDLLARKVEPPFKPLL 280 (323)
T ss_pred cCCCcCCCCHHHHhcCCCCCCcCCCC
Confidence 99999999997553 34445555443
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-52 Score=401.00 Aligned_cols=266 Identities=32% Similarity=0.554 Sum_probs=221.8
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHH----------HHHHHHHHHHHHhhcCC
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHE----------AERRARWEIRVLSRLSH 82 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~----------~~~~~~~Ei~il~~l~h 82 (412)
....+++|++++.||+|.||+|-+|++...+.. ||||++.|..+..... -.+++++||.||++|.|
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l----~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H 167 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKL----YAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHH 167 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcE----EEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCC
Confidence 456789999999999999999999999875554 9999998876532211 22478899999999999
Q ss_pred CccceeeeeEEeC--CeEEEEeeccCCCCchhHHHhhCCCC-CCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEc
Q 042539 83 PFLPKLLGSLETD--EFLAWAVPYCPGGDLNVLRYKQNDRV-FSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIR 159 (412)
Q Consensus 83 pnIv~l~~~~~~~--~~~~lv~e~~~gg~L~~~~~~~~~~~-l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~ 159 (412)
||||+|+++..+. +.+|||+|||..|.+.. ...... +++.+++.|++.++.||+|||.+|||||||||+|+|++
T Consensus 168 ~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w---~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 168 PNVVKLIEVLDDPESDKLYLVLEYCSKGEVKW---CPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLS 244 (576)
T ss_pred cCeeEEEEeecCcccCceEEEEEeccCCcccc---CCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEc
Confidence 9999999999764 68999999999988732 223344 89999999999999999999999999999999999999
Q ss_pred cCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCcccccccc
Q 042539 160 QSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSF 239 (412)
Q Consensus 160 ~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (412)
.+|+|||+|||.+..+..... -
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~----------------------------------------------------------~ 266 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSD----------------------------------------------------------E 266 (576)
T ss_pred CCCcEEeeccceeeecccCCc----------------------------------------------------------c
Confidence 999999999999875421100 0
Q ss_pred CCCCCCcccccCCCCccceeecCC---CC-CchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC---CCCh
Q 042539 240 DNGERSNSFVGTEEYVSPEVVRGD---GH-EFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV---GQRT 312 (412)
Q Consensus 240 ~~~~~~~~~~gt~~Y~APE~l~~~---~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~ 312 (412)
.........+|||.|||||...+. .+ +++.||||+||+||-|+.|+.||.+....+++.+|+.....++ .+..
T Consensus 267 ~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e 346 (576)
T KOG0585|consen 267 GSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLEFPENPEINE 346 (576)
T ss_pred ccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcccCCCcccccH
Confidence 011112236899999999998773 23 7899999999999999999999999999999999998765544 4578
Q ss_pred HHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCC
Q 042539 313 ALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 313 ~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
+++|||.+||.+||+.|+ ++.+++.|||...
T Consensus 347 ~~kDli~~lL~KdP~~Ri----~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 347 DLKDLIKRLLEKDPEQRI----TLPDIKLHPWVTR 377 (576)
T ss_pred HHHHHHHHHhhcChhhee----ehhhheecceecc
Confidence 999999999999999999 6899999999864
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-54 Score=379.87 Aligned_cols=259 Identities=29% Similarity=0.458 Sum_probs=228.0
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
.+.-++|++-++||+|.|+.|+.+.+..++. .||+|+|....+... ..+.+.+|++|-+.|+|||||+|++.+.
T Consensus 7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~----~fa~kiin~~k~~~~--~~e~l~rEarIC~~LqHP~IvrL~~ti~ 80 (355)
T KOG0033|consen 7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGL----EFAAKIINTKKLSAR--DFQKLEREARICRKLQHPNIVRLHDSIQ 80 (355)
T ss_pred cccchhhhHHHHHccCchHHHHHHHhccchH----HHHHHHhhhhhhccc--cHHHHHHHHHHHHhcCCCcEeehhhhhc
Confidence 4456789999999999999999887776554 499999977666443 4567788999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccC---CCEEEcccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQS---GHVTLTDFD 170 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~---g~vkL~DFG 170 (412)
.....|+|+|++.|++|..-+-.+ ..++|..+..+++||+.||.|+|.+||||||+||+|+|+-+. --+||+|||
T Consensus 81 ~~~~~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FG 158 (355)
T KOG0033|consen 81 EESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFG 158 (355)
T ss_pred ccceeEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccc
Confidence 999999999999999996554444 348999999999999999999999999999999999999654 348999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+|..+. .+.....++|
T Consensus 159 vAi~l~----------------------------------------------------------------~g~~~~G~~G 174 (355)
T KOG0033|consen 159 LAIEVN----------------------------------------------------------------DGEAWHGFAG 174 (355)
T ss_pred eEEEeC----------------------------------------------------------------CccccccccC
Confidence 998652 3445567899
Q ss_pred CCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-----CCCCCChHHHHHHHHhhhhC
Q 042539 251 TEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP-----EFVGQRTALTDLIQRLLEKD 325 (412)
Q Consensus 251 t~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-----~~~~~~~~~~dli~~~L~~d 325 (412)
||.|||||++...+|+.++||||.|||||-|+.|++||-+.+...++++|..+.. .++.+++++++||++||..|
T Consensus 175 tP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~d 254 (355)
T KOG0033|consen 175 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVN 254 (355)
T ss_pred CCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccC
Confidence 9999999999999999999999999999999999999999999999999987653 55667899999999999999
Q ss_pred CCccCCCCCChhhhhcCCCCCCC
Q 042539 326 PVKRLGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 326 P~~R~~~~~~~~e~l~h~ff~~~ 348 (412)
|.+|+ |+.|+|+|||+.+-
T Consensus 255 P~kRI----ta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 255 PKKRI----TADEALKHPWICNR 273 (355)
T ss_pred hhhhc----cHHHHhCCchhcch
Confidence 99999 79999999999863
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-52 Score=412.03 Aligned_cols=316 Identities=31% Similarity=0.547 Sum_probs=242.2
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
...-.-|..++.||-|+||+|+||+...++. .||+|.+.|.++..++ ....+..|..||..-++++||+||..|+
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~----lYAmKTLrKaDVl~rn-QvaHVKAERDILAEADn~WVVrLyySFQ 699 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRA----LYAMKTLRKADVLMRN-QVAHVKAERDILAEADNEWVVRLYYSFQ 699 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchhh----HHHHhhhHHHHHHhhh-hhhhhhhhhhhHhhcCCcceEEEEEEec
Confidence 3445678899999999999999999887644 4999999988865543 3456777999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
+++++|+||+|++|||+-.++... +.|+|+.|++|++++.+|+++.|..|+|||||||+|||||.+|++||+|||||.
T Consensus 700 DkdnLYFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCT 777 (1034)
T KOG0608|consen 700 DKDNLYFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 777 (1034)
T ss_pred cCCceEEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccc
Confidence 999999999999999998776554 469999999999999999999999999999999999999999999999999998
Q ss_pred hhh---chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCC--CCccccccccCCCCCCccc
Q 042539 174 NLV---KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARV--SPVSRRQQSFDNGERSNSF 248 (412)
Q Consensus 174 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 248 (412)
.+. ++..|. .+...++..- ..-.+| ..... .....+-......-...++
T Consensus 778 GfRWTHdskYYq------~gdH~RqDSm------ep~~e~--------------~d~~~~lkvL~~ra~~~h~r~~ahsl 831 (1034)
T KOG0608|consen 778 GFRWTHDSKYYQ------EGDHHRQDSM------EPSPEW--------------ADISKCLKVLERRAMRQHQRILAHSL 831 (1034)
T ss_pred cceecccccccc------CCCccccccC------CCchhh--------------ccccccchHHHHHHHhhhhhhhhhhh
Confidence 762 111110 0000100000 000011 00000 0000000000112234689
Q ss_pred ccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-----CCCCCCChHHHHHHHHhhh
Q 042539 249 VGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT-----PEFVGQRTALTDLIQRLLE 323 (412)
Q Consensus 249 ~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-----~~~~~~~~~~~dli~~~L~ 323 (412)
+||+.|+|||++...+|+..|||||.|||||||+.|++||-.....++..++.+.. +...++++++.++|.+++
T Consensus 832 vgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc- 910 (1034)
T KOG0608|consen 832 VGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC- 910 (1034)
T ss_pred cCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-
Confidence 99999999999999999999999999999999999999999887777666665432 344567899999999876
Q ss_pred hCCCccCCCCCChhhhhcCCCCCCCCchhhcccCCCCCCCCC
Q 042539 324 KDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSR 365 (412)
Q Consensus 324 ~dP~~R~~~~~~~~e~l~h~ff~~~~~~~~~~~~~pp~~p~~ 365 (412)
.+++.|++- .++++++.||||+++||..+... +.|++|..
T Consensus 911 ~sad~RLGk-ng~d~vKaHpfFkgIDfsslRkq-~ApYIP~I 950 (1034)
T KOG0608|consen 911 CSADSRLGK-NGADQVKAHPFFKGIDFSSLRKQ-RAPYIPRI 950 (1034)
T ss_pred cChhhhhcc-cchhhhhcCccccccchHhhhhc-cCCcCccc
Confidence 788999984 46788999999999999987664 34466644
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=407.45 Aligned_cols=322 Identities=31% Similarity=0.548 Sum_probs=237.1
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
++|++++.||+|+||+||+|+++.++. .||||++.+..... ......+.+|+.+++.++|+||+++++.|.+++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~----~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNA----LYAMKTLRKADVLM-RNQAAHVKAERDILAEADNEWVVKLYYSFQDKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCC----EEEEEEEcHHHHHh-hhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCE
Confidence 479999999999999999999887544 49999997655422 2345667789999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+|+|||||.||+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|..+..
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999999998887654 4589999999999999999999999999999999999999999999999999865421
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
.... ........ .... ...... ...........+...............+++||+.||||
T Consensus 154 ~~~~--~~~~~~~~-~~~~----------------~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 213 (376)
T cd05598 154 THDS--KYYQKGDH-HRQD----------------SMEPSE-EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAP 213 (376)
T ss_pred cccc--cccccccc-cccc----------------cccccc-cccccccccccchhhhhhhhcccccccccCCCccccCH
Confidence 1000 00000000 0000 000000 00000000000000000000111223467899999999
Q ss_pred eeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-----CCCCCCChHHHHHHHHhhhhCCCccCCC
Q 042539 258 EVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT-----PEFVGQRTALTDLIQRLLEKDPVKRLGY 332 (412)
Q Consensus 258 E~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-----~~~~~~~~~~~dli~~~L~~dP~~R~~~ 332 (412)
|++.+..++.++|||||||++|||++|+.||.+.+..+....+.... +.....+.++.+||.+|+ .+|.+|++.
T Consensus 214 E~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~ 292 (376)
T cd05598 214 EVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGK 292 (376)
T ss_pred HHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCC
Confidence 99999999999999999999999999999999988777766665432 223356789999999976 699999953
Q ss_pred CCChhhhhcCCCCCCCCchhhcccCCCCCCCCCCCc
Q 042539 333 LRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREEN 368 (412)
Q Consensus 333 ~~~~~e~l~h~ff~~~~~~~~~~~~~pp~~p~~~~~ 368 (412)
.++.++++||||++++|..+.....+|+.|....+
T Consensus 293 -~t~~ell~h~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (376)
T cd05598 293 -NGADEIKAHPFFKGIDFASLIRRQKAPYIPKITHP 327 (376)
T ss_pred -CCHHHHhCCCCcCCCCHHHHhhcCCCCCCCcCCCc
Confidence 26999999999999999877666667777665443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-51 Score=395.88 Aligned_cols=277 Identities=32% Similarity=0.630 Sum_probs=233.5
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEEeCCe
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLETDEF 97 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 97 (412)
+|.+++.||+|+||+||+|+++.++. .||||++++..... .........|+.++..+. |++|+++++++.+.+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDE----LYAIKILKKDVVIQ-DDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCC----EEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCE
Confidence 68999999999999999999887544 49999998764322 233445666888888885 8999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+|+||||+.||+|..++... +.+++.++..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999999998776554 3599999999999999999999999999999999999999999999999999864310
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
........+||+.|+||
T Consensus 154 ---------------------------------------------------------------~~~~~~~~~gt~~y~aP 170 (323)
T cd05616 154 ---------------------------------------------------------------DGVTTKTFCGTPDYIAP 170 (323)
T ss_pred ---------------------------------------------------------------CCCccccCCCChhhcCH
Confidence 11122356799999999
Q ss_pred eeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCccCCCC-CC
Q 042539 258 EVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKRLGYL-RG 335 (412)
Q Consensus 258 E~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R~~~~-~~ 335 (412)
|++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......++ ..+.++.+||.+||++||.+|++.. ..
T Consensus 171 E~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~ 250 (323)
T cd05616 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEG 250 (323)
T ss_pred HHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCC
Confidence 999999999999999999999999999999999988888888877665543 4678999999999999999999753 24
Q ss_pred hhhhhcCCCCCCCCchhhcc-cCCCCCCCCC
Q 042539 336 ACEIKEHVFFKGVRWDLLTD-VLRPPFIPSR 365 (412)
Q Consensus 336 ~~e~l~h~ff~~~~~~~~~~-~~~pp~~p~~ 365 (412)
..++++|+||+.++|..... ...||+.|..
T Consensus 251 ~~~i~~h~~~~~~~~~~~~~~~~~~~~~~~~ 281 (323)
T cd05616 251 ERDIKEHAFFRYIDWEKLERKEVQPPYKPKA 281 (323)
T ss_pred HHHHhcCCCcCCCCHHHHHhCCCCCCcCCcC
Confidence 68999999999999986654 4567777653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-51 Score=405.04 Aligned_cols=302 Identities=32% Similarity=0.556 Sum_probs=231.6
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
++|++++.||+|+||+||+|+++.++. .||||++++.... .......+.+|+.++..++|+||+++++.+++++.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGH----IYAMKILRKADML-EKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCC----EEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 589999999999999999999887554 4999999765432 23345677889999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+|+|||||.||+|..++... +.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.+..
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred EEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999998877654 3599999999999999999999999999999999999999999999999999976532
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
........ ..+..... .........................+.+||+.|+||
T Consensus 154 ~~~~~~~~---------------------------~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 205 (360)
T cd05627 154 AHRTEFYR---------------------------NLTHNPPS-DFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAP 205 (360)
T ss_pred cccccccc---------------------------ccccCCcc-cccccccccccccccccccccccccccCCCccccCH
Confidence 11100000 00000000 000000000000000000111223467899999999
Q ss_pred eeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-----CCCCCCChHHHHHHHHhhhhCCCccCCC
Q 042539 258 EVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT-----PEFVGQRTALTDLIQRLLEKDPVKRLGY 332 (412)
Q Consensus 258 E~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-----~~~~~~~~~~~dli~~~L~~dP~~R~~~ 332 (412)
|++.+..++.++|||||||++|||++|++||.+.+..+.+.+++... +.....+.++++||.+|+ .||.+|++.
T Consensus 206 E~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~ 284 (360)
T cd05627 206 EVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGS 284 (360)
T ss_pred HHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCC
Confidence 99999999999999999999999999999999988888888777532 222346789999999987 499999963
Q ss_pred CCChhhhhcCCCCCCCCchhhccc
Q 042539 333 LRGACEIKEHVFFKGVRWDLLTDV 356 (412)
Q Consensus 333 ~~~~~e~l~h~ff~~~~~~~~~~~ 356 (412)
.+++++++||||++++|..+...
T Consensus 285 -~~~~ei~~hp~f~~~~~~~~~~~ 307 (360)
T cd05627 285 -NGVEEIKSHPFFEGVDWGHIRER 307 (360)
T ss_pred -CCHHHHhcCCCCCCCCHHHHhcC
Confidence 36899999999999999877553
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-52 Score=388.13 Aligned_cols=272 Identities=25% Similarity=0.366 Sum_probs=225.4
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe---
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET--- 94 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--- 94 (412)
..|..++.||+|+||.|+.|.++.++.. ||||.+... .......++..||+++|+.++|+||+.+++++..
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~----VAIKKi~~~--F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEK----VAIKKILNP--FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCE----eehhhhhhh--hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 3555689999999999999999987644 999998532 3445678889999999999999999999999965
Q ss_pred --CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 95 --DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 95 --~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
-+.+|+|+|+| +.||...+..+.. +++..++.+++||+.||+|+|+.||+||||||.|+|++.++.+||||||+|
T Consensus 96 ~~f~DvYiV~elM-etDL~~iik~~~~--L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 96 DKFNDVYLVFELM-ETDLHQIIKSQQD--LTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred cccceeEEehhHH-hhHHHHHHHcCcc--ccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccce
Confidence 25799999999 7788888776543 999999999999999999999999999999999999999999999999999
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+..... ......+..+.|.
T Consensus 173 R~~~~~-------------------------------------------------------------~~~~~mTeYVaTR 191 (359)
T KOG0660|consen 173 RYLDKF-------------------------------------------------------------FEDGFMTEYVATR 191 (359)
T ss_pred eecccc-------------------------------------------------------------Ccccchhcceeee
Confidence 876321 1122234568899
Q ss_pred CCccceeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-----------------------C---
Q 042539 253 EYVSPEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT-----------------------P--- 305 (412)
Q Consensus 253 ~Y~APE~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-----------------------~--- 305 (412)
+|.|||++.. ..|+.++||||+|||+.||++|++.|.|.+..+++..|+.-. +
T Consensus 192 WYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p 271 (359)
T KOG0660|consen 192 WYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIP 271 (359)
T ss_pred eecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCC
Confidence 9999999764 679999999999999999999999999998877766654211 1
Q ss_pred ------CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCchhhcccCCCCCCC
Q 042539 306 ------EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIP 363 (412)
Q Consensus 306 ------~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~~~~~~~~pp~~p 363 (412)
.++..++.+.||+.+||+.||.+|+ |++|+|+|||+....-...+....++|.+
T Consensus 272 ~~~f~~~fp~a~p~AidLlekmL~fdP~kRi----ta~eAL~hPYl~~~hdp~dEP~~~~~~~~ 331 (359)
T KOG0660|consen 272 KQPFSSIFPNANPLAIDLLEKMLVFDPKKRI----TAEEALAHPYLAPYHDPEDEPVCQPIFDS 331 (359)
T ss_pred CCCHHHHcCCCCHHHHHHHHHHhccCccccC----CHHHHhcChhhhhhcCCccCCCCCCCCcc
Confidence 1346678999999999999999999 79999999999987655444445555543
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-51 Score=408.02 Aligned_cols=326 Identities=30% Similarity=0.534 Sum_probs=238.1
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
.+|+++++||+|+||+||+|+++.++. .||+|++.+.... .......+.+|+.++++++|+|||++++.|.+++.
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~----~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~ 75 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKA----LYAMKTLRKKDVL-LRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN 75 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCC----EEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCE
Confidence 369999999999999999999887554 4999999775432 23345677889999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+|+|||||.||+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.+..
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~ 153 (382)
T cd05625 76 LYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (382)
T ss_pred EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence 99999999999998877654 3589999999999999999999999999999999999999999999999999865421
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
...... ...+.. ...... . +...| .....+. ......+...............+.+||+.|+||
T Consensus 154 ~~~~~~--~~~~~~-~~~~~~---~---~~~~~-----~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aP 217 (382)
T cd05625 154 THDSKY--YQSGDH-VRQDSM---D---FSNEW-----GDPANCR--CGDRLKPLERRAARQHQRCLAHSLVGTPNYIAP 217 (382)
T ss_pred cccccc--cccccc-cccccc---c---ccccc-----ccccccc--ccccccchhhhhccccccccccccccCcccCCH
Confidence 110000 000000 000000 0 00000 0000000 000000000000000111223467899999999
Q ss_pred eeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-----CCCCCCChHHHHHHHHhhhhCCCccCCC
Q 042539 258 EVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT-----PEFVGQRTALTDLIQRLLEKDPVKRLGY 332 (412)
Q Consensus 258 E~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-----~~~~~~~~~~~dli~~~L~~dP~~R~~~ 332 (412)
|++.+..++.++|||||||++|||++|++||.+.+..+...++.... +.....++++.++|.+|+ .+|.+|++.
T Consensus 218 E~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~ 296 (382)
T cd05625 218 EVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGK 296 (382)
T ss_pred HHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCC
Confidence 99999999999999999999999999999999988877777766432 233456899999999986 599999952
Q ss_pred CCChhhhhcCCCCCCCCchhhcccCCCCCCCCCCCc
Q 042539 333 LRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREEN 368 (412)
Q Consensus 333 ~~~~~e~l~h~ff~~~~~~~~~~~~~pp~~p~~~~~ 368 (412)
.+++++++||||++++|........+|+.|.....
T Consensus 297 -~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 331 (382)
T cd05625 297 -NGADEIKAHPFFKTIDFSSDLRQQSAPYIPKITHP 331 (382)
T ss_pred -CCHHHHhcCCCcCCcChHHHHhcCCCCccCcCCCc
Confidence 35999999999999999865455667777775544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-51 Score=396.81 Aligned_cols=273 Identities=35% Similarity=0.665 Sum_probs=230.2
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeeeeEEeCCeEEEEe
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLGSLETDEFLAWAV 102 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~ 102 (412)
++||+|+||+||+|+++.++. .||||++++..... ......+..|++++..+ +||||++++++|.+++.+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~~~~-~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDE----VYAIKVLKKDVILQ-DDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCC----EEEEEEEeHHHhhh-hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEE
Confidence 469999999999999877544 49999997764422 33445566789999876 6999999999999999999999
Q ss_pred eccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhh
Q 042539 103 PYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFE 182 (412)
Q Consensus 103 e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~ 182 (412)
|||.||+|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 76 E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~----- 148 (321)
T cd05591 76 EYVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL----- 148 (321)
T ss_pred eCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc-----
Confidence 999999998776544 3589999999999999999999999999999999999999999999999999864311
Q ss_pred hhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecC
Q 042539 183 KQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRG 262 (412)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~ 262 (412)
........+||+.|+|||++.+
T Consensus 149 ----------------------------------------------------------~~~~~~~~~gt~~y~aPE~~~~ 170 (321)
T cd05591 149 ----------------------------------------------------------NGVTTTTFCGTPDYIAPEILQE 170 (321)
T ss_pred ----------------------------------------------------------CCccccccccCccccCHHHHcC
Confidence 1112234579999999999999
Q ss_pred CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC-CChHHHHHHHHhhhhCCCccCCCCC---Chhh
Q 042539 263 DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVG-QRTALTDLIQRLLEKDPVKRLGYLR---GACE 338 (412)
Q Consensus 263 ~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~dli~~~L~~dP~~R~~~~~---~~~e 338 (412)
..++.++|||||||++|+|++|+.||.+.+..+.+..+......++. .+.++.+||.+||+.||++|+++.. ++++
T Consensus 171 ~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~ 250 (321)
T cd05591 171 LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDA 250 (321)
T ss_pred CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHH
Confidence 89999999999999999999999999999988888888876655443 5789999999999999999997654 7999
Q ss_pred hhcCCCCCCCCchhhcc-cCCCCCCCCCC
Q 042539 339 IKEHVFFKGVRWDLLTD-VLRPPFIPSRE 366 (412)
Q Consensus 339 ~l~h~ff~~~~~~~~~~-~~~pp~~p~~~ 366 (412)
+++||||.+++|..+.. ...+||.|...
T Consensus 251 ~~~hp~~~~~~~~~~~~~~~~~~~~~~~~ 279 (321)
T cd05591 251 IKQHPFFKEIDWVLLEQRKIKPPFKPKIK 279 (321)
T ss_pred HhcCCccCCCCHHHHHhCCCCCCCCCCCC
Confidence 99999999999986644 34566666543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-51 Score=395.26 Aligned_cols=274 Identities=39% Similarity=0.701 Sum_probs=227.3
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHH-HHhhcCCCccceeeeeEEeCCeEEEEe
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIR-VLSRLSHPFLPKLLGSLETDEFLAWAV 102 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lv~ 102 (412)
+.||+|+||+||+|+++.++. .||+|++.+........ ...+..|.. +++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~-~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGK----FYAVKVLQKKAILKKKE-QKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCC----EEEEEEEEHHHHhhhhH-HHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEE
Confidence 479999999999999987554 49999998765433332 334444554 567889999999999999999999999
Q ss_pred eccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhh
Q 042539 103 PYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFE 182 (412)
Q Consensus 103 e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~ 182 (412)
|||.||+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 76 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~----- 148 (323)
T cd05575 76 DYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE----- 148 (323)
T ss_pred cCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc-----
Confidence 999999998776543 3599999999999999999999999999999999999999999999999999864310
Q ss_pred hhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecC
Q 042539 183 KQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRG 262 (412)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~ 262 (412)
........+||+.|+|||++.+
T Consensus 149 ----------------------------------------------------------~~~~~~~~~gt~~y~aPE~~~~ 170 (323)
T cd05575 149 ----------------------------------------------------------HSKTTSTFCGTPEYLAPEVLRK 170 (323)
T ss_pred ----------------------------------------------------------CCCccccccCChhhcChhhhcC
Confidence 1112234579999999999999
Q ss_pred CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-CCCChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 263 DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF-VGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 263 ~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
..++.++|||||||++|+|++|..||.+.+..+.+.++....... +..+..+.++|.+||+.||.+|++......++++
T Consensus 171 ~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~ 250 (323)
T cd05575 171 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKN 250 (323)
T ss_pred CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHc
Confidence 999999999999999999999999999988888888887654333 4568899999999999999999986666789999
Q ss_pred CCCCCCCCchhhcc-cCCCCCCCCCCC
Q 042539 342 HVFFKGVRWDLLTD-VLRPPFIPSREE 367 (412)
Q Consensus 342 h~ff~~~~~~~~~~-~~~pp~~p~~~~ 367 (412)
||||..++|..+.. ...+|+.|....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (323)
T cd05575 251 HVFFSSINWDDLVNKKITPPFNPNVSG 277 (323)
T ss_pred CCCcCCCCHHHHhhccCCCCcCCCCCC
Confidence 99999999976543 456677765443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-51 Score=396.50 Aligned_cols=273 Identities=39% Similarity=0.680 Sum_probs=234.5
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
++|++++.||+|+||.||+|++..++. .||||++++..... ......+.+|+.+++.++||||+++++++.+++.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGE----IVALKRMKKSLLFK-LNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCC----EEEEEEEEHHHHhh-hhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCE
Confidence 479999999999999999999987554 49999998765432 2345567789999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+|+|||||.||+|..++... +.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999998887654 3589999999999999999999999999999999999999999999999999865321
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
.....+||+.|+||
T Consensus 154 ------------------------------------------------------------------~~~~~~gt~~y~aP 167 (333)
T cd05600 154 ------------------------------------------------------------------YANSVVGSPDYMAP 167 (333)
T ss_pred ------------------------------------------------------------------ccCCcccCccccCh
Confidence 12345799999999
Q ss_pred eeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-----CCCC----CCChHHHHHHHHhhhhCCCc
Q 042539 258 EVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT-----PEFV----GQRTALTDLIQRLLEKDPVK 328 (412)
Q Consensus 258 E~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-----~~~~----~~~~~~~dli~~~L~~dP~~ 328 (412)
|++.+..++.++|||||||++|||++|..||.+.+..+.+..+.... +... ..++++.+||.+||..+|.+
T Consensus 168 E~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~r 247 (333)
T cd05600 168 EVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRR 247 (333)
T ss_pred hHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhh
Confidence 99999999999999999999999999999999988877776665322 2221 45789999999999999999
Q ss_pred cCCCCCChhhhhcCCCCCCCCchhhcccCCCCCCCCCCCc
Q 042539 329 RLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREEN 368 (412)
Q Consensus 329 R~~~~~~~~e~l~h~ff~~~~~~~~~~~~~pp~~p~~~~~ 368 (412)
|+ +++++++||||++++|..+. ...||+.|.....
T Consensus 248 r~----s~~~ll~h~~~~~~~~~~~~-~~~~~~~~~~~~~ 282 (333)
T cd05600 248 FG----SLEDIKNHPFFKEVDWNELR-ELKPPFVPELESE 282 (333)
T ss_pred cC----CHHHHHhCcccCCCCHHHHh-hCCCCCCCCCCCc
Confidence 98 69999999999999998776 5677888876554
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-51 Score=401.57 Aligned_cols=305 Identities=37% Similarity=0.672 Sum_probs=238.3
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
++|++++.||+|+||+||+|++..++. .||||++++..... ......+.+|+.++..++|+||+++++++.+++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQ----VYAMKVLRKSDMIK-RNQIAHVRAERDILADADSPWIVKLYYSFQDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCC----EEEEEEEEHHHHhh-ccHHHHHHHHHHHHHhcCCCCccchhhheecCCe
Confidence 589999999999999999999987544 49999998765432 2345567789999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+|+|||||.|++|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 99999999999998887655 4599999999999999999999999999999999999999999999999999976532
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
........... ..... . .. ....... ...........+||+.|+||
T Consensus 154 ~~~~~~~~~~~-----------------------------~~~~~--~-~~-~~~~~~~-~~~~~~~~~~~~gt~~y~aP 199 (350)
T cd05573 154 AKDREYYLNDS-----------------------------HNLLF--R-DN-VLVRRRD-HKQRRVRANSTVGTPDYIAP 199 (350)
T ss_pred cCccccccccc-----------------------------ccccc--c-cc-ccccccc-cccccccccccccCccccCH
Confidence 21000000000 00000 0 00 0000000 00111223456799999999
Q ss_pred eeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhc--C---CCCCCCCChHHHHHHHHhhhhCCCccCCC
Q 042539 258 EVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLM--K---TPEFVGQRTALTDLIQRLLEKDPVKRLGY 332 (412)
Q Consensus 258 E~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~--~---~~~~~~~~~~~~dli~~~L~~dP~~R~~~ 332 (412)
|++.+..++.++|||||||++|+|++|+.||.+.+..+...++.. . .+.....++++.+||.+||. ||.+|++
T Consensus 200 E~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~- 277 (350)
T cd05573 200 EVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLG- 277 (350)
T ss_pred HHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCC-
Confidence 999999999999999999999999999999999888777777765 2 23334468999999999997 9999994
Q ss_pred CCChhhhhcCCCCCCCCchhhcccCCCCCCCCCCCc
Q 042539 333 LRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREEN 368 (412)
Q Consensus 333 ~~~~~e~l~h~ff~~~~~~~~~~~~~pp~~p~~~~~ 368 (412)
+++++++||||++++|+... ...+|+.|.....
T Consensus 278 --s~~~ll~hp~~~~~~~~~~~-~~~~~~~~~~~~~ 310 (350)
T cd05573 278 --SFEEIKSHPFFKGIDWENLR-ETKPPFVPELSSP 310 (350)
T ss_pred --CHHHHhcCCCcCCCCHHHHh-hCCCCcCCCCCCc
Confidence 39999999999999998776 4557777765544
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-51 Score=395.78 Aligned_cols=275 Identities=35% Similarity=0.653 Sum_probs=230.2
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeeeeEEeCCeEEEEe
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLGSLETDEFLAWAV 102 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~ 102 (412)
+.||+|+||+||+|+++.++. .||||++++..... ......+.+|+.++..+ +||||+++++++.+.+.+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGR----LYAVKVLKKDVILQ-DDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCC----EEEEEEEEHHHHhh-ccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEE
Confidence 479999999999999887554 49999998765432 23345566788888877 5999999999999999999999
Q ss_pred eccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhh
Q 042539 103 PYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFE 182 (412)
Q Consensus 103 e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~ 182 (412)
|||.||+|..++... ..+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 76 Ey~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~----- 148 (320)
T cd05590 76 EFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF----- 148 (320)
T ss_pred cCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc-----
Confidence 999999998776544 3599999999999999999999999999999999999999999999999999864310
Q ss_pred hhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecC
Q 042539 183 KQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRG 262 (412)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~ 262 (412)
........+||+.|+|||++.+
T Consensus 149 ----------------------------------------------------------~~~~~~~~~gt~~y~aPE~~~~ 170 (320)
T cd05590 149 ----------------------------------------------------------NGKTTSTFCGTPDYIAPEILQE 170 (320)
T ss_pred ----------------------------------------------------------CCCcccccccCccccCHHHHcC
Confidence 1112234579999999999999
Q ss_pred CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCccCCCC--CChhhh
Q 042539 263 DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKRLGYL--RGACEI 339 (412)
Q Consensus 263 ~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R~~~~--~~~~e~ 339 (412)
..++.++|||||||++|+|++|+.||.+.+..+.+..+......++ ..+.++.+||.+||+.||.+|++.. ...+++
T Consensus 171 ~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~ 250 (320)
T cd05590 171 MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAI 250 (320)
T ss_pred CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHH
Confidence 8899999999999999999999999999998888888877665544 3678999999999999999999642 124899
Q ss_pred hcCCCCCCCCchhhcc-cCCCCCCCCCCCc
Q 042539 340 KEHVFFKGVRWDLLTD-VLRPPFIPSREEN 368 (412)
Q Consensus 340 l~h~ff~~~~~~~~~~-~~~pp~~p~~~~~ 368 (412)
++||||++++|+.+.. ...|||.|.....
T Consensus 251 ~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~ 280 (320)
T cd05590 251 LRHPFFKELDWEKLNRRQIEPPFRPRIKSR 280 (320)
T ss_pred HcCCCcCCCCHHHHHhCCCCCCcCCCCCCc
Confidence 9999999999987654 4567787775443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-51 Score=395.27 Aligned_cols=275 Identities=36% Similarity=0.673 Sum_probs=230.0
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEEEee
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVP 103 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~e 103 (412)
+.||+|+||.||+|+++.++. .||+|++++..... ......+.+|+++++.++||||++++++|..++.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGR----YYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCC----EEEEEEEEHHHhhh-hHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEe
Confidence 479999999999999877554 49999997765432 2334566779999999999999999999999999999999
Q ss_pred ccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhhh
Q 042539 104 YCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEK 183 (412)
Q Consensus 104 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~ 183 (412)
||.||+|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 76 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~------ 147 (323)
T cd05595 76 YANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS------ 147 (323)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC------
Confidence 99999997766543 3589999999999999999999999999999999999999999999999998864210
Q ss_pred hcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecCC
Q 042539 184 QSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGD 263 (412)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~ 263 (412)
........+||+.|+|||++.+.
T Consensus 148 ---------------------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~ 170 (323)
T cd05595 148 ---------------------------------------------------------DGATMKTFCGTPEYLAPEVLEDN 170 (323)
T ss_pred ---------------------------------------------------------CCCccccccCCcCcCCcccccCC
Confidence 01112345799999999999999
Q ss_pred CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCccCCCC-CChhhhhc
Q 042539 264 GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKRLGYL-RGACEIKE 341 (412)
Q Consensus 264 ~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R~~~~-~~~~e~l~ 341 (412)
.++.++|||||||++|+|++|+.||.+.+.......+......++ ..++++.+||.+||..||.+|++.. .++.++++
T Consensus 171 ~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 999999999999999999999999999888888877776554443 4678999999999999999998542 37999999
Q ss_pred CCCCCCCCchhhcc-cCCCCCCCCCCCc
Q 042539 342 HVFFKGVRWDLLTD-VLRPPFIPSREEN 368 (412)
Q Consensus 342 h~ff~~~~~~~~~~-~~~pp~~p~~~~~ 368 (412)
|+||.+++|..... ...||+.|.....
T Consensus 251 h~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (323)
T cd05595 251 HRFFLSINWQDVVQKKLLPPFKPQVTSE 278 (323)
T ss_pred CCCcCCCCHHHHHhCCCCCCcCCCCCCh
Confidence 99999999985543 4456666655443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-51 Score=389.08 Aligned_cols=272 Identities=27% Similarity=0.420 Sum_probs=235.7
Q ss_pred CCCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCcccee
Q 042539 9 PQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKL 88 (412)
Q Consensus 9 ~~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l 88 (412)
......+..++|++..+||.|.-++||+|+...++.. ||||++..+..+. ....+++|++.|..++||||+++
T Consensus 17 ~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~----VAIK~inLEkc~~---~ld~l~kE~~~msl~~HPNIv~~ 89 (516)
T KOG0582|consen 17 SEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEV----VAIKIINLEKCNN---DLDALRKEVQTMSLIDHPNIVTY 89 (516)
T ss_pred ccccCCCCccceeEEEEEeccceeEeeeeeecccCCE----EEEEEeehhhhhh---hHHHHHHHHHHhhhcCCCCcceE
Confidence 3456789999999999999999999999999987655 9999998776533 25678889999999999999999
Q ss_pred eeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcc
Q 042539 89 LGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTD 168 (412)
Q Consensus 89 ~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~D 168 (412)
+.+|..+..+|+||.||.+|++.+++...-...|+|..+..++++++.||.|||++|.||||||+.||||+.+|.|||+|
T Consensus 90 ~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLad 169 (516)
T KOG0582|consen 90 HCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLAD 169 (516)
T ss_pred EEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcC
Confidence 99999999999999999999999998887777799999999999999999999999999999999999999999999999
Q ss_pred ccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccc
Q 042539 169 FDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248 (412)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (412)
||.+-.+..+.. ....+.+++
T Consensus 170 Fgvsa~l~~~G~-----------------------------------------------------------R~~~rf~tf 190 (516)
T KOG0582|consen 170 FGVSASLFDSGD-----------------------------------------------------------RQVTRFNTF 190 (516)
T ss_pred ceeeeeecccCc-----------------------------------------------------------eeeEeeccc
Confidence 998865532110 111122688
Q ss_pred ccCCCCccceeecC--CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-----------CCChHHH
Q 042539 249 VGTEEYVSPEVVRG--DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-----------GQRTALT 315 (412)
Q Consensus 249 ~gt~~Y~APE~l~~--~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-----------~~~~~~~ 315 (412)
+||+.|||||++.. .+|++|+||||||++..||.+|..||......+++..-+.+.++.+ ..++.++
T Consensus 191 vgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~ 270 (516)
T KOG0582|consen 191 VGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFR 270 (516)
T ss_pred cCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHH
Confidence 99999999999654 4799999999999999999999999999888887777676665422 2346799
Q ss_pred HHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCc
Q 042539 316 DLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRW 350 (412)
Q Consensus 316 dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~ 350 (412)
.+|..||++||++|| +++++++|+||+.+.-
T Consensus 271 e~i~~CL~kDP~kRp----tAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 271 EMIALCLVKDPSKRP----TASKLLKHAFFKKAKS 301 (516)
T ss_pred HHHHHHhhcCcccCC----CHHHHhccHHHhhccc
Confidence 999999999999999 7999999999987653
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-51 Score=393.64 Aligned_cols=270 Identities=39% Similarity=0.719 Sum_probs=228.2
Q ss_pred eeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEEEeecc
Q 042539 26 LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYC 105 (412)
Q Consensus 26 LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 105 (412)
||+|+||+||+|++..++. .||+|++++..... ......+.+|+.++++++||||+++++++.+++.+|+|||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~----~~aiK~i~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQR----IYALKTIRKAHIVS-RSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCC----EEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCC
Confidence 7999999999999877544 49999997654322 233456778999999999999999999999999999999999
Q ss_pred CCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhhhhc
Q 042539 106 PGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQS 185 (412)
Q Consensus 106 ~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~ 185 (412)
.||+|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 76 ~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~-------- 145 (312)
T cd05585 76 NGGELFHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK-------- 145 (312)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc--------
Confidence 999998777654 4599999999999999999999999999999999999999999999999999864311
Q ss_pred ccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecCCCC
Q 042539 186 LNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGH 265 (412)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~ 265 (412)
........+||+.|+|||++.+..+
T Consensus 146 -------------------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~ 170 (312)
T cd05585 146 -------------------------------------------------------DDDKTNTFCGTPEYLAPELLLGHGY 170 (312)
T ss_pred -------------------------------------------------------CCCccccccCCcccCCHHHHcCCCC
Confidence 1112235679999999999999999
Q ss_pred CchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCC
Q 042539 266 EFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVF 344 (412)
Q Consensus 266 ~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~f 344 (412)
+.++|||||||++|+|++|+.||.+.+..+.+..+......++ ..++++++||.+||..||.+|++. .++.+++.|||
T Consensus 171 ~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~-~~~~e~l~hp~ 249 (312)
T cd05585 171 TKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGY-NGAQEIKNHPF 249 (312)
T ss_pred CCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCC-CCHHHHHcCCC
Confidence 9999999999999999999999999888888888877655543 467899999999999999999975 36899999999
Q ss_pred CCCCCchhhcc-cCCCCCCCCCC
Q 042539 345 FKGVRWDLLTD-VLRPPFIPSRE 366 (412)
Q Consensus 345 f~~~~~~~~~~-~~~pp~~p~~~ 366 (412)
|+..+|..... ...+++.|...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~ 272 (312)
T cd05585 250 FSQLSWKKLLMKGIQPPFKPAVS 272 (312)
T ss_pred cCCCCHHHHHhCCCCCCcCCCCC
Confidence 99999875533 34556665543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-51 Score=397.25 Aligned_cols=275 Identities=39% Similarity=0.679 Sum_probs=230.2
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEEEee
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVP 103 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~e 103 (412)
+.||+|+||.||+|+++.++. .||+|++.+..... ......+.+|+++++.++||||+++++++..++.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~----~~avK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGK----YYAMKILKKEVIIA-KDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCC----EEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEe
Confidence 479999999999999887554 49999997765432 2345567789999999999999999999999999999999
Q ss_pred ccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhhh
Q 042539 104 YCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEK 183 (412)
Q Consensus 104 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~ 183 (412)
|+.||+|..++... ..+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 76 y~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~------ 147 (328)
T cd05593 76 YVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT------ 147 (328)
T ss_pred CCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC------
Confidence 99999997766543 4599999999999999999999999999999999999999999999999999864311
Q ss_pred hcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecCC
Q 042539 184 QSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGD 263 (412)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~ 263 (412)
........+||+.|+|||++.+.
T Consensus 148 ---------------------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~ 170 (328)
T cd05593 148 ---------------------------------------------------------DAATMKTFCGTPEYLAPEVLEDN 170 (328)
T ss_pred ---------------------------------------------------------cccccccccCCcCccChhhhcCC
Confidence 01112345799999999999998
Q ss_pred CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCccCCCC-CChhhhhc
Q 042539 264 GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKRLGYL-RGACEIKE 341 (412)
Q Consensus 264 ~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R~~~~-~~~~e~l~ 341 (412)
.++.++|||||||++|+|++|+.||.+.+..+....+......++ ..+.++.+||.+||.+||.+|++.. .++.++++
T Consensus 171 ~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 899999999999999999999999999888887777766554443 4678999999999999999998542 37999999
Q ss_pred CCCCCCCCchhhcc-cCCCCCCCCCCCc
Q 042539 342 HVFFKGVRWDLLTD-VLRPPFIPSREEN 368 (412)
Q Consensus 342 h~ff~~~~~~~~~~-~~~pp~~p~~~~~ 368 (412)
|+||.+++|..+.. ...+|+.|.....
T Consensus 251 h~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (328)
T cd05593 251 HSFFTGVNWQDVYDKKLVPPFKPQVTSE 278 (328)
T ss_pred CCCcCCCCHHHHHhCCCCCCcCCcCCCc
Confidence 99999999986544 3456666655433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-51 Score=394.15 Aligned_cols=274 Identities=40% Similarity=0.695 Sum_probs=226.4
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHH-HHHhhcCCCccceeeeeEEeCCeEEEEe
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI-RVLSRLSHPFLPKLLGSLETDEFLAWAV 102 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei-~il~~l~hpnIv~l~~~~~~~~~~~lv~ 102 (412)
++||+|+||+||+|++..++. .||+|++.+...... .....+.+|+ .+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~~~~~-~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGS----FYAVKVLQKKTILKK-KEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCC----EEEEEEEEHHHHHHh-hHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEE
Confidence 479999999999999877544 499999987654322 2234444455 4678899999999999999999999999
Q ss_pred eccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhh
Q 042539 103 PYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFE 182 (412)
Q Consensus 103 e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~ 182 (412)
|||.||+|...+... ..+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 76 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~----- 148 (321)
T cd05603 76 DYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE----- 148 (321)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC-----
Confidence 999999997666543 4589999999999999999999999999999999999999999999999999864210
Q ss_pred hhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecC
Q 042539 183 KQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRG 262 (412)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~ 262 (412)
........+||+.|+|||++.+
T Consensus 149 ----------------------------------------------------------~~~~~~~~~gt~~y~aPE~~~~ 170 (321)
T cd05603 149 ----------------------------------------------------------PEETTSTFCGTPEYLAPEVLRK 170 (321)
T ss_pred ----------------------------------------------------------CCCccccccCCcccCCHHHhcC
Confidence 0111234679999999999999
Q ss_pred CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 263 DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 263 ~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
..++.++|||||||++|||++|..||.+.+....+..+......++ ..+.++.++|.+||+.||.+|++...+..++++
T Consensus 171 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~ 250 (321)
T cd05603 171 EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKN 250 (321)
T ss_pred CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhC
Confidence 8899999999999999999999999999988888888776554443 467889999999999999999987667889999
Q ss_pred CCCCCCCCchhhcc-cCCCCCCCCCCC
Q 042539 342 HVFFKGVRWDLLTD-VLRPPFIPSREE 367 (412)
Q Consensus 342 h~ff~~~~~~~~~~-~~~pp~~p~~~~ 367 (412)
|+||..++|..+.. ...+++.+....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (321)
T cd05603 251 HVFFSPINWDDLYHKRITPPYNPNVAG 277 (321)
T ss_pred CCCcCCCCHHHHhcCCCCCCcCCCCCC
Confidence 99999999986643 445666555433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-51 Score=394.94 Aligned_cols=272 Identities=39% Similarity=0.694 Sum_probs=225.2
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHH-HHHhhcCCCccceeeeeEEeCCeEEEEe
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI-RVLSRLSHPFLPKLLGSLETDEFLAWAV 102 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei-~il~~l~hpnIv~l~~~~~~~~~~~lv~ 102 (412)
+.||+|+||+||+|+++.++. .||+|++.+........ ...+..|. .+++.++|+||+++++++.+++.+|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~-~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEK----FYAVKVLQKKAILKKKE-EKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCC----EEEEEEEEHHHHHhhhH-HHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEE
Confidence 479999999999999887544 49999997765432222 23333444 4567889999999999999999999999
Q ss_pred eccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhh
Q 042539 103 PYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFE 182 (412)
Q Consensus 103 e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~ 182 (412)
|||.||+|..++... ..+.+..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 76 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~----- 148 (325)
T cd05602 76 DYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE----- 148 (325)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc-----
Confidence 999999998777653 3589999999999999999999999999999999999999999999999999864311
Q ss_pred hhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecC
Q 042539 183 KQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRG 262 (412)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~ 262 (412)
........+||+.|+|||++.+
T Consensus 149 ----------------------------------------------------------~~~~~~~~~gt~~y~aPE~~~~ 170 (325)
T cd05602 149 ----------------------------------------------------------HNGTTSTFCGTPEYLAPEVLHK 170 (325)
T ss_pred ----------------------------------------------------------CCCCcccccCCccccCHHHHcC
Confidence 1112235679999999999999
Q ss_pred CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC-CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 263 DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE-FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 263 ~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
..++.++|||||||++|+|++|.+||.+.+..+.+..+...... .+..++.+.++|.+||++||.+|++......++++
T Consensus 171 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05602 171 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKN 250 (325)
T ss_pred CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhc
Confidence 99999999999999999999999999998888888887765433 34678999999999999999999987667789999
Q ss_pred CCCCCCCCchhhcc-cCCCCCCCCC
Q 042539 342 HVFFKGVRWDLLTD-VLRPPFIPSR 365 (412)
Q Consensus 342 h~ff~~~~~~~~~~-~~~pp~~p~~ 365 (412)
|+||..++|+.+.. ...+|+.|..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (325)
T cd05602 251 HIFFSPINWDDLINKKITPPFNPNV 275 (325)
T ss_pred CcccCCCCHHHHHhCCCCcCcCCCC
Confidence 99999999986543 3455555543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=392.79 Aligned_cols=277 Identities=32% Similarity=0.643 Sum_probs=232.2
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCC-CccceeeeeEEeCCe
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH-PFLPKLLGSLETDEF 97 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~ 97 (412)
+|++++.||+|+||.||+|+++.++. .||||++.+..... ......+..|++++..+.| ++|+++++++.+.+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDE----LYAIKILKKDVIIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCC----EEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCE
Confidence 68999999999999999999887544 49999998765422 2344567779999999976 568999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+|+|||||.||+|..++... +.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999999998776544 3589999999999999999999999999999999999999999999999999864210
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
........+||+.|+||
T Consensus 154 ---------------------------------------------------------------~~~~~~~~~gt~~y~aP 170 (324)
T cd05587 154 ---------------------------------------------------------------GGKTTRTFCGTPDYIAP 170 (324)
T ss_pred ---------------------------------------------------------------CCCceeeecCCccccCh
Confidence 11122356799999999
Q ss_pred eeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCccCCCCC-C
Q 042539 258 EVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKRLGYLR-G 335 (412)
Q Consensus 258 E~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R~~~~~-~ 335 (412)
|++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+......++ ..+.++.++|.+||.+||.+|++... .
T Consensus 171 E~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~ 250 (324)
T cd05587 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTG 250 (324)
T ss_pred hhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCC
Confidence 999999999999999999999999999999999998888888877665544 46789999999999999999997532 3
Q ss_pred hhhhhcCCCCCCCCchhhcc-cCCCCCCCCC
Q 042539 336 ACEIKEHVFFKGVRWDLLTD-VLRPPFIPSR 365 (412)
Q Consensus 336 ~~e~l~h~ff~~~~~~~~~~-~~~pp~~p~~ 365 (412)
.+++++||||++++|..+.. ...+|+.|..
T Consensus 251 ~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~ 281 (324)
T cd05587 251 ERDIREHAFFRRIDWEKLERREIQPPFKPKV 281 (324)
T ss_pred HHHHhcCCCcCCCCHHHHHhCCCCCCccCcC
Confidence 58999999999999986644 3455665554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-52 Score=398.38 Aligned_cols=261 Identities=27% Similarity=0.411 Sum_probs=222.8
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
.....+.|+.+++||+|+||.||+|++..++.. ||+|.+..+.. +........|||.||++|+||||++|.+..
T Consensus 112 ~~r~~~~feki~kIGeGTyg~VYkAr~~~tgki----vALKKvr~d~~--~~~~~~t~~REI~ILr~l~HpNIikL~eiv 185 (560)
T KOG0600|consen 112 GPRRADSFEKIEKIGEGTYGQVYKARDLETGKI----VALKKVRFDNE--KEGFPITAIREIKILRRLDHPNIIKLEEIV 185 (560)
T ss_pred cccchHHHHHHHHhcCcchhheeEeeecccCcE----EEEEEeecccC--CCcchHHHHHHHHHHHhcCCCcccceeeEE
Confidence 356778999999999999999999999886655 99999987753 456677888999999999999999999998
Q ss_pred EeC--CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccc
Q 042539 93 ETD--EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 93 ~~~--~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
... ..+|||+|||+. ||.-++.. ..-.|++.++++|+.||+.||+|||++||+|||||.+|||||.+|.+||+|||
T Consensus 186 t~~~~~siYlVFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFG 263 (560)
T KOG0600|consen 186 TSKLSGSIYLVFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFG 263 (560)
T ss_pred EecCCceEEEEEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEecccc
Confidence 776 689999999976 66555543 33469999999999999999999999999999999999999999999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
||+.+... .....++.+-
T Consensus 264 LAr~y~~~--------------------------------------------------------------~~~~~T~rVv 281 (560)
T KOG0600|consen 264 LARFYTPS--------------------------------------------------------------GSAPYTSRVV 281 (560)
T ss_pred ceeeccCC--------------------------------------------------------------CCcccccceE
Confidence 99876321 1122445678
Q ss_pred CCCCccceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhc--CCCC---------------------
Q 042539 251 TEEYVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLM--KTPE--------------------- 306 (412)
Q Consensus 251 t~~Y~APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~--~~~~--------------------- 306 (412)
|.+|+|||++.|. .|+.++|+||.||||.||+.|++.|.|.++.+++..|.. +.|.
T Consensus 282 TLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y 361 (560)
T KOG0600|consen 282 TLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPY 361 (560)
T ss_pred EeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcc
Confidence 9999999999996 589999999999999999999999999999999888863 1110
Q ss_pred -------CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCC
Q 042539 307 -------FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 307 -------~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
+...+..+.+|+..||..||.+|. ||.++|+|+||..
T Consensus 362 ~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~----tA~~aL~seyF~t 405 (560)
T KOG0600|consen 362 KRRLRETFKDFPASALDLLEKLLSLDPDKRG----TASSALQSEYFTT 405 (560)
T ss_pred cchHHHHhccCCHHHHHHHHHHhccCccccc----cHHHHhcCccccc
Confidence 113456788999999999999998 7999999999954
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-52 Score=381.21 Aligned_cols=288 Identities=35% Similarity=0.683 Sum_probs=245.6
Q ss_pred CCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceee
Q 042539 11 TTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLL 89 (412)
Q Consensus 11 ~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~ 89 (412)
..+.+.+++|.++++||+|+|++|.+++.+.+++. ||+|+++|+..+. .+...-++.|..++.+.. ||++|.|+
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qi----yamkvvkkel~nd-dedidwvqtek~vfe~asn~pflvglh 317 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQI----YAMKVVKKELVND-DEDIDWVQTEKHVFEQASNNPFLVGLH 317 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehccccee----eehhhHHHHhcCC-cccchhHHhhHHHHHhccCCCeEEehh
Confidence 35678899999999999999999999999886655 9999998876644 445556777999999885 99999999
Q ss_pred eeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccc
Q 042539 90 GSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169 (412)
Q Consensus 90 ~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DF 169 (412)
.+|+++..+++|.||++||+|-..+.. .+.++|+.|++|..+|+.||.|||+.|||+||||.+|+|+|..|++||+|+
T Consensus 318 scfqtesrlffvieyv~ggdlmfhmqr--qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdy 395 (593)
T KOG0695|consen 318 SCFQTESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDY 395 (593)
T ss_pred hhhcccceEEEEEEEecCcceeeehhh--hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeeccc
Confidence 999999999999999999999544443 445999999999999999999999999999999999999999999999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|+++.-. ..+..++++|
T Consensus 396 gmcke~l---------------------------------------------------------------~~gd~tstfc 412 (593)
T KOG0695|consen 396 GMCKEGL---------------------------------------------------------------GPGDTTSTFC 412 (593)
T ss_pred chhhcCC---------------------------------------------------------------CCCccccccc
Confidence 9997542 3455677999
Q ss_pred cCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCC-------CCHHH-HHHHHhcCCCCCC-CCChHHHHHHHH
Q 042539 250 GTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRG-------KNRKE-TFRNVLMKTPEFV-GQRTALTDLIQR 320 (412)
Q Consensus 250 gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-------~~~~~-~~~~i~~~~~~~~-~~~~~~~dli~~ 320 (412)
|||.|+|||++.|..|++.+|||||||++|||+.|+.||.- .+.++ +++-|+......+ ..+-.+..++..
T Consensus 413 gtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsvkas~vlkg 492 (593)
T KOG0695|consen 413 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKASHVLKG 492 (593)
T ss_pred CCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehhhHHHHHH
Confidence 99999999999999999999999999999999999999953 23333 4455555554444 345677889999
Q ss_pred hhhhCCCccCCCCC--ChhhhhcCCCCCCCCchhhcc-cCCCCCCCCCCCc
Q 042539 321 LLEKDPVKRLGYLR--GACEIKEHVFFKGVRWDLLTD-VLRPPFIPSREEN 368 (412)
Q Consensus 321 ~L~~dP~~R~~~~~--~~~e~l~h~ff~~~~~~~~~~-~~~pp~~p~~~~~ 368 (412)
.|++||.+|+++.. +..+++.|+||+.++|+.+.. .+.|||.|..+++
T Consensus 493 flnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~i~~d 543 (593)
T KOG0695|consen 493 FLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQITDD 543 (593)
T ss_pred hhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCccccc
Confidence 99999999999853 578999999999999997755 6789999987654
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=394.36 Aligned_cols=274 Identities=34% Similarity=0.672 Sum_probs=223.2
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeeeeEEeCCeEEEEe
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLGSLETDEFLAWAV 102 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~ 102 (412)
++||+|+||+||+|+++.++. .||+|++++..... ......+.+|+.+++.+ +||||++++++|.+++.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~----~~aiK~i~~~~~~~-~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRR----IYAMKVIKKELVND-DEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCC----EEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEE
Confidence 479999999999999887554 49999998765432 33455677899999999 6999999999999999999999
Q ss_pred eccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhh
Q 042539 103 PYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFE 182 (412)
Q Consensus 103 e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~ 182 (412)
|||.||+|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 76 e~~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~------ 147 (329)
T cd05588 76 EFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI------ 147 (329)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccc------
Confidence 999999997766543 459999999999999999999999999999999999999999999999999986421
Q ss_pred hhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecC
Q 042539 183 KQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRG 262 (412)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~ 262 (412)
.......+.+||+.|+|||++.+
T Consensus 148 ---------------------------------------------------------~~~~~~~~~~gt~~y~aPE~~~~ 170 (329)
T cd05588 148 ---------------------------------------------------------RPGDTTSTFCGTPNYIAPEILRG 170 (329)
T ss_pred ---------------------------------------------------------cCCCccccccCCccccCHHHHcC
Confidence 01122335689999999999999
Q ss_pred CCCCchhhHHHHHHHHHHHhhCCCCCCCC---------CHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCccCCC
Q 042539 263 DGHEFAVDWWALGILTYEMLYGTTPFRGK---------NRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKRLGY 332 (412)
Q Consensus 263 ~~~~~~~DiwSlGvil~ell~g~~Pf~~~---------~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R~~~ 332 (412)
..++.++|+|||||++|+|++|+.||... ........+.......+ ..+.++.++|.+||+.||.+|++.
T Consensus 171 ~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 99999999999999999999999999632 11223444444444433 467899999999999999999974
Q ss_pred C--CChhhhhcCCCCCCCCchhhcc-cCCCCCCCCCCC
Q 042539 333 L--RGACEIKEHVFFKGVRWDLLTD-VLRPPFIPSREE 367 (412)
Q Consensus 333 ~--~~~~e~l~h~ff~~~~~~~~~~-~~~pp~~p~~~~ 367 (412)
. .+++++++||||..++|..... ...|++.|....
T Consensus 251 ~~~~~~~~i~~hp~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (329)
T cd05588 251 HPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPNIES 288 (329)
T ss_pred CCCCCHHHHhcCCCCCCCCHHHHHhCCCCCCccccCCC
Confidence 3 3589999999999999986654 345566665443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=391.88 Aligned_cols=271 Identities=36% Similarity=0.743 Sum_probs=225.0
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeeeeEEeCCeEEEEe
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLGSLETDEFLAWAV 102 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~ 102 (412)
++||+|+||+||+|++..++. .||||++++...... ........|..++..+ +||||+++++++..++.+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNE----FFAIKALKKDVVLED-DDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCC----EEEEEEEEHHHhhhh-hhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEE
Confidence 479999999999999887554 499999987653222 2333445577777765 7999999999999999999999
Q ss_pred eccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhh
Q 042539 103 PYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFE 182 (412)
Q Consensus 103 e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~ 182 (412)
|||.||+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 76 e~~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~----- 148 (316)
T cd05592 76 EYLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN----- 148 (316)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC-----
Confidence 999999998776543 3599999999999999999999999999999999999999999999999999864311
Q ss_pred hhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecC
Q 042539 183 KQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRG 262 (412)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~ 262 (412)
........+||+.|+|||++.+
T Consensus 149 ----------------------------------------------------------~~~~~~~~~gt~~y~aPE~~~~ 170 (316)
T cd05592 149 ----------------------------------------------------------GEGKASTFCGTPDYIAPEILKG 170 (316)
T ss_pred ----------------------------------------------------------CCCccccccCCccccCHHHHcC
Confidence 1122335679999999999999
Q ss_pred CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC-CChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 263 DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVG-QRTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 263 ~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
..++.++|||||||++|+|++|..||.+.+..+.+..+....+.++. .++++.+||.+||..||.+|++ ...+++.
T Consensus 171 ~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~---~~~~l~~ 247 (316)
T cd05592 171 QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRLG---VDGDIRQ 247 (316)
T ss_pred CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCC---ChHHHHc
Confidence 88999999999999999999999999999988888887766555443 5789999999999999999995 3568999
Q ss_pred CCCCCCCCchhhcc-cCCCCCCCCCCC
Q 042539 342 HVFFKGVRWDLLTD-VLRPPFIPSREE 367 (412)
Q Consensus 342 h~ff~~~~~~~~~~-~~~pp~~p~~~~ 367 (412)
|+||+.++|..+.. ...|++.|....
T Consensus 248 h~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (316)
T cd05592 248 HPFFRGIDWERLEKREIPPPFKPKVKS 274 (316)
T ss_pred CcccCCCCHHHHHhCCCCCCcCCCCCC
Confidence 99999999986654 345666665433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-51 Score=395.95 Aligned_cols=274 Identities=38% Similarity=0.691 Sum_probs=228.6
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEEEee
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVP 103 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~e 103 (412)
+.||+|+||+||+|+++.++. .||+|++++...... .......+|+++++.++||||+++++++.+++.+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~----~~a~K~~~~~~~~~~-~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGR----YYAMKILKKEVIVAK-DEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCC----EEEEEEEEHHHhhhh-hHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEe
Confidence 479999999999999877554 499999987654332 334556679999999999999999999999999999999
Q ss_pred ccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeeCCCCceEEccCCCEEEccccccchhhchhhhh
Q 042539 104 YCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN-MGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFE 182 (412)
Q Consensus 104 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~ 182 (412)
||.||+|..++... ..+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+++....
T Consensus 76 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~----- 148 (325)
T cd05594 76 YANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK----- 148 (325)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC-----
Confidence 99999997766543 359999999999999999999998 7999999999999999999999999999864311
Q ss_pred hhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecC
Q 042539 183 KQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRG 262 (412)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~ 262 (412)
........+||+.|+|||++.+
T Consensus 149 ----------------------------------------------------------~~~~~~~~~gt~~y~aPE~~~~ 170 (325)
T cd05594 149 ----------------------------------------------------------DGATMKTFCGTPEYLAPEVLED 170 (325)
T ss_pred ----------------------------------------------------------CCcccccccCCcccCCHHHHcc
Confidence 1111234579999999999999
Q ss_pred CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCccCCCC-CChhhhh
Q 042539 263 DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKRLGYL-RGACEIK 340 (412)
Q Consensus 263 ~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R~~~~-~~~~e~l 340 (412)
..++.++|||||||++|+|++|..||.+.+.......+......++ ..++++.+||.+||++||++|++.. .++.+++
T Consensus 171 ~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il 250 (325)
T cd05594 171 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIM 250 (325)
T ss_pred CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHh
Confidence 8999999999999999999999999999888888777776555544 4678999999999999999998542 3799999
Q ss_pred cCCCCCCCCchhhcc-cCCCCCCCCCCC
Q 042539 341 EHVFFKGVRWDLLTD-VLRPPFIPSREE 367 (412)
Q Consensus 341 ~h~ff~~~~~~~~~~-~~~pp~~p~~~~ 367 (412)
+|+||.++.|..... ...+|+.+....
T Consensus 251 ~h~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (325)
T cd05594 251 QHKFFAGIVWQDVYEKKLVPPFKPQVTS 278 (325)
T ss_pred cCCCcCCCCHHHHHhCCCCCCcCCcCCC
Confidence 999999999985543 345666655443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=394.23 Aligned_cols=274 Identities=38% Similarity=0.670 Sum_probs=226.9
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHH-HHhhcCCCccceeeeeEEeCCeEEEEe
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIR-VLSRLSHPFLPKLLGSLETDEFLAWAV 102 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lv~ 102 (412)
+.||+|+||+||+|+++.++. .||+|++.+...... .....+.+|.. +++.++||||+++++++..++.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~-~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGK----CYAVKVLQKKIVLNR-KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCC----EEEEEEEEHHHhhhh-hHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEE
Confidence 479999999999999877544 499999977644322 22334444554 567789999999999999999999999
Q ss_pred eccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhh
Q 042539 103 PYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFE 182 (412)
Q Consensus 103 e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~ 182 (412)
|||.||+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 76 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~----- 148 (325)
T cd05604 76 DFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA----- 148 (325)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC-----
Confidence 999999997666543 4599999999999999999999999999999999999999999999999999864210
Q ss_pred hhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecC
Q 042539 183 KQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRG 262 (412)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~ 262 (412)
........+||+.|+|||++.+
T Consensus 149 ----------------------------------------------------------~~~~~~~~~gt~~y~aPE~~~~ 170 (325)
T cd05604 149 ----------------------------------------------------------QSDTTTTFCGTPEYLAPEVIRK 170 (325)
T ss_pred ----------------------------------------------------------CCCCcccccCChhhCCHHHHcC
Confidence 1112235679999999999999
Q ss_pred CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC-CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 263 DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE-FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 263 ~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
..++.++|||||||++|+|++|.+||.+.+..+.+.++...... .+..+..+.++|.+||+.||.+|++...+..++++
T Consensus 171 ~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05604 171 QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQE 250 (325)
T ss_pred CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhc
Confidence 99999999999999999999999999998888888887765433 34577899999999999999999987777889999
Q ss_pred CCCCCCCCchhhcc-cCCCCCCCCCCC
Q 042539 342 HVFFKGVRWDLLTD-VLRPPFIPSREE 367 (412)
Q Consensus 342 h~ff~~~~~~~~~~-~~~pp~~p~~~~ 367 (412)
||||.+++|..+.. ...+|+.|....
T Consensus 251 h~~f~~~~~~~~~~~~~~~~~~~~~~~ 277 (325)
T cd05604 251 HPFFESLSWTDLEQKKIPPPFNPNVEG 277 (325)
T ss_pred CCCcCCCCHHHHHhCCCCCCcCCcCCC
Confidence 99999999976654 345566665443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-50 Score=399.31 Aligned_cols=283 Identities=29% Similarity=0.551 Sum_probs=234.5
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
...+..++|++++.||+|+||+||+|+++.++.. ||+|++.+..... ......+.+|+.+++.++||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----~aiK~~~~~~~~~-~~~~~~~~~e~~il~~~~h~~iv~~~~~ 111 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQV----YAMKLLSKFEMIK-RSDSAFFWEERDIMAHANSEWIVQLHYA 111 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCE----EEEEEEEHHHhhh-hhhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 4567789999999999999999999999875544 9999997654422 2234456779999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
+.+++.+|+|||||.||+|..++... .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus 112 ~~~~~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~ 188 (370)
T cd05596 112 FQDDKYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT 188 (370)
T ss_pred EecCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccc
Confidence 99999999999999999998877542 489999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
++..... ........+||
T Consensus 189 ~~~~~~~--------------------------------------------------------------~~~~~~~~~gt 206 (370)
T cd05596 189 CMKMDAN--------------------------------------------------------------GMVRCDTAVGT 206 (370)
T ss_pred eeeccCC--------------------------------------------------------------CcccCCCCCCC
Confidence 8754210 00112356799
Q ss_pred CCCccceeecCC----CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-----CCCCCCChHHHHHHHHhh
Q 042539 252 EEYVSPEVVRGD----GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT-----PEFVGQRTALTDLIQRLL 322 (412)
Q Consensus 252 ~~Y~APE~l~~~----~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-----~~~~~~~~~~~dli~~~L 322 (412)
+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+....+.++.... +.....+.++.+||.+||
T Consensus 207 ~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 286 (370)
T cd05596 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFL 286 (370)
T ss_pred cCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHc
Confidence 999999998764 36889999999999999999999999998888888887543 222346899999999999
Q ss_pred hhCCCc--cCCCCCChhhhhcCCCCCCCCchhhcc-cCCCCCCCCCCCc
Q 042539 323 EKDPVK--RLGYLRGACEIKEHVFFKGVRWDLLTD-VLRPPFIPSREEN 368 (412)
Q Consensus 323 ~~dP~~--R~~~~~~~~e~l~h~ff~~~~~~~~~~-~~~pp~~p~~~~~ 368 (412)
+.+|.+ |+ +++++++||||++.+|..... ...+|+.|.....
T Consensus 287 ~~~p~r~~R~----s~~ell~h~~~~~~~~~~~~~~~~~~~~~p~~~~~ 331 (370)
T cd05596 287 TDREVRLGRN----GVDEIKSHPFFKNDQWTFDNIRETVAPVVPELSSD 331 (370)
T ss_pred cChhhccCCC----CHHHHhcCcccCCCChhhHHhcCCCcCccCcCCCc
Confidence 999987 87 699999999999998874432 3346677765443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-50 Score=389.46 Aligned_cols=271 Identities=35% Similarity=0.713 Sum_probs=225.5
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeeeeEEeCCeEEEEe
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLGSLETDEFLAWAV 102 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~ 102 (412)
++||+|+||.||+|+++.++. .||+|++++...... ........|+.++..+ +||||+++++++.+++.+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~----~~avK~~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGE----YFAVKALKKDVVLID-DDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCC----EEEEEEEEHHHhhhc-chHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEE
Confidence 479999999999999987554 499999987643222 2334556688888765 7999999999999999999999
Q ss_pred eccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhh
Q 042539 103 PYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFE 182 (412)
Q Consensus 103 e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~ 182 (412)
|||.||+|..++... ..+++.++..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 76 E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~----- 148 (316)
T cd05620 76 EFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF----- 148 (316)
T ss_pred CCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc-----
Confidence 999999998776543 4589999999999999999999999999999999999999999999999999863210
Q ss_pred hhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecC
Q 042539 183 KQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRG 262 (412)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~ 262 (412)
........+||+.|+|||++.+
T Consensus 149 ----------------------------------------------------------~~~~~~~~~gt~~y~aPE~~~~ 170 (316)
T cd05620 149 ----------------------------------------------------------GDNRASTFCGTPDYIAPEILQG 170 (316)
T ss_pred ----------------------------------------------------------CCCceeccCCCcCccCHHHHcC
Confidence 1112235679999999999999
Q ss_pred CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC-CChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 263 DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVG-QRTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 263 ~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
..++.++|||||||++|+|++|..||.+.+..+....+....+.++. .+.++++||.+||+.||++|++ .++++++
T Consensus 171 ~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~---~~~~~~~ 247 (316)
T cd05620 171 LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRLG---VVGNIRG 247 (316)
T ss_pred CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHHcCC---ChHHHHc
Confidence 99999999999999999999999999999888888887766655544 6789999999999999999995 3578999
Q ss_pred CCCCCCCCchhhcc-cCCCCCCCCCCC
Q 042539 342 HVFFKGVRWDLLTD-VLRPPFIPSREE 367 (412)
Q Consensus 342 h~ff~~~~~~~~~~-~~~pp~~p~~~~ 367 (412)
||||++++|..+.. ...+|+.|....
T Consensus 248 h~~f~~~~~~~~~~~~~~~~~~~~~~~ 274 (316)
T cd05620 248 HPFFKTINWTALEKRELDPPFKPKVKS 274 (316)
T ss_pred CCCcCCCCHHHHHhCCCCCCcCCCCCC
Confidence 99999999986543 345666665443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-50 Score=398.97 Aligned_cols=282 Identities=29% Similarity=0.565 Sum_probs=230.0
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
...+..++|++++.||+|+||.||+|+++.++.. ||+|++.+..... ......+.+|+.+++.++||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~----~aiK~~~~~~~~~-~~~~~~~~~e~~i~~~~~hp~iv~~~~~ 111 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKV----YAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFCA 111 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCE----EEEEEEEHHHhhh-hhhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 3456778999999999999999999999875544 9999997654322 2334557779999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
+.+++.+|+|||||.||+|..++... .+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus 112 ~~~~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 112 FQDDKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred EEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEeccc
Confidence 99999999999999999998877543 489999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
|+..... ......+.+||
T Consensus 189 a~~~~~~--------------------------------------------------------------~~~~~~~~~gt 206 (370)
T cd05621 189 CMKMDET--------------------------------------------------------------GMVRCDTAVGT 206 (370)
T ss_pred ceecccC--------------------------------------------------------------CceecccCCCC
Confidence 9754210 01122356899
Q ss_pred CCCccceeecCCC----CCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-----CCCCCCChHHHHHHHHhh
Q 042539 252 EEYVSPEVVRGDG----HEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT-----PEFVGQRTALTDLIQRLL 322 (412)
Q Consensus 252 ~~Y~APE~l~~~~----~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-----~~~~~~~~~~~dli~~~L 322 (412)
+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+....+.+++... +.....+..++++|.+||
T Consensus 207 ~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L 286 (370)
T cd05621 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFL 286 (370)
T ss_pred cccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHc
Confidence 9999999997653 6789999999999999999999999998888888887533 222345789999999999
Q ss_pred hhCCCc--cCCCCCChhhhhcCCCCCCCCchhhcc-cCCCCCCCCCCC
Q 042539 323 EKDPVK--RLGYLRGACEIKEHVFFKGVRWDLLTD-VLRPPFIPSREE 367 (412)
Q Consensus 323 ~~dP~~--R~~~~~~~~e~l~h~ff~~~~~~~~~~-~~~pp~~p~~~~ 367 (412)
..++.+ |+ +++++++||||++..|+.... ...+|+.|....
T Consensus 287 ~~~~~r~~R~----~~~e~l~hp~~~~~~~~~~~~~~~~~~~~p~~~~ 330 (370)
T cd05621 287 TDREVRLGRN----GVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSS 330 (370)
T ss_pred cCchhccCCC----CHHHHhcCcccCCCCcChHhcCCCCCCcCCCCCC
Confidence 844433 55 799999999999977753322 345667666543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-50 Score=389.14 Aligned_cols=276 Identities=33% Similarity=0.648 Sum_probs=232.7
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEEeCCe
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLETDEF 97 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 97 (412)
+|++++.||+|+||+||+|+++.++. .||||++.+..... ......+..|+.++..+. |++|+++++++++.+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDE----LYAIKILKKDVVIQ-DDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCC----EEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccCCCchhheeeEEecCCE
Confidence 58899999999999999999887554 49999998764422 233456667999998886 5788899999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+|+|||||.||+|..++... +.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999999998776544 3599999999999999999999999999999999999999999999999999864310
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
........+||+.|+||
T Consensus 154 ---------------------------------------------------------------~~~~~~~~~gt~~y~aP 170 (323)
T cd05615 154 ---------------------------------------------------------------DGVTTRTFCGTPDYIAP 170 (323)
T ss_pred ---------------------------------------------------------------CCccccCccCCccccCH
Confidence 11122355799999999
Q ss_pred eeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCccCCCC-CC
Q 042539 258 EVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKRLGYL-RG 335 (412)
Q Consensus 258 E~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R~~~~-~~ 335 (412)
|++.+..++.++|||||||++|+|++|++||.+.+.......+......++ ..+.++.++|.+||.+||.+|++.. ..
T Consensus 171 E~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 250 (323)
T cd05615 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEG 250 (323)
T ss_pred HHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccCHhhCCCCCCCC
Confidence 999998899999999999999999999999999988888888877665543 4678999999999999999999753 24
Q ss_pred hhhhhcCCCCCCCCchhhcc-cCCCCCCCC
Q 042539 336 ACEIKEHVFFKGVRWDLLTD-VLRPPFIPS 364 (412)
Q Consensus 336 ~~e~l~h~ff~~~~~~~~~~-~~~pp~~p~ 364 (412)
.+++++|+||++++|..+.. ...+|+.|.
T Consensus 251 ~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~ 280 (323)
T cd05615 251 ERDIREHAFFRRIDWDKLENREIQPPFKPK 280 (323)
T ss_pred HHHHhcCcccCCCCHHHHhcCCCCcCccCc
Confidence 68999999999999987755 346677664
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-50 Score=392.11 Aligned_cols=275 Identities=40% Similarity=0.745 Sum_probs=228.5
Q ss_pred eeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEEEe
Q 042539 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAV 102 (412)
Q Consensus 23 ~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 102 (412)
++.||+|+||.||++++.. +..+++.||+|++++..... .....+.+|++++++++||||+++++++.+++.+|+||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~-~~~~~~~~aiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 77 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKIT-GPDAGQLYAMKVLKKATLKV--RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLIL 77 (318)
T ss_pred CceeeeCCCEEEEEEEEec-cCCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEE
Confidence 4689999999999998742 22356679999998765422 23445667999999999999999999999999999999
Q ss_pred eccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhh
Q 042539 103 PYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFE 182 (412)
Q Consensus 103 e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~ 182 (412)
|||.||+|..++... ..+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 78 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~----- 150 (318)
T cd05582 78 DFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID----- 150 (318)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCC-----
Confidence 999999998777543 3589999999999999999999999999999999999999999999999999864321
Q ss_pred hhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecC
Q 042539 183 KQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRG 262 (412)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~ 262 (412)
........+||+.|+|||++.+
T Consensus 151 ----------------------------------------------------------~~~~~~~~~g~~~y~aPE~~~~ 172 (318)
T cd05582 151 ----------------------------------------------------------HEKKAYSFCGTVEYMAPEVVNR 172 (318)
T ss_pred ----------------------------------------------------------CCCceecccCChhhcCHHHHcC
Confidence 1112235679999999999999
Q ss_pred CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCccCCCCC-Chhhhh
Q 042539 263 DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKRLGYLR-GACEIK 340 (412)
Q Consensus 263 ~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R~~~~~-~~~e~l 340 (412)
..++.++|||||||++|+|++|+.||.+.+..+....+.......+ ..++++.+||++||+.||++|++... .+++++
T Consensus 173 ~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~ 252 (318)
T cd05582 173 RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIK 252 (318)
T ss_pred CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHh
Confidence 8899999999999999999999999999888888887776555443 46789999999999999999996422 278899
Q ss_pred cCCCCCCCCchhhcc-cCCCCCCCCC
Q 042539 341 EHVFFKGVRWDLLTD-VLRPPFIPSR 365 (412)
Q Consensus 341 ~h~ff~~~~~~~~~~-~~~pp~~p~~ 365 (412)
.|+||..++|..+.. ...|++.+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (318)
T cd05582 253 RHPFFSTIDWNKLYRREIKPPFKPAV 278 (318)
T ss_pred CCCCcCCCCHHHHHhcCCCCCcCCCC
Confidence 999999999985543 3455665543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-51 Score=395.76 Aligned_cols=260 Identities=28% Similarity=0.453 Sum_probs=234.0
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
..=|.+.+.||+|.|++|-+|++.-++.. ||||+|.|..+..- ....+.+|++.|+.++|||||+||++..++.
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGek----VAVKviDKTKlD~~--st~hlfqEVRCMKLVQHpNiVRLYEViDTQT 90 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEK----VAVKVIDKTKLDTL--STGHLFQEVRCMKLVQHPNIVRLYEVIDTQT 90 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccce----eEEEEecccccchh--hhhHHHHHHHHHHHhcCcCeeeeeehhcccc
Confidence 34588889999999999999988775554 99999999876432 3456777999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccC-CCEEEccccccchh
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQS-GHVTLTDFDLSRNL 175 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~-g~vkL~DFGla~~~ 175 (412)
.+|||+|+=.||||++++-.... .+.|+.++.|++||+.|+.|+|+..+|||||||+|+++.+. |-|||+|||++..+
T Consensus 91 KlyLiLELGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred eEEEEEEecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccC
Confidence 99999999999999999877654 49999999999999999999999999999999999988765 99999999998544
Q ss_pred hchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCc
Q 042539 176 VKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYV 255 (412)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 255 (412)
..++..+++||+..|-
T Consensus 170 ----------------------------------------------------------------~PG~kL~TsCGSLAYS 185 (864)
T KOG4717|consen 170 ----------------------------------------------------------------QPGKKLTTSCGSLAYS 185 (864)
T ss_pred ----------------------------------------------------------------CCcchhhcccchhhcc
Confidence 4566778999999999
Q ss_pred cceeecCCCCC-chhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC-CChHHHHHHHHhhhhCCCccCCCC
Q 042539 256 SPEVVRGDGHE-FAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVG-QRTALTDLIQRLLEKDPVKRLGYL 333 (412)
Q Consensus 256 APE~l~~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~dli~~~L~~dP~~R~~~~ 333 (412)
|||++.|..|+ .++||||||||||.|++|++||...+..+++..|+...+..+. .+++++|||.+||+.||.+|.
T Consensus 186 APEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~sMLvRdPkkRA--- 262 (864)
T KOG4717|consen 186 APEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQSMLVRDPKKRA--- 262 (864)
T ss_pred CchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHHHHhcCchhhc---
Confidence 99999999994 7899999999999999999999999999999999998887776 589999999999999999998
Q ss_pred CChhhhhcCCCCCCCCch
Q 042539 334 RGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 334 ~~~~e~l~h~ff~~~~~~ 351 (412)
++++|..|+|+++++-.
T Consensus 263 -slEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 263 -SLEEIVSTSWLQAGDRG 279 (864)
T ss_pred -cHHHHhccccccCCCCC
Confidence 69999999999998743
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=397.01 Aligned_cols=259 Identities=32% Similarity=0.546 Sum_probs=231.5
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSL 92 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~ 92 (412)
.-..+.|++.+.||+|.||.||+|+++.++.. ||+|++.|....... ....+.+|+++|+++. |||||.++++|
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~----~A~K~i~k~~~~~~~-~~~~v~~Ev~il~~l~~hpniv~l~~~~ 105 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKE----VACKVIPKRKLRGKE-DREDVRREVAILQQLSGHPNIVQLKDAF 105 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCce----eEEEEeehhhccccc-cHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 34456899999999999999999999986554 999999888765432 4556778999999998 99999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccC----CCEEEcc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQS----GHVTLTD 168 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~----g~vkL~D 168 (412)
++...+++|||+|.||+|.+.+... .++|..+..++.|++.|+.|||+.||+||||||+|+|+... +.+|++|
T Consensus 106 e~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 106 EDPDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred EcCCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEee
Confidence 9999999999999999998887766 29999999999999999999999999999999999999754 4799999
Q ss_pred ccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccc
Q 042539 169 FDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248 (412)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (412)
||+|.... .+......
T Consensus 183 FGla~~~~----------------------------------------------------------------~~~~~~~~ 198 (382)
T KOG0032|consen 183 FGLAKFIK----------------------------------------------------------------PGERLHTI 198 (382)
T ss_pred CCCceEcc----------------------------------------------------------------CCceEeee
Confidence 99998752 23455688
Q ss_pred ccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-----CCCCCChHHHHHHHHhhh
Q 042539 249 VGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP-----EFVGQRTALTDLIQRLLE 323 (412)
Q Consensus 249 ~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-----~~~~~~~~~~dli~~~L~ 323 (412)
|||+.|+|||++.+.+|+..+||||+||++|.|++|.+||.+.+....+.++..+.. .++.++..++|||++||.
T Consensus 199 ~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~ 278 (382)
T KOG0032|consen 199 VGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLE 278 (382)
T ss_pred cCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcc
Confidence 999999999999999999999999999999999999999999999999999987654 456778999999999999
Q ss_pred hCCCccCCCCCChhhhhcCCCCCCC
Q 042539 324 KDPVKRLGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 324 ~dP~~R~~~~~~~~e~l~h~ff~~~ 348 (412)
.||.+|+ ++.++|+|||+++.
T Consensus 279 ~dp~~R~----ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 279 FDPRKRL----TAAQALQHPWIKSI 299 (382)
T ss_pred cCcccCC----CHHHHhcCccccCC
Confidence 9999999 79999999999875
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=394.62 Aligned_cols=271 Identities=37% Similarity=0.675 Sum_probs=225.2
Q ss_pred eeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc---CCCccceeeeeEEeCCeEEEEe
Q 042539 26 LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL---SHPFLPKLLGSLETDEFLAWAV 102 (412)
Q Consensus 26 LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~lv~ 102 (412)
||+|+||+||+|+++.++. .||+|++.+....... .......|..++..+ .||||+++++++.+.+.+|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~----~~avK~~~~~~~~~~~-~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRR----IYAMKVLSKKEIVAKK-EVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCC----EEEEEEEeHHHHhhhh-HHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEE
Confidence 7999999999999887554 4999999776543322 233445577777665 5999999999999999999999
Q ss_pred eccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhh
Q 042539 103 PYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFE 182 (412)
Q Consensus 103 e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~ 182 (412)
||+.||+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 76 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~----- 148 (330)
T cd05586 76 DYMSGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT----- 148 (330)
T ss_pred cCCCCChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC-----
Confidence 999999997776543 4599999999999999999999999999999999999999999999999999864311
Q ss_pred hhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecC
Q 042539 183 KQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRG 262 (412)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~ 262 (412)
........+||+.|+|||++.+
T Consensus 149 ----------------------------------------------------------~~~~~~~~~gt~~y~aPE~~~~ 170 (330)
T cd05586 149 ----------------------------------------------------------DNKTTNTFCGTTEYLAPEVLLD 170 (330)
T ss_pred ----------------------------------------------------------CCCCccCccCCccccCHHHHcC
Confidence 1112335689999999999876
Q ss_pred C-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC--CCChHHHHHHHHhhhhCCCccCCCCCChhhh
Q 042539 263 D-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV--GQRTALTDLIQRLLEKDPVKRLGYLRGACEI 339 (412)
Q Consensus 263 ~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~ 339 (412)
. .++.++|||||||++|+|++|..||.+.+..+.+.++......++ ..++++.+||.+||..||.+|++...+++++
T Consensus 171 ~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~l 250 (330)
T cd05586 171 EKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVEL 250 (330)
T ss_pred CCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHH
Confidence 5 478999999999999999999999999888888888876655444 3578999999999999999999877789999
Q ss_pred hcCCCCCCCCchhhcc-cCCCCCCCCCC
Q 042539 340 KEHVFFKGVRWDLLTD-VLRPPFIPSRE 366 (412)
Q Consensus 340 l~h~ff~~~~~~~~~~-~~~pp~~p~~~ 366 (412)
++||||...+|+.+.. ...+|+.|...
T Consensus 251 l~h~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (330)
T cd05586 251 KEHPFFADIDWDLLSKKQITPPFKPIVD 278 (330)
T ss_pred hcCccccCCCHHHHHhCCCCCCccCCCC
Confidence 9999999999986644 34566666544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-51 Score=386.69 Aligned_cols=260 Identities=31% Similarity=0.506 Sum_probs=214.5
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
..+|...+.||+|+||.||++.++.++.. +|||.+..... .. .+.+.+|+++|.+++|||||++++.....+
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~----~AvK~v~~~~~---~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~ 87 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGEL----MAVKSVELEDS---PT-SESLEREIRILSRLNHPNIVQYYGSSSSRE 87 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcc----eeeeeeecccc---hh-HHHHHHHHHHHHhCCCCCEEeeCCcccccc
Confidence 56799999999999999999999876444 99999866521 11 566778999999999999999999865554
Q ss_pred --eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEcc-CCCEEEccccccc
Q 042539 97 --FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQ-SGHVTLTDFDLSR 173 (412)
Q Consensus 97 --~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~-~g~vkL~DFGla~ 173 (412)
.+++.|||+.||+|.+++...++ .|+|..++.|.+||+.||+|||++|||||||||+|||++. +|.+||+|||+++
T Consensus 88 ~~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~ 166 (313)
T KOG0198|consen 88 NDEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAK 166 (313)
T ss_pred CeeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccc
Confidence 69999999999999999887665 7999999999999999999999999999999999999999 7999999999998
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
..... .........+.||+.
T Consensus 167 ~~~~~------------------------------------------------------------~~~~~~~~~~~Gtp~ 186 (313)
T KOG0198|consen 167 KLESK------------------------------------------------------------GTKSDSELSVQGTPN 186 (313)
T ss_pred ccccc------------------------------------------------------------cccccccccccCCcc
Confidence 65310 011233446789999
Q ss_pred CccceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCC--CCCC-CCChHHHHHHHHhhhhCCCc
Q 042539 254 YVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRG-KNRKETFRNVLMKT--PEFV-GQRTALTDLIQRLLEKDPVK 328 (412)
Q Consensus 254 Y~APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~--~~~~-~~~~~~~dli~~~L~~dP~~ 328 (412)
|||||++.+. ...+++|||||||++.||+||.+||.. ....+.+-.+.... |.++ .+++++++||.+||.+||++
T Consensus 187 ~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~ 266 (313)
T KOG0198|consen 187 YMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEK 266 (313)
T ss_pred ccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCccc
Confidence 9999999962 234599999999999999999999987 34334333343332 3333 46789999999999999999
Q ss_pred cCCCCCChhhhhcCCCCCCCC
Q 042539 329 RLGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 329 R~~~~~~~~e~l~h~ff~~~~ 349 (412)
|| +|+++|+|||.....
T Consensus 267 Rp----ta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 267 RP----TAEELLEHPFLKQNS 283 (313)
T ss_pred Cc----CHHHHhhChhhhccc
Confidence 99 799999999997643
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-50 Score=390.96 Aligned_cols=277 Identities=33% Similarity=0.618 Sum_probs=232.0
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
++|++.+.||+|+||+||+|+++.++. .||+|++++.... .......+.+|+.+++.++|+||+++++++.+++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~~~-~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGD----IYAMKVMKKSVLL-AQETVSFFEEERDILSISNSPWIPQLQYAFQDKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCC----EEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCe
Confidence 589999999999999999999887554 4999999876542 23345667789999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+|+|||||.||+|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+..
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred EEEEECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 99999999999998887654 24599999999999999999999999999999999999999999999999999975421
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
.. .......+||+.|+||
T Consensus 155 ~~--------------------------------------------------------------~~~~~~~~gt~~y~aP 172 (330)
T cd05601 155 NK--------------------------------------------------------------MVNSKLPVGTPDYIAP 172 (330)
T ss_pred CC--------------------------------------------------------------ceeeecccCCccccCH
Confidence 10 0111234789999999
Q ss_pred eeec------CCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-----CCCCCCChHHHHHHHHhhhhCC
Q 042539 258 EVVR------GDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT-----PEFVGQRTALTDLIQRLLEKDP 326 (412)
Q Consensus 258 E~l~------~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-----~~~~~~~~~~~dli~~~L~~dP 326 (412)
|++. +..++.++|||||||++|+|++|..||.+.+....+.+++... +..+..++++.+||++||. ||
T Consensus 173 E~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p 251 (330)
T cd05601 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQ 251 (330)
T ss_pred HHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-Ch
Confidence 9987 4457889999999999999999999999988888877776432 2334568899999999997 99
Q ss_pred CccCCCCCChhhhhcCCCCCCCCchhhcccCCCCCCCCCCCc
Q 042539 327 VKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREEN 368 (412)
Q Consensus 327 ~~R~~~~~~~~e~l~h~ff~~~~~~~~~~~~~pp~~p~~~~~ 368 (412)
.+|+ +++++++||||..++|..+.. ..|++.|.....
T Consensus 252 ~~R~----t~~~l~~h~~~~~~~~~~~~~-~~~~~~~~~~~~ 288 (330)
T cd05601 252 KERL----GYEGLCCHPFFSKIDWNNIRN-SLPPFVPTLKSD 288 (330)
T ss_pred hhCC----CHHHHhCCCCcCCCCHHHHhh-CCCCccCcCCCc
Confidence 9999 689999999999999987765 345666655443
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=386.29 Aligned_cols=274 Identities=36% Similarity=0.687 Sum_probs=227.3
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeeeeEEeCCeEEEEe
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLGSLETDEFLAWAV 102 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~ 102 (412)
+.||+|+||+||+|+++.++. .||||++++..... ......+.+|+.+++.+ +||||+++++++.+.+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~-~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDE----LYAVKVLKKDVILQ-DDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCC----EEEEEEEEHHHHhh-hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEE
Confidence 479999999999999877544 49999998765432 23345566799999888 5999999999999999999999
Q ss_pred eccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhh
Q 042539 103 PYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFE 182 (412)
Q Consensus 103 e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~ 182 (412)
|||.||+|..++... +.+++.++..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 76 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~----- 148 (318)
T cd05570 76 EYVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL----- 148 (318)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc-----
Confidence 999999997766543 3599999999999999999999999999999999999999999999999999864210
Q ss_pred hhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecC
Q 042539 183 KQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRG 262 (412)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~ 262 (412)
........+||+.|+|||++.+
T Consensus 149 ----------------------------------------------------------~~~~~~~~~g~~~y~aPE~~~~ 170 (318)
T cd05570 149 ----------------------------------------------------------GGVTTSTFCGTPDYIAPEILSY 170 (318)
T ss_pred ----------------------------------------------------------CCCcccceecCccccCHHHhcC
Confidence 1112234579999999999999
Q ss_pred CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCccCCCC-CChhhhh
Q 042539 263 DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKRLGYL-RGACEIK 340 (412)
Q Consensus 263 ~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R~~~~-~~~~e~l 340 (412)
..++.++|+|||||++|+|++|+.||.+.+.......+......++ ..++.+.+||.+||..||.+|++.. ....+++
T Consensus 171 ~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll 250 (318)
T cd05570 171 QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIK 250 (318)
T ss_pred CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHh
Confidence 9999999999999999999999999999888888887776665544 3678999999999999999999521 1139999
Q ss_pred cCCCCCCCCchhhcc-cCCCCCCCCCCC
Q 042539 341 EHVFFKGVRWDLLTD-VLRPPFIPSREE 367 (412)
Q Consensus 341 ~h~ff~~~~~~~~~~-~~~pp~~p~~~~ 367 (412)
+||||+.++|..... ...||+.|....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (318)
T cd05570 251 GHPFFREIDWDKLERKEIKPPFKPKIKG 278 (318)
T ss_pred cCCCcCCCCHHHHHhCCCCCCcCCCCCC
Confidence 999999999975543 445666665443
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=380.09 Aligned_cols=276 Identities=36% Similarity=0.622 Sum_probs=227.6
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeE
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFL 98 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 98 (412)
+|++.+.||+|+||+||++.+..++. .||+|++.+..... ......+.+|+.+++.++|+||+++++++.+++.+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGK----MYACKKLEKKRIKK-RKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCc----eEEEEEEehhhhhh-hhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeE
Confidence 58999999999999999999876544 49999997655432 22345567799999999999999999999999999
Q ss_pred EEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhch
Q 042539 99 AWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~ 178 (412)
|+|||||.||+|..++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~- 154 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE- 154 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC-
Confidence 9999999999998777665555699999999999999999999999999999999999999999999999999865311
Q ss_pred hhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccce
Q 042539 179 TAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPE 258 (412)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 258 (412)
.......+||+.|+|||
T Consensus 155 ---------------------------------------------------------------~~~~~~~~~~~~y~aPE 171 (285)
T cd05605 155 ---------------------------------------------------------------GETIRGRVGTVGYMAPE 171 (285)
T ss_pred ---------------------------------------------------------------CCccccccCCCCccCcH
Confidence 01112447899999999
Q ss_pred eecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHH----HhcCCCCC-CCCChHHHHHHHHhhhhCCCccCCCC
Q 042539 259 VVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRN----VLMKTPEF-VGQRTALTDLIQRLLEKDPVKRLGYL 333 (412)
Q Consensus 259 ~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~----i~~~~~~~-~~~~~~~~dli~~~L~~dP~~R~~~~ 333 (412)
++.+..++.++||||+||++|+|++|+.||.+.+....... +......+ ...+..+.+||.+||..||.+|+++.
T Consensus 172 ~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05605 172 VVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCR 251 (285)
T ss_pred HhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCC
Confidence 99988899999999999999999999999998665433222 22222222 34678999999999999999999652
Q ss_pred -CChhhhhcCCCCCCCCchhhcc-cCCCCCCC
Q 042539 334 -RGACEIKEHVFFKGVRWDLLTD-VLRPPFIP 363 (412)
Q Consensus 334 -~~~~e~l~h~ff~~~~~~~~~~-~~~pp~~p 363 (412)
.+++++++|+||...+|+.+.. ...|||.|
T Consensus 252 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (285)
T cd05605 252 GEGAEEVKAHPFFRTANFKRLEAGMLEPPFCP 283 (285)
T ss_pred CCCHHHHhcCcCccCCCHHHHhhCCCCCCCCC
Confidence 2689999999999999987755 34566665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-49 Score=385.46 Aligned_cols=280 Identities=33% Similarity=0.624 Sum_probs=226.5
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
++|++++.||+|+||+||+++++.++. .||+|++.+.... .......+.+|+.+++.++|+||+++++++.++++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQ----VYAMKILNKWEML-KRAETACFREERDVLVNGDRRWITNLHYAFQDENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCC----EEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCe
Confidence 589999999999999999999887554 4999999765432 22344567779999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+|+||||+.||+|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+..
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred EEEEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999998887643 34589999999999999999999999999999999999999999999999999865421
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
. ........+||+.|+||
T Consensus 155 ~--------------------------------------------------------------~~~~~~~~~gt~~y~aP 172 (331)
T cd05597 155 D--------------------------------------------------------------GTVQSNVAVGTPDYISP 172 (331)
T ss_pred C--------------------------------------------------------------CCccccceeccccccCH
Confidence 1 00111234699999999
Q ss_pred eeecC-----CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC------CCCCCChHHHHHHHHhhhhCC
Q 042539 258 EVVRG-----DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP------EFVGQRTALTDLIQRLLEKDP 326 (412)
Q Consensus 258 E~l~~-----~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~------~~~~~~~~~~dli~~~L~~dP 326 (412)
|++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+..... .....+..+++||++||.. |
T Consensus 173 E~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~-~ 251 (331)
T cd05597 173 EILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICS-P 251 (331)
T ss_pred HHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccC-c
Confidence 99874 3467899999999999999999999999888887777764321 1234678999999999975 3
Q ss_pred CccCCCCCChhhhhcCCCCCCCCchhhcccCCCCCCCCCCCc
Q 042539 327 VKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREEN 368 (412)
Q Consensus 327 ~~R~~~~~~~~e~l~h~ff~~~~~~~~~~~~~pp~~p~~~~~ 368 (412)
.+|++- .+++++++||||.+++|...... .+++.|.....
T Consensus 252 ~~r~~r-~~~~~~l~hp~~~~~~~~~~~~~-~~~~~~~~~~~ 291 (331)
T cd05597 252 ETRLGR-NGLQDFKDHPFFEGIDWDNIRNS-TAPYVPEVSSP 291 (331)
T ss_pred ccccCC-CCHHHHhcCCCCCCCCHHHHhhC-CCCccCcCCCc
Confidence 443321 17999999999999999877653 45566655443
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=378.17 Aligned_cols=270 Identities=33% Similarity=0.600 Sum_probs=220.0
Q ss_pred eeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEEEeecc
Q 042539 26 LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYC 105 (412)
Q Consensus 26 LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 105 (412)
||+|+||+||+|.++.++. .||+|++.+...... .....+..|+++++.++|+||+++++++..+..+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~----~~avK~~~~~~~~~~-~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGK----LYACKKLNKKRLKKR-KGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCc----EEEEEeeeHHHHhhh-HHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCC
Confidence 7999999999999887554 499999976654322 23455677999999999999999999999999999999999
Q ss_pred CCCCchhHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhhh
Q 042539 106 PGGDLNVLRYKQ--NDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEK 183 (412)
Q Consensus 106 ~gg~L~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~ 183 (412)
.||+|..++... ....+++..+..++.||+.||.|||++||+||||||+||+++.+|.+||+|||++..+...
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~----- 150 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG----- 150 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC-----
Confidence 999998766432 2346899999999999999999999999999999999999999999999999998654210
Q ss_pred hcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecCC
Q 042539 184 QSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGD 263 (412)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~ 263 (412)
........||+.|+|||++.+.
T Consensus 151 ----------------------------------------------------------~~~~~~~~g~~~y~aPE~~~~~ 172 (280)
T cd05608 151 ----------------------------------------------------------QSKTKGYAGTPGFMAPELLQGE 172 (280)
T ss_pred ----------------------------------------------------------CccccccCCCcCccCHHHhcCC
Confidence 0112245789999999999999
Q ss_pred CCCchhhHHHHHHHHHHHhhCCCCCCCCCH----HHHHHHHhcCCCCC-CCCChHHHHHHHHhhhhCCCccCCCCC-Chh
Q 042539 264 GHEFAVDWWALGILTYEMLYGTTPFRGKNR----KETFRNVLMKTPEF-VGQRTALTDLIQRLLEKDPVKRLGYLR-GAC 337 (412)
Q Consensus 264 ~~~~~~DiwSlGvil~ell~g~~Pf~~~~~----~~~~~~i~~~~~~~-~~~~~~~~dli~~~L~~dP~~R~~~~~-~~~ 337 (412)
.++.++|+|||||++|+|++|+.||..... ......+......+ ...+..+.++|.+||+.||++|+++.. +++
T Consensus 173 ~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~ 252 (280)
T cd05608 173 EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCD 252 (280)
T ss_pred CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHH
Confidence 999999999999999999999999987542 22333333332222 346789999999999999999998754 799
Q ss_pred hhhcCCCCCCCCchhhcc-cCCCCCCC
Q 042539 338 EIKEHVFFKGVRWDLLTD-VLRPPFIP 363 (412)
Q Consensus 338 e~l~h~ff~~~~~~~~~~-~~~pp~~p 363 (412)
++++||||++++|..+.. ...+||.|
T Consensus 253 ~~l~h~~~~~~~~~~~~~~~~~~~~~~ 279 (280)
T cd05608 253 GLRTHPLFRDLNWRQLEAGMLPPPFVP 279 (280)
T ss_pred HHhcChhhhcCCHhHHhhccCCCCCCC
Confidence 999999999999986544 34455554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-49 Score=385.20 Aligned_cols=273 Identities=35% Similarity=0.680 Sum_probs=221.4
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeeeeEEeCCeEEEEe
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLGSLETDEFLAWAV 102 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~ 102 (412)
+.||+|+||+||+|+++.++. .||+|++++..... ......+.+|+.++.++ +||||+++++++.+++.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTER----IYAMKVVKKELVND-DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCC----EEEEEEEEhhHhcc-hhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEE
Confidence 479999999999999887554 49999998765432 23445677799998887 6999999999999999999999
Q ss_pred eccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhh
Q 042539 103 PYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFE 182 (412)
Q Consensus 103 e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~ 182 (412)
|||.||+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 76 E~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~----- 148 (329)
T cd05618 76 EYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR----- 148 (329)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC-----
Confidence 999999997766543 4599999999999999999999999999999999999999999999999999864310
Q ss_pred hhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecC
Q 042539 183 KQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRG 262 (412)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~ 262 (412)
.......++||+.|+|||++.+
T Consensus 149 ----------------------------------------------------------~~~~~~~~~gt~~y~aPE~~~~ 170 (329)
T cd05618 149 ----------------------------------------------------------PGDTTSTFCGTPNYIAPEILRG 170 (329)
T ss_pred ----------------------------------------------------------CCCccccccCCccccCHHHHcC
Confidence 1112235689999999999999
Q ss_pred CCCCchhhHHHHHHHHHHHhhCCCCCCCC---------CHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCccCCC
Q 042539 263 DGHEFAVDWWALGILTYEMLYGTTPFRGK---------NRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKRLGY 332 (412)
Q Consensus 263 ~~~~~~~DiwSlGvil~ell~g~~Pf~~~---------~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R~~~ 332 (412)
..++.++|||||||++|+|++|+.||... ........+......++ ..+..+.+||.+||+.||.+|++.
T Consensus 171 ~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 99999999999999999999999999521 12223444444444433 467889999999999999999964
Q ss_pred C--CChhhhhcCCCCCCCCchhhcc-cCCCCCCCCCC
Q 042539 333 L--RGACEIKEHVFFKGVRWDLLTD-VLRPPFIPSRE 366 (412)
Q Consensus 333 ~--~~~~e~l~h~ff~~~~~~~~~~-~~~pp~~p~~~ 366 (412)
. .+..++++||||++++|..... ...|++.|...
T Consensus 251 ~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~~~~~~~~ 287 (329)
T cd05618 251 HPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNIS 287 (329)
T ss_pred CCCCCHHHHhcCCCCCCCCHHHHHcCCCCcCccCCCC
Confidence 2 2468999999999999986654 44666666543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-51 Score=397.05 Aligned_cols=252 Identities=29% Similarity=0.443 Sum_probs=219.8
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
..|....+||+|+-|.||.|+...++.. ||||.+..... .....+.+|+.+|+..+|+|||.+++.|..++.
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~----VaiK~m~l~~Q----~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~de 344 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQE----VAIKRMDLRKQ----PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDE 344 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCce----EEEEEEEeccC----CchhhhHHHHHHHHhccchHHHHHHHHhcccce
Confidence 4678889999999999999998886555 99999977543 334567779999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+|+||||++||+|.+.+... .++|.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||+|..+..
T Consensus 345 LWVVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 345 LWVVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred eEEEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 99999999999998877643 399999999999999999999999999999999999999999999999999987631
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
......+.+|||.||||
T Consensus 422 ---------------------------------------------------------------~~~KR~TmVGTPYWMAP 438 (550)
T KOG0578|consen 422 ---------------------------------------------------------------EQSKRSTMVGTPYWMAP 438 (550)
T ss_pred ---------------------------------------------------------------ccCccccccCCCCccch
Confidence 22245678999999999
Q ss_pred eeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhc-CCCCC---CCCChHHHHHHHHhhhhCCCccCCCC
Q 042539 258 EVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLM-KTPEF---VGQRTALTDLIQRLLEKDPVKRLGYL 333 (412)
Q Consensus 258 E~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~-~~~~~---~~~~~~~~dli~~~L~~dP~~R~~~~ 333 (412)
|++....|+.++||||||++++||+-|.+||-..+.-..+..|.. +.+.+ ...++.++||+++||+.|+.+|+
T Consensus 439 EVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~Ra--- 515 (550)
T KOG0578|consen 439 EVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRA--- 515 (550)
T ss_pred hhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCC---
Confidence 999999999999999999999999999999987665555555554 34443 34689999999999999999999
Q ss_pred CChhhhhcCCCCCC
Q 042539 334 RGACEIKEHVFFKG 347 (412)
Q Consensus 334 ~~~~e~l~h~ff~~ 347 (412)
+|.|||+||||+-
T Consensus 516 -sA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 516 -SAKELLEHPFLKM 528 (550)
T ss_pred -CHHHHhcChhhhh
Confidence 6999999999964
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-49 Score=384.21 Aligned_cols=278 Identities=33% Similarity=0.604 Sum_probs=226.8
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
++|+++++||+|+||+||+++++.++. .||+|++.+.... .......+..|+.++..++|+||+++++++.+.+.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~----~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADK----VFAMKILNKWEML-KRAETACFREERDVLVNGDNQWITTLHYAFQDENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCC----EEEEEEEeHHHHH-HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCE
Confidence 589999999999999999999877544 4999999765432 22334456779999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+|+||||+.||+|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999999988876532 3589999999999999999999999999999999999999999999999999865421
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
. ........+||+.|+||
T Consensus 155 ~--------------------------------------------------------------~~~~~~~~~gt~~y~aP 172 (332)
T cd05623 155 D--------------------------------------------------------------GTVQSSVAVGTPDYISP 172 (332)
T ss_pred C--------------------------------------------------------------CcceecccccCccccCH
Confidence 0 00112245799999999
Q ss_pred eeecC-----CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC------CCCCChHHHHHHHHhhhhCC
Q 042539 258 EVVRG-----DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE------FVGQRTALTDLIQRLLEKDP 326 (412)
Q Consensus 258 E~l~~-----~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~------~~~~~~~~~dli~~~L~~dP 326 (412)
|++.+ ..++.++|||||||++|||++|+.||.+.+..+.+.++...... ....++++++||.+||..++
T Consensus 173 E~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~ 252 (332)
T cd05623 173 EILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSRE 252 (332)
T ss_pred HHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChh
Confidence 99863 35788999999999999999999999999888888888754321 13468899999999997654
Q ss_pred CccCCCCCChhhhhcCCCCCCCCchhhcccCCCCCCCCCC
Q 042539 327 VKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSRE 366 (412)
Q Consensus 327 ~~R~~~~~~~~e~l~h~ff~~~~~~~~~~~~~pp~~p~~~ 366 (412)
.+ ++- .+++++++||||.+++|+.+.. ..+|++|...
T Consensus 253 ~r-~~r-~~~~~~~~h~~f~~~~~~~~~~-~~~~~~~~~~ 289 (332)
T cd05623 253 HR-LGQ-NGIEDFKQHPFFTGIDWDNIRN-CEAPYIPEVS 289 (332)
T ss_pred hh-cCC-CCHHHHhCCCCcCCCCHHHHhh-CCCCccCCCC
Confidence 43 321 2799999999999999998764 4555665543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-49 Score=390.19 Aligned_cols=284 Identities=31% Similarity=0.572 Sum_probs=230.6
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
...+..++|++++.||+|+||.||+|+++.++. .||+|++.+..... ......+.+|+.+++.++||||++++++
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~----~~aiK~i~~~~~~~-~~~~~~~~~e~~i~~~~~hp~iv~~~~~ 111 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRK----VYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFYA 111 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCc----EEEEEEEEHHHhhh-hHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 356777999999999999999999999987554 49999997654322 2334556779999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
+.+++.+|+|||||.||+|..++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus 112 ~~~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 112 FQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred EEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 99999999999999999998877543 489999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
++..... ......+.+||
T Consensus 189 a~~~~~~--------------------------------------------------------------~~~~~~~~~gt 206 (371)
T cd05622 189 CMKMNKE--------------------------------------------------------------GMVRCDTAVGT 206 (371)
T ss_pred eeEcCcC--------------------------------------------------------------CcccccCcccC
Confidence 8754210 00112356899
Q ss_pred CCCccceeecCCC----CCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-----CCCCCCChHHHHHHHHhh
Q 042539 252 EEYVSPEVVRGDG----HEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT-----PEFVGQRTALTDLIQRLL 322 (412)
Q Consensus 252 ~~Y~APE~l~~~~----~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-----~~~~~~~~~~~dli~~~L 322 (412)
+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+....+.+++... +.....+..+++||.+||
T Consensus 207 ~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 286 (371)
T cd05622 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFL 286 (371)
T ss_pred ccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHc
Confidence 9999999997643 6889999999999999999999999999888888887543 223357889999999999
Q ss_pred hhCCCccCCCCCChhhhhcCCCCCCCCchhhc-ccCCCCCCCCCCC
Q 042539 323 EKDPVKRLGYLRGACEIKEHVFFKGVRWDLLT-DVLRPPFIPSREE 367 (412)
Q Consensus 323 ~~dP~~R~~~~~~~~e~l~h~ff~~~~~~~~~-~~~~pp~~p~~~~ 367 (412)
. +|..|++- .+++++++|+||++..|.... ....+|+.|....
T Consensus 287 ~-~~~~r~~r-~~~~ei~~h~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (371)
T cd05622 287 T-DREVRLGR-NGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSS 330 (371)
T ss_pred C-ChhhhcCC-CCHHHHhcCcccCCCChhHHhcCCCCCCCCCCCCC
Confidence 8 66665432 279999999999997664322 2234566665433
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-49 Score=383.09 Aligned_cols=272 Identities=35% Similarity=0.702 Sum_probs=225.1
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeeeeEEeCCeEEEEe
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLGSLETDEFLAWAV 102 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~ 102 (412)
+.||+|+||+||+|+++.++. .||||++++...... ........|..++..+ +||||+++++++.+++.+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQ----FFAIKALKKDVVLMD-DDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCC----EEEEEEEEHHHhhhc-chHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEE
Confidence 479999999999999887554 499999977643222 2234455688888765 7999999999999999999999
Q ss_pred eccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhh
Q 042539 103 PYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFE 182 (412)
Q Consensus 103 e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~ 182 (412)
||+.||+|..++... ..+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 76 ey~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~----- 148 (316)
T cd05619 76 EYLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML----- 148 (316)
T ss_pred eCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC-----
Confidence 999999998777543 3589999999999999999999999999999999999999999999999999864210
Q ss_pred hhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecC
Q 042539 183 KQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRG 262 (412)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~ 262 (412)
........+||+.|+|||++.+
T Consensus 149 ----------------------------------------------------------~~~~~~~~~gt~~y~aPE~~~~ 170 (316)
T cd05619 149 ----------------------------------------------------------GDAKTCTFCGTPDYIAPEILLG 170 (316)
T ss_pred ----------------------------------------------------------CCCceeeecCCccccCHHHHcC
Confidence 0111234579999999999999
Q ss_pred CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 263 DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 263 ~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
..++.++|||||||++|+|++|..||.+.+..+.+..+....+.++ ..+.++++||.+||+.||.+|++ ..++++.
T Consensus 171 ~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~---~~~~l~~ 247 (316)
T cd05619 171 QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRLG---VKGDIRQ 247 (316)
T ss_pred CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhhcCC---ChHHHHc
Confidence 8999999999999999999999999999888888877766555444 36789999999999999999995 2359999
Q ss_pred CCCCCCCCchhhcc-cCCCCCCCCCCCc
Q 042539 342 HVFFKGVRWDLLTD-VLRPPFIPSREEN 368 (412)
Q Consensus 342 h~ff~~~~~~~~~~-~~~pp~~p~~~~~ 368 (412)
||||+.++|..+.. ...+|+.|.....
T Consensus 248 h~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (316)
T cd05619 248 HPFFREIDWSALEEREIEPPFKPKVKSA 275 (316)
T ss_pred CcccCCCCHHHHHhCCCCCCcCCCCCCc
Confidence 99999999986644 4567777665433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-49 Score=384.03 Aligned_cols=279 Identities=31% Similarity=0.608 Sum_probs=228.3
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
++|++++.||+|+||+||+++++.++. .||+|++.+..... ......+..|+.++..++|+||+++++++.+++.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~----~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTER----IYAMKILNKWEMLK-RAETACFREERNVLVNGDCQWITTLHYAFQDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCC----EEEEEEEeHHHHHh-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 589999999999999999999877544 49999997654322 2334556779999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+|+|||||.||+|..++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.+..
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999998876532 3589999999999999999999999999999999999999999999999999875421
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
. ........+||+.|+||
T Consensus 155 ~--------------------------------------------------------------~~~~~~~~~gt~~y~aP 172 (331)
T cd05624 155 D--------------------------------------------------------------GTVQSSVAVGTPDYISP 172 (331)
T ss_pred C--------------------------------------------------------------CceeeccccCCcccCCH
Confidence 1 00111235799999999
Q ss_pred eeecC-----CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC--C----CCCCChHHHHHHHHhhhhCC
Q 042539 258 EVVRG-----DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP--E----FVGQRTALTDLIQRLLEKDP 326 (412)
Q Consensus 258 E~l~~-----~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~--~----~~~~~~~~~dli~~~L~~dP 326 (412)
|++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+..... . ....+.++++||.+||..++
T Consensus 173 E~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~ 252 (331)
T cd05624 173 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRE 252 (331)
T ss_pred HHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCch
Confidence 99876 4578899999999999999999999999888888877765331 1 23457899999999998655
Q ss_pred CccCCCCCChhhhhcCCCCCCCCchhhcccCCCCCCCCCCC
Q 042539 327 VKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREE 367 (412)
Q Consensus 327 ~~R~~~~~~~~e~l~h~ff~~~~~~~~~~~~~pp~~p~~~~ 367 (412)
+|++. .+++++++|+||++++|..+.. ..+|++|....
T Consensus 253 -~~~~~-~~~~~~~~h~~f~~~~~~~~~~-~~~~~~p~~~~ 290 (331)
T cd05624 253 -RRLGQ-NGIEDFKKHAFFEGIDWENIRN-LEAPYIPDVSS 290 (331)
T ss_pred -hhcCC-CCHHHHhcCCCcCCCCHHHHhh-CCCCccCCCCC
Confidence 44431 3799999999999999998754 44667766444
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-49 Score=383.86 Aligned_cols=274 Identities=36% Similarity=0.675 Sum_probs=223.7
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeeeeEEeCCeEEEEe
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLGSLETDEFLAWAV 102 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~ 102 (412)
+.||+|+||+||+|+++.++. .||+|++++..... ......+.+|+.++.++ +|+||+++++++.+.+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQ----IYAMKVVKKELVHD-DEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCC----EEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEE
Confidence 479999999999999887554 49999998765432 33456677899999998 5999999999999999999999
Q ss_pred eccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhh
Q 042539 103 PYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFE 182 (412)
Q Consensus 103 e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~ 182 (412)
|||.||+|..++... +.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 76 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~----- 148 (327)
T cd05617 76 EYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG----- 148 (327)
T ss_pred eCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC-----
Confidence 999999997766543 3599999999999999999999999999999999999999999999999999864210
Q ss_pred hhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecC
Q 042539 183 KQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRG 262 (412)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~ 262 (412)
......+.+||+.|+|||++.+
T Consensus 149 ----------------------------------------------------------~~~~~~~~~gt~~y~aPE~~~~ 170 (327)
T cd05617 149 ----------------------------------------------------------PGDTTSTFCGTPNYIAPEILRG 170 (327)
T ss_pred ----------------------------------------------------------CCCceecccCCcccCCHHHHCC
Confidence 1112235689999999999999
Q ss_pred CCCCchhhHHHHHHHHHHHhhCCCCCCCC-------CHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCccCCCC-
Q 042539 263 DGHEFAVDWWALGILTYEMLYGTTPFRGK-------NRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKRLGYL- 333 (412)
Q Consensus 263 ~~~~~~~DiwSlGvil~ell~g~~Pf~~~-------~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R~~~~- 333 (412)
..++.++|||||||++|+|++|..||... ........+......++ ..+..+.++|.+||+.||.+|++..
T Consensus 171 ~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~ 250 (327)
T cd05617 171 EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQP 250 (327)
T ss_pred CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCC
Confidence 99999999999999999999999999642 22334444444433333 4578899999999999999999642
Q ss_pred -CChhhhhcCCCCCCCCchhhcc-cCCCCCCCCCCC
Q 042539 334 -RGACEIKEHVFFKGVRWDLLTD-VLRPPFIPSREE 367 (412)
Q Consensus 334 -~~~~e~l~h~ff~~~~~~~~~~-~~~pp~~p~~~~ 367 (412)
.+.+++++|+||++++|+.+.. ...++|.|....
T Consensus 251 ~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~ 286 (327)
T cd05617 251 QTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQITD 286 (327)
T ss_pred CCCHHHHHcCCCCCCCCHHHHHhCCCCCCccCCCCC
Confidence 3578999999999999997765 445667766543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=371.76 Aligned_cols=269 Identities=32% Similarity=0.584 Sum_probs=218.5
Q ss_pred eeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEEEeecc
Q 042539 26 LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYC 105 (412)
Q Consensus 26 LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 105 (412)
||+|+||+||+|+++.++. .||+|++.+..+... .....+..|+++++.++||||++++++++++..+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~----~~a~K~~~~~~~~~~-~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGK----MYACKKLDKKRLKKK-SGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCc----EEEEEEEcHHHhhcc-hhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecC
Confidence 7999999999999887554 499999976554322 22344556999999999999999999999999999999999
Q ss_pred CCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhhhhc
Q 042539 106 PGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQS 185 (412)
Q Consensus 106 ~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~ 185 (412)
.|++|..++.......+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~------- 148 (277)
T cd05607 76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG------- 148 (277)
T ss_pred CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC-------
Confidence 9999987776655556899999999999999999999999999999999999999999999999998654210
Q ss_pred ccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecCCCC
Q 042539 186 LNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGH 265 (412)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~ 265 (412)
.......||..|+|||++.+..+
T Consensus 149 ---------------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~ 171 (277)
T cd05607 149 ---------------------------------------------------------KTITQRAGTNGYMAPEILKEEPY 171 (277)
T ss_pred ---------------------------------------------------------ceeeccCCCCCccCHHHHccCCC
Confidence 01123468999999999998889
Q ss_pred CchhhHHHHHHHHHHHhhCCCCCCCCCH----HHHHHHHhcCCCC--CCCCChHHHHHHHHhhhhCCCccCCCCCChhhh
Q 042539 266 EFAVDWWALGILTYEMLYGTTPFRGKNR----KETFRNVLMKTPE--FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEI 339 (412)
Q Consensus 266 ~~~~DiwSlGvil~ell~g~~Pf~~~~~----~~~~~~i~~~~~~--~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~ 339 (412)
+.++|+|||||++|+|++|..||.+... .+........... ....++++++||++||++||++|++.....+++
T Consensus 172 ~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 172 SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 9999999999999999999999976432 2333444333322 235688999999999999999999643334789
Q ss_pred hcCCCCCCCCchhhcc-cCCCCCCC
Q 042539 340 KEHVFFKGVRWDLLTD-VLRPPFIP 363 (412)
Q Consensus 340 l~h~ff~~~~~~~~~~-~~~pp~~p 363 (412)
+.|+||++++|..+.. ...|||.|
T Consensus 252 ~~h~~f~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd05607 252 RKHEFFKTINFPRLEAGLIPPPFVP 276 (277)
T ss_pred hcChhhcCCCHHHHhcCcCCCCCCC
Confidence 9999999999987765 34556654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-49 Score=375.51 Aligned_cols=254 Identities=26% Similarity=0.401 Sum_probs=209.2
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
++|++++.||+|+||+||+|+++.++. .||+|+++..... ......+.+|+.+++.++|+||+++++++..++.
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~avK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKE----IVAIKKFKDSEEN--EEVKETTLRELKMLRTLKQENIVELKEAFRRRGK 74 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCc----EEEEEEEeccccc--ccchhhHHHHHHHHHhCCCccccchhhhEecCCE
Confidence 579999999999999999999987544 4999999765322 2334566779999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+|+||||+.++.+..+... ...+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++.+..
T Consensus 75 ~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 75 LYLVFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred EEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 9999999999877654332 34599999999999999999999999999999999999999999999999999975421
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
. .........||+.|+||
T Consensus 153 ~--------------------------------------------------------------~~~~~~~~~~~~~y~aP 170 (287)
T cd07848 153 G--------------------------------------------------------------SNANYTEYVATRWYRSP 170 (287)
T ss_pred c--------------------------------------------------------------ccccccccccccccCCc
Confidence 1 00111245789999999
Q ss_pred eeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--------------CCC-----------------
Q 042539 258 EVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK--------------TPE----------------- 306 (412)
Q Consensus 258 E~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--------------~~~----------------- 306 (412)
|++.+..++.++|||||||++|+|++|++||.+.+..+....+... .+.
T Consensus 171 E~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (287)
T cd07848 171 ELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLER 250 (287)
T ss_pred HHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHH
Confidence 9999988999999999999999999999999987665543332210 000
Q ss_pred --CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCC
Q 042539 307 --FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 307 --~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff 345 (412)
....++++.+||.+||++||++|+ +++++++||||
T Consensus 251 ~~~~~~s~~~~dll~~~L~~~P~~R~----s~~~~l~hp~f 287 (287)
T cd07848 251 RYLGILSGVLLDLMKNLLKLNPTDRY----LTEQCLNHPAF 287 (287)
T ss_pred hhhcccCHHHHHHHHHHccCCcccCC----CHHHHhcCCCC
Confidence 012467799999999999999999 69999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-49 Score=377.85 Aligned_cols=259 Identities=26% Similarity=0.389 Sum_probs=206.9
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
.++|++++.||+|+||+||+|+++.++. .||||+++..... .....+.+|+.+++.++||||+++++++.++.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 76 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGK----LVALKVIRLQEEE---GTPFTAIREASLLKGLKHANIVLLHDIIHTKE 76 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCC----EEEEEEecccccc---ccchhHHHHHHHHhhCCCCCcCeEEEEEecCC
Confidence 5799999999999999999999976544 4999999754321 12334567999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
.+|+||||+. ++|..++... .+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 77 ~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 77 TLTLVFEYVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred eEEEEEECCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 9999999996 4665555443 3458999999999999999999999999999999999999999999999999986431
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
. ........+||+.|+|
T Consensus 155 ~---------------------------------------------------------------~~~~~~~~~~~~~y~a 171 (303)
T cd07869 155 V---------------------------------------------------------------PSHTYSNEVVTLWYRP 171 (303)
T ss_pred C---------------------------------------------------------------CCccCCCCcccCCCCC
Confidence 0 0011123468999999
Q ss_pred ceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCH-HHHHHHHhc--CCC------------C--------------
Q 042539 257 PEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNR-KETFRNVLM--KTP------------E-------------- 306 (412)
Q Consensus 257 PE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-~~~~~~i~~--~~~------------~-------------- 306 (412)
||++.+. .++.++|||||||++|+|++|..||.+... .+.+..+.. ..+ .
T Consensus 172 PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (303)
T cd07869 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNL 251 (303)
T ss_pred hHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccH
Confidence 9998764 578899999999999999999999987543 233332221 000 0
Q ss_pred -----CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCch
Q 042539 307 -----FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 307 -----~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~ 351 (412)
....++.+.+||++||++||++|+ +++++++||||+++.+.
T Consensus 252 ~~~~~~~~~~~~~~dli~~mL~~dp~~R~----s~~~~l~h~~f~~~~~~ 297 (303)
T cd07869 252 RQAWNKLSYVNHAEDLASKLLQCFPKNRL----SAQAALSHEYFSDLPPR 297 (303)
T ss_pred HHHhhccCCChHHHHHHHHHhccCchhcc----CHHHHhcCcccccCChh
Confidence 001346789999999999999999 69999999999988753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-49 Score=374.55 Aligned_cols=254 Identities=26% Similarity=0.382 Sum_probs=208.8
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
.+++|++++.||+|+||+||+|+++.++. .||+|+++..... .....+.+|+++++.++||||+++++++.++
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTEN----LVALKEIRLEHEE---GAPCTAIREVSLLKNLKHANIVTLHDIIHTE 75 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCC----EEEEEEecccccC---CcchhHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 57899999999999999999999877554 4999999754321 1234456799999999999999999999999
Q ss_pred CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchh
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
+.+|+||||+.| +|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 76 ~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~ 153 (288)
T cd07871 76 RCLTLVFEYLDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAK 153 (288)
T ss_pred CeEEEEEeCCCc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeec
Confidence 999999999975 787666543 235889999999999999999999999999999999999999999999999998643
Q ss_pred hchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCc
Q 042539 176 VKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYV 255 (412)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 255 (412)
... ........||+.|+
T Consensus 154 ~~~---------------------------------------------------------------~~~~~~~~~~~~y~ 170 (288)
T cd07871 154 SVP---------------------------------------------------------------TKTYSNEVVTLWYR 170 (288)
T ss_pred cCC---------------------------------------------------------------CccccCceeccccc
Confidence 110 01112346899999
Q ss_pred cceeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC----------------------CC------
Q 042539 256 SPEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT----------------------PE------ 306 (412)
Q Consensus 256 APE~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~----------------------~~------ 306 (412)
|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.... +.
T Consensus 171 aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (288)
T cd07871 171 PPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPL 250 (288)
T ss_pred ChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCch
Confidence 9999876 457999999999999999999999999887766554443210 00
Q ss_pred ---CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCC
Q 042539 307 ---FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 307 ---~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff 345 (412)
.+..+.+++|||.+||++||.+|+ +++|+++||||
T Consensus 251 ~~~~~~~~~~~~dll~~mL~~dp~~R~----t~~~~l~hp~f 288 (288)
T cd07871 251 INHAPRLDTDGIDLLSSLLLYETKSRI----SAEAALRHSYF 288 (288)
T ss_pred HHhCCCCCHHHHHHHHHhcCcCcccCC----CHHHHhcCCCC
Confidence 123467899999999999999999 79999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-49 Score=366.94 Aligned_cols=259 Identities=27% Similarity=0.421 Sum_probs=217.7
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCc-cceeeeeEEeC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPF-LPKLLGSLETD 95 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~ 95 (412)
+..|+.+++||+|+||+||+|+.+.++.. ||+|.+..+.-. +..-....||+.+|+.|+|+| ||.|++++.+.
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~----VALKkirl~~~~--EG~P~taiREisllk~L~~~~~iv~L~dv~~~~ 83 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKF----VALKKIRLEFEE--EGVPSTAIREISLLKRLSHANHIVRLHDVIHTS 83 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCE----EEEEEEeccccc--cCCCchhhHHHHHHHHhCCCcceEEEEeeeeec
Confidence 67899999999999999999999987654 999999765421 334556778999999999999 99999999887
Q ss_pred C------eEEEEeeccCCCCchhHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEc
Q 042539 96 E------FLAWAVPYCPGGDLNVLRYKQND--RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLT 167 (412)
Q Consensus 96 ~------~~~lv~e~~~gg~L~~~~~~~~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~ 167 (412)
+ .+++|+||+ ..||..++..... ..++...++.+++||+.||+|||++||+||||||+||||+++|.+||+
T Consensus 84 ~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKla 162 (323)
T KOG0594|consen 84 NNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLA 162 (323)
T ss_pred ccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeee
Confidence 7 899999999 4578777766543 358889999999999999999999999999999999999999999999
Q ss_pred cccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcc
Q 042539 168 DFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNS 247 (412)
Q Consensus 168 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (412)
|||+|+.+.- .......
T Consensus 163 DFGlAra~~i---------------------------------------------------------------p~~~yt~ 179 (323)
T KOG0594|consen 163 DFGLARAFSI---------------------------------------------------------------PMRTYTP 179 (323)
T ss_pred ccchHHHhcC---------------------------------------------------------------Ccccccc
Confidence 9999985421 0111234
Q ss_pred cccCCCCccceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhc--CCC---C-------------C-
Q 042539 248 FVGTEEYVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLM--KTP---E-------------F- 307 (412)
Q Consensus 248 ~~gt~~Y~APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~--~~~---~-------------~- 307 (412)
-++|.+|+|||++.|. .|+..+||||+|||++||+++++.|.|.+..+++..|.. +.| . +
T Consensus 180 evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~ 259 (323)
T KOG0594|consen 180 EVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFP 259 (323)
T ss_pred cEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCc
Confidence 5789999999999997 689999999999999999999999999999888877753 111 0 1
Q ss_pred ------------CCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCC
Q 042539 308 ------------VGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 308 ------------~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~ 349 (412)
+..+++..|++.+||+++|.+|. +++.++.|+||....
T Consensus 260 ~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~----Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 260 KWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRI----SAKGALTHPYFSELP 309 (323)
T ss_pred CCCCccchHHhccccCccHHHHHHHHhccCcccCc----CHHHHhcChhhcccc
Confidence 11224789999999999999999 699999999999764
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-50 Score=359.03 Aligned_cols=257 Identities=30% Similarity=0.510 Sum_probs=224.6
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhh----hhhHHHHHHHHHHHHHHhhcC-CCccceeeee
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTL----HAKHEAERRARWEIRVLSRLS-HPFLPKLLGS 91 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~----~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~ 91 (412)
.+.|.-.+.||.|..++|-.|.++.++.. +|+|+|....- .+........++|+.||+++. ||+|+++.++
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e----~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ 91 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKE----FAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV 91 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccc----eeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence 35678889999999999999888886655 99999864321 123345566778999999996 9999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
|+++..+++|+|.|+.|.|.+++...- .++|..++.+++|++.|++|||.++||||||||+|||++++-++||+|||+
T Consensus 92 yes~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 92 YESDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred ccCcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccce
Confidence 999999999999999999998887654 499999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
|+.+. .++.....|||
T Consensus 170 a~~l~----------------------------------------------------------------~GekLrelCGT 185 (411)
T KOG0599|consen 170 ACQLE----------------------------------------------------------------PGEKLRELCGT 185 (411)
T ss_pred eeccC----------------------------------------------------------------CchhHHHhcCC
Confidence 98763 44556678999
Q ss_pred CCCccceeecC------CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-----CCCCCCChHHHHHHHH
Q 042539 252 EEYVSPEVVRG------DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT-----PEFVGQRTALTDLIQR 320 (412)
Q Consensus 252 ~~Y~APE~l~~------~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-----~~~~~~~~~~~dli~~ 320 (412)
|+|.|||.+.. .+|+..+|+||+|||+|-|+.|.+||-.....-+++.|+.+. +++.+.+..++|||.+
T Consensus 186 PgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsr 265 (411)
T KOG0599|consen 186 PGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISR 265 (411)
T ss_pred CcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHH
Confidence 99999999853 468999999999999999999999998877777788888765 5566788999999999
Q ss_pred hhhhCCCccCCCCCChhhhhcCCCCCC
Q 042539 321 LLEKDPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 321 ~L~~dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
||+.||++|+ |++|+|+||||..
T Consensus 266 lLqVdp~~Ri----take~LaHpff~q 288 (411)
T KOG0599|consen 266 LLQVDPTKRI----TAKEALAHPFFIQ 288 (411)
T ss_pred HHeeCchhcc----cHHHHhcChHHHH
Confidence 9999999999 7999999999954
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-48 Score=369.85 Aligned_cols=277 Identities=35% Similarity=0.621 Sum_probs=225.1
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeE
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFL 98 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 98 (412)
.|++.+.||+|+||.||++.+..++.. ||+|.+.+..... ......+.+|+.+++.++|+||+.+++.+.+++.+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~----~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKM----YACKKLEKKRIKK-RKGESMALNEKQILEKVNSRFVVSLAYAYETKDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCce----EEEEEEehhhccc-hHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEE
Confidence 478899999999999999999886544 9999987654322 23344566799999999999999999999999999
Q ss_pred EEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhch
Q 042539 99 AWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~ 178 (412)
|+||||+.|++|..++.......+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~- 154 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE- 154 (285)
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC-
Confidence 9999999999998887665555699999999999999999999999999999999999999999999999998864311
Q ss_pred hhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccce
Q 042539 179 TAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPE 258 (412)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 258 (412)
.......+||..|+|||
T Consensus 155 ---------------------------------------------------------------~~~~~~~~g~~~y~aPE 171 (285)
T cd05630 155 ---------------------------------------------------------------GQTIKGRVGTVGYMAPE 171 (285)
T ss_pred ---------------------------------------------------------------CccccCCCCCccccChH
Confidence 01112346899999999
Q ss_pred eecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHH---HHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCccCCCC
Q 042539 259 VVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRK---ETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVKRLGYL 333 (412)
Q Consensus 259 ~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~R~~~~ 333 (412)
++.+..++.++|+|||||++|+|++|+.||.+.... .....+.... ......++++.+||.+||+.||++|+++.
T Consensus 172 ~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~ 251 (285)
T cd05630 172 VVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQ 251 (285)
T ss_pred HHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCC
Confidence 999988999999999999999999999999875421 2222222111 11234678899999999999999999642
Q ss_pred -CChhhhhcCCCCCCCCchhhcc-cCCCCCCCC
Q 042539 334 -RGACEIKEHVFFKGVRWDLLTD-VLRPPFIPS 364 (412)
Q Consensus 334 -~~~~e~l~h~ff~~~~~~~~~~-~~~pp~~p~ 364 (412)
.+++++++||||++++|+.... ...|||.|.
T Consensus 252 ~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05630 252 GGGAREVKEHPLFKQINFKRLEAGMLEPPFKPD 284 (285)
T ss_pred CCchHHHHcChhhhccCHHHHhcCCCCCCCCCC
Confidence 2489999999999999987655 335667664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=388.98 Aligned_cols=251 Identities=27% Similarity=0.458 Sum_probs=215.1
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CC-----ccceeeeeE
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HP-----FLPKLLGSL 92 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hp-----nIv~l~~~~ 92 (412)
+|.+++.||+|+||.|.+|.+..++.. ||||+|++.. ....+...|+++|..|+ |. |||+++++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~----VAIKIiKN~k-----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F 257 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEI----VAIKIIKNKK-----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF 257 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcE----EEEEeeccCh-----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence 789999999999999999999986655 9999997643 33444556999999997 43 899999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCC--CEEEcccc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG--HVTLTDFD 170 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g--~vkL~DFG 170 (412)
...+++|||+|++ +-+|++++....-.+|+...++.++.||+.||.+||+.||||+|||||||||.+-+ .|||+|||
T Consensus 258 ~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 258 YFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred ccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecc
Confidence 9999999999999 67899999988888899999999999999999999999999999999999998654 69999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
.|.... ...-+++.
T Consensus 337 SSc~~~------------------------------------------------------------------q~vytYiQ 350 (586)
T KOG0667|consen 337 SSCFES------------------------------------------------------------------QRVYTYIQ 350 (586)
T ss_pred cccccC------------------------------------------------------------------Ccceeeee
Confidence 997542 22237788
Q ss_pred CCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhc--CCCC----------------------
Q 042539 251 TEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLM--KTPE---------------------- 306 (412)
Q Consensus 251 t~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~--~~~~---------------------- 306 (412)
+..|+|||++.|.+|+.+.||||||||++||++|.+.|.|.+..+++..|+. +.|+
T Consensus 351 SRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~ 430 (586)
T KOG0667|consen 351 SRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPR 430 (586)
T ss_pred ccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCcee
Confidence 9999999999999999999999999999999999999999999988877651 0000
Q ss_pred ----------------------------CC------------CCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCC
Q 042539 307 ----------------------------FV------------GQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346 (412)
Q Consensus 307 ----------------------------~~------------~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~ 346 (412)
.+ .....+.|||.+||.+||.+|+ |+.++++||||.
T Consensus 431 ~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~----tp~qal~Hpfl~ 506 (586)
T KOG0667|consen 431 LCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI----TPAQALNHPFLT 506 (586)
T ss_pred eeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC----CHHHHhcCcccc
Confidence 01 0013578999999999999999 799999999999
Q ss_pred CCC
Q 042539 347 GVR 349 (412)
Q Consensus 347 ~~~ 349 (412)
+..
T Consensus 507 ~~~ 509 (586)
T KOG0667|consen 507 GTS 509 (586)
T ss_pred ccc
Confidence 654
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-49 Score=383.31 Aligned_cols=259 Identities=29% Similarity=0.456 Sum_probs=232.3
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
.+++|..++++|+|+||.+++++++..+.. |++|.|.......+ ..+.+.+|+.+++++.|||||.+++.|..+
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~----~vlK~I~l~~~t~~--~r~~A~~E~~lis~~~hP~iv~y~ds~~~~ 75 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKL----YVLKKINLEKLTEP--ERRSAIQEMDLLSKLLHPNIVEYKDSFEED 75 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCce----EEEEEEeccccCch--hhHHHHHHHHHHHhccCCCeeeeccchhcC
Confidence 578999999999999999999998876554 99999987765433 344777899999999999999999999988
Q ss_pred Ce-EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 96 EF-LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 96 ~~-~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
+. +||||+||+||+|...+..++...|+|+.+..|+.|++.||.|||+++|+|||||+.||++++++.|||.|||+|+.
T Consensus 76 ~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~ 155 (426)
T KOG0589|consen 76 GQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKI 155 (426)
T ss_pred CceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhh
Confidence 87 99999999999999998888777899999999999999999999999999999999999999999999999999997
Q ss_pred hhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCC
Q 042539 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254 (412)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 254 (412)
+... .....+.+|||.|
T Consensus 156 l~~~---------------------------------------------------------------~~~a~tvvGTp~Y 172 (426)
T KOG0589|consen 156 LNPE---------------------------------------------------------------DSLASTVVGTPYY 172 (426)
T ss_pred cCCc---------------------------------------------------------------hhhhheecCCCcc
Confidence 6321 2245688999999
Q ss_pred ccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCccCCC
Q 042539 255 VSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVKRLGY 332 (412)
Q Consensus 255 ~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~R~~~ 332 (412)
|+||++.+.+|+.++|||||||++|||++-+++|.+.+......+|.... |.....+.+++.+|..||..+|..||
T Consensus 173 mcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RP-- 250 (426)
T KOG0589|consen 173 MCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRP-- 250 (426)
T ss_pred cCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCC--
Confidence 99999999999999999999999999999999999999999998888765 33345679999999999999999999
Q ss_pred CCChhhhhcCCCCCC
Q 042539 333 LRGACEIKEHVFFKG 347 (412)
Q Consensus 333 ~~~~~e~l~h~ff~~ 347 (412)
++.++|.+|....
T Consensus 251 --sa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 251 --SALELLRRPHLLR 263 (426)
T ss_pred --CHHHHhhChhhhh
Confidence 6999999988763
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=373.11 Aligned_cols=258 Identities=24% Similarity=0.391 Sum_probs=215.1
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
++..++|++++.||+|+||.||+|+++.++.. ||+|++.... .......+.+|++++++++||||+++++++.
T Consensus 1 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 73 (331)
T cd06649 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLI----MARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFY 73 (331)
T ss_pred CCCcccceEEEeecCCCCEEEEEEEECCCCcE----EEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence 36679999999999999999999999875544 9999996542 2334567888999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeeeCCCCceEEccCCCEEEcccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNM-GIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~-~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
.++.+++||||+.||+|..++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.+|.+||+|||++
T Consensus 74 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 151 (331)
T cd06649 74 SDGEISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVS 151 (331)
T ss_pred ECCEEEEEeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccc
Confidence 9999999999999999988876543 489999999999999999999986 6999999999999999999999999998
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+.... ......+||+
T Consensus 152 ~~~~~-----------------------------------------------------------------~~~~~~~g~~ 166 (331)
T cd06649 152 GQLID-----------------------------------------------------------------SMANSFVGTR 166 (331)
T ss_pred ccccc-----------------------------------------------------------------cccccCCCCc
Confidence 64421 1112457999
Q ss_pred CCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHh-------------------------------
Q 042539 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL------------------------------- 301 (412)
Q Consensus 253 ~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~------------------------------- 301 (412)
.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.
T Consensus 167 ~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (331)
T cd06649 167 SYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMD 246 (331)
T ss_pred CcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccc
Confidence 9999999999889999999999999999999999998765443322110
Q ss_pred ---------------cCC-CC--CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCC
Q 042539 302 ---------------MKT-PE--FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 302 ---------------~~~-~~--~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~ 349 (412)
... +. ....++++++||.+||++||++|| +++++++||||+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rp----t~~ell~h~~~~~~~ 308 (331)
T cd06649 247 SRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERA----DLKMLMNHTFIKRSE 308 (331)
T ss_pred cccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCC----CHHHHhcChHHhhcc
Confidence 000 11 113467899999999999999999 799999999998643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-49 Score=368.48 Aligned_cols=252 Identities=27% Similarity=0.496 Sum_probs=209.5
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC--
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD-- 95 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-- 95 (412)
-.|.-.+++|+|+||.||.+....++ ..||||.+-.+.- .-.+|+++|+.++|||||+|..+|...
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~----~~vAIKKv~~d~r--------~knrEl~im~~l~HpNIV~L~~~f~~~~~ 91 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETE----EEVAIKKVLQDKR--------YKNRELQIMRKLDHPNIVRLLYFFSSSTE 91 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCC----ceeEEEEecCCCC--------cCcHHHHHHHhcCCcCeeeEEEEEEecCC
Confidence 36788899999999999999988764 4499998754331 112499999999999999999998643
Q ss_pred C---eEEEEeeccCCCCchhHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccC-CCEEEccc
Q 042539 96 E---FLAWAVPYCPGGDLNVLRYK--QNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQS-GHVTLTDF 169 (412)
Q Consensus 96 ~---~~~lv~e~~~gg~L~~~~~~--~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~-g~vkL~DF 169 (412)
. .+.+||||++ .+|...+.. ..+..++.-.++.|..||++||.|||++||+||||||+|+|+|.+ |.+|||||
T Consensus 92 ~d~~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDF 170 (364)
T KOG0658|consen 92 SDEVYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDF 170 (364)
T ss_pred CchhHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccC
Confidence 2 5789999995 567666553 234468999999999999999999999999999999999999987 99999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|.|+.+. .++...++.
T Consensus 171 GSAK~L~----------------------------------------------------------------~~epniSYi 186 (364)
T KOG0658|consen 171 GSAKVLV----------------------------------------------------------------KGEPNISYI 186 (364)
T ss_pred Ccceeec----------------------------------------------------------------cCCCceeEE
Confidence 9999873 334456788
Q ss_pred cCCCCccceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhc--CCC------------------C--
Q 042539 250 GTEEYVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLM--KTP------------------E-- 306 (412)
Q Consensus 250 gt~~Y~APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~--~~~------------------~-- 306 (412)
.|+.|+|||.+.|. .|+.+.||||.||++.||+-|++.|.|.+..+++..|+. +.| .
T Consensus 187 cSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik 266 (364)
T KOG0658|consen 187 CSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIK 266 (364)
T ss_pred EeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccc
Confidence 99999999999986 589999999999999999999999999998888777652 111 1
Q ss_pred --------CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCc
Q 042539 307 --------FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRW 350 (412)
Q Consensus 307 --------~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~ 350 (412)
....++++.||+.++|.++|.+|. ++.|++.||||+...-
T Consensus 267 ~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~----~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 267 AHPWHKVFFKRLPPDALDLLSKLLQYSPSKRL----SALEALAHPFFDELRD 314 (364)
T ss_pred cccceeecccCCCHHHHHHHHHHhccChhhcC----CHHHHhcchhhHHhhC
Confidence 123468999999999999999999 6999999999987653
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-48 Score=375.05 Aligned_cols=252 Identities=30% Similarity=0.471 Sum_probs=216.0
Q ss_pred CCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeee
Q 042539 11 TTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLG 90 (412)
Q Consensus 11 ~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 90 (412)
....+..+++.+.+.||+|+||+||.+.++.... ||+|++......... ...+.+|+.+|.+++|||||++++
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~-----vavK~~~~~~~~~~~--~~~f~~E~~il~~l~HpNIV~f~G 106 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDV-----VAVKIISDPDFDDES--RKAFRREASLLSRLRHPNIVQFYG 106 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeCCcee-----EEEEEecchhcChHH--HHHHHHHHHHHHhCCCCCeeeEEE
Confidence 4567788899999999999999999999875432 899999876654333 778889999999999999999999
Q ss_pred eEEeCC-eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcC-ceeeeCCCCceEEccCC-CEEEc
Q 042539 91 SLETDE-FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMG-IAYRDLKPENILIRQSG-HVTLT 167 (412)
Q Consensus 91 ~~~~~~-~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~-iiHrDlKp~NiLl~~~g-~vkL~ 167 (412)
++.... .+++||||+.+|+|..+++....+.++...+..++.||+.|+.|||+++ ||||||||+|||++.++ ++|||
T Consensus 107 ~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~ 186 (362)
T KOG0192|consen 107 ACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIA 186 (362)
T ss_pred EEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEEC
Confidence 999887 7999999999999999988754567999999999999999999999999 99999999999999998 99999
Q ss_pred cccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcc
Q 042539 168 DFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNS 247 (412)
Q Consensus 168 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (412)
|||+++...... .....
T Consensus 187 DFGlsr~~~~~~---------------------------------------------------------------~~~~~ 203 (362)
T KOG0192|consen 187 DFGLSREKVISK---------------------------------------------------------------TSMTS 203 (362)
T ss_pred CCccceeecccc---------------------------------------------------------------ccccC
Confidence 999997642110 11123
Q ss_pred cccCCCCccceeec--CCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CCCCCC-CChHHHHHHHHhh
Q 042539 248 FVGTEEYVSPEVVR--GDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK--TPEFVG-QRTALTDLIQRLL 322 (412)
Q Consensus 248 ~~gt~~Y~APE~l~--~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~~~-~~~~~~dli~~~L 322 (412)
..||+.|||||++. ...|+.++||||||+++|||+||+.||.+....+....+... .+..+. +++.+..||.+||
T Consensus 204 ~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW 283 (362)
T KOG0192|consen 204 VAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCW 283 (362)
T ss_pred CCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhC
Confidence 57999999999999 568999999999999999999999999998886666666533 244444 7789999999999
Q ss_pred hhCCCccCCC
Q 042539 323 EKDPVKRLGY 332 (412)
Q Consensus 323 ~~dP~~R~~~ 332 (412)
..||.+||++
T Consensus 284 ~~dp~~RP~f 293 (362)
T KOG0192|consen 284 LVDPSRRPSF 293 (362)
T ss_pred CCCCCcCCCH
Confidence 9999999965
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=368.95 Aligned_cols=309 Identities=48% Similarity=0.834 Sum_probs=241.7
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
++|++.+.||+|+||+||+|.+..++ ..||+|.+.+..... ......+.+|+++++.++|+||+++++.+.+++.
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~----~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTG----KLFALKVLDKKEMIK-RNKVKRVLTEQEILATLDHPFLPTLYASFQTETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCC----cEEEEEEEeccccch-HHHHHHHHHHHHHHHhCCCCCchhheeeeecCCE
Confidence 58999999999999999999987744 449999997765432 2345667889999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
.|+||||+.|++|..++.......+++..++.++.|++.||+|||+.|++|+||||+||+++.+|.++|+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 99999999999999887765556799999999999999999999999999999999999999999999999999875532
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
........... . ..... ..+.. ............+.++||..|+||
T Consensus 156 ~~~~~~~~~~~--~-----------------------~~~~~-~~~~~--------~~~~~~~~~~~~~~~~g~~~y~aP 201 (316)
T cd05574 156 EPPPVSKALRK--G-----------------------SRRSS-VNSIP--------SETFSEEPSFRSNSFVGTEEYIAP 201 (316)
T ss_pred ccccccccccc--c-----------------------ccccc-ccccc--------hhhhcccccCCCCCCcCccCCcCH
Confidence 21100000000 0 00000 00000 000000122234567899999999
Q ss_pred eeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC---CChHHHHHHHHhhhhCCCccCCCCC
Q 042539 258 EVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVG---QRTALTDLIQRLLEKDPVKRLGYLR 334 (412)
Q Consensus 258 E~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~dli~~~L~~dP~~R~~~~~ 334 (412)
|++.+..++.++|||||||++|+|++|..||.+.+....+.++......++. .++.+.++|.+||..||++|++...
T Consensus 202 E~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~ 281 (316)
T cd05574 202 EVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKR 281 (316)
T ss_pred HHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchh
Confidence 9999988999999999999999999999999998888888777765544433 4789999999999999999996655
Q ss_pred ChhhhhcCCCCCCCCchhhcccCCCCCCCCCC
Q 042539 335 GACEIKEHVFFKGVRWDLLTDVLRPPFIPSRE 366 (412)
Q Consensus 335 ~~~e~l~h~ff~~~~~~~~~~~~~pp~~p~~~ 366 (412)
++++++.|+||++.+|..+.. ..||-+|..+
T Consensus 282 ~~~~ll~~~~~~~~~~~~~~~-~~~~~~~~~~ 312 (316)
T cd05574 282 GAAEIKQHPFFRGVNWALIRH-TTPPIIPRPD 312 (316)
T ss_pred hHHHHHcCchhhcCChhhccc-CCCCCCCCcc
Confidence 699999999999999987766 4455555443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=365.93 Aligned_cols=254 Identities=27% Similarity=0.373 Sum_probs=205.8
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc---CCCccceeeeeEE-
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL---SHPFLPKLLGSLE- 93 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~- 93 (412)
++|++++.||+|+||+||+|++... .+..||+|+++...... .......+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~---~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~ 75 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKN---GGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 75 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCC---CCeEEEEEEEecccCCC--CchHHHHHHHHHHHhhcccCCCCcceEEEEEec
Confidence 4799999999999999999988543 23459999986543211 1223344577777666 5999999999885
Q ss_pred ----eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccc
Q 042539 94 ----TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169 (412)
Q Consensus 94 ----~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DF 169 (412)
....+++||||+. ++|..++.......+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+||
T Consensus 76 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 76 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred ccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccc
Confidence 2456999999996 57877776655556899999999999999999999999999999999999999999999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|+++.... ........
T Consensus 155 g~~~~~~~----------------------------------------------------------------~~~~~~~~ 170 (290)
T cd07862 155 GLARIYSF----------------------------------------------------------------QMALTSVV 170 (290)
T ss_pred cceEeccC----------------------------------------------------------------Cccccccc
Confidence 99865311 11223457
Q ss_pred cCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--C---C------------------
Q 042539 250 GTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT--P---E------------------ 306 (412)
Q Consensus 250 gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~---~------------------ 306 (412)
||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+.+..+.... + .
T Consensus 171 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (290)
T cd07862 171 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQ 250 (290)
T ss_pred ccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCC
Confidence 8999999999998889999999999999999999999999988777766664311 0 0
Q ss_pred -----CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCC
Q 042539 307 -----FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 307 -----~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff 345 (412)
.+..+..+.+||.+||+.||++|| ++.++++||||
T Consensus 251 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~----s~~~~l~hp~f 290 (290)
T cd07862 251 PIEKFVTDIDELGKDLLLKCLTFNPAKRI----SAYSALSHPYF 290 (290)
T ss_pred CHHHHccCCCHHHHHHHHHHhccCchhcC----CHHHHhcCCCC
Confidence 123567789999999999999999 69999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-47 Score=362.72 Aligned_cols=277 Identities=34% Similarity=0.602 Sum_probs=227.6
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeE
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFL 98 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 98 (412)
.|+..+.||+|+||+||++.+..++.. ||+|++.+..... ......+.+|+++++.++|+||+.+++++.+++.+
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~----~aiK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKM----YACKRLEKKRIKK-RKGESMALNEKQILEKVNSQFVVNLAYAYETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcE----EEEEEeehhhhhh-hhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEE
Confidence 478899999999999999998875544 9999997655432 23345567799999999999999999999999999
Q ss_pred EEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhch
Q 042539 99 AWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~ 178 (412)
|+||||+.|++|..++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~- 154 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE- 154 (285)
T ss_pred EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC-
Confidence 9999999999998877765555699999999999999999999999999999999999999999999999998864310
Q ss_pred hhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccce
Q 042539 179 TAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPE 258 (412)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 258 (412)
........|+..|+|||
T Consensus 155 ---------------------------------------------------------------~~~~~~~~g~~~~~aPE 171 (285)
T cd05632 155 ---------------------------------------------------------------GESIRGRVGTVGYMAPE 171 (285)
T ss_pred ---------------------------------------------------------------CCcccCCCCCcCccChH
Confidence 01112346899999999
Q ss_pred eecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHh----cCCCC-CCCCChHHHHHHHHhhhhCCCccCCCC
Q 042539 259 VVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL----MKTPE-FVGQRTALTDLIQRLLEKDPVKRLGYL 333 (412)
Q Consensus 259 ~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~----~~~~~-~~~~~~~~~dli~~~L~~dP~~R~~~~ 333 (412)
++.+..++.++|+|||||++|+|++|..||.+.........+. ..... ....+.++.+||.+||+.||++|+++.
T Consensus 172 ~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred HhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 9998889999999999999999999999998876544333322 22222 234678899999999999999999753
Q ss_pred C-ChhhhhcCCCCCCCCchhhcc-cCCCCCCCC
Q 042539 334 R-GACEIKEHVFFKGVRWDLLTD-VLRPPFIPS 364 (412)
Q Consensus 334 ~-~~~e~l~h~ff~~~~~~~~~~-~~~pp~~p~ 364 (412)
. .+.+++.|+||+.++|+.+.. ...|+|.|.
T Consensus 252 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05632 252 EEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPD 284 (285)
T ss_pred ccChHHHHcChhhhcCCHHHHhcCcCCCCCCCC
Confidence 2 389999999999999986544 446777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=372.52 Aligned_cols=260 Identities=25% Similarity=0.365 Sum_probs=206.9
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC---
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD--- 95 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--- 95 (412)
+|++.+.||+|+||.||+|+++.++. .||||.+..... .......+.+|+++++.++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 74 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGE----KVAIKKINDVFE--HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 74 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCC----EEEEEEechhhc--cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCC
Confidence 58999999999999999999877554 499999864322 122345677899999999999999999988543
Q ss_pred --CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 96 --EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 96 --~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
..+|+|||||. ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++
T Consensus 75 ~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 75 EFKDIYVVFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred CCceEEEEEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccc
Confidence 35899999994 6787766543 349999999999999999999999999999999999999999999999999997
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
...... .........+||+.
T Consensus 152 ~~~~~~------------------------------------------------------------~~~~~~~~~~~t~~ 171 (338)
T cd07859 152 VAFNDT------------------------------------------------------------PTAIFWTDYVATRW 171 (338)
T ss_pred cccccc------------------------------------------------------------CccccccCCCCCCC
Confidence 542110 00011234579999
Q ss_pred CccceeecC--CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHh---------------------------cCC
Q 042539 254 YVSPEVVRG--DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL---------------------------MKT 304 (412)
Q Consensus 254 Y~APE~l~~--~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~---------------------------~~~ 304 (412)
|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+. ...
T Consensus 172 y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 251 (338)
T cd07859 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQ 251 (338)
T ss_pred cCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccC
Confidence 999999876 567899999999999999999999998876543322111 000
Q ss_pred -----CCCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCch
Q 042539 305 -----PEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 305 -----~~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~ 351 (412)
..++..++.+.++|.+||+.||++|| +++++++||||+++...
T Consensus 252 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp----t~~e~l~hp~f~~~~~~ 299 (338)
T cd07859 252 PVPFSQKFPNADPLALRLLERLLAFDPKDRP----TAEEALADPYFKGLAKV 299 (338)
T ss_pred CCchHHhcCCCChHHHHHHHHHcCcCcccCC----CHHHHhcCchhhhcCcc
Confidence 01234567899999999999999999 69999999999986653
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-50 Score=378.89 Aligned_cols=256 Identities=27% Similarity=0.437 Sum_probs=220.3
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
..|..++.||+|+||.||++.+..++.. ||+|++..+.. .+....+.+|+.+|.+++++||.++|+.|..+..
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~----vAiKii~Le~~---~deIediqqei~~Ls~~~~~~it~yygsyl~g~~ 85 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKV----VAIKIIDLEEA---EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK 85 (467)
T ss_pred cccccchhccccccceeeeeeeccccce----EEEEEechhhc---chhhHHHHHHHHHHHhcCcchHHhhhhheeeccc
Confidence 4677789999999999999999886655 99999976653 3344556679999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
++++||||.||++..++... +.+.|.++..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+..+.+
T Consensus 86 LwiiMey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 86 LWIIMEYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred HHHHHHHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeec
Confidence 99999999999998887653 3469999999999999999999999999999999999999999999999999976521
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
...+..+|+|||.||||
T Consensus 164 ---------------------------------------------------------------~~~rr~tfvGTPfwMAP 180 (467)
T KOG0201|consen 164 ---------------------------------------------------------------TVKRRKTFVGTPFWMAP 180 (467)
T ss_pred ---------------------------------------------------------------hhhccccccccccccch
Confidence 22334799999999999
Q ss_pred eeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-C-CCChHHHHHHHHhhhhCCCccCCCCCC
Q 042539 258 EVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF-V-GQRTALTDLIQRLLEKDPVKRLGYLRG 335 (412)
Q Consensus 258 E~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-~-~~~~~~~dli~~~L~~dP~~R~~~~~~ 335 (412)
|++++..|+.++||||||++.+||++|.+|+........+..|-...|+. . .+++.+++||..||.+||+.|| +
T Consensus 181 EVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~Rp----s 256 (467)
T KOG0201|consen 181 EVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRP----S 256 (467)
T ss_pred hhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCc----C
Confidence 99999999999999999999999999999999877644444443433332 2 4578899999999999999999 6
Q ss_pred hhhhhcCCCCCCCC
Q 042539 336 ACEIKEHVFFKGVR 349 (412)
Q Consensus 336 ~~e~l~h~ff~~~~ 349 (412)
|.++++|+|++...
T Consensus 257 A~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 257 AKELLKHKFIKRAK 270 (467)
T ss_pred HHHHhhhHHHHhcC
Confidence 99999999998754
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=359.29 Aligned_cols=275 Identities=38% Similarity=0.680 Sum_probs=233.3
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
++|++++.||+|+||.||++.+...+ +.||+|++.+.... .......+.+|+++++.++||||+++++++.+++.
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~----~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSG----KYYALKILSKAKIV-KLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCC----CEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCe
Confidence 58999999999999999999988754 44999999765442 22345667889999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+|+||||+.|++|..++... ..+++..+..++.|++.||.|||++||+|+||+|+|||++.+|.+||+|||+++....
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred EEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999998887654 4599999999999999999999999999999999999999999999999999865421
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
. ....+|++.|+||
T Consensus 154 ~------------------------------------------------------------------~~~~~~~~~y~aP 167 (290)
T cd05580 154 R------------------------------------------------------------------TYTLCGTPEYLAP 167 (290)
T ss_pred C------------------------------------------------------------------CCCCCCCccccCh
Confidence 0 2234689999999
Q ss_pred eeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCccCCC-CCC
Q 042539 258 EVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKRLGY-LRG 335 (412)
Q Consensus 258 E~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R~~~-~~~ 335 (412)
|.+.+..++.++|+|||||++|+|++|..||...+......++......++ ..+..++++|.+||..||.+|++. ..+
T Consensus 168 E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~ 247 (290)
T cd05580 168 EIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNG 247 (290)
T ss_pred hhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHccCCHHHccCcccCC
Confidence 999888889999999999999999999999998887777777776554443 457899999999999999999965 347
Q ss_pred hhhhhcCCCCCCCCchhhc-ccCCCCCCCCC
Q 042539 336 ACEIKEHVFFKGVRWDLLT-DVLRPPFIPSR 365 (412)
Q Consensus 336 ~~e~l~h~ff~~~~~~~~~-~~~~pp~~p~~ 365 (412)
++++++||||+.++|..+. .....|+.|..
T Consensus 248 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (290)
T cd05580 248 VNDIKNHPWFAGIDWIALLQRKIEAPFIPKV 278 (290)
T ss_pred HHHHHcCcccccCCHHHHhhccCCCCccCCC
Confidence 9999999999999997553 34456666554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-47 Score=378.19 Aligned_cols=252 Identities=25% Similarity=0.343 Sum_probs=202.6
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
.+..++|++++.||+|+||.||+|.+..++.. ||+|.... ..+.+|++++++++|||||+++++|.
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~----vaiK~~~~----------~~~~~E~~il~~l~HpnIv~~~~~~~ 153 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEH----VVIKAGQR----------GGTATEAHILRAINHPSIIQLKGTFT 153 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCCCE----EEEechhh----------hhhHHHHHHHHhCCCCCCCCEeEEEE
Confidence 45667899999999999999999999876554 99997532 23456999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
.+...|+|||++. ++|..++... ..+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+
T Consensus 154 ~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~ 230 (391)
T PHA03212 154 YNKFTCLILPRYK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAAC 230 (391)
T ss_pred ECCeeEEEEecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccc
Confidence 9999999999995 6776665443 358999999999999999999999999999999999999999999999999986
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
..... ........+||+.
T Consensus 231 ~~~~~--------------------------------------------------------------~~~~~~~~~gt~~ 248 (391)
T PHA03212 231 FPVDI--------------------------------------------------------------NANKYYGWAGTIA 248 (391)
T ss_pred ccccc--------------------------------------------------------------cccccccccCccC
Confidence 43110 0112234679999
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCC-------HHHHHHHHhc------------------------
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKN-------RKETFRNVLM------------------------ 302 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-------~~~~~~~i~~------------------------ 302 (412)
|+|||++.+..++.++|||||||++|||++|..||.+.. ....+..++.
T Consensus 249 y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~ 328 (391)
T PHA03212 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGL 328 (391)
T ss_pred CCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHH
Confidence 999999999999999999999999999999998875421 1111111110
Q ss_pred --CC---C----C---CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCC
Q 042539 303 --KT---P----E---FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 303 --~~---~----~---~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~ 348 (412)
.. + . ....+.++.+||.+||+.||.+|| +++|+++||||+.+
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rp----ta~elL~hp~f~~~ 382 (391)
T PHA03212 329 AKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRP----SAEALLDFAAFQDI 382 (391)
T ss_pred HhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCC----CHHHHhcChhhccC
Confidence 00 0 0 012345789999999999999999 79999999999864
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-47 Score=383.97 Aligned_cols=255 Identities=25% Similarity=0.432 Sum_probs=204.0
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET 94 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 94 (412)
...++|++++.||+|+||+||+|.+..++. .||||++.+.. ....+|+.+++.++|+|||+++++|..
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~----~vAiK~i~~~~--------~~~~~Ei~il~~l~h~niv~l~~~~~~ 130 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSE----KVAIKKVLQDP--------QYKNRELLIMKNLNHINIIFLKDYYYT 130 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCC----EEEEEEEecCc--------chHHHHHHHHHhcCCCCCcceeeeEee
Confidence 345689999999999999999999876544 49999885432 122359999999999999999998753
Q ss_pred C--------CeEEEEeeccCCCCchhHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCC-C
Q 042539 95 D--------EFLAWAVPYCPGGDLNVLRYK--QNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG-H 163 (412)
Q Consensus 95 ~--------~~~~lv~e~~~gg~L~~~~~~--~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g-~ 163 (412)
. ..+++|||||.+ +|..++.. .....+++..++.++.||+.||.|||++||+||||||+|||++.++ .
T Consensus 131 ~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~ 209 (440)
T PTZ00036 131 ECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHT 209 (440)
T ss_pred cccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCc
Confidence 2 257899999976 45444332 2345699999999999999999999999999999999999999765 6
Q ss_pred EEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCC
Q 042539 164 VTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGE 243 (412)
Q Consensus 164 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (412)
+||+|||+|+.+.. +.
T Consensus 210 vkL~DFGla~~~~~----------------------------------------------------------------~~ 225 (440)
T PTZ00036 210 LKLCDFGSAKNLLA----------------------------------------------------------------GQ 225 (440)
T ss_pred eeeeccccchhccC----------------------------------------------------------------CC
Confidence 99999999975421 11
Q ss_pred CCcccccCCCCccceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--C---------------
Q 042539 244 RSNSFVGTEEYVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT--P--------------- 305 (412)
Q Consensus 244 ~~~~~~gt~~Y~APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~--------------- 305 (412)
...+.+||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+.+.+++... +
T Consensus 226 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~ 305 (440)
T PTZ00036 226 RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADI 305 (440)
T ss_pred CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcc
Confidence 22345789999999998764 68999999999999999999999999987766655554210 0
Q ss_pred CC-------------CCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCc
Q 042539 306 EF-------------VGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRW 350 (412)
Q Consensus 306 ~~-------------~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~ 350 (412)
.+ ...++++.+||.+||++||.+|+ ++.++++||||..+..
T Consensus 306 ~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~----ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 306 KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRL----NPIEALADPFFDDLRD 359 (440)
T ss_pred cCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCc----CHHHHhCChhHHhhhc
Confidence 01 12457899999999999999999 7999999999987654
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-47 Score=371.81 Aligned_cols=254 Identities=26% Similarity=0.429 Sum_probs=205.0
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET 94 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 94 (412)
...++|++++.||+|+||.||+|++..++. .||+|++.+... .......+.+|+.+++.++||||+++++++..
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGI----NVAVKKLSRPFQ--NQTHAKRAYRELVLLKCVNHKNIISLLNVFTP 91 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCc----eeEEEEeccccc--chhHHHHHHHHHHHHHhCCCCCEeeeeeeecc
Confidence 346899999999999999999999877554 499999976532 22345567789999999999999999999865
Q ss_pred CC------eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcc
Q 042539 95 DE------FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTD 168 (412)
Q Consensus 95 ~~------~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~D 168 (412)
.. .+|+||||+.++ |...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~-l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~D 166 (359)
T cd07876 92 QKSLEEFQDVYLVMELMDAN-LCQVIH----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 166 (359)
T ss_pred CCCccccceeEEEEeCCCcC-HHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEec
Confidence 43 579999999765 433332 2388999999999999999999999999999999999999999999999
Q ss_pred ccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccc
Q 042539 169 FDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248 (412)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (412)
||+++.... .......
T Consensus 167 fg~a~~~~~----------------------------------------------------------------~~~~~~~ 182 (359)
T cd07876 167 FGLARTACT----------------------------------------------------------------NFMMTPY 182 (359)
T ss_pred CCCcccccc----------------------------------------------------------------CccCCCC
Confidence 999864311 1112234
Q ss_pred ccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhc----------------------CCCC
Q 042539 249 VGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLM----------------------KTPE 306 (412)
Q Consensus 249 ~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~----------------------~~~~ 306 (412)
.||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..++. ..+.
T Consensus 183 ~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (359)
T cd07876 183 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQ 262 (359)
T ss_pred cccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCC
Confidence 789999999999999999999999999999999999999998765443322211 1111
Q ss_pred CC---------------------CCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCC
Q 042539 307 FV---------------------GQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 307 ~~---------------------~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
.. ..++.+++||.+||..||++|+ ++.|+++||||..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~----t~~e~l~hp~~~~ 320 (359)
T cd07876 263 YPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRI----SVDEALRHPYITV 320 (359)
T ss_pred CCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCC----CHHHHhcCchhhh
Confidence 11 1246789999999999999999 6999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-47 Score=372.04 Aligned_cols=255 Identities=28% Similarity=0.444 Sum_probs=206.6
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
...+++|+++++||+|+||+||+|++..++. .||||++.... .......+.+|+++++.++|+||+++++++.
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 142 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGR----LYALKVIYGNH---EDTVRRQICREIEILRDVNHPNVVKCHDMFD 142 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCC----EEEEEEEecCC---cHHHHHHHHHHHHHHHhCCCCCcceeeeEec
Confidence 4457899999999999999999999876544 49999996543 2334566788999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
.++.+|+|||||.||+|... ....+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 143 ~~~~~~lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~ 216 (353)
T PLN00034 143 HNGEIQVLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSR 216 (353)
T ss_pred cCCeEEEEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccce
Confidence 99999999999999998532 236788889999999999999999999999999999999999999999999987
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
.+... .......+||..
T Consensus 217 ~~~~~---------------------------------------------------------------~~~~~~~~gt~~ 233 (353)
T PLN00034 217 ILAQT---------------------------------------------------------------MDPCNSSVGTIA 233 (353)
T ss_pred ecccc---------------------------------------------------------------cccccccccCcc
Confidence 54210 011234579999
Q ss_pred CccceeecCC-----CCCchhhHHHHHHHHHHHhhCCCCCCCCCH---HHHHHHHhcCC-C-CCCCCChHHHHHHHHhhh
Q 042539 254 YVSPEVVRGD-----GHEFAVDWWALGILTYEMLYGTTPFRGKNR---KETFRNVLMKT-P-EFVGQRTALTDLIQRLLE 323 (412)
Q Consensus 254 Y~APE~l~~~-----~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---~~~~~~i~~~~-~-~~~~~~~~~~dli~~~L~ 323 (412)
|+|||++... ..+.++|||||||++|||++|+.||..... ......+.... + .....+.++++||.+||.
T Consensus 234 y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 313 (353)
T PLN00034 234 YMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQ 313 (353)
T ss_pred ccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHHHHHcc
Confidence 9999998532 235689999999999999999999974332 22222222221 1 223567899999999999
Q ss_pred hCCCccCCCCCChhhhhcCCCCCCC
Q 042539 324 KDPVKRLGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 324 ~dP~~R~~~~~~~~e~l~h~ff~~~ 348 (412)
.||++|+ ++.|+++||||.+.
T Consensus 314 ~~P~~Rp----t~~ell~hp~~~~~ 334 (353)
T PLN00034 314 REPAKRW----SAMQLLQHPFILRA 334 (353)
T ss_pred CChhhCc----CHHHHhcCcccccC
Confidence 9999999 69999999999863
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=359.18 Aligned_cols=252 Identities=27% Similarity=0.369 Sum_probs=202.8
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc---CCCccceeeeeEEe-
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL---SHPFLPKLLGSLET- 94 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~- 94 (412)
+|++++.||+|+||+||+|+++.++. .||+|.++...... .......+|+.+++.+ +||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~----~~aiK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~ 74 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGH----FVALKSVRVQTNED--GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATS 74 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCc----EEEEEEeccCcCCC--CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence 58999999999999999999987554 49999987543211 1122334466666655 69999999998864
Q ss_pred ----CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccc
Q 042539 95 ----DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 95 ----~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
...++++|||+.+ +|..++.......+++.+++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||
T Consensus 75 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 75 RTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred cCCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccC
Confidence 3468999999975 77777665544568999999999999999999999999999999999999999999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+++..... .......|
T Consensus 154 ~~~~~~~~----------------------------------------------------------------~~~~~~~~ 169 (288)
T cd07863 154 LARIYSCQ----------------------------------------------------------------MALTPVVV 169 (288)
T ss_pred ccccccCc----------------------------------------------------------------ccCCCccc
Confidence 98654210 11123468
Q ss_pred CCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--C-----------------------
Q 042539 251 TEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT--P----------------------- 305 (412)
Q Consensus 251 t~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~----------------------- 305 (412)
|..|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+.++.... +
T Consensus 170 ~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (288)
T cd07863 170 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRP 249 (288)
T ss_pred cccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCc
Confidence 999999999999889999999999999999999999999887766655543210 0
Q ss_pred ---CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCC
Q 042539 306 ---EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 306 ---~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff 345 (412)
..+..+..+.+||.+||++||++|+ ++.+++.||||
T Consensus 250 ~~~~~~~~~~~~~~li~~~L~~dP~~R~----t~~~~l~hp~f 288 (288)
T cd07863 250 VQSVVPEIEESGAQLLLEMLTFNPHKRI----SAFRALQHPFF 288 (288)
T ss_pred hHHhCcCcCHHHHHHHHHHhccCcccCC----CHHHHhcCCCC
Confidence 0124567789999999999999999 69999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=370.37 Aligned_cols=253 Identities=25% Similarity=0.425 Sum_probs=206.4
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
..++|++++.||+|+||.||+|.+..++.. ||||++.+... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~ 95 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERN----VAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQ 95 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcE----EEEEEeCcccc--CchhHHHHHHHHHHHHhcCCCCccccceeeccc
Confidence 468999999999999999999998775544 99999975432 223345677899999999999999999988643
Q ss_pred ------CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccc
Q 042539 96 ------EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169 (412)
Q Consensus 96 ------~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DF 169 (412)
..+|+||||+.+ +|...+.. .+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+||
T Consensus 96 ~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Df 170 (364)
T cd07875 96 KSLEEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 170 (364)
T ss_pred ccccccCeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeC
Confidence 358999999976 45444432 3889999999999999999999999999999999999999999999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|+++.... ........
T Consensus 171 G~a~~~~~----------------------------------------------------------------~~~~~~~~ 186 (364)
T cd07875 171 GLARTAGT----------------------------------------------------------------SFMMTPYV 186 (364)
T ss_pred CCccccCC----------------------------------------------------------------CCcccCCc
Confidence 99964311 01122457
Q ss_pred cCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC----------------------CCC
Q 042539 250 GTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT----------------------PEF 307 (412)
Q Consensus 250 gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~----------------------~~~ 307 (412)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+.+++... +.+
T Consensus 187 ~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (364)
T cd07875 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKY 266 (364)
T ss_pred ccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCc
Confidence 8999999999999999999999999999999999999999988766655543211 110
Q ss_pred C---------------------CCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCC
Q 042539 308 V---------------------GQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 308 ~---------------------~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
. ..++.+++||.+||+.||.+|+ ++.++++||||..
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~----t~~e~L~hp~~~~ 323 (364)
T cd07875 267 AGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI----SVDEALQHPYINV 323 (364)
T ss_pred CCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCC----CHHHHhcCccccc
Confidence 0 1235789999999999999999 7999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=364.99 Aligned_cols=256 Identities=26% Similarity=0.427 Sum_probs=211.9
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
++..++|++++.||+|+||.||++.+..++.. +|+|++.... .......+.+|+++++.++|+||++++++|.
T Consensus 1 ~l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~----~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 73 (333)
T cd06650 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLI----MARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFY 73 (333)
T ss_pred CcchhhhheeccccCCCCEEEEEEEECCCCcE----EEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCcccceeEEEE
Confidence 35678999999999999999999998875544 9999886542 2334556778999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeeeCCCCceEEccCCCEEEcccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNM-GIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~-~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
+++.+|+||||+.||+|..++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.+|.+||+|||++
T Consensus 74 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~ 151 (333)
T cd06650 74 SDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 151 (333)
T ss_pred ECCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcc
Confidence 9999999999999999988876543 489999999999999999999985 7999999999999999999999999998
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
..+... .....+||.
T Consensus 152 ~~~~~~-----------------------------------------------------------------~~~~~~~~~ 166 (333)
T cd06650 152 GQLIDS-----------------------------------------------------------------MANSFVGTR 166 (333)
T ss_pred hhhhhh-----------------------------------------------------------------ccccCCCCc
Confidence 654210 112347899
Q ss_pred CCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH--------------------------------
Q 042539 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNV-------------------------------- 300 (412)
Q Consensus 253 ~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i-------------------------------- 300 (412)
.|+|||++.+..++.++|+|||||++|+|++|+.||...........+
T Consensus 167 ~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (333)
T cd06650 167 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSR 246 (333)
T ss_pred cccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhccccc
Confidence 999999999988999999999999999999999999865443322111
Q ss_pred ------------hcCC-CCC--CCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCC
Q 042539 301 ------------LMKT-PEF--VGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 301 ------------~~~~-~~~--~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
.... +.. ...+.++++||.+||++||++|| ++++++.|+||+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rp----t~~ell~h~~~~~ 304 (333)
T cd06650 247 PPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERA----DLKQLMVHAFIKR 304 (333)
T ss_pred ccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCc----CHHHHhhCHHHhc
Confidence 1111 111 12457899999999999999999 6999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=361.19 Aligned_cols=258 Identities=25% Similarity=0.384 Sum_probs=209.6
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET 94 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 94 (412)
..+++|++++.||+|+||+||+|+++.++. .||+|+++..... .....+.+|+++++.++|+||+++++++..
T Consensus 3 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 75 (309)
T cd07872 3 GKMETYIKLEKLGEGTYATVFKGRSKLTEN----LVALKEIRLEHEE---GAPCTAIREVSLLKDLKHANIVTLHDIVHT 75 (309)
T ss_pred CCCCceEEEEEecccCCEEEEEEEecCCCC----eEEEEEeeccccC---CcchhHHHHHHHHHhCCCCCcceEEEEEee
Confidence 457899999999999999999999876544 4999999754321 123345679999999999999999999999
Q ss_pred CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
++..|+||||+.+ +|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 76 ~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 153 (309)
T cd07872 76 DKSLTLVFEYLDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA 153 (309)
T ss_pred CCeEEEEEeCCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcccccee
Confidence 9999999999975 676665443 34589999999999999999999999999999999999999999999999999864
Q ss_pred hhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCC
Q 042539 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254 (412)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 254 (412)
.... ........+|+.|
T Consensus 154 ~~~~---------------------------------------------------------------~~~~~~~~~~~~y 170 (309)
T cd07872 154 KSVP---------------------------------------------------------------TKTYSNEVVTLWY 170 (309)
T ss_pred cCCC---------------------------------------------------------------ccccccccccccc
Confidence 3110 0111234678999
Q ss_pred ccceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC----------------------C------
Q 042539 255 VSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT----------------------P------ 305 (412)
Q Consensus 255 ~APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~----------------------~------ 305 (412)
+|||++.+. .++.++|||||||++|+|++|++||.+.+..+....+.... +
T Consensus 171 ~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (309)
T cd07872 171 RPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQP 250 (309)
T ss_pred cCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCc
Confidence 999998764 57899999999999999999999999877655544332110 0
Q ss_pred ---CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCC
Q 042539 306 ---EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 306 ---~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~ 348 (412)
..+..+.++++||.+||+.||.+|+ +++|+++||||++.
T Consensus 251 ~~~~~~~~~~~~~~li~~~L~~dp~~R~----t~~e~l~h~~~~~~ 292 (309)
T cd07872 251 LINHAPRLDTEGIELLTKFLQYESKKRI----SAEEAMKHAYFRSL 292 (309)
T ss_pred hhhhccCCCHHHHHHHHHhccCChhhCC----CHHHHhcChhhhhc
Confidence 0123567899999999999999999 79999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=367.49 Aligned_cols=254 Identities=26% Similarity=0.423 Sum_probs=204.8
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
..++|++++.||+|+||.||+|.+..++. .||||++.+... .......+.+|+.+++.++|+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 88 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDR----NVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ 88 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCc----eEEEEEeCCccc--ChHHHHHHHHHHHHHHHhCCCchhceeeeeecc
Confidence 46899999999999999999999876544 499999975432 223455677899999999999999999998654
Q ss_pred ------CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccc
Q 042539 96 ------EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169 (412)
Q Consensus 96 ------~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DF 169 (412)
..+|+||||+.++ |...+.. .+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+||
T Consensus 89 ~~~~~~~~~~lv~e~~~~~-l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 89 KSLEEFQDVYLVMELMDAN-LCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred ccccccceeEEEhhhhccc-HHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeC
Confidence 3579999999764 4333322 3889999999999999999999999999999999999999999999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|+++.... .......+
T Consensus 164 g~~~~~~~----------------------------------------------------------------~~~~~~~~ 179 (355)
T cd07874 164 GLARTAGT----------------------------------------------------------------SFMMTPYV 179 (355)
T ss_pred cccccCCC----------------------------------------------------------------ccccCCcc
Confidence 99964311 11122457
Q ss_pred cCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC----------------------CCCC
Q 042539 250 GTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK----------------------TPEF 307 (412)
Q Consensus 250 gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~----------------------~~~~ 307 (412)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..++.. .+.+
T Consensus 180 ~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (355)
T cd07874 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKY 259 (355)
T ss_pred ccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCcc
Confidence 899999999999999999999999999999999999999987755543332210 0000
Q ss_pred ---------------------CCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCC
Q 042539 308 ---------------------VGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 308 ---------------------~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~ 348 (412)
...+.++++||.+||..||++|| ++.|+++||||...
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rp----s~~ell~hp~~~~~ 317 (355)
T cd07874 260 AGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI----SVDEALQHPYINVW 317 (355)
T ss_pred ccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcC----CHHHHhcCcchhcc
Confidence 01235789999999999999999 69999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=347.83 Aligned_cols=251 Identities=29% Similarity=0.438 Sum_probs=211.6
Q ss_pred ccCceee-eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEEe
Q 042539 17 LDNLKAL-KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLET 94 (412)
Q Consensus 17 ~~~y~~~-~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~ 94 (412)
.++|.+- ++||-|-.|+|-.|.++.++.. ||+|++..+ ..+++|+++.-... |||||+++++|++
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ek----fALKvL~Ds---------~KARrEVeLHw~~s~h~~iV~IidVyeN 126 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEK----FALKVLLDS---------PKARREVELHWMASGHPHIVSIIDVYEN 126 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhh----hHHHHHhcC---------HHHHhHhhhhhhhcCCCceEEeehhhhh
Confidence 3566554 5899999999999999987665 999998332 23455787766665 9999999998864
Q ss_pred ----CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccC---CCEEEc
Q 042539 95 ----DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQS---GHVTLT 167 (412)
Q Consensus 95 ----~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~---g~vkL~ 167 (412)
...+.+|||.++||+|.+.+..++...|+|.++..++.||+.|+.|||+.+|.||||||+|+|.... ..+||+
T Consensus 127 s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 127 SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEec
Confidence 4579999999999999998888888889999999999999999999999999999999999999765 468999
Q ss_pred cccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcc
Q 042539 168 DFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNS 247 (412)
Q Consensus 168 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (412)
|||+|+.-.. .....+
T Consensus 207 DfGFAK~t~~----------------------------------------------------------------~~~L~T 222 (400)
T KOG0604|consen 207 DFGFAKETQE----------------------------------------------------------------PGDLMT 222 (400)
T ss_pred ccccccccCC----------------------------------------------------------------CccccC
Confidence 9999985321 122345
Q ss_pred cccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCH----HHHHHHHhcCCCCCCC-----CChHHHHHH
Q 042539 248 FVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNR----KETFRNVLMKTPEFVG-----QRTALTDLI 318 (412)
Q Consensus 248 ~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~----~~~~~~i~~~~~~~~~-----~~~~~~dli 318 (412)
-|-||.|.|||++-...|+..+|+||+||++|-|++|++||..+.. ..+..+|..+...|+. .|++++|+|
T Consensus 223 Pc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlI 302 (400)
T KOG0604|consen 223 PCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLI 302 (400)
T ss_pred CcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHH
Confidence 6889999999999999999999999999999999999999976432 3356677777666654 578999999
Q ss_pred HHhhhhCCCccCCCCCChhhhhcCCCCCCC
Q 042539 319 QRLLEKDPVKRLGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 319 ~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~ 348 (412)
++||..+|++|+ |+++++.|||+.+.
T Consensus 303 R~LLkt~PteRl----TI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 303 RKLLKTEPTERL----TIEEVMDHPWINQY 328 (400)
T ss_pred HHHhcCCchhhe----eHHHhhcCchhccc
Confidence 999999999999 79999999999863
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=378.82 Aligned_cols=250 Identities=27% Similarity=0.378 Sum_probs=196.9
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCC------Cccceeee
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH------PFLPKLLG 90 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~h------pnIv~l~~ 90 (412)
.++|+++++||+|+||+||+|.+..++. .||||++++... .......|+++++.+.| .+|+++++
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~----~vAvK~i~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~ 198 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKE----YCAVKIVRNVPK-----YTRDAKIEIQFMEKVRQADPADRFPLMKIQR 198 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCe----EEEEEEEecchh-----hHHHHHHHHHHHHHHhhcCcccCcceeeeEE
Confidence 4789999999999999999999877544 499999964321 12223446666666654 46899999
Q ss_pred eEEeC-CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeeCCCCceEEccCC------
Q 042539 91 SLETD-EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN-MGIAYRDLKPENILIRQSG------ 162 (412)
Q Consensus 91 ~~~~~-~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDlKp~NiLl~~~g------ 162 (412)
+|..+ .++|+||+++ |++|..++... +.+++.+++.++.||+.||+|||+ .|||||||||+|||++.++
T Consensus 199 ~~~~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 199 YFQNETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred EEEcCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccc
Confidence 99765 5799999998 77776666543 359999999999999999999998 5999999999999998776
Q ss_pred ----------CEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCc
Q 042539 163 ----------HVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPV 232 (412)
Q Consensus 163 ----------~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (412)
.+||+|||++....
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~-------------------------------------------------------- 299 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDER-------------------------------------------------------- 299 (467)
T ss_pred cccccCCCCceEEECCCCccccCc--------------------------------------------------------
Confidence 49999999874321
Q ss_pred cccccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC------
Q 042539 233 SRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE------ 306 (412)
Q Consensus 233 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~------ 306 (412)
.....++||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+..+......
T Consensus 300 ----------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~ 369 (467)
T PTZ00284 300 ----------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWA 369 (467)
T ss_pred ----------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHH
Confidence 1123568999999999999999999999999999999999999999987765544332211000
Q ss_pred -----------------------------------C--CCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCC
Q 042539 307 -----------------------------------F--VGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 307 -----------------------------------~--~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~ 348 (412)
. ...++.+.|||.+||++||++|+ +++|+++||||...
T Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~----ta~e~L~Hp~~~~~ 444 (467)
T PTZ00284 370 GRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL----NARQMTTHPYVLKY 444 (467)
T ss_pred hhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC----CHHHHhcCcccccc
Confidence 0 00134578999999999999999 79999999999853
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=369.76 Aligned_cols=257 Identities=23% Similarity=0.336 Sum_probs=208.1
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC--
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE-- 96 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-- 96 (412)
+|++++.||+|+||+||+|.+..++. .||||++.+... .....+++.+|+.+++.++|+||+++++++...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 74 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGK----RVALKKMPNVFQ--NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHID 74 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCC----EEEEEecccccc--chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCcc
Confidence 58899999999999999999876544 499999865321 2233456778999999999999999999998776
Q ss_pred ---eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 97 ---FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 97 ---~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
.+|+||||+. ++|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 75 ~~~~~~lv~e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 75 PFEEIYVVTELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred ccceEEEEeeccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEecccccee
Confidence 8999999996 566655543 3459999999999999999999999999999999999999999999999999987
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
..... ........++|+.
T Consensus 152 ~~~~~--------------------------------------------------------------~~~~~~~~~~~~~ 169 (372)
T cd07853 152 VEEPD--------------------------------------------------------------ESKHMTQEVVTQY 169 (372)
T ss_pred ecccC--------------------------------------------------------------ccccCCCCCcCCC
Confidence 53110 0011123468899
Q ss_pred CccceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-----------------------C---C-
Q 042539 254 YVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK-----------------------T---P- 305 (412)
Q Consensus 254 Y~APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~-----------------------~---~- 305 (412)
|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+..+... . +
T Consensus 170 y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (372)
T cd07853 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPS 249 (372)
T ss_pred cCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCc
Confidence 9999999875 4789999999999999999999999988766555444210 0 0
Q ss_pred ------CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCc
Q 042539 306 ------EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRW 350 (412)
Q Consensus 306 ------~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~ 350 (412)
.....++++.+||.+||+.||.+|+ ++.++++||||.+..+
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~----t~~e~l~hp~~~~~~~ 296 (372)
T cd07853 250 LPVLYTLSSQATHEAVHLLCRMLVFDPDKRI----SAADALAHPYLDEGRL 296 (372)
T ss_pred hHHhcccCCCCCHHHHHHHHHhCCCChhhCc----CHHHHhcCHhhCCCcc
Confidence 0123467899999999999999999 6999999999998654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-46 Score=379.49 Aligned_cols=260 Identities=24% Similarity=0.386 Sum_probs=219.0
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
...|++.+.||+|+||.||+|.+..+. +..||+|.+.... ......+.+|+.+++.++|||||++++++..++
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~---~~~vv~K~~~~~~----~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~ 138 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDP---KEKVVAKFVMLND----ERQAAYARSELHCLAACDHFGIVKHFDDFKSDD 138 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCC---CeEEEEEEcccCC----HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC
Confidence 445999999999999999999876541 3348888774432 233456677999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQ--NDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
.+|+|||||.||+|..++... ....+++.++..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 139 ~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~ 218 (478)
T PTZ00267 139 KLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQ 218 (478)
T ss_pred EEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCcee
Confidence 999999999999998776532 334589999999999999999999999999999999999999999999999999975
Q ss_pred hhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCC
Q 042539 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254 (412)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 254 (412)
+.... ......+.+||+.|
T Consensus 219 ~~~~~-------------------------------------------------------------~~~~~~~~~gt~~y 237 (478)
T PTZ00267 219 YSDSV-------------------------------------------------------------SLDVASSFCGTPYY 237 (478)
T ss_pred cCCcc-------------------------------------------------------------ccccccccCCCccc
Confidence 42110 01123456899999
Q ss_pred ccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC--CCCCChHHHHHHHHhhhhCCCccCCC
Q 042539 255 VSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE--FVGQRTALTDLIQRLLEKDPVKRLGY 332 (412)
Q Consensus 255 ~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~dli~~~L~~dP~~R~~~ 332 (412)
+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..++.+... ....++++.+||.+||..||++||
T Consensus 238 ~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-- 315 (478)
T PTZ00267 238 LAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRP-- 315 (478)
T ss_pred cCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHHHHHhccChhhCc--
Confidence 9999999999999999999999999999999999998888888877654432 235678999999999999999999
Q ss_pred CCChhhhhcCCCCCCC
Q 042539 333 LRGACEIKEHVFFKGV 348 (412)
Q Consensus 333 ~~~~~e~l~h~ff~~~ 348 (412)
++++++.|+|++.+
T Consensus 316 --s~~~~l~~~~~~~~ 329 (478)
T PTZ00267 316 --TTQQLLHTEFLKYV 329 (478)
T ss_pred --CHHHHHhCHHHHHH
Confidence 69999999998643
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=365.45 Aligned_cols=253 Identities=25% Similarity=0.423 Sum_probs=206.6
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC-
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD- 95 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~- 95 (412)
.++|++++.||+|+||+||+|.+..++. .||||++.+.... ......+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQ----KVAVKKLSRPFQS--LIHARRTYRELRLLKHMKHENVIGLLDVFTPAT 87 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCC----EEEEEEeCchhhh--hHHHHHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence 4789999999999999999999877544 4999999765321 22344566799999999999999999988643
Q ss_pred -----CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccc
Q 042539 96 -----EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 96 -----~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
..+|++|+++ |++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||
T Consensus 88 ~~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 88 SIENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCc
Confidence 3579999998 7888766542 359999999999999999999999999999999999999999999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+++.... .....+|
T Consensus 164 ~~~~~~~------------------------------------------------------------------~~~~~~~ 177 (343)
T cd07878 164 LARQADD------------------------------------------------------------------EMTGYVA 177 (343)
T ss_pred cceecCC------------------------------------------------------------------CcCCccc
Confidence 9864311 1124578
Q ss_pred CCCCccceeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-----------------------CC
Q 042539 251 TEEYVSPEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT-----------------------PE 306 (412)
Q Consensus 251 t~~Y~APE~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-----------------------~~ 306 (412)
|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.... +.
T Consensus 178 t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (343)
T cd07878 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPH 257 (343)
T ss_pred cccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhcccc
Confidence 999999999987 467899999999999999999999999877655544432110 00
Q ss_pred ---------CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCC
Q 042539 307 ---------FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 307 ---------~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~ 349 (412)
+...++.+.+||.+||+.||.+|+ ++.++++||||....
T Consensus 258 ~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~----s~~ell~hp~~~~~~ 305 (343)
T cd07878 258 MPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRI----SASEALAHPYFSQYH 305 (343)
T ss_pred ccchhHHHhccCCCHHHHHHHHHHcCCChhhCC----CHHHHhcCcchhccC
Confidence 113456688999999999999999 699999999998643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=363.90 Aligned_cols=262 Identities=22% Similarity=0.321 Sum_probs=206.8
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCC-CCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAAD-PTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLL 89 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~ 89 (412)
++.+..++|++.++||+|+||.||+|.+...+ ..++..||+|+++.... ......+.+|+.+++.+ +||||++++
T Consensus 1 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~niv~~~ 77 (338)
T cd05102 1 QWEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT---ASEHKALMSELKILIHIGNHLNVVNLL 77 (338)
T ss_pred CcccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc---hHHHHHHHHHHHHHHHhccCcceeeEE
Confidence 35677899999999999999999999864432 22345699999965421 22345677899999999 799999999
Q ss_pred eeEEeC-CeEEEEeeccCCCCchhHHHhhC--------------------------------------------------
Q 042539 90 GSLETD-EFLAWAVPYCPGGDLNVLRYKQN-------------------------------------------------- 118 (412)
Q Consensus 90 ~~~~~~-~~~~lv~e~~~gg~L~~~~~~~~-------------------------------------------------- 118 (412)
+++... ..+|+|||||.||+|..++....
T Consensus 78 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (338)
T cd05102 78 GACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGST 157 (338)
T ss_pred eEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccc
Confidence 988754 46899999999999988876432
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhhhhcccC
Q 042539 119 ----------DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNN 188 (412)
Q Consensus 119 ----------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 188 (412)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 158 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~-------- 229 (338)
T cd05102 158 NPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-------- 229 (338)
T ss_pred ccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcc--------
Confidence 12377888999999999999999999999999999999999999999999999975421100
Q ss_pred CCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecCCCCCch
Q 042539 189 NKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFA 268 (412)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~ 268 (412)
.....+..+++.|+|||++.+..++.+
T Consensus 230 -----------------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~ 256 (338)
T cd05102 230 -----------------------------------------------------YVRKGSARLPLKWMAPESIFDKVYTTQ 256 (338)
T ss_pred -----------------------------------------------------hhcccCCCCCccccCcHHhhcCCCCcc
Confidence 011123346788999999999889999
Q ss_pred hhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--C-CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 269 VDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--P-EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 269 ~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~-~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
+|||||||++|||++ |..||.+....+.+...+... + .....++++.+||.+||..||.+|| ++.++++
T Consensus 257 sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP----s~~el~~ 329 (338)
T cd05102 257 SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERP----TFSALVE 329 (338)
T ss_pred cCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCc----CHHHHHH
Confidence 999999999999997 999998865444333333222 1 1234578899999999999999999 5777764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=352.11 Aligned_cols=294 Identities=35% Similarity=0.614 Sum_probs=232.9
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
++|++++.||+|+||.||++.+..++. .||+|.+.+..... ......+.+|+.+++.++|+||+++++.+..++.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~----~v~ik~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQ----RFAMKKINKQNLIL-RNQIQQVFVERDILTFAENPFVVSMFCSFETKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCc----EEEEEEeehhhhhh-HHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCE
Confidence 579999999999999999999877544 49999997664322 2334567789999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+|+||||+.|++|..++... +.+++..+..++.|++.||.|||++|++||||||+||+++.+|.+||+|||+++....
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred EEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999999998887654 3589999999999999999999999999999999999999999999999999864211
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
.... .... ..... . ..........|+..|+||
T Consensus 154 ~~~~---~~~~------------------------------~~~~~-----------~----~~~~~~~~~~~~~~y~aP 185 (305)
T cd05609 154 SLTT---NLYE------------------------------GHIEK-----------D----TREFLDKQVCGTPEYIAP 185 (305)
T ss_pred Cccc---cccc------------------------------ccccc-----------c----hhhccccCCccCccccCc
Confidence 0000 0000 00000 0 000111235688999999
Q ss_pred eeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC----CCChHHHHHHHHhhhhCCCccCCCC
Q 042539 258 EVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV----GQRTALTDLIQRLLEKDPVKRLGYL 333 (412)
Q Consensus 258 E~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~dli~~~L~~dP~~R~~~~ 333 (412)
|.+.+..++.++|+|||||++|+|++|..||.+.+..+....+.......+ ..+.++.++|.+||..||++|+++.
T Consensus 186 E~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 265 (305)
T cd05609 186 EVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTG 265 (305)
T ss_pred hhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCcc
Confidence 999888899999999999999999999999999888777777665433222 4578899999999999999999752
Q ss_pred CChhhhhcCCCCCCCCchhhcccCCCCCCCCCCCc
Q 042539 334 RGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREEN 368 (412)
Q Consensus 334 ~~~~e~l~h~ff~~~~~~~~~~~~~pp~~p~~~~~ 368 (412)
++.++++||||...+|....... ..++|..+..
T Consensus 266 -~~~~ll~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 298 (305)
T cd05609 266 -GAFEVKQHRFFLGLDWNGLLRQK-AEFIPQLESE 298 (305)
T ss_pred -CHHHHHhCccccCCCHHHHhhcC-CCCCCCCCCc
Confidence 58999999999999998766543 3566665443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-46 Score=351.45 Aligned_cols=269 Identities=38% Similarity=0.665 Sum_probs=220.6
Q ss_pred eeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEEEeecc
Q 042539 26 LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYC 105 (412)
Q Consensus 26 LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 105 (412)
||+|+||+||+|.+..++.. ||+|++.+...... .....+..|+.+++.++||||+++++++...+.+|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~----~~ik~~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKM----YACKKLDKKRLKKR-KGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcE----EEEEEEehhhhhhh-hhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecC
Confidence 69999999999998875544 99999976554322 23455667999999999999999999999999999999999
Q ss_pred CCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhhhhc
Q 042539 106 PGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQS 185 (412)
Q Consensus 106 ~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~ 185 (412)
.|++|..++.......+++.++..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++.....
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-------- 147 (277)
T cd05577 76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-------- 147 (277)
T ss_pred CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc--------
Confidence 999998888766545699999999999999999999999999999999999999999999999998865421
Q ss_pred ccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecCCCC
Q 042539 186 LNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGH 265 (412)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~ 265 (412)
........++..|+|||.+.+..+
T Consensus 148 --------------------------------------------------------~~~~~~~~~~~~y~~PE~~~~~~~ 171 (277)
T cd05577 148 --------------------------------------------------------GKKIKGRAGTPGYMAPEVLQGEVY 171 (277)
T ss_pred --------------------------------------------------------CCccccccCCCCcCCHHHhcCCCC
Confidence 011123357889999999988889
Q ss_pred CchhhHHHHHHHHHHHhhCCCCCCCCCH----HHHHHHHhcCCCCC-CCCChHHHHHHHHhhhhCCCccCCCCC-Chhhh
Q 042539 266 EFAVDWWALGILTYEMLYGTTPFRGKNR----KETFRNVLMKTPEF-VGQRTALTDLIQRLLEKDPVKRLGYLR-GACEI 339 (412)
Q Consensus 266 ~~~~DiwSlGvil~ell~g~~Pf~~~~~----~~~~~~i~~~~~~~-~~~~~~~~dli~~~L~~dP~~R~~~~~-~~~e~ 339 (412)
+.++|+|||||++|+|++|+.||..... ......+....... ...++.+.++|.+||+.||.+|+++.. ++.++
T Consensus 172 ~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l 251 (277)
T cd05577 172 DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEV 251 (277)
T ss_pred CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHH
Confidence 9999999999999999999999987543 22222222222222 346789999999999999999998877 89999
Q ss_pred hcCCCCCCCCchhhcc-cCCCCCCC
Q 042539 340 KEHVFFKGVRWDLLTD-VLRPPFIP 363 (412)
Q Consensus 340 l~h~ff~~~~~~~~~~-~~~pp~~p 363 (412)
++||||...+|..... ...|||.+
T Consensus 252 l~h~~~~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd05577 252 REHPLFKDLNWRRLEAGMLEPPFIP 276 (277)
T ss_pred HhChhhhcCChhhhhcCCCCCCCCC
Confidence 9999999999986644 34566654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-46 Score=379.51 Aligned_cols=266 Identities=26% Similarity=0.402 Sum_probs=223.2
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
+.....++|++.+.||+|+||+||+|++..++. .||||++...... ......+.+|+.++..++|+||+++++.
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~----~vAvK~i~~~~~~--~~~~~~~~~Ei~~l~~~~h~~iv~~~~~ 99 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGE----PFAVKVVDMEGMS--EADKNRAQAEVCCLLNCDFFSIVKCHED 99 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCC----EEEEEEEecccCC--HHHHHHHHHHHHHHhcCCCCcEEEeecc
Confidence 445566899999999999999999999877554 4999999765442 2345567789999999999999999988
Q ss_pred EEeCC--------eEEEEeeccCCCCchhHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccC
Q 042539 92 LETDE--------FLAWAVPYCPGGDLNVLRYKQ--NDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQS 161 (412)
Q Consensus 92 ~~~~~--------~~~lv~e~~~gg~L~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~ 161 (412)
+...+ .+++||||+.||+|..++... ....+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 100 ~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~ 179 (496)
T PTZ00283 100 FAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSN 179 (496)
T ss_pred eecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCC
Confidence 75432 378999999999998877543 23468999999999999999999999999999999999999999
Q ss_pred CCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCC
Q 042539 162 GHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDN 241 (412)
Q Consensus 162 g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (412)
+.+||+|||+++.+... ..
T Consensus 180 ~~vkL~DFGls~~~~~~-------------------------------------------------------------~~ 198 (496)
T PTZ00283 180 GLVKLGDFGFSKMYAAT-------------------------------------------------------------VS 198 (496)
T ss_pred CCEEEEecccCeecccc-------------------------------------------------------------cc
Confidence 99999999999764211 00
Q ss_pred CCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC--CCCCCChHHHHHHH
Q 042539 242 GERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP--EFVGQRTALTDLIQ 319 (412)
Q Consensus 242 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~dli~ 319 (412)
.....+.+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+..... .....++++.+||.
T Consensus 199 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 278 (496)
T PTZ00283 199 DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVT 278 (496)
T ss_pred ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 1122356899999999999999999999999999999999999999999888888777765432 23456889999999
Q ss_pred HhhhhCCCccCCCCCChhhhhcCCCCCCC
Q 042539 320 RLLEKDPVKRLGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 320 ~~L~~dP~~R~~~~~~~~e~l~h~ff~~~ 348 (412)
+||..||.+|| ++.++++|||++..
T Consensus 279 ~~L~~dP~~RP----s~~ell~~p~~~~~ 303 (496)
T PTZ00283 279 ALLSSDPKRRP----SSSKLLNMPICKLF 303 (496)
T ss_pred HHcccChhhCc----CHHHHHhCHHHHHh
Confidence 99999999999 68999999998754
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-47 Score=346.54 Aligned_cols=263 Identities=28% Similarity=0.427 Sum_probs=218.1
Q ss_pred Cceee-eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEEeCC
Q 042539 19 NLKAL-KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLETDE 96 (412)
Q Consensus 19 ~y~~~-~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 96 (412)
-|++. +.||+|+|+.|--|....++.. ||||+|.|..- -...++.||++++.+++ |+||++|+++|++++
T Consensus 78 ~YkLt~e~LGeGAyasVqtcv~i~t~~E----YAVKiidKq~g----HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 78 MYKLTSELLGEGAYASVQTCVSIQTGKE----YAVKIIDKQPG----HSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHhHHHHhcCccceeeeeeeeeccchh----hhhhhhhcCCc----hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 34443 5799999999999888776655 99999988643 34677888999999997 999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCC---EEEccccccc
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGH---VTLTDFDLSR 173 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~---vkL~DFGla~ 173 (412)
.+|||||.+.||.|...+..+. .|+|.+|..++..|+.||.|||.+||.||||||+|||..+-++ ||||||.++.
T Consensus 150 ~FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgS 227 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGS 227 (463)
T ss_pred eEEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccc
Confidence 9999999999999977776655 4999999999999999999999999999999999999976654 7999999886
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
.+..... .+ | .......+-||+..
T Consensus 228 g~k~~~~----------------------------------------------~s--p--------astP~L~tPvGSAE 251 (463)
T KOG0607|consen 228 GIKLNND----------------------------------------------CS--P--------ASTPELLTPVGSAE 251 (463)
T ss_pred ccccCCC----------------------------------------------CC--C--------CCCccccCcccchh
Confidence 5422111 00 0 11122346699999
Q ss_pred Cccceeec---C--CCCCchhhHHHHHHHHHHHhhCCCCCCCCC---------------HHHHHHHHhcCCCCCCC----
Q 042539 254 YVSPEVVR---G--DGHEFAVDWWALGILTYEMLYGTTPFRGKN---------------RKETFRNVLMKTPEFVG---- 309 (412)
Q Consensus 254 Y~APE~l~---~--~~~~~~~DiwSlGvil~ell~g~~Pf~~~~---------------~~~~~~~i~~~~~~~~~---- 309 (412)
|||||++. + ..|++++|.||||||||-||.|++||.|.- ...+|..|..+..+|++
T Consensus 252 fMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWa 331 (463)
T KOG0607|consen 252 FMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWA 331 (463)
T ss_pred hcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhH
Confidence 99999863 3 357999999999999999999999998742 34578888888887775
Q ss_pred -CChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCch
Q 042539 310 -QRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 310 -~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~ 351 (412)
++.+++|+|+.+|.+|+..|+ .+.++++|||++.+..+
T Consensus 332 hIS~eakdlisnLlvrda~~rl----sa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 332 HISSEAKDLISNLLVRDAKQRL----SAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HhhHHHHHHHHHHHhccHHhhh----hhhhccCCccccccchh
Confidence 579999999999999999999 58999999999987654
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=371.44 Aligned_cols=262 Identities=28% Similarity=0.442 Sum_probs=233.7
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
..+.....|.++++||+|.|++|.++++..++.. ||||.|+|..++.. ..+.+.+|+++|+.|+|||||+++.+
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~----VaiK~idkt~ln~~--~~~k~~rev~imk~l~HPnIvkl~~v 123 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTE----VAIKIIDKTQLNPS--KRQKLGREVDIMKSLNHPNIVKLFSV 123 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCce----EEEEEehhcccChH--HHHHHHHHHHHHHhcCCcceeeeeee
Confidence 5567788999999999999999999999887665 99999999876443 33447889999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
.++...+|+||||+.||++.+++.... ++.+..++.++.|++.|++|||+++|||||||++|||++.+-++||+|||+
T Consensus 124 ~~t~~~lylV~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgf 201 (596)
T KOG0586|consen 124 IETEATLYLVMEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGF 201 (596)
T ss_pred eeecceeEEEEEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeecccc
Confidence 999999999999999999988887654 488899999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
+..+ +.+....++||+
T Consensus 202 S~~~----------------------------------------------------------------~~~~~lqt~cgs 217 (596)
T KOG0586|consen 202 STFF----------------------------------------------------------------DYGLMLQTFCGS 217 (596)
T ss_pred ceee----------------------------------------------------------------cccccccccCCC
Confidence 9765 344556789999
Q ss_pred CCCccceeecCCCC-CchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC-CChHHHHHHHHhhhhCCCcc
Q 042539 252 EEYVSPEVVRGDGH-EFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVG-QRTALTDLIQRLLEKDPVKR 329 (412)
Q Consensus 252 ~~Y~APE~l~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~dli~~~L~~dP~~R 329 (412)
+.|.|||++.|..| +..+|+||+|++||.|+.|..||.|.+..+...+.+.+....+. .+.++.++|+++|..+|.+|
T Consensus 218 ppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr 297 (596)
T KOG0586|consen 218 PPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKR 297 (596)
T ss_pred CCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHHhhccCcccc
Confidence 99999999999988 78999999999999999999999999988888777776655544 46789999999999999999
Q ss_pred CCCCCChhhhhcCCCCCCCC
Q 042539 330 LGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 330 ~~~~~~~~e~l~h~ff~~~~ 349 (412)
. +.+++..|.|.....
T Consensus 298 ~----~~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 298 G----PCDQIMKDRWRNDLL 313 (596)
T ss_pred C----CHHHhhhhcccchhh
Confidence 9 689999999987543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=365.34 Aligned_cols=251 Identities=21% Similarity=0.345 Sum_probs=216.8
Q ss_pred CCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceee
Q 042539 10 QTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLL 89 (412)
Q Consensus 10 ~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~ 89 (412)
...+++..+.+++++.||+|-||.||+++++.... ||+|.++...+. ...+.+|+++|++|+|+|||+++
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~-----vavk~ik~~~m~-----~~~f~~Ea~iMk~L~H~~lV~l~ 267 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTK-----VAVKTIKEGSMS-----PEAFLREAQIMKKLRHEKLVKLY 267 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCc-----ccceEEeccccC-----hhHHHHHHHHHHhCcccCeEEEE
Confidence 34567888899999999999999999999986533 899999765432 23455799999999999999999
Q ss_pred eeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccc
Q 042539 90 GSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169 (412)
Q Consensus 90 ~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DF 169 (412)
+++..++.+||||||+..|+|.+++.......+...+...++.|||.|++||+++++|||||...|||+++++.+||+||
T Consensus 268 gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDF 347 (468)
T KOG0197|consen 268 GVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDF 347 (468)
T ss_pred EEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEccc
Confidence 99999999999999999999999998866778999999999999999999999999999999999999999999999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|||+.+. ..+|..+ ..+ +
T Consensus 348 GLAr~~~-d~~Y~~~--~~~---------------------------------------k-------------------- 365 (468)
T KOG0197|consen 348 GLARLIG-DDEYTAS--EGG---------------------------------------K-------------------- 365 (468)
T ss_pred ccccccC-CCceeec--CCC---------------------------------------C--------------------
Confidence 9999432 2222110 001 1
Q ss_pred cCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCC
Q 042539 250 GTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDP 326 (412)
Q Consensus 250 gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP 326 (412)
-..-|.|||.+....++.+||||||||+||||+| |+.||.+.+..++++.+-.+. +....+++.+.+++..||..+|
T Consensus 366 fPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P 445 (468)
T KOG0197|consen 366 FPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDP 445 (468)
T ss_pred CCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCc
Confidence 1235999999999999999999999999999997 999999999999999988654 6667899999999999999999
Q ss_pred CccCCC
Q 042539 327 VKRLGY 332 (412)
Q Consensus 327 ~~R~~~ 332 (412)
++||+|
T Consensus 446 ~~RPtF 451 (468)
T KOG0197|consen 446 EDRPTF 451 (468)
T ss_pred ccCCCH
Confidence 999976
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=366.96 Aligned_cols=261 Identities=23% Similarity=0.302 Sum_probs=209.1
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
...+|++++.||+|+||.||+|...... .+..||+|.+.+.. ...+|++++++++|+|||++++++..+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~--~~~~v~vK~~~~~~---------~~~~E~~il~~l~h~~iv~~~~~~~~~ 158 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDE--QRKKVIVKAVTGGK---------TPGREIDILKTISHRAIINLIHAYRWK 158 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCc--cceeEEEEeccccc---------cHHHHHHHHHhcCCCCccceeeeEeeC
Confidence 3457999999999999999999765322 45569999885432 233599999999999999999999999
Q ss_pred CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchh
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
..+|+|||++. ++|..++.. ...+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+
T Consensus 159 ~~~~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 159 STVCMVMPKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred CEEEEEehhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 99999999995 567666633 345999999999999999999999999999999999999999999999999999754
Q ss_pred hchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCc
Q 042539 176 VKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYV 255 (412)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 255 (412)
.... ........+||+.|+
T Consensus 236 ~~~~-------------------------------------------------------------~~~~~~~~~gt~~y~ 254 (392)
T PHA03207 236 DAHP-------------------------------------------------------------DTPQCYGWSGTLETN 254 (392)
T ss_pred Cccc-------------------------------------------------------------ccccccccccccCcc
Confidence 2110 011123467999999
Q ss_pred cceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCH---HHHHHHHhcC---------------------------CC
Q 042539 256 SPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNR---KETFRNVLMK---------------------------TP 305 (412)
Q Consensus 256 APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---~~~~~~i~~~---------------------------~~ 305 (412)
|||++.+..++.++|||||||++|||++|+.||.+... ...+..++.. .+
T Consensus 255 aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (392)
T PHA03207 255 SPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRP 334 (392)
T ss_pred CHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccC
Confidence 99999999999999999999999999999999976431 2222222110 00
Q ss_pred CC--------CCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCchhhcc
Q 042539 306 EF--------VGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTD 355 (412)
Q Consensus 306 ~~--------~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~~~~~ 355 (412)
.+ ...+.++.+||.+||..||.+|| ++.+++.||||....|+.++.
T Consensus 335 ~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rp----sa~e~l~~p~f~~~~~~~~~~ 388 (392)
T PHA03207 335 PYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRP----SAQDILSLPLFTKEPINLLNI 388 (392)
T ss_pred CccccchhhccCcchhHHHHHHHHhccChhhCC----CHHHHhhCchhhccchhhhcC
Confidence 00 12346788999999999999999 799999999999988887653
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=352.12 Aligned_cols=259 Identities=25% Similarity=0.366 Sum_probs=209.9
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET 94 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 94 (412)
..+++|++++.||+|+||.||+|+++.++. .||+|.++..... .....+.+|+.+++.++|+||+++++++..
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~----~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~ 75 (301)
T cd07873 3 GKLETYIKLDKLGEGTYATVYKGRSKLTDN----LVALKEIRLEHEE---GAPCTAIREVSLLKDLKHANIVTLHDIIHT 75 (301)
T ss_pred ccccceEEeeEeccCcCEEEEEEEEcCCCc----EEEEEEEeccccc---CchhHHHHHHHHHHhcCCCCcceEEEEEec
Confidence 467899999999999999999999876544 4999998654321 123345679999999999999999999999
Q ss_pred CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
++.+|+||||+. ++|..++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 76 ~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 153 (301)
T cd07873 76 EKSLTLVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA 153 (301)
T ss_pred CCeEEEEEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhc
Confidence 999999999997 4776666543 33589999999999999999999999999999999999999999999999999864
Q ss_pred hhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCC
Q 042539 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254 (412)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 254 (412)
.... ........+++.|
T Consensus 154 ~~~~---------------------------------------------------------------~~~~~~~~~~~~y 170 (301)
T cd07873 154 KSIP---------------------------------------------------------------TKTYSNEVVTLWY 170 (301)
T ss_pred cCCC---------------------------------------------------------------CCcccccceeecc
Confidence 3110 0011123578899
Q ss_pred ccceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC----------------------CC-----
Q 042539 255 VSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT----------------------PE----- 306 (412)
Q Consensus 255 ~APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~----------------------~~----- 306 (412)
+|||++.+. .++.++|||||||++|+|++|++||.+.+..+....+.... +.
T Consensus 171 ~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (301)
T cd07873 171 RPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADC 250 (301)
T ss_pred cCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCcccccc
Confidence 999998764 46889999999999999999999999887665544332110 00
Q ss_pred ----CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCC
Q 042539 307 ----FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 307 ----~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~ 349 (412)
....++.+++||.+||+.||.+|+ +++++++||||....
T Consensus 251 ~~~~~~~~~~~~~~li~~ml~~dp~~R~----t~~eil~h~~f~~~~ 293 (301)
T cd07873 251 LHNHAPRLDSDGAELLSKLLQFEGRKRI----SAEEAMKHPYFHCLG 293 (301)
T ss_pred HHhhcCCCCHHHHHHHHHHhcCCcccCc----CHHHHhcCccccccc
Confidence 123567899999999999999999 699999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-47 Score=371.19 Aligned_cols=257 Identities=27% Similarity=0.450 Sum_probs=219.8
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
+-|.|+..||.|+||+||+|..+.++. ..|-|+|.... .+....++-||.||..++||+||+|++.|..++.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~----lAAaKvIetks----eEELEDylVEIeILa~CdHP~ivkLl~ayy~enk 103 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKL----LAAAKVIETKS----EEELEDYLVEIEILAECDHPVIVKLLSAYYFENK 103 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchh----hhhhhhhcccc----hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc
Confidence 457899999999999999988876544 47889985432 2334445569999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
++|+.|||.||-.+..+..- ...|++.+++.+++|+|.||.|||+++|||||||..|||++.+|.++|+|||.+.....
T Consensus 104 LwiliEFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~ 182 (1187)
T KOG0579|consen 104 LWILIEFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS 182 (1187)
T ss_pred eEEEEeecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh
Confidence 99999999999987665543 35699999999999999999999999999999999999999999999999998754311
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
.-....+|+|||+||||
T Consensus 183 ---------------------------------------------------------------t~qkRDsFIGTPYWMAP 199 (1187)
T KOG0579|consen 183 ---------------------------------------------------------------TRQKRDSFIGTPYWMAP 199 (1187)
T ss_pred ---------------------------------------------------------------HHhhhccccCCcccccc
Confidence 12345689999999999
Q ss_pred eeec-----CCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC----CCChHHHHHHHHhhhhCCCc
Q 042539 258 EVVR-----GDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV----GQRTALTDLIQRLLEKDPVK 328 (412)
Q Consensus 258 E~l~-----~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~dli~~~L~~dP~~ 328 (412)
|++. ..+|+.++||||||++|.||..+.+|-...+...++-+|....|+.. .++..+.||+.+||.+||..
T Consensus 200 EVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~ 279 (1187)
T KOG0579|consen 200 EVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRN 279 (1187)
T ss_pred hheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCcc
Confidence 9874 46899999999999999999999999999999988888887665432 34578999999999999999
Q ss_pred cCCCCCChhhhhcCCCCCCCCc
Q 042539 329 RLGYLRGACEIKEHVFFKGVRW 350 (412)
Q Consensus 329 R~~~~~~~~e~l~h~ff~~~~~ 350 (412)
|| ++.++++||||.++.-
T Consensus 280 Rp----~aaqll~Hpfv~~~~S 297 (1187)
T KOG0579|consen 280 RP----PAAQLLKHPFVQNAPS 297 (1187)
T ss_pred CC----CHHHHhhCcccccCCc
Confidence 99 6999999999997754
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=338.39 Aligned_cols=254 Identities=25% Similarity=0.421 Sum_probs=213.5
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe-CCe
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET-DEF 97 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~ 97 (412)
+|++++.||+|+||.||++.++.++. .||+|.+...... ......+.+|+.++++++|+||+++++.+.. +..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~~k~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGK----QYVIKKLNLRNAS--RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGL 74 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCc----EEEEEEEehhhcC--HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCE
Confidence 58999999999999999999876544 4999999665432 2234557779999999999999999998874 446
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+|++|||+.|++|..++.......+++.++..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..+..
T Consensus 75 ~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 75 LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred EEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 89999999999998887765555689999999999999999999999999999999999999999999999999875421
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
. ........|++.|+||
T Consensus 155 ~---------------------------------------------------------------~~~~~~~~~~~~y~aP 171 (257)
T cd08223 155 Q---------------------------------------------------------------CDMASTLIGTPYYMSP 171 (257)
T ss_pred c---------------------------------------------------------------CCccccccCCcCccCh
Confidence 0 0112245689999999
Q ss_pred eeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-C-CCCCChHHHHHHHHhhhhCCCccCCCCCC
Q 042539 258 EVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP-E-FVGQRTALTDLIQRLLEKDPVKRLGYLRG 335 (412)
Q Consensus 258 E~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-~-~~~~~~~~~dli~~~L~~dP~~R~~~~~~ 335 (412)
|++.+..++.++|+|||||++|+|++|+.||.+.+.......+..... . ....++.+.+||.+||+.||.+|| +
T Consensus 172 E~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----~ 247 (257)
T cd08223 172 ELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRP----S 247 (257)
T ss_pred hHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHhccCcccCC----C
Confidence 999998889999999999999999999999998877666555554332 2 234678999999999999999999 6
Q ss_pred hhhhhcCCCC
Q 042539 336 ACEIKEHVFF 345 (412)
Q Consensus 336 ~~e~l~h~ff 345 (412)
+.++++||||
T Consensus 248 ~~~~l~~~~~ 257 (257)
T cd08223 248 VKSILRQPYI 257 (257)
T ss_pred HHHHhcCCCC
Confidence 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=346.35 Aligned_cols=260 Identities=28% Similarity=0.470 Sum_probs=216.1
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
-+.|+++++||+|+||.||++++..++. .||+|++.... ......+.+|+.+++.++|+||+++++++..+.
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~----~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGA----LAAAKVIETKS----EEELEDYMVEIEILATCNHPYIVKLLGAFYWDG 82 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCc----eEEEEEeccCC----HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC
Confidence 3679999999999999999999877554 49999986542 233556677999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
.+|+||||+.|++|..++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.+|.+||+|||++....
T Consensus 83 ~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 83 KLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV 161 (292)
T ss_pred eEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecc
Confidence 9999999999999977654433 458999999999999999999999999999999999999999999999999886431
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
. .........|++.|+|
T Consensus 162 ~---------------------------------------------------------------~~~~~~~~~~~~~y~a 178 (292)
T cd06644 162 K---------------------------------------------------------------TLQRRDSFIGTPYWMA 178 (292)
T ss_pred c---------------------------------------------------------------cccccceecCCccccC
Confidence 1 0111224568889999
Q ss_pred ceeecC-----CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC----CCCCChHHHHHHHHhhhhCCC
Q 042539 257 PEVVRG-----DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE----FVGQRTALTDLIQRLLEKDPV 327 (412)
Q Consensus 257 PE~l~~-----~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~dli~~~L~~dP~ 327 (412)
||++.+ ..++.++|+|||||++|+|++|.+||...+......++...... ....+.++.++|.+||..||+
T Consensus 179 PE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 258 (292)
T cd06644 179 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPE 258 (292)
T ss_pred ceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcc
Confidence 999853 34678999999999999999999999887766666555443221 224567899999999999999
Q ss_pred ccCCCCCChhhhhcCCCCCCCCchh
Q 042539 328 KRLGYLRGACEIKEHVFFKGVRWDL 352 (412)
Q Consensus 328 ~R~~~~~~~~e~l~h~ff~~~~~~~ 352 (412)
+|| +++++++||||..++|..
T Consensus 259 ~Rp----~~~~il~~~~~~~~~~~~ 279 (292)
T cd06644 259 TRP----SAAQLLEHPFVSSVTSNR 279 (292)
T ss_pred cCc----CHHHHhcCccccccccch
Confidence 999 699999999999988764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=339.55 Aligned_cols=258 Identities=28% Similarity=0.431 Sum_probs=213.8
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhh-hHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHA-KHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
++|++.+.||+|+||.||+|.+..++. .||+|++....... .......+.+|+.++++++||||+++++++.+++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~----~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 77 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGR----ELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE 77 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCc----EEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC
Confidence 579999999999999999998876444 49999987654321 1223456778999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
.+|+||||+.|++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++...
T Consensus 78 ~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 78 TLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred eEEEEEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999999988776543 48999999999999999999999999999999999999999999999999987542
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
.... .........|+..|+|
T Consensus 156 ~~~~------------------------------------------------------------~~~~~~~~~~~~~y~a 175 (263)
T cd06625 156 TICS------------------------------------------------------------SGTGMKSVTGTPYWMS 175 (263)
T ss_pred cccc------------------------------------------------------------ccccccCCCcCccccC
Confidence 1100 0001123468889999
Q ss_pred ceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--CCC-CCCChHHHHHHHHhhhhCCCccCCCC
Q 042539 257 PEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT--PEF-VGQRTALTDLIQRLLEKDPVKRLGYL 333 (412)
Q Consensus 257 PE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~-~~~~~~~~dli~~~L~~dP~~R~~~~ 333 (412)
||++.+..++.++|||||||++|+|++|+.||...+......++.... +.. ...+..+.++|.+||..+|.+||
T Consensus 176 PE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp--- 252 (263)
T cd06625 176 PEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRP--- 252 (263)
T ss_pred cceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCC---
Confidence 999999889999999999999999999999998876666555544332 222 24578999999999999999999
Q ss_pred CChhhhhcCCCC
Q 042539 334 RGACEIKEHVFF 345 (412)
Q Consensus 334 ~~~~e~l~h~ff 345 (412)
++.++++|+||
T Consensus 253 -t~~~ll~~~~~ 263 (263)
T cd06625 253 -SAEELLRHFFV 263 (263)
T ss_pred -CHHHHhhCCCC
Confidence 79999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=341.50 Aligned_cols=254 Identities=39% Similarity=0.690 Sum_probs=210.4
Q ss_pred eeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHH-hhcCCCccceeeeeEEeCCeEEEE
Q 042539 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVL-SRLSHPFLPKLLGSLETDEFLAWA 101 (412)
Q Consensus 23 ~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~~~~~~lv 101 (412)
++.||+|+||.||+|.+...+. .||+|++.+......... .....|..++ ...+|+||+++++++..++.+|+|
T Consensus 1 ~~~l~~g~~~~v~~a~~~~~~~----~vavK~~~~~~~~~~~~~-~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 75 (260)
T cd05611 1 LKPISKGAFGSVYLAKKRSTGD----YFAIKVLKKSDMIAKNQV-TNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLV 75 (260)
T ss_pred CccCCcCCCeeEEEEEecCCCC----eEEEEEecchhhhHHHHH-HHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEE
Confidence 3679999999999999877544 499999977654332222 2333454444 445799999999999999999999
Q ss_pred eeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhh
Q 042539 102 VPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAF 181 (412)
Q Consensus 102 ~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~ 181 (412)
|||+.|++|..++... +.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||+++....
T Consensus 76 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 149 (260)
T cd05611 76 MEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---- 149 (260)
T ss_pred EeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence 9999999998887654 3489999999999999999999999999999999999999999999999998864310
Q ss_pred hhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeec
Q 042539 182 EKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVR 261 (412)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~ 261 (412)
.....|+..|+|||.+.
T Consensus 150 ---------------------------------------------------------------~~~~~~~~~y~~pe~~~ 166 (260)
T cd05611 150 ---------------------------------------------------------------NKKFVGTPDYLAPETIL 166 (260)
T ss_pred ---------------------------------------------------------------cccCCCCcCccChhhhc
Confidence 12346888999999999
Q ss_pred CCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-----CCCChHHHHHHHHhhhhCCCccCCCCCCh
Q 042539 262 GDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF-----VGQRTALTDLIQRLLEKDPVKRLGYLRGA 336 (412)
Q Consensus 262 ~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~dli~~~L~~dP~~R~~~~~~~ 336 (412)
+..++.++|||||||++|+|++|..||...+....+..+......+ ..+++.+.++|.+||+.||.+|++. .++
T Consensus 167 ~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~-~~~ 245 (260)
T cd05611 167 GVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGA-NGY 245 (260)
T ss_pred CCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCC-CcH
Confidence 8888999999999999999999999999988877777665443222 2467899999999999999999963 257
Q ss_pred hhhhcCCCCCCCCch
Q 042539 337 CEIKEHVFFKGVRWD 351 (412)
Q Consensus 337 ~e~l~h~ff~~~~~~ 351 (412)
+|+++||||+.++|+
T Consensus 246 ~~~l~~~~~~~~~~~ 260 (260)
T cd05611 246 QEIKSHPFFKSINWD 260 (260)
T ss_pred HHHHcChHhhcCCCC
Confidence 899999999999995
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=354.06 Aligned_cols=263 Identities=20% Similarity=0.300 Sum_probs=207.2
Q ss_pred eeeeeeecc--CceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeE
Q 042539 21 KALKILGKG--AMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFL 98 (412)
Q Consensus 21 ~~~~~LG~G--~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 98 (412)
+++++||+| +||+||++.++.++.. ||+|.++.... .......+.+|+++++.++||||+++++++.+++.+
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~----vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~ 74 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEY----VTVRRINLEAC--TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 74 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcE----EEEEEechhhc--cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEE
Confidence 467899999 7899999998876554 99999976543 233455677799999999999999999999999999
Q ss_pred EEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhch
Q 042539 99 AWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~ 178 (412)
|+||||+.+|+|.+++.......+++..++.++.|++.||+|||++||+||||||+|||++.++.++++|||.+......
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~ 154 (327)
T cd08227 75 WVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINH 154 (327)
T ss_pred EEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccc
Confidence 99999999999998876554455899999999999999999999999999999999999999999999999866433110
Q ss_pred hhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccce
Q 042539 179 TAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPE 258 (412)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 258 (412)
..... .........+++..|+|||
T Consensus 155 ~~~~~--------------------------------------------------------~~~~~~~~~~~~~~y~aPE 178 (327)
T cd08227 155 GQRLR--------------------------------------------------------VVHDFPKYSVKVLPWLSPE 178 (327)
T ss_pred ccccc--------------------------------------------------------ccccccccccceecccChH
Confidence 00000 0000112335778899999
Q ss_pred eecC--CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-------------------------------
Q 042539 259 VVRG--DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP------------------------------- 305 (412)
Q Consensus 259 ~l~~--~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~------------------------------- 305 (412)
++.+ ..++.++|||||||++|||++|+.||.................
T Consensus 179 ~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (327)
T cd08227 179 VLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGEST 258 (327)
T ss_pred HhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCccc
Confidence 9976 4588999999999999999999999987654443322221110
Q ss_pred ----------------CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCC
Q 042539 306 ----------------EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 306 ----------------~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~ 349 (412)
.....++.+.+||.+||+.||++|| +++++++||||+.+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp----t~~ell~~p~f~~~~ 314 (327)
T cd08227 259 TVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARP----SASTLLNHSFFKQIK 314 (327)
T ss_pred ccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcC----CHHHHhcChhhhhcc
Confidence 0011346799999999999999999 699999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=343.49 Aligned_cols=251 Identities=37% Similarity=0.636 Sum_probs=208.7
Q ss_pred ceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEE
Q 042539 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLA 99 (412)
Q Consensus 20 y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 99 (412)
|++++.||+|+||+||+|++...+. .||+|++....... .......+|+.++++++|+||+++++++.++..++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~----~~~~K~~~~~~~~~--~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 74 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQ----KVAVKIIDKSEIEE--EEREENIREIKILRRLRHPNIVQILDVFQDDNYLY 74 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTE----EEEEEEEESTTHHH--HHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCe----EEEEEEeccccccc--cccchhhhhhhcccccccccccccccccccccccc
Confidence 7899999999999999999988554 49999998775432 22333445999999999999999999999999999
Q ss_pred EEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchh
Q 042539 100 WAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKT 179 (412)
Q Consensus 100 lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~ 179 (412)
+|||++.+++|..++.... .+++.++..++.||+.||.+||++||+|+||||+||+++.+|.++|+|||++....
T Consensus 75 ~v~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--- 149 (260)
T PF00069_consen 75 IVMEYCPGGSLQDYLQKNK--PLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--- 149 (260)
T ss_dssp EEEEEETTEBHHHHHHHHS--SBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST---
T ss_pred ccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccc---
Confidence 9999999999988887433 48999999999999999999999999999999999999999999999999986431
Q ss_pred hhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcccee
Q 042539 180 AFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEV 259 (412)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 259 (412)
..........+|..|+|||+
T Consensus 150 ------------------------------------------------------------~~~~~~~~~~~~~~y~aPE~ 169 (260)
T PF00069_consen 150 ------------------------------------------------------------ENNENFNPFVGTPEYMAPEV 169 (260)
T ss_dssp ------------------------------------------------------------STTSEBSSSSSSGGGSCHHH
T ss_pred ------------------------------------------------------------cccccccccccccccccccc
Confidence 11122335578999999999
Q ss_pred ec-CCCCCchhhHHHHHHHHHHHhhCCCCCCCCC---HHHHHHHHhcCC-----CCCCCCChHHHHHHHHhhhhCCCccC
Q 042539 260 VR-GDGHEFAVDWWALGILTYEMLYGTTPFRGKN---RKETFRNVLMKT-----PEFVGQRTALTDLIQRLLEKDPVKRL 330 (412)
Q Consensus 260 l~-~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~---~~~~~~~i~~~~-----~~~~~~~~~~~dli~~~L~~dP~~R~ 330 (412)
+. +..++.++|+||||+++|+|++|..||...+ ......+..... .........+.++|.+||+.||++||
T Consensus 170 ~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~ 249 (260)
T PF00069_consen 170 LQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRP 249 (260)
T ss_dssp HTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGST
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCc
Confidence 98 7788999999999999999999999999873 333333333211 11112237899999999999999999
Q ss_pred CCCCChhhhhcCCCC
Q 042539 331 GYLRGACEIKEHVFF 345 (412)
Q Consensus 331 ~~~~~~~e~l~h~ff 345 (412)
++.++++||||
T Consensus 250 ----~~~~l~~~~~~ 260 (260)
T PF00069_consen 250 ----SAEELLKHPWF 260 (260)
T ss_dssp ----THHHHHTSGGG
T ss_pred ----CHHHHhcCCCC
Confidence 69999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=386.75 Aligned_cols=267 Identities=26% Similarity=0.388 Sum_probs=217.5
Q ss_pred CCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceee
Q 042539 10 QTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLL 89 (412)
Q Consensus 10 ~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~ 89 (412)
....+..+++|++++.||+|+||+||+|++..++. .||+|++...... ......+.+|+.++++|+|||||+++
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~----~vAlKvIk~~~l~--e~~~~~~~~EI~IL~~L~HPNIVrl~ 78 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQE----FFCWKAISYRGLK--EREKSQLVIEVNVMRELKHKNIVRYI 78 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCe----EEEEEEEeccccC--HHHHHHHHHHHHHHHHcCCCCcCeEE
Confidence 34567888999999999999999999999987544 4999999765432 23456677899999999999999999
Q ss_pred eeEEe--CCeEEEEeeccCCCCchhHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHc-------CceeeeCCCCceEE
Q 042539 90 GSLET--DEFLAWAVPYCPGGDLNVLRYKQ--NDRVFSPSVIRFYLSEIICAIEHLHNM-------GIAYRDLKPENILI 158 (412)
Q Consensus 90 ~~~~~--~~~~~lv~e~~~gg~L~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~yLH~~-------~iiHrDlKp~NiLl 158 (412)
++|.+ ...+|||||||.+|+|..++... ....+++..++.|+.||+.||.|||+. +||||||||+||||
T Consensus 79 d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL 158 (1021)
T PTZ00266 79 DRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL 158 (1021)
T ss_pred EEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEe
Confidence 99865 45799999999999998887642 234599999999999999999999995 49999999999999
Q ss_pred cc-----------------CCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCcccc
Q 042539 159 RQ-----------------SGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGL 221 (412)
Q Consensus 159 ~~-----------------~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (412)
+. .+.+||+|||+++.+..
T Consensus 159 ~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~-------------------------------------------- 194 (1021)
T PTZ00266 159 STGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI-------------------------------------------- 194 (1021)
T ss_pred ecCccccccccccccccCCCCceEEccCCccccccc--------------------------------------------
Confidence 64 24589999999965411
Q ss_pred ccccccCCCCccccccccCCCCCCcccccCCCCccceeecCC--CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHH
Q 042539 222 KKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGD--GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRN 299 (412)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~ 299 (412)
.......+||+.|+|||++.+. .++.++||||||||||+|++|..||...+....+..
T Consensus 195 --------------------~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~ 254 (1021)
T PTZ00266 195 --------------------ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLIS 254 (1021)
T ss_pred --------------------cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHH
Confidence 1112345799999999998653 478899999999999999999999987665554444
Q ss_pred HhcCCCCC--CCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCc
Q 042539 300 VLMKTPEF--VGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRW 350 (412)
Q Consensus 300 i~~~~~~~--~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~ 350 (412)
.+...+.+ ...+.++.+||.+||..+|.+|| ++.+++.|+|++.+..
T Consensus 255 ~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRP----Sa~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 255 ELKRGPDLPIKGKSKELNILIKNLLNLSAKERP----SALQCLGYQIIKNVGP 303 (1021)
T ss_pred HHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCc----CHHHHhccHHHhhcCC
Confidence 44433333 45678999999999999999999 6999999999987654
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=353.33 Aligned_cols=250 Identities=25% Similarity=0.364 Sum_probs=190.4
Q ss_pred eeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe--CCeEEE
Q 042539 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET--DEFLAW 100 (412)
Q Consensus 23 ~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~l 100 (412)
.++||+|+||+||+|+++... ..+.||+|++..... ...+.+|+++++.++||||+++++++.. +..+|+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~--~~~~~aiK~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGK--DDRDYALKQIEGTGI------SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 77 (317)
T ss_pred ccccccCCCeEEEEEEEccCC--CCceEEEEEECCCCC------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEE
Confidence 468999999999999875422 345599999965432 2234569999999999999999999864 457899
Q ss_pred EeeccCCCCchhHHHhh-------CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEE----ccCCCEEEccc
Q 042539 101 AVPYCPGGDLNVLRYKQ-------NDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILI----RQSGHVTLTDF 169 (412)
Q Consensus 101 v~e~~~gg~L~~~~~~~-------~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl----~~~g~vkL~DF 169 (412)
+|||+.+ +|..++... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 78 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred EEeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 9999954 666555432 12248999999999999999999999999999999999999 45678999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|+|+.+.... .........+
T Consensus 157 G~a~~~~~~~------------------------------------------------------------~~~~~~~~~~ 176 (317)
T cd07868 157 GFARLFNSPL------------------------------------------------------------KPLADLDPVV 176 (317)
T ss_pred CceeccCCCC------------------------------------------------------------ccccccCCcc
Confidence 9997542110 0011123457
Q ss_pred cCCCCccceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCH---------HHHHHHHhcC--C------------C
Q 042539 250 GTEEYVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNR---------KETFRNVLMK--T------------P 305 (412)
Q Consensus 250 gt~~Y~APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---------~~~~~~i~~~--~------------~ 305 (412)
||+.|+|||++.+. .++.++|||||||++|+|++|++||.+... ...+.++... . +
T Consensus 177 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (317)
T cd07868 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMP 256 (317)
T ss_pred ccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhcc
Confidence 89999999999874 579999999999999999999999975432 1111111110 0 0
Q ss_pred C-------------------------CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCC
Q 042539 306 E-------------------------FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 306 ~-------------------------~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff 345 (412)
. ....+..+.|||.+||+.||.+|+ |++|+++||||
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~----t~~e~l~hp~f 317 (317)
T cd07868 257 EHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI----TSEQAMQDPYF 317 (317)
T ss_pred chhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCC----CHHHHhcCCCC
Confidence 0 011245688999999999999999 79999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=348.64 Aligned_cols=252 Identities=27% Similarity=0.427 Sum_probs=209.2
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
++|++++.||+|+||.||++.+..++. .+|+|.+.... .......+.+|++++++++||||+++++++.+++.
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~----~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 73 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGL----IMARKLIHLEI---KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGE 73 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCe----EEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCE
Confidence 579999999999999999999877554 49999986542 23345567789999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN-MGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
+|+||||+.|++|..++... ..+++..++.++.|++.||.|||+ .+++||||||+|||++.+|.+||+|||++....
T Consensus 74 ~~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 74 ISICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151 (308)
T ss_pred EEEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence 99999999999998887654 458999999999999999999998 599999999999999999999999999886431
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
. ......+|++.|+|
T Consensus 152 ~-----------------------------------------------------------------~~~~~~~~~~~~~a 166 (308)
T cd06615 152 D-----------------------------------------------------------------SMANSFVGTRSYMS 166 (308)
T ss_pred c-----------------------------------------------------------------cccccCCCCcCccC
Confidence 1 11234578999999
Q ss_pred ceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC---------------------------------
Q 042539 257 PEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK--------------------------------- 303 (412)
Q Consensus 257 PE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--------------------------------- 303 (412)
||++.+..++.++|+|||||++|+|++|+.||...+.......+...
T Consensus 167 PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (308)
T cd06615 167 PERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYI 246 (308)
T ss_pred hhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHH
Confidence 99998888899999999999999999999999765533322211100
Q ss_pred ----CCCC--CCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCC
Q 042539 304 ----TPEF--VGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 304 ----~~~~--~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
.+.. ...+.++++||.+||..||++|| ++.++++||||.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp----t~~~ll~~~~~~~ 292 (308)
T cd06615 247 VNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERA----DLKELTKHPFIKR 292 (308)
T ss_pred hcCCCccCcCcccCHHHHHHHHHHccCChhhCc----CHHHHhcChhhhh
Confidence 0111 12467899999999999999999 6999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=342.24 Aligned_cols=257 Identities=37% Similarity=0.649 Sum_probs=201.4
Q ss_pred eeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHh---hcCCCccceeeeeEEeCCeEEEE
Q 042539 25 ILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLS---RLSHPFLPKLLGSLETDEFLAWA 101 (412)
Q Consensus 25 ~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~---~l~hpnIv~l~~~~~~~~~~~lv 101 (412)
.||+|+||.||++++..++. .||+|++.+....... ......+|..+++ ...|+||+.+++++..++..|+|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGK----MYAMKCLDKKRIKMKQ-GETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCc----EEEEEEEEccccccch-HHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEE
Confidence 48999999999999876544 4999999765442221 1222333444333 34699999999999999999999
Q ss_pred eeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhh
Q 042539 102 VPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAF 181 (412)
Q Consensus 102 ~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~ 181 (412)
|||+.||+|..++... +.+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 76 ~e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--- 150 (279)
T cd05633 76 LDLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--- 150 (279)
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc---
Confidence 9999999998776644 35999999999999999999999999999999999999999999999999998643110
Q ss_pred hhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeec
Q 042539 182 EKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVR 261 (412)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~ 261 (412)
......||..|+|||.+.
T Consensus 151 --------------------------------------------------------------~~~~~~~~~~y~aPE~~~ 168 (279)
T cd05633 151 --------------------------------------------------------------KPHASVGTHGYMAPEVLQ 168 (279)
T ss_pred --------------------------------------------------------------CccCcCCCcCccCHHHhc
Confidence 011236899999999986
Q ss_pred -CCCCCchhhHHHHHHHHHHHhhCCCCCCCCC---HHHHHHHHhcCCCC-CCCCChHHHHHHHHhhhhCCCccCCCC-CC
Q 042539 262 -GDGHEFAVDWWALGILTYEMLYGTTPFRGKN---RKETFRNVLMKTPE-FVGQRTALTDLIQRLLEKDPVKRLGYL-RG 335 (412)
Q Consensus 262 -~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~---~~~~~~~i~~~~~~-~~~~~~~~~dli~~~L~~dP~~R~~~~-~~ 335 (412)
+..++.++|+|||||++|+|++|..||.+.. .............. ....+.++.++|.+||..||++|+++. .+
T Consensus 169 ~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 248 (279)
T cd05633 169 KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRG 248 (279)
T ss_pred CCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCC
Confidence 4567899999999999999999999997543 22222222222222 235678999999999999999999642 46
Q ss_pred hhhhhcCCCCCCCCchhh
Q 042539 336 ACEIKEHVFFKGVRWDLL 353 (412)
Q Consensus 336 ~~e~l~h~ff~~~~~~~~ 353 (412)
+.++++||||++++|...
T Consensus 249 ~~~~~~h~~~~~~~~~~~ 266 (279)
T cd05633 249 AQEVKEHVFFKGIDWQQV 266 (279)
T ss_pred HHHHHhCccccCCCHhHH
Confidence 999999999999988644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=358.51 Aligned_cols=251 Identities=25% Similarity=0.325 Sum_probs=197.7
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
.+...+|++++.||+|+||.||+|++..++. .||+|+..+.. ...|+.+++.++|+||+++++++.
T Consensus 62 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~valK~~~~~~----------~~~E~~~l~~l~h~~iv~~~~~~~ 127 (357)
T PHA03209 62 VVASLGYTVIKTLTPGSEGRVFVATKPGQPD----PVVLKIGQKGT----------TLIEAMLLQNVNHPSVIRMKDTLV 127 (357)
T ss_pred hhhhcCcEEEEEecCCCCeEEEEEEECCCCc----eEEEEeCCccc----------cHHHHHHHHhCCCCCCcChhheEE
Confidence 3445689999999999999999999877544 49999864432 124899999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
.....|+|||++. ++|..++... ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 128 ~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~ 205 (357)
T PHA03209 128 SGAITCMVLPHYS-SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205 (357)
T ss_pred eCCeeEEEEEccC-CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccc
Confidence 9999999999995 5676665543 3468999999999999999999999999999999999999999999999999986
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
.... ........||+.
T Consensus 206 ~~~~----------------------------------------------------------------~~~~~~~~gt~~ 221 (357)
T PHA03209 206 FPVV----------------------------------------------------------------APAFLGLAGTVE 221 (357)
T ss_pred cccc----------------------------------------------------------------Cccccccccccc
Confidence 4210 011124568999
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhhCC-CCCCCCCH---------HHHHHHHhcC----CCCC------------
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLYGT-TPFRGKNR---------KETFRNVLMK----TPEF------------ 307 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~-~Pf~~~~~---------~~~~~~i~~~----~~~~------------ 307 (412)
|+|||++.+..++.++|||||||++|||+++. ++|..... ...+..++.. ...+
T Consensus 222 y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (357)
T PHA03209 222 TNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGF 301 (357)
T ss_pred ccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHH
Confidence 99999999999999999999999999999754 44443211 1111111110 0000
Q ss_pred -------------------CCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCC
Q 042539 308 -------------------VGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 308 -------------------~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~ 348 (412)
...+.++.+||.+||+.||++|| ++.|+++||||+.+
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rp----ta~e~l~hp~f~~~ 357 (357)
T PHA03209 302 IEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRP----SAEEILNYPMFAQL 357 (357)
T ss_pred HhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCc----CHHHHhcCchhccC
Confidence 13356778899999999999999 79999999999853
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=342.68 Aligned_cols=270 Identities=19% Similarity=0.262 Sum_probs=217.1
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCC-CCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAA-DPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~-~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
+++..++|++.+.||+|+||.||+|.++.. .......||+|.++.... ......+.+|+.+++.++|+||++++++
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 77 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS---LRERIEFLNEASVMKGFTCHHVVRLLGV 77 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 456788999999999999999999876532 122345699999865432 1223456779999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCC
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQND--------RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGH 163 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~--------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~ 163 (412)
+.+++..|+||||+.||+|..++..... ..++...+..++.|++.||.|||++||+||||||+|||++.++.
T Consensus 78 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~ 157 (288)
T cd05061 78 VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT 157 (288)
T ss_pred EcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc
Confidence 9999999999999999999988765321 23466788999999999999999999999999999999999999
Q ss_pred EEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCC
Q 042539 164 VTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGE 243 (412)
Q Consensus 164 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (412)
+||+|||+++....... ..
T Consensus 158 ~~L~Dfg~~~~~~~~~~-------------------------------------------------------------~~ 176 (288)
T cd05061 158 VKIGDFGMTRDIYETDY-------------------------------------------------------------YR 176 (288)
T ss_pred EEECcCCcccccccccc-------------------------------------------------------------cc
Confidence 99999999875421100 00
Q ss_pred CCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC-CCC-CCCChHHHHHHHH
Q 042539 244 RSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT-PEF-VGQRTALTDLIQR 320 (412)
Q Consensus 244 ~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~-~~~-~~~~~~~~dli~~ 320 (412)
......++..|+|||.+.+..++.++|+|||||++|||++ |..||.+.+..+....+.... ... ...++.+.++|.+
T Consensus 177 ~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 256 (288)
T cd05061 177 KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRM 256 (288)
T ss_pred ccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 0112345778999999998889999999999999999998 899999988777766665432 222 2446889999999
Q ss_pred hhhhCCCccCCCCCChhhhhc------CCCCCCCCc
Q 042539 321 LLEKDPVKRLGYLRGACEIKE------HVFFKGVRW 350 (412)
Q Consensus 321 ~L~~dP~~R~~~~~~~~e~l~------h~ff~~~~~ 350 (412)
||+.||.+|| ++.++++ ||||++++|
T Consensus 257 ~l~~~p~~Rp----s~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 257 CWQFNPKMRP----TFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred HcCCChhHCc----CHHHHHHHHHhhcCCCCCCCCC
Confidence 9999999999 4667665 999999998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=342.04 Aligned_cols=250 Identities=24% Similarity=0.437 Sum_probs=207.1
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
++|+++++||+|+||+||+|.+..++. .||+|++.+... ......+.+|++++++++||||+++++++..++.
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~----~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 73 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRR----ILAVKVIPLDIT---VELQKQIMSELEILYKCDSPYIIGFYGAFFVENR 73 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCc----EEEEEEEecCCC---hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCE
Confidence 579999999999999999999876544 499999865421 2334567789999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
.++||||+.|++|..+ ..+++..+..++.|++.||.|||++||+|+||||+|||++.+|.+||+|||++..+..
T Consensus 74 ~~lv~e~~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 74 ISICTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred EEEEEecCCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 9999999999998543 1378999999999999999999999999999999999999999999999999865421
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
......+||..|+||
T Consensus 148 -----------------------------------------------------------------~~~~~~~~~~~y~aP 162 (279)
T cd06619 148 -----------------------------------------------------------------SIAKTYVGTNAYMAP 162 (279)
T ss_pred -----------------------------------------------------------------ccccCCCCChhhcCc
Confidence 012245789999999
Q ss_pred eeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCH-------HHHHHHHhcCC-CC--CCCCChHHHHHHHHhhhhCCC
Q 042539 258 EVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNR-------KETFRNVLMKT-PE--FVGQRTALTDLIQRLLEKDPV 327 (412)
Q Consensus 258 E~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-------~~~~~~i~~~~-~~--~~~~~~~~~dli~~~L~~dP~ 327 (412)
|++.+..++.++|+|||||++|+|++|..||..... ......+.... +. ....+.++.+||.+||+.||.
T Consensus 163 E~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 242 (279)
T cd06619 163 ERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPK 242 (279)
T ss_pred eeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChh
Confidence 999998899999999999999999999999965321 12222222222 11 223568899999999999999
Q ss_pred ccCCCCCChhhhhcCCCCCCCC
Q 042539 328 KRLGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 328 ~R~~~~~~~~e~l~h~ff~~~~ 349 (412)
+|| ++++++.|+||...+
T Consensus 243 ~Rp----~~~eil~~~~~~~~~ 260 (279)
T cd06619 243 ERP----APENLMDHPFIVQYN 260 (279)
T ss_pred hCC----CHHHHhcCccccccc
Confidence 999 699999999998654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=342.98 Aligned_cols=253 Identities=25% Similarity=0.355 Sum_probs=203.5
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeE
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFL 98 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 98 (412)
+|++++.||+|+||.||+|+++.++. .||+|+++..... ......+.+|+.++++++||||+++++++.+++.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQ----IVAMKKIRLESEE--EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRL 74 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCc----EEEEEEecccccc--CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeE
Confidence 68999999999999999999876544 4999998654321 22334566799999999999999999999999999
Q ss_pred EEEeeccCCCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 99 AWAVPYCPGGDLNVLRYKQN-DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~~~~~~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
|+||||+. ++|..++.... ...+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++.....
T Consensus 75 ~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 153 (285)
T cd07861 75 YLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI 153 (285)
T ss_pred EEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCC
Confidence 99999997 46766654433 25689999999999999999999999999999999999999999999999999864311
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
. ........+++.|+||
T Consensus 154 ~---------------------------------------------------------------~~~~~~~~~~~~y~aP 170 (285)
T cd07861 154 P---------------------------------------------------------------VRVYTHEVVTLWYRAP 170 (285)
T ss_pred C---------------------------------------------------------------cccccCCcccccccCh
Confidence 0 0011123578899999
Q ss_pred eeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC---------------------C---------CC
Q 042539 258 EVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK---------------------T---------PE 306 (412)
Q Consensus 258 E~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~---------------------~---------~~ 306 (412)
|++.+. .++.++|||||||++|+|++|++||.+.+.......+... . ..
T Consensus 171 E~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (285)
T cd07861 171 EVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSA 250 (285)
T ss_pred HHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHh
Confidence 998764 4688999999999999999999999887654433222110 0 01
Q ss_pred CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCC
Q 042539 307 FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 307 ~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff 345 (412)
....++++.+||.+||+.||.+|| ++.++++||||
T Consensus 251 ~~~~~~~~~~li~~~l~~dP~~Rp----t~~~ll~~~~~ 285 (285)
T cd07861 251 VKNLDEDGLDLLEKMLIYDPAKRI----SAKKALNHPYF 285 (285)
T ss_pred cCCCCHHHHHHHHHHhcCChhhCC----CHHHHhcCCCC
Confidence 224578899999999999999999 79999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=334.05 Aligned_cols=254 Identities=26% Similarity=0.430 Sum_probs=217.1
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeE
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFL 98 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 98 (412)
+|.+.+.||+|+||.||+|.++.++.. |++|.+...... ......+.+|+++++.++|+||+++++++.+++..
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~----~~~k~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRV----YAMKQIDLSKMN--RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKL 74 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcE----EEEEEeehhhCC--HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEE
Confidence 689999999999999999998775544 999998765432 23445677899999999999999999999999999
Q ss_pred EEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhch
Q 042539 99 AWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~ 178 (412)
|+||||+.|++|..++.......+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||+++.+...
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 75 NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred EEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 99999999999998887654556999999999999999999999999999999999999999999999999998754211
Q ss_pred hhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccce
Q 042539 179 TAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPE 258 (412)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 258 (412)
........|++.|+|||
T Consensus 155 ---------------------------------------------------------------~~~~~~~~~~~~y~aPE 171 (256)
T cd08529 155 ---------------------------------------------------------------TNFANTIVGTPYYLSPE 171 (256)
T ss_pred ---------------------------------------------------------------cchhhccccCccccCHH
Confidence 01112446889999999
Q ss_pred eecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-CCCC-CCChHHHHHHHHhhhhCCCccCCCCCCh
Q 042539 259 VVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT-PEFV-GQRTALTDLIQRLLEKDPVKRLGYLRGA 336 (412)
Q Consensus 259 ~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~~-~~~~~~~dli~~~L~~dP~~R~~~~~~~ 336 (412)
++.+..++.++|+|||||++|+|++|+.||...+..+....+.... +... ..+..+.++|.+||+.+|++|| ++
T Consensus 172 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp----~~ 247 (256)
T cd08529 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRP----DT 247 (256)
T ss_pred HhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccCCcccCc----CH
Confidence 9998889999999999999999999999999888777666666543 2222 4578899999999999999999 69
Q ss_pred hhhhcCCCC
Q 042539 337 CEIKEHVFF 345 (412)
Q Consensus 337 ~e~l~h~ff 345 (412)
.+++.|||+
T Consensus 248 ~~ll~~~~~ 256 (256)
T cd08529 248 FQLLRNPSL 256 (256)
T ss_pred HHHhhCCCC
Confidence 999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=360.56 Aligned_cols=271 Identities=28% Similarity=0.468 Sum_probs=225.1
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEEEee
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVP 103 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~e 103 (412)
++||+|-||+||-++++.+++. ||||+|.|-....+++ ..++.|+.||+.+.||.||.|-..|++.+.+++|||
T Consensus 570 evLGSGQFG~VYgg~hRktGrd----VAvKvIdKlrFp~kqe--sqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVME 643 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRD----VAVKVIDKLRFPTKQE--SQLRNEVAILQNLHHPGIVNLECMFETPERVFVVME 643 (888)
T ss_pred hhccCCcceeeecceecccCce----eeeeeeecccCCCchH--HHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEeh
Confidence 6899999999999988886665 9999999887655543 667789999999999999999999999999999999
Q ss_pred ccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccC---CCEEEccccccchhhchhh
Q 042539 104 YCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQS---GHVTLTDFDLSRNLVKKTA 180 (412)
Q Consensus 104 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~---g~vkL~DFGla~~~~~~~~ 180 (412)
.+.| |+.+++.....+++++...++++.||+.||.|||.+||+|+||||+|+|+... -.+||||||+|+.+..+
T Consensus 644 Kl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-- 720 (888)
T KOG4236|consen 644 KLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-- 720 (888)
T ss_pred hhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh--
Confidence 9955 56566666667889999999999999999999999999999999999999765 46999999999987422
Q ss_pred hhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceee
Q 042539 181 FEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVV 260 (412)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l 260 (412)
.-..+.+|||.|.|||++
T Consensus 721 --------------------------------------------------------------sFRrsVVGTPAYLaPEVL 738 (888)
T KOG4236|consen 721 --------------------------------------------------------------SFRRSVVGTPAYLAPEVL 738 (888)
T ss_pred --------------------------------------------------------------hhhhhhcCCccccCHHHH
Confidence 223578999999999999
Q ss_pred cCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCH-HHHHHHH--hcCCCCCCCCChHHHHHHHHhhhhCCCccCCCCCChh
Q 042539 261 RGDGHEFAVDWWALGILTYEMLYGTTPFRGKNR-KETFRNV--LMKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGAC 337 (412)
Q Consensus 261 ~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-~~~~~~i--~~~~~~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~ 337 (412)
..++|+..-|+||+|||+|.-+.|..||+...+ .+++++. +....++..++..+.|||+.+|+..-.+|. +++
T Consensus 739 rnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRy----svd 814 (888)
T KOG4236|consen 739 RNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRY----SVD 814 (888)
T ss_pred hhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhc----chH
Confidence 999999999999999999999999999976432 2333322 233345667889999999999999999999 699
Q ss_pred hhhcCCCCCCCC-chhhcc---cCCCCCCCCCCCch
Q 042539 338 EIKEHVFFKGVR-WDLLTD---VLRPPFIPSREEND 369 (412)
Q Consensus 338 e~l~h~ff~~~~-~~~~~~---~~~pp~~p~~~~~~ 369 (412)
+.+.|||+++.. |-.+.+ ..-+-|+.+..++.
T Consensus 815 k~lsh~Wlq~yq~w~DLRelE~~igeRyiThesDD~ 850 (888)
T KOG4236|consen 815 KSLSHPWLQDYQTWLDLRELEVRIGERYITHESDDA 850 (888)
T ss_pred hhccchhhhcchHHHHHHHHHHhhCcceecCcchhh
Confidence 999999999853 544433 34456776655443
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=341.80 Aligned_cols=253 Identities=28% Similarity=0.453 Sum_probs=206.8
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
++|++++.||+|+||.||+|+++.++. .||+|++.+.... ....+.+.+|+.++++++|+||+++++++.....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~----~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 74 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQ----IVAIKKFVESEDD--PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRK 74 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCc----EEEEEEEeecccC--ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCE
Confidence 579999999999999999999876544 4999998654321 1233456779999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+++||||+.++.|..+.... ..+++..++.++.|++.||+|||++||+||||||+||+++.+|.+||+|||++..+..
T Consensus 75 ~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 75 LHLVFEYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred EEEEEeccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 99999999999887665432 3589999999999999999999999999999999999999999999999999875421
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
.. .......++..|+||
T Consensus 153 ~~---------------------------------------------------------------~~~~~~~~~~~~~aP 169 (286)
T cd07847 153 PG---------------------------------------------------------------DDYTDYVATRWYRAP 169 (286)
T ss_pred Cc---------------------------------------------------------------ccccCcccccccCCH
Confidence 10 011234578899999
Q ss_pred eeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC----------------------CC---------
Q 042539 258 EVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK----------------------TP--------- 305 (412)
Q Consensus 258 E~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~----------------------~~--------- 305 (412)
|++.+ ..++.++|+|||||++|+|++|.+||.+.+..+....+... .+
T Consensus 170 E~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (286)
T cd07847 170 ELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLE 249 (286)
T ss_pred HHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHH
Confidence 99876 45788999999999999999999999987765544332210 00
Q ss_pred -CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCC
Q 042539 306 -EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 306 -~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff 345 (412)
.+...+..+.+||.+||..||++|| ++.+++.||||
T Consensus 250 ~~~~~~~~~~~~li~~~l~~~p~~Rp----~~~eil~~~~f 286 (286)
T cd07847 250 SKFPNISSPALSFLKGCLQMDPTERL----SCEELLEHPYF 286 (286)
T ss_pred HHhccCCHHHHHHHHHHhcCCccccC----CHHHHhcCCCC
Confidence 0234567899999999999999999 69999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=355.48 Aligned_cols=259 Identities=28% Similarity=0.426 Sum_probs=208.2
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSL 92 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~ 92 (412)
.+.-..|+++++||+||-++||+|.....+. ||+|.+.... ........+..|+..|.+|+ |.+||+||+|-
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~i-----yalkkv~~~~--~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE 429 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQI-----YALKKVVLLE--ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE 429 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcc-----hhhhHHHHhh--cCHHHHHHHHHHHHHHHHhcCCceEEEEeeee
Confidence 3445689999999999999999998754433 6776654332 34456778888999999997 99999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
..++.+|+||||= ..||..++.... ...+.-.+++|+.||+.|+.++|.+||||.||||.|+|+ -.|.+||+|||+|
T Consensus 430 v~d~~lYmvmE~G-d~DL~kiL~k~~-~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA 506 (677)
T KOG0596|consen 430 VTDGYLYMVMECG-DIDLNKILKKKK-SIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIA 506 (677)
T ss_pred ccCceEEEEeecc-cccHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechh
Confidence 9999999999985 458887776654 334446899999999999999999999999999999999 5689999999999
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
..+... +..-...+.+||+
T Consensus 507 ~aI~~D-------------------------------------------------------------TTsI~kdsQvGT~ 525 (677)
T KOG0596|consen 507 NAIQPD-------------------------------------------------------------TTSIVKDSQVGTV 525 (677)
T ss_pred cccCcc-------------------------------------------------------------ccceeeccccCcc
Confidence 765321 1112334679999
Q ss_pred CCccceeecCCC-----------CCchhhHHHHHHHHHHHhhCCCCCCCCC-HHHHHHHHhcCC--CCCCCCC--hHHHH
Q 042539 253 EYVSPEVVRGDG-----------HEFAVDWWALGILTYEMLYGTTPFRGKN-RKETFRNVLMKT--PEFVGQR--TALTD 316 (412)
Q Consensus 253 ~Y~APE~l~~~~-----------~~~~~DiwSlGvil~ell~g~~Pf~~~~-~~~~~~~i~~~~--~~~~~~~--~~~~d 316 (412)
.||+||.+.... .+.++||||||||||+|++|++||.... ...-+..|.... .+|+..+ .++.+
T Consensus 526 NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~ 605 (677)
T KOG0596|consen 526 NYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPENDELID 605 (677)
T ss_pred cccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCCchHHHH
Confidence 999999986432 3578999999999999999999998743 344455555432 3566654 45999
Q ss_pred HHHHhhhhCCCccCCCCCChhhhhcCCCCCC
Q 042539 317 LIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 317 li~~~L~~dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
++..||.+||.+|| ++.++|+|||+..
T Consensus 606 ~mK~CL~rdPkkR~----si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 606 VMKCCLARDPKKRW----SIPELLQHPFLQI 632 (677)
T ss_pred HHHHHHhcCcccCC----CcHHHhcCccccc
Confidence 99999999999999 6899999999975
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=341.16 Aligned_cols=277 Identities=44% Similarity=0.777 Sum_probs=223.1
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEEeCCe
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLETDEF 97 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 97 (412)
+|++.+.||+|+||.||++++.... ..+..||||++++............+.+|++++.++. |+||+++++.+..+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~ 79 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGH-DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTK 79 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccc-cCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCE
Confidence 5899999999999999999865432 2455699999987655444455667788999999995 9999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+|+||||+.||+|..++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++.+..
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 99999999999998776543 3589999999999999999999999999999999999999999999999999865421
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
. ........+|+..|+||
T Consensus 158 ~--------------------------------------------------------------~~~~~~~~~~~~~y~aP 175 (288)
T cd05583 158 E--------------------------------------------------------------EEERAYSFCGTIEYMAP 175 (288)
T ss_pred c--------------------------------------------------------------cccccccccCCccccCH
Confidence 1 00112235688999999
Q ss_pred eeecCCC--CCchhhHHHHHHHHHHHhhCCCCCCCCC----HHHHHHHHhcCCCCC-CCCChHHHHHHHHhhhhCCCccC
Q 042539 258 EVVRGDG--HEFAVDWWALGILTYEMLYGTTPFRGKN----RKETFRNVLMKTPEF-VGQRTALTDLIQRLLEKDPVKRL 330 (412)
Q Consensus 258 E~l~~~~--~~~~~DiwSlGvil~ell~g~~Pf~~~~----~~~~~~~i~~~~~~~-~~~~~~~~dli~~~L~~dP~~R~ 330 (412)
|.+.+.. .+.++|+||||+++|+|++|..||.... ..+....+....+.. ...+..+.++|.+||+.||++||
T Consensus 176 E~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~ 255 (288)
T cd05583 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRL 255 (288)
T ss_pred HHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHHHHHHHHHhcCCHhhcc
Confidence 9987764 6889999999999999999999996432 223333444333333 34578899999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCchhhccc-CCCCC
Q 042539 331 GYLRGACEIKEHVFFKGVRWDLLTDV-LRPPF 361 (412)
Q Consensus 331 ~~~~~~~e~l~h~ff~~~~~~~~~~~-~~pp~ 361 (412)
+. .++.++++|+||+.++|+.+... ..++|
T Consensus 256 t~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 286 (288)
T cd05583 256 GA-NGADEIKNHPFFQGIDWDDLAAKRIPAPF 286 (288)
T ss_pred Cc-chHHHHhcCcccccCCHHHHhhhccCCCC
Confidence 64 35889999999999999877553 34444
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=341.66 Aligned_cols=257 Identities=26% Similarity=0.420 Sum_probs=215.1
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
.++|++++.||.|+||.||++.+..++ ..||+|++.... ......+.+|+.+++.++|+||+++++++..+.
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~----~~~~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETG----LFAAAKIIQIES----EEELEDFMVEIDILSECKHPNIVGLYEAYFYEN 75 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCC----cEEEEEEEeeCC----HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC
Confidence 468999999999999999999887644 449999986542 223455677999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
.+|+||||+.|++|..++.... ..+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++....
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 76 KLWILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred eEEEEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 9999999999999988776533 359999999999999999999999999999999999999999999999999876432
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
. .........||+.|+|
T Consensus 155 ~---------------------------------------------------------------~~~~~~~~~~~~~y~~ 171 (280)
T cd06611 155 S---------------------------------------------------------------TLQKRDTFIGTPYWMA 171 (280)
T ss_pred c---------------------------------------------------------------cccccceeecchhhcC
Confidence 1 0111234568999999
Q ss_pred ceeecC-----CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC----CCCCChHHHHHHHHhhhhCCC
Q 042539 257 PEVVRG-----DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE----FVGQRTALTDLIQRLLEKDPV 327 (412)
Q Consensus 257 PE~l~~-----~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~dli~~~L~~dP~ 327 (412)
||++.. ..++.++|+|||||++|+|++|++||.+.+......++....+. ....+.++.++|.+||..+|.
T Consensus 172 PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 251 (280)
T cd06611 172 PEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPD 251 (280)
T ss_pred HHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChh
Confidence 999853 44678999999999999999999999988777766666654322 124578999999999999999
Q ss_pred ccCCCCCChhhhhcCCCCCCCC
Q 042539 328 KRLGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 328 ~R~~~~~~~~e~l~h~ff~~~~ 349 (412)
+|| ++.++++|+||....
T Consensus 252 ~Rp----s~~~il~~~~~~~~~ 269 (280)
T cd06611 252 DRP----TAAELLKHPFVSDQS 269 (280)
T ss_pred hCc----CHHHHhcChhhcccc
Confidence 999 699999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=337.10 Aligned_cols=255 Identities=38% Similarity=0.710 Sum_probs=214.2
Q ss_pred eeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEEEeecc
Q 042539 26 LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYC 105 (412)
Q Consensus 26 LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 105 (412)
||.|+||.||+|.+..++. .||+|++.+..... ....+.+.+|+.+++.++|+||+++++.+.+++.+|++|||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~----~~~iK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNR----TFALKCVKKRHIVE-TGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCc----EEEEEEEehhcchh-hhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecC
Confidence 7999999999999876444 49999997655322 234567888999999999999999999999999999999999
Q ss_pred CCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhhhhc
Q 042539 106 PGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQS 185 (412)
Q Consensus 106 ~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~ 185 (412)
.|++|..++.... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++.....
T Consensus 76 ~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~------- 146 (262)
T cd05572 76 LGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG------- 146 (262)
T ss_pred CCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc-------
Confidence 9999988876543 4899999999999999999999999999999999999999999999999998754211
Q ss_pred ccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecCCCC
Q 042539 186 LNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGH 265 (412)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~ 265 (412)
.......|++.|+|||.+.+..+
T Consensus 147 ---------------------------------------------------------~~~~~~~~~~~~~~PE~~~~~~~ 169 (262)
T cd05572 147 ---------------------------------------------------------QKTWTFCGTPEYVAPEIILNKGY 169 (262)
T ss_pred ---------------------------------------------------------cccccccCCcCccChhHhcCCCC
Confidence 11223468899999999988888
Q ss_pred CchhhHHHHHHHHHHHhhCCCCCCCCC--HHHHHHHHhc--CCCCCC-CCChHHHHHHHHhhhhCCCccCCCC-CChhhh
Q 042539 266 EFAVDWWALGILTYEMLYGTTPFRGKN--RKETFRNVLM--KTPEFV-GQRTALTDLIQRLLEKDPVKRLGYL-RGACEI 339 (412)
Q Consensus 266 ~~~~DiwSlGvil~ell~g~~Pf~~~~--~~~~~~~i~~--~~~~~~-~~~~~~~dli~~~L~~dP~~R~~~~-~~~~e~ 339 (412)
+.++|+|||||++|+|++|..||.... ..+.+..+.. ....++ ..++.+.++|.+||..||.+|+++. ..++|+
T Consensus 170 ~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l 249 (262)
T cd05572 170 DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDI 249 (262)
T ss_pred CChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHH
Confidence 999999999999999999999998876 5666666663 223333 3468999999999999999999532 238999
Q ss_pred hcCCCCCCCCch
Q 042539 340 KEHVFFKGVRWD 351 (412)
Q Consensus 340 l~h~ff~~~~~~ 351 (412)
++||||++.+|+
T Consensus 250 ~~~~~~~~~~~~ 261 (262)
T cd05572 250 KKHKWFNGFDWE 261 (262)
T ss_pred hcChhhhCCCCC
Confidence 999999999885
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-46 Score=361.24 Aligned_cols=251 Identities=24% Similarity=0.357 Sum_probs=215.6
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeE
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFL 98 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 98 (412)
.|.-++.||+|+||.||.|++..+... ||||.+..+.. ...+.++.+++|++.|.++.|||++.+-++|..+...
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~ev----VAIKKMsySGK-Qs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~Ta 101 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEV----VAIKKMSYSGK-QSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTA 101 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccce----eeeeecccccc-ccHHHHHHHHHHHHHHHhccCCCcccccceeeccchH
Confidence 578899999999999999999886555 99999976654 3456678889999999999999999999999999999
Q ss_pred EEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhch
Q 042539 99 AWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~ 178 (412)
|||||||-| +-.+++.-.. .++.+.++..|..+.+.||.|||+++.||||||..|||+++.|.|||+|||.|...
T Consensus 102 WLVMEYClG-SAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~--- 176 (948)
T KOG0577|consen 102 WLVMEYCLG-SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM--- 176 (948)
T ss_pred HHHHHHHhc-cHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc---
Confidence 999999966 4445554433 35999999999999999999999999999999999999999999999999988644
Q ss_pred hhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccce
Q 042539 179 TAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPE 258 (412)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 258 (412)
...++|+|||.|||||
T Consensus 177 ----------------------------------------------------------------~PAnsFvGTPywMAPE 192 (948)
T KOG0577|consen 177 ----------------------------------------------------------------APANSFVGTPYWMAPE 192 (948)
T ss_pred ----------------------------------------------------------------CchhcccCCccccchh
Confidence 2456899999999999
Q ss_pred eecC---CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-CCC--CCCChHHHHHHHHhhhhCCCccCCC
Q 042539 259 VVRG---DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT-PEF--VGQRTALTDLIQRLLEKDPVKRLGY 332 (412)
Q Consensus 259 ~l~~---~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~--~~~~~~~~dli~~~L~~dP~~R~~~ 332 (412)
++.. ..|+-++||||||+++.||.-.+||+...+-...+..|..+. |.+ ..+++.++.||..||++-|.+||
T Consensus 193 VILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRp-- 270 (948)
T KOG0577|consen 193 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERP-- 270 (948)
T ss_pred HheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCC--
Confidence 9865 458999999999999999999999977766666566665544 443 34678999999999999999999
Q ss_pred CCChhhhhcCCCCCC
Q 042539 333 LRGACEIKEHVFFKG 347 (412)
Q Consensus 333 ~~~~~e~l~h~ff~~ 347 (412)
+.++++.|+|...
T Consensus 271 --tse~ll~H~fv~R 283 (948)
T KOG0577|consen 271 --TSEELLKHRFVLR 283 (948)
T ss_pred --cHHHHhhcchhcc
Confidence 6899999999864
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=339.32 Aligned_cols=271 Identities=42% Similarity=0.725 Sum_probs=219.5
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEEeCCe
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLETDEF 97 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 97 (412)
+|++.+.||.|+||.||+|++.... .++..||+|++++...........++.+|+++++++. |+||++++++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~-~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGH-DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK 79 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCC-CCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe
Confidence 5899999999999999999875321 2445699999976554333445566778999999994 8999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+|+||||+.|++|..++... ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||+++....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 80 LHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 99999999999998877654 3489999999999999999999999999999999999999999999999999865421
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
. .........|+..|+||
T Consensus 158 ~--------------------------------------------------------------~~~~~~~~~~~~~y~aP 175 (290)
T cd05613 158 D--------------------------------------------------------------EVERAYSFCGTIEYMAP 175 (290)
T ss_pred c--------------------------------------------------------------cccccccccCCcccCCh
Confidence 1 00112245689999999
Q ss_pred eeecCC--CCCchhhHHHHHHHHHHHhhCCCCCCCCC----HHHHHHHHhcCCCCC-CCCChHHHHHHHHhhhhCCCccC
Q 042539 258 EVVRGD--GHEFAVDWWALGILTYEMLYGTTPFRGKN----RKETFRNVLMKTPEF-VGQRTALTDLIQRLLEKDPVKRL 330 (412)
Q Consensus 258 E~l~~~--~~~~~~DiwSlGvil~ell~g~~Pf~~~~----~~~~~~~i~~~~~~~-~~~~~~~~dli~~~L~~dP~~R~ 330 (412)
|.+.+. .++.++|||||||++|+|++|..||.... ..+....+....+.+ ...+..+.++|.+||..||.+|+
T Consensus 176 E~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~ 255 (290)
T cd05613 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRL 255 (290)
T ss_pred hhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHHHHHHHHhcCCHHHhc
Confidence 998753 46789999999999999999999997532 233344444433333 34578899999999999999998
Q ss_pred CCC-CChhhhhcCCCCCCCCchhhc
Q 042539 331 GYL-RGACEIKEHVFFKGVRWDLLT 354 (412)
Q Consensus 331 ~~~-~~~~e~l~h~ff~~~~~~~~~ 354 (412)
+.+ .+++++++||||..++|+.+.
T Consensus 256 ~~~~~~~~~l~~~~~~~~~~~~~~~ 280 (290)
T cd05613 256 GCGPSDADEIKKHPFFQKINWDDLA 280 (290)
T ss_pred CCCCCCHHHHHcCcccccCCHHHHh
Confidence 653 469999999999999998653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=375.92 Aligned_cols=153 Identities=31% Similarity=0.504 Sum_probs=136.0
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
.+++|+++++||+|+||+||+|.+...+. .||||++++..... ......+.+|+.+++.++|+||+++++++...
T Consensus 2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAiKvi~~~~~~~-~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 76 (669)
T cd05610 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSK----LYAVKVVKKADMIN-KNMVHQVQAERDALALSKSPFIVHLYYSLQSA 76 (669)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCc----EEEEEEEehhhccC-HHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC
Confidence 47899999999999999999999987544 49999997655422 33456677899999999999999999999999
Q ss_pred CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchh
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
..+|+||||+.|++|..++... +.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+++..
T Consensus 77 ~~~~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~ 154 (669)
T cd05610 77 NNVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154 (669)
T ss_pred CEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccc
Confidence 9999999999999998887654 34899999999999999999999999999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=338.64 Aligned_cols=254 Identities=24% Similarity=0.354 Sum_probs=207.2
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
....++|++.+.||+|+||.||+|++..++. .||+|+++.... .....+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~----~~~~~~~~e~~~~~~l~h~~ii~~~~~~~ 76 (267)
T cd06645 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGE----LAAIKVIKLEPG----EDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76 (267)
T ss_pred cCcHHHHHHHHHhCCCCCeEEEEEEEcCCCc----EEEEEEEecCch----hHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 3455799999999999999999998876544 499999865432 12334667999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
.++.+|+||||+.+++|..++... +.+++.+++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||++.
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~ 154 (267)
T cd06645 77 RRDKLWICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSA 154 (267)
T ss_pred eCCEEEEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeee
Confidence 999999999999999998877554 359999999999999999999999999999999999999999999999999986
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
..... ........||..
T Consensus 155 ~~~~~---------------------------------------------------------------~~~~~~~~~~~~ 171 (267)
T cd06645 155 QITAT---------------------------------------------------------------IAKRKSFIGTPY 171 (267)
T ss_pred EccCc---------------------------------------------------------------ccccccccCccc
Confidence 54210 011123468999
Q ss_pred Cccceeec---CCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC---C---CCCCChHHHHHHHHhhhh
Q 042539 254 YVSPEVVR---GDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP---E---FVGQRTALTDLIQRLLEK 324 (412)
Q Consensus 254 Y~APE~l~---~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~---~---~~~~~~~~~dli~~~L~~ 324 (412)
|+|||++. ...++.++|+|||||++|+|++|..||................. . ....+..+.+||.+||..
T Consensus 172 y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 251 (267)
T cd06645 172 WMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTK 251 (267)
T ss_pred ccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccC
Confidence 99999975 44578899999999999999999999976554333332222211 1 123567899999999999
Q ss_pred CCCccCCCCCChhhhhcCCC
Q 042539 325 DPVKRLGYLRGACEIKEHVF 344 (412)
Q Consensus 325 dP~~R~~~~~~~~e~l~h~f 344 (412)
||++|| +++++++|||
T Consensus 252 ~P~~R~----~~~~ll~~~~ 267 (267)
T cd06645 252 NPKKRP----TAEKLLQHPF 267 (267)
T ss_pred CchhCc----CHHHHhcCCC
Confidence 999999 6999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=344.22 Aligned_cols=254 Identities=25% Similarity=0.406 Sum_probs=216.0
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
+-|.++.+||+|+||.||+|.++.++. .+|||.+..+ ...+.+.+||.||++++.++||++|+.+..+..
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~----v~AIK~VPV~------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD 102 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGH----VLAIKKVPVD------TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD 102 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCc----EEEEEecCcc------chHHHHHHHHHHHHHcCCchhhhhhhhhccCCc
Confidence 357899999999999999888777554 4999998543 235566779999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+|+|||||..|+..+.++.++ ..++|+++..+++..+.||+|||...-||||||..|||++-+|+.||+|||.|..+.+
T Consensus 103 LWIVMEYCGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD 181 (502)
T KOG0574|consen 103 LWIVMEYCGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD 181 (502)
T ss_pred eEeehhhcCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh
Confidence 999999999999999887655 5799999999999999999999999999999999999999999999999999976632
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
. ....++..|||-||||
T Consensus 182 T---------------------------------------------------------------MAKRNTVIGTPFWMAP 198 (502)
T KOG0574|consen 182 T---------------------------------------------------------------MAKRNTVIGTPFWMAP 198 (502)
T ss_pred h---------------------------------------------------------------HHhhCccccCcccccH
Confidence 1 2235688999999999
Q ss_pred eeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-CCCCC---CCChHHHHHHHHhhhhCCCccCCCC
Q 042539 258 EVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK-TPEFV---GQRTALTDLIQRLLEKDPVKRLGYL 333 (412)
Q Consensus 258 E~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~-~~~~~---~~~~~~~dli~~~L~~dP~~R~~~~ 333 (412)
|++..-+|+.++||||||++..||..|++||........+--|-.+ .|.|. ..++++.|||++||.++|++|-
T Consensus 199 EVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~--- 275 (502)
T KOG0574|consen 199 EVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERK--- 275 (502)
T ss_pred HHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHH---
Confidence 9999999999999999999999999999999875533222112122 22222 3468899999999999999998
Q ss_pred CChhhhhcCCCCCCCC
Q 042539 334 RGACEIKEHVFFKGVR 349 (412)
Q Consensus 334 ~~~~e~l~h~ff~~~~ 349 (412)
|+-++++|+|.++..
T Consensus 276 -TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 276 -TALRLCEHTFIKNAP 290 (502)
T ss_pred -HHHHHhhhhhhcCCC
Confidence 799999999998754
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=334.74 Aligned_cols=258 Identities=27% Similarity=0.446 Sum_probs=216.0
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
++|++++.||.|+||+||+|.+..++ ..+|+|++....... ....+.+|+.+++.++|+||+++++.+..++.
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNN----EKVAIKRIDLEKCQT---SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDE 73 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCC----cEEEEEEeccCCcch---HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCE
Confidence 58999999999999999999887644 349999997654322 44567789999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 98 LAWAVPYCPGGDLNVLRYKQND-RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
.|+|||++.|++|..++..... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++..+.
T Consensus 74 ~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~ 153 (267)
T cd06610 74 LWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLA 153 (267)
T ss_pred EEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhc
Confidence 9999999999999888765432 468999999999999999999999999999999999999999999999999987653
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
.... .........+|+..|+|
T Consensus 154 ~~~~-----------------------------------------------------------~~~~~~~~~~~~~~y~~ 174 (267)
T cd06610 154 DGGD-----------------------------------------------------------RTRKVRKTFVGTPCWMA 174 (267)
T ss_pred cCcc-----------------------------------------------------------ccccccccccCChhhcC
Confidence 2110 00012235578999999
Q ss_pred ceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC-------CCCCChHHHHHHHHhhhhCCCc
Q 042539 257 PEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE-------FVGQRTALTDLIQRLLEKDPVK 328 (412)
Q Consensus 257 PE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~-------~~~~~~~~~dli~~~L~~dP~~ 328 (412)
||++... .++.++|+|||||++|+|++|+.||...+....+.++....+. ....+..+.++|.+||..||++
T Consensus 175 Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 254 (267)
T cd06610 175 PEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSK 254 (267)
T ss_pred hHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhh
Confidence 9998876 6789999999999999999999999987776666665544321 1245688999999999999999
Q ss_pred cCCCCCChhhhhcCCCC
Q 042539 329 RLGYLRGACEIKEHVFF 345 (412)
Q Consensus 329 R~~~~~~~~e~l~h~ff 345 (412)
|| ++.++++||||
T Consensus 255 Rp----~~~~ll~~p~~ 267 (267)
T cd06610 255 RP----TAEELLKHKFF 267 (267)
T ss_pred Cc----CHHHHhhCCCC
Confidence 99 69999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=338.03 Aligned_cols=252 Identities=23% Similarity=0.400 Sum_probs=206.3
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeeeeEEeC-
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLGSLETD- 95 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~- 95 (412)
+.|.+.+.||+|+||.||+|.+..++. .||+|++..... ....+.+|+.+++.+ +|+||+++++++...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~----~~aik~~~~~~~-----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 76 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQ----LAAIKVMDVTGD-----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 76 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCc----EEEEEEEEcCCc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecC
Confidence 468999999999999999998876544 499999865421 123456699999998 699999999998753
Q ss_pred -----CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccc
Q 042539 96 -----EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 96 -----~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
..+|++|||+.+++|..++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 77 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred CCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCC
Confidence 468999999999999988776555568999999999999999999999999999999999999999999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+++..... ........|
T Consensus 157 ~~~~~~~~---------------------------------------------------------------~~~~~~~~g 173 (272)
T cd06637 157 VSAQLDRT---------------------------------------------------------------VGRRNTFIG 173 (272)
T ss_pred Cceecccc---------------------------------------------------------------cccCCcccc
Confidence 98654210 112234578
Q ss_pred CCCCccceeecC-----CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC---CCCCCCChHHHHHHHHhh
Q 042539 251 TEEYVSPEVVRG-----DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT---PEFVGQRTALTDLIQRLL 322 (412)
Q Consensus 251 t~~Y~APE~l~~-----~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~dli~~~L 322 (412)
+..|+|||++.+ ..++.++|||||||++|+|++|..||...........+.... ......+..+.+||.+||
T Consensus 174 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 253 (272)
T cd06637 174 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCL 253 (272)
T ss_pred cccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHc
Confidence 999999999863 357889999999999999999999998766554443333221 122345789999999999
Q ss_pred hhCCCccCCCCCChhhhhcCCCC
Q 042539 323 EKDPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 323 ~~dP~~R~~~~~~~~e~l~h~ff 345 (412)
..||.+|| ++.+++.||||
T Consensus 254 ~~~p~~Rp----t~~~il~~~~~ 272 (272)
T cd06637 254 VKNHSQRP----TTEQLMKHPFI 272 (272)
T ss_pred CCChhhCC----CHHHHhhCCCC
Confidence 99999999 69999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=339.60 Aligned_cols=261 Identities=20% Similarity=0.303 Sum_probs=215.2
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCC-CCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAAD-PTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
++.+++|++++.||+|+||.||+|.+...+ ......||+|.++... .......+.+|++++..++||||+++++++
T Consensus 1 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~ 77 (283)
T cd05048 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA---EPKVQQEFRQEAELMSDLQHPNIVCLLGVC 77 (283)
T ss_pred CCChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC---CHHHHHHHHHHHHHHHhcCCcccceEEEEE
Confidence 367789999999999999999999876544 2234569999986443 223455677899999999999999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEE
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQND--------------RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILI 158 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~--------------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl 158 (412)
.+....|++|||+.+++|..++..... ..+++.++..++.|++.||.|||++|++||||||+||++
T Consensus 78 ~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~ 157 (283)
T cd05048 78 TKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV 157 (283)
T ss_pred cCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE
Confidence 999999999999999999888765421 357889999999999999999999999999999999999
Q ss_pred ccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccc
Q 042539 159 RQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQS 238 (412)
Q Consensus 159 ~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (412)
+.++.+||+|||+++......
T Consensus 158 ~~~~~~~L~dfg~~~~~~~~~----------------------------------------------------------- 178 (283)
T cd05048 158 GEGLTVKISDFGLSRDIYSAD----------------------------------------------------------- 178 (283)
T ss_pred cCCCcEEECCCcceeeccccc-----------------------------------------------------------
Confidence 999999999999987542110
Q ss_pred cCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCC--CCCCCChHHH
Q 042539 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTP--EFVGQRTALT 315 (412)
Q Consensus 239 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~ 315 (412)
.........+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+..... .....++++.
T Consensus 179 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 256 (283)
T cd05048 179 --YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVY 256 (283)
T ss_pred --cccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHH
Confidence 0011123356889999999988889999999999999999997 9999999888877776654432 2235678999
Q ss_pred HHHHHhhhhCCCccCCCCCChhhhhcC
Q 042539 316 DLIQRLLEKDPVKRLGYLRGACEIKEH 342 (412)
Q Consensus 316 dli~~~L~~dP~~R~~~~~~~~e~l~h 342 (412)
+|+.+||+.||.+|| ++.+++++
T Consensus 257 ~l~~~c~~~~p~~Rp----~~~~i~~~ 279 (283)
T cd05048 257 ALMIECWNEIPARRP----RFKDIHTR 279 (283)
T ss_pred HHHHHHccCChhhCc----CHHHHHHH
Confidence 999999999999999 68888763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=338.76 Aligned_cols=254 Identities=27% Similarity=0.420 Sum_probs=210.8
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeE
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFL 98 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 98 (412)
-|++++.||+|+||.||++.+..++. .+|+|.+.... ......+.+|+.+++.++|+||+++++++..++..
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~----~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~ 77 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGV----LAAAKVIDTKS----EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNL 77 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCe----EEEEEEeCCCC----HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEE
Confidence 36899999999999999999877554 48999986543 22345567799999999999999999999999999
Q ss_pred EEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhch
Q 042539 99 AWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~ 178 (412)
|+||||+.|++|..++... ...+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++......
T Consensus 78 ~~v~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~ 156 (282)
T cd06643 78 WILIEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 156 (282)
T ss_pred EEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc
Confidence 9999999999997766542 345899999999999999999999999999999999999999999999999998654210
Q ss_pred hhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccce
Q 042539 179 TAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPE 258 (412)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 258 (412)
........||..|+|||
T Consensus 157 ---------------------------------------------------------------~~~~~~~~~~~~y~aPE 173 (282)
T cd06643 157 ---------------------------------------------------------------IQRRDSFIGTPYWMAPE 173 (282)
T ss_pred ---------------------------------------------------------------ccccccccccccccCHh
Confidence 01122456899999999
Q ss_pred eec-----CCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC----CCCCChHHHHHHHHhhhhCCCcc
Q 042539 259 VVR-----GDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE----FVGQRTALTDLIQRLLEKDPVKR 329 (412)
Q Consensus 259 ~l~-----~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~dli~~~L~~dP~~R 329 (412)
++. +..++.++|+|||||++|+|++|.+||...+..+...++....+. ....+.++.+||.+||..||.+|
T Consensus 174 ~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 253 (282)
T cd06643 174 VVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDAR 253 (282)
T ss_pred hccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhC
Confidence 984 345678999999999999999999999988776666665543221 22456889999999999999999
Q ss_pred CCCCCChhhhhcCCCCCCC
Q 042539 330 LGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 330 ~~~~~~~~e~l~h~ff~~~ 348 (412)
| +++++++||||...
T Consensus 254 p----~~~~il~~~~~~~~ 268 (282)
T cd06643 254 W----TTTQLLQHPFVTVN 268 (282)
T ss_pred c----CHHHHhcCCCEecc
Confidence 9 68999999999853
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=342.81 Aligned_cols=252 Identities=27% Similarity=0.425 Sum_probs=202.0
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeE
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFL 98 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 98 (412)
+|++++.||+|+||.||+|++..++. .||+|+++.... .......+.+|+.++++++|+||+++++++.+.+.+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~----~~~~k~~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 74 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHE----IVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKL 74 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCc----EEEEEEeecccc--cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCce
Confidence 58999999999999999999987554 499999975432 122334566799999999999999999999999999
Q ss_pred EEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhch
Q 042539 99 AWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~ 178 (412)
|+++||+.+ +|..++... .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 75 ~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 75 TLVFEYCDQ-DLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred EEEEecCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 999999975 665555433 345899999999999999999999999999999999999999999999999998643110
Q ss_pred hhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccce
Q 042539 179 TAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPE 258 (412)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 258 (412)
........+++.|+|||
T Consensus 153 ---------------------------------------------------------------~~~~~~~~~~~~y~aPE 169 (284)
T cd07839 153 ---------------------------------------------------------------VRCYSAEVVTLWYRPPD 169 (284)
T ss_pred ---------------------------------------------------------------CCCcCCCccccCCcChH
Confidence 00112235788999999
Q ss_pred eecCCC-CCchhhHHHHHHHHHHHhhCCCC-CCCCCHHHHHHHHhcCC------------------------------CC
Q 042539 259 VVRGDG-HEFAVDWWALGILTYEMLYGTTP-FRGKNRKETFRNVLMKT------------------------------PE 306 (412)
Q Consensus 259 ~l~~~~-~~~~~DiwSlGvil~ell~g~~P-f~~~~~~~~~~~i~~~~------------------------------~~ 306 (412)
++.+.. ++.++|||||||++|+|++|..| |.+.+..+.+..+.... ..
T Consensus 170 ~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (284)
T cd07839 170 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNV 249 (284)
T ss_pred HHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhh
Confidence 987754 68999999999999999998877 55555555444332100 01
Q ss_pred CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCC
Q 042539 307 FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 307 ~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff 345 (412)
.+..++++++||.+||..||.+|| +++++++||||
T Consensus 250 ~~~~~~~~~~li~~~l~~~P~~R~----t~~~il~h~~f 284 (284)
T cd07839 250 VPKLNSTGRDLLQNLLVCNPVQRI----SAEEALQHPYF 284 (284)
T ss_pred cccCCHHHHHHHHHHhcCChhhcC----CHHHHhcCCCC
Confidence 124568899999999999999999 69999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=327.74 Aligned_cols=259 Identities=25% Similarity=0.406 Sum_probs=217.5
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLG 90 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~ 90 (412)
+...++++++++..||+|+-|.||+++.+.++.. .|||.+.+.. +.+..++++..+.++.... +|+||++++
T Consensus 86 r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~i----iAVK~M~rt~---Nkee~kRILmDldvv~~s~dcpyIV~c~G 158 (391)
T KOG0983|consen 86 RYQADINDLENLGDLGSGTCGQVWKMRFRSTGHI----IAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPYIVQCFG 158 (391)
T ss_pred ccccChHHhhhHHhhcCCCccceEEEEEcccceE----EEEEeecccC---CHHHHHHHHHhhhHHhhccCCCeeeeeee
Confidence 4567788999999999999999999999886655 9999997764 3445677777888887775 999999999
Q ss_pred eEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeeCCCCceEEccCCCEEEccc
Q 042539 91 SLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN-MGIAYRDLKPENILIRQSGHVTLTDF 169 (412)
Q Consensus 91 ~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDlKp~NiLl~~~g~vkL~DF 169 (412)
+|..+..+++.||.| +.-++.++.. ..+.++|..+-.+...++.||.||-. +||||||+||+|||+|..|++|||||
T Consensus 159 yFi~n~dV~IcMelM-s~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDF 236 (391)
T KOG0983|consen 159 YFITNTDVFICMELM-STCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDF 236 (391)
T ss_pred EEeeCchHHHHHHHH-HHHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecc
Confidence 999999999999998 3334444443 34569999999999999999999975 68999999999999999999999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|++..+.++... +.-.
T Consensus 237 GIsGrlvdSkAh----------------------------------------------------------------trsA 252 (391)
T KOG0983|consen 237 GISGRLVDSKAH----------------------------------------------------------------TRSA 252 (391)
T ss_pred cccceeeccccc----------------------------------------------------------------cccc
Confidence 999887544322 1224
Q ss_pred cCCCCccceeecC---CCCCchhhHHHHHHHHHHHhhCCCCCCCCC-HHHHHHHHhcCCCCCC----CCChHHHHHHHHh
Q 042539 250 GTEEYVSPEVVRG---DGHEFAVDWWALGILTYEMLYGTTPFRGKN-RKETFRNVLMKTPEFV----GQRTALTDLIQRL 321 (412)
Q Consensus 250 gt~~Y~APE~l~~---~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-~~~~~~~i~~~~~~~~----~~~~~~~dli~~~ 321 (412)
|-+.|||||.+.- ..|+.++||||||++++||.||+.||.+.+ +-+++.+++...|+.. ..++++.+|+..|
T Consensus 253 GC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~C 332 (391)
T KOG0983|consen 253 GCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDC 332 (391)
T ss_pred CCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHH
Confidence 8889999999864 368999999999999999999999999954 5578888887665432 3689999999999
Q ss_pred hhhCCCccCCCCCChhhhhcCCCCCC
Q 042539 322 LEKDPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 322 L~~dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
|++|+.+|| ...++++|||+..
T Consensus 333 L~kd~r~RP----~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 333 LTKDHRKRP----KYNKLLEHPFIKR 354 (391)
T ss_pred hhcCcccCc----chHHHhcCcceee
Confidence 999999999 5799999999874
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=334.20 Aligned_cols=260 Identities=27% Similarity=0.449 Sum_probs=213.5
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhh-----hHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHA-----KHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
+|.+.+.||+|+||.||+|.+...+ ..||+|++....... .......+.+|+.++++++||||+++++++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSG----ELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL 76 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCC----cEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE
Confidence 4788999999999999999887644 349999886543321 2234466788999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
..+..+++|||+.|++|..++... +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 77 DADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred eCCccEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999999998887654 348999999999999999999999999999999999999999999999999987
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
........ .........+.|+..
T Consensus 155 ~~~~~~~~---------------------------------------------------------~~~~~~~~~~~~~~~ 177 (267)
T cd06628 155 KLEANSLS---------------------------------------------------------TKTNGARPSLQGSVF 177 (267)
T ss_pred cccccccc---------------------------------------------------------CCccccccccCCCcC
Confidence 65311000 001112234568899
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-CCCC-CCCChHHHHHHHHhhhhCCCccCC
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK-TPEF-VGQRTALTDLIQRLLEKDPVKRLG 331 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~-~~~~-~~~~~~~~dli~~~L~~dP~~R~~ 331 (412)
|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+......++... .+.. ...+..+.++|.+||+.||.+||
T Consensus 178 y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp- 256 (267)
T cd06628 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRP- 256 (267)
T ss_pred ccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHHHHHHHHHHccCCchhCc-
Confidence 99999999888899999999999999999999999987665555544332 2222 34578899999999999999999
Q ss_pred CCCChhhhhcCCCC
Q 042539 332 YLRGACEIKEHVFF 345 (412)
Q Consensus 332 ~~~~~~e~l~h~ff 345 (412)
++.++++|+||
T Consensus 257 ---~~~~il~~~~~ 267 (267)
T cd06628 257 ---TAAELLKHPFL 267 (267)
T ss_pred ---CHHHHhhCCCC
Confidence 69999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=330.73 Aligned_cols=254 Identities=30% Similarity=0.465 Sum_probs=217.6
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeE
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFL 98 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 98 (412)
+|++++.||.|+||.||++++..++. .+++|.+...... ......+.+|+.++++++|+||+++++++.+.+.+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~----~~~~k~~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 74 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDS----LVVWKEVNLTRLS--EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTL 74 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCc----EEEEEEEeecccc--hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeE
Confidence 69999999999999999999876544 4999998665432 23345677899999999999999999999999999
Q ss_pred EEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhch
Q 042539 99 AWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~ 178 (412)
+++||||.|++|..++.......+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++......
T Consensus 75 ~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 75 LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred EEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 99999999999998887654556899999999999999999999999999999999999999999999999998754211
Q ss_pred hhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccce
Q 042539 179 TAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPE 258 (412)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 258 (412)
. .......|++.|+|||
T Consensus 155 ~---------------------------------------------------------------~~~~~~~~~~~y~ape 171 (256)
T cd08221 155 Y---------------------------------------------------------------SMAETVVGTPYYMSPE 171 (256)
T ss_pred c---------------------------------------------------------------ccccccCCCccccCHh
Confidence 0 0123456899999999
Q ss_pred eecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC--CCCCChHHHHHHHHhhhhCCCccCCCCCCh
Q 042539 259 VVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE--FVGQRTALTDLIQRLLEKDPVKRLGYLRGA 336 (412)
Q Consensus 259 ~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~dli~~~L~~dP~~R~~~~~~~ 336 (412)
.+.+..++.++|+|||||++|+|++|..||...+..+....+...... ....+.++.++|.+||..+|.+|| ++
T Consensus 172 ~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~----s~ 247 (256)
T cd08221 172 LCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRP----TA 247 (256)
T ss_pred hcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcccCcccCC----CH
Confidence 999888889999999999999999999999998888877777654322 234578999999999999999999 69
Q ss_pred hhhhcCCCC
Q 042539 337 CEIKEHVFF 345 (412)
Q Consensus 337 ~e~l~h~ff 345 (412)
.++++|+|+
T Consensus 248 ~~ll~~~~l 256 (256)
T cd08221 248 DEVLDQPLL 256 (256)
T ss_pred HHHhhCcCC
Confidence 999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=341.82 Aligned_cols=258 Identities=22% Similarity=0.267 Sum_probs=205.1
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCC------------CCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCC
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAAD------------PTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~------------~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~h 82 (412)
+..++|++.++||+|+||.||+|.+.... ...+..||+|++..... ......+.+|++++++++|
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h 78 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN---KNARNDFLKEVKILSRLKD 78 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC---HHHHHHHHHHHHHHhhcCC
Confidence 45689999999999999999999875432 11334699999865432 2345567789999999999
Q ss_pred CccceeeeeEEeCCeEEEEeeccCCCCchhHHHhhC-----------------CCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 042539 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQN-----------------DRVFSPSVIRFYLSEIICAIEHLHNMG 145 (412)
Q Consensus 83 pnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~-----------------~~~l~~~~~~~~~~qi~~aL~yLH~~~ 145 (412)
|||+++++++.+.+.+|+||||+.+|+|..++.... ...++...+..++.||+.||.|||++|
T Consensus 79 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ 158 (304)
T cd05096 79 PNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN 158 (304)
T ss_pred CCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence 999999999999999999999999999988775432 123677888999999999999999999
Q ss_pred ceeeeCCCCceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCcccccccc
Q 042539 146 IAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTK 225 (412)
Q Consensus 146 iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (412)
|+||||||+|||++.++.+||+|||+++.......
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~--------------------------------------------- 193 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDY--------------------------------------------- 193 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceecccCce---------------------------------------------
Confidence 99999999999999999999999999875421100
Q ss_pred ccCCCCccccccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh--CCCCCCCCCHHHHHHHHhc-
Q 042539 226 SARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY--GTTPFRGKNRKETFRNVLM- 302 (412)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~--g~~Pf~~~~~~~~~~~i~~- 302 (412)
........++..|+|||++.+..++.++|||||||++|+|++ +..||.+.+..+....+..
T Consensus 194 ----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~ 257 (304)
T cd05096 194 ----------------YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEF 257 (304)
T ss_pred ----------------eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHH
Confidence 001123456789999999988889999999999999999986 6789988776665443321
Q ss_pred --C------CCCCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhh
Q 042539 303 --K------TPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIK 340 (412)
Q Consensus 303 --~------~~~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l 340 (412)
. ....+.++..+.+||.+||..||.+|| ++.++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP----s~~~i~ 299 (304)
T cd05096 258 FRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERP----SFSDIH 299 (304)
T ss_pred hhhccccccccCCCCCCHHHHHHHHHHccCCchhCc----CHHHHH
Confidence 1 012235678899999999999999999 577774
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=339.14 Aligned_cols=253 Identities=27% Similarity=0.395 Sum_probs=206.8
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeE
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFL 98 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 98 (412)
+|++++.||.|+||.||+|+++.++. .||||.+..... .......+.+|++++++++||||+++++++.+++..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGE----VVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 74 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCC----EEEEEEcccccc--ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcE
Confidence 58999999999999999999877554 499999865432 122345677799999999999999999999999999
Q ss_pred EEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhch
Q 042539 99 AWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~ 178 (412)
++||||+. ++|..++.......+++..++.++.|++.||+|||++|++||||+|+||+++.++.+||+|||+++.....
T Consensus 75 ~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 75 YLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred EEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 99999996 57877776655567999999999999999999999999999999999999999999999999998644210
Q ss_pred hhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccce
Q 042539 179 TAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPE 258 (412)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 258 (412)
........+++.|+|||
T Consensus 154 ---------------------------------------------------------------~~~~~~~~~~~~y~aPE 170 (284)
T cd07860 154 ---------------------------------------------------------------VRTYTHEVVTLWYRAPE 170 (284)
T ss_pred ---------------------------------------------------------------ccccccccccccccCCe
Confidence 00111235688999999
Q ss_pred eecCCC-CCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC---------------------C---------CC
Q 042539 259 VVRGDG-HEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT---------------------P---------EF 307 (412)
Q Consensus 259 ~l~~~~-~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~---------------------~---------~~ 307 (412)
++.+.. ++.++|||||||++|+|++|..||.+.+......++.... + ..
T Consensus 171 ~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (284)
T cd07860 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVV 250 (284)
T ss_pred EEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHc
Confidence 987754 5889999999999999999999998877655443332110 0 01
Q ss_pred CCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCC
Q 042539 308 VGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 308 ~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff 345 (412)
+..+.+++++|.+||+.||++|| +++++++||||
T Consensus 251 ~~~~~~~~~li~~~l~~~P~~Rp----t~~~~l~~~~f 284 (284)
T cd07860 251 PPLDEDGRDLLSQMLHYDPNKRI----SAKAALAHPFF 284 (284)
T ss_pred ccCCHHHHHHHHHhcCCCcccCC----CHHHHhcCCCC
Confidence 23567889999999999999999 69999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=336.75 Aligned_cols=252 Identities=23% Similarity=0.358 Sum_probs=205.2
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
..++|++++.||+|+||.||+++++.++. .||+|++..... .....+.+|+.++++++|+||+++++++..+
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~----~~aik~~~~~~~----~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~ 78 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGE----LAAVKIIKLEPG----DDFSLIQQEIFMVKECKHCNIVAYFGSYLSR 78 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCe----EEEEEEEecCcc----chHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Confidence 45689999999999999999999876544 499999865432 1233566799999999999999999999999
Q ss_pred CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchh
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
+.+|+||||+.+++|..++... +.+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||++...
T Consensus 79 ~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 156 (267)
T cd06646 79 EKLWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKI 156 (267)
T ss_pred CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceee
Confidence 9999999999999998877543 35899999999999999999999999999999999999999999999999998754
Q ss_pred hchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCc
Q 042539 176 VKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYV 255 (412)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 255 (412)
... ........|++.|+
T Consensus 157 ~~~---------------------------------------------------------------~~~~~~~~~~~~y~ 173 (267)
T cd06646 157 TAT---------------------------------------------------------------IAKRKSFIGTPYWM 173 (267)
T ss_pred ccc---------------------------------------------------------------ccccCccccCcccc
Confidence 210 01122456889999
Q ss_pred cceeecC---CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC---CCC---CCCChHHHHHHHHhhhhCC
Q 042539 256 SPEVVRG---DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT---PEF---VGQRTALTDLIQRLLEKDP 326 (412)
Q Consensus 256 APE~l~~---~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~---~~~---~~~~~~~~dli~~~L~~dP 326 (412)
|||.+.+ ..++.++|+|||||++|||++|+.||...+.......+.... +.. ...+..+.+||++||..||
T Consensus 174 ~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 253 (267)
T cd06646 174 APEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNP 253 (267)
T ss_pred CHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCCh
Confidence 9999853 346789999999999999999999997654433322222211 111 2346889999999999999
Q ss_pred CccCCCCCChhhhhcCCC
Q 042539 327 VKRLGYLRGACEIKEHVF 344 (412)
Q Consensus 327 ~~R~~~~~~~~e~l~h~f 344 (412)
++|| +++++++|+|
T Consensus 254 ~~Rp----~~~~il~~l~ 267 (267)
T cd06646 254 KKRP----TAERLLTHLF 267 (267)
T ss_pred hhCc----CHHHHhcCCC
Confidence 9999 6999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=333.13 Aligned_cols=259 Identities=24% Similarity=0.364 Sum_probs=211.2
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhh--hhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTL--HAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
+|++.+.||+|+||.||++.+. + +..+|+|.+..... .........+.+|+++++.++|+||+++++++.+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~----~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 75 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-Q----GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDN 75 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-C----CCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCC
Confidence 5889999999999999999763 2 33499999865432 122334456888999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
.+|++|||+.|++|..++.... .+++..+..++.|++.||+|||+.||+|+||||+||+++.+|.++|+|||++....
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 76 TISIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred eEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 9999999999999988876543 48999999999999999999999999999999999999999999999999987542
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
..... ...........|+..|+|
T Consensus 154 ~~~~~---------------------------------------------------------~~~~~~~~~~~~~~~~~~ 176 (265)
T cd06631 154 WVGLH---------------------------------------------------------GTHSNMLKSMHGTPYWMA 176 (265)
T ss_pred hcccc---------------------------------------------------------ccccccccccCCCccccC
Confidence 11000 000111234568999999
Q ss_pred ceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC---C-CCCCCChHHHHHHHHhhhhCCCccCCC
Q 042539 257 PEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT---P-EFVGQRTALTDLIQRLLEKDPVKRLGY 332 (412)
Q Consensus 257 PE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~---~-~~~~~~~~~~dli~~~L~~dP~~R~~~ 332 (412)
||.+.+..++.++|+|||||++|+|++|..||...+.......+.... + .....+.++.++|.+||..+|.+||
T Consensus 177 pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp-- 254 (265)
T cd06631 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERP-- 254 (265)
T ss_pred hhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCC--
Confidence 999999889999999999999999999999998876555444443321 2 2234578899999999999999999
Q ss_pred CCChhhhhcCCCC
Q 042539 333 LRGACEIKEHVFF 345 (412)
Q Consensus 333 ~~~~~e~l~h~ff 345 (412)
++.++++||||
T Consensus 255 --~~~~~l~~~~~ 265 (265)
T cd06631 255 --SALQLLRHDFL 265 (265)
T ss_pred --CHHHHhcCCCC
Confidence 79999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=337.00 Aligned_cols=259 Identities=34% Similarity=0.627 Sum_probs=204.9
Q ss_pred eeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHH---HHHHhhcCCCccceeeeeEEeCCeEEEE
Q 042539 25 ILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWE---IRVLSRLSHPFLPKLLGSLETDEFLAWA 101 (412)
Q Consensus 25 ~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~E---i~il~~l~hpnIv~l~~~~~~~~~~~lv 101 (412)
.||+|+||.||+|++..++. .||+|++.+........ ......| ++.+....|+||+++++++...+.+|+|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGK----MYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCC----EEEEEEeeccccccchh-HHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEE
Confidence 48999999999999876444 49999997754332111 1112223 3445555799999999999999999999
Q ss_pred eeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhh
Q 042539 102 VPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAF 181 (412)
Q Consensus 102 ~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~ 181 (412)
|||+.||+|..++... +.+++..++.++.|++.||.|||+.+|+||||||+||+++.++.+||+|||+++.+..
T Consensus 76 ~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~---- 149 (278)
T cd05606 76 LDLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK---- 149 (278)
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCc----
Confidence 9999999998776543 4599999999999999999999999999999999999999999999999999864311
Q ss_pred hhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeec
Q 042539 182 EKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVR 261 (412)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~ 261 (412)
......+|+..|+|||++.
T Consensus 150 -------------------------------------------------------------~~~~~~~~~~~y~aPE~~~ 168 (278)
T cd05606 150 -------------------------------------------------------------KKPHASVGTHGYMAPEVLQ 168 (278)
T ss_pred -------------------------------------------------------------cCCcCcCCCcCCcCcHHhc
Confidence 0112346899999999987
Q ss_pred CC-CCCchhhHHHHHHHHHHHhhCCCCCCCC---CHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCccCCCC-CC
Q 042539 262 GD-GHEFAVDWWALGILTYEMLYGTTPFRGK---NRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKRLGYL-RG 335 (412)
Q Consensus 262 ~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~---~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R~~~~-~~ 335 (412)
+. .++.++|+||+||++|+|++|+.||.+. ........+....+..+ ..+.++.++|.+||..+|.+|+.+. .+
T Consensus 169 ~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~ 248 (278)
T cd05606 169 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRG 248 (278)
T ss_pred CCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCC
Confidence 54 5789999999999999999999999875 33333333333333333 3578999999999999999999542 26
Q ss_pred hhhhhcCCCCCCCCchhhcc
Q 042539 336 ACEIKEHVFFKGVRWDLLTD 355 (412)
Q Consensus 336 ~~e~l~h~ff~~~~~~~~~~ 355 (412)
+.++++||||++.+|.....
T Consensus 249 ~~~ll~~~~~~~~~~~~~~~ 268 (278)
T cd05606 249 AQEVKEHPFFRSLDWQMVFL 268 (278)
T ss_pred HHHHHhCccccCCCchHhhh
Confidence 99999999999999986643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=336.65 Aligned_cols=254 Identities=31% Similarity=0.472 Sum_probs=210.5
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeE
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFL 98 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 98 (412)
+|++.+.||+|+||.||+|.+..++.. ||+|++...... ......+.+|+.+++.++|+||+++++++..+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~----~~vK~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 74 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGET----VALKKVALRRLE--GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGF 74 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCce----EEEEEEEccccc--chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCee
Confidence 689999999999999999998775544 999999765432 23345677899999999999999999999999999
Q ss_pred EEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhch
Q 042539 99 AWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~ 178 (412)
|+||||+ |++|..++.... ..+++.+++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 75 ~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 75 VLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred EEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9999999 999988776543 46999999999999999999999999999999999999999999999999998754211
Q ss_pred hhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccce
Q 042539 179 TAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPE 258 (412)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 258 (412)
. ........|+..|+|||
T Consensus 153 ~--------------------------------------------------------------~~~~~~~~~~~~y~aPE 170 (286)
T cd07832 153 E--------------------------------------------------------------PRLYSHQVATRWYRAPE 170 (286)
T ss_pred C--------------------------------------------------------------CCccccccCcccccCce
Confidence 0 00112346899999999
Q ss_pred eecCCC-CCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-------------------------------C
Q 042539 259 VVRGDG-HEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP-------------------------------E 306 (412)
Q Consensus 259 ~l~~~~-~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-------------------------------~ 306 (412)
.+.+.. ++.++|||||||++|+|++|.+||.+.+....+..+..... .
T Consensus 171 ~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (286)
T cd07832 171 LLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEI 250 (286)
T ss_pred eeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHh
Confidence 987654 58999999999999999999999988776665554432100 0
Q ss_pred CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCC
Q 042539 307 FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346 (412)
Q Consensus 307 ~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~ 346 (412)
++..+..+.+||++||..||.+|| +++++++||||.
T Consensus 251 ~~~~~~~~~~li~~~l~~~p~~R~----~~~~~l~h~~~~ 286 (286)
T cd07832 251 FPDASPEALDLLKGLLVYDPSKRL----SAAEALRHPYFT 286 (286)
T ss_pred CCCccHHHHHHHHHHhccChhhCC----CHHHHhhCcCcC
Confidence 123467899999999999999999 699999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=355.73 Aligned_cols=262 Identities=20% Similarity=0.280 Sum_probs=209.5
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCC-CCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADP-TARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLL 89 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~ 89 (412)
.+.+..++|++.+.||+|+||.||+|.+...+. .+...||+|+++.... ......+.+|+.+++.+ +|+|||+++
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~il~~l~~h~nIv~~~ 108 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH---TDEREALMSELKILSHLGQHKNIVNLL 108 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC---HHHHHHHHHHHHHHHhhccCCceeeEe
Confidence 456778899999999999999999998765443 2445699999975432 22345677899999999 799999999
Q ss_pred eeEEeCCeEEEEeeccCCCCchhHHHhhC---------------------------------------------------
Q 042539 90 GSLETDEFLAWAVPYCPGGDLNVLRYKQN--------------------------------------------------- 118 (412)
Q Consensus 90 ~~~~~~~~~~lv~e~~~gg~L~~~~~~~~--------------------------------------------------- 118 (412)
+++.....+|+|||||.||+|.+++....
T Consensus 109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (374)
T cd05106 109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS 188 (374)
T ss_pred eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence 99999999999999999999988875421
Q ss_pred -----------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhh
Q 042539 119 -----------------DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAF 181 (412)
Q Consensus 119 -----------------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~ 181 (412)
...+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~- 267 (374)
T cd05106 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN- 267 (374)
T ss_pred ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc-
Confidence 12478889999999999999999999999999999999999999999999999875421100
Q ss_pred hhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeec
Q 042539 182 EKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVR 261 (412)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~ 261 (412)
.....+..++..|||||++.
T Consensus 268 ------------------------------------------------------------~~~~~~~~~~~~y~aPE~~~ 287 (374)
T cd05106 268 ------------------------------------------------------------YVVKGNARLPVKWMAPESIF 287 (374)
T ss_pred ------------------------------------------------------------eeeccCCCCccceeCHHHhc
Confidence 00111233567899999999
Q ss_pred CCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCC-CCCChHHHHHHHHhhhhCCCccCCCCCChh
Q 042539 262 GDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEF-VGQRTALTDLIQRLLEKDPVKRLGYLRGAC 337 (412)
Q Consensus 262 ~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~-~~~~~~~~dli~~~L~~dP~~R~~~~~~~~ 337 (412)
+..++.++|||||||++|+|++ |..||........+....... +.. ...++++.++|.+||+.||.+|| ++.
T Consensus 288 ~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP----s~~ 363 (374)
T cd05106 288 DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERP----TFS 363 (374)
T ss_pred CCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCc----CHH
Confidence 8889999999999999999997 999998865544444443322 112 23478999999999999999999 577
Q ss_pred hhhc
Q 042539 338 EIKE 341 (412)
Q Consensus 338 e~l~ 341 (412)
++.+
T Consensus 364 ~l~~ 367 (374)
T cd05106 364 QISQ 367 (374)
T ss_pred HHHH
Confidence 7664
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=337.03 Aligned_cols=256 Identities=29% Similarity=0.486 Sum_probs=215.7
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
++|++++.||.|+||.||++++..++ ..||+|++..... ......+.+|+++++.++|+||+++++++.++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTN----QVVAIKVIDLEEA---EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSK 73 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCC----eEEEEEEeecccc---chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCe
Confidence 57999999999999999999987654 4499999975532 2223456679999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+|+|+||+.|++|.+++... .+++..+..++.|++.||.|||++|++||||+|+||+++.+|.++|+|||+++.+..
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 74 LWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTS 150 (274)
T ss_pred EEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence 99999999999998877643 589999999999999999999999999999999999999999999999999976531
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
.. .......|++.|+||
T Consensus 151 ~~---------------------------------------------------------------~~~~~~~~~~~y~~P 167 (274)
T cd06609 151 TM---------------------------------------------------------------SKRNTFVGTPFWMAP 167 (274)
T ss_pred cc---------------------------------------------------------------cccccccCCccccCh
Confidence 10 112245688999999
Q ss_pred eeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-CCC--CCChHHHHHHHHhhhhCCCccCCCCC
Q 042539 258 EVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP-EFV--GQRTALTDLIQRLLEKDPVKRLGYLR 334 (412)
Q Consensus 258 E~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~~--~~~~~~~dli~~~L~~dP~~R~~~~~ 334 (412)
|.+.+..++.++|||||||++|+|++|..||...+.......+....+ ... ..+.++.++|.+||..+|.+||
T Consensus 168 E~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rp---- 243 (274)
T cd06609 168 EVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERP---- 243 (274)
T ss_pred hhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCc----
Confidence 999988899999999999999999999999988776555554444322 222 2578899999999999999999
Q ss_pred ChhhhhcCCCCCCCCc
Q 042539 335 GACEIKEHVFFKGVRW 350 (412)
Q Consensus 335 ~~~e~l~h~ff~~~~~ 350 (412)
+++++++|+||.+..-
T Consensus 244 t~~~il~~~~~~~~~~ 259 (274)
T cd06609 244 SAKELLKHKFIKKAKK 259 (274)
T ss_pred CHHHHhhChhhcCCCc
Confidence 7999999999987653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=336.78 Aligned_cols=261 Identities=20% Similarity=0.282 Sum_probs=213.1
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
++.+++|++.+.||+|+||+||+|.+...+......||+|.+..... ......+.+|+.+++.++|+||+++++++.
T Consensus 1 ~~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 77 (283)
T cd05090 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN---PQQWGEFQQEASLMAELHHPNIVCLLGVVT 77 (283)
T ss_pred CCChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC---HHHHHHHHHHHHHHhhCCCCCeeeEEEEEe
Confidence 36789999999999999999999987655555666799999965332 233456778999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEE
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQN---------------DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILI 158 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~---------------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl 158 (412)
.++..|+||||+.+++|..++.... ...+++.++..++.|++.||.|||++||+||||||+|||+
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili 157 (283)
T cd05090 78 QEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI 157 (283)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE
Confidence 9999999999999999988875332 1247889999999999999999999999999999999999
Q ss_pred ccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccc
Q 042539 159 RQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQS 238 (412)
Q Consensus 159 ~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (412)
+.++.+||+|||+++......
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~----------------------------------------------------------- 178 (283)
T cd05090 158 GEQLHVKISDLGLSREIYSAD----------------------------------------------------------- 178 (283)
T ss_pred cCCCcEEeccccccccccCCc-----------------------------------------------------------
Confidence 999999999999997652110
Q ss_pred cCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHH
Q 042539 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALT 315 (412)
Q Consensus 239 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~ 315 (412)
.........++..|+|||++.+..++.++|+|||||++|||++ |.+||.+.+.......+.... +.....+.++.
T Consensus 179 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (283)
T cd05090 179 --YYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMY 256 (283)
T ss_pred --ceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHH
Confidence 0011223346778999999988889999999999999999998 999999887766665554433 12234678999
Q ss_pred HHHHHhhhhCCCccCCCCCChhhhhcC
Q 042539 316 DLIQRLLEKDPVKRLGYLRGACEIKEH 342 (412)
Q Consensus 316 dli~~~L~~dP~~R~~~~~~~~e~l~h 342 (412)
++|.+||+.||++|| ++.+++++
T Consensus 257 ~li~~cl~~~p~~Rp----~~~~i~~~ 279 (283)
T cd05090 257 SLMTECWQEGPSRRP----RFKDIHTR 279 (283)
T ss_pred HHHHHHcccCcccCc----CHHHHHHH
Confidence 999999999999999 56777653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=335.55 Aligned_cols=254 Identities=36% Similarity=0.617 Sum_probs=211.8
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeE
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFL 98 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 98 (412)
+|++.+.||.|+||.||+|++..++. .||+|++.+..... ....+.+.+|++++++++||||+++++++.+++.+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKK----MFAMKYMNKQKCVE-KGSVRNVLNERRILQELNHPFLVNLWYSFQDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCc----EEEEEEEehhhhcc-hhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeE
Confidence 58999999999999999999876544 49999997765422 23456788899999999999999999999999999
Q ss_pred EEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhch
Q 042539 99 AWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~ 178 (412)
|+|+||+.|++|..++... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred EEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999999998877654 35999999999999999999999999999999999999999999999999988654211
Q ss_pred hhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccce
Q 042539 179 TAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPE 258 (412)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 258 (412)
.......|+..|+|||
T Consensus 154 ----------------------------------------------------------------~~~~~~~~~~~y~~PE 169 (258)
T cd05578 154 ----------------------------------------------------------------TLTTSTSGTPGYMAPE 169 (258)
T ss_pred ----------------------------------------------------------------ccccccCCChhhcCHH
Confidence 0112345788999999
Q ss_pred eecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCH---HHHHHHHhcCCC-CCCCCChHHHHHHHHhhhhCCCccCCCCC
Q 042539 259 VVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNR---KETFRNVLMKTP-EFVGQRTALTDLIQRLLEKDPVKRLGYLR 334 (412)
Q Consensus 259 ~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---~~~~~~i~~~~~-~~~~~~~~~~dli~~~L~~dP~~R~~~~~ 334 (412)
++.+..++.++|+|||||++|+|++|..||...+. ...........+ .....+..+.++|++||..||.+|++..
T Consensus 170 ~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~- 248 (258)
T cd05578 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDN- 248 (258)
T ss_pred HHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHccCChhHcCCcc-
Confidence 99988889999999999999999999999988763 333333332222 2234578999999999999999999521
Q ss_pred ChhhhhcCCCC
Q 042539 335 GACEIKEHVFF 345 (412)
Q Consensus 335 ~~~e~l~h~ff 345 (412)
..++++||||
T Consensus 249 -~~~l~~~~~~ 258 (258)
T cd05578 249 -LKDLKNHPYF 258 (258)
T ss_pred -HHHHhcCCCC
Confidence 4999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=330.34 Aligned_cols=250 Identities=27% Similarity=0.460 Sum_probs=211.1
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeE
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFL 98 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 98 (412)
+|++.+.||+|+||.||++.+..++.. ||+|.++.... ......+.+|+.+++.++|+||+++++.+.+++.+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~----~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 73 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQK----YAMKEIRLPKS---SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHL 73 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCce----EEEEEEEcCcc---hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence 689999999999999999998875544 99999865432 22345666799999999999999999999999999
Q ss_pred EEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhch
Q 042539 99 AWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~ 178 (412)
|++|||+.|++|..++.......+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 74 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 74 YIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred EEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence 99999999999988776555556899999999999999999999999999999999999999999999999998654211
Q ss_pred hhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccce
Q 042539 179 TAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPE 258 (412)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 258 (412)
........|++.|+|||
T Consensus 154 ---------------------------------------------------------------~~~~~~~~~~~~~~aPE 170 (255)
T cd08219 154 ---------------------------------------------------------------GAYACTYVGTPYYVPPE 170 (255)
T ss_pred ---------------------------------------------------------------ccccccccCCccccCHH
Confidence 11122456899999999
Q ss_pred eecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC--CCCCCChHHHHHHHHhhhhCCCccCCCCCCh
Q 042539 259 VVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP--EFVGQRTALTDLIQRLLEKDPVKRLGYLRGA 336 (412)
Q Consensus 259 ~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~ 336 (412)
++.+..++.++|+|||||++|+|++|..||...+.......+..... .....+..+.+||.+||+.||.+|| ++
T Consensus 171 ~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp----~~ 246 (255)
T cd08219 171 IWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRP----SA 246 (255)
T ss_pred HHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhCCcccCC----CH
Confidence 99988899999999999999999999999998887776666654432 2234578899999999999999999 68
Q ss_pred hhhhcC
Q 042539 337 CEIKEH 342 (412)
Q Consensus 337 ~e~l~h 342 (412)
.+++.-
T Consensus 247 ~~il~~ 252 (255)
T cd08219 247 TTILSR 252 (255)
T ss_pred HHHhhc
Confidence 888763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=357.99 Aligned_cols=250 Identities=23% Similarity=0.281 Sum_probs=197.7
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
...|.+.+.||+|+||.||+|.+..++. .||||..... ...+|+++|++++|+|||++++++..++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~----~vavK~~~~~----------~~~~E~~iL~~L~HpnIv~l~~~~~~~~ 233 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQ----RVVVKAGWYA----------SSVHEARLLRRLSHPAVLALLDVRVVGG 233 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCC----EEEEeccccc----------CHHHHHHHHHHCCCCCCCcEEEEEEECC
Confidence 4579999999999999999999887544 4999964221 2345999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
..|+|||++. ++|..++... ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 234 ~~~lv~e~~~-~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~ 311 (461)
T PHA03211 234 LTCLVLPKYR-SDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311 (461)
T ss_pred EEEEEEEccC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence 9999999995 5776665543 2359999999999999999999999999999999999999999999999999997542
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
... .......++||+.|+|
T Consensus 312 ~~~-------------------------------------------------------------~~~~~~~~~GT~~Y~A 330 (461)
T PHA03211 312 GSW-------------------------------------------------------------STPFHYGIAGTVDTNA 330 (461)
T ss_pred ccc-------------------------------------------------------------ccccccccCCCcCCcC
Confidence 100 0011124579999999
Q ss_pred ceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCC--------HHHHHHHHhcCC---CC-------------------
Q 042539 257 PEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKN--------RKETFRNVLMKT---PE------------------- 306 (412)
Q Consensus 257 PE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~--------~~~~~~~i~~~~---~~------------------- 306 (412)
||++.+..++.++|||||||++|||++|..++.... ..++.+.+.... ..
T Consensus 331 PE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 410 (461)
T PHA03211 331 PEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAAR 410 (461)
T ss_pred HHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhc
Confidence 999999999999999999999999999876543211 122222111100 00
Q ss_pred -------------CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCC
Q 042539 307 -------------FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 307 -------------~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
+...+.++.+||.+||+.||.+|| ++.|+|+||||+.
T Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RP----sa~elL~hp~f~~ 460 (461)
T PHA03211 411 NRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRP----SAAELLRLPLFQS 460 (461)
T ss_pred ccCCccCCcchhhhccccchHHHHHHHHcccChhhCc----CHHHHhhCcccCC
Confidence 012345789999999999999999 6999999999974
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=329.61 Aligned_cols=253 Identities=28% Similarity=0.424 Sum_probs=215.2
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeE
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFL 98 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 98 (412)
+|++++.||+|+||.||+|.+..++ ..+|+|++....... .....+.+|+++++.++|+||+++++.+..++.+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 74 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQ----KLVIIKQIPVEQMTK--DERLAAQNECQVLKLLSHPNIIEYYENFLEDKAL 74 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCC----cEEEEEEEecccccc--HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEE
Confidence 5899999999999999999987644 449999997654422 3356677899999999999999999999999999
Q ss_pred EEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCC-CEEEccccccchhhc
Q 042539 99 AWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG-HVTLTDFDLSRNLVK 177 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g-~vkL~DFGla~~~~~ 177 (412)
++||||+.|++|.+++.......+++..+..++.|++.||.|||++||+|+||||+||+++.++ .+||+|||++.....
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 75 MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 9999999999999888765555689999999999999999999999999999999999998664 579999999875421
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
. .......|+..|+||
T Consensus 155 ~----------------------------------------------------------------~~~~~~~~~~~y~aP 170 (256)
T cd08220 155 K----------------------------------------------------------------SKAYTVVGTPCYISP 170 (256)
T ss_pred C----------------------------------------------------------------ccccccccCCcccCc
Confidence 0 111234688999999
Q ss_pred eeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-C-CCCCChHHHHHHHHhhhhCCCccCCCCCC
Q 042539 258 EVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP-E-FVGQRTALTDLIQRLLEKDPVKRLGYLRG 335 (412)
Q Consensus 258 E~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-~-~~~~~~~~~dli~~~L~~dP~~R~~~~~~ 335 (412)
|.+.+..++.++|+|||||++|+|++|..||.+.+.......+..... . ....+.++.++|.+||..||.+|| +
T Consensus 171 E~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp----t 246 (256)
T cd08220 171 ELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRP----Q 246 (256)
T ss_pred hhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHccCChhhCC----C
Confidence 999988889999999999999999999999998877776666654332 2 234678999999999999999999 7
Q ss_pred hhhhhcCCCC
Q 042539 336 ACEIKEHVFF 345 (412)
Q Consensus 336 ~~e~l~h~ff 345 (412)
+.++++||||
T Consensus 247 ~~~ll~~p~~ 256 (256)
T cd08220 247 LSQIMAQPIC 256 (256)
T ss_pred HHHHhhCCCC
Confidence 9999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=333.49 Aligned_cols=257 Identities=18% Similarity=0.265 Sum_probs=210.0
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
+++.++|++.+.||+|+||.||++.++... .....||+|.++.... ......+.+|+.++++++||||+++++++.
T Consensus 1 ~i~~~~~~~~~~ig~G~fg~V~~~~~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 76 (266)
T cd05064 1 ELDNKSIKIERILGTGRFGELCRGCLKLPS-KRELPVAIHTLRAGCS---DKQRRGFLAEALTLGQFDHSNIVRLEGVIT 76 (266)
T ss_pred CCchHHeEEeeeecccCCCeEEEEEEecCC-CceeeEEEEecCCCCC---HHHHHHHHHHHHHHhcCCCCCcCeEEEEEe
Confidence 356789999999999999999999875432 2455699999975432 223456778999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
.++.+|+||||+.||+|..++.... ..+++..++.++.|++.||+|||++|++||||||+|||++.++.+|++|||.+.
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 77 RGNTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred cCCCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccc
Confidence 9999999999999999988876543 458999999999999999999999999999999999999999999999999775
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
...... ........++..
T Consensus 156 ~~~~~~--------------------------------------------------------------~~~~~~~~~~~~ 173 (266)
T cd05064 156 EDKSEA--------------------------------------------------------------IYTTMSGKSPVL 173 (266)
T ss_pred cccccc--------------------------------------------------------------hhcccCCCCcee
Confidence 421100 000112345678
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHh-hCCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCccC
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEML-YGTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVKRL 330 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell-~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~R~ 330 (412)
|+|||++.+..++.++|||||||++||++ +|..||.+.+..+....+.... +.....+..+.+++.+||..+|.+||
T Consensus 174 y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP 253 (266)
T cd05064 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERP 253 (266)
T ss_pred ecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCC
Confidence 99999999999999999999999999977 5999999988777766665432 33345678899999999999999999
Q ss_pred CCCCChhhhhc
Q 042539 331 GYLRGACEIKE 341 (412)
Q Consensus 331 ~~~~~~~e~l~ 341 (412)
+++++++
T Consensus 254 ----~~~~i~~ 260 (266)
T cd05064 254 ----RFSQIHS 260 (266)
T ss_pred ----CHHHHHH
Confidence 5677664
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=330.77 Aligned_cols=254 Identities=27% Similarity=0.455 Sum_probs=216.1
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeE
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFL 98 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 98 (412)
+|++++.||+|+||.||++++...+. .||+|.+....... .....+.+|+.++++++|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~----~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGK----QYVIKEINISKMSP--KEREESRKEVAVLSNMKHPNIVQYQESFEENGNL 74 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCC----EEEEEEEEhHhCCh--HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeE
Confidence 58999999999999999999876544 49999997654322 2345677899999999999999999999999999
Q ss_pred EEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhch
Q 042539 99 AWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~ 178 (412)
|+||||+.|++|..++.......+++.++..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++......
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 75 YIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 99999999999988876654446899999999999999999999999999999999999999999999999998754211
Q ss_pred hhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccce
Q 042539 179 TAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPE 258 (412)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 258 (412)
. .......|++.|+|||
T Consensus 155 ~---------------------------------------------------------------~~~~~~~~~~~~~~pe 171 (256)
T cd08218 155 V---------------------------------------------------------------ELARTCIGTPYYLSPE 171 (256)
T ss_pred h---------------------------------------------------------------hhhhhccCCccccCHH
Confidence 1 0112345888999999
Q ss_pred eecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC--CCCCChHHHHHHHHhhhhCCCccCCCCCCh
Q 042539 259 VVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE--FVGQRTALTDLIQRLLEKDPVKRLGYLRGA 336 (412)
Q Consensus 259 ~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~dli~~~L~~dP~~R~~~~~~~ 336 (412)
++.+..++.++|+|||||++|+|++|..||...+..+....++.+... ....+.++.++|.+||+.+|.+|| ++
T Consensus 172 ~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----~~ 247 (256)
T cd08218 172 ICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRP----SV 247 (256)
T ss_pred HhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhhCChhhCc----CH
Confidence 999888889999999999999999999999988877777776654422 234578899999999999999999 69
Q ss_pred hhhhcCCCC
Q 042539 337 CEIKEHVFF 345 (412)
Q Consensus 337 ~e~l~h~ff 345 (412)
.++++|+||
T Consensus 248 ~~vl~~~~~ 256 (256)
T cd08218 248 NSILEKNFI 256 (256)
T ss_pred HHHhhCcCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=338.71 Aligned_cols=255 Identities=27% Similarity=0.402 Sum_probs=213.9
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
..+|++++.||.|+||.||++.+...+. .||+|.+..... .....+.+|+.+++.++|+||+++++++..++
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~----~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 89 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQ----EVAIKQINLQKQ----PKKELIINEILVMKELKNPNIVNFLDSFLVGD 89 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCc----EEEEEEEecccC----chHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence 4679999999999999999998876544 499999865432 12345677999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
.+|+|+||+.|++|..++.. ..+++.++..++.|++.||.|||++|++||||||+||+++.+|.+||+|||++....
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~ 166 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT 166 (296)
T ss_pred eEEEEEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcc
Confidence 99999999999999877653 248999999999999999999999999999999999999999999999999886542
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
.. ........|+..|+|
T Consensus 167 ~~---------------------------------------------------------------~~~~~~~~~~~~y~a 183 (296)
T cd06655 167 PE---------------------------------------------------------------QSKRSTMVGTPYWMA 183 (296)
T ss_pred cc---------------------------------------------------------------cccCCCcCCCccccC
Confidence 10 011123468899999
Q ss_pred ceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC----CCCCCChHHHHHHHHhhhhCCCccCCC
Q 042539 257 PEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP----EFVGQRTALTDLIQRLLEKDPVKRLGY 332 (412)
Q Consensus 257 PE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~----~~~~~~~~~~dli~~~L~~dP~~R~~~ 332 (412)
||.+.+..++.++|+|||||++|+|++|+.||.+.+.......+..... .....++.+.+||.+||..||.+|+
T Consensus 184 PE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-- 261 (296)
T cd06655 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRG-- 261 (296)
T ss_pred cchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCC--
Confidence 9999988889999999999999999999999998876665554443221 2234578899999999999999999
Q ss_pred CCChhhhhcCCCCCCCC
Q 042539 333 LRGACEIKEHVFFKGVR 349 (412)
Q Consensus 333 ~~~~~e~l~h~ff~~~~ 349 (412)
++.+++.|+||+...
T Consensus 262 --t~~~il~~~~~~~~~ 276 (296)
T cd06655 262 --SAKELLQHPFLKLAK 276 (296)
T ss_pred --CHHHHhhChHhhhcc
Confidence 699999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=336.87 Aligned_cols=254 Identities=24% Similarity=0.428 Sum_probs=208.1
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeeeeEEe
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLGSLET 94 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 94 (412)
..+.|++.+.||.|+||.||+|++...+. .||+|++.... .....+..|+.+++.+ +|+||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~----~~a~K~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQ----LAAIKVMDVTE-----DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCc----EEEEEEEecCh-----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 44799999999999999999999876544 49999986542 1234456789999999 59999999999853
Q ss_pred ------CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcc
Q 042539 95 ------DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTD 168 (412)
Q Consensus 95 ------~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~D 168 (412)
+..+|++|||+.+|+|..++.......+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~d 164 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVD 164 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEee
Confidence 46789999999999999888765556689999999999999999999999999999999999999999999999
Q ss_pred ccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccc
Q 042539 169 FDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248 (412)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (412)
||++...... .......
T Consensus 165 fg~~~~~~~~---------------------------------------------------------------~~~~~~~ 181 (282)
T cd06636 165 FGVSAQLDRT---------------------------------------------------------------VGRRNTF 181 (282)
T ss_pred Ccchhhhhcc---------------------------------------------------------------ccCCCcc
Confidence 9998654210 0112345
Q ss_pred ccCCCCccceeec-----CCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC---CCCCCChHHHHHHHH
Q 042539 249 VGTEEYVSPEVVR-----GDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP---EFVGQRTALTDLIQR 320 (412)
Q Consensus 249 ~gt~~Y~APE~l~-----~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~dli~~ 320 (412)
+|++.|+|||++. +..++.++|+|||||++|+|++|..||...........+....+ .....+..+.+||++
T Consensus 182 ~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 261 (282)
T cd06636 182 IGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEG 261 (282)
T ss_pred cccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccCHHHHHHHHH
Confidence 7899999999986 34578899999999999999999999987665554443333221 122467899999999
Q ss_pred hhhhCCCccCCCCCChhhhhcCCCC
Q 042539 321 LLEKDPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 321 ~L~~dP~~R~~~~~~~~e~l~h~ff 345 (412)
||..||.+|| ++.++++||||
T Consensus 262 cl~~~p~~Rp----~~~ell~~~~~ 282 (282)
T cd06636 262 CLVKNYLSRP----STEQLLKHPFI 282 (282)
T ss_pred HhCCChhhCc----CHHHHhcCCCC
Confidence 9999999999 79999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=332.50 Aligned_cols=262 Identities=39% Similarity=0.691 Sum_probs=217.2
Q ss_pred eeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEEEeecc
Q 042539 26 LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYC 105 (412)
Q Consensus 26 LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 105 (412)
||+|+||.||+|++..++. .||+|++.+..... ......+.+|+++++.++|+||+++++.+..+...|++|||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~----~~~~k~~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGD----IYAIKVIKKADMIR-KNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCC----EEEEEEecchhhhh-hhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecC
Confidence 6899999999999876544 49999997665422 345667788999999999999999999999999999999999
Q ss_pred CCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhhhhc
Q 042539 106 PGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQS 185 (412)
Q Consensus 106 ~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~ 185 (412)
.|++|..++.... .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++...........
T Consensus 76 ~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~-- 151 (265)
T cd05579 76 PGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL-- 151 (265)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc--
Confidence 9999988876544 589999999999999999999999999999999999999999999999999875421100000
Q ss_pred ccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecCCCC
Q 042539 186 LNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGH 265 (412)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~ 265 (412)
...........++..|+|||.+.+..+
T Consensus 152 -----------------------------------------------------~~~~~~~~~~~~~~~~~~Pe~~~~~~~ 178 (265)
T cd05579 152 -----------------------------------------------------NDDEKEDKRIVGTPDYIAPEVILGQGH 178 (265)
T ss_pred -----------------------------------------------------ccccccccCcccCccccCHHHhcCCCC
Confidence 000112234568889999999988888
Q ss_pred CchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCC---ChHHHHHHHHhhhhCCCccCCCCCChhhhhcC
Q 042539 266 EFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVGQ---RTALTDLIQRLLEKDPVKRLGYLRGACEIKEH 342 (412)
Q Consensus 266 ~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~---~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h 342 (412)
+.++|+|||||++|+|++|..||......+.+..+......++.. +..+.+||.+||+.+|.+||++ ..+.++++|
T Consensus 179 ~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~-~~~~~~l~~ 257 (265)
T cd05579 179 SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGA-KSIEEIKNH 257 (265)
T ss_pred CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCC-ccHHHHhcC
Confidence 999999999999999999999999988888777776544444333 7899999999999999999952 234999999
Q ss_pred CCCCCCCc
Q 042539 343 VFFKGVRW 350 (412)
Q Consensus 343 ~ff~~~~~ 350 (412)
|||++++|
T Consensus 258 ~~~~~~~~ 265 (265)
T cd05579 258 PFFKGIDW 265 (265)
T ss_pred ccccCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=338.78 Aligned_cols=254 Identities=28% Similarity=0.403 Sum_probs=211.5
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
..+|++++.||+|+||.||++.+..++. .||+|.+...... ....+.+|+.+++.+.|+||+++++.+..+.
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~v~ik~~~~~~~~----~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~ 90 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQ----EVAIRQMNLQQQP----KKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCc----EEEEEEEecCCcc----hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC
Confidence 3699999999999999999999876554 4999999765432 2345667999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
..|+||||+.|++|..++.. ..+++.++..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~ 167 (296)
T cd06654 91 ELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (296)
T ss_pred EEEEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence 99999999999999887753 248999999999999999999999999999999999999999999999999886432
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
.. ........|++.|+|
T Consensus 168 ~~---------------------------------------------------------------~~~~~~~~~~~~y~a 184 (296)
T cd06654 168 PE---------------------------------------------------------------QSKRSTMVGTPYWMA 184 (296)
T ss_pred cc---------------------------------------------------------------ccccCcccCCccccC
Confidence 10 001123468899999
Q ss_pred ceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-CCC---CCCCChHHHHHHHHhhhhCCCccCCC
Q 042539 257 PEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK-TPE---FVGQRTALTDLIQRLLEKDPVKRLGY 332 (412)
Q Consensus 257 PE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~-~~~---~~~~~~~~~dli~~~L~~dP~~R~~~ 332 (412)
||.+.+..++.++|+|||||++|+|++|+.||...+.......+... .+. ....+..+.+||.+||..||++||
T Consensus 185 PE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-- 262 (296)
T cd06654 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRG-- 262 (296)
T ss_pred HHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCc--
Confidence 99999888899999999999999999999999887655443333322 211 224567899999999999999999
Q ss_pred CCChhhhhcCCCCCCC
Q 042539 333 LRGACEIKEHVFFKGV 348 (412)
Q Consensus 333 ~~~~~e~l~h~ff~~~ 348 (412)
++.+++.|+||...
T Consensus 263 --t~~eil~~~~~~~~ 276 (296)
T cd06654 263 --SAKELLQHQFLKIA 276 (296)
T ss_pred --CHHHHhhChhhhcc
Confidence 79999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=338.63 Aligned_cols=255 Identities=24% Similarity=0.420 Sum_probs=208.8
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
++|++++.||+|+||.||+|++...+. .||+|.++... .......+.+|+.++++++|+||+++++++..++.
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~----~~a~k~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 73 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGV----TMAMKEIRLEL---DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGA 73 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCc----EEEEEEeeccc---CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCe
Confidence 589999999999999999999876554 49999986532 22234567789999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeeCCCCceEEccCCCEEEccccccchh
Q 042539 98 LAWAVPYCPGGDLNVLRYKQN-DRVFSPSVIRFYLSEIICAIEHLHN-MGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~-~~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
+|+|||||.|++|..++.... ...+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++..+
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 153 (286)
T cd06622 74 VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL 153 (286)
T ss_pred EEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999999999987765431 2358999999999999999999997 59999999999999999999999999998654
Q ss_pred hchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCc
Q 042539 176 VKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYV 255 (412)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 255 (412)
.. .......|++.|+
T Consensus 154 ~~-----------------------------------------------------------------~~~~~~~~~~~y~ 168 (286)
T cd06622 154 VA-----------------------------------------------------------------SLAKTNIGCQSYM 168 (286)
T ss_pred cC-----------------------------------------------------------------CccccCCCccCcc
Confidence 21 0112335888999
Q ss_pred cceeecCC------CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHH---HhcCC-C-CCCCCChHHHHHHHHhhhh
Q 042539 256 SPEVVRGD------GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRN---VLMKT-P-EFVGQRTALTDLIQRLLEK 324 (412)
Q Consensus 256 APE~l~~~------~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~---i~~~~-~-~~~~~~~~~~dli~~~L~~ 324 (412)
|||++.+. .++.++|+|||||++|+|++|..||........+.. +.... + .....+.++.+||.+||+.
T Consensus 169 aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 248 (286)
T cd06622 169 APERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNK 248 (286)
T ss_pred CcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHccc
Confidence 99998654 347899999999999999999999987655444333 33222 1 2234678999999999999
Q ss_pred CCCccCCCCCChhhhhcCCCCCCC
Q 042539 325 DPVKRLGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 325 dP~~R~~~~~~~~e~l~h~ff~~~ 348 (412)
+|.+|| ++++++.||||...
T Consensus 249 ~p~~Rp----~~~~l~~~~~~~~~ 268 (286)
T cd06622 249 IPNRRP----TYAQLLEHPWLVKY 268 (286)
T ss_pred CcccCC----CHHHHhcChhhhhc
Confidence 999999 69999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=329.81 Aligned_cols=252 Identities=27% Similarity=0.408 Sum_probs=210.9
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
.++|++.+.||.|+||.||+|.+..++. .+|+|++..... .....+.+|+.++++++||||+++++++.++.
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGE----LVAIKVIKLEPG----DDFEIIQQEISMLKECRHPNIVAYFGSYLRRD 73 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCC----EEEEEEEEcCch----hhHHHHHHHHHHHHhCCCCChhceEEEEEeCC
Confidence 4789999999999999999999876543 499999975532 23466778999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
.+|++|||+.|++|..++... ...+++.++..++.|++.||.|||++||+|+||||+||+++.+|.+||+|||++..+.
T Consensus 74 ~~~l~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 152 (262)
T cd06613 74 KLWIVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLT 152 (262)
T ss_pred EEEEEEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhh
Confidence 999999999999998876654 2459999999999999999999999999999999999999999999999999987542
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
.. ........|+..|+|
T Consensus 153 ~~---------------------------------------------------------------~~~~~~~~~~~~y~~ 169 (262)
T cd06613 153 AT---------------------------------------------------------------IAKRKSFIGTPYWMA 169 (262)
T ss_pred hh---------------------------------------------------------------hhccccccCCccccC
Confidence 11 011224568889999
Q ss_pred ceeecCC---CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--CC----CCCCChHHHHHHHHhhhhCCC
Q 042539 257 PEVVRGD---GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT--PE----FVGQRTALTDLIQRLLEKDPV 327 (412)
Q Consensus 257 PE~l~~~---~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~~----~~~~~~~~~dli~~~L~~dP~ 327 (412)
||.+.+. .++.++|+|||||++|+|++|.+||.+.+.......+.... +. ....+.++.+||.+||..+|.
T Consensus 170 Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 249 (262)
T cd06613 170 PEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPK 249 (262)
T ss_pred chhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChh
Confidence 9999877 78899999999999999999999998877665544443331 11 112356899999999999999
Q ss_pred ccCCCCCChhhhhcCCC
Q 042539 328 KRLGYLRGACEIKEHVF 344 (412)
Q Consensus 328 ~R~~~~~~~~e~l~h~f 344 (412)
+|| ++.+++.|+|
T Consensus 250 ~Rp----t~~~il~~~~ 262 (262)
T cd06613 250 KRP----TATKLLQHPF 262 (262)
T ss_pred hCC----CHHHHhcCCC
Confidence 999 6999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=347.45 Aligned_cols=253 Identities=25% Similarity=0.422 Sum_probs=204.4
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
..++|++++.||+|+||+||+|++..++.. ||||++.+... .......+.+|+.+++.++|+||++++++|...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~----vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQN----VAIKKLSRPFQ--NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQ 87 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCE----EEEEecCcccc--ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccC
Confidence 468899999999999999999998875544 99999865432 223344566799999999999999999998644
Q ss_pred ------CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccc
Q 042539 96 ------EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169 (412)
Q Consensus 96 ------~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DF 169 (412)
..+|+|||||.+ +|...+.. .+++..+..++.|++.||+|||++||+||||||+||+++.+|.+||+||
T Consensus 88 ~~~~~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Df 162 (353)
T cd07850 88 KSLEEFQDVYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 162 (353)
T ss_pred CCccccCcEEEEEeccCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccC
Confidence 357999999965 66555432 2899999999999999999999999999999999999999999999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|+++.... ........
T Consensus 163 g~~~~~~~----------------------------------------------------------------~~~~~~~~ 178 (353)
T cd07850 163 GLARTAGT----------------------------------------------------------------SFMMTPYV 178 (353)
T ss_pred ccceeCCC----------------------------------------------------------------CCCCCCCc
Confidence 99865421 01112346
Q ss_pred cCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC----------------------CC-
Q 042539 250 GTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT----------------------PE- 306 (412)
Q Consensus 250 gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~----------------------~~- 306 (412)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+.+++... +.
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (353)
T cd07850 179 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKY 258 (353)
T ss_pred ccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCC
Confidence 8899999999999999999999999999999999999998877555444432100 00
Q ss_pred ---------------------CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCC
Q 042539 307 ---------------------FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 307 ---------------------~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
....++.+++||.+||+.||++|| ++.+++.||||+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~----t~~eiL~~~~~~~ 316 (353)
T cd07850 259 AGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRI----SVDDALQHPYINV 316 (353)
T ss_pred CCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCc----CHHHHhcChhHhh
Confidence 001245689999999999999999 6999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=337.60 Aligned_cols=249 Identities=16% Similarity=0.206 Sum_probs=206.5
Q ss_pred CCCccCceee--eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 14 SLDLDNLKAL--KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 14 ~~~~~~y~~~--~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
.+..++++.. ..||+|++|.||++... +..||||++++... ........+.+|+.+|++++|||||+++++
T Consensus 14 ~i~~~~i~~~~~~~i~~g~~~~v~~~~~~------~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~ 86 (283)
T PHA02988 14 CIESDDIDKYTSVLIKENDQNSIYKGIFN------NKEVIIRTFKKFHK-GHKVLIDITENEIKNLRRIDSNNILKIYGF 86 (283)
T ss_pred ecCHHHcCCCCCeEEeeCCceEEEEEEEC------CEEEEEEecccccc-ccHHHHHHHHHHHHHHHhcCCCCEEEEeee
Confidence 4555666666 78999999999999873 23499999976543 223345667789999999999999999999
Q ss_pred EEe----CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeeeCCCCceEEccCCCEEE
Q 042539 92 LET----DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNM-GIAYRDLKPENILIRQSGHVTL 166 (412)
Q Consensus 92 ~~~----~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~-~iiHrDlKp~NiLl~~~g~vkL 166 (412)
+.+ ...+++|||||.||+|..++.... .+++..+..++.|++.||.|||+. +++||||||+|||++.+|.+||
T Consensus 87 ~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl 164 (283)
T PHA02988 87 IIDIVDDLPRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKI 164 (283)
T ss_pred EEecccCCCceEEEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEE
Confidence 877 357899999999999998876543 588999999999999999999985 9999999999999999999999
Q ss_pred ccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCc
Q 042539 167 TDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSN 246 (412)
Q Consensus 167 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (412)
+|||+++..... ..
T Consensus 165 ~dfg~~~~~~~~------------------------------------------------------------------~~ 178 (283)
T PHA02988 165 ICHGLEKILSSP------------------------------------------------------------------PF 178 (283)
T ss_pred cccchHhhhccc------------------------------------------------------------------cc
Confidence 999998754210 11
Q ss_pred ccccCCCCccceeecC--CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--CCCC-CCChHHHHHHHHh
Q 042539 247 SFVGTEEYVSPEVVRG--DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT--PEFV-GQRTALTDLIQRL 321 (412)
Q Consensus 247 ~~~gt~~Y~APE~l~~--~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~~-~~~~~~~dli~~~ 321 (412)
..+||..|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+.+..+.... +..+ ..++.+.+||.+|
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 258 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEAC 258 (283)
T ss_pred cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHH
Confidence 2368899999999976 678999999999999999999999999988888777775433 2333 5678999999999
Q ss_pred hhhCCCccCCCCCChhhhhc
Q 042539 322 LEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 322 L~~dP~~R~~~~~~~~e~l~ 341 (412)
|+.||.+|| ++.++++
T Consensus 259 l~~dp~~Rp----s~~ell~ 274 (283)
T PHA02988 259 TSHDSIKRP----NIKEILY 274 (283)
T ss_pred hcCCcccCc----CHHHHHH
Confidence 999999999 5777774
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=352.47 Aligned_cols=262 Identities=21% Similarity=0.299 Sum_probs=207.6
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCC-CCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAA-DPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLL 89 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~-~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~ 89 (412)
...+..++|++.++||+|+||+||+|.+... ...++..||+|+++.... ......+.+|+++++.+ +||||++++
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~~Ei~il~~l~~HpnIv~l~ 105 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH---LTEREALMSELKVLSYLGNHINIVNLL 105 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC---cHHHHHHHHHHHHHHHhcCCcceeeee
Confidence 4466677999999999999999999976432 223455699999965432 22345677899999999 799999999
Q ss_pred eeEEeCCeEEEEeeccCCCCchhHHHhhC---------------------------------------------------
Q 042539 90 GSLETDEFLAWAVPYCPGGDLNVLRYKQN--------------------------------------------------- 118 (412)
Q Consensus 90 ~~~~~~~~~~lv~e~~~gg~L~~~~~~~~--------------------------------------------------- 118 (412)
+++.+++..++|||||.||+|..++....
T Consensus 106 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 185 (375)
T cd05104 106 GACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADK 185 (375)
T ss_pred eeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccc
Confidence 99999999999999999999988875422
Q ss_pred ----------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 119 ----------------------DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 119 ----------------------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 186 RRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred ccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceecc
Confidence 1247788899999999999999999999999999999999999999999999997542
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
.... ........++..|+|
T Consensus 266 ~~~~-------------------------------------------------------------~~~~~~~~~~~~y~a 284 (375)
T cd05104 266 NDSN-------------------------------------------------------------YVVKGNARLPVKWMA 284 (375)
T ss_pred Cccc-------------------------------------------------------------ccccCCCCCCcceeC
Confidence 1100 001112345678999
Q ss_pred ceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--C-CCCCCChHHHHHHHHhhhhCCCccCCC
Q 042539 257 PEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--P-EFVGQRTALTDLIQRLLEKDPVKRLGY 332 (412)
Q Consensus 257 PE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~-~~~~~~~~~~dli~~~L~~dP~~R~~~ 332 (412)
||++.+..++.++|||||||++|||++ |..||.+......+.+.+... . .....+.++.+||.+||..||++||
T Consensus 285 PE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-- 362 (375)
T cd05104 285 PESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRP-- 362 (375)
T ss_pred hhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCc--
Confidence 999999999999999999999999997 999998865544444443322 1 1223468899999999999999999
Q ss_pred CCChhhhhc
Q 042539 333 LRGACEIKE 341 (412)
Q Consensus 333 ~~~~~e~l~ 341 (412)
++.++++
T Consensus 363 --s~~eil~ 369 (375)
T cd05104 363 --TFKQIVQ 369 (375)
T ss_pred --CHHHHHH
Confidence 5788775
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=307.17 Aligned_cols=256 Identities=27% Similarity=0.462 Sum_probs=212.8
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
+.|.-.++||+|.||+||+++++.++.. ||+|.++.+. ..+.+-...+|||-+|+.++|.|||+++++...++.
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~ei----valkrvrldd--ddegvpssalreicllkelkhknivrl~dvlhsdkk 75 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEI----VALKRVRLDD--DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK 75 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccce----EEEEEEeccC--CCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCce
Confidence 5688889999999999999988876655 9999997664 234456678889999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+-+|+|||. .+|..+...- ++-++.+.++.++.|++.||.|+|+++++||||||+|+||+.+|.+||+|||+|+-+.-
T Consensus 76 ltlvfe~cd-qdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgi 153 (292)
T KOG0662|consen 76 LTLVFEFCD-QDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGI 153 (292)
T ss_pred eEEeHHHhh-HHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence 999999994 4665554433 35699999999999999999999999999999999999999999999999999986621
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
|+.. .+.-+-|.+|.+|
T Consensus 154 --------------pvrc-------------------------------------------------ysaevvtlwyrpp 170 (292)
T KOG0662|consen 154 --------------PVRC-------------------------------------------------YSAEVVTLWYRPP 170 (292)
T ss_pred --------------ceEe-------------------------------------------------eeceeeeeeccCc
Confidence 1111 1123568899999
Q ss_pred eeecCCC-CCchhhHHHHHHHHHHHh-hCCCCCCCCCHHHHHHHHhcC--CC------------C------C--------
Q 042539 258 EVVRGDG-HEFAVDWWALGILTYEML-YGTTPFRGKNRKETFRNVLMK--TP------------E------F-------- 307 (412)
Q Consensus 258 E~l~~~~-~~~~~DiwSlGvil~ell-~g~~Pf~~~~~~~~~~~i~~~--~~------------~------~-------- 307 (412)
.++.|.. |+...|+||.|||+.|+. .|++.|+|.+..+++.+|... .+ . +
T Consensus 171 dvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsq 250 (292)
T KOG0662|consen 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQ 250 (292)
T ss_pred ceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHH
Confidence 9999865 799999999999999998 599999999998888887631 11 1 1
Q ss_pred --CCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCC
Q 042539 308 --VGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 308 --~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~ 348 (412)
+.....-+||++++|..+|..|+ +++++++||||.+.
T Consensus 251 ivp~lns~grdllqkll~cnp~qri----saeaalqhpyf~d~ 289 (292)
T KOG0662|consen 251 IVPKLNSTGRDLLQKLLKCNPAQRI----SAEAALQHPYFSDF 289 (292)
T ss_pred HhhhhcchhHHHHHHHhccCccccc----CHHHHhcCcccccc
Confidence 11223568999999999999999 59999999999853
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=341.13 Aligned_cols=258 Identities=27% Similarity=0.356 Sum_probs=208.3
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
.+++|++++.||+|+||.||+|.++.++. .||+|+++..... ........+|+.++++++|+||+++++++...
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~----~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGE----IVALKKVRMDNER--DGIPISSLREITLLLNLRHPNIVELKEVVVGK 78 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCc----EEEEEEEEeccCC--CCCcchhhHHHHHHHhCCCCCCcceEEEEecC
Confidence 57899999999999999999999887554 4999998654321 12223345699999999999999999999765
Q ss_pred --CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 96 --EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 96 --~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
+.+|+||||+.+ +|..++... ...+++.++..++.||+.||.|||+.|++||||||+||+++.+|.+||+|||++.
T Consensus 79 ~~~~~~lv~e~~~~-~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~ 156 (309)
T cd07845 79 HLDSIFLVMEYCEQ-DLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLAR 156 (309)
T ss_pred CCCeEEEEEecCCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceee
Confidence 578999999965 676665543 2458999999999999999999999999999999999999999999999999987
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
...... .......+++.
T Consensus 157 ~~~~~~---------------------------------------------------------------~~~~~~~~~~~ 173 (309)
T cd07845 157 TYGLPA---------------------------------------------------------------KPMTPKVVTLW 173 (309)
T ss_pred ecCCcc---------------------------------------------------------------CCCCccccccc
Confidence 542110 01112245788
Q ss_pred CccceeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-------------------C-------
Q 042539 254 YVSPEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP-------------------E------- 306 (412)
Q Consensus 254 Y~APE~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-------------------~------- 306 (412)
|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+..... .
T Consensus 174 y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (309)
T cd07845 174 YRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYN 253 (309)
T ss_pred ccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCC
Confidence 999999876 4578999999999999999999999999887777665543110 0
Q ss_pred -----CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCC
Q 042539 307 -----FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 307 -----~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~ 348 (412)
+...++.+.+||.+||+.||++|| ++++++.|+||++.
T Consensus 254 ~~~~~~~~~~~~~~~li~~ml~~dp~~R~----t~~~il~h~~f~~~ 296 (309)
T cd07845 254 NLKHKFPWLSEAGLRLLNFLLMYDPKKRA----TAEEALESSYFKEK 296 (309)
T ss_pred chHHhccccCHHHHHHHHHHhcCChhhCc----CHHHHhcChhhccC
Confidence 112467889999999999999999 69999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=333.71 Aligned_cols=259 Identities=27% Similarity=0.447 Sum_probs=209.9
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhh--hhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTL--HAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
+|+..+.||+|+||.||++.+..++. .||+|++.+... .........+.+|+++++.++|+||+++++++.+.+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~----~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 76 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGT----LMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS 76 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCc----EEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC
Confidence 58899999999999999998876554 499999975432 122234677888999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCC-CEEEccccccchh
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG-HVTLTDFDLSRNL 175 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g-~vkL~DFGla~~~ 175 (412)
.+++||||+.|++|..++.... .+++..+..++.|++.||.|||++|++|+||||+||+++.++ .+||+|||++..+
T Consensus 77 ~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 77 HFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred eEEEEEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999988876543 589999999999999999999999999999999999998876 5899999998765
Q ss_pred hchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCc
Q 042539 176 VKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYV 255 (412)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 255 (412)
..... ..........||..|+
T Consensus 155 ~~~~~-----------------------------------------------------------~~~~~~~~~~~~~~~~ 175 (268)
T cd06630 155 AAKGT-----------------------------------------------------------GAGEFQGQLLGTIAFM 175 (268)
T ss_pred ccccc-----------------------------------------------------------cCCcccccccccccee
Confidence 32100 0011123456899999
Q ss_pred cceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH---HHhc--CCCCC-CCCChHHHHHHHHhhhhCCCcc
Q 042539 256 SPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFR---NVLM--KTPEF-VGQRTALTDLIQRLLEKDPVKR 329 (412)
Q Consensus 256 APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~---~i~~--~~~~~-~~~~~~~~dli~~~L~~dP~~R 329 (412)
|||.+.+..++.++|+|||||++|+|++|..||...+...... ++.. ..+.. ...++++.++|.+||..+|.+|
T Consensus 176 ~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 255 (268)
T cd06630 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDR 255 (268)
T ss_pred CHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccC
Confidence 9999988888999999999999999999999997644322222 2211 12222 2456889999999999999999
Q ss_pred CCCCCChhhhhcCCCCC
Q 042539 330 LGYLRGACEIKEHVFFK 346 (412)
Q Consensus 330 ~~~~~~~~e~l~h~ff~ 346 (412)
| ++.++++||||+
T Consensus 256 ~----~~~~ll~~~~~~ 268 (268)
T cd06630 256 P----PSRELLKHPVFR 268 (268)
T ss_pred c----CHHHHhcCcccC
Confidence 9 699999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=337.82 Aligned_cols=253 Identities=31% Similarity=0.461 Sum_probs=207.3
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
++|++++.||+|+||.||+|.++.++. .||+|++.+.... ......+.+|+++++.++|+||+++++++.+++.
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~----~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 74 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQ----IVAIKKFLESEDD--KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKR 74 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCC----EEEEEeHhhccCc--chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCe
Confidence 579999999999999999999876443 4999998664322 2334556779999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
.|+||||+.+++|..+.... ..+++.++..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++..+..
T Consensus 75 ~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 75 LYLVFEFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred EEEEEecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 99999999999887665433 3489999999999999999999999999999999999999999999999999875421
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
. ........|+..|+||
T Consensus 153 ~---------------------------------------------------------------~~~~~~~~~~~~y~aP 169 (286)
T cd07846 153 P---------------------------------------------------------------GEVYTDYVATRWYRAP 169 (286)
T ss_pred C---------------------------------------------------------------ccccCcccceeeccCc
Confidence 1 0111234688999999
Q ss_pred eeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC----------------------C---------
Q 042539 258 EVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT----------------------P--------- 305 (412)
Q Consensus 258 E~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~----------------------~--------- 305 (412)
|++.+. .++.++|||||||++|+|++|++||.+.+..+....+.... +
T Consensus 170 E~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (286)
T cd07846 170 ELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLE 249 (286)
T ss_pred HHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHH
Confidence 998764 46889999999999999999999998766544433332100 0
Q ss_pred -CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCC
Q 042539 306 -EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 306 -~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff 345 (412)
..+..+..+.+||.+||..+|++|| ++.++++|+||
T Consensus 250 ~~~~~~~~~~~~li~~~l~~~P~~Rp----~~~~il~~~~~ 286 (286)
T cd07846 250 KRFPKLSGLVLDLAKQCLRIDPDDRP----SSSQLLHHEFF 286 (286)
T ss_pred HhCCCcCHHHHHHHHHHhcCCcccch----hHHHHhcCCCC
Confidence 1234567899999999999999999 68999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=335.23 Aligned_cols=254 Identities=26% Similarity=0.376 Sum_probs=202.2
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
.+++|++++.||+|+||.||++.++.++ ..||||.+....... ....+.+|+++++.++|+||+++++++.++
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~----~~~~iK~~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTG----QLVALKEIRLEHEEG---APFTAIREASLLKDLKHANIVTLHDIIHTK 75 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCC----cEEEEEEEecccccC---CchhHHHHHHHHhhCCCcceeeEEEEEecC
Confidence 5789999999999999999999987644 349999986543211 123355699999999999999999999999
Q ss_pred CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchh
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
+..|+||||+.+ +|..++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++..
T Consensus 76 ~~~~lv~e~~~~-~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 153 (291)
T cd07844 76 KTLTLVFEYLDT-DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAK 153 (291)
T ss_pred CeEEEEEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECcccccccc
Confidence 999999999975 8877765433 36899999999999999999999999999999999999999999999999998643
Q ss_pred hchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCc
Q 042539 176 VKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYV 255 (412)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 255 (412)
... ........++..|+
T Consensus 154 ~~~---------------------------------------------------------------~~~~~~~~~~~~~~ 170 (291)
T cd07844 154 SVP---------------------------------------------------------------SKTYSNEVVTLWYR 170 (291)
T ss_pred CCC---------------------------------------------------------------CccccccccccccC
Confidence 100 00011224678999
Q ss_pred cceeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCC-HHHHHHHHhcC---C--------------------------
Q 042539 256 SPEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKN-RKETFRNVLMK---T-------------------------- 304 (412)
Q Consensus 256 APE~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-~~~~~~~i~~~---~-------------------------- 304 (412)
|||++.+ ..++.++|||||||++|+|++|+.||.+.. ..+.+..+... .
T Consensus 171 aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (291)
T cd07844 171 PPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRP 250 (291)
T ss_pred CcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChh
Confidence 9999876 457889999999999999999999997765 22322222110 0
Q ss_pred --CCCCCCC--hHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCC
Q 042539 305 --PEFVGQR--TALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 305 --~~~~~~~--~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff 345 (412)
......+ .++.++|.+||+.||++|| ++.++++|+||
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~L~~~p~~Rp----s~~e~l~~~~f 291 (291)
T cd07844 251 LINHAPRLDRIPHGEELALKFLQYEPKKRI----SAAEAMKHPYF 291 (291)
T ss_pred HHHhCcCCCCchhHHHHHHHHhccCccccc----CHHHHhcCCCC
Confidence 0011233 7788999999999999999 69999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=338.89 Aligned_cols=254 Identities=28% Similarity=0.397 Sum_probs=210.4
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
.++|++++.||+|+||.||++.+..++. .||+|.+...... ....+.+|+.+++.++|+||+++++++..++
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~----~vaiK~~~~~~~~----~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 89 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQ----EVAIKQMNLQQQP----KKELIINEILVMRENKNPNIVNYLDSYLVGD 89 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCC----EEEEEEEecCccc----hHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 3799999999999999999999876544 4999999654322 2345677999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
.+|+||||++|++|..++.. ..+++.++..++.|++.||.|||+.||+||||||+|||++.+|.++|+|||++....
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 90 ELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (297)
T ss_pred EEEEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence 99999999999999887654 248999999999999999999999999999999999999999999999999986432
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
.. ........|++.|+|
T Consensus 167 ~~---------------------------------------------------------------~~~~~~~~~~~~y~a 183 (297)
T cd06656 167 PE---------------------------------------------------------------QSKRSTMVGTPYWMA 183 (297)
T ss_pred CC---------------------------------------------------------------ccCcCcccCCccccC
Confidence 10 011123468899999
Q ss_pred ceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhc-CCCC---CCCCChHHHHHHHHhhhhCCCccCCC
Q 042539 257 PEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLM-KTPE---FVGQRTALTDLIQRLLEKDPVKRLGY 332 (412)
Q Consensus 257 PE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~-~~~~---~~~~~~~~~dli~~~L~~dP~~R~~~ 332 (412)
||.+.+..++.++|+|||||++|+|++|..||.+.+.......+.. ..+. ....+..+++||.+||..||.+||
T Consensus 184 PE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-- 261 (297)
T cd06656 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRG-- 261 (297)
T ss_pred HHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCc--
Confidence 9999988889999999999999999999999987665433322222 1111 123567899999999999999999
Q ss_pred CCChhhhhcCCCCCCC
Q 042539 333 LRGACEIKEHVFFKGV 348 (412)
Q Consensus 333 ~~~~~e~l~h~ff~~~ 348 (412)
+++++++||||...
T Consensus 262 --s~~~il~~~~~~~~ 275 (297)
T cd06656 262 --SAKELLQHPFLKLA 275 (297)
T ss_pred --CHHHHhcCchhccc
Confidence 69999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=341.86 Aligned_cols=250 Identities=25% Similarity=0.364 Sum_probs=189.1
Q ss_pred eeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe--CCeEEE
Q 042539 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET--DEFLAW 100 (412)
Q Consensus 23 ~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~l 100 (412)
..+||+|+||+||+|+++... ....||+|.+..... ...+.+|+.+++.++||||+++++++.. +..+|+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~--~~~~~a~k~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGK--DEKEYALKQIEGTGI------SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWL 77 (317)
T ss_pred ceEeccCCCeeEEEEEecCCC--ccceEEEEEecCCCC------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEE
Confidence 368999999999999875432 345599999865432 2235569999999999999999999854 567899
Q ss_pred EeeccCCCCchhHHHhh-------CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEE----ccCCCEEEccc
Q 042539 101 AVPYCPGGDLNVLRYKQ-------NDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILI----RQSGHVTLTDF 169 (412)
Q Consensus 101 v~e~~~gg~L~~~~~~~-------~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl----~~~g~vkL~DF 169 (412)
||||+.+ +|..++... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.+|.+||+||
T Consensus 78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 78 LFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred EEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 9999965 555554321 12248899999999999999999999999999999999999 56689999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|+++.+.... .........+
T Consensus 157 G~a~~~~~~~------------------------------------------------------------~~~~~~~~~~ 176 (317)
T cd07867 157 GFARLFNSPL------------------------------------------------------------KPLADLDPVV 176 (317)
T ss_pred cceeccCCCc------------------------------------------------------------ccccccCcce
Confidence 9997542110 0011123457
Q ss_pred cCCCCccceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHH---------HHHHHHhc--C------------CC
Q 042539 250 GTEEYVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRK---------ETFRNVLM--K------------TP 305 (412)
Q Consensus 250 gt~~Y~APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---------~~~~~i~~--~------------~~ 305 (412)
||+.|+|||++.+. .++.++|||||||++|||++|.+||...... ..+..+.. + .+
T Consensus 177 ~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (317)
T cd07867 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMP 256 (317)
T ss_pred ecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 89999999999874 4789999999999999999999999754321 11111110 0 00
Q ss_pred C-------------------------CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCC
Q 042539 306 E-------------------------FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 306 ~-------------------------~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff 345 (412)
. ....+..+.+||.+||+.||.+|+ +++|+++||||
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~----t~~e~l~hp~f 317 (317)
T cd07867 257 EYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRI----TSEQALQDPYF 317 (317)
T ss_pred cchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCccccc----CHHHHhcCCCC
Confidence 0 011245688999999999999999 79999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=336.78 Aligned_cols=258 Identities=28% Similarity=0.411 Sum_probs=210.4
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhh-hhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLH-AKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
+|++++.||+|+||.||+|.+..++. .||||.++..... ........+..|+++++.++|+||+++++++.+++.
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 76 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGR----IVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSN 76 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCc----EEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCE
Confidence 58999999999999999999876543 4999999766532 112344556679999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+|+||||+ +++|..++.... ..+++..+..++.||+.||.|||++||+|+||||+||+++.+|.++|+|||+++....
T Consensus 77 ~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 77 INLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred EEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 99999999 899988876543 3599999999999999999999999999999999999999999999999999875421
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
.. .......+++.|+||
T Consensus 155 ~~---------------------------------------------------------------~~~~~~~~~~~y~aP 171 (298)
T cd07841 155 PN---------------------------------------------------------------RKMTHQVVTRWYRAP 171 (298)
T ss_pred CC---------------------------------------------------------------ccccccccceeeeCH
Confidence 10 111123467889999
Q ss_pred eeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--C---------------------------CC
Q 042539 258 EVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT--P---------------------------EF 307 (412)
Q Consensus 258 E~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~---------------------------~~ 307 (412)
|.+.+ ..++.++|+|||||++|+|++|.++|.+.+..+.+.++.... + .+
T Consensus 172 E~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T cd07841 172 ELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIF 251 (298)
T ss_pred HHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhc
Confidence 99865 456899999999999999999999998877665554443210 0 01
Q ss_pred CCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCC
Q 042539 308 VGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 308 ~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~ 349 (412)
...+..+.+||.+||..||.+|+ ++.+++.|+||++..
T Consensus 252 ~~~~~~~~~li~~~l~~~P~~R~----s~~e~l~~~~~~~~~ 289 (298)
T cd07841 252 PAASDDALDLLQRLLTLNPNKRI----TARQALEHPYFSNDP 289 (298)
T ss_pred ccccHHHHHHHHHHhcCCcccCc----CHHHHhhCccccCCC
Confidence 23457899999999999999999 699999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=333.34 Aligned_cols=259 Identities=20% Similarity=0.283 Sum_probs=213.5
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCC-CCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAAD-PTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
+..++|.+++.||+|+||.||+|.+.... ......||+|+++.... .+....+.+|+++++.++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 78 (280)
T cd05049 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS---NDARKDFEREAELLTNFQHENIVKFYGVCT 78 (280)
T ss_pred CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC---HHHHHHHHHHHHHHHhcCCCCchheeeEEe
Confidence 45788999999999999999999875432 22455699999865432 334567788999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhC------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccC
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQN------------DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQS 161 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~------------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~ 161 (412)
.+...++||||+.|++|..++.... ...+++.++..++.|++.||.|||++|++||||||+||+++.+
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~ 158 (280)
T cd05049 79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD 158 (280)
T ss_pred cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCC
Confidence 9999999999999999998876542 2347899999999999999999999999999999999999999
Q ss_pred CCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCC
Q 042539 162 GHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDN 241 (412)
Q Consensus 162 g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (412)
+.+||+|||+++.......
T Consensus 159 ~~~kl~d~g~~~~~~~~~~------------------------------------------------------------- 177 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDY------------------------------------------------------------- 177 (280)
T ss_pred CeEEECCcccceecccCcc-------------------------------------------------------------
Confidence 9999999999865421100
Q ss_pred CCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCCC--CCCCChHHHHHH
Q 042539 242 GERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTPE--FVGQRTALTDLI 318 (412)
Q Consensus 242 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~dli 318 (412)
........+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+...... ....+..+.++|
T Consensus 178 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 257 (280)
T cd05049 178 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPRTCPSEVYDIM 257 (280)
T ss_pred eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHH
Confidence 001122346788999999999999999999999999999998 99999988877777766654322 234678999999
Q ss_pred HHhhhhCCCccCCCCCChhhhhc
Q 042539 319 QRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 319 ~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
.+||..||.+|| ++.|+++
T Consensus 258 ~~~l~~~p~~Rp----~~~eil~ 276 (280)
T cd05049 258 LGCWKRDPQQRI----NIKDIHE 276 (280)
T ss_pred HHHcCCCcccCC----CHHHHHH
Confidence 999999999999 6788774
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=364.93 Aligned_cols=270 Identities=24% Similarity=0.327 Sum_probs=198.7
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCC-----------CceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCc
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTAR-----------CPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPF 84 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~-----------~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpn 84 (412)
..++|++++.||+|+||+||+|..+....... ...+.|++.+. ..........+.+|+.+|+.++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~-~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKR-VKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHH-hhcchHHHHHHHHHHHHHHhCCCCC
Confidence 35789999999999999999987654322110 00111112111 1122234556788999999999999
Q ss_pred cceeeeeEEeCCeEEEEeeccCCCCchhHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccC
Q 042539 85 LPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQN---DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQS 161 (412)
Q Consensus 85 Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~---~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~ 161 (412)
||++++++.+.+..|+|++++.+ +|..++.... .......+++.++.||+.||+|||++|||||||||+|||++.+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 99999999999999999999954 5555544321 1223467788999999999999999999999999999999999
Q ss_pred CCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCC
Q 042539 162 GHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDN 241 (412)
Q Consensus 162 g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (412)
|.+||+|||+++.+... .
T Consensus 304 ~~vkL~DFGla~~~~~~--------------------------------------------------------------~ 321 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKE--------------------------------------------------------------R 321 (501)
T ss_pred CCEEEEeCCCceecCcc--------------------------------------------------------------c
Confidence 99999999999765211 0
Q ss_pred CCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCC-CCCCC--CHHHHHHHHhcCC----CC--------
Q 042539 242 GERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTT-PFRGK--NRKETFRNVLMKT----PE-------- 306 (412)
Q Consensus 242 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~-Pf~~~--~~~~~~~~i~~~~----~~-------- 306 (412)
.......+||+.|+|||++.+..++.++|||||||++|||++|.. ||.+. +....+.+++... ..
T Consensus 322 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 401 (501)
T PHA03210 322 EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKL 401 (501)
T ss_pred ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHH
Confidence 111234679999999999999999999999999999999999875 44332 2222222222100 00
Q ss_pred ---------------------CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCchhh
Q 042539 307 ---------------------FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLL 353 (412)
Q Consensus 307 ---------------------~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~~~ 353 (412)
....+.++.++|.+||++||.+|| ++.|+++||||.+......
T Consensus 402 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rp----sa~elL~hp~f~~~~~~~~ 465 (501)
T PHA03210 402 FDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRP----GAAELLALPLFSAEEEEEI 465 (501)
T ss_pred HHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCc----CHHHHhhChhhhcCCchHH
Confidence 012345788899999999999999 7999999999998765533
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=331.00 Aligned_cols=253 Identities=24% Similarity=0.399 Sum_probs=207.5
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeeeeEEeC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLGSLETD 95 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 95 (412)
.++|++.+.||+|+||.||+|.++..+ +.|++|++..... ....+.+|+.+++++ .|+||+++++++...
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~----~~~~~k~~~~~~~-----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 75 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTG----QLVAIKIMDIIED-----EEEEIKEEYNILRKYSNHPNIATFYGAFIKK 75 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCC----cEEEEEEEecCch-----hHHHHHHHHHHHHHhcCCCChheEEEEEEec
Confidence 489999999999999999999987644 3499999865432 234567799999999 699999999999764
Q ss_pred C------eEEEEeeccCCCCchhHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEc
Q 042539 96 E------FLAWAVPYCPGGDLNVLRYKQN--DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLT 167 (412)
Q Consensus 96 ~------~~~lv~e~~~gg~L~~~~~~~~--~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~ 167 (412)
. .+|+||||+.+++|.+++.... ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~ 155 (275)
T cd06608 76 NPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLV 155 (275)
T ss_pred CCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEEC
Confidence 4 5899999999999988766533 4569999999999999999999999999999999999999999999999
Q ss_pred cccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcc
Q 042539 168 DFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNS 247 (412)
Q Consensus 168 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (412)
|||++....... .....
T Consensus 156 d~~~~~~~~~~~---------------------------------------------------------------~~~~~ 172 (275)
T cd06608 156 DFGVSAQLDSTL---------------------------------------------------------------GRRNT 172 (275)
T ss_pred CCccceecccch---------------------------------------------------------------hhhcC
Confidence 999986542110 11123
Q ss_pred cccCCCCccceeecC-----CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC----CCCChHHHHHH
Q 042539 248 FVGTEEYVSPEVVRG-----DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF----VGQRTALTDLI 318 (412)
Q Consensus 248 ~~gt~~Y~APE~l~~-----~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~dli 318 (412)
..|+..|+|||++.. ..++.++|||||||++|+|++|.+||..........++....... ...+.++.+||
T Consensus 173 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 252 (275)
T cd06608 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFI 252 (275)
T ss_pred ccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHH
Confidence 468999999999864 245788999999999999999999998766555555554433211 12567899999
Q ss_pred HHhhhhCCCccCCCCCChhhhhcCCCC
Q 042539 319 QRLLEKDPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 319 ~~~L~~dP~~R~~~~~~~~e~l~h~ff 345 (412)
++||..||++|| ++.++++|||+
T Consensus 253 ~~~l~~dp~~Rp----t~~~ll~~~~~ 275 (275)
T cd06608 253 SECLIKNYEQRP----FMEELLEHPFI 275 (275)
T ss_pred HHHhhcChhhCc----CHHHHhcCCCC
Confidence 999999999999 69999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=328.96 Aligned_cols=253 Identities=18% Similarity=0.274 Sum_probs=210.5
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
+++..++|+++++||+|+||.||+|.+... ..||+|.+..... ..+.+.+|+.+++.++|+||+++++++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~-----~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~ 70 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNS-----TKVAVKTLKPGTM-----SVQAFLEEANLMKTLQHDKLVRLYAVV 70 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCC-----ceEEEEEccCCch-----hHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 467889999999999999999999986532 2399999865432 234567799999999999999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
.+.+..+++|||+.|++|..++.......++...+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++
T Consensus 71 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 150 (261)
T cd05072 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLA 150 (261)
T ss_pred cCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccc
Confidence 99999999999999999998887665556889999999999999999999999999999999999999999999999999
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+...... ........++.
T Consensus 151 ~~~~~~~--------------------------------------------------------------~~~~~~~~~~~ 168 (261)
T cd05072 151 RVIEDNE--------------------------------------------------------------YTAREGAKFPI 168 (261)
T ss_pred eecCCCc--------------------------------------------------------------eeccCCCccce
Confidence 7542110 00011234567
Q ss_pred CCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCcc
Q 042539 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVKR 329 (412)
Q Consensus 253 ~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~R 329 (412)
.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+.... +.....+.++.++|.+||..+|++|
T Consensus 169 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 248 (261)
T cd05072 169 KWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEER 248 (261)
T ss_pred ecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCcccC
Confidence 8999999988888999999999999999998 999999887777766665432 2334567899999999999999999
Q ss_pred CCCCCChhhhhc
Q 042539 330 LGYLRGACEIKE 341 (412)
Q Consensus 330 ~~~~~~~~e~l~ 341 (412)
| +++++.+
T Consensus 249 p----~~~~i~~ 256 (261)
T cd05072 249 P----TFDYLQS 256 (261)
T ss_pred c----CHHHHHH
Confidence 9 5676653
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=327.23 Aligned_cols=251 Identities=26% Similarity=0.413 Sum_probs=211.2
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
-++|.+.+.||+|+||.||++.++..+ ..||+|.+..... ...+.+|+++++.++|+||+++++++.++.
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~----~~~~~k~~~~~~~------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETG----QVVAIKVVPVEED------LQEIIKEISILKQCDSPYIVKYYGSYFKNT 71 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCC----cEEEEEEeecHHH------HHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence 378999999999999999999987644 4499999865421 456777999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
.+|+++||+.|++|..++.... ..+++..++.++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++....
T Consensus 72 ~~~l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~ 150 (256)
T cd06612 72 DLWIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLT 150 (256)
T ss_pred cEEEEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcc
Confidence 9999999999999988876433 468999999999999999999999999999999999999999999999999987542
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
.. ........|+..|+|
T Consensus 151 ~~---------------------------------------------------------------~~~~~~~~~~~~y~~ 167 (256)
T cd06612 151 DT---------------------------------------------------------------MAKRNTVIGTPFWMA 167 (256)
T ss_pred cC---------------------------------------------------------------ccccccccCCccccC
Confidence 11 001223457889999
Q ss_pred ceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC----CCCCChHHHHHHHHhhhhCCCccCCC
Q 042539 257 PEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE----FVGQRTALTDLIQRLLEKDPVKRLGY 332 (412)
Q Consensus 257 PE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~dli~~~L~~dP~~R~~~ 332 (412)
||++.+..++.++|||||||++|+|++|+.||...+.......+...... ....+..+.++|.+||+.||.+||
T Consensus 168 PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp-- 245 (256)
T cd06612 168 PEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERP-- 245 (256)
T ss_pred HHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCc--
Confidence 99999988999999999999999999999999887655544443332211 123467899999999999999999
Q ss_pred CCChhhhhcCCCC
Q 042539 333 LRGACEIKEHVFF 345 (412)
Q Consensus 333 ~~~~~e~l~h~ff 345 (412)
++.++++||||
T Consensus 246 --s~~~il~~~~~ 256 (256)
T cd06612 246 --SAIQLLQHPFI 256 (256)
T ss_pred --CHHHHhcCCCC
Confidence 69999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=365.81 Aligned_cols=258 Identities=25% Similarity=0.376 Sum_probs=204.1
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeE-
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSL- 92 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~- 92 (412)
+---+++|.+.|.+|||+.||+|++...+. .||+|.+--. .+...+.+.+||++|++|+ |+|||.+++..
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~----~~AlKrm~~~----de~~L~~v~~EI~~MK~L~gh~nIV~yidss~ 105 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGK----KYALKRMYVN----DEEALNAVKREIDIMKLLSGHKNIVSYIDSSA 105 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCc----eeeeeeeecC----CHHHHHHHHHHHHHHHHhcCCCceeeEecccc
Confidence 334467899999999999999999987653 3999988432 3456777888999999998 99999999943
Q ss_pred Ee---C---CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeeeCCCCceEEccCCCE
Q 042539 93 ET---D---EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMG--IAYRDLKPENILIRQSGHV 164 (412)
Q Consensus 93 ~~---~---~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~--iiHrDlKp~NiLl~~~g~v 164 (412)
.. + -.++|+||||.||.|-+++..+....|+|.++..|++++|+||.+||... |||||||-|||||+.+|+.
T Consensus 106 ~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~ 185 (738)
T KOG1989|consen 106 INRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNY 185 (738)
T ss_pred ccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCE
Confidence 21 1 24789999999999988888766667999999999999999999999998 9999999999999999999
Q ss_pred EEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCC
Q 042539 165 TLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGER 244 (412)
Q Consensus 165 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (412)
||||||.|........ ..........-
T Consensus 186 KLCDFGSatt~~~~~~---------------~~~e~~~ve~e-------------------------------------- 212 (738)
T KOG1989|consen 186 KLCDFGSATTKILSPT---------------SAQEVNYVEEE-------------------------------------- 212 (738)
T ss_pred EeCcccccccccCCCc---------------cHHHHHHHHHH--------------------------------------
Confidence 9999999865421110 00000000000
Q ss_pred CcccccCCCCccceee---cCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhc---CCCCCCCCChHHHHHH
Q 042539 245 SNSFVGTEEYVSPEVV---RGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLM---KTPEFVGQRTALTDLI 318 (412)
Q Consensus 245 ~~~~~gt~~Y~APE~l---~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~---~~~~~~~~~~~~~dli 318 (412)
-....|+.|+|||.+ .+.+.+.|+|||||||+||-|++...||.+.... .|+. ..|.++.+++.+++||
T Consensus 213 -I~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----aIlng~Y~~P~~p~ys~~l~~LI 287 (738)
T KOG1989|consen 213 -IEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----AILNGNYSFPPFPNYSDRLKDLI 287 (738)
T ss_pred -HHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----eEEeccccCCCCccHHHHHHHHH
Confidence 012469999999986 5678899999999999999999999999875322 3444 3466667789999999
Q ss_pred HHhhhhCCCccCCCCCChhhhhcC
Q 042539 319 QRLLEKDPVKRLGYLRGACEIKEH 342 (412)
Q Consensus 319 ~~~L~~dP~~R~~~~~~~~e~l~h 342 (412)
+.||+.||.+|| ++-+++.+
T Consensus 288 ~~mL~~nP~~RP----nI~Qv~~~ 307 (738)
T KOG1989|consen 288 RTMLQPNPDERP----NIYQVLEE 307 (738)
T ss_pred HHHhccCcccCC----CHHHHHHH
Confidence 999999999999 56666654
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=329.44 Aligned_cols=258 Identities=28% Similarity=0.390 Sum_probs=208.9
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhh-hhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe--
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLH-AKHEAERRARWEIRVLSRLSHPFLPKLLGSLET-- 94 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-- 94 (412)
.+|++.+.||+|+||.||+|.+..++. .||+|++...... ........+.+|+.+++.++|+||+++++++.+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~----~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 77 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGR----ELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRA 77 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCc----EEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCC
Confidence 479999999999999999999877554 4999998654321 122344567789999999999999999999876
Q ss_pred CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
+..++++|||+.|++|..++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.
T Consensus 78 ~~~~~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 78 EKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 367899999999999988776543 489999999999999999999999999999999999999999999999999875
Q ss_pred hhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCC
Q 042539 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254 (412)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 254 (412)
..... ..........|+..|
T Consensus 156 ~~~~~------------------------------------------------------------~~~~~~~~~~~~~~y 175 (266)
T cd06651 156 LQTIC------------------------------------------------------------MSGTGIRSVTGTPYW 175 (266)
T ss_pred ccccc------------------------------------------------------------ccCCccccCCccccc
Confidence 42100 000111234588999
Q ss_pred ccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--CCCC-CCChHHHHHHHHhhhhCCCccCC
Q 042539 255 VSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT--PEFV-GQRTALTDLIQRLLEKDPVKRLG 331 (412)
Q Consensus 255 ~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~~-~~~~~~~dli~~~L~~dP~~R~~ 331 (412)
+|||++.+..++.++|+|||||++|+|++|+.||...........+.... +.++ ..++.+.++| +||..+|++||
T Consensus 176 ~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp- 253 (266)
T cd06651 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRP- 253 (266)
T ss_pred cCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCc-
Confidence 99999998888999999999999999999999998876665555444322 2222 3467889999 57778999999
Q ss_pred CCCChhhhhcCCCCC
Q 042539 332 YLRGACEIKEHVFFK 346 (412)
Q Consensus 332 ~~~~~~e~l~h~ff~ 346 (412)
+++++++||||+
T Consensus 254 ---~~~eil~hp~~~ 265 (266)
T cd06651 254 ---SAEELLRHPFAQ 265 (266)
T ss_pred ---CHHHHhcCcccc
Confidence 699999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=328.21 Aligned_cols=254 Identities=21% Similarity=0.295 Sum_probs=211.4
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
+++...+|.+.+.||+|+||.||+|.++..+.. ||+|++.++.. ....+.+|+++++.++|+||+++++++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~----~~~K~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~ 71 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLT----VAVKTLKEDTM-----EVEEFLKEAAVMKEIKHPNLVQLLGVC 71 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCce----EEEEEecCCch-----HHHHHHHHHHHHHhCCCCChhheEEEE
Confidence 357788999999999999999999998765544 99999865432 234567799999999999999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
..++.++++|||+.+++|..++.......+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~ 151 (263)
T cd05052 72 TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS 151 (263)
T ss_pred cCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccc
Confidence 99999999999999999998876655556899999999999999999999999999999999999999999999999998
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+....... .......++.
T Consensus 152 ~~~~~~~~--------------------------------------------------------------~~~~~~~~~~ 169 (263)
T cd05052 152 RLMTGDTY--------------------------------------------------------------TAHAGAKFPI 169 (263)
T ss_pred ccccccee--------------------------------------------------------------eccCCCCCcc
Confidence 75421100 0011123466
Q ss_pred CCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCcc
Q 042539 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVKR 329 (412)
Q Consensus 253 ~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~R 329 (412)
.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+.... ......+..+.++|.+||..||++|
T Consensus 170 ~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 249 (263)
T cd05052 170 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDR 249 (263)
T ss_pred ccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccC
Confidence 8999999998889999999999999999998 999999988877776665432 2224567899999999999999999
Q ss_pred CCCCCChhhhhc
Q 042539 330 LGYLRGACEIKE 341 (412)
Q Consensus 330 ~~~~~~~~e~l~ 341 (412)
| ++.++++
T Consensus 250 p----~~~~l~~ 257 (263)
T cd05052 250 P----SFAEIHQ 257 (263)
T ss_pred C----CHHHHHH
Confidence 9 5777654
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=335.31 Aligned_cols=259 Identities=27% Similarity=0.400 Sum_probs=207.8
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
+++|++.+.||+|++|+||++.++.++. .||+|.+...... ......+.+|++++++++|+||+++++++.+++
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~----~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNE----TIALKKIRLEQED--EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK 74 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCc----EEEEEehhhcccc--ccchHHHHHHHHHHHhccCCCEeeEEEEEecCC
Confidence 4789999999999999999999876544 4999998665321 223445667999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEcc-CCCEEEccccccchh
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQ-SGHVTLTDFDLSRNL 175 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~-~g~vkL~DFGla~~~ 175 (412)
..|+||||+.+ +|..++.......+++..++.++.||+.||+|||++|++||||||+||+++. ++.+||+|||++...
T Consensus 75 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 75 RLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (294)
T ss_pred eEEEEEecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence 99999999964 6766655444444788999999999999999999999999999999999985 457999999998644
Q ss_pred hchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCc
Q 042539 176 VKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYV 255 (412)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 255 (412)
... ........|++.|+
T Consensus 154 ~~~---------------------------------------------------------------~~~~~~~~~~~~y~ 170 (294)
T PLN00009 154 GIP---------------------------------------------------------------VRTFTHEVVTLWYR 170 (294)
T ss_pred CCC---------------------------------------------------------------ccccccCceeeccc
Confidence 210 00011235788999
Q ss_pred cceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--C-------------------C--------
Q 042539 256 SPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK--T-------------------P-------- 305 (412)
Q Consensus 256 APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~-------------------~-------- 305 (412)
|||++.+. .++.++|||||||++|+|++|.+||.+.+..+...++... . +
T Consensus 171 ~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (294)
T PLN00009 171 APEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLA 250 (294)
T ss_pred CHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHH
Confidence 99998764 5788999999999999999999999887766555544321 0 0
Q ss_pred -CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCC
Q 042539 306 -EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 306 -~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~ 349 (412)
..+..++.++++|.+||..||++|| ++.++++|+||.+++
T Consensus 251 ~~~~~~~~~~~~~i~~~l~~~P~~Rp----s~~~~l~~~~~~~~~ 291 (294)
T PLN00009 251 TVVPTLEPAGVDLLSKMLRLDPSKRI----TARAALEHEYFKDLG 291 (294)
T ss_pred HhCcCCChHHHHHHHHHccCChhhCc----CHHHHhcCchHhHHh
Confidence 0134567899999999999999999 699999999998654
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=327.85 Aligned_cols=258 Identities=27% Similarity=0.390 Sum_probs=209.2
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhh-hhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC-
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLH-AKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD- 95 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~- 95 (412)
.+|++.+.||+|+||+||++.+..++. .||||.+...... ........+.+|+++++.+.|+||+++++++.+.
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~----~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 77 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGR----ELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM 77 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCc----EEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC
Confidence 689999999999999999999876554 4999998643221 1223456778899999999999999999998764
Q ss_pred -CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 96 -EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 96 -~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
..++++|||+.|++|..++.... .+++..+..++.|++.||+|||++||+|+||||+||+++.++.++|+|||+++.
T Consensus 78 ~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 78 ERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred CceEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 57899999999999988776543 488999999999999999999999999999999999999999999999999875
Q ss_pred hhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCC
Q 042539 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254 (412)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 254 (412)
..... ..........|+..|
T Consensus 156 ~~~~~------------------------------------------------------------~~~~~~~~~~~~~~y 175 (265)
T cd06652 156 LQTIC------------------------------------------------------------LSGTGMKSVTGTPYW 175 (265)
T ss_pred ccccc------------------------------------------------------------ccccccccCCCCccc
Confidence 42100 000112234688999
Q ss_pred ccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--CCC-CCCChHHHHHHHHhhhhCCCccCC
Q 042539 255 VSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT--PEF-VGQRTALTDLIQRLLEKDPVKRLG 331 (412)
Q Consensus 255 ~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~-~~~~~~~~dli~~~L~~dP~~R~~ 331 (412)
+|||++.+..++.++|+|||||++|+|++|+.||...+......++.... +.. ...+..+.++|++|| .+|.+||
T Consensus 176 ~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l-~~p~~Rp- 253 (265)
T cd06652 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIF-VEAKLRP- 253 (265)
T ss_pred cChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHh-cChhhCC-
Confidence 99999988888999999999999999999999998876665555544322 212 234678999999999 4999999
Q ss_pred CCCChhhhhcCCCCC
Q 042539 332 YLRGACEIKEHVFFK 346 (412)
Q Consensus 332 ~~~~~~e~l~h~ff~ 346 (412)
+++++++|+|+.
T Consensus 254 ---~~~~il~~~~~~ 265 (265)
T cd06652 254 ---SADELLRHTFVH 265 (265)
T ss_pred ---CHHHHhcCcccC
Confidence 699999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-45 Score=340.04 Aligned_cols=255 Identities=26% Similarity=0.405 Sum_probs=210.2
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-C-C----ccce
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-H-P----FLPK 87 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-h-p----nIv~ 87 (412)
....++|++++.||+|+||+|..|.++.++ ..||||+++.- .......+-|+++|.++. + | -+|+
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~----~~vAlKIik~V-----~kYreAa~iEi~vLqki~~~DP~g~~rcv~ 155 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETK----EHVALKIIKNV-----DKYREAALIEIEVLQKINESDPNGKFRCVQ 155 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCC----ceehHHHHHHH-----HHHhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence 344689999999999999999999998864 44999998532 233444556999999995 2 3 3889
Q ss_pred eeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEcc-------
Q 042539 88 LLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQ------- 160 (412)
Q Consensus 88 l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~------- 160 (412)
+.++|.-.++.|||+|.+ |.++.+++...+-..|+..+++.+.+|++.+++|||+.+++|-||||+|||+.+
T Consensus 156 m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~ 234 (415)
T KOG0671|consen 156 MRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTY 234 (415)
T ss_pred eehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEe
Confidence 999999999999999999 768888888777778999999999999999999999999999999999999853
Q ss_pred -------------CCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCcccccccccc
Q 042539 161 -------------SGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSA 227 (412)
Q Consensus 161 -------------~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (412)
+..+||+|||.|+..
T Consensus 235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~---------------------------------------------------- 262 (415)
T KOG0671|consen 235 NPKKKVCFIRPLKSTAIKVIDFGSATFD---------------------------------------------------- 262 (415)
T ss_pred ccCCccceeccCCCcceEEEecCCccee----------------------------------------------------
Confidence 234899999988642
Q ss_pred CCCCccccccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHH---HHHHHhcCC
Q 042539 228 RVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKE---TFRNVLMKT 304 (412)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~~~~i~~~~ 304 (412)
.+...+++.|.+|+|||++.|.+++.++||||+||||+|+++|...|.+.+..+ +++.|+...
T Consensus 263 --------------~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~ 328 (415)
T KOG0671|consen 263 --------------HEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPI 328 (415)
T ss_pred --------------ccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCC
Confidence 233367899999999999999999999999999999999999999999977555 555554322
Q ss_pred CC------------------CCC--------------------------CChHHHHHHHHhhhhCCCccCCCCCChhhhh
Q 042539 305 PE------------------FVG--------------------------QRTALTDLIQRLLEKDPVKRLGYLRGACEIK 340 (412)
Q Consensus 305 ~~------------------~~~--------------------------~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l 340 (412)
|. ++. ...++.|||++||.+||++|+ |+.|++
T Consensus 329 P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri----Tl~EAL 404 (415)
T KOG0671|consen 329 PSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI----TLREAL 404 (415)
T ss_pred cHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc----cHHHHh
Confidence 11 000 013588999999999999999 799999
Q ss_pred cCCCCCCC
Q 042539 341 EHVFFKGV 348 (412)
Q Consensus 341 ~h~ff~~~ 348 (412)
.||||+..
T Consensus 405 ~HpFF~~~ 412 (415)
T KOG0671|consen 405 SHPFFARL 412 (415)
T ss_pred cCHHhhcC
Confidence 99999853
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=341.65 Aligned_cols=257 Identities=24% Similarity=0.383 Sum_probs=203.6
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC--
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD-- 95 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-- 95 (412)
++|++++.||+|+||.||++.+..++. .||+|++.... .......+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~----~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 77 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGV----KVAIKKISPFE---HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSF 77 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCC----eEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCcCchhheeecccc
Confidence 689999999999999999999877554 49999986422 223445567799999999999999999987644
Q ss_pred ---CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 96 ---EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 96 ---~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
..+|+|+||+.+ +|..++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 78 ~~~~~~~lv~e~~~~-~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 78 ESFNDVYIVQELMET-DLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred cccceEEEEehhccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccce
Confidence 358999999964 66555432 35999999999999999999999999999999999999999999999999998
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+...... .........+||+
T Consensus 154 ~~~~~~~------------------------------------------------------------~~~~~~~~~~~~~ 173 (336)
T cd07849 154 RIADPEH------------------------------------------------------------DHTGFLTEYVATR 173 (336)
T ss_pred eeccccc------------------------------------------------------------cccCCcCCcCcCC
Confidence 7542110 0001122357899
Q ss_pred CCccceeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhc--C---------------------CC---
Q 042539 253 EYVSPEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLM--K---------------------TP--- 305 (412)
Q Consensus 253 ~Y~APE~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~--~---------------------~~--- 305 (412)
.|+|||.+.+ ..++.++|||||||++|+|++|++||.+.+.......+.. + .+
T Consensus 174 ~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (336)
T cd07849 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKP 253 (336)
T ss_pred CccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCC
Confidence 9999998765 4578999999999999999999999988765443322211 0 00
Q ss_pred ------CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCC
Q 042539 306 ------EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 306 ------~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~ 349 (412)
..+..+.++.+||.+||+.||++|| ++.++++||||+...
T Consensus 254 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp----t~~e~l~hp~~~~~~ 299 (336)
T cd07849 254 KVPWNKLFPNADPKALDLLDKMLTFNPHKRI----TVEEALAHPYLEQYH 299 (336)
T ss_pred cccHHHHhcccCcHHHHHHHHHcCCChhhCc----CHHHHhcCccccccC
Confidence 0124567899999999999999999 699999999998653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=334.14 Aligned_cols=255 Identities=25% Similarity=0.423 Sum_probs=212.1
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET 94 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 94 (412)
+..++|++++.||+|+||+||++.+..++. .||+|++.... .......+.+|+++++.++|+||+++++++..
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~----~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGT----VMAKKVVHIGA---KSSVRKQILRELQIMHECRSPYIVSFYGAFLN 74 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCc----EEEEEEEEecC---cchHHHHHHHHHHHHHHcCCCCcceEeeeEec
Confidence 567899999999999999999999876554 49999986542 23345677889999999999999999999999
Q ss_pred CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN-MGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
.+.+|+||||+.|++|..++... +.+++..+..++.|++.||.|||+ +|++||||||+||+++.++.++|+|||++.
T Consensus 75 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~ 152 (284)
T cd06620 75 ENNICMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSG 152 (284)
T ss_pred CCEEEEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCccc
Confidence 99999999999999998776553 358999999999999999999997 699999999999999999999999999886
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
..... .....+||..
T Consensus 153 ~~~~~-----------------------------------------------------------------~~~~~~~~~~ 167 (284)
T cd06620 153 ELINS-----------------------------------------------------------------IADTFVGTST 167 (284)
T ss_pred chhhh-----------------------------------------------------------------ccCccccCcc
Confidence 43110 1123578999
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHH-----------HHHHHHhcCC-CCC--CCCChHHHHHHH
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRK-----------ETFRNVLMKT-PEF--VGQRTALTDLIQ 319 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-----------~~~~~i~~~~-~~~--~~~~~~~~dli~ 319 (412)
|+|||++.+..++.++|+|||||++|+|++|..||...+.. +....+.... +.+ ...+..+.+||.
T Consensus 168 ~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 247 (284)
T cd06620 168 YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVD 247 (284)
T ss_pred cCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHH
Confidence 99999998888899999999999999999999999875542 2233333322 111 125678999999
Q ss_pred HhhhhCCCccCCCCCChhhhhcCCCCCC
Q 042539 320 RLLEKDPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 320 ~~L~~dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
+||..||.+|| ++.|+++|+||..
T Consensus 248 ~~l~~dp~~Rp----t~~e~~~~~~~~~ 271 (284)
T cd06620 248 ACLLKDPTERP----TPQQLCAMPPFIQ 271 (284)
T ss_pred HHhcCCcccCc----CHHHHhcCccccc
Confidence 99999999999 6999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=332.23 Aligned_cols=255 Identities=27% Similarity=0.424 Sum_probs=204.9
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeeeeEE
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLGSLE 93 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 93 (412)
-..++|++++.||+|+||+||+|.++.++. .||+|++..... ....+.+|+.+++.+ +|+||+++++++.
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~----~~~ik~~~~~~~-----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGS----KAAVKILDPIHD-----IDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCc----eeEEEeeccccc-----hHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 356899999999999999999999877554 499998854321 123455699999999 6999999999873
Q ss_pred -----eCCeEEEEeeccCCCCchhHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEE
Q 042539 94 -----TDEFLAWAVPYCPGGDLNVLRYK--QNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTL 166 (412)
Q Consensus 94 -----~~~~~~lv~e~~~gg~L~~~~~~--~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL 166 (412)
.++.+|+||||++|++|..++.. .....+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEE
Confidence 44679999999999999877653 22345899999999999999999999999999999999999999999999
Q ss_pred ccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCc
Q 042539 167 TDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSN 246 (412)
Q Consensus 167 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (412)
+|||+++.+... .....
T Consensus 166 ~dfg~~~~~~~~---------------------------------------------------------------~~~~~ 182 (286)
T cd06638 166 VDFGVSAQLTST---------------------------------------------------------------RLRRN 182 (286)
T ss_pred ccCCceeecccC---------------------------------------------------------------CCccc
Confidence 999998754210 01112
Q ss_pred ccccCCCCccceeecC-----CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-CC---CCCChHHHHH
Q 042539 247 SFVGTEEYVSPEVVRG-----DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP-EF---VGQRTALTDL 317 (412)
Q Consensus 247 ~~~gt~~Y~APE~l~~-----~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~---~~~~~~~~dl 317 (412)
...|++.|+|||++.. ..++.++|||||||++|+|++|+.||..........++..... .. ...+.++.+|
T Consensus 183 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 262 (286)
T cd06638 183 TSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDF 262 (286)
T ss_pred cccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHH
Confidence 3468999999999853 4478899999999999999999999987765544443332221 11 1245789999
Q ss_pred HHHhhhhCCCccCCCCCChhhhhcCCCC
Q 042539 318 IQRLLEKDPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 318 i~~~L~~dP~~R~~~~~~~~e~l~h~ff 345 (412)
|.+||+.||++|| ++.++++|+||
T Consensus 263 i~~~l~~~p~~Rp----s~~ell~~~~~ 286 (286)
T cd06638 263 IRKCLTKDYEKRP----TVSDLLQHVFI 286 (286)
T ss_pred HHHHccCCcccCC----CHHHHhhcccC
Confidence 9999999999999 69999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=353.54 Aligned_cols=249 Identities=28% Similarity=0.455 Sum_probs=209.8
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEEEee
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVP 103 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~e 103 (412)
-+||+|+||+||-++|+.++.. +|||-|..... ...+-+..||.+.++|+|.|||++++.+..++++-|.||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvr----IaIKEIpekds----r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFME 652 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVR----IAIKEIPEKDS----REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFME 652 (1226)
T ss_pred EEeecCceeEEEeeccccceeE----EEeeecccccc----hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEee
Confidence 3799999999999999986655 99999865432 234456669999999999999999999999999999999
Q ss_pred ccCCCCchhHHHhhCCCCC--CHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEcc-CCCEEEccccccchhhchhh
Q 042539 104 YCPGGDLNVLRYKQNDRVF--SPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQ-SGHVTLTDFDLSRNLVKKTA 180 (412)
Q Consensus 104 ~~~gg~L~~~~~~~~~~~l--~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~-~g~vkL~DFGla~~~~~~~~ 180 (412)
-++||+|+.++.. .-+++ +|..+.+|..||+.||+|||++.|||||||-+|+|++- +|.+||+|||-++++.
T Consensus 653 qVPGGSLSsLLrs-kWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA---- 727 (1226)
T KOG4279|consen 653 QVPGGSLSSLLRS-KWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA---- 727 (1226)
T ss_pred cCCCCcHHHHHHh-ccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhc----
Confidence 9999999988765 34566 89999999999999999999999999999999999975 5999999999998763
Q ss_pred hhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceee
Q 042539 181 FEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVV 260 (412)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l 260 (412)
.-...+.+|.||..|||||++
T Consensus 728 -----------------------------------------------------------ginP~TETFTGTLQYMAPEvI 748 (1226)
T KOG4279|consen 728 -----------------------------------------------------------GINPCTETFTGTLQYMAPEVI 748 (1226)
T ss_pred -----------------------------------------------------------cCCccccccccchhhhChHhh
Confidence 112345588999999999999
Q ss_pred cCC--CCCchhhHHHHHHHHHHHhhCCCCCCCC--CHHHHHHHHhc-CCCCCC-CCChHHHHHHHHhhhhCCCccCCCCC
Q 042539 261 RGD--GHEFAVDWWALGILTYEMLYGTTPFRGK--NRKETFRNVLM-KTPEFV-GQRTALTDLIQRLLEKDPVKRLGYLR 334 (412)
Q Consensus 261 ~~~--~~~~~~DiwSlGvil~ell~g~~Pf~~~--~~~~~~~~i~~-~~~~~~-~~~~~~~dli~~~L~~dP~~R~~~~~ 334 (412)
... +|+.++|||||||++.||.||++||-.. ....+|+-.+. ..|+.+ ..+.+++.||.+|+.+||.+|+
T Consensus 749 DqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~---- 824 (1226)
T KOG4279|consen 749 DQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRP---- 824 (1226)
T ss_pred ccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCc----
Confidence 754 6899999999999999999999999653 33445544433 334444 4578899999999999999999
Q ss_pred ChhhhhcCCCCCCC
Q 042539 335 GACEIKEHVFFKGV 348 (412)
Q Consensus 335 ~~~e~l~h~ff~~~ 348 (412)
.|.++|..||++.-
T Consensus 825 sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 825 SAKDLLQDPFLQHN 838 (1226)
T ss_pred cHHHhccCcccccC
Confidence 59999999999754
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=331.48 Aligned_cols=254 Identities=27% Similarity=0.414 Sum_probs=206.3
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeeeeEEeC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLGSLETD 95 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 95 (412)
.++|.+.+.||+|+||.||+|.++.++. .+|+|++..... ....+.+|+.+++.+ +|+||+++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~----~~aik~~~~~~~-----~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGS----LAAVKILDPISD-----VDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCC----EEEEEEeccccc-----HHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 5789999999999999999999876544 499999865321 223455689999999 799999999998754
Q ss_pred -----CeEEEEeeccCCCCchhHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcc
Q 042539 96 -----EFLAWAVPYCPGGDLNVLRYK--QNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTD 168 (412)
Q Consensus 96 -----~~~~lv~e~~~gg~L~~~~~~--~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~D 168 (412)
...|+||||+.|++|..++.. .....+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~d 171 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVD 171 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEee
Confidence 368999999999999887653 2234589999999999999999999999999999999999999999999999
Q ss_pred ccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccc
Q 042539 169 FDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248 (412)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (412)
||++....... ......
T Consensus 172 fg~~~~~~~~~---------------------------------------------------------------~~~~~~ 188 (291)
T cd06639 172 FGVSAQLTSTR---------------------------------------------------------------LRRNTS 188 (291)
T ss_pred cccchhccccc---------------------------------------------------------------ccccCc
Confidence 99987542110 011234
Q ss_pred ccCCCCccceeecCC-----CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC----CCCCChHHHHHHH
Q 042539 249 VGTEEYVSPEVVRGD-----GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE----FVGQRTALTDLIQ 319 (412)
Q Consensus 249 ~gt~~Y~APE~l~~~-----~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~dli~ 319 (412)
.|+..|+|||++... .++.++|||||||++|+|++|++||...+.......+....+. ....+..+.+||.
T Consensus 189 ~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 268 (291)
T cd06639 189 VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFIS 268 (291)
T ss_pred cCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHH
Confidence 688999999998643 2578999999999999999999999887766655555433221 1234578999999
Q ss_pred HhhhhCCCccCCCCCChhhhhcCCCCC
Q 042539 320 RLLEKDPVKRLGYLRGACEIKEHVFFK 346 (412)
Q Consensus 320 ~~L~~dP~~R~~~~~~~~e~l~h~ff~ 346 (412)
+||..||++|| ++.++++||||+
T Consensus 269 ~~l~~~p~~Rp----s~~~il~~~~~~ 291 (291)
T cd06639 269 QCLIKDFEARP----SVTHLLEHPFIK 291 (291)
T ss_pred HHhhcChhhCc----CHHHHhcCcccC
Confidence 99999999999 699999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=335.36 Aligned_cols=255 Identities=25% Similarity=0.401 Sum_probs=207.5
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
.+++|++.+.||.|+||.||+|.++.++. .||+|.++..... ......+.+|+.++++++||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 76 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGE----IVALKKLKMEKEK--EGFPITSLREINILLKLQHPNIVTVKEVVVGS 76 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCc----EEEEEEEeecccc--ccchhhHHHHHHHHHhcCCCCEEEEEEEEEec
Confidence 35789999999999999999999876544 4999999765432 22334556799999999999999999999877
Q ss_pred --CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 96 --EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 96 --~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
..+|+||||+.+ +|..++.... ..+++.+++.++.|++.||+|||++||+|+||||+|||++.+|.+||+|||+++
T Consensus 77 ~~~~~~lv~e~~~~-~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~ 154 (293)
T cd07843 77 NLDKIYMVMEYVEH-DLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR 154 (293)
T ss_pred CCCcEEEEehhcCc-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCcee
Confidence 899999999975 7877665433 358999999999999999999999999999999999999999999999999987
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
...... .......+++.
T Consensus 155 ~~~~~~---------------------------------------------------------------~~~~~~~~~~~ 171 (293)
T cd07843 155 EYGSPL---------------------------------------------------------------KPYTQLVVTLW 171 (293)
T ss_pred eccCCc---------------------------------------------------------------ccccccccccc
Confidence 542110 11122357889
Q ss_pred CccceeecCCC-CCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC----------------------------
Q 042539 254 YVSPEVVRGDG-HEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT---------------------------- 304 (412)
Q Consensus 254 Y~APE~l~~~~-~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~---------------------------- 304 (412)
|+|||.+.+.. ++.++|+|||||++|+|++|.+||.+.+..+.+.++....
T Consensus 172 ~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (293)
T cd07843 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYN 251 (293)
T ss_pred ccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccch
Confidence 99999987654 5889999999999999999999999877666554443110
Q ss_pred ---CCCCC--CChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCC
Q 042539 305 ---PEFVG--QRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 305 ---~~~~~--~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff 345 (412)
..++. .++.+.++|++||+.||++|| ++.|+++|+||
T Consensus 252 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~----t~~ell~~~~f 293 (293)
T cd07843 252 QLRKKFPALSLSDNGFDLLNRLLTYDPAKRI----SAEDALKHPYF 293 (293)
T ss_pred hhhccccccCCChHHHHHHHHHhccCccccC----CHHHHhcCCCC
Confidence 11222 377899999999999999999 69999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=337.25 Aligned_cols=253 Identities=23% Similarity=0.394 Sum_probs=211.2
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
+.|.....||+|+||.||++.+..++. .||||.+.... ......+.+|+.+++.++|+||+++++.+..++.
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~----~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~ 93 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGK----QVAVKKMDLRK----QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDE 93 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCC----EEEEEEEecch----HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCe
Confidence 556667889999999999998876544 49999986533 2334557789999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
.|+||||+.|++|..++.. ..+++.++..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 94 ~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (292)
T cd06658 94 LWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK 170 (292)
T ss_pred EEEEEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence 9999999999999877643 3489999999999999999999999999999999999999999999999999864421
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
. ........|+..|+||
T Consensus 171 ~---------------------------------------------------------------~~~~~~~~~~~~y~aP 187 (292)
T cd06658 171 E---------------------------------------------------------------VPKRKSLVGTPYWMAP 187 (292)
T ss_pred c---------------------------------------------------------------cccCceeecCccccCH
Confidence 0 0111245689999999
Q ss_pred eeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC----CCCCChHHHHHHHHhhhhCCCccCCCC
Q 042539 258 EVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE----FVGQRTALTDLIQRLLEKDPVKRLGYL 333 (412)
Q Consensus 258 E~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~dli~~~L~~dP~~R~~~~ 333 (412)
|.+.+..++.++|+|||||++|||++|..||.+.+....+..+....+. ....+..+.++|.+||..||.+||
T Consensus 188 E~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp--- 264 (292)
T cd06658 188 EVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRA--- 264 (292)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccCChhHCc---
Confidence 9998888999999999999999999999999987776655554432221 123567899999999999999999
Q ss_pred CChhhhhcCCCCCCC
Q 042539 334 RGACEIKEHVFFKGV 348 (412)
Q Consensus 334 ~~~~e~l~h~ff~~~ 348 (412)
+++++++|+||...
T Consensus 265 -t~~~il~~~~~~~~ 278 (292)
T cd06658 265 -TAQELLQHPFLKLA 278 (292)
T ss_pred -CHHHHhhChhhhcc
Confidence 69999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=330.11 Aligned_cols=246 Identities=28% Similarity=0.447 Sum_probs=199.2
Q ss_pred ccCceeeeee--eccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeeeeEE
Q 042539 17 LDNLKALKIL--GKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLGSLE 93 (412)
Q Consensus 17 ~~~y~~~~~L--G~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 93 (412)
.++|.+.+.+ |+|+||.||++.++.++.. +|+|++.+...... |+.+...+ +|+||++++++|.
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~----~~~k~~~~~~~~~~---------e~~~~~~~~~h~~iv~~~~~~~ 79 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKL----FVQKIIKAKNFNAI---------EPMVHQLMKDNPNFIKLYYSVT 79 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcE----EEEEEEehhhcchh---------hHHHHHHhhcCCCEEEEEEEEe
Confidence 3567777776 9999999999998875544 99999976543211 22222223 6999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCC-CEEEcccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG-HVTLTDFDLS 172 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g-~vkL~DFGla 172 (412)
.++.+|+||||+.|++|..++.... .+++.+++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 80 TLKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred cCCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 9999999999999999988876543 599999999999999999999999999999999999999998 9999999988
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+.... .....|+.
T Consensus 158 ~~~~~-------------------------------------------------------------------~~~~~~~~ 170 (267)
T PHA03390 158 KIIGT-------------------------------------------------------------------PSCYDGTL 170 (267)
T ss_pred eecCC-------------------------------------------------------------------CccCCCCC
Confidence 64311 01235788
Q ss_pred CCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHH----HHHHhcCC-CCCCCCChHHHHHHHHhhhhCCC
Q 042539 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKET----FRNVLMKT-PEFVGQRTALTDLIQRLLEKDPV 327 (412)
Q Consensus 253 ~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~----~~~i~~~~-~~~~~~~~~~~dli~~~L~~dP~ 327 (412)
.|+|||++.+..++.++|||||||++|+|++|..||........ +....... ......+..+.+||.+||+.||.
T Consensus 171 ~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 250 (267)
T PHA03390 171 DYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNIN 250 (267)
T ss_pred cccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChh
Confidence 99999999998899999999999999999999999986543321 22222222 22335789999999999999999
Q ss_pred ccCCCCCChhhhhcCCCCCC
Q 042539 328 KRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 328 ~R~~~~~~~~e~l~h~ff~~ 347 (412)
+|++ +++++++||||..
T Consensus 251 ~R~~---~~~~~l~h~~~~~ 267 (267)
T PHA03390 251 YRLT---NYNEIIKHPFLKI 267 (267)
T ss_pred hCCc---hHHHHhcCCcccC
Confidence 9994 4699999999973
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=328.55 Aligned_cols=266 Identities=26% Similarity=0.388 Sum_probs=209.6
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe-C
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET-D 95 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~ 95 (412)
+..|++++.||+|+||.||+|..+.+.......||||.++.+.- .......+.||+.+++.++||||+.|..+|.. +
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd--~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD--GTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC--CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 56899999999999999999965555443344799999965532 22345667789999999999999999999987 7
Q ss_pred CeEEEEeeccCCCCchhHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccC----CCEEEcc
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQN---DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQS----GHVTLTD 168 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~---~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~----g~vkL~D 168 (412)
..+++++||++. ||...++-.. ...++...++.++.||++|+.|||++-|+||||||.|||+..+ |.|||+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 799999999976 5555554432 2358999999999999999999999999999999999999887 8999999
Q ss_pred ccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccc
Q 042539 169 FDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248 (412)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (412)
||+|+.+.+. ..|. ......
T Consensus 180 lGlaR~~~~p--------------lkpl----------------------------------------------~s~d~V 199 (438)
T KOG0666|consen 180 LGLARLFNNP--------------LKPL----------------------------------------------ASLDPV 199 (438)
T ss_pred ccHHHHhhcc--------------cccc----------------------------------------------ccCCce
Confidence 9999987432 1111 112345
Q ss_pred ccCCCCccceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCH---------HHHHHHHhc--CCCC----------
Q 042539 249 VGTEEYVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNR---------KETFRNVLM--KTPE---------- 306 (412)
Q Consensus 249 ~gt~~Y~APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---------~~~~~~i~~--~~~~---------- 306 (412)
+-|.+|+|||++.|. .|+.++||||+|||+.||++-.+.|.+... .+++.+|+. +.|.
T Consensus 200 VVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~ 279 (438)
T KOG0666|consen 200 VVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKM 279 (438)
T ss_pred EEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhC
Confidence 789999999999996 479999999999999999999999977431 223344431 1111
Q ss_pred --C------------C------------CCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCC
Q 042539 307 --F------------V------------GQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 307 --~------------~------------~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~ 349 (412)
+ . .-++.+.+|+.+||++||.+|+ |++++++|+||..-.
T Consensus 280 Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRI----ta~qAleh~yF~~d~ 344 (438)
T KOG0666|consen 280 PEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRI----TAEQALEHPYFTEDP 344 (438)
T ss_pred cchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhc----cHHHHhcccccccCC
Confidence 1 0 1234588999999999999999 799999999998753
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=343.42 Aligned_cols=263 Identities=22% Similarity=0.306 Sum_probs=208.2
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCC-CCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAAD-PTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLL 89 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~ 89 (412)
++++..++|++++.||+|+||.||+|.+..++ ..+++.||+|+++.... ......+.+|+.++.++ +|+||++++
T Consensus 1 ~~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~~E~~~~~~l~~h~niv~~~ 77 (337)
T cd05054 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT---ASEYKALMTELKILIHIGHHLNVVNLL 77 (337)
T ss_pred CcccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC---HHHHHHHHHHHHHHHhhccCcchhhee
Confidence 35677889999999999999999999765543 23456799999864321 22345567799999999 799999999
Q ss_pred eeEEe-CCeEEEEeeccCCCCchhHHHhhCC-------------------------------------------------
Q 042539 90 GSLET-DEFLAWAVPYCPGGDLNVLRYKQND------------------------------------------------- 119 (412)
Q Consensus 90 ~~~~~-~~~~~lv~e~~~gg~L~~~~~~~~~------------------------------------------------- 119 (412)
+++.. +..++++|||+.|++|..++.....
T Consensus 78 ~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (337)
T cd05054 78 GACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVE 157 (337)
T ss_pred eeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcc
Confidence 98865 4578999999999999888754321
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhhhhcccCC
Q 042539 120 ----------RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNN 189 (412)
Q Consensus 120 ----------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 189 (412)
..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 158 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~--------- 228 (337)
T cd05054 158 EDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD--------- 228 (337)
T ss_pred cchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcc---------
Confidence 2578899999999999999999999999999999999999999999999999976521110
Q ss_pred CCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecCCCCCchh
Q 042539 190 KFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAV 269 (412)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~ 269 (412)
.....+..++..|+|||++.+..++.++
T Consensus 229 ----------------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 256 (337)
T cd05054 229 ----------------------------------------------------YVRKGDARLPLKWMAPESIFDKVYTTQS 256 (337)
T ss_pred ----------------------------------------------------hhhccCCCCCccccCcHHhcCCCCCccc
Confidence 0112234567789999999999999999
Q ss_pred hHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC---CCCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcC
Q 042539 270 DWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT---PEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEH 342 (412)
Q Consensus 270 DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h 342 (412)
|||||||++|||++ |..||.+....+.+...+... ......++++.+++.+||+.+|++|| +++++++|
T Consensus 257 Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RP----s~~ell~~ 329 (337)
T cd05054 257 DVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRP----TFSELVEI 329 (337)
T ss_pred cHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCc----CHHHHHHH
Confidence 99999999999997 999998755444443333221 11224568899999999999999999 68888864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=333.59 Aligned_cols=255 Identities=25% Similarity=0.398 Sum_probs=204.1
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEEeCC
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLETDE 96 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 96 (412)
++|++.+.||+|+||.||+|.+..++. .||+|+++.... .......+.+|+.+++.+. |+||+++++++...+
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~----~v~lK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 74 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGK----LVALKKTRLEMD--EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEE 74 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCc----EEEEEeehhhcc--ccCCchHHHHHHHHHHHccCCCCccceeeeEeecC
Confidence 579999999999999999999876544 499999865432 1123345667999999996 699999999998766
Q ss_pred e-----EEEEeeccCCCCchhHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEcc-CCCEEEc
Q 042539 97 F-----LAWAVPYCPGGDLNVLRYKQN---DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQ-SGHVTLT 167 (412)
Q Consensus 97 ~-----~~lv~e~~~gg~L~~~~~~~~---~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~-~g~vkL~ 167 (412)
. .|+||||+.+ +|..++.... ...+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+
T Consensus 75 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~ 153 (295)
T cd07837 75 KNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIA 153 (295)
T ss_pred CCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEe
Confidence 5 8999999986 6766665432 235899999999999999999999999999999999999999 8999999
Q ss_pred cccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcc
Q 042539 168 DFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNS 247 (412)
Q Consensus 168 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (412)
|||+++.+... ......
T Consensus 154 dfg~~~~~~~~---------------------------------------------------------------~~~~~~ 170 (295)
T cd07837 154 DLGLGRAFSIP---------------------------------------------------------------VKSYTH 170 (295)
T ss_pred ecccceecCCC---------------------------------------------------------------ccccCC
Confidence 99998754210 001112
Q ss_pred cccCCCCccceeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--------------------C-
Q 042539 248 FVGTEEYVSPEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT--------------------P- 305 (412)
Q Consensus 248 ~~gt~~Y~APE~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--------------------~- 305 (412)
..+++.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+..+....+.... +
T Consensus 171 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (295)
T cd07837 171 EIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQ 250 (295)
T ss_pred cccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCc
Confidence 256889999998876 456899999999999999999999999877665554433210 0
Q ss_pred --------CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCC
Q 042539 306 --------EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346 (412)
Q Consensus 306 --------~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~ 346 (412)
..+..+.++.+||.+||..||.+|| ++.+++.||||+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~----~~~eil~~~~~~ 295 (295)
T cd07837 251 WKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRI----SAKAALTHPYFD 295 (295)
T ss_pred ccchhHHHhccccCHHHHHHHHHHccCChhhcC----CHHHHhcCCCcC
Confidence 0134678899999999999999999 699999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=331.53 Aligned_cols=257 Identities=23% Similarity=0.383 Sum_probs=203.0
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHH-HhhcCCCccceeeeeEEeCC
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRV-LSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~ 96 (412)
++|++++.||+|+||.||+|.++.++.. ||+|++++..... ....+..|+.+ ++.++|+||+++++++..+.
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~----vaiK~~~~~~~~~---~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~ 73 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTI----MAVKRIRATVNSQ---EQKRLLMDLDISMRSVDCPYTVTFYGALFREG 73 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcE----EEEEEEecCCCcH---HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC
Confidence 5899999999999999999998875544 9999997653211 12334446554 66678999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeeeCCCCceEEccCCCEEEccccccc
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQ--NDRVFSPSVIRFYLSEIICAIEHLHNM-GIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~yLH~~-~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
.+|++|||+. |+|..++... ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++
T Consensus 74 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~ 152 (283)
T cd06617 74 DVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG 152 (283)
T ss_pred cEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 9999999996 5666555432 234689999999999999999999997 99999999999999999999999999986
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
.+... .......|+..
T Consensus 153 ~~~~~----------------------------------------------------------------~~~~~~~~~~~ 168 (283)
T cd06617 153 YLVDS----------------------------------------------------------------VAKTIDAGCKP 168 (283)
T ss_pred ccccc----------------------------------------------------------------cccccccCCcc
Confidence 54210 01112357889
Q ss_pred CccceeecC----CCCCchhhHHHHHHHHHHHhhCCCCCCCC-CHHHHHHHHhcCC-CCC--CCCChHHHHHHHHhhhhC
Q 042539 254 YVSPEVVRG----DGHEFAVDWWALGILTYEMLYGTTPFRGK-NRKETFRNVLMKT-PEF--VGQRTALTDLIQRLLEKD 325 (412)
Q Consensus 254 Y~APE~l~~----~~~~~~~DiwSlGvil~ell~g~~Pf~~~-~~~~~~~~i~~~~-~~~--~~~~~~~~dli~~~L~~d 325 (412)
|+|||++.+ ..++.++|+|||||++|+|++|+.||... ...+.+..+.... +.. ...+.++.+||.+||..+
T Consensus 169 y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 248 (283)
T cd06617 169 YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKN 248 (283)
T ss_pred ccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCC
Confidence 999999865 44688999999999999999999999753 2233333443322 222 245789999999999999
Q ss_pred CCccCCCCCChhhhhcCCCCCCCCc
Q 042539 326 PVKRLGYLRGACEIKEHVFFKGVRW 350 (412)
Q Consensus 326 P~~R~~~~~~~~e~l~h~ff~~~~~ 350 (412)
|.+|| +++++++|+||....+
T Consensus 249 p~~Rp----~~~~il~~~~~~~~~~ 269 (283)
T cd06617 249 YKERP----NYPELLQHPFFELHLS 269 (283)
T ss_pred hhhCc----CHHHHhcCchhhhccc
Confidence 99999 6899999999987654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=369.14 Aligned_cols=271 Identities=23% Similarity=0.351 Sum_probs=207.6
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
+++|+++++||+|+||.||+|.+..++. .||||++.+... ......+++.+|+++++.++||||+++++++.+++
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~----~VAIK~I~~~l~-~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~ 75 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSR----RVALKKIREDLS-ENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD 75 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCc----EEEEEEECcccc-cCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC
Confidence 4799999999999999999999877554 499999975432 23345667888999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhC---------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEc
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQN---------DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLT 167 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~---------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~ 167 (412)
..|+|||||+||+|..++.... ...++...+..++.||+.||+|||++||+||||||+|||++.+|.+||+
T Consensus 76 ~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLi 155 (932)
T PRK13184 76 PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVIL 155 (932)
T ss_pred EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEE
Confidence 9999999999999988775421 1234566788899999999999999999999999999999999999999
Q ss_pred cccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcc
Q 042539 168 DFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNS 247 (412)
Q Consensus 168 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (412)
|||+++.......... . .. .. ..............
T Consensus 156 DFGLAk~i~~~~~~~~-~---------------------------------l~------~~-----~~~s~~s~~t~~g~ 190 (932)
T PRK13184 156 DWGAAIFKKLEEEDLL-D---------------------------------ID------VD-----ERNICYSSMTIPGK 190 (932)
T ss_pred ecCcceeccccccccc-c---------------------------------cc------cc-----cccccccccccCCC
Confidence 9999986521110000 0 00 00 00000011122345
Q ss_pred cccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC----CCCCCCChHHHHHHHHhhh
Q 042539 248 FVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT----PEFVGQRTALTDLIQRLLE 323 (412)
Q Consensus 248 ~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~----~~~~~~~~~~~dli~~~L~ 323 (412)
.+||+.|||||++.+..++.++|||||||++|||++|..||.+.+............ ......++.+.+++.+||.
T Consensus 191 ~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~ 270 (932)
T PRK13184 191 IVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALA 270 (932)
T ss_pred CCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHcc
Confidence 689999999999999999999999999999999999999998865444322221111 1223567889999999999
Q ss_pred hCCCccCCCCCChhhhh
Q 042539 324 KDPVKRLGYLRGACEIK 340 (412)
Q Consensus 324 ~dP~~R~~~~~~~~e~l 340 (412)
.||.+|++ ++++++
T Consensus 271 ~DP~kR~s---s~eeLl 284 (932)
T PRK13184 271 VDPAERYS---SVQELK 284 (932)
T ss_pred CChhhCcC---HHHHHH
Confidence 99999996 445444
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=329.08 Aligned_cols=261 Identities=18% Similarity=0.241 Sum_probs=213.3
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCC-CCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAAD-PTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
+++..++|++++.||+|+||.||++.++... ......||+|.+..... ......+.+|+.+++.++|+||++++++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~ 77 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS---MRERIEFLNEASVMKEFNCHHVVRLLGV 77 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC---HHHHHHHHHHHHHHHhCCCCceeEEEEE
Confidence 3577899999999999999999999887544 22445699999865431 2234556779999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCC
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQN--------DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGH 163 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~--------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~ 163 (412)
+..+...|+||||+.+|+|..++.... ...+++..+..++.|++.||.|||++||+||||||+|||++.+|.
T Consensus 78 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~ 157 (277)
T cd05032 78 VSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT 157 (277)
T ss_pred EcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC
Confidence 999999999999999999988876532 123678899999999999999999999999999999999999999
Q ss_pred EEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCC
Q 042539 164 VTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGE 243 (412)
Q Consensus 164 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (412)
+||+|||+++.+..... ..
T Consensus 158 ~kl~dfg~~~~~~~~~~-------------------------------------------------------------~~ 176 (277)
T cd05032 158 VKIGDFGMTRDIYETDY-------------------------------------------------------------YR 176 (277)
T ss_pred EEECCcccchhhccCcc-------------------------------------------------------------cc
Confidence 99999999875421100 01
Q ss_pred CCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC-CC-CCCCChHHHHHHHH
Q 042539 244 RSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT-PE-FVGQRTALTDLIQR 320 (412)
Q Consensus 244 ~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~-~~-~~~~~~~~~dli~~ 320 (412)
......+|..|+|||.+.+..++.++|||||||++||+++ |..||.+.+..+....+.... +. ....+.++.++|.+
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 256 (277)
T cd05032 177 KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRM 256 (277)
T ss_pred cCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 1123356788999999988888999999999999999998 999999988777777666432 12 23457899999999
Q ss_pred hhhhCCCccCCCCCChhhhhc
Q 042539 321 LLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 321 ~L~~dP~~R~~~~~~~~e~l~ 341 (412)
||+.+|++|| ++.++++
T Consensus 257 ~l~~~p~~Rp----t~~~l~~ 273 (277)
T cd05032 257 CWQYNPKMRP----TFLEIVS 273 (277)
T ss_pred HcCCChhhCC----CHHHHHH
Confidence 9999999999 6788775
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=332.96 Aligned_cols=260 Identities=18% Similarity=0.304 Sum_probs=213.3
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCC-CCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAAD-PTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
++.+.+|+++++||+|+||+||++.+..+. ......||||+++... .......+.+|+.++..++||||+++++++
T Consensus 1 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~ 77 (283)
T cd05091 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGPLREEFKHEAMMRSRLQHPNIVCLLGVV 77 (283)
T ss_pred CCCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence 467889999999999999999999876532 2234569999997543 223455677899999999999999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEE
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQN--------------DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILI 158 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~--------------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl 158 (412)
.+...+++++||+.+++|..++.... ...+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 78 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~ 157 (283)
T cd05091 78 TKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV 157 (283)
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe
Confidence 99999999999999999988875321 2347888999999999999999999999999999999999
Q ss_pred ccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccc
Q 042539 159 RQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQS 238 (412)
Q Consensus 159 ~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (412)
+.++.+||+|||+++.......
T Consensus 158 ~~~~~~kl~Dfg~~~~~~~~~~---------------------------------------------------------- 179 (283)
T cd05091 158 FDKLNVKISDLGLFREVYAADY---------------------------------------------------------- 179 (283)
T ss_pred cCCCceEecccccccccccchh----------------------------------------------------------
Confidence 9999999999999875421100
Q ss_pred cCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCCC--CCCCChHHH
Q 042539 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTPE--FVGQRTALT 315 (412)
Q Consensus 239 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~ 315 (412)
........+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+...... ....+..+.
T Consensus 180 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 256 (283)
T cd05091 180 ---YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVY 256 (283)
T ss_pred ---eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHH
Confidence 011123346789999999988889999999999999999998 99999998888877777655422 245678899
Q ss_pred HHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 316 DLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 316 dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
+||.+||+.+|.+|| ++.+++.
T Consensus 257 ~li~~cl~~~p~~RP----~~~~i~~ 278 (283)
T cd05091 257 TLMLECWNEFPSRRP----RFKDIHS 278 (283)
T ss_pred HHHHHHhCCCcccCC----CHHHHHH
Confidence 999999999999999 5787775
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=336.36 Aligned_cols=257 Identities=22% Similarity=0.348 Sum_probs=208.2
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeeee
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLGS 91 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~ 91 (412)
+.+++++|++.+.||+|+||.||+|.++.++. ...+|+|.++... .......+.+|+.++.++ +|+||++++++
T Consensus 2 ~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~--~~~~~ik~~~~~~---~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~ 76 (303)
T cd05088 2 PVLEWNDIKFQDVIGEGNFGQVLKARIKKDGL--RMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGA 76 (303)
T ss_pred CccchhhceeeeeecCCCCceEEEEEEccCCc--eeeEEEEEecccC---CHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence 45788999999999999999999999866432 2336787775322 223455677799999999 79999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceE
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQN--------------DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENIL 157 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~--------------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiL 157 (412)
+.+++.+|+||||+.|++|..++.... ...+++..++.++.|++.||+|||++||+||||||+|||
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nil 156 (303)
T cd05088 77 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL 156 (303)
T ss_pred ECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEE
Confidence 999999999999999999988876432 135889999999999999999999999999999999999
Q ss_pred EccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCcccccc
Q 042539 158 IRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQ 237 (412)
Q Consensus 158 l~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (412)
++.++.+||+|||+++.....
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~----------------------------------------------------------- 177 (303)
T cd05088 157 VGENYVAKIADFGLSRGQEVY----------------------------------------------------------- 177 (303)
T ss_pred ecCCCcEEeCccccCcccchh-----------------------------------------------------------
Confidence 999999999999988532100
Q ss_pred ccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC-C-CCCCCChHH
Q 042539 238 SFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT-P-EFVGQRTAL 314 (412)
Q Consensus 238 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~-~-~~~~~~~~~ 314 (412)
.......++..|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+.... . .....+.++
T Consensus 178 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (303)
T cd05088 178 -----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEV 252 (303)
T ss_pred -----hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcCCCCCCCCHHH
Confidence 00011234667999999988888999999999999999998 999999887777666554332 1 122457889
Q ss_pred HHHHHHhhhhCCCccCCCCCChhhhhcC
Q 042539 315 TDLIQRLLEKDPVKRLGYLRGACEIKEH 342 (412)
Q Consensus 315 ~dli~~~L~~dP~~R~~~~~~~~e~l~h 342 (412)
.+||.+||..+|.+|| ++++++++
T Consensus 253 ~~li~~~l~~~p~~Rp----~~~~il~~ 276 (303)
T cd05088 253 YDLMRQCWREKPYERP----SFAQILVS 276 (303)
T ss_pred HHHHHHHcCCChhhCc----CHHHHHHH
Confidence 9999999999999999 57888764
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=331.22 Aligned_cols=255 Identities=27% Similarity=0.406 Sum_probs=213.1
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
..|+.++.||.|+||.||+|.++.++. .||+|++..... ......+.+|+.+++++.|+||+++++++.++..
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~----~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQ----VVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTK 76 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCE----EEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence 468899999999999999999876544 499999875432 2334667789999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
.|+||||+.|++|.+++.. +.+++.++..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++..+..
T Consensus 77 ~~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 77 LWIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred EEEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 9999999999999887653 3489999999999999999999999999999999999999999999999999865421
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
. ........++..|+||
T Consensus 154 ~---------------------------------------------------------------~~~~~~~~~~~~y~ap 170 (277)
T cd06640 154 T---------------------------------------------------------------QIKRNTFVGTPFWMAP 170 (277)
T ss_pred C---------------------------------------------------------------ccccccccCcccccCH
Confidence 1 0112234688899999
Q ss_pred eeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC-C-CCCChHHHHHHHHhhhhCCCccCCCCCC
Q 042539 258 EVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE-F-VGQRTALTDLIQRLLEKDPVKRLGYLRG 335 (412)
Q Consensus 258 E~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~-~-~~~~~~~~dli~~~L~~dP~~R~~~~~~ 335 (412)
|++.+...+.++|+|||||++|+|++|.+||.+.+.......+....+. . ...+..+.++|.+||..+|.+|| +
T Consensus 171 E~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----~ 246 (277)
T cd06640 171 EVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRP----T 246 (277)
T ss_pred hHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCc----C
Confidence 9998888899999999999999999999999987766555444332221 1 23467899999999999999999 6
Q ss_pred hhhhhcCCCCCCCC
Q 042539 336 ACEIKEHVFFKGVR 349 (412)
Q Consensus 336 ~~e~l~h~ff~~~~ 349 (412)
+.++++|+||....
T Consensus 247 ~~~il~~~~~~~~~ 260 (277)
T cd06640 247 AKELLKHKFIVKNA 260 (277)
T ss_pred HHHHHhChHhhhcc
Confidence 99999999997654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=332.68 Aligned_cols=253 Identities=28% Similarity=0.388 Sum_probs=199.9
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
.++|++++.||+|+||.||+|.++.++.. ||+|++..... ......+.+|+.+++.++|+||+++++++.+++
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~----~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 76 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQL----VALKVISMKTE---EGVPFTAIREASLLKGLKHANIVLLHDIIHTKE 76 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcE----EEEEEecccCc---CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCC
Confidence 37899999999999999999998775544 99999965432 122334567999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
..|+||||+. ++|...+... ...+++..++.++.|++.||.|||++||+|+||||+|||++.+|.+||+|||+++...
T Consensus 77 ~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 77 TLTFVFEYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred eEEEEEeccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 9999999996 5565554432 2457889999999999999999999999999999999999999999999999986431
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
.. ........+++.|+|
T Consensus 155 ~~---------------------------------------------------------------~~~~~~~~~~~~y~a 171 (291)
T cd07870 155 IP---------------------------------------------------------------SQTYSSEVVTLWYRP 171 (291)
T ss_pred CC---------------------------------------------------------------CCCCCCccccccccC
Confidence 10 011123357889999
Q ss_pred ceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHH-HHHHHHhc--------------CCCC--------------
Q 042539 257 PEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRK-ETFRNVLM--------------KTPE-------------- 306 (412)
Q Consensus 257 PE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~~i~~--------------~~~~-------------- 306 (412)
||++.+. .++.++|||||||++|+|++|..||.+.+.. +.+..+.. ..+.
T Consensus 172 PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (291)
T cd07870 172 PDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQL 251 (291)
T ss_pred CceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcch
Confidence 9998764 4788999999999999999999999875532 22222210 0000
Q ss_pred -----CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCC
Q 042539 307 -----FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 307 -----~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff 345 (412)
....+..+.++|.+||..||++|| ++.+++.||||
T Consensus 252 ~~~~~~~~~~~~~~~ll~~~l~~dp~~R~----t~~~~l~h~~~ 291 (291)
T cd07870 252 RVVWKRLSRPPKAEDLASQMLMMFPKDRI----SAQDALLHPYF 291 (291)
T ss_pred hhhccccCCChHHHHHHHHHhCcCcccCc----CHHHHhcCCCC
Confidence 011246789999999999999999 69999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=324.81 Aligned_cols=254 Identities=25% Similarity=0.451 Sum_probs=214.3
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeE
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFL 98 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 98 (412)
+|.+.+.||+|+||.||++.++..+.. ||+|.+....... .....+.+|+++++.++|+||+++++.+..+...
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~----~~ik~~~~~~~~~--~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~ 74 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEH----CVIKEIDLTKMPV--KEKEASKKEVILLAKMKHPNIVTFFASFQENGRL 74 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCce----EEEEEeeHhhccc--hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeE
Confidence 589999999999999999999876554 9999997654322 2344567799999999999999999999999999
Q ss_pred EEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCC-EEEccccccchhhc
Q 042539 99 AWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGH-VTLTDFDLSRNLVK 177 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~-vkL~DFGla~~~~~ 177 (412)
|+|+||+.|++|..++.......+++..+..++.|++.||.|||+++++|+||||+||+++.++. +||+|||.+.....
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 75 FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 99999999999988877655556899999999999999999999999999999999999998865 69999998865421
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
. ........|++.|+||
T Consensus 155 ~---------------------------------------------------------------~~~~~~~~~~~~~~ap 171 (257)
T cd08225 155 S---------------------------------------------------------------MELAYTCVGTPYYLSP 171 (257)
T ss_pred C---------------------------------------------------------------cccccccCCCccccCH
Confidence 1 0111234588999999
Q ss_pred eeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC--CCCCCChHHHHHHHHhhhhCCCccCCCCCC
Q 042539 258 EVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP--EFVGQRTALTDLIQRLLEKDPVKRLGYLRG 335 (412)
Q Consensus 258 E~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~dli~~~L~~dP~~R~~~~~~ 335 (412)
|++.+..++.++|+|||||++|+|++|..||...+..+....+..... ..+..+.++.++|.+||..+|++|| +
T Consensus 172 e~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp----t 247 (257)
T cd08225 172 EICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRP----S 247 (257)
T ss_pred HHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhccChhhCc----C
Confidence 999888889999999999999999999999998777766666554332 2334678999999999999999999 6
Q ss_pred hhhhhcCCCC
Q 042539 336 ACEIKEHVFF 345 (412)
Q Consensus 336 ~~e~l~h~ff 345 (412)
+.+++.||||
T Consensus 248 ~~~ll~~~~~ 257 (257)
T cd08225 248 ITSILKRPFL 257 (257)
T ss_pred HHHHhhCCCC
Confidence 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=329.08 Aligned_cols=261 Identities=17% Similarity=0.242 Sum_probs=210.0
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCC-CCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAAD-PTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
+.+..++|++.+.||+|+||.||++.++... ......||+|++..... ......+.+|+.+++.++|+||++++++
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~ 77 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS---MRERIEFLNEASVMKEFNCHHVVRLLGV 77 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 3566789999999999999999999876432 12345699999865321 1234456789999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCC
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQND--------RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGH 163 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~--------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~ 163 (412)
+..+...++||||+.+|+|..++..... ..++...+..++.|++.||.|||+.|++||||||+||+++.++.
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 78 VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 157 (277)
T ss_pred EcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC
Confidence 9999999999999999999988765321 23567888999999999999999999999999999999999999
Q ss_pred EEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCC
Q 042539 164 VTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGE 243 (412)
Q Consensus 164 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (412)
+||+|||+++.+...... .
T Consensus 158 ~~l~dfg~~~~~~~~~~~-------------------------------------------------------------~ 176 (277)
T cd05062 158 VKIGDFGMTRDIYETDYY-------------------------------------------------------------R 176 (277)
T ss_pred EEECCCCCccccCCccee-------------------------------------------------------------e
Confidence 999999998754211000 0
Q ss_pred CCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCC-C-CCCCChHHHHHHHH
Q 042539 244 RSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTP-E-FVGQRTALTDLIQR 320 (412)
Q Consensus 244 ~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~-~-~~~~~~~~~dli~~ 320 (412)
......+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+..... . ....++.+.++|.+
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 256 (277)
T cd05062 177 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRM 256 (277)
T ss_pred cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 0112245788999999998889999999999999999998 7999999887777766655432 2 23456889999999
Q ss_pred hhhhCCCccCCCCCChhhhhc
Q 042539 321 LLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 321 ~L~~dP~~R~~~~~~~~e~l~ 341 (412)
||+.||++|| ++.++++
T Consensus 257 ~l~~~p~~Rp----s~~e~l~ 273 (277)
T cd05062 257 CWQYNPKMRP----SFLEIIS 273 (277)
T ss_pred HcCCChhhCc----CHHHHHH
Confidence 9999999999 5788775
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=324.52 Aligned_cols=250 Identities=22% Similarity=0.300 Sum_probs=206.5
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET 94 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 94 (412)
+..++|++++.||+|+||.||++.++.. ..+|+|.+.+.... ...+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~-----~~~a~K~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 70 (256)
T cd05114 1 INPSELTFMKELGSGQFGVVHLGKWRAQ-----IKVAIKAINEGAMS-----EEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70 (256)
T ss_pred CCHHHcEEeeEecCCcCceEEEEEeccC-----ceEEEEecccCCcc-----HHHHHHHHHHHHHCCCCCceeEEEEEcc
Confidence 3567899999999999999999987642 23899998654321 2346679999999999999999999999
Q ss_pred CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
++.+|+||||+.||+|..++.... +.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.
T Consensus 71 ~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~ 149 (256)
T cd05114 71 QKPLYIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRY 149 (256)
T ss_pred CCCEEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccc
Confidence 999999999999999988776433 3589999999999999999999999999999999999999999999999998875
Q ss_pred hhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCC
Q 042539 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254 (412)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 254 (412)
...... .......++..|
T Consensus 150 ~~~~~~--------------------------------------------------------------~~~~~~~~~~~y 167 (256)
T cd05114 150 VLDDEY--------------------------------------------------------------TSSSGAKFPVKW 167 (256)
T ss_pred cCCCce--------------------------------------------------------------eccCCCCCchhh
Confidence 421100 001122356689
Q ss_pred ccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCCC--CCCCChHHHHHHHHhhhhCCCccCC
Q 042539 255 VSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTPE--FVGQRTALTDLIQRLLEKDPVKRLG 331 (412)
Q Consensus 255 ~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~dli~~~L~~dP~~R~~ 331 (412)
+|||++.+..++.++|+|||||++|+|++ |+.||...+..+....+...... ....+..+.++|.+||..||.+||
T Consensus 168 ~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp- 246 (256)
T cd05114 168 SPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRP- 246 (256)
T ss_pred CChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCc-
Confidence 99999998889999999999999999999 99999998888877777654322 223467899999999999999999
Q ss_pred CCCChhhhhc
Q 042539 332 YLRGACEIKE 341 (412)
Q Consensus 332 ~~~~~~e~l~ 341 (412)
+++++++
T Consensus 247 ---s~~~l~~ 253 (256)
T cd05114 247 ---TFAELLR 253 (256)
T ss_pred ---CHHHHHH
Confidence 5788764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=323.95 Aligned_cols=254 Identities=26% Similarity=0.432 Sum_probs=212.4
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe--CC
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET--DE 96 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~ 96 (412)
+|++++.||.|+||.||+|.+..++. .||+|++...... ......+..|+++++.++|+||+++++++.. +.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~~k~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGK----ILVWKEIDYGNMT--EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ 74 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCC----EEEEEEEecccCC--HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCC
Confidence 58999999999999999998877544 4999999765442 2334567789999999999999999998764 45
Q ss_pred eEEEEeeccCCCCchhHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHH-----HcCceeeeCCCCceEEccCCCEEEccc
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQ--NDRVFSPSVIRFYLSEIICAIEHLH-----NMGIAYRDLKPENILIRQSGHVTLTDF 169 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~yLH-----~~~iiHrDlKp~NiLl~~~g~vkL~DF 169 (412)
.+|++|||+.+++|..++... ....+++..++.++.||+.||.||| +.+++|+||||+||+++.++.+||+||
T Consensus 75 ~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~ 154 (265)
T cd08217 75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDF 154 (265)
T ss_pred EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecc
Confidence 789999999999998887543 2346899999999999999999999 999999999999999999999999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|++...... ........
T Consensus 155 g~~~~~~~~---------------------------------------------------------------~~~~~~~~ 171 (265)
T cd08217 155 GLAKILGHD---------------------------------------------------------------SSFAKTYV 171 (265)
T ss_pred cccccccCC---------------------------------------------------------------cccccccc
Confidence 998754211 01122346
Q ss_pred cCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-CC-CCCChHHHHHHHHhhhhCCC
Q 042539 250 GTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP-EF-VGQRTALTDLIQRLLEKDPV 327 (412)
Q Consensus 250 gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~-~~~~~~~~dli~~~L~~dP~ 327 (412)
|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+..+....+..... .. ...+.++.+++.+||..+|.
T Consensus 172 ~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~ 251 (265)
T cd08217 172 GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPD 251 (265)
T ss_pred cCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcc
Confidence 89999999999988889999999999999999999999999886666666554432 22 24568999999999999999
Q ss_pred ccCCCCCChhhhhcCCCC
Q 042539 328 KRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 328 ~R~~~~~~~~e~l~h~ff 345 (412)
+|| ++.++++|||+
T Consensus 252 ~Rp----~~~~il~~~~~ 265 (265)
T cd08217 252 KRP----STEELLQLPLI 265 (265)
T ss_pred cCC----CHHHHhhCCCC
Confidence 999 79999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=334.72 Aligned_cols=260 Identities=26% Similarity=0.385 Sum_probs=207.8
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEEe
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLET 94 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~ 94 (412)
+.++|+.++.||+|+||.||++.+..++. .||+|.+.+.... .....+.+|+.++.++. |+||+++++++..
T Consensus 2 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~----~~aiK~~~~~~~~---~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~ 74 (288)
T cd06616 2 TAEDLKDLGEIGRGAFGTVNKMLHKPSGT----IMAVKRIRSTVDE---KEQKRLLMDLDVVMRSSDCPYIVKFYGALFR 74 (288)
T ss_pred cHHHhHHHHHhCCCCceEEEEEEECCCCC----EEEEEEehhccCh---HHHHHHHHHHHHHHHhcCCCCEeeeeeEEec
Confidence 56789999999999999999999877544 4999998765422 34556778999999996 9999999999999
Q ss_pred CCeEEEEeeccCCCCchhH---HHhhCCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeeeCCCCceEEccCCCEEEcccc
Q 042539 95 DEFLAWAVPYCPGGDLNVL---RYKQNDRVFSPSVIRFYLSEIICAIEHLHNM-GIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~---~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~-~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
+...+++|||+.+ ++..+ +.......+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||
T Consensus 75 ~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg 153 (288)
T cd06616 75 EGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFG 153 (288)
T ss_pred CCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecc
Confidence 9999999999864 44332 2333345699999999999999999999975 99999999999999999999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+++.+... .......|
T Consensus 154 ~~~~~~~~----------------------------------------------------------------~~~~~~~~ 169 (288)
T cd06616 154 ISGQLVDS----------------------------------------------------------------IAKTRDAG 169 (288)
T ss_pred hhHHhccC----------------------------------------------------------------CccccccC
Confidence 98754211 01122358
Q ss_pred CCCCccceeecCC---CCCchhhHHHHHHHHHHHhhCCCCCCCCCH-HHHHHHHhcCC-CCC-----CCCChHHHHHHHH
Q 042539 251 TEEYVSPEVVRGD---GHEFAVDWWALGILTYEMLYGTTPFRGKNR-KETFRNVLMKT-PEF-----VGQRTALTDLIQR 320 (412)
Q Consensus 251 t~~Y~APE~l~~~---~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-~~~~~~i~~~~-~~~-----~~~~~~~~dli~~ 320 (412)
|..|+|||++.+. .++.++|||||||++|+|++|++||...+. .+...++.... +.. ...+.++.+||.+
T Consensus 170 ~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 249 (288)
T cd06616 170 CRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINL 249 (288)
T ss_pred ccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHH
Confidence 8899999999876 578999999999999999999999976542 22333333222 111 1356889999999
Q ss_pred hhhhCCCccCCCCCChhhhhcCCCCCCCCch
Q 042539 321 LLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 321 ~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~ 351 (412)
||+.||++|| +++++++||||+...|.
T Consensus 250 ~l~~~p~~Rp----t~~~i~~~~~~~~~~~~ 276 (288)
T cd06616 250 CLIKDESKRP----KYKELLEHPFIKDYEER 276 (288)
T ss_pred HccCChhhCc----CHHHHhcChhhhchhhc
Confidence 9999999999 69999999999876553
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=331.54 Aligned_cols=254 Identities=28% Similarity=0.455 Sum_probs=208.0
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
++|++.+.||+|+||.||+|.+..++ +.||+|+++.... .......+.+|+++++.++|+||+++++++.+++.
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~----~~v~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 74 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATG----EIVAIKKFKESED--DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGR 74 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCC----cEEEEehhhhhcc--cccchhHHHHHHHHHHhcCCCCeeehhheEEECCE
Confidence 47999999999999999999987654 3499999865432 22345667789999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+|+||||+.++.+..+... ...+++.++..++.||+.||.|||++|++||||+|+||+++.++.+||+|||++.....
T Consensus 75 ~~iv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 75 LYLVFEYVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred EEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 9999999998877655443 23489999999999999999999999999999999999999999999999999875421
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
.. .......+++..|+||
T Consensus 153 ~~--------------------------------------------------------------~~~~~~~~~~~~~~~P 170 (288)
T cd07833 153 RP--------------------------------------------------------------ASPLTDYVATRWYRAP 170 (288)
T ss_pred Cc--------------------------------------------------------------cccccCcccccCCcCC
Confidence 10 0112345688999999
Q ss_pred eeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--------------CC-----------------
Q 042539 258 EVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK--------------TP----------------- 305 (412)
Q Consensus 258 E~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--------------~~----------------- 305 (412)
|++.+. .++.++|+|||||++|+|++|++||.+.+..+....+... ..
T Consensus 171 E~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (288)
T cd07833 171 ELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLE 250 (288)
T ss_pred chhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHH
Confidence 999888 7899999999999999999999999887655433322110 00
Q ss_pred -CCC-CCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCC
Q 042539 306 -EFV-GQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 306 -~~~-~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff 345 (412)
.++ ..+.++++||.+||..+|++|| +++++++|+||
T Consensus 251 ~~~~~~~~~~~~~li~~~l~~~p~~Rp----s~~~il~~~~f 288 (288)
T cd07833 251 RRYPGKVSSPALDFLKACLRMDPKERL----TCDELLQHPYF 288 (288)
T ss_pred HhcCCccchHHHHHHHHHhccCchhcc----cHHHHhcCCCC
Confidence 011 1267899999999999999999 69999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=336.38 Aligned_cols=259 Identities=20% Similarity=0.247 Sum_probs=208.6
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
.+...+|++++.||+|+||+||+|.+...+......||+|+++... .....+.+.+|+.+++.++|+||+++++++.
T Consensus 3 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~ 79 (316)
T cd05108 3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICL 79 (316)
T ss_pred ccchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEc
Confidence 3567899999999999999999999876665555669999986432 2234556778999999999999999999987
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
.. ..++++||+.+|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 80 ~~-~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 80 TS-TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred CC-CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccc
Confidence 65 5789999999999988876543 358899999999999999999999999999999999999999999999999997
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
....... ........++..
T Consensus 158 ~~~~~~~-------------------------------------------------------------~~~~~~~~~~~~ 176 (316)
T cd05108 158 LLGADEK-------------------------------------------------------------EYHAEGGKVPIK 176 (316)
T ss_pred cccCCCc-------------------------------------------------------------ceeccCCcccee
Confidence 6521100 000112234678
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCChHHHHHHHHhhhhCCCccC
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMK--TPEFVGQRTALTDLIQRLLEKDPVKRL 330 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~dli~~~L~~dP~~R~ 330 (412)
|+|||++.+..++.++|||||||++|||++ |..||.+....+....+... .+.....+.++.++|.+||..||.+||
T Consensus 177 y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp 256 (316)
T cd05108 177 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRP 256 (316)
T ss_pred ecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence 999999999999999999999999999997 99999987766544333222 123345678899999999999999999
Q ss_pred CCCCChhhhhcC
Q 042539 331 GYLRGACEIKEH 342 (412)
Q Consensus 331 ~~~~~~~e~l~h 342 (412)
++.+++.+
T Consensus 257 ----s~~~l~~~ 264 (316)
T cd05108 257 ----KFRELIIE 264 (316)
T ss_pred ----CHHHHHHH
Confidence 57888764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=342.70 Aligned_cols=262 Identities=22% Similarity=0.367 Sum_probs=208.2
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe---
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET--- 94 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--- 94 (412)
++|++.+.||+|+||.||+|.++.++. .||+|++.+... .......+.+|+.+++.++|+||++++++|..
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~----~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 78 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGK----KVAIKKIPHAFD--VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGA 78 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCC----EEEEEEeccccc--cccchHHHHHHHHHHHhcCCCCccCHHHhccccCC
Confidence 789999999999999999999887554 499999975432 12334566779999999999999999998863
Q ss_pred -CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 95 -DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 95 -~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
...+|+||||+. ++|..++... ..+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 79 DFKDVYVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred CCceEEEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccce
Confidence 357899999995 5777666543 349999999999999999999999999999999999999999999999999987
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
....... .........+|+..
T Consensus 156 ~~~~~~~-----------------------------------------------------------~~~~~~~~~~~~~~ 176 (334)
T cd07855 156 GLSSSPT-----------------------------------------------------------EHKYFMTEYVATRW 176 (334)
T ss_pred eecccCc-----------------------------------------------------------CCCccccccccccc
Confidence 5532100 01111224578999
Q ss_pred CccceeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhc-----------------------CCC---C
Q 042539 254 YVSPEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLM-----------------------KTP---E 306 (412)
Q Consensus 254 Y~APE~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~-----------------------~~~---~ 306 (412)
|+|||.+.+ ..++.++|||||||++|+|++|++||.+.+....+..+.. ..+ .
T Consensus 177 y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (334)
T cd07855 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQP 256 (334)
T ss_pred ccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCC
Confidence 999999866 4578999999999999999999999988765443322211 000 0
Q ss_pred ------CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCch
Q 042539 307 ------FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 307 ------~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~ 351 (412)
.+..+.++.++|.+||+.+|.+|| ++++++.||||.+..-.
T Consensus 257 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp----t~~~~l~~~~~~~~~~~ 303 (334)
T cd07855 257 VPWSKIFPKASPEALDLLSQMLQFDPEERI----TVEQALQHPFLAQYHDP 303 (334)
T ss_pred CCHHHHcccCCHHHHHHHHHHccCChhhCc----CHHHHHhChhhhhccCC
Confidence 134578899999999999999999 69999999999865543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=325.67 Aligned_cols=257 Identities=21% Similarity=0.294 Sum_probs=211.9
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET 94 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 94 (412)
++.++|++.+.||+|+||+||+|.++..+. ....||+|+++.... ......+.+|+.+++.++|+||+++++++..
T Consensus 1 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~-~~~~vaik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (266)
T cd05033 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGK-KEIDVAIKTLKAGSS---DKQRLDFLTEASIMGQFDHPNIIRLEGVVTK 76 (266)
T ss_pred CChHHceeeeEecCCccceEEEEEEccCCC-CcceEEEEEcCCCCC---hHHHHHHHHHHHHHHhCCCCCcceEeEEEec
Confidence 356899999999999999999998865422 344599999865432 2344567789999999999999999999999
Q ss_pred CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
++..+++|||+.|++|..++.... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhc
Confidence 999999999999999998876543 3689999999999999999999999999999999999999999999999999976
Q ss_pred hhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCC
Q 042539 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254 (412)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 254 (412)
...... ........++..|
T Consensus 156 ~~~~~~-------------------------------------------------------------~~~~~~~~~~~~y 174 (266)
T cd05033 156 LEDSEA-------------------------------------------------------------TYTTKGGKIPIRW 174 (266)
T ss_pred cccccc-------------------------------------------------------------ceeccCCCCCccc
Confidence 521000 0001122356789
Q ss_pred ccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCccCC
Q 042539 255 VSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVKRLG 331 (412)
Q Consensus 255 ~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~R~~ 331 (412)
+|||.+.+..++.++|||||||++|+|++ |..||......+....+.... +.....+..+.+|+.+||+.+|++||
T Consensus 175 ~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp- 253 (266)
T cd05033 175 TAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERP- 253 (266)
T ss_pred cChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCc-
Confidence 99999998889999999999999999997 999998877777766665432 33345678999999999999999999
Q ss_pred CCCChhhhhc
Q 042539 332 YLRGACEIKE 341 (412)
Q Consensus 332 ~~~~~~e~l~ 341 (412)
++.++++
T Consensus 254 ---~~~ei~~ 260 (266)
T cd05033 254 ---TFSQIVS 260 (266)
T ss_pred ---CHHHHHH
Confidence 5788775
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=329.72 Aligned_cols=258 Identities=21% Similarity=0.300 Sum_probs=211.2
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCC-CCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAAD-PTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
++.++|.+.+.||+|+||+||++.+.... ...+..+|+|.+.+.. ......+.+|+.++++++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS----DNARKDFHREAELLTNLQHEHIVKFYGVCV 77 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC----HHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 56789999999999999999999864432 2234558999986542 234556778999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhC-----------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCC
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQN-----------DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG 162 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~-----------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g 162 (412)
.++.+++||||+.+++|..++.... ...+++..+..++.|++.||+|||++|++||||||+|||++.++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 78 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 157 (288)
T ss_pred cCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 9999999999999999988876432 12489999999999999999999999999999999999999999
Q ss_pred CEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCC
Q 042539 163 HVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNG 242 (412)
Q Consensus 163 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (412)
.+||+|||+++....... .
T Consensus 158 ~~kl~dfg~~~~~~~~~~-------------------------------------------------------------~ 176 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDY-------------------------------------------------------------Y 176 (288)
T ss_pred cEEeccCCccccccCCce-------------------------------------------------------------e
Confidence 999999999875421100 0
Q ss_pred CCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCC-C-CCCCChHHHHHHH
Q 042539 243 ERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTP-E-FVGQRTALTDLIQ 319 (412)
Q Consensus 243 ~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~-~-~~~~~~~~~dli~ 319 (412)
.......++..|+|||++.+..++.++|+|||||++|+|++ |.+||.+.+..+....+..... . ....+.++.+||.
T Consensus 177 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 256 (288)
T cd05093 177 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPKEVYDLML 256 (288)
T ss_pred ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHH
Confidence 01122346788999999998889999999999999999998 9999998887777777765442 2 2245789999999
Q ss_pred HhhhhCCCccCCCCCChhhhhc
Q 042539 320 RLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 320 ~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
+||+.||.+|| ++.++++
T Consensus 257 ~~l~~~p~~Rp----t~~~v~~ 274 (288)
T cd05093 257 GCWQREPHMRL----NIKEIHS 274 (288)
T ss_pred HHccCChhhCC----CHHHHHH
Confidence 99999999999 5777653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=329.88 Aligned_cols=252 Identities=27% Similarity=0.430 Sum_probs=205.1
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeE
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFL 98 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 98 (412)
+|++++.||.|++|.||+|++..++. .||||+++..... .....+.+|+.++++++|+||+++++++.+.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~----~~~iK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 73 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGE----IVALKEIHLDAEE---GTPSTAIREISLMKELKHENIVRLHDVIHTENKL 73 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCe----EEEEEEecccccc---cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcE
Confidence 68999999999999999999876544 4999999765321 2234556799999999999999999999999999
Q ss_pred EEEeeccCCCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 99 AWAVPYCPGGDLNVLRYKQN-DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~~~~~~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
++||||+.| +|..++.... ...+++..+..++.|++.||.|||++|++||||||+||+++.+|.++|+|||+++....
T Consensus 74 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~ 152 (284)
T cd07836 74 MLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI 152 (284)
T ss_pred EEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcC
Confidence 999999986 6766655433 24589999999999999999999999999999999999999999999999999864421
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
. ........+|..|++|
T Consensus 153 ~---------------------------------------------------------------~~~~~~~~~~~~y~~P 169 (284)
T cd07836 153 P---------------------------------------------------------------VNTFSNEVVTLWYRAP 169 (284)
T ss_pred C---------------------------------------------------------------ccccccccccccccCh
Confidence 0 0011223578899999
Q ss_pred eeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--------------C----C------------
Q 042539 258 EVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT--------------P----E------------ 306 (412)
Q Consensus 258 E~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--------------~----~------------ 306 (412)
|++.+. .++.++|+|||||++|+|++|..||.+.+..+....+.... + .
T Consensus 170 E~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (284)
T cd07836 170 DVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQL 249 (284)
T ss_pred HHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHH
Confidence 998764 46889999999999999999999999877666555443210 0 0
Q ss_pred CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCC
Q 042539 307 FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 307 ~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff 345 (412)
.+..+..++++|.+||+.||.+|+ ++.++++||||
T Consensus 250 ~~~~~~~~~~~i~~~l~~~p~~R~----~~~~~l~~~~f 284 (284)
T cd07836 250 FPHADPLGIDLLHRLLQLNPELRI----SAHDALQHPWF 284 (284)
T ss_pred hhhcCcHHHHHHHHHhcCCcccCC----CHHHHhcCCCC
Confidence 123467889999999999999999 69999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=329.26 Aligned_cols=248 Identities=27% Similarity=0.402 Sum_probs=198.6
Q ss_pred ceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEEeC--C
Q 042539 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLETD--E 96 (412)
Q Consensus 20 y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~--~ 96 (412)
|++++.||+|+||.||++.++.++. .||+|++++..... ......+|+.++.++. |+||+++++++.++ +
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~----~~aik~~~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 73 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGK----YYAIKCMKKHFKSL---EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTG 73 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCc----EEEEEEehhccCCc---hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCC
Confidence 7889999999999999999876554 49999987643211 1223346899999996 99999999999987 8
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
.+++||||+.| +|...+... ...+++..++.++.|++.||+|||+.|++||||||+||+++. |.+||+|||+++.+.
T Consensus 74 ~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 74 RLALVFELMDM-NLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIY 150 (282)
T ss_pred cEEEEEecCCc-cHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccc
Confidence 89999999975 665555432 245899999999999999999999999999999999999999 999999999987542
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
.. .......++..|+|
T Consensus 151 ~~----------------------------------------------------------------~~~~~~~~~~~y~a 166 (282)
T cd07831 151 SK----------------------------------------------------------------PPYTEYISTRWYRA 166 (282)
T ss_pred cC----------------------------------------------------------------CCcCCCCCCcccCC
Confidence 11 11123457889999
Q ss_pred ceeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC------------------CC-----------
Q 042539 257 PEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT------------------PE----------- 306 (412)
Q Consensus 257 PE~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~------------------~~----------- 306 (412)
||++.+ ..++.++|||||||++|||++|.+||.+.+..+.+..+.... ..
T Consensus 167 PE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (282)
T cd07831 167 PECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRK 246 (282)
T ss_pred hhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHH
Confidence 998755 446889999999999999999999999877655444332100 00
Q ss_pred -CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCC
Q 042539 307 -FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 307 -~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff 345 (412)
....+..+.+||.+||.+||++|| +++++++||||
T Consensus 247 ~~~~~~~~~~~li~~~l~~~P~~R~----~~~~~l~~~~~ 282 (282)
T cd07831 247 LLPNASAEGLDLLKKLLAYDPDERI----TAKQALRHPYF 282 (282)
T ss_pred HcccccHHHHHHHHHHhccCccccc----CHHHHhhCCCC
Confidence 123468899999999999999999 69999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=340.69 Aligned_cols=268 Identities=22% Similarity=0.357 Sum_probs=209.7
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC--
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD-- 95 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-- 95 (412)
++|++++.||+|+||+||+|++..++. .||||.+.+.... ......+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~----~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~ 78 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNE----KVAIKKIANAFDN--RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHR 78 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCC----eEEEEEecccccc--cchhHHHHHHHHHHHhcCCCCccchHHheecccc
Confidence 579999999999999999999876544 4999998754321 22234566799999999999999999988654
Q ss_pred ---CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 96 ---EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 96 ---~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
..+|+||||+. ++|..++.. .+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++
T Consensus 79 ~~~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 79 EAFNDVYIVYELMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred cccCcEEEEEeCCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 35899999995 677666543 345999999999999999999999999999999999999999999999999998
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+..... ........||.
T Consensus 156 ~~~~~~---------------------------------------------------------------~~~~~~~~~~~ 172 (337)
T cd07858 156 RTTSEK---------------------------------------------------------------GDFMTEYVVTR 172 (337)
T ss_pred cccCCC---------------------------------------------------------------ccccccccccc
Confidence 654210 01122446788
Q ss_pred CCccceeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhc-----------------------CC----
Q 042539 253 EYVSPEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLM-----------------------KT---- 304 (412)
Q Consensus 253 ~Y~APE~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~-----------------------~~---- 304 (412)
.|+|||.+.+ ..++.++|+|||||++|+|++|++||.+.+.......+.. ..
T Consensus 173 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (337)
T cd07858 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTP 252 (337)
T ss_pred CccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCccc
Confidence 9999998865 4578999999999999999999999988765433322210 00
Q ss_pred -----CCCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCchhhcccCCCCC
Q 042539 305 -----PEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPF 361 (412)
Q Consensus 305 -----~~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~~~~~~~~pp~ 361 (412)
...+..++++.+||.+||+.||++|| +++++++||||..+.-.........||
T Consensus 253 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp----s~~ell~h~~~~~~~~~~~~~~~~~~~ 310 (337)
T cd07858 253 RQSFARLFPHANPLAIDLLEKMLVFDPSKRI----TVEEALAHPYLASLHDPSDEPVCQTPF 310 (337)
T ss_pred ccCHHHHcccCCHHHHHHHHHHhcCChhhcc----CHHHHHcCcchhhhcCcccCccCCCcc
Confidence 01235678899999999999999999 699999999998765443333333344
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=328.49 Aligned_cols=278 Identities=37% Similarity=0.580 Sum_probs=221.5
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEEeCC
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLETDE 96 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 96 (412)
++|++.+.||+|+||.||+|.+..++ +.||+|++.++.... ......+.+|+.+++++. |+||+++++++.+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~----~~~~ik~~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETN----KEYAIKILDKRQLIK-EKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCC----CEEEEEEechHhccc-hHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCc
Confidence 58999999999999999999987644 449999997755432 233456777999999998 999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
.+++|||++.|++|..++.... .+++..+..++.|++.||.|||++|++|+||||+||+++.+|.++|+|||++....
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 9999999999999988876543 59999999999999999999999999999999999999999999999999997653
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
........... .+ ...............+.|+..|+|
T Consensus 154 ~~~~~~~~~~~--------------------------------~~-----------~~~~~~~~~~~~~~~~~~~~~~~~ 190 (280)
T cd05581 154 PNSSPESNKGD--------------------------------AT-----------NIDSQIEKNRRRFASFVGTAEYVS 190 (280)
T ss_pred CccccccCCCC--------------------------------Cc-----------cccccccccccccccccCCccccC
Confidence 22110000000 00 000001112233456778999999
Q ss_pred ceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-CCCChHHHHHHHHhhhhCCCccCCCCCC
Q 042539 257 PEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF-VGQRTALTDLIQRLLEKDPVKRLGYLRG 335 (412)
Q Consensus 257 PE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~dli~~~L~~dP~~R~~~~~~ 335 (412)
||++.+..++.++|+|||||++|++++|+.||...+....+..+......+ ...++.+.+||.+||+.||.+||+....
T Consensus 191 Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 270 (280)
T cd05581 191 PELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEG 270 (280)
T ss_pred HHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccC
Confidence 999988888999999999999999999999999988777777766544333 3457899999999999999999942112
Q ss_pred hhhhhcCCCC
Q 042539 336 ACEIKEHVFF 345 (412)
Q Consensus 336 ~~e~l~h~ff 345 (412)
.+++++||||
T Consensus 271 ~~~ll~~~~~ 280 (280)
T cd05581 271 YDELKAHPFF 280 (280)
T ss_pred HHHHhcCCCC
Confidence 2999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=331.97 Aligned_cols=263 Identities=21% Similarity=0.315 Sum_probs=213.7
Q ss_pred CCCCCCccCceeeeeeeccCceEEEEEEEcCC-CCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCcccee
Q 042539 11 TTPSLDLDNLKALKILGKGAMGTVFLVHDRAA-DPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKL 88 (412)
Q Consensus 11 ~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~-~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l 88 (412)
..+++..++|.+.+.||+|+||.||++.+... .......||+|++++... ......+.+|+.+++++ +|+||+++
T Consensus 28 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~iv~~ 104 (302)
T cd05055 28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH---SSEREALMSELKIMSHLGNHENIVNL 104 (302)
T ss_pred ccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC---hHHHHHHHHHHHHHHhccCCCCcceE
Confidence 35678889999999999999999999986432 222445699999865432 23345677899999999 79999999
Q ss_pred eeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcc
Q 042539 89 LGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTD 168 (412)
Q Consensus 89 ~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~D 168 (412)
++++...+.+|+||||+.||+|..++.......+++.++..++.|++.||+|||++||+|+||||+|||++.++.+||+|
T Consensus 105 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~d 184 (302)
T cd05055 105 LGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICD 184 (302)
T ss_pred EEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECC
Confidence 99999999999999999999999887754444589999999999999999999999999999999999999999999999
Q ss_pred ccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccc
Q 042539 169 FDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248 (412)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (412)
||+++.+..... .......
T Consensus 185 fg~~~~~~~~~~-------------------------------------------------------------~~~~~~~ 203 (302)
T cd05055 185 FGLARDIMNDSN-------------------------------------------------------------YVVKGNA 203 (302)
T ss_pred CcccccccCCCc-------------------------------------------------------------eeecCCC
Confidence 999875421100 0011223
Q ss_pred ccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCC---CCCCCChHHHHHHHHhhhh
Q 042539 249 VGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTP---EFVGQRTALTDLIQRLLEK 324 (412)
Q Consensus 249 ~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~dli~~~L~~ 324 (412)
.++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+.+.+...... .....+.++.+||.+||..
T Consensus 204 ~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 283 (302)
T cd05055 204 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDA 283 (302)
T ss_pred CcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCC
Confidence 46788999999999889999999999999999998 9999988776655555443321 1234578999999999999
Q ss_pred CCCccCCCCCChhhhhc
Q 042539 325 DPVKRLGYLRGACEIKE 341 (412)
Q Consensus 325 dP~~R~~~~~~~~e~l~ 341 (412)
+|++|| ++.++++
T Consensus 284 ~p~~Rp----t~~ell~ 296 (302)
T cd05055 284 DPLKRP----TFKQIVQ 296 (302)
T ss_pred CchhCc----CHHHHHH
Confidence 999999 5788764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=346.39 Aligned_cols=262 Identities=22% Similarity=0.315 Sum_probs=208.5
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCC-CCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADP-TARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLL 89 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~ 89 (412)
+.++..++|++++.||+|+||.||+|.+...+. .+...||||+++... .....+.+.+|+++++.+. |||||+++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~~l~~l~~HpnIv~l~ 107 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA---RSSEKQALMSELKIMTHLGPHLNIVNLL 107 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCCCeeeEE
Confidence 667888999999999999999999998765432 234469999996543 2233456788999999996 99999999
Q ss_pred eeEEeCCeEEEEeeccCCCCchhHHHhhC---------------------------------------------------
Q 042539 90 GSLETDEFLAWAVPYCPGGDLNVLRYKQN--------------------------------------------------- 118 (412)
Q Consensus 90 ~~~~~~~~~~lv~e~~~gg~L~~~~~~~~--------------------------------------------------- 118 (412)
+++.+...+|+|||||.||+|..++....
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (400)
T cd05105 108 GACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ 187 (400)
T ss_pred EEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence 99999999999999999999988765421
Q ss_pred -------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCc
Q 042539 119 -------------------------------------------DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPEN 155 (412)
Q Consensus 119 -------------------------------------------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~N 155 (412)
...+++..+..++.||+.||+|||++||+||||||+|
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~N 267 (400)
T cd05105 188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARN 267 (400)
T ss_pred cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHh
Confidence 1247888899999999999999999999999999999
Q ss_pred eEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCcccc
Q 042539 156 ILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRR 235 (412)
Q Consensus 156 iLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (412)
||++.++.+||+|||+++......
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~-------------------------------------------------------- 291 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDS-------------------------------------------------------- 291 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccccc--------------------------------------------------------
Confidence 999999999999999987542110
Q ss_pred ccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC---CCCCCCC
Q 042539 236 QQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT---PEFVGQR 311 (412)
Q Consensus 236 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~---~~~~~~~ 311 (412)
.........+++.|+|||++.+..++.++|||||||++|+|++ |..||.+......+...+... +.....+
T Consensus 292 -----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (400)
T cd05105 292 -----NYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHAT 366 (400)
T ss_pred -----cccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCCccCC
Confidence 0011123457789999999999889999999999999999997 999998765444333333222 1223467
Q ss_pred hHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 312 TALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 312 ~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
.++.++|.+||+.||++||+ +.++.+
T Consensus 367 ~~l~~li~~cl~~dP~~RPt----~~~l~~ 392 (400)
T cd05105 367 QEVYDIMVKCWNSEPEKRPS----FLHLSD 392 (400)
T ss_pred HHHHHHHHHHCccCHhHCcC----HHHHHH
Confidence 88999999999999999994 555543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=336.36 Aligned_cols=281 Identities=24% Similarity=0.358 Sum_probs=214.1
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEEeC--
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLETD-- 95 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~-- 95 (412)
+|.+.+.||+|+||.||+|++.... .+..||+|++.... ......+.+.+|+.+++.+. |+||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~--~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 76 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETS--EEETVAIKKITNVF--SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPG 76 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCC--cCceEEEEEecccc--ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccc
Confidence 5899999999999999999987651 24459999986432 12234556677999999995 99999999875432
Q ss_pred --CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 96 --EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 96 --~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
..+|++|+|+. ++|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++
T Consensus 77 ~~~~~~~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 77 NFNELYLYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred cCCcEEEEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 46889999985 578766643 3459999999999999999999999999999999999999999999999999997
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
.+..... .........+||+.
T Consensus 154 ~~~~~~~-----------------------------------------------------------~~~~~~~~~~g~~~ 174 (332)
T cd07857 154 GFSENPG-----------------------------------------------------------ENAGFMTEYVATRW 174 (332)
T ss_pred ecccccc-----------------------------------------------------------cccccccCcccCcc
Confidence 6531100 00111234578999
Q ss_pred CccceeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC----------------------------
Q 042539 254 YVSPEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT---------------------------- 304 (412)
Q Consensus 254 Y~APE~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~---------------------------- 304 (412)
|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..++...
T Consensus 175 y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (332)
T cd07857 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPK 254 (332)
T ss_pred ccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCC
Confidence 999998876 467999999999999999999999998876544333222100
Q ss_pred C----CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCchhhcccCCCCCCCCCCCch
Q 042539 305 P----EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREEND 369 (412)
Q Consensus 305 ~----~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~~~~~~~~pp~~p~~~~~~ 369 (412)
. ..+..+..+.+||.+||+.||.+|| ++.+++.||||+...-..-...+..|+.+..++++
T Consensus 255 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~----t~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (332)
T cd07857 255 KPFESIFPNANPLALDLLEKLLAFDPTKRI----SVEEALEHPYLAIWHDPDDEPVCQKPFDFSFESED 319 (332)
T ss_pred cchHhhCCCCCHHHHHHHHHHccCCcccCC----CHHHHhcChhhhhhcCccccccccccccCCccccc
Confidence 0 1123467899999999999999999 69999999999865433333345555555555544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=328.17 Aligned_cols=253 Identities=26% Similarity=0.452 Sum_probs=212.5
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
++|++.+.||+|+||.||+|.++..+.. ||+|.+.+... ......+.+|+++++.++||||+++++.+..++.
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~----~~ik~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 73 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKI----MAVKTIRLEIN---EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGD 73 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcE----EEEEEEecccC---hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCE
Confidence 5789999999999999999999775544 99999876532 2345667789999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN-MGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
+|+++||+.|++|..++.... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.+|.++|+|||.+..+.
T Consensus 74 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 74 ISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 999999999999998876543 458999999999999999999999 999999999999999999999999999986552
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
... .....|+..|+|
T Consensus 153 ~~~-----------------------------------------------------------------~~~~~~~~~y~~ 167 (265)
T cd06605 153 NSL-----------------------------------------------------------------AKTFVGTSSYMA 167 (265)
T ss_pred HHH-----------------------------------------------------------------hhcccCChhccC
Confidence 110 011468889999
Q ss_pred ceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCC-----CHHHHHHHHhcCC-CCCCC--CChHHHHHHHHhhhhCCCc
Q 042539 257 PEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGK-----NRKETFRNVLMKT-PEFVG--QRTALTDLIQRLLEKDPVK 328 (412)
Q Consensus 257 PE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~-----~~~~~~~~i~~~~-~~~~~--~~~~~~dli~~~L~~dP~~ 328 (412)
||.+.+..++.++|+|||||++|+|++|..||... ...+....+.... +..+. .+.++.++|.+||..||++
T Consensus 168 PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 247 (265)
T cd06605 168 PERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRE 247 (265)
T ss_pred HHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchh
Confidence 99999988999999999999999999999999764 2233444444332 22222 5788999999999999999
Q ss_pred cCCCCCChhhhhcCCCCCC
Q 042539 329 RLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 329 R~~~~~~~~e~l~h~ff~~ 347 (412)
|| ++.+++.||||+.
T Consensus 248 Rp----t~~~ll~~~~~~~ 262 (265)
T cd06605 248 RP----SYKELLEHPFIKK 262 (265)
T ss_pred Cc----CHHHHhhCchhhc
Confidence 99 6999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=334.25 Aligned_cols=254 Identities=24% Similarity=0.396 Sum_probs=211.4
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
..|.....||+|+||.||+|.+...+. .||+|++..... .....+.+|+.+++.++||||+++++.+..++.
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~----~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~ 92 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGR----QVAVKMMDLRKQ----QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEE 92 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCC----EEEEEEEEeccc----chHHHHHHHHHHHHhCCCCchhhhhhheeeCCe
Confidence 445566789999999999998876444 499999865432 223456779999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
.|+||||+.|++|..++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||++..+..
T Consensus 93 ~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 93 LWVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169 (297)
T ss_pred EEEEEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence 9999999999999876543 3489999999999999999999999999999999999999999999999999864421
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
. .......+|+..|+||
T Consensus 170 ~---------------------------------------------------------------~~~~~~~~~~~~y~aP 186 (297)
T cd06659 170 D---------------------------------------------------------------VPKRKSLVGTPYWMAP 186 (297)
T ss_pred c---------------------------------------------------------------cccccceecCccccCH
Confidence 1 0112345789999999
Q ss_pred eeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC----CCCCChHHHHHHHHhhhhCCCccCCCC
Q 042539 258 EVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE----FVGQRTALTDLIQRLLEKDPVKRLGYL 333 (412)
Q Consensus 258 E~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~dli~~~L~~dP~~R~~~~ 333 (412)
|++.+..++.++|+|||||++|+|++|+.||...+..+....+...... ....+..+.++|++||+.+|.+||
T Consensus 187 E~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rp--- 263 (297)
T cd06659 187 EVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERA--- 263 (297)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCc---
Confidence 9999888999999999999999999999999887766666555433221 234567899999999999999999
Q ss_pred CChhhhhcCCCCCCCC
Q 042539 334 RGACEIKEHVFFKGVR 349 (412)
Q Consensus 334 ~~~~e~l~h~ff~~~~ 349 (412)
++.++++|+||.+..
T Consensus 264 -s~~~ll~~~~~~~~~ 278 (297)
T cd06659 264 -TAQELLDHPFLLQTG 278 (297)
T ss_pred -CHHHHhhChhhccCC
Confidence 699999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=321.71 Aligned_cols=253 Identities=30% Similarity=0.471 Sum_probs=210.0
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhh-hhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLH-AKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
+|+..+.||+|+||+||+|.+...+. .|++|++...... ...+..+.+.+|+.+++.++|+||+++++++.++..
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 76 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGD----FFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDN 76 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCc----EEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCe
Confidence 57888999999999999998875444 4999998664321 223345667889999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+|++|||+.|++|..++.... .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++.....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 77 LYIFLELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999988876543 489999999999999999999999999999999999999999999999998865421
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
. .......|+..|+||
T Consensus 155 ~----------------------------------------------------------------~~~~~~~~~~~y~~p 170 (258)
T cd06632 155 F----------------------------------------------------------------SFAKSFKGSPYWMAP 170 (258)
T ss_pred c----------------------------------------------------------------ccccccCCCcceeCH
Confidence 1 012245688999999
Q ss_pred eeecCCC-CCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhc--CCCCC-CCCChHHHHHHHHhhhhCCCccCCCC
Q 042539 258 EVVRGDG-HEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLM--KTPEF-VGQRTALTDLIQRLLEKDPVKRLGYL 333 (412)
Q Consensus 258 E~l~~~~-~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~-~~~~~~~~dli~~~L~~dP~~R~~~~ 333 (412)
|.+.... ++.++|+|||||++|+|++|+.||...........+.. ..+.. ...+..+.+||.+||..+|.+||
T Consensus 171 e~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp--- 247 (258)
T cd06632 171 EVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRP--- 247 (258)
T ss_pred HHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCc---
Confidence 9988776 88999999999999999999999987665554444433 11222 34578899999999999999999
Q ss_pred CChhhhhcCCCC
Q 042539 334 RGACEIKEHVFF 345 (412)
Q Consensus 334 ~~~~e~l~h~ff 345 (412)
++.+++.|||+
T Consensus 248 -~~~~~l~~~~~ 258 (258)
T cd06632 248 -TAAELLEHPFV 258 (258)
T ss_pred -CHHHHhcCCCC
Confidence 69999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=324.89 Aligned_cols=256 Identities=25% Similarity=0.434 Sum_probs=207.9
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhh------hhHHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLH------AKHEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~------~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
+|.+.+.||.|+||.||++.+..++. .||+|.++..... ......+.+.+|+.+++.++|+||+++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~----~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 77 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGE----MMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE 77 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCc----eeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe
Confidence 58899999999999999998876544 4999988643211 1122345677899999999999999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
...+.+++||||+.|++|..++... +.+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 78 TTEEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ccCCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccc
Confidence 9999999999999999998887654 45899999999999999999999999999999999999999999999999998
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+..... ..........|+.
T Consensus 156 ~~~~~~-------------------------------------------------------------~~~~~~~~~~~~~ 174 (272)
T cd06629 156 KKSDDI-------------------------------------------------------------YDNDQNMSMQGSV 174 (272)
T ss_pred cccccc-------------------------------------------------------------ccccccccccCCc
Confidence 653210 0011123456889
Q ss_pred CCccceeecCCC--CCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CCC-----CCCCChHHHHHHHHhhh
Q 042539 253 EYVSPEVVRGDG--HEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK--TPE-----FVGQRTALTDLIQRLLE 323 (412)
Q Consensus 253 ~Y~APE~l~~~~--~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~~~-----~~~~~~~~~dli~~~L~ 323 (412)
.|+|||.+.+.. ++.++|+|||||++|+|++|..||...+..+....+... .+. ...++..+.++|.+||.
T Consensus 175 ~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 254 (272)
T cd06629 175 FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFT 254 (272)
T ss_pred cccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhc
Confidence 999999987754 789999999999999999999999876555444333221 111 12457899999999999
Q ss_pred hCCCccCCCCCChhhhhcCCCC
Q 042539 324 KDPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 324 ~dP~~R~~~~~~~~e~l~h~ff 345 (412)
.+|.+|| +++++++||||
T Consensus 255 ~~p~~Rp----s~~~il~~~~~ 272 (272)
T cd06629 255 INPDNRP----TARELLQHPFI 272 (272)
T ss_pred CChhhCC----CHHHHhhCCCC
Confidence 9999999 69999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=322.30 Aligned_cols=252 Identities=21% Similarity=0.286 Sum_probs=208.7
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
++..++|++.+.||+|+||.||+|.+... ..||+|.++..... .+.+.+|+.++++++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~-----~~v~iK~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNT-----TPVAVKTLKPGTMD-----PKDFLAEAQIMKKLRHPKLIQLYAVCT 71 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecCC-----eEEEEEeeCCCccc-----HHHHHHHHHHHHHCCCCCccceeEEEe
Confidence 56778999999999999999999986532 23999999765431 334667999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
..+.+|+||||+.|++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~ 151 (261)
T cd05068 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLAR 151 (261)
T ss_pred cCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEE
Confidence 99999999999999999988766554568999999999999999999999999999999999999999999999999997
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
....... .......++..
T Consensus 152 ~~~~~~~--------------------------------------------------------------~~~~~~~~~~~ 169 (261)
T cd05068 152 VIKEDIY--------------------------------------------------------------EAREGAKFPIK 169 (261)
T ss_pred EccCCcc--------------------------------------------------------------cccCCCcCcee
Confidence 6521100 00001123457
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCccC
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVKRL 330 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~R~ 330 (412)
|+|||.+.+..++.++|+|||||++|+|++ |+.||.+.+.......+.... +.....+..+.++|.+||+.+|.+||
T Consensus 170 y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 249 (261)
T cd05068 170 WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRP 249 (261)
T ss_pred ccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCC
Confidence 999999998889999999999999999998 999999988777776665432 22345678999999999999999999
Q ss_pred CCCCChhhhhc
Q 042539 331 GYLRGACEIKE 341 (412)
Q Consensus 331 ~~~~~~~e~l~ 341 (412)
++.++.+
T Consensus 250 ----~~~~l~~ 256 (261)
T cd05068 250 ----TFETLQW 256 (261)
T ss_pred ----CHHHHHH
Confidence 5777653
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=334.26 Aligned_cols=256 Identities=26% Similarity=0.412 Sum_probs=212.2
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
+.|++++.||+|+||.||++.+..++ ..||+|+++.... ......+.+|+.+++.++|+||+++++++..++.
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~----~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTK----EVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTK 76 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCC----eEEEEEEeccccc---hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCc
Confidence 46888999999999999999887644 3499999865432 2234567789999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+|+||||+.|++|..++.. +.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..+..
T Consensus 77 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 77 LWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred eEEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccC
Confidence 9999999999999877643 3589999999999999999999999999999999999999999999999999865421
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
.. .......|+..|+||
T Consensus 154 ~~---------------------------------------------------------------~~~~~~~~~~~y~aP 170 (277)
T cd06642 154 TQ---------------------------------------------------------------IKRNTFVGTPFWMAP 170 (277)
T ss_pred cc---------------------------------------------------------------hhhhcccCcccccCH
Confidence 10 111234688899999
Q ss_pred eeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-CC-CCCChHHHHHHHHhhhhCCCccCCCCCC
Q 042539 258 EVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP-EF-VGQRTALTDLIQRLLEKDPVKRLGYLRG 335 (412)
Q Consensus 258 E~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~-~~~~~~~~dli~~~L~~dP~~R~~~~~~ 335 (412)
|++.+..++.++|+|||||++|+|++|..||...........+....+ .. ...+.++.++|.+||..+|.+|| +
T Consensus 171 E~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----~ 246 (277)
T cd06642 171 EVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRP----T 246 (277)
T ss_pred HHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccCCcccCc----C
Confidence 999988889999999999999999999999987665554444333222 11 23567899999999999999999 6
Q ss_pred hhhhhcCCCCCCCCc
Q 042539 336 ACEIKEHVFFKGVRW 350 (412)
Q Consensus 336 ~~e~l~h~ff~~~~~ 350 (412)
+.++++|+||....+
T Consensus 247 ~~~il~~~~~~~~~~ 261 (277)
T cd06642 247 AKELLKHKFITRYTK 261 (277)
T ss_pred HHHHHHhHHHHHHhh
Confidence 999999999986554
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=337.98 Aligned_cols=254 Identities=26% Similarity=0.419 Sum_probs=207.1
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
..++|++++.||+|+||.||++.+..++. .||||++.+... .......+.+|+.+++.++|+||+++++++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGA----KVAIKKLYRPFQ--SELFAKRAYRELRLLKHMKHENVIGLLDVFTPD 86 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCc----EEEEEEeccccc--chHHHHHHHHHHHHHHhcCCCCccceeeeecCC
Confidence 35789999999999999999999877544 499999865421 223445677899999999999999999999765
Q ss_pred C------eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccc
Q 042539 96 E------FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169 (412)
Q Consensus 96 ~------~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DF 169 (412)
. .+++||||+ |++|..++.. ..+++..++.++.|++.||+|||++||+||||||+||+++.+|.+||+||
T Consensus 87 ~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 87 LSLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeec
Confidence 4 469999999 7788766543 34899999999999999999999999999999999999999999999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|++..... ......
T Consensus 163 g~~~~~~~------------------------------------------------------------------~~~~~~ 176 (343)
T cd07880 163 GLARQTDS------------------------------------------------------------------EMTGYV 176 (343)
T ss_pred cccccccc------------------------------------------------------------------Cccccc
Confidence 99864311 011335
Q ss_pred cCCCCccceeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-----------------------
Q 042539 250 GTEEYVSPEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP----------------------- 305 (412)
Q Consensus 250 gt~~Y~APE~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~----------------------- 305 (412)
+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.+....+..++....
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (343)
T cd07880 177 VTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLP 256 (343)
T ss_pred cCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhcc
Confidence 7889999999876 3578999999999999999999999998776554444332110
Q ss_pred ---------CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCC
Q 042539 306 ---------EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 306 ---------~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~ 349 (412)
.....++.+.++|.+||+.||.+|+ ++.+++.||||+...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~----t~~~~l~~~~~~~~~ 305 (343)
T cd07880 257 RFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRI----TAAEALAHPYFEEFH 305 (343)
T ss_pred ccCcchHHHhccCCChHHHHHHHHHcCCChhhCC----CHHHHhcCccHhhhc
Confidence 0134567899999999999999999 699999999998654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=329.71 Aligned_cols=264 Identities=19% Similarity=0.278 Sum_probs=215.3
Q ss_pred CCCCCCCccCceeeeeeeccCceEEEEEEEcCCCC-CCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccce
Q 042539 10 QTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADP-TARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPK 87 (412)
Q Consensus 10 ~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~ 87 (412)
.....+..++|++.+.||+|+||.||++.++.... .....+|+|.+..... ......+.+|+.+++.+ +|+||++
T Consensus 4 ~~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~i~~ 80 (293)
T cd05053 4 DPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT---EKDLSDLVSEMEMMKMIGKHKNIIN 80 (293)
T ss_pred CcccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC---HHHHHHHHHHHHHHHhhcCCCCeee
Confidence 45678888999999999999999999998865442 2345699999865422 22345577899999999 7999999
Q ss_pred eeeeEEeCCeEEEEeeccCCCCchhHHHhh--------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCC
Q 042539 88 LLGSLETDEFLAWAVPYCPGGDLNVLRYKQ--------------NDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKP 153 (412)
Q Consensus 88 l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~--------------~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp 153 (412)
+++++..++.++++|||+.+|+|..++... ....+++..+..++.|++.||.|||++||+||||||
T Consensus 81 ~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp 160 (293)
T cd05053 81 LLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAA 160 (293)
T ss_pred EEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccce
Confidence 999999999999999999999998887542 234689999999999999999999999999999999
Q ss_pred CceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCcc
Q 042539 154 ENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVS 233 (412)
Q Consensus 154 ~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (412)
+|||++.++.+||+|||+++.+.....
T Consensus 161 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~----------------------------------------------------- 187 (293)
T cd05053 161 RNVLVTEDHVMKIADFGLARDIHHIDY----------------------------------------------------- 187 (293)
T ss_pred eeEEEcCCCeEEeCccccccccccccc-----------------------------------------------------
Confidence 999999999999999999976421100
Q ss_pred ccccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCC--CCCCC
Q 042539 234 RRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTP--EFVGQ 310 (412)
Q Consensus 234 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~--~~~~~ 310 (412)
........++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+.+..+..... .....
T Consensus 188 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (293)
T cd05053 188 --------YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRMEKPQNC 259 (293)
T ss_pred --------eeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCC
Confidence 000111234668999999988889999999999999999997 9999999887777766654321 22345
Q ss_pred ChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 311 RTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 311 ~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
+..+.+||.+||..||.+|| ++.++++
T Consensus 260 ~~~~~~li~~~l~~~p~~Rp----s~~eil~ 286 (293)
T cd05053 260 TQELYHLMRDCWHEVPSQRP----TFKQLVE 286 (293)
T ss_pred CHHHHHHHHHHcccCcccCc----CHHHHHH
Confidence 68999999999999999999 6888876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=332.69 Aligned_cols=260 Identities=26% Similarity=0.357 Sum_probs=201.7
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET 94 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 94 (412)
-.+++|+++++||+|+||.||+|.++.++. .||||.+..... .......+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~aik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 82 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQ----IVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRT 82 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCc----EEEEEEEeccCC--cCCchhHHHHHHHHHHhCCCCCccceEEEEec
Confidence 346789999999999999999999877544 499999865432 11223345679999999999999999998865
Q ss_pred CC--------eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEE
Q 042539 95 DE--------FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTL 166 (412)
Q Consensus 95 ~~--------~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL 166 (412)
.. ..|+||||+.+ +|..++... ...+++.+++.++.|++.||.|||++|++|+||||+||+++.++.+||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl 160 (310)
T cd07865 83 KATPYNRYKGSFYLVFEFCEH-DLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKL 160 (310)
T ss_pred ccccccCCCceEEEEEcCCCc-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEE
Confidence 43 46999999965 666655443 235899999999999999999999999999999999999999999999
Q ss_pred ccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCc
Q 042539 167 TDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSN 246 (412)
Q Consensus 167 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (412)
+|||++..+..... .......
T Consensus 161 ~dfg~~~~~~~~~~-----------------------------------------------------------~~~~~~~ 181 (310)
T cd07865 161 ADFGLARAFSLSKN-----------------------------------------------------------SKPNRYT 181 (310)
T ss_pred CcCCCcccccCCcc-----------------------------------------------------------cCCCCcc
Confidence 99999975521100 0001112
Q ss_pred ccccCCCCccceeecCCC-CCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhc---CCC----------------C
Q 042539 247 SFVGTEEYVSPEVVRGDG-HEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLM---KTP----------------E 306 (412)
Q Consensus 247 ~~~gt~~Y~APE~l~~~~-~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~---~~~----------------~ 306 (412)
...++..|+|||++.+.. ++.++|+|||||++|+|++|++||.+.+.......+.. ..+ .
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (310)
T cd07865 182 NRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKME 261 (310)
T ss_pred CcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhcc
Confidence 346788999999987654 68899999999999999999999988765543322211 000 0
Q ss_pred --------------CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCC
Q 042539 307 --------------FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 307 --------------~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff 345 (412)
....+..+.+||.+||..||.+|| +++++++||||
T Consensus 262 ~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~----t~~e~l~h~~f 310 (310)
T cd07865 262 LPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRI----DADTALNHDFF 310 (310)
T ss_pred CCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhcc----CHHHHhcCCCC
Confidence 001246788999999999999999 69999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=322.75 Aligned_cols=256 Identities=29% Similarity=0.507 Sum_probs=215.7
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
++|++.+.||+|++|.||+|.+..++. .||+|++...... .....+.+|+.++..++|+||+++++++...+.
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~----~~~vk~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGK----IYALKKIHVDGDE---EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGE 73 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCc----EEEEEEeccCcch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCe
Confidence 479999999999999999999887544 4999998765421 345667789999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN-MGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
+++||||+.|++|..++... ..+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++....
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~ 151 (264)
T cd06623 74 ISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLE 151 (264)
T ss_pred EEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 99999999999999887654 459999999999999999999999 999999999999999999999999999987542
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
.. ........++..|+|
T Consensus 152 ~~---------------------------------------------------------------~~~~~~~~~~~~y~~ 168 (264)
T cd06623 152 NT---------------------------------------------------------------LDQCNTFVGTVTYMS 168 (264)
T ss_pred cC---------------------------------------------------------------CCcccceeecccccC
Confidence 11 011124468889999
Q ss_pred ceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCC---CHHHHHHHHhcCC-CCC-CC-CChHHHHHHHHhhhhCCCccC
Q 042539 257 PEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGK---NRKETFRNVLMKT-PEF-VG-QRTALTDLIQRLLEKDPVKRL 330 (412)
Q Consensus 257 PE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~---~~~~~~~~i~~~~-~~~-~~-~~~~~~dli~~~L~~dP~~R~ 330 (412)
||.+.+..++.++|+|||||++|+|++|..||... ...+....+.... +.. .. .+..+.++|.+||..+|++||
T Consensus 169 pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~ 248 (264)
T cd06623 169 PERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRP 248 (264)
T ss_pred HhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCC
Confidence 99999888899999999999999999999999886 4445555554332 122 22 578899999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCC
Q 042539 331 GYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 331 ~~~~~~~e~l~h~ff~~~~ 349 (412)
++.++++||||+..+
T Consensus 249 ----~~~~ll~~~~~~~~~ 263 (264)
T cd06623 249 ----SAAELLQHPFIKKAD 263 (264)
T ss_pred ----CHHHHHhCHHHHhcc
Confidence 699999999998653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=326.81 Aligned_cols=254 Identities=24% Similarity=0.413 Sum_probs=212.2
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
.+|...+.||+|++|.||++.+...+. .+|+|+++... ......+.+|+.+++.++|+||+++++++...+.
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~----~~~iK~~~~~~----~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~ 90 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGR----QVAVKKMDLRK----QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE 90 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCC----EEEEEEEeccc----hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCe
Confidence 356667899999999999998876543 49999885432 1234456789999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
.|+++||+.|++|..++.. ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++.....
T Consensus 91 ~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~ 167 (285)
T cd06648 91 LWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK 167 (285)
T ss_pred EEEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence 9999999999999887765 3489999999999999999999999999999999999999999999999998764321
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
. ........|++.|+||
T Consensus 168 ~---------------------------------------------------------------~~~~~~~~~~~~y~aP 184 (285)
T cd06648 168 E---------------------------------------------------------------VPRRKSLVGTPYWMAP 184 (285)
T ss_pred C---------------------------------------------------------------CcccccccCCccccCH
Confidence 0 0111234689999999
Q ss_pred eeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC----CCCChHHHHHHHHhhhhCCCccCCCC
Q 042539 258 EVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF----VGQRTALTDLIQRLLEKDPVKRLGYL 333 (412)
Q Consensus 258 E~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~dli~~~L~~dP~~R~~~~ 333 (412)
|.+.+..++.++|+|||||++|+|++|..||...+.......+....+.. ...+..+.+||++||..+|.+||
T Consensus 185 E~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp--- 261 (285)
T cd06648 185 EVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRA--- 261 (285)
T ss_pred HHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCc---
Confidence 99988889999999999999999999999998877766666665443221 22568899999999999999999
Q ss_pred CChhhhhcCCCCCCCC
Q 042539 334 RGACEIKEHVFFKGVR 349 (412)
Q Consensus 334 ~~~~e~l~h~ff~~~~ 349 (412)
++.++++|+||+...
T Consensus 262 -t~~~il~~~~~~~~~ 276 (285)
T cd06648 262 -TAAELLNHPFLAKAG 276 (285)
T ss_pred -CHHHHccCcccccCC
Confidence 689999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=322.67 Aligned_cols=251 Identities=23% Similarity=0.284 Sum_probs=207.0
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET 94 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 94 (412)
+..++|++++.||+|+||+||++++... ..+|+|.++..... ...+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~-----~~~aik~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 70 (256)
T cd05113 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQ-----YDVAIKMIKEGSMS-----EDEFIEEAKVMMKLSHEKLVQLYGVCTK 70 (256)
T ss_pred CChHHeEEeeEecCcccceEEEEEecCC-----CcEEEEEcCCCccc-----HHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 3568999999999999999999987542 23899998754331 2346679999999999999999999999
Q ss_pred CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
+..+|+||||+.+|+|..++.... ..+++.++..++.||+.||.|||++|++|+||||+||+++.++.+||+|||+++.
T Consensus 71 ~~~~~lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~ 149 (256)
T cd05113 71 QRPIYIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRY 149 (256)
T ss_pred CCCcEEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCcccee
Confidence 999999999999999988876533 3589999999999999999999999999999999999999999999999998865
Q ss_pred hhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCC
Q 042539 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254 (412)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 254 (412)
...... .......++..|
T Consensus 150 ~~~~~~--------------------------------------------------------------~~~~~~~~~~~y 167 (256)
T cd05113 150 VLDDEY--------------------------------------------------------------TSSVGSKFPVRW 167 (256)
T ss_pred cCCCce--------------------------------------------------------------eecCCCccChhh
Confidence 421100 000112356789
Q ss_pred ccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCCC--CCCCChHHHHHHHHhhhhCCCccCC
Q 042539 255 VSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTPE--FVGQRTALTDLIQRLLEKDPVKRLG 331 (412)
Q Consensus 255 ~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~dli~~~L~~dP~~R~~ 331 (412)
+|||.+.+..++.++|+|||||++|+|++ |..||...+..+....+...... ....+..+.++|.+||..||.+||
T Consensus 168 ~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp- 246 (256)
T cd05113 168 SPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERP- 246 (256)
T ss_pred CCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCC-
Confidence 99999998889999999999999999998 99999988877776666654322 233568999999999999999999
Q ss_pred CCCChhhhhcC
Q 042539 332 YLRGACEIKEH 342 (412)
Q Consensus 332 ~~~~~~e~l~h 342 (412)
++.+++++
T Consensus 247 ---~~~~ll~~ 254 (256)
T cd05113 247 ---TFQQLLSS 254 (256)
T ss_pred ---CHHHHHHh
Confidence 68888753
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=330.80 Aligned_cols=264 Identities=19% Similarity=0.257 Sum_probs=212.3
Q ss_pred CCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCC---CCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCcc
Q 042539 10 QTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPT---ARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFL 85 (412)
Q Consensus 10 ~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnI 85 (412)
.+..++..++|.+.+.||+|+||.||+|++...+.. ....+|+|.++... .......+.+|+.+++.+ +|+||
T Consensus 10 ~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~~h~~i 86 (307)
T cd05098 10 DPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNI 86 (307)
T ss_pred CCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC---ChHHHHHHHHHHHHHHHhcCCCCE
Confidence 345677789999999999999999999987653321 23459999997542 122345677799999999 69999
Q ss_pred ceeeeeEEeCCeEEEEeeccCCCCchhHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeeC
Q 042539 86 PKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQND--------------RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDL 151 (412)
Q Consensus 86 v~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~--------------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDl 151 (412)
+++++++..++.+|+||||+.+|+|..++..... ..++..++..++.|++.||+|||++|++||||
T Consensus 87 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dl 166 (307)
T cd05098 87 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDL 166 (307)
T ss_pred eeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccc
Confidence 9999999999999999999999999988865421 24788999999999999999999999999999
Q ss_pred CCCceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCC
Q 042539 152 KPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSP 231 (412)
Q Consensus 152 Kp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (412)
||+|||++.++.+||+|||+++.......
T Consensus 167 kp~Nill~~~~~~kL~dfg~a~~~~~~~~--------------------------------------------------- 195 (307)
T cd05098 167 AARNVLVTEDNVMKIADFGLARDIHHIDY--------------------------------------------------- 195 (307)
T ss_pred cHHheEEcCCCcEEECCCcccccccccch---------------------------------------------------
Confidence 99999999999999999999875421100
Q ss_pred ccccccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCC-C-CC
Q 042539 232 VSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTP-E-FV 308 (412)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~-~-~~ 308 (412)
........++..|+|||++.+..++.++|+|||||++|+|++ |..||.+.+..+.+..+..... . ..
T Consensus 196 ----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 265 (307)
T cd05098 196 ----------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPS 265 (307)
T ss_pred ----------hhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCCCCCCCC
Confidence 000111234578999999998889999999999999999998 9999998887776666554332 2 23
Q ss_pred CCChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 309 GQRTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 309 ~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
..+.++.+||.+||..+|.+|| ++.++++
T Consensus 266 ~~~~~~~~li~~~l~~~p~~Rp----s~~evl~ 294 (307)
T cd05098 266 NCTNELYMMMRDCWHAVPSQRP----TFKQLVE 294 (307)
T ss_pred cCCHHHHHHHHHHcccChhhCc----CHHHHHH
Confidence 4578999999999999999999 5777765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=323.24 Aligned_cols=251 Identities=20% Similarity=0.270 Sum_probs=205.9
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
++..++|+++++||+|+||.||+|.+..+. .||+|.+++.... ...+.+|+++++.++|+||+++++.+.
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-----~valK~~~~~~~~-----~~~~~~E~~~l~~l~~~~i~~~~~~~~ 71 (262)
T cd05071 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTT-----RVAIKTLKPGTMS-----PEAFLQEAQVMKKLRHEKLVQLYAVVS 71 (262)
T ss_pred CCChHHeeEeeecCCCCCCcEEEEEecCCc-----eEEEEecccCccC-----HHHHHHHHHHHHhCCCCCcceEEEEEC
Confidence 456789999999999999999999876432 2999999764431 234677999999999999999999875
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
. ...|+||||+.+|+|..++.......+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++
T Consensus 72 ~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~ 150 (262)
T cd05071 72 E-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 150 (262)
T ss_pred C-CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCcee
Confidence 4 568999999999999988876544568899999999999999999999999999999999999999999999999986
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
.+.... ........++..
T Consensus 151 ~~~~~~--------------------------------------------------------------~~~~~~~~~~~~ 168 (262)
T cd05071 151 LIEDNE--------------------------------------------------------------YTARQGAKFPIK 168 (262)
T ss_pred eccccc--------------------------------------------------------------cccccCCcccce
Confidence 542110 000112346778
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCccC
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVKRL 330 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~R~ 330 (412)
|+|||++.+..++.++|+|||||++|+|++ |..||.+....+....+.... +.....+..+.++|.+||+.||++||
T Consensus 169 y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 248 (262)
T cd05071 169 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERP 248 (262)
T ss_pred ecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCC
Confidence 999999988889999999999999999999 999999887777776665432 22345678899999999999999999
Q ss_pred CCCCChhhhhc
Q 042539 331 GYLRGACEIKE 341 (412)
Q Consensus 331 ~~~~~~~e~l~ 341 (412)
++.++++
T Consensus 249 ----~~~~~~~ 255 (262)
T cd05071 249 ----TFEYLQA 255 (262)
T ss_pred ----CHHHHHH
Confidence 5676654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=329.37 Aligned_cols=259 Identities=24% Similarity=0.311 Sum_probs=210.6
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCC------------CCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCC
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPT------------ARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~------------~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~h 82 (412)
+..++|+++++||+|+||.||+|.+...+.. ....||+|++..... ......+.+|++++++++|
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~~e~~~l~~l~~ 78 (296)
T cd05051 2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS---DNAREDFLKEVKILSRLSD 78 (296)
T ss_pred CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC---HHHHHHHHHHHHHHHhcCC
Confidence 4678999999999999999999987654422 234589999876532 2345667789999999999
Q ss_pred CccceeeeeEEeCCeEEEEeeccCCCCchhHHHhhC---------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCC
Q 042539 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQN---------DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKP 153 (412)
Q Consensus 83 pnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~---------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp 153 (412)
+||+++++++..++.++++||++.+++|..++.... ...+++..+..++.|++.||.|||++||+||||||
T Consensus 79 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp 158 (296)
T cd05051 79 PNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLAT 158 (296)
T ss_pred CCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccch
Confidence 999999999999999999999999999988876543 12589999999999999999999999999999999
Q ss_pred CceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCcc
Q 042539 154 ENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVS 233 (412)
Q Consensus 154 ~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (412)
+||+++.++.++|+|||+++......
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~------------------------------------------------------ 184 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNLYSSD------------------------------------------------------ 184 (296)
T ss_pred hceeecCCCceEEccccceeecccCc------------------------------------------------------
Confidence 99999999999999999986542110
Q ss_pred ccccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh--CCCCCCCCCHHHHHHHHhcC--------
Q 042539 234 RRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY--GTTPFRGKNRKETFRNVLMK-------- 303 (412)
Q Consensus 234 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~--g~~Pf~~~~~~~~~~~i~~~-------- 303 (412)
.........++..|+|||++.+..++.++|||||||++|||++ |..||...+..+.+..+...
T Consensus 185 -------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 257 (296)
T cd05051 185 -------YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQI 257 (296)
T ss_pred -------ceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccc
Confidence 0011223456789999999988889999999999999999997 78999887777766655432
Q ss_pred -CCCCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 304 -TPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 304 -~~~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
.+.....+.++.++|.+||+.||.+|| ++.++++
T Consensus 258 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp----t~~el~~ 292 (296)
T cd05051 258 YLPRPPNCPKDIYELMLECWRRDEEDRP----TFREIHL 292 (296)
T ss_pred cCCCccCCCHHHHHHHHHHhccChhcCC----CHHHHHH
Confidence 111234568999999999999999999 6788764
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=333.03 Aligned_cols=259 Identities=26% Similarity=0.360 Sum_probs=200.1
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC--C
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD--E 96 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~ 96 (412)
+|.+++.||+|+||.||+|.+... ..+..||+|++.+.... .......+.+|+.+++.++||||+++++++.+. .
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~--~~~~~~alK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG--KDGKEYAIKKFKGDKEQ-YTGISQSACREIALLRELKHENVVSLVEVFLEHADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC--CCCCeEEEEEecccccc-ccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCc
Confidence 589999999999999999998762 13345999999764321 122234556799999999999999999999988 7
Q ss_pred eEEEEeeccCCCCchhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEcc----CCCEEEccc
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQ---NDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQ----SGHVTLTDF 169 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~---~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~----~g~vkL~DF 169 (412)
.+|+||||+.+ +|..++... ....+++..++.++.||+.||.|||++||+||||||+|||++. +|.+||+||
T Consensus 78 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 78 SVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred eEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 89999999976 454443322 1235899999999999999999999999999999999999999 899999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|+++.+..... ........+
T Consensus 157 g~~~~~~~~~~------------------------------------------------------------~~~~~~~~~ 176 (316)
T cd07842 157 GLARLFNAPLK------------------------------------------------------------PLADLDPVV 176 (316)
T ss_pred ccccccCCCcc------------------------------------------------------------cccccCCcc
Confidence 99875421100 001122456
Q ss_pred cCCCCccceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHH---------HHHHHhc-----------------
Q 042539 250 GTEEYVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKE---------TFRNVLM----------------- 302 (412)
Q Consensus 250 gt~~Y~APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---------~~~~i~~----------------- 302 (412)
+|+.|+|||++.+. .++.++|||||||++|+|++|++||.+..... .+..++.
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 256 (316)
T cd07842 177 VTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMP 256 (316)
T ss_pred ccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcc
Confidence 88999999988764 57899999999999999999999998654321 1111100
Q ss_pred ---------CCCCCC------------CCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCC
Q 042539 303 ---------KTPEFV------------GQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 303 ---------~~~~~~------------~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff 345 (412)
....+. ..+.++.++|.+||+.||++|| ++.++++||||
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp----s~~eil~~~~f 316 (316)
T cd07842 257 EYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRI----TAEEALEHPYF 316 (316)
T ss_pred cchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCc----CHHHHhcCCCC
Confidence 001111 3456799999999999999999 69999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=326.02 Aligned_cols=261 Identities=19% Similarity=0.304 Sum_probs=209.0
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCC-CCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAAD-PTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
++..++|++.+.||+|+||.||+|.+...+ ......||+|.+..... ......+.+|+.+++.++|+||+++++++
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 78 (277)
T cd05036 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS---EQDESDFLMEALIMSKFNHQNIVRLIGVS 78 (277)
T ss_pred CCCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 456789999999999999999999886521 11344599998854322 22345577799999999999999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCC---CE
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQND-----RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG---HV 164 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~-----~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g---~v 164 (412)
.+.+..++||||+.|++|..++..... ..+++..+..++.||+.||+|||++|++||||||+|||++.++ .+
T Consensus 79 ~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 79 FERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred ccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcce
Confidence 999999999999999999988765432 2488999999999999999999999999999999999998765 58
Q ss_pred EEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCC
Q 042539 165 TLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGER 244 (412)
Q Consensus 165 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (412)
||+|||+++.+...... ..
T Consensus 159 kl~dfg~~~~~~~~~~~-------------------------------------------------------------~~ 177 (277)
T cd05036 159 KIADFGMARDIYRASYY-------------------------------------------------------------RK 177 (277)
T ss_pred EeccCccccccCCccce-------------------------------------------------------------ec
Confidence 99999999764211000 00
Q ss_pred CcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC-C-CCCCCChHHHHHHHHh
Q 042539 245 SNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT-P-EFVGQRTALTDLIQRL 321 (412)
Q Consensus 245 ~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~-~-~~~~~~~~~~dli~~~ 321 (412)
.....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.... . .....+..+.++|.+|
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~c 257 (277)
T cd05036 178 GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDC 257 (277)
T ss_pred CCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHH
Confidence 112233567999999998889999999999999999996 999999888777665554332 1 2234678999999999
Q ss_pred hhhCCCccCCCCCChhhhhcC
Q 042539 322 LEKDPVKRLGYLRGACEIKEH 342 (412)
Q Consensus 322 L~~dP~~R~~~~~~~~e~l~h 342 (412)
|+.+|++|| ++.++++|
T Consensus 258 l~~~p~~Rp----s~~~vl~~ 274 (277)
T cd05036 258 WQHTPEDRP----NFATILER 274 (277)
T ss_pred cCCCcccCc----CHHHHHHH
Confidence 999999999 68888875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=320.96 Aligned_cols=256 Identities=30% Similarity=0.478 Sum_probs=209.8
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeE
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFL 98 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 98 (412)
+|++.+.||+|+||.||++.+...+. .||+|+++..... ......+..|+.+++.++|+||+++++.+.+.+.+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~----~~~ik~~~~~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 74 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGE----LMAVKEIRIQDND--PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKV 74 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCc----EEEEEEEECcccc--hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEE
Confidence 68999999999999999998876444 4999999766532 34567788899999999999999999999999999
Q ss_pred EEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhch
Q 042539 99 AWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~ 178 (412)
++|+||+.|++|.+++... ..+++..++.++.|++.||.|||++||+|+||+|+||+++.++.+||+|||++......
T Consensus 75 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 75 YIFMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred EEEEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 9999999999998887653 34889999999999999999999999999999999999999999999999998765321
Q ss_pred hhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccce
Q 042539 179 TAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPE 258 (412)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 258 (412)
.. ..........++..|+|||
T Consensus 153 ~~-----------------------------------------------------------~~~~~~~~~~~~~~~~~PE 173 (264)
T cd06626 153 TT-----------------------------------------------------------TMGEEVQSLAGTPAYMAPE 173 (264)
T ss_pred CC-----------------------------------------------------------cccccccCCcCCcCccChh
Confidence 10 0000012346888999999
Q ss_pred eecCCC---CCchhhHHHHHHHHHHHhhCCCCCCCCCH-HHHHHHHhcC-CCCC---CCCChHHHHHHHHhhhhCCCccC
Q 042539 259 VVRGDG---HEFAVDWWALGILTYEMLYGTTPFRGKNR-KETFRNVLMK-TPEF---VGQRTALTDLIQRLLEKDPVKRL 330 (412)
Q Consensus 259 ~l~~~~---~~~~~DiwSlGvil~ell~g~~Pf~~~~~-~~~~~~i~~~-~~~~---~~~~~~~~dli~~~L~~dP~~R~ 330 (412)
++.+.. ++.++|||||||++|+|++|+.||...+. ......+... .+.+ ...+..+.+||.+||+.+|.+||
T Consensus 174 ~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 253 (264)
T cd06626 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRP 253 (264)
T ss_pred hccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCC
Confidence 998766 78999999999999999999999977533 3333233322 2222 23478899999999999999999
Q ss_pred CCCCChhhhhcCCCC
Q 042539 331 GYLRGACEIKEHVFF 345 (412)
Q Consensus 331 ~~~~~~~e~l~h~ff 345 (412)
++.+++.|||+
T Consensus 254 ----~~~~i~~~~~~ 264 (264)
T cd06626 254 ----TASELLQHPFV 264 (264)
T ss_pred ----CHHHHhcCCCC
Confidence 69999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=322.88 Aligned_cols=253 Identities=29% Similarity=0.442 Sum_probs=205.7
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
+++|++.++||+|+||.||+|+++.++. .||||.+...... .......+.+|+.+++.++||||+++++++.+.+
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~----~~~iK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRK----PVALKKVQIFEMM-DAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN 75 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCC----EEEEEEeeccccC-CHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC
Confidence 4789999999999999999999877554 4999988654332 2344556778999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQ--NDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
..+++|||+.+|+|..++... ....+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..
T Consensus 76 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~ 155 (267)
T cd08228 76 ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF 155 (267)
T ss_pred eEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECcccccee
Confidence 999999999999998776532 234588999999999999999999999999999999999999999999999999875
Q ss_pred hhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCC
Q 042539 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254 (412)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 254 (412)
..... .......|++.|
T Consensus 156 ~~~~~---------------------------------------------------------------~~~~~~~~~~~~ 172 (267)
T cd08228 156 FSSKT---------------------------------------------------------------TAAHSLVGTPYY 172 (267)
T ss_pred ccchh---------------------------------------------------------------HHHhcCCCCccc
Confidence 42111 011234688899
Q ss_pred ccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCC--HHHHHHHHhcCC-CCC--CCCChHHHHHHHHhhhhCCCcc
Q 042539 255 VSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKN--RKETFRNVLMKT-PEF--VGQRTALTDLIQRLLEKDPVKR 329 (412)
Q Consensus 255 ~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~--~~~~~~~i~~~~-~~~--~~~~~~~~dli~~~L~~dP~~R 329 (412)
+|||.+.+..++.++|+|||||++|+|++|+.||.... .......+.... +.. ...+..+.++|.+||..+|++|
T Consensus 173 ~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 252 (267)
T cd08228 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQR 252 (267)
T ss_pred cChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccC
Confidence 99999998888999999999999999999999996543 233333333222 222 2356789999999999999999
Q ss_pred CCCCCChhhhhc
Q 042539 330 LGYLRGACEIKE 341 (412)
Q Consensus 330 ~~~~~~~~e~l~ 341 (412)
| ++.++++
T Consensus 253 p----~~~~vl~ 260 (267)
T cd08228 253 P----DIGYVHQ 260 (267)
T ss_pred c----CHHHHHH
Confidence 9 5788775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=337.71 Aligned_cols=261 Identities=23% Similarity=0.328 Sum_probs=203.8
Q ss_pred eeeeecc--CceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEE
Q 042539 23 LKILGKG--AMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAW 100 (412)
Q Consensus 23 ~~~LG~G--~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 100 (412)
...||+| +||+||+|++..++.. ||+|++...... ....+.+.+|+.+++.++||||++++++|..++.+|+
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~----vaiK~~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~ 76 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTL----VTVRITDLENCT--EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWV 76 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcE----EEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEE
Confidence 3466776 9999999998775544 999998765432 2334677889999999999999999999999999999
Q ss_pred EeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhh
Q 042539 101 AVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTA 180 (412)
Q Consensus 101 v~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~ 180 (412)
||||+.+++|..++.......+++..++.++.|++.||+|||++||+||||||+|||++.++.++++|||.+........
T Consensus 77 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~ 156 (328)
T cd08226 77 ISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ 156 (328)
T ss_pred EEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc
Confidence 99999999998887765445689999999999999999999999999999999999999999999999986643211000
Q ss_pred hhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceee
Q 042539 181 FEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVV 260 (412)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l 260 (412)
.. . ..........++..|+|||++
T Consensus 157 ~~----------------------------------------~----------------~~~~~~~~~~~~~~y~aPE~~ 180 (328)
T cd08226 157 KA----------------------------------------K----------------VVYDFPQFSTSVLPWLSPELL 180 (328)
T ss_pred cc----------------------------------------c----------------ccccccccccCccCccChhhh
Confidence 00 0 000001122356779999999
Q ss_pred cCC--CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC--------------------------------
Q 042539 261 RGD--GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE-------------------------------- 306 (412)
Q Consensus 261 ~~~--~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~-------------------------------- 306 (412)
.+. .++.++|||||||++|+|++|.+||.+..........+...+.
T Consensus 181 ~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (328)
T cd08226 181 RQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVA 260 (328)
T ss_pred cCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhc
Confidence 774 4688999999999999999999999887655554443322110
Q ss_pred ----------------CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCC
Q 042539 307 ----------------FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 307 ----------------~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~ 349 (412)
....++.+.+||.+||+.||++|| +++++++|+||+.+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp----ta~e~l~~~~~~~~~ 315 (328)
T cd08226 261 AGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRP----SASSLLSHAFFKQVK 315 (328)
T ss_pred cccccccccccccchhhhhhhHHHHHHHHHHccCCcccCC----CHHHHhhCHHHHHHH
Confidence 012346789999999999999999 799999999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=327.04 Aligned_cols=252 Identities=26% Similarity=0.398 Sum_probs=204.7
Q ss_pred ceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEE
Q 042539 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLA 99 (412)
Q Consensus 20 y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 99 (412)
|++++.||.|++|.||++.++.++. .||+|++...... ......+.+|+++++.++|+||+++++++.+++..|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~----~~~ik~~~~~~~~--~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~ 74 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGE----IVALKKIRLETED--EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLY 74 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCC----EEEEEEeeccccc--ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEE
Confidence 6889999999999999999877554 4999999765322 223345667999999999999999999999999999
Q ss_pred EEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchh
Q 042539 100 WAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKT 179 (412)
Q Consensus 100 lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~ 179 (412)
++|||+. ++|..++.......+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||+++.....
T Consensus 75 iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~- 152 (283)
T cd07835 75 LVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP- 152 (283)
T ss_pred EEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC-
Confidence 9999995 57877776554346899999999999999999999999999999999999999999999999998643210
Q ss_pred hhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcccee
Q 042539 180 AFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEV 259 (412)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 259 (412)
........++..|+|||+
T Consensus 153 --------------------------------------------------------------~~~~~~~~~~~~~~aPE~ 170 (283)
T cd07835 153 --------------------------------------------------------------VRTYTHEVVTLWYRAPEI 170 (283)
T ss_pred --------------------------------------------------------------ccccCccccccCCCCCce
Confidence 000112246889999999
Q ss_pred ecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC---------------------CC---------CCC
Q 042539 260 VRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK---------------------TP---------EFV 308 (412)
Q Consensus 260 l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~---------------------~~---------~~~ 308 (412)
+.+. .++.++|+|||||++|+|++|.+||.+.+....+.++... .+ ..+
T Consensus 171 ~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (283)
T cd07835 171 LLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVP 250 (283)
T ss_pred eecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcC
Confidence 8765 4688999999999999999999999887765544433221 00 013
Q ss_pred CCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCC
Q 042539 309 GQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 309 ~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff 345 (412)
..+..+.++|.+||+.||++|| ++++++.|+||
T Consensus 251 ~~~~~~~~li~~~l~~~P~~Rp----t~~~il~~~~~ 283 (283)
T cd07835 251 NLDEDGLDLLSKMLVYDPAKRI----SAKAALQHPYF 283 (283)
T ss_pred CCCHHHHHHHHHHhcCChhhCc----CHHHHhcCCCC
Confidence 4567899999999999999999 69999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=328.41 Aligned_cols=263 Identities=19% Similarity=0.273 Sum_probs=213.5
Q ss_pred CCCCCCccCceeeeeeeccCceEEEEEEEcCCC---CCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccc
Q 042539 11 TTPSLDLDNLKALKILGKGAMGTVFLVHDRAAD---PTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLP 86 (412)
Q Consensus 11 ~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~---~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv 86 (412)
+...+..++|.+.+.||+|+||.||+|++.... ......||+|++..... ......+.+|+.+++.+ +|+||+
T Consensus 8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~i~ 84 (304)
T cd05101 8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT---EKDLSDLVSEMEMMKMIGKHKNII 84 (304)
T ss_pred CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc---hHHHHHHHHHHHHHHhhccCCCch
Confidence 356788999999999999999999999864322 22334699999865421 23345677899999999 799999
Q ss_pred eeeeeEEeCCeEEEEeeccCCCCchhHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCC
Q 042539 87 KLLGSLETDEFLAWAVPYCPGGDLNVLRYKQND--------------RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLK 152 (412)
Q Consensus 87 ~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~--------------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlK 152 (412)
++++++.....+|++|||+.+|+|..++..... ..++..++..++.||+.||.|||++||+|||||
T Consensus 85 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlk 164 (304)
T cd05101 85 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLA 164 (304)
T ss_pred heeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccc
Confidence 999999999999999999999999988765421 247778899999999999999999999999999
Q ss_pred CCceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCc
Q 042539 153 PENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPV 232 (412)
Q Consensus 153 p~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (412)
|+|||++.++.+||+|||+++.......
T Consensus 165 p~Nili~~~~~~kl~D~g~~~~~~~~~~---------------------------------------------------- 192 (304)
T cd05101 165 ARNVLVTENNVMKIADFGLARDVNNIDY---------------------------------------------------- 192 (304)
T ss_pred cceEEEcCCCcEEECCCccceecccccc----------------------------------------------------
Confidence 9999999999999999999975521100
Q ss_pred cccccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCC--CCCC
Q 042539 233 SRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTP--EFVG 309 (412)
Q Consensus 233 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~--~~~~ 309 (412)
........+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+..... ....
T Consensus 193 ---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 263 (304)
T cd05101 193 ---------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPAN 263 (304)
T ss_pred ---------cccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCC
Confidence 001112346678999999998889999999999999999998 8999999888887776654332 2234
Q ss_pred CChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 310 QRTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 310 ~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
.+..+.+||.+||..+|.+|| ++.++++
T Consensus 264 ~~~~~~~li~~cl~~~p~~Rp----s~~e~l~ 291 (304)
T cd05101 264 CTNELYMMMRDCWHAIPSHRP----TFKQLVE 291 (304)
T ss_pred CCHHHHHHHHHHcccChhhCC----CHHHHHH
Confidence 678999999999999999999 5777775
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=330.76 Aligned_cols=255 Identities=29% Similarity=0.416 Sum_probs=211.2
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
.++|++++.||+|+||.||++.+..++. .||+|++..... .....+.+|+.+++.++||||+++++.+...+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~----~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~ 89 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQ----EVAIKQMNLQQQ----PKKELIINEILVMRENKHPNIVNYLDSYLVGD 89 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCC----EEEEEEeccccc----hHHHHHHHHHHHHhhcCCCCeeehhheeeeCC
Confidence 5899999999999999999998766544 399999864432 22355677999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
..|+|+||+.|++|..++... .+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~ 166 (293)
T cd06647 90 ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (293)
T ss_pred cEEEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccc
Confidence 999999999999998877542 48899999999999999999999999999999999999999999999999886442
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
.. ........|++.|+|
T Consensus 167 ~~---------------------------------------------------------------~~~~~~~~~~~~y~~ 183 (293)
T cd06647 167 PE---------------------------------------------------------------QSKRSTMVGTPYWMA 183 (293)
T ss_pred cc---------------------------------------------------------------ccccccccCChhhcC
Confidence 11 011123468899999
Q ss_pred ceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhc-CCCCC---CCCChHHHHHHHHhhhhCCCccCCC
Q 042539 257 PEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLM-KTPEF---VGQRTALTDLIQRLLEKDPVKRLGY 332 (412)
Q Consensus 257 PE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~-~~~~~---~~~~~~~~dli~~~L~~dP~~R~~~ 332 (412)
||.+.+..++.++|+|||||++|++++|+.||...+.......+.. ..+.+ ...+..++++|++||..+|.+||
T Consensus 184 PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-- 261 (293)
T cd06647 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRG-- 261 (293)
T ss_pred chhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCc--
Confidence 9999888889999999999999999999999988765544333322 22222 23457899999999999999999
Q ss_pred CCChhhhhcCCCCCCCC
Q 042539 333 LRGACEIKEHVFFKGVR 349 (412)
Q Consensus 333 ~~~~~e~l~h~ff~~~~ 349 (412)
++.+++.|+||+...
T Consensus 262 --~~~~il~h~~~~~~~ 276 (293)
T cd06647 262 --SAKELLQHPFLKIAK 276 (293)
T ss_pred --CHHHHhcCHHHhcCc
Confidence 699999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=327.34 Aligned_cols=252 Identities=21% Similarity=0.318 Sum_probs=204.4
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeeeeEEeC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLGSLETD 95 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 95 (412)
.++|++.+.||+|+||.||+|.++..+. ...+++|.++... .....+.+.+|+.++.++ +||||+++++++...
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~--~~~~~ik~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 75 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGL--KMNAAIKMLKEFA---SENDHRDFAGELEVLCKLGHHPNIINLLGACENR 75 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCC--cceeEEEEccccC---CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC
Confidence 4789999999999999999998876542 2237888875322 122345677899999999 699999999999999
Q ss_pred CeEEEEeeccCCCCchhHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccC
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQN--------------DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQS 161 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~--------------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~ 161 (412)
..+|+||||+.+++|..++.... ...+++..++.++.|++.||+|||++||+||||||+|||++.+
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~ 155 (297)
T cd05089 76 GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN 155 (297)
T ss_pred CcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC
Confidence 99999999999999988876432 1248899999999999999999999999999999999999999
Q ss_pred CCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCC
Q 042539 162 GHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDN 241 (412)
Q Consensus 162 g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (412)
+.+||+|||++......
T Consensus 156 ~~~kl~dfg~~~~~~~~--------------------------------------------------------------- 172 (297)
T cd05089 156 LASKIADFGLSRGEEVY--------------------------------------------------------------- 172 (297)
T ss_pred CeEEECCcCCCccccce---------------------------------------------------------------
Confidence 99999999988532100
Q ss_pred CCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHH
Q 042539 242 GERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLI 318 (412)
Q Consensus 242 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli 318 (412)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+.... ......+..+.+||
T Consensus 173 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 251 (297)
T cd05089 173 -VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKPRNCDDEVYELM 251 (297)
T ss_pred -eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 00011123457999999998889999999999999999997 999999988877777665432 12234678999999
Q ss_pred HHhhhhCCCccCCCCCChhhhhc
Q 042539 319 QRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 319 ~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
.+||..+|.+|| +++++++
T Consensus 252 ~~~l~~~p~~Rp----~~~~i~~ 270 (297)
T cd05089 252 RQCWRDRPYERP----PFAQISV 270 (297)
T ss_pred HHHcCCChhhCc----CHHHHHH
Confidence 999999999999 5777765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=323.93 Aligned_cols=258 Identities=21% Similarity=0.279 Sum_probs=208.0
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
-+..++|++++.||+|+||+||+|.+..++......||+|+++.... ......+.+|+.+++.++|+||+++++++.
T Consensus 3 ~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (279)
T cd05109 3 ILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS---PKANKEILDEAYVMAGVGSPYVCRLLGICL 79 (279)
T ss_pred ccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC---HHHHHHHHHHHHHHHhcCCCCCceEEEEEc
Confidence 35678999999999999999999998776655445689999865432 233456777999999999999999999987
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
. ...+++|+|+++|+|..++... .+.+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 80 ~-~~~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 80 T-STVQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred C-CCcEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCcee
Confidence 5 4578999999999998877643 3458999999999999999999999999999999999999999999999999997
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
....... ........+++.
T Consensus 158 ~~~~~~~-------------------------------------------------------------~~~~~~~~~~~~ 176 (279)
T cd05109 158 LLDIDET-------------------------------------------------------------EYHADGGKVPIK 176 (279)
T ss_pred ecccccc-------------------------------------------------------------eeecCCCccchh
Confidence 5521100 000111234678
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCccC
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVKRL 330 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~R~ 330 (412)
|+|||.+.+..++.++|||||||++|||++ |..||...........+.... +.....+.++.++|.+||..||++||
T Consensus 177 y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 256 (279)
T cd05109 177 WMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRP 256 (279)
T ss_pred hCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCc
Confidence 999999998889999999999999999998 999998877666554443322 23345678999999999999999999
Q ss_pred CCCCChhhhhc
Q 042539 331 GYLRGACEIKE 341 (412)
Q Consensus 331 ~~~~~~~e~l~ 341 (412)
++.+++.
T Consensus 257 ----~~~~l~~ 263 (279)
T cd05109 257 ----RFRELVD 263 (279)
T ss_pred ----CHHHHHH
Confidence 5788774
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=323.19 Aligned_cols=251 Identities=20% Similarity=0.277 Sum_probs=210.5
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET 94 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 94 (412)
....+|+++++||.|+||.||+|.++. +. .+|+|++.+... .....+.+|+++++.++|+||+++++++.+
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~----~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 73 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKN-RV----RVAIKILKSDDL----LKQQDFQKEVQALKRLRHKHLISLFAVCSV 73 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecC-CC----cEEEEeccccch----hhHHHHHHHHHHHhcCCCcchhheeeeEec
Confidence 345789999999999999999999876 33 399999976542 123456679999999999999999999999
Q ss_pred CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
.+..++||||+.+++|..++.......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~ 153 (261)
T cd05148 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARL 153 (261)
T ss_pred CCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhh
Confidence 99999999999999999888765556689999999999999999999999999999999999999999999999999865
Q ss_pred hhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCC
Q 042539 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254 (412)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 254 (412)
..... .......++..|
T Consensus 154 ~~~~~---------------------------------------------------------------~~~~~~~~~~~~ 170 (261)
T cd05148 154 IKEDV---------------------------------------------------------------YLSSDKKIPYKW 170 (261)
T ss_pred cCCcc---------------------------------------------------------------ccccCCCCceEe
Confidence 42110 001122356789
Q ss_pred ccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCccCC
Q 042539 255 VSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVKRLG 331 (412)
Q Consensus 255 ~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~R~~ 331 (412)
+|||.+.+..++.++|||||||++|+|++ |+.||.+.+..+.+..+.... +.....++.+.++|.+||+.||.+||
T Consensus 171 ~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp- 249 (261)
T cd05148 171 TAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRP- 249 (261)
T ss_pred cCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCc-
Confidence 99999988888999999999999999998 899999988887777776432 22345678999999999999999999
Q ss_pred CCCChhhhhc
Q 042539 332 YLRGACEIKE 341 (412)
Q Consensus 332 ~~~~~~e~l~ 341 (412)
++.++++
T Consensus 250 ---t~~~l~~ 256 (261)
T cd05148 250 ---SFKALRE 256 (261)
T ss_pred ---CHHHHHH
Confidence 5777664
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=324.79 Aligned_cols=258 Identities=19% Similarity=0.284 Sum_probs=209.7
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCC-CCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAA-DPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~-~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
+..++|.+.++||+|+||.||+|..... ....+..+|+|.+.... ......+.+|+++++.++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS----ESARQDFQREAELLTVLQHQHIVRFYGVCT 77 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC----HHHHHHHHHHHHHHhcCCCCCCceEEEEEe
Confidence 5678999999999999999999976432 22234458999886543 233456778999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCC-------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEcc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQND-------------RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQ 160 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~-------------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~ 160 (412)
++...+++|||+.+++|..++..... ..+++..+..++.|++.||+|||++||+||||||+|||++.
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~ 157 (280)
T cd05092 78 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQ 157 (280)
T ss_pred cCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcC
Confidence 99999999999999999888765432 34889999999999999999999999999999999999999
Q ss_pred CCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccC
Q 042539 161 SGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFD 240 (412)
Q Consensus 161 ~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (412)
++.+||+|||+++.......
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~------------------------------------------------------------ 177 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDY------------------------------------------------------------ 177 (280)
T ss_pred CCCEEECCCCceeEcCCCce------------------------------------------------------------
Confidence 99999999999865421100
Q ss_pred CCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCC--CCCCCChHHHHH
Q 042539 241 NGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTP--EFVGQRTALTDL 317 (412)
Q Consensus 241 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~dl 317 (412)
........+++.|+|||.+.+..++.++|||||||++|+|++ |.+||......+....+..... .....++.+.+|
T Consensus 178 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 256 (280)
T cd05092 178 -YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPRTCPPEVYAI 256 (280)
T ss_pred -eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCccCCCCCCCCHHHHHH
Confidence 000122345788999999999889999999999999999998 9999988777776666655432 223467899999
Q ss_pred HHHhhhhCCCccCCCCCChhhhhc
Q 042539 318 IQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 318 i~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
|.+||..||.+|| ++.++++
T Consensus 257 i~~cl~~~P~~Rp----~~~~l~~ 276 (280)
T cd05092 257 MQGCWQREPQQRM----VIKDIHS 276 (280)
T ss_pred HHHHccCChhhCC----CHHHHHH
Confidence 9999999999999 5777764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=325.05 Aligned_cols=253 Identities=27% Similarity=0.419 Sum_probs=211.3
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeE
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFL 98 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 98 (412)
-|++++.||+|+||.||++.+...+. .||+|++..... ......+.+|+.+++.++|+||+++++++..++.+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~----~~aiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 77 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQK----VVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 77 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCc----EEEEEEeccccc---hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeE
Confidence 47889999999999999998876443 499999865432 22345677899999999999999999999999999
Q ss_pred EEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhch
Q 042539 99 AWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~ 178 (412)
|+||||+.|++|..++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.+|.++|+|||++..+...
T Consensus 78 ~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 78 WIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154 (277)
T ss_pred EEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence 999999999999877643 34899999999999999999999999999999999999999999999999998654211
Q ss_pred hhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccce
Q 042539 179 TAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPE 258 (412)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 258 (412)
........|+..|+|||
T Consensus 155 ---------------------------------------------------------------~~~~~~~~~~~~y~~PE 171 (277)
T cd06641 155 ---------------------------------------------------------------QIKRNTFVGTPFWMAPE 171 (277)
T ss_pred ---------------------------------------------------------------hhhhccccCCccccChh
Confidence 01112346888999999
Q ss_pred eecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC-C-CCCChHHHHHHHHhhhhCCCccCCCCCCh
Q 042539 259 VVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE-F-VGQRTALTDLIQRLLEKDPVKRLGYLRGA 336 (412)
Q Consensus 259 ~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~-~-~~~~~~~~dli~~~L~~dP~~R~~~~~~~ 336 (412)
.+.+...+.++|+|||||++|+|++|..||...+.......+...... . ...+.++.++|.+||..+|.+|| ++
T Consensus 172 ~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp----~~ 247 (277)
T cd06641 172 VIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRP----TA 247 (277)
T ss_pred hhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccCChhhCc----CH
Confidence 998888889999999999999999999999887766655554433222 2 23568899999999999999999 69
Q ss_pred hhhhcCCCCCCC
Q 042539 337 CEIKEHVFFKGV 348 (412)
Q Consensus 337 ~e~l~h~ff~~~ 348 (412)
.++++|+||...
T Consensus 248 ~~~l~~~~~~~~ 259 (277)
T cd06641 248 KELLKHKFIVRF 259 (277)
T ss_pred HHHHhCHHHhhh
Confidence 999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=320.96 Aligned_cols=252 Identities=21% Similarity=0.294 Sum_probs=206.2
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
+++..++|++++.||+|+||.||+|.+... ..||+|.+...... ...+.+|+.++++++|+||+++++++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~-----~~~~~k~~~~~~~~-----~~~~~~E~~~l~~l~~~~i~~~~~~~ 70 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGN-----TKVAVKTLKPGTMS-----PESFLEEAQIMKKLRHDKLVQLYAVV 70 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCC-----ceeEEEEecCCCCC-----HHHHHHHHHHHHhcCCCceEEEEeEE
Confidence 356788999999999999999999977532 23899998764432 23467799999999999999999988
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
. ....|++|||+.|++|..++.......+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++
T Consensus 71 ~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~ 149 (260)
T cd05070 71 S-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLA 149 (260)
T ss_pred C-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceee
Confidence 5 456899999999999998887655556899999999999999999999999999999999999999999999999999
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
..+.... ........++.
T Consensus 150 ~~~~~~~--------------------------------------------------------------~~~~~~~~~~~ 167 (260)
T cd05070 150 RLIEDNE--------------------------------------------------------------YTARQGAKFPI 167 (260)
T ss_pred eeccCcc--------------------------------------------------------------cccccCCCCCc
Confidence 7542110 00011223566
Q ss_pred CCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCcc
Q 042539 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVKR 329 (412)
Q Consensus 253 ~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~R 329 (412)
.|+|||.+.+..++.++|+|||||++|+|++ |.+||.+.+..+....+.... +.....+..+.+||.+||.++|.+|
T Consensus 168 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 247 (260)
T cd05070 168 KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEER 247 (260)
T ss_pred cccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccC
Confidence 8999999988888999999999999999999 999999988777777665432 2233457889999999999999999
Q ss_pred CCCCCChhhhhc
Q 042539 330 LGYLRGACEIKE 341 (412)
Q Consensus 330 ~~~~~~~~e~l~ 341 (412)
| ++.++.+
T Consensus 248 p----t~~~l~~ 255 (260)
T cd05070 248 P----TFEYLQS 255 (260)
T ss_pred c----CHHHHHH
Confidence 9 5676653
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=321.88 Aligned_cols=254 Identities=21% Similarity=0.295 Sum_probs=203.8
Q ss_pred ceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe--
Q 042539 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF-- 97 (412)
Q Consensus 20 y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-- 97 (412)
|++.+.||+|+||.||+|....... +...||+|.++..... ......+.+|+.+++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 77 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDG-SQLKVAVKTMKLDIHT--YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ 77 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCC-CcceEEEEEeccCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence 6789999999999999998754332 3455999998754332 2234567789999999999999999998765443
Q ss_pred ----EEEEeeccCCCCchhHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccc
Q 042539 98 ----LAWAVPYCPGGDLNVLRYKQN----DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169 (412)
Q Consensus 98 ----~~lv~e~~~gg~L~~~~~~~~----~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DF 169 (412)
.+++|||+.+|+|..++.... ...+++..+..++.|++.||.|||+.||+||||||+||++++++.+||+||
T Consensus 78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCc
Confidence 899999999999987765432 235899999999999999999999999999999999999999999999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|+++.......+ .......
T Consensus 158 g~~~~~~~~~~~-------------------------------------------------------------~~~~~~~ 176 (273)
T cd05035 158 GLSKKIYSGDYY-------------------------------------------------------------RQGRIAK 176 (273)
T ss_pred cceeeccccccc-------------------------------------------------------------ccccccc
Confidence 998755211100 0011223
Q ss_pred cCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCC
Q 042539 250 GTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDP 326 (412)
Q Consensus 250 gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP 326 (412)
++..|+|||.+.+..++.++|||||||++|||++ |.+||.+.+..+.+..+.... ......+..+.++|.+||+.||
T Consensus 177 ~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 256 (273)
T cd05035 177 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADP 256 (273)
T ss_pred CCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCCh
Confidence 4678999999988889999999999999999998 999999988777776665432 1223467899999999999999
Q ss_pred CccCCCCCChhhhhc
Q 042539 327 VKRLGYLRGACEIKE 341 (412)
Q Consensus 327 ~~R~~~~~~~~e~l~ 341 (412)
.+|| ++.++++
T Consensus 257 ~~Rp----~~~e~~~ 267 (273)
T cd05035 257 KDRP----TFTKLRE 267 (273)
T ss_pred hhCc----CHHHHHH
Confidence 9999 5777775
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=324.18 Aligned_cols=255 Identities=27% Similarity=0.475 Sum_probs=206.9
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC--
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD-- 95 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-- 95 (412)
++|..++.||.|++|.||+|.+..++ +.||+|.+..... ......+.+|+++++.++|+||+++++++.+.
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~----~~~~~k~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 73 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTG----MIFALKTITTDPN---PDLQKQILRELEINKSCKSPYIVKYYGAFLDESS 73 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCC----eEEEEEEEecCCc---hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCC
Confidence 57999999999999999999987644 4499999875432 23456677899999999999999999988654
Q ss_pred CeEEEEeeccCCCCchhHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 96 EFLAWAVPYCPGGDLNVLRYK--QNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~--~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
..+|+||||+.|++|.+++.. .....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~ 153 (287)
T cd06621 74 SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG 153 (287)
T ss_pred CeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccc
Confidence 479999999999999876543 223458999999999999999999999999999999999999999999999999986
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
..... ......++..
T Consensus 154 ~~~~~-----------------------------------------------------------------~~~~~~~~~~ 168 (287)
T cd06621 154 ELVNS-----------------------------------------------------------------LAGTFTGTSF 168 (287)
T ss_pred ccccc-----------------------------------------------------------------ccccccCCcc
Confidence 43210 0113357888
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCC-----CHHHHHHHHhcCC-CCCC-------CCChHHHHHHHH
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGK-----NRKETFRNVLMKT-PEFV-------GQRTALTDLIQR 320 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~-----~~~~~~~~i~~~~-~~~~-------~~~~~~~dli~~ 320 (412)
|+|||.+.+..++.++|+|||||++|+|++|..||... ...+....+.... +... ..++.+.+||.+
T Consensus 169 y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 248 (287)
T cd06621 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQ 248 (287)
T ss_pred ccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHH
Confidence 99999999888999999999999999999999999875 2233333333311 1111 234689999999
Q ss_pred hhhhCCCccCCCCCChhhhhcCCCCCCC
Q 042539 321 LLEKDPVKRLGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 321 ~L~~dP~~R~~~~~~~~e~l~h~ff~~~ 348 (412)
||..||.+|| ++.|++.|+||+..
T Consensus 249 ~l~~~p~~Rp----t~~eil~~~~~~~~ 272 (287)
T cd06621 249 CLEKDPTRRP----TPWDMLEHPWIKAQ 272 (287)
T ss_pred HcCCCcccCC----CHHHHHhCcccccc
Confidence 9999999999 69999999999754
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=316.54 Aligned_cols=254 Identities=31% Similarity=0.514 Sum_probs=216.0
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeE
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFL 98 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 98 (412)
+|.+.+.||+|+||.||++.+..++ ..||+|++...... ......+.+|+++++.++|+|++++++.+..+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 74 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDG----KLYVLKEIDLSNMS--EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKL 74 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCC----cEEEEEEeecccCC--hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEE
Confidence 6899999999999999999987644 44999999765432 23455677899999999999999999999999999
Q ss_pred EEEeeccCCCCchhHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 99 AWAVPYCPGGDLNVLRYKQN--DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~~~~~~--~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
++|+|+++|++|..++.... ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 154 (258)
T cd08215 75 CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS 154 (258)
T ss_pred EEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecc
Confidence 99999999999988776543 3569999999999999999999999999999999999999999999999999886542
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
.. .......+|++.|+|
T Consensus 155 ~~---------------------------------------------------------------~~~~~~~~~~~~y~~ 171 (258)
T cd08215 155 ST---------------------------------------------------------------VDLAKTVVGTPYYLS 171 (258)
T ss_pred cC---------------------------------------------------------------cceecceeeeecccC
Confidence 11 012234578999999
Q ss_pred ceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-CCCC-CCChHHHHHHHHhhhhCCCccCCCCC
Q 042539 257 PEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT-PEFV-GQRTALTDLIQRLLEKDPVKRLGYLR 334 (412)
Q Consensus 257 PE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~~-~~~~~~~dli~~~L~~dP~~R~~~~~ 334 (412)
||.+.+..++.++|+||+|+++|+|++|..||...+..+......... ...+ ..+.++.++|.+||..+|++||
T Consensus 172 pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp---- 247 (258)
T cd08215 172 PELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERP---- 247 (258)
T ss_pred hhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCc----
Confidence 999988889999999999999999999999998887777666665433 2222 4678999999999999999999
Q ss_pred ChhhhhcCCCC
Q 042539 335 GACEIKEHVFF 345 (412)
Q Consensus 335 ~~~e~l~h~ff 345 (412)
++.++++||||
T Consensus 248 ~~~~ll~~~~~ 258 (258)
T cd08215 248 SIAQILQSPFI 258 (258)
T ss_pred CHHHHhcCCCC
Confidence 79999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=324.91 Aligned_cols=258 Identities=21% Similarity=0.295 Sum_probs=210.4
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCC-CCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAAD-PTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
+...+|.+.+.||+|+||.||+|++.... ......+++|.+..... ...+.+.+|+.+++.++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL----AARKDFQREAELLTNLQHEHIVKFYGVCG 77 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH----HHHHHHHHHHHHHhcCCCCCcceEEEEEc
Confidence 56788999999999999999999865432 22444589998865432 23355677999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQN--------------DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIR 159 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~--------------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~ 159 (412)
.++..++||||+.|++|.+++.... .+.+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~ 157 (291)
T cd05094 78 DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG 157 (291)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence 9999999999999999998876532 23488999999999999999999999999999999999999
Q ss_pred cCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCcccccccc
Q 042539 160 QSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSF 239 (412)
Q Consensus 160 ~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (412)
.++.++|+|||+++......
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~------------------------------------------------------------ 177 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTD------------------------------------------------------------ 177 (291)
T ss_pred cCCcEEECCCCcccccCCCc------------------------------------------------------------
Confidence 99999999999986542110
Q ss_pred CCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCCC--CCCCChHHHH
Q 042539 240 DNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTPE--FVGQRTALTD 316 (412)
Q Consensus 240 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~d 316 (412)
.........|+..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+...... ....+..+.+
T Consensus 178 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (291)
T cd05094 178 -YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYD 256 (291)
T ss_pred -eeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCCCCCCccCCHHHHH
Confidence 0011123457889999999999889999999999999999998 99999888877766665543322 2345788999
Q ss_pred HHHHhhhhCCCccCCCCCChhhhhc
Q 042539 317 LIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 317 li~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
+|.+||+.||.+|| ++.++++
T Consensus 257 li~~~l~~~P~~Rp----t~~~v~~ 277 (291)
T cd05094 257 IMLGCWQREPQQRL----NIKEIYK 277 (291)
T ss_pred HHHHHcccChhhCc----CHHHHHH
Confidence 99999999999999 5777764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=319.94 Aligned_cols=249 Identities=23% Similarity=0.298 Sum_probs=204.9
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
...+|++.+.||+|+||.||+++++. + ..+|+|++.+.... ...+.+|+.+++.++|+||+++++++...
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~~-~----~~~~iK~~~~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWRG-K----IDVAIKMIREGAMS-----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEecC-C----ccEEEEEeccCCCC-----HHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence 45789999999999999999998753 2 23899998654432 22455699999999999999999999999
Q ss_pred CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchh
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
+..|+||||+.|++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++..
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~ 150 (256)
T cd05059 72 RPIFIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYV 150 (256)
T ss_pred CceEEEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceec
Confidence 99999999999999988876543 35899999999999999999999999999999999999999999999999998754
Q ss_pred hchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCc
Q 042539 176 VKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYV 255 (412)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 255 (412)
.+... .......++..|+
T Consensus 151 ~~~~~--------------------------------------------------------------~~~~~~~~~~~y~ 168 (256)
T cd05059 151 LDDQY--------------------------------------------------------------TSSQGTKFPVKWA 168 (256)
T ss_pred ccccc--------------------------------------------------------------cccCCCCCCcccc
Confidence 21100 0000112345799
Q ss_pred cceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCccCCC
Q 042539 256 SPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVKRLGY 332 (412)
Q Consensus 256 APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~R~~~ 332 (412)
|||.+.+..++.++|+|||||++|+|++ |.+||.+.+..+....+.... ......+.++.+++.+||..+|++||
T Consensus 169 ~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-- 246 (256)
T cd05059 169 PPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRP-- 246 (256)
T ss_pred CHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCc--
Confidence 9999998889999999999999999998 899999887777766665432 22334678999999999999999999
Q ss_pred CCChhhhhc
Q 042539 333 LRGACEIKE 341 (412)
Q Consensus 333 ~~~~~e~l~ 341 (412)
++.++++
T Consensus 247 --t~~~~l~ 253 (256)
T cd05059 247 --AFKKLLS 253 (256)
T ss_pred --CHHHHHH
Confidence 6888875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=324.76 Aligned_cols=254 Identities=26% Similarity=0.468 Sum_probs=209.0
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC---CCccceeeeeEEeC
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS---HPFLPKLLGSLETD 95 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~ 95 (412)
.|++++.||+|+||.||+|.+..++. .||+|+++.... ......+.+|+.+++.+. |+||+++++++..+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~----~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~ 74 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGR----VVALKIINLDTP---DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG 74 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCc----EEEEEEecCCCC---chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC
Confidence 58899999999999999999876544 499999865432 223445667999999997 99999999999999
Q ss_pred CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchh
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
...|+||||+.|++|..++.. +.+++..+..++.|++.||.|||+.||+|+||+|+||+++.+|.++|+|||++...
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 75 PRLWIIMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALL 151 (277)
T ss_pred CEEEEEEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence 999999999999999877644 25899999999999999999999999999999999999999999999999998754
Q ss_pred hchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCc
Q 042539 176 VKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYV 255 (412)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 255 (412)
... ........|+..|+
T Consensus 152 ~~~---------------------------------------------------------------~~~~~~~~~~~~y~ 168 (277)
T cd06917 152 NQN---------------------------------------------------------------SSKRSTFVGTPYWM 168 (277)
T ss_pred CCC---------------------------------------------------------------ccccccccCCccee
Confidence 211 01122346889999
Q ss_pred cceeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-CCCC--CCChHHHHHHHHhhhhCCCccCC
Q 042539 256 SPEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT-PEFV--GQRTALTDLIQRLLEKDPVKRLG 331 (412)
Q Consensus 256 APE~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~~--~~~~~~~dli~~~L~~dP~~R~~ 331 (412)
|||.+.+ ..++.++|+|||||++|+|++|..||.+.+.......+.... +.+. ..+.++.++|.+||+.||.+||
T Consensus 169 aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~- 247 (277)
T cd06917 169 APEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERL- 247 (277)
T ss_pred CHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCc-
Confidence 9999875 456889999999999999999999998876655443332222 2222 2568899999999999999999
Q ss_pred CCCChhhhhcCCCCCCCC
Q 042539 332 YLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 332 ~~~~~~e~l~h~ff~~~~ 349 (412)
++.+++.|+||+...
T Consensus 248 ---~~~~il~~~~~~~~~ 262 (277)
T cd06917 248 ---SAEELLKSKWIKAHS 262 (277)
T ss_pred ---CHHHHhhChHhhccc
Confidence 699999999997644
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=328.50 Aligned_cols=263 Identities=19% Similarity=0.260 Sum_probs=212.1
Q ss_pred CCCCCCccCceeeeeeeccCceEEEEEEEcCCCC---CCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccc
Q 042539 11 TTPSLDLDNLKALKILGKGAMGTVFLVHDRAADP---TARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLP 86 (412)
Q Consensus 11 ~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv 86 (412)
....+..++|.+.+.||+|+||.||+|++..... .....||+|.++.... ......+.+|+.+++++ +||||+
T Consensus 5 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~iv 81 (314)
T cd05099 5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT---DKDLADLISEMELMKLIGKHKNII 81 (314)
T ss_pred ccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC---hHHHHHHHHHHHHHHhccCCCCee
Confidence 4557788999999999999999999998754322 2344599999865422 22345577799999999 599999
Q ss_pred eeeeeEEeCCeEEEEeeccCCCCchhHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCC
Q 042539 87 KLLGSLETDEFLAWAVPYCPGGDLNVLRYKQN--------------DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLK 152 (412)
Q Consensus 87 ~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~--------------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlK 152 (412)
++++++..+..+|++|||+.+|+|..++.... ...++..++..++.|++.||.|||++||+|||||
T Consensus 82 ~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlk 161 (314)
T cd05099 82 NLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLA 161 (314)
T ss_pred eEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccc
Confidence 99999999999999999999999998876532 1348889999999999999999999999999999
Q ss_pred CCceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCc
Q 042539 153 PENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPV 232 (412)
Q Consensus 153 p~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (412)
|+|||++.++.+||+|||+++.......
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~---------------------------------------------------- 189 (314)
T cd05099 162 ARNVLVTEDNVMKIADFGLARGVHDIDY---------------------------------------------------- 189 (314)
T ss_pred ceeEEEcCCCcEEEcccccccccccccc----------------------------------------------------
Confidence 9999999999999999999975421100
Q ss_pred cccccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCC-C-CCC
Q 042539 233 SRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTP-E-FVG 309 (412)
Q Consensus 233 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~-~-~~~ 309 (412)
........++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+.+..+..... . ...
T Consensus 190 ---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 260 (314)
T cd05099 190 ---------YKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKPSN 260 (314)
T ss_pred ---------ccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 000111234567999999998889999999999999999998 9999999888777776655432 1 234
Q ss_pred CChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 310 QRTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 310 ~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
.+.+++++|.+||..||++|| ++.++++
T Consensus 261 ~~~~l~~li~~cl~~~p~~Rp----s~~~ll~ 288 (314)
T cd05099 261 CTHELYMLMRECWHAVPTQRP----TFKQLVE 288 (314)
T ss_pred CCHHHHHHHHHHcCCCcccCc----CHHHHHH
Confidence 567899999999999999999 5777775
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=335.09 Aligned_cols=257 Identities=25% Similarity=0.361 Sum_probs=202.6
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC--
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD-- 95 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-- 95 (412)
.+|.+.+.||.|+||.||+|.++.++. .||+|.+..... ...+.+.+|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~----~v~iK~i~~~~~----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~ 76 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDK----RVAVKKIVLTDP----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGS 76 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCc----EEEEEEEecCCC----chHHHHHHHHHHHHhcCCCcchhhHhhhccccc
Confidence 689999999999999999999887554 499999866543 2345566799999999999999999876543
Q ss_pred ------------CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEcc-CC
Q 042539 96 ------------EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQ-SG 162 (412)
Q Consensus 96 ------------~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~-~g 162 (412)
...|+||||+. ++|..++.. +.+++..++.++.||+.||.|||++||+||||||+||+++. ++
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~ 152 (342)
T cd07854 77 DLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL 152 (342)
T ss_pred ccccccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCc
Confidence 36899999996 577665532 35899999999999999999999999999999999999985 45
Q ss_pred CEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCC
Q 042539 163 HVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNG 242 (412)
Q Consensus 163 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (412)
.+||+|||+++....... ..
T Consensus 153 ~~kl~dfg~~~~~~~~~~------------------------------------------------------------~~ 172 (342)
T cd07854 153 VLKIGDFGLARIVDPHYS------------------------------------------------------------HK 172 (342)
T ss_pred eEEECCcccceecCCccc------------------------------------------------------------cc
Confidence 789999999865421000 00
Q ss_pred CCCcccccCCCCccceeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC----------------
Q 042539 243 ERSNSFVGTEEYVSPEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP---------------- 305 (412)
Q Consensus 243 ~~~~~~~gt~~Y~APE~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~---------------- 305 (412)
.......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....+
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (342)
T cd07854 173 GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPS 252 (342)
T ss_pred cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhh
Confidence 01112357889999998755 4578899999999999999999999988766555444332110
Q ss_pred ---------------CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCc
Q 042539 306 ---------------EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRW 350 (412)
Q Consensus 306 ---------------~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~ 350 (412)
..+..+.++.+||.+||+.||.+|| ++.+++.|+||+...+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~----t~~ell~h~~~~~~~~ 308 (342)
T cd07854 253 FVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRL----TAEEALMHPYMSCYSC 308 (342)
T ss_pred hhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhcc----CHHHHhCCCccccccC
Confidence 0124567899999999999999999 6999999999986543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=334.04 Aligned_cols=252 Identities=24% Similarity=0.416 Sum_probs=203.7
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC-
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD- 95 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~- 95 (412)
.++|.+++.||+|+||.||++.+..++ ..||+|++++.... ......+.+|+.++++++|+||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~----~~vaiK~~~~~~~~--~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTG----LRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCC----eEEEEEEecCcchh--hHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 488999999999999999999887644 44999999764321 22345567799999999999999999988643
Q ss_pred -----CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccc
Q 042539 96 -----EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 96 -----~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
..+|++++++ |++|..++.. ..+++..++.++.|++.||+|||++||+||||||+||+++.+|.+||+|||
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg 165 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG 165 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccc
Confidence 3478888887 7888766543 248999999999999999999999999999999999999999999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+++.... ......|
T Consensus 166 ~~~~~~~------------------------------------------------------------------~~~~~~~ 179 (345)
T cd07877 166 LARHTDD------------------------------------------------------------------EMTGYVA 179 (345)
T ss_pred ccccccc------------------------------------------------------------------ccccccc
Confidence 8864310 1123467
Q ss_pred CCCCccceeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-----------------------CC
Q 042539 251 TEEYVSPEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT-----------------------PE 306 (412)
Q Consensus 251 t~~Y~APE~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-----------------------~~ 306 (412)
|..|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+.... +.
T Consensus 180 ~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (345)
T cd07877 180 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 259 (345)
T ss_pred CCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcc
Confidence 889999999876 467889999999999999999999998876655443332110 00
Q ss_pred ---------CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCC
Q 042539 307 ---------FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 307 ---------~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~ 348 (412)
....++++.+||.+||+.||.+|+ ++.+++.||||.+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~----t~~e~l~h~~f~~~ 306 (345)
T cd07877 260 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI----TAAQALAHAYFAQY 306 (345)
T ss_pred cCCcchhhhcCCCCHHHHHHHHHHcCCChhhcC----CHHHHhcChhhhhc
Confidence 113467899999999999999999 69999999999863
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=345.39 Aligned_cols=254 Identities=23% Similarity=0.327 Sum_probs=210.5
Q ss_pred CCCCCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccc
Q 042539 7 PQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLP 86 (412)
Q Consensus 7 ~~~~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv 86 (412)
.-....+++..+++++...||+|+||+||+++|.+. ||||+++...... +..+.++.|+.++++-+|.||+
T Consensus 381 s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd-------VAVK~Lnv~~pt~--~qlqaFKnEVa~lkkTRH~NIl 451 (678)
T KOG0193|consen 381 SDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD-------VAVKLLNVDDPTP--EQLQAFKNEVAVLKKTRHENIL 451 (678)
T ss_pred CccccccccCHHHhhccceeccccccceeecccccc-------eEEEEEecCCCCH--HHHHHHHHHHHHHhhcchhhhe
Confidence 334567899999999999999999999999999764 9999998776533 3678889999999999999999
Q ss_pred eeeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEE
Q 042539 87 KLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTL 166 (412)
Q Consensus 87 ~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL 166 (412)
-+.+++..... .||+-+|+|.+|+.+++... ..|+....+.|+.||+.|+.|||.++|||||||..||++.++++|||
T Consensus 452 LFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkI 529 (678)
T KOG0193|consen 452 LFMGACMNPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKI 529 (678)
T ss_pred eeehhhcCCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEE
Confidence 99999988777 99999999999998888655 46999999999999999999999999999999999999999999999
Q ss_pred ccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCc
Q 042539 167 TDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSN 246 (412)
Q Consensus 167 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (412)
+||||+..-. .| .......
T Consensus 530 gDFGLatvk~--------------------------------~w-----------------------------~g~~q~~ 548 (678)
T KOG0193|consen 530 GDFGLATVKT--------------------------------RW-----------------------------SGEQQLE 548 (678)
T ss_pred ecccceeeee--------------------------------ee-----------------------------ccccccC
Confidence 9999996421 11 0111122
Q ss_pred ccccCCCCccceeecC---CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--CC----CCCCChHHHHH
Q 042539 247 SFVGTEEYVSPEVVRG---DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT--PE----FVGQRTALTDL 317 (412)
Q Consensus 247 ~~~gt~~Y~APE~l~~---~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~~----~~~~~~~~~dl 317 (412)
.-.|...|||||++.. .+|++.+|||||||++|||++|..||...+...++-.+-.+. +. ..++++++++|
T Consensus 549 qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~L 628 (678)
T KOG0193|consen 549 QPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRL 628 (678)
T ss_pred CCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHHHHH
Confidence 3347788999999874 468999999999999999999999999766555443332221 11 23456799999
Q ss_pred HHHhhhhCCCccCCC
Q 042539 318 IQRLLEKDPVKRLGY 332 (412)
Q Consensus 318 i~~~L~~dP~~R~~~ 332 (412)
+..||.+++++||.+
T Consensus 629 l~~C~~~~~~eRP~F 643 (678)
T KOG0193|consen 629 LSDCWKFDREERPLF 643 (678)
T ss_pred HHHHHhcCcccCccH
Confidence 999999999999964
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=333.79 Aligned_cols=260 Identities=24% Similarity=0.358 Sum_probs=212.5
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC--
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE-- 96 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-- 96 (412)
+|++.+.||.|+||.||+|++..++. .||||++.+... .....+.+.+|+.+++.++|+||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~----~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGR----KVAIKKISNVFD--DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPE 74 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCc----EEEEEeeccccc--cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcc
Confidence 68999999999999999999876544 499999865431 2334566778999999999999999999998775
Q ss_pred ---eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 97 ---FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 97 ---~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
.+|++|||+. ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||++.
T Consensus 75 ~~~~~~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 75 DFNDVYIVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred cccceEEEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 7999999997 4776666543 369999999999999999999999999999999999999999999999999997
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
....... .........+|..
T Consensus 152 ~~~~~~~------------------------------------------------------------~~~~~~~~~~~~~ 171 (330)
T cd07834 152 GVDPDED------------------------------------------------------------EKGFLTEYVVTRW 171 (330)
T ss_pred eeccccc------------------------------------------------------------ccccccccccccC
Confidence 6421100 0011233468899
Q ss_pred CccceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC---------------------------
Q 042539 254 YVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP--------------------------- 305 (412)
Q Consensus 254 Y~APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~--------------------------- 305 (412)
|+|||++.+. .++.++|+|||||++|+|++|.+||.+.+..+.+..+.....
T Consensus 172 y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (330)
T cd07834 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPK 251 (330)
T ss_pred cCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCc
Confidence 9999999988 789999999999999999999999999887766655543110
Q ss_pred -----CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCch
Q 042539 306 -----EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 306 -----~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~ 351 (412)
..+..+..+.+||.+||+.+|.+|| ++++++.||||+++.-.
T Consensus 252 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp----t~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 252 KPLSKLFPGASPEAIDLLEKMLVFDPKKRI----TADEALAHPYLAQLHDP 298 (330)
T ss_pred chhHHhcccCCHHHHHHHHHHccCChhhCC----CHHHHHhCccHHhhccc
Confidence 0123567899999999999999999 69999999999976543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=318.50 Aligned_cols=246 Identities=23% Similarity=0.347 Sum_probs=204.1
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeE-
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSL- 92 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~- 92 (412)
.+.+++|++.+.||+|+||.||++...+ ..||+|.++... ..+.+.+|+.+++.++|+||+++++++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~------~~~~~k~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 69 (256)
T cd05082 2 ALNMKELKLLQTIGKGEFGDVMLGDYRG------NKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIV 69 (256)
T ss_pred CccHHhCeeeeeecccCCCeEEEEEEcC------CcEEEEEeCCCc------hHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 4678899999999999999999987642 238999985432 234567799999999999999999975
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
..++..|++|||+.+++|..++.......+++..+..++.|++.||+|||++|++||||||+||+++.+|.+||+|||++
T Consensus 70 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~ 149 (256)
T cd05082 70 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLT 149 (256)
T ss_pred cCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccc
Confidence 45568999999999999998877655556889999999999999999999999999999999999999999999999998
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+..... .....++.
T Consensus 150 ~~~~~~------------------------------------------------------------------~~~~~~~~ 163 (256)
T cd05082 150 KEASST------------------------------------------------------------------QDTGKLPV 163 (256)
T ss_pred eecccc------------------------------------------------------------------CCCCccce
Confidence 643110 01223456
Q ss_pred CCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCC--CCCCCChHHHHHHHHhhhhCCCcc
Q 042539 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTP--EFVGQRTALTDLIQRLLEKDPVKR 329 (412)
Q Consensus 253 ~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~dli~~~L~~dP~~R 329 (412)
.|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+..... .....++.+.++|.+||..+|++|
T Consensus 164 ~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 243 (256)
T cd05082 164 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATR 243 (256)
T ss_pred eecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhC
Confidence 7999999998889999999999999999997 9999998877776666654322 123467899999999999999999
Q ss_pred CCCCCChhhhhc
Q 042539 330 LGYLRGACEIKE 341 (412)
Q Consensus 330 ~~~~~~~~e~l~ 341 (412)
| ++.++++
T Consensus 244 p----t~~~l~~ 251 (256)
T cd05082 244 P----SFLQLRE 251 (256)
T ss_pred c----CHHHHHH
Confidence 9 5777764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=345.93 Aligned_cols=251 Identities=24% Similarity=0.386 Sum_probs=217.2
Q ss_pred eeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe--E
Q 042539 21 KALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF--L 98 (412)
Q Consensus 21 ~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~--~ 98 (412)
+.-.+||+|+|-+||+|.|..++.. ||.-.++...+.......+++..|+.+|+.|+|+|||++|++|.+..+ +
T Consensus 43 k~~evLGrGafKtVYka~De~~giE----VAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIE----VAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred ehhhhcccccceeeeeccccccchh----hHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence 4557899999999999998776555 888888777777777778999999999999999999999999987654 8
Q ss_pred EEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeeeCCCCceEEccC-CCEEEccccccchh
Q 042539 99 AWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMG--IAYRDLKPENILIRQS-GHVTLTDFDLSRNL 175 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~--iiHrDlKp~NiLl~~~-g~vkL~DFGla~~~ 175 (412)
.+|+|++.+|+|..|+..... .+...++.|++||+.||.|||++. |||||||.+||+|+.+ |.|||+|+|||...
T Consensus 119 n~iTEL~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred eeeeecccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 999999999999888776654 899999999999999999999997 9999999999999876 99999999999865
Q ss_pred hchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCc
Q 042539 176 VKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYV 255 (412)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 255 (412)
. .....+++|||.||
T Consensus 197 r-----------------------------------------------------------------~s~aksvIGTPEFM 211 (632)
T KOG0584|consen 197 R-----------------------------------------------------------------KSHAKSVIGTPEFM 211 (632)
T ss_pred h-----------------------------------------------------------------ccccceeccCcccc
Confidence 2 22334579999999
Q ss_pred cceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCCC--CCC-CChHHHHHHHHhhhhCCCccCC
Q 042539 256 SPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRG-KNRKETFRNVLMKTPE--FVG-QRTALTDLIQRLLEKDPVKRLG 331 (412)
Q Consensus 256 APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~--~~~-~~~~~~dli~~~L~~dP~~R~~ 331 (412)
|||... ..|+..+||||||+++.||+|+..||.. .+..++++++..+..+ +-. -.+++++||.+||.. .++|+
T Consensus 212 APEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~- 288 (632)
T KOG0584|consen 212 APEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERL- 288 (632)
T ss_pred ChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhcc-
Confidence 999998 7799999999999999999999999977 5666778887765532 112 258999999999999 89999
Q ss_pred CCCChhhhhcCCCCCCC
Q 042539 332 YLRGACEIKEHVFFKGV 348 (412)
Q Consensus 332 ~~~~~~e~l~h~ff~~~ 348 (412)
++.|+|+|+||..-
T Consensus 289 ---sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 289 ---SAKELLKDPFFDED 302 (632)
T ss_pred ---CHHHHhhChhhccc
Confidence 69999999999874
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=319.02 Aligned_cols=256 Identities=28% Similarity=0.435 Sum_probs=204.1
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
++..+++.....||+|+||.||++.+..++ ..||+|.+..... ...+.+.+|+.+++.++|+||+++++++.
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~----~~v~~k~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 75 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQ----VRIAIKEIPERDS----RYVQPLHEEIALHSYLKHRNIVQYLGSDS 75 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCC----cEEEEEEecCCCH----HHHHHHHHHHHHHHhcCCCCeeeeeeeec
Confidence 455566666789999999999999887644 4499999865432 23456778999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCC--CHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEcc-CCCEEEcccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVF--SPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQ-SGHVTLTDFD 170 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l--~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~-~g~vkL~DFG 170 (412)
.++..++|+||+.|++|..++.... ..+ ++..+..++.||+.||.|||++||+||||||+||+++. .+.++|+|||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg 154 (268)
T cd06624 76 ENGFFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFG 154 (268)
T ss_pred cCCEEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecch
Confidence 9999999999999999988876542 234 78899999999999999999999999999999999986 6799999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
++..+... ........|
T Consensus 155 ~~~~~~~~---------------------------------------------------------------~~~~~~~~~ 171 (268)
T cd06624 155 TSKRLAGI---------------------------------------------------------------NPCTETFTG 171 (268)
T ss_pred hheecccC---------------------------------------------------------------CCccccCCC
Confidence 88654210 001122357
Q ss_pred CCCCccceeecCCC--CCchhhHHHHHHHHHHHhhCCCCCCCCCHHH--HHHHH-hcCCCCCC-CCChHHHHHHHHhhhh
Q 042539 251 TEEYVSPEVVRGDG--HEFAVDWWALGILTYEMLYGTTPFRGKNRKE--TFRNV-LMKTPEFV-GQRTALTDLIQRLLEK 324 (412)
Q Consensus 251 t~~Y~APE~l~~~~--~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--~~~~i-~~~~~~~~-~~~~~~~dli~~~L~~ 324 (412)
++.|+|||.+.+.. ++.++|+|||||++|+|++|++||....... ..... ....+..+ ..++++.+||.+||..
T Consensus 172 ~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 251 (268)
T cd06624 172 TLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEP 251 (268)
T ss_pred CccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCC
Confidence 88999999987643 7889999999999999999999997643221 11111 12222222 4568899999999999
Q ss_pred CCCccCCCCCChhhhhcCCCC
Q 042539 325 DPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 325 dP~~R~~~~~~~~e~l~h~ff 345 (412)
+|.+|| ++.+++.||||
T Consensus 252 ~p~~Rp----t~~~ll~~~~~ 268 (268)
T cd06624 252 DPDKRA----SAHDLLQDPFL 268 (268)
T ss_pred CchhCC----CHHHHHhCCCC
Confidence 999999 69999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=321.32 Aligned_cols=252 Identities=29% Similarity=0.424 Sum_probs=204.9
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
+++|++.+.||+|+||.||++.++.++.. ||||.+.+..... ......+.+|+.+++.++|+||+++++++..++
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~----~~vK~~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 75 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVP----VALKKVQIFDLMD-AKARADCIKEIDLLKQLNHPNVIKYYASFIEDN 75 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCce----EEEEeeeehhhhh-HHHHHHHHHHHHHHHHccCCchhhhhheeEeCC
Confidence 46899999999999999999998765544 9999886644322 233456778999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQ--NDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
..+++|||+.|++|..++... ....+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..
T Consensus 76 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd08229 76 ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF 155 (267)
T ss_pred eEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhc
Confidence 999999999999998877532 234589999999999999999999999999999999999999999999999998865
Q ss_pred hhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCC
Q 042539 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254 (412)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 254 (412)
.... .......+|+..|
T Consensus 156 ~~~~---------------------------------------------------------------~~~~~~~~~~~~~ 172 (267)
T cd08229 156 FSSK---------------------------------------------------------------TTAAHSLVGTPYY 172 (267)
T ss_pred cccC---------------------------------------------------------------CcccccccCCcCc
Confidence 4211 0111234688999
Q ss_pred ccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCH--HHHHHHHhcCC-CC--CCCCChHHHHHHHHhhhhCCCcc
Q 042539 255 VSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNR--KETFRNVLMKT-PE--FVGQRTALTDLIQRLLEKDPVKR 329 (412)
Q Consensus 255 ~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--~~~~~~i~~~~-~~--~~~~~~~~~dli~~~L~~dP~~R 329 (412)
+|||++.+..++.++|+|||||++|+|++|..||.+... ......+.... +. ....+..+.++|.+||..||.+|
T Consensus 173 ~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 252 (267)
T cd08229 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKR 252 (267)
T ss_pred cCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccC
Confidence 999999988899999999999999999999999976543 23333333222 11 22356899999999999999999
Q ss_pred CCCCCChhhhh
Q 042539 330 LGYLRGACEIK 340 (412)
Q Consensus 330 ~~~~~~~~e~l 340 (412)
| ++.++.
T Consensus 253 p----t~~~i~ 259 (267)
T cd08229 253 P----DITYVY 259 (267)
T ss_pred C----CHHHHH
Confidence 9 567655
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=326.59 Aligned_cols=254 Identities=24% Similarity=0.348 Sum_probs=207.9
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
.+.|++++.||+|+||+||++.+...+. .||+|++....... .+..+.+.+|+.+++.++||||+++++++.+++
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~----~v~iK~~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~ 88 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNE----VVAIKKMSYSGKQS-NEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH 88 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCc----EEEEEEEeccccCc-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC
Confidence 3569999999999999999999876444 49999986543322 233456778999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
..|+||||+.| ++..++.... ..+++.++..++.|++.||.|||+.||+||||+|+||+++.+|.+||+|||++....
T Consensus 89 ~~~lv~e~~~g-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 89 TAWLVMEYCLG-SASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred eEEEEHHhhCC-CHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 99999999975 5545544322 358999999999999999999999999999999999999999999999999885431
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
......|++.|+|
T Consensus 167 -------------------------------------------------------------------~~~~~~~~~~y~a 179 (307)
T cd06607 167 -------------------------------------------------------------------PANSFVGTPYWMA 179 (307)
T ss_pred -------------------------------------------------------------------CCCCccCCccccC
Confidence 0123467889999
Q ss_pred ceeec---CCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-CCC--CCCChHHHHHHHHhhhhCCCccC
Q 042539 257 PEVVR---GDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT-PEF--VGQRTALTDLIQRLLEKDPVKRL 330 (412)
Q Consensus 257 PE~l~---~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~--~~~~~~~~dli~~~L~~dP~~R~ 330 (412)
||++. ...++.++|||||||++|+|++|.+||.+.+.......+.... +.. ...+..+.++|.+||..||.+||
T Consensus 180 PE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 259 (307)
T cd06607 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRP 259 (307)
T ss_pred ceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCc
Confidence 99985 3457889999999999999999999998877666555544332 222 23567899999999999999999
Q ss_pred CCCCChhhhhcCCCCCCC
Q 042539 331 GYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 331 ~~~~~~~e~l~h~ff~~~ 348 (412)
++.+++.|+||...
T Consensus 260 ----~~~~il~~~~~~~~ 273 (307)
T cd06607 260 ----SSEELLKHRFVLRE 273 (307)
T ss_pred ----CHHHHhcChhhccc
Confidence 69999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=318.27 Aligned_cols=253 Identities=21% Similarity=0.274 Sum_probs=210.8
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
+++..++|.+.++||+|+||.||+|.+... ..||||.+...... ...+.+|+.+++.++|+||+++++++
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~-----~~~~vK~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~ 70 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGT-----TKVAVKTLKPGTMS-----PEAFLQEAQIMKKLRHDKLVQLYAVC 70 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCC-----ceEEEEEecCCccC-----HHHHHHHHHHHhhCCCCCEeeeeeee
Confidence 357789999999999999999999987542 33899999764432 23466799999999999999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
..+..+++||||+.|++|..++.......++...+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++
T Consensus 71 ~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~ 150 (261)
T cd05034 71 SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLA 150 (261)
T ss_pred ecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccc
Confidence 99899999999999999998887655456899999999999999999999999999999999999999999999999998
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+.+..... .......++.
T Consensus 151 ~~~~~~~~--------------------------------------------------------------~~~~~~~~~~ 168 (261)
T cd05034 151 RLIEDDEY--------------------------------------------------------------TAREGAKFPI 168 (261)
T ss_pred eeccchhh--------------------------------------------------------------hhhhccCCCc
Confidence 75421100 0001112456
Q ss_pred CCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCcc
Q 042539 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVKR 329 (412)
Q Consensus 253 ~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~R 329 (412)
.|+|||.+.+..++.++|+|||||++|+|++ |+.||.+.+.......+.... +.....+.++.++|.+||..+|.+|
T Consensus 169 ~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 248 (261)
T cd05034 169 KWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEER 248 (261)
T ss_pred cccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccC
Confidence 8999999998889999999999999999998 999999988877777776532 2334557899999999999999999
Q ss_pred CCCCCChhhhhc
Q 042539 330 LGYLRGACEIKE 341 (412)
Q Consensus 330 ~~~~~~~~e~l~ 341 (412)
| +++++.+
T Consensus 249 p----~~~~l~~ 256 (261)
T cd05034 249 P----TFEYLQS 256 (261)
T ss_pred C----CHHHHHH
Confidence 9 5777663
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=317.71 Aligned_cols=257 Identities=27% Similarity=0.397 Sum_probs=209.4
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhh-hhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC-
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTL-HAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD- 95 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~- 95 (412)
.+|.+.+.||+|+||.||++.+..++ ..||+|.+..... .........+.+|+.+++.++|+||+++++++.+.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 77 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTG----RELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE 77 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCC----CEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC
Confidence 58999999999999999999987654 4499998854321 11233456778899999999999999999998764
Q ss_pred -CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 96 -EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 96 -~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
..++++|||+.|++|..++.... .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++.
T Consensus 78 ~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 78 EKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 46899999999999988776543 488999999999999999999999999999999999999999999999999875
Q ss_pred hhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCC
Q 042539 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254 (412)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 254 (412)
..... ..........|+..|
T Consensus 156 ~~~~~------------------------------------------------------------~~~~~~~~~~~~~~y 175 (264)
T cd06653 156 IQTIC------------------------------------------------------------MSGTGIKSVTGTPYW 175 (264)
T ss_pred ccccc------------------------------------------------------------ccCccccccCCcccc
Confidence 42100 001111245689999
Q ss_pred ccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--CCC-CCCChHHHHHHHHhhhhCCCccCC
Q 042539 255 VSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT--PEF-VGQRTALTDLIQRLLEKDPVKRLG 331 (412)
Q Consensus 255 ~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~-~~~~~~~~dli~~~L~~dP~~R~~ 331 (412)
+|||++.+...+.++|+|||||++|+|++|+.||......+...++.... +.+ ...++.+.++|.+||+ +|.+||
T Consensus 176 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~- 253 (264)
T cd06653 176 MSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRP- 253 (264)
T ss_pred cCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCc-
Confidence 99999998888999999999999999999999998877666655555332 222 3456889999999998 579999
Q ss_pred CCCChhhhhcCCCC
Q 042539 332 YLRGACEIKEHVFF 345 (412)
Q Consensus 332 ~~~~~~e~l~h~ff 345 (412)
++.+++.|||.
T Consensus 254 ---~~~~~~~~~~~ 264 (264)
T cd06653 254 ---TAEFLLRHPFV 264 (264)
T ss_pred ---cHHHHhcCCCC
Confidence 69999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=322.67 Aligned_cols=251 Identities=27% Similarity=0.384 Sum_probs=204.1
Q ss_pred ceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc---CCCccceeeeeEEeCC
Q 042539 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL---SHPFLPKLLGSLETDE 96 (412)
Q Consensus 20 y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~ 96 (412)
|++++.||+|+||.||+++++.++ ..||+|+++..... ......+.+|+.+++++ +|+||+++++++...+
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~----~~~aiK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 74 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTG----RFVALKKVRVPLSE--EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPR 74 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCC----CEEEEEEecccccc--chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence 789999999999999999987643 44999999754321 12233455677777666 5999999999998877
Q ss_pred e-----EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 97 F-----LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 97 ~-----~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
. ++++|||+.+ +|..++.......+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||+
T Consensus 75 ~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 75 TDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred CCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCc
Confidence 6 9999999975 777776654444689999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
+...... .......++
T Consensus 154 ~~~~~~~----------------------------------------------------------------~~~~~~~~~ 169 (287)
T cd07838 154 ARIYSFE----------------------------------------------------------------MALTSVVVT 169 (287)
T ss_pred ceeccCC----------------------------------------------------------------ccccccccc
Confidence 8654211 111233578
Q ss_pred CCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC----------------C---------
Q 042539 252 EEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP----------------E--------- 306 (412)
Q Consensus 252 ~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~----------------~--------- 306 (412)
..|+|||.+.+..++.++|+|||||++|+|++|.+||.+.+..+.+.++..... .
T Consensus 170 ~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (287)
T cd07838 170 LWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSF 249 (287)
T ss_pred ccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccch
Confidence 899999999998899999999999999999999999999887777666643110 0
Q ss_pred ---CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCC
Q 042539 307 ---FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 307 ---~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff 345 (412)
.+..+..+.++|.+||..||.+|| ++++++.|+||
T Consensus 250 ~~~~~~~~~~~~~li~~~l~~dp~~Rp----~~~~il~~~~~ 287 (287)
T cd07838 250 KSFVPEICEEGLDLLKKMLTFNPHKRI----SAFEALQHPYF 287 (287)
T ss_pred hhhhhhhhHHHHHHHHHHhccCCccCC----CHHHHhcCcCC
Confidence 012346788999999999999999 69999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=339.88 Aligned_cols=263 Identities=21% Similarity=0.307 Sum_probs=211.1
Q ss_pred CCCCCCccCceeeeeeeccCceEEEEEEEcCC-CCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCcccee
Q 042539 11 TTPSLDLDNLKALKILGKGAMGTVFLVHDRAA-DPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKL 88 (412)
Q Consensus 11 ~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~-~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l 88 (412)
..+++..++|.+.+.||+|+||.||+|+++.. +...+..||+|+++.... ....+.+.+|+.+|..+. |||||++
T Consensus 30 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~~E~~~l~~l~~H~niv~~ 106 (401)
T cd05107 30 SAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR---SSEKQALMSELKIMSHLGPHLNIVNL 106 (401)
T ss_pred CcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC---hhHHHHHHHHHHHHHhcCCCCCeEEE
Confidence 35788889999999999999999999997643 223455699999975432 223446778999999997 9999999
Q ss_pred eeeEEeCCeEEEEeeccCCCCchhHHHhhCC-------------------------------------------------
Q 042539 89 LGSLETDEFLAWAVPYCPGGDLNVLRYKQND------------------------------------------------- 119 (412)
Q Consensus 89 ~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~------------------------------------------------- 119 (412)
++++..++.+|+|||||.||+|.+++.....
T Consensus 107 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (401)
T cd05107 107 LGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDES 186 (401)
T ss_pred EEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccc
Confidence 9999999999999999999999888764321
Q ss_pred -----------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCC
Q 042539 120 -----------------------------------------------RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLK 152 (412)
Q Consensus 120 -----------------------------------------------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlK 152 (412)
..++...+..++.||+.||+|||+.||+|||||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlk 266 (401)
T cd05107 187 ADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLA 266 (401)
T ss_pred cCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCC
Confidence 135677788999999999999999999999999
Q ss_pred CCceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCc
Q 042539 153 PENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPV 232 (412)
Q Consensus 153 p~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (412)
|+|||++.++.+||+|||+++.......
T Consensus 267 p~NiLl~~~~~~kL~DfGla~~~~~~~~---------------------------------------------------- 294 (401)
T cd05107 267 ARNVLICEGKLVKICDFGLARDIMRDSN---------------------------------------------------- 294 (401)
T ss_pred cceEEEeCCCEEEEEecCcceecccccc----------------------------------------------------
Confidence 9999999999999999999975421100
Q ss_pred cccccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC---CCCC
Q 042539 233 SRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT---PEFV 308 (412)
Q Consensus 233 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~---~~~~ 308 (412)
.....+..++..|+|||++.+..++.++|||||||++|||++ |..||......+.....+... ....
T Consensus 295 ---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~ 365 (401)
T cd05107 295 ---------YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPA 365 (401)
T ss_pred ---------cccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCC
Confidence 001123357889999999998888999999999999999998 899998766555444443322 1223
Q ss_pred CCChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 309 GQRTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 309 ~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
..+.++.+||.+||..+|.+|| ++.+++.
T Consensus 366 ~~~~~l~~li~~cl~~~P~~RP----s~~ell~ 394 (401)
T cd05107 366 HASDEIYEIMQKCWEEKFEIRP----DFSQLVH 394 (401)
T ss_pred CCCHHHHHHHHHHcCCChhHCc----CHHHHHH
Confidence 4578999999999999999999 5777765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=318.95 Aligned_cols=251 Identities=20% Similarity=0.288 Sum_probs=206.2
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
++..++|+++++||+|+||.||+|..+. +..||+|.+...... ...+.+|+.+++.++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~-----~~~~a~K~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~ 71 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNG-----HTKVAIKSLKQGSMS-----PEAFLAEANLMKQLQHPRLVRLYAVVT 71 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCC-----CceEEEEEecCCCCc-----HHHHHHHHHHHHhcCCcCeeeEEEEEc
Confidence 5677899999999999999999998653 234999998755432 234667999999999999999999874
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
.+..|++|||+.+++|.+++.......+++.++..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.
T Consensus 72 -~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 150 (260)
T cd05067 72 -QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLAR 150 (260)
T ss_pred -cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCccee
Confidence 5678999999999999888776555678999999999999999999999999999999999999999999999999986
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
...... ........++..
T Consensus 151 ~~~~~~--------------------------------------------------------------~~~~~~~~~~~~ 168 (260)
T cd05067 151 LIEDNE--------------------------------------------------------------YTAREGAKFPIK 168 (260)
T ss_pred ecCCCC--------------------------------------------------------------cccccCCccccc
Confidence 542100 001112345678
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCccC
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVKRL 330 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~R~ 330 (412)
|+|||++.+..++.++|||||||++|+|++ |++||.+.+..+....+.... +.....+.++.++|.+||..+|++||
T Consensus 169 y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 248 (260)
T cd05067 169 WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERP 248 (260)
T ss_pred ccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCC
Confidence 999999998888999999999999999998 999999888777666554332 22334568999999999999999999
Q ss_pred CCCCChhhhhc
Q 042539 331 GYLRGACEIKE 341 (412)
Q Consensus 331 ~~~~~~~e~l~ 341 (412)
+++++++
T Consensus 249 ----~~~~l~~ 255 (260)
T cd05067 249 ----TFEYLRS 255 (260)
T ss_pred ----CHHHHHH
Confidence 5777664
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=335.35 Aligned_cols=253 Identities=26% Similarity=0.418 Sum_probs=208.0
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
..++|++++.||+|+||.||+|++..++. .||+|++..... .......+.+|+.++++++|+||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~----~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGR----KVAIKKLSRPFQ--SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPA 86 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCc----EEEEEecccccc--hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcc
Confidence 35789999999999999999999977544 499999865432 122345567799999999999999999988765
Q ss_pred Ce------EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccc
Q 042539 96 EF------LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169 (412)
Q Consensus 96 ~~------~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DF 169 (412)
+. +|+|+||+ |++|..++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.+|.+||+||
T Consensus 87 ~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 87 SSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred ccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccc
Confidence 54 99999999 6788777654 35999999999999999999999999999999999999999999999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|++..... ......
T Consensus 163 g~~~~~~~------------------------------------------------------------------~~~~~~ 176 (343)
T cd07851 163 GLARHTDD------------------------------------------------------------------EMTGYV 176 (343)
T ss_pred cccccccc------------------------------------------------------------------cccCCc
Confidence 99864311 012346
Q ss_pred cCCCCccceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-----------------------
Q 042539 250 GTEEYVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP----------------------- 305 (412)
Q Consensus 250 gt~~Y~APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~----------------------- 305 (412)
+|..|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (343)
T cd07851 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLP 256 (343)
T ss_pred ccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhcc
Confidence 78899999998653 578899999999999999999999988776665554432110
Q ss_pred ---------CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCC
Q 042539 306 ---------EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 306 ---------~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~ 348 (412)
.+...+.++.+||.+||..||.+|| ++.++++||||...
T Consensus 257 ~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rp----t~~ell~h~~~~~~ 304 (343)
T cd07851 257 QMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRI----TAAEALAHPYLAEY 304 (343)
T ss_pred ccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCC----CHHHHhcCCCcccc
Confidence 0123578899999999999999999 79999999999854
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=376.56 Aligned_cols=258 Identities=28% Similarity=0.452 Sum_probs=216.2
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeE
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFL 98 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 98 (412)
+++-...||.|.||.||-|.+..+|.. .|+|-|+-.... ......+.+|..+|..++|||+|++|++-.+.+.+
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGel----lAvKEI~iq~~~--~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGEL----LAVKEIKIQDSD--HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccch----hhhhhhhcCccc--cccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 566778899999999999888776554 899988655432 34455667799999999999999999999999999
Q ss_pred EEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhch
Q 042539 99 AWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~ 178 (412)
+|.||||.||+|.+++.... ..+|...+.|..|++.|+.|||++|||||||||+||+++.+|.+|++|||.|..+..+
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 99999999999998876543 4889999999999999999999999999999999999999999999999999887543
Q ss_pred hhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccce
Q 042539 179 TAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPE 258 (412)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 258 (412)
.+ +-.......+||+.|||||
T Consensus 1388 ~~-----------------------------------------------------------~~~~el~~~~GT~~YMAPE 1408 (1509)
T KOG4645|consen 1388 AQ-----------------------------------------------------------TMPGELQSMMGTPMYMAPE 1408 (1509)
T ss_pred hh-----------------------------------------------------------cCCHHHHhhcCCchhcCch
Confidence 21 1123344678999999999
Q ss_pred eecC---CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHH-HHHHHHhc-CCCCCC-CCChHHHHHHHHhhhhCCCccCCC
Q 042539 259 VVRG---DGHEFAVDWWALGILTYEMLYGTTPFRGKNRK-ETFRNVLM-KTPEFV-GQRTALTDLIQRLLEKDPVKRLGY 332 (412)
Q Consensus 259 ~l~~---~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~~i~~-~~~~~~-~~~~~~~dli~~~L~~dP~~R~~~ 332 (412)
++.+ .+...+.|||||||++.||+||+.||...+.. +++.++-. ..|..| ..+.+.+|||.+||+.||++|+
T Consensus 1409 vit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw-- 1486 (1509)
T KOG4645|consen 1409 VITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRW-- 1486 (1509)
T ss_pred hhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhh--
Confidence 9976 45678999999999999999999999875544 44444433 345544 4789999999999999999998
Q ss_pred CCChhhhhcCCCCCC
Q 042539 333 LRGACEIKEHVFFKG 347 (412)
Q Consensus 333 ~~~~~e~l~h~ff~~ 347 (412)
++.|+++|.|-+.
T Consensus 1487 --~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1487 --TASQLLEHAFGKS 1499 (1509)
T ss_pred --HHHHHHHhhcccc
Confidence 7899999998764
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=342.35 Aligned_cols=261 Identities=24% Similarity=0.355 Sum_probs=218.2
Q ss_pred CCCCCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccc
Q 042539 7 PQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLP 86 (412)
Q Consensus 7 ~~~~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv 86 (412)
|.+...+++..++..+.++||+|+||.||+++.+..+......||+|..+.+.. ...+....+++|+++|++++|||||
T Consensus 146 PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~-~~~~~~~e~m~EArvMr~l~H~NVV 224 (474)
T KOG0194|consen 146 PIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSE-LTKEQIKEFMKEARVMRQLNHPNVV 224 (474)
T ss_pred cccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeeccccc-ccHHHHHHHHHHHHHHHhCCCCCEE
Confidence 456678999999999999999999999999988776552233399999875332 2345677888999999999999999
Q ss_pred eeeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEE
Q 042539 87 KLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTL 166 (412)
Q Consensus 87 ~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL 166 (412)
++||+...+..+|+|||+|.||+|.+++..... .++..+...++.+.+.||+|||++++|||||-.+|+|++.++.+||
T Consensus 225 r~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKI 303 (474)
T KOG0194|consen 225 RFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKI 303 (474)
T ss_pred EEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEe
Confidence 999999999999999999999999999887653 5899999999999999999999999999999999999999999999
Q ss_pred ccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCc
Q 042539 167 TDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSN 246 (412)
Q Consensus 167 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (412)
+|||+++.-. .+. . ...
T Consensus 304 SDFGLs~~~~---~~~----------------------------------------~--------------------~~~ 320 (474)
T KOG0194|consen 304 SDFGLSRAGS---QYV----------------------------------------M--------------------KKF 320 (474)
T ss_pred CccccccCCc---cee----------------------------------------e--------------------ccc
Confidence 9999986431 000 0 000
Q ss_pred ccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC---CCCCCCChHHHHHHHHhh
Q 042539 247 SFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT---PEFVGQRTALTDLIQRLL 322 (412)
Q Consensus 247 ~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~dli~~~L 322 (412)
...-...|+|||.+...-|+.++|||||||++||+++ |..||.+....++...|.... +.....+.++..++.+|+
T Consensus 321 ~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~ 400 (474)
T KOG0194|consen 321 LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCW 400 (474)
T ss_pred cccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhc
Confidence 0012357999999999999999999999999999997 899999999999999985433 222345678889999999
Q ss_pred hhCCCccCCC
Q 042539 323 EKDPVKRLGY 332 (412)
Q Consensus 323 ~~dP~~R~~~ 332 (412)
..||++|+++
T Consensus 401 ~~~p~~R~tm 410 (474)
T KOG0194|consen 401 KKDPEDRPTM 410 (474)
T ss_pred cCChhhccCH
Confidence 9999999965
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=316.73 Aligned_cols=245 Identities=21% Similarity=0.310 Sum_probs=198.0
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEEEee
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVP 103 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~e 103 (412)
+.||+|+||.||+|.++..+. .||+|.+.... ..+....+.+|+++++.++|+||+++++++.....+|+|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~----~~a~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 73 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNT----PVAVKSCRETL---PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 73 (252)
T ss_pred CccCcccCccEEEEEEecCCc----eEEEEecCccC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEe
Confidence 479999999999999876544 49999886432 23445667789999999999999999999999999999999
Q ss_pred ccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhhh
Q 042539 104 YCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEK 183 (412)
Q Consensus 104 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~ 183 (412)
|+.|++|..++... ...+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 74 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--- 149 (252)
T cd05084 74 LVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY--- 149 (252)
T ss_pred eccCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccc---
Confidence 99999998887543 23589999999999999999999999999999999999999999999999999864321000
Q ss_pred hcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecCC
Q 042539 184 QSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGD 263 (412)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~ 263 (412)
........++..|+|||.+.+.
T Consensus 150 ----------------------------------------------------------~~~~~~~~~~~~y~aPE~~~~~ 171 (252)
T cd05084 150 ----------------------------------------------------------ASTGGMKQIPVKWTAPEALNYG 171 (252)
T ss_pred ----------------------------------------------------------cccCCCCCCceeecCchhhcCC
Confidence 0000011234579999999988
Q ss_pred CCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhh
Q 042539 264 GHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIK 340 (412)
Q Consensus 264 ~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l 340 (412)
.++.++|+|||||++|+|++ |.+||...+.......+.... +.....+..+.+||.+||+.+|++|| ++.+++
T Consensus 172 ~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----s~~~~~ 247 (252)
T cd05084 172 RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRP----SFSTVH 247 (252)
T ss_pred CCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCc----CHHHHH
Confidence 89999999999999999997 999998877666655554432 22234578999999999999999999 577776
Q ss_pred c
Q 042539 341 E 341 (412)
Q Consensus 341 ~ 341 (412)
+
T Consensus 248 ~ 248 (252)
T cd05084 248 Q 248 (252)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=333.57 Aligned_cols=254 Identities=28% Similarity=0.463 Sum_probs=205.1
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
.++|.+.+.||+|+||.||+|.+..++. .||+|++.+... .......+.+|+.+++.++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~----~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 87 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGE----KVAIKKLSRPFQ--SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAV 87 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCc----EEEEEEecCccc--cccchhHHHHHHHHHHhcCCCCccchhheecccc
Confidence 3689999999999999999999876544 499999976432 2223455678999999999999999999987543
Q ss_pred ------eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccc
Q 042539 97 ------FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 97 ------~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
.+|+||||+.+ +|..+. ...+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||
T Consensus 88 ~~~~~~~~~lv~e~~~~-~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg 162 (342)
T cd07879 88 SGDEFQDFYLVMPYMQT-DLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFG 162 (342)
T ss_pred cCCCCceEEEEeccccc-CHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCC
Confidence 56999999953 554432 2348999999999999999999999999999999999999999999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+++.... ......|
T Consensus 163 ~~~~~~~------------------------------------------------------------------~~~~~~~ 176 (342)
T cd07879 163 LARHADA------------------------------------------------------------------EMTGYVV 176 (342)
T ss_pred CCcCCCC------------------------------------------------------------------CCCCcee
Confidence 9864310 1113467
Q ss_pred CCCCccceeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-----------------------C-
Q 042539 251 TEEYVSPEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT-----------------------P- 305 (412)
Q Consensus 251 t~~Y~APE~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-----------------------~- 305 (412)
|+.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+....+..+.... +
T Consensus 177 ~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (342)
T cd07879 177 TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPK 256 (342)
T ss_pred eecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCC
Confidence 889999999876 457899999999999999999999999877655544433210 0
Q ss_pred --------CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCch
Q 042539 306 --------EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 306 --------~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~ 351 (412)
.++..++.+.+||.+||+.||.+|+ ++++++.||||.++.+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~----~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 257 YPRKDFSTLFPKASPQAVDLLEKMLELDVDKRL----TATEALEHPYFDSFRDA 306 (342)
T ss_pred cccchHHHHhcCCCHHHHHHHHHHcCCChhhCc----CHHHHhcCcchhhcccc
Confidence 0134567899999999999999999 69999999999988753
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=323.39 Aligned_cols=259 Identities=27% Similarity=0.394 Sum_probs=217.3
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
..+.|++.+.||+|+||.||++.+...+ ..||+|+++.... ....+.+|+++++.++|+||+++++.+..+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~----~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 87 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATG----KEVAIKKMRLRKQ-----NKELIINEILIMKDCKHPNIVDYYDSYLVG 87 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCC----cEEEEEEEecCch-----hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC
Confidence 4567999999999999999999987644 3499999965432 344566799999999999999999999999
Q ss_pred CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchh
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
...|+++||+.|++|.+++.... ..++...+..++.|++.||.|||+.||+|+||+|+||+++.+|.++|+|||++...
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 88 DELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166 (286)
T ss_pred CEEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence 99999999999999998887654 35999999999999999999999999999999999999999999999999988644
Q ss_pred hchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCc
Q 042539 176 VKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYV 255 (412)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 255 (412)
.... .......++..|+
T Consensus 167 ~~~~---------------------------------------------------------------~~~~~~~~~~~y~ 183 (286)
T cd06614 167 TKEK---------------------------------------------------------------SKRNSVVGTPYWM 183 (286)
T ss_pred ccch---------------------------------------------------------------hhhccccCCcccC
Confidence 2110 0112345788999
Q ss_pred cceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-C---CCCCChHHHHHHHHhhhhCCCccCC
Q 042539 256 SPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP-E---FVGQRTALTDLIQRLLEKDPVKRLG 331 (412)
Q Consensus 256 APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-~---~~~~~~~~~dli~~~L~~dP~~R~~ 331 (412)
|||.+.+..++.++|+|||||++|+|++|..||...+.......+..... . ....+..+.+||.+||+.+|.+||
T Consensus 184 ~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp- 262 (286)
T cd06614 184 APEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRP- 262 (286)
T ss_pred CHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCc-
Confidence 99999888889999999999999999999999998776665555543322 1 123578899999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCch
Q 042539 332 YLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 332 ~~~~~~e~l~h~ff~~~~~~ 351 (412)
++.++++|+||+...|.
T Consensus 263 ---t~~~il~~~~~~~~~~~ 279 (286)
T cd06614 263 ---SAEELLQHPFLKKACPK 279 (286)
T ss_pred ---CHHHHhhChHhhccCch
Confidence 69999999999986653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=319.46 Aligned_cols=258 Identities=22% Similarity=0.316 Sum_probs=208.7
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET 94 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 94 (412)
+..++|++.+.||+|+||.||+|.++.++. ....+|+|.++.... ......+.+|+.+++.++||||+++++++.+
T Consensus 1 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (267)
T cd05066 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGK-REIPVAIKTLKAGYT---EKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76 (267)
T ss_pred CCHHHeEeeeeecccCCCceEEEEEecCCC-CceEEEEEECCCCCC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 356799999999999999999998765432 233589999865432 2334567789999999999999999999999
Q ss_pred CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
++..|+||||+.|++|..++.... ..+++.++..++.|++.||.|||++|++||||||+|||++.++.++|+|||+++.
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 999999999999999998876543 4589999999999999999999999999999999999999999999999999975
Q ss_pred hhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCC
Q 042539 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254 (412)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 254 (412)
+...... ........++..|
T Consensus 156 ~~~~~~~------------------------------------------------------------~~~~~~~~~~~~y 175 (267)
T cd05066 156 LEDDPEA------------------------------------------------------------AYTTRGGKIPIRW 175 (267)
T ss_pred cccccce------------------------------------------------------------eeecCCCccceee
Confidence 5211000 0000112345689
Q ss_pred ccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCccCC
Q 042539 255 VSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVKRLG 331 (412)
Q Consensus 255 ~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~R~~ 331 (412)
+|||.+.+..++.++|+|||||++|++++ |..||.+.+..+....+.... +.....+..+.+++.+||+++|.+||
T Consensus 176 ~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp- 254 (267)
T cd05066 176 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERP- 254 (267)
T ss_pred cCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCC-
Confidence 99999998889999999999999999886 999998887776666665432 23335678999999999999999999
Q ss_pred CCCChhhhhc
Q 042539 332 YLRGACEIKE 341 (412)
Q Consensus 332 ~~~~~~e~l~ 341 (412)
++.++++
T Consensus 255 ---~~~~i~~ 261 (267)
T cd05066 255 ---KFEQIVS 261 (267)
T ss_pred ---CHHHHHH
Confidence 4666653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=329.04 Aligned_cols=254 Identities=22% Similarity=0.317 Sum_probs=197.7
Q ss_pred CceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEEEeeccCCCC
Q 042539 30 AMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGD 109 (412)
Q Consensus 30 ~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~ 109 (412)
++|.||+++++.+ +..||||++..... .......+.+|+.+++.++|+||++++++|.+++..|++|||+.+|+
T Consensus 12 ~~~~v~~~~~~~~----~~~~avK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 12 DLMIVHLAKHKPT----NTLVAVKKINLDSC--SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred CCceEEEEEecCC----CCEEEEEEEecccc--chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 4455666666553 34499999976532 22345678889999999999999999999999999999999999999
Q ss_pred chhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhhhhcccCC
Q 042539 110 LNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNN 189 (412)
Q Consensus 110 L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 189 (412)
|..++.......+++..++.++.|++.||+|||++||+||||||+||+++.+|.+||+|||.+..........
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~------- 158 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ------- 158 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccc-------
Confidence 9988876655569999999999999999999999999999999999999999999999999886543111000
Q ss_pred CCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecCC--CCCc
Q 042539 190 KFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGD--GHEF 267 (412)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~~~ 267 (412)
...........++..|+|||++.+. .++.
T Consensus 159 -------------------------------------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 189 (314)
T cd08216 159 -------------------------------------------------RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNE 189 (314)
T ss_pred -------------------------------------------------cccccccccccccccccCHHHhcCCCCCCCc
Confidence 0001112344678899999998763 5788
Q ss_pred hhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-CC----------------------------------CCCCCh
Q 042539 268 AVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT-PE----------------------------------FVGQRT 312 (412)
Q Consensus 268 ~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-~~----------------------------------~~~~~~ 312 (412)
++|+|||||++|+|++|..||..............+. +. ....+.
T Consensus 190 ~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (314)
T cd08216 190 KSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSE 269 (314)
T ss_pred chhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHH
Confidence 9999999999999999999998765444322211110 00 001135
Q ss_pred HHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCC
Q 042539 313 ALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 313 ~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~ 349 (412)
++.+||.+||+.||++|| +++++++||||+.+.
T Consensus 270 ~~~~li~~~l~~~P~~Rp----t~~~ll~~p~~~~~~ 302 (314)
T cd08216 270 HFHQFVELCLQRDPESRP----SASQLLNHSFFKQCK 302 (314)
T ss_pred HHHHHHHHHhhcCCCcCc----CHHHHhcCchHhhhc
Confidence 788999999999999999 699999999998764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=330.20 Aligned_cols=265 Identities=18% Similarity=0.265 Sum_probs=214.4
Q ss_pred CCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCC---CCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCcc
Q 042539 10 QTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPT---ARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFL 85 (412)
Q Consensus 10 ~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnI 85 (412)
.+.+++...+|++++.||+|+||.||+|++...+.. ....||+|+++... .......+.+|+++++++ +|+||
T Consensus 4 ~~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i 80 (334)
T cd05100 4 DPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA---TDKDLSDLVSEMEMMKMIGKHKNI 80 (334)
T ss_pred CcccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc---CHHHHHHHHHHHHHHHhhcCCCCe
Confidence 467788888999999999999999999987553321 22358999886432 223355677899999999 79999
Q ss_pred ceeeeeEEeCCeEEEEeeccCCCCchhHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeC
Q 042539 86 PKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQN--------------DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDL 151 (412)
Q Consensus 86 v~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~--------------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDl 151 (412)
+++++++..++.+|++|||+.+|+|..++.... ...++..++..++.|++.||.|||++||+||||
T Consensus 81 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dl 160 (334)
T cd05100 81 INLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDL 160 (334)
T ss_pred eeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccc
Confidence 999999999999999999999999988876532 124677888999999999999999999999999
Q ss_pred CCCceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCC
Q 042539 152 KPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSP 231 (412)
Q Consensus 152 Kp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (412)
||+|||++.++.+||+|||+++.......
T Consensus 161 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~--------------------------------------------------- 189 (334)
T cd05100 161 AARNVLVTEDNVMKIADFGLARDVHNIDY--------------------------------------------------- 189 (334)
T ss_pred ccceEEEcCCCcEEECCcccceecccccc---------------------------------------------------
Confidence 99999999999999999999875421100
Q ss_pred ccccccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCC--CCC
Q 042539 232 VSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTP--EFV 308 (412)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~--~~~ 308 (412)
........++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.+..+..... ...
T Consensus 190 ----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 259 (334)
T cd05100 190 ----------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPA 259 (334)
T ss_pred ----------cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 000112234567999999999889999999999999999998 9999999888887776655332 223
Q ss_pred CCChHHHHHHHHhhhhCCCccCCCCCChhhhhcC
Q 042539 309 GQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEH 342 (412)
Q Consensus 309 ~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h 342 (412)
..+.++.+||.+||+.+|.+|| ++.+++++
T Consensus 260 ~~~~~l~~li~~cl~~~p~~Rp----s~~ell~~ 289 (334)
T cd05100 260 NCTHELYMIMRECWHAVPSQRP----TFKQLVED 289 (334)
T ss_pred CCCHHHHHHHHHHcccChhhCc----CHHHHHHH
Confidence 4578899999999999999999 57888864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=333.93 Aligned_cols=263 Identities=24% Similarity=0.351 Sum_probs=206.0
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCC-CCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADP-TARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLL 89 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~ 89 (412)
++.+..++|++++.||+|+||+||+|.+...+. .+++.||||+++.... ......+.+|+.++..+ +|+||++++
T Consensus 1 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~niv~~~ 77 (343)
T cd05103 1 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT---HSEHRALMSELKILIHIGHHLNVVNLL 77 (343)
T ss_pred CcccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC---hHHHHHHHHHHHHHHhccCCccHhhhc
Confidence 467788999999999999999999998765432 3456799999965432 23345677899999999 589999999
Q ss_pred eeEEe-CCeEEEEeeccCCCCchhHHHhhC--------------------------------------------------
Q 042539 90 GSLET-DEFLAWAVPYCPGGDLNVLRYKQN-------------------------------------------------- 118 (412)
Q Consensus 90 ~~~~~-~~~~~lv~e~~~gg~L~~~~~~~~-------------------------------------------------- 118 (412)
+++.. +..+++|||||.||+|.+++....
T Consensus 78 ~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (343)
T cd05103 78 GACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKS 157 (343)
T ss_pred ceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCc
Confidence 98765 457899999999999988876432
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhhh
Q 042539 119 ---------------DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEK 183 (412)
Q Consensus 119 ---------------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~ 183 (412)
...++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-- 235 (343)
T cd05103 158 LSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-- 235 (343)
T ss_pred cccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch--
Confidence 123677888999999999999999999999999999999999999999999998754211000
Q ss_pred hcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecCC
Q 042539 184 QSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGD 263 (412)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~ 263 (412)
.......++..|+|||++.+.
T Consensus 236 -----------------------------------------------------------~~~~~~~~~~~y~aPE~~~~~ 256 (343)
T cd05103 236 -----------------------------------------------------------VRKGDARLPLKWMAPETIFDR 256 (343)
T ss_pred -----------------------------------------------------------hhcCCCCCCcceECcHHhcCC
Confidence 011122456789999999988
Q ss_pred CCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcC-C-CC-CCCCChHHHHHHHHhhhhCCCccCCCCCChhhh
Q 042539 264 GHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMK-T-PE-FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEI 339 (412)
Q Consensus 264 ~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~-~-~~-~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~ 339 (412)
.++.++|||||||++|+|++ |..||.+......+...+.. . .. ....++++.+++.+||..||.+|| ++.++
T Consensus 257 ~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rp----s~~ei 332 (343)
T cd05103 257 VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP----TFSEL 332 (343)
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhhCc----CHHHH
Confidence 89999999999999999996 99999876543333333222 1 11 123467899999999999999999 68888
Q ss_pred hcC
Q 042539 340 KEH 342 (412)
Q Consensus 340 l~h 342 (412)
++|
T Consensus 333 l~~ 335 (343)
T cd05103 333 VEH 335 (343)
T ss_pred HHH
Confidence 864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=321.22 Aligned_cols=257 Identities=18% Similarity=0.234 Sum_probs=204.2
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET 94 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 94 (412)
+..++|++++.||+|+||+||+|.+..++......|++|.+.... .......+..|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~- 79 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS---GRQTFQEITDHMLAMGSLDHAYIVRLLGICP- 79 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc---chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-
Confidence 567899999999999999999999877665444457888774321 1233455667888999999999999999875
Q ss_pred CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
+...++++||+.+|+|.+++.... +.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++.
T Consensus 80 ~~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 80 GASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred CCccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 456789999999999988876543 4589999999999999999999999999999999999999999999999999975
Q ss_pred hhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCC
Q 042539 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254 (412)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 254 (412)
..... .........|+..|
T Consensus 159 ~~~~~-------------------------------------------------------------~~~~~~~~~~~~~y 177 (279)
T cd05111 159 LYPDD-------------------------------------------------------------KKYFYSEHKTPIKW 177 (279)
T ss_pred ccCCC-------------------------------------------------------------cccccCCCCCcccc
Confidence 42110 00011234567789
Q ss_pred ccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCC-C-CCCCChHHHHHHHHhhhhCCCccCC
Q 042539 255 VSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTP-E-FVGQRTALTDLIQRLLEKDPVKRLG 331 (412)
Q Consensus 255 ~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~-~-~~~~~~~~~dli~~~L~~dP~~R~~ 331 (412)
+|||.+.+..++.++|||||||++|||++ |..||.+.........+..+.. . ....+.++.+++.+||..||.+||
T Consensus 178 ~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp- 256 (279)
T cd05111 178 MALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRP- 256 (279)
T ss_pred cCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCc-
Confidence 99999998889999999999999999998 9999998776655443333221 1 123457899999999999999999
Q ss_pred CCCChhhhhc
Q 042539 332 YLRGACEIKE 341 (412)
Q Consensus 332 ~~~~~~e~l~ 341 (412)
++.++++
T Consensus 257 ---s~~el~~ 263 (279)
T cd05111 257 ---TFKELAN 263 (279)
T ss_pred ---CHHHHHH
Confidence 5777764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=316.86 Aligned_cols=242 Identities=19% Similarity=0.283 Sum_probs=194.8
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEEEee
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVP 103 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~e 103 (412)
++||+|+||.||+|.++... ++..+|+|+++.... .......+.+|+.+++.++|+||+++++++. .+..++|||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~--~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e 75 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKK--SEKTVAVKILKNDNN--DPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVME 75 (257)
T ss_pred CcCCCcCCcceEEeEEecCC--CceEEEEEEccCCCC--cHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEe
Confidence 36899999999998764332 344599999865432 2334566778999999999999999999875 456799999
Q ss_pred ccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhhh
Q 042539 104 YCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEK 183 (412)
Q Consensus 104 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~ 183 (412)
|+.+|+|..++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 76 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~-- 151 (257)
T cd05116 76 LAELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY-- 151 (257)
T ss_pred cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCe--
Confidence 99999998887644 35899999999999999999999999999999999999999999999999998754211000
Q ss_pred hcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecCC
Q 042539 184 QSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGD 263 (412)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~ 263 (412)
........++..|+|||.+.+.
T Consensus 152 ----------------------------------------------------------~~~~~~~~~~~~y~aPE~~~~~ 173 (257)
T cd05116 152 ----------------------------------------------------------YKAKTHGKWPVKWYAPECMNYY 173 (257)
T ss_pred ----------------------------------------------------------eeecCCCCCCccccCHhHhccC
Confidence 0001122356789999999888
Q ss_pred CCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC-CC-CCCCChHHHHHHHHhhhhCCCccCCC
Q 042539 264 GHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT-PE-FVGQRTALTDLIQRLLEKDPVKRLGY 332 (412)
Q Consensus 264 ~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~-~~-~~~~~~~~~dli~~~L~~dP~~R~~~ 332 (412)
.++.++|+|||||++|||++ |..||.+.+..+....+.... +. ....+.++.++|.+||+.||.+||++
T Consensus 174 ~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~ 245 (257)
T cd05116 174 KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGF 245 (257)
T ss_pred CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCH
Confidence 88999999999999999997 999999887777766665432 22 23467899999999999999999953
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=332.41 Aligned_cols=263 Identities=28% Similarity=0.407 Sum_probs=207.3
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeeeeEE
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLGSLE 93 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 93 (412)
...++|++.+.||+|+||.||+|.+..++ ..||+|++.+.... ......+.+|+.+++++ +|+||+++++++.
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~----~~~~vK~~~~~~~~--~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~ 77 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTK----EVVALKKIFDAFRN--ATDAQRTFREIMFLQELGDHPNIVKLLNVIK 77 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCC----eEEEEEeeccccCc--chhhhhhhHHHHHHHHhcCCCCccceeeeec
Confidence 34679999999999999999999987644 44999988653221 12234566799999999 9999999999986
Q ss_pred eC--CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 94 TD--EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 94 ~~--~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
.. ..+|+||||+. ++|..++... .+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||+
T Consensus 78 ~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~ 153 (337)
T cd07852 78 AENDKDIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGL 153 (337)
T ss_pred cCCCceEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccc
Confidence 54 46899999997 4887665432 588999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
++........ ........+.||
T Consensus 154 ~~~~~~~~~~----------------------------------------------------------~~~~~~~~~~~~ 175 (337)
T cd07852 154 ARSLSELEEN----------------------------------------------------------PENPVLTDYVAT 175 (337)
T ss_pred hhcccccccc----------------------------------------------------------ccCcchhccccc
Confidence 9765321100 000122345789
Q ss_pred CCCccceeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--------------------------
Q 042539 252 EEYVSPEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT-------------------------- 304 (412)
Q Consensus 252 ~~Y~APE~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-------------------------- 304 (412)
..|+|||.+.+ ..++.++|+|||||++|+|++|++||.+....+....+....
T Consensus 176 ~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (337)
T cd07852 176 RWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSR 255 (337)
T ss_pred ccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccc
Confidence 99999998865 456889999999999999999999998866554433322110
Q ss_pred ------CCCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCC
Q 042539 305 ------PEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 305 ------~~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~ 349 (412)
...+..+.++.+||.+||+.||.+|| ++.++++|+||+.++
T Consensus 256 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp----s~~~il~~~~~~~~~ 302 (337)
T cd07852 256 PRKPLDELLPKASDDALDLLKKLLVFNPNKRL----TAEEALEHPYVAQFH 302 (337)
T ss_pred cccchhhhccCCCHHHHHHHHHhccCCccccc----CHHHHhhChhhhhhc
Confidence 01223578899999999999999999 699999999998764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=316.73 Aligned_cols=253 Identities=30% Similarity=0.445 Sum_probs=205.6
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
.++|++.+.||+|+||.||+|.+..++ +.||+|.++...... ......+.+|++++++++|+||+++++++..++
T Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~-~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~ 75 (267)
T cd08224 1 LGNFKIEKKIGKGQFSVVYKAICLLDG----RVVALKKVQIFEMMD-AKARQDCLKEIDLLKQLDHPNVIKYLASFIENN 75 (267)
T ss_pred CCceeeeeeeccCCceEEEEEEEcCCC----CEEEEEEeecccccc-hhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence 368999999999999999999987644 449999987544322 234566778999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQ--NDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
..++||||+.|++|..++... ....+++.++..++.|++.||.|||+.||+||||||+||+++.+|.++|+|||++..
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~ 155 (267)
T cd08224 76 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRF 155 (267)
T ss_pred eEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeee
Confidence 999999999999998877542 234589999999999999999999999999999999999999999999999999865
Q ss_pred hhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCC
Q 042539 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254 (412)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 254 (412)
+... ........|+..|
T Consensus 156 ~~~~---------------------------------------------------------------~~~~~~~~~~~~y 172 (267)
T cd08224 156 FSSK---------------------------------------------------------------TTAAHSLVGTPYY 172 (267)
T ss_pred ccCC---------------------------------------------------------------CcccceecCCccc
Confidence 4211 0111234688899
Q ss_pred ccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCC--HHHHHHHHhcCC-CCC--CCCChHHHHHHHHhhhhCCCcc
Q 042539 255 VSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKN--RKETFRNVLMKT-PEF--VGQRTALTDLIQRLLEKDPVKR 329 (412)
Q Consensus 255 ~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~--~~~~~~~i~~~~-~~~--~~~~~~~~dli~~~L~~dP~~R 329 (412)
+|||.+.+..++.++|+|||||++|+|++|..||.... ..+....+.... +.. ...+..+.++|.+||..+|.+|
T Consensus 173 ~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~R 252 (267)
T cd08224 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKR 252 (267)
T ss_pred cCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccC
Confidence 99999998889999999999999999999999996543 223333333221 111 2456789999999999999999
Q ss_pred CCCCCChhhhhc
Q 042539 330 LGYLRGACEIKE 341 (412)
Q Consensus 330 ~~~~~~~~e~l~ 341 (412)
| ++.++++
T Consensus 253 p----~~~~il~ 260 (267)
T cd08224 253 P----DISYVLQ 260 (267)
T ss_pred C----CHHHHHH
Confidence 9 5777664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=322.32 Aligned_cols=259 Identities=21% Similarity=0.270 Sum_probs=209.3
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCC-CCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAAD-PTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
+..++|++++.||+|+||.||+|++.... ..+...||+|++..... ......+.+|+.++++++||||+++++++.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~ 78 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS---ADMQADFQREAALMAEFDHPNIVKLLGVCA 78 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC---HHHHHHHHHHHHHHHhcCCCchheEEEEEc
Confidence 56789999999999999999999875421 12445699999865432 233456778999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCC
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQN--------------------DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKP 153 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~--------------------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp 153 (412)
++..+|++|||+.+|+|..++.... ...+++.++..++.|++.||+|||++|++||||||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p 158 (288)
T cd05050 79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLAT 158 (288)
T ss_pred CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccH
Confidence 9999999999999999988876432 12478888999999999999999999999999999
Q ss_pred CceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCcc
Q 042539 154 ENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVS 233 (412)
Q Consensus 154 ~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (412)
+||+++.++.+||+|||+++.......
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~----------------------------------------------------- 185 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADY----------------------------------------------------- 185 (288)
T ss_pred hheEecCCCceEECccccceecccCcc-----------------------------------------------------
Confidence 999999999999999999865421100
Q ss_pred ccccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCC--CCCCC
Q 042539 234 RRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTP--EFVGQ 310 (412)
Q Consensus 234 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~--~~~~~ 310 (412)
........++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+..... .....
T Consensus 186 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (288)
T cd05050 186 --------YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSCPDNC 257 (288)
T ss_pred --------ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Confidence 000111234567999999998889999999999999999997 8899998888877776654432 12345
Q ss_pred ChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 311 RTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 311 ~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
+.++.+||.+||+.||.+|| ++.|+++
T Consensus 258 ~~~l~~li~~~l~~~p~~Rp----t~~el~~ 284 (288)
T cd05050 258 PLELYNLMRLCWSKLPSDRP----SFASINR 284 (288)
T ss_pred CHHHHHHHHHHcccCcccCC----CHHHHHH
Confidence 78999999999999999999 5777653
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=318.95 Aligned_cols=253 Identities=18% Similarity=0.256 Sum_probs=201.2
Q ss_pred ceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC----
Q 042539 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD---- 95 (412)
Q Consensus 20 y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 95 (412)
|.+.+.||+|+||.||++.+...+. ...||+|.++.... .......+.+|+.+++.++|+||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~--~~~~a~k~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 76 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDS--ILKVAVKTMKIAIC--TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESE 76 (272)
T ss_pred CccccccCcccCceEEEeEEccCCC--eeeEEEEecccCcC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCccc
Confidence 3567899999999999998866542 12489999866432 223355677799999999999999999976421
Q ss_pred --CeEEEEeeccCCCCchhHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccc
Q 042539 96 --EFLAWAVPYCPGGDLNVLRYKQ----NDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169 (412)
Q Consensus 96 --~~~~lv~e~~~gg~L~~~~~~~----~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DF 169 (412)
...+++|||+.+|+|..++... ....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 77 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df 156 (272)
T cd05075 77 GYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADF 156 (272)
T ss_pred CCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCC
Confidence 2578999999999998776432 2234889999999999999999999999999999999999999999999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|+++.+..... ........
T Consensus 157 g~~~~~~~~~~-------------------------------------------------------------~~~~~~~~ 175 (272)
T cd05075 157 GLSKKIYNGDY-------------------------------------------------------------YRQGRIAK 175 (272)
T ss_pred CcccccCcccc-------------------------------------------------------------eecCCccc
Confidence 99875421100 00011234
Q ss_pred cCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCC
Q 042539 250 GTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDP 326 (412)
Q Consensus 250 gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP 326 (412)
+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+....+....+.... +.....+..+.++|.+||..||
T Consensus 176 ~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 255 (272)
T cd05075 176 MPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNP 255 (272)
T ss_pred CCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCc
Confidence 6778999999999889999999999999999998 899999888777766665543 2234567889999999999999
Q ss_pred CccCCCCCChhhhhc
Q 042539 327 VKRLGYLRGACEIKE 341 (412)
Q Consensus 327 ~~R~~~~~~~~e~l~ 341 (412)
++|| ++.++++
T Consensus 256 ~~Rp----s~~~l~~ 266 (272)
T cd05075 256 KDRP----SFETLRC 266 (272)
T ss_pred ccCc----CHHHHHH
Confidence 9999 5788775
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=344.20 Aligned_cols=244 Identities=31% Similarity=0.445 Sum_probs=204.9
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeeeeEEe
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLGSLET 94 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 94 (412)
..+.|.+...+|.|+|+.|-.+.+..++.. +++|++.+..... .+|+.++... +||||+++++.+.+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~----~~vkii~~~~~~~--------~~e~~~~~~~~~h~niv~~~~v~~~ 387 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQE----PAVKIISKRADDN--------QDEIPISLLVRDHPNIVKSHDVYED 387 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccc----hhheecccccccc--------ccccchhhhhcCCCcceeecceecC
Confidence 467899999999999999999999886665 9999997762211 1267666666 59999999999999
Q ss_pred CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEE-ccCCCEEEccccccc
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILI-RQSGHVTLTDFDLSR 173 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl-~~~g~vkL~DFGla~ 173 (412)
+.+.|+|||++.|+.+...+..... +. .++..|++||+.|+.|||++|+|||||||+|||+ +..|+++|+|||.++
T Consensus 388 ~~~~~~v~e~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 388 GKEIYLVMELLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWS 464 (612)
T ss_pred CceeeeeehhccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhh
Confidence 9999999999999988655554432 33 8888999999999999999999999999999999 688999999999997
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
..... ..+-|-|..
T Consensus 465 ~~~~~------------------------------------------------------------------~~tp~~t~~ 478 (612)
T KOG0603|consen 465 ELERS------------------------------------------------------------------CDTPALTLQ 478 (612)
T ss_pred hCchh------------------------------------------------------------------hcccchhhc
Confidence 65211 112356889
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHH-HHHHHHhcCCCCCCCCChHHHHHHHHhhhhCCCccCCC
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRK-ETFRNVLMKTPEFVGQRTALTDLIQRLLEKDPVKRLGY 332 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~dli~~~L~~dP~~R~~~ 332 (412)
|.|||++...+|+.+|||||||++||+||+|+.||...... ++..++..... -..+|+.++|||++||+.||.+|+
T Consensus 479 y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~-s~~vS~~AKdLl~~LL~~dP~~Rl-- 555 (612)
T KOG0603|consen 479 YVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKF-SECVSDEAKDLLQQLLQVDPALRL-- 555 (612)
T ss_pred ccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCcc-ccccCHHHHHHHHHhccCChhhCc--
Confidence 99999999999999999999999999999999999887666 44444433322 267899999999999999999999
Q ss_pred CCChhhhhcCCCC
Q 042539 333 LRGACEIKEHVFF 345 (412)
Q Consensus 333 ~~~~~e~l~h~ff 345 (412)
++.+++.|+||
T Consensus 556 --~~~~i~~h~w~ 566 (612)
T KOG0603|consen 556 --GADEIGAHPWF 566 (612)
T ss_pred --ChhhhccCcch
Confidence 69999999999
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=325.46 Aligned_cols=252 Identities=24% Similarity=0.396 Sum_probs=208.7
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeE
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFL 98 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 98 (412)
.|....+||+|+||.||++.++.++. .||||++.... ......+.+|+.+++.++|+||+++++.+..++..
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~----~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGK----LVAVKKMDLRK----QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDEL 92 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCe----EEEEEEecccc----hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEE
Confidence 34455789999999999998876544 49999885432 22345677899999999999999999999999999
Q ss_pred EEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhch
Q 042539 99 AWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~ 178 (412)
|+||||+.+++|..++.. +.+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus 93 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~ 169 (292)
T cd06657 93 WVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 169 (292)
T ss_pred EEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccc
Confidence 999999999999876543 34899999999999999999999999999999999999999999999999987643210
Q ss_pred hhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccce
Q 042539 179 TAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPE 258 (412)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 258 (412)
........||+.|+|||
T Consensus 170 ---------------------------------------------------------------~~~~~~~~~~~~y~~pE 186 (292)
T cd06657 170 ---------------------------------------------------------------VPRRKSLVGTPYWMAPE 186 (292)
T ss_pred ---------------------------------------------------------------cccccccccCccccCHH
Confidence 01112346889999999
Q ss_pred eecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC----CCCCCChHHHHHHHHhhhhCCCccCCCCC
Q 042539 259 VVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP----EFVGQRTALTDLIQRLLEKDPVKRLGYLR 334 (412)
Q Consensus 259 ~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~----~~~~~~~~~~dli~~~L~~dP~~R~~~~~ 334 (412)
.+.+..++.++|+|||||++|+|++|..||.+.+..+....+....+ .....+..+.++|.+||..||.+|+
T Consensus 187 ~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~---- 262 (292)
T cd06657 187 LISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRA---- 262 (292)
T ss_pred HhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCc----
Confidence 99888889999999999999999999999998776665554433222 2234678899999999999999999
Q ss_pred ChhhhhcCCCCCCC
Q 042539 335 GACEIKEHVFFKGV 348 (412)
Q Consensus 335 ~~~e~l~h~ff~~~ 348 (412)
++.+++.|+||...
T Consensus 263 ~~~~ll~~~~~~~~ 276 (292)
T cd06657 263 TAAELLKHPFLAKA 276 (292)
T ss_pred CHHHHhcChHHhcc
Confidence 69999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=316.53 Aligned_cols=251 Identities=20% Similarity=0.270 Sum_probs=205.0
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
++..++|++.+.||+|+||.||+|.+.... .+|+|.+..... ....+.+|+++++.++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~-----~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 71 (260)
T cd05069 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTT-----KVAIKTLKPGTM-----MPEAFLQEAQIMKKLRHDKLVPLYAVVS 71 (260)
T ss_pred cCChHHeeeeeeecCcCCCeEEEEEEcCCc-----eEEEEEcccCCc-----cHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 456788999999999999999999876532 389998865432 2345667999999999999999999875
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
.+..|++|||+.+++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+++
T Consensus 72 -~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~ 150 (260)
T cd05069 72 -EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLAR 150 (260)
T ss_pred -CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccce
Confidence 4568999999999999888876544458899999999999999999999999999999999999999999999999986
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
...... ........++..
T Consensus 151 ~~~~~~--------------------------------------------------------------~~~~~~~~~~~~ 168 (260)
T cd05069 151 LIEDNE--------------------------------------------------------------YTARQGAKFPIK 168 (260)
T ss_pred EccCCc--------------------------------------------------------------ccccCCCccchh
Confidence 542110 001112245678
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCC--CCCCCChHHHHHHHHhhhhCCCccC
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTP--EFVGQRTALTDLIQRLLEKDPVKRL 330 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~dli~~~L~~dP~~R~ 330 (412)
|+|||.+.+..++.++|+|||||++|+|++ |..||.+....+....+..... .....+..+.++|.+||.+||.+||
T Consensus 169 y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 248 (260)
T cd05069 169 WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERP 248 (260)
T ss_pred hCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHccCCcccCc
Confidence 999999988889999999999999999999 9999999887777766654421 2234678899999999999999999
Q ss_pred CCCCChhhhhc
Q 042539 331 GYLRGACEIKE 341 (412)
Q Consensus 331 ~~~~~~~e~l~ 341 (412)
+++++++
T Consensus 249 ----~~~~i~~ 255 (260)
T cd05069 249 ----TFEYIQS 255 (260)
T ss_pred ----CHHHHHH
Confidence 5677664
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=330.19 Aligned_cols=273 Identities=25% Similarity=0.356 Sum_probs=208.5
Q ss_pred ccCce-eeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhH----------HHHHHHHHHHHHHhhcCCCcc
Q 042539 17 LDNLK-ALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKH----------EAERRARWEIRVLSRLSHPFL 85 (412)
Q Consensus 17 ~~~y~-~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~----------~~~~~~~~Ei~il~~l~hpnI 85 (412)
.++|. +.+.||+|+||+||+|.++..+ +.||||+++........ .....+.+|+++++.++|+||
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 82 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTG----KIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENI 82 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCC----CeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcce
Confidence 35665 4577999999999999987644 44999998765432110 011246679999999999999
Q ss_pred ceeeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEE
Q 042539 86 PKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVT 165 (412)
Q Consensus 86 v~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vk 165 (412)
+++++++..++.+|+||||+. |+|..++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+|
T Consensus 83 v~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 83 MGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred eeeeEEEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEE
Confidence 999999999999999999996 5787766543 3489999999999999999999999999999999999999999999
Q ss_pred EccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCC
Q 042539 166 LTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERS 245 (412)
Q Consensus 166 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (412)
|+|||+++............ ... ........
T Consensus 160 l~dfg~~~~~~~~~~~~~~~-----------------------------------------~~~--------~~~~~~~~ 190 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLS-----------------------------------------KDE--------TMQRREEM 190 (335)
T ss_pred ECCccceeeccccccccccc-----------------------------------------ccc--------cccccccc
Confidence 99999997653211000000 000 00000111
Q ss_pred cccccCCCCccceeecCCC-CCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--C-----------------
Q 042539 246 NSFVGTEEYVSPEVVRGDG-HEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT--P----------------- 305 (412)
Q Consensus 246 ~~~~gt~~Y~APE~l~~~~-~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~----------------- 305 (412)
....+++.|+|||.+.+.. ++.++|+|||||++|+|++|.+||.+.+..+.+..+.... +
T Consensus 191 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 270 (335)
T PTZ00024 191 TSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEF 270 (335)
T ss_pred cccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhccccccc
Confidence 2345788999999997754 6899999999999999999999999988776655543210 0
Q ss_pred ----------CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCC
Q 042539 306 ----------EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 306 ----------~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~ 349 (412)
.....+..+.++|.+||..+|++|+ ++++++.|+||++..
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~----s~~~~l~~~~~~~~~ 320 (335)
T PTZ00024 271 TPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERI----SAKEALKHEYFKSDP 320 (335)
T ss_pred CcCCcccHHHhCcCCChHHHHHHHHHcCCCchhcc----CHHHHhcCcccCCCC
Confidence 0123467899999999999999999 699999999998643
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=323.53 Aligned_cols=259 Identities=23% Similarity=0.303 Sum_probs=203.7
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCC------------CCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCC
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAAD------------PTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~------------~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~h 82 (412)
+..++|++.+.||+|+||.||+|++.... ......||+|++.... .......+.+|+.+++.++|
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~~E~~~l~~l~~ 78 (296)
T cd05095 2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA---NKNARNDFLKEIKIMSRLKD 78 (296)
T ss_pred CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCC
Confidence 34578999999999999999998765422 1123458999986542 22345567789999999999
Q ss_pred CccceeeeeEEeCCeEEEEeeccCCCCchhHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCC
Q 042539 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQND---------RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKP 153 (412)
Q Consensus 83 pnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~---------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp 153 (412)
+||+++++++..++.+|+||||+.|++|..++..... ..+++.++..++.|++.||+|||++||+||||||
T Consensus 79 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp 158 (296)
T cd05095 79 PNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLAT 158 (296)
T ss_pred CCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCCh
Confidence 9999999999999999999999999999888765321 2367788999999999999999999999999999
Q ss_pred CceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCcc
Q 042539 154 ENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVS 233 (412)
Q Consensus 154 ~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (412)
+|||++.++.++|+|||+++.+.....
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~----------------------------------------------------- 185 (296)
T cd05095 159 RNCLVGKNYTIKIADFGMSRNLYSGDY----------------------------------------------------- 185 (296)
T ss_pred heEEEcCCCCEEeccCcccccccCCcc-----------------------------------------------------
Confidence 999999999999999999875421100
Q ss_pred ccccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh--CCCCCCCCCHHHHHHHHhc---------
Q 042539 234 RRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY--GTTPFRGKNRKETFRNVLM--------- 302 (412)
Q Consensus 234 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~--g~~Pf~~~~~~~~~~~i~~--------- 302 (412)
........++..|+|||+..+..++.++|+|||||++|||++ |..||...+..+.......
T Consensus 186 --------~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 257 (296)
T cd05095 186 --------YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQV 257 (296)
T ss_pred --------eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccc
Confidence 001112345678999999888889999999999999999998 7899987766554433211
Q ss_pred CCCCCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 303 KTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 303 ~~~~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
..+....+++.+.+||.+||+.||.+|| ++.++.+
T Consensus 258 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp----~~~~i~~ 292 (296)
T cd05095 258 YLPKPALCPDSLYKLMLSCWRRNAKERP----SFQEIHA 292 (296)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCcccCC----CHHHHHH
Confidence 0122334668999999999999999999 4666653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=327.60 Aligned_cols=266 Identities=27% Similarity=0.379 Sum_probs=204.4
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
.+++|.+++.||+|+||.||+|.++.++. .||+|++....... .....+.+|+++++.++|+||+++++++...
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGR----VVALKKILMHNEKD--GFPITALREIKILKKLKHPNVVPLIDMAVER 79 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCc----EEEEEEEEeccCCC--CcchhHHHHHHHHHhcCCCCccchhhheecc
Confidence 37999999999999999999999877554 49999986543221 1223455799999999999999999987543
Q ss_pred --------CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEc
Q 042539 96 --------EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLT 167 (412)
Q Consensus 96 --------~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~ 167 (412)
..+|+||||+.+ +|...+.. ....+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+
T Consensus 80 ~~~~~~~~~~~~lv~~~~~~-~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~ 157 (311)
T cd07866 80 PDKSKRKRGSVYMVTPYMDH-DLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIA 157 (311)
T ss_pred cccccccCceEEEEEecCCc-CHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEC
Confidence 357999999965 55444433 23459999999999999999999999999999999999999999999999
Q ss_pred cccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcc
Q 042539 168 DFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNS 247 (412)
Q Consensus 168 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (412)
|||+++.......... . ...........
T Consensus 158 dfg~~~~~~~~~~~~~-------------------------------------~---------------~~~~~~~~~~~ 185 (311)
T cd07866 158 DFGLARPYDGPPPNPK-------------------------------------G---------------GGGGGTRKYTN 185 (311)
T ss_pred cCccchhccCCCcccc-------------------------------------c---------------CCccccccccc
Confidence 9999975432110000 0 00001112235
Q ss_pred cccCCCCccceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--------------C-------
Q 042539 248 FVGTEEYVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT--------------P------- 305 (412)
Q Consensus 248 ~~gt~~Y~APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--------------~------- 305 (412)
..|++.|+|||++.+. .++.++|||||||++|+|++|++||.+.+.......+.... +
T Consensus 186 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (311)
T cd07866 186 LVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHS 265 (311)
T ss_pred ceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhccccccccc
Confidence 5789999999988764 47889999999999999999999999887766555443210 0
Q ss_pred ----------CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCC
Q 042539 306 ----------EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 306 ----------~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff 345 (412)
.+......+.+||.+||+.||++|| ++.+++.||||
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~----t~~ell~~~~f 311 (311)
T cd07866 266 FTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRL----TASDALEHPYF 311 (311)
T ss_pred CCCCCccHHHHcccCChhHHHHHHHHcccCcccCc----CHHHHhcCCCC
Confidence 0112346788999999999999999 69999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=313.91 Aligned_cols=247 Identities=23% Similarity=0.314 Sum_probs=207.8
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
.+..++|++.+.||.|+||.||+|... ++.||+|.++.... ..+++.+|+.+++.++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~~ig~g~~g~v~~~~~~------~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 70 (256)
T cd05039 2 AINSKELKLGATIGKGEFGDVMLGDYR------GQKVAVKCLKDDST-----AAQAFLAEASVMTTLRHPNLVQLLGVVL 70 (256)
T ss_pred ccChhhccceeeeecCCCceEEEEEec------CcEEEEEEeccchh-----HHHHHHHHHHHHHhcCCcceeeeEEEEc
Confidence 456789999999999999999999764 23499999965432 3556778999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
+.+..|+||||+.+++|..++.......+++..+..++.|++.||.|||++|++||||||+||+++.+|.+||+|||+++
T Consensus 71 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~ 150 (256)
T cd05039 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK 150 (256)
T ss_pred CCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccc
Confidence 99999999999999999988876654468999999999999999999999999999999999999999999999999987
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
..... .....++..
T Consensus 151 ~~~~~------------------------------------------------------------------~~~~~~~~~ 164 (256)
T cd05039 151 EASQG------------------------------------------------------------------QDSGKLPVK 164 (256)
T ss_pred ccccc------------------------------------------------------------------cccCCCccc
Confidence 54210 001234567
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCC--CCCCCChHHHHHHHHhhhhCCCccC
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTP--EFVGQRTALTDLIQRLLEKDPVKRL 330 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~dli~~~L~~dP~~R~ 330 (412)
|+|||.+.+..++.++|+|||||++|+|++ |..||...+..+....+..... .....++.+.++|.+||..+|++||
T Consensus 165 ~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 244 (256)
T cd05039 165 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRP 244 (256)
T ss_pred ccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCc
Confidence 999999988888899999999999999997 9999998887776665554321 1234578999999999999999999
Q ss_pred CCCCChhhhhc
Q 042539 331 GYLRGACEIKE 341 (412)
Q Consensus 331 ~~~~~~~e~l~ 341 (412)
+++++++
T Consensus 245 ----~~~~l~~ 251 (256)
T cd05039 245 ----TFKQLRE 251 (256)
T ss_pred ----CHHHHHH
Confidence 5788775
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=318.25 Aligned_cols=255 Identities=28% Similarity=0.470 Sum_probs=207.7
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhh-hhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLH-AKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
+|.+.+.||+|+||+||++++...+.. +++|+++..... ........+.+|+.+++.++||||+++++++.+.+.
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAE----ERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDA 76 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCc----ceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCc
Confidence 589999999999999999998765433 667766543221 111223456669999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchh
Q 042539 98 LAWAVPYCPGGDLNVLRYK--QNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~--~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
.++||||+.+++|..++.. .....+++.+++.++.|++.||.|||++|++|+||||+||+++. +.+||+|||+++..
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 77 FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred eEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeec
Confidence 9999999999999877653 23346899999999999999999999999999999999999975 67999999998654
Q ss_pred hchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCc
Q 042539 176 VKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYV 255 (412)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 255 (412)
... ........|++.|+
T Consensus 156 ~~~---------------------------------------------------------------~~~~~~~~~~~~~~ 172 (260)
T cd08222 156 MGS---------------------------------------------------------------CDLATTFTGTPYYM 172 (260)
T ss_pred CCC---------------------------------------------------------------cccccCCCCCcCcc
Confidence 211 01122345788999
Q ss_pred cceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-CCC-CCCChHHHHHHHHhhhhCCCccCCCC
Q 042539 256 SPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT-PEF-VGQRTALTDLIQRLLEKDPVKRLGYL 333 (412)
Q Consensus 256 APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~-~~~~~~~~dli~~~L~~dP~~R~~~~ 333 (412)
|||.+.+..++.++|+||||+++|+|++|..||.+.+.......+.... +.. ...+.++.++|.+||..||++||
T Consensus 173 ~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp--- 249 (260)
T cd08222 173 SPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRP--- 249 (260)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHHHHhcCChhhCc---
Confidence 9999988888899999999999999999999998877766666665433 222 24568999999999999999999
Q ss_pred CChhhhhcCCCC
Q 042539 334 RGACEIKEHVFF 345 (412)
Q Consensus 334 ~~~~e~l~h~ff 345 (412)
++.++++||||
T Consensus 250 -~~~~il~~~~~ 260 (260)
T cd08222 250 -SAAEILRNPFI 260 (260)
T ss_pred -CHHHHhhCCCC
Confidence 69999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=341.09 Aligned_cols=247 Identities=27% Similarity=0.419 Sum_probs=209.2
Q ss_pred CCCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCcccee
Q 042539 9 PQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKL 88 (412)
Q Consensus 9 ~~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l 88 (412)
....+++-++...-++=||.|+.|.||+++.+.. .||||.++. + -..+|+-|++|+|+||+.+
T Consensus 115 q~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~ne------tVAVKKV~e--l---------kETdIKHLRkLkH~NII~F 177 (904)
T KOG4721|consen 115 QEELWEIPFEEISELEWLGSGAQGAVFLGRLHNE------TVAVKKVRE--L---------KETDIKHLRKLKHPNIITF 177 (904)
T ss_pred hhhhccCCHHHhhhhhhhccCcccceeeeeccCc------eehhHHHhh--h---------hhhhHHHHHhccCcceeeE
Confidence 3456788888888899999999999999887542 399998732 1 1138899999999999999
Q ss_pred eeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcc
Q 042539 89 LGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTD 168 (412)
Q Consensus 89 ~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~D 168 (412)
.+++...-.+|||||||..|.|...+... +.++......|..+|+.|+.|||.+.|||||||.-||||+.+..|||+|
T Consensus 178 kGVCtqsPcyCIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsD 255 (904)
T KOG4721|consen 178 KGVCTQSPCYCIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISD 255 (904)
T ss_pred eeeecCCceeEEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEecc
Confidence 99999999999999999999998887654 4589999999999999999999999999999999999999999999999
Q ss_pred ccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccc
Q 042539 169 FDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248 (412)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (412)
||-++...+. ...-+|
T Consensus 256 FGTS~e~~~~----------------------------------------------------------------STkMSF 271 (904)
T KOG4721|consen 256 FGTSKELSDK----------------------------------------------------------------STKMSF 271 (904)
T ss_pred ccchHhhhhh----------------------------------------------------------------hhhhhh
Confidence 9999876321 223478
Q ss_pred ccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC---CCCCCCCChHHHHHHHHhhhhC
Q 042539 249 VGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK---TPEFVGQRTALTDLIQRLLEKD 325 (412)
Q Consensus 249 ~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~dli~~~L~~d 325 (412)
+||..|||||++...+++.++|||||||+|||||||..||...+...++--+-.+ .+-...+++.++=||..||+-.
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sK 351 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSK 351 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcC
Confidence 9999999999999999999999999999999999999999887766544322221 2233356788999999999999
Q ss_pred CCccCCCCCChhhhhcC
Q 042539 326 PVKRLGYLRGACEIKEH 342 (412)
Q Consensus 326 P~~R~~~~~~~~e~l~h 342 (412)
|..||+ ..+++.|
T Consensus 352 pRNRPS----Frqil~H 364 (904)
T KOG4721|consen 352 PRNRPS----FRQILLH 364 (904)
T ss_pred CCCCcc----HHHHHHH
Confidence 999996 5777777
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=326.79 Aligned_cols=254 Identities=27% Similarity=0.433 Sum_probs=204.3
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe-
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET- 94 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~- 94 (412)
.-++|++++.||.|+||.||+|.+..++.. ||+|.+.+.... ....+.+.+|+.+++.++||||++++++|..
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~----vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 81 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQN----VAIKKIMKPFST--PVLAKRTYRELKLLKHLRHENIISLSDIFISP 81 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCE----EEEEEecccccc--cchhHHHHHHHHHHHhcCCCCeeeEeeeEecC
Confidence 457899999999999999999998875544 999998664321 2234556679999999999999999999876
Q ss_pred CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
....|++|||+ +++|..++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 82 ~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 82 LEDIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred CCcEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 56789999999 5678666542 3488999999999999999999999999999999999999999999999998863
Q ss_pred hhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCC
Q 042539 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254 (412)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 254 (412)
.. .......++..|
T Consensus 158 ~~------------------------------------------------------------------~~~~~~~~~~~y 171 (328)
T cd07856 158 QD------------------------------------------------------------------PQMTGYVSTRYY 171 (328)
T ss_pred cC------------------------------------------------------------------CCcCCCcccccc
Confidence 21 011234678899
Q ss_pred ccceeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhc-----------------------C----CC-
Q 042539 255 VSPEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLM-----------------------K----TP- 305 (412)
Q Consensus 255 ~APE~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~-----------------------~----~~- 305 (412)
+|||.+.+ ..++.++|+|||||++|+|++|++||.+.+....+..+.. . .+
T Consensus 172 ~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (328)
T cd07856 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPV 251 (328)
T ss_pred cCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCC
Confidence 99999876 5689999999999999999999999988765332211110 0 00
Q ss_pred ----CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCC
Q 042539 306 ----EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 306 ----~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~ 349 (412)
..+..+..+.++|.+||+.+|++|+ ++++++.|+||...+
T Consensus 252 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~----t~~ell~~~~~~~~~ 295 (328)
T cd07856 252 PFSEKFKNADPSAIDLLEKMLVFDPQKRI----SAAEALAHPYLAPYH 295 (328)
T ss_pred cHHHHcCCCCHHHHHHHHHHcCCChhhCC----CHHHHhcCCcccccc
Confidence 1134568899999999999999999 699999999997543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=317.08 Aligned_cols=260 Identities=21% Similarity=0.281 Sum_probs=209.5
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET 94 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 94 (412)
+...+|++.+.||+|+||.||+|.++..+. ....||||++++.. .......+..|+.+++.++||||+++++++.+
T Consensus 1 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 76 (269)
T cd05065 1 IDVSCVKIEEVIGAGEFGEVCRGRLKLPGK-REIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76 (269)
T ss_pred CChHHeEEEeEecCCCCCeEEEEEEecCCC-CceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCcCcceEEEEECC
Confidence 356789999999999999999999876543 23459999986542 23345667889999999999999999999999
Q ss_pred CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
++..++||||+.|++|..++... .+.+++.+++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 77 SRPVMIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 155 (269)
T ss_pred CCceEEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccc
Confidence 99999999999999998877653 34589999999999999999999999999999999999999999999999999865
Q ss_pred hhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCC
Q 042539 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254 (412)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 254 (412)
....... ..........++..|
T Consensus 156 ~~~~~~~----------------------------------------------------------~~~~~~~~~~~~~~y 177 (269)
T cd05065 156 LEDDTSD----------------------------------------------------------PTYTSSLGGKIPIRW 177 (269)
T ss_pred cccCccc----------------------------------------------------------cccccccCCCcceee
Confidence 4211000 000000011124579
Q ss_pred ccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCccCC
Q 042539 255 VSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVKRLG 331 (412)
Q Consensus 255 ~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~R~~ 331 (412)
+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+.... +.....+..+.+++.+||..+|.+||
T Consensus 178 ~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp- 256 (269)
T cd05065 178 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARP- 256 (269)
T ss_pred cCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCc-
Confidence 99999998889999999999999999886 999999888777666664322 33345678899999999999999999
Q ss_pred CCCChhhhhc
Q 042539 332 YLRGACEIKE 341 (412)
Q Consensus 332 ~~~~~~e~l~ 341 (412)
++.+++.
T Consensus 257 ---~~~~i~~ 263 (269)
T cd05065 257 ---KFGQIVS 263 (269)
T ss_pred ---CHHHHHH
Confidence 5777764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=316.18 Aligned_cols=259 Identities=20% Similarity=0.288 Sum_probs=209.7
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
++..++|...+.||+|+||.||+|+++..+. ....+|+|.++.... ....+.+..|+++++.++|+||+++++++.
T Consensus 1 ~i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~-~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (268)
T cd05063 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGR-KEVAVAIKTLKPGYT---EKQRQDFLSEASIMGQFSHHNIIRLEGVVT 76 (268)
T ss_pred CCChHHceEeeEecCCCCccEEEEEEecCCC-CceEEEEEeccccCC---HHHHHHHHHHHHHHhcCCCCCeeEEEEEEc
Confidence 3567899999999999999999999875443 234599999865432 223456777999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
+.+..|+||||+.+++|..++.... +.+++.++..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 155 (268)
T cd05063 77 KFKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSR 155 (268)
T ss_pred cCCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccce
Confidence 9999999999999999988876533 458999999999999999999999999999999999999999999999999986
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
....... ..........+..
T Consensus 156 ~~~~~~~------------------------------------------------------------~~~~~~~~~~~~~ 175 (268)
T cd05063 156 VLEDDPE------------------------------------------------------------GTYTTSGGKIPIR 175 (268)
T ss_pred ecccccc------------------------------------------------------------cceeccCCCcCce
Confidence 5421100 0000011223567
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCccC
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVKRL 330 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~R~ 330 (412)
|+|||++.+..++.++|||||||++|||++ |..||...+..+....+.... +.....+..+.+++.+||..+|.+||
T Consensus 176 y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp 255 (268)
T cd05063 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRP 255 (268)
T ss_pred ecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCc
Confidence 999999988888999999999999999997 999998888777777665432 23334678999999999999999999
Q ss_pred CCCCChhhhhc
Q 042539 331 GYLRGACEIKE 341 (412)
Q Consensus 331 ~~~~~~~e~l~ 341 (412)
++.++++
T Consensus 256 ----~~~~i~~ 262 (268)
T cd05063 256 ----RFVDIVN 262 (268)
T ss_pred ----CHHHHHH
Confidence 4677664
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=318.55 Aligned_cols=258 Identities=23% Similarity=0.360 Sum_probs=211.3
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCC-CCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADP-TARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
+..++|++++.||+|+||+||+|+.+.... .....||+|.+.... .......+.+|++++++++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 78 (275)
T cd05046 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK---DENLQSEFRRELDMFRKLSHKNVVRLLGLCR 78 (275)
T ss_pred CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc---chHHHHHHHHHHHHHHhcCCcceeeeEEEEC
Confidence 456899999999999999999999765432 244569999885532 2234566778999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCC-------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEE
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQND-------RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTL 166 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~-------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL 166 (412)
+.+..|+||||+.+|+|..++..... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 79 EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred CCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEE
Confidence 99999999999999999988765541 15899999999999999999999999999999999999999999999
Q ss_pred ccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCc
Q 042539 167 TDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSN 246 (412)
Q Consensus 167 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (412)
+|||+++..... ......
T Consensus 159 ~~~~~~~~~~~~--------------------------------------------------------------~~~~~~ 176 (275)
T cd05046 159 SLLSLSKDVYNS--------------------------------------------------------------EYYKLR 176 (275)
T ss_pred cccccccccCcc--------------------------------------------------------------cccccC
Confidence 999988643110 000112
Q ss_pred ccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCCC---CCCCChHHHHHHHHhh
Q 042539 247 SFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTPE---FVGQRTALTDLIQRLL 322 (412)
Q Consensus 247 ~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~dli~~~L 322 (412)
...++..|+|||.+.+...+.++|||||||++|+|++ |..||.+.........+...... ....+..+.++|.+||
T Consensus 177 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l 256 (275)
T cd05046 177 NALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCW 256 (275)
T ss_pred CceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHc
Confidence 3356778999999988888899999999999999998 89999887777766666543322 2346789999999999
Q ss_pred hhCCCccCCCCCChhhhhc
Q 042539 323 EKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 323 ~~dP~~R~~~~~~~~e~l~ 341 (412)
..||.+|| ++.+++.
T Consensus 257 ~~~p~~Rp----~~~~~l~ 271 (275)
T cd05046 257 AVNPKDRP----SFSELVS 271 (275)
T ss_pred CCCcccCC----CHHHHHH
Confidence 99999999 6888875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=314.23 Aligned_cols=251 Identities=20% Similarity=0.265 Sum_probs=205.6
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
+++..++|++.+.||+|+||.||++.+... ..+|+|.+..... ....+.+|+.+++.++|+||+++++.+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~-----~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~ 70 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKH-----TKVAVKTMKPGSM-----SVEAFLAEANVMKTLQHDKLVKLHAVV 70 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCC-----ccEEEEecCCChh-----HHHHHHHHHHHHHhcCCCCcceEEEEE
Confidence 467889999999999999999999976432 2389998865422 234567799999999999999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
.. ...|++|||+.+++|.+++.......++...+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++
T Consensus 71 ~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~ 149 (260)
T cd05073 71 TK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA 149 (260)
T ss_pred cC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcce
Confidence 87 78899999999999998887655556888999999999999999999999999999999999999999999999998
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
..+.... ........++.
T Consensus 150 ~~~~~~~--------------------------------------------------------------~~~~~~~~~~~ 167 (260)
T cd05073 150 RVIEDNE--------------------------------------------------------------YTAREGAKFPI 167 (260)
T ss_pred eeccCCC--------------------------------------------------------------cccccCCcccc
Confidence 6542110 00011223567
Q ss_pred CCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCcc
Q 042539 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVKR 329 (412)
Q Consensus 253 ~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~R 329 (412)
.|+|||++.+..++.++|+|||||++|++++ |..||.+.+.......+.... +.....+.++.+++.+||..+|.+|
T Consensus 168 ~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 247 (260)
T cd05073 168 KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEER 247 (260)
T ss_pred cccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHHHHcccCcccC
Confidence 7999999988888999999999999999998 999999887776666554432 2234567899999999999999999
Q ss_pred CCCCCChhhhh
Q 042539 330 LGYLRGACEIK 340 (412)
Q Consensus 330 ~~~~~~~~e~l 340 (412)
| ++.+++
T Consensus 248 p----~~~~l~ 254 (260)
T cd05073 248 P----TFEYIQ 254 (260)
T ss_pred c----CHHHHH
Confidence 9 466655
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=311.07 Aligned_cols=252 Identities=29% Similarity=0.479 Sum_probs=212.7
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeE
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFL 98 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 98 (412)
+|++.+.||+|++|.||++.+...+. .||+|.+.+.... ......+.+|++++.+++|+||+++++++.+++..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGD----FVAIKQISLEKIK--EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSL 74 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCc----EEEEEEecccccC--HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Confidence 58999999999999999998876543 4999999776542 23456788899999999999999999999999999
Q ss_pred EEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhch
Q 042539 99 AWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~ 178 (412)
+++|||+.|++|..++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 75 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 75 YIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred EEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 9999999999998887654 45899999999999999999999999999999999999999999999999999765311
Q ss_pred hhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccce
Q 042539 179 TAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPE 258 (412)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 258 (412)
. .......|+..|+|||
T Consensus 153 ~---------------------------------------------------------------~~~~~~~~~~~y~~pe 169 (254)
T cd06627 153 S---------------------------------------------------------------KDDASVVGTPYWMAPE 169 (254)
T ss_pred c---------------------------------------------------------------ccccccccchhhcCHh
Confidence 0 0122346788999999
Q ss_pred eecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-CCCC-CCCChHHHHHHHHhhhhCCCccCCCCCCh
Q 042539 259 VVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK-TPEF-VGQRTALTDLIQRLLEKDPVKRLGYLRGA 336 (412)
Q Consensus 259 ~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~-~~~~-~~~~~~~~dli~~~L~~dP~~R~~~~~~~ 336 (412)
.+.+..++.++|+||||+++|+|++|..||...+.......+... .+.. ...+..+.++|.+||..+|++|| ++
T Consensus 170 ~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~----~~ 245 (254)
T cd06627 170 VIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRP----TA 245 (254)
T ss_pred hhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCChhhCc----CH
Confidence 998888899999999999999999999999877655544444322 2222 34568999999999999999999 69
Q ss_pred hhhhcCCCC
Q 042539 337 CEIKEHVFF 345 (412)
Q Consensus 337 ~e~l~h~ff 345 (412)
.+++.|+||
T Consensus 246 ~~~l~~~~~ 254 (254)
T cd06627 246 KQLLKHPWI 254 (254)
T ss_pred HHHhcCCCC
Confidence 999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=350.52 Aligned_cols=257 Identities=22% Similarity=0.351 Sum_probs=222.3
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCC-CCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAAD-PTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLG 90 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 90 (412)
..++...+.+..+.||+|+||+||+++..... ....+.||||.++... ..+..+.|+||+++|..++|||||+|++
T Consensus 480 ~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a---~~~~~~dF~REaeLla~l~H~nIVrLlG 556 (774)
T KOG1026|consen 480 VLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA---ENQARQDFRREAELLAELQHPNIVRLLG 556 (774)
T ss_pred eeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc---cHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 45778889999999999999999999876544 2356789999997653 3446778899999999999999999999
Q ss_pred eEEeCCeEEEEeeccCCCCchhHHHhhCC------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEE
Q 042539 91 SLETDEFLAWAVPYCPGGDLNVLRYKQND------------RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILI 158 (412)
Q Consensus 91 ~~~~~~~~~lv~e~~~gg~L~~~~~~~~~------------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl 158 (412)
++..++.+|+|+|||..|||..++..... ..++..+...++.||+.|++||-++.+|||||..+|+||
T Consensus 557 VC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV 636 (774)
T KOG1026|consen 557 VCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV 636 (774)
T ss_pred EEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee
Confidence 99999999999999999999999877542 127889999999999999999999999999999999999
Q ss_pred ccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccc
Q 042539 159 RQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQS 238 (412)
Q Consensus 159 ~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (412)
.++-.|||+||||++.+.....|..+.
T Consensus 637 ge~l~VKIsDfGLsRdiYssDYYk~~~----------------------------------------------------- 663 (774)
T KOG1026|consen 637 GENLVVKISDFGLSRDIYSSDYYKVRG----------------------------------------------------- 663 (774)
T ss_pred ccceEEEecccccchhhhhhhhhcccC-----------------------------------------------------
Confidence 999999999999999887655543211
Q ss_pred cCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHH
Q 042539 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALT 315 (412)
Q Consensus 239 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~ 315 (412)
++ .-..+||+||.+....++.+|||||+||+|||+++ |..||.+.+.++++.-|..+. +...+++.++.
T Consensus 664 -------~t-~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~lL~~Pe~CP~~vY 735 (774)
T KOG1026|consen 664 -------NT-LLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQLLSCPENCPTEVY 735 (774)
T ss_pred -------Cc-eeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCcccCCCCCCHHHH
Confidence 01 12458999999999999999999999999999995 999999999999999887665 33456889999
Q ss_pred HHHHHhhhhCCCccCCC
Q 042539 316 DLIQRLLEKDPVKRLGY 332 (412)
Q Consensus 316 dli~~~L~~dP~~R~~~ 332 (412)
+|+..||+.+|.+||++
T Consensus 736 ~LM~~CW~~~P~~RPsF 752 (774)
T KOG1026|consen 736 SLMLECWNENPKRRPSF 752 (774)
T ss_pred HHHHHHhhcCcccCCCH
Confidence 99999999999999975
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=313.17 Aligned_cols=249 Identities=45% Similarity=0.757 Sum_probs=210.0
Q ss_pred eeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEEEeecc
Q 042539 26 LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYC 105 (412)
Q Consensus 26 LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 105 (412)
||.|+||.||++.+...+ ..||+|++.+..... ......+..|+.+++.++|+||+++++.++.+...|+||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~----~~~~~k~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTG----KLYAMKVLKKKKIIK-RKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCC----cEEEEEEeehhhhcc-hHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecC
Confidence 799999999999987644 449999997765432 234556778999999999999999999999999999999999
Q ss_pred CCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhhhhc
Q 042539 106 PGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQS 185 (412)
Q Consensus 106 ~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~ 185 (412)
.+++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 76 ~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~------ 147 (250)
T cd05123 76 PGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG------ 147 (250)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC------
Confidence 9999988876543 48999999999999999999999999999999999999999999999999986542110
Q ss_pred ccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecCCCC
Q 042539 186 LNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGH 265 (412)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~ 265 (412)
.......|+..|+|||.+.+...
T Consensus 148 ---------------------------------------------------------~~~~~~~~~~~~~~Pe~~~~~~~ 170 (250)
T cd05123 148 ---------------------------------------------------------SRTNTFCGTPEYLAPEVLLGKGY 170 (250)
T ss_pred ---------------------------------------------------------CcccCCcCCccccChHHhCCCCC
Confidence 11234468889999999998888
Q ss_pred CchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC-CChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCC
Q 042539 266 EFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVG-QRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVF 344 (412)
Q Consensus 266 ~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~f 344 (412)
+.++|+|||||++|+|++|..||...+..+....+......++. .++.+.++|.+||..||.+||+... ++++++|||
T Consensus 171 ~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~-~~~l~~~~~ 249 (250)
T cd05123 171 GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGG-AEEIKAHPF 249 (250)
T ss_pred CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCccc-HHHHHhCCC
Confidence 99999999999999999999999988877777777664444443 4789999999999999999995221 299999999
Q ss_pred C
Q 042539 345 F 345 (412)
Q Consensus 345 f 345 (412)
|
T Consensus 250 f 250 (250)
T cd05123 250 F 250 (250)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=317.71 Aligned_cols=258 Identities=21% Similarity=0.256 Sum_probs=211.0
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
.+..++|++++.||+|+||+||+|.++.++......||+|++.+... ......+.+|+.+++.++|+||+++++++.
T Consensus 3 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 79 (279)
T cd05057 3 ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS---PKANKEILDEAYVMASVDHPHVVRLLGICL 79 (279)
T ss_pred ccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 45678999999999999999999998776655556799999876542 234456777999999999999999999988
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
. ...++||||+.+|+|..++.... ..+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 80 ~-~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 80 S-SQVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred c-CceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccc
Confidence 7 78999999999999988876543 348999999999999999999999999999999999999999999999999997
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
....... ........++..
T Consensus 158 ~~~~~~~-------------------------------------------------------------~~~~~~~~~~~~ 176 (279)
T cd05057 158 LLDVDEK-------------------------------------------------------------EYHAEGGKVPIK 176 (279)
T ss_pred cccCccc-------------------------------------------------------------ceecCCCccccc
Confidence 5421100 000011123568
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCccC
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVKRL 330 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~R~ 330 (412)
|+|||.+.+..++.++|+|||||++||+++ |..||.+....+....+.... +.....+..+.+++.+||..||.+||
T Consensus 177 y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp 256 (279)
T cd05057 177 WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRP 256 (279)
T ss_pred ccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCC
Confidence 999999988888999999999999999998 999999988777666665433 22334568899999999999999999
Q ss_pred CCCCChhhhhc
Q 042539 331 GYLRGACEIKE 341 (412)
Q Consensus 331 ~~~~~~~e~l~ 341 (412)
++.++++
T Consensus 257 ----~~~~l~~ 263 (279)
T cd05057 257 ----TFKELIN 263 (279)
T ss_pred ----CHHHHHH
Confidence 4666653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=323.02 Aligned_cols=254 Identities=24% Similarity=0.364 Sum_probs=207.0
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
+.|..+++||+|+||+||+|++..++. .||+|++....... ......+.+|+++++.++|+||+++++++.+++.
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~----~v~ik~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 95 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNE----VVAVKKMSYSGKQT-NEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHT 95 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCc----EEEEEEEeccccCc-hHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCE
Confidence 347778899999999999998876544 49999997654322 2334567779999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
.|+||||+.| ++..++... ...+++.++..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++...
T Consensus 96 ~~lv~e~~~~-~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~-- 171 (313)
T cd06633 96 AWLVMEYCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKS-- 171 (313)
T ss_pred EEEEEecCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCccc--
Confidence 9999999965 565555443 345899999999999999999999999999999999999999999999999987421
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
.......|+..|+||
T Consensus 172 -----------------------------------------------------------------~~~~~~~~~~~y~aP 186 (313)
T cd06633 172 -----------------------------------------------------------------SPANSFVGTPYWMAP 186 (313)
T ss_pred -----------------------------------------------------------------CCCCCccccccccCh
Confidence 011244688999999
Q ss_pred eeec---CCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-CC--CCCCChHHHHHHHHhhhhCCCccCC
Q 042539 258 EVVR---GDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT-PE--FVGQRTALTDLIQRLLEKDPVKRLG 331 (412)
Q Consensus 258 E~l~---~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-~~--~~~~~~~~~dli~~~L~~dP~~R~~ 331 (412)
|++. +..++.++|+|||||++|+|++|..||.+.+.......+.... +. ....+..+++||.+||+++|.+||
T Consensus 187 E~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp- 265 (313)
T cd06633 187 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERP- 265 (313)
T ss_pred hhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCc-
Confidence 9985 3457889999999999999999999998877665555554332 22 223567899999999999999999
Q ss_pred CCCChhhhhcCCCCCCCC
Q 042539 332 YLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 332 ~~~~~~e~l~h~ff~~~~ 349 (412)
++.+++.||||...+
T Consensus 266 ---~~~~~l~~~~~~~~~ 280 (313)
T cd06633 266 ---ASAELLRHDFVRRDR 280 (313)
T ss_pred ---CHHHHhcCcccCCCc
Confidence 699999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=313.89 Aligned_cols=250 Identities=25% Similarity=0.349 Sum_probs=207.8
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEEEee
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVP 103 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~e 103 (412)
+.||+|+||.||+|.+.... ..+..||+|++....... ....+.+|+++++.++|+||+++++++.++..+++|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~-~~~~~~~ik~~~~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 76 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKD-GKTTEVAVKTLKEDASEE---ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE 76 (262)
T ss_pred CccccCCceEEEEEEEecCC-CCCceEEeEeeccccchh---HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEE
Confidence 47999999999999987541 234559999997654322 45667789999999999999999999999999999999
Q ss_pred ccCCCCchhHHHhhC-------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 104 YCPGGDLNVLRYKQN-------DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 104 ~~~gg~L~~~~~~~~-------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
|+.|++|..++.... ...+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||.+....
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence 999999998877641 2458999999999999999999999999999999999999999999999999997653
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
.... ........++..|+|
T Consensus 157 ~~~~-------------------------------------------------------------~~~~~~~~~~~~y~a 175 (262)
T cd00192 157 DDDY-------------------------------------------------------------YRKKTGGKLPIRWMA 175 (262)
T ss_pred cccc-------------------------------------------------------------cccccCCCcCccccC
Confidence 2110 011223457889999
Q ss_pred ceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCccCCCC
Q 042539 257 PEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVKRLGYL 333 (412)
Q Consensus 257 PE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~R~~~~ 333 (412)
||.+.+..++.++|+|||||++|+|++ |..||.+.+..+....+.... ......+.++.++|.+||..||.+||
T Consensus 176 PE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp--- 252 (262)
T cd00192 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRP--- 252 (262)
T ss_pred HHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHHHHHHHHccCCcccCc---
Confidence 999988889999999999999999998 699999988777777766432 22234578999999999999999999
Q ss_pred CChhhhhcC
Q 042539 334 RGACEIKEH 342 (412)
Q Consensus 334 ~~~~e~l~h 342 (412)
++.+++++
T Consensus 253 -s~~~l~~~ 260 (262)
T cd00192 253 -TFSELVER 260 (262)
T ss_pred -CHHHHHHh
Confidence 68888864
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=324.35 Aligned_cols=258 Identities=24% Similarity=0.310 Sum_probs=205.3
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
+...++|++.+.||+|+||.||+|.++.++ +.||+|+++.... .......+.+|+++++.++||||+++++++.
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~----~~v~iK~~~~~~~--~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~ 76 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTG----ELVALKKVRLDNE--KEGFPITAIREIKILRQLNHRNIVNLKEIVT 76 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCC----cEEEEEEEeeccc--ccCchHHHHHHHHHHHhCCCCCeeeeeheec
Confidence 456789999999999999999999987654 3499999975432 1122345567999999999999999999987
Q ss_pred eCC----------eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCC
Q 042539 94 TDE----------FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGH 163 (412)
Q Consensus 94 ~~~----------~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~ 163 (412)
+.. .+|+|+||+.+ ++..++... ...+++.+++.++.|++.||.|||+.||+||||||+||+++.++.
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~ 154 (302)
T cd07864 77 DKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ 154 (302)
T ss_pred CcchhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc
Confidence 654 89999999987 554444432 345899999999999999999999999999999999999999999
Q ss_pred EEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCC
Q 042539 164 VTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGE 243 (412)
Q Consensus 164 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (412)
+||+|||++........ .
T Consensus 155 ~kl~dfg~~~~~~~~~~--------------------------------------------------------------~ 172 (302)
T cd07864 155 IKLADFGLARLYNSEES--------------------------------------------------------------R 172 (302)
T ss_pred EEeCcccccccccCCcc--------------------------------------------------------------c
Confidence 99999999875521100 0
Q ss_pred CCcccccCCCCccceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC---C---------------
Q 042539 244 RSNSFVGTEEYVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK---T--------------- 304 (412)
Q Consensus 244 ~~~~~~gt~~Y~APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~---~--------------- 304 (412)
......++..|+|||++.+. .++.++|||||||++|+|++|++||...+..+.+..+... .
T Consensus 173 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T cd07864 173 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFN 252 (302)
T ss_pred ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccccccc
Confidence 11122457789999988754 4688999999999999999999999887765554443321 0
Q ss_pred -------------CCCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCC
Q 042539 305 -------------PEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 305 -------------~~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff 345 (412)
..+...+..+.++|.+||..||.+|| ++.+++.||||
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp----~~~~il~~~~~ 302 (302)
T cd07864 253 TMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRC----TAEEALNSPWL 302 (302)
T ss_pred ccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCC----CHHHHhcCCCC
Confidence 01223568899999999999999999 69999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=320.27 Aligned_cols=255 Identities=21% Similarity=0.318 Sum_probs=204.6
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCC-CCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADP-TARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
+|++.+.||+|+||.||+|.+..... .....+|+|.+.+... ......+.+|+.+++.++||||+++++.+..++.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS---SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC---HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCC
Confidence 58899999999999999998754322 1234589998865432 2234567789999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQN----------------------DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPEN 155 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~----------------------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~N 155 (412)
.+++|||+.||+|..++.... ...+++..+..++.|++.||+|||++||+||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 999999999999988765421 1347889999999999999999999999999999999
Q ss_pred eEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCcccc
Q 042539 156 ILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRR 235 (412)
Q Consensus 156 iLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (412)
||++.++.+||+|||+++.......+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~------------------------------------------------------ 183 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSY------------------------------------------------------ 183 (290)
T ss_pred EEEcCCCcEEeccccccccccCccch------------------------------------------------------
Confidence 99999999999999998754211100
Q ss_pred ccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCCh
Q 042539 236 QQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRT 312 (412)
Q Consensus 236 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~ 312 (412)
.......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+....+.... ......+.
T Consensus 184 -------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (290)
T cd05045 184 -------VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERPENCSE 256 (290)
T ss_pred -------hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCH
Confidence 00112345678999999988889999999999999999998 999999888777665544321 22334678
Q ss_pred HHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 313 ALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 313 ~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
++.+||.+||+.+|.+|| ++.++++
T Consensus 257 ~~~~~i~~cl~~~P~~Rp----~~~~i~~ 281 (290)
T cd05045 257 EMYNLMLTCWKQEPDKRP----TFADISK 281 (290)
T ss_pred HHHHHHHHHccCCcccCC----CHHHHHH
Confidence 999999999999999999 5777764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=318.78 Aligned_cols=252 Identities=28% Similarity=0.448 Sum_probs=204.6
Q ss_pred ceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC--Ce
Q 042539 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD--EF 97 (412)
Q Consensus 20 y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~ 97 (412)
|++++.||+|+||.||+|.+..++. .||+|++.... ........+.+|+++++.++|+||+++++++... +.
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~----~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 74 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGE----LVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGS 74 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCe----EEEEEEEeccc--ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCc
Confidence 7899999999999999999877544 49999997664 2223345566799999999999999999999988 89
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
.++||||+.+ +|..++.... ..+++..++.++.||+.||+|||++|++|+||||+||+++.+|.+||+|||++.....
T Consensus 75 ~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 75 IYMVFEYMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred EEEEeccccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 9999999975 7776665432 4699999999999999999999999999999999999999999999999999875421
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
.. ........++..|+||
T Consensus 153 ~~--------------------------------------------------------------~~~~~~~~~~~~y~~P 170 (287)
T cd07840 153 RN--------------------------------------------------------------SADYTNRVITLWYRPP 170 (287)
T ss_pred CC--------------------------------------------------------------cccccccccccccCCc
Confidence 10 0011123467889999
Q ss_pred eeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--C------C----------------------
Q 042539 258 EVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT--P------E---------------------- 306 (412)
Q Consensus 258 E~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~------~---------------------- 306 (412)
|.+.+. .++.++|||||||++|+|++|+.||...+....+..+.... + .
T Consensus 171 E~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (287)
T cd07840 171 ELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLRE 250 (287)
T ss_pred eeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHH
Confidence 988764 57899999999999999999999999887666555443210 0 0
Q ss_pred -CCC-CChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCC
Q 042539 307 -FVG-QRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 307 -~~~-~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff 345 (412)
+.. .+..+.++|.+||..||.+|| +++++++|+||
T Consensus 251 ~~~~~~~~~~~~~i~~~l~~~P~~Rp----~~~~~l~~~~~ 287 (287)
T cd07840 251 FFKHLIDPSALDLLDKLLTLDPKKRI----SADQALQHEYF 287 (287)
T ss_pred HhcccCCHHHHHHHHHHcCCChhhCc----CHHHHhhCcCC
Confidence 011 267899999999999999999 69999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=321.91 Aligned_cols=259 Identities=22% Similarity=0.281 Sum_probs=204.2
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCC----------CCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCc
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADP----------TARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPF 84 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~----------~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpn 84 (412)
+..++|++.+.||+|+||.||+|++..++. .....||+|.++.... ......+.+|++++++++|+|
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~ei~~l~~l~h~~ 78 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT---KTARNDFLKEIKIMSRLKNPN 78 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC---HHHHHHHHHHHHHHHhCCCCC
Confidence 456799999999999999999998764321 1223489999865421 233456778999999999999
Q ss_pred cceeeeeEEeCCeEEEEeeccCCCCchhHHHhhCC----------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCC
Q 042539 85 LPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQND----------RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPE 154 (412)
Q Consensus 85 Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~----------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~ 154 (412)
|+++++++...+..++||||+.|++|..++..... ..+++..+..++.|++.||.|||++|++||||||+
T Consensus 79 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ 158 (295)
T cd05097 79 IIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATR 158 (295)
T ss_pred cCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChh
Confidence 99999999999999999999999999888754321 13678889999999999999999999999999999
Q ss_pred ceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccc
Q 042539 155 NILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSR 234 (412)
Q Consensus 155 NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (412)
||+++.++.+||+|||+++......
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~------------------------------------------------------- 183 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGD------------------------------------------------------- 183 (295)
T ss_pred hEEEcCCCcEEecccccccccccCc-------------------------------------------------------
Confidence 9999999999999999986542110
Q ss_pred cccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh--CCCCCCCCCHHHHHHHHhc-----CC---
Q 042539 235 RQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY--GTTPFRGKNRKETFRNVLM-----KT--- 304 (412)
Q Consensus 235 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~--g~~Pf~~~~~~~~~~~i~~-----~~--- 304 (412)
.........++..|+|||++.+..++.++|+|||||++|+|++ |..||...+..+....+.. ..
T Consensus 184 ------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (295)
T cd05097 184 ------YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIY 257 (295)
T ss_pred ------ceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhcccccc
Confidence 0001122345778999999988889999999999999999987 7789988776665544321 01
Q ss_pred -CCCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 305 -PEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 305 -~~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
...+..+..+.+||.+||..||.+|| +++++++
T Consensus 258 ~~~~~~~~~~l~~li~~~l~~~p~~RP----s~~~i~~ 291 (295)
T cd05097 258 LSQTPLCPSPVFKLMMRCWSRDIKDRP----TFNKIHH 291 (295)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCc----CHHHHHH
Confidence 11234568899999999999999999 4676653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=318.85 Aligned_cols=254 Identities=20% Similarity=0.267 Sum_probs=197.1
Q ss_pred cCc-eeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC-
Q 042539 18 DNL-KALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD- 95 (412)
Q Consensus 18 ~~y-~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~- 95 (412)
++| ++++.||+|+||+||++.........+..||+|+++.... ......+.+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG---QQNTSGWKKEINILKTLYHENIVKYKGCCSEQG 79 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 455 9999999999999999876554444666799999965432 22345667799999999999999999987653
Q ss_pred -CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 96 -EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 96 -~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
..+|++|||+.+++|..++... .+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccc
Confidence 4689999999999998887543 399999999999999999999999999999999999999999999999999875
Q ss_pred hhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCC
Q 042539 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254 (412)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 254 (412)
....... ........++..|
T Consensus 157 ~~~~~~~------------------------------------------------------------~~~~~~~~~~~~~ 176 (283)
T cd05080 157 VPEGHEY------------------------------------------------------------YRVREDGDSPVFW 176 (283)
T ss_pred cCCcchh------------------------------------------------------------hccCCCCCCCcee
Confidence 5321100 0001112356679
Q ss_pred ccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHH--HH------------HHHHhcCC---CCCCCCChHHHHH
Q 042539 255 VSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRK--ET------------FRNVLMKT---PEFVGQRTALTDL 317 (412)
Q Consensus 255 ~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--~~------------~~~i~~~~---~~~~~~~~~~~dl 317 (412)
+|||++.+..++.++|||||||++|+|++|..||...... +. ....+... +.....+..+.++
T Consensus 177 ~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 256 (283)
T cd05080 177 YAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYIL 256 (283)
T ss_pred eCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHH
Confidence 9999998888899999999999999999999998653211 00 11111111 1123456899999
Q ss_pred HHHhhhhCCCccCCCCCChhhhhc
Q 042539 318 IQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 318 i~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
+.+||..||++|| +++++++
T Consensus 257 i~~cl~~~p~~Rp----s~~~i~~ 276 (283)
T cd05080 257 MKNCWETEAKFRP----TFRSLIP 276 (283)
T ss_pred HHHHhccChhhCC----CHHHHHH
Confidence 9999999999999 5777764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=313.69 Aligned_cols=249 Identities=22% Similarity=0.283 Sum_probs=204.5
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEEEee
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVP 103 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~e 103 (412)
+.||+|+||.||+|.+...+ .....||||++...... ...+.+.+|+.++++++|+||+++++.+.. ..+++|||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~-~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e 75 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSG-GKVIPVAVKCLKSDKLS---DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTE 75 (257)
T ss_pred CcCCccCcccEEeeeEecCC-CCceEEEEeecCCcccH---HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEE
Confidence 47899999999999986532 23345899999776543 456677889999999999999999999988 89999999
Q ss_pred ccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhhh
Q 042539 104 YCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEK 183 (412)
Q Consensus 104 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~ 183 (412)
|+.+++|..++.......+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++.+......
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-- 153 (257)
T cd05040 76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH-- 153 (257)
T ss_pred ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc--
Confidence 999999988876654346899999999999999999999999999999999999999999999999999765321000
Q ss_pred hcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecCC
Q 042539 184 QSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGD 263 (412)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~ 263 (412)
........++..|+|||++.+.
T Consensus 154 ----------------------------------------------------------~~~~~~~~~~~~y~~pE~~~~~ 175 (257)
T cd05040 154 ----------------------------------------------------------YVMEEHLKVPFAWCAPESLRTR 175 (257)
T ss_pred ----------------------------------------------------------eecccCCCCCceecCHHHhccc
Confidence 0001134567889999999988
Q ss_pred CCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCCC---CCCCChHHHHHHHHhhhhCCCccCCCCCChhhh
Q 042539 264 GHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTPE---FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEI 339 (412)
Q Consensus 264 ~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~ 339 (412)
.++.++|||||||++|+|++ |..||...+..+....+...... ....+..+.++|.+||..+|++|| ++.++
T Consensus 176 ~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----s~~~~ 251 (257)
T cd05040 176 TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRP----TFAAL 251 (257)
T ss_pred CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCC----CHHHH
Confidence 89999999999999999998 99999988877776666543222 224568999999999999999999 57777
Q ss_pred hc
Q 042539 340 KE 341 (412)
Q Consensus 340 l~ 341 (412)
++
T Consensus 252 ~~ 253 (257)
T cd05040 252 RE 253 (257)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=317.94 Aligned_cols=253 Identities=30% Similarity=0.437 Sum_probs=203.5
Q ss_pred eeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEE
Q 042539 21 KALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAW 100 (412)
Q Consensus 21 ~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 100 (412)
.+.+.||.|+||.||+|..+..+...+..|+||+++... .......+.+|++++++++||||+++++++...+..++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS---SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS---SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc---ccccceeeeecccccccccccccccccccccccccccc
Confidence 578999999999999999985444466779999995432 22346677789999999999999999999998888999
Q ss_pred EeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhh
Q 042539 101 AVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTA 180 (412)
Q Consensus 101 v~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~ 180 (412)
|||||.+|+|.+++.......++..+...++.||+.||.|||+++++|+||+++|||++.++.+||+|||+++.......
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999998887455699999999999999999999999999999999999999999999999999875411100
Q ss_pred hhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceee
Q 042539 181 FEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVV 260 (412)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l 260 (412)
........+...|+|||.+
T Consensus 159 -------------------------------------------------------------~~~~~~~~~~~~~~aPE~~ 177 (259)
T PF07714_consen 159 -------------------------------------------------------------YKNDSSQQLPLRYLAPEVL 177 (259)
T ss_dssp -------------------------------------------------------------EEESTTSESGGGGS-HHHH
T ss_pred -------------------------------------------------------------ccccccccccccccccccc
Confidence 0111223466789999999
Q ss_pred cCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCccCCCCCChh
Q 042539 261 RGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVKRLGYLRGAC 337 (412)
Q Consensus 261 ~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~ 337 (412)
.+..++.++||||||+++||+++ |+.||...+..+....+.... +.....+..+.++|.+||..||.+|| ++.
T Consensus 178 ~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RP----s~~ 253 (259)
T PF07714_consen 178 KDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRP----SFQ 253 (259)
T ss_dssp HHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS------HH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHHHHHcCCChhhCc----CHH
Confidence 99889999999999999999999 789999988888777775433 22335688999999999999999999 577
Q ss_pred hhhc
Q 042539 338 EIKE 341 (412)
Q Consensus 338 e~l~ 341 (412)
++++
T Consensus 254 ~i~~ 257 (259)
T PF07714_consen 254 EILQ 257 (259)
T ss_dssp HHHH
T ss_pred HHHh
Confidence 7764
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=312.16 Aligned_cols=252 Identities=27% Similarity=0.407 Sum_probs=212.5
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeE
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFL 98 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 98 (412)
+|++.+.||+|+||.||++.++.++. .||+|.+.+.... ......+.+|+++++.++|+||+++++++.++...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQ----FYALKEVDLGSMS--QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKL 74 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCC----EEEEEEEehhhcc--HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEE
Confidence 58999999999999999998876544 4999999765542 23345667799999999999999999999999999
Q ss_pred EEEeeccCCCCchhHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 99 AWAVPYCPGGDLNVLRYKQN--DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~~~~~~--~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
|+||||+.|++|..++.... ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++....
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~ 154 (256)
T cd08530 75 CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLK 154 (256)
T ss_pred EEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhc
Confidence 99999999999988765522 2458999999999999999999999999999999999999999999999999986542
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
.. ......|++.|+|
T Consensus 155 ~~-----------------------------------------------------------------~~~~~~~~~~~~~ 169 (256)
T cd08530 155 KN-----------------------------------------------------------------MAKTQIGTPHYMA 169 (256)
T ss_pred cC-----------------------------------------------------------------CcccccCCccccC
Confidence 11 1112357889999
Q ss_pred ceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-C-CCCCChHHHHHHHHhhhhCCCccCCCCC
Q 042539 257 PEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP-E-FVGQRTALTDLIQRLLEKDPVKRLGYLR 334 (412)
Q Consensus 257 PE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-~-~~~~~~~~~dli~~~L~~dP~~R~~~~~ 334 (412)
||.+.+..++.++|+||||+++|+|++|+.||...+..+....+..... . ....+.+++++|.+||..+|.+||
T Consensus 170 Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---- 245 (256)
T cd08530 170 PEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRP---- 245 (256)
T ss_pred HHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCC----
Confidence 9999998889999999999999999999999999887766655554332 1 124568899999999999999999
Q ss_pred ChhhhhcCCCC
Q 042539 335 GACEIKEHVFF 345 (412)
Q Consensus 335 ~~~e~l~h~ff 345 (412)
++.++++||++
T Consensus 246 ~~~~~l~~p~~ 256 (256)
T cd08530 246 NCDKILASPAV 256 (256)
T ss_pred CHHHHhcCCCC
Confidence 69999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=320.25 Aligned_cols=260 Identities=25% Similarity=0.400 Sum_probs=207.2
Q ss_pred CCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceee
Q 042539 11 TTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLL 89 (412)
Q Consensus 11 ~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~ 89 (412)
....+..++|++.+.||+|+||+||+|.+..++ ..||||.+++.... .....+.+|+.++..+. |+||++++
T Consensus 8 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~----~~~avK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~~i~~~~ 80 (296)
T cd06618 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTG----HVMAVKQMRRTGNK---EENKRILMDLDVVLKSHDCPYIVKCY 80 (296)
T ss_pred eeccCCcchheeeeEeeccCCeEEEEEEECCCC----eEEEEEEEeccCCh---HHHHHHHHHHHHHHhccCCCchHhhh
Confidence 455788999999999999999999999987644 44999999765321 22344555777676665 99999999
Q ss_pred eeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeeCCCCceEEccCCCEEEcc
Q 042539 90 GSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN-MGIAYRDLKPENILIRQSGHVTLTD 168 (412)
Q Consensus 90 ~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDlKp~NiLl~~~g~vkL~D 168 (412)
+++.++..+|++|||+. +.|..++.... ..+++..+..++.|++.||.|||+ .||+||||+|+||+++.++.+||+|
T Consensus 81 ~~~~~~~~~~~v~e~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~d 158 (296)
T cd06618 81 GYFITDSDVFICMELMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCD 158 (296)
T ss_pred eeeecCCeEEEEeeccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECc
Confidence 99999999999999985 46666554433 468999999999999999999997 5999999999999999999999999
Q ss_pred ccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccc
Q 042539 169 FDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248 (412)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (412)
||++..+... ......
T Consensus 159 fg~~~~~~~~----------------------------------------------------------------~~~~~~ 174 (296)
T cd06618 159 FGISGRLVDS----------------------------------------------------------------KAKTRS 174 (296)
T ss_pred cccchhccCC----------------------------------------------------------------CcccCC
Confidence 9998654211 001122
Q ss_pred ccCCCCccceeecCCC----CCchhhHHHHHHHHHHHhhCCCCCCCCCH-HHHHHHHhcCC-CCC---CCCChHHHHHHH
Q 042539 249 VGTEEYVSPEVVRGDG----HEFAVDWWALGILTYEMLYGTTPFRGKNR-KETFRNVLMKT-PEF---VGQRTALTDLIQ 319 (412)
Q Consensus 249 ~gt~~Y~APE~l~~~~----~~~~~DiwSlGvil~ell~g~~Pf~~~~~-~~~~~~i~~~~-~~~---~~~~~~~~dli~ 319 (412)
.++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||..... .+.+..++... +.. ...+.++.+||.
T Consensus 175 ~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 254 (296)
T cd06618 175 AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVD 254 (296)
T ss_pred CCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Confidence 4788999999997654 68899999999999999999999976432 34444444432 221 235788999999
Q ss_pred HhhhhCCCccCCCCCChhhhhcCCCCCC
Q 042539 320 RLLEKDPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 320 ~~L~~dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
+||..||.+|| ++++++.|+||..
T Consensus 255 ~~l~~~p~~Rp----~~~~il~~~~~~~ 278 (296)
T cd06618 255 LCLTKDHRKRP----KYRELLQHPFIRR 278 (296)
T ss_pred HHccCChhhCC----CHHHHhcChhhhc
Confidence 99999999999 6899999999974
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=309.52 Aligned_cols=254 Identities=32% Similarity=0.490 Sum_probs=211.2
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC--C
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD--E 96 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~ 96 (412)
+|++.+.||+|++|.||++.+..++. .|++|++...... ......+.+|+.++++++|+||+++++.+... +
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGE----LMAVKSVELSGDS--EEELEALEREIRILSSLQHPNIVRYYGSERDEEKN 74 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCc----EEEEEEeeccccc--hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCC
Confidence 58899999999999999999876444 4999999765432 34456777899999999999999999999988 8
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
.+++++||+.|++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 75 TLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred eEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 9999999999999988876554 59999999999999999999999999999999999999999999999999987653
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
.... ........++..|+|
T Consensus 153 ~~~~-------------------------------------------------------------~~~~~~~~~~~~y~~ 171 (260)
T cd06606 153 DIET-------------------------------------------------------------GEGTGSVRGTPYWMA 171 (260)
T ss_pred cccc-------------------------------------------------------------cccccCCCCCccccC
Confidence 2110 001223468889999
Q ss_pred ceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCC-HHHHHHHHhc--CCCC-CCCCChHHHHHHHHhhhhCCCccCCC
Q 042539 257 PEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKN-RKETFRNVLM--KTPE-FVGQRTALTDLIQRLLEKDPVKRLGY 332 (412)
Q Consensus 257 PE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-~~~~~~~i~~--~~~~-~~~~~~~~~dli~~~L~~dP~~R~~~ 332 (412)
||.+.+...+.++|+|||||++|+|++|..||...+ .......+.. ..+. ....+..+.+||.+||..||.+||
T Consensus 172 pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp-- 249 (260)
T cd06606 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRP-- 249 (260)
T ss_pred HhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCC--
Confidence 999988889999999999999999999999998866 2233333332 1122 223478999999999999999999
Q ss_pred CCChhhhhcCCCC
Q 042539 333 LRGACEIKEHVFF 345 (412)
Q Consensus 333 ~~~~~e~l~h~ff 345 (412)
++.+++.||||
T Consensus 250 --~~~~ll~~~~~ 260 (260)
T cd06606 250 --TADELLQHPFL 260 (260)
T ss_pred --CHHHHhhCCCC
Confidence 69999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=318.02 Aligned_cols=250 Identities=29% Similarity=0.470 Sum_probs=203.2
Q ss_pred ceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEEeCCeE
Q 042539 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLETDEFL 98 (412)
Q Consensus 20 y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 98 (412)
|++.+.||+|+||+||+|.+..++. .||||.+.+.... .......+|+..++.++ |+||+++++++.+++..
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~----~~~ik~~~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 73 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGE----LVAIKKMKKKFYS---WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDEL 73 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCc----EEEEEEehhhccc---hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcE
Confidence 7889999999999999999876544 4999998654321 11223346899999999 99999999999999999
Q ss_pred EEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhch
Q 042539 99 AWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~ 178 (412)
|+||||+ +|+|..++.......+++.++..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||+++.....
T Consensus 74 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 74 YFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR 152 (283)
T ss_pred EEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence 9999999 778877766554446899999999999999999999999999999999999999999999999998654211
Q ss_pred hhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccce
Q 042539 179 TAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPE 258 (412)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 258 (412)
.......|+..|+|||
T Consensus 153 ----------------------------------------------------------------~~~~~~~~~~~~~aPE 168 (283)
T cd07830 153 ----------------------------------------------------------------PPYTDYVSTRWYRAPE 168 (283)
T ss_pred ----------------------------------------------------------------CCcCCCCCcccccCce
Confidence 1112346788999999
Q ss_pred eecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--C-----------------------------C
Q 042539 259 VVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT--P-----------------------------E 306 (412)
Q Consensus 259 ~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~-----------------------------~ 306 (412)
++.+ ..++.++|+|||||++|+|++|++||.+.+..+.+..+.... + .
T Consensus 169 ~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (283)
T cd07830 169 ILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQL 248 (283)
T ss_pred eeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHH
Confidence 8854 456899999999999999999999998877655544332100 0 0
Q ss_pred CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCC
Q 042539 307 FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 307 ~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff 345 (412)
.+..+.++.+||++||..||.+|| +++|++.||||
T Consensus 249 ~~~~~~~~~~li~~cl~~~p~~Rp----t~~ei~~~~~~ 283 (283)
T cd07830 249 IPNASPEAIDLIKDMLRWDPKKRP----TASQALQHPYF 283 (283)
T ss_pred cccCCHHHHHHHHHhcccCcccCC----CHHHHhhCCCC
Confidence 112357899999999999999999 69999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=308.23 Aligned_cols=249 Identities=29% Similarity=0.514 Sum_probs=208.5
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeE
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFL 98 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 98 (412)
+|.+.+.||+|++|.||++.+...+ ..|++|++..... .....+.+|+.+++.++|+||+++++++..+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~----~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 72 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTG----KEVAIKVIKLESK----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDEL 72 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCC----cEEEEEEecccch----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence 5889999999999999999987644 3499999966543 2345677799999999999999999999999999
Q ss_pred EEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhch
Q 042539 99 AWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~ 178 (412)
++++||+.|++|..++.... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+......
T Consensus 73 ~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 73 WIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred EEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 99999999999988876543 45899999999999999999999999999999999999999999999999988654211
Q ss_pred hhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccce
Q 042539 179 TAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPE 258 (412)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 258 (412)
.......|+..|+|||
T Consensus 152 ----------------------------------------------------------------~~~~~~~~~~~~~~PE 167 (253)
T cd05122 152 ----------------------------------------------------------------KARNTMVGTPYWMAPE 167 (253)
T ss_pred ----------------------------------------------------------------ccccceecCCcccCHH
Confidence 0023456888999999
Q ss_pred eecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhc-CCCCCC---CCChHHHHHHHHhhhhCCCccCCCCC
Q 042539 259 VVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLM-KTPEFV---GQRTALTDLIQRLLEKDPVKRLGYLR 334 (412)
Q Consensus 259 ~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~-~~~~~~---~~~~~~~dli~~~L~~dP~~R~~~~~ 334 (412)
.+.+..++.++|+|||||++|+|++|+.||...+.......... ..+... ..+..+.++|.+||+.||++||
T Consensus 168 ~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~---- 243 (253)
T cd05122 168 VINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRP---- 243 (253)
T ss_pred HHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCChhhCC----
Confidence 99888889999999999999999999999988754443333322 222222 2268899999999999999999
Q ss_pred ChhhhhcCCC
Q 042539 335 GACEIKEHVF 344 (412)
Q Consensus 335 ~~~e~l~h~f 344 (412)
++.++++|||
T Consensus 244 t~~~~l~~~~ 253 (253)
T cd05122 244 TAEQLLKHPF 253 (253)
T ss_pred CHHHHhcCCC
Confidence 6999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=315.91 Aligned_cols=241 Identities=20% Similarity=0.288 Sum_probs=192.4
Q ss_pred eeeeccCceEEEEEEEcCCCC---CCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEE
Q 042539 24 KILGKGAMGTVFLVHDRAADP---TARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAW 100 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 100 (412)
+.||+|+||.||+|.++..+. .....||+|.+.+.. ......+..|+.+++.++||||+++++++..++..++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH----RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh----HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEE
Confidence 469999999999998765432 234458888875543 2334456679999999999999999999999999999
Q ss_pred EeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCC--------EEEcccccc
Q 042539 101 AVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGH--------VTLTDFDLS 172 (412)
Q Consensus 101 v~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~--------vkL~DFGla 172 (412)
||||+.+|+|..++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. ++++|||++
T Consensus 77 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred EEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999988876543 35899999999999999999999999999999999999988765 699999987
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
.... ......++.
T Consensus 156 ~~~~-------------------------------------------------------------------~~~~~~~~~ 168 (258)
T cd05078 156 ITVL-------------------------------------------------------------------PKEILLERI 168 (258)
T ss_pred cccC-------------------------------------------------------------------CchhccccC
Confidence 5431 012346788
Q ss_pred CCccceeecCC-CCCchhhHHHHHHHHHHHhhC-CCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCcc
Q 042539 253 EYVSPEVVRGD-GHEFAVDWWALGILTYEMLYG-TTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKR 329 (412)
Q Consensus 253 ~Y~APE~l~~~-~~~~~~DiwSlGvil~ell~g-~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R 329 (412)
.|+|||++.+. .++.++|||||||++|+|++| .+||...+...... +.......+ ..+.++.+||.+||+.||.+|
T Consensus 169 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 247 (258)
T cd05078 169 PWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQLPAPKWTELANLINQCMDYEPDFR 247 (258)
T ss_pred CccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccccCCCCCcHHHHHHHHHHhccChhhC
Confidence 99999999874 478999999999999999998 57777666554433 222222333 345789999999999999999
Q ss_pred CCCCCChhhhhc
Q 042539 330 LGYLRGACEIKE 341 (412)
Q Consensus 330 ~~~~~~~~e~l~ 341 (412)
| +++++++
T Consensus 248 p----s~~~il~ 255 (258)
T cd05078 248 P----SFRAIIR 255 (258)
T ss_pred C----CHHHHHH
Confidence 9 6888875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=311.83 Aligned_cols=247 Identities=19% Similarity=0.271 Sum_probs=198.8
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEEEee
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVP 103 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~e 103 (412)
++||+|+||.||+|.+...+. ....||+|.+...... .....+.+|+++++.+.|+||+++++++. .+..++|||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~-~~~~~~iK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e 75 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSG-KEVEVAVKTLKQEHIA---AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVME 75 (257)
T ss_pred CccCccCceeEEEeEeeccCC-CcceEEEEecccccch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEE
Confidence 579999999999998765442 2345999999765432 34556778999999999999999999876 456899999
Q ss_pred ccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhhh
Q 042539 104 YCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEK 183 (412)
Q Consensus 104 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~ 183 (412)
|+.+|+|..++.... .+++..+..++.|++.||+|||+.|++||||||+|||++.++.+||+|||+++........
T Consensus 76 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~-- 151 (257)
T cd05060 76 LAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY-- 151 (257)
T ss_pred eCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcc--
Confidence 999999988876544 5899999999999999999999999999999999999999999999999998754211000
Q ss_pred hcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecCC
Q 042539 184 QSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGD 263 (412)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~ 263 (412)
........++..|+|||.+.+.
T Consensus 152 ----------------------------------------------------------~~~~~~~~~~~~y~aPE~~~~~ 173 (257)
T cd05060 152 ----------------------------------------------------------YRATTAGRWPLKWYAPECINYG 173 (257)
T ss_pred ----------------------------------------------------------cccccCccccccccCHHHhcCC
Confidence 0000111245679999999988
Q ss_pred CCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhh
Q 042539 264 GHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIK 340 (412)
Q Consensus 264 ~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l 340 (412)
.++.++|||||||++|+|++ |.+||...+..+....+.... +.....+..++++|.+||..+|.+|| ++.+++
T Consensus 174 ~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp----~~~~l~ 249 (257)
T cd05060 174 KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRP----TFSELE 249 (257)
T ss_pred CCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCc----CHHHHH
Confidence 89999999999999999997 999999887776666655433 22334678999999999999999999 567766
Q ss_pred c
Q 042539 341 E 341 (412)
Q Consensus 341 ~ 341 (412)
+
T Consensus 250 ~ 250 (257)
T cd05060 250 S 250 (257)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=322.03 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=208.2
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
..|..++.||+|+||.||++++..++. .||+|++.+.... ..+....+.+|+++++.++|+||+++++++.+++.
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~----~valK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNE----VVAIKKMSYSGKQ-SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHT 99 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCc----EEEEEEEecCCCC-chHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCe
Confidence 458899999999999999999876544 4999998765432 23445567789999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
.|+||||+.| +|..++... ...+++.++..++.|++.||.|||++||+||||+|+||+++.++.+||+|||++....
T Consensus 100 ~~lv~e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~- 176 (317)
T cd06635 100 AWLVMEYCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS- 176 (317)
T ss_pred EEEEEeCCCC-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC-
Confidence 9999999975 665555433 3458999999999999999999999999999999999999999999999999875321
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
......|++.|+||
T Consensus 177 ------------------------------------------------------------------~~~~~~~~~~y~aP 190 (317)
T cd06635 177 ------------------------------------------------------------------PANSFVGTPYWMAP 190 (317)
T ss_pred ------------------------------------------------------------------CcccccCCccccCh
Confidence 01234688899999
Q ss_pred eeec---CCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-C--CCCCChHHHHHHHHhhhhCCCccCC
Q 042539 258 EVVR---GDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP-E--FVGQRTALTDLIQRLLEKDPVKRLG 331 (412)
Q Consensus 258 E~l~---~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-~--~~~~~~~~~dli~~~L~~dP~~R~~ 331 (412)
|++. +..++.++|||||||++|+|++|..||...+.......+..... . ....++.+++||.+||+.+|.+||
T Consensus 191 E~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp- 269 (317)
T cd06635 191 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRP- 269 (317)
T ss_pred hhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCc-
Confidence 9974 34578899999999999999999999988776666665554332 2 224567899999999999999999
Q ss_pred CCCChhhhhcCCCCCC
Q 042539 332 YLRGACEIKEHVFFKG 347 (412)
Q Consensus 332 ~~~~~~e~l~h~ff~~ 347 (412)
++.++++|+|+..
T Consensus 270 ---t~~~il~~~~~~~ 282 (317)
T cd06635 270 ---TSEELLKHMFVLR 282 (317)
T ss_pred ---CHHHHHhChhhhc
Confidence 6999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=315.39 Aligned_cols=260 Identities=19% Similarity=0.230 Sum_probs=209.3
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
.+..++|++.+.||+|+||.||+|.+...+......||+|.+.... .......+.+|+.+++.++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 78 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA---SEIQVTLLLQESCLLYGLSHQNILPILHVCI 78 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 4667899999999999999999999876543345669999886432 2334566778999999999999999999876
Q ss_pred e-CCeEEEEeeccCCCCchhHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEE
Q 042539 94 T-DEFLAWAVPYCPGGDLNVLRYKQND------RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTL 166 (412)
Q Consensus 94 ~-~~~~~lv~e~~~gg~L~~~~~~~~~------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL 166 (412)
. +...+++++|+.+++|..++..... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||
T Consensus 79 ~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 79 EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred cCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEE
Confidence 5 5678999999999999888765422 35899999999999999999999999999999999999999999999
Q ss_pred ccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCc
Q 042539 167 TDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSN 246 (412)
Q Consensus 167 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (412)
+|||+++.+...... ....
T Consensus 159 ~d~g~~~~~~~~~~~-------------------------------------------------------------~~~~ 177 (280)
T cd05043 159 TDNALSRDLFPMDYH-------------------------------------------------------------CLGD 177 (280)
T ss_pred CCCCCcccccCCceE-------------------------------------------------------------EeCC
Confidence 999999754211000 0001
Q ss_pred ccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCC--CCCCCChHHHHHHHHhhh
Q 042539 247 SFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTP--EFVGQRTALTDLIQRLLE 323 (412)
Q Consensus 247 ~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~dli~~~L~ 323 (412)
...++..|+|||++.+..++.++|||||||++||+++ |++||...+..+....+..... .....++++.++|.+||.
T Consensus 178 ~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 257 (280)
T cd05043 178 NENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWA 257 (280)
T ss_pred CCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcC
Confidence 1235678999999998889999999999999999998 9999998877666555544321 223457889999999999
Q ss_pred hCCCccCCCCCChhhhhc
Q 042539 324 KDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 324 ~dP~~R~~~~~~~~e~l~ 341 (412)
.||++|| ++.++++
T Consensus 258 ~~p~~Rp----s~~~~~~ 271 (280)
T cd05043 258 LDPEERP----SFSQLVQ 271 (280)
T ss_pred CChhhCC----CHHHHHH
Confidence 9999999 5677764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=318.00 Aligned_cols=251 Identities=29% Similarity=0.454 Sum_probs=205.2
Q ss_pred ceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEE
Q 042539 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLA 99 (412)
Q Consensus 20 y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 99 (412)
|++.+.||.|++|.||+|.+...+ +.+|+|.++..... ......+.+|+++++.++|+||+++++++.+++.+|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 74 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTG----EIVAIKKIKLRFES--EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLY 74 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCC----cEEEEEEecccccc--chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEE
Confidence 678899999999999999886644 44999998765432 233456777999999999999999999999999999
Q ss_pred EEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchh
Q 042539 100 WAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKT 179 (412)
Q Consensus 100 lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~ 179 (412)
+||||+.+ +|..++.... ..+++.++..++.|++.||.|||++||+|+||||+||+++.++.+||+|||.+.......
T Consensus 75 ~v~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 75 LVFEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred EEEeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 99999975 7766655433 468999999999999999999999999999999999999999999999999886542110
Q ss_pred hhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcccee
Q 042539 180 AFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEV 259 (412)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 259 (412)
.......++..|+|||.
T Consensus 153 ---------------------------------------------------------------~~~~~~~~~~~~~~PE~ 169 (283)
T cd05118 153 ---------------------------------------------------------------RPYTHYVVTRWYRAPEL 169 (283)
T ss_pred ---------------------------------------------------------------ccccCccCcccccCcHH
Confidence 01112357889999999
Q ss_pred ecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-------------------------------CC
Q 042539 260 VRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP-------------------------------EF 307 (412)
Q Consensus 260 l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-------------------------------~~ 307 (412)
+.+. .++.++|+|||||++|+|++|+.||.+.+..+.+..+..... ..
T Consensus 170 ~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (283)
T cd05118 170 LLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLF 249 (283)
T ss_pred HhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhh
Confidence 8876 679999999999999999999999998876655444432100 01
Q ss_pred CCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCC
Q 042539 308 VGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 308 ~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff 345 (412)
+..+.++.+||.+||..||.+|| ++.+++.||||
T Consensus 250 ~~~~~~~~~~i~~~l~~~P~~Rp----~~~~ll~~~~~ 283 (283)
T cd05118 250 PNASPQALDLLSQMLHYDPHKRI----TAEQALAHPYF 283 (283)
T ss_pred hhhCHHHHHHHHHHhccCcccCc----CHHHHhhCCCC
Confidence 13467899999999999999999 69999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=312.86 Aligned_cols=241 Identities=18% Similarity=0.277 Sum_probs=193.0
Q ss_pred eeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEEEeec
Q 042539 25 ILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPY 104 (412)
Q Consensus 25 ~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~e~ 104 (412)
.||+|+||.||++.++... .+..||+|++.... .......+.+|+.++++++|+||++++++++ ....++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~--~~~~vavk~~~~~~---~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRK--KQIDVAIKVLKNEN---EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCC--CceeEEEEEccccc---ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEe
Confidence 4899999999998775332 23349999986543 2334566778999999999999999999886 4578999999
Q ss_pred cCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhhhh
Q 042539 105 CPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQ 184 (412)
Q Consensus 105 ~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~ 184 (412)
+.|++|..++... ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++........
T Consensus 76 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~--- 151 (257)
T cd05115 76 ASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY--- 151 (257)
T ss_pred CCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccc---
Confidence 9999998877643 345899999999999999999999999999999999999999999999999998754211000
Q ss_pred cccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecCCC
Q 042539 185 SLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDG 264 (412)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~ 264 (412)
........++..|+|||++.+..
T Consensus 152 ---------------------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~ 174 (257)
T cd05115 152 ---------------------------------------------------------YKARSAGKWPLKWYAPECINFRK 174 (257)
T ss_pred ---------------------------------------------------------eeccCCCCCCcccCCHHHHccCC
Confidence 00001112357899999998888
Q ss_pred CCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCC-C-CCCCChHHHHHHHHhhhhCCCccCCC
Q 042539 265 HEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTP-E-FVGQRTALTDLIQRLLEKDPVKRLGY 332 (412)
Q Consensus 265 ~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~-~-~~~~~~~~~dli~~~L~~dP~~R~~~ 332 (412)
++.++|||||||++|+|++ |..||.+....+....+..... . ....+.++.++|.+||..||++||++
T Consensus 175 ~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~ 245 (257)
T cd05115 175 FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNF 245 (257)
T ss_pred CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence 9999999999999999996 9999998887776666654332 2 23457899999999999999999953
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=313.61 Aligned_cols=243 Identities=19% Similarity=0.244 Sum_probs=190.3
Q ss_pred eeeeccCceEEEEEEEcCCCC--------CCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 24 KILGKGAMGTVFLVHDRAADP--------TARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~--------~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
+.||+|+||.||++....... .....||+|++.... ......+..|+.+++.++||||+++++++..+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH----RDISLAFFETASMMRQVSHKHIVLLYGVCVRD 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh----hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 468999999999997532211 123348888875532 23445667789999999999999999999999
Q ss_pred CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCC-------EEEcc
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGH-------VTLTD 168 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~-------vkL~D 168 (412)
...++||||+.+|+|..++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++. +|++|
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 9999999999999998776543 345899999999999999999999999999999999999987764 89999
Q ss_pred ccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccc
Q 042539 169 FDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248 (412)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (412)
||++..... ....
T Consensus 156 ~g~~~~~~~-------------------------------------------------------------------~~~~ 168 (262)
T cd05077 156 PGIPITVLS-------------------------------------------------------------------RQEC 168 (262)
T ss_pred CCCCccccC-------------------------------------------------------------------cccc
Confidence 998854311 1123
Q ss_pred ccCCCCccceeec-CCCCCchhhHHHHHHHHHHHh-hCCCCCCCCCHHHHHHHHhcCCCCCCCCChHHHHHHHHhhhhCC
Q 042539 249 VGTEEYVSPEVVR-GDGHEFAVDWWALGILTYEML-YGTTPFRGKNRKETFRNVLMKTPEFVGQRTALTDLIQRLLEKDP 326 (412)
Q Consensus 249 ~gt~~Y~APE~l~-~~~~~~~~DiwSlGvil~ell-~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~dli~~~L~~dP 326 (412)
.|+..|+|||++. +..++.++|||||||++|+|+ +|..||......+...............++++.+||.+||+.||
T Consensus 169 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp 248 (262)
T cd05077 169 VERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVTPSCKELADLMTHCMNYDP 248 (262)
T ss_pred cccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCccCCCCChHHHHHHHHHHcCCCh
Confidence 5788899999987 456899999999999999997 69999987665444322211112222345789999999999999
Q ss_pred CccCCCCCChhhhhcC
Q 042539 327 VKRLGYLRGACEIKEH 342 (412)
Q Consensus 327 ~~R~~~~~~~~e~l~h 342 (412)
.+|| +..+++.+
T Consensus 249 ~~Rp----~~~~il~~ 260 (262)
T cd05077 249 NQRP----FFRAIMRD 260 (262)
T ss_pred hhCc----CHHHHHHh
Confidence 9999 57888753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=310.22 Aligned_cols=249 Identities=20% Similarity=0.274 Sum_probs=204.6
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
...+|++.+.||+|+||.||++.+.. + ..+|+|.+...... ...+.+|++++++++|+||+++++++...
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~~-~----~~~~~k~~~~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWLE-K----RKVAIKTIREGAMS-----EEDFIEEAQVMMKLSHPKLVQLYGVCTER 71 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEeC-C----CeEEEEECCCCCCC-----HHHHHHHHHHHHhCCCCCeeeEEEEEccC
Confidence 46789999999999999999998753 2 23899998755432 23456799999999999999999999999
Q ss_pred CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchh
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
...|+||||+.|++|..++.... +.+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||+++..
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 150 (256)
T cd05112 72 SPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFV 150 (256)
T ss_pred CceEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeec
Confidence 99999999999999988776433 35889999999999999999999999999999999999999999999999998654
Q ss_pred hchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCc
Q 042539 176 VKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYV 255 (412)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 255 (412)
.... ........++..|+
T Consensus 151 ~~~~--------------------------------------------------------------~~~~~~~~~~~~~~ 168 (256)
T cd05112 151 LDDQ--------------------------------------------------------------YTSSTGTKFPVKWS 168 (256)
T ss_pred ccCc--------------------------------------------------------------ccccCCCccchhhc
Confidence 2100 00011223567899
Q ss_pred cceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCCC--CCCCChHHHHHHHHhhhhCCCccCCC
Q 042539 256 SPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTPE--FVGQRTALTDLIQRLLEKDPVKRLGY 332 (412)
Q Consensus 256 APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~dli~~~L~~dP~~R~~~ 332 (412)
|||.+.+..++.++|+|||||++|||++ |+.||...........+...... ....+..+.+|+.+||..+|++||
T Consensus 169 aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp-- 246 (256)
T cd05112 169 SPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRP-- 246 (256)
T ss_pred CHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhCC--
Confidence 9999998889999999999999999998 99999988877777666543221 223578999999999999999999
Q ss_pred CCChhhhhc
Q 042539 333 LRGACEIKE 341 (412)
Q Consensus 333 ~~~~~e~l~ 341 (412)
++.++++
T Consensus 247 --~~~~~l~ 253 (256)
T cd05112 247 --SFSLLLH 253 (256)
T ss_pred --CHHHHHH
Confidence 6888875
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=306.34 Aligned_cols=265 Identities=25% Similarity=0.329 Sum_probs=205.1
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
+..++-++|.+.+.||+|||+.||+|+...++.. ||+|.|.... .+.....++|++..++++||||++++++
T Consensus 15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~----YAlKkI~c~~----~~~~e~~~rEid~~rkf~s~~vl~l~dh 86 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHL----YALKKILCHS----QEDIEEALREIDNHRKFNSPNVLRLVDH 86 (302)
T ss_pred cEEEcCceEEEeeeecCCCceeeeeecccCcccc----hhhheeeccc----hHHHHHHHHHHHHHHhhCCcchHHHHHH
Confidence 3456678999999999999999999997665544 9999996653 3456778889999999999999999998
Q ss_pred EEeCC-----eEEEEeeccCCCCchhHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeeeCCCCceEEccCC
Q 042539 92 LETDE-----FLAWAVPYCPGGDLNVLRYKQN--DRVFSPSVIRFYLSEIICAIEHLHNMG--IAYRDLKPENILIRQSG 162 (412)
Q Consensus 92 ~~~~~-----~~~lv~e~~~gg~L~~~~~~~~--~~~l~~~~~~~~~~qi~~aL~yLH~~~--iiHrDlKp~NiLl~~~g 162 (412)
...+. ..||+++|...|+|.+.+.... +..++|.++..|+.+|+.||++||+.. ++||||||.|||+...+
T Consensus 87 ~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~ 166 (302)
T KOG2345|consen 87 QLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG 166 (302)
T ss_pred HHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC
Confidence 75433 4999999999999977765543 335999999999999999999999999 99999999999999999
Q ss_pred CEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCC
Q 042539 163 HVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNG 242 (412)
Q Consensus 163 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (412)
..+|.|||.++..........+.. .+.+|
T Consensus 167 ~~vl~D~GS~~~a~i~i~~~~~a~-------------------~lQe~-------------------------------- 195 (302)
T KOG2345|consen 167 LPVLMDLGSATQAPIQIEGSRQAL-------------------RLQEW-------------------------------- 195 (302)
T ss_pred ceEEEeccCccccceEeechHHHH-------------------HHHHH--------------------------------
Confidence 999999999876643222111110 01111
Q ss_pred CCCcccccCCCCccceeecCC---CCCchhhHHHHHHHHHHHhhCCCCCCCCCHH--HHHHHHhcCC---CCCCCCChHH
Q 042539 243 ERSNSFVGTEEYVSPEVVRGD---GHEFAVDWWALGILTYEMLYGTTPFRGKNRK--ETFRNVLMKT---PEFVGQRTAL 314 (412)
Q Consensus 243 ~~~~~~~gt~~Y~APE~l~~~---~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--~~~~~i~~~~---~~~~~~~~~~ 314 (412)
..-..|..|+|||.+.-+ ..+.++|||||||+||+|+.|..||+..-.. .+.-.+.... |.-...+..+
T Consensus 196 ---a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l 272 (302)
T KOG2345|consen 196 ---AEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEAL 272 (302)
T ss_pred ---HHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHH
Confidence 122468889999998654 3488999999999999999999999642110 0011122222 3333467899
Q ss_pred HHHHHHhhhhCCCccCCCCCChhhhhcC
Q 042539 315 TDLIQRLLEKDPVKRLGYLRGACEIKEH 342 (412)
Q Consensus 315 ~dli~~~L~~dP~~R~~~~~~~~e~l~h 342 (412)
.+||.+||+.||.+|| ++.+++.+
T Consensus 273 ~~lik~mlqvdP~qRP----~i~~ll~~ 296 (302)
T KOG2345|consen 273 HQLIKSMLQVDPNQRP----TIPELLSK 296 (302)
T ss_pred HHHHHHHhcCCcccCC----CHHHHHHH
Confidence 9999999999999999 68888763
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=309.50 Aligned_cols=253 Identities=24% Similarity=0.349 Sum_probs=209.4
Q ss_pred ceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEE
Q 042539 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLA 99 (412)
Q Consensus 20 y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 99 (412)
+++++.||.|+||.||++.+...+......||+|++..... ......+..|+.+++.++|+||+++++++.+.+..|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD---EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC---hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeE
Confidence 46789999999999999999876534456699999965532 124556778999999999999999999999999999
Q ss_pred EEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchh
Q 042539 100 WAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKT 179 (412)
Q Consensus 100 lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~ 179 (412)
++|||+.|++|..++.......+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++......
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 99999999999888765443338999999999999999999999999999999999999999999999999987653210
Q ss_pred hhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcccee
Q 042539 180 AFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEV 259 (412)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 259 (412)
.+ . .....+++.|+|||.
T Consensus 158 ~~----------------------------------------------------------~----~~~~~~~~~y~~Pe~ 175 (258)
T smart00219 158 YY----------------------------------------------------------K----KKGGKLPIRWMAPES 175 (258)
T ss_pred cc----------------------------------------------------------c----cccCCCcccccChHH
Confidence 00 0 001126789999999
Q ss_pred ecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCC--CCCCCChHHHHHHHHhhhhCCCccCCCCCCh
Q 042539 260 VRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTP--EFVGQRTALTDLIQRLLEKDPVKRLGYLRGA 336 (412)
Q Consensus 260 l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~ 336 (412)
+.+..++.++|+|||||++|+|++ |.+||.+.+.......+..... .....+.++.+++.+||..||++|| ++
T Consensus 176 ~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp----t~ 251 (258)
T smart00219 176 LKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRP----TF 251 (258)
T ss_pred hccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCc----CH
Confidence 988888999999999999999998 8999998887777776654432 2234578999999999999999999 68
Q ss_pred hhhhc
Q 042539 337 CEIKE 341 (412)
Q Consensus 337 ~e~l~ 341 (412)
.++++
T Consensus 252 ~~ll~ 256 (258)
T smart00219 252 SELVE 256 (258)
T ss_pred HHHHh
Confidence 88875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=314.21 Aligned_cols=245 Identities=22% Similarity=0.341 Sum_probs=196.6
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeeeeEEeCCeEEEEe
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLGSLETDEFLAWAV 102 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~ 102 (412)
+.||+|+||.||+++++.++. ...+|+|.++... .......+.+|++++.++ +||||+++++++...+.+|+||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~--~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGL--RMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCC--eeEEEEEEccccC---CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEE
Confidence 468999999999999876542 2337888886432 123345677799999999 6999999999999999999999
Q ss_pred eccCCCCchhHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcc
Q 042539 103 PYCPGGDLNVLRYKQN--------------DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTD 168 (412)
Q Consensus 103 e~~~gg~L~~~~~~~~--------------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~D 168 (412)
||+.+|+|..++.... ...+++.+++.++.|++.||+|||++|++||||||+|||++.++.+||+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~d 155 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIAD 155 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECC
Confidence 9999999988876432 12478999999999999999999999999999999999999999999999
Q ss_pred ccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccc
Q 042539 169 FDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248 (412)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (412)
||++...... ......
T Consensus 156 fgl~~~~~~~----------------------------------------------------------------~~~~~~ 171 (270)
T cd05047 156 FGLSRGQEVY----------------------------------------------------------------VKKTMG 171 (270)
T ss_pred CCCccccchh----------------------------------------------------------------hhccCC
Confidence 9988532100 000112
Q ss_pred ccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCC--CCCCCChHHHHHHHHhhhhC
Q 042539 249 VGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTP--EFVGQRTALTDLIQRLLEKD 325 (412)
Q Consensus 249 ~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~dli~~~L~~d 325 (412)
..+..|+|||++.+..++.++|+|||||++|||++ |..||.+.+..+.+..+..... .....+.++.++|.+||..|
T Consensus 172 ~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 251 (270)
T cd05047 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREK 251 (270)
T ss_pred CCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccC
Confidence 34567999999988889999999999999999996 9999998887777666644321 22345688999999999999
Q ss_pred CCccCCCCCChhhhhc
Q 042539 326 PVKRLGYLRGACEIKE 341 (412)
Q Consensus 326 P~~R~~~~~~~~e~l~ 341 (412)
|.+|| ++.++++
T Consensus 252 p~~Rp----s~~~il~ 263 (270)
T cd05047 252 PYERP----SFAQILV 263 (270)
T ss_pred hhhCC----CHHHHHH
Confidence 99999 5677664
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=316.71 Aligned_cols=257 Identities=20% Similarity=0.253 Sum_probs=201.5
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC-
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD- 95 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~- 95 (412)
-.-|++++.||+|+||.||+|+....+..++..||+|.++.... ......+.+|+++++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG---GNHIADLKKEIEILRNLYHENIVKYKGICTEDG 79 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc---HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 35689999999999999999987665555677799999865421 23345678899999999999999999998875
Q ss_pred -CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 96 -EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 96 -~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
...++||||+.|++|..++.... ..+++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccc
Confidence 57899999999999988875432 3589999999999999999999999999999999999999999999999999875
Q ss_pred hhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCC
Q 042539 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254 (412)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 254 (412)
+...... ........|+..|
T Consensus 159 ~~~~~~~------------------------------------------------------------~~~~~~~~~~~~y 178 (284)
T cd05079 159 IETDKEY------------------------------------------------------------YTVKDDLDSPVFW 178 (284)
T ss_pred cccCccc------------------------------------------------------------eeecCCCCCCccc
Confidence 5211100 0011234577789
Q ss_pred ccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCC--------------HHHHHHHHhc---CCCCCCCCChHHHHH
Q 042539 255 VSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKN--------------RKETFRNVLM---KTPEFVGQRTALTDL 317 (412)
Q Consensus 255 ~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~--------------~~~~~~~i~~---~~~~~~~~~~~~~dl 317 (412)
+|||.+.+..++.++|||||||++|+|+++..|+.... ........+. ..+.....+..+.+|
T Consensus 179 ~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (284)
T cd05079 179 YAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQL 258 (284)
T ss_pred cCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHH
Confidence 99999988888999999999999999999876643210 0111111111 112234567899999
Q ss_pred HHHhhhhCCCccCCCCCChhhhhc
Q 042539 318 IQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 318 i~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
|.+||+.||.+|| ++.++++
T Consensus 259 i~~~l~~~p~~Rp----t~~~il~ 278 (284)
T cd05079 259 MRKCWEFQPSKRT----TFQNLIE 278 (284)
T ss_pred HHHHccCCcccCc----CHHHHHH
Confidence 9999999999999 6888875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=311.98 Aligned_cols=256 Identities=20% Similarity=0.333 Sum_probs=207.2
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
++..++|.+.+.||+|+||.||+|.+.... .....||||.+..... ....+.+.+|+++++.++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~v~ik~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 77 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPE-NEKIAVAVKTCKNCTS---PSVREKFLQEAYIMRQFDHPHIVKLIGVIT 77 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCC-CCCcceEEEecCCcCC---HHHHHHHHHHHHHHHhCCCCchhceeEEEc
Confidence 355678999999999999999999876542 1334589998865431 234456778999999999999999999887
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
+ +..|+||||+.+|+|..++.... ..+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+++
T Consensus 78 ~-~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~ 155 (270)
T cd05056 78 E-NPVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSR 155 (270)
T ss_pred C-CCcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceee
Confidence 5 45789999999999998876533 358999999999999999999999999999999999999999999999999987
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
....... .......++..
T Consensus 156 ~~~~~~~--------------------------------------------------------------~~~~~~~~~~~ 173 (270)
T cd05056 156 YLEDESY--------------------------------------------------------------YKASKGKLPIK 173 (270)
T ss_pred ecccccc--------------------------------------------------------------eecCCCCcccc
Confidence 5421100 00012234568
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCccC
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVKRL 330 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~R~ 330 (412)
|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+.... +.....+..+.++|.+||..+|.+||
T Consensus 174 y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 253 (270)
T cd05056 174 WMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRP 253 (270)
T ss_pred ccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCc
Confidence 999999988889999999999999999986 999999988777666665432 23345678999999999999999999
Q ss_pred CCCCChhhhhc
Q 042539 331 GYLRGACEIKE 341 (412)
Q Consensus 331 ~~~~~~~e~l~ 341 (412)
++.+++.
T Consensus 254 ----t~~~~~~ 260 (270)
T cd05056 254 ----RFTELKA 260 (270)
T ss_pred ----CHHHHHH
Confidence 5777765
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=310.61 Aligned_cols=244 Identities=22% Similarity=0.299 Sum_probs=201.0
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET 94 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 94 (412)
+.+++|++.+.||+|+||.||++.. .++.||+|.++... ....+.+|+.+++.++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~------~~~~~~iK~~~~~~------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 70 (254)
T cd05083 3 LNLQKLTLGEIIGEGEFGAVLQGEY------TGQKVAVKNIKCDV------TAQAFLEETAVMTKLHHKNLVRLLGVILH 70 (254)
T ss_pred ccHHHceeeeeeccCCCCceEeccc------CCCceEEEeecCcc------hHHHHHHHHHHHHhCCCCCcCeEEEEEcC
Confidence 4678999999999999999998753 23349999985432 23456779999999999999999999875
Q ss_pred CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
+ ..|+||||+.|++|..++.......+++..+..++.|++.||.|||++|++||||||+||+++.+|.+||+|||+++.
T Consensus 71 ~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~ 149 (254)
T cd05083 71 N-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARV 149 (254)
T ss_pred C-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCcccee
Confidence 4 479999999999999888766555689999999999999999999999999999999999999999999999998864
Q ss_pred hhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCC
Q 042539 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254 (412)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 254 (412)
.... ......+..|
T Consensus 150 ~~~~------------------------------------------------------------------~~~~~~~~~y 163 (254)
T cd05083 150 GSMG------------------------------------------------------------------VDNSKLPVKW 163 (254)
T ss_pred cccc------------------------------------------------------------------CCCCCCCcee
Confidence 3100 0011234679
Q ss_pred ccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCccCC
Q 042539 255 VSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVKRLG 331 (412)
Q Consensus 255 ~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~R~~ 331 (412)
+|||.+.+..++.++|+|||||++|+|++ |++||.+.+..+....+.... ......+..+.++|.+||..+|.+||
T Consensus 164 ~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp- 242 (254)
T cd05083 164 TAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRP- 242 (254)
T ss_pred cCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCc-
Confidence 99999988889999999999999999997 999999988777666554432 12234678999999999999999999
Q ss_pred CCCChhhhhc
Q 042539 332 YLRGACEIKE 341 (412)
Q Consensus 332 ~~~~~~e~l~ 341 (412)
+++++++
T Consensus 243 ---~~~~l~~ 249 (254)
T cd05083 243 ---SFHKLRE 249 (254)
T ss_pred ---CHHHHHH
Confidence 5777664
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=317.33 Aligned_cols=251 Identities=29% Similarity=0.436 Sum_probs=205.8
Q ss_pred ceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEE
Q 042539 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLA 99 (412)
Q Consensus 20 y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 99 (412)
|++.+.||+|+||.||+|.+..++. .||+|++..... .......+..|+.+++.++|+||+++++++.+.+.++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~----~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 74 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGE----IVALKKIRLDNE--EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLY 74 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCc----EEEEEEeccccc--cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceE
Confidence 6788999999999999998876544 499999976541 2233455667999999999999999999999999999
Q ss_pred EEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchh
Q 042539 100 WAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKT 179 (412)
Q Consensus 100 lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~ 179 (412)
+||||+. ++|..++.... ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||+++.....
T Consensus 75 ~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~- 151 (282)
T cd07829 75 LVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP- 151 (282)
T ss_pred EEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCC-
Confidence 9999997 58888776543 35999999999999999999999999999999999999999999999999998754211
Q ss_pred hhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcccee
Q 042539 180 AFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEV 259 (412)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 259 (412)
........++..|+|||.
T Consensus 152 --------------------------------------------------------------~~~~~~~~~~~~~~aPE~ 169 (282)
T cd07829 152 --------------------------------------------------------------LRTYTHEVVTLWYRAPEI 169 (282)
T ss_pred --------------------------------------------------------------ccccCccccCcCcCChHH
Confidence 001112345778999999
Q ss_pred ecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC------------------------------CCCC
Q 042539 260 VRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT------------------------------PEFV 308 (412)
Q Consensus 260 l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~------------------------------~~~~ 308 (412)
+.+. .++.++|+|||||++|||++|.+||.+.+..+.+.++.... ..++
T Consensus 170 ~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (282)
T cd07829 170 LLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLP 249 (282)
T ss_pred hcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcc
Confidence 8776 67899999999999999999999999877665544433100 0112
Q ss_pred CCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCC
Q 042539 309 GQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 309 ~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff 345 (412)
..+..+.++|.+||..||++|| ++++++.||||
T Consensus 250 ~~~~~~~~~i~~~l~~~P~~Rp----~~~~~l~~p~~ 282 (282)
T cd07829 250 RLDPEGIDLLSKMLQYNPAKRI----SAKEALKHPYF 282 (282)
T ss_pred cccHHHHHHHHHhhccCcccCC----CHHHHhhCcCC
Confidence 3467899999999999999999 79999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=310.43 Aligned_cols=263 Identities=24% Similarity=0.372 Sum_probs=215.8
Q ss_pred CCCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccce
Q 042539 9 PQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPK 87 (412)
Q Consensus 9 ~~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~ 87 (412)
+.....++.++++-+..||.|+||+|++-.++..+ +..|||.|+.... +..+++++.|..+..+- ++||||+
T Consensus 55 ~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg----~~mAVKrIr~~n~---~keq~rll~e~d~~mks~~cp~IVk 127 (361)
T KOG1006|consen 55 DAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSG----KLMAVKRIRSNNI---EKEQKRLLMEHDTVMKSSNCPNIVK 127 (361)
T ss_pred cccccccccchHHHHHHhcCCcchhhhhhhcCccC----cEEEEEEeeeccc---hHHHHHHHHHHHHHHhhcCCcHHHH
Confidence 44567889999999999999999999987776644 4599999976543 44567778888877666 5999999
Q ss_pred eeeeEEeCCeEEEEeeccCCCCch---hHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeeCCCCceEEccCCC
Q 042539 88 LLGSLETDEFLAWAVPYCPGGDLN---VLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN-MGIAYRDLKPENILIRQSGH 163 (412)
Q Consensus 88 l~~~~~~~~~~~lv~e~~~gg~L~---~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDlKp~NiLl~~~g~ 163 (412)
+|++...++.-|+.||+|. .+|+ .+.+......++|+.+-.+..-.+.||.||-. .+|||||+||+|||++..|.
T Consensus 128 fyGa~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~ 206 (361)
T KOG1006|consen 128 FYGALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGD 206 (361)
T ss_pred HhhhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCC
Confidence 9999998889999999994 3443 23444455669999999999999999999975 58999999999999999999
Q ss_pred EEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCC
Q 042539 164 VTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGE 243 (412)
Q Consensus 164 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (412)
+||||||++..+.++...
T Consensus 207 vKLCDFGIcGqLv~SiAk-------------------------------------------------------------- 224 (361)
T KOG1006|consen 207 VKLCDFGICGQLVDSIAK-------------------------------------------------------------- 224 (361)
T ss_pred EeeecccchHhHHHHHHh--------------------------------------------------------------
Confidence 999999999887654331
Q ss_pred CCcccccCCCCccceeecC--CCCCchhhHHHHHHHHHHHhhCCCCCCCCC-HHHHHHHHhcCCCCCC-------CCChH
Q 042539 244 RSNSFVGTEEYVSPEVVRG--DGHEFAVDWWALGILTYEMLYGTTPFRGKN-RKETFRNVLMKTPEFV-------GQRTA 313 (412)
Q Consensus 244 ~~~~~~gt~~Y~APE~l~~--~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-~~~~~~~i~~~~~~~~-------~~~~~ 313 (412)
+.-.|-..|||||.+.. .+|+.+||+||||++|||+.||..|+.+-+ ..+++.+++.+.++.. ..+..
T Consensus 225 --T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~ 302 (361)
T KOG1006|consen 225 --TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFS 302 (361)
T ss_pred --hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHH
Confidence 11247788999999864 468999999999999999999999999854 4466677777765532 34678
Q ss_pred HHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCC
Q 042539 314 LTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 314 ~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
+..||+-||.+|...||. ..++++++|++-
T Consensus 303 ~~~fintCl~Kd~~~Rpk----y~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 303 MVRFINTCLIKDRSDRPK----YDDLKKFPFYRM 332 (361)
T ss_pred HHHHHHHHhhcccccCcc----hhhhhcCchhhh
Confidence 999999999999999995 799999999974
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=318.30 Aligned_cols=258 Identities=21% Similarity=0.283 Sum_probs=205.8
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
-+..++|++++.||+|+||.||++.+..++......||+|++..... ......+.+|+.+++.++|+||+++++++.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~l~h~niv~~~~~~~ 79 (303)
T cd05110 3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG---PKANVEFMDEALIMASMDHPHLVRLLGVCL 79 (303)
T ss_pred ccchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence 35678999999999999999999998776654445689998865432 223345677999999999999999999887
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
.. ..++++||+.+|+|..++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++
T Consensus 80 ~~-~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 80 SP-TIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred CC-CceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccc
Confidence 54 4679999999999988876543 358899999999999999999999999999999999999999999999999997
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
.+..... ........++..
T Consensus 158 ~~~~~~~-------------------------------------------------------------~~~~~~~~~~~~ 176 (303)
T cd05110 158 LLEGDEK-------------------------------------------------------------EYNADGGKMPIK 176 (303)
T ss_pred cccCccc-------------------------------------------------------------ccccCCCccccc
Confidence 5421100 001112345778
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCccC
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVKRL 330 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~R~ 330 (412)
|+|||.+.+..++.++|||||||++|||++ |..||.+.........+.... +.....+..+.++|.+||..+|++||
T Consensus 177 y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp 256 (303)
T cd05110 177 WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRP 256 (303)
T ss_pred cCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCc
Confidence 999999998889999999999999999997 999998876555443333221 22334568899999999999999999
Q ss_pred CCCCChhhhhc
Q 042539 331 GYLRGACEIKE 341 (412)
Q Consensus 331 ~~~~~~~e~l~ 341 (412)
+++++++
T Consensus 257 ----~~~~l~~ 263 (303)
T cd05110 257 ----KFKELAA 263 (303)
T ss_pred ----CHHHHHH
Confidence 5777765
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=319.71 Aligned_cols=255 Identities=23% Similarity=0.328 Sum_probs=207.3
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
..+.|+.++.||+|+||.||+++++.++ ..||+|.+....... ......+.+|+++++.++|+||+++++++..+
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~----~~~~ik~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 87 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNS----EVVAIKKMSYSGKQS-NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE 87 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCC----cEEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC
Confidence 3456888999999999999999987654 349999986543222 23345667799999999999999999999999
Q ss_pred CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchh
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
...++||||+. |++..++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.+|.+||+|||++...
T Consensus 88 ~~~~lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 165 (308)
T cd06634 88 HTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (308)
T ss_pred CeeEEEEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceee
Confidence 99999999996 46665554333 45899999999999999999999999999999999999999999999999988643
Q ss_pred hchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCc
Q 042539 176 VKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYV 255 (412)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 255 (412)
.. .....|++.|+
T Consensus 166 ~~-------------------------------------------------------------------~~~~~~~~~y~ 178 (308)
T cd06634 166 AP-------------------------------------------------------------------ANXFVGTPYWM 178 (308)
T ss_pred cC-------------------------------------------------------------------cccccCCcccc
Confidence 10 11346888999
Q ss_pred cceeecC---CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-CC--CCCCChHHHHHHHHhhhhCCCcc
Q 042539 256 SPEVVRG---DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT-PE--FVGQRTALTDLIQRLLEKDPVKR 329 (412)
Q Consensus 256 APE~l~~---~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-~~--~~~~~~~~~dli~~~L~~dP~~R 329 (412)
|||.+.+ ..++.++|||||||++|+|++|..||...+..+....+.... +. ....+..+.+||.+||..+|.+|
T Consensus 179 aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~R 258 (308)
T cd06634 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDR 258 (308)
T ss_pred CHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccC
Confidence 9999753 456889999999999999999999998766555544444332 22 22467889999999999999999
Q ss_pred CCCCCChhhhhcCCCCCCC
Q 042539 330 LGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 330 ~~~~~~~~e~l~h~ff~~~ 348 (412)
| +++++++|+|+...
T Consensus 259 p----~~~~ll~~~~~~~~ 273 (308)
T cd06634 259 P----TSEVLLKHRFVLRE 273 (308)
T ss_pred C----CHHHHhhCcccccc
Confidence 9 69999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=313.70 Aligned_cols=257 Identities=23% Similarity=0.308 Sum_probs=199.4
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe-
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET- 94 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~- 94 (412)
+-++|++++.||+|+||.||++.....+...+..||+|.+.... ....+.+.+|+++++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 77 (284)
T cd05081 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST----AEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 77 (284)
T ss_pred ccccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC----HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC
Confidence 34689999999999999999998665455566679999986543 2334567789999999999999999998643
Q ss_pred -CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 95 -DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 95 -~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
...+++||||+.|++|..++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 78 GRRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred CCCceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccc
Confidence 357899999999999998875432 358999999999999999999999999999999999999999999999999997
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
........ ........++..
T Consensus 157 ~~~~~~~~------------------------------------------------------------~~~~~~~~~~~~ 176 (284)
T cd05081 157 VLPQDKEY------------------------------------------------------------YKVREPGESPIF 176 (284)
T ss_pred cccCCCcc------------------------------------------------------------eeecCCCCCceE
Confidence 55211100 000011123456
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHH---------------HHHHHhcCC---CCCCCCChHHH
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKE---------------TFRNVLMKT---PEFVGQRTALT 315 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---------------~~~~i~~~~---~~~~~~~~~~~ 315 (412)
|+|||++.+..++.++|||||||++|||++|..++....... .+..++... +.....+.++.
T Consensus 177 y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (284)
T cd05081 177 WYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIY 256 (284)
T ss_pred eeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHH
Confidence 999999998889999999999999999999887764432110 011122211 22345678999
Q ss_pred HHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 316 DLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 316 dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
+||.+||..+|++|| ++.++++
T Consensus 257 ~li~~cl~~~p~~Rp----t~~ei~~ 278 (284)
T cd05081 257 AIMKECWNNDPSQRP----SFSELAL 278 (284)
T ss_pred HHHHHHccCChhhCC----CHHHHHH
Confidence 999999999999999 6888775
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=305.09 Aligned_cols=243 Identities=21% Similarity=0.311 Sum_probs=197.3
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEEEee
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVP 103 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~e 103 (412)
++||+|+||.||++.... +..||+|++..... ......+.+|+++++.++|+||+++++++...+..++|||
T Consensus 1 ~~ig~g~~g~vy~~~~~~-----~~~~a~K~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 72 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKD-----KTPVAVKTCKEDLP---QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVME 72 (250)
T ss_pred CccCCCCCceEEEEEecC-----CcEEEEEecCCcCC---HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEE
Confidence 479999999999997542 23499999865432 2334567789999999999999999999999999999999
Q ss_pred ccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhhh
Q 042539 104 YCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEK 183 (412)
Q Consensus 104 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~ 183 (412)
|+.|++|..++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 73 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~---- 147 (250)
T cd05085 73 LVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI---- 147 (250)
T ss_pred CCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccc----
Confidence 999999988765433 458899999999999999999999999999999999999999999999999986431100
Q ss_pred hcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecCC
Q 042539 184 QSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGD 263 (412)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~ 263 (412)
........++..|+|||++.+.
T Consensus 148 ----------------------------------------------------------~~~~~~~~~~~~y~aPE~~~~~ 169 (250)
T cd05085 148 ----------------------------------------------------------YSSSGLKQIPIKWTAPEALNYG 169 (250)
T ss_pred ----------------------------------------------------------cccCCCCCCcccccCHHHhccC
Confidence 0000112345679999999888
Q ss_pred CCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCC--CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhh
Q 042539 264 GHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTP--EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIK 340 (412)
Q Consensus 264 ~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l 340 (412)
.++.++|||||||++|++++ |..||.+.........+..... .....+..+.++|.+||..+|++|| ++.+++
T Consensus 170 ~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----~~~~l~ 245 (250)
T cd05085 170 RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRP----KFSELQ 245 (250)
T ss_pred CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCC----CHHHHH
Confidence 88999999999999999998 9999998877776666554321 2234678999999999999999999 577776
Q ss_pred c
Q 042539 341 E 341 (412)
Q Consensus 341 ~ 341 (412)
+
T Consensus 246 ~ 246 (250)
T cd05085 246 K 246 (250)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=311.96 Aligned_cols=250 Identities=22% Similarity=0.322 Sum_probs=200.3
Q ss_pred eeeeccCceEEEEEEEcCCC--CCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEEE
Q 042539 24 KILGKGAMGTVFLVHDRAAD--PTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWA 101 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 101 (412)
+.||+|+||.||+++++... ...++.+|+|.+.+... ......+.+|+++++.++||||+++++++..++..|+|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT---DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc---hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence 46999999999999876543 22345699998865431 22345677799999999999999999999999999999
Q ss_pred eeccCCCCchhHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCC-----CEEEccccc
Q 042539 102 VPYCPGGDLNVLRYKQN-----DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG-----HVTLTDFDL 171 (412)
Q Consensus 102 ~e~~~gg~L~~~~~~~~-----~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g-----~vkL~DFGl 171 (412)
|||+.|++|..++.... ...+++..+..++.|++.||.|||+.+++|+||||+||+++.++ .++|+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999988876532 23478899999999999999999999999999999999999888 899999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
++........ .......++
T Consensus 158 ~~~~~~~~~~-------------------------------------------------------------~~~~~~~~~ 176 (269)
T cd05044 158 ARDIYKSDYY-------------------------------------------------------------RKEGEGLLP 176 (269)
T ss_pred cccccccccc-------------------------------------------------------------ccCcccCCC
Confidence 8754211000 001122456
Q ss_pred CCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCc
Q 042539 252 EEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVK 328 (412)
Q Consensus 252 ~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~ 328 (412)
..|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+.... ......+..+.++|.+||..+|.+
T Consensus 177 ~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 256 (269)
T cd05044 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSE 256 (269)
T ss_pred ccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccchHHHHHHHHHHcCCCccc
Confidence 78999999998889999999999999999998 999998877777666554322 222346788999999999999999
Q ss_pred cCCCCCChhhhhc
Q 042539 329 RLGYLRGACEIKE 341 (412)
Q Consensus 329 R~~~~~~~~e~l~ 341 (412)
|| +++++++
T Consensus 257 Rp----~~~~i~~ 265 (269)
T cd05044 257 RP----TFDRIQE 265 (269)
T ss_pred CC----CHHHHHH
Confidence 99 5777654
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=314.94 Aligned_cols=265 Identities=14% Similarity=0.158 Sum_probs=191.8
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHH-------HHHHHHHHHHHHhhcCCCcc
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHE-------AERRARWEIRVLSRLSHPFL 85 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~-------~~~~~~~Ei~il~~l~hpnI 85 (412)
.++.-++|++.+.||+|+||+||+|.+..++. ....+|+|+..........+ .......+...+..+.|+||
T Consensus 7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~-~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i 85 (294)
T PHA02882 7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHC-INNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGI 85 (294)
T ss_pred eccCCCceEEeeEEecCCCceEEEEEEcCCcc-cccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence 34566799999999999999999999876532 12337777643322110000 01112234455667789999
Q ss_pred ceeeeeEEeCC----eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccC
Q 042539 86 PKLLGSLETDE----FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQS 161 (412)
Q Consensus 86 v~l~~~~~~~~----~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~ 161 (412)
++++++..... ..+++|+++.. ++..++... ..+++..++.++.|++.||+|||++||+||||||+|||++.+
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 86 PKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGN 162 (294)
T ss_pred CcEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 99999776543 45788888743 444444332 236788999999999999999999999999999999999999
Q ss_pred CCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCC
Q 042539 162 GHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDN 241 (412)
Q Consensus 162 g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (412)
+.++|+|||+|+.+........ ..
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~--------------------------------------------------------~~ 186 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIE--------------------------------------------------------YS 186 (294)
T ss_pred CcEEEEEcCCceeeccCCcccc--------------------------------------------------------cc
Confidence 9999999999986532110000 00
Q ss_pred CCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCH-HH--------HHHHHhcCCCCCCCCCh
Q 042539 242 GERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNR-KE--------TFRNVLMKTPEFVGQRT 312 (412)
Q Consensus 242 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-~~--------~~~~i~~~~~~~~~~~~ 312 (412)
........||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+. .. ...++..........++
T Consensus 187 ~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (294)
T PHA02882 187 KEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKIKNANK 266 (294)
T ss_pred cccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhhccCCCCH
Confidence 1112345799999999999999999999999999999999999999987632 21 12333333344566788
Q ss_pred HHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 313 ALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 313 ~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
.+.++++.|+..+|++|| +.+++++
T Consensus 267 ~~~~~~~~~~~~~~~~rp----~~~~l~~ 291 (294)
T PHA02882 267 FIYDFIECVTKLSYEEKP----DYDALIK 291 (294)
T ss_pred HHHHHHHHHHhCCCCCCC----CHHHHHH
Confidence 999999999999999999 5677664
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=311.34 Aligned_cols=242 Identities=20% Similarity=0.226 Sum_probs=189.3
Q ss_pred eeeccCceEEEEEEEcCCC--------------------CCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCc
Q 042539 25 ILGKGAMGTVFLVHDRAAD--------------------PTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPF 84 (412)
Q Consensus 25 ~LG~G~fg~V~la~~~~~~--------------------~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpn 84 (412)
.||+|+||.||++.....+ ......||+|++.... ......+.+|+.+++.++|||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~~~~~~~~l~h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH----RDIALAFFETASLMSQVSHIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH----HHHHHHHHHHHHHHhcCCCCC
Confidence 6999999999998743211 1123458999986542 233455677899999999999
Q ss_pred cceeeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCC--
Q 042539 85 LPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG-- 162 (412)
Q Consensus 85 Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g-- 162 (412)
|+++++++..+...++|||||.||+|..++... .+.+++..+..++.||+.||+|||++||+||||||+|||++..|
T Consensus 78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcc
Confidence 999999999999999999999999998776543 34689999999999999999999999999999999999998654
Q ss_pred -----CEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCcccccc
Q 042539 163 -----HVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQ 237 (412)
Q Consensus 163 -----~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (412)
.+|++|||++.....
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~------------------------------------------------------------ 176 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALS------------------------------------------------------------ 176 (274)
T ss_pred cCccceeeecCCcccccccc------------------------------------------------------------
Confidence 389999998753210
Q ss_pred ccCCCCCCcccccCCCCccceeecC-CCCCchhhHHHHHHHHHHHh-hCCCCCCCCCHHHHHHHHhcCCCCCCCCChHHH
Q 042539 238 SFDNGERSNSFVGTEEYVSPEVVRG-DGHEFAVDWWALGILTYEML-YGTTPFRGKNRKETFRNVLMKTPEFVGQRTALT 315 (412)
Q Consensus 238 ~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DiwSlGvil~ell-~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 315 (412)
.....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||.+....+....+...........+.+.
T Consensus 177 -------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (274)
T cd05076 177 -------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKHRLPEPSCKELA 249 (274)
T ss_pred -------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHhccCCCCCCChHHH
Confidence 011246778999999876 45789999999999999984 799999887655443322222222223457899
Q ss_pred HHHHHhhhhCCCccCCCCCChhhhhcC
Q 042539 316 DLIQRLLEKDPVKRLGYLRGACEIKEH 342 (412)
Q Consensus 316 dli~~~L~~dP~~R~~~~~~~~e~l~h 342 (412)
++|.+||+.+|++|| ++.+++++
T Consensus 250 ~li~~cl~~~p~~Rp----s~~~il~~ 272 (274)
T cd05076 250 TLISQCLTYEPTQRP----SFRTILRD 272 (274)
T ss_pred HHHHHHcccChhhCc----CHHHHHHh
Confidence 999999999999999 57888763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=322.58 Aligned_cols=266 Identities=25% Similarity=0.397 Sum_probs=213.8
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeec--chhh-hhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVD--KSTL-HAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~--~~~~-~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
+--++|.++..||+|||+.||+|.|...+.+ ||+|+-. |..- ..++...+.+.||.+|.+.|+||.||++|++
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRY----vAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDy 535 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRY----VAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDY 535 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhhe----eeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeee
Confidence 3457899999999999999999988765554 9999653 3322 1233456788899999999999999999999
Q ss_pred EE-eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeeeCCCCceEEcc---CCCEE
Q 042539 92 LE-TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMG--IAYRDLKPENILIRQ---SGHVT 165 (412)
Q Consensus 92 ~~-~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~--iiHrDlKp~NiLl~~---~g~vk 165 (412)
|. +.+.+|-|+|||+|.||+.++.... .++|.+|+.|+.||+.||.||.... |||-||||.|||+.. .|.+|
T Consensus 536 fslDtdsFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIK 613 (775)
T KOG1151|consen 536 FSLDTDSFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIK 613 (775)
T ss_pred eeeccccceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeE
Confidence 96 5568999999999999998877654 4999999999999999999999875 999999999999954 47899
Q ss_pred EccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCC
Q 042539 166 LTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERS 245 (412)
Q Consensus 166 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (412)
|+||||++.+...... +++..+.+
T Consensus 614 ITDFGLSKIMdddSy~--------------------------------------------------------~vdGmeLT 637 (775)
T KOG1151|consen 614 ITDFGLSKIMDDDSYN--------------------------------------------------------SVDGMELT 637 (775)
T ss_pred eeecchhhhccCCccC--------------------------------------------------------cccceeee
Confidence 9999999987533210 11223445
Q ss_pred cccccCCCCccceeecCC----CCCchhhHHHHHHHHHHHhhCCCCCCCCCHH-HHHH--HHhc----CCCCCCCCChHH
Q 042539 246 NSFVGTEEYVSPEVVRGD----GHEFAVDWWALGILTYEMLYGTTPFRGKNRK-ETFR--NVLM----KTPEFVGQRTAL 314 (412)
Q Consensus 246 ~~~~gt~~Y~APE~l~~~----~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~--~i~~----~~~~~~~~~~~~ 314 (412)
+.+.||.+|++||++.-. ..+.++||||+|||+|.+++|+-||...-.. +++. .|+. ..|.-+..+.++
T Consensus 638 SQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseA 717 (775)
T KOG1151|consen 638 SQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEA 717 (775)
T ss_pred cccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHH
Confidence 567899999999997532 3488999999999999999999999775332 2222 2232 234456678999
Q ss_pred HHHHHHhhhhCCCccCCCCCChhhhhcCCCCC
Q 042539 315 TDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346 (412)
Q Consensus 315 ~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~ 346 (412)
++||++||.+.-++|+ ++.++..||||.
T Consensus 718 kaFIRRCLaYRKeDR~----DV~qLA~dpyll 745 (775)
T KOG1151|consen 718 KAFIRRCLAYRKEDRI----DVQQLACDPYLL 745 (775)
T ss_pred HHHHHHHHHhhhhhhh----hHHHHccCcccc
Confidence 9999999999999999 799999999985
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=306.74 Aligned_cols=240 Identities=21% Similarity=0.254 Sum_probs=191.3
Q ss_pred eeeeccCceEEEEEEEcCCC------CCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 24 KILGKGAMGTVFLVHDRAAD------PTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~------~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
+.||+|+||.||++.+..++ ......+++|++..... ....+.+|+.+++.++|+||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR-----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh-----hHHHHHHHHHHHHcCCCcchhheeeEEec-CC
Confidence 46999999999999987655 22233478887754321 14667779999999999999999999988 77
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCC-------CEEEcccc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG-------HVTLTDFD 170 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g-------~vkL~DFG 170 (412)
.++||||+.+|+|..++.... ..++...+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 899999999999998876644 2589999999999999999999999999999999999999888 89999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
++..... .....+
T Consensus 154 ~a~~~~~-------------------------------------------------------------------~~~~~~ 166 (259)
T cd05037 154 IPITVLS-------------------------------------------------------------------REERVE 166 (259)
T ss_pred ccccccc-------------------------------------------------------------------cccccc
Confidence 9875421 112346
Q ss_pred CCCCccceeecCC--CCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCCCCCCCChHHHHHHHHhhhhCCC
Q 042539 251 TEEYVSPEVVRGD--GHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTPEFVGQRTALTDLIQRLLEKDPV 327 (412)
Q Consensus 251 t~~Y~APE~l~~~--~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~dli~~~L~~dP~ 327 (412)
+..|+|||++.+. .++.++|||||||++|+|++ |..||...+..+..................+.++|.+||..+|.
T Consensus 167 ~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 246 (259)
T cd05037 167 RIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDCAELANLINQCWTYDPT 246 (259)
T ss_pred CCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCCCCCchHHHHHHHHHhccChh
Confidence 6789999999876 67999999999999999998 68889876544433333222211122237899999999999999
Q ss_pred ccCCCCCChhhhhc
Q 042539 328 KRLGYLRGACEIKE 341 (412)
Q Consensus 328 ~R~~~~~~~~e~l~ 341 (412)
+|| ++.++++
T Consensus 247 ~Rp----t~~~il~ 256 (259)
T cd05037 247 KRP----SFRAILR 256 (259)
T ss_pred hCC----CHHHHHH
Confidence 999 5777764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=309.13 Aligned_cols=247 Identities=18% Similarity=0.287 Sum_probs=191.9
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEEEee
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVP 103 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~e 103 (412)
++||+|+||+||++..... .....+|+|.+.... .......+.+|+.+++.++|+||+++++.+.+...+|+|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~--~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRG--MSKARVVVKELRASA---TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecC--CCCeEEEEeecCccC---ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEE
Confidence 4699999999999975432 234458888775432 23344567779999999999999999999999999999999
Q ss_pred ccCCCCchhHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhh
Q 042539 104 YCPGGDLNVLRYKQND---RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTA 180 (412)
Q Consensus 104 ~~~gg~L~~~~~~~~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~ 180 (412)
|+.+|+|..++..... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY 155 (269)
T ss_pred eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchh
Confidence 9999999988765432 2356788899999999999999999999999999999999999999999999864321100
Q ss_pred hhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceee
Q 042539 181 FEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVV 260 (412)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l 260 (412)
+ .......++..|+|||++
T Consensus 156 ~-------------------------------------------------------------~~~~~~~~~~~y~aPE~~ 174 (269)
T cd05042 156 Y-------------------------------------------------------------ITKDCHAVPLRWLAPELV 174 (269)
T ss_pred e-------------------------------------------------------------eccCCCCCcccccCHHHH
Confidence 0 001233467789999987
Q ss_pred cC-------CCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCC-C------CCCCChHHHHHHHHhhhhC
Q 042539 261 RG-------DGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTP-E------FVGQRTALTDLIQRLLEKD 325 (412)
Q Consensus 261 ~~-------~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~-~------~~~~~~~~~dli~~~L~~d 325 (412)
.. ..++.++|||||||++|||++ |..||......+.+..+..... . ....+..+.+++..|+ .|
T Consensus 175 ~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~d 253 (269)
T cd05042 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LD 253 (269)
T ss_pred hhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cC
Confidence 53 346789999999999999998 8999988877766665543321 1 1234678889999998 59
Q ss_pred CCccCCCCCChhhhhc
Q 042539 326 PVKRLGYLRGACEIKE 341 (412)
Q Consensus 326 P~~R~~~~~~~~e~l~ 341 (412)
|++|| +++++++
T Consensus 254 p~~Rp----t~~~v~~ 265 (269)
T cd05042 254 PETRP----TAEEVHE 265 (269)
T ss_pred ccccc----CHHHHHH
Confidence 99999 5777664
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=308.41 Aligned_cols=247 Identities=21% Similarity=0.291 Sum_probs=190.8
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEEEee
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVP 103 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~e 103 (412)
+.||+|+||.||++.+.... +...+|+|.++.... ......+.+|+.+++.++||||+++++++.+...+++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~--~~~~~~~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGY--TPAQVVVKELRVSAS---VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCC--CceEEEEEecCCCCC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEE
Confidence 46999999999999865322 344589998865432 2233457779999999999999999999999999999999
Q ss_pred ccCCCCchhHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhh
Q 042539 104 YCPGGDLNVLRYKQND---RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTA 180 (412)
Q Consensus 104 ~~~gg~L~~~~~~~~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~ 180 (412)
|+.||+|..++..... ...++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||+++......
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~- 154 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED- 154 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc-
Confidence 9999999888765321 245677888999999999999999999999999999999999999999999986431100
Q ss_pred hhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceee
Q 042539 181 FEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVV 260 (412)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l 260 (412)
.........|+..|+|||++
T Consensus 155 ------------------------------------------------------------~~~~~~~~~~~~~y~aPE~~ 174 (269)
T cd05087 155 ------------------------------------------------------------YYVTPDQLWVPLRWIAPELV 174 (269)
T ss_pred ------------------------------------------------------------eeecCCCcCCcccccCHhHh
Confidence 00111234678899999998
Q ss_pred cCC-------CCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC------CCC-CCCChHHHHHHHHhhhhC
Q 042539 261 RGD-------GHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT------PEF-VGQRTALTDLIQRLLEKD 325 (412)
Q Consensus 261 ~~~-------~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~------~~~-~~~~~~~~dli~~~L~~d 325 (412)
.+. .++.++|+|||||++|||++ |..||......+......... +.. ...++.+.++|++|+ .+
T Consensus 175 ~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~ 253 (269)
T cd05087 175 DEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQ 253 (269)
T ss_pred ccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cC
Confidence 643 35789999999999999996 999998876665544333211 111 134678999999998 68
Q ss_pred CCccCCCCCChhhhhc
Q 042539 326 PVKRLGYLRGACEIKE 341 (412)
Q Consensus 326 P~~R~~~~~~~~e~l~ 341 (412)
|++|| +++++..
T Consensus 254 P~~Rp----t~~~l~~ 265 (269)
T cd05087 254 PEQRP----SAEEVHL 265 (269)
T ss_pred cccCC----CHHHHHH
Confidence 99999 5777763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=306.27 Aligned_cols=250 Identities=19% Similarity=0.254 Sum_probs=195.1
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE-eCCeEEEEe
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE-TDEFLAWAV 102 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~~lv~ 102 (412)
+.||+|+||.||+|.+..... ....||+|.+.... .......+.+|+.+++.++||||+++++++. .+...+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~-~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDG-QKIHCAVKSLNRIT---DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCC-ceEEEEEEecCccC---CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence 468999999999998754332 34559999885422 1223456677999999999999999999765 455689999
Q ss_pred eccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhh
Q 042539 103 PYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFE 182 (412)
Q Consensus 103 e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~ 182 (412)
||+.+|+|..++.... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.+......
T Consensus 77 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~- 154 (262)
T cd05058 77 PYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY- 154 (262)
T ss_pred ecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcce-
Confidence 9999999988876533 34677888899999999999999999999999999999999999999999998754211000
Q ss_pred hhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecC
Q 042539 183 KQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRG 262 (412)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~ 262 (412)
.........++..|+|||.+.+
T Consensus 155 ----------------------------------------------------------~~~~~~~~~~~~~y~aPE~~~~ 176 (262)
T cd05058 155 ----------------------------------------------------------SVHNHTGAKLPVKWMALESLQT 176 (262)
T ss_pred ----------------------------------------------------------eecccccCcCCccccChhHhcc
Confidence 0000112345778999999988
Q ss_pred CCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCCC--CCCCChHHHHHHHHhhhhCCCccCCCCCChhhh
Q 042539 263 DGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTPE--FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEI 339 (412)
Q Consensus 263 ~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~ 339 (412)
..++.++|||||||++|||++ |.+||...+..+....+...... ....++.+.+++.+||..+|++|| ++.++
T Consensus 177 ~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp----~~~~i 252 (262)
T cd05058 177 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRP----TFSEL 252 (262)
T ss_pred CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCC----CHHHH
Confidence 889999999999999999999 67788887776666665543321 123468899999999999999999 57777
Q ss_pred hc
Q 042539 340 KE 341 (412)
Q Consensus 340 l~ 341 (412)
++
T Consensus 253 l~ 254 (262)
T cd05058 253 VS 254 (262)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=304.06 Aligned_cols=244 Identities=21% Similarity=0.287 Sum_probs=199.1
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEEEee
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVP 103 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~e 103 (412)
++||+|+||.||+|.+.. +.. ||+|.+...... .....+.+|++++++++|+||+++++++.+....++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~----v~~K~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 72 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTE----VAVKTCRSTLPP---DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVME 72 (251)
T ss_pred CccccCCCceEEEEEEeC-CCc----EEEEeccccCCH---HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEE
Confidence 479999999999998865 444 999998765432 345567789999999999999999999999999999999
Q ss_pred ccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhhh
Q 042539 104 YCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEK 183 (412)
Q Consensus 104 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~ 183 (412)
|+.|++|..++.... ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++.......
T Consensus 73 ~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~--- 148 (251)
T cd05041 73 LVPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY--- 148 (251)
T ss_pred cCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcc---
Confidence 999999988876533 3578999999999999999999999999999999999999999999999999865421000
Q ss_pred hcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecCC
Q 042539 184 QSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGD 263 (412)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~ 263 (412)
........++..|+|||.+.+.
T Consensus 149 ----------------------------------------------------------~~~~~~~~~~~~y~~PE~~~~~ 170 (251)
T cd05041 149 ----------------------------------------------------------TVSDGLKQIPIKWTAPEALNYG 170 (251)
T ss_pred ----------------------------------------------------------eeccccCcceeccCChHhhccC
Confidence 0000112235679999999888
Q ss_pred CCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhh
Q 042539 264 GHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIK 340 (412)
Q Consensus 264 ~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l 340 (412)
.++.++|+|||||++|+|++ |..||.+.........+.... ......+..+.++|.+||+.+|.+|| ++.+++
T Consensus 171 ~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----~~~ell 246 (251)
T cd05041 171 RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRP----SFSEIY 246 (251)
T ss_pred CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhhCc----CHHHHH
Confidence 89999999999999999998 899998887666655554332 12234568999999999999999999 688887
Q ss_pred c
Q 042539 341 E 341 (412)
Q Consensus 341 ~ 341 (412)
+
T Consensus 247 ~ 247 (251)
T cd05041 247 N 247 (251)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=305.85 Aligned_cols=233 Identities=27% Similarity=0.374 Sum_probs=186.9
Q ss_pred cCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEEEeeccCCC
Q 042539 29 GAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGG 108 (412)
Q Consensus 29 G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg 108 (412)
|.||+||+|+++.++.. ||+|++.+... ..+|...+....||||+++++++.+.+..|+||||+.||
T Consensus 4 g~~~~v~~~~~~~~~~~----~~~K~i~~~~~---------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 70 (237)
T cd05576 4 GVIDKVLLVMDTRTQQT----FILKGLRKSSE---------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGG 70 (237)
T ss_pred cccceEEEEEEccCCcE----EEEEeecchhh---------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCC
Confidence 89999999999876554 99999976531 112444555667999999999999999999999999999
Q ss_pred CchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhhhhcccC
Q 042539 109 DLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNN 188 (412)
Q Consensus 109 ~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 188 (412)
+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.+|.++|+|||++.....
T Consensus 71 ~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~----------- 137 (237)
T cd05576 71 KLWSHISKFL--NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED----------- 137 (237)
T ss_pred CHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc-----------
Confidence 9988776543 489999999999999999999999999999999999999999999999998754311
Q ss_pred CCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecCCCCCch
Q 042539 189 NKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFA 268 (412)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~ 268 (412)
......++..|+|||.+.+..++.+
T Consensus 138 -------------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~ 162 (237)
T cd05576 138 -------------------------------------------------------SCDGEAVENMYCAPEVGGISEETEA 162 (237)
T ss_pred -------------------------------------------------------ccccCCcCccccCCcccCCCCCCch
Confidence 0112345678999999988888999
Q ss_pred hhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCChHHHHHHHHhhhhCCCccCCCC-CChhhhhcCCCC
Q 042539 269 VDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVGQRTALTDLIQRLLEKDPVKRLGYL-RGACEIKEHVFF 345 (412)
Q Consensus 269 ~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~dli~~~L~~dP~~R~~~~-~~~~e~l~h~ff 345 (412)
+|+||+||++|+|++|+.||......... ..........+..+++||.+||+.||.+|++.. .+++++++||||
T Consensus 163 ~DvwslG~il~el~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 163 CDWWSLGAILFELLTGKTLVECHPSGINT---HTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred hhHHHHHHHHHHHHHCcchhhcCchhccc---ccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 99999999999999999988653221100 000011124578899999999999999999641 246999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=307.08 Aligned_cols=247 Identities=19% Similarity=0.282 Sum_probs=191.4
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEEEee
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVP 103 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~e 103 (412)
+.||+|+||+||+++..... ....+++|.++... .......+.+|+.+++.++||||+++++.+.+....|+|||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~--~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e 75 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDT--GVARVVVKELKANA---SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFE 75 (268)
T ss_pred CcCCCCcCceEEEEEEEcCC--CcceEEEEEecCCC---ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEe
Confidence 46999999999998764332 22335677665432 22345677889999999999999999999999999999999
Q ss_pred ccCCCCchhHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhh
Q 042539 104 YCPGGDLNVLRYKQN--DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAF 181 (412)
Q Consensus 104 ~~~gg~L~~~~~~~~--~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~ 181 (412)
||.||+|..++.... ...+++..++.++.||+.||+|||+++++||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~-- 153 (268)
T cd05086 76 YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED-- 153 (268)
T ss_pred cCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcch--
Confidence 999999988876542 2236777888999999999999999999999999999999999999999999875321100
Q ss_pred hhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeec
Q 042539 182 EKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVR 261 (412)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~ 261 (412)
........+|+..|+|||++.
T Consensus 154 -----------------------------------------------------------~~~~~~~~~~~~~y~aPE~~~ 174 (268)
T cd05086 154 -----------------------------------------------------------YIETEDDKCVPLRWLAPELVG 174 (268)
T ss_pred -----------------------------------------------------------hhhcccCCcCcccccCchhcc
Confidence 001112456889999999985
Q ss_pred C-------CCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC------CCC-CCCChHHHHHHHHhhhhCC
Q 042539 262 G-------DGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT------PEF-VGQRTALTDLIQRLLEKDP 326 (412)
Q Consensus 262 ~-------~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~------~~~-~~~~~~~~dli~~~L~~dP 326 (412)
. ..++.++|||||||++|||++ |..||...+..+.+..+.... +.. ...++.+.+++..|| .+|
T Consensus 175 ~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P 253 (268)
T cd05086 175 EFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSP 253 (268)
T ss_pred cccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCc
Confidence 3 234779999999999999996 688998877777766655432 111 235688999999999 789
Q ss_pred CccCCCCCChhhhhc
Q 042539 327 VKRLGYLRGACEIKE 341 (412)
Q Consensus 327 ~~R~~~~~~~~e~l~ 341 (412)
.+|| +++++++
T Consensus 254 ~~Rp----~~~~i~~ 264 (268)
T cd05086 254 EKRA----TAEEVHR 264 (268)
T ss_pred ccCC----CHHHHHH
Confidence 9999 5777754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=307.57 Aligned_cols=254 Identities=18% Similarity=0.286 Sum_probs=201.4
Q ss_pred ceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC---
Q 042539 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE--- 96 (412)
Q Consensus 20 y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 96 (412)
|.+.++||+|+||.||+|.++..+ .+++.||||++...... ......+.+|+++++.++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~-~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSED-GSFQKVAVKMLKADIFS--SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG 77 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccC-CCceEEEEEEeccccCC--hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence 678899999999999999876432 24566999999654322 223456778999999999999999999886532
Q ss_pred ---eEEEEeeccCCCCchhHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccc
Q 042539 97 ---FLAWAVPYCPGGDLNVLRYKQN----DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169 (412)
Q Consensus 97 ---~~~lv~e~~~gg~L~~~~~~~~----~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DF 169 (412)
..+++++|+.+|+|..++.... ...++...+..++.|++.||+|||++||+||||||+||+++.++.+||+||
T Consensus 78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999987764322 124788999999999999999999999999999999999999999999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|+++....... ........
T Consensus 158 g~~~~~~~~~~-------------------------------------------------------------~~~~~~~~ 176 (273)
T cd05074 158 GLSKKIYSGDY-------------------------------------------------------------YRQGCASK 176 (273)
T ss_pred cccccccCCcc-------------------------------------------------------------eecCCCcc
Confidence 99875421100 00011224
Q ss_pred cCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCC--CCCCCChHHHHHHHHhhhhCC
Q 042539 250 GTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTP--EFVGQRTALTDLIQRLLEKDP 326 (412)
Q Consensus 250 gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~dli~~~L~~dP 326 (412)
+++.|++||.+.+..++.++|||||||++|+|++ |.+||.+.+..+.+..+..... ..+..+..+.+++.+||..+|
T Consensus 177 ~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p 256 (273)
T cd05074 177 LPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEP 256 (273)
T ss_pred CchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCh
Confidence 5678999999998888999999999999999998 9999998887777666654322 223466899999999999999
Q ss_pred CccCCCCCChhhhhc
Q 042539 327 VKRLGYLRGACEIKE 341 (412)
Q Consensus 327 ~~R~~~~~~~~e~l~ 341 (412)
.+|| ++.+++.
T Consensus 257 ~~Rp----s~~~~~~ 267 (273)
T cd05074 257 KCRP----SFQHLRD 267 (273)
T ss_pred hhCc----CHHHHHH
Confidence 9999 5777764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=342.36 Aligned_cols=261 Identities=22% Similarity=0.338 Sum_probs=218.6
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCC-CCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPT-ARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
+.+..+...+++.||+|+||.||.+........ ....||||.+++.. .......+++|+.+|+.++|||||+++++
T Consensus 687 p~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~---~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv 763 (1025)
T KOG1095|consen 687 PEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS---SEQEVSDFLKEALLMSKFDHPNIVSLIGV 763 (1025)
T ss_pred ccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC---CHHHHHHHHHHHHHHhcCCCcceeeEEEe
Confidence 457788999999999999999999876654432 14558999997653 23456678889999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEE
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQN-----DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTL 166 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~-----~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL 166 (412)
..+....+|++|||.||||..+++... ...++......++.+|+.|..||+++++|||||..+|+|++....|||
T Consensus 764 ~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKI 843 (1025)
T KOG1095|consen 764 CLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKI 843 (1025)
T ss_pred ecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEE
Confidence 999999999999999999999988752 235889999999999999999999999999999999999999999999
Q ss_pred ccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCc
Q 042539 167 TDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSN 246 (412)
Q Consensus 167 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (412)
+|||+|+.+.+...|.... +
T Consensus 844 aDFGlArDiy~~~yyr~~~----------------------------------------------------------~-- 863 (1025)
T KOG1095|consen 844 ADFGLARDIYDKDYYRKHG----------------------------------------------------------E-- 863 (1025)
T ss_pred cccchhHhhhhchheeccC----------------------------------------------------------c--
Confidence 9999999775544432211 0
Q ss_pred ccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhh
Q 042539 247 SFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLE 323 (412)
Q Consensus 247 ~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~ 323 (412)
..-...|||||.+....++.++|||||||+|||+++ |..||.+.+..+++..++.+. +....+++.+.++|..||+
T Consensus 864 -a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~ 942 (1025)
T KOG1095|consen 864 -AMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWK 942 (1025)
T ss_pred -cccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCCCChHHHHHHHHHcc
Confidence 112347999999999889999999999999999997 999999999999888676544 3344678899999999999
Q ss_pred hCCCccCCCCCChhhhhc
Q 042539 324 KDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 324 ~dP~~R~~~~~~~~e~l~ 341 (412)
.+|++||+| ..|++
T Consensus 943 ~~pe~RP~F----~~i~~ 956 (1025)
T KOG1095|consen 943 HDPEDRPSF----RTIVE 956 (1025)
T ss_pred CChhhCccH----HHHHh
Confidence 999999964 55554
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=308.68 Aligned_cols=258 Identities=22% Similarity=0.294 Sum_probs=204.3
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe-
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET- 94 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~- 94 (412)
..++|++++.||+|+||.||+|+....+..++..||+|++...... .....+.+|+++++.++|+||+++++++..
T Consensus 2 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~ 78 (284)
T cd05038 2 EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE---QHRSDFEREIEILRTLDHENIVKYKGVCEKP 78 (284)
T ss_pred chhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch---HHHHHHHHHHHHHHhCCCCChheEEeeeecC
Confidence 4578999999999999999999876554445667999999765432 345667889999999999999999999887
Q ss_pred -CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 95 -DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 95 -~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
....+++|||+.|++|..++.... ..+++..+..++.|++.||+|||++||+|+||||+||+++.++.++|+|||++.
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 79 GGRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred CCCceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 568999999999999988876543 358999999999999999999999999999999999999999999999999997
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
........ ........++..
T Consensus 158 ~~~~~~~~------------------------------------------------------------~~~~~~~~~~~~ 177 (284)
T cd05038 158 VLPEDKDY------------------------------------------------------------YYVKEPGESPIF 177 (284)
T ss_pred ccccCCcc------------------------------------------------------------eeccCCCCCccc
Confidence 65311100 000011234567
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHH--------------HHHHHhcCC---CCCCCCChHHHH
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKE--------------TFRNVLMKT---PEFVGQRTALTD 316 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--------------~~~~i~~~~---~~~~~~~~~~~d 316 (412)
|+|||.+.+..++.++|+|||||++|||++|..||....... .....+... +.....+.++.+
T Consensus 178 ~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (284)
T cd05038 178 WYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYD 257 (284)
T ss_pred ccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHH
Confidence 999999988888999999999999999999999986542211 112222222 222345678999
Q ss_pred HHHHhhhhCCCccCCCCCChhhhhc
Q 042539 317 LIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 317 li~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
|+.+||..+|.+|| ++.++++
T Consensus 258 li~~cl~~~p~~Rp----t~~ei~~ 278 (284)
T cd05038 258 LMKLCWEAEPQDRP----SFADLIL 278 (284)
T ss_pred HHHHHhccChhhCC----CHHHHHH
Confidence 99999999999999 5787764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=305.14 Aligned_cols=252 Identities=24% Similarity=0.354 Sum_probs=203.7
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhh------hhHHHHHHHHHHHHHHhh-cCCCccceeeee
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLH------AKHEAERRARWEIRVLSR-LSHPFLPKLLGS 91 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~------~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~ 91 (412)
+|++.+.||+|+||.||++.++.. ++..+|+|.+...... ........+.+|+.++.+ ++|+||++++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~---~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~ 77 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNN---GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKT 77 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCC---CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEee
Confidence 588999999999999999998762 2345999988643321 122344556678888875 689999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeeCCCCceEEccCCCEEEcc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYK--QNDRVFSPSVIRFYLSEIICAIEHLHN-MGIAYRDLKPENILIRQSGHVTLTD 168 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~--~~~~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDlKp~NiLl~~~g~vkL~D 168 (412)
+..++..+++|||+.|++|..++.. .....+++..++.++.|++.||.|||+ .|++|+||||+||+++.++.+||+|
T Consensus 78 ~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 78 FLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred EccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999999877643 233458999999999999999999996 6899999999999999999999999
Q ss_pred ccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccc
Q 042539 169 FDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248 (412)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (412)
||++...... ......
T Consensus 158 fg~~~~~~~~----------------------------------------------------------------~~~~~~ 173 (269)
T cd08528 158 FGLAKQKQPE----------------------------------------------------------------SKLTSV 173 (269)
T ss_pred ccceeecccc----------------------------------------------------------------cccccc
Confidence 9998654211 012244
Q ss_pred ccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC---CCCCChHHHHHHHHhhhhC
Q 042539 249 VGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE---FVGQRTALTDLIQRLLEKD 325 (412)
Q Consensus 249 ~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~dli~~~L~~d 325 (412)
.|+..|+|||.+.+..++.++|+|||||++|+|++|++||...+.......+...... ....+..+.++|.+||+.|
T Consensus 174 ~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 253 (269)
T cd08528 174 VGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPD 253 (269)
T ss_pred cCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCC
Confidence 6888999999999888899999999999999999999999887766666555543321 1245789999999999999
Q ss_pred CCccCCCCCChhhhhc
Q 042539 326 PVKRLGYLRGACEIKE 341 (412)
Q Consensus 326 P~~R~~~~~~~~e~l~ 341 (412)
|.+|| ++.|+.+
T Consensus 254 p~~Rp----~~~e~~~ 265 (269)
T cd08528 254 AEARP----DIIQVSA 265 (269)
T ss_pred CccCC----CHHHHHH
Confidence 99999 5677654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=304.87 Aligned_cols=261 Identities=26% Similarity=0.376 Sum_probs=207.6
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe-
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET- 94 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~- 94 (412)
....|+-+.+||+|.||.||+|+.+.++.. ||+|.+-.++ .++..-...++|+++|..|+|+|++.+++.+..
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kk----valkkvlmen--eKeGfpitalreikiL~~lkHenv~nliEic~tk 88 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKK----VALKKVLMEN--EKEGFPITALREIKILQLLKHENVVNLIEICRTK 88 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccch----hHHHHHHHhc--cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhc
Confidence 456788889999999999999998876654 8988764332 233344566789999999999999999987642
Q ss_pred -------CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEc
Q 042539 95 -------DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLT 167 (412)
Q Consensus 95 -------~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~ 167 (412)
...+|+|+.+|+. ||..++... ..+|+..+++.++.+++.||.|+|+..|+|||+|++|+||+.+|.+||+
T Consensus 89 ~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklA 166 (376)
T KOG0669|consen 89 ATPTNRDRATFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLA 166 (376)
T ss_pred cCCcccccceeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEee
Confidence 2359999999976 565555433 2459999999999999999999999999999999999999999999999
Q ss_pred cccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcc
Q 042539 168 DFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNS 247 (412)
Q Consensus 168 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (412)
|||+++.+..... ....+...
T Consensus 167 DFGlar~fs~~~n-----------------------------------------------------------~~kprytn 187 (376)
T KOG0669|consen 167 DFGLARAFSTSKN-----------------------------------------------------------VVKPRYTN 187 (376)
T ss_pred ccccccceecccc-----------------------------------------------------------cCCCCccc
Confidence 9999987642211 01122334
Q ss_pred cccCCCCccceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhc--CC------C-------------
Q 042539 248 FVGTEEYVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLM--KT------P------------- 305 (412)
Q Consensus 248 ~~gt~~Y~APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~--~~------~------------- 305 (412)
.+-|.+|++||.+.|. .|+.+.|||+.|||+.||.+|.+.|.+++...++..|.. +. |
T Consensus 188 rvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ 267 (376)
T KOG0669|consen 188 RVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIEL 267 (376)
T ss_pred ceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccC
Confidence 5679999999999985 589999999999999999999999999988887665531 10 0
Q ss_pred -CCC--------------CCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCC
Q 042539 306 -EFV--------------GQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 306 -~~~--------------~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
+.+ .-++++.||+.+||..||.+|+ ++++++.|.||..
T Consensus 268 ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~----~ad~alnh~~F~k 320 (376)
T KOG0669|consen 268 EPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRI----DADQALNHDFFWK 320 (376)
T ss_pred CCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCc----chHhhhchhhhhc
Confidence 000 1124788999999999999999 7999999999964
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=330.72 Aligned_cols=257 Identities=26% Similarity=0.451 Sum_probs=215.5
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEEe
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLET 94 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~ 94 (412)
.-+-|+|+.+||.|.||+||+++.+.++.. .|+|++....- ....+..|.+||+... |||++.+|++|..
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~----aa~kI~~~~~d-----~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQL----AAIKIMDPTED-----EEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCce----eeeEeecCCcc-----ccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 346799999999999999999998886554 88888755432 2233444889999996 9999999999863
Q ss_pred -----CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccc
Q 042539 95 -----DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169 (412)
Q Consensus 95 -----~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DF 169 (412)
++.+|||||||.||+..+++..-.+..+.|..+..|+++++.||.+||.+.++|||||=.|||++.+|.|||+||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDF 167 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDF 167 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeee
Confidence 468999999999999999988777778999999999999999999999999999999999999999999999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|.+..+. ..-.+.++++
T Consensus 168 GvSaQld---------------------------------------------------------------sT~grRnT~i 184 (953)
T KOG0587|consen 168 GVSAQLD---------------------------------------------------------------STVGRRNTFI 184 (953)
T ss_pred eeeeeee---------------------------------------------------------------cccccccCcC
Confidence 9997653 1234667899
Q ss_pred cCCCCccceeecCC-----CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-CC---CCCChHHHHHHHH
Q 042539 250 GTEEYVSPEVVRGD-----GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP-EF---VGQRTALTDLIQR 320 (412)
Q Consensus 250 gt~~Y~APE~l~~~-----~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~---~~~~~~~~dli~~ 320 (412)
|||.|||||++... .|+..+|+||||++..||.-|.+|+.+.-....+-.|-.+.| .+ ...++++.|||..
T Consensus 185 GtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~ 264 (953)
T KOG0587|consen 185 GTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFIST 264 (953)
T ss_pred CCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHH
Confidence 99999999998643 468899999999999999999999988766554444443333 22 2356889999999
Q ss_pred hhhhCCCccCCCCCChhhhhcCCCCCCC
Q 042539 321 LLEKDPVKRLGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 321 ~L~~dP~~R~~~~~~~~e~l~h~ff~~~ 348 (412)
||.+|-++|| ...+++.|||++..
T Consensus 265 cL~Kd~e~RP----~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 265 CLVKDYEQRP----STEELLKHPFITEQ 288 (953)
T ss_pred HHhhccccCc----chhhhccCCccccc
Confidence 9999999999 58999999999843
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=331.89 Aligned_cols=242 Identities=33% Similarity=0.499 Sum_probs=194.6
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC-
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE- 96 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~- 96 (412)
..|..-+.||+||||.||+++++.+|.. ||||++++... .+ ...+..+|+++|++++|+|||+++++-++..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~----vAvK~~~~~~~-~r--~~e~~~~EieilkKLnh~NIVk~f~iee~~~~ 85 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRL----VAVKTFNKESS-LR--PRERWCREIEILKKLNHPNIVKLFDIEETKFL 85 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccc----hhHHhhhhhcc-cc--hHHHHHHHHHHHHHcCchhhhhhcccCCcccc
Confidence 4566778899999999999988876655 99999977542 11 2345566999999999999999999876544
Q ss_pred -----eEEEEeeccCCCCchhHHHh-hCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccC--CC--EEE
Q 042539 97 -----FLAWAVPYCPGGDLNVLRYK-QNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQS--GH--VTL 166 (412)
Q Consensus 97 -----~~~lv~e~~~gg~L~~~~~~-~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~--g~--vkL 166 (412)
.-.+|||||.||||...+.. ++..+|+|.++..++..++.||.|||++|||||||||.||++-.. |+ -||
T Consensus 86 ~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKL 165 (732)
T KOG4250|consen 86 GLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKL 165 (732)
T ss_pred CcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEee
Confidence 46899999999999877654 344579999999999999999999999999999999999998543 33 599
Q ss_pred ccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCc
Q 042539 167 TDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSN 246 (412)
Q Consensus 167 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (412)
+|||.|+.+. ++....
T Consensus 166 tDfG~Arel~----------------------------------------------------------------d~s~~~ 181 (732)
T KOG4250|consen 166 TDFGAARELD----------------------------------------------------------------DNSLFT 181 (732)
T ss_pred ecccccccCC----------------------------------------------------------------CCCeee
Confidence 9999998763 445667
Q ss_pred ccccCCCCccceeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCC----CCHHHHHHHHhcCCCCC--------------
Q 042539 247 SFVGTEEYVSPEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRG----KNRKETFRNVLMKTPEF-------------- 307 (412)
Q Consensus 247 ~~~gt~~Y~APE~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~----~~~~~~~~~i~~~~~~~-------------- 307 (412)
+++||+.|.+||++.. ..|+..+|.|||||++|+++||..||.. .+..++..++..+.+.-
T Consensus 182 S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~ 261 (732)
T KOG4250|consen 182 SLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVE 261 (732)
T ss_pred eecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCcee
Confidence 8999999999999984 7789999999999999999999999954 23344555555433211
Q ss_pred -----C---CCC----hHHHHHHHHhhhhCCCccC
Q 042539 308 -----V---GQR----TALTDLIQRLLEKDPVKRL 330 (412)
Q Consensus 308 -----~---~~~----~~~~dli~~~L~~dP~~R~ 330 (412)
+ ..+ ..+..++..+|+.+|.+|.
T Consensus 262 ~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 262 WSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 1 112 3466789999999999998
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=342.41 Aligned_cols=271 Identities=27% Similarity=0.430 Sum_probs=205.3
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
+--+.+|+.++.||+||||.||+|+++-.+.. ||||.|.... ......++.+|+.+|++|+|||||++|..|.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~----YAIKKIpl~~---s~~~~skI~rEVk~LArLnHpNVVRYysAWV 547 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGRE----YAIKKIPLKA---SDKLYSKILREVKLLARLNHPNVVRYYSAWV 547 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchh----hhhhhccCch---HHHHHHHHHHHHHHHhhcCCcceeeeehhhh
Confidence 34567899999999999999999999875554 9999996543 3456677888999999999999999973210
Q ss_pred -----------------------------------------------------------e--------------------
Q 042539 94 -----------------------------------------------------------T-------------------- 94 (412)
Q Consensus 94 -----------------------------------------------------------~-------------------- 94 (412)
+
T Consensus 548 Es~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg 627 (1351)
T KOG1035|consen 548 ESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDG 627 (1351)
T ss_pred ccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccc
Confidence 0
Q ss_pred --------------------------------C--------CeEEEEeeccCCCCchhHHHhhCCCCC--CHHHHHHHHH
Q 042539 95 --------------------------------D--------EFLAWAVPYCPGGDLNVLRYKQNDRVF--SPSVIRFYLS 132 (412)
Q Consensus 95 --------------------------------~--------~~~~lv~e~~~gg~L~~~~~~~~~~~l--~~~~~~~~~~ 132 (412)
+ ..+||.||||+...+..++.... + ....++.+++
T Consensus 628 ~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~---~~~~~d~~wrLFr 704 (1351)
T KOG1035|consen 628 RNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH---FNSQRDEAWRLFR 704 (1351)
T ss_pred cccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc---cchhhHHHHHHHH
Confidence 0 13799999998877776665433 4 4788999999
Q ss_pred HHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhc
Q 042539 133 EIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLH 212 (412)
Q Consensus 133 qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (412)
||+.||.|+|+.|||||||||.||+++..+.|||+|||+|+..........+..
T Consensus 705 eIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~-------------------------- 758 (1351)
T KOG1035|consen 705 EILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDL-------------------------- 758 (1351)
T ss_pred HHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhcc--------------------------
Confidence 999999999999999999999999999999999999999987421111100000
Q ss_pred cCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecCCC---CCchhhHHHHHHHHHHHhhCCCCCC
Q 042539 213 ALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDG---HEFAVDWWALGILTYEMLYGTTPFR 289 (412)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~---~~~~~DiwSlGvil~ell~g~~Pf~ 289 (412)
+... ...-.+....++.+||.-|+|||++.+.. |+.++|+||||+|+|||++ ||.
T Consensus 759 -----~~~~--------------~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~ 816 (1351)
T KOG1035|consen 759 -----SFST--------------NRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFG 816 (1351)
T ss_pred -----Cccc--------------cccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCC
Confidence 0000 00001223445789999999999998754 9999999999999999996 465
Q ss_pred C-CCHHHHHHHHhcCCCCCC-----CCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCC
Q 042539 290 G-KNRKETFRNVLMKTPEFV-----GQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346 (412)
Q Consensus 290 ~-~~~~~~~~~i~~~~~~~~-----~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~ 346 (412)
. ..+..++.++..+..+.+ ...+.-+.+|+.||+.||.+|| ||.|+|++.||.
T Consensus 817 TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRP----tA~eLL~s~llp 875 (1351)
T KOG1035|consen 817 TSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRP----TATELLNSELLP 875 (1351)
T ss_pred chHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCC----CHHHHhhccCCC
Confidence 4 344455666554443333 1235677899999999999999 799999999998
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=319.93 Aligned_cols=255 Identities=22% Similarity=0.374 Sum_probs=206.8
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCC------Cccce
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH------PFLPK 87 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~h------pnIv~ 87 (412)
++--.+|.+....|+|-|++|..|++...+.. ||||+|....+ ..+.-++|++||++|+. -|+++
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~----vAiKIIRnNE~-----M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQE----VAIKIIRNNEV-----MHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCe----eEEEEeecchH-----HhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 44456899999999999999999999887664 99999976543 33445569999999973 38999
Q ss_pred eeeeEEeCCeEEEEeeccCCCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccC-CCEE
Q 042539 88 LLGSLETDEFLAWAVPYCPGGDLNVLRYKQN-DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQS-GHVT 165 (412)
Q Consensus 88 l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~-g~vk 165 (412)
|+-.|...+++|||+|-+ ...|..++..-+ +-.|....++.|+.|+..||..|-..||+|.||||+|||++.+ ..+|
T Consensus 499 l~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLK 577 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILK 577 (752)
T ss_pred HHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceee
Confidence 999999999999999988 456666665543 3358899999999999999999999999999999999999987 4679
Q ss_pred EccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCC
Q 042539 166 LTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERS 245 (412)
Q Consensus 166 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (412)
|||||.|.....+ ..
T Consensus 578 LCDfGSA~~~~en-----------------------------------------------------------------ei 592 (752)
T KOG0670|consen 578 LCDFGSASFASEN-----------------------------------------------------------------EI 592 (752)
T ss_pred eccCccccccccc-----------------------------------------------------------------cc
Confidence 9999998654221 11
Q ss_pred cccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-----------------
Q 042539 246 NSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV----------------- 308 (412)
Q Consensus 246 ~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~----------------- 308 (412)
+-+.-+.-|.|||++.|.+|+...|+||+||+||||+||+..|+|.+...+++-.+.....++
T Consensus 593 tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d 672 (752)
T KOG0670|consen 593 TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQD 672 (752)
T ss_pred cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccc
Confidence 122345679999999999999999999999999999999999999887766554432111110
Q ss_pred -------------------------------------CCC-------hHHHHHHHHhhhhCCCccCCCCCChhhhhcCCC
Q 042539 309 -------------------------------------GQR-------TALTDLIQRLLEKDPVKRLGYLRGACEIKEHVF 344 (412)
Q Consensus 309 -------------------------------------~~~-------~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~f 344 (412)
..+ ..++||+.+||..||++|+ ++.++|+|||
T Consensus 673 ~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi----t~nqAL~HpF 748 (752)
T KOG0670|consen 673 LNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI----TVNQALKHPF 748 (752)
T ss_pred cceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC----CHHHHhcCCc
Confidence 011 3588999999999999999 6999999999
Q ss_pred CCC
Q 042539 345 FKG 347 (412)
Q Consensus 345 f~~ 347 (412)
|.+
T Consensus 749 i~~ 751 (752)
T KOG0670|consen 749 ITE 751 (752)
T ss_pred ccC
Confidence 974
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=301.84 Aligned_cols=257 Identities=26% Similarity=0.462 Sum_probs=210.6
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
.......+|.-++.+|.|+- .|..|.|.-. +++||+|.+.... ....-.++..+|..++..++|+||++++.+
T Consensus 11 s~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~----~~~v~ikk~~~pf--~n~~~akra~rel~l~~~v~~~nii~l~n~ 83 (369)
T KOG0665|consen 11 STFTVPKRYVNLKPIGSGAQ-IVVAAFDQVL----GRPVAIKKLSRPF--QNQTHAKRAYRELKLMKCVNHKNIISLLNV 83 (369)
T ss_pred cceeeeeeeeeecccCCCCc-eEEecchhhc----cCceehhhhcCcc--ccCccchhhhhhhhhhhhhcccceeeeeec
Confidence 33456679999999999999 7777666554 4459999886652 334567888999999999999999999999
Q ss_pred EEeC------CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEE
Q 042539 92 LETD------EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVT 165 (412)
Q Consensus 92 ~~~~------~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vk 165 (412)
|.-. ..+|+|||++. .+|...+..+ ++-..++.++.|+++|++|||+.||+||||||+||++..++.+|
T Consensus 84 ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~~e----lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lK 158 (369)
T KOG0665|consen 84 FTPQKTLEEFQEVYLVMELMD-ANLCQVILME----LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLK 158 (369)
T ss_pred cCccccHHHHHhHHHHHHhhh-hHHHHHHHHh----cchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhhee
Confidence 9644 36899999994 4666666533 67889999999999999999999999999999999999999999
Q ss_pred EccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCC
Q 042539 166 LTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERS 245 (412)
Q Consensus 166 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (412)
|+|||+|+... ..-+.
T Consensus 159 i~dfg~ar~e~----------------------------------------------------------------~~~~m 174 (369)
T KOG0665|consen 159 ILDFGLARTED----------------------------------------------------------------TDFMM 174 (369)
T ss_pred eccchhhcccC----------------------------------------------------------------ccccc
Confidence 99999997531 11234
Q ss_pred cccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CC------------------
Q 042539 246 NSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK--TP------------------ 305 (412)
Q Consensus 246 ~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~~------------------ 305 (412)
+-++.|..|.|||++.+.+|...+||||+|||+.||++|...|+|.+.-+++.++... .+
T Consensus 175 tpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~ 254 (369)
T KOG0665|consen 175 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVEN 254 (369)
T ss_pred CchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhc
Confidence 4568899999999999999999999999999999999999999998877766555421 10
Q ss_pred --C---------CC------------CCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCc
Q 042539 306 --E---------FV------------GQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRW 350 (412)
Q Consensus 306 --~---------~~------------~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~ 350 (412)
. ++ .....++|++.+||..||++|+ +++++|.|||++ -|
T Consensus 255 ~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Ri----sv~daL~HPY~~--vw 316 (369)
T KOG0665|consen 255 RPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRI----SVDDALRHPYIK--VW 316 (369)
T ss_pred ChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcc----cHHHHhcCCeee--ee
Confidence 0 01 1124689999999999999999 599999999999 55
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=331.34 Aligned_cols=265 Identities=19% Similarity=0.205 Sum_probs=183.9
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
.+.+..++|++.+.||+|+||+||+|.+..+....+..||+|.+..... .+. ...| .+....+.+++.++..
T Consensus 126 ~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~---~~~e--~l~~~~~~~~~~~~~~ 197 (566)
T PLN03225 126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEI---WMNE--RVRRACPNSCADFVYG 197 (566)
T ss_pred CCCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHH---HHHH--HHHhhchhhHHHHHHh
Confidence 5677889999999999999999999999876333456699998854321 000 0001 1122222233322222
Q ss_pred ------EEeCCeEEEEeeccCCCCchhHHHhhCC------------------CCCCHHHHHHHHHHHHHHHHHHHHcCce
Q 042539 92 ------LETDEFLAWAVPYCPGGDLNVLRYKQND------------------RVFSPSVIRFYLSEIICAIEHLHNMGIA 147 (412)
Q Consensus 92 ------~~~~~~~~lv~e~~~gg~L~~~~~~~~~------------------~~l~~~~~~~~~~qi~~aL~yLH~~~ii 147 (412)
...+..+++||||+.+++|..++..... ....+..++.++.||+.||+|||++||+
T Consensus 198 ~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIi 277 (566)
T PLN03225 198 FLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIV 277 (566)
T ss_pred hhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 1345689999999999999887754321 0112455778999999999999999999
Q ss_pred eeeCCCCceEEcc-CCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccc
Q 042539 148 YRDLKPENILIRQ-SGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKS 226 (412)
Q Consensus 148 HrDlKp~NiLl~~-~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (412)
||||||+|||++. ++.+||+|||+|+.+...
T Consensus 278 HRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~------------------------------------------------ 309 (566)
T PLN03225 278 HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVG------------------------------------------------ 309 (566)
T ss_pred eCcCCHHHEEEeCCCCcEEEEeCCCccccccc------------------------------------------------
Confidence 9999999999986 589999999999754211
Q ss_pred cCCCCccccccccCCCCCCcccccCCCCccceeecCC----------------------CCCchhhHHHHHHHHHHHhhC
Q 042539 227 ARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGD----------------------GHEFAVDWWALGILTYEMLYG 284 (412)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~----------------------~~~~~~DiwSlGvil~ell~g 284 (412)
.......++||+.|||||++... .++.++|||||||++|||+++
T Consensus 310 --------------~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~ 375 (566)
T PLN03225 310 --------------INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFP 375 (566)
T ss_pred --------------cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhC
Confidence 11122356899999999976432 234467999999999999997
Q ss_pred CCCCCCCCHHHHHHHHhcC-CC-----------C-----------CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 285 TTPFRGKNRKETFRNVLMK-TP-----------E-----------FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 285 ~~Pf~~~~~~~~~~~i~~~-~~-----------~-----------~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
..++.. ....+...+.. .. . ........+|||.+||++||++|| ++.++++
T Consensus 376 ~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~----ta~e~L~ 449 (566)
T PLN03225 376 NLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRI----SAKAALA 449 (566)
T ss_pred cCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCC----CHHHHhC
Confidence 766543 22222222110 00 0 001123466999999999999999 7999999
Q ss_pred CCCCCCCCchh
Q 042539 342 HVFFKGVRWDL 352 (412)
Q Consensus 342 h~ff~~~~~~~ 352 (412)
||||++..+..
T Consensus 450 Hpff~~~~~~~ 460 (566)
T PLN03225 450 HPYFDREGLLG 460 (566)
T ss_pred CcCcCCCCccc
Confidence 99999988753
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=284.51 Aligned_cols=249 Identities=25% Similarity=0.444 Sum_probs=202.7
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEEe
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLET 94 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~ 94 (412)
..++|++++++|+|.|+.||.+....++ +.++||+++. -..+.+.||+.||+.|. ||||++|+++..+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~----eK~ViKiLKP-------VkkkKIkREikIL~nL~gg~NIi~L~DiV~D 104 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNN----EKCVIKILKP-------VKKKKIKREIKILQNLRGGPNIIKLLDIVKD 104 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCC----ceEEEeeech-------HHHHHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence 5789999999999999999988765543 4499999843 23556778999999998 9999999999987
Q ss_pred CC--eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccC-CCEEEccccc
Q 042539 95 DE--FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQS-GHVTLTDFDL 171 (412)
Q Consensus 95 ~~--~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~-g~vkL~DFGl 171 (412)
.. ...|++||++..|+..+-. .|+.-.++.|+.|++.||.|||+.||+|||+||.|++||.. -.++|+|+|+
T Consensus 105 p~SktpaLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGL 179 (338)
T KOG0668|consen 105 PESKTPSLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGL 179 (338)
T ss_pred ccccCchhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecch
Confidence 54 5789999999988754422 38889999999999999999999999999999999999976 5799999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
|....... ..+..+.+
T Consensus 180 AEFYHp~~----------------------------------------------------------------eYnVRVAS 195 (338)
T KOG0668|consen 180 AEFYHPGK----------------------------------------------------------------EYNVRVAS 195 (338)
T ss_pred HhhcCCCc----------------------------------------------------------------eeeeeeeh
Confidence 98774333 33455778
Q ss_pred CCCccceeecCC-CCCchhhHHHHHHHHHHHhhCCCCC-CCCCHHHHHHHHhcC-----------------CCCCC----
Q 042539 252 EEYVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPF-RGKNRKETFRNVLMK-----------------TPEFV---- 308 (412)
Q Consensus 252 ~~Y~APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf-~~~~~~~~~~~i~~~-----------------~~~~~---- 308 (412)
..|--||++..- .|+.+-|+|||||++..|+..+-|| .|.+..+++.+|..- .+.+.
T Consensus 196 RyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~ 275 (338)
T KOG0668|consen 196 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILG 275 (338)
T ss_pred hhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhh
Confidence 889999998774 5799999999999999999887775 566666655444310 01110
Q ss_pred -----------------CCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCC
Q 042539 309 -----------------GQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 309 -----------------~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~ 348 (412)
-.++++.||+.++|.+|-.+|+ ||.|++.||||..+
T Consensus 276 ~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRl----TakEam~HpyF~~~ 328 (338)
T KOG0668|consen 276 RHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERL----TAKEAMAHPYFAPV 328 (338)
T ss_pred ccccccHHHhCCccccccCChHHHHHHHHHHhhcccccc----chHHHhcCchHHHH
Confidence 1248899999999999999999 79999999999754
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=312.39 Aligned_cols=253 Identities=21% Similarity=0.345 Sum_probs=212.3
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
++..+...+.+.||.|-||.||.+.........+.-||||..+++.- .+..+.++.|+.+|+.++|||||+|++++.
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t---~d~tekflqEa~iMrnfdHphIikLIGv~~ 461 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT---PDDTEKFLQEASIMRNFDHPHIIKLIGVCV 461 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC---hhhHHHHHHHHHHHHhCCCcchhheeeeee
Confidence 45555666778999999999999987655444555699999977542 233567788999999999999999999987
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
+ ...|||||++.-|+|..++..+. ..++......|+.||+.||.|||++++|||||...|||+.....|||+|||+++
T Consensus 462 e-~P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 462 E-QPMWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred c-cceeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhh
Confidence 5 46899999999999999987655 458899999999999999999999999999999999999999999999999999
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
.+.+...|... .. .-..-
T Consensus 540 ~~ed~~yYkaS------------------------------------------~~--------------------kLPIK 557 (974)
T KOG4257|consen 540 YLEDDAYYKAS------------------------------------------RG--------------------KLPIK 557 (974)
T ss_pred hccccchhhcc------------------------------------------cc--------------------cccee
Confidence 88655444210 11 12345
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCccC
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVKRL 330 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~R~ 330 (412)
|||||.+.-..++.++|||-|||.+||+++ |.-||.|..+.+++..+-++. |..+++++.+..|+.+||.++|.+||
T Consensus 558 WmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRP 637 (974)
T KOG4257|consen 558 WMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRP 637 (974)
T ss_pred ecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCC
Confidence 999999999999999999999999999985 999999988888777666543 56678999999999999999999999
Q ss_pred CCC
Q 042539 331 GYL 333 (412)
Q Consensus 331 ~~~ 333 (412)
.+.
T Consensus 638 rft 640 (974)
T KOG4257|consen 638 RFT 640 (974)
T ss_pred cHH
Confidence 763
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=307.68 Aligned_cols=243 Identities=24% Similarity=0.304 Sum_probs=188.6
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC-
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE- 96 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~- 96 (412)
++|.--..||+|+||.||++..... ..||||.+....... .+.+.+|+.++.+++|||+|+|++++.+.+
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~-----~~vAVK~~~~~~~~~----~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~ 145 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDG-----TVVAVKRLSSNSGQG----EREFLNEVEILSRLRHPNLVKLLGYCLEGGE 145 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCC-----CEEEEEEecCCCCcc----hhHHHHHHHHHhcCCCcCcccEEEEEecCCc
Confidence 3555667999999999999877543 349999886543211 334888999999999999999999999888
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcC---ceeeeCCCCceEEccCCCEEEccccccc
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMG---IAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~---iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
..+||+||+..|+|.+.++......++......|+.+++.||+|||... |||||||++|||+|.+...||+|||+|+
T Consensus 146 ~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~ 225 (361)
T KOG1187|consen 146 HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAK 225 (361)
T ss_pred eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcc
Confidence 5999999999999998888755326899999999999999999999864 9999999999999999999999999996
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccc-ccCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF-VGTE 252 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~gt~ 252 (412)
..... .....+. .||.
T Consensus 226 ~~~~~---------------------------------------------------------------~~~~~~~~~gt~ 242 (361)
T KOG1187|consen 226 LGPEG---------------------------------------------------------------DTSVSTTVMGTF 242 (361)
T ss_pred cCCcc---------------------------------------------------------------ccceeeecCCCC
Confidence 43210 0111122 7999
Q ss_pred CCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCC---H---HHHHHHHhcC-------CCCCC--CCC-----h
Q 042539 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKN---R---KETFRNVLMK-------TPEFV--GQR-----T 312 (412)
Q Consensus 253 ~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~---~---~~~~~~i~~~-------~~~~~--~~~-----~ 312 (412)
+|+|||.+.....+.++|||||||+|.|+++|+.+..... . .+-....+.. ++.+. ... .
T Consensus 243 gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~ 322 (361)
T KOG1187|consen 243 GYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVK 322 (361)
T ss_pred ccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHH
Confidence 9999999998778999999999999999999998877432 1 1100111111 12211 112 2
Q ss_pred HHHHHHHHhhhhCCCccCCC
Q 042539 313 ALTDLIQRLLEKDPVKRLGY 332 (412)
Q Consensus 313 ~~~dli~~~L~~dP~~R~~~ 332 (412)
.+..+..+|++.+|.+||++
T Consensus 323 ~~~~~a~~C~~~~~~~RP~m 342 (361)
T KOG1187|consen 323 KLAELALRCLRPDPKERPTM 342 (361)
T ss_pred HHHHHHHHHcCcCCCcCcCH
Confidence 36678889999999999964
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=310.83 Aligned_cols=273 Identities=19% Similarity=0.214 Sum_probs=193.1
Q ss_pred CCCCCCCCCccCceeeeeeeccCceEEEEEEEcCCC------------CCCCCceEEeeecchhhhhhHH----------
Q 042539 8 QPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAAD------------PTARCPFALKVVDKSTLHAKHE---------- 65 (412)
Q Consensus 8 ~~~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~------------~~~~~~vAiK~i~~~~~~~~~~---------- 65 (412)
.......+..++|.+.++||+|+||+||++.....+ ...++.||||.+.........+
T Consensus 135 ~~~~~~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~ 214 (507)
T PLN03224 135 ADGANSRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKG 214 (507)
T ss_pred cccCCCCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhc
Confidence 333455678999999999999999999998753322 2234569999986432111111
Q ss_pred HHHHHHHHHHHHhhcCCCcc-----ceeeeeEEe--------CCeEEEEeeccCCCCchhHHHhhCC-------------
Q 042539 66 AERRARWEIRVLSRLSHPFL-----PKLLGSLET--------DEFLAWAVPYCPGGDLNVLRYKQND------------- 119 (412)
Q Consensus 66 ~~~~~~~Ei~il~~l~hpnI-----v~l~~~~~~--------~~~~~lv~e~~~gg~L~~~~~~~~~------------- 119 (412)
.......|+.++.+++|.++ +++++++.. +...++||||+.+++|.++++....
T Consensus 215 ~~e~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g 294 (507)
T PLN03224 215 SAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAG 294 (507)
T ss_pred ccchhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcC
Confidence 11223447778888876544 667776643 3568999999999999888764211
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhhhhcccCCC
Q 042539 120 ---------RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNK 190 (412)
Q Consensus 120 ---------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~ 190 (412)
..++...++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++......
T Consensus 295 ~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~----------- 363 (507)
T PLN03224 295 KKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI----------- 363 (507)
T ss_pred CchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-----------
Confidence 124567889999999999999999999999999999999999999999999986432100
Q ss_pred CCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecCCC------
Q 042539 191 FPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDG------ 264 (412)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~------ 264 (412)
........+|+.|+|||++....
T Consensus 364 ---------------------------------------------------~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~ 392 (507)
T PLN03224 364 ---------------------------------------------------NFNPLYGMLDPRYSPPEELVMPQSCPRAP 392 (507)
T ss_pred ---------------------------------------------------ccCccccCCCcceeChhhhcCCCCCCccc
Confidence 00011224589999999986432
Q ss_pred --------------C--CchhhHHHHHHHHHHHhhCCC-CCCCCCHHH-----------HHHHHhcCCC---CCCCCChH
Q 042539 265 --------------H--EFAVDWWALGILTYEMLYGTT-PFRGKNRKE-----------TFRNVLMKTP---EFVGQRTA 313 (412)
Q Consensus 265 --------------~--~~~~DiwSlGvil~ell~g~~-Pf~~~~~~~-----------~~~~i~~~~~---~~~~~~~~ 313 (412)
| ....|+||+||++|+|++|.. ||.+..... .++.+..... .+...++.
T Consensus 393 ~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~ 472 (507)
T PLN03224 393 APAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEA 472 (507)
T ss_pred hhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChH
Confidence 1 124799999999999999875 776422111 1111111222 23456789
Q ss_pred HHHHHHHhhhhCC---CccCCCCCChhhhhcCCCCC
Q 042539 314 LTDLIQRLLEKDP---VKRLGYLRGACEIKEHVFFK 346 (412)
Q Consensus 314 ~~dli~~~L~~dP---~~R~~~~~~~~e~l~h~ff~ 346 (412)
++|||.+||.++| .+|+ +++|+|+||||.
T Consensus 473 ~~dLi~~LL~~~~~~~~~Rl----Sa~eaL~Hp~f~ 504 (507)
T PLN03224 473 GWDLACKLITKRDQANRGRL----SVGQALSHRFFL 504 (507)
T ss_pred HHHHHHHHhccCCCCcccCC----CHHHHhCCCCcC
Confidence 9999999999876 6899 699999999995
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=294.38 Aligned_cols=139 Identities=25% Similarity=0.326 Sum_probs=116.3
Q ss_pred CCCCCc-cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-----C---
Q 042539 12 TPSLDL-DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-----H--- 82 (412)
Q Consensus 12 ~~~~~~-~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-----h--- 82 (412)
...+.- .+|.+.++||-|.|++||||.|....+. ||+||++-.. -..+..+.||++|++++ |
T Consensus 71 IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~----VAlKVvKSAq-----hYtEaAlDEIklL~~v~~~Dp~~~~~ 141 (590)
T KOG1290|consen 71 IGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRY----VALKVVKSAQ-----HYTEAALDEIKLLQQVREGDPNDPGK 141 (590)
T ss_pred ccccccCceEEEEEeccccccceeEEEeeccCCeE----EEEEEEehhh-----HHHHHHHHHHHHHHHHHhcCCCCCCC
Confidence 333334 8999999999999999999999886555 9999996543 23344566999999995 2
Q ss_pred CccceeeeeEEe----CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeeeCCCCceE
Q 042539 83 PFLPKLLGSLET----DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNM-GIAYRDLKPENIL 157 (412)
Q Consensus 83 pnIv~l~~~~~~----~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~-~iiHrDlKp~NiL 157 (412)
.+||+|++.|.. +.++|+|+|++ |..|..++.....+.++...++.|++||+.||.|||+. ||||-||||+|||
T Consensus 142 ~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvL 220 (590)
T KOG1290|consen 142 KCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVL 220 (590)
T ss_pred ceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceee
Confidence 369999999974 46999999999 77787788777777899999999999999999999975 9999999999999
Q ss_pred Ecc
Q 042539 158 IRQ 160 (412)
Q Consensus 158 l~~ 160 (412)
+..
T Consensus 221 l~~ 223 (590)
T KOG1290|consen 221 LCS 223 (590)
T ss_pred eec
Confidence 853
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=312.24 Aligned_cols=256 Identities=21% Similarity=0.281 Sum_probs=216.1
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
+.-|-.++.++.++||+|+||.|+.+.|+.... ..-.||||.++...+.. ....+++|+.+|.+|+|+|+++||++
T Consensus 104 kclIpee~i~l~e~LG~GsFgvV~rg~Wt~psg-k~V~VAVKclr~d~l~~---~mddflrEas~M~~L~H~hliRLyGv 179 (1039)
T KOG0199|consen 104 KCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSG-KHVNVAVKCLRDDSLNA---IMDDFLREASHMLKLQHPHLIRLYGV 179 (1039)
T ss_pred ceeccHHHHHHHHHhcCcceeeEeeccccCCCC-cEEeEEEEeccCCccch---hHHHHHHHHHHHHhccCcceeEEeee
Confidence 334556788889999999999999999987544 34459999997765533 56678889999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
..+ ..+.+|||+|.+|+|.+.++......|.-.....|+.||+.|+.||.++++|||||...|+|+-.-..||||||||
T Consensus 180 Vl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGL 258 (1039)
T KOG0199|consen 180 VLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGL 258 (1039)
T ss_pred ecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccc
Confidence 988 7889999999999998888875666788999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
.+-+..+..+. .+.....-.
T Consensus 259 mRaLg~ned~Y------------------------------------------------------------vm~p~rkvP 278 (1039)
T KOG0199|consen 259 MRALGENEDMY------------------------------------------------------------VMAPQRKVP 278 (1039)
T ss_pred eeccCCCCcce------------------------------------------------------------EecCCCcCc
Confidence 98764332210 011111234
Q ss_pred CCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCc
Q 042539 252 EEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVK 328 (412)
Q Consensus 252 ~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~ 328 (412)
..|.|||.+....++.++|+|++||+||||++ |..||.|.....++++|-.+. +....++.++.+++..||..+|.+
T Consensus 279 fAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paD 358 (1039)
T KOG0199|consen 279 FAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPAD 358 (1039)
T ss_pred ccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHHHHHHhccCCccc
Confidence 57999999999999999999999999999995 999999999999998887432 455678899999999999999999
Q ss_pred cCCC
Q 042539 329 RLGY 332 (412)
Q Consensus 329 R~~~ 332 (412)
|++|
T Consensus 359 RptF 362 (1039)
T KOG0199|consen 359 RPTF 362 (1039)
T ss_pred cccH
Confidence 9976
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=303.51 Aligned_cols=253 Identities=22% Similarity=0.302 Sum_probs=209.4
Q ss_pred CCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeee
Q 042539 11 TTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLG 90 (412)
Q Consensus 11 ~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 90 (412)
...++-.+.+.+.++||+|-||.|.+|.-.. ...||+|.++... .......+.+||++|.+|+|||||.|++
T Consensus 531 al~EfPRs~L~~~ekiGeGqFGEVhLCeveg-----~lkVAVK~Lr~~a---~~~~r~~F~kEIkiLsqLkhPNIveLvG 602 (807)
T KOG1094|consen 531 ALVEFPRSRLRFKEKIGEGQFGEVHLCEVEG-----PLKVAVKILRPDA---TKNARNDFLKEIKILSRLKHPNIVELLG 602 (807)
T ss_pred chhhcchhheehhhhhcCcccceeEEEEecC-----ceEEEEeecCccc---chhHHHHHHHHHHHHhccCCCCeeEEEe
Confidence 3456777888999999999999999998654 3459999996653 2234577888999999999999999999
Q ss_pred eEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccc
Q 042539 91 SLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 91 ~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
++..++.+|++|||++.|||.+++..+....+.......++.||+.|++||.+.++|||||.+.|+|++.++++||+|||
T Consensus 603 VC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfg 682 (807)
T KOG1094|consen 603 VCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFG 682 (807)
T ss_pred eeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcc
Confidence 99999999999999999999999887654334555566799999999999999999999999999999999999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+++.+.....|..| ..++-
T Consensus 683 msR~lysg~yy~vq-------------------------------------------------------------gr~vl 701 (807)
T KOG1094|consen 683 MSRNLYSGDYYRVQ-------------------------------------------------------------GRAVL 701 (807)
T ss_pred cccccccCCceeee-------------------------------------------------------------cceee
Confidence 99976544333221 23355
Q ss_pred CCCCccceeecCCCCCchhhHHHHHHHHHHHh--hCCCCCCCCCHHHHHHHHhc---CC------CCCCCCChHHHHHHH
Q 042539 251 TEEYVSPEVVRGDGHEFAVDWWALGILTYEML--YGTTPFRGKNRKETFRNVLM---KT------PEFVGQRTALTDLIQ 319 (412)
Q Consensus 251 t~~Y~APE~l~~~~~~~~~DiwSlGvil~ell--~g~~Pf~~~~~~~~~~~i~~---~~------~~~~~~~~~~~dli~ 319 (412)
..+|||+|.+.-..++.++|+|+||+++||++ +...||....+++..++... .. ...+.++..+.++|-
T Consensus 702 piRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml 781 (807)
T KOG1094|consen 702 PIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELML 781 (807)
T ss_pred eeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHH
Confidence 67899999999889999999999999999986 68899999888877766532 11 122346788999999
Q ss_pred HhhhhCCCccCCC
Q 042539 320 RLLEKDPVKRLGY 332 (412)
Q Consensus 320 ~~L~~dP~~R~~~ 332 (412)
+||.++-++||++
T Consensus 782 ~Cw~~es~~RPsF 794 (807)
T KOG1094|consen 782 RCWRRESEQRPSF 794 (807)
T ss_pred HHhchhhhcCCCH
Confidence 9999999999964
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=285.96 Aligned_cols=258 Identities=25% Similarity=0.375 Sum_probs=203.2
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC-
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE- 96 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~- 96 (412)
.|.+--+.||.|+||+||.+.|-..+ +.||+|.+.. ....-...+++.+|+.+|...+|.|++..++..+-..
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdg----rrvalkK~pn--vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~ 126 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSG----KRVALKKMPN--VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANP 126 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCc----cchhHhhcch--HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCc
Confidence 35556679999999999998776644 4499998743 3344456678888999999999999999999887543
Q ss_pred ----eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 97 ----FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 97 ----~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
.+|+++|++ ..||...+- ....++.+.++-+++||+.||+|||+.||+||||||.|+|++.|..+||||||+|
T Consensus 127 dfFqEiYV~TELm-QSDLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLA 203 (449)
T KOG0664|consen 127 SFFQELYVLTELM-QSDLHKIIV--SPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLA 203 (449)
T ss_pred hHHHHHHHHHHHH-Hhhhhheec--cCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccc
Confidence 578899998 456755543 3456999999999999999999999999999999999999999999999999999
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+...... ....+.-+-|.
T Consensus 204 Rvee~d~--------------------------------------------------------------~~hMTqEVVTQ 221 (449)
T KOG0664|consen 204 RTWDQRD--------------------------------------------------------------RLNMTHEVVTQ 221 (449)
T ss_pred cccchhh--------------------------------------------------------------hhhhHHHHHHH
Confidence 8652111 01111225678
Q ss_pred CCccceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHh-----------------------cCCCCCC
Q 042539 253 EYVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL-----------------------MKTPEFV 308 (412)
Q Consensus 253 ~Y~APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~-----------------------~~~~~~~ 308 (412)
.|+|||++.|. .|+.++||||+|||+.||+..+..|...+..+++.-|. .+....+
T Consensus 222 YYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~P 301 (449)
T KOG0664|consen 222 YYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAP 301 (449)
T ss_pred HhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCC
Confidence 99999999986 47999999999999999999999999988766654443 1111111
Q ss_pred CC------------ChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCc
Q 042539 309 GQ------------RTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRW 350 (412)
Q Consensus 309 ~~------------~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~ 350 (412)
+. ..+..+++.+||..||.+|+ ..++++.|++......
T Consensus 302 s~~vLYtlsS~~~~~heav~~~~~~l~~d~dkri----s~~~A~~~~~~~e~R~ 351 (449)
T KOG0664|consen 302 DTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRI----SVEEALQHRYLEEGRL 351 (449)
T ss_pred CccceeeecCCcccchHHHHHHHHHhCCCCcccc----cHhhhcccccccccce
Confidence 11 14678899999999999999 5899999999876543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=275.90 Aligned_cols=239 Identities=42% Similarity=0.686 Sum_probs=199.0
Q ss_pred CceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEEEeeccCCCC
Q 042539 30 AMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGD 109 (412)
Q Consensus 30 ~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~ 109 (412)
+||.||++.+..++ +.+|+|++........ ...+.+|+++++.++|+||+++++.+......++++|++.+++
T Consensus 1 ~~g~v~~~~~~~~~----~~~~~k~~~~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 73 (244)
T smart00220 1 SFGKVYLARDKKTG----KLVAIKVIKKEKIKKK---RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGD 73 (244)
T ss_pred CceEEEEEEECCCC----cEEEEEEecccccccH---HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCC
Confidence 68999999987644 4499999976543221 4667789999999999999999999999999999999999999
Q ss_pred chhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhhhhcccCC
Q 042539 110 LNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNN 189 (412)
Q Consensus 110 L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 189 (412)
|..++..... ++...+..++.+++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 74 L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---------- 141 (244)
T smart00220 74 LFDLLKKRGR--LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---------- 141 (244)
T ss_pred HHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc----------
Confidence 9887765433 8899999999999999999999999999999999999999999999999987652110
Q ss_pred CCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecCCCCCchh
Q 042539 190 KFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAV 269 (412)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~ 269 (412)
......++..|++||.+.+..++.++
T Consensus 142 ------------------------------------------------------~~~~~~~~~~~~~pE~~~~~~~~~~~ 167 (244)
T smart00220 142 ------------------------------------------------------LLTTFVGTPEYMAPEVLLGKGYGKAV 167 (244)
T ss_pred ------------------------------------------------------ccccccCCcCCCCHHHHccCCCCchh
Confidence 12234678899999999888888899
Q ss_pred hHHHHHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCCCCCC----CChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCC
Q 042539 270 DWWALGILTYEMLYGTTPFRG-KNRKETFRNVLMKTPEFVG----QRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVF 344 (412)
Q Consensus 270 DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~----~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~f 344 (412)
|+||||+++|+|++|..||.. .+.......+......... .+.++.+++.+||..+|.+|| ++.++++|||
T Consensus 168 Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp----~~~~~~~~~~ 243 (244)
T smart00220 168 DVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRL----TAEEALQHPF 243 (244)
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhcc----CHHHHhhCCC
Confidence 999999999999999999988 4444444444433322221 678999999999999999999 6999999999
Q ss_pred C
Q 042539 345 F 345 (412)
Q Consensus 345 f 345 (412)
|
T Consensus 244 ~ 244 (244)
T smart00220 244 F 244 (244)
T ss_pred C
Confidence 7
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=309.53 Aligned_cols=259 Identities=21% Similarity=0.337 Sum_probs=222.9
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
.-+++....+|.++||.|.||.||.++.+..++ ....||||.++... .+.....|+.|+.||-+++||||++|.++
T Consensus 623 akEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgk-re~~VAIKTLK~Gy---tekqrrdFL~EAsIMGQFdHPNIIrLEGV 698 (996)
T KOG0196|consen 623 AKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGK-REITVAIKTLKAGY---TEKQRRDFLSEASIMGQFDHPNIIRLEGV 698 (996)
T ss_pred hhhcChhheEEEEEEecccccceecccccCCCC-cceeEEEeeeccCc---cHHHHhhhhhhhhhcccCCCCcEEEEEEE
Confidence 457888899999999999999999999876654 45669999997654 34557778899999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
......+.||+|||+.|+|+.+++.+. +.|+..+...+++.|+.|++||-+.|+|||||...|||++.+-.+|++|||+
T Consensus 699 VTks~PvMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGL 777 (996)
T KOG0196|consen 699 VTKSKPVMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGL 777 (996)
T ss_pred EecCceeEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccc
Confidence 999999999999999999999988765 5699999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc-
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG- 250 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g- 250 (412)
++.+.+..+ ...++.-|
T Consensus 778 SRvledd~~--------------------------------------------------------------~~ytt~GGK 795 (996)
T KOG0196|consen 778 SRVLEDDPE--------------------------------------------------------------AAYTTLGGK 795 (996)
T ss_pred eeecccCCC--------------------------------------------------------------ccccccCCc
Confidence 997632210 00111111
Q ss_pred -CCCCccceeecCCCCCchhhHHHHHHHHHHHh-hCCCCCCCCCHHHHHHHHhcC--CCCCCCCChHHHHHHHHhhhhCC
Q 042539 251 -TEEYVSPEVVRGDGHEFAVDWWALGILTYEML-YGTTPFRGKNRKETFRNVLMK--TPEFVGQRTALTDLIQRLLEKDP 326 (412)
Q Consensus 251 -t~~Y~APE~l~~~~~~~~~DiwSlGvil~ell-~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~dli~~~L~~dP 326 (412)
..+|.|||.+....++.++||||+|+++||.+ +|..||=..++++++..|..+ .|...+++..+..|+..||++|.
T Consensus 796 IPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR 875 (996)
T KOG0196|consen 796 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDR 875 (996)
T ss_pred cceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHh
Confidence 35799999999999999999999999999977 699999999999999998865 46777899999999999999999
Q ss_pred CccCCCCCChhhhhc
Q 042539 327 VKRLGYLRGACEIKE 341 (412)
Q Consensus 327 ~~R~~~~~~~~e~l~ 341 (412)
.+||. ..+|..
T Consensus 876 ~~RP~----F~qiV~ 886 (996)
T KOG0196|consen 876 NRRPK----FAQIVS 886 (996)
T ss_pred hcCCC----HHHHHH
Confidence 99995 456554
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=298.67 Aligned_cols=252 Identities=21% Similarity=0.275 Sum_probs=214.1
Q ss_pred CCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeee
Q 042539 11 TTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLG 90 (412)
Q Consensus 11 ~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 90 (412)
-.++++.-++...++||-|-||.||.+.|+..... ||||.++.+.. ....++.|+.+|+.++|||+|+|++
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslT----vAVKtLKEDtM-----eveEFLkEAAvMKeikHpNLVqLLG 330 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLT----VAVKTLKEDTM-----EVEEFLKEAAVMKEIKHPNLVQLLG 330 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeecccee----eehhhhhhcch-----hHHHHHHHHHHHHhhcCccHHHHhh
Confidence 46777788888999999999999999999875544 99999965442 3456777999999999999999999
Q ss_pred eEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccc
Q 042539 91 SLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 91 ~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
++..+-.+|||+|||..|.|.+++..-+..-++.-....++.||..|++||..+++|||||...|+|+.++..||++|||
T Consensus 331 VCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFG 410 (1157)
T KOG4278|consen 331 VCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFG 410 (1157)
T ss_pred hhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccc
Confidence 99999999999999999999999887776668888889999999999999999999999999999999999999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
|++.+...+.-. .....-
T Consensus 411 LsRlMtgDTYTA--------------------------------------------------------------HAGAKF 428 (1157)
T KOG4278|consen 411 LSRLMTGDTYTA--------------------------------------------------------------HAGAKF 428 (1157)
T ss_pred hhhhhcCCceec--------------------------------------------------------------ccCccC
Confidence 999874322100 000011
Q ss_pred CCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCC
Q 042539 251 TEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPV 327 (412)
Q Consensus 251 t~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~ 327 (412)
..-|.|||-+....++.++|||||||+|||+.| |..||.|.+...++.-+-.+. ....++++.+..|++.||+++|.
T Consensus 429 PIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPs 508 (1157)
T KOG4278|consen 429 PIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPS 508 (1157)
T ss_pred cccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcc
Confidence 346999999999999999999999999999985 999999999888877655443 23457889999999999999999
Q ss_pred ccCCCC
Q 042539 328 KRLGYL 333 (412)
Q Consensus 328 ~R~~~~ 333 (412)
+||+|.
T Consensus 509 DRPsFa 514 (1157)
T KOG4278|consen 509 DRPSFA 514 (1157)
T ss_pred cCccHH
Confidence 999873
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=313.65 Aligned_cols=243 Identities=33% Similarity=0.423 Sum_probs=195.0
Q ss_pred eeeeeccCceE-EEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEEeCCeEEE
Q 042539 23 LKILGKGAMGT-VFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLETDEFLAW 100 (412)
Q Consensus 23 ~~~LG~G~fg~-V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~l 100 (412)
.+.+|.|+.|+ ||++.. .++.||||.+- .+....+.|||+.|+..+ |||||++|+.-++..++||
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y------e~R~VAVKrll-------~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YI 580 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY------EGREVAVKRLL-------EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYI 580 (903)
T ss_pred HHHcccCCCCcEEEEEee------CCceehHHHHh-------hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEE
Confidence 35789999987 566554 34459999873 345567778999999996 9999999999999999999
Q ss_pred EeeccCCCCchhHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEcc---CC--CEEEccccccc
Q 042539 101 AVPYCPGGDLNVLRYKQ--NDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQ---SG--HVTLTDFDLSR 173 (412)
Q Consensus 101 v~e~~~gg~L~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~---~g--~vkL~DFGla~ 173 (412)
+.|+|. -+|.+++... ..........+..+.|++.||++||+.+||||||||+||||+. ++ .++|+|||+|+
T Consensus 581 alELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 581 ALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred EehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 999994 5888888763 1111111455788999999999999999999999999999987 34 58999999999
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
.+..... .-.+.++..||-+
T Consensus 660 kl~~~~s------------------------------------------------------------S~~r~s~~sGt~G 679 (903)
T KOG1027|consen 660 KLAGGKS------------------------------------------------------------SFSRLSGGSGTSG 679 (903)
T ss_pred ccCCCcc------------------------------------------------------------hhhcccCCCCccc
Confidence 8742211 1122456789999
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhhC-CCCCCCCCHHHHHHHHhcCCCCCCCCC--h--HHHHHHHHhhhhCCCc
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLYG-TTPFRGKNRKETFRNVLMKTPEFVGQR--T--ALTDLIQRLLEKDPVK 328 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~--~~~dli~~~L~~dP~~ 328 (412)
|+|||++....-+.++||+||||++|+.++| ..||... .+...+|+.+........ + +++|||.+||.++|..
T Consensus 680 W~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~--~~R~~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~ 757 (903)
T KOG1027|consen 680 WQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS--LERQANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQL 757 (903)
T ss_pred ccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch--HHhhhhhhcCccceeeeccCchHHHHHHHHHhcCCCccc
Confidence 9999999998888899999999999999985 9999764 444457777765543321 2 8999999999999999
Q ss_pred cCCCCCChhhhhcCCCC
Q 042539 329 RLGYLRGACEIKEHVFF 345 (412)
Q Consensus 329 R~~~~~~~~e~l~h~ff 345 (412)
|| +|.+++.||||
T Consensus 758 RP----sa~~VL~HPlF 770 (903)
T KOG1027|consen 758 RP----SATDVLNHPLF 770 (903)
T ss_pred CC----CHHHHhCCCcc
Confidence 99 69999999999
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=308.84 Aligned_cols=299 Identities=36% Similarity=0.630 Sum_probs=244.4
Q ss_pred eeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEEeCCeEEEEee
Q 042539 25 ILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLETDEFLAWAVP 103 (412)
Q Consensus 25 ~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~e 103 (412)
++|+|+||.|++|+.. .+...+..+|+|+.++.....+... +...|..++..++ ||++|+++..|+.+..++++++
T Consensus 1 vlg~g~~gkvfLvrk~-~g~da~~~yamkvl~k~t~~~~~~~--~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld 77 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKA-GGADAGHLYAMKVLKKATLKVRDRT--HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD 77 (612)
T ss_pred CCCcCCCcchHHHHHh-ccccccchhhhhccccccccccccc--ccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence 4799999999999854 4455677799999998887555444 5666899999998 9999999999999999999999
Q ss_pred ccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhhh
Q 042539 104 YCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEK 183 (412)
Q Consensus 104 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~ 183 (412)
+..||+|...+... ..+++...+.+.++++.|++++|+.||+|||+|++||+++.+|++++.|||+++......
T Consensus 78 ~~rgg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---- 151 (612)
T KOG0603|consen 78 FLRGGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---- 151 (612)
T ss_pred hcccchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence 99999996655443 459999999999999999999999999999999999999999999999999998774321
Q ss_pred hcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecCC
Q 042539 184 QSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGD 263 (412)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~ 263 (412)
..|||..|||||++.
T Consensus 152 ---------------------------------------------------------------~~cgt~eymApEI~~-- 166 (612)
T KOG0603|consen 152 ---------------------------------------------------------------IACGTYEYRAPEIIN-- 166 (612)
T ss_pred ---------------------------------------------------------------hcccchhhhhhHhhh--
Confidence 118999999999998
Q ss_pred CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCccCCCC-CChhhhhc
Q 042539 264 GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKRLGYL-RGACEIKE 341 (412)
Q Consensus 264 ~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R~~~~-~~~~e~l~ 341 (412)
++..++|+||||++.|||++|..||.+ ++.++|+......+ ..+..+.+++..|+..+|.+|++.. ..+.++++
T Consensus 167 gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~ 242 (612)
T KOG0603|consen 167 GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQ 242 (612)
T ss_pred ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence 677899999999999999999999998 77788887555444 4568899999999999999999864 46999999
Q ss_pred CCCCCCCCchhhcc-cCCCCCCCCCCCchhhhhhhcCCCCChhhhhhccCCCCCCCCCCCCCCCC-CCCccCC
Q 042539 342 HVFFKGVRWDLLTD-VLRPPFIPSREENDLTEKAMSGGGVDIREYFENLRAPPPSMPPSPLPSPS-HRSFAEY 412 (412)
Q Consensus 342 h~ff~~~~~~~~~~-~~~pp~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~-~~~~~~~ 412 (412)
|+||..++|+.+.. ..+|||.|....++. ...+-..+....|...|.-.++++ ++-|.||
T Consensus 243 h~f~~~i~~~~l~~r~~~~~fkp~~~~e~~-----------~~~fd~eft~~~P~dsp~~~~~~s~~~if~g~ 304 (612)
T KOG0603|consen 243 HEFFQSIDWNELEARSRPPPFKPGSITERD-----------VAQFDPEFTSQVPADSPLLSASGSDHTIFSGP 304 (612)
T ss_pred cchheeeeHhhHhhcCCCCCCCCcccchhh-----------hhhcCchhccCCcccCCCCCCCccccchhcCC
Confidence 99999999997655 457788887655432 222333455666666555444444 3666554
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=261.77 Aligned_cols=220 Identities=24% Similarity=0.395 Sum_probs=179.1
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeeeeE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLGSL 92 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 92 (412)
++..+++..+..||+|+||.|=+.++..++. ..|+|.++... + ....++.++|+.+.... .||++|++|+.+
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~----imAvKri~~tv-n--~q~q~r~L~dldi~~r~~~CPf~V~FyGa~ 114 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGT----IMAVKRIRATV-N--SQEQKRLLMDLDIIMRTVDCPFTVHFYGAL 114 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCe----EEEEeeehhhc-C--hHHHHHHHHhhhhhccCCCCCeEEEeehhh
Confidence 4555677788899999999999888877554 49999996543 2 34566777799887776 599999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeeeCCCCceEEccCCCEEEccc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYK--QNDRVFSPSVIRFYLSEIICAIEHLHNM-GIAYRDLKPENILIRQSGHVTLTDF 169 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~--~~~~~l~~~~~~~~~~qi~~aL~yLH~~-~iiHrDlKp~NiLl~~~g~vkL~DF 169 (412)
.....+++.||.|. .+|+.+... ..++.++|..+-.++..++.||.|||++ .+||||+||+||||+..|+||+|||
T Consensus 115 ~regdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDF 193 (282)
T KOG0984|consen 115 FREGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDF 193 (282)
T ss_pred hccccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccc
Confidence 99999999999994 455544222 2456799999999999999999999987 8999999999999999999999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|++..+.++.... .-.
T Consensus 194 GIsG~L~dSiAkt----------------------------------------------------------------~da 209 (282)
T KOG0984|consen 194 GISGYLVDSIAKT----------------------------------------------------------------MDA 209 (282)
T ss_pred ccceeehhhhHHH----------------------------------------------------------------Hhc
Confidence 9998876543321 124
Q ss_pred cCCCCccceeecC----CCCCchhhHHHHHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCC
Q 042539 250 GTEEYVSPEVVRG----DGHEFAVDWWALGILTYEMLYGTTPFRG-KNRKETFRNVLMKTP 305 (412)
Q Consensus 250 gt~~Y~APE~l~~----~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~ 305 (412)
|-..|||||.+.. .+|+.++||||||++++||.+++.||.. .+.-+++++++...+
T Consensus 210 GCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~ 270 (282)
T KOG0984|consen 210 GCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPS 270 (282)
T ss_pred CCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCC
Confidence 6778999999854 4789999999999999999999999976 566778888876543
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=298.47 Aligned_cols=203 Identities=29% Similarity=0.485 Sum_probs=174.0
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhH----HHHHHHHHHHHHHhhcC---CCcccee
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKH----EAERRARWEIRVLSRLS---HPFLPKL 88 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~----~~~~~~~~Ei~il~~l~---hpnIv~l 88 (412)
.+.+|..++.||.|+||+|++|.++..+.. |+||.|.|+.+.... ...-.+--||+||..|+ |+||+++
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~e----VViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKl 634 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYE----VVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKL 634 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceE----EEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhh
Confidence 346799999999999999999999886544 999999887652211 11112334999999998 9999999
Q ss_pred eeeEEeCCeEEEEeecc-CCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEc
Q 042539 89 LGSLETDEFLAWAVPYC-PGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLT 167 (412)
Q Consensus 89 ~~~~~~~~~~~lv~e~~-~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~ 167 (412)
+++|++++++||+||-- +|.||.+++..+.+ ++|.+++.++.|++.|+++||+.||||||||=+|+.++.+|.+||+
T Consensus 635 LdfFEddd~yyl~te~hg~gIDLFd~IE~kp~--m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 635 LDFFEDDDYYYLETEVHGEGIDLFDFIEFKPR--MDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred hheeecCCeeEEEecCCCCCcchhhhhhccCc--cchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEe
Confidence 99999999999999875 45677777766554 9999999999999999999999999999999999999999999999
Q ss_pred cccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcc
Q 042539 168 DFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNS 247 (412)
Q Consensus 168 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (412)
|||.|... ....-.+
T Consensus 713 dfgsaa~~-----------------------------------------------------------------ksgpfd~ 727 (772)
T KOG1152|consen 713 DFGSAAYT-----------------------------------------------------------------KSGPFDV 727 (772)
T ss_pred eccchhhh-----------------------------------------------------------------cCCCcce
Confidence 99988543 3345568
Q ss_pred cccCCCCccceeecCCCC-CchhhHHHHHHHHHHHhhCCCCCC
Q 042539 248 FVGTEEYVSPEVVRGDGH-EFAVDWWALGILTYEMLYGTTPFR 289 (412)
Q Consensus 248 ~~gt~~Y~APE~l~~~~~-~~~~DiwSlGvil~ell~g~~Pf~ 289 (412)
|+||..|.|||++.|..| ++.-||||||++||-+++..-||.
T Consensus 728 f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 728 FVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999999999999998 889999999999999999998885
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=280.79 Aligned_cols=298 Identities=23% Similarity=0.345 Sum_probs=207.0
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEE
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLE 93 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~ 93 (412)
...+.|.++.+||+|+|++||++.+... ......||+|.|.... ...++..|+++|..+. +.||+++.+++.
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~-~~~~~~valk~i~~ts------~p~ri~~El~~L~~~gG~~ni~~~~~~~r 105 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQ-DTKRRYVALKAIYRTS------SPSRILNELEMLYRLGGSDNIIKLNGCFR 105 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhh-ccccceEeeeeccccc------CchHHHHHHHHHHHhccchhhhcchhhhc
Confidence 3457899999999999999999887652 2245669999985543 2345777999999996 899999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccC-CCEEEcccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQS-GHVTLTDFDLS 172 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~-g~vkL~DFGla 172 (412)
.++++.+||||++..+..++... ++-.+++.|++.++.||.++|.+|||||||||.|+|.+.. +.-.|+|||+|
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred cCCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhH
Confidence 99999999999999888766533 7789999999999999999999999999999999999876 77899999999
Q ss_pred chhhchh--hhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 173 RNLVKKT--AFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 173 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
....... +....-.... ..|.. .....+....++........-.............|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~---~~~~~------------------g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAG 239 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRH---ATPAM------------------GKDVHCQSVATASKPAGYYRRCNDGRPSERANRAG 239 (418)
T ss_pred HHHHhhhhhhhhhhhhccc---CCccc------------------cCcccccccccccCCCCceeccCCCccceecccCC
Confidence 8532111 1100000000 00000 00000111111000000000001122233456789
Q ss_pred CCCCccceeecCCC-CCchhhHHHHHHHHHHHhhCCCCCCCCCH-HHHHHHHh--------------cCC----------
Q 042539 251 TEEYVSPEVVRGDG-HEFAVDWWALGILTYEMLYGTTPFRGKNR-KETFRNVL--------------MKT---------- 304 (412)
Q Consensus 251 t~~Y~APE~l~~~~-~~~~~DiwSlGvil~ell~g~~Pf~~~~~-~~~~~~i~--------------~~~---------- 304 (412)
|++|.|||++...+ .+.++||||.|||+.-+++++.||-.... ...+..+. .+.
T Consensus 240 T~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~ 319 (418)
T KOG1167|consen 240 TPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIP 319 (418)
T ss_pred CCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeecccccc
Confidence 99999999998765 58899999999999999999999854321 11100000 000
Q ss_pred --------------------CC-------C-CCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCC
Q 042539 305 --------------------PE-------F-VGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 305 --------------------~~-------~-~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~ 349 (412)
.. . .-.+..+.||+.+||+.||.+|+ +++++|+||||...+
T Consensus 320 ~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRi----tAEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 320 TIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRI----TAEDALKHPFFDEAD 388 (418)
T ss_pred ccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcc----cHHHHhcCcCCcchh
Confidence 00 0 01123688999999999999999 799999999999654
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=297.81 Aligned_cols=257 Identities=25% Similarity=0.353 Sum_probs=209.6
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCC---CCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccce
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPT---ARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPK 87 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~ 87 (412)
.+++..+++++.+.||+|+||+|+++.-+..... ....||||.++..... ...+.+..|+++|+.+. |+||+.
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~---~~~~~~~~El~~m~~~g~H~niv~ 366 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS---SEKKDLMSELNVLKELGKHPNIVN 366 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc---HHHHHHHHHHHHHHHhcCCcchhh
Confidence 6788888889999999999999999876544432 2567999999665432 45667778999999995 999999
Q ss_pred eeeeEEeCCeEEEEeeccCCCCchhHHHhhC-------C-------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCC
Q 042539 88 LLGSLETDEFLAWAVPYCPGGDLNVLRYKQN-------D-------RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKP 153 (412)
Q Consensus 88 l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~-------~-------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp 153 (412)
+++++...+.+++|+|||..|+|..++.... . ..++..+...++.||+.|++||++..+|||||-.
T Consensus 367 llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAa 446 (609)
T KOG0200|consen 367 LLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAA 446 (609)
T ss_pred heeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhh
Confidence 9999999999999999999999998887655 0 1388899999999999999999999999999999
Q ss_pred CceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCcc
Q 042539 154 ENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVS 233 (412)
Q Consensus 154 ~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (412)
.|||+..+..+||+|||+|+.......+..+
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~------------------------------------------------- 477 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTK------------------------------------------------- 477 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEec-------------------------------------------------
Confidence 9999999999999999999865433222110
Q ss_pred ccccccCCCCCCccccc--CCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCC-HHHHHHHHhcCC--CCC
Q 042539 234 RRQQSFDNGERSNSFVG--TEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKN-RKETFRNVLMKT--PEF 307 (412)
Q Consensus 234 ~~~~~~~~~~~~~~~~g--t~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~-~~~~~~~i~~~~--~~~ 307 (412)
.-.| ...|||||.+....|+.++||||+|++|||+++ |..||.+.. ..+.+..+..+. ...
T Consensus 478 -------------~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P 544 (609)
T KOG0200|consen 478 -------------SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQP 544 (609)
T ss_pred -------------CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCCC
Confidence 0011 224999999999999999999999999999997 999999865 556655444433 223
Q ss_pred CCCChHHHHHHHHhhhhCCCccCCCC
Q 042539 308 VGQRTALTDLIQRLLEKDPVKRLGYL 333 (412)
Q Consensus 308 ~~~~~~~~dli~~~L~~dP~~R~~~~ 333 (412)
..+++++.+++..||+.+|++||++.
T Consensus 545 ~~c~~eiY~iM~~CW~~~p~~RP~F~ 570 (609)
T KOG0200|consen 545 EHCSDEIYDLMKSCWNADPEDRPTFS 570 (609)
T ss_pred CCCCHHHHHHHHHHhCCCcccCCCHH
Confidence 34589999999999999999999753
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=296.08 Aligned_cols=255 Identities=26% Similarity=0.387 Sum_probs=210.3
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
.++|.++..+|.|+||.||+|+++.++. ..|+|+++..- .+...-+.+|+-+++.++|+|||.+++.+...+
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~e----laavkvVkLep----~dd~~~iqqei~~~~dc~h~nivay~gsylr~d 85 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGE----LAAVKVVKLEP----GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD 85 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCc----hhhheeeeccC----CccccccccceeeeecCCCcChHHHHhhhhhhc
Confidence 4799999999999999999999988554 49999997653 234555667999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
.++++||||.||+|.+.-+ ..+.++|.++....++.+.||+|||+.|-+|||||=.|||+++.|.+|++|||.+..+.
T Consensus 86 klwicMEycgggslQdiy~--~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqit 163 (829)
T KOG0576|consen 86 KLWICMEYCGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT 163 (829)
T ss_pred CcEEEEEecCCCcccceee--ecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhh
Confidence 9999999999999976533 34579999999999999999999999999999999999999999999999999987663
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
.- -....+|.||+.|||
T Consensus 164 at---------------------------------------------------------------i~KrksfiGtpywma 180 (829)
T KOG0576|consen 164 AT---------------------------------------------------------------IAKRKSFIGTPYWMA 180 (829)
T ss_pred hh---------------------------------------------------------------hhhhhcccCCccccc
Confidence 11 112347899999999
Q ss_pred ceeec---CCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC---CCCC---CCChHHHHHHHHhhhhCCC
Q 042539 257 PEVVR---GDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT---PEFV---GQRTALTDLIQRLLEKDPV 327 (412)
Q Consensus 257 PE~l~---~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~---~~~~---~~~~~~~dli~~~L~~dP~ 327 (412)
||+-. ..+|+..+|+||+|++..|+---++|-...-....+.-.-+.. +.+. ..++.+.+|++.+|.++|.
T Consensus 181 pEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpK 260 (829)
T KOG0576|consen 181 PEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPK 260 (829)
T ss_pred hhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCc
Confidence 99863 4578999999999999999998888865544333332222222 2222 2457899999999999999
Q ss_pred ccCCCCCChhhhhcCCCCCCC
Q 042539 328 KRLGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 328 ~R~~~~~~~~e~l~h~ff~~~ 348 (412)
+|| +++.++.|||....
T Consensus 261 kRp----taeklL~h~fvs~~ 277 (829)
T KOG0576|consen 261 KRP----TAEKLLQHPFVSQT 277 (829)
T ss_pred cCC----Chhhheeceeeccc
Confidence 999 79999999998753
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=320.39 Aligned_cols=235 Identities=21% Similarity=0.282 Sum_probs=181.4
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
++|...+.||+|+||.||+|+++..+. .||+|.++..... ...|++++++++|||||++++++.+++.
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~--------~~~~~~~l~~l~HpnIv~~~~~~~~~~~ 757 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGM----QFVVKEINDVNSI--------PSSEIADMGKLQHPNIVKLIGLCRSEKG 757 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCc----EEEEEEccCCccc--------cHHHHHHHhhCCCCCcceEEEEEEcCCC
Confidence 356677899999999999999876544 4999998643211 1136889999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLH---NMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH---~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
.|+|||||+||+|.+++.. +++..+..++.|++.||+||| +.+|+||||||+||+++.++..+++ ||.+..
T Consensus 758 ~~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~ 831 (968)
T PLN00113 758 AYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL 831 (968)
T ss_pred CEEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence 9999999999999888742 788999999999999999999 6699999999999999998888775 654432
Q ss_pred hhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCC
Q 042539 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254 (412)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 254 (412)
.. ......||+.|
T Consensus 832 ~~-------------------------------------------------------------------~~~~~~~t~~y 844 (968)
T PLN00113 832 LC-------------------------------------------------------------------TDTKCFISSAY 844 (968)
T ss_pred cc-------------------------------------------------------------------cCCCccccccc
Confidence 10 00123688999
Q ss_pred ccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCH-----HHHHHHHhcC-------CCCCC-------CCChHHH
Q 042539 255 VSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNR-----KETFRNVLMK-------TPEFV-------GQRTALT 315 (412)
Q Consensus 255 ~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-----~~~~~~i~~~-------~~~~~-------~~~~~~~ 315 (412)
||||++.+..++.++|||||||++|||++|+.||..... .+..+..... .+... ....++.
T Consensus 845 ~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 924 (968)
T PLN00113 845 VAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVM 924 (968)
T ss_pred cCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHH
Confidence 999999999999999999999999999999999854211 1111110000 01110 0113577
Q ss_pred HHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 316 DLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 316 dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
+++.+||+.||++|| ++.++++
T Consensus 925 ~l~~~Cl~~~P~~RP----t~~evl~ 946 (968)
T PLN00113 925 NLALHCTATDPTARP----CANDVLK 946 (968)
T ss_pred HHHHhhCcCCchhCc----CHHHHHH
Confidence 899999999999999 5777775
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=291.06 Aligned_cols=248 Identities=22% Similarity=0.256 Sum_probs=205.9
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeE
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFL 98 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 98 (412)
..+..++||+|+||+||++.+-..+...+.+||||++..... ......++.|+-+|.+|+|||+++|+++..... +
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~---~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS---PKASIELLDEALRMASLDHPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC---chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-H
Confidence 445668999999999999988877888899999999976543 344566778999999999999999999998766 8
Q ss_pred EEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhch
Q 042539 99 AWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~ 178 (412)
.||++|+++|.|.++++.+.. .+-.+....|..||+.|+.|||.+++|||||-.+|+|+..-.++||.|||+|+.....
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~-~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRD-NIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhc-cccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 899999999999998877553 5788899999999999999999999999999999999999999999999999876322
Q ss_pred hhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccce
Q 042539 179 TAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPE 258 (412)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 258 (412)
... -.+....-.+-|||-|
T Consensus 852 ~~e-------------------------------------------------------------y~~~~gK~pikwmale 870 (1177)
T KOG1025|consen 852 EKE-------------------------------------------------------------YSAPGGKVPIKWMALE 870 (1177)
T ss_pred ccc-------------------------------------------------------------ccccccccCcHHHHHH
Confidence 110 0001112245699999
Q ss_pred eecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCChHHHHHHHHhhhhCCCccCCC
Q 042539 259 VVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMK--TPEFVGQRTALTDLIQRLLEKDPVKRLGY 332 (412)
Q Consensus 259 ~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~dli~~~L~~dP~~R~~~ 332 (412)
.+....|+.++||||+||++||++| |..|+.+....++-..+..+ .+..+.++-++.-++.+||..|+..||.+
T Consensus 871 ~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~f 947 (1177)
T KOG1025|consen 871 SIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTF 947 (1177)
T ss_pred HhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccH
Confidence 9999999999999999999999997 99999998877764444332 34455677899999999999999999965
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=271.82 Aligned_cols=253 Identities=24% Similarity=0.329 Sum_probs=188.8
Q ss_pred CCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHh--hcCCCccce
Q 042539 10 QTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLS--RLSHPFLPK 87 (412)
Q Consensus 10 ~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~--~l~hpnIv~ 87 (412)
...+..-..+.++++.||+|.||.||++++++.. ||||++... ++ ....||.+|.+ .|+|+||+.
T Consensus 203 lLVQRTiarqI~L~e~IGkGRyGEVwrG~wrGe~------VAVKiF~sr-----dE--~SWfrEtEIYqTvmLRHENILg 269 (513)
T KOG2052|consen 203 LLVQRTIARQIVLQEIIGKGRFGEVWRGRWRGED------VAVKIFSSR-----DE--RSWFRETEIYQTVMLRHENILG 269 (513)
T ss_pred hHhHHhhhheeEEEEEecCccccceeeccccCCc------eEEEEeccc-----ch--hhhhhHHHHHHHHHhccchhhh
Confidence 3345566788999999999999999999987533 999999432 22 22333555554 558999999
Q ss_pred eeeeEEeCC----eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHc--------CceeeeCCCCc
Q 042539 88 LLGSLETDE----FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNM--------GIAYRDLKPEN 155 (412)
Q Consensus 88 l~~~~~~~~----~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~--------~iiHrDlKp~N 155 (412)
+++.-..++ .+|||++|-+.|+|++++.. ..++.+....++..+++||++||-. .|.|||||..|
T Consensus 270 FIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKN 346 (513)
T KOG2052|consen 270 FIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKN 346 (513)
T ss_pred hhhccccCCCceEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccccc
Confidence 998765443 69999999999999999876 3499999999999999999999953 49999999999
Q ss_pred eEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCcccc
Q 042539 156 ILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRR 235 (412)
Q Consensus 156 iLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (412)
||+.++|...|+|+|||-.....+.
T Consensus 347 ILVKkn~~C~IADLGLAv~h~~~t~------------------------------------------------------- 371 (513)
T KOG2052|consen 347 ILVKKNGTCCIADLGLAVRHDSDTD------------------------------------------------------- 371 (513)
T ss_pred EEEccCCcEEEeeceeeEEecccCC-------------------------------------------------------
Confidence 9999999999999999976532211
Q ss_pred ccccCCCCCCcccccCCCCccceeecCCC----C--CchhhHHHHHHHHHHHhhC----------CCCCCCC----CHHH
Q 042539 236 QQSFDNGERSNSFVGTEEYVSPEVVRGDG----H--EFAVDWWALGILTYEMLYG----------TTPFRGK----NRKE 295 (412)
Q Consensus 236 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~----~--~~~~DiwSlGvil~ell~g----------~~Pf~~~----~~~~ 295 (412)
.-....+..+||.+|||||++...- + -+.+||||||.++||++.. ++||.+. ...+
T Consensus 372 ----~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~e 447 (513)
T KOG2052|consen 372 ----TIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFE 447 (513)
T ss_pred ----cccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHH
Confidence 2233445679999999999997531 1 2578999999999999842 4677542 2234
Q ss_pred HHHHHhcCC---CCCCC--CC----hHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 296 TFRNVLMKT---PEFVG--QR----TALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 296 ~~~~i~~~~---~~~~~--~~----~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
.+++++.-. |..++ .+ ..+..+++.||..||..|+ ||-.+++
T Consensus 448 eMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRl----tALriKK 498 (513)
T KOG2052|consen 448 EMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARL----TALRIKK 498 (513)
T ss_pred HHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhh----HHHHHHH
Confidence 444444322 22222 12 3466789999999999999 4555553
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=269.78 Aligned_cols=244 Identities=24% Similarity=0.352 Sum_probs=186.4
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc--CCCccceee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL--SHPFLPKLL 89 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l--~hpnIv~l~ 89 (412)
.+-++++..+++++||+|.||.||+|.... +.||||++... ..+.+..|.+|.+.. +|+||++++
T Consensus 204 spl~~l~pl~l~eli~~Grfg~V~KaqL~~------~~VAVKifp~~-------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi 270 (534)
T KOG3653|consen 204 SPLLELDPLQLLELIGRGRFGCVWKAQLDN------RLVAVKIFPEQ-------EKQSFQNEKNIYSLPGMKHENILQFI 270 (534)
T ss_pred cccccCCchhhHHHhhcCccceeehhhccC------ceeEEEecCHH-------HHHHHHhHHHHHhccCccchhHHHhh
Confidence 445668899999999999999999886543 55999998432 344555677776655 699999999
Q ss_pred eeEEeCC----eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHc---------CceeeeCCCCce
Q 042539 90 GSLETDE----FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNM---------GIAYRDLKPENI 156 (412)
Q Consensus 90 ~~~~~~~----~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~---------~iiHrDlKp~Ni 156 (412)
++-.... .++||++|-+.|+|.+++... .++......++..|++||+|||+- .|+|||||..||
T Consensus 271 ~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNV 347 (534)
T KOG3653|consen 271 GAEKRGTADRMEYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNV 347 (534)
T ss_pred chhccCCccccceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccce
Confidence 9887655 799999999999999998764 489999999999999999999963 499999999999
Q ss_pred EEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccc
Q 042539 157 LIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQ 236 (412)
Q Consensus 157 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (412)
|+.++++..|+|||+|..+... .
T Consensus 348 LvK~DlTccIaDFGLAl~~~p~---------------~------------------------------------------ 370 (534)
T KOG3653|consen 348 LVKNDLTCCIADFGLALRLEPG---------------K------------------------------------------ 370 (534)
T ss_pred EEccCCcEEeeccceeEEecCC---------------C------------------------------------------
Confidence 9999999999999999876311 0
Q ss_pred cccCCCCCCcccccCCCCccceeecCCC-C-----CchhhHHHHHHHHHHHhhCCC------------CCCC-----CCH
Q 042539 237 QSFDNGERSNSFVGTEEYVSPEVVRGDG-H-----EFAVDWWALGILTYEMLYGTT------------PFRG-----KNR 293 (412)
Q Consensus 237 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~-----~~~~DiwSlGvil~ell~g~~------------Pf~~-----~~~ 293 (412)
....+..-+||.+|||||++.|.- . -.+.||||+|.+||||++.-. ||.. .+-
T Consensus 371 ----~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~ 446 (534)
T KOG3653|consen 371 ----PQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTL 446 (534)
T ss_pred ----CCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCH
Confidence 111122368999999999998752 1 257899999999999997532 3321 122
Q ss_pred HHHHHHHhc--CCCCCCCC------ChHHHHHHHHhhhhCCCccCCC
Q 042539 294 KETFRNVLM--KTPEFVGQ------RTALTDLIQRLLEKDPVKRLGY 332 (412)
Q Consensus 294 ~~~~~~i~~--~~~~~~~~------~~~~~dli~~~L~~dP~~R~~~ 332 (412)
+++...++. ..|.+++. ..-+++.|..||..||+.|++.
T Consensus 447 e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA 493 (534)
T KOG3653|consen 447 EEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTA 493 (534)
T ss_pred HHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhh
Confidence 333333332 22333321 2568899999999999999964
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-31 Score=240.26 Aligned_cols=215 Identities=38% Similarity=0.600 Sum_probs=177.6
Q ss_pred ceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEE
Q 042539 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLA 99 (412)
Q Consensus 20 y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 99 (412)
|.+.+.||.|++|.||++.+..++ ..+|+|.+...... .....+.+|+++++.++|+||+++++++......+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~----~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~ 73 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTG----ELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLY 73 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCC----cEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceE
Confidence 678899999999999999887644 34999999766432 23556777999999999999999999999999999
Q ss_pred EEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchh
Q 042539 100 WAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKT 179 (412)
Q Consensus 100 lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~ 179 (412)
+++|++.+++|..++..... .+++..+..++.+++.+|.+||++|++|+||+|.||+++.++.++|+|||++.......
T Consensus 74 ~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 74 LVMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred EEEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence 99999999999888765432 17899999999999999999999999999999999999999999999999987653210
Q ss_pred hhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcccee
Q 042539 180 AFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEV 259 (412)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 259 (412)
........++..|++||.
T Consensus 153 --------------------------------------------------------------~~~~~~~~~~~~~~~pe~ 170 (225)
T smart00221 153 --------------------------------------------------------------AALLKTVKGTPFYLAPEV 170 (225)
T ss_pred --------------------------------------------------------------cccccceeccCCcCCHhH
Confidence 001223467889999999
Q ss_pred e-cCCCCCchhhHHHHHHHHHHHhhCCCCCCC-CCHH-HHHHHHhcCC
Q 042539 260 V-RGDGHEFAVDWWALGILTYEMLYGTTPFRG-KNRK-ETFRNVLMKT 304 (412)
Q Consensus 260 l-~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~-~~~~~i~~~~ 304 (412)
+ ....++.++|+||||+++|+|++|+.||.. .+.. .+...+..+.
T Consensus 171 ~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 171 LLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred hcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 8 666678899999999999999999999987 4444 5555555554
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=234.57 Aligned_cols=213 Identities=39% Similarity=0.633 Sum_probs=181.0
Q ss_pred eeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEEEeecc
Q 042539 26 LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYC 105 (412)
Q Consensus 26 LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 105 (412)
||+|++|.||++.+...+ ..+++|++....... ....+.+|+++++.+.|++|+++++++......++++|++
T Consensus 1 l~~g~~~~v~~~~~~~~~----~~~~~K~~~~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~ 73 (215)
T cd00180 1 LGEGGFGTVYLARDKKTG----KKVAIKIIKKEDSSS---LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYC 73 (215)
T ss_pred CCcCCceEEEEEEecCCC----cEEEEEEeccccchh---HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecC
Confidence 689999999999887633 449999997654321 3466778999999999999999999999999999999999
Q ss_pred CCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEcc-CCCEEEccccccchhhchhhhhhh
Q 042539 106 PGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQ-SGHVTLTDFDLSRNLVKKTAFEKQ 184 (412)
Q Consensus 106 ~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~-~g~vkL~DFGla~~~~~~~~~~~~ 184 (412)
.|++|..++.... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++. .+.++|+|||.+........
T Consensus 74 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---- 148 (215)
T cd00180 74 EGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---- 148 (215)
T ss_pred CCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----
Confidence 9999988876542 34899999999999999999999999999999999999999 89999999999875421100
Q ss_pred cccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecCC-
Q 042539 185 SLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGD- 263 (412)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~- 263 (412)
......+...|++||.+...
T Consensus 149 -----------------------------------------------------------~~~~~~~~~~~~~pe~~~~~~ 169 (215)
T cd00180 149 -----------------------------------------------------------LLKTIVGTPAYMAPEVLLGKG 169 (215)
T ss_pred -----------------------------------------------------------hhhcccCCCCccChhHhcccC
Confidence 11234577889999999887
Q ss_pred CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCC
Q 042539 264 GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHV 343 (412)
Q Consensus 264 ~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ 343 (412)
.++.++|+|+||+++|+| ..+.+++.+||..||.+|+ +++++++|+
T Consensus 170 ~~~~~~D~~~lg~~~~~l------------------------------~~~~~~l~~~l~~~p~~R~----~~~~l~~~~ 215 (215)
T cd00180 170 YYSEKSDIWSLGVILYEL------------------------------PELKDLIRKMLQKDPEKRP----SAKEILEHL 215 (215)
T ss_pred CCCchhhhHHHHHHHHHH------------------------------HHHHHHHHHHhhCCcccCc----CHHHHhhCC
Confidence 778999999999999999 6789999999999999999 688888764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=293.07 Aligned_cols=230 Identities=17% Similarity=0.234 Sum_probs=156.0
Q ss_pred cCC-CccceeeeeE-------EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeC
Q 042539 80 LSH-PFLPKLLGSL-------ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDL 151 (412)
Q Consensus 80 l~h-pnIv~l~~~~-------~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDl 151 (412)
++| .||++++++| .....++++||++ +++|..++... ...+++.+++.++.||+.||.|||++||+||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 345 5888888887 2334678888987 66998887643 345999999999999999999999999999999
Q ss_pred CCCceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccC-CC
Q 042539 152 KPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSAR-VS 230 (412)
Q Consensus 152 Kp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 230 (412)
||+||||+..|.+|++|||++...........+ ..+.|........ ..
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~k-------------------------------i~DfG~a~~~~~~~~~ 155 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTK-------------------------------SREIGSSRREEILSER 155 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCccc-------------------------------cccccccccccccccc
Confidence 999999998888888888887643211100000 0001111000000 00
Q ss_pred Cc-ccccc-ccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CCC
Q 042539 231 PV-SRRQQ-SFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK--TPE 306 (412)
Q Consensus 231 ~~-~~~~~-~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~~~ 306 (412)
.. ..... ...........+||+.|||||++.+..|+.++|||||||+||||++|.+|+.... ..+..+... .+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~ 233 (793)
T PLN00181 156 RIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQ 233 (793)
T ss_pred chhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChh
Confidence 00 00000 0000111234579999999999999999999999999999999999999886432 122222111 111
Q ss_pred CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCC
Q 042539 307 FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 307 ~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~ 348 (412)
.........+++.+||++||.+|| ++.++++||||...
T Consensus 234 ~~~~~~~~~~~~~~~L~~~P~~Rp----s~~eil~h~~~~~~ 271 (793)
T PLN00181 234 ILLNWPKEASFCLWLLHPEPSCRP----SMSELLQSEFINEP 271 (793)
T ss_pred hhhcCHHHHHHHHHhCCCChhhCc----ChHHHhhchhhhhh
Confidence 122345678999999999999999 68999999999763
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=243.37 Aligned_cols=236 Identities=23% Similarity=0.349 Sum_probs=183.3
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeee-eEEe
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLG-SLET 94 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~-~~~~ 94 (412)
.+.|.|.+.||+|.||++-+|+++.++. .+++|.+.+.. ...+.+.+|...--.|. |.||+.-|+ .|++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t----~ivlKavp~p~-----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt 93 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKT----RIVLKAVPRPQ-----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQT 93 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCce----EEEeeccCcch-----hhHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence 3689999999999999999999988554 49999997654 23455667887766775 899999887 5888
Q ss_pred CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccC--CCEEEcccccc
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQS--GHVTLTDFDLS 172 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~--g~vkL~DFGla 172 (412)
.+.+.+++|||+-|||.+-+ ...++-|...+.++.|+++||+|+|++++||||||.+||||-.. -.|||||||++
T Consensus 94 ~d~YvF~qE~aP~gdL~snv---~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t 170 (378)
T KOG1345|consen 94 SDAYVFVQEFAPRGDLRSNV---EAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLT 170 (378)
T ss_pred CceEEEeeccCccchhhhhc---CcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccc
Confidence 89999999999999996543 33458999999999999999999999999999999999999654 47999999988
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+....- ....--+.
T Consensus 171 ~k~g~t------------------------------------------------------------------V~~~~~~~ 184 (378)
T KOG1345|consen 171 RKVGTT------------------------------------------------------------------VKYLEYVN 184 (378)
T ss_pred cccCce------------------------------------------------------------------ehhhhhhc
Confidence 643211 11122355
Q ss_pred CCccceeecC---CC--CCchhhHHHHHHHHHHHhhCCCCCCCCCH----HHHHHHHhcCC-C----CCCCCChHHHHHH
Q 042539 253 EYVSPEVVRG---DG--HEFAVDWWALGILTYEMLYGTTPFRGKNR----KETFRNVLMKT-P----EFVGQRTALTDLI 318 (412)
Q Consensus 253 ~Y~APE~l~~---~~--~~~~~DiwSlGvil~ell~g~~Pf~~~~~----~~~~~~i~~~~-~----~~~~~~~~~~dli 318 (412)
.|-+||+... .. .++.+|+|.||+++|.+++|.+||..... ...+.+...+. + .+...++.+..+.
T Consensus 185 ~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~F 264 (378)
T KOG1345|consen 185 NYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLF 264 (378)
T ss_pred ccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHH
Confidence 7899997643 22 37889999999999999999999986432 22233333222 2 2345678899999
Q ss_pred HHhhhhCCCccC
Q 042539 319 QRLLEKDPVKRL 330 (412)
Q Consensus 319 ~~~L~~dP~~R~ 330 (412)
++-|..++++|.
T Consensus 265 kk~lt~~~~drc 276 (378)
T KOG1345|consen 265 KKSLTPRFKDRC 276 (378)
T ss_pred HHhcCCcccccc
Confidence 999999999994
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=275.32 Aligned_cols=262 Identities=35% Similarity=0.614 Sum_probs=198.2
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
...-++|..++.|..|+||.||+++++.+ +++||+| |.|.++-.+ .++....+|++|
T Consensus 79 ~p~e~df~~IklisngAygavylvrh~~t----rqrfa~k-iNkq~lilR-----------nilt~a~npfvv------- 135 (1205)
T KOG0606|consen 79 APSESDFNTIKLISNGAYGAVYLVRHKET----RQRFAMK-INKQNLILR-----------NILTFAGNPFVV------- 135 (1205)
T ss_pred CCCccccceeEeeccCCCCceeeeecccc----ccchhhc-ccccchhhh-----------ccccccCCccee-------
Confidence 44567999999999999999999999874 4559994 544433111 155555677776
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
||-..++...+ .++.+ ++.+++|||+.||+|||+||+|.+|+.-|++|++|||+++
T Consensus 136 --------------gDc~tllk~~g--~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk 191 (1205)
T KOG0606|consen 136 --------------GDCATLLKNIG--PLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSK 191 (1205)
T ss_pred --------------chhhhhcccCC--CCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhh
Confidence 44444444332 24322 3889999999999999999999999999999999999998
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
...-... +..+ .-.|+. +...-.....||||.
T Consensus 192 ~GLms~a---------------------------------------tnl~-----eg~I~k----~t~Ef~dKqvcgTPe 223 (1205)
T KOG0606|consen 192 KGLMSLA---------------------------------------TNLK-----EGHIEK----DTHEFQDKQVCGTPE 223 (1205)
T ss_pred hhhhhcc---------------------------------------chhh-----hcchHH----HHHHhhhccccCCcc
Confidence 7632110 0000 011111 111122345699999
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC----CChHHHHHHHHhhhhCCCcc
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVG----QRTALTDLIQRLLEKDPVKR 329 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~dli~~~L~~dP~~R 329 (412)
|+|||++.-.+|++.+||||+|+|+||++.|..||.|...++++..++.....++. ..++++++|.+||+.+|..|
T Consensus 224 yiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~R 303 (1205)
T KOG0606|consen 224 YIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCR 303 (1205)
T ss_pred ccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhh
Confidence 99999999999999999999999999999999999999999999998876655543 45899999999999999999
Q ss_pred CCCCCChhhhhcCCCCCCCCchhhcccCCCCCCCCCCCchhhh
Q 042539 330 LGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREENDLTE 372 (412)
Q Consensus 330 ~~~~~~~~e~l~h~ff~~~~~~~~~~~~~pp~~p~~~~~~~~~ 372 (412)
.+.. ++-++++|.||...||.-+-. ++.+|+|..+..+.+.
T Consensus 304 lgt~-ga~evk~h~ff~~LDw~~llR-qkaefvpql~~eddts 344 (1205)
T KOG0606|consen 304 LGTG-GALEVKQHGFFQLLDWKSLLR-QKAEFVPQLESEDDTS 344 (1205)
T ss_pred cccc-hhhhhhhccceeecccchhhh-hhccccccccccccch
Confidence 9754 789999999999999985532 3567888777665443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-27 Score=222.55 Aligned_cols=259 Identities=34% Similarity=0.517 Sum_probs=201.9
Q ss_pred ceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCC-ccceeeeeEEeCCeE
Q 042539 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP-FLPKLLGSLETDEFL 98 (412)
Q Consensus 20 y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~ 98 (412)
|.+.+.||.|+||.||++.+. ..+++|++.+..... ......+.+|+.+++.+.|+ +|+++++.+......
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-------~~~~~k~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-------KLVALKVLAKKLESK-SKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-------cEEEEEeechhhccc-hhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEE
Confidence 789999999999999999887 338999997765432 23566778899999999987 799999999888889
Q ss_pred EEEeeccCCCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCC-CEEEccccccchhh
Q 042539 99 AWAVPYCPGGDLNVLRYKQND-RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG-HVTLTDFDLSRNLV 176 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~~~~~~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g-~vkL~DFGla~~~~ 176 (412)
+++++++.|+++..++..... ..+.+..+..++.|++.+++|+|+.|++|||+||+||+++..+ .++++|||+++...
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 999999999999855444321 1589999999999999999999999999999999999999998 79999999987432
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
...... .........+||..|+|
T Consensus 154 ~~~~~~---------------------------------------------------------~~~~~~~~~~~t~~~~~ 176 (384)
T COG0515 154 DPGSTS---------------------------------------------------------SIPALPSTSVGTPGYMA 176 (384)
T ss_pred CCCccc---------------------------------------------------------cccccccccccccccCC
Confidence 110000 00013456789999999
Q ss_pred ceeecC---CCCCchhhHHHHHHHHHHHhhCCCCCCCCCH----HHHHHHHhcCCCC--CCCC--C------hHHHHHHH
Q 042539 257 PEVVRG---DGHEFAVDWWALGILTYEMLYGTTPFRGKNR----KETFRNVLMKTPE--FVGQ--R------TALTDLIQ 319 (412)
Q Consensus 257 PE~l~~---~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~----~~~~~~i~~~~~~--~~~~--~------~~~~dli~ 319 (412)
||.+.+ ..++...|+||+|++++++++|..||..... ......+...... .... . ..+.+++.
T Consensus 177 pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (384)
T COG0515 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLK 256 (384)
T ss_pred HHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHH
Confidence 999988 5678999999999999999999999888763 3444444333222 1111 1 47889999
Q ss_pred HhhhhCCCccCCCCCChhhhhcCCCCCC
Q 042539 320 RLLEKDPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 320 ~~L~~dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
+++..+|..|.+ ..+...+.|...
T Consensus 257 ~~~~~~~~~r~~----~~~~~~~~~~~~ 280 (384)
T COG0515 257 KLLAKDPKNRLS----SSSDLSHDLLAH 280 (384)
T ss_pred HHHhcCchhcCC----HHHHhhchHhhC
Confidence 999999999994 566565555443
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-28 Score=227.86 Aligned_cols=255 Identities=21% Similarity=0.224 Sum_probs=203.6
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCC-CceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTAR-CPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~-~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
.+..+++++...+-+|.||.||.+.++..+...+ +.|-+|.++.. ..+.....++.|.-.+..+.|||+..+.++.
T Consensus 280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~---AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH---ASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc---ccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 4556778888999999999999997776554433 34667776432 2344566778899999999999999999987
Q ss_pred Ee-CCeEEEEeeccCCCCchhHHHhh------CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEE
Q 042539 93 ET-DEFLAWAVPYCPGGDLNVLRYKQ------NDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVT 165 (412)
Q Consensus 93 ~~-~~~~~lv~e~~~gg~L~~~~~~~------~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vk 165 (412)
.. ...-++++.+..-|.|..++..- ....++..+...++.|+..|++|||++|+||.||...|++|++.-.+|
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVk 436 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVK 436 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEE
Confidence 54 45678888999889998887632 223578889999999999999999999999999999999999999999
Q ss_pred EccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCC
Q 042539 166 LTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERS 245 (412)
Q Consensus 166 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (412)
|+|=.+++.+-..... |- |..+
T Consensus 437 ltDsaLSRDLFP~DYh---------------------------------cL---GDnE---------------------- 458 (563)
T KOG1024|consen 437 LTDSALSRDLFPGDYH---------------------------------CL---GDNE---------------------- 458 (563)
T ss_pred eccchhccccCccccc---------------------------------cc---CCCC----------------------
Confidence 9999999876322110 00 0000
Q ss_pred cccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhh
Q 042539 246 NSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLL 322 (412)
Q Consensus 246 ~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L 322 (412)
-....||+||.+....|+.++|+|||||++|||+| |+.|+...+..++..-+..+. -...++++++..++..||
T Consensus 459 ---nRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCW 535 (563)
T KOG1024|consen 459 ---NRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPFNCPDELFTVMACCW 535 (563)
T ss_pred ---CCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCCCCCcHHHHHHHHHHH
Confidence 12346999999999999999999999999999997 999999999998877666544 344578999999999999
Q ss_pred hhCCCccCCC
Q 042539 323 EKDPVKRLGY 332 (412)
Q Consensus 323 ~~dP~~R~~~ 332 (412)
...|++||++
T Consensus 536 allpeeRPsf 545 (563)
T KOG1024|consen 536 ALLPEERPSF 545 (563)
T ss_pred hcCcccCCCH
Confidence 9999999964
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-29 Score=260.81 Aligned_cols=263 Identities=25% Similarity=0.397 Sum_probs=197.8
Q ss_pred cCc-eeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecch--hhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe
Q 042539 18 DNL-KALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKS--TLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET 94 (412)
Q Consensus 18 ~~y-~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~--~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 94 (412)
+.| .....+|.|++|.|+.+........ ++.|..... ...........+..|.-+-..+.|+||+..+..+++
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~----~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~ 392 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKS----FPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQE 392 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCcc----chhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhh
Confidence 434 5778999999998887766543332 444433211 111122222235668888888899999888887776
Q ss_pred CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
....+-.||||++ ||..++... +.++..++..++.|++.||+|+|+.||.|||||++|++++.+|.+||+|||.+..
T Consensus 393 ~~~~~~~mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~v 469 (601)
T KOG0590|consen 393 IDGILQSMEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASV 469 (601)
T ss_pred cccchhhhhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCccee
Confidence 6655556999999 998877654 3589999999999999999999999999999999999999999999999999876
Q ss_pred hhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCC
Q 042539 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254 (412)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 254 (412)
+....+ ........++|+..|
T Consensus 470 f~~~~e-----------------------------------------------------------~~~~~~~g~~gS~pY 490 (601)
T KOG0590|consen 470 FRYPWE-----------------------------------------------------------KNIHESSGIVGSDPY 490 (601)
T ss_pred eccCcc-----------------------------------------------------------hhhhhhcCcccCCcC
Confidence 632211 111334567999999
Q ss_pred ccceeecCCCC-CchhhHHHHHHHHHHHhhCCCCCCCCCHHHHH-HHHhcCCC---------CCCCCChHHHHHHHHhhh
Q 042539 255 VSPEVVRGDGH-EFAVDWWALGILTYEMLYGTTPFRGKNRKETF-RNVLMKTP---------EFVGQRTALTDLIQRLLE 323 (412)
Q Consensus 255 ~APE~l~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~-~~i~~~~~---------~~~~~~~~~~dli~~~L~ 323 (412)
+|||++.+..| ....||||.|++++.|++|+.||......+.. ........ .+-.++.+.+.+|.+||+
T Consensus 491 ~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~ 570 (601)
T KOG0590|consen 491 LAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQ 570 (601)
T ss_pred cCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHcc
Confidence 99999999998 56799999999999999999999775544331 11111100 112345678899999999
Q ss_pred hCCCccCCCCCChhhhhcCCCCCCCCc
Q 042539 324 KDPVKRLGYLRGACEIKEHVFFKGVRW 350 (412)
Q Consensus 324 ~dP~~R~~~~~~~~e~l~h~ff~~~~~ 350 (412)
.||.+|+ |+++|++.+||+.+.-
T Consensus 571 ~~P~~R~----ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 571 LDPTKRI----TIEQILNDEWIRSIEC 593 (601)
T ss_pred CChhhee----cHHHHhhChHhhhcce
Confidence 9999999 7999999999998753
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=216.65 Aligned_cols=158 Identities=20% Similarity=0.209 Sum_probs=126.5
Q ss_pred CCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhhhhccc
Q 042539 108 GDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLN 187 (412)
Q Consensus 108 g~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 187 (412)
|+|.+++... ...+++.+++.++.|++.||.|||+++ ||+|||++.++.+|+ ||+++....
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~---------- 61 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP---------- 61 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc----------
Confidence 6787777653 345999999999999999999999999 999999999999999 998865311
Q ss_pred CCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecCCCCCc
Q 042539 188 NNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEF 267 (412)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~ 267 (412)
....||+.|||||++.+..++.
T Consensus 62 ----------------------------------------------------------~~~~g~~~y~aPE~~~~~~~~~ 83 (176)
T smart00750 62 ----------------------------------------------------------EQSRVDPYFMAPEVIQGQSYTE 83 (176)
T ss_pred ----------------------------------------------------------ccCCCcccccChHHhcCCCCcc
Confidence 0115889999999999999999
Q ss_pred hhhHHHHHHHHHHHhhCCCCCCCCCHH-HHHHHHhcCCCCC--------CCCCh--HHHHHHHHhhhhCCCccCCCCCCh
Q 042539 268 AVDWWALGILTYEMLYGTTPFRGKNRK-ETFRNVLMKTPEF--------VGQRT--ALTDLIQRLLEKDPVKRLGYLRGA 336 (412)
Q Consensus 268 ~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~~i~~~~~~~--------~~~~~--~~~dli~~~L~~dP~~R~~~~~~~ 336 (412)
++|||||||++|||++|+.||...... ..+..+....... ...+. .+.++|.+||..||.+|| ++
T Consensus 84 ~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp----~~ 159 (176)
T smart00750 84 KADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQRRE----AA 159 (176)
T ss_pred hhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhccccccc----CH
Confidence 999999999999999999999765432 3333333222111 11222 699999999999999999 68
Q ss_pred hhhhcCCCCC
Q 042539 337 CEIKEHVFFK 346 (412)
Q Consensus 337 ~e~l~h~ff~ 346 (412)
.++++|+|+.
T Consensus 160 ~~ll~~~~~~ 169 (176)
T smart00750 160 NHYLAHCRAL 169 (176)
T ss_pred HHHHHHHHHH
Confidence 9999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=231.96 Aligned_cols=152 Identities=20% Similarity=0.179 Sum_probs=118.5
Q ss_pred CCCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhh-hhhHHHHHHHHHHHHHHhhcCCCccce
Q 042539 9 PQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTL-HAKHEAERRARWEIRVLSRLSHPFLPK 87 (412)
Q Consensus 9 ~~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~~Ei~il~~l~hpnIv~ 87 (412)
|......-.++|.+.+.||+|+||+||+|.++... ++.||||++..... .........+.+|+++|++++|+||+.
T Consensus 9 ~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~ 85 (365)
T PRK09188 9 PGDQIPALSARFVETAVLKRDVFSTVERGYFAGDP---GTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVP 85 (365)
T ss_pred cccccccccCCceEccEEeecCcEEEEEEEEcCCC---CeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCc
Confidence 33445667789999999999999999999887532 23379998753211 012334566888999999999999985
Q ss_pred -eeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeC-CCCceEEccCCCEE
Q 042539 88 -LLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDL-KPENILIRQSGHVT 165 (412)
Q Consensus 88 -l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDl-Kp~NiLl~~~g~vk 165 (412)
++++ +..|+|||||.|++|... .. .. ...++.|++.||.|||++||+|||| ||+|||++.+|.+|
T Consensus 86 ~l~~~----~~~~LVmE~~~G~~L~~~---~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ik 152 (365)
T PRK09188 86 QLLAT----GKDGLVRGWTEGVPLHLA---RP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAA 152 (365)
T ss_pred EEEEc----CCcEEEEEccCCCCHHHh---Cc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEE
Confidence 5442 457999999999998521 11 11 1467899999999999999999999 99999999999999
Q ss_pred Eccccccchhh
Q 042539 166 LTDFDLSRNLV 176 (412)
Q Consensus 166 L~DFGla~~~~ 176 (412)
|+|||+|+.+.
T Consensus 153 LiDFGlA~~~~ 163 (365)
T PRK09188 153 VIDFQLASVFR 163 (365)
T ss_pred EEECccceecc
Confidence 99999998763
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=225.66 Aligned_cols=251 Identities=26% Similarity=0.347 Sum_probs=189.3
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC----CCccceeeeeE-E
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS----HPFLPKLLGSL-E 93 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~----hpnIv~l~~~~-~ 93 (412)
+|++.+.||+|+||.||+|.+.... ...+|+|+......... ..+..|+.++..+. ..++..+++.+ .
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~---~~~~a~K~e~~~~~~~~----~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~ 91 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK---NKEYAKKLEKKELGSKP----SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRS 91 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC---CeeEEEEEEEecccCCC----ccchhHHHHHHHHhhhcCCCCCCEEEEeccC
Confidence 8999999999999999999987654 33489998866432111 13444888888887 26899999999 5
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCC-----CEEEcc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG-----HVTLTD 168 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g-----~vkL~D 168 (412)
.+..-|+||+.+ |.+|.++......+.|+...+..++.|++.+|++||+.|++||||||+|+++...+ .+.|.|
T Consensus 92 ~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 92 TEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred CCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEe
Confidence 778899999999 89999887666667899999999999999999999999999999999999998763 599999
Q ss_pred ccccchh--hchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCc
Q 042539 169 FDLSRNL--VKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSN 246 (412)
Q Consensus 169 FGla~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (412)
||+|+.. ........+ ..-....
T Consensus 171 fGlar~~~~~~~~~~~~~-------------------------------------------------------~~r~~~~ 195 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLR-------------------------------------------------------PPRPQKG 195 (322)
T ss_pred cCCCccccccCCCCcccc-------------------------------------------------------cCCCCcc
Confidence 9999833 211100000 0001123
Q ss_pred ccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHH---HHHHHhcCCC-C-C-CCCChHHHHHHHH
Q 042539 247 SFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKE---TFRNVLMKTP-E-F-VGQRTALTDLIQR 320 (412)
Q Consensus 247 ~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~~~~i~~~~~-~-~-~~~~~~~~dli~~ 320 (412)
.+.||..|+++.+..+...+.+.|+||++-++.+++.|..||.+..... .+.+...... . + ...+..+.++...
T Consensus 196 ~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (322)
T KOG1164|consen 196 LFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEY 275 (322)
T ss_pred CCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHH
Confidence 5679999999999999999999999999999999999999998765322 2222221111 1 1 2234567777777
Q ss_pred hhhhCCCccCCC
Q 042539 321 LLEKDPVKRLGY 332 (412)
Q Consensus 321 ~L~~dP~~R~~~ 332 (412)
+-..+...+|.+
T Consensus 276 ~~~~~~~~~Pdy 287 (322)
T KOG1164|consen 276 IDSLDYEDKPDY 287 (322)
T ss_pred hhccCCcCCCCH
Confidence 767788888843
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=203.67 Aligned_cols=250 Identities=17% Similarity=0.235 Sum_probs=191.5
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSL 92 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~ 92 (412)
.+....|+++++||.|+||-+|++.....+.. ||||+-....-+ -.+..|.++...|+ ...|..+..++
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~----VAiK~Es~~a~h------pqL~yEskvY~iL~~g~GiP~i~~y~ 80 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEE----VAIKLESSKAKH------PQLLYESKVYRILQGGVGIPHIRHYG 80 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCce----EEEEeecccCCC------cchhHHHHHHHHhccCCCCchhhhhc
Confidence 46678999999999999999999988876555 999987543221 23445899999998 47899999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccC---CCEEEccc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQS---GHVTLTDF 169 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~---g~vkL~DF 169 (412)
.+..+-.+||+++ |.+|.++..-- .+.|+..++..++.|++.-++|+|.+++|||||||+|+|+.-+ ..+.|+||
T Consensus 81 ~e~~ynvlVMdLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDF 158 (341)
T KOG1163|consen 81 TEKDYNVLVMDLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDF 158 (341)
T ss_pred cccccceeeeecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEec
Confidence 9999999999999 88998775543 3469999999999999999999999999999999999999754 56999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|+|+.+.+...... -.-.......
T Consensus 159 GLaKky~d~~t~~H--------------------------------------------------------Ipyre~r~lt 182 (341)
T KOG1163|consen 159 GLAKKYRDIRTRQH--------------------------------------------------------IPYREDRNLT 182 (341)
T ss_pred cchhhhcccccccc--------------------------------------------------------CccccCCccc
Confidence 99998743321110 1112234567
Q ss_pred cCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCC---HHHHHHHHhcCCCC------CCCCChHHHHHHHH
Q 042539 250 GTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKN---RKETFRNVLMKTPE------FVGQRTALTDLIQR 320 (412)
Q Consensus 250 gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~---~~~~~~~i~~~~~~------~~~~~~~~~dli~~ 320 (412)
||.+|.+--...+...+..-|+=|+|.+|.++.-|..||.|.. ..+.+++|...... ..+.+.++.-.++.
T Consensus 183 GTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y 262 (341)
T KOG1163|consen 183 GTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNY 262 (341)
T ss_pred eeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHH
Confidence 9999999888888878899999999999999999999999843 33445555443322 23455666666666
Q ss_pred hhhhCCCccCC
Q 042539 321 LLEKDPVKRLG 331 (412)
Q Consensus 321 ~L~~dP~~R~~ 331 (412)
|=...-++-|.
T Consensus 263 ~R~L~F~E~Pd 273 (341)
T KOG1163|consen 263 CRGLGFEEKPD 273 (341)
T ss_pred HhhcCCCCCCc
Confidence 65555555443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7e-26 Score=209.31 Aligned_cols=215 Identities=24% Similarity=0.357 Sum_probs=173.9
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEEeCC
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLETDE 96 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 96 (412)
-.|++.++||+|+||+.+++...- ++++||||.-....- .-.+..|.+..+.|. .+.|...|.+.+.+.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~----nne~VAIKfEPrkS~------APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~ 97 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLY----NNEPVAIKFEPRKSE------APQLRDEYRTYKLLGGTEGIPQVYYFGQEGK 97 (449)
T ss_pred ccceeccccccCcceeeecccccc----cCceEEEEeccccCC------cchHHHHHHHHHHHcCCCCCCceeeeccccc
Confidence 479999999999999999865544 566799997644321 223444888888886 799999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCC-----CEEEccccc
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG-----HVTLTDFDL 171 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g-----~vkL~DFGl 171 (412)
+-.||||++ |-+|.++...-+ +.|+...+..++.|++.-++|+|++++|+|||||+|+||..-| .+.|+|||+
T Consensus 98 ~NiLVidLL-GPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 98 YNILVIDLL-GPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred hhhhhhhhh-CcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccc
Confidence 999999999 889988876644 5799999999999999999999999999999999999997654 489999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
|+.+.+..-... ..-...-+..||
T Consensus 176 AK~YrDp~TkqH--------------------------------------------------------IPYrE~KSLsGT 199 (449)
T KOG1165|consen 176 AKEYRDPKTKQH--------------------------------------------------------IPYREHKSLSGT 199 (449)
T ss_pred hhhhcCcccccc--------------------------------------------------------Cccccccccccc
Confidence 998743211000 011123467799
Q ss_pred CCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCC---CHHHHHHHH
Q 042539 252 EEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGK---NRKETFRNV 300 (412)
Q Consensus 252 ~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~---~~~~~~~~i 300 (412)
.+||+--...|...+.+-|+=|||-+++++|-|..||.|. +..+-+++|
T Consensus 200 ARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI 251 (449)
T KOG1165|consen 200 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI 251 (449)
T ss_pred eeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence 9999999999999999999999999999999999999884 344445444
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.7e-25 Score=199.66 Aligned_cols=142 Identities=20% Similarity=0.191 Sum_probs=114.2
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHH------HHHHHHHHhhcCCCccceee
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERR------ARWEIRVLSRLSHPFLPKLL 89 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~------~~~Ei~il~~l~hpnIv~l~ 89 (412)
--++|+++++||.|+||.||++.+. +. .+|||++....... +....+ +.+|++.+.++.|++|..+.
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~--~~----~~iiKvf~~~~~~~-~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~ 101 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTD--YG----KYILKVFAPKVKRT-ERFLKSFVKGDYYENLIVQTDRVRSEGLASLN 101 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecC--CC----cEEEEEechhcCch-HHHHHhhhhhHHHHHHHHHHHHHHHCCCCcce
Confidence 3578999999999999999997552 22 29999997654322 233333 57899999999999999999
Q ss_pred eeEEeC--------CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccC
Q 042539 90 GSLETD--------EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQS 161 (412)
Q Consensus 90 ~~~~~~--------~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~ 161 (412)
+++... ...+++|||++|.+|.++.. +++. ...+++.+|..+|++|++|||+||+||+++.+
T Consensus 102 d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 102 DFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKN 171 (232)
T ss_pred EeeeecccccccccCCeEEEEEEECCccHHHhhh------ccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCC
Confidence 987643 35899999999999866521 3332 35699999999999999999999999999999
Q ss_pred CCEEEccccccchh
Q 042539 162 GHVTLTDFDLSRNL 175 (412)
Q Consensus 162 g~vkL~DFGla~~~ 175 (412)
| ++|+|||.++..
T Consensus 172 g-i~liDfg~~~~~ 184 (232)
T PRK10359 172 G-LRIIDLSGKRCT 184 (232)
T ss_pred C-EEEEECCCcccc
Confidence 9 999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=192.47 Aligned_cols=144 Identities=21% Similarity=0.192 Sum_probs=109.3
Q ss_pred eeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhH----------------------HHHHHHHHHHHHHhh
Q 042539 22 ALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKH----------------------EAERRARWEIRVLSR 79 (412)
Q Consensus 22 ~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~----------------------~~~~~~~~Ei~il~~ 79 (412)
+...||+|+||.||+|.+. ++ +.||||+++........ .......+|++++..
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g----~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 75 (190)
T cd05147 1 INGCISTGKEANVYHATTA-NG----EERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKR 75 (190)
T ss_pred CCCccccccceEEEEEECC-CC----CEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHH
Confidence 3578999999999999875 33 45999999765321111 112334569999999
Q ss_pred cCCCccceeeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHH-HHcCceeeeCCCCceEE
Q 042539 80 LSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHL-HNMGIAYRDLKPENILI 158 (412)
Q Consensus 80 l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yL-H~~~iiHrDlKp~NiLl 158 (412)
+.+++|....... ... .+|||||+.|+++...... ...+++..+..++.|++.+|.|+ |+.||+||||||+|||+
T Consensus 76 l~~~~v~~p~~~~-~~~-~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli 151 (190)
T cd05147 76 LVTAGIPCPEPIL-LKS-HVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLY 151 (190)
T ss_pred HHHCCCCCCcEEE-ecC-CEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE
Confidence 9887764433322 222 3899999999877544322 24589999999999999999999 79999999999999999
Q ss_pred ccCCCEEEccccccchh
Q 042539 159 RQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 159 ~~~g~vkL~DFGla~~~ 175 (412)
+ ++.++|+|||+|...
T Consensus 152 ~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 152 H-DGKLYIIDVSQSVEH 167 (190)
T ss_pred E-CCcEEEEEccccccC
Confidence 8 588999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5e-25 Score=229.29 Aligned_cols=244 Identities=21% Similarity=0.269 Sum_probs=181.2
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhh-hhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLH-AKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
+|...+.||++.|=+|.+|++.... |+|||+-+..-. .-....+++ .|++ ...+++||++.+.-+..++..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~------vVvKVFvk~~p~~sL~~~~qrL-~~ik-~~l~~~pn~lPfqk~~~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL------VVVKVFVKQDPTISLRPFKQRL-EEIK-FALMKAPNCLPFQKVLVTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce------EEEEEEeccCCCCCchHHHHHH-HHHH-HHhhcCCcccchHHHHHhhHH
Confidence 7888999999999999998876422 899999776522 222344444 3666 777789999999999889999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
.|||-.|+.. +|++.+..+. -+..-+.+.|+.|++.||.-+|..||+|||||.|||||+.-+.+.|+||..-+.
T Consensus 96 AylvRqyvkh-nLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKP--- 169 (1431)
T KOG1240|consen 96 AYLVRQYVKH-NLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKP--- 169 (1431)
T ss_pred HHHHHHHHhh-hhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCC---
Confidence 9999999955 5555544433 378889999999999999999999999999999999999999999999975432
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
.=-.++|+..+-++.+ +-..-.+|+||
T Consensus 170 ---------------tYLPeDNPadf~fFFD--------------------------------------TSrRRtCYiAP 196 (1431)
T KOG1240|consen 170 ---------------TYLPEDNPADFTFFFD--------------------------------------TSRRRTCYIAP 196 (1431)
T ss_pred ---------------ccCCCCCcccceEEEe--------------------------------------cCCceeeecCh
Confidence 1222344444433332 11122369999
Q ss_pred eeecCC----------C-CCchhhHHHHHHHHHHHhh-CCCCCCCC-----------CHHHHHHHHhcCCCCCCCCChHH
Q 042539 258 EVVRGD----------G-HEFAVDWWALGILTYEMLY-GTTPFRGK-----------NRKETFRNVLMKTPEFVGQRTAL 314 (412)
Q Consensus 258 E~l~~~----------~-~~~~~DiwSlGvil~ell~-g~~Pf~~~-----------~~~~~~~~i~~~~~~~~~~~~~~ 314 (412)
|.+... + .+++.||||+||+++||++ |++||.-. +.+..+++| .+..+
T Consensus 197 ERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le~I---------ed~~~ 267 (1431)
T KOG1240|consen 197 ERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLLEKI---------EDVSL 267 (1431)
T ss_pred HhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHHHhC---------cCccH
Confidence 987542 2 4678999999999999986 89999531 111122211 12468
Q ss_pred HHHHHHhhhhCCCccCCCCCChhhhhcC
Q 042539 315 TDLIQRLLEKDPVKRLGYLRGACEIKEH 342 (412)
Q Consensus 315 ~dli~~~L~~dP~~R~~~~~~~~e~l~h 342 (412)
+.+|..|++.||++|+ .|++.|+-
T Consensus 268 Rnlil~Mi~rdPs~Rl----SAedyL~~ 291 (1431)
T KOG1240|consen 268 RNLILSMIQRDPSKRL----SAEDYLQK 291 (1431)
T ss_pred HHHHHHHHccCchhcc----CHHHHHHh
Confidence 9999999999999999 58888875
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=187.52 Aligned_cols=147 Identities=19% Similarity=0.180 Sum_probs=112.5
Q ss_pred eeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhh----------------------hhHHHHHHHHHHHHHHhh
Q 042539 22 ALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLH----------------------AKHEAERRARWEIRVLSR 79 (412)
Q Consensus 22 ~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~----------------------~~~~~~~~~~~Ei~il~~ 79 (412)
+.+.||+|+||.||+|.+. ++ +.||||+++..... ..........+|.+.+.+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g----~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 75 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DG----EELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKR 75 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CC----CEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 4678999999999999875 33 45999999865311 001112334679999999
Q ss_pred cCCCccceeeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeeCCCCceEE
Q 042539 80 LSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN-MGIAYRDLKPENILI 158 (412)
Q Consensus 80 l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDlKp~NiLl 158 (412)
+.|++|.....+.... .|+||||+.|+++...... ...+++..+..++.|++.+|.++|+ +||+||||||+|||+
T Consensus 76 l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll 151 (190)
T cd05145 76 LYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILY 151 (190)
T ss_pred HHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEE
Confidence 9999875544443332 4899999998865433222 2347889999999999999999999 999999999999999
Q ss_pred ccCCCEEEccccccchhhch
Q 042539 159 RQSGHVTLTDFDLSRNLVKK 178 (412)
Q Consensus 159 ~~~g~vkL~DFGla~~~~~~ 178 (412)
+ +|.++|+|||+|+.....
T Consensus 152 ~-~~~~~liDFG~a~~~~~~ 170 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDHP 170 (190)
T ss_pred E-CCCEEEEEcccceecCCC
Confidence 8 899999999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=186.06 Aligned_cols=202 Identities=20% Similarity=0.237 Sum_probs=141.0
Q ss_pred eeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEEeCCeEE
Q 042539 21 KALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLETDEFLA 99 (412)
Q Consensus 21 ~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 99 (412)
.+...|++|+||+|+++.. .+..++.+.+..............+.+|+++|++|. |++|++++++ +..|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~ 74 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRH 74 (218)
T ss_pred ccceeecCCCcceEEEeec------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEE
Confidence 3568899999999997654 223367666655443223334456888999999996 5889999986 4469
Q ss_pred EEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeC-CCCceEEccCCCEEEccccccchhhch
Q 042539 100 WAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDL-KPENILIRQSGHVTLTDFDLSRNLVKK 178 (412)
Q Consensus 100 lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDl-Kp~NiLl~~~g~vkL~DFGla~~~~~~ 178 (412)
++|+|+.|.+|..... .. ...++.|++.+|+++|++||+|||| ||+|||++.+|.++|+|||+|......
T Consensus 75 lvmeyI~G~~L~~~~~--------~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 75 LDRSYLAGAAMYQRPP--------RG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred EEEeeecCccHHhhhh--------hh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 9999999998853211 11 1357889999999999999999999 799999999999999999999754322
Q ss_pred hhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccce
Q 042539 179 TAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPE 258 (412)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 258 (412)
..... .+.. ++ ... -.......++.|+.|+
T Consensus 146 ~~~~r----------------------~L~~------rD---------------------l~~-llk~~~~y~~~~l~~~ 175 (218)
T PRK12274 146 ARWMR----------------------LLAR------ED---------------------LRH-LLKHKRMYCPAALTPV 175 (218)
T ss_pred chHHH----------------------HHHH------HH---------------------HHH-HHHHHHhcCCCCCCHH
Confidence 11000 0000 00 000 0001123577888888
Q ss_pred eecCC-CCC-chhhHHHHHHHHHHHhhCCCCCCCC
Q 042539 259 VVRGD-GHE-FAVDWWALGILTYEMLYGTTPFRGK 291 (412)
Q Consensus 259 ~l~~~-~~~-~~~DiwSlGvil~ell~g~~Pf~~~ 291 (412)
...-. ..+ ...+|++.|+-+|.++|+..++-+.
T Consensus 176 ~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 176 ERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 65433 223 5789999999999999999887543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-24 Score=221.46 Aligned_cols=313 Identities=28% Similarity=0.427 Sum_probs=236.9
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
.....+++.+++.+-+|+++.++.++-...+.. .++|+..+...-..+ ..+..+++-.++-...+|.+++....|
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~----~~~~v~~~ap~i~~~-~~~s~r~~s~~~i~p~~P~v~~~~~s~ 873 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHT----RPSKVHGLAPKIRTN-DYESIRSKSNILITPRSPAVVRSFPSF 873 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccc----cchhhhccchhhccc-cccccCCccCccccCCCCceecccCCC
Confidence 567899999999999999999999877665533 677776554432221 123333455555556678888887777
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
.....++||++|+.|++|...++... ..+++-++.++..++.+++|||+..++|||++|.|+|+..+|+.++.|||..
T Consensus 874 ~~rsP~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~ 951 (1205)
T KOG0606|consen 874 PCRSPLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTL 951 (1205)
T ss_pred CCCCCcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccc
Confidence 77889999999999999988776654 5888999999999999999999999999999999999999999999999955
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccC--CCCCCccccc
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFD--NGERSNSFVG 250 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~g 250 (412)
....-- .+.. +..|.......+......+..+.. +.......+|
T Consensus 952 ~~vg~~---------------~p~~-------------------~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 997 (1205)
T KOG0606|consen 952 SKVGLI---------------PPTT-------------------DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVG 997 (1205)
T ss_pred cccccc---------------cCcC-------------------CcccccccCccccccccccccccccchhhccccccC
Confidence 433110 0000 111222211111111111111111 2234557889
Q ss_pred CCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCC----ChHHHHHHHHhhhhCC
Q 042539 251 TEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVGQ----RTALTDLIQRLLEKDP 326 (412)
Q Consensus 251 t~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~----~~~~~dli~~~L~~dP 326 (412)
|+.|.+||.+.+......+|||++|++++|.++|.+||.....+..+++|......++.. +..+.+++.++|..+|
T Consensus 998 t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~ 1077 (1205)
T KOG0606|consen 998 TPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEP 1077 (1205)
T ss_pred CCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCc
Confidence 999999999999999999999999999999999999999999999999999988777654 5789999999999999
Q ss_pred CccCCCCCChhhhhcCCCCCCCCchhhcccCCCCCCCCCCCc
Q 042539 327 VKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREEN 368 (412)
Q Consensus 327 ~~R~~~~~~~~e~l~h~ff~~~~~~~~~~~~~pp~~p~~~~~ 368 (412)
.+|.+.. .+.+.+.|+||++++|+.+... .-.|+|..++.
T Consensus 1078 ~qr~~a~-~~~e~k~~~~~~~~~~~~l~~q-~~~~~p~~~s~ 1117 (1205)
T KOG0606|consen 1078 TQRLGAK-GAAEVKGHPFFQDVDWENLALQ-KAEFVPQPEST 1117 (1205)
T ss_pred hhccCcc-cccccccCCccCCCCccccccc-cCccCCCCCCC
Confidence 9999743 4569999999999999988663 34566665543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-23 Score=195.36 Aligned_cols=236 Identities=25% Similarity=0.278 Sum_probs=144.7
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCC----------Ccccee
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH----------PFLPKL 88 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~h----------pnIv~l 88 (412)
.+...+.||.|+++.||.|.+..++. .+|+|+...... ......+.+.+|.-....+.+ -.++-.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~----~~avkvf~~~~~-~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P 87 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGE----EFAVKVFLLPAD-ASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP 87 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTE----EEEEEEEEESST-THTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred EEEEccccccCCceEEEEEEEccCCc----eEEEEEEecccc-cchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee
Confidence 56788999999999999999988554 499999865542 222334445545433333222 122222
Q ss_pred eeeE---------EeCC--------eEEEEeeccCCCCchhHHH---hhCCCC-CCHHHH-HHHHHHHHHHHHHHHHcCc
Q 042539 89 LGSL---------ETDE--------FLAWAVPYCPGGDLNVLRY---KQNDRV-FSPSVI-RFYLSEIICAIEHLHNMGI 146 (412)
Q Consensus 89 ~~~~---------~~~~--------~~~lv~e~~~gg~L~~~~~---~~~~~~-l~~~~~-~~~~~qi~~aL~yLH~~~i 146 (412)
++.. .... +.+++|+-+ .+||..++. ...... -....| ..+..|++..+++||+.|+
T Consensus 88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~Gl 166 (288)
T PF14531_consen 88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGL 166 (288)
T ss_dssp SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred eEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcce
Confidence 2222 2111 347788877 456765533 232211 112334 3445999999999999999
Q ss_pred eeeeCCCCceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccc
Q 042539 147 AYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKS 226 (412)
Q Consensus 147 iHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (412)
+|+||||+|++++.+|.++|+||+........
T Consensus 167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~------------------------------------------------ 198 (288)
T PF14531_consen 167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR------------------------------------------------ 198 (288)
T ss_dssp EEST-SGGGEEE-TTS-EEE--GGGEEETTEE------------------------------------------------
T ss_pred EecccceeeEEEcCCCCEEEcChHHHeecCce------------------------------------------------
Confidence 99999999999999999999999877543211
Q ss_pred cCCCCccccccccCCCCCCcccccCCCCccceeecCC--------CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH
Q 042539 227 ARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGD--------GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFR 298 (412)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~--------~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~ 298 (412)
......+..|.+||..... .++.+.|.|+||+++|.|.+|..||..........
T Consensus 199 ------------------~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~ 260 (288)
T PF14531_consen 199 ------------------YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPE 260 (288)
T ss_dssp ------------------EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSG
T ss_pred ------------------eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcccccc
Confidence 1111244679999976432 46889999999999999999999998754322111
Q ss_pred HHhcCCCCCCCCChHHHHHHHHhhhhCCCcc
Q 042539 299 NVLMKTPEFVGQRTALTDLIQRLLEKDPVKR 329 (412)
Q Consensus 299 ~i~~~~~~~~~~~~~~~dli~~~L~~dP~~R 329 (412)
. ......+.+..+++||..||++||.+|
T Consensus 261 ~---~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 261 W---DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp G---GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred c---cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 1 111122667889999999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.7e-22 Score=179.90 Aligned_cols=139 Identities=18% Similarity=0.232 Sum_probs=106.2
Q ss_pred eeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-----CCCccceeeeeEEeC
Q 042539 21 KALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-----SHPFLPKLLGSLETD 95 (412)
Q Consensus 21 ~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-----~hpnIv~l~~~~~~~ 95 (412)
.-.+.||+|+||.||. +... .. .+||++..... .....+.+|+++++.+ +||||+++|++++++
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~----~~-k~IKv~~~~~~----~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~ 73 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPED----AQ-RCIKIVYHRGD----GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETD 73 (210)
T ss_pred CCcceecCCCceEEEE--CCCC----cC-eEEEEEecccc----chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeC
Confidence 3457899999999995 3332 22 37998865432 1235578899999999 579999999999987
Q ss_pred C---eEE-EEeec--cCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHH-HHHHHcCceeeeCCCCceEEccC----CCE
Q 042539 96 E---FLA-WAVPY--CPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAI-EHLHNMGIAYRDLKPENILIRQS----GHV 164 (412)
Q Consensus 96 ~---~~~-lv~e~--~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL-~yLH~~~iiHrDlKp~NiLl~~~----g~v 164 (412)
. .++ +|||| +.+|+|.+++... .+++. ..++.|++.++ +|||+++|+||||||+|||++.. +.+
T Consensus 74 ~g~g~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~ 148 (210)
T PRK10345 74 CGTGYVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIP 148 (210)
T ss_pred CCCeEEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcE
Confidence 4 434 78999 5579999888542 36666 35678888888 99999999999999999999753 379
Q ss_pred EEccccccchh
Q 042539 165 TLTDFDLSRNL 175 (412)
Q Consensus 165 kL~DFGla~~~ 175 (412)
+|+||+.++.+
T Consensus 149 ~LiDg~G~~~~ 159 (210)
T PRK10345 149 VVCDNIGESTF 159 (210)
T ss_pred EEEECCCCcce
Confidence 99995545444
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=184.57 Aligned_cols=269 Identities=19% Similarity=0.292 Sum_probs=174.3
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCC-------------------------------CCCceEEeeecchhh
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPT-------------------------------ARCPFALKVVDKSTL 60 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~-------------------------------~~~~vAiK~i~~~~~ 60 (412)
...+++++|+|...||+|....||.|+....+.. ..-+.|||.+=.-..
T Consensus 151 dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~ 230 (598)
T KOG4158|consen 151 DSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEH 230 (598)
T ss_pred hcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhccccc
Confidence 4578999999999999999999999875431100 011356675522111
Q ss_pred -hhhHHHHHHHHHHH------------H--HHh-------h-cCCCccceeeeeEEe-----------------------
Q 042539 61 -HAKHEAERRARWEI------------R--VLS-------R-LSHPFLPKLLGSLET----------------------- 94 (412)
Q Consensus 61 -~~~~~~~~~~~~Ei------------~--il~-------~-l~hpnIv~l~~~~~~----------------------- 94 (412)
.......+...+|. . ..+ + -+|||||++..+|.+
T Consensus 231 ~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~ 310 (598)
T KOG4158|consen 231 DSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPS 310 (598)
T ss_pred CCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccc
Confidence 11111122222221 0 011 1 249999999987743
Q ss_pred ----CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEcc--C--CCEEE
Q 042539 95 ----DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQ--S--GHVTL 166 (412)
Q Consensus 95 ----~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~--~--g~vkL 166 (412)
+..+|+||.-+. -+|..++-.+. .+....+.++.|++.|+.|||++||.|||+|.+|||+.- + -.+.|
T Consensus 311 g~g~~~tlylvMkrY~-~tLr~yl~~~~---~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVv 386 (598)
T KOG4158|consen 311 GAGEPKTLYLVMKRYR-QTLREYLWTRH---RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVV 386 (598)
T ss_pred ccCCCceEEEehhcch-hhHHHHHhcCC---CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEE
Confidence 235899998774 46777765443 678899999999999999999999999999999999843 3 35899
Q ss_pred ccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCc
Q 042539 167 TDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSN 246 (412)
Q Consensus 167 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (412)
+|||++--- ++... +. .-....-
T Consensus 387 aDFGCcLAd-~~hGl-------------ql-------------------------------------------py~S~~V 409 (598)
T KOG4158|consen 387 ADFGCCLAD-DNHGL-------------QL-------------------------------------------PYESDEV 409 (598)
T ss_pred cccceeeec-ccccc-------------cc-------------------------------------------ccccccc
Confidence 999987321 11000 00 0000011
Q ss_pred ccccCCCCccceeecCCCC------CchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHh--cCCCCCC-CCChHHHHH
Q 042539 247 SFVGTEEYVSPEVVRGDGH------EFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL--MKTPEFV-GQRTALTDL 317 (412)
Q Consensus 247 ~~~gt~~Y~APE~l~~~~~------~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~--~~~~~~~-~~~~~~~dl 317 (412)
..-|.-.-||||+....+- -.++|.|+.|.+.||+++..-||.+......-.+-. ...|..+ .+++.++++
T Consensus 410 d~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rql 489 (598)
T KOG4158|consen 410 DLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQL 489 (598)
T ss_pred cCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHH
Confidence 2246667899999865321 248999999999999999999998743322111111 1123332 457889999
Q ss_pred HHHhhhhCCCccCCCCCChhhhhcC
Q 042539 318 IQRLLEKDPVKRLGYLRGACEIKEH 342 (412)
Q Consensus 318 i~~~L~~dP~~R~~~~~~~~e~l~h 342 (412)
+..+|+.||++|++- +.+..+++-
T Consensus 490 V~~lL~r~pskRvsp-~iAANvl~L 513 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSP-NIAANVLNL 513 (598)
T ss_pred HHHHhcCCccccCCc-cHHHhHHHH
Confidence 999999999999973 234555543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.2e-21 Score=178.80 Aligned_cols=146 Identities=22% Similarity=0.198 Sum_probs=111.6
Q ss_pred CceeeeeeeccCceEEEEEE-EcCCCCCCCCceEEeeecchhhh--------------------hhHHHHHHHHHHHHHH
Q 042539 19 NLKALKILGKGAMGTVFLVH-DRAADPTARCPFALKVVDKSTLH--------------------AKHEAERRARWEIRVL 77 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~-~~~~~~~~~~~vAiK~i~~~~~~--------------------~~~~~~~~~~~Ei~il 77 (412)
.|++.+.||+|+||.||+|. +..+ ++.||||+++..... ........+.+|++++
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~----g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L 104 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGS----GKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL 104 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCC----CcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence 47899999999999999998 4343 445999999754321 0111234567899999
Q ss_pred hhcCCC--ccceeeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcC-ceeeeCCCC
Q 042539 78 SRLSHP--FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMG-IAYRDLKPE 154 (412)
Q Consensus 78 ~~l~hp--nIv~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~-iiHrDlKp~ 154 (412)
+++.+. .+.++++ .. ..++||||+.|++|...... ...+...++..++.|++.+|.+||++| |+||||||+
T Consensus 105 ~~L~~~~i~~p~~~~---~~-~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~ 178 (237)
T smart00090 105 QRLYEAGVPVPKPIA---WR-RNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEY 178 (237)
T ss_pred HHHHhcCCCCCeeeE---ec-CceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChh
Confidence 999753 2344443 22 35899999999888654322 234667778899999999999999999 999999999
Q ss_pred ceEEccCCCEEEccccccchh
Q 042539 155 NILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 155 NiLl~~~g~vkL~DFGla~~~ 175 (412)
||+++ ++.++|+|||.|...
T Consensus 179 NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hEEEE-CCCEEEEEChhhhcc
Confidence 99999 889999999999764
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.4e-21 Score=205.29 Aligned_cols=207 Identities=24% Similarity=0.389 Sum_probs=164.5
Q ss_pred CCCCCCCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC---
Q 042539 5 PPPQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS--- 81 (412)
Q Consensus 5 ~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~--- 81 (412)
|..++.+..++.-+.|.|-+.||+|+||+||.|.... ++.||+|+-+...... ++-=.+++.+|+
T Consensus 685 ~~l~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-----~~~~alK~e~P~~~WE-------fYI~~q~~~RLk~~~ 752 (974)
T KOG1166|consen 685 PKLNPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-----GKLVALKVEKPPNPWE-------FYICLQVMERLKPQM 752 (974)
T ss_pred cccCccceeeecceeEEEEeeeccccceEEEEeecCC-----CcEEEEEeecCCCcee-------eeehHHHHHhhchhh
Confidence 3444566678888999999999999999999987754 4459999976544211 111123334443
Q ss_pred CCccceeeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccC
Q 042539 82 HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQS 161 (412)
Q Consensus 82 hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~ 161 (412)
-+.|+.+..++.-.+.-+||++|.+-|+|.+++. ..+.+++..+.+++.|++..|+.||..+|||+||||+|+||...
T Consensus 753 ~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~ 830 (974)
T KOG1166|consen 753 LPSIMHISSAHVFQNASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRRE 830 (974)
T ss_pred hcchHHHHHHHccCCcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecc
Confidence 3567778888888888899999999999988876 44569999999999999999999999999999999999999532
Q ss_pred -------CCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccc
Q 042539 162 -------GHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSR 234 (412)
Q Consensus 162 -------g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (412)
-.++|+|||.|-.+.
T Consensus 831 ~~~~~~~~~l~lIDfG~siDm~---------------------------------------------------------- 852 (974)
T KOG1166|consen 831 ICADSDSKGLYLIDFGRSIDMK---------------------------------------------------------- 852 (974)
T ss_pred cCCCCcccceEEEecccceeee----------------------------------------------------------
Confidence 348999999886542
Q ss_pred cccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCC
Q 042539 235 RQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTT 286 (412)
Q Consensus 235 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~ 286 (412)
-|.++..-...++|-.+-++|...|.+++..+|.|-|+-+++.||.|+.
T Consensus 853 ---lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 853 ---LFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ---EcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 1234445556788999999999999999999999999999999999864
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.5e-21 Score=174.86 Aligned_cols=241 Identities=20% Similarity=0.282 Sum_probs=191.8
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
.+.+.++.++-+|.+...|..|++++.+.+ ++.|+++-..... ...+.+..|.-.|+.+.||||+.+++.+.
T Consensus 186 gid~~~lnl~tkl~e~hsgelwrgrwqgnd------ivakil~vr~~t~--risrdfneefp~lrifshpnilpvlgacn 257 (448)
T KOG0195|consen 186 GIDVSSLNLITKLAESHSGELWRGRWQGND------IVAKILNVREVTA--RISRDFNEEFPALRIFSHPNILPVLGACN 257 (448)
T ss_pred CcchhhhhhhhhhccCCCcccccccccCcc------hhhhhhhhhhcch--hhcchhhhhCcceeeecCCchhhhhhhcc
Confidence 466677788889999999999999997655 6778776554322 23445666888899999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeeeCCCCceEEccCCCEEEc--cc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMG--IAYRDLKPENILIRQSGHVTLT--DF 169 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~--iiHrDlKp~NiLl~~~g~vkL~--DF 169 (412)
...++.++..|++-|+|+++++...+-..+..++..++..++.|+.|||+.. |.---|....++||++-+.+|. |-
T Consensus 258 sppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~ 337 (448)
T KOG0195|consen 258 SPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADT 337 (448)
T ss_pred CCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccc
Confidence 9999999999999999999999887777888999999999999999999985 3334678888999888665553 32
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
-++.. .. ...
T Consensus 338 kfsfq------------------------------------------------------------------e~----gr~ 347 (448)
T KOG0195|consen 338 KFSFQ------------------------------------------------------------------EV----GRA 347 (448)
T ss_pred eeeee------------------------------------------------------------------cc----ccc
Confidence 22211 00 112
Q ss_pred cCCCCccceeecCCCC---CchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC---CCCCCCChHHHHHHHHhhh
Q 042539 250 GTEEYVSPEVVRGDGH---EFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT---PEFVGQRTALTDLIQRLLE 323 (412)
Q Consensus 250 gt~~Y~APE~l~~~~~---~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~dli~~~L~ 323 (412)
-.|.||+||.++..+. -.++|+|||++++|||.|...||...+..+.-.+|.... -..++++..+..|++-|++
T Consensus 348 y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~icmn 427 (448)
T KOG0195|consen 348 YSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMN 427 (448)
T ss_pred cCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhc
Confidence 3688999999988764 368999999999999999999999988888766665432 2346788899999999999
Q ss_pred hCCCccCCC
Q 042539 324 KDPVKRLGY 332 (412)
Q Consensus 324 ~dP~~R~~~ 332 (412)
.||.+||.+
T Consensus 428 edpgkrpkf 436 (448)
T KOG0195|consen 428 EDPGKRPKF 436 (448)
T ss_pred CCCCcCCCc
Confidence 999999964
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.3e-22 Score=207.31 Aligned_cols=263 Identities=22% Similarity=0.345 Sum_probs=206.8
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEEe
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLET 94 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~ 94 (412)
....|.+.+.||+|+|+.|-++..... ....+|+|.+.... .......++..|..+-+.+. |.|++++++....
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~---~~~~~a~~~~s~~~--~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~ 92 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRD---PESSSATKPISIPP--KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS 92 (601)
T ss_pred ccccccccccccccccchhhhhhhcCC---CcceeeccCCCCCC--CccchhhhcCccccccccccccccccccCCccCC
Confidence 577899999999999999998765332 33447777765443 22334555566888888887 9999999999999
Q ss_pred CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH-HcCceeeeCCCCceEEccCC-CEEEcccccc
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLH-NMGIAYRDLKPENILIRQSG-HVTLTDFDLS 172 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH-~~~iiHrDlKp~NiLl~~~g-~vkL~DFGla 172 (412)
.+..++.+++..|+++..-+........+...+..++.|+..++.|+| ..++.||||||+|.+++.++ .++++|||+|
T Consensus 93 ~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~A 172 (601)
T KOG0590|consen 93 PRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLA 172 (601)
T ss_pred CcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhh
Confidence 999999999999999977662222214788899999999999999999 99999999999999999999 9999999999
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc-C
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG-T 251 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g-t 251 (412)
..+.... .........+| +
T Consensus 173 t~~~~~~------------------------------------------------------------g~~~~~~~~~g~s 192 (601)
T KOG0590|consen 173 TAYRNKN------------------------------------------------------------GAERSLKDRCGSS 192 (601)
T ss_pred ccccccC------------------------------------------------------------CcceeeecccCCC
Confidence 7664310 01112234567 9
Q ss_pred CCCccceeecCCCC-CchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH-HHhc-----CCCCCCCCChHHHHHHHHhhhh
Q 042539 252 EEYVSPEVVRGDGH-EFAVDWWALGILTYEMLYGTTPFRGKNRKETFR-NVLM-----KTPEFVGQRTALTDLIQRLLEK 324 (412)
Q Consensus 252 ~~Y~APE~l~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~-~i~~-----~~~~~~~~~~~~~dli~~~L~~ 324 (412)
+.|+|||...+..| ....|+||.|+++..+++|..|+.......... .... ....+...+....+++.++|..
T Consensus 193 ~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~ 272 (601)
T KOG0590|consen 193 PPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKE 272 (601)
T ss_pred CCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCChhhhhcccccccC
Confidence 99999999998655 788999999999999999999997755443221 1111 1234456678899999999999
Q ss_pred CCCccCCCCCChhhhhcCCCCCC
Q 042539 325 DPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 325 dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
+|..|. +.+++..++|+..
T Consensus 273 ~~~~r~----s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 273 NPSNRL----SIEELKLDNWLSS 291 (601)
T ss_pred Cchhcc----ccccccccccccc
Confidence 999999 6899999999987
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.9e-20 Score=166.49 Aligned_cols=140 Identities=21% Similarity=0.223 Sum_probs=113.4
Q ss_pred eeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhh----hHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeE
Q 042539 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHA----KHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFL 98 (412)
Q Consensus 23 ~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 98 (412)
++.||+|++|.||++++. + ..+++|+........ ......++.+|+.++..+.|++|+....++.+.+..
T Consensus 1 ~~~l~~G~~~~vy~~~~~--~----~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 74 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDFL--G----IKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENF 74 (211)
T ss_pred CcccccCceEEEEEEeeC--C----CceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCC
Confidence 468999999999999872 2 238999865432211 111234677899999999999988877777777889
Q ss_pred EEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchh
Q 042539 99 AWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
+++|||++|++|..++... .. ....++.+++.+|.++|+.|++|||++|.|||++ ++.++|+|||+++..
T Consensus 75 ~lv~e~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred EEEEEEeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999999999998876532 12 7788999999999999999999999999999999 889999999998753
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.6e-19 Score=161.61 Aligned_cols=134 Identities=24% Similarity=0.251 Sum_probs=104.7
Q ss_pred eeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhh----hHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEE
Q 042539 25 ILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHA----KHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAW 100 (412)
Q Consensus 25 ~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 100 (412)
.||+|+||.||++.+.+ ..+++|+........ ......++.+|++++..+.|+++....-++...+..++
T Consensus 1 ~ig~G~~~~vy~~~~~~------~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 74 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLG------LKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTI 74 (199)
T ss_pred CCCCCceEEEEEeecCC------ccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEE
Confidence 48999999999998432 338999865432211 11223567789999999998876555555556677899
Q ss_pred EeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 101 AVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 101 v~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
||||++|++|..++.... . .++.|++.+|.+||+.|++|||++|+||+++ ++.++++|||+++.
T Consensus 75 v~e~~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 75 VMEYIEGKPLKDVIEEGN---D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEECCccHHHHHhhcH---H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999999977654311 1 7889999999999999999999999999999 89999999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.1e-19 Score=184.93 Aligned_cols=140 Identities=21% Similarity=0.188 Sum_probs=111.6
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhh----hhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLH----AKHEAERRARWEIRVLSRLSHPFLPKLLGSLET 94 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~----~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 94 (412)
.|...+.||+|+||+||++.+.... +++|+....... .......++.+|+++++.++|++|+..+.+..+
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~------~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 407 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRD------AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD 407 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCcc------ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence 3456889999999999998775432 444433221111 111234567889999999999999988877777
Q ss_pred CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
....++||||++|++|..++. ....++.|++.+|.+||+.|++||||||+|||+ .++.++|+|||+++.
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 778899999999999987654 346789999999999999999999999999999 678999999999976
Q ss_pred h
Q 042539 175 L 175 (412)
Q Consensus 175 ~ 175 (412)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 4
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.3e-19 Score=161.09 Aligned_cols=140 Identities=23% Similarity=0.186 Sum_probs=107.2
Q ss_pred ceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhh------------------HHHHHHHHHHHHHHhhcC
Q 042539 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAK------------------HEAERRARWEIRVLSRLS 81 (412)
Q Consensus 20 y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~------------------~~~~~~~~~Ei~il~~l~ 81 (412)
|.+.+.||+|+||.||++... +++.||||++........ ........+|+.++..+.
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 91 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-----DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY 91 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-----CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence 788899999999999998764 234599999865431000 011223567899999998
Q ss_pred CC--ccceeeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEc
Q 042539 82 HP--FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIR 159 (412)
Q Consensus 82 hp--nIv~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~ 159 (412)
|. .++..++ ....++||||+.|++|..+.. ...+..++.+++.++.++|+.||+||||||+||+++
T Consensus 92 ~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~--------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~ 159 (198)
T cd05144 92 EEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV--------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD 159 (198)
T ss_pred HcCCCCCceee----cCCceEEEEEeCCcchhhccc--------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc
Confidence 76 4444443 234589999999999865421 134567889999999999999999999999999999
Q ss_pred cCCCEEEccccccchhh
Q 042539 160 QSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 160 ~~g~vkL~DFGla~~~~ 176 (412)
.++.++|+|||++....
T Consensus 160 ~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 160 DDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCCcEEEEECCccccCC
Confidence 99999999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.6e-20 Score=181.55 Aligned_cols=254 Identities=26% Similarity=0.293 Sum_probs=167.6
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeee-------e
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLG-------S 91 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~-------~ 91 (412)
.+.+.+..+.+++|.++..+-... ......++-|..+.+.+ .......+++-.+....|.+..-+.+ .
T Consensus 245 s~~~~k~~~~~~~~~~~~~q~~~~-~s~~E~~~s~~~~~d~~----~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~ 319 (516)
T KOG1033|consen 245 SSSISKSSERVSSGIVFEKQGKNN-SSLREWLKSKRADVDSL----CACKYTFRQLGVLVDSSHSNRSILEDLRPSLFES 319 (516)
T ss_pred cccccccccccccCCchhhhhccc-chhhhhccchhhhccch----hhhhhhhhhhhheeccccCCcccccCCCCchhhh
Confidence 445566667777777664332211 00112233333222211 12233444666666665544443333 1
Q ss_pred EEe-----CCeEEEEeeccCCCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEE
Q 042539 92 LET-----DEFLAWAVPYCPGGDLNVLRYKQN-DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVT 165 (412)
Q Consensus 92 ~~~-----~~~~~lv~e~~~gg~L~~~~~~~~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vk 165 (412)
+.. ..++||.|++|.-.+|.+++..+. ...-+......++.|+..|++| +|.+|||+||.||++..++.+|
T Consensus 320 ~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~k 396 (516)
T KOG1033|consen 320 SKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLK 396 (516)
T ss_pred ccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhh
Confidence 111 236899999999999999886433 2235668889999999999999 9999999999999999999999
Q ss_pred EccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCC
Q 042539 166 LTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERS 245 (412)
Q Consensus 166 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (412)
|.|||+........ +........
T Consensus 397 IgDFgl~ts~~~~~---------------------------------------------------------~~~~~~a~~ 419 (516)
T KOG1033|consen 397 IGDFGLVTSQDKDE---------------------------------------------------------TVAPAAASH 419 (516)
T ss_pred hhhhhheeecccCC---------------------------------------------------------cccchhhhh
Confidence 99999986543211 000112233
Q ss_pred cccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCCC--CCCCChHHHHHHHHhh
Q 042539 246 NSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTPE--FVGQRTALTDLIQRLL 322 (412)
Q Consensus 246 ~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~dli~~~L 322 (412)
..-+||..||+||++.+..|+.++||||||+||||+++ -...|. ...++..+..+..+ +..-.+.-.+|+.+||
T Consensus 420 t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~r~g~ip~~~~~d~p~e~~ll~~ll 496 (516)
T KOG1033|consen 420 TQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---RIATLTDIRDGIIPPEFLQDYPEEYTLLQQLL 496 (516)
T ss_pred hhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---HHHhhhhhhcCCCChHHhhcCcHHHHHHHHhc
Confidence 45589999999999999999999999999999999997 333332 23444555444433 3333456779999999
Q ss_pred hhCCCccCCCCCChhhhhcCCC
Q 042539 323 EKDPVKRLGYLRGACEIKEHVF 344 (412)
Q Consensus 323 ~~dP~~R~~~~~~~~e~l~h~f 344 (412)
...|.+|| .+.+.--|.|
T Consensus 497 s~~p~~RP----~~~~~~~~~~ 514 (516)
T KOG1033|consen 497 SPSPEERP----SAIEVALHEF 514 (516)
T ss_pred CCCcccCc----hHHHHhhhhh
Confidence 99999999 3555555554
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.6e-18 Score=151.81 Aligned_cols=142 Identities=22% Similarity=0.238 Sum_probs=100.0
Q ss_pred eeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHH--------------------HHHHHHHHHHHhhcC
Q 042539 22 ALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEA--------------------ERRARWEIRVLSRLS 81 (412)
Q Consensus 22 ~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~--------------------~~~~~~Ei~il~~l~ 81 (412)
+.+.||+|+||+||+|.+. . ++.||||++........... ......|.+.+..+.
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~----~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 75 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-D----GEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLY 75 (187)
T ss_pred CCcccccccceeEEEEECC-C----CCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHH
Confidence 3578999999999999875 2 34599999875432111111 011234666777765
Q ss_pred CC--ccceeeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeeCCCCceEE
Q 042539 82 HP--FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN-MGIAYRDLKPENILI 158 (412)
Q Consensus 82 hp--nIv~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDlKp~NiLl 158 (412)
+. .+.+.+++ ...++||||+.|+.+........ ....+++.++.+++.++.++|+ .||+||||||+||++
T Consensus 76 ~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~---~~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili 148 (187)
T cd05119 76 EAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV---RLLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILV 148 (187)
T ss_pred HcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhh---hhcccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE
Confidence 43 24455443 23589999999965432111111 1116788999999999999999 999999999999999
Q ss_pred ccCCCEEEccccccchhh
Q 042539 159 RQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 159 ~~~g~vkL~DFGla~~~~ 176 (412)
+ ++.++|+|||.+....
T Consensus 149 ~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 149 D-DGKVYIIDVPQAVEID 165 (187)
T ss_pred E-CCcEEEEECccccccc
Confidence 9 8999999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.4e-17 Score=153.11 Aligned_cols=139 Identities=24% Similarity=0.312 Sum_probs=103.9
Q ss_pred eeee-ccCceEEEEEEEcCCCCCCCCceEEeeecchhhhh---------hHHHHHHHHHHHHHHhhcCCCcc--ceeeee
Q 042539 24 KILG-KGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHA---------KHEAERRARWEIRVLSRLSHPFL--PKLLGS 91 (412)
Q Consensus 24 ~~LG-~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~---------~~~~~~~~~~Ei~il~~l~hpnI--v~l~~~ 91 (412)
..|| .||.|+||.+... +..++||.+.+..+-. ......++.+|+.++..|.|++| +..+++
T Consensus 37 ~~lg~~~g~gtv~~v~~~------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~ 110 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAA 110 (239)
T ss_pred ceeecCCCCccEEEEEeC------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEee
Confidence 4577 7888888888664 2238999886533211 11234567889999999998774 677776
Q ss_pred EEeCC-e---EEEEeeccCC-CCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEE
Q 042539 92 LETDE-F---LAWAVPYCPG-GDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTL 166 (412)
Q Consensus 92 ~~~~~-~---~~lv~e~~~g-g~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL 166 (412)
..... . .++|||+++| .+|..++.. ..+++.. +.|++.+|.+||++||+||||||+|||++.++.++|
T Consensus 111 ~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 111 RVVRHGLFYRADILIERIEGARDLVALLQE---APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred eeeecCcceeeeEEEEecCCCCCHHHHHhc---CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEE
Confidence 54332 2 3599999998 688766543 2355543 578999999999999999999999999999999999
Q ss_pred ccccccchh
Q 042539 167 TDFDLSRNL 175 (412)
Q Consensus 167 ~DFGla~~~ 175 (412)
+|||.+...
T Consensus 184 IDfg~~~~~ 192 (239)
T PRK01723 184 IDFDRGELR 192 (239)
T ss_pred EECCCcccC
Confidence 999998764
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.1e-17 Score=138.46 Aligned_cols=133 Identities=21% Similarity=0.319 Sum_probs=111.4
Q ss_pred eeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCC--CccceeeeeEEeCCeEE
Q 042539 22 ALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH--PFLPKLLGSLETDEFLA 99 (412)
Q Consensus 22 ~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~ 99 (412)
+++.||+|+++.||++.... ..+++|+...... ...+.+|+.+++.+.| .++++++.++...+..+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~------~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~ 69 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD------EDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASGESDGWSY 69 (155)
T ss_pred cceecccccccceEEEEecC------CeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccE
Confidence 56889999999999998754 2389999865432 3456679999999976 58999999998888999
Q ss_pred EEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHc---CceeeeCCCCceEEccCCCEEEccccccchh
Q 042539 100 WAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNM---GIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 100 lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~---~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
++|||+.|+.+..+ +......++.+++.+|.++|.. +++|+|++|+||+++..+.++++|||.++..
T Consensus 70 ~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 70 LLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred EEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 99999999887543 4456677889999999999985 7999999999999999899999999999764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.8e-16 Score=156.79 Aligned_cols=194 Identities=26% Similarity=0.323 Sum_probs=148.6
Q ss_pred HhhcCCCccceeeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCc-eeeeCCCCc
Q 042539 77 LSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGI-AYRDLKPEN 155 (412)
Q Consensus 77 l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~i-iHrDlKp~N 155 (412)
|+.+.|.|+.++++...++..++.|.+||.-|+|.+.+.... -.++.--...+++.|+.||.|||.--| .|+.++..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 467889999999999999999999999999999998887633 347777788899999999999998755 999999999
Q ss_pred eEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCcccc
Q 042539 156 ILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRR 235 (412)
Q Consensus 156 iLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (412)
++++....+||+|||+........+
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~------------------------------------------------------- 104 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAE------------------------------------------------------- 104 (484)
T ss_pred ceeeeeEEEEechhhhccccccccc-------------------------------------------------------
Confidence 9999999999999998865421000
Q ss_pred ccccCCCCCCcccccCCCCccceeecCCC-------CCchhhHHHHHHHHHHHhhCCCCCCCCC----HHHHHHHHhc-C
Q 042539 236 QQSFDNGERSNSFVGTEEYVSPEVVRGDG-------HEFAVDWWALGILTYEMLYGTTPFRGKN----RKETFRNVLM-K 303 (412)
Q Consensus 236 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-------~~~~~DiwSlGvil~ell~g~~Pf~~~~----~~~~~~~i~~-~ 303 (412)
........-...|.|||.+.+.. .+.+.|+||+|++++|+++..-||.... ..+....+.. +
T Consensus 105 ------~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~ 178 (484)
T KOG1023|consen 105 ------PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGG 178 (484)
T ss_pred ------ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcC
Confidence 00000111234699999998741 3677999999999999999999997632 2234444433 1
Q ss_pred C-CCCC------CCChHHHHHHHHhhhhCCCccCCC
Q 042539 304 T-PEFV------GQRTALTDLIQRLLEKDPVKRLGY 332 (412)
Q Consensus 304 ~-~~~~------~~~~~~~dli~~~L~~dP~~R~~~ 332 (412)
. +..+ ...+++..+++.||..+|.+||++
T Consensus 179 ~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~ 214 (484)
T KOG1023|consen 179 SNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSI 214 (484)
T ss_pred CCCcCcchhhhhhcchHHHHHHHHhcccChhhCccH
Confidence 1 1111 233578899999999999999964
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.7e-16 Score=158.51 Aligned_cols=267 Identities=21% Similarity=0.231 Sum_probs=196.9
Q ss_pred CCCCCccCceeeeeeec--cCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCcccee
Q 042539 12 TPSLDLDNLKALKILGK--GAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKL 88 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~--G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l 88 (412)
-..+.-..+.+.+.+|. |.+|.||.++... ......+|+|.=+... .......+-++|+...+.++ |+|.++.
T Consensus 108 ~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~--~~s~~~~a~k~s~~p~--s~p~~~~~k~~~~~s~~~i~~~~~~v~~ 183 (524)
T KOG0601|consen 108 FDSFFDQRFPISSRTGSLPGSKGSVFKSRCTN--SESPHKFAVKKSKIPF--SPPLDSKRKLREFLSHHKIDSHENPVRD 183 (524)
T ss_pred ccchhhhhcccccccccCCCCCceeecccCCc--ccCCcccccccccCCC--CCccccccccchhhcccccCcccccccc
Confidence 34566678889999999 9999999887622 2344558998732211 11122334445777888886 9999999
Q ss_pred eeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHH----HHHHHHHcCceeeeCCCCceEEccC-CC
Q 042539 89 LGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIIC----AIEHLHNMGIAYRDLKPENILIRQS-GH 163 (412)
Q Consensus 89 ~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~----aL~yLH~~~iiHrDlKp~NiLl~~~-g~ 163 (412)
+..++..+.+|+-+|+| |.+|..+.... ...+++..++.++.+... ||.++|+.+|+|-|+||+||++..+ ..
T Consensus 184 ~~~~e~~~~lfiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s 261 (524)
T KOG0601|consen 184 SPAWEGSGILFIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTS 261 (524)
T ss_pred CcccccCCcceeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccce
Confidence 99999999999999999 56776665543 335889999999999999 9999999999999999999999999 78
Q ss_pred EEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCC
Q 042539 164 VTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGE 243 (412)
Q Consensus 164 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (412)
.+++|||+...+....-.. .-.
T Consensus 262 ~~~~df~~v~~i~~~~~~~----------------------------------------------------------~~~ 283 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSS----------------------------------------------------------VFK 283 (524)
T ss_pred eecCCcceeEEccCCcccc----------------------------------------------------------cee
Confidence 9999999998774332100 000
Q ss_pred CCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCC--CHHHHHHHHhcCCCCCCCCChHHHHHHHHh
Q 042539 244 RSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGK--NRKETFRNVLMKTPEFVGQRTALTDLIQRL 321 (412)
Q Consensus 244 ~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~dli~~~ 321 (412)
..-...|...|++||.+++. ++...|++|||.++.+..+|..++... +....+++...........+.++...+..|
T Consensus 284 ~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~ 362 (524)
T KOG0601|consen 284 VSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQM 362 (524)
T ss_pred eeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHHHHh
Confidence 00111466689999999875 678999999999999999887766543 333334443322222234456677799999
Q ss_pred hhhCCCccCCCCCChhhhhcCCCCCC
Q 042539 322 LEKDPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 322 L~~dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
+..+|..|+ +++.+++|.+...
T Consensus 363 ~d~~~~~~~----~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 363 LDEDPRLRL----TAQILTALNVIHS 384 (524)
T ss_pred cCcchhhhh----HHHHHhccccccc
Confidence 999999998 6889999998874
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.6e-15 Score=154.73 Aligned_cols=148 Identities=15% Similarity=0.218 Sum_probs=98.9
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhh------------------------------hHHH
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHA------------------------------KHEA 66 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~------------------------------~~~~ 66 (412)
+.+|.. +.||+|++|.||.|+.+.++ +.||||+++...... -.+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G----~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~ 193 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNG----REVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEF 193 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCC----CEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHH
Confidence 345666 89999999999999987644 449999997542110 0122
Q ss_pred HHHHHHHHHHHhhcCCCccceeeeeEEeC-------------CeEEEEeeccCCCCchhHHHhhCCC----CCCHHHHHH
Q 042539 67 ERRARWEIRVLSRLSHPFLPKLLGSLETD-------------EFLAWAVPYCPGGDLNVLRYKQNDR----VFSPSVIRF 129 (412)
Q Consensus 67 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-------------~~~~lv~e~~~gg~L~~~~~~~~~~----~l~~~~~~~ 129 (412)
.+.+.+|++..... .|+.++...|.+. ..-+||||||.|+.+.++......+ .+.+..+..
T Consensus 194 ~~~l~~ElD~~~Ea--~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~ 271 (537)
T PRK04750 194 EKTLHDELDLMREA--ANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEV 271 (537)
T ss_pred HHHHHHhhCHHHHH--HHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHH
Confidence 33334444444333 2444444433333 3456999999999997653322222 244555555
Q ss_pred HHHHHHHHHHHHHHcCceeeeCCCCceEEccCC----CEEEccccccchhhch
Q 042539 130 YLSEIICAIEHLHNMGIAYRDLKPENILIRQSG----HVTLTDFDLSRNLVKK 178 (412)
Q Consensus 130 ~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g----~vkL~DFGla~~~~~~ 178 (412)
++.|++ ..|++|+|+||.||+++.+| .++++|||++..+...
T Consensus 272 ~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 272 FFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 555554 59999999999999999988 9999999999887544
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.53 E-value=6.7e-14 Score=141.05 Aligned_cols=146 Identities=16% Similarity=0.145 Sum_probs=96.9
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhH------------------------------HHH------
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKH------------------------------EAE------ 67 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~------------------------------~~~------ 67 (412)
+.||.|++|.||+|+.+ +++.||||+.+......-. +..
T Consensus 123 ~plasaSigQVh~A~l~-----~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-----DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred cceeeeehhheEEEEec-----CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 67999999999999875 2345999998654211100 000
Q ss_pred HHHHHHHHHHhhcC----CCccceeeeeE-EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHH-HHHHH
Q 042539 68 RRARWEIRVLSRLS----HPFLPKLLGSL-ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIIC-AIEHL 141 (412)
Q Consensus 68 ~~~~~Ei~il~~l~----hpnIv~l~~~~-~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~-aL~yL 141 (412)
-.+.+|++.+..+. |.+-+.+-.++ .....-++||||++|++|.++......+ .+ ...++.+++. .+..+
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~-~~---~~~ia~~~~~~~l~ql 273 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG-LD---RKALAENLARSFLNQV 273 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC-CC---HHHHHHHHHHHHHHHH
Confidence 12344565555553 22222222222 2234568999999999998775443211 22 2334455554 47889
Q ss_pred HHcCceeeeCCCCceEEccCCCEEEccccccchhhch
Q 042539 142 HNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178 (412)
Q Consensus 142 H~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~ 178 (412)
|..|++|+|+||.||+++.+|.++|+|||++..+...
T Consensus 274 ~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~~ 310 (437)
T TIGR01982 274 LRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSEE 310 (437)
T ss_pred HhCCceeCCCCcccEEECCCCcEEEEeCCCeeECCHH
Confidence 9999999999999999999999999999999887543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.48 E-value=6.6e-13 Score=134.27 Aligned_cols=119 Identities=18% Similarity=0.269 Sum_probs=97.3
Q ss_pred CCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHH
Q 042539 46 ARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPS 125 (412)
Q Consensus 46 ~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~ 125 (412)
.+.+|.|.+.+.+.- .....+.+-++-|+.++||||+++++.++.+..+|||+|-+.- |..++.. +...
T Consensus 36 ~~~~vsVF~~~~~~~----~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~-----l~~~ 104 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG----EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKE-----LGKE 104 (690)
T ss_pred cCCceEEEEEeCCCc----hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHH-----hHHH
Confidence 455588888866542 2334455577899999999999999999999999999999953 4445544 3467
Q ss_pred HHHHHHHHHHHHHHHHH-HcCceeeeCCCCceEEccCCCEEEccccccchh
Q 042539 126 VIRFYLSEIICAIEHLH-NMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 126 ~~~~~~~qi~~aL~yLH-~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
.+..-+.||+.||.||| +.+++|++|.-+.++++..|.+||++|-++...
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~ 155 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKA 155 (690)
T ss_pred HHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEecc
Confidence 78888999999999997 668999999999999999999999999988543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.47 E-value=4.6e-13 Score=119.71 Aligned_cols=146 Identities=14% Similarity=0.170 Sum_probs=103.5
Q ss_pred eeeeeccCceEEEEEEEcCC--CCCCCCceEEeeecchhhh--h--------------------hHHHHHHHHHHHHHHh
Q 042539 23 LKILGKGAMGTVFLVHDRAA--DPTARCPFALKVVDKSTLH--A--------------------KHEAERRARWEIRVLS 78 (412)
Q Consensus 23 ~~~LG~G~fg~V~la~~~~~--~~~~~~~vAiK~i~~~~~~--~--------------------~~~~~~~~~~Ei~il~ 78 (412)
...||.|--+.||.|..... ....+..+|||+.+-+... . ......-+.+|.+.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 46799999999999975421 0112345999988643210 0 1111222447999999
Q ss_pred hcC--CCccceeeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHH-HHcCceeeeCCCCc
Q 042539 79 RLS--HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHL-HNMGIAYRDLKPEN 155 (412)
Q Consensus 79 ~l~--hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yL-H~~~iiHrDlKp~N 155 (412)
++. .-++...+++ ..-+|||||+.|+.+..-.. ....+++.++..+..|++.+|..| |+.||||+||++.|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L--kd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL--KDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh--hccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 996 3567777765 45689999997754422111 112366677788889999999999 89999999999999
Q ss_pred eEEccCCCEEEccccccchh
Q 042539 156 ILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 156 iLl~~~g~vkL~DFGla~~~ 175 (412)
||++ +|.+.|+|||.|...
T Consensus 156 IL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 156 MLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred EEEE-CCcEEEEECCCceeC
Confidence 9996 578999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.3e-13 Score=119.17 Aligned_cols=129 Identities=19% Similarity=0.163 Sum_probs=94.9
Q ss_pred eeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCc-cceeeeeEEeCCeEEEE
Q 042539 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPF-LPKLLGSLETDEFLAWA 101 (412)
Q Consensus 23 ~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~lv 101 (412)
++.|+.|.++.||+++.. +..|++|+...... ......+|+.+++.+.+.+ +.+++.+.. ...++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~------~~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv 69 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA------NKKYVVRIPGNGTE-----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLI 69 (170)
T ss_pred eeecCCcccCceEEEEEC------CeEEEEEeCCCCcc-----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEE
Confidence 578899999999998864 22399998754421 1112345888999886544 445555443 335799
Q ss_pred eeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCc-----eeeeCCCCceEEccCCCEEEccccccchh
Q 042539 102 VPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGI-----AYRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 102 ~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~i-----iHrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
||+++|.++... . . ....++.+++.+|..||+.++ +|+|++|.||+++ ++.++++|||.+...
T Consensus 70 ~e~i~G~~l~~~----~---~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 70 TEFIEGSELLTE----D---F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred EEecCCCccccc----c---c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 999999987532 0 1 123456799999999999985 9999999999998 678999999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=4.1e-14 Score=141.56 Aligned_cols=251 Identities=20% Similarity=0.226 Sum_probs=183.1
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSL 92 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~ 92 (412)
.....+|..+..||.|.|+.|+.+..+. .+++.|++|-+.+..... .....-+.|+.+...+. |.++++.+..|
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~---~~~~~Y~~ke~~~~l~~~--~~di~sl~ev~l~~~l~~~~~~~g~~~~W 335 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRP---EGDCIYAAKELLNGLATF--ASDIFSLGEVILEAILGSHLPSVGKNSSW 335 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecC---CCCceEeChhhhccccch--HhhhcchhhhhHhhHhhcccccCCCCCCc
Confidence 3456789999999999999999876432 245669999886654322 22344556888888886 99999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccC-CCEEEccccc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQS-GHVTLTDFDL 171 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~-g~vkL~DFGl 171 (412)
....+.|+-.|||.|+++....... ..+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||.
T Consensus 336 ~~~r~~~ip~e~~~~~s~~l~~~~~--~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 336 SQLRQGYIPLEFCEGGSSSLRSVTS--QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred cccccccCchhhhcCcchhhhhHHH--HhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccc
Confidence 9999999999999999886554322 248899999999999999999999999999999999999886 6779999998
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
...+.-. ...+.++
T Consensus 414 ~t~~~~~------------------------------------------------------------------~~~~~~~ 427 (524)
T KOG0601|consen 414 WTRLAFS------------------------------------------------------------------SGVFHHI 427 (524)
T ss_pred cccccee------------------------------------------------------------------ccccccc
Confidence 8642100 0111223
Q ss_pred CCCc--cceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-CCCCCCCChHHHHHHHHhhhhCCCc
Q 042539 252 EEYV--SPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK-TPEFVGQRTALTDLIQRLLEKDPVK 328 (412)
Q Consensus 252 ~~Y~--APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~dli~~~L~~dP~~ 328 (412)
-.++ +++......+..++|++|||..+.+.++|...=....... .+..+ .+..++....+..+...++..++..
T Consensus 428 ~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~---~i~~~~~p~~~~~~~~~q~~~kv~~~~~~~~ 504 (524)
T KOG0601|consen 428 DRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL---TIRSGDTPNLPGLKLQLQVLLKVMINPDRKR 504 (524)
T ss_pred ccccccchhhccccccccccccccccccccccccCcccCcccccce---eeecccccCCCchHHhhhhhhhhhcCCcccc
Confidence 3344 5555556677889999999999999999875433222111 12222 2334444567888899999999999
Q ss_pred cCCCCCChhhhhcCCC
Q 042539 329 RLGYLRGACEIKEHVF 344 (412)
Q Consensus 329 R~~~~~~~~e~l~h~f 344 (412)
|+. +.++..|.=
T Consensus 505 ~~l----~~~l~~~~~ 516 (524)
T KOG0601|consen 505 RPS----AVELSLHSE 516 (524)
T ss_pred chh----hhhhcccch
Confidence 984 556555543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.2e-13 Score=128.53 Aligned_cols=211 Identities=16% Similarity=0.172 Sum_probs=145.8
Q ss_pred HHHhhcCCCccceeeeeEEeCC-----eEEEEeeccCCCCchhHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHcC--
Q 042539 75 RVLSRLSHPFLPKLLGSLETDE-----FLAWAVPYCPGGDLNVLRYKQN--DRVFSPSVIRFYLSEIICAIEHLHNMG-- 145 (412)
Q Consensus 75 ~il~~l~hpnIv~l~~~~~~~~-----~~~lv~e~~~gg~L~~~~~~~~--~~~l~~~~~~~~~~qi~~aL~yLH~~~-- 145 (412)
.-|-++.|.|||+++.++.+.. ...+++||+..|+|..+++... ...+....-+.|+.||+.||.|||+..
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 3455556999999999997543 5899999999999988776533 234777888899999999999999986
Q ss_pred ceeeeCCCCceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCcccccccc
Q 042539 146 IAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTK 225 (412)
Q Consensus 146 iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (412)
|+|+++..+-|++..+|-+|+.--.-...- . -..+.
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h-----~--------------------s~~~~------------------- 234 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTH-----P--------------------SVNST------------------- 234 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccc-----h--------------------hhhhh-------------------
Confidence 999999999999999998887532111000 0 00000
Q ss_pred ccCCCCccccccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCC-CCCCCHHHHHHHHhcCC
Q 042539 226 SARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTP-FRGKNRKETFRNVLMKT 304 (412)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~P-f~~~~~~~~~~~i~~~~ 304 (412)
.......-.|-++|.|||.=.....+.++|||++|....+|..+..- -.+.+..+.-.++....
T Consensus 235 ---------------~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i 299 (458)
T KOG1266|consen 235 ---------------REAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVI 299 (458)
T ss_pred ---------------hHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhe
Confidence 00011111345678899876666667899999999999999887643 33333222222222211
Q ss_pred CCCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCc
Q 042539 305 PEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRW 350 (412)
Q Consensus 305 ~~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~ 350 (412)
+....+.-+++|.+||+..|..|+ ++.+++-||-+-++.-
T Consensus 300 --~~len~lqr~~i~kcl~~eP~~rp----~ar~llfHpllfeVhs 339 (458)
T KOG1266|consen 300 --IGLENGLQRGSITKCLEGEPNGRP----DARLLLFHPLLFEVHS 339 (458)
T ss_pred --eeccCccccCcCcccccCCCCCCc----chhhhhcCceeeecch
Confidence 111123346899999999999999 6999999998766653
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=4.2e-11 Score=104.11 Aligned_cols=135 Identities=19% Similarity=0.197 Sum_probs=95.8
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhh----hHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEE
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHA----KHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLA 99 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 99 (412)
..+++|+-+.++.+.+.... +.+|.=.++.... ..--..+..+|++++.++.--.|..-+=++.+.....
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~------av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~ 75 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLP------AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGL 75 (204)
T ss_pred chhhCCcceeEEeeeccCcc------eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCE
Confidence 46789999999988654322 5666332222211 1223456778999999997444444444445566778
Q ss_pred EEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 100 WAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 100 lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
|+|||++|..|.+.+... .-.++..+=.-+.-||..||||+||.++||++...+ +.++||||++.
T Consensus 76 I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 76 IVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999998887665443 134566677778899999999999999999996655 99999999974
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=7.3e-11 Score=102.24 Aligned_cols=146 Identities=20% Similarity=0.172 Sum_probs=106.2
Q ss_pred eeeeeeccCceEEEEEEEcCCCCCCCCceEEe-----eecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 22 ALKILGKGAMGTVFLVHDRAADPTARCPFALK-----VVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 22 ~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK-----~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
.+..|-+|+-+.|+++.+.+.. +.|| ..+...+. ..-..++..+|+++|.++.--.|.--.-+|.+..
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~------~iIK~Rf~K~YRHP~LD-~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~ 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEA------AIIKERFSKRYRHPALD-QKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY 83 (229)
T ss_pred cceeeeccceeeEeeeccCCce------eEEeecccccccchHHH-HHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC
Confidence 6788999999999988775432 4554 22222332 2345678888999999997444444444566777
Q ss_pred eEEEEeeccCC-CCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCC---EEEcccccc
Q 042539 97 FLAWAVPYCPG-GDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGH---VTLTDFDLS 172 (412)
Q Consensus 97 ~~~lv~e~~~g-g~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~---vkL~DFGla 172 (412)
.-+|+|||++| .++..++...............++.+|=..|.-||+++|||+||..+||++..+|. +.|+|||++
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence 77899999988 35555555544333444444788899999999999999999999999999987763 589999998
Q ss_pred ch
Q 042539 173 RN 174 (412)
Q Consensus 173 ~~ 174 (412)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 64
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.21 E-value=8.3e-11 Score=107.34 Aligned_cols=142 Identities=20% Similarity=0.233 Sum_probs=105.3
Q ss_pred eeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCC--CccceeeeeEEeC---Ce
Q 042539 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH--PFLPKLLGSLETD---EF 97 (412)
Q Consensus 23 ~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~---~~ 97 (412)
++.||.|..+.||++.... +..+++|+....... .....+.+|+++++.+.+ ..+.+++.+.... +.
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-----g~~~ilK~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~ 74 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-----GRRLVLRRPPPGALL---PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGT 74 (223)
T ss_pred ceecCCCccceEEEEEecC-----CcceEEEeCCCcccC---cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCC
Confidence 3678999999999987643 234999987654321 123345669999999975 4567777776654 36
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN---------------------------------- 143 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~---------------------------------- 143 (412)
.++||||+.|.++...+.. ..+++.....++.+++.+|..||+
T Consensus 75 ~~~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (223)
T cd05154 75 PFYVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRT 151 (223)
T ss_pred ceEEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcc
Confidence 7899999999988654321 236777777778888888888874
Q ss_pred ----------------------cCceeeeCCCCceEEcc--CCCEEEccccccchh
Q 042539 144 ----------------------MGIAYRDLKPENILIRQ--SGHVTLTDFDLSRNL 175 (412)
Q Consensus 144 ----------------------~~iiHrDlKp~NiLl~~--~g~vkL~DFGla~~~ 175 (412)
..++|+|+.|.||+++. ++.+.|+||+.+...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 152 DEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred cccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 23699999999999998 567899999988754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.2e-11 Score=125.64 Aligned_cols=166 Identities=17% Similarity=0.236 Sum_probs=122.0
Q ss_pred HHHHHHHHHHHHc-CceeeeCCCCceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhh
Q 042539 132 SEIICAIEHLHNM-GIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRW 210 (412)
Q Consensus 132 ~qi~~aL~yLH~~-~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (412)
.++.+|+.|+|+. ++||++|.|++|.++.+|.+||++|+.+.......++....
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~------------------------- 160 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSE------------------------- 160 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCcccccc-------------------------
Confidence 3455999999975 89999999999999999999999999886554322221100
Q ss_pred hccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHh-hCCCCCC
Q 042539 211 LHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEML-YGTTPFR 289 (412)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell-~g~~Pf~ 289 (412)
.+........-...|.|||.+.+...+.++|++||||++|.+. .|+..+.
T Consensus 161 -----------------------------yd~~lp~~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~ 211 (700)
T KOG2137|consen 161 -----------------------------YDPPLPLLLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIA 211 (700)
T ss_pred -----------------------------CCCCCChhhccCcccccchhhccccccccccceeeeeEEEEEecCCcchhh
Confidence 1112222334466899999999988899999999999999999 6777776
Q ss_pred CCCHHHHHHHHh--cCCC---CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCchhhcc
Q 042539 290 GKNRKETFRNVL--MKTP---EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTD 355 (412)
Q Consensus 290 ~~~~~~~~~~i~--~~~~---~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~~~~~ 355 (412)
+.+....+..-. .+-. .-..++.++++=|.++|..++..|+ ++.+++..+||.+.....++.
T Consensus 212 a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp----~~~~l~~~~ff~D~~~~aLrf 278 (700)
T KOG2137|consen 212 ANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRP----TLDLLLSIPFFSDPGLKALRF 278 (700)
T ss_pred ccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCc----chhhhhcccccCCchhhhhhh
Confidence 653332222111 1111 1135678999999999999999999 689999999999887665544
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.13 E-value=6.1e-10 Score=99.19 Aligned_cols=101 Identities=30% Similarity=0.326 Sum_probs=70.9
Q ss_pred HHHHHHHHHHHHhhcCCC--ccceeeeeEEeCCeEEEEeeccC--CCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHH-
Q 042539 66 AERRARWEIRVLSRLSHP--FLPKLLGSLETDEFLAWAVPYCP--GGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEH- 140 (412)
Q Consensus 66 ~~~~~~~Ei~il~~l~hp--nIv~l~~~~~~~~~~~lv~e~~~--gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~y- 140 (412)
....+.+|.+.|.++..- ++.+.+++. .-+|||||+. |..+..+.... ++......++.+++..+..
T Consensus 51 ~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~ 122 (188)
T PF01163_consen 51 IREWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKM 122 (188)
T ss_dssp HHHHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHH
Confidence 445678899999999844 677777553 2379999998 76665543322 3356667788888886665
Q ss_pred HHHcCceeeeCCCCceEEccCCCEEEccccccchh
Q 042539 141 LHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 141 LH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
+|+.||+|+||.+.|||++.+ .+.|+|||.+...
T Consensus 123 ~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 123 LHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp HHCTTEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred HHhcCceecCCChhhEEeecc-eEEEEecCcceec
Confidence 579999999999999999877 9999999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.08 E-value=3.2e-09 Score=104.95 Aligned_cols=213 Identities=16% Similarity=0.224 Sum_probs=147.1
Q ss_pred ceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe----CCeEEEEeeccC
Q 042539 31 MGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET----DEFLAWAVPYCP 106 (412)
Q Consensus 31 fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~lv~e~~~ 106 (412)
-.+.|+|.....|.. |++|.+.......... ...-+++++++.|.|||.+.++|.+ +..+++|++|.+
T Consensus 289 ~~Ttyk~~s~~DG~~----YvLkRlhg~r~~~~nk----~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP 360 (655)
T KOG3741|consen 289 SITTYKATSNVDGNA----YVLKRLHGDRDQSTNK----DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYP 360 (655)
T ss_pred cceeEeeeeccCCce----eeeeeeccccccCccc----chHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCC
Confidence 356788777665554 9999994333222111 1225678999999999999999974 357999999998
Q ss_pred C-CCchhHHHh-------------hCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 107 G-GDLNVLRYK-------------QNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 107 g-g~L~~~~~~-------------~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
+ ++|.++-.. ..+...+|..++.|+.|+..||.++|+.|+.-+-|.|.+||++.+-.++|..-|+.
T Consensus 361 ~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~ 440 (655)
T KOG3741|consen 361 SSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIM 440 (655)
T ss_pred CCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccce
Confidence 6 455443221 12335789999999999999999999999999999999999998888888877765
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
-.+.... +
T Consensus 441 Dvl~~d~----------------------------------------------------------------------~-- 448 (655)
T KOG3741|consen 441 DVLQEDP----------------------------------------------------------------------T-- 448 (655)
T ss_pred eeecCCC----------------------------------------------------------------------C--
Confidence 3321100 0
Q ss_pred CCccceeecCCCCCchhhHHHHHHHHHHHhhCCCC-CCCCCHHHH-HHHHhcCCCCCCCCChHHHHHHHHhhhhCCCccC
Q 042539 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTP-FRGKNRKET-FRNVLMKTPEFVGQRTALTDLIQRLLEKDPVKRL 330 (412)
Q Consensus 253 ~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~P-f~~~~~~~~-~~~i~~~~~~~~~~~~~~~dli~~~L~~dP~~R~ 330 (412)
|-+. .-++-|.=.||.+++.|.||..= +......+. .+.| ....+.+++++|.-+..-++.++
T Consensus 449 -----~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I------~~~yS~D~rn~v~yl~s~~~~~k- 513 (655)
T KOG3741|consen 449 -----EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI------TTTYSTDLRNVVEYLESLNFREK- 513 (655)
T ss_pred -----cchh---HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh------hhhhhHHHHHHHHHHHhcCcccc-
Confidence 1111 12467888999999999999642 222222222 2222 23456789999999988888853
Q ss_pred CCCCChhhhhcC
Q 042539 331 GYLRGACEIKEH 342 (412)
Q Consensus 331 ~~~~~~~e~l~h 342 (412)
++.+++.+
T Consensus 514 ----sI~~llp~ 521 (655)
T KOG3741|consen 514 ----SIQDLLPM 521 (655)
T ss_pred ----cHHHHHHH
Confidence 46777655
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.04 E-value=4.9e-09 Score=98.82 Aligned_cols=106 Identities=15% Similarity=0.091 Sum_probs=81.4
Q ss_pred HHHHHHHHHhhcCC--CccceeeeeEEe-----CCeEEEEeeccCCC-CchhHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q 042539 69 RARWEIRVLSRLSH--PFLPKLLGSLET-----DEFLAWAVPYCPGG-DLNVLRYKQNDRVFSPSVIRFYLSEIICAIEH 140 (412)
Q Consensus 69 ~~~~Ei~il~~l~h--pnIv~l~~~~~~-----~~~~~lv~e~~~gg-~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~y 140 (412)
.+.+|.+.+..|.. -.++.++.+++. ...-+||||++.|. +|.+++........++.....++.++...+.-
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~ 153 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD 153 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 36678888888853 334455555543 23578999999886 78777643222335677888999999999999
Q ss_pred HHHcCceeeeCCCCceEEcc-------CCCEEEccccccch
Q 042539 141 LHNMGIAYRDLKPENILIRQ-------SGHVTLTDFDLSRN 174 (412)
Q Consensus 141 LH~~~iiHrDlKp~NiLl~~-------~g~vkL~DFGla~~ 174 (412)
||++||+|+|+++.|||++. ++.+.|+||+.++.
T Consensus 154 LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 154 MHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 99999999999999999985 46799999998853
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.87 E-value=3e-08 Score=90.09 Aligned_cols=107 Identities=31% Similarity=0.332 Sum_probs=85.4
Q ss_pred HHHHHHHHHHHhhcC--CCccceeeeeEEeCC----eEEEEeeccCCC-CchhHHHhhCCCCCCHHHHHHHHHHHHHHHH
Q 042539 67 ERRARWEIRVLSRLS--HPFLPKLLGSLETDE----FLAWAVPYCPGG-DLNVLRYKQNDRVFSPSVIRFYLSEIICAIE 139 (412)
Q Consensus 67 ~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~----~~~lv~e~~~gg-~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~ 139 (412)
..+..+|...+..|. .-.++..+.+.+... ..+||+|+++|. +|..++..... .+......++.++...+.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 446777888888885 334566666665432 468999999884 78777665333 667788899999999999
Q ss_pred HHHHcCceeeeCCCCceEEccCC---CEEEccccccchh
Q 042539 140 HLHNMGIAYRDLKPENILIRQSG---HVTLTDFDLSRNL 175 (412)
Q Consensus 140 yLH~~~iiHrDlKp~NiLl~~~g---~vkL~DFGla~~~ 175 (412)
-||++||+|+|+++.|||++.++ .+.|+||+.++..
T Consensus 133 ~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999999999999999987 8999999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.4e-07 Score=85.19 Aligned_cols=142 Identities=18% Similarity=0.176 Sum_probs=92.4
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHH-----HHHHHHHHhhcC---CCccce
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERR-----ARWEIRVLSRLS---HPFLPK 87 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~-----~~~Ei~il~~l~---hpnIv~ 87 (412)
.-.+|++++++-......|.+..-.. ..+.+|+.+............. ..+++..+..+. .-.+..
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~~------~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~ 102 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEIDG------KKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPAD 102 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEECC------cEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccc
Confidence 34678888999888888888776533 2389998765432211111111 233444444443 233334
Q ss_pred eeeeEEe-----CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCC
Q 042539 88 LLGSLET-----DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG 162 (412)
Q Consensus 88 l~~~~~~-----~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g 162 (412)
++.+.+. ....+++|||++|..|.++.. +++. +...+..++.-||+.|+.|+|..|.|++++.+
T Consensus 103 ~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~- 171 (229)
T PF06176_consen 103 PYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN- 171 (229)
T ss_pred ceeeeeeeeccceeEEEEEEEEecCeecccchh------cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-
Confidence 3333322 235678999999998865532 3332 34567778999999999999999999999855
Q ss_pred CEEEccccccch
Q 042539 163 HVTLTDFDLSRN 174 (412)
Q Consensus 163 ~vkL~DFGla~~ 174 (412)
.++++||+..+.
T Consensus 172 ~i~iID~~~k~~ 183 (229)
T PF06176_consen 172 GIRIIDTQGKRM 183 (229)
T ss_pred cEEEEECccccc
Confidence 599999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.6e-09 Score=109.40 Aligned_cols=241 Identities=18% Similarity=0.210 Sum_probs=162.8
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCc-cceeeeeEEeCCe
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPF-LPKLLGSLETDEF 97 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~ 97 (412)
-+...+-+++|+++++++.|..++.. ...+++... ...+ -++++|.+++||| .+..++-++.+..
T Consensus 243 ws~~fh~fvK~altknpKkRptaekl-----L~h~fvs~~-------l~~r--l~~eLLdK~n~P~~~v~~~~d~~~E~~ 308 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKL-----LQHPFVSQT-------LSRR--LAIELLDKVNNPNPVVRYLEDYDGEDY 308 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhh-----eeceeeccc-------hhhH--HHHHHHHHccCCCCcccccccCCcccc
Confidence 45677888999999999876654322 235655322 1222 2889999999999 7777777777889
Q ss_pred EEEEeeccCCC-CchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 98 LAWAVPYCPGG-DLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 98 ~~lv~e~~~gg-~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
.+++|++|.++ +-... .....-.+.+-+...+.+.-..+++++|+.-=+||| ||+..+ +..|..||+....+.
T Consensus 309 ~~i~~~i~s~~rs~~~~-~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~ 382 (829)
T KOG0576|consen 309 LWIPMRICSTGRSSALE-MTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLT 382 (829)
T ss_pred cchhhhhhcCCcccccc-CChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccC
Confidence 99999999887 21111 111111255555666777888899999998778998 777644 788999998775431
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
..-..+++.+|+.++|
T Consensus 383 ----------------------------------------------------------------~~~~~~t~~~~~~~~~ 398 (829)
T KOG0576|consen 383 ----------------------------------------------------------------RTMKPRTAIGTPEPLA 398 (829)
T ss_pred ----------------------------------------------------------------cccccccCCCCCCCCC
Confidence 1113457789999999
Q ss_pred ceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--CCCCC---CC-hHHHHHHHHhhhhCCCccC
Q 042539 257 PEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT--PEFVG---QR-TALTDLIQRLLEKDPVKRL 330 (412)
Q Consensus 257 PE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~~~---~~-~~~~dli~~~L~~dP~~R~ 330 (412)
||+.....+....|.||+|+-..+|.-|-+|-...- .....+-.+. +.+.. .+ ..-+++...|+..-|..|.
T Consensus 399 pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pk 476 (829)
T KOG0576|consen 399 PEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPP--AVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPK 476 (829)
T ss_pred chhhcccccccCCCccCCCcchhhcCCCCCCCCCCc--cccCCCCCCCCccccchhhhcCcccccCCcccccCCCCCCCc
Confidence 999999999999999999998778887877754410 0000000000 00000 00 1112577788888888887
Q ss_pred CCCCChhhhhcCCCCCCCC
Q 042539 331 GYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 331 ~~~~~~~e~l~h~ff~~~~ 349 (412)
+...++-|.+|+++.
T Consensus 477 ----v~mgacfsKvfngCp 491 (829)
T KOG0576|consen 477 ----VHMGACFSKVFNGCP 491 (829)
T ss_pred ----chhhHHHHHHhccCc
Confidence 678888899998865
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.7e-07 Score=90.90 Aligned_cols=233 Identities=18% Similarity=0.261 Sum_probs=148.3
Q ss_pred eeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeeeeE------E
Q 042539 21 KALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLGSL------E 93 (412)
Q Consensus 21 ~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~------~ 93 (412)
-..+.||+|+-+.+|-.-... + .+-|+..+.......+ .+..|... .||-+-.=+.+= -
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~-----d--~VAKIYh~Pppa~~aq-------k~a~la~~p~~p~~~~rvaWPqa~L~G~ 79 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVR-----D--QVAKIYHAPPPAAQAQ-------KVAELAATPDAPLLNYRVAWPQATLHGG 79 (637)
T ss_pred CCCccccCCccceeeecchhh-----c--hhheeecCCCchHHHH-------HHHHhccCCCCcchhhhhcccHHHhhCC
Confidence 356789999999999543221 1 2457776544322111 22334444 466443312211 1
Q ss_pred e-CCeEEEEeeccCCCCchhHHHh-----hCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEc
Q 042539 94 T-DEFLAWAVPYCPGGDLNVLRYK-----QNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLT 167 (412)
Q Consensus 94 ~-~~~~~lv~e~~~gg~L~~~~~~-----~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~ 167 (412)
+ +..+-++|..+.|..=-..++. +....+..+-+....+.++.+..-||.+|.+-+|+.++|||+++.+.|.|.
T Consensus 80 ~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LV 159 (637)
T COG4248 80 RRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLV 159 (637)
T ss_pred CccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEE
Confidence 2 2337889999887532112221 112235667888899999999999999999999999999999999999998
Q ss_pred cccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcc
Q 042539 168 DFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNS 247 (412)
Q Consensus 168 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (412)
|=..-. + ..++.....
T Consensus 160 dsDsfq-i---------------------------------------------------------------~~ng~~~~c 175 (637)
T COG4248 160 DSDSFQ-I---------------------------------------------------------------NANGTLHLC 175 (637)
T ss_pred ccccee-e---------------------------------------------------------------ccCCceEec
Confidence 732110 0 023344456
Q ss_pred cccCCCCccceeec-----CCCCCchhhHHHHHHHHHHHhhC-CCCCCCCC-------HHH-HHHHHhc-----------
Q 042539 248 FVGTEEYVSPEVVR-----GDGHEFAVDWWALGILTYEMLYG-TTPFRGKN-------RKE-TFRNVLM----------- 302 (412)
Q Consensus 248 ~~gt~~Y~APE~l~-----~~~~~~~~DiwSlGvil~ell~g-~~Pf~~~~-------~~~-~~~~i~~----------- 302 (412)
-+|.+.|.+||.-. +-.-+...|.|-|||++|+++.| +.||.|.. ..+ .+.....
T Consensus 176 pVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~ 255 (637)
T COG4248 176 PVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLK 255 (637)
T ss_pred ccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCC
Confidence 68999999999754 33446789999999999999876 99998742 112 1111110
Q ss_pred ---CCCCCCCCChHHHHHHHHhhhh--CCCccCC
Q 042539 303 ---KTPEFVGQRTALTDLIQRLLEK--DPVKRLG 331 (412)
Q Consensus 303 ---~~~~~~~~~~~~~dli~~~L~~--dP~~R~~ 331 (412)
..+++...++++..|..+|+.. ++.-||+
T Consensus 256 p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~ 289 (637)
T COG4248 256 PPPRSIPLSMLPPDVQALFQQAFTESGVATPRPT 289 (637)
T ss_pred CCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCC
Confidence 0122334568888999999864 3567885
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=2e-07 Score=86.05 Aligned_cols=137 Identities=22% Similarity=0.230 Sum_probs=98.1
Q ss_pred eeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhh------h------------HHHHHHHHHHHHHHhhcCC
Q 042539 21 KALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHA------K------------HEAERRARWEIRVLSRLSH 82 (412)
Q Consensus 21 ~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~------~------------~~~~~~~~~Ei~il~~l~h 82 (412)
.+...||-|--+.||.|.+.. +..+|||.=+.....- + ......+.+|.++|..|..
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~-----g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~ 168 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPK-----GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYP 168 (304)
T ss_pred hhccccccCccceEEEEECCC-----CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhh
Confidence 356789999999999998752 3348998533211100 0 1123457789999999974
Q ss_pred C--ccceeeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEcc
Q 042539 83 P--FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQ 160 (412)
Q Consensus 83 p--nIv~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~ 160 (412)
. .|.+-++ .+...+|||+++|-.|.... ++...+..++..|+.-+.-+-..||||+|+.+=||+++.
T Consensus 169 ~G~~VP~P~~----~nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 169 EGVKVPKPIA----WNRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTE 237 (304)
T ss_pred cCCCCCCccc----cccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEec
Confidence 3 5666655 35568999999998775432 234455556666776666666899999999999999999
Q ss_pred CCCEEEccccccc
Q 042539 161 SGHVTLTDFDLSR 173 (412)
Q Consensus 161 ~g~vkL~DFGla~ 173 (412)
+|.+.++||--+.
T Consensus 238 dg~~~vIDwPQ~v 250 (304)
T COG0478 238 DGDIVVIDWPQAV 250 (304)
T ss_pred CCCEEEEeCcccc
Confidence 9999999997553
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.60 E-value=6.2e-07 Score=80.76 Aligned_cols=142 Identities=14% Similarity=0.132 Sum_probs=99.8
Q ss_pred eccCceEEEEEEEcCCCCCCCCceEEeeecchh---hhhhHHHHHHHHHHHHHHhhcCC--CccceeeeeEEeC----Ce
Q 042539 27 GKGAMGTVFLVHDRAADPTARCPFALKVVDKST---LHAKHEAERRARWEIRVLSRLSH--PFLPKLLGSLETD----EF 97 (412)
Q Consensus 27 G~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~----~~ 97 (412)
|+||-+-|+.....+. .|-+|.-.... +.. .--...+.+|...+..|.. -.+.+....-... -.
T Consensus 27 ~rgG~SgV~r~~~~g~------~~ylKrq~nhl~~s~r~-P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~r 99 (216)
T PRK09902 27 RRNGMSGVQCVERNGK------KLYVKRMTHHLFHSVRY-PFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWR 99 (216)
T ss_pred CCCCcceEEEEEeCCc------EEEEEeccCcccccccC-CCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceE
Confidence 5588888987654332 26777653111 110 1234567789999999963 3355555222221 24
Q ss_pred EEEEeeccCC-CCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCC--EEEccccccch
Q 042539 98 LAWAVPYCPG-GDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGH--VTLTDFDLSRN 174 (412)
Q Consensus 98 ~~lv~e~~~g-g~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~--vkL~DFGla~~ 174 (412)
-+||+|-+.| -+|..++....-...++.....++.++...|.-||+.|+.|+|+-+.|||++..|. ++++||.-++.
T Consensus 100 A~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 100 ALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 7899997754 57766654433334677888899999999999999999999999999999987777 99999998876
Q ss_pred h
Q 042539 175 L 175 (412)
Q Consensus 175 ~ 175 (412)
.
T Consensus 180 ~ 180 (216)
T PRK09902 180 R 180 (216)
T ss_pred h
Confidence 5
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.56 E-value=9.7e-07 Score=95.11 Aligned_cols=243 Identities=21% Similarity=0.235 Sum_probs=159.0
Q ss_pred eeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC----eEEEE
Q 042539 26 LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE----FLAWA 101 (412)
Q Consensus 26 LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~~~lv 101 (412)
|..-.+|+|+++++...-...-.++-++.=.-+.. ...........|+..+..+.|+|++.++.+..... .+.+.
T Consensus 186 ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~~-~~k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~ 264 (1351)
T KOG1035|consen 186 LSHLTQGTLLLVKWVEQAQSLSEPIEISHDYESTP-CGKKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVL 264 (1351)
T ss_pred eccccCceEEEEehhhhHHhhcCcccccCcccCcc-chHHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHH
Confidence 66778888888876532221111122221111111 11123344455888888899999999998875443 23445
Q ss_pred eeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCC---ceEEccCCCEEEc--cccccchhh
Q 042539 102 VPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPE---NILIRQSGHVTLT--DFDLSRNLV 176 (412)
Q Consensus 102 ~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~---NiLl~~~g~vkL~--DFGla~~~~ 176 (412)
.++|.+-++...++... ..+...++.+..+++.||.|+|+....|.-+... +--.+..+.+.+. ||+.++...
T Consensus 265 ~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~ 342 (1351)
T KOG1035|consen 265 QEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLP 342 (1351)
T ss_pred HhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCC
Confidence 58899988877776554 4889999999999999999999997666655555 4444555666666 777766542
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
+. ....+...+.-+.+
T Consensus 343 d~----------------------------------------------------------------~~~~~~~~~~~~~~ 358 (1351)
T KOG1035|consen 343 DN----------------------------------------------------------------EKSFSDLLAEIRNA 358 (1351)
T ss_pred Cc----------------------------------------------------------------ccchhhcCcccccc
Confidence 21 11223344556888
Q ss_pred ceeecCCCCCc--hhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCChHHHHHHHHhhhhCCCccCCCCC
Q 042539 257 PEVVRGDGHEF--AVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLR 334 (412)
Q Consensus 257 PE~l~~~~~~~--~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~dli~~~L~~dP~~R~~~~~ 334 (412)
+|........+ ..|+|.+|..+..+..|..+-... .+...++.. .......+++.+|+.-+.++|+
T Consensus 359 ~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~---~~~~~~l~~-----~~~~~~~d~~~~~~~~~~~~Rl---- 426 (1351)
T KOG1035|consen 359 DEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKS---AVPVSLLDV-----LSTSELLDALPKCLDEDSEERL---- 426 (1351)
T ss_pred ccccccccchhhhhhHHHHHHHHHhhhhhcCcccccc---cchhhhhcc-----ccchhhhhhhhhhcchhhhhcc----
Confidence 88888776644 479999999999998876543221 111112111 1112577899999999999999
Q ss_pred ChhhhhcCCCCCC
Q 042539 335 GACEIKEHVFFKG 347 (412)
Q Consensus 335 ~~~e~l~h~ff~~ 347 (412)
.+.+++.|+|.+.
T Consensus 427 ~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 427 SALELLTHPFLRF 439 (1351)
T ss_pred chhhhhhchhccc
Confidence 5899999999874
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=1e-06 Score=90.10 Aligned_cols=146 Identities=19% Similarity=0.222 Sum_probs=94.2
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHH------------------------------HHH-----
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHE------------------------------AER----- 68 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~------------------------------~~~----- 68 (412)
..|+.++-|.||.|+.+. ++.|||||.+..-...-.. ..+
T Consensus 131 ~PiAsASIaQVH~A~L~s-----G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~E 205 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-----GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREE 205 (517)
T ss_pred CchhhhhHhhheeEEecC-----CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHH
Confidence 578899999999999874 4559999987542211110 011
Q ss_pred -HHHHHHHHHhhcC-----CCc--cceeeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q 042539 69 -RARWEIRVLSRLS-----HPF--LPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEH 140 (412)
Q Consensus 69 -~~~~Ei~il~~l~-----hpn--Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~y 140 (412)
.+.+|+.-+.++. .++ |.++| ++-...-.|+|||+.|-.+.+...... ..++...+...+.++. +..
T Consensus 206 lDy~~EA~n~~~~~~nf~~~~~v~VP~V~--we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q 280 (517)
T COG0661 206 LDYRREAANAERFRENFKDDPDVYVPKVY--WEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQ 280 (517)
T ss_pred hCHHHHHHHHHHHHHHcCCCCCeEeceee--hhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHH
Confidence 1333555455443 122 22222 222334579999999998887754444 3466444444333333 234
Q ss_pred HHHcCceeeeCCCCceEEccCCCEEEccccccchhhchh
Q 042539 141 LHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKT 179 (412)
Q Consensus 141 LH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~ 179 (412)
+-..|+.|.|..|.||+++.+|.+.+.|||+...+....
T Consensus 281 ~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~~ 319 (517)
T COG0661 281 LLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPKF 319 (517)
T ss_pred HHhcCccccCCCccceEEecCCcEEEEcCcceecCCHHH
Confidence 445899999999999999999999999999998875543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.8e-06 Score=79.56 Aligned_cols=135 Identities=12% Similarity=0.078 Sum_probs=82.6
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCC--ccceeeeeEEeCCeEEEE
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP--FLPKLLGSLETDEFLAWA 101 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~~~~~~~~lv 101 (412)
..||+|..+.||+.. +. .+++|....... ...+.+|.++++.+..- -+.+.+++..+.+...+|
T Consensus 7 ~~i~~G~t~~~y~~~----~~----~~VlR~~~~~~~------~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv 72 (226)
T TIGR02172 7 TQTGEGGNGESYTHK----TG----KWMLKLYNPGFD------KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLI 72 (226)
T ss_pred eeecCCCCcceeEec----CC----CEEEEeCCCCCC------HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeee
Confidence 678999999999731 21 278888754221 12346699999998633 357788888888888999
Q ss_pred eeccCCCC-chhH---------------------HHhh--CCCCCCHHHHHHHHHH----------HHH-HHHHHHH---
Q 042539 102 VPYCPGGD-LNVL---------------------RYKQ--NDRVFSPSVIRFYLSE----------IIC-AIEHLHN--- 143 (412)
Q Consensus 102 ~e~~~gg~-L~~~---------------------~~~~--~~~~l~~~~~~~~~~q----------i~~-aL~yLH~--- 143 (412)
||++.|.+ +... ++.. ....+.... ..+..+ +.. ...+|.+
T Consensus 73 ~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~-~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~ 151 (226)
T TIGR02172 73 YELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYK-EKIRKFIEEKDFVPKDYKEKARAFIKEVPD 151 (226)
T ss_pred eeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHH-HHHHHHHHhccCCCHHHHHHHHHHHHhCCC
Confidence 99999964 1100 0000 000111100 111000 111 1122221
Q ss_pred -cCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 144 -MGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 144 -~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
..++|+|+.|.||+++.+| +.|+||+.+..
T Consensus 152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 2478999999999999888 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.43 E-value=3.2e-06 Score=77.39 Aligned_cols=142 Identities=18% Similarity=0.161 Sum_probs=96.8
Q ss_pred eeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhH--------------------HHHHHHHHHHHHHhhcC-
Q 042539 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKH--------------------EAERRARWEIRVLSRLS- 81 (412)
Q Consensus 23 ~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~--------------------~~~~~~~~Ei~il~~l~- 81 (412)
...|..|--+.||+|... .+..||+|+.+......+. ....=..+|..-|+++.
T Consensus 53 ~g~istGKEA~Vy~a~~~-----~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~e 127 (268)
T COG1718 53 VGCISTGKEANVYLAETG-----DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYE 127 (268)
T ss_pred EeeecCCcceEEEeeccC-----CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHH
Confidence 347788888999998652 2344999999765442221 11112445777777774
Q ss_pred -CCccceeeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeeCCCCceEEc
Q 042539 82 -HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN-MGIAYRDLKPENILIR 159 (412)
Q Consensus 82 -hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDlKp~NiLl~ 159 (412)
+-.+.+-+.+... .|||||+... .. ---.-....++..++..+..+++..+.-|-. .|+||+||..=|||+.
T Consensus 128 AGVrvP~Pi~~~~n----VLvMEfIg~~-g~-pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~ 201 (268)
T COG1718 128 AGVRVPEPIAFRNN----VLVMEFIGDD-GL-PAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH 201 (268)
T ss_pred cCCCCCCceeecCC----eEEEEeccCC-CC-CCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE
Confidence 4455555555443 6999999443 11 0001112224555788899999999998876 8999999999999998
Q ss_pred cCCCEEEccccccchhh
Q 042539 160 QSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 160 ~~g~vkL~DFGla~~~~ 176 (412)
+|.+.|+|||-|....
T Consensus 202 -~~~p~iID~~QaV~~~ 217 (268)
T COG1718 202 -DGEPYIIDVSQAVTID 217 (268)
T ss_pred -CCeEEEEECccccccC
Confidence 8899999999887653
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.38 E-value=6.5e-06 Score=73.64 Aligned_cols=130 Identities=27% Similarity=0.356 Sum_probs=89.2
Q ss_pred ccCceeeeeeeccCc-eEEEEEEEcCCCCCCCCceEEeeecc---hh-------hhhhH-------HHHHHHHHHHHHHh
Q 042539 17 LDNLKALKILGKGAM-GTVFLVHDRAADPTARCPFALKVVDK---ST-------LHAKH-------EAERRARWEIRVLS 78 (412)
Q Consensus 17 ~~~y~~~~~LG~G~f-g~V~la~~~~~~~~~~~~vAiK~i~~---~~-------~~~~~-------~~~~~~~~Ei~il~ 78 (412)
-.+++.++.||.|+- |.||+++..+. .||+|+.+. .. ..... ....-+..|-+...
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I~g~------~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfg 109 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEIDGR------IYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFG 109 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEECCe------EEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhH
Confidence 379999999999999 99999987542 499999322 10 00000 11223555777777
Q ss_pred hcC---CCcc--ceeeeeEEeC------------------CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHH
Q 042539 79 RLS---HPFL--PKLLGSLETD------------------EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEII 135 (412)
Q Consensus 79 ~l~---hpnI--v~l~~~~~~~------------------~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~ 135 (412)
+|+ +.++ |++++++.-. ....||-||+.... .+.... +.+|+
T Consensus 110 RLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~~----~~~~~ 174 (207)
T PF13095_consen 110 RLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIRD----IPQML 174 (207)
T ss_pred HHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchhH----HHHHH
Confidence 775 4455 9999987311 12467778775543 133333 46788
Q ss_pred HHHHHHHHcCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 136 CAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 136 ~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
.-+..+|+.||+-+|+|+.|.. .=||+|||.+
T Consensus 175 ~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 175 RDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 8889999999999999999987 2478999864
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.34 E-value=7.5e-06 Score=74.85 Aligned_cols=141 Identities=25% Similarity=0.332 Sum_probs=82.2
Q ss_pred eeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-C-CccceeeeeEEe---CCe
Q 042539 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-H-PFLPKLLGSLET---DEF 97 (412)
Q Consensus 23 ~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-h-pnIv~l~~~~~~---~~~ 97 (412)
++.|+.|..+.||++.... + .+++|+.... .....+.+|..+++.+. + .-+.+++..... ...
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~-----~~vlK~~~~~------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~ 69 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-G-----RYVLKFYRPP------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGF 69 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-S-----EEEEEEESSH------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSE
T ss_pred CccCCCCCeeeEEEEEECC-c-----EEEEEEeCCC------CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccccccc
Confidence 5789999999999988754 2 3899997543 23344556888888886 2 235677764432 345
Q ss_pred EEEEeeccCCCCchh----------------HH---Hhh--CCCCCCHHH------HHHH---------------HHHHH
Q 042539 98 LAWAVPYCPGGDLNV----------------LR---YKQ--NDRVFSPSV------IRFY---------------LSEII 135 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~----------------~~---~~~--~~~~l~~~~------~~~~---------------~~qi~ 135 (412)
.+++|+++.|..+.. .+ +.. ....+.... .... ...+.
T Consensus 70 ~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (239)
T PF01636_consen 70 PYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELE 149 (239)
T ss_dssp EEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHH
T ss_pred ceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHH
Confidence 799999999987766 00 011 000010000 0000 11122
Q ss_pred H-HHHHHHH-------cCceeeeCCCCceEEc-cCCCEEEccccccchh
Q 042539 136 C-AIEHLHN-------MGIAYRDLKPENILIR-QSGHVTLTDFDLSRNL 175 (412)
Q Consensus 136 ~-aL~yLH~-------~~iiHrDlKp~NiLl~-~~g~vkL~DFGla~~~ 175 (412)
. .++.+++ ..++|+|+.|.|||++ .+|.+-|+||+.+...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 150 ERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred HHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 2 3334432 3599999999999999 6677789999988654
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.24 E-value=9.4e-06 Score=75.49 Aligned_cols=137 Identities=16% Similarity=0.137 Sum_probs=81.9
Q ss_pred eeeccCc-eEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEEeCCeEEEEe
Q 042539 25 ILGKGAM-GTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLETDEFLAWAV 102 (412)
Q Consensus 25 ~LG~G~f-g~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~ 102 (412)
.|-.|.+ ..||++.... . .+.+|...... .....+|+++++.+. +--+.+++++...++..++||
T Consensus 5 ~~~~g~~~~~v~~~~~~~--~----~~~vk~~~~~~-------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 71 (244)
T cd05150 5 RVTEGQSGATVYRLDGKN--P----GLYLKIAPSGP-------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLT 71 (244)
T ss_pred ecCCCCCcCeEEEEcCCC--C----cEEEEecCCCc-------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEE
Confidence 3444555 8899875432 1 27888764332 123445888888885 444678888887777789999
Q ss_pred eccCCCCchhHHH-------------------hhC--CCCCCHH------HHHHHHH----------------HHHHHHH
Q 042539 103 PYCPGGDLNVLRY-------------------KQN--DRVFSPS------VIRFYLS----------------EIICAIE 139 (412)
Q Consensus 103 e~~~gg~L~~~~~-------------------~~~--~~~l~~~------~~~~~~~----------------qi~~aL~ 139 (412)
++++|..+..... ... ...+... .....+. .+...+.
T Consensus 72 e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (244)
T cd05150 72 SAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYA 151 (244)
T ss_pred EeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHH
Confidence 9999987753321 000 0011100 0000000 0111112
Q ss_pred HH-------HHcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 140 HL-------HNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 140 yL-------H~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
.| ....++|+|+.|.|||++.++.+.|+||+.|..
T Consensus 152 ~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 152 ELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred HHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 22 123489999999999999977789999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.5e-05 Score=81.49 Aligned_cols=146 Identities=22% Similarity=0.217 Sum_probs=93.4
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhh---------------------------HHHHHH------H
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAK---------------------------HEAERR------A 70 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~---------------------------~~~~~~------~ 70 (412)
+.||..+.|.|+.|+-+. ++.|||||-+...-..- .+..+. +
T Consensus 167 ~piaaASlaQVhrA~L~~-----G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF 241 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-----GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDF 241 (538)
T ss_pred chhhhcchhheEEEEecC-----CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcch
Confidence 679999999999999875 34499998764321110 011112 2
Q ss_pred HHHHHHHhhc----CCCc------cceeeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q 042539 71 RWEIRVLSRL----SHPF------LPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEH 140 (412)
Q Consensus 71 ~~Ei~il~~l----~hpn------Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~y 140 (412)
.+|++-..++ .|-+ |.++|..+. ..-.|+||||+|..++++...... .++...+...+.++.. +-
T Consensus 242 ~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~~--~q 316 (538)
T KOG1235|consen 242 TKEAKNAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAYL--EQ 316 (538)
T ss_pred HHHHHhHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHHH--HH
Confidence 2233333322 2333 333333332 245799999999988887666554 3666655444444332 33
Q ss_pred HHHcCceeeeCCCCceEEcc----CCCEEEccccccchhhchh
Q 042539 141 LHNMGIAYRDLKPENILIRQ----SGHVTLTDFDLSRNLVKKT 179 (412)
Q Consensus 141 LH~~~iiHrDlKp~NiLl~~----~g~vkL~DFGla~~~~~~~ 179 (412)
+-..|++|+|=.|.||+++. ++.+.+-|||+...+....
T Consensus 317 If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~~ 359 (538)
T KOG1235|consen 317 IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHKT 359 (538)
T ss_pred HHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHHH
Confidence 44578999999999999994 5679999999998886544
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.16 E-value=3.9e-05 Score=69.00 Aligned_cols=133 Identities=22% Similarity=0.290 Sum_probs=89.6
Q ss_pred eeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhh------------hHHHHHHHHHHHHHHhhcC------CCc
Q 042539 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHA------------KHEAERRARWEIRVLSRLS------HPF 84 (412)
Q Consensus 23 ~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~------------~~~~~~~~~~Ei~il~~l~------hpn 84 (412)
...||+|+.-.||..- .+.. ..|||+....... .....+...+|+.....+. +.+
T Consensus 6 ~~~i~~G~~R~cy~HP---~dp~----~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~ 78 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHP---DDPN----LCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSH 78 (199)
T ss_pred CcccccCCCceEEECC---CCCC----eEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccc
Confidence 4679999999999732 2222 6899997765000 0112334445665555555 789
Q ss_pred cceeeeeEEeCCeEEEEeeccCC------CCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEE
Q 042539 85 LPKLLGSLETDEFLAWAVPYCPG------GDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILI 158 (412)
Q Consensus 85 Iv~l~~~~~~~~~~~lv~e~~~g------g~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl 158 (412)
|.++|++.+++.-+-+|+|.+.. -+|..++.. +.+++ .+... +-.-.+||-+++|+.+||+|.||++
T Consensus 79 i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~~~~~---L~~f~~~l~~~~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 79 IPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE-ELRQA---LDEFKRYLLDHHIVIRDLNPHNIVV 151 (199)
T ss_pred cccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH-HHHHH---HHHHHHHHHHcCCeecCCCcccEEE
Confidence 99999999999999999998753 245555532 23665 33333 3344568889999999999999999
Q ss_pred ccCC----CEEEccc
Q 042539 159 RQSG----HVTLTDF 169 (412)
Q Consensus 159 ~~~g----~vkL~DF 169 (412)
...+ .+.|+|-
T Consensus 152 ~~~~~~~~~lvlIDG 166 (199)
T PF10707_consen 152 QRRDSGEFRLVLIDG 166 (199)
T ss_pred EecCCCceEEEEEeC
Confidence 7553 4777763
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.4e-05 Score=69.40 Aligned_cols=130 Identities=25% Similarity=0.278 Sum_probs=89.8
Q ss_pred ceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCcc-ceeeeeEEeCCeE
Q 042539 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFL-PKLLGSLETDEFL 98 (412)
Q Consensus 20 y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~ 98 (412)
.+..+.||+|++|.||++.+... .+|+|+=..+. -...+..|+++|..+.-.++ .++|.+..+
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~~------~~a~Kvrr~ds------~r~~l~kEakiLeil~g~~~~p~vy~yg~~---- 87 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRGG------EVALKVRRRDS------PRRNLEKEAKILEILAGEGVTPEVYFYGED---- 87 (201)
T ss_pred hhhhhhhhcccccEEEEeeccCc------eEEEEEecCCc------chhhHHHHHHHHHHhhhcCCCceEEEechh----
Confidence 35668899999999999988653 38999864432 23455669999999986554 456655544
Q ss_pred EEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCC-CCceEEccCCCEEEccccccch
Q 042539 99 AWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLK-PENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlK-p~NiLl~~~g~vkL~DFGla~~ 174 (412)
++.|||+.|-.|...... .+.++ +..++.+---|-..||-|+.|. |..+++...+.+.|+||-.|+.
T Consensus 88 ~i~me~i~G~~L~~~~~~-----~~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 88 FIRMEYIDGRPLGKLEIG-----GDRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhhcCcchhhhhhc-----ccHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 355999999888544321 12223 3345555444556799999885 6666666677999999998874
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.09 E-value=3.2e-05 Score=84.53 Aligned_cols=150 Identities=16% Similarity=0.236 Sum_probs=91.0
Q ss_pred eeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCcc--ceeeeeEEeC---
Q 042539 22 ALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFL--PKLLGSLETD--- 95 (412)
Q Consensus 22 ~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnI--v~l~~~~~~~--- 95 (412)
-++.|+.|.++.+|++.....+ ....+++|+........ ....+.+|+++|+.+. |.+| .+++.++.+.
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~--~~~~~VLR~~p~~~~~~---~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~ 116 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGG--SVKRYVLRKKPPGKLLQ---SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVI 116 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCC--cceeEEEEeCCCCccCc---cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcC
Confidence 4678899999999998764322 11236777654332111 1234567999999996 6664 7777777654
Q ss_pred CeEEEEeeccCCCCchhH-----------------------HHhhCCC--C---------CCHHHHHHHHHH--------
Q 042539 96 EFLAWAVPYCPGGDLNVL-----------------------RYKQNDR--V---------FSPSVIRFYLSE-------- 133 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~-----------------------~~~~~~~--~---------l~~~~~~~~~~q-------- 133 (412)
+..|+||||+.|..+.+. ++..... . +-..++..|..+
T Consensus 117 G~~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~ 196 (822)
T PLN02876 117 GTAFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEG 196 (822)
T ss_pred CCceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhccc
Confidence 467899999998653210 1100000 0 111233322222
Q ss_pred -------HHHHHHHHHH-----------cCceeeeCCCCceEEccC-CC-EEEccccccchhh
Q 042539 134 -------IICAIEHLHN-----------MGIAYRDLKPENILIRQS-GH-VTLTDFDLSRNLV 176 (412)
Q Consensus 134 -------i~~aL~yLH~-----------~~iiHrDlKp~NiLl~~~-g~-vkL~DFGla~~~~ 176 (412)
+...+.+|.. ..+||+|+++.|+|++.. +. +-|.||+++..-+
T Consensus 197 ~~~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 197 KPPRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred CCCCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 2233556633 249999999999999853 34 5799999987653
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.94 E-value=1.6e-06 Score=95.41 Aligned_cols=205 Identities=10% Similarity=-0.065 Sum_probs=138.6
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhh-hHHHHHHHHHHHHHHhhcCCCccceeeeeEEe-
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHA-KHEAERRARWEIRVLSRLSHPFLPKLLGSLET- 94 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~- 94 (412)
++.+++.=-+|.|.+++--..+.+. . -+-+|+.+...+.. .+...+....|..-++...|++++..+.-...
T Consensus 1228 ~e~~EV~l~i~~~~~~R~k~Lr~ki-----d-~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps 1301 (2724)
T KOG1826|consen 1228 MEHSEVNLGISNHFHFRNKWLRSKI-----D-WFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPS 1301 (2724)
T ss_pred hhhhheeeecccceeeccchHhhhh-----c-eeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCC
Confidence 3455555556666555432111111 1 15667664443321 22234445556666677789998877765543
Q ss_pred -CCeEEEEeeccCCCCchhHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHHc-----CceeeeCCCCceEEccCCCEEE
Q 042539 95 -DEFLAWAVPYCPGGDLNVLRYKQNDR--VFSPSVIRFYLSEIICAIEHLHNM-----GIAYRDLKPENILIRQSGHVTL 166 (412)
Q Consensus 95 -~~~~~lv~e~~~gg~L~~~~~~~~~~--~l~~~~~~~~~~qi~~aL~yLH~~-----~iiHrDlKp~NiLl~~~g~vkL 166 (412)
+...|.+++||.+|.+...+.+.... .+.+.-+.....+.+.+..-+|+. --+|+++|+-|-+|..+-.+|+
T Consensus 1302 ~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~ 1381 (2724)
T KOG1826|consen 1302 ESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKL 1381 (2724)
T ss_pred CChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccc
Confidence 34679999999999998776653321 233444444444447778887764 2789999999999999999999
Q ss_pred ccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCc
Q 042539 167 TDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSN 246 (412)
Q Consensus 167 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (412)
.++|+.+..... .....
T Consensus 1382 gk~gLdKIknp~---------------------------------------------------------------~sf~G 1398 (2724)
T KOG1826|consen 1382 GKGGLDKIKNPV---------------------------------------------------------------LSFFG 1398 (2724)
T ss_pred cccccccccCch---------------------------------------------------------------Hhhhh
Confidence 999999832211 11123
Q ss_pred ccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCC
Q 042539 247 SFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRG 290 (412)
Q Consensus 247 ~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 290 (412)
..++++.|+++++.....++.++|+|..||-+|+..-|..+|..
T Consensus 1399 l~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~ 1442 (2724)
T KOG1826|consen 1399 LELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIF 1442 (2724)
T ss_pred hhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHH
Confidence 56788999999999998898889999999999999999888743
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.84 E-value=7.7e-05 Score=69.06 Aligned_cols=74 Identities=18% Similarity=0.234 Sum_probs=45.1
Q ss_pred eeeeeccCce-EEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCC---ccceeeeeEEeC---
Q 042539 23 LKILGKGAMG-TVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP---FLPKLLGSLETD--- 95 (412)
Q Consensus 23 ~~~LG~G~fg-~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hp---nIv~l~~~~~~~--- 95 (412)
+..|+.|+.. .||++. .. +.+|+..... ....+.+|.+++..+... -+..+++.....
T Consensus 2 ~~~~~~gG~~n~vy~~~-----~~----~VlR~~~~~~------~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~ 66 (235)
T cd05155 2 IEPVDSGGTDNATFRLG-----DD----MSVRLPSAAG------YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGY 66 (235)
T ss_pred ceeccCCCcccceEEcC-----Cc----eEEEcCCccc------hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCC
Confidence 4567777766 599752 11 6788754321 123566699999888631 344555444332
Q ss_pred CeEEEEeeccCCCCch
Q 042539 96 EFLAWAVPYCPGGDLN 111 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~ 111 (412)
...+++|++++|.++.
T Consensus 67 ~~~~~l~~~i~G~~l~ 82 (235)
T cd05155 67 PWPWSVYRWLEGETAT 82 (235)
T ss_pred CcceEEEEeecCCCCC
Confidence 2358899999997763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00057 Score=62.99 Aligned_cols=76 Identities=21% Similarity=0.320 Sum_probs=47.1
Q ss_pred eeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEEeCCeEEEE
Q 042539 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLETDEFLAWA 101 (412)
Q Consensus 23 ~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv 101 (412)
++.|..|-...||++..... ....|.+|+....... .....+|+.+++.+. +.-+++++..+.. .++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~---~~~~~vlR~~~~~~~~-----~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l 70 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKED---NQDAVLVRVYGNKTEL-----IIDRERELRIHKLLSKHGLAPKLYATFQN----GLI 70 (235)
T ss_pred EEEcCCcccceEEEEEcCCC---CCCeEEEEEccCCccc-----eecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEE
Confidence 56788888899999864320 1123889976543211 011224888888885 3345566554432 379
Q ss_pred eeccCCCCc
Q 042539 102 VPYCPGGDL 110 (412)
Q Consensus 102 ~e~~~gg~L 110 (412)
|||++|..+
T Consensus 71 ~e~i~G~~l 79 (235)
T cd05157 71 YEFIPGRTL 79 (235)
T ss_pred EEeeCCCcC
Confidence 999999766
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.0002 Score=64.01 Aligned_cols=99 Identities=22% Similarity=0.176 Sum_probs=76.7
Q ss_pred HHHHHhhcCC-CccceeeeeEEeCCeEEEEeeccCCCCchhHH-HhhCCCCCCHHHHHHHHHHHHHHHHHHHH---cCce
Q 042539 73 EIRVLSRLSH-PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLR-YKQNDRVFSPSVIRFYLSEIICAIEHLHN---MGIA 147 (412)
Q Consensus 73 Ei~il~~l~h-pnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~~-~~~~~~~l~~~~~~~~~~qi~~aL~yLH~---~~ii 147 (412)
|.-+++.+++ +++++++|++-+ ++|+||...+++.... ....-..-+......++.+++..+++|+. ..+.
T Consensus 9 E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~ 84 (188)
T PF12260_consen 9 EPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFY 84 (188)
T ss_pred HHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEE
Confidence 7778888875 699999998843 6799999877653210 00011125778889999999999999987 3477
Q ss_pred eeeCCCCceEEccCCCEEEccccccchh
Q 042539 148 YRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 148 HrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
-.|++++||-++++|.+|++|...+...
T Consensus 85 lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 85 LCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EeecchHHeEEeCCCcEEEEechhcchh
Confidence 7999999999999999999999877554
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00067 Score=64.91 Aligned_cols=142 Identities=16% Similarity=0.195 Sum_probs=84.6
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCC--ccceeeee-----
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP--FLPKLLGS----- 91 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~----- 91 (412)
+..-++.|..|....+|++.... . .+++|+.... . ...+..|++++..+.+. .+.+++..
T Consensus 15 ~~~~i~~i~~G~~n~~y~v~~~~--~----~~vLr~~~~~---~----~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~ 81 (296)
T cd05153 15 ELLSFEGISAGIENTNYFVTTDS--G----RYVLTLFEKV---S----AEELPFFLALLDHLAERGLPVPRPIADRDGEY 81 (296)
T ss_pred chhheecccCccccceEEEEeCC--C----cEEEEEcCCC---C----hHhccHHHHHHHHHHHCCCCCCccccCCCCcE
Confidence 33446788888889999886432 1 2899987531 1 12344477888887522 25555442
Q ss_pred -EEeCCeEEEEeeccCCCCchh----H----------HHhhCCCCCCH--------HHH------------HHHHHHHHH
Q 042539 92 -LETDEFLAWAVPYCPGGDLNV----L----------RYKQNDRVFSP--------SVI------------RFYLSEIIC 136 (412)
Q Consensus 92 -~~~~~~~~lv~e~~~gg~L~~----~----------~~~~~~~~l~~--------~~~------------~~~~~qi~~ 136 (412)
...++..++|+++++|..+.. . ++.... .+.. ... ......+..
T Consensus 82 ~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 160 (296)
T cd05153 82 LSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQ-SFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLAD 160 (296)
T ss_pred eeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhc-cCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHH
Confidence 234456789999999977532 0 010000 0000 000 001112233
Q ss_pred HHHHHHH-------cCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 137 AIEHLHN-------MGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 137 aL~yLH~-------~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
++.++.+ .++||+|+.|.|||++.++.+.|+||+.+..
T Consensus 161 ~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 161 ELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred HHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4445443 4799999999999999877778999998863
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00082 Score=64.82 Aligned_cols=146 Identities=18% Similarity=0.236 Sum_probs=84.3
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCC--CccceeeeeE-
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH--PFLPKLLGSL- 92 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~- 92 (412)
.++....++.++.|.-..||++... .+ .+.+|+..... . ...+..|++++..|.. -.|.+++..-
T Consensus 20 ~~~~~~~i~~~~~G~~n~~y~v~t~-~~-----~~vLK~~~~~~--~----~~~i~~e~~~l~~L~~~g~pvp~~i~t~~ 87 (307)
T TIGR00938 20 DLGELLSLKGIAEGVENSNYLLTTD-VG-----RYILTLYEKRV--K----AEELPFFLALTTHLAARGLPVPKPVKSRD 87 (307)
T ss_pred CCCCceeccccCCccccceEEEEeC-CC-----cEEEEEecCCC--C----HHHHHHHHHHHHHHHHCCCCCCccccCCC
Confidence 3344556788888888999988642 11 27889774421 1 1122346677777742 1244444421
Q ss_pred -----EeCCeEEEEeeccCCCCchhH--------------HHhhCCCCCC---------HH----HHH----------HH
Q 042539 93 -----ETDEFLAWAVPYCPGGDLNVL--------------RYKQNDRVFS---------PS----VIR----------FY 130 (412)
Q Consensus 93 -----~~~~~~~lv~e~~~gg~L~~~--------------~~~~~~~~l~---------~~----~~~----------~~ 130 (412)
..++..+++++|++|..+... ++.... .++ .. ... ..
T Consensus 88 g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~-~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~ 166 (307)
T TIGR00938 88 GRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGA-HFPENRKNSLRLEAWHILAEKCFEAAPQLEAHM 166 (307)
T ss_pred CCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhc-cCCCCCCCCCChHHHHHHHHhhhhcccccCHHH
Confidence 234567899999998654210 111000 010 00 000 01
Q ss_pred HHHHHHHHHHHHH-------cCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 131 LSEIICAIEHLHN-------MGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 131 ~~qi~~aL~yLH~-------~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
...+...++++.. .++||+|+.+.||+++.++.+.|+||+.+..
T Consensus 167 ~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 167 GAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 1123334555542 5899999999999999888778999998853
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0014 Score=65.34 Aligned_cols=80 Identities=19% Similarity=0.215 Sum_probs=52.8
Q ss_pred eeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhh--hh--HHHHHHHHHHHHHHhhcC---CCccceeeeeEEe
Q 042539 22 ALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLH--AK--HEAERRARWEIRVLSRLS---HPFLPKLLGSLET 94 (412)
Q Consensus 22 ~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~--~~--~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~ 94 (412)
-.+.||.|.+..||++.....+ +.|.||.-.. ... .. .....+...|.+.|+.+. -.++++++.+ +
T Consensus 30 ~~~elggGn~N~VyrV~~~~g~----~svIVKqa~p-~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D 102 (401)
T PRK09550 30 TAREIGDGNLNLVFRVSDTEGG----KSVIVKQALP-YVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--D 102 (401)
T ss_pred eeeEcCCCceEEEEEEEeCCCC----eEEEEEecCc-ccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--C
Confidence 4578999999999999875321 2389997431 110 00 112345566888888874 2467777777 3
Q ss_pred CCeEEEEeeccCCC
Q 042539 95 DEFLAWAVPYCPGG 108 (412)
Q Consensus 95 ~~~~~lv~e~~~gg 108 (412)
.+..++|||++.+.
T Consensus 103 ~~~~~lVME~L~~~ 116 (401)
T PRK09550 103 EELAVTVMEDLSDH 116 (401)
T ss_pred CCCCEEEEecCCCc
Confidence 35578999999764
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00022 Score=67.87 Aligned_cols=136 Identities=19% Similarity=0.278 Sum_probs=93.1
Q ss_pred ceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhh-----hhhHH-------------HHHHHHHHHHHHhhcC
Q 042539 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTL-----HAKHE-------------AERRARWEIRVLSRLS 81 (412)
Q Consensus 20 y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~-----~~~~~-------------~~~~~~~Ei~il~~l~ 81 (412)
+-+..+||-|--+-||++-+... .+.++|.=+.... ..+.+ ....+.+|...|+.|.
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G-----~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~ 168 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEG-----NPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALY 168 (465)
T ss_pred hhhccccccccccceEEEecCCC-----CchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHH
Confidence 34678899999999999877532 2367774332211 11110 1123566888899885
Q ss_pred -CCc-cceeeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEc
Q 042539 82 -HPF-LPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIR 159 (412)
Q Consensus 82 -hpn-Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~ 159 (412)
|-+ |.+.+ +.+..++|||++.|-.|....+.. .+..+...++.-+.-|-.+|+||+|..-=||+++
T Consensus 169 e~gfpVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v~--------d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 169 ERGFPVPKPI----DHNRHCVVMELVDGYPLRQVRHVE--------DPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVK 236 (465)
T ss_pred HcCCCCCCcc----cccceeeHHHhhcccceeeeeecC--------ChHHHHHHHHHHHHHHHHcCceecccchheeEEe
Confidence 544 33333 345679999999998886543222 2234455566667778889999999999999999
Q ss_pred cCCCEEEcccccc
Q 042539 160 QSGHVTLTDFDLS 172 (412)
Q Consensus 160 ~~g~vkL~DFGla 172 (412)
.+++++++||--.
T Consensus 237 dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 237 DDDKIVVIDFPQM 249 (465)
T ss_pred cCCCEEEeechHh
Confidence 9999999999644
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0027 Score=61.05 Aligned_cols=80 Identities=13% Similarity=0.116 Sum_probs=54.7
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-C--CccceeeeeEEeC
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-H--PFLPKLLGSLETD 95 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-h--pnIv~l~~~~~~~ 95 (412)
...-.+.||.|..+.||....... .+.+|+.+... ....+.+|+..|+.|. + -.|.++++++.++
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~------~~~~k~~~~~~------~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~ 82 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQG------NPMPLMARSFS------TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE 82 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCC------CEEEEEecccc------cchHHHHHHHHHHHHccCCCCCcCcEEEEeccC
Confidence 344567899999999998754221 16778743211 1134556888998885 2 3678888877543
Q ss_pred ---CeEEEEeeccCCCCc
Q 042539 96 ---EFLAWAVPYCPGGDL 110 (412)
Q Consensus 96 ---~~~~lv~e~~~gg~L 110 (412)
+.-+||||+++|+.+
T Consensus 83 ~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 83 QSPGPDVLLLERLRGVSV 100 (297)
T ss_pred CcCCCeEEEEeccCCEec
Confidence 568999999998765
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0038 Score=60.42 Aligned_cols=31 Identities=26% Similarity=0.360 Sum_probs=26.4
Q ss_pred cCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 144 MGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 144 ~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
.|+||+|+.|.|||++.+...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 3899999999999998655558999998863
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0033 Score=58.90 Aligned_cols=136 Identities=16% Similarity=0.187 Sum_probs=75.7
Q ss_pred eeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCC-ccceeeeeEEeCCeEEEEee
Q 042539 25 ILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP-FLPKLLGSLETDEFLAWAVP 103 (412)
Q Consensus 25 ~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~lv~e 103 (412)
.+..|-.+.+|++... +..+++|+........ .....+|..+++.+..- -..+++.... -++|||
T Consensus 3 ~~~~G~tn~~y~~~~~------~~~~vlR~~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e 68 (256)
T TIGR02721 3 TLSGGLTNRSWRIEHP------GISFVWRPQSPVCKAL----GVDRQREYQILQALSALGLAPKPILVNE----HWLLVE 68 (256)
T ss_pred cCCCcCcCCeEEEEeC------CccEEEeeCCcccccc----cCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEE
Confidence 3566888899987622 2238888764332110 01124488888888632 2344544432 268999
Q ss_pred ccCCCCchhH-----------------HHhhC--CCCCCH-HHHHHHHHHH---------HHHHHHHHH--------cCc
Q 042539 104 YCPGGDLNVL-----------------RYKQN--DRVFSP-SVIRFYLSEI---------ICAIEHLHN--------MGI 146 (412)
Q Consensus 104 ~~~gg~L~~~-----------------~~~~~--~~~l~~-~~~~~~~~qi---------~~aL~yLH~--------~~i 146 (412)
|++|..+... ++... ...++. ..+..+..++ ...+..+-+ ..+
T Consensus 69 ~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 148 (256)
T TIGR02721 69 WLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAP 148 (256)
T ss_pred eccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCee
Confidence 9999765321 11110 011111 1222222222 111222221 258
Q ss_pred eeeeCCCCceEEccCCCEEEccccccchh
Q 042539 147 AYRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 147 iHrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
+|+|+.|.||+++.++ +.|+||..|..-
T Consensus 149 ~H~Dl~~~Nil~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 149 LHMDVHAYNLVVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred ecCCCCcCcEEEeCCC-CEEEeccccCcC
Confidence 9999999999999877 789999988643
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0023 Score=61.45 Aligned_cols=80 Identities=21% Similarity=0.239 Sum_probs=47.8
Q ss_pred eeeeeccCceEEEEEEEcCC--CCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCC-CccceeeeeEEeCCeEE
Q 042539 23 LKILGKGAMGTVFLVHDRAA--DPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH-PFLPKLLGSLETDEFLA 99 (412)
Q Consensus 23 ~~~LG~G~fg~V~la~~~~~--~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~ 99 (412)
++.|..|--..||++..... ....+..|++|+...... ......+|..+++.+.. --..++++++.. .
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~ 73 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-----LLIDRERELVVFARLSERNLGPKLYGIFPN----G 73 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-----ceechHHHHHHHHHHHhCCCCCceEEEeCC----C
Confidence 45677777789998864321 011234488998754321 11123348888888852 234566666542 3
Q ss_pred EEeeccCCCCch
Q 042539 100 WAVPYCPGGDLN 111 (412)
Q Consensus 100 lv~e~~~gg~L~ 111 (412)
+|++|++|..+.
T Consensus 74 ~v~e~i~G~~l~ 85 (302)
T cd05156 74 RIEEFIPSRTLT 85 (302)
T ss_pred chhheeCCCcCC
Confidence 589999987664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0063 Score=59.75 Aligned_cols=147 Identities=19% Similarity=0.224 Sum_probs=83.9
Q ss_pred ceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEEeCCeE
Q 042539 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLETDEFL 98 (412)
Q Consensus 20 y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 98 (412)
..-++.|-.|-...+|++............|.+|+..... .....+ .+|..+++.+. +.--.++++.+..+
T Consensus 38 ~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t----~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g--- 109 (344)
T PLN02236 38 ALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV----ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG--- 109 (344)
T ss_pred cEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC----Ceeech-HHHHHHHHHHHHcCCCCceEEEECCc---
Confidence 3445566568889999987543222233458899875432 112222 34888888886 33345666766443
Q ss_pred EEEeeccCCCCchhH-----------------HHhhC-C--C-CCCHHHHHHHHHHH-----------------HHHHHH
Q 042539 99 AWAVPYCPGGDLNVL-----------------RYKQN-D--R-VFSPSVIRFYLSEI-----------------ICAIEH 140 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~-----------------~~~~~-~--~-~l~~~~~~~~~~qi-----------------~~aL~y 140 (412)
.|++|++|.++... ++... . . ......+..+..++ ...+..
T Consensus 110 -~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~ 188 (344)
T PLN02236 110 -RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINL 188 (344)
T ss_pred -eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHH
Confidence 57999988776421 00000 0 0 01112233332221 111112
Q ss_pred H----H----HcCceeeeCCCCceEEcc-CCCEEEccccccchh
Q 042539 141 L----H----NMGIAYRDLKPENILIRQ-SGHVTLTDFDLSRNL 175 (412)
Q Consensus 141 L----H----~~~iiHrDlKp~NiLl~~-~g~vkL~DFGla~~~ 175 (412)
| . ...++|+|+++.|||++. ++.+.|+||..|...
T Consensus 189 L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 189 LEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred HHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 2 1 235899999999999986 468999999988643
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.016 Score=55.69 Aligned_cols=30 Identities=30% Similarity=0.473 Sum_probs=26.3
Q ss_pred cCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 144 MGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 144 ~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
.++||+|+.+.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 47899999999999987 7789999997654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0087 Score=56.86 Aligned_cols=30 Identities=27% Similarity=0.424 Sum_probs=25.6
Q ss_pred CceeeeCCCCceEEccCCC-EEEccccccch
Q 042539 145 GIAYRDLKPENILIRQSGH-VTLTDFDLSRN 174 (412)
Q Consensus 145 ~iiHrDlKp~NiLl~~~g~-vkL~DFGla~~ 174 (412)
.++|+|+.|.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997565 46999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.012 Score=57.24 Aligned_cols=143 Identities=21% Similarity=0.205 Sum_probs=94.4
Q ss_pred eeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhh----------------------HHHHHHHHHHHHHHhhc
Q 042539 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAK----------------------HEAERRARWEIRVLSRL 80 (412)
Q Consensus 23 ~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~----------------------~~~~~~~~~Ei~il~~l 80 (412)
-..|..|--+-||.|... .+..+|||+++.+.+.-+ ..+..-+..|++-|++|
T Consensus 149 nGCiSTGKEANVYHat~~-----dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl 223 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEE-----DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRL 223 (520)
T ss_pred ccccccCccceeEeeecC-----CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHH
Confidence 356778888999987543 233499999876543211 11222345577778888
Q ss_pred CCCccceeeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHH-HHcCceeeeCCCCceEEc
Q 042539 81 SHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHL-HNMGIAYRDLKPENILIR 159 (412)
Q Consensus 81 ~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yL-H~~~iiHrDlKp~NiLl~ 159 (412)
..-.|..---... ....|||+|+.+ +=+-. -.-....++...++.+-.|++.-+.-| |..++||.||.-=|+|+
T Consensus 224 ~~aGIP~PePIlL--k~hVLVM~FlGr-dgw~a-PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly- 298 (520)
T KOG2270|consen 224 NNAGIPCPEPILL--KNHVLVMEFLGR-DGWAA-PKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY- 298 (520)
T ss_pred HhcCCCCCCceee--ecceEeeeeccC-CCCcC-cccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-
Confidence 6443321111111 234689999953 32211 111233478888999999998888887 56799999999999998
Q ss_pred cCCCEEEccccccchh
Q 042539 160 QSGHVTLTDFDLSRNL 175 (412)
Q Consensus 160 ~~g~vkL~DFGla~~~ 175 (412)
.+|.+.|+|-+-+...
T Consensus 299 hdG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 299 HDGKLYIIDVSQSVEH 314 (520)
T ss_pred ECCEEEEEEccccccC
Confidence 7789999999877654
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.0033 Score=63.37 Aligned_cols=77 Identities=19% Similarity=0.263 Sum_probs=59.0
Q ss_pred hhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC-------------CCCCChHHHHHHHHhhhhCCCccCCCCC
Q 042539 268 AVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE-------------FVGQRTALTDLIQRLLEKDPVKRLGYLR 334 (412)
Q Consensus 268 ~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~-------------~~~~~~~~~dli~~~L~~dP~~R~~~~~ 334 (412)
++||||+|.|+.++.-|...+......+..+.+..-... ....+..+.++..+|+-..|..|+
T Consensus 111 KsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~---- 186 (725)
T KOG1093|consen 111 KSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRP---- 186 (725)
T ss_pred chhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCcccccccc----
Confidence 999999999999999999988877666665555432111 012345677899999999999999
Q ss_pred ChhhhhcCCCCCCC
Q 042539 335 GACEIKEHVFFKGV 348 (412)
Q Consensus 335 ~~~e~l~h~ff~~~ 348 (412)
...++.+++-|.++
T Consensus 187 l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 187 LPMELSKRCSFTEV 200 (725)
T ss_pred chhHHhcCccHHHH
Confidence 57888888888765
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.012 Score=57.63 Aligned_cols=78 Identities=22% Similarity=0.217 Sum_probs=46.7
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhh---hhHHHHHHHHHHHHHHhhcC--CC-ccceeeeeEEeCCe
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLH---AKHEAERRARWEIRVLSRLS--HP-FLPKLLGSLETDEF 97 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~---~~~~~~~~~~~Ei~il~~l~--hp-nIv~l~~~~~~~~~ 97 (412)
+.||.|....||++.+...+ ..|+||.-..-.-. .-.-...+...|..+|+... .| .++++|.+ +.+.
T Consensus 1 ~EigdGnlN~VfrV~~~~g~----~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~ 74 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQEGD----RAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEM 74 (370)
T ss_pred CcCCCCceEEEEEEEcCCCC----eeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--cccc
Confidence 36899999999999864321 23898865311100 00123345556888988875 35 45555433 3445
Q ss_pred EEEEeeccCC
Q 042539 98 LAWAVPYCPG 107 (412)
Q Consensus 98 ~~lv~e~~~g 107 (412)
..+|||++..
T Consensus 75 ~~~vMEdL~~ 84 (370)
T TIGR01767 75 AVTVMEDLSH 84 (370)
T ss_pred ceehHhhCcc
Confidence 5689999854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.022 Score=55.55 Aligned_cols=148 Identities=16% Similarity=0.203 Sum_probs=80.6
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCc-cceeeeeEEe
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPF-LPKLLGSLET 94 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~ 94 (412)
..+++.+... ..|=...+|++....... ....|.+|+...... ....+ .+|..+++.+..-+ -.++++++..
T Consensus 13 ~~~~i~i~~l-~gGlTN~~~~v~~~~~~~-~~~~~v~Ri~g~~t~----~~IdR-~~E~~il~~l~~~gl~P~~l~~~~~ 85 (330)
T PLN02421 13 DDSDFSVERI-SGGITNLLLKVSVKEENG-NEVSVTVRLFGPNTD----YVIDR-ERELQAIKYLSAAGFGAKLLGVFGN 85 (330)
T ss_pred CcCceEEEEe-CCcccceEEEEEecCCCC-CCceEEEEEecCCcC----eEech-HHHHHHHHHHHhcCCCCceeEEeCC
Confidence 3345555444 447778899886543211 122488898744321 11111 23888888886433 3566766643
Q ss_pred CCeEEEEeeccCCCCchhH-------HHh--------hC-C----CCCC-HHHHHHHHHHH-------------------
Q 042539 95 DEFLAWAVPYCPGGDLNVL-------RYK--------QN-D----RVFS-PSVIRFYLSEI------------------- 134 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~-------~~~--------~~-~----~~l~-~~~~~~~~~qi------------------- 134 (412)
+ +|.+|++|..|... +.. +. . ..++ ...+..+..++
T Consensus 86 G----~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~ 161 (330)
T PLN02421 86 G----MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISF 161 (330)
T ss_pred c----EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCH
Confidence 2 48999988765321 000 11 0 0011 12222232222
Q ss_pred ---HHHHHHHH----Hc----CceeeeCCCCceEEcc-CCCEEEccccccch
Q 042539 135 ---ICAIEHLH----NM----GIAYRDLKPENILIRQ-SGHVTLTDFDLSRN 174 (412)
Q Consensus 135 ---~~aL~yLH----~~----~iiHrDlKp~NiLl~~-~g~vkL~DFGla~~ 174 (412)
..-+..+. .. -.+|.|+.+.|||++. ++.++++||..|..
T Consensus 162 ~~l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 162 EELRDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11122222 11 2799999999999975 47899999998864
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.058 Score=53.84 Aligned_cols=78 Identities=17% Similarity=0.221 Sum_probs=50.7
Q ss_pred eeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhH---HHHHHHHHHHHHHhhcC--C-CccceeeeeEEeC
Q 042539 22 ALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKH---EAERRARWEIRVLSRLS--H-PFLPKLLGSLETD 95 (412)
Q Consensus 22 ~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~~~Ei~il~~l~--h-pnIv~l~~~~~~~ 95 (412)
..+.||.|.-..||++.+.. . .|.||.-......... -...+...|+..|+.+. . .++.++|.+..
T Consensus 36 ~~~eiggGn~N~VyrV~~~~--~----svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de-- 107 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSSS--G----SFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR-- 107 (418)
T ss_pred eEEEcCCCceeeEEEEEcCC--c----cEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--
Confidence 57889999999999988632 1 2888865411110000 12344455778887775 2 47888888777
Q ss_pred CeEEEEeeccCC
Q 042539 96 EFLAWAVPYCPG 107 (412)
Q Consensus 96 ~~~~lv~e~~~g 107 (412)
+.-+++||++.+
T Consensus 108 d~~vlvME~L~~ 119 (418)
T PLN02756 108 TMALIGMRYLEP 119 (418)
T ss_pred CCCEEEEeecCC
Confidence 345778999976
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.94 E-value=0.028 Score=51.05 Aligned_cols=84 Identities=18% Similarity=0.145 Sum_probs=57.4
Q ss_pred HHHHHHHHHhhcCCCccceeeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH--cCc
Q 042539 69 RARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN--MGI 146 (412)
Q Consensus 69 ~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~--~~i 146 (412)
.+..+.++++++. .|++|..- +.-.+-+++|+|.-... . ..-++. -=+.+|.-.|+ .+.
T Consensus 104 ~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-----------~---~~N~i~-agi~~L~~fH~~~~~~ 164 (308)
T PF07387_consen 104 LYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-----------N---FSNFIT-AGIKDLMDFHSENQHC 164 (308)
T ss_pred hhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-----------c---hhHHHH-HhHHHHHHhhccCCCe
Confidence 3456788888875 57777632 33357788999943211 1 111111 12466778884 369
Q ss_pred eeeeCCCCceEEccCCCEEEccccc
Q 042539 147 AYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 147 iHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
+|+|..|+|||-|+.|.+||.|=+.
T Consensus 165 lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 165 LHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred ecCCCChhheeecCCCCEEecChhh
Confidence 9999999999999999999999763
|
The function of this family is unknown. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.027 Score=54.83 Aligned_cols=71 Identities=27% Similarity=0.335 Sum_probs=54.1
Q ss_pred CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeeeCCCCceEEccCCCEEEccccccch
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNM-GIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~-~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
..+|++|++- |+.+... .. -..+++..++.+.+..+.-+..+ ..=|||+.-.||||+ +|+|.|+||-+|+.
T Consensus 299 ~y~yl~~kdh-gt~is~i-k~-----~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 299 LYLYLHFKDH-GTPISII-KA-----DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred eEEEEEEecC-Cceeeee-ec-----ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 4677888875 6666422 11 34567777888887777766654 689999999999999 99999999999984
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.042 Score=54.67 Aligned_cols=85 Identities=13% Similarity=0.187 Sum_probs=48.4
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCC--CCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEE
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAAD--PTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLE 93 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~ 93 (412)
.+++. ++.|..|-...+|++...... ....+.|.+.+... .......+ .+|+++++.+. +..-.++++.|.
T Consensus 50 ~~~i~-i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~----~~~l~IdR-~~E~~i~~~Ls~~glgP~l~~~f~ 123 (383)
T PTZ00384 50 PEFIE-IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST----YNSLVIDN-DLQYNIAKLLGDNNFGPKIIGRFG 123 (383)
T ss_pred cccEE-EEEeCCcccceEEEEEecCCCCCccccceEEEEeccC----CCceEecc-HHHHHHHHHHHhCCCCCeEEEecC
Confidence 33444 445555888999998653321 11111133333211 11111111 34899999997 455677777776
Q ss_pred eCCeEEEEeeccCCCCch
Q 042539 94 TDEFLAWAVPYCPGGDLN 111 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~ 111 (412)
. +++.||++|..|.
T Consensus 124 ~----g~l~efIeGr~l~ 137 (383)
T PTZ00384 124 D----FTIQEWVEGNTMG 137 (383)
T ss_pred C----EEEEEEeccccCC
Confidence 4 5999999998764
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.61 E-value=0.08 Score=52.60 Aligned_cols=79 Identities=20% Similarity=0.222 Sum_probs=49.6
Q ss_pred eeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhh---hHHHHHHHHHHHHHHhhcC--CC-ccceeeeeEEeC
Q 042539 22 ALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHA---KHEAERRARWEIRVLSRLS--HP-FLPKLLGSLETD 95 (412)
Q Consensus 22 ~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~---~~~~~~~~~~Ei~il~~l~--hp-nIv~l~~~~~~~ 95 (412)
.++.||.|.-..||++.+...+. .|+||.-..- +.. -.-...|...|..+|+... .| +++++|.+ +.
T Consensus 33 ~~~eigdGnlN~VfrV~~~~~~~----svIVKQAlp~-vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~ 105 (409)
T PRK12396 33 QCKEIGDGNLNYVFRVWDEQKNI----SVIVKQAGDT-ARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DS 105 (409)
T ss_pred eeeEcCCCceEEEEEEeeCCCCc----eEEEEeccHh-hccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--Cc
Confidence 37889999999999998742122 2888864211 111 0123456666999999885 45 45556543 34
Q ss_pred CeEEEEeeccCC
Q 042539 96 EFLAWAVPYCPG 107 (412)
Q Consensus 96 ~~~~lv~e~~~g 107 (412)
+...+|||++..
T Consensus 106 e~~~~vMEdL~~ 117 (409)
T PRK12396 106 VMNCCVMEDLSD 117 (409)
T ss_pred HHhhHHHHhCcc
Confidence 455688888753
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.84 E-value=0.31 Score=47.09 Aligned_cols=34 Identities=18% Similarity=0.238 Sum_probs=29.9
Q ss_pred CceeeeCCCCceEEccCCCEEEccccccchhhch
Q 042539 145 GIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178 (412)
Q Consensus 145 ~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~ 178 (412)
.++|+|+.+.|++++.++-+=+.||+++..-+..
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~ 232 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPL 232 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEeccccccCCcH
Confidence 4899999999999999999999999999765443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=94.74 E-value=0.0073 Score=60.70 Aligned_cols=75 Identities=21% Similarity=0.428 Sum_probs=60.8
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
..-+++++.....+|.|+||+|+.+..+..+ ..+|||.|... +......+..+|..-+..+.|++|+++...|
T Consensus 44 ~sr~a~~~e~~~~~~~~g~~~~~~~~n~~d~----~~~avkritlk---n~e~s~~rvl~~~~s~a~feh~g~~~~~ha~ 116 (516)
T KOG1033|consen 44 TSREANDFEPGQCLGRGGFGVVFSAQNKADE----NKYAVKRITLK---NREESRSRVLREVSSLAEFEHPGIKRYFHAW 116 (516)
T ss_pred hhhhhccccccccccccCccccCCccccccc----hhhHHHHhccc---chhhhhhhhhccccchhhhcccchhhheece
Confidence 4556789999999999999999987766543 34899988544 3456677888899999999999999998887
Q ss_pred Ee
Q 042539 93 ET 94 (412)
Q Consensus 93 ~~ 94 (412)
..
T Consensus 117 ~~ 118 (516)
T KOG1033|consen 117 YE 118 (516)
T ss_pred ec
Confidence 54
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.39 E-value=0.73 Score=51.85 Aligned_cols=31 Identities=23% Similarity=0.338 Sum_probs=26.5
Q ss_pred cCceeeeCCCCceEEccCC--CEE-Eccccccch
Q 042539 144 MGIAYRDLKPENILIRQSG--HVT-LTDFDLSRN 174 (412)
Q Consensus 144 ~~iiHrDlKp~NiLl~~~g--~vk-L~DFGla~~ 174 (412)
.++||.|+.+.|||++.++ .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999875 565 999998764
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.10 E-value=0.87 Score=43.50 Aligned_cols=76 Identities=16% Similarity=0.180 Sum_probs=44.8
Q ss_pred ceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC---CCccceeeeeEEeCC
Q 042539 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS---HPFLPKLLGSLETDE 96 (412)
Q Consensus 20 y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~ 96 (412)
.+-.+.++.|.-..+|.+.. .+..+-||+-.... ...+..|+.-|+.|. .-.+++.+.+...++
T Consensus 19 i~~~~~v~GG~i~~a~~~~~------~~~~~FvK~~~~~~-------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~ 85 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLDT------DGGSYFVKVNSESG-------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD 85 (288)
T ss_dssp --EEEEE--SSSSEEEEEET------TS-EEEEEEEEGGG-------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS
T ss_pred eeeeEecCCCChhheEEEEC------CCccEEEEecChhh-------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC
Confidence 44567889999999998762 22348999875221 123344777777773 456889999998877
Q ss_pred eEEEEeeccCCC
Q 042539 97 FLAWAVPYCPGG 108 (412)
Q Consensus 97 ~~~lv~e~~~gg 108 (412)
.-||||||++.+
T Consensus 86 ~~fLlle~l~~~ 97 (288)
T PF03881_consen 86 DAFLLLEFLEMG 97 (288)
T ss_dssp CCEEEEE-----
T ss_pred CceEEEEeecCC
Confidence 779999998766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.59 E-value=0.16 Score=48.95 Aligned_cols=52 Identities=33% Similarity=0.421 Sum_probs=37.7
Q ss_pred HHHHHHHHHHHHHHHHHHHH----cCceeeeCCCCceEEccCC------------------CEEEccccccchh
Q 042539 124 PSVIRFYLSEIICAIEHLHN----MGIAYRDLKPENILIRQSG------------------HVTLTDFDLSRNL 175 (412)
Q Consensus 124 ~~~~~~~~~qi~~aL~yLH~----~~iiHrDlKp~NiLl~~~g------------------~vkL~DFGla~~~ 175 (412)
.+-+++++.||+.-.-.+-. .+.+|-||||+|||+-.+. .++|.||.+|+..
T Consensus 278 ~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 351 (444)
T PHA03111 278 VEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQVA 351 (444)
T ss_pred HHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHHc
Confidence 35678888888765534422 3699999999999996544 2678888888654
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=93.36 E-value=0.091 Score=49.69 Aligned_cols=48 Identities=27% Similarity=0.344 Sum_probs=36.0
Q ss_pred HHHHHHHHHHHHHHHHc--CceeeeCCCCceEEccCCCEEEccccccchh
Q 042539 128 RFYLSEIICAIEHLHNM--GIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 128 ~~~~~qi~~aL~yLH~~--~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
+..+..+-.++.-.|.. -++|.|+.|+|+|.+..|.++|+||-.|..-
T Consensus 135 ~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~~ 184 (269)
T COG0510 135 RKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGLN 184 (269)
T ss_pred HHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCCc
Confidence 33444444455555443 5899999999999999999999999888653
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.32 E-value=0.46 Score=47.22 Aligned_cols=64 Identities=17% Similarity=0.115 Sum_probs=46.2
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHH-HHcCceeeeCCCCceEEccCCC
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHL-HNMGIAYRDLKPENILIRQSGH 163 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yL-H~~~iiHrDlKp~NiLl~~~g~ 163 (412)
...++-+|..|..+..++.... .+|...+.++.-.++||--+ --.+.+|.|+.|.||++..+.+
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~t 383 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNKT 383 (565)
T ss_pred cceeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecCC
Confidence 4567778999988877776544 45656666666666665544 3458999999999999976644
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=93.29 E-value=0.17 Score=49.04 Aligned_cols=52 Identities=31% Similarity=0.405 Sum_probs=36.1
Q ss_pred HHHHHHHHHHHHHHHHHHH----HcCceeeeCCCCceEEccCC------------------CEEEccccccchh
Q 042539 124 PSVIRFYLSEIICAIEHLH----NMGIAYRDLKPENILIRQSG------------------HVTLTDFDLSRNL 175 (412)
Q Consensus 124 ~~~~~~~~~qi~~aL~yLH----~~~iiHrDlKp~NiLl~~~g------------------~vkL~DFGla~~~ 175 (412)
.+-+++++.||+.-.--+- -.+.+|-||||+|||+-++. .++|.||.+|+..
T Consensus 274 ~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 274 VEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred HHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence 3556777777765332121 24699999999999986443 2788899988754
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.29 E-value=0.059 Score=47.90 Aligned_cols=30 Identities=20% Similarity=0.312 Sum_probs=26.4
Q ss_pred CceeeeCCCCceEEccCCCEEEccccccchh
Q 042539 145 GIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 145 ~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
-.+|+|+.|.||+++.+| ++|+||+.|...
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~g 107 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGDG 107 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccCC
Confidence 469999999999998877 999999998654
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 412 | ||||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-33 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-33 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-33 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-28 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-28 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-28 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-28 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-27 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-27 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-27 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-26 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-22 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-26 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-22 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-26 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-22 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-26 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-26 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-25 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-24 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-25 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-24 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-23 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-22 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-17 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-22 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-17 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-22 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-18 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-22 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-17 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-22 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-18 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-22 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-18 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-22 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-22 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-22 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-18 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-22 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-18 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-22 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-18 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-22 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-18 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-22 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-18 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-22 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-22 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-22 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-22 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-22 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-22 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-22 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-22 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-22 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-22 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-22 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-22 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-22 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-22 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-22 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-22 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-22 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-22 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-21 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-20 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-20 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-20 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-15 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-20 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-15 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-20 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-15 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-20 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-15 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-19 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-15 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-19 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-15 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-19 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-15 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-19 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-15 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-19 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-15 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-19 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-15 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-19 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-15 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-19 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-15 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-19 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-15 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-19 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-15 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-19 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-15 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-19 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-15 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-19 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-15 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-19 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-15 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-19 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-15 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-19 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-19 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-16 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-19 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-15 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-19 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-15 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-19 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-15 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-19 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-15 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-19 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-15 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-19 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-15 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-19 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-15 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-18 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-15 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-18 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-12 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-18 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-15 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-18 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-15 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-18 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-15 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-18 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-15 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-18 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-15 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-18 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-15 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-18 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-15 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-18 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-15 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-18 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-14 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-18 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-14 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-18 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-15 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-18 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-14 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-18 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-15 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-18 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-18 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-17 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-18 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-15 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-18 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-15 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-18 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-15 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-18 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-15 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-18 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-15 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-18 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-15 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-18 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-15 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-18 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-15 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-18 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-15 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-18 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-15 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-18 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-15 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-18 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-17 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-17 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-17 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-17 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-17 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-17 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-17 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-17 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-17 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-17 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-17 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-15 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-15 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-15 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-15 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-15 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-15 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-15 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-14 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-14 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-14 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-14 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-14 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-14 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-14 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-14 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-14 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-14 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-14 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-14 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-14 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-09 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-13 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-06 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-06 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-06 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-12 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-12 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-12 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-11 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-06 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-11 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-10 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 8e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-04 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-04 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-06 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-06 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-04 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-07 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-04 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-07 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 8e-04 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-07 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-07 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-07 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-07 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-07 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-07 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-07 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-07 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-07 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-07 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-04 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-07 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-07 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-07 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-07 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-07 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 8e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 9e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 9e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-06 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-04 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-06 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-06 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-06 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-06 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-05 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-06 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-06 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-06 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-06 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-06 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-06 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-04 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-06 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-06 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-04 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-06 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-06 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-06 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-06 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-04 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-04 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-04 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-06 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-04 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-06 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-06 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-04 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-06 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-04 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-04 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-04 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-06 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 9e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 9e-06 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-05 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-05 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-05 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-05 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-05 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-05 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-05 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-05 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-05 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-05 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-05 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-05 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-05 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-05 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-05 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-05 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-05 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-05 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-05 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-05 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-05 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-05 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-05 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-05 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-05 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-05 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-05 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-05 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-05 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-05 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-05 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-05 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-05 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-05 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-05 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-05 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-05 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-05 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-05 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-05 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 4e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-05 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-05 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-05 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-05 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-05 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 7e-05 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-05 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-05 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-05 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 8e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 8e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-05 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-05 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 9e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 9e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 9e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 9e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 9e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-04 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-04 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-04 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-04 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-04 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-04 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-04 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-04 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-04 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-04 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-04 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-04 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-04 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-04 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-04 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-04 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-04 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-04 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-04 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-04 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-04 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-04 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-04 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-04 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-04 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-04 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 2e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-04 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-04 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-04 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 3e-04 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 3e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-04 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 4e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-04 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-04 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 5e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-04 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-04 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 5e-04 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-04 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-04 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-04 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-04 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-04 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-04 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-04 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-04 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-04 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-04 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-04 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 9e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 9e-04 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 9e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-04 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-04 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 9e-04 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-04 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-04 |
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 412 | |||
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 4e-80 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 5e-58 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-52 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-51 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 2e-50 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 2e-50 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 1e-46 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 6e-44 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 2e-45 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 3e-45 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 7e-39 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 5e-45 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 1e-42 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 2e-44 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-41 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 4e-44 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 7e-42 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 4e-43 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 3e-41 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-42 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 2e-39 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 2e-42 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 5e-38 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 3e-42 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 5e-37 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-41 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-37 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 3e-41 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 8e-41 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 4e-41 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 2e-39 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 6e-41 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 7e-41 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 9e-41 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 9e-36 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 9e-41 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 2e-39 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 1e-40 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 7e-39 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 2e-40 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 2e-37 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 3e-39 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 2e-38 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 5e-39 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 5e-38 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 8e-39 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 2e-37 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 3e-38 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-37 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 4e-38 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 2e-34 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 3e-34 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 3e-20 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 7e-34 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 8e-34 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 5e-29 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 3e-33 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-19 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 4e-33 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-28 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 5e-33 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-13 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-32 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 4e-31 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 1e-14 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 1e-30 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 7e-16 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-29 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-16 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 4e-29 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 5e-29 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 3e-17 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-28 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 6e-16 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 1e-27 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 9e-23 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-27 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 1e-16 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-27 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-16 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 4e-27 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 9e-16 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 6e-26 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-15 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-25 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-19 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 4e-25 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 8e-18 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 3e-24 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 3e-20 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 4e-24 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 1e-17 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 6e-24 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 8e-21 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 8e-24 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-19 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 9e-24 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 5e-21 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 9e-24 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 8e-20 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 1e-23 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 3e-18 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 1e-23 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 1e-14 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-23 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 2e-20 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 1e-23 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 4e-19 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 2e-23 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 6e-21 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 2e-23 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 9e-21 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 2e-23 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 7e-22 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-23 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 8e-21 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 2e-23 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 6e-20 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 3e-23 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 3e-18 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 4e-23 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 1e-15 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 4e-23 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 9e-13 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 4e-23 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 5e-11 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 4e-23 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 1e-13 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 5e-23 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-21 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 5e-23 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 3e-14 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 9e-23 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 4e-19 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 1e-22 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 3e-18 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 2e-22 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 5e-11 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 3e-22 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 1e-18 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 3e-22 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 4e-19 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 4e-22 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 5e-22 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 4e-22 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 9e-08 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 5e-22 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 2e-19 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 5e-22 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 5e-17 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 9e-22 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 2e-06 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 1e-21 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 5e-18 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 2e-21 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 6e-13 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-21 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 6e-14 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-21 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 3e-13 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 2e-21 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 4e-13 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 3e-21 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 1e-13 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 3e-21 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 1e-08 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 3e-21 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 5e-20 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 5e-21 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 6e-16 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 9e-21 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-20 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 2e-07 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 1e-20 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 2e-06 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-20 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 3e-20 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 2e-11 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 4e-20 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 5e-20 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 7e-14 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 5e-20 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 9e-10 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 5e-20 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 2e-15 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 5e-20 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 1e-17 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 6e-20 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 4e-15 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 3e-19 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 3e-15 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 3e-19 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 6e-15 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 4e-19 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 1e-05 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 4e-19 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 9e-16 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 5e-19 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-08 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 7e-19 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 3e-09 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-18 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 4e-18 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 2e-08 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 5e-18 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-05 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 6e-18 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 6e-18 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 7e-18 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 3e-06 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 8e-18 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 4e-10 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 8e-18 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 1e-15 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 8e-18 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 1e-06 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 1e-17 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 3e-05 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-17 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 2e-08 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-17 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 4e-17 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 7e-10 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 1e-16 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 2e-04 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-16 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 5e-05 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 3e-16 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 2e-04 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 9e-16 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-15 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 5e-10 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 2e-15 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 2e-15 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 5e-09 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 3e-15 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 3e-15 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 3e-15 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 4e-15 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 4e-15 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 3e-04 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 4e-15 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 4e-15 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 7e-15 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 8e-15 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 1e-14 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 1e-14 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 3e-10 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 1e-14 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-14 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-14 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 1e-13 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 1e-13 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 1e-13 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 2e-13 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 3e-13 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 3e-13 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 3e-13 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 5e-13 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 5e-13 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 5e-13 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 6e-13 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 1e-12 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 2e-12 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 2e-12 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 2e-12 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 2e-12 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 3e-12 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 3e-12 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 4e-12 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 6e-12 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 7e-12 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 7e-12 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 8e-12 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 1e-11 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 1e-11 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 2e-11 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 2e-11 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 3e-11 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 5e-11 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 6e-11 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 6e-11 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 7e-11 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-04 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 8e-11 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 9e-04 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 8e-11 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-10 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-10 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 3e-10 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 3e-10 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 4e-10 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 9e-10 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 9e-10 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 1e-09 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 1e-09 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 1e-09 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-09 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-09 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 2e-09 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 2e-09 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-09 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 5e-09 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 5e-09 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 7e-09 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 9e-09 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 2e-08 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 2e-08 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-08 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 2e-08 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 3e-08 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 3e-08 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 3e-08 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 3e-08 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 2e-06 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 3e-08 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 4e-08 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 4e-08 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 4e-08 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 4e-08 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 5e-08 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 5e-08 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 5e-08 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 6e-08 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 7e-08 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 7e-08 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 9e-08 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 9e-08 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 9e-08 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 1e-07 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 2e-07 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 2e-07 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-07 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 2e-07 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 3e-07 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 3e-07 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 4e-07 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 4e-07 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 5e-07 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 7e-07 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 1e-06 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 1e-06 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 2e-06 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 2e-06 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 1e-05 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-05 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 6e-04 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-04 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 2e-04 |
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 4e-80
Identities = 92/366 (25%), Positives = 153/366 (41%), Gaps = 77/366 (21%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
+ D ++LG+G G VF +A +A K ++K L + + A E
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKL----YACKKLNKKRLKKRKGYQG-AMVEK 236
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDL--NVLRYKQNDRVFSPSVIRFYLS 132
++L+++ F+ L + ET L + GGD+ ++ +++ F FY +
Sbjct: 237 KILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA 296
Query: 133 EIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFP 192
+I+ +EHLH I YRDLKPEN+L+ G+V ++D L+
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV------------------- 337
Query: 193 VLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252
E K G KTK + GT
Sbjct: 338 -----------------------ELKAGQTKTK---------------------GYAGTP 353
Query: 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRK----ETFRNVLMKTPEF- 307
+++PE++ G+ ++F+VD++ALG+ YEM+ PFR + K E + VL + +
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP 413
Query: 308 VGQRTALTDLIQRLLEKDPVKRLGYL-RGACEIKEHVFFKGVRWD-LLTDVLRPPFIPSR 365
A D + LL+KDP KRLG+ ++ H F+ + W L +L PPF+P
Sbjct: 414 DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDS 473
Query: 366 EENDLT 371
Sbjct: 474 RTVYAK 479
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 5e-58
Identities = 69/356 (19%), Positives = 125/356 (35%), Gaps = 85/356 (23%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
+ +LG+GA G V + +A+K + + E E+ +L+ L+H
Sbjct: 11 IAVLGQGAFGQVVKARNA----LDSRYYAIKKIRHT-----EEKLSTILSEVMLLASLNH 61
Query: 83 PFLPKLLGSLETDEFLAWAVP-------------YCPGGDLNVLRYKQNDRVFSPSVIRF 129
++ + + + YC G L +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYD-LIHSENLNQQRDEYWR 120
Query: 130 YLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNN 189
+I+ A+ ++H+ GI +RDLKP NI I +S +V + DF L++N+ + K N
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN- 179
Query: 190 KFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249
+ + S +
Sbjct: 180 ------------------------------------------------LPGSSDNLTSAI 191
Query: 250 GTEEYVSPEVVRGDGH-EFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV 308
GT YV+ EV+ G GH +D ++LGI+ +EM+Y G R + + + EF
Sbjct: 192 GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKKLRSVSIEFP 249
Query: 309 GQ-----RTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD-LLTDVLR 358
+I+ L++ DP KR GA + + D ++ + L+
Sbjct: 250 PDFDDNKMKVEKKIIRLLIDHDPNKRP----GARTLLNSGWLPVKHQDEVIKEALK 301
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 2e-52
Identities = 72/327 (22%), Positives = 125/327 (38%), Gaps = 80/327 (24%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP 83
+LGKG+ V+ A+K++DK ++ K +R + E+++ +L HP
Sbjct: 17 NLLGKGSFAGVYRAESIHTGLE----VAIKMIDKKAMY-KAGMVQRVQNEVKIHCQLKHP 71
Query: 84 FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRY-KQNDRVFSPSVIRFYLSEIICAIEHLH 142
+ +L E ++ + C G++N RY K + FS + R ++ +II + +LH
Sbjct: 72 SILELYNYFEDSNYVYLVLEMCHNGEMN--RYLKNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 143 NMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKR 202
+ GI +RDL N+L+ ++ ++ + DF L+
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLA------------------------------ 159
Query: 203 HRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRG 262
+ T GT Y+SPE+
Sbjct: 160 ----------TQLKMPHEKHYT-----------------------LCGTPNYISPEIATR 186
Query: 263 DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLM---KTPEFVGQRTALTDLIQ 319
H D W+LG + Y +L G PF K T V++ + P F+ DLI
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLS--IEAKDLIH 244
Query: 320 RLLEKDPVKRLGYLRGACEIKEHVFFK 346
+LL ++P RL + +H F
Sbjct: 245 QLLRRNPADRL----SLSSVLDHPFMS 267
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-51
Identities = 76/347 (21%), Positives = 119/347 (34%), Gaps = 80/347 (23%)
Query: 3 ATPPPQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHA 62
A P+ P + LGKG F +D + FA K+V KS L
Sbjct: 1 AKEIPEVLVDPR-SRRRYVRGRFLGKGGFAKCFE----ISDADTKEVFAGKIVPKSLL-L 54
Query: 63 KHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVF 122
K + EI + L+H + G E ++F+ + C L + +
Sbjct: 55 KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLL--ELHKRRKAL 112
Query: 123 SPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFE 182
+ R+YL +I+ ++LH + +RDLK N+ + + V + DF L+
Sbjct: 113 TEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA---------- 162
Query: 183 KQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNG 242
E KK
Sbjct: 163 ------------------------------TKVEYDGERKKV------------------ 174
Query: 243 ERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLM 302
GT Y++PEV+ GH F VD W++G + Y +L G PF KET+ +
Sbjct: 175 -----LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK 229
Query: 303 ---KTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
P+ + LIQ++L+ DP R E+ FF
Sbjct: 230 NEYSIPKHIN--PVAASLIQKMLQTDPTARP----TINELLNDEFFT 270
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-50
Identities = 73/348 (20%), Positives = 115/348 (33%), Gaps = 79/348 (22%)
Query: 2 EATPPPQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLH 61
+ LGKG F +D + FA K+V KS L
Sbjct: 25 PPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFE----ISDADTKEVFAGKIVPKSLL- 79
Query: 62 AKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRV 121
K + EI + L+H + G E ++F+ + C L + +
Sbjct: 80 LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLL--ELHKRRKA 137
Query: 122 FSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAF 181
+ R+YL +I+ ++LH + +RDLK N+ + + V + DF L+
Sbjct: 138 LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA--------- 188
Query: 182 EKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDN 241
E KK
Sbjct: 189 -------------------------------TKVEYDGERKKV----------------- 200
Query: 242 GERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL 301
GT Y++PEV+ GH F VD W++G + Y +L G PF KET+ +
Sbjct: 201 ------LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK 254
Query: 302 M---KTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
P+ + LIQ++L+ DP R E+ FF
Sbjct: 255 KNEYSIPKHIN--PVAASLIQKMLQTDPTARP----TINELLNDEFFT 296
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 2e-50
Identities = 67/346 (19%), Positives = 123/346 (35%), Gaps = 81/346 (23%)
Query: 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRV 76
L + + ++ LG+G G VF ++ D C +A+K + L + A + E++
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDD----CNYAIKRIR---LPNRELAREKVMREVKA 56
Query: 77 LSRLSHPFLPKLLGSLETDEFLAWAVP------------YCPGGDL-NVLRYKQNDRVFS 123
L++L HP + + + P C +L + + +
Sbjct: 57 LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116
Query: 124 PSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEK 183
SV +I A+E LH+ G+ +RDLKP NI V + DF L +
Sbjct: 117 RSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM-------- 168
Query: 184 QSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGE 243
+ + + +
Sbjct: 169 --------------------------------DQDEEEQTVLTPMPAYARH--------- 187
Query: 244 RSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK 303
VGT+ Y+SPE + G+ + VD ++LG++ +E+LY PF + + +
Sbjct: 188 --TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRN 242
Query: 304 ---TPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
P F + ++Q +L P++R A I E+ F+
Sbjct: 243 LKFPPLFTQKYPCEYVMVQDMLSPSPMERP----EAINIIENAVFE 284
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-46
Identities = 65/182 (35%), Positives = 104/182 (57%), Gaps = 10/182 (5%)
Query: 2 EATPPPQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLH 61
A PPPQP+ ++ K KILG+G+ TV L + A T+R +A+K+++K +
Sbjct: 17 HAQPPPQPRK---KRPEDFKFGKILGEGSFSTVVLARELA---TSR-EYAIKILEKRHII 69
Query: 62 AKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRV 121
+++ E V+SRL HPF KL + + DE L + + Y G+L L+Y +
Sbjct: 70 KENKVPY-VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL--LKYIRKIGS 126
Query: 122 FSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAF 181
F + RFY +EI+ A+E+LH GI +RDLKPENIL+ + H+ +TDF ++ L ++
Sbjct: 127 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 186
Query: 182 EK 183
+
Sbjct: 187 AR 188
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 6e-44
Identities = 44/128 (34%), Positives = 66/128 (51%), Gaps = 4/128 (3%)
Query: 240 DNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRN 299
R+NSFVGT +YVSPE++ + D WALG + Y+++ G PFR N F+
Sbjct: 184 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK 243
Query: 300 VLMKTPEF-VGQRTALTDLIQRLLEKDPVKRLGY--LRGACEIKEHVFFKGVRWDLLTDV 356
++ +F DL+++LL D KRLG + G +K H FF+ V W+ L
Sbjct: 244 IIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQ 303
Query: 357 LRPPFIPS 364
PP + +
Sbjct: 304 -TPPKLTA 310
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 160 bits (405), Expect = 2e-45
Identities = 50/344 (14%), Positives = 94/344 (27%), Gaps = 61/344 (17%)
Query: 5 PPPQPQTTPSLDLDNLKALKILGKGAMGTVFLV-HDRAADPTARCPFALKVVDKSTLHAK 63
P +P+T L + +LG+GA V+ D + F LKV +
Sbjct: 52 PAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEF 111
Query: 64 HEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLN---VLRYKQNDR 120
+ + + L K + G L L ++
Sbjct: 112 YIGTQ----LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEK 167
Query: 121 VFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTA 180
V ++ + ++ IE +H+ I + D+KP+N ++ + DLS +
Sbjct: 168 VMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAG-LALID 226
Query: 181 FEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFD 240
G S + F
Sbjct: 227 L--------------------------------------GQ-----------SIDMKLFP 237
Query: 241 NGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNV 300
G + T + E++ + +D++ + Y ML+GT E
Sbjct: 238 KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEG 297
Query: 301 LMKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVF 344
L + + +L L L + + VF
Sbjct: 298 LFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-45
Identities = 54/137 (39%), Positives = 79/137 (57%), Gaps = 3/137 (2%)
Query: 237 QSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKET 296
++ ++ +++F GT EY++PEV+ ++ VDWW LG + YEMLYG PF +N E
Sbjct: 188 ENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 247
Query: 297 FRNVLMKTPEFVGQRT-ALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTD 355
+ N+L K + T + L++ LL+KD KRLG EIK HVFF + WD L +
Sbjct: 248 YDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLIN 307
Query: 356 V-LRPPFIPS-REENDL 370
+ PPF P+ NDL
Sbjct: 308 KKITPPFNPNVSGPNDL 324
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-39
Identities = 61/172 (35%), Positives = 89/172 (51%), Gaps = 8/172 (4%)
Query: 2 EATPPPQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLH 61
P + P + LK++GKG+ G V L +A + +A+KV+ K +
Sbjct: 22 SQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEE----VFYAVKVLQKKAIL 77
Query: 62 AKHEAERRARWEIRVLSR-LSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDR 120
K E + E VL + + HPFL L S +T + L + + Y GG+L + Q +R
Sbjct: 78 KKKEEKH-IMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL--FYHLQRER 134
Query: 121 VFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172
F RFY +EI A+ +LH++ I YRDLKPENIL+ GH+ LTDF L
Sbjct: 135 CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC 186
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 5e-45
Identities = 52/131 (39%), Positives = 75/131 (57%), Gaps = 3/131 (2%)
Query: 237 QSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKET 296
+S D+ +++ SF GT EY++PEVV GH + DWW+ G+L +EML GT PF+GK+RKET
Sbjct: 175 ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET 234
Query: 297 FRNVLMKTPEF-VGQRTALTDLIQRLLEKDPVKRLGY-LRGACEIKEHVFFKGVRWD-LL 353
+L L++ L +++P RLG G EIK H FF + W+ L
Sbjct: 235 MTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLY 294
Query: 354 TDVLRPPFIPS 364
+ PPF P+
Sbjct: 295 RREIHPPFKPA 305
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-42
Identities = 59/164 (35%), Positives = 95/164 (57%), Gaps = 5/164 (3%)
Query: 9 PQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAER 68
+ D + LK+LG+G+ G VFLV + + +A+KV+ K+TL +
Sbjct: 15 KEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQL-YAMKVLKKATLKVRDRVRT 73
Query: 69 RARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIR 128
+ E +L ++HPF+ KL + +T+ L + + GGDL + +F+ ++
Sbjct: 74 KM--ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVK 129
Query: 129 FYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172
FYL+E+ A++HLH++GI YRDLKPENIL+ + GH+ LTDF LS
Sbjct: 130 FYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS 173
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-44
Identities = 52/133 (39%), Positives = 80/133 (60%), Gaps = 7/133 (5%)
Query: 237 QSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKET 296
+S +G +++F GT EY++PE++ GH AVDWW+LG L Y+ML G PF G+NRK+T
Sbjct: 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT 229
Query: 297 FRNVLMKT---PEFVGQRTALTDLIQRLLEKDPVKRLGY-LRGACEIKEHVFFKGVRWD- 351
+L P ++ Q DL+++LL+++ RLG A E++ H FF+ + W+
Sbjct: 230 IDKILKCKLNLPPYLTQEAR--DLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEE 287
Query: 352 LLTDVLRPPFIPS 364
LL + PPF P
Sbjct: 288 LLARKVEPPFKPL 300
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 1e-41
Identities = 56/166 (33%), Positives = 84/166 (50%), Gaps = 3/166 (1%)
Query: 7 PQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEA 66
+ + + + L++LGKG G VF V T + FA+KV+ K+ + +
Sbjct: 6 SVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKI-FAMKVLKKAMIVRNAKD 64
Query: 67 ERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSV 126
+ E +L + HPF+ L+ + +T L + Y GG+L + + +F
Sbjct: 65 TAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDT 122
Query: 127 IRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172
FYL+EI A+ HLH GI YRDLKPENI++ GHV LTDF L
Sbjct: 123 ACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC 168
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 154 bits (393), Expect = 4e-44
Identities = 52/167 (31%), Positives = 90/167 (53%), Gaps = 7/167 (4%)
Query: 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARW 72
P L + + L+ LG G+ G V L+ R +A+KV+ K + + E
Sbjct: 1 PKYSLQDFQILRTLGTGSFGRVHLIRSRHNGR----YYAMKVLKKEIVVRLKQVEH-TND 55
Query: 73 EIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLS 132
E +LS ++HPF+ ++ G+ + + + + Y GG+L + + F V +FY +
Sbjct: 56 ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYAA 113
Query: 133 EIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKT 179
E+ A+E+LH+ I YRDLKPENIL+ ++GH+ +TDF ++ + T
Sbjct: 114 EVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 160
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 7e-42
Identities = 45/126 (35%), Positives = 71/126 (56%), Gaps = 3/126 (2%)
Query: 241 NGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNV 300
+ + + GT +Y++PEVV + ++DWW+ GIL YEML G TPF N +T+ +
Sbjct: 156 VPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI 215
Query: 301 LMKTPEF-VGQRTALTDLIQRLLEKDPVKRLGYLR-GACEIKEHVFFKGVRWD-LLTDVL 357
L F + DL+ RL+ +D +RLG L+ G ++K H +FK V W+ LL+ +
Sbjct: 216 LNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNI 275
Query: 358 RPPFIP 363
P+ P
Sbjct: 276 ETPYEP 281
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 4e-43
Identities = 53/178 (29%), Positives = 92/178 (51%), Gaps = 7/178 (3%)
Query: 2 EATPPPQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLH 61
+ + + + LD +K LG G+ G V LV + + +A+K++DK +
Sbjct: 25 DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNH----YAMKILDKQKVV 80
Query: 62 AKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRV 121
+ E E R+L ++ PFL KL S + + L + Y GG++ + +
Sbjct: 81 KLKQIEH-TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGR 137
Query: 122 FSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKT 179
FS RFY ++I+ E+LH++ + YRDLKPEN+LI Q G++ +TDF ++ + +T
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-41
Identities = 43/126 (34%), Positives = 64/126 (50%), Gaps = 3/126 (2%)
Query: 241 NGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNV 300
R+ + GT E ++PE++ G+ AVDWWALG+L YEM G PF + + +
Sbjct: 191 VKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250
Query: 301 LMKTPEFVGQRT-ALTDLIQRLLEKDPVKRLGYLR-GACEIKEHVFFKGVRWD-LLTDVL 357
+ F + L DL++ LL+ D KR G L+ G +IK H +F W + +
Sbjct: 251 VSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKV 310
Query: 358 RPPFIP 363
PFIP
Sbjct: 311 EAPFIP 316
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 1e-42
Identities = 47/127 (37%), Positives = 69/127 (54%), Gaps = 3/127 (2%)
Query: 241 NGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNV 300
+G +F GT EY++PEV+ + + AVDWW LG++ YEM+ G PF ++ + F +
Sbjct: 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217
Query: 301 LMKTPEFVGQRTALT-DLIQRLLEKDPVKRLGY-LRGACEIKEHVFFKGVRWDLLTD-VL 357
LM+ F + L+ LL+KDP +RLG A E+ EH FF + W + L
Sbjct: 218 LMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKL 277
Query: 358 RPPFIPS 364
PPF P
Sbjct: 278 LPPFKPQ 284
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-39
Identities = 56/158 (35%), Positives = 90/158 (56%), Gaps = 7/158 (4%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
+ +++ LK+LGKG G V LV ++A +A+K++ K + AK E E
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATG----RYYAMKILRKEVIIAKDEVAH-TVTES 56
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEI 134
RVL HPFL L + +T + L + + Y GG+L + +RVF+ RFY +EI
Sbjct: 57 RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEI 114
Query: 135 ICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172
+ A+E+LH+ + YRD+K EN+++ + GH+ +TDF L
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC 152
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-42
Identities = 51/172 (29%), Positives = 83/172 (48%), Gaps = 22/172 (12%)
Query: 241 NGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNV 300
+G + +F GT +Y++PE++ + +VDWWA G+L YEML G PF G++ E F+++
Sbjct: 174 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 233
Query: 301 LMKT---PEFVGQRTALTDLIQRLLEKDPVKRLGY-LRGACEIKEHVFFKGVRWDLLTD- 355
+ P+ + + + + L+ K P KRLG G +IKEH FF+ + W+ L
Sbjct: 234 MEHNVAYPKSMSKEAV--AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERK 291
Query: 356 VLRPPFIPSREENDLTEKAMSGGGVDIREYF--ENLRAPPPSMPPSPLPSPS 405
++PP+ P + E F R PP PP +
Sbjct: 292 EIQPPYKPKACGRNA-------------ENFDRFFTRHPPVLTPPDQEVIRN 330
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-38
Identities = 48/172 (27%), Positives = 78/172 (45%), Gaps = 8/172 (4%)
Query: 2 EATPPPQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLH 61
+ + L + L +LGKG+ G V L + D +A+K++ K +
Sbjct: 4 TVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTD----ELYAVKILKKDVVI 59
Query: 62 AKHEAERRARWEIRVLSR-LSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDR 120
+ E E RVL+ PFL +L +T + L + + Y GGDL + + Q
Sbjct: 60 QDDDVEC-TMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVG 116
Query: 121 VFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172
F FY +EI + L + GI YRDLK +N+++ GH+ + DF +
Sbjct: 117 RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 168
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-42
Identities = 52/175 (29%), Positives = 95/175 (54%), Gaps = 9/175 (5%)
Query: 6 PPQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHE 65
PP ++ D+ + L+ +GKG+ G V +V +A+K ++K ++E
Sbjct: 3 PPVFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKM----YAMKYMNKQKCVERNE 58
Query: 66 AERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYK-QNDRVFSP 124
+ E++++ L HPFL L S + +E + V GGDL RY Q + F
Sbjct: 59 VRNVFK-ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDL---RYHLQQNVHFKE 114
Query: 125 SVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKT 179
++ ++ E++ A+++L N I +RD+KP+NIL+ + GHV +TDF+++ L ++T
Sbjct: 115 ETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-37
Identities = 35/135 (25%), Positives = 64/135 (47%), Gaps = 11/135 (8%)
Query: 239 FDNGERSNSFVGTEEYVSPEVV---RGDGHEFAVDWWALGILTYEMLYGTTPFRGK---N 292
+ + GT+ Y++PE+ +G G+ FAVDWW+LG+ YE+L G P+ + +
Sbjct: 165 LPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS 224
Query: 293 RKETFRNVLMKTPEF-VGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351
KE + + L+++LLE +P +R +++ + + WD
Sbjct: 225 SKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFS---QLSDVQNFPYMNDINWD 281
Query: 352 -LLTDVLRPPFIPSR 365
+ L P FIP++
Sbjct: 282 AVFQKRLIPGFIPNK 296
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-41
Identities = 45/128 (35%), Positives = 67/128 (52%), Gaps = 4/128 (3%)
Query: 241 NGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNV 300
NG + +F GT +Y++PE+++ + AVDWWA+G+L YEML G PF +N + F +
Sbjct: 177 NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI 236
Query: 301 LMKTPEFVGQRTAL-TDLIQRLLEKDPVKRLGYLR--GACEIKEHVFFKGVRWD-LLTDV 356
L + T +++ + K+P RLG L G I H FFK + W L
Sbjct: 237 LNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQ 296
Query: 357 LRPPFIPS 364
+ PPF P
Sbjct: 297 IEPPFRPR 304
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-37
Identities = 56/172 (32%), Positives = 89/172 (51%), Gaps = 8/172 (4%)
Query: 2 EATPPPQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLH 61
+ ++ L +DN + +++LGKG+ G V L + +A+KV+ K +
Sbjct: 7 KEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETG----DLYAVKVLKKDVIL 62
Query: 62 AKHEAERRARWEIRVLSR-LSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDR 120
+ E E R+LS +HPFL +L +T + L + + + GGDL + + Q R
Sbjct: 63 QDDDVEC-TMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSR 119
Query: 121 VFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172
F + RFY +EII A+ LH+ GI YRDLK +N+L+ GH L DF +
Sbjct: 120 RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC 171
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-41
Identities = 62/172 (36%), Positives = 93/172 (54%), Gaps = 4/172 (2%)
Query: 2 EATPPPQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLH 61
E + ++N + LK+LG GA G VFLV + T + +A+KV+ K+T+
Sbjct: 38 ELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKL-YAMKVLKKATIV 96
Query: 62 AKHEAERRARWEIRVLSRLSH-PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDR 120
K + R E +VL + PFL L + +T+ L + Y GG+L +
Sbjct: 97 QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGEL--FTHLSQRE 154
Query: 121 VFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172
F+ ++ Y+ EI+ A+EHLH +GI YRD+K ENIL+ +GHV LTDF LS
Sbjct: 155 RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 206
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 8e-41
Identities = 61/135 (45%), Positives = 79/135 (58%), Gaps = 9/135 (6%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGD--GHEFAVDWWALGILTYEMLYGTTPF----RGKN 292
D ER+ F GT EY++P++VRG GH+ AVDWW+LG+L YE+L G +PF +
Sbjct: 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS 270
Query: 293 RKETFRNVLMKTPEF-VGQRTALTDLIQRLLEKDPVKRLGYL-RGACEIKEHVFFKGVRW 350
+ E R +L P + DLIQRLL KDP KRLG R A EIKEH+FF+ + W
Sbjct: 271 QAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 330
Query: 351 DLLTD-VLRPPFIPS 364
D L + PF P
Sbjct: 331 DDLAAKKVPAPFKPV 345
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-41
Identities = 55/175 (31%), Positives = 89/175 (50%), Gaps = 6/175 (3%)
Query: 3 ATPPPQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHA 62
A P L ++ + LK++G+GA G V +V + AD FA+K+++K +
Sbjct: 59 AKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKV----FAMKILNKWEMLK 114
Query: 63 KHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVF 122
+ E R E VL ++ L + + D L + Y GGDL L K DR
Sbjct: 115 RAETAC-FREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR-L 172
Query: 123 SPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177
+ RFYL+E++ AI+ +H + +RD+KP+NIL+ +GH+ L DF L++
Sbjct: 173 PEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-39
Identities = 52/188 (27%), Positives = 80/188 (42%), Gaps = 29/188 (15%)
Query: 240 DNGERSNSFVGTEEYVSPEVVRGD-----GHEFAVDWWALGILTYEMLYGTTPFRGKNRK 294
D +S+ VGT +Y+SPE+++ + DWW+LG+ YEMLYG TPF ++
Sbjct: 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 287
Query: 295 ETFRNVL-----MKTPEFVGQ-RTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGV 348
ET+ ++ + P V DLI+RL+ RLG G + K+H FF G+
Sbjct: 288 ETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLI-CSREHRLGQ-NGIEDFKKHPFFSGI 345
Query: 349 RWDLLTDVLRPPFIPSREENDLTEKAMSGGGVDIR---EYFENLRAPPPSMPPSPLPSPS 405
WD + + P+IP D + L+ PP+
Sbjct: 346 DWDNIRNC-EAPYIPEVS-----------SPTDTSNFDVDDDCLKNSETMPPPTHTAFSG 393
Query: 406 -HRSFAEY 412
H F +
Sbjct: 394 HHLPFVGF 401
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 6e-41
Identities = 47/186 (25%), Positives = 73/186 (39%), Gaps = 27/186 (14%)
Query: 240 DNGERSNSFVGTEEYVSPEVVRGDG----HEFAVDWWALGILTYEMLYGTTPFRGKNRKE 295
+ R ++ VGT +Y+SPEV++ G + DWW++G+ YEML G TPF +
Sbjct: 221 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 280
Query: 296 TFRNVLM-----KTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRW 350
T+ ++ P+ +LI L D RLG G EIK H+FFK +W
Sbjct: 281 TYSKIMNHKNSLTFPDDNDISKEAKNLICAFL-TDREVRLGR-NGVEEIKRHLFFKNDQW 338
Query: 351 DLLTD-VLRPPFIPSREENDLTEKAMSGGGVDIR---EYFENLRAPPPSMPPSPLPSPSH 406
T P +P +D + E+ + P +
Sbjct: 339 AWETLRDTVAPVVPDLS-----------SDIDTSNFDDLEEDKG-EEETFPIPKAFVGNQ 386
Query: 407 RSFAEY 412
F +
Sbjct: 387 LPFVGF 392
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 7e-41
Identities = 44/174 (25%), Positives = 90/174 (51%), Gaps = 8/174 (4%)
Query: 5 PPPQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKH 64
+ ++ + +K++G+GA G V LV ++ +A+K++ K + +
Sbjct: 56 DTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKV----YAMKLLSKFEMIKRS 111
Query: 65 EAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSP 124
++ E +++ + P++ +L + + D +L + Y PGGDL + N
Sbjct: 112 DSAF-FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL--VNLMSNYD-VPE 167
Query: 125 SVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178
RFY +E++ A++ +H+MG +RD+KP+N+L+ +SGH+ L DF + K+
Sbjct: 168 KWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 9e-41
Identities = 50/171 (29%), Positives = 81/171 (47%), Gaps = 18/171 (10%)
Query: 240 DNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRN 299
+G + +F GT +Y++PE++ + +VDWWA G+L YEML G PF G++ E F++
Sbjct: 494 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS 553
Query: 300 VLMKTPEFVGQRTAL-TDLIQRLLEKDPVKRLGY-LRGACEIKEHVFFKGVRWDLLTD-V 356
++ + + + + L+ K P KRLG G +IKEH FF+ + W+ L
Sbjct: 554 IMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKE 613
Query: 357 LRPPFIPSREENDLTEKAMSGGGVDIREYF--ENLRAPPPSMPPSPLPSPS 405
++PP+ P + E F R PP PP +
Sbjct: 614 IQPPYKPKASGRNA-------------ENFDRFFTRHPPVLTPPDQEVIRN 651
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 9e-36
Identities = 48/172 (27%), Positives = 78/172 (45%), Gaps = 8/172 (4%)
Query: 2 EATPPPQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLH 61
+ + L + L +LGKG+ G V L + D +A+K++ K +
Sbjct: 325 TISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTD----ELYAVKILKKDVVI 380
Query: 62 AKHEAERRARWEIRVLSR-LSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDR 120
+ E E RVL+ PFL +L +T + L + + Y GGDL + + Q
Sbjct: 381 QDDDVEC-TMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVG 437
Query: 121 VFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172
F FY +EI + L + GI YRDLK +N+++ GH+ + DF +
Sbjct: 438 RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 489
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 9e-41
Identities = 49/170 (28%), Positives = 80/170 (47%), Gaps = 21/170 (12%)
Query: 241 NGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNV 300
++N+F GT +Y++PE++ G + +VDWW+ G+L YEML G +PF G++ +E F ++
Sbjct: 171 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 230
Query: 301 LMKTPEF-VGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD-LLTDVLR 358
M P + DL+ +L ++P KRLG +I++H F+ + W+ L +
Sbjct: 231 RMDNPFYPRWLEKEAKDLLVKLFVREPEKRLG---VRGDIRQHPLFREINWEELERKEID 287
Query: 359 PPFIPS-REENDLTEKAMSGGGVDIREYF--ENLRAPPPSMPPSPLPSPS 405
PPF P + D F E L P S
Sbjct: 288 PPFRPKVKSPFDC-------------SNFDKEFLNEKPRLSFADRALINS 324
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-39
Identities = 57/169 (33%), Positives = 87/169 (51%), Gaps = 8/169 (4%)
Query: 5 PPPQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKH 64
+P L +++ K+LGKG+ G VFL + + FA+K + K +
Sbjct: 4 NKERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTN----QFFAIKALKKDVVLMDD 59
Query: 65 EAERRARWEIRVLSR-LSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFS 123
+ E E RVLS HPFL + + +T E L + + Y GGDL + + Q+ F
Sbjct: 60 DVEC-TMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFD 116
Query: 124 PSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172
S FY +EII ++ LH+ GI YRDLK +NIL+ + GH+ + DF +
Sbjct: 117 LSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC 165
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-40
Identities = 50/164 (30%), Positives = 85/164 (51%), Gaps = 6/164 (3%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
L D+ + LK++G+GA V +V + +A+K+++K + + E R E
Sbjct: 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQV----YAMKIMNKWDMLKRGEVSC-FREER 112
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEI 134
VL ++ +L + + + +L + Y GGDL L K +R + RFYL+EI
Sbjct: 113 DVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGER-IPAEMARFYLAEI 171
Query: 135 ICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178
+ AI+ +H +G +RD+KP+NIL+ + GH+ L DF L
Sbjct: 172 VMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 7e-39
Identities = 57/187 (30%), Positives = 73/187 (39%), Gaps = 31/187 (16%)
Query: 240 DNGERSNSFVGTEEYVSPEVVRGDG-------HEFAVDWWALGILTYEMLYGTTPFRGKN 292
D RS VGT +Y+SPE+++ G + DWWALG+ YEM YG TPF +
Sbjct: 215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274
Query: 293 RKETFRNVLMKTPEFVGQRTALT------DLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
ET+ ++ D IQRLL P RLG GA + + H FF
Sbjct: 275 TAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLL-CPPETRLGR-GGAGDFRTHPFFF 332
Query: 347 GVRWDLLTDVLRPPFIPSREENDLTEKAMSGGGVDIR---EYFENLRAPPPSMPPSPLPS 403
G+ WD L D PPF P E G D + L S L
Sbjct: 333 GLDWDGLRDS-VPPFTPDFE-----------GATDTCNFDLVEDGLT-AMVSGGGETLSD 379
Query: 404 PSHRSFA 410
+
Sbjct: 380 IREGAPL 386
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-40
Identities = 48/127 (37%), Positives = 70/127 (55%), Gaps = 3/127 (2%)
Query: 240 DNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRN 299
+G +F GT EY++PEV+ + + AVDWW LG++ YEM+ G PF ++ ++ F
Sbjct: 301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 360
Query: 300 VLMKTPEFVGQRTA-LTDLIQRLLEKDPVKRLGYL-RGACEIKEHVFFKGVRWD-LLTDV 356
+LM+ F L+ LL+KDP +RLG A EI +H FF G+ W +
Sbjct: 361 ILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKK 420
Query: 357 LRPPFIP 363
L PPF P
Sbjct: 421 LSPPFKP 427
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 59/172 (34%), Positives = 92/172 (53%), Gaps = 8/172 (4%)
Query: 2 EATPPPQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLH 61
E + + ++ + LK+LGKG G V LV ++A +A+K++ K +
Sbjct: 132 EEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRY----YAMKILKKEVIV 187
Query: 62 AKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRV 121
AK E E RVL HPFL L S +T + L + + Y GG+L + +RV
Sbjct: 188 AKDEVAH-TLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERV 244
Query: 122 FSPSVIRFYLSEIICAIEHLHN-MGIAYRDLKPENILIRQSGHVTLTDFDLS 172
FS RFY +EI+ A+++LH+ + YRDLK EN+++ + GH+ +TDF L
Sbjct: 245 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC 296
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-39
Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 14/144 (9%)
Query: 241 NGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPF---------RGK 291
G+ +++F GT Y++PE++RG+ + F+VDWWALG+L +EM+ G +PF
Sbjct: 163 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 222
Query: 292 NRKETFRNVLMKTPEFVGQRTAL-TDLIQRLLEKDPVKRLGY--LRGACEIKEHVFFKGV 348
F+ +L K + +++ L KDP +RLG G +I+ H FF+ V
Sbjct: 223 TEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282
Query: 349 RWDLLTD-VLRPPFIPS-REENDL 370
WD++ + PPF P+ E L
Sbjct: 283 DWDMMEQKQVVPPFKPNISGEFGL 306
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-38
Identities = 52/162 (32%), Positives = 83/162 (51%), Gaps = 8/162 (4%)
Query: 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRAR 71
L L + L+++G+G+ V LV + D +A+KVV K ++ + + +
Sbjct: 3 MDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTD----RIYAMKVVKKELVNDDEDIDW-VQ 57
Query: 72 WEIRVLSR-LSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFY 130
E V + +HPFL L +T+ L + + Y GGDL + + Q R RFY
Sbjct: 58 TEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFY 115
Query: 131 LSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172
+EI A+ +LH GI YRDLK +N+L+ GH+ LTD+ +
Sbjct: 116 SAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 157
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-39
Identities = 52/170 (30%), Positives = 86/170 (50%), Gaps = 8/170 (4%)
Query: 4 TPPPQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAK 63
+ + SL L + L+++G+G+ V LV + D +A++VV K ++
Sbjct: 38 NTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTD----RIYAMRVVKKELVNDD 93
Query: 64 HEAERRARWEIRVLSR-LSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVF 122
+ + + E V + +HPFL L +T+ L + + Y GGDL + + Q R
Sbjct: 94 EDIDW-VQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKL 150
Query: 123 SPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172
RFY +EI A+ +LH GI YRDLK +N+L+ GH+ LTD+ +
Sbjct: 151 PEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 200
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-38
Identities = 49/147 (33%), Positives = 79/147 (53%), Gaps = 18/147 (12%)
Query: 240 DNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPF---------RG 290
G+ +++F GT Y++PE++RG+ + F+VDWWALG+L +EM+ G +PF
Sbjct: 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 264
Query: 291 KNRKETFRNVLMKT---PEFVGQRTALTDLIQRLLEKDPVKRLGY--LRGACEIKEHVFF 345
F+ +L K P + + A +++ L KDP +RLG G +I+ H FF
Sbjct: 265 NTEDYLFQVILEKQIRIPRSLSVKAA--SVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322
Query: 346 KGVRWDLLTD-VLRPPFIPS-REENDL 370
+ V WD++ + PPF P+ E L
Sbjct: 323 RNVDWDMMEQKQVVPPFKPNISGEFGL 349
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 8e-39
Identities = 50/178 (28%), Positives = 84/178 (47%), Gaps = 19/178 (10%)
Query: 242 GERSNSFVGTEEYVSPEVV-RGDGHEFAVDWWALGILTYEMLYGTTPFRG---KNRKETF 297
++ ++ VGT Y++PEV+ +G ++ + DW++LG + +++L G +PFR K++ E
Sbjct: 344 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403
Query: 298 RNVLMKTPEFVGQRTA-LTDLIQRLLEKDPVKRLGYL-RGACEIKEHVFFKGVRWD-LLT 354
R L E + L L++ LL++D +RLG L RGA E+KE FF+ + W +
Sbjct: 404 RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFL 463
Query: 355 DVLRPPFIPSREENDLTEKAMSGGGVDIREYFENLRAPPPSMPPSPLPSPSHRSFAEY 412
PP IP R E + DI F+ L + +
Sbjct: 464 QKYPPPLIPPRGEVNAA------DAFDI-GSFD-----EEDTKGIKLLDSDQELYRNF 509
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-37
Identities = 54/176 (30%), Positives = 88/176 (50%), Gaps = 10/176 (5%)
Query: 8 QPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAE 67
+ L +++ +I+G+G G V+ +A+K +DK + K E
Sbjct: 179 NVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKM----YAMKCLDKKRIKMKQG-E 233
Query: 68 RRARWEIRVLSRLS---HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSP 124
A E +LS +S PF+ + + T + L++ + GGDL + VFS
Sbjct: 234 TLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSE 291
Query: 125 SVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTA 180
+ +RFY +EII +EH+HN + YRDLKP NIL+ + GHV ++D L+ + KK
Sbjct: 292 ADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 347
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-38
Identities = 50/133 (37%), Positives = 71/133 (53%), Gaps = 7/133 (5%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRK---- 294
G+ VGT Y++PEVV+ + + F+ DWWALG L YEM+ G +PF+ + +K
Sbjct: 336 VPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE 395
Query: 295 ETFRNVLMKTPEFVGQRT-ALTDLIQRLLEKDPVKRLGYL-RGACEIKEHVFFKGVRWD- 351
E R V E+ + + L +LL KDP +RLG A E+KEH FK + +
Sbjct: 396 EVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKR 455
Query: 352 LLTDVLRPPFIPS 364
L +L PPF P
Sbjct: 456 LGAGMLEPPFKPD 468
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 48/171 (28%), Positives = 79/171 (46%), Gaps = 5/171 (2%)
Query: 8 QPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAE 67
+ + + + ++LGKG G V RA +A K ++K + +
Sbjct: 174 KWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKM----YACKKLEKKRIKKRKGEA 229
Query: 68 RRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVI 127
A E ++L +++ F+ L + ET + L + GGDL Y F +
Sbjct: 230 M-ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARA 288
Query: 128 RFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178
FY +EI C +E LH I YRDLKPENIL+ GH+ ++D L+ ++ +
Sbjct: 289 VFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-38
Identities = 61/348 (17%), Positives = 111/348 (31%), Gaps = 78/348 (22%)
Query: 11 TTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRA 70
T L L+ ++L +G V+ D + +ALK + + +
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGS----GREYALKRLLSNEEEKNRAIIQ-- 74
Query: 71 RWEIRVLSRLS-HPFLPKLLGS-------LETDEFLAWAVP-YCPGGDLNVLRYKQNDRV 121
E+ + +LS HP + + + +T + + C G + L+ ++
Sbjct: 75 --EVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP 132
Query: 122 FSPSVIRFYLSEIICAIEHLHNMG--IAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKT 179
S + + A++H+H I +RDLK EN+L+ G + L DF + +
Sbjct: 133 LSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYP 192
Query: 180 AFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSF 239
S Q
Sbjct: 193 ---------------------------------------------------DYSWSAQRR 201
Query: 240 DNGERSNSFVGTEEYVSPEVVRGDGHE---FAVDWWALGILTYEMLYGTTPFRGKNRKET 296
E + T Y +PE++ + D WALG + Y + + PF +
Sbjct: 202 ALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR- 260
Query: 297 FRNVLMKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVF 344
N P Q T LI+ +L+ +P +RL E+ +
Sbjct: 261 IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERL----SIAEVVHQLQ 304
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 2e-34
Identities = 51/291 (17%), Positives = 92/291 (31%), Gaps = 64/291 (21%)
Query: 63 KHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRV 121
+IR + S L +L + C +L + + + +
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 122 FSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAF 181
V +I A+E LH+ G+ +RDLKP NI V + DF L +
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM------ 214
Query: 182 EKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDN 241
+ + +
Sbjct: 215 ----------------------------------DQDEEEQTVLT-----------PMPA 229
Query: 242 GERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFR-GKNRKETFRNV 300
VGT+ Y+SPE + G+ + VD ++LG++ +E+LY F R +
Sbjct: 230 YATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITD- 285
Query: 301 LMK---TPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGV 348
+ F + ++Q +L P +R A +I E+ F+ +
Sbjct: 286 VRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERP----EATDIIENAIFENL 332
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-34
Identities = 43/173 (24%), Positives = 67/173 (38%), Gaps = 9/173 (5%)
Query: 4 TPPPQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAK 63
+P P S + + L LG G+ G VF V + +A+K K
Sbjct: 43 SPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSK----EDGRLYAVKRSMSPFRGPK 98
Query: 64 HEAERRARWEIRVLSRL-SHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVF 122
A + A E+ ++ HP +L + E L C G L +
Sbjct: 99 DRARKLA--EVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQ-QHCEAWGASL 154
Query: 123 SPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
+ + YL + + A+ HLH+ G+ + D+KP NI + G L DF L L
Sbjct: 155 PEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-20
Identities = 23/109 (21%), Positives = 43/109 (39%), Gaps = 9/109 (8%)
Query: 240 DNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTT-PFRGKNRKETFR 298
G Y++PE+++G + A D ++LG+ E+ P G+ ++ +
Sbjct: 208 GTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQ 266
Query: 299 NVLMKTPEFVGQRT-ALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
L PEF + L ++ +LE DP R A + +
Sbjct: 267 GYLP--PEFTAGLSSELRSVLVMMLEPDPKLRA----TAEALLALPVLR 309
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 7e-34
Identities = 78/347 (22%), Positives = 127/347 (36%), Gaps = 89/347 (25%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-H 82
KILG G+ GTV R P A+K + + EI++L+ H
Sbjct: 21 KILGYGSSGTVVFQGSF----QGR-PVAVKRMLID----FCDIALM---EIKLLTESDDH 68
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVL-----RYKQNDRVFSPSVIRFYLSEIICA 137
P + + S TD FL A+ C +L L +N ++ L +I
Sbjct: 69 PNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 138 IEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTA-FEKQSLNNNKFPVLPV 196
+ HLH++ I +RDLKP+NIL+ S T + NL + F
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF--------------- 172
Query: 197 TENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256
GL K + Q SF N+ GT + +
Sbjct: 173 -----------------------GLCKK-------LDSGQSSFRT--NLNNPSGTSGWRA 200
Query: 257 PEVVRGDGHE-------FAVDWWALGILTYEML-YGTTPFRGKNRKETFRNVLMKTPEFV 308
PE++ + ++D +++G + Y +L G PF K +E+ N++
Sbjct: 201 PELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES--NIIRGIFSLD 258
Query: 309 GQRTAL--------TDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347
+ TDLI ++++ DP+KR A ++ H F
Sbjct: 259 EMKCLHDRSLIAEATDLISQMIDHDPLKRP----TAMKVLRHPLFWP 301
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-34
Identities = 43/163 (26%), Positives = 73/163 (44%), Gaps = 7/163 (4%)
Query: 10 QTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERR 69
+D+ + LGKG G V+L ++ ALKV+ KS L K E +
Sbjct: 6 MPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQ---NKF-IMALKVLFKSQLE-KEGVEHQ 60
Query: 70 ARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRF 129
R EI + S L HP + ++ + + + + P G+L + Q F
Sbjct: 61 LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL--YKELQKHGRFDEQRSAT 118
Query: 130 YLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172
++ E+ A+ + H + +RD+KPEN+L+ G + + DF S
Sbjct: 119 FMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS 161
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-29
Identities = 39/128 (30%), Positives = 58/128 (45%), Gaps = 14/128 (10%)
Query: 242 GERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL 301
R + GT +Y+ PE++ G H+ VD W G+L YE L G PF + ET R ++
Sbjct: 166 SLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV 225
Query: 302 ---MKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLR 358
+K P F+ DLI +LL P +RL + EH + K + +
Sbjct: 226 NVDLKFPPFLS--DGSKDLISKLLRYHPPQRL----PLKGVMEHPWVK-----ANSRRVL 274
Query: 359 PPFIPSRE 366
PP S +
Sbjct: 275 PPVYQSTQ 282
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-33
Identities = 46/176 (26%), Positives = 82/176 (46%), Gaps = 8/176 (4%)
Query: 9 PQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAER 68
+ ++ L+ +G+G+ G LV + +K ++ S + +K ER
Sbjct: 15 TENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQ----YVIKEINISRMSSK---ER 67
Query: 69 R-ARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVI 127
+R E+ VL+ + HP + + S E + L + YC GGDL Q +F I
Sbjct: 68 EESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI 127
Query: 128 RFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEK 183
+ +I A++H+H+ I +RD+K +NI + + G V L DF ++R L +
Sbjct: 128 LDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR 183
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-19
Identities = 32/175 (18%), Positives = 57/175 (32%), Gaps = 11/175 (6%)
Query: 241 NGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNV 300
E + + +GT Y+SPE+ + D WALG + YE+ F + K +
Sbjct: 178 TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI 237
Query: 301 LMKTPEFVGQR--TALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLR 358
+ + V L L+ +L +++P R I E F L+ L
Sbjct: 238 ISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRP----SVNSILEKGFIAKRIEKFLSPQLI 293
Query: 359 PPFIPSREENDLTEKAM-----SGGGVDIREYFENLRAPPPSMPPSPLPSPSHRS 408
+ + + + + G I P + PL +
Sbjct: 294 AEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYGIPLAYKKYGD 348
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-33
Identities = 45/156 (28%), Positives = 77/156 (49%), Gaps = 7/156 (4%)
Query: 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRV 76
L++ + + LGKG G V+L ++ + ALKV+ K+ L K E + R E+ +
Sbjct: 8 LEDFEIGRPLGKGKFGNVYLAREKQ---SKF-ILALKVLFKAQLE-KAGVEHQLRREVEI 62
Query: 77 LSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIIC 136
S L HP + +L G + + Y P G + R Q F Y++E+
Sbjct: 63 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY--RELQKLSKFDEQRTATYITELAN 120
Query: 137 AIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172
A+ + H+ + +RD+KPEN+L+ +G + + DF S
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 156
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-28
Identities = 36/108 (33%), Positives = 53/108 (49%), Gaps = 9/108 (8%)
Query: 242 GERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL 301
R GT +Y+ PE++ G H+ VD W+LG+L YE L G PF +ET++ +
Sbjct: 161 SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 220
Query: 302 ---MKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
P+FV DLI RLL+ +P +R E+ EH +
Sbjct: 221 RVEFTFPDFVT--EGARDLISRLLKHNPSQRP----MLREVLEHPWIT 262
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-33
Identities = 47/184 (25%), Positives = 76/184 (41%), Gaps = 8/184 (4%)
Query: 2 EATPPPQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLH 61
+ +P + L N + K +G+G V+ ALK V L
Sbjct: 17 QPQKALRPDMGYN-TLANFRIEKKIGRGQFSEVYRAACLLDGVP----VALKKVQIFDL- 70
Query: 62 AKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVL--RYKQND 119
+A EI +L +L+HP + K S D L + GDL+ + +K+
Sbjct: 71 MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK 130
Query: 120 RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKT 179
R+ + Y ++ A+EH+H+ + +RD+KP N+ I +G V L D L R KT
Sbjct: 131 RLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 190
Query: 180 AFEK 183
Sbjct: 191 TAAH 194
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 29/89 (32%), Positives = 40/89 (44%), Gaps = 5/89 (5%)
Query: 246 NSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGK--NRKETFRNVL-M 302
+S VGT Y+SPE + +G+ F D W+LG L YEM +PF G N + +
Sbjct: 194 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC 253
Query: 303 KTPEFVGQR--TALTDLIQRLLEKDPVKR 329
P L L+ + DP KR
Sbjct: 254 DYPPLPSDHYSEELRQLVNMCINPDPEKR 282
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 64/349 (18%), Positives = 117/349 (33%), Gaps = 71/349 (20%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAK-HEAERRARWEIRVLSRLSH 82
+G+G+ G V + + R A+K+++K+ + + R + E+R++ +L H
Sbjct: 32 GAIGQGSYGVVRVAIENQT----RAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLH 142
P + +L E ++++ + C GG L + +
Sbjct: 88 PNIARLYEVYEDEQYICLVMELCHGGH---------------------LLDKLNVFIDDS 126
Query: 143 NMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKR 202
A +K + + + E
Sbjct: 127 TGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQ---------------REKLIS 171
Query: 203 H--RRILT--RWLHAL--------PENKTGLKKTKSARVSP----VSRRQQSFDNGERS- 245
+ R+I + +LH PEN KS + +S+ +NGE
Sbjct: 172 NIMRQIFSALHYLHNQGICHRDIKPENFL-FSTNKSFEIKLVDFGLSKEFYKLNNGEYYG 230
Query: 246 -NSFVGTEEYVSPEVVRGDGHE--FAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLM 302
+ GT +V+PEV+ D W+ G+L + +L G PF G N +T VL
Sbjct: 231 MTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLN 290
Query: 303 KTPEFVGQR-----TALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
K F DL+ LL ++ +R A +H +
Sbjct: 291 KKLCFENPNYNVLSPLARDLLSNLLNRNVDERF----DAMRALQHPWIS 335
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-31
Identities = 42/184 (22%), Positives = 67/184 (36%), Gaps = 14/184 (7%)
Query: 9 PQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAER 68
+D + ++ LG+G V LV +ALK + + EA+R
Sbjct: 20 QGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHF----YALKRILCHEQQDREEAQR 75
Query: 69 RARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAV----PYCPGGDL--NVLRYKQNDRVF 122
E + +HP + +L+ + P+ G L + R K
Sbjct: 76 ----EADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFL 131
Query: 123 SPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFE 182
+ I + L I +E +H G A+RDLKP NIL+ G L D
Sbjct: 132 TEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGS 191
Query: 183 KQSL 186
+Q+L
Sbjct: 192 RQAL 195
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 22/128 (17%), Positives = 46/128 (35%), Gaps = 12/128 (9%)
Query: 226 SARVSPVS-RRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHE---FAVDWWALGILTYEM 281
S + + + + + T Y +PE+ H D W+LG + Y M
Sbjct: 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAM 239
Query: 282 LYGTTPFRGKNRK-ETFRNVLM---KTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGAC 337
++G P+ +K ++ + P+ +AL L+ ++ DP +R
Sbjct: 240 MFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRP----HIP 295
Query: 338 EIKEHVFF 345
+ +
Sbjct: 296 LLLSQLEA 303
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 34/182 (18%), Positives = 65/182 (35%), Gaps = 28/182 (15%)
Query: 10 QTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERR 69
T + K ++++G G G VF R + +K V + +
Sbjct: 3 HTVDKRFGMDFKEIELIGSGGFGQVFKAKHR----IDGKTYVIKRVKYN--------NEK 50
Query: 70 ARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVP----------------YCPGGDLNVL 113
A E++ L++L H + G + ++ +C G L
Sbjct: 51 AEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQW 110
Query: 114 RYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
K+ + +I ++++H+ + RDLKP NI + + V + DF L
Sbjct: 111 IEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT 170
Query: 174 NL 175
+L
Sbjct: 171 SL 172
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 7e-16
Identities = 27/110 (24%), Positives = 42/110 (38%), Gaps = 9/110 (8%)
Query: 238 SFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKET 296
S N + GT Y+SPE + + VD +ALG++ E+L+ T F
Sbjct: 171 SLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTD 230
Query: 297 FRNVLMKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
R+ + + L+Q+LL K P R EI +
Sbjct: 231 LRDG--IISDIFDK--KEKTLLQKLLSKKPEDRP----NTSEILRTLTVW 272
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 46/161 (28%), Positives = 67/161 (41%), Gaps = 18/161 (11%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP 83
ILG+GA VF + T FA+KV + + + + R E VL +L+H
Sbjct: 15 DILGQGATANVFRGRHKK---TGD-LFAIKVFNNISFLRPVDVQMR---EFEVLKKLNHK 67
Query: 84 FLPKLLGSLETDE----FLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYLSEIICAI 138
+ KL E L + +CP G L VL N S L +++ +
Sbjct: 68 NIVKLFAIEEETTTRHKVLI--MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 139 EHLHNMGIAYRDLKPENILIRQS----GHVTLTDFDLSRNL 175
HL GI +R++KP NI+ LTDF +R L
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 30/153 (19%), Positives = 49/153 (32%), Gaps = 48/153 (31%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEF--------AVDWWALGILTYEMLYGTTPFR- 289
++ E+ S GTEEY+ P++ VD W++G+ Y G+ PFR
Sbjct: 166 LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225
Query: 290 ---GKNRKETFRNVLMKTPEFV--------------------------GQRTALTDLIQR 320
+ KE ++ P G + LT ++
Sbjct: 226 FEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLAN 285
Query: 321 LLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLL 353
+LE D K G + D+L
Sbjct: 286 ILEADQEKCW----GFDQFFAET------SDIL 308
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-29
Identities = 52/333 (15%), Positives = 105/333 (31%), Gaps = 65/333 (19%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS- 81
L+ +G G G+VF R C +A+K K + E + A E+ + L
Sbjct: 16 LEKIGSGEFGSVFKCVKR----LDGCIYAIKRSKKPLAGSVDE--QNALREVYAHAVLGQ 69
Query: 82 HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVL--RYKQNDRVFSPSVIRFYLSEIICAIE 139
H + + + D+ + YC GG L + F + ++ L ++ +
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 140 HLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTEN 199
++H+M + + D+ K + N F ++
Sbjct: 130 YIHSMSLVHMDI--------------------------KPS--------NIF----ISRT 151
Query: 200 PKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEV 259
+ NK K V+ +S G +++ EV
Sbjct: 152 SIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP----------QVEEGDSRFLANEV 201
Query: 260 VRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVGQRT-ALTDL 317
++ + H D +AL + R ++ R + P + T+L
Sbjct: 202 LQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQ--GRLPRIPQVLSQEFTEL 259
Query: 318 IQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRW 350
++ ++ DP +R A + +H
Sbjct: 260 LKVMIHPDPERRP----SAMALVKHSVLLSASR 288
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-29
Identities = 36/174 (20%), Positives = 73/174 (41%), Gaps = 15/174 (8%)
Query: 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRV 76
++ + L +G G+ G + ++ K +D ++ ++ E+ +
Sbjct: 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKI----LVWKELDYGSMTEA--EKQMLVSEVNL 58
Query: 77 LSRLSHPFLPKLLGS--LETDEFLAWAVPYCPGGDLNVL--RYKQNDRVFSPSVIRFYLS 132
L L HP + + T+ L + YC GGDL + + + + + ++
Sbjct: 59 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 133 EIICAIEHLHNMG-----IAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAF 181
++ A++ H + +RDLKP N+ + +V L DF L+R L T+F
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF 172
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-17
Identities = 28/108 (25%), Positives = 44/108 (40%), Gaps = 6/108 (5%)
Query: 241 NGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNV 300
+ + +FVGT Y+SPE + + D W+LG L YE+ PF ++KE +
Sbjct: 169 DTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI 228
Query: 301 LMKTPEFVGQR--TALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
+ R L ++I R+L R EI E+
Sbjct: 229 REGKFRRIPYRYSDELNEIITRMLNLKDYHRP----SVEEILENPLIL 272
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 47/168 (27%), Positives = 68/168 (40%), Gaps = 18/168 (10%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP 83
ILG+GA VF + T FA+KV + + + + R E VL +L+H
Sbjct: 15 DILGQGATANVFRGRHK---KTGD-LFAIKVFNNISFLRPVDVQMR---EFEVLKKLNHK 67
Query: 84 FLPKLLGSLETDE----FLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYLSEIICAI 138
+ KL E L + +CP G L VL N S L +++ +
Sbjct: 68 NIVKLFAIEEETTTRHKVLI--MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 139 EHLHNMGIAYRDLKPENILIRQS----GHVTLTDFDLSRNLVKKTAFE 182
HL GI +R++KP NI+ LTDF +R L F
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV 173
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 6e-16
Identities = 28/132 (21%), Positives = 46/132 (34%), Gaps = 38/132 (28%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEF--------AVDWWALGILTYEMLYGTTPFR- 289
++ E+ S GTEEY+ P++ VD W++G+ Y G+ PFR
Sbjct: 166 LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225
Query: 290 ---GKNRKETFRNVLMKTPEFV--------------------------GQRTALTDLIQR 320
+ KE ++ P G + LT ++
Sbjct: 226 FEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLAN 285
Query: 321 LLEKDPVKRLGY 332
+LE D K G+
Sbjct: 286 ILEADQEKCWGF 297
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-27
Identities = 34/191 (17%), Positives = 72/191 (37%), Gaps = 28/191 (14%)
Query: 3 ATPPPQPQTTPSLDLDNLKALKILGKGAMGTVFLV-HDRAADPTARCPFALKVVDKSTLH 61
+ +++ + ++ L +G + L D +ALK +KS L
Sbjct: 16 LIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEKDNKF-------YALKKYEKSLLE 68
Query: 62 AKHEAERRARW-------------EIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGG 108
K + + E+++++ + + + G + + + Y
Sbjct: 69 KKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMEND 128
Query: 109 DL-NVLRY-----KQNDRVFSPSVIRFYLSEIICAIEHLHN-MGIAYRDLKPENILIRQS 161
+ Y K VI+ + ++ + ++HN I +RD+KP NIL+ ++
Sbjct: 129 SILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN 188
Query: 162 GHVTLTDFDLS 172
G V L+DF S
Sbjct: 189 GRVKLSDFGES 199
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 9e-23
Identities = 28/144 (19%), Positives = 51/144 (35%), Gaps = 28/144 (19%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDG--HEFAVDWWALGILTYEMLYGTTPFRGK-NRKE 295
+ + GT E++ PE + + VD W+LGI Y M Y PF K + E
Sbjct: 202 MVDKKI-KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260
Query: 296 TFRNVL---MKTPEFVGQRTALT-----------------DLIQRLLEKDPVKRLGYLRG 335
F N+ ++ P D ++ L K+P +R+
Sbjct: 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI----T 316
Query: 336 ACEIKEHVFFKGVRWDLLTDVLRP 359
+ + +H + + L + +
Sbjct: 317 SEDALKHEWLADTNIEDLREFSKE 340
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 41/163 (25%), Positives = 67/163 (41%), Gaps = 21/163 (12%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
LK +G G VF V + +A+K V+ ++ R EI L++L
Sbjct: 33 LKQIGSGGSSKVFQVLNEKKQI-----YAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQ 85
Query: 83 PFLP--KLLGSLETDEFLAWAVPY----CPGGDLNVLRYKQNDRVFSPSVIRFYLSEIIC 136
+L TD+++ Y C DLN + + + P + Y ++
Sbjct: 86 HSDKIIRLYDYEITDQYI-----YMVMECGNIDLN--SWLKKKKSIDPWERKSYWKNMLE 138
Query: 137 AIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKT 179
A+ +H GI + DLKP N LI G + L DF ++ + T
Sbjct: 139 AVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT 180
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-16
Identities = 29/132 (21%), Positives = 53/132 (40%), Gaps = 23/132 (17%)
Query: 232 VSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHE-----------FAVDWWALGILTYE 280
++ + Q +S VGT Y+ PE ++ D W+LG + Y
Sbjct: 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 231
Query: 281 MLYGTTPFRGKN------RKETFRNVLMKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLR 334
M YG TPF+ N ++ P+ + L D+++ L++DP +R+
Sbjct: 232 MTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK--DLQDVLKCCLKRDPKQRI---- 285
Query: 335 GACEIKEHVFFK 346
E+ H + +
Sbjct: 286 SIPELLAHPYVQ 297
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 41/159 (25%), Positives = 68/159 (42%), Gaps = 13/159 (8%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
LK +G G VF V + +A+K V+ ++ R EI L++L
Sbjct: 14 LKQIGSGGSSKVFQVLNEKKQI-----YAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQ 66
Query: 83 PFLP--KLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEH 140
+L TD+++ + V C DLN + + + P + Y ++ A+
Sbjct: 67 HSDKIIRLYDYEITDQYI-YMVMECGNIDLN--SWLKKKKSIDPWERKSYWKNMLEAVHT 123
Query: 141 LHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKT 179
+H GI + DLKP N LI G + L DF ++ + T
Sbjct: 124 IHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT 161
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 29/132 (21%), Positives = 53/132 (40%), Gaps = 23/132 (17%)
Query: 232 VSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHE-----------FAVDWWALGILTYE 280
++ + Q +S VGT Y+ PE ++ D W+LG + Y
Sbjct: 153 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 212
Query: 281 MLYGTTPFRGKN------RKETFRNVLMKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLR 334
M YG TPF+ N ++ P+ + L D+++ L++DP +R+
Sbjct: 213 MTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK--DLQDVLKCCLKRDPKQRI---- 266
Query: 335 GACEIKEHVFFK 346
E+ H + +
Sbjct: 267 SIPELLAHPYVQ 278
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 44/179 (24%), Positives = 71/179 (39%), Gaps = 17/179 (9%)
Query: 7 PQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEA 66
+ + P+ + + LG G G V + T A+K + E
Sbjct: 3 GRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQ---DTGE-QVAIKQCRQELSPKNRER 58
Query: 67 ERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVP------YCPGGDL-NVLRYKQND 119
EI+++ +L+HP + + + LA YC GGDL L +N
Sbjct: 59 WCL---EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENC 115
Query: 120 RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVT---LTDFDLSRNL 175
IR LS+I A+ +LH I +RDLKPENI+++ + D ++ L
Sbjct: 116 CGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL 174
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 78.2 bits (192), Expect = 9e-16
Identities = 24/133 (18%), Positives = 43/133 (32%), Gaps = 29/133 (21%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFR 298
D GE FVGT +Y++PE++ + VD+W+ G L +E + G PF + +
Sbjct: 174 LDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWH 233
Query: 299 NVLMKTPEFV-------------------------GQRTALTDLIQRLLEKDPVKRLGYL 333
+ + L +Q +L +R
Sbjct: 234 GKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDP 293
Query: 334 RGACEIKEHVFFK 346
+ F+
Sbjct: 294 ----QNPNVGCFQ 302
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 41/163 (25%), Positives = 67/163 (41%), Gaps = 21/163 (12%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
LK +G G VF V + +A+K V+ ++ R EI L++L
Sbjct: 61 LKQIGSGGSSKVFQVLNEKKQI-----YAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQ 113
Query: 83 PFLP--KLLGSLETDEFLAWAVPY----CPGGDLNVLRYKQNDRVFSPSVIRFYLSEIIC 136
+L TD+++ Y C DLN + + + P + Y ++
Sbjct: 114 HSDKIIRLYDYEITDQYI-----YMVMECGNIDLN--SWLKKKKSIDPWERKSYWKNMLE 166
Query: 137 AIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKT 179
A+ +H GI + DLKP N LI G + L DF ++ + T
Sbjct: 167 AVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDT 208
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 28/132 (21%), Positives = 52/132 (39%), Gaps = 23/132 (17%)
Query: 232 VSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHE-----------FAVDWWALGILTYE 280
++ + Q +S VG Y+ PE ++ D W+LG + Y
Sbjct: 200 IANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 259
Query: 281 MLYGTTPFRGKN------RKETFRNVLMKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLR 334
M YG TPF+ N ++ P+ + L D+++ L++DP +R+
Sbjct: 260 MTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK--DLQDVLKCCLKRDPKQRI---- 313
Query: 335 GACEIKEHVFFK 346
E+ H + +
Sbjct: 314 SIPELLAHPYVQ 325
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 44/158 (27%), Positives = 73/158 (46%), Gaps = 20/158 (12%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP 83
++LGKG+ G V L D+ A+KV+ K + K + E R E+++L +L HP
Sbjct: 32 RVLGKGSFGEVILCKDKITG----QECAVKVISKRQVKQKTDKESLLR-EVQLLKQLDHP 86
Query: 84 FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRV-----FSPSVIRFYLSEIICAI 138
+ KL E + GG+L D + FS + +++ I
Sbjct: 87 NIMKLYEFFEDKGYFYLVGEVYTGGELF-------DEIISRKRFSEVDAARIIRQVLSGI 139
Query: 139 EHLHNMGIAYRDLKPENILIR---QSGHVTLTDFDLSR 173
++H I +RDLKPEN+L+ + ++ + DF LS
Sbjct: 140 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 26/97 (26%), Positives = 46/97 (47%), Gaps = 6/97 (6%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFR 298
F+ ++ +GT Y++PEV+ G ++ D W+ G++ Y +L G PF G N + +
Sbjct: 179 FEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILK 237
Query: 299 NVLMKTPEFVGQRTALT-----DLIQRLLEKDPVKRL 330
V F + DLI+++L P R+
Sbjct: 238 KVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRI 274
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 40/160 (25%), Positives = 74/160 (46%), Gaps = 10/160 (6%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRA-RWEIRVLSRLSH 82
+++GKG V +R T + FA+K+VD + + + E + L H
Sbjct: 30 EVIGKGPFSVVRRCINRE---TGQ-QFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDL--NVLRYKQNDRVFSPSVIRFYLSEIICAIEH 140
P + +LL + +D L + G DL +++ V+S +V Y+ +I+ A+ +
Sbjct: 86 PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 141 LHNMGIAYRDLKPENILIR---QSGHVTLTDFDLSRNLVK 177
H+ I +RD+KP +L+ S V L F ++ L +
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE 185
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 8e-18
Identities = 29/115 (25%), Positives = 54/115 (46%), Gaps = 12/115 (10%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFR 298
++G + VGT +++PEVV+ + + VD W G++ + +L G PF G + F
Sbjct: 184 GESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFE 242
Query: 299 NVLMKTPEFVGQ------RTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347
++ + + +A DL++R+L DP +R+ E H + K
Sbjct: 243 GIIKGKYKMNPRQWSHISESA-KDLVRRMLMLDPAERI----TVYEALNHPWLKE 292
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 43/162 (26%), Positives = 69/162 (42%), Gaps = 26/162 (16%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP 83
+ LG GA G V LV +R++ +K ++K E EI VL L HP
Sbjct: 28 RKLGSGAFGDVHLVEERSSG----LERVIKTINKDRSQVPMEQIEA---EIEVLKSLDHP 80
Query: 84 FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSE---------I 134
+ K+ E + + C GG+L +R+ S LSE +
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELL-------ERIVSAQARGKALSEGYVAELMKQM 133
Query: 135 ICAIEHLHNMGIAYRDLKPENILIR---QSGHVTLTDFDLSR 173
+ A+ + H+ + ++DLKPENIL + + + DF L+
Sbjct: 134 MNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-20
Identities = 36/112 (32%), Positives = 58/112 (51%), Gaps = 9/112 (8%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFR 298
F + E S + GT Y++PEV + D F D W+ G++ Y +L G PF G + +E +
Sbjct: 177 FKSDEHSTNAAGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ 235
Query: 299 NVLMKTPEFVGQRTALT----DLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
K P + + LT DL++++L KDP +R A ++ H +FK
Sbjct: 236 KATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRP----SAAQVLHHEWFK 283
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 37/205 (18%), Positives = 57/205 (27%), Gaps = 38/205 (18%)
Query: 2 EATPPPQPQTTPSL---DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKS 58
P T SL LK ++ L G VFLV D FALKV
Sbjct: 43 TVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVER----LEDFALKVFTMG 98
Query: 59 TLHAKHEAERRARWEIRVLSRLSHPFLPKLLG--------------------SLETDEFL 98
+++ E ER +RL + L +
Sbjct: 99 AENSRSELERLHE-ATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDD 157
Query: 99 AWAVPYC-----PGGDLNVL-----RYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAY 148
Y DL +L + +++I +L + G+ +
Sbjct: 158 YAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVH 217
Query: 149 RDLKPENILIRQSGHVTLTDFDLSR 173
P+N+ I G + L D
Sbjct: 218 GHFTPDNLFIMPDGRLMLGDVSALW 242
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 23/127 (18%), Positives = 41/127 (32%), Gaps = 16/127 (12%)
Query: 238 SFDNGERSNSFVGTEEYVSPEVVRGDG--HEFAVDWWALGILTYEMLYGTTPFRGKN--R 293
+ G R + Y E + A++ W LG+ Y + PF
Sbjct: 241 LWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300
Query: 294 KETFRNVLMKTPEFVGQRT--------ALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345
K +++ ++ P + LI R L D +RL E E F
Sbjct: 301 KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRL----LPLEAMETPEF 356
Query: 346 KGVRWDL 352
++ ++
Sbjct: 357 LQLQNEI 363
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 41/173 (23%), Positives = 66/173 (38%), Gaps = 30/173 (17%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRA--RWEIRVLSRLS 81
+ LG G V +++ T +A K + K A R E+ +L ++
Sbjct: 18 EELGSGQFAIVKKCREKS---TGLE-YAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 82 HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSE-------- 133
HP + L E + + GG+L D + + LSE
Sbjct: 74 HPNIITLHDVYENRTDVVLILELVSGGELF-------DFL----AQKESLSEEEATSFIK 122
Query: 134 -IICAIEHLHNMGIAYRDLKPENILIR----QSGHVTLTDFDLSRNLVKKTAF 181
I+ + +LH IA+ DLKPENI++ H+ L DF L+ + F
Sbjct: 123 QILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF 175
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 8e-21
Identities = 31/98 (31%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFR 298
++G + GT E+V+PE+V + D W++G++TY +L G +PF G ++ET
Sbjct: 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228
Query: 299 NVLMKTPEFVGQ------RTALTDLIQRLLEKDPVKRL 330
N+ + +F + A D I++LL K+ KRL
Sbjct: 229 NITAVSYDFDEEFFSQTSELAK-DFIRKLLVKETRKRL 265
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 21/158 (13%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP 83
+LGKG+ G V DR + +A+KV++K++ K++ E+ +L +L HP
Sbjct: 28 CMLGKGSFGEVLKCKDRIT----QQEYAVKVINKASA--KNKDTSTILREVELLKKLDHP 81
Query: 84 FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRV-----FSPSVIRFYLSEIICAI 138
+ KL LE GG+L D + FS + ++ I
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELF-------DEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 139 EHLHNMGIAYRDLKPENILIR---QSGHVTLTDFDLSR 173
++H I +RDLKPENIL+ + + + DF LS
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 6/97 (6%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFR 298
F + +GT Y++PEV+RG ++ D W+ G++ Y +L GT PF GKN + +
Sbjct: 174 FQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK 232
Query: 299 NVLMKTPEFVGQRTALT-----DLIQRLLEKDPVKRL 330
V F + DLI+++L P R+
Sbjct: 233 RVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI 269
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 9e-24
Identities = 40/173 (23%), Positives = 65/173 (37%), Gaps = 30/173 (17%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRA--RWEIRVLSRLS 81
+ LG G V +++ T +A K + K A R E+ +L ++
Sbjct: 18 EELGSGQFAIVKKCREKS---TGLE-YAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 82 HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSE-------- 133
H + L E + + GG+L D + + LSE
Sbjct: 74 HHNVITLHDVYENRTDVVLILELVSGGELF-------DFL----AQKESLSEEEATSFIK 122
Query: 134 -IICAIEHLHNMGIAYRDLKPENILIRQ----SGHVTLTDFDLSRNLVKKTAF 181
I+ + +LH IA+ DLKPENI++ H+ L DF L+ + F
Sbjct: 123 QILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF 175
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 5e-21
Identities = 31/98 (31%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFR 298
++G + GT E+V+PE+V + D W++G++TY +L G +PF G ++ET
Sbjct: 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228
Query: 299 NVLMKTPEFVGQ------RTALTDLIQRLLEKDPVKRL 330
N+ + +F + A D I++LL K+ KRL
Sbjct: 229 NITSVSYDFDEEFFSHTSELAK-DFIRKLLVKETRKRL 265
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-24
Identities = 41/158 (25%), Positives = 68/158 (43%), Gaps = 21/158 (13%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP 83
K LG GA G V L D+ A+K++ K+++ + + E+ VL L HP
Sbjct: 43 KKLGSGAYGEVLLCRDKVTH----VERAIKIIRKTSV--STSSNSKLLEEVAVLKLLDHP 96
Query: 84 FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRV-----FSPSVIRFYLSEIICAI 138
+ KL E + GG+L D + F+ + +++ +
Sbjct: 97 NIMKLYDFFEDKRNYYLVMECYKGGELF-------DEIIHRMKFNEVDAAVIIKQVLSGV 149
Query: 139 EHLHNMGIAYRDLKPENILIR---QSGHVTLTDFDLSR 173
+LH I +RDLKPEN+L+ + + + DF LS
Sbjct: 150 TYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 8e-20
Identities = 27/97 (27%), Positives = 50/97 (51%), Gaps = 6/97 (6%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFR 298
F+N ++ +GT Y++PEV+R ++ D W++G++ + +L G PF G+ +E R
Sbjct: 189 FENQKKMKERLGTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILR 247
Query: 299 NVLMKTPEFVGQRTALT-----DLIQRLLEKDPVKRL 330
V F DLI+++L+ D +R+
Sbjct: 248 KVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRI 284
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 1e-23
Identities = 45/158 (28%), Positives = 71/158 (44%), Gaps = 21/158 (13%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP 83
+LGKG+ G V DR T + +A+KV++K++ K++ E+ +L +L HP
Sbjct: 28 CMLGKGSFGEVLKCKDRI---TQQ-EYAVKVINKASA--KNKDTSTILREVELLKKLDHP 81
Query: 84 FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRV-----FSPSVIRFYLSEIICAI 138
+ KL LE GG+L D + FS + ++ I
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELF-------DEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 139 EHLHNMGIAYRDLKPENILIRQSG---HVTLTDFDLSR 173
++H I +RDLKPENIL+ + + DF LS
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 3e-18
Identities = 33/115 (28%), Positives = 54/115 (46%), Gaps = 12/115 (10%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFR 298
F + +GT Y++PEV+RG ++ D W+ G++ Y +L GT PF GKN + +
Sbjct: 174 FQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK 232
Query: 299 NVLMKTPEFVGQR------TALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347
V F + A DLI+++L P R+ A + EH + +
Sbjct: 233 RVETGKYAFDLPQWRTISDDAK-DLIRKMLTFHPSLRI----TATQCLEHPWIQK 282
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 47/186 (25%), Positives = 83/186 (44%), Gaps = 27/186 (14%)
Query: 1 MEATPPPQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTL 60
+ T Q +L D K LG GA G V L +R T + A++++ K
Sbjct: 119 FDLTVDDQSVYPKAL-RDEYIMSKTLGSGACGEVKLAFERK---TCK-KVAIRIISKRKF 173
Query: 61 HAKHEAER----RARWEIRVLSRLSHPFLPKLLGSLETDE-FLAWAVPYCPGGDLNVLRY 115
E EI +L +L+HP + K+ + ++ ++ + GG+L
Sbjct: 174 AIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIV--LELMEGGELF---- 227
Query: 116 KQNDRV-----FSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIR---QSGHVTLT 167
D+V + + Y +++ A+++LH GI +RDLKPEN+L+ + + +T
Sbjct: 228 ---DKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 284
Query: 168 DFDLSR 173
DF S+
Sbjct: 285 DFGHSK 290
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 29/119 (24%), Positives = 47/119 (39%), Gaps = 15/119 (12%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHE---FAVDWWALGILTYEMLYGTTPFRGKNRKE 295
+ GT Y++PEV+ G AVD W+LG++ + L G PF +
Sbjct: 292 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 351
Query: 296 T-FRNVLMKTPEFVGQ------RTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347
+ + F+ + AL DL+++LL DP R E H + +
Sbjct: 352 SLKDQITSGKYNFIPEVWAEVSEKAL-DLVKKLLVVDPKARF----TTEEALRHPWLQD 405
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-23
Identities = 41/159 (25%), Positives = 72/159 (45%), Gaps = 23/159 (14%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAK-HEAERRARWEIRVLSRLSH 82
+ LGKGA V + FA K+++ L A+ + R E R+ +L H
Sbjct: 12 EELGKGAFSVVRRCVHKTT----GLEFAAKIINTKKLSARDFQKLER---EARICRKLQH 64
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRV-----FSPSVIRFYLSEIICA 137
P + +L S++ + F GG+L + + +S + + +I+ +
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELF-------EDIVAREFYSEADASHCIQQILES 117
Query: 138 IEHLHNMGIAYRDLKPENILIR---QSGHVTLTDFDLSR 173
I + H+ GI +R+LKPEN+L+ + V L DF L+
Sbjct: 118 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 156
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 2e-20
Identities = 28/115 (24%), Positives = 51/115 (44%), Gaps = 11/115 (9%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFR 298
++ E + F GT Y+SPEV++ D + VD WA G++ Y +L G PF +++ +
Sbjct: 158 VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA 217
Query: 299 NVLMKTPEFVGQ------RTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347
+ ++ A LI +L +P KR+ A + + +
Sbjct: 218 QIKAGAYDYPSPEWDTVTPEAK-SLIDSMLTVNPKKRI----TADQALKVPWICN 267
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 100 bits (249), Expect = 1e-23
Identities = 25/210 (11%), Positives = 55/210 (26%), Gaps = 37/210 (17%)
Query: 5 PPPQPQTTPSLD---LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLH 61
QP S L +LG+ D+ F + V +
Sbjct: 57 NTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQET----GESFEVHVPYFTERP 112
Query: 62 AKHEAER------------------------RARWEIRVLSRLSHPFLPKLLGSLET--- 94
+ ++ R + ++ + ++
Sbjct: 113 PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWV 172
Query: 95 -DEFLAWAVPYCPGGDL--NVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDL 151
F + +L + + ++I + LH+ G+ + L
Sbjct: 173 LSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 232
Query: 152 KPENILIRQSGHVTLTDFDLSRNLVKKTAF 181
+P +I++ Q G V LT F+ +
Sbjct: 233 RPVDIVLDQRGGVFLTGFEHLVRDGARVVS 262
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 87.4 bits (216), Expect = 4e-19
Identities = 19/120 (15%), Positives = 34/120 (28%), Gaps = 24/120 (20%)
Query: 244 RSNSFVGTEEYVSPEVV-----------RGDGHEFAVDWWALGILTYEMLYGTTPFRGKN 292
+ + PE+ R F+ D WALG++ Y + P
Sbjct: 258 ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDA 317
Query: 293 RKETFRNVL---MKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349
+ P+ V L++ L RL + E ++ +R
Sbjct: 318 ALGGSEWIFRSCKNIPQPV------RALLEGFLRYPKEDRL----LPLQAMETPEYEQLR 367
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 41/160 (25%), Positives = 72/160 (45%), Gaps = 11/160 (6%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP 83
+ LG GA G V ++A T R F K ++ K+ + EI ++++L HP
Sbjct: 57 EELGSGAFGVVHRCVEKA---TGR-VFVAKFINTPYPLDKYTVKN----EISIMNQLHHP 108
Query: 84 FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN 143
L L + E + + + GG+L R D S + + Y+ + ++H+H
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGEL-FDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 167
Query: 144 MGIAYRDLKPENILI--RQSGHVTLTDFDLSRNLVKKTAF 181
I + D+KPENI+ +++ V + DF L+ L
Sbjct: 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 207
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 6e-21
Identities = 34/98 (34%), Positives = 49/98 (50%), Gaps = 7/98 (7%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFR 298
+ E T E+ +PE+V + F D WA+G+L Y +L G +PF G++ ET +
Sbjct: 201 LNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ 260
Query: 299 NVLMKTPEFVGQ------RTALTDLIQRLLEKDPVKRL 330
NV EF A D I+ LL+K+P KRL
Sbjct: 261 NVKRCDWEFDEDAFSSVSPEAK-DFIKNLLQKEPRKRL 297
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 47/189 (24%), Positives = 77/189 (40%), Gaps = 17/189 (8%)
Query: 1 MEATPPPQPQTTPSLDLDNLKAL------KILGKGAMGTVFLVHDRAADPTARCPFALKV 54
+ A P P + + + +ILG G G V + A T A K+
Sbjct: 66 IPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETA---TGL-KLAAKI 121
Query: 55 VDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLR 114
+ + K E + EI V+++L H L +L + E+ + + Y GG+L R
Sbjct: 122 IKTRGMKDKEEVKN----EISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL-FDR 176
Query: 115 YKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILI--RQSGHVTLTDFDLS 172
+ ++ +I I H+H M I + DLKPENIL R + + + DF L+
Sbjct: 177 IIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLA 236
Query: 173 RNLVKKTAF 181
R +
Sbjct: 237 RRYKPREKL 245
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 9e-21
Identities = 30/98 (30%), Positives = 48/98 (48%), Gaps = 7/98 (7%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFR 298
+ E+ GT E+++PEVV D F D W++G++ Y +L G +PF G N ET
Sbjct: 239 YKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN 298
Query: 299 NVLMKTPEFVGQ------RTALTDLIQRLLEKDPVKRL 330
N+L + + A + I +LL K+ R+
Sbjct: 299 NILACRWDLEDEEFQDISEEA-KEFISKLLIKEKSWRI 335
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 2e-23
Identities = 37/169 (21%), Positives = 66/169 (39%), Gaps = 22/169 (13%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRA--RWEIRVLSRLS 81
+ LG G V + T + +A K + K L + R E+ +L +
Sbjct: 11 EELGSGQFAIVRKCRQKG---TGK-EYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 82 HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRV-----FSPSVIRFYLSEIIC 136
HP + L E + + GG+L D + + +L +I+
Sbjct: 67 HPNIITLHDIFENKTDVVLILELVSGGELF-------DFLAEKESLTEDEATQFLKQILD 119
Query: 137 AIEHLHNMGIAYRDLKPENILI----RQSGHVTLTDFDLSRNLVKKTAF 181
+ +LH+ IA+ DLKPENI++ + + L DF ++ + F
Sbjct: 120 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF 168
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 7e-22
Identities = 32/98 (32%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFR 298
+ G + GT E+V+PE+V + D W++G++TY +L G +PF G+ ++ET
Sbjct: 162 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT 221
Query: 299 NVLMKTPEFVGQ------RTALTDLIQRLLEKDPVKRL 330
N+ +F + A D I+RLL KDP +R+
Sbjct: 222 NISAVNYDFDEEYFSNTSELAK-DFIRRLLVKDPKRRM 258
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 46/160 (28%), Positives = 69/160 (43%), Gaps = 11/160 (6%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP 83
+ LG GA G V V +RA T FA K V K + EI+ +S L HP
Sbjct: 163 EELGTGAFGVVHRVTERA---TGN-NFAAKFVMTPHESDKETVRK----EIQTMSVLRHP 214
Query: 84 FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN 143
L L + E D + + GG+L + S Y+ ++ + H+H
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGEL-FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 273
Query: 144 MGIAYRDLKPENILI--RQSGHVTLTDFDLSRNLVKKTAF 181
+ DLKPENI+ ++S + L DF L+ +L K +
Sbjct: 274 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 313
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 8e-21
Identities = 31/98 (31%), Positives = 45/98 (45%), Gaps = 7/98 (7%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFR 298
D + GT E+ +PEV G + D W++G+L+Y +L G +PF G+N ET R
Sbjct: 307 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR 366
Query: 299 NVLMKTPEFVGQ------RTALTDLIQRLLEKDPVKRL 330
NV D I++LL DP R+
Sbjct: 367 NVKSCDWNMDDSAFSGISEDGK-DFIRKLLLADPNTRM 403
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-23
Identities = 41/159 (25%), Positives = 72/159 (45%), Gaps = 23/159 (14%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAK-HEAERRARWEIRVLSRLSH 82
+ LGKGA V + FA K+++ L A+ + R E R+ +L H
Sbjct: 35 EELGKGAFSVVRRCVHKTT----GLEFAAKIINTKKLSARDFQKLER---EARICRKLQH 87
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRV-----FSPSVIRFYLSEIICA 137
P + +L S++ + F GG+L + + +S + + +I+ +
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELF-------EDIVAREFYSEADASHCIQQILES 140
Query: 138 IEHLHNMGIAYRDLKPENILIR---QSGHVTLTDFDLSR 173
I + H+ GI +R+LKPEN+L+ + V L DF L+
Sbjct: 141 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 6e-20
Identities = 28/115 (24%), Positives = 51/115 (44%), Gaps = 11/115 (9%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFR 298
++ E + F GT Y+SPEV++ D + VD WA G++ Y +L G PF +++ +
Sbjct: 181 VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA 240
Query: 299 NVLMKTPEFVGQ------RTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347
+ ++ A LI +L +P KR+ A + + +
Sbjct: 241 QIKAGAYDYPSPEWDTVTPEAK-SLIDSMLTVNPKKRI----TADQALKVPWICN 290
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 3e-23
Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 23/158 (14%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP 83
++LG GA VFLV R T + FALK + KS E EI VL ++ H
Sbjct: 15 EVLGSGAFSEVFLVKQRL---TGK-LFALKCIKKSPAFRDSSLEN----EIAVLKKIKHE 66
Query: 84 FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRV-----FSPSVIRFYLSEIICAI 138
+ L E+ + GG+L DR+ ++ + +++ A+
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELF-------DRILERGVYTEKDASLVIQQVLSAV 119
Query: 139 EHLHNMGIAYRDLKPENILIRQSG---HVTLTDFDLSR 173
++LH GI +RDLKPEN+L + +TDF LS+
Sbjct: 120 KYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK 157
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 3e-18
Identities = 31/98 (31%), Positives = 47/98 (47%), Gaps = 7/98 (7%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFR 298
+ ++ GT YV+PEV+ + AVD W++G++TY +L G PF + + F
Sbjct: 158 MEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFE 217
Query: 299 NVLMKTPEFVGQ------RTALTDLIQRLLEKDPVKRL 330
+ EF +A D I LLEKDP +R
Sbjct: 218 KIKEGYYEFESPFWDDISESAK-DFICHLLEKDPNERY 254
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 4e-23
Identities = 39/151 (25%), Positives = 70/151 (46%), Gaps = 7/151 (4%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP 83
+LG+G+ G V D C A+K++ K L E + EI++L RL H
Sbjct: 11 DLLGEGSYGKVKE----VLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 84 FLPKLLG--SLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHL 141
+ +L+ E + + + YC G +L R F Y ++I +E+L
Sbjct: 67 NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR-FPVCQAHGYFCQLIDGLEYL 125
Query: 142 HNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172
H+ GI ++D+KP N+L+ G + ++ ++
Sbjct: 126 HSQGIVHKDIKPGNLLLTTGGTLKISALGVA 156
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 1e-15
Identities = 37/145 (25%), Positives = 59/145 (40%), Gaps = 18/145 (12%)
Query: 232 VSRRQQSFDNGERSNSFVGTEEYVSPEVVRG----DGHEFAVDWWALGILTYEMLYGTTP 287
V+ F + + G+ + PE+ G G F VD W+ G+ Y + G P
Sbjct: 155 VAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSG--FKVDIWSAGVTLYNITTGLYP 212
Query: 288 FRGKNRKETFRNVLM---KTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVF 344
F G N + F N+ P G L+DL++ +LE +P KR +I++H +
Sbjct: 213 FEGDNIYKLFENIGKGSYAIPGDCG--PPLSDLLKGMLEYEPAKRFSIR----QIRQHSW 266
Query: 345 FKGVRWDLLTDVLRPPFIPSREEND 369
F+ P PS + D
Sbjct: 267 FRK---KHPPAEAPVPIPPSPDTKD 288
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 4e-23
Identities = 43/174 (24%), Positives = 72/174 (41%), Gaps = 14/174 (8%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-H 82
+LG+GA V + +A+K+++K H + R E+ +L + H
Sbjct: 19 DVLGEGAHARVQTCINLIT----SQEYAVKIIEKQPGHIRSRVFR----EVEMLYQCQGH 70
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLH 142
+ +L+ E ++ GG + L + R F+ + ++ A++ LH
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSI--LSHIHKRRHFNELEASVVVQDVASALDFLH 128
Query: 143 NMGIAYRDLKPENILIRQSGHVT---LTDFDLSRNLVKKTAFEKQSLNNNKFPV 193
N GIA+RDLKPENIL V+ + DFDL + S P
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 9e-13
Identities = 33/126 (26%), Positives = 53/126 (42%), Gaps = 31/126 (24%)
Query: 248 FVGTEEYVSPEVVRGDGHEF-----AVDWWALGILTYEMLYGTTPFRGKNRKET------ 296
G+ EY++PEVV E D W+LG++ Y +L G PF G+ +
Sbjct: 181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE 240
Query: 297 ---------FRNVLMKTPEFVGQ------RTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341
F ++ EF + A DLI +LL +D +RL A ++ +
Sbjct: 241 ACPACQNMLFESIQEGKYEFPDKDWAHISCAA-KDLISKLLVRDAKQRL----SAAQVLQ 295
Query: 342 HVFFKG 347
H + +G
Sbjct: 296 HPWVQG 301
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-23
Identities = 39/149 (26%), Positives = 70/149 (46%), Gaps = 9/149 (6%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP 83
+ LG+GA G V L A + A+K+VD E ++ EI + L+H
Sbjct: 13 QTLGEGAYGEVQL----AVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHE 65
Query: 84 FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN 143
+ K G + YC GG+L + D + + +++ + +LH
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 144 MGIAYRDLKPENILIRQSGHVTLTDFDLS 172
+GI +RD+KPEN+L+ + ++ ++DF L+
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLA 152
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 5e-11
Identities = 24/116 (20%), Positives = 49/116 (42%), Gaps = 14/116 (12%)
Query: 246 NSFVGTEEYVSPEVVRG---DGHEFAVDWWALGILTYEMLYGTTPFRG-KNRKETFRNVL 301
N GT YV+PE+++ VD W+ GI+ ML G P+ + + + +
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEP--VDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK 222
Query: 302 ---MKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF-KGVRWDLL 353
+ +A L+ ++L ++P R+ +IK+ ++ K ++
Sbjct: 223 EKKTYLNPWKKIDSAPLALLHKILVENPSARITIP----DIKKDRWYNKPLKKGAK 274
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 4e-23
Identities = 42/185 (22%), Positives = 67/185 (36%), Gaps = 21/185 (11%)
Query: 1 MEATPPPQPQTTPSLD------LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKV 54
M PP+ L + LG GA G V+ A D +K
Sbjct: 1 MALEEPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWT----AVDKEKNKEVVVKF 56
Query: 55 VDKSTLHAKHEAERRARW----EIRVLSRLSHPFLPKLLGSLETDEFLAWAV--PYCPGG 108
+ K + E EI +LSR+ H + K+L E F V + G
Sbjct: 57 IKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFF-QLVMEKHGSGL 115
Query: 109 DL-NVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLT 167
DL + + + +++ A+ +L I +RD+K ENI+I + + L
Sbjct: 116 DLFAFIDRHPR---LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLI 172
Query: 168 DFDLS 172
DF +
Sbjct: 173 DFGSA 177
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 35/161 (21%), Positives = 63/161 (39%), Gaps = 17/161 (10%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRG---DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKE 295
+ G+ +F GT EY +PEV+ G G E ++ W+LG+ Y +++ PF +E
Sbjct: 180 LERGKLFYTFCGTIEYCAPEVLMGNPYRGPE--LEMWSLGVTLYTLVFEENPFC--ELEE 235
Query: 296 TFRNVLMKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF-KGVRWDLLT 354
T + P V L L+ LL+ P +R ++ + + V T
Sbjct: 236 TVEAAI-HPPYLVS--KELMSLVSGLLQPVPERRTTLE----KLVTDPWVTQPVNLADYT 288
Query: 355 --DVLRPPFIPSREENDLTEKAMSGGGVDIREYFENLRAPP 393
+V R S + + + + D+ + E
Sbjct: 289 WEEVFRVNKPESGVLSAASLEMGNRSLSDVAQAQELCGGEG 329
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 5e-23
Identities = 37/173 (21%), Positives = 66/173 (38%), Gaps = 30/173 (17%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRA--RWEIRVLSRLS 81
+ LG G V +++ T +A K + K + R E+ +L +
Sbjct: 17 EELGSGQFAVVKKCREKS---TGL-QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 82 HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSE-------- 133
HP + L E + + GG+L D + + L+E
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELF-------DFL----AEKESLTEEEATEFLK 121
Query: 134 -IICAIEHLHNMGIAYRDLKPENILIR----QSGHVTLTDFDLSRNLVKKTAF 181
I+ + +LH++ IA+ DLKPENI++ + + DF L+ + F
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 36/97 (37%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFR 298
D G + GT E+V+PE+V + D W++G++TY +L G +PF G ++ET
Sbjct: 168 IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 299 NVLMKTPEFVGQRTALT-----DLIQRLLEKDPVKRL 330
NV EF + + T D I+RLL KDP KR+
Sbjct: 228 NVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 264
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 5e-23
Identities = 44/163 (26%), Positives = 76/163 (46%), Gaps = 26/163 (15%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAER----RARWEIRVLSR 79
K LG GA G V L +R T + A+K++ K E EI +L +
Sbjct: 16 KTLGSGACGEVKLAFERK---TCK-KVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 80 LSHPFLPKLLGSLETDE-FLAWAVPYCPGGDLNVLRYKQNDRV-----FSPSVIRFYLSE 133
L+HP + K+ + ++ ++ + GG+L D+V + + Y +
Sbjct: 72 LNHPCIIKIKNFFDAEDYYIV--LELMEGGELF-------DKVVGNKRLKEATCKLYFYQ 122
Query: 134 IICAIEHLHNMGIAYRDLKPENILIRQSG---HVTLTDFDLSR 173
++ A+++LH GI +RDLKPEN+L+ + +TDF S+
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 29/119 (24%), Positives = 48/119 (40%), Gaps = 15/119 (12%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGD---GHEFAVDWWALGILTYEMLYGTTPFRGKNRKE 295
+ GT Y++PEV+ G+ AVD W+LG++ + L G PF +
Sbjct: 167 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 226
Query: 296 T-FRNVLMKTPEFVGQ------RTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347
+ + F+ + AL DL+++LL DP R E H + +
Sbjct: 227 SLKDQITSGKYNFIPEVWAEVSEKAL-DLVKKLLVVDPKARF----TTEEALRHPWLQD 280
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 9e-23
Identities = 38/158 (24%), Positives = 68/158 (43%), Gaps = 23/158 (14%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP 83
+G+G+ G V + + R A K + K + ++ EI ++ L HP
Sbjct: 15 NTIGRGSWGEVKIAVQKGT----RIRRAAKKIPKYFVEDVDRFKQ----EIEIMKSLDHP 66
Query: 84 FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRV-----FSPSVIRFYLSEIICAI 138
+ +L + E + + + C GG+L +RV F S + +++ A+
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELF-------ERVVHKRVFRESDAARIMKDVLSAV 119
Query: 139 EHLHNMGIAYRDLKPENILIRQSGH---VTLTDFDLSR 173
+ H + +A+RDLKPEN L + L DF L+
Sbjct: 120 AYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 4e-19
Identities = 33/114 (28%), Positives = 51/114 (44%), Gaps = 10/114 (8%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFR 298
F G+ + VGT YVSP+V+ G + D W+ G++ Y +L G PF E
Sbjct: 159 FKPGKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVML 217
Query: 299 NVLMKTPEFVGQRTALT-----DLIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347
+ T F + LI+RLL K P +R+ + + EH +F+
Sbjct: 218 KIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRI----TSLQALEHEWFEK 267
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-22
Identities = 45/178 (25%), Positives = 76/178 (42%), Gaps = 23/178 (12%)
Query: 7 PQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKS-----TLH 61
P +T +N + +ILG+G V + T + +A+K++D + +
Sbjct: 7 PGSHSTHGFY-ENYEPKEILGRGVSSVVRRCIHKP---TCK-EYAVKIIDVTGGGSFSAE 61
Query: 62 AKHEAERRARWEIRVLSRLS-HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDR 120
E E+ +L ++S HP + +L + ET+ F G+L D
Sbjct: 62 EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF-------DY 114
Query: 121 V-----FSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+ S R + ++ I LH + I +RDLKPENIL+ ++ LTDF S
Sbjct: 115 LTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 172
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 3e-18
Identities = 32/125 (25%), Positives = 52/125 (41%), Gaps = 17/125 (13%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEF------AVDWWALGILTYEMLYGTTPFRGKN 292
D GE+ GT Y++PE++ ++ VD W+ G++ Y +L G+ PF +
Sbjct: 174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233
Query: 293 RKETFRNVLMKTPEFVGQ------RTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
+ R ++ +F T DL+ R L P KR A E H FF+
Sbjct: 234 QMLMLRMIMSGNYQFGSPEWDDYSDTVK-DLVSRFLVVQPQKRY----TAEEALAHPFFQ 288
Query: 347 GVRWD 351
+
Sbjct: 289 QYVVE 293
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 39/149 (26%), Positives = 70/149 (46%), Gaps = 9/149 (6%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP 83
+ LG+GA G V L A + A+K+VD E ++ EI + L+H
Sbjct: 13 QTLGEGAYGEVQL----AVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHE 65
Query: 84 FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN 143
+ K G + YC GG+L + D + + +++ + +LH
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 144 MGIAYRDLKPENILIRQSGHVTLTDFDLS 172
+GI +RD+KPEN+L+ + ++ ++DF L+
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLA 152
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 5e-11
Identities = 26/131 (19%), Positives = 49/131 (37%), Gaps = 16/131 (12%)
Query: 246 NSFVGTEEYVSPEVVRG---DGHEFAVDWWALGILTYEMLYGTTPFRG-KNRKETFRNVL 301
N GT YV+PE+++ VD W+ GI+ ML G P+ + + + +
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEP--VDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK 222
Query: 302 ---MKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLR 358
+ +A L+ ++L ++P R+ +IK+ ++ L R
Sbjct: 223 EKKTYLNPWKKIDSAPLALLHKILVENPSARITIP----DIKKDRWYNK---PLKKGAKR 275
Query: 359 PPFIPSREEND 369
P
Sbjct: 276 PRVTSGGVSES 286
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 41/159 (25%), Positives = 69/159 (43%), Gaps = 23/159 (14%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAK-HEAERRARWEIRVLSRLSH 82
+ LGKGA V A +A +++ L A+ H+ R E R+ L H
Sbjct: 17 EELGKGAFSVVRRCVKVLA----GQEYAAMIINTKKLSARDHQKLER---EARICRLLKH 69
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRV-----FSPSVIRFYLSEIICA 137
P + +L S+ + GG+L + + +S + + +I+ A
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELF-------EDIVAREYYSEADASHCIQQILEA 122
Query: 138 IEHLHNMGIAYRDLKPENILIR---QSGHVTLTDFDLSR 173
+ H H MG+ +R+LKPEN+L+ + V L DF L+
Sbjct: 123 VLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 32/114 (28%), Positives = 52/114 (45%), Gaps = 11/114 (9%)
Query: 240 DNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRN 299
+ F GT Y+SPEV+R D + VD WA G++ Y +L G PF +++ ++
Sbjct: 165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ 224
Query: 300 VLMKTPEFVGQ------RTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347
+ +F A DLI ++L +P KR+ A E +H +
Sbjct: 225 IKAGAYDFPSPEWDTVTPEAK-DLINKMLTINPSKRI----TAAEALKHPWISH 273
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 97.0 bits (241), Expect = 3e-22
Identities = 28/185 (15%), Positives = 55/185 (29%), Gaps = 36/185 (19%)
Query: 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSR 79
L +LG+ D+ T F + V + A ++ + E+ L
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQE---TGE-SFEVHVPYFT-ERPPSNAIKQMKEEVLRLRL 134
Query: 80 LS----------------------HPFLPKLLGSLETDE-------FLAWAVPYCPGGDL 110
L P K++ + F +
Sbjct: 135 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 194
Query: 111 --NVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTD 168
+L + + ++I + LH+ G+ + L+P +I++ Q G V LT
Sbjct: 195 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 254
Query: 169 FDLSR 173
F+
Sbjct: 255 FEHLV 259
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 87.8 bits (217), Expect = 4e-19
Identities = 20/130 (15%), Positives = 37/130 (28%), Gaps = 14/130 (10%)
Query: 244 RSNSFVGTEEYVSPEVVRGDGHE-----FAVDWWALGILTYEMLYGTTPFRGKNRKETFR 298
E + ++ H FA D W LG+ Y + P
Sbjct: 268 PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSE 327
Query: 299 NVLMKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDV-- 356
+ + L++ L RL + E ++ +R +L +
Sbjct: 328 WIFRSCKNI---PQPVRALLEGFLRYPKEDRL----LPLQAMETPEYEQLRTELSAALPL 380
Query: 357 LRPPFIPSRE 366
+ P+RE
Sbjct: 381 YQTDGEPTRE 390
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 4e-22
Identities = 27/98 (27%), Positives = 42/98 (42%), Gaps = 7/98 (7%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFR 298
G+ EY +PEV + D A D W+LG L Y +L G PF + ++
Sbjct: 154 LKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE 213
Query: 299 NVLMKTPEFVGQ------RTALTDLIQRLLEKDPVKRL 330
N++ F + A+ D + RLL K+ R+
Sbjct: 214 NIMNAEYTFDEEAFKEISIEAM-DFVDRLLVKERKSRM 250
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 5e-22
Identities = 36/160 (22%), Positives = 68/160 (42%), Gaps = 12/160 (7%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP 83
+ LG+G G V + + + + + K V ++ EI +L+ H
Sbjct: 11 EDLGRGEFGIVHRCVETS---SKK-TYMAKFVKVKGT--DQVLVKK---EISILNIARHR 61
Query: 84 FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN 143
+ L S E+ E L + G D+ R + + I Y+ ++ A++ LH+
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDI-FERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 144 MGIAYRDLKPENILI--RQSGHVTLTDFDLSRNLVKKTAF 181
I + D++PENI+ R+S + + +F +R L F
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-22
Identities = 44/165 (26%), Positives = 74/165 (44%), Gaps = 10/165 (6%)
Query: 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARW 72
+ D +LGKG G V+ D + + A+K + +
Sbjct: 17 YDYEYDENGDRVVLGKGTYGIVYA----GRDLSNQVRIAIKEIPERDSRYSQPLHE---- 68
Query: 73 EIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYL 131
EI + L H + + LGS + F+ + PGG L +LR K + I FY
Sbjct: 69 EIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYT 128
Query: 132 SEIICAIEHLHNMGIAYRDLKPENILI-RQSGHVTLTDFDLSRNL 175
+I+ +++LH+ I +RD+K +N+LI SG + ++DF S+ L
Sbjct: 129 KQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 9e-08
Identities = 27/99 (27%), Positives = 39/99 (39%), Gaps = 12/99 (12%)
Query: 240 DNGERSNSFVGTEEYVSPEVVRGD--GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETF 297
+ +F GT +Y++PE++ G+ A D W+LG EM G PF E
Sbjct: 175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY--ELGEPQ 232
Query: 298 RNVLMK------TPEFVGQRT-ALTDLIQRLLEKDPVKR 329
+ K PE + I + E DP KR
Sbjct: 233 A-AMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKR 270
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 5e-22
Identities = 42/167 (25%), Positives = 67/167 (40%), Gaps = 28/167 (16%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKH---------EAERRARWEI 74
+ LG GA G V L ++ A+KV+ KS + EI
Sbjct: 42 RKLGSGAYGEVLLCKEKN---GHS-EKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRV-----FSPSVIRF 129
+L L HP + KL E ++ + GG+L +++ F
Sbjct: 98 SLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELF-------EQIINRHKFDECDAAN 150
Query: 130 YLSEIICAIEHLHNMGIAYRDLKPENILIR---QSGHVTLTDFDLSR 173
+ +I+ I +LH I +RD+KPENIL+ ++ + DF LS
Sbjct: 151 IMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS 197
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 25/97 (25%), Positives = 43/97 (44%), Gaps = 6/97 (6%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFR 298
F + +GT Y++PEV++ + D W+ G++ Y +L G PF G+N ++ +
Sbjct: 199 FSKDYKLRDRLGTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIK 257
Query: 299 NVLMKTPEFVGQR-----TALTDLIQRLLEKDPVKRL 330
V F +LI+ +L D KR
Sbjct: 258 KVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRC 294
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 5e-22
Identities = 40/160 (25%), Positives = 67/160 (41%), Gaps = 21/160 (13%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAK----HEAERRARWEIRVLSR 79
++G+G V RA FA+K+++ + E R E +L +
Sbjct: 100 DVIGRGVSSVVRRCVHRAT----GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 80 LS-HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRV-----FSPSVIRFYLSE 133
++ HP + L+ S E+ F+ G+L D + S R +
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELF-------DYLTEKVALSEKETRSIMRS 208
Query: 134 IICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
++ A+ LH I +RDLKPENIL+ + + L+DF S
Sbjct: 209 LLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC 248
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 5e-17
Identities = 34/120 (28%), Positives = 55/120 (45%), Gaps = 17/120 (14%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEF------AVDWWALGILTYEMLYGTTPFRGKN 292
+ GE+ GT Y++PE+++ E VD WA G++ + +L G+ PF +
Sbjct: 250 LEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309
Query: 293 RKETFRNVLMKTPEFVGQ------RTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
+ R ++ +F T DLI RLL+ DP RL A + +H FF+
Sbjct: 310 QILMLRMIMEGQYQFSSPEWDDRSSTVK-DLISRLLQVDPEARL----TAEQALQHPFFE 364
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 9e-22
Identities = 41/194 (21%), Positives = 74/194 (38%), Gaps = 22/194 (11%)
Query: 2 EATPPPQPQTTPSLDLDNLKA-------------LKILGKGAMGTVFLVHDRAADPTARC 48
P P SL ++ L+ +G G+ G V+ D
Sbjct: 25 AMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVV-- 82
Query: 49 PFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAV-PYCPG 107
A+K + S + + + + E+R L +L HP + G + W V YC G
Sbjct: 83 --AIKKMSYSGKQSNEKWQDIIK-EVRFLQKLRHPNTIQYRGCYLREHTA-WLVMEYCLG 138
Query: 108 GDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLT 167
++L + + + I + + +LH+ + +RD+K NIL+ + G V L
Sbjct: 139 SASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLG 196
Query: 168 DFDLSRNLVKKTAF 181
DF + + +F
Sbjct: 197 DFGSASIMAPANSF 210
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 26/112 (23%), Positives = 44/112 (39%), Gaps = 10/112 (8%)
Query: 244 RSNSFVGTEEYVSPEVVRGD---GHEFAVDWWALGILTYEMLYGTTPFRGKN-RKETFRN 299
+NSFVGT +++PEV+ ++ VD W+LGI E+ P N +
Sbjct: 206 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 265
Query: 300 VLMKTPEFVGQR--TALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349
++P + + L+K P R + + +H F R
Sbjct: 266 AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRP----TSEVLLKHRFVLRER 313
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 43/150 (28%), Positives = 73/150 (48%), Gaps = 8/150 (5%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
LK +GKG V L T R A+K++DK+ L + ++ E+R++ L+H
Sbjct: 20 LKTIGKGNFAKVKLARHI---LTGR-EVAIKIIDKTQL--NPTSLQKLFREVRIMKILNH 73
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLH 142
P + KL +ET++ L + Y GG++ Y R +I+ A+++ H
Sbjct: 74 PNIVKLFEVIETEKTLYLIMEYASGGEV--FDYLVAHGRMKEKEARSKFRQIVSAVQYCH 131
Query: 143 NMGIAYRDLKPENILIRQSGHVTLTDFDLS 172
I +RDLK EN+L+ ++ + DF S
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGFS 161
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 5e-18
Identities = 46/164 (28%), Positives = 74/164 (45%), Gaps = 18/164 (10%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRG---DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKE 295
F G + ++F G Y +PE+ +G DG E VD W+LG++ Y ++ G+ PF G+N KE
Sbjct: 164 FTVGGKLDAFCGAPPYAAPELFQGKKYDGPE--VDVWSLGVILYTLVSGSLPFDGQNLKE 221
Query: 296 TFRNVLM---KTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDL 352
VL + P ++ T +L++R L +P+KR +I + +
Sbjct: 222 LRERVLRGKYRIPFYMS--TDCENLLKRFLVLNPIKRG----TLEQIMKDRWIN---AGH 272
Query: 353 LTDVLRPPFIPSREEND-LTEKAMSGGGVDIREYFENLRAPPPS 395
D L+P P + +D M G G E E+L
Sbjct: 273 EEDELKPFVEPELDISDQKRIDIMVGMGYSQEEIQESLSKMKYD 316
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 46/186 (24%), Positives = 72/186 (38%), Gaps = 15/186 (8%)
Query: 5 PPPQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKH 64
PP + +LGKG GTVF H A+KV+ ++ +
Sbjct: 18 TPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLT---DRL-QVAIKVIPRNRVLGWS 73
Query: 65 EAERRARW--EIRVLSRLS----HPFLPKLLGSLETDEFLAWAVPY-CPGGDLNVLRYKQ 117
E+ +L ++ HP + +LL ET E + P DL Y
Sbjct: 74 PLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDL--FDYIT 131
Query: 118 NDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILI-RQSGHVTLTDFDLSRNLV 176
R + +++ AI+H H+ G+ +RD+K ENILI + G L DF L+
Sbjct: 132 EKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG-ALL 190
Query: 177 KKTAFE 182
+
Sbjct: 191 HDEPYT 196
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 6e-13
Identities = 28/102 (27%), Positives = 36/102 (35%), Gaps = 14/102 (13%)
Query: 248 FVGTEEYVSPEVVRG---DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT 304
F GT Y PE + W+LGIL Y+M+ G PF +E L
Sbjct: 198 FDGTRVYSPPEWISRHQYHALP--ATVWSLGILLYDMVCGDIPFER--DQEILEAEL-HF 252
Query: 305 PEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
P V LI+R L P R EI + +
Sbjct: 253 PAHVS--PDCCALIRRCLAPKPSSRPSL----EEILLDPWMQ 288
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-21
Identities = 37/164 (22%), Positives = 66/164 (40%), Gaps = 7/164 (4%)
Query: 9 PQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAER 68
+ + + + LG G G V + A+K++++ + + +
Sbjct: 2 SKHDGRVKIGHYVLGDTLGVGTFGKVKI----GEHQLTGHKVAVKILNRQKIRSLDVVGK 57
Query: 69 RARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIR 128
R EI+ L HP + KL + T + Y GG+L Y R
Sbjct: 58 IKR-EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGEL--FDYICKHGRVEEMEAR 114
Query: 129 FYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172
+I+ A+++ H + +RDLKPEN+L+ + + DF LS
Sbjct: 115 RLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS 158
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 6e-14
Identities = 34/114 (29%), Positives = 58/114 (50%), Gaps = 14/114 (12%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRG---DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKE 295
+GE + G+ Y +PEV+ G G E VD W+ G++ Y +L GT PF ++
Sbjct: 161 MSDGEFLRTSCGSPNYAAPEVISGRLYAGPE--VDIWSCGVILYALLCGTLPFDDEHVPT 218
Query: 296 TFRNVLM---KTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
F+ + PE++ ++ L+ +L+ DP+KR +I+EH +FK
Sbjct: 219 LFKKIRGGVFYIPEYLN--RSVATLLMHMLQVDPLKRATIK----DIREHEWFK 266
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 39/159 (24%), Positives = 62/159 (38%), Gaps = 20/159 (12%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-H 82
+LG GA GT+ R A+K + A+R E+++L H
Sbjct: 30 DVLGHGAEGTIVYRGMF----DNR-DVAVKRILPECFSF---ADR----EVQLLRESDEH 77
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLH 142
P + + + + +F A+ C L +Q D L + + HLH
Sbjct: 78 PNVIRYFCTEKDRQFQYIAIELC-AATLQE-YVEQKDFAHLGLEPITLLQQTTSGLAHLH 135
Query: 143 NMGIAYRDLKPENILIRQSGH-----VTLTDFDLSRNLV 176
++ I +RDLKP NILI ++DF L + L
Sbjct: 136 SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 29/122 (23%), Positives = 56/122 (45%), Gaps = 19/122 (15%)
Query: 236 QQSFDNGERSNSFVGTEEYVSPEVVRGDGHE---FAVDWWALGILTYEML-YGTTPFRGK 291
+ SF R + GTE +++PE++ D E + VD ++ G + Y ++ G+ PF
Sbjct: 177 RHSF---SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS 233
Query: 292 NRKETFRNVLMKTPEF------VGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345
+++ N+L+ + +LI++++ DP KR A + +H FF
Sbjct: 234 LQRQA--NILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRP----SAKHVLKHPFF 287
Query: 346 KG 347
Sbjct: 288 WS 289
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-21
Identities = 43/185 (23%), Positives = 72/185 (38%), Gaps = 15/185 (8%)
Query: 5 PPPQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTL--HA 62
P + +LG G G+V+ + P A+K V+K +
Sbjct: 30 TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVS---DNL-PVAIKHVEKDRISDWG 85
Query: 63 KHEAERRARWEIRVLSRLSHPFLP---KLLGSLETDEFLAWAVPYC-PGGDLNVLRYKQN 118
+ R E+ +L ++S F +LL E + + P DL +
Sbjct: 86 ELPNGTRVPMEVVLLKKVSSGF-SGVIRLLDWFERPDSFVLILERPEPVQDL--FDFITE 142
Query: 119 DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILI-RQSGHVTLTDFDLSRNLVK 177
+ R + +++ A+ H HN G+ +RD+K ENILI G + L DF L+K
Sbjct: 143 RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLK 201
Query: 178 KTAFE 182
T +
Sbjct: 202 DTVYT 206
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 4e-13
Identities = 35/127 (27%), Positives = 49/127 (38%), Gaps = 22/127 (17%)
Query: 248 FVGTEEYVSPEVVRG---DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT 304
F GT Y PE +R G W+LGIL Y+M+ G PF +E R +
Sbjct: 208 FDGTRVYSPPEWIRYHRYHGRS--AAVWSLGILLYDMVCGDIPFEH--DEEIIRGQV-FF 262
Query: 305 PEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPS 364
+ V + LI+ L P R + EI+ H W + DVL P
Sbjct: 263 RQRVS--SECQHLIRWCLALRPSDRPTFE----EIQNH------PW--MQDVLLPQETAE 308
Query: 365 REENDLT 371
+ L+
Sbjct: 309 IHLHSLS 315
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 3e-21
Identities = 46/176 (26%), Positives = 76/176 (43%), Gaps = 15/176 (8%)
Query: 1 MEATPPPQ-PQTTPSL-DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKS 58
M+ P P P + D D +K +G G G L+ D+ T A+K +++
Sbjct: 1 MDRAPVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDK---LTKE-LVAVKYIERG 56
Query: 59 TLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQN 118
++ +R EI L HP + + + T LA + Y GG+L N
Sbjct: 57 AAIDEN-VQR----EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGEL--YERICN 109
Query: 119 DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILI--RQSGHVTLTDFDLS 172
FS RF+ +++ + + H+M I +RDLK EN L+ + + + DF S
Sbjct: 110 AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS 165
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 33/119 (27%), Positives = 47/119 (39%), Gaps = 16/119 (13%)
Query: 238 SFDNGERSNSFVGTEEYVSPEVVRG---DGHEFAVDWWALGILTYEMLYGTTPFRGKNRK 294
S + S VGT Y++PEV+ DG D W+ G+ Y ML G PF
Sbjct: 167 SSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKI--ADVWSCGVTLYVMLVGAYPFEDPEEP 224
Query: 295 ETFRNVLMK-------TPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
+R + + P+ + LI R+ DP R+ EIK H +F
Sbjct: 225 RDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIP----EIKTHSWFL 279
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-21
Identities = 46/196 (23%), Positives = 81/196 (41%), Gaps = 28/196 (14%)
Query: 1 MEATPPPQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTL 60
M P + D+ + +++G GA V A + A+K ++
Sbjct: 1 MSEDSSALPWSINR---DDYELQEVIGSGATAVVQ----AAYCAPKKEKVAIKRINLEKC 53
Query: 61 HAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAV-PYCPGGDL-NVLRYKQN 118
+ + EI+ +S+ HP + S + L W V GG + +++++
Sbjct: 54 QTSMDELLK---EIQAMSQCHHPNIVSYYTSFVVKDEL-WLVMKLLSGGSVLDIIKHIVA 109
Query: 119 D-----RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF---- 169
V S I L E++ +E+LH G +RD+K NIL+ + G V + DF
Sbjct: 110 KGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA 169
Query: 170 ------DLSRNLVKKT 179
D++RN V+KT
Sbjct: 170 FLATGGDITRNKVRKT 185
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 29/116 (25%), Positives = 49/116 (42%), Gaps = 16/116 (13%)
Query: 246 NSFVGTEEYVSPEVV-RGDGHEFAVDWWALGILTYEMLYGTTPFRG-----------KNR 293
+FVGT +++PEV+ + G++F D W+ GI E+ G P+ +N
Sbjct: 184 KTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND 243
Query: 294 KETFRNVLMKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349
+ + + +I L+KDP KR A E+ H FF+ +
Sbjct: 244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP----TAAELLRHKFFQKAK 295
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-21
Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFR 298
+ +GT EY++PE++ D A D W +GI+ Y +L T+PF G++ +ET+
Sbjct: 184 IGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL 243
Query: 299 NVLMKTPEFVGQ------RTALTDLIQRLLEKDPVKRL 330
N+ ++ + + A TD IQ LL K+P KR
Sbjct: 244 NISQVNVDYSEETFSSVSQLA-TDFIQSLLVKNPEKRP 280
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 5e-20
Identities = 38/161 (23%), Positives = 62/161 (38%), Gaps = 24/161 (14%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH- 82
K LG+G V ++ T + +A K + K AE EI VL
Sbjct: 35 KELGRGKFAVVRQCISKS---TGQ-EYAAKFLKKRRRGQDCRAE--ILHEIAVLELAKSC 88
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRV-------FSPSVIRFYLSEII 135
P + L E + + Y GG++ S + + + +I+
Sbjct: 89 PRVINLHEVYENTSEIILILEYAAGGEIF-------SLCLPELAEMVSENDVIRLIKQIL 141
Query: 136 CAIEHLHNMGIAYRDLKPENILI---RQSGHVTLTDFDLSR 173
+ +LH I + DLKP+NIL+ G + + DF +SR
Sbjct: 142 EGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 5e-21
Identities = 35/154 (22%), Positives = 65/154 (42%), Gaps = 17/154 (11%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-H 82
K LG+G+ + + FA+K++ K + EI L H
Sbjct: 17 KPLGEGSFSICRKCVHKKS----NQAFAVKIISKRMEA-------NTQKEITALKLCEGH 65
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLH 142
P + KL + GG+L + + FS + + + +++ A+ H+H
Sbjct: 66 PNIVKLHEVFHDQLHTFLVMELLNGGEL--FERIKKKKHFSETEASYIMRKLVSAVSHMH 123
Query: 143 NMGIAYRDLKPENILIR---QSGHVTLTDFDLSR 173
++G+ +RDLKPEN+L + + + DF +R
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 6e-16
Identities = 31/121 (25%), Positives = 55/121 (45%), Gaps = 18/121 (14%)
Query: 240 DNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRK----- 294
+ + + T Y +PE++ +G++ + D W+LG++ Y ML G PF+ +R
Sbjct: 161 PDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS 220
Query: 295 --ETFRNVLMKTPEFVGQ------RTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
E + + F G+ + A DLIQ LL DP KRL ++ + + +
Sbjct: 221 AVEIMKKIKKGDFSFEGEAWKNVSQEA-KDLIQGLLTVDPNKRL----KMSGLRYNEWLQ 275
Query: 347 G 347
Sbjct: 276 D 276
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 9e-21
Identities = 64/324 (19%), Positives = 116/324 (35%), Gaps = 72/324 (22%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
+L ++LGKG G V R +V K + E +R E+
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEV--------MVMKELIRFDEETQRTFLKEV 58
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYLSE 133
+V+ L HP + K +G L D+ L + Y GG L +++ D + S + +
Sbjct: 59 KVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIK--SMDSQYPWSQRVSFAKD 116
Query: 134 IICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPV 193
I + +LH+M I +RDL N L+R++ +V + DF L+R L+ + + L + K P
Sbjct: 117 IASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLAR-LMVDEKTQPEGLRSLKKPD 175
Query: 194 LPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253
++ + VG
Sbjct: 176 ------------------------------------------------RKKRYTVVGNPY 187
Query: 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVGQR-- 311
+++PE++ G ++ VD ++ GI+ E++ R +
Sbjct: 188 WMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD----YLPRTMDFGLNVRGFLDRY 243
Query: 312 ------TALTDLIQRLLEKDPVKR 329
+ + R + DP KR
Sbjct: 244 CPPNCPPSFFPITVRCCDLDPEKR 267
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 43/171 (25%), Positives = 76/171 (44%), Gaps = 10/171 (5%)
Query: 8 QPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAE 67
Q Q L D+ + + LG G G VF V + P+ A K++ L K
Sbjct: 23 QKQKVGELKDDDFEKISELGAGNGGVVFKVSHK---PSGL-VMARKLIH---LEIKPAIR 75
Query: 68 RRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVI 127
+ E++VL + P++ G+ +D ++ + + GG L+ + K+ R ++
Sbjct: 76 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV-LKKAGR-IPEQIL 133
Query: 128 RFYLSEIICAIEHLHNMG-IAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177
+I + +L I +RD+KP NIL+ G + L DF +S L+
Sbjct: 134 GKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 20/55 (36%), Positives = 29/55 (52%)
Query: 245 SNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRN 299
+NSFVGT Y+SPE ++G + D W++G+ EM G P + KE
Sbjct: 187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 241
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-20
Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
+ LG GA G V+ ++ A A KV++ + + EI +L+ H
Sbjct: 24 VGELGDGAFGKVYKAKNKETGALA----AAKVIETKSEEELEDYIV----EIEILATCDH 75
Query: 83 PFLPKLLGSLETDEFLAWAV-PYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHL 141
P++ KLLG+ D L W + +CPGG ++ + + DR + I+ +++ A+ L
Sbjct: 76 PYIVKLLGAYYHDGKL-WIMIEFCPGGAVDAI-MLELDRGLTEPQIQVVCRQMLEALNFL 133
Query: 142 HNMGIAYRDLKPENILIRQSGHVTLTDF----DLSRNLVKKTAF 181
H+ I +RDLK N+L+ G + L DF + L K+ +F
Sbjct: 134 HSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF 177
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 30/129 (23%), Positives = 53/129 (41%), Gaps = 27/129 (20%)
Query: 237 QSFDNGERSNSFVGTEEYVSPEVV-----RGDGHEFAVDWWALGILTYEMLYG------T 285
++ ++ +SF+GT +++PEVV + +++ D W+LGI EM
Sbjct: 166 KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225
Query: 286 TPFR-----GKNRKETFRNVLMKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIK 340
P R K+ T + EF D ++ L+K+P R A ++
Sbjct: 226 NPMRVLLKIAKSDPPTLLTPSKWSVEFR-------DFLKIALDKNPETRP----SAAQLL 274
Query: 341 EHVFFKGVR 349
EH F +
Sbjct: 275 EHPFVSSIT 283
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-20
Identities = 72/404 (17%), Positives = 126/404 (31%), Gaps = 126/404 (31%)
Query: 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWE 73
++++L+ L +G G G V+ + R T A+K + E +R +
Sbjct: 21 QAEINDLENLGEMGSGTCGQVWKMRFR---KTGHV-IAVKQMR---RSGNKEENKRILMD 73
Query: 74 IRVLSRLS-HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLS 132
+ V+ + P++ + G+ T+ + A+ K+ ++
Sbjct: 74 LDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAE--KLKKRMQGPIPERILGKMTV 131
Query: 133 EIICAIEHLH-NMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKF 191
I+ A+ +L G+ +RD+KP NIL+ + G + L DF +S LV ++
Sbjct: 132 AIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD-------DKAKDRS 184
Query: 192 PVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251
A PE R+ P + +D
Sbjct: 185 --------------AGCAAYMA-PE-----------RIDPPDPTKPDYD----------- 207
Query: 252 EEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK-------- 303
D W+LGI E+ G P++ T VL K
Sbjct: 208 ---------------IRADVWSLGISLVELATGQFPYKNCK---TDFEVLTKVLQEEPPL 249
Query: 304 -------TPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDV 356
+ +F ++ L KD KR Y LL
Sbjct: 250 LPGHMGFSGDFQ-------SFVKDCLTKDHRKRPKY-----------------NKLLEH- 284
Query: 357 LRPPFIPSREENDLTEKAMSGGGVDIREYFENLRAPPPSMPPSP 400
FI E + VD+ +F+++ A S P
Sbjct: 285 ---SFIKRYETLE----------VDVASWFKDVMAKTESPRSGP 315
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 3e-20
Identities = 32/171 (18%), Positives = 62/171 (36%), Gaps = 18/171 (10%)
Query: 7 PQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEA 66
++ + +G+G+ G V D A+K V +
Sbjct: 47 KPVDYEYREEVHWMTHQPRVGRGSFGEVHR----MKDKQTGFQCAVKKVRLEVFRVE--- 99
Query: 67 ERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPS 125
E+ + LS P + L G++ ++ + GG L +++
Sbjct: 100 ------ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK---QMGCLPED 150
Query: 126 VIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG-HVTLTDFDLSRNL 175
+YL + + +E+LH I + D+K +N+L+ G L DF + L
Sbjct: 151 RALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCL 201
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 26/129 (20%), Positives = 41/129 (31%), Gaps = 22/129 (17%)
Query: 229 VSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPF 288
+ + + + GTE +++PEVV G + VD W+ + ML G P+
Sbjct: 197 HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW 256
Query: 289 R-----------GKNRKETFRNVLMKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGAC 337
+ P IQ L K+PV R A
Sbjct: 257 TQYFRGPLCLKIASEPPPIR-----EIPPSCAP--LTAQAIQEGLRKEPVHRA----SAM 305
Query: 338 EIKEHVFFK 346
E++ V
Sbjct: 306 ELRRKVGKA 314
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 90.4 bits (224), Expect = 4e-20
Identities = 76/395 (19%), Positives = 125/395 (31%), Gaps = 107/395 (27%)
Query: 21 KALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL 80
++ LG G TV+L D + A+KVV KS A+H E A EIR+L +
Sbjct: 40 HVIRKLGWGHFSTVWLSWDI----QGKKFVAMKVV-KS---AEHYTET-ALDEIRLLKSV 90
Query: 81 -----SHP---FLPKLLGSLETD-----------EFLAWAVPYCPGGDLNVLRYKQNDRV 121
+ P + +LL + E L G L K N +
Sbjct: 91 RNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL--------GHHLLKWIIKSNYQG 142
Query: 122 FSPSVIRFYLSEIICAIEHLHN-MGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTA 180
++ + +++ +++LH I + D+KPENIL +++ + + R
Sbjct: 143 LPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENIL------LSVNEQYIRRL------ 190
Query: 181 FEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFD 240
+ + P +L E K K +
Sbjct: 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH--- 247
Query: 241 NGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPF------------ 288
+ + T +Y S EV+ G G+ D W+ + +E+ G F
Sbjct: 248 --KHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDE 305
Query: 289 -------------------RGKNRKETF-----------------RNVLMKTPEFVGQ-R 311
GK KE F VL++ E+ +
Sbjct: 306 DHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEA 365
Query: 312 TALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
TD + +LE P KR A E H +
Sbjct: 366 AGFTDFLLPMLELIPEKRA----TAAECLRHPWLN 396
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 5e-20
Identities = 47/164 (28%), Positives = 75/164 (45%), Gaps = 16/164 (9%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
L+ +GKG+ G VF D A+K++D + E ++ EI VLS+
Sbjct: 27 LEKIGKGSFGEVFKGIDNRTQKVV----AIKIIDLEEAEDEIEDIQQ---EITVLSQCDS 79
Query: 83 PFLPKLLGSLETDEFLAWAV-PYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHL 141
P++ K GS D L W + Y GG L + + I L EI+ +++L
Sbjct: 80 PYVTKYYGSYLKDTKL-WIIMEYLGGGSALDL-LEPG--PLDETQIATILREILKGLDYL 135
Query: 142 HNMGIAYRDLKPENILIRQSGHVTLTDF----DLSRNLVKKTAF 181
H+ +RD+K N+L+ + G V L DF L+ +K+ F
Sbjct: 136 HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF 179
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 9e-10
Identities = 29/115 (25%), Positives = 51/115 (44%), Gaps = 12/115 (10%)
Query: 237 QSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKET 296
Q D + N+FVGT +++PEV++ ++ D W+LGI E+ G P +
Sbjct: 168 QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH---P 224
Query: 297 FRNVLM----KTPEFVGQRT-ALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
+ + + P G + L + ++ L K+P R A E+ +H F
Sbjct: 225 MKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRP----TAKELLKHKFIL 275
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 5e-20
Identities = 46/173 (26%), Positives = 73/173 (42%), Gaps = 31/173 (17%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARW----------- 72
+GKG+ G V L A + +A+KV+ K L + RR
Sbjct: 19 DEIGKGSYGVVKL----AYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 73 -----------EIRVLSRLSHPFLPKLLGSLE--TDEFLAWAVPYCPGGDLNVLRYKQND 119
EI +L +L HP + KL+ L+ ++ L G + +
Sbjct: 75 QPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV--MEVPTLK 132
Query: 120 RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172
S RFY ++I IE+LH I +RD+KP N+L+ + GH+ + DF +S
Sbjct: 133 P-LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS 184
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 29/105 (27%), Positives = 48/105 (45%), Gaps = 10/105 (9%)
Query: 248 FVGTEEYVSPEVVRGDGHEF---AVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL--- 301
VGT +++PE + F A+D WA+G+ Y ++G PF + +
Sbjct: 197 TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQA 256
Query: 302 MKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
++ P+ L DLI R+L+K+P R+ EIK H +
Sbjct: 257 LEFPDQPDIAEDLKDLITRMLDKNPESRIVVP----EIKLHPWVT 297
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 5e-20
Identities = 52/162 (32%), Positives = 74/162 (45%), Gaps = 33/162 (20%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP 83
LG+GA V+ + P+ALKV+ K+ + R EI VL RLSHP
Sbjct: 59 SELGRGATSIVYRCKQKGTQ----KPYALKVLKKT---VDKKIVRT---EIGVLLRLSHP 108
Query: 84 FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSE---------I 134
+ KL ET ++ + GG+L DR+ V + Y SE I
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELF-------DRI----VEKGYYSERDAADAVKQI 157
Query: 135 ICAIEHLHNMGIAYRDLKPENILIRQSG---HVTLTDFDLSR 173
+ A+ +LH GI +RDLKPEN+L + + DF LS+
Sbjct: 158 LEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 33/116 (28%), Positives = 55/116 (47%), Gaps = 12/116 (10%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGK-NRKETF 297
++ + GT Y +PE++RG + VD W++GI+TY +L G PF + + F
Sbjct: 201 VEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF 260
Query: 298 RNVLMKTPEFVGQ------RTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347
R +L F+ A DL+++L+ DP KRL + +H + G
Sbjct: 261 RRILNCEYYFISPWWDEVSLNAK-DLVRKLIVLDPKKRL----TTFQALQHPWVTG 311
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 6e-20
Identities = 36/170 (21%), Positives = 68/170 (40%), Gaps = 7/170 (4%)
Query: 3 ATPPPQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHA 62
+ + + + + LG G G V + A+K++++ + +
Sbjct: 1 GPMAEKQKHDGRVKIGHYILGDTLGVGTFGKVKV----GKHELTGHKVAVKILNRQKIRS 56
Query: 63 KHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVF 122
+ R EI+ L HP + KL + T + + Y GG+L Y +
Sbjct: 57 LDVVGKIRR-EIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGEL--FDYICKNGRL 113
Query: 123 SPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172
R +I+ +++ H + +RDLKPEN+L+ + + DF LS
Sbjct: 114 DEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS 163
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 39/166 (23%), Positives = 71/166 (42%), Gaps = 21/166 (12%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRG---DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKE 295
+GE + G+ Y +PEV+ G G E VD W+ G++ Y +L GT PF +
Sbjct: 166 MSDGEFLRTSCGSPNYAAPEVISGRLYAGPE--VDIWSSGVILYALLCGTLPFDDDHVPT 223
Query: 296 TFRNVLM---KTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDL 352
F+ + TP+++ ++ L++ +L+ DP+KR +I+EH +FK
Sbjct: 224 LFKKICDGIFYTPQYLN--PSVISLLKHMLQVDPMKRATIK----DIREHEWFK----QD 273
Query: 353 LTDVLRPP---FIPSREENDLTEKAMSGGGVDIREYFENLRAPPPS 395
L L P + + +++ ++ E L
Sbjct: 274 LPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQ 319
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 44/175 (25%), Positives = 72/175 (41%), Gaps = 22/175 (12%)
Query: 7 PQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEA 66
P+P+ D L ++LG G G V R ALK++ S
Sbjct: 19 PEPKKYAVTDDYQLSK-QVLGLGVNGKVLECFHRRT----GQKCALKLLYDS-------- 65
Query: 67 ERRARWEIRVLSRLS-HPFLPKLLGSLETDEFLAWAV----PYCPGGDLNVLRYKQNDRV 121
+AR E+ + S P + +L E + GG+L ++ D+
Sbjct: 66 -PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA 124
Query: 122 FSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILI---RQSGHVTLTDFDLSR 173
F+ + +I AI+ LH+ IA+RD+KPEN+L + + LTDF ++
Sbjct: 125 FTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 26/102 (25%), Positives = 43/102 (42%), Gaps = 12/102 (11%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKET-- 296
+ T YV+PEV+ + ++ + D W+LG++ Y +L G PF +
Sbjct: 181 TTQNALQ-TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP 239
Query: 297 --FRNVLMKTPEFVGQ------RTALTDLIQRLLEKDPVKRL 330
R + + F A LI+ LL+ DP +RL
Sbjct: 240 GMKRRIRLGQYGFPNPEWSEVSEDAK-QLIRLLLKTDPTERL 280
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 39/155 (25%), Positives = 63/155 (40%), Gaps = 19/155 (12%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-H 82
+ +G G+ +A FA+K++DKS +R EI +L R H
Sbjct: 28 EDIGVGSYSVCKRCIHKAT----NMEFAVKIIDKS--------KRDPTEEIEILLRYGQH 75
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLH 142
P + L + +++ GG+L L + FS L I +E+LH
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGEL--LDKILRQKFFSEREASAVLFTITKTVEYLH 133
Query: 143 NMGIAYRDLKPENILIR----QSGHVTLTDFDLSR 173
G+ +RDLKP NIL + + DF ++
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 6e-15
Identities = 32/109 (29%), Positives = 47/109 (43%), Gaps = 14/109 (12%)
Query: 248 FVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGK---NRKETFRNVLMKT 304
T +V+PEV+ G++ A D W+LG+L Y ML G TPF +E +
Sbjct: 180 PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK 239
Query: 305 PEFVGQ------RTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347
G TA DL+ ++L DP +RL A + H +
Sbjct: 240 FSLSGGYWNSVSDTAK-DLVSKMLHVDPHQRL----TAALVLRHPWIVH 283
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 4e-19
Identities = 42/176 (23%), Positives = 80/176 (45%), Gaps = 11/176 (6%)
Query: 9 PQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAER 68
P+ ++LK L +G+GA G+V + + P+ + A+K + + ++
Sbjct: 13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHK---PSGQ-IMAVKRIR---STVDEKEQK 65
Query: 69 RARWEIRVLSRLS-HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLR--YKQNDRVFSPS 125
+ ++ V+ R S P++ + G+L + + + Y D V
Sbjct: 66 QLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEE 125
Query: 126 VIRFYLSEIICAIEHLH-NMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTA 180
++ + A+ HL N+ I +RD+KP NIL+ +SG++ L DF +S LV A
Sbjct: 126 ILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA 181
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 36/182 (19%), Positives = 57/182 (31%), Gaps = 62/182 (34%)
Query: 246 NSFVGTEEYVSPEVV----RGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL 301
G Y++PE + G++ D W+LGI YE+ G P+ N + + L
Sbjct: 183 TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN---SVFDQL 239
Query: 302 MK-----------------TPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVF 344
+ +P F+ + + L KD KR Y
Sbjct: 240 TQVVKGDPPQLSNSEEREFSPSFI-------NFVNLCLTKDESKRPKY------------ 280
Query: 345 FKGVRWDLLTDVLRPPFIPSREENDLTEKAMSGGGVDIREYFENLRAPPPSMPPSPLPSP 404
+LL PFI V++ Y + P+ P SP+
Sbjct: 281 -----KELLKH----PFI----------LMYEERAVEVACYVCKILDQMPATPSSPMYVD 321
Query: 405 SH 406
H
Sbjct: 322 HH 323
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 4e-19
Identities = 51/158 (32%), Positives = 75/158 (47%), Gaps = 9/158 (5%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP 83
+ LG+G+ G V L A + ALK + + L R R EI L L HP
Sbjct: 15 ETLGEGSFGKVKL----ATHYKTQQKVALKFISRQLLKKSDMHMRVER-EISYLKLLRHP 69
Query: 84 FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN 143
+ KL + T + + Y GG+L Y + + R + +IICAIE+ H
Sbjct: 70 HIIKLYDVITTPTDIVMVIEYA-GGEL--FDYIVEKKRMTEDEGRRFFQQIICAIEYCHR 126
Query: 144 MGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAF 181
I +RDLKPEN+L+ + +V + DF LS N++ F
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLS-NIMTDGNF 163
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 9e-16
Identities = 44/165 (26%), Positives = 66/165 (40%), Gaps = 20/165 (12%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRG---DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKE 295
+G + G+ Y +PEV+ G G E VD W+ GI+ Y ML G PF +
Sbjct: 158 MTDGNFLKTSCGSPNYAAPEVINGKLYAGPE--VDVWSCGIVLYVMLVGRLPFDDEFIPN 215
Query: 296 TFRNVLM---KTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDL 352
F+ V P+F+ LI+R++ DP++R+ EI+ +F
Sbjct: 216 LFKKVNSCVYVMPDFLS--PGAQSLIRRMIVADPMQRITIQ----EIRRDPWFNVN---- 265
Query: 353 LTDVLRPPFIPSREEND--LTEKAMSGGGVDIREYFENLRAPPPS 395
L D LRP D + K G E LR+ +
Sbjct: 266 LPDYLRPMEEVQGSYADSRIVSKLGEAMGFSEDYIVEALRSDENN 310
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 5e-19
Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 17/164 (10%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
L+ LG+G+ G+V+ + A+K V + + + + EI ++ +
Sbjct: 34 LEKLGEGSYGSVYKAIHKETGQIV----AIKQVP---VESDLQEIIK---EISIMQQCDS 83
Query: 83 PFLPKLLGSLETDEFLAWAV-PYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHL 141
P + K GS + L W V YC G ++ + + ++ + I L + +E+L
Sbjct: 84 PHVVKYYGSYFKNTDL-WIVMEYCGAGSVSDI-IRLRNKTLTEDEIATILQSTLKGLEYL 141
Query: 142 HNMGIAYRDLKPENILIRQSGHVTLTDF----DLSRNLVKKTAF 181
H M +RD+K NIL+ GH L DF L+ + K+
Sbjct: 142 HFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV 185
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 28/110 (25%), Positives = 50/110 (45%), Gaps = 8/110 (7%)
Query: 244 RSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNR-KETFRNVLM 302
+ N+ +GT +++PEV++ G+ D W+LGI EM G P+ + + F
Sbjct: 181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN 240
Query: 303 KTPEFVGQRT---ALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349
P F TD +++ L K P +R A ++ +H F + +
Sbjct: 241 PPPTFRKPELWSDNFTDFVKQCLVKSPEQRA----TATQLLQHPFVRSAK 286
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 7e-19
Identities = 37/168 (22%), Positives = 65/168 (38%), Gaps = 15/168 (8%)
Query: 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSR 79
LK +G+G+ TV+ + D A + +R + E +L
Sbjct: 28 LKFDIEIGRGSFKTVY----KGLDTETTVEVAWCELQDR--KLTKSERQRFKEEAEMLKG 81
Query: 80 LSHPFLPKLLGS----LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEII 135
L HP + + S ++ + + G L Y + +V V+R + +I+
Sbjct: 82 LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLK--TYLKRFKVMKIKVLRSWCRQIL 139
Query: 136 CAIEHLHNMG--IAYRDLKPENILI-RQSGHVTLTDFDLSRNLVKKTA 180
++ LH I +RDLK +NI I +G V + D L+ A
Sbjct: 140 KGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA 187
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 20/110 (18%), Positives = 49/110 (44%), Gaps = 9/110 (8%)
Query: 241 NGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRG-KNRKETFRN 299
+ + +GT E+++PE+ + ++ +VD +A G+ EM P+ +N + +R
Sbjct: 183 RASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR 241
Query: 300 VLMKTPEFVGQRT---ALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
V + + ++I+ + ++ +R ++ H FF+
Sbjct: 242 VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERY----SIKDLLNHAFFQ 287
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 60/328 (18%), Positives = 104/328 (31%), Gaps = 90/328 (27%)
Query: 16 DLDNLKALKILGKGAMGTVFL------VHDRAADPTARCPFALKVVDKSTLHAKHEAERR 69
+ + +G G+ GTV+ V A+K+++ + + +
Sbjct: 22 PDGQITVGQRIGSGSFGTVYKGKWHGDV-------------AVKMLNVTAPTPQQLQAFK 68
Query: 70 ARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIR 128
E+ VL + H + +G T LA +C G L + L ++ F +
Sbjct: 69 N--EVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLH--ASETKFEMKKLI 123
Query: 129 FYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNN 188
+ +++LH I +RDLK NI + + V + DF L+ K
Sbjct: 124 DIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT--EKSRWSGSHQFEQ 181
Query: 189 NKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248
+ W+ A PE V R Q S +S
Sbjct: 182 LSGSI---------------LWM-A-PE---------------VIRMQDSNPYSFQS--- 206
Query: 249 VGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETF-----RNVLMK 303
D +A GI+ YE++ G P+ N ++ R L
Sbjct: 207 ---------------------DVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP 245
Query: 304 TPEFVGQRT--ALTDLIQRLLEKDPVKR 329
V + L+ L+K +R
Sbjct: 246 DLSKVRSNCPKRMKRLMAECLKKKRDER 273
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 4e-18
Identities = 37/169 (21%), Positives = 75/169 (44%), Gaps = 17/169 (10%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVL 77
L + +G+G+ G V L ++ + A+K++D K + E+ ++
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQV----AVKMMDLR----KQQRRELLFNEVVIM 96
Query: 78 SRLSHPFLPKLLGSLETDEFLAWAV-PYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIIC 136
H + ++ S E L W + + GG L + Q + I ++
Sbjct: 97 RDYQHFNVVEMYKSYLVGEEL-WVLMEFLQGGALTDI-VSQV--RLNEEQIATVCEAVLQ 152
Query: 137 AIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF----DLSRNLVKKTAF 181
A+ +LH G+ +RD+K ++IL+ G V L+DF +S+++ K+ +
Sbjct: 153 ALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 201
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 30/107 (28%), Positives = 50/107 (46%), Gaps = 8/107 (7%)
Query: 244 RSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKN-RKETFRNVLM 302
+ S VGT +++PEV+ + VD W+LGI+ EM+ G P+ + + R
Sbjct: 197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS 256
Query: 303 KTPEFVGQR---TALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
P+ L D ++R+L +DP +R A E+ +H F
Sbjct: 257 PPPKLKNSHKVSPVLRDFLERMLVRDPQERA----TAQELLDHPFLL 299
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 5e-18
Identities = 38/169 (22%), Positives = 71/169 (42%), Gaps = 10/169 (5%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
+ D+L+ + LG+GA G V + P+ + A+K + + ++R ++
Sbjct: 4 VKADDLEPIMELGRGAYGVVEKMRHV---PSGQ-IMAVKRIR---ATVNSQEQKRLLMDL 56
Query: 75 RVLSRLS-HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRY-KQNDRVFSPSVIRFYLS 132
+ R PF G+L + + + + + ++
Sbjct: 57 DISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAV 116
Query: 133 EIICAIEHLH-NMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTA 180
I+ A+EHLH + + +RD+KP N+LI G V + DF +S LV A
Sbjct: 117 SIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA 165
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 1e-05
Identities = 25/119 (21%), Positives = 44/119 (36%), Gaps = 32/119 (26%)
Query: 246 NSFVGTEEYVSPEVVRGDGHE----FAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL 301
+ G + Y++PE + + ++ D W+LGI E+ P+ T L
Sbjct: 167 DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG---TPFQQL 223
Query: 302 MK--------------TPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
+ + EFV D + L+K+ +R Y E+ +H FF
Sbjct: 224 KQVVEEPSPQLPADKFSAEFV-------DFTSQCLKKNSKERPTYP----ELMQHPFFT 271
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 6e-18
Identities = 54/320 (16%), Positives = 104/320 (32%), Gaps = 69/320 (21%)
Query: 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIR 75
+ L+ +++GKG G V+ A++++D + + E+
Sbjct: 31 PFEQLEIGELIGKGRFGQVY----HG---RWHGEVAIRLIDIERDNEDQLKAFKR--EVM 81
Query: 76 VLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYLSEI 134
+ H + +G+ + LA C G L +V+R V + R EI
Sbjct: 82 AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR--DAKIVLDVNKTRQIAQEI 139
Query: 135 ICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVL 194
+ + +LH GI ++DLK +N+ +G V +TDF L + + + +
Sbjct: 140 VKGMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLFS--ISGVLQAGRREDKLRIQ-- 194
Query: 195 PVTENPKRHRRILTRWLHAL-PENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253
WL L PE L P S+
Sbjct: 195 -------------NGWLCHLAPEIIRQLSPDTEEDKLPFSK------------------- 222
Query: 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETF----RNVLMKTPEFVG 309
D +ALG + YE+ PF+ + + + +
Sbjct: 223 --------------HSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGM 268
Query: 310 QRTALTDLIQRLLEKDPVKR 329
+ ++D++ + +R
Sbjct: 269 GK-EISDILLFCWAFEQEER 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 6e-18
Identities = 46/166 (27%), Positives = 81/166 (48%), Gaps = 21/166 (12%)
Query: 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRA-RWEI 74
D ++ +++G+GA G V RA D A+K + + E+ER+A E+
Sbjct: 6 DYKEIEVEEVVGRGAFGVVCKAKWRAKD------VAIKQI-------ESESERKAFIVEL 52
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYLSE 133
R LSR++HP + KL G+ + + Y GG L NVL + ++ + + +
Sbjct: 53 RQLSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ 110
Query: 134 IICAIEHLHNM---GIAYRDLKPENILIRQSGHVT-LTDFDLSRNL 175
+ +LH+M + +RDLKP N+L+ G V + DF + ++
Sbjct: 111 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 7e-18
Identities = 38/161 (23%), Positives = 67/161 (41%), Gaps = 11/161 (6%)
Query: 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIR 75
+L + +G G+ GTV +D A+K++ + HA+ E E+
Sbjct: 35 PWCDLNIKEKIGAGSFGTVHRAEWHGSD------VAVKILMEQDFHAERVNEFLR--EVA 86
Query: 76 VLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYLSEI 134
++ RL HP + +G++ L+ Y G L +L ++
Sbjct: 87 IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDV 146
Query: 135 ICAIEHLHNMG--IAYRDLKPENILIRQSGHVTLTDFDLSR 173
+ +LHN I +R+LK N+L+ + V + DF LSR
Sbjct: 147 AKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 23/106 (21%), Positives = 43/106 (40%), Gaps = 15/106 (14%)
Query: 232 VSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGK 291
+SR + S S GT E+++PEV+R + D ++ G++ +E+ P+
Sbjct: 185 LSRLKA--STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242
Query: 292 NRKETFRNVLMKTPEFVGQR--------TALTDLIQRLLEKDPVKR 329
N + V K +R + +I+ +P KR
Sbjct: 243 NPAQVVAAVGFK-----CKRLEIPRNLNPQVAAIIEGCWTNEPWKR 283
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 8e-18
Identities = 40/157 (25%), Positives = 68/157 (43%), Gaps = 20/157 (12%)
Query: 26 LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAE--RRARWEIRVLSRLSHP 83
+ G +G ++L DR + R P LK L +AE A E + L+ + HP
Sbjct: 88 IAHGGLGWIYLALDRNVN--GR-PVVLKG-----LVHSGDAEAQAMAMAERQFLAEVVHP 139
Query: 84 FLPKLLGSLETDEFLAWAVPY-----CPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAI 138
+ ++ +E + V Y G L + + + YL EI+ A+
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIAYLLEILPAL 195
Query: 139 EHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
+LH++G+ Y DLKPENI++ + + L D +
Sbjct: 196 SYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRI 231
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 17/86 (19%), Positives = 32/86 (37%), Gaps = 6/86 (6%)
Query: 244 RSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK 303
GT + +PE+VR G A D + +G + G+ L +
Sbjct: 233 SFGYLYGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPTRNGRYVDG-----LPE 286
Query: 304 TPEFVGQRTALTDLIQRLLEKDPVKR 329
+ + L++R ++ DP +R
Sbjct: 287 DDPVLKTYDSYGRLLRRAIDPDPRQR 312
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 8e-18
Identities = 47/191 (24%), Positives = 81/191 (42%), Gaps = 34/191 (17%)
Query: 4 TPPPQPQTTPSLDLDNLKALK-------------ILGKGAMGTVFLVHDRAADPTARCPF 50
PPP PQ P + + +K +LG G G V + ++ + F
Sbjct: 35 PPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRT----QEKF 90
Query: 51 ALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLETDEFLAWAV----PYC 105
ALK++ +AR E+ + R S P + +++ E +
Sbjct: 91 ALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 141
Query: 106 PGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILI---RQSG 162
GG+L + D+ F+ + I AI++LH++ IA+RD+KPEN+L R +
Sbjct: 142 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA 201
Query: 163 HVTLTDFDLSR 173
+ LTDF ++
Sbjct: 202 ILKLTDFGFAK 212
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 24/101 (23%), Positives = 44/101 (43%), Gaps = 9/101 (8%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKET-- 296
+ + T YV+PEV+ + ++ + D W+LG++ Y +L G PF +
Sbjct: 214 TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 273
Query: 297 --FRNVLMKTPEFVGQR-----TALTDLIQRLLEKDPVKRL 330
+ M EF + LI+ LL+ +P +R+
Sbjct: 274 GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM 314
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 8e-18
Identities = 44/195 (22%), Positives = 78/195 (40%), Gaps = 29/195 (14%)
Query: 6 PPQPQTTPSLDLDNLK-------ALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKS 58
++ +DL L+ ++++G G G V+ A A+KV+D
Sbjct: 5 DSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLA----AIKVMD-- 58
Query: 59 TLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGS------LETDEFLAWAV-PYCPGGDL 110
+ E + EI +L + S H + G+ D+ L W V +C G +
Sbjct: 59 ---VTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL-WLVMEFCGAGSV 114
Query: 111 NVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF- 169
L I + EI+ + HLH + +RD+K +N+L+ ++ V L DF
Sbjct: 115 TDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG 174
Query: 170 ---DLSRNLVKKTAF 181
L R + ++ F
Sbjct: 175 VSAQLDRTVGRRNTF 189
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 36/147 (24%), Positives = 57/147 (38%), Gaps = 18/147 (12%)
Query: 244 RSNSFVGTEEYVSPEVVRGD-----GHEFAVDWWALGILTYEMLYGTTPFRGKN-RKETF 297
R N+F+GT +++PEV+ D ++F D W+LGI EM G P + + F
Sbjct: 185 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF 244
Query: 298 RNVLMKTPEFVGQR--TALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR-----W 350
P ++ I+ L K+ +R ++ +H F +
Sbjct: 245 LIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRP----ATEQLMKHPFIRDQPNERQVR 300
Query: 351 DLLTDVLRPPFIPSREENDLTEKAMSG 377
L D + R E D TE SG
Sbjct: 301 IQLKDHIDRT-KKKRGEKDETEYEYSG 326
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 32/150 (21%), Positives = 59/150 (39%), Gaps = 10/150 (6%)
Query: 23 LKILGKGAM--GTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL 80
L ++GKG TV L + ++ ++ +E + E+ V
Sbjct: 30 LTVIGKGFEDLMTVNLARYKPTGEYV----TVRRINLE--ACSNEMVTFLQGELHVSKLF 83
Query: 81 SHPFLPKLLGSLETDEFLAWAV-PYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIE 139
+HP + + D L W V + G L + I + L ++ A++
Sbjct: 84 NHPNIVPYRATFIADNEL-WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD 142
Query: 140 HLHNMGIAYRDLKPENILIRQSGHVTLTDF 169
++H+MG +R +K +ILI G V L+
Sbjct: 143 YIHHMGYVHRSVKASHILISVDGKVYLSGL 172
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 35/200 (17%), Positives = 61/200 (30%), Gaps = 64/200 (32%)
Query: 237 QSFDNGERSNS-------FVGTEEYVSPEVVR--GDGHEFAVDWWALGILTYEMLYGTTP 287
+G+R V ++SPEV++ G++ D +++GI E+ G P
Sbjct: 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
Query: 288 F--------------------------------------------RGKNRKETFRNVLMK 303
F T R
Sbjct: 237 FKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGD 296
Query: 304 TPEFVGQRT---ALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR---WDLLTDVL 357
+P RT +++ L+++P R A + H FFK ++ + L ++L
Sbjct: 297 SPSHPYHRTFSPHFHHFVEQCLQRNPDARP----SASTLLNHSFFKQIKRRASEALPELL 352
Query: 358 RPPFIPSREENDLTEKAMSG 377
R P P + SG
Sbjct: 353 R-PVTPITNFEGSQSQDHSG 371
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 42/165 (25%), Positives = 71/165 (43%), Gaps = 19/165 (11%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
+ +G+GA GTV+ D A A++ ++ + + EI V+ +
Sbjct: 25 FEKIGQGASGTVYTAMDVATGQEV----AIRQMNLQ----QQPKKELIINEILVMRENKN 76
Query: 83 PFLPKLLGSLETDEFLAWAV-PYCPGGDL-NVLRYKQNDRVFSPSVIRFYLSEIICAIEH 140
P + L S + L W V Y GG L +V+ + I E + A+E
Sbjct: 77 PNIVNYLDSYLVGDEL-WVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEF 131
Query: 141 LHNMGIAYRDLKPENILIRQSGHVTLTDF----DLSRNLVKKTAF 181
LH+ + +RD+K +NIL+ G V LTDF ++ K++
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 33/107 (30%), Positives = 50/107 (46%), Gaps = 8/107 (7%)
Query: 244 RSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKN-RKETFRNVLM 302
+ ++ VGT +++PEVV + VD W+LGI+ EM+ G P+ +N + +
Sbjct: 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231
Query: 303 KTPEFVGQR---TALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
TPE D + R LE D KR A E+ +H F K
Sbjct: 232 GTPELQNPEKLSAIFRDFLNRCLEMDVEKRG----SAKELLQHQFLK 274
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 4e-17
Identities = 39/163 (23%), Positives = 71/163 (43%), Gaps = 21/163 (12%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-H 82
++LG G G V + ++ + FALK++ RR E+ + R S
Sbjct: 24 QVLGLGINGKVLQIFNKRT----QEKFALKMLQDC------PKARR---EVELHWRASQC 70
Query: 83 PFLPKLLGSLETDEFLAWAV----PYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAI 138
P + +++ E + GG+L + D+ F+ + I AI
Sbjct: 71 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 130
Query: 139 EHLHNMGIAYRDLKPENILIR---QSGHVTLTDFDLSRNLVKK 178
++LH++ IA+RD+KPEN+L + + LTDF ++ +
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE 173
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 7e-10
Identities = 19/84 (22%), Positives = 33/84 (39%), Gaps = 12/84 (14%)
Query: 257 PEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKET----FRNVLMKTPEFVGQ-- 310
E ++ + D W+LG++ Y +L G PF + + M EF
Sbjct: 168 KETTGE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 226
Query: 311 ----RTALTDLIQRLLEKDPVKRL 330
LI+ LL+ +P +R+
Sbjct: 227 SEVSEEV-KMLIRNLLKTEPTQRM 249
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-16
Identities = 29/170 (17%), Positives = 59/170 (34%), Gaps = 14/170 (8%)
Query: 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIR 75
D L L L + G ++ + D +KV+ + + E
Sbjct: 8 DFKQLNFLTKLNENHSGELWKGRWQGND------IVVKVLKVRDWSTRKSRDFNE--ECP 59
Query: 76 VLSRLSHPFLPKLLGSLETDEFLAWAV--PYCPGGDL-NVLRYKQNDRVFSPSVIRFYLS 132
L SHP + +LG+ ++ + + P G L NVL + + V S +
Sbjct: 60 RLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH-EGTNFVVDQSQAVKFAL 118
Query: 133 EIICAIEHLHNMG--IAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTA 180
++ + LH + I L +++I + ++ D+ +
Sbjct: 119 DMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR 168
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 5e-05
Identities = 20/96 (20%), Positives = 41/96 (42%), Gaps = 16/96 (16%)
Query: 245 SNSFVGTEEYVSPEVVRG---DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL 301
S + +V+PE ++ D + + D W+ +L +E++ PF + E V
Sbjct: 165 SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVA 224
Query: 302 MKTPEFVGQR--------TALTDLIQRLLEKDPVKR 329
++ G R ++ L++ + +DP KR
Sbjct: 225 LE-----GLRPTIPPGISPHVSKLMKICMNEDPAKR 255
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-16
Identities = 41/182 (22%), Positives = 69/182 (37%), Gaps = 31/182 (17%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARW-- 72
L + ++ K +GKG G V + + A+K + + E + +
Sbjct: 16 LADNEIEYEKQIGKGGFGLVH----KGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ 71
Query: 73 -EIRVLSRLSHPFLPKLLGSLETDEFLAWAVP------YCPGGDL-NVLRYKQNDRVFSP 124
E+ ++S L+HP + KL G P + P GDL + L
Sbjct: 72 REVFIMSNLNHPNIVKLYG--------LMHNPPRMVMEFVPCGDLYHRLL--DKAHPIKW 121
Query: 125 SVIRFYLSEIICAIEHLHNMG--IAYRDLKPENILIRQSG-----HVTLTDFDLSRNLVK 177
SV + +I IE++ N I +RDL+ NI ++ + DF LS+ V
Sbjct: 122 SVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH 181
Query: 178 KT 179
Sbjct: 182 SV 183
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 17/105 (16%), Positives = 40/105 (38%), Gaps = 19/105 (18%)
Query: 238 SFDNGERSNSFVGTEEYVSPEVVRGDGHEF--AVDWWALGILTYEMLYGTTPFRGKNRKE 295
S + + +G ++++PE + + + D ++ ++ Y +L G PF + +
Sbjct: 176 SQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235
Query: 296 TFRNVLMKTPEFVGQRT-----------ALTDLIQRLLEKDPVKR 329
+K + + L ++I+ DP KR
Sbjct: 236 ------IKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKR 274
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 9e-16
Identities = 77/388 (19%), Positives = 127/388 (32%), Gaps = 118/388 (30%)
Query: 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAE---RRARWE 73
++ + + +G+G+ G VF +R T + A+K + + A E
Sbjct: 2 MEKYEKIGKIGEGSYGVVFKCRNRD---TGQI-VAIKKF-----LESEDDPVIKKIALRE 52
Query: 74 IRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRY-KQNDRVFSPSVIRFYLS 132
IR+L +L HP L LL L YC D VL + R +++
Sbjct: 53 IRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC---DHTVLHELDRYQRGVPEHLVKSITW 109
Query: 133 EIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFP 192
+ + A+ H +RD+KPENILI + + L DF +R L P
Sbjct: 110 QTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLL--------------TGP 155
Query: 193 VLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252
+ + TRW
Sbjct: 156 SDYYDD------EVATRW------------------------------------------ 167
Query: 253 EYVSPEVVRGDGH-EFAVDWWALGILTYEMLYGTTPFRGKNRKE----TFR--------- 298
Y SPE++ GD VD WA+G + E+L G + GK+ + +
Sbjct: 168 -YRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRH 226
Query: 299 -NVLMKTPEFVGQR------------------TALTDLIQRLLEKDPVKRLGYLRGACEI 339
V F G + L++ L DP +RL ++
Sbjct: 227 QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERL----TCEQL 282
Query: 340 KEHVFFKGVRWDLLTDVLRPPFIPSREE 367
H +F+ +R + D+ + P+
Sbjct: 283 LHHPYFENIR--EIEDLAKEHDKPAENL 308
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 1e-15
Identities = 40/153 (26%), Positives = 72/153 (47%), Gaps = 11/153 (7%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
+ LG G M TV+L D + A+K + K E +R E+ S+LSH
Sbjct: 16 VDKLGGGGMSTVYLAEDTILN---I-KVAIKAI-FIPPREKEETLKRFEREVHNSSQLSH 70
Query: 83 PFLPKLL--GSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEH 140
+ ++ + +L + Y G L+ Y ++ S + ++I+ I+H
Sbjct: 71 QNIVSMIDVDEEDDCYYLV--MEYIEGPTLS--EYIESHGPLSVDTAINFTNQILDGIKH 126
Query: 141 LHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
H+M I +RD+KP+NILI + + + DF +++
Sbjct: 127 AHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAK 159
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 5e-10
Identities = 30/96 (31%), Positives = 48/96 (50%), Gaps = 14/96 (14%)
Query: 244 RSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK 303
++N +GT +Y SPE +G+ + D +++GI+ YEML G PF G ET ++ +K
Sbjct: 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG----ETAVSIAIK 223
Query: 304 -----TPEFVGQRT-----ALTDLIQRLLEKDPVKR 329
P +L+++I R EKD R
Sbjct: 224 HIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANR 259
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 41/193 (21%), Positives = 67/193 (34%), Gaps = 28/193 (14%)
Query: 9 PQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAER 68
P + + +GKG G V+ R + A+K+ ++ E
Sbjct: 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEE------VAVKI-----FSSREERSW 81
Query: 69 RARWEIRVLSRLSHPFLPKLLGSLETDEFLA---WAV-PYCPGGDL-NVLRYKQNDRVFS 123
EI L H + + + D W V Y G L + L
Sbjct: 82 FREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV--- 138
Query: 124 PSVIRFYLSEIICAIEHLH--------NMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
+I+ LS + HLH IA+RDLK +NIL++++G + D L+
Sbjct: 139 EGMIKLALS-TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 197
Query: 176 VKKTAFEKQSLNN 188
T + N+
Sbjct: 198 DSATDTIDIAPNH 210
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 43/173 (24%), Positives = 69/173 (39%), Gaps = 11/173 (6%)
Query: 1 MEATPPPQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTL 60
M+ T + T + +++G+G MG V+ A D ALK++ TL
Sbjct: 21 MDGTAESREGTQ----FGPYRLRRLVGRGGMGDVY----EAEDTVRERIVALKLM-SETL 71
Query: 61 HAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDR 120
+ R + E R RL P + + E D L + G DL +
Sbjct: 72 SSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLA--AMLRRQG 129
Query: 121 VFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+P + +I A++ H G +RD+KPENIL+ L DF ++
Sbjct: 130 PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIAS 182
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 5e-09
Identities = 21/91 (23%), Positives = 37/91 (40%), Gaps = 6/91 (6%)
Query: 244 RSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK 303
+ + VGT Y++PE + D +AL + YE L G+ P++G + + +
Sbjct: 191 QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAH-INQ 249
Query: 304 TPEFVGQR-----TALTDLIQRLLEKDPVKR 329
A +I R + K+P R
Sbjct: 250 AIPRPSTVRPGIPVAFDAVIARGMAKNPEDR 280
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 39/200 (19%), Positives = 69/200 (34%), Gaps = 34/200 (17%)
Query: 6 PPQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARC---PFALKVVDKSTLHA 62
P ++ +K +GKG G V++ + A+KV
Sbjct: 25 SGLPLLVQRTIAKQIQMVKQIGKGRYGEVWM---------GKWRGEKVAVKV-----FFT 70
Query: 63 KHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLA---WAV-PYCPGGDL-NVLRYKQ 117
EA EI + H + + + + + Y G L + L+
Sbjct: 71 TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT 130
Query: 118 NDRVFSPSVIRFYLSEIICAIEHLH--------NMGIAYRDLKPENILIRQSGHVTLTDF 169
D S+++ S + + HLH IA+RDLK +NIL++++G + D
Sbjct: 131 LDA---KSMLKLAYS-SVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186
Query: 170 DLSRNLVKKTAFEKQSLNNN 189
L+ + T N
Sbjct: 187 GLAVKFISDTNEVDIPPNTR 206
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 3e-15
Identities = 79/371 (21%), Positives = 131/371 (35%), Gaps = 127/371 (34%)
Query: 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAER-------- 68
++ L+ +G+G G V+ +A + FALK + + E E
Sbjct: 1 MEKYHGLEKIGEGTYGVVY----KAQNNYGET-FALKKI-------RLEKEDEGIPSTTI 48
Query: 69 RARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIR 128
R EI +L L H + KL + T + L + DL L + +
Sbjct: 49 R---EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKL-LDVCEGGLESVTAK 103
Query: 129 FYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNN 188
+L +++ I + H+ + +RDLKP+N+LI + G + + DF L+R AF
Sbjct: 104 SFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR------AF------- 150
Query: 189 NKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248
PV T I+T W
Sbjct: 151 -GIPVRKYTH------EIVTLW-------------------------------------- 165
Query: 249 VGTEEYVSPEVVRGDGH-EFAVDWWALGILTYEMLYGTTPFRGKNRKET----FRNVLMK 303
Y +P+V+ G +D W++G + EM+ GT F G + + FR ++
Sbjct: 166 -----YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR--ILG 218
Query: 304 TP----------------EFVGQR--------TALT----DLIQRLLEKDPVKRLGYLRG 335
TP F L DL+ ++L+ DP +R+
Sbjct: 219 TPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI----T 274
Query: 336 ACEIKEHVFFK 346
A + EH +FK
Sbjct: 275 AKQALEHAYFK 285
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 73/369 (19%), Positives = 129/369 (34%), Gaps = 122/369 (33%)
Query: 21 KALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL 80
K++G G+ G VF + A+K V + + R E++++ +
Sbjct: 43 TNCKVIGNGSFGVVFQAKLV---ESDE--VAIKKV-------LQDKRFKNR-ELQIMRIV 89
Query: 81 SHPFLPKLL------GSLETDEFLAWAVPYCPGGDL-NVLR-YKQNDRVFSPSVIRFYLS 132
HP + L G + + FL + Y P + R Y + + +I+ Y+
Sbjct: 90 KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMY 148
Query: 133 EIICAIEHLHNMGIAYRDLKPENILI-RQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKF 191
+++ ++ ++H++GI +RD+KP+N+L+ SG + L DF ++ L+
Sbjct: 149 QLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI--------------- 193
Query: 192 PVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251
P I +R+ A PE G
Sbjct: 194 AGEPNVS------YICSRYYRA-PEL------------------------------IFGA 216
Query: 252 EEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKN---------------RKET 296
Y + +D W+ G + E++ G F G++ +E
Sbjct: 217 TNYTT-----------NIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ 265
Query: 297 FRNVL-----MKTPEFVGQR-----------TALTDLIQRLLEKDPVKRLGYLRGACEIK 340
+ + K P+ A+ DLI RLLE P RL A E
Sbjct: 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAI-DLISRLLEYTPSARL----TAIEAL 320
Query: 341 EHVFFKGVR 349
H FF +R
Sbjct: 321 CHPFFDELR 329
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 69/368 (18%), Positives = 123/368 (33%), Gaps = 119/368 (32%)
Query: 21 KALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL 80
K++G G+ G V+ + A+K V + + R E++++ +L
Sbjct: 57 TDTKVIGNGSFGVVYQAKLC---DSGE-LVAIKKV-------LQDKRFKNR-ELQIMRKL 104
Query: 81 SHPFLPKLL------GSLETDEFLAWAVPYCPGGDL-NVLR-YKQNDRVFSPSVIRFYLS 132
H + +L G + + +L + Y P + V R Y + + ++ Y+
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 133 EIICAIEHLHNMGIAYRDLKPENILI-RQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKF 191
++ ++ ++H+ GI +RD+KP+N+L+ + + L DF ++ LV
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--------------- 208
Query: 192 PVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251
P I +R+ A PE G
Sbjct: 209 RGEPNVS------YICSRYYRA-PEL------------------------------IFGA 231
Query: 252 EEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKN---------------RKET 296
+Y S ++D W+ G + E+L G F G + +E
Sbjct: 232 TDYTS-----------SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280
Query: 297 FRNVL-----MKTPEFVGQRTALT----------DLIQRLLEKDPVKRLGYLRGACEIKE 341
R + K P+ L RLLE P RL E
Sbjct: 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL----TPLEACA 336
Query: 342 HVFFKGVR 349
H FF +R
Sbjct: 337 HSFFDELR 344
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-15
Identities = 36/174 (20%), Positives = 54/174 (31%), Gaps = 17/174 (9%)
Query: 1 MEATPPPQPQTTPSLDLDN----LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVD 56
+ PP Q P + N L G + D A D R AL VD
Sbjct: 12 ESSAPPDDVQLVPGARIANGRYRLLIF--HGGVPPLQFWQALDTALD---R-QVALTFVD 65
Query: 57 KSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAV-PYCPGGDLNVLRY 115
+ + LSR+ P + ++L + T V + GG L +
Sbjct: 66 PQGVLPDDVLQETLS-RTLRLSRIDKPGVARVLDVVHTRA-GGLVVAEWIRGGSLQEVA- 122
Query: 116 KQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169
D SP + + A + H G+A P + + G V L
Sbjct: 123 ---DTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYP 173
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 3e-04
Identities = 9/70 (12%), Positives = 17/70 (24%), Gaps = 8/70 (11%)
Query: 268 AVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV--------GQRTALTDLIQ 319
D +G Y +L P + T ++ +
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAA 241
Query: 320 RLLEKDPVKR 329
R ++ D R
Sbjct: 242 RSVQGDGGIR 251
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 4e-15
Identities = 49/205 (23%), Positives = 75/205 (36%), Gaps = 37/205 (18%)
Query: 1 MEATPPPQPQTTPSLDLDNLKALKILGKGAMGTVF--LVHDRAADPTARCPFALKVVDKS 58
MEA PSLDLDNLK L+++G+G G V+ + +R P A+KV
Sbjct: 1 MEAAASE-----PSLDLDNLKLLELIGRGRYGAVYKGSLDER--------PVAVKV---- 43
Query: 59 TLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLA----WAV-PYCPGGDLNVL 113
+ I + + H + + + E V Y P G L
Sbjct: 44 -FSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLX-- 100
Query: 114 RYKQNDRVFSPSVIRFYLSEIICAIEHLH---------NMGIAYRDLKPENILIRQSGHV 164
+Y S R S + + +LH I++RDL N+L++ G
Sbjct: 101 KYLSLHTSDWVSSCRLAHS-VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159
Query: 165 TLTDFDLSRNLVKKTAFEKQSLNNN 189
++DF LS L +N
Sbjct: 160 VISDFGLSMRLTGNRLVRPGEEDNA 184
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 8e-15
Identities = 81/372 (21%), Positives = 129/372 (34%), Gaps = 128/372 (34%)
Query: 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAER-------- 68
++ + L+ +G+G G V+ +A D R ALK + + +AE
Sbjct: 20 MEKYQKLEKVGEGTYGVVY----KAKDSQGRI-VALKRI-------RLDAEDEGIPSTAI 67
Query: 69 RARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIR 128
R EI +L L HP + L+ + ++ L + DL + +N S I+
Sbjct: 68 R---EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKV-LDENKTGLQDSQIK 122
Query: 129 FYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNN 188
YL +++ + H H I +RDLKP+N+LI G + L DF L+R AF
Sbjct: 123 IYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR------AF------- 169
Query: 189 NKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248
PV T ++T W
Sbjct: 170 -GIPVRSYTH------EVVTLW-------------------------------------- 184
Query: 249 VGTEEYVSPEVVRGDGH-EFAVDWWALGILTYEMLYGTTPFRGKNRKE----TFRNVLMK 303
Y +P+V+ G +VD W++G + EM+ G F G + F ++
Sbjct: 185 -----YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFS--ILG 237
Query: 304 TP-----------------------------EFVGQRTALTDLIQRLLEKDPVKRLGYLR 334
TP G DL+ +L DP KR+
Sbjct: 238 TPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRI---- 293
Query: 335 GACEIKEHVFFK 346
A + H +FK
Sbjct: 294 SARDAMNHPYFK 305
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 83/379 (21%), Positives = 126/379 (33%), Gaps = 118/379 (31%)
Query: 6 PPQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHE 65
+ ++ + L ++G+G+ G V ++ T R A+K +
Sbjct: 13 DLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKD---TGRI-VAIKKF-----LESDD 63
Query: 66 AE---RRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRY-KQNDRV 121
+ + A EI++L +L H L LL + + + D +L +
Sbjct: 64 DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV---DHTILDDLELFPNG 120
Query: 122 FSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAF 181
V++ YL +II I H+ I +RD+KPENIL+ QSG V L DF +R L
Sbjct: 121 LDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL------ 174
Query: 182 EKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDN 241
P + + TRW
Sbjct: 175 --------AAPGEVYDD------EVATRW------------------------------- 189
Query: 242 GERSNSFVGTEEYVSPEVVRGDGH-EFAVDWWALGILTYEMLYGTTPFRGKNRKET---- 296
Y +PE++ GD AVD WA+G L EM G F G + +
Sbjct: 190 ------------YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHI 237
Query: 297 FRNVL-----------MKTPEFVGQR------------------TALTDLIQRLLEKDPV 327
L K P F G R + DL ++ L DP
Sbjct: 238 MM-CLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPD 296
Query: 328 KRLGYLRGACEIKEHVFFK 346
KR E+ H FF+
Sbjct: 297 KRP----FCAELLHHDFFQ 311
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 42/156 (26%), Positives = 67/156 (42%), Gaps = 13/156 (8%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
+ILG G M V L D R A+KV+ ++ L R R E + + L+H
Sbjct: 17 GEILGFGGMSEVHLARDLRDH---R-DVAVKVL-RADLARDPSFYLRFRREAQNAAALNH 71
Query: 83 PFLPKLLGSLETDEFLAWAVPY-----CPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICA 137
P + + + E E A +PY G L + +P +++ A
Sbjct: 72 PAIVAVYDTGE-AETPAGPLPYIVMEYVDGVTLR--DIVHTEGPMTPKRAIEVIADACQA 128
Query: 138 IEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+ H GI +RD+KP NI+I + V + DF ++R
Sbjct: 129 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR 164
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 27/95 (28%), Positives = 46/95 (48%), Gaps = 13/95 (13%)
Query: 244 RSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK 303
++ + +GT +Y+SPE RGD + D ++LG + YE+L G PF G ++ +V +
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG----DSPVSVAYQ 230
Query: 304 ----TPEFVGQRT-----ALTDLIQRLLEKDPVKR 329
P R L ++ + L K+P R
Sbjct: 231 HVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 265
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 40/170 (23%), Positives = 66/170 (38%), Gaps = 32/170 (18%)
Query: 19 NLKALKILGKGAMGTVFLVHDRAADPTARC---PFALKVVDKSTLHAKHEAERRARWEIR 75
++ L+ +GKG G V+ A+K+ ++ E E+
Sbjct: 9 DITLLECVGKGRYGEVWR---------GSWQGENVAVKI-----FSSRDEKSWFRETELY 54
Query: 76 VLSRLSHPFLPKLLGSLETDEFLA---WAV-PYCPGGDLNVLRYKQNDRVFSPSVIRFYL 131
L H + + S T + W + Y G L Y Q + + S +R L
Sbjct: 55 NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLY--DYLQLTTLDTVSCLRIVL 112
Query: 132 SEIICAIEHLH--------NMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
S I + HLH IA+RDLK +NIL++++G + D L+
Sbjct: 113 S-IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV 161
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 67/377 (17%), Positives = 124/377 (32%), Gaps = 130/377 (34%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVL 77
D+ + ++ LG+G VF A + T +K++ K +++ + EI++L
Sbjct: 36 DDYQLVRKLGRGKYSEVF----EAINITNNEKVVVKIL-------KPVKKKKIKREIKIL 84
Query: 78 SRLS-HPFLPKLLGSL--ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEI 134
L P + L + A + D L + IRFY+ EI
Sbjct: 85 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEI 139
Query: 135 ICAIEHLHNMGIAYRDLKPENILI-RQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPV 193
+ A+++ H+MGI +RD+KP N++I + + L D+ L+ Q N
Sbjct: 140 LKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-----FYHPGQEYNV----- 189
Query: 194 LPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253
R+ +R+
Sbjct: 190 -----------RVASRY------------------------------------------- 195
Query: 254 YVSPEVVRGDGH-EFAVDWWALGILTYEMLYGTTP-FRGKN------------------- 292
+ PE++ ++++D W+LG + M++ P F G +
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 255
Query: 293 --------------------RKETFRNVLMKTPEFVGQRTALTDLIQRLLEKDPVKRLGY 332
++ + + + + AL D + +LL D RL
Sbjct: 256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEAL-DFLDKLLRYDHQSRL-- 312
Query: 333 LRGACEIKEHVFFKGVR 349
A E EH +F V
Sbjct: 313 --TAREAMEHPYFYTVV 327
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 41/170 (24%), Positives = 66/170 (38%), Gaps = 22/170 (12%)
Query: 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIR 75
D L +I+G G G V+ + A+K + R E +
Sbjct: 5 DFAELTLEEIIGIGGFGKVYRAFWIGDE------VAVKAARHDPDEDISQTIENVRQEAK 58
Query: 76 VLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYLSEI 134
+ + L HP + L G + L + + GG L VL + P ++ + +I
Sbjct: 59 LFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS----GKRIPPDILVNWAVQI 114
Query: 135 ICAIEHLHNMG---IAYRDLKPENILIRQSGH--------VTLTDFDLSR 173
+ +LH+ I +RDLK NILI Q + +TDF L+R
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 44/209 (21%), Positives = 75/209 (35%), Gaps = 31/209 (14%)
Query: 5 PPPQPQTTPS-LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAK 63
P + P+ + LK ++ LG+G G V L A+K +L +
Sbjct: 7 KKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVK-----SLKPE 61
Query: 64 HEAERRARW--EIRVLSRLSHPFLPKLLG--SLETDEFLAWAVPYCPGGDLNVLRY-KQN 118
A EI +L L H + K G + + + + + P G L Y +N
Sbjct: 62 SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSL--KEYLPKN 119
Query: 119 DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL--- 175
+ Y +I +++L + +RDL N+L+ V + DF L++ +
Sbjct: 120 KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179
Query: 176 -------------VKKTAFEKQSLNNNKF 191
V A E L +KF
Sbjct: 180 KEYYTVKDDRDSPVFWYAPE--CLMQSKF 206
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 26/173 (15%), Positives = 66/173 (38%), Gaps = 28/173 (16%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
L+ L++ +G G V+ A+K+ + + + +E+
Sbjct: 21 FQSMPLQLLEVKARGRFGCVWKAQLLNEY------VAVKI-----FPIQDKQSWQNEYEV 69
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLA---WAV-PYCPGGDLNVLRYKQNDRVFSPSVIRFY 130
L + H + + +G+ + + W + + G L+ + + + V +
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLS--DFLKANVVSWNELCHIA 127
Query: 131 LSEIICAIEHLH----------NMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+ + + +LH I++RD+K +N+L++ + + DF L+
Sbjct: 128 ET-MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 74/399 (18%), Positives = 126/399 (31%), Gaps = 117/399 (29%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVD--KSTLHAKHEAERRARWEIRVLSRL 80
+LG+GA G V A A+K ++ L A R EI++L
Sbjct: 16 KSLLGEGAYGVVC----SATHKPTGEIVAIKKIEPFDKPLFAL-----RTLREIKILKHF 66
Query: 81 SHPFLPKLLGSLETDEFLAWAVPYCP----GGDLN-VLRYKQNDRVFSPSVIRFYLSEII 135
H + + D F + Y DL+ V+ + S I++++ + +
Sbjct: 67 KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM----LSDDHIQYFIYQTL 122
Query: 136 CAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLP 195
A++ LH + +RDLKP N+LI + + + DF L+R + + A +
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG---- 178
Query: 196 VTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYV 255
+ E + TRW Y
Sbjct: 179 MVEF------VATRW-------------------------------------------YR 189
Query: 256 SPEVVRGDGH-EFAVDWWALGILTYEMLYGTTPFRGKN---------------------- 292
+PEV+ A+D W+ G + E+ F G++
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLR 249
Query: 293 --RKETFRNVLMKTPEFVGQ----------RTALTDLIQRLLEKDPVKRLGYLRGACEIK 340
R + P + + DL+QR+L DP KR+ A E
Sbjct: 250 CIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGI-DLLQRMLVFDPAKRI----TAKEAL 304
Query: 341 EHVFFKGVR----WDLLTDVLRPPFIPSREENDLTEKAM 375
EH + + + F + LT K +
Sbjct: 305 EHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDL 343
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 83/449 (18%), Positives = 151/449 (33%), Gaps = 154/449 (34%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDK---STLHAKHEAERRARWEIRVLSR 79
LK +G GA G V A D A+K + + + HAK RA E+ ++
Sbjct: 67 LKPIGSGAQGIV----CAAYDAVLDRNVAIKKLSRPFQNQTHAK-----RAYRELVLMKC 117
Query: 80 LSHPFLPKLL------GSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSE 133
++H + LL +LE + + + V +L + + + + L +
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDV-YLVMELMDANLCQVIQME----LDHERMSYLLYQ 172
Query: 134 IICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPV 193
++C I+HLH+ GI +RDLKP NI+++ + + DF L+R + +
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTSFM-- 219
Query: 194 LPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253
+T ++TR+
Sbjct: 220 --MTPY------VVTRY------------------------------------------- 228
Query: 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNR-------------------- 293
Y +PEV+ G G++ VD W++G + EM+ F G++
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288
Query: 294 ---------------------KETFRNVLMKTPEFVGQRTAL--TDLIQRLLEKDPVKRL 330
+ F + L + A DL+ ++L DP KR+
Sbjct: 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 348
Query: 331 GYLRGACEIKEHVFFKGVRWDLLTDVLRPP---FIPSREENDLTEKAMSGGGVDIRE--- 384
+ +H + W +V PP + +E + T + + +E
Sbjct: 349 ----SVDDALQHPYINV--WYDPAEVEAPPPQIYDKQLDEREHTIE-------EWKELIY 395
Query: 385 -----YFENLRAPPPSMPPSPLPSPSHRS 408
E + PSP + + S
Sbjct: 396 KEVMNSEEKTKNGVVKGQPSPSGAAVNSS 424
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 65/397 (16%), Positives = 115/397 (28%), Gaps = 149/397 (37%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS- 81
++ +G G G V + +A+KVV ++ + A+ E +L ++
Sbjct: 40 IRKMGDGTFGRVL----LCQHIDNKKYYAVKVV-RNI-KKYTRS---AKIEADILKKIQN 90
Query: 82 -------------------HPFL--PKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDR 120
H L L SL E + +N+
Sbjct: 91 DDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLY--EII-----------------TRNNY 131
Query: 121 V-FSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKT 179
F I+ Y EI+ A+ +L M + + DLKPENIL
Sbjct: 132 NGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENIL---------------------- 169
Query: 180 AFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKT---GLKKTKSARVSPVSRRQ 236
L++ F +T + + + K G A
Sbjct: 170 ------LDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-----CA--------- 209
Query: 237 QSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKN---- 292
+F + + S + T +Y +PEV+ G + + D W+ G + E+ G+ FR
Sbjct: 210 -TFKS-DYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEH 267
Query: 293 ----------------RKETFRNVL---------------------------MKTPEFVG 309
+ T N +
Sbjct: 268 LAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKII 327
Query: 310 QRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
+ D + +L+ DP R E+ +H F +
Sbjct: 328 KHELFCDFLYSILQIDPTLRP----SPAELLKHKFLE 360
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 3e-13
Identities = 77/372 (20%), Positives = 132/372 (35%), Gaps = 127/372 (34%)
Query: 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAER-------- 68
+ + L+ +G+G GTVF +R ALK V + + +
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIV----ALKRV-------RLDDDDEGVPSSAL 49
Query: 69 RARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIR 128
R EI +L L H + +L L +D+ L +C DL + + P +++
Sbjct: 50 R---EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKY-FDSCNGDLDPEIVK 104
Query: 129 FYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNN 188
+L +++ + H+ + +RDLKP+N+LI ++G + L +F L+R AF
Sbjct: 105 SFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR------AFG------ 152
Query: 189 NKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248
PV + ++T W
Sbjct: 153 --IPVRCYSA------EVVTLW-------------------------------------- 166
Query: 249 VGTEEYVSPEVVRGDGH-EFAVDWWALGILTYEMLYGTTP-FRGKNRKE----TFRNVLM 302
Y P+V+ G ++D W+ G + E+ P F G + + FR L+
Sbjct: 167 -----YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR--LL 219
Query: 303 KTP------------------------EFVGQRTALT----DLIQRLLEKDPVKRLGYLR 334
TP V L DL+Q LL+ +PV+R+
Sbjct: 220 GTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI---- 275
Query: 335 GACEIKEHVFFK 346
A E +H +F
Sbjct: 276 SAEEALQHPYFS 287
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 3e-13
Identities = 51/155 (32%), Positives = 80/155 (51%), Gaps = 13/155 (8%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAE----RRARWEIRVLS 78
L LG+G TV+ D+ T + A+K K L + EA+ R A EI++L
Sbjct: 15 LDFLGEGQFATVYKARDKN---TNQ-IVAIK---KIKLGHRSEAKDGINRTALREIKLLQ 67
Query: 79 RLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAI 138
LSHP + LL + ++ + DL V+ K N V +PS I+ Y+ + +
Sbjct: 68 ELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVI-IKDNSLVLTPSHIKAYMLMTLQGL 125
Query: 139 EHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
E+LH I +RDLKP N+L+ ++G + L DF L++
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 5e-13
Identities = 64/356 (17%), Positives = 114/356 (32%), Gaps = 121/356 (33%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALK-VVDKSTLHAKHEAERRARWEIRVLSRLS 81
LK LG G G VF A D A+K +V K A EI+++ RL
Sbjct: 16 LKPLGCGGNGLVF----SAVDNDCDKRVAIKKIVLTDPQSVK-----HALREIKIIRRLD 66
Query: 82 HPFLPKLLGSLETDEFLAWAVPYCPGG-------------DLNVLRYKQNDRVFSPSVIR 128
H + K+ L DL + + R
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP---LLEEHAR 123
Query: 129 FYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG-HVTLTDFDLSRNLVKKTAFEKQSLN 187
++ +++ ++++H+ + +RDLKP N+ I + + DF L+R ++
Sbjct: 124 LFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLAR-----------IMD 172
Query: 188 NNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNS 247
+ ++E ++T+W
Sbjct: 173 PHYSHKGHLSEG------LVTKW------------------------------------- 189
Query: 248 FVGTEEYVSPEVVRGDGH-EFAVDWWALGILTYEMLYGTTPFRGKN-------------- 292
Y SP ++ + A+D WA G + EML G T F G +
Sbjct: 190 ------YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243
Query: 293 -RKETFRNVLMKTPEFVGQR-----------------TALTDLIQRLLEKDPVKRL 330
+E + +L P ++ A+ D ++++L P+ RL
Sbjct: 244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAV-DFLEQILTFSPMDRL 298
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 5e-13
Identities = 74/379 (19%), Positives = 122/379 (32%), Gaps = 135/379 (35%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAE--------RR 69
K L+ LG G TV+ ++ ALK V K ++E R
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVY----VALKEV-------KLDSEEGTPSTAIR- 52
Query: 70 ARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVL----RYKQNDRVFSPS 125
EI ++ L H + +L + T+ L + DL R +
Sbjct: 53 ---EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELN 108
Query: 126 VIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQS 185
+++++ +++ + H I +RDLKP+N+LI + G + L DF L+R AF
Sbjct: 109 LVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR------AF---- 158
Query: 186 LNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERS 245
PV + ++T W
Sbjct: 159 ----GIPVNTFSS------EVVTLW----------------------------------- 173
Query: 246 NSFVGTEEYVSPEVVRGDGH-EFAVDWWALGILTYEMLYGTTPFRGKNRKE----TFRNV 300
Y +P+V+ G ++D W+ G + EM+ G F G N +E F
Sbjct: 174 --------YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFD-- 223
Query: 301 LMKTP----------------EFVGQR-----------------TALTDLIQRLLEKDPV 327
+M TP + L D + LL+ +P
Sbjct: 224 IMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPD 283
Query: 328 KRLGYLRGACEIKEHVFFK 346
RL A + H +F
Sbjct: 284 MRL----SAKQALHHPWFA 298
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 5e-13
Identities = 73/406 (17%), Positives = 116/406 (28%), Gaps = 167/406 (41%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVV-DKSTLHAKHEAERRARWEIRVLSRLS 81
+ LG+GA G V D A+K+V + AR EI+VL L+
Sbjct: 19 VDTLGEGAFGKVVECIDHK---AGGRHVAVKIVKNVDRYC------EAARSEIQVLEHLN 69
Query: 82 HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRY-------------------------K 116
TD P ++ K
Sbjct: 70 -----------TTD----------PNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIK 108
Query: 117 QNDRV-FSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
+N + F IR +I ++ LH+ + + DLKPENIL
Sbjct: 109 ENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENIL------------------ 150
Query: 176 VKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTK-------SAR 228
+ + + + R L SA
Sbjct: 151 ----------FVQSDYTEAYNPKIKRDERT---------------LINPDIKVVDFGSA- 184
Query: 229 VSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPF 288
++D+ E ++ V T Y +PEV+ G D W++G + E G T F
Sbjct: 185 ---------TYDD-EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234
Query: 289 RGKN------------------------RKETFRNVLMKTPEFVGQR------------- 311
+ +++ F + + E
Sbjct: 235 PTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEF 294
Query: 312 --------TALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349
L DLIQ++LE DP KR+ E +H FF ++
Sbjct: 295 MLSQDVEHERLFDLIQKMLEYDPAKRI----TLREALKHPFFDLLK 336
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 6e-13
Identities = 74/394 (18%), Positives = 136/394 (34%), Gaps = 119/394 (30%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVD--KSTLHAKHEAERRARWEIRVLSRL 80
L +G+GA G V A D + A+K + + + + R EI++L R
Sbjct: 32 LSYIGEGAYGMVC----SAYDNLNKVRVAIKKISPFEHQTYCQ-----RTLREIKILLRF 82
Query: 81 SHPFLPKLL-----GSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEII 135
H + + ++E + + + V DL L Q+ S I ++L +I+
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDV-YIVQDLMETDLYKLLKTQH---LSNDHICYFLYQIL 138
Query: 136 CAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLP 195
++++H+ + +RDLKP N+L+ + + + DF L+R +++ L
Sbjct: 139 RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR---------VADPDHDHTGFL- 188
Query: 196 VTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYV 255
TE + TRW Y
Sbjct: 189 -TEY------VATRW-------------------------------------------YR 198
Query: 256 SPEVVRGDGH-EFAVDWWALGILTYEMLYGTTPFRGKN---------------------- 292
+PE++ ++D W++G + EML F GK+
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258
Query: 293 -RKETFRNVLMKTPEFVGQ----------RTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341
RN L+ P AL DL+ ++L +P KR+ +
Sbjct: 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKAL-DLLDKMLTFNPHKRI----EVEQALA 313
Query: 342 HVFFKGVRWDLLTDVLRPPFIPSREENDLTEKAM 375
H + + + PF E +DL ++ +
Sbjct: 314 HPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKL 347
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 76/389 (19%), Positives = 129/389 (33%), Gaps = 129/389 (33%)
Query: 3 ATPPPQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHA 62
+ +D + + LG+G G V+ D + T A+K +
Sbjct: 19 PGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNET----VAIKRI------- 67
Query: 63 KHEAER--------RARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLR 114
+ E E R E+ +L L H + +L + + L Y + ++ +
Sbjct: 68 RLEHEEEGVPGTAIR---EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA---ENDLKK 121
Query: 115 YKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILI-----RQSGHVTLTDF 169
Y + S VI+ +L ++I + H+ +RDLKP+N+L+ ++ + + DF
Sbjct: 122 YMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDF 181
Query: 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARV 229
L+R AF P+ T I+T W
Sbjct: 182 GLAR------AF--------GIPIRQFTH------EIITLW------------------- 202
Query: 230 SPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGH-EFAVDWWALGILTYEMLYGTTPF 288
Y PE++ G H +VD W++ + EML T F
Sbjct: 203 ------------------------YRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF 238
Query: 289 RGKNRKET----FR-----------------NVLMKTPEFVGQR----------TALTDL 317
G + + F + P+F G+ DL
Sbjct: 239 PGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDL 298
Query: 318 IQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
+ +LE DPVKR+ A EH +F
Sbjct: 299 LTAMLEMDPVKRI----SAKNALEHPYFS 323
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 71/400 (17%), Positives = 115/400 (28%), Gaps = 157/400 (39%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVV-DKSTLHAKHEAERRARWEIRVLSRLS 81
+ LG+G G V D A + ALK++ + AR EI VL ++
Sbjct: 24 VGNLGEGTFGKVVECLDHA---RGKSQVALKIIRNVGKYR------EAARLEINVLKKIK 74
Query: 82 HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRY-------------------------K 116
E D + K
Sbjct: 75 -----------EKD----------KENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLK 113
Query: 117 QNDRV-FSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
+N+ + +R ++ A+ LH + + DLKPENIL
Sbjct: 114 ENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENIL------------------ 155
Query: 176 VKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTK--SARVSPVS 233
N++F L + + T ++ SA
Sbjct: 156 ----------FVNSEFETLYNEHKSCEEKSV----------KNTSIRVADFGSA------ 189
Query: 234 RRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKN- 292
+FD+ E + V T Y PEV+ G D W++G + +E G T F+
Sbjct: 190 ----TFDH-EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244
Query: 293 -----------------------RKETFRNVLMKTPE---------------------FV 308
+++ F + E
Sbjct: 245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDS 304
Query: 309 GQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGV 348
+ L DL++R+LE DP +R+ E H FF G+
Sbjct: 305 LEHVQLFDLMRRMLEFDPAQRI----TLAEALLHPFFAGL 340
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 45/193 (23%), Positives = 78/193 (40%), Gaps = 19/193 (9%)
Query: 7 PQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEA 66
P L K +K+LG GA GTV+ + P A+K L +
Sbjct: 4 PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK-----EL--REAT 56
Query: 67 ERRARWEI----RVLSRLSHPFLPKLLGSLETDEFLAWAV-PYCPGGDLNVLRY-KQNDR 120
+A EI V++ + +P + +LLG T + P G L L Y +++
Sbjct: 57 SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTV--QLITQLMPFGCL--LDYVREHKD 112
Query: 121 VFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTA 180
+ + +I + +L + + +RDL N+L++ HV +TDF L++ L +
Sbjct: 113 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
Query: 181 FEKQSLNNNKFPV 193
K P+
Sbjct: 173 EYHAE--GGKVPI 183
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 49/204 (24%), Positives = 84/204 (41%), Gaps = 23/204 (11%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDK---STLHAKHEAERRARWEIRVLSR 79
++G+G+ G V+ A D A+K V++ + K R EI +L+R
Sbjct: 31 KHLIGRGSYGYVY----LAYDKNTEKNVAIKKVNRMFEDLIDCK-----RILREITILNR 81
Query: 80 LSHPFLPKLLGSLETDEFLAWAVPYC----PGGDLN-VLRYKQNDRVFSPSVIRFYLSEI 134
L ++ +L + D+ L + Y DL + + + I+ L +
Sbjct: 82 LKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIF---LTEEHIKTILYNL 138
Query: 135 ICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVL 194
+ +H GI +RDLKP N L+ Q V + DF L+R + + +
Sbjct: 139 LLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 195 PVTENPKRH--RRILTRWLHALPE 216
P +N K+ ++TRW A PE
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRA-PE 221
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 39/157 (24%), Positives = 69/157 (43%), Gaps = 9/157 (5%)
Query: 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRV 76
++ L LG+G TV+ + D ALK + L + A A E+ +
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLV----ALK---EIRLEHEEGAPCTAIREVSL 53
Query: 77 LSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIIC 136
L L H + L + T++ L Y DL + + ++ +L +++
Sbjct: 54 LKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQY-LDDCGNIINMHNVKLFLFQLLR 111
Query: 137 AIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+ + H + +RDLKP+N+LI + G + L DF L+R
Sbjct: 112 GLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 84/421 (19%), Positives = 138/421 (32%), Gaps = 139/421 (33%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDK---STLHAKHEAERRARWEIRVLSR 79
+K LGKGA G V+ ++ D A+K + ++ A+ R EI +L+
Sbjct: 14 VKKLGKGAYGIVW----KSIDRRTGEVVAVKKIFDAFQNSTDAQ-----RTFREIMILTE 64
Query: 80 LS-HPFLPKLLGSLETDEF--------LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFY 130
LS H + LL L D DL+ + + P ++
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYM-------ETDLHAVIRAN---ILEPVHKQYV 114
Query: 131 LSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNK 190
+ ++I I++LH+ G+ +RD+KP NIL+ HV + DF LSR+ ++ NN
Sbjct: 115 VYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSF----VNIRRVTNNIP 170
Query: 191 FPVLPVTENPKRHRRIL-----TRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERS 245
+ TEN + IL TRW
Sbjct: 171 LSINENTENFDDDQPILTDYVATRW----------------------------------- 195
Query: 246 NSFVGTEEYVSPEVVRGDGH-EFAVDWWALG-ILTYEMLYGTTPFRGKN----------- 292
Y +PE++ G +D W+LG IL E+L G F G +
Sbjct: 196 --------YRAPEILLGSTKYTKGIDMWSLGCILG-EILCGKPIFPGSSTMNQLERIIGV 246
Query: 293 ------------RKETFRNVLMKTPEFVGQRTALT------------------------- 315
+ + ++ E V R +
Sbjct: 247 IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEAL 306
Query: 316 DLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREEN-DLTEKA 374
DL+ +LL+ +P KR+ A + +H F +N +
Sbjct: 307 DLLDKLLQFNPNKRI----SANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDD 362
Query: 375 M 375
Sbjct: 363 Y 363
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 50/214 (23%), Positives = 83/214 (38%), Gaps = 38/214 (17%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
++G G+ G V A D + A+K + + +R R EI +L+RL+H
Sbjct: 58 RHLIGTGSYGHVC----EAYDKLEKRVVAIKKILRVFEDLID-CKRILR-EIAILNRLNH 111
Query: 83 PFLPKLL-----GSLETD-------EFLAWAVPYCPGGDLN-VLRYKQNDRVFSPSVIRF 129
+ K+L +E E D + R + I+
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADS--------DFKKLFRTPVY---LTELHIKT 160
Query: 130 YLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR--NLVKKTAFEKQSLN 187
L ++ ++++H+ GI +RDLKP N L+ Q V + DF L+R + + +
Sbjct: 161 LLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220
Query: 188 NNKFPVLPVTENPKRHRRIL-----TRWLHALPE 216
L + K +R L TRW A PE
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYRA-PE 253
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 4e-12
Identities = 47/206 (22%), Positives = 70/206 (33%), Gaps = 30/206 (14%)
Query: 6 PPQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHE 65
P LK ++ LG+G G V L + A+K L A
Sbjct: 19 FQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVK-----ALKADAG 73
Query: 66 AERRARW--EIRVLSRLSHPFLPKLLG-SLETDEFLAWAV-PYCPGGDLNVLRYKQNDRV 121
+ R+ W EI +L L H + K G + V Y P G L Y +
Sbjct: 74 PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSL--RDYLPRHSI 131
Query: 122 FSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL------ 175
++ F +I + +LH +RDL N+L+ V + DF L++ +
Sbjct: 132 GLAQLLLF-AQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 190
Query: 176 ----------VKKTAFEKQSLNNNKF 191
V A E L KF
Sbjct: 191 YRVREDGDSPVFWYAPE--CLKEYKF 214
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 6e-12
Identities = 38/186 (20%), Positives = 71/186 (38%), Gaps = 20/186 (10%)
Query: 16 DLDNLKALKILGKGAMGTVF--LVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARW- 72
+ +++G+G G V+ + D A+K +L +
Sbjct: 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKI---HCAVK-----SL--NRITDIGEVSQ 72
Query: 73 ---EIRVLSRLSHPFLPKLLGSLETDEFLAWAV-PYCPGGDL-NVLRYKQNDRVFSPSVI 127
E ++ SHP + LLG E V PY GDL N +R + +
Sbjct: 73 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTVKDL 130
Query: 128 RFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLN 187
+ ++ +++L + +RDL N ++ + V + DF L+R++ K + +
Sbjct: 131 IGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 190
Query: 188 NNKFPV 193
K PV
Sbjct: 191 GAKLPV 196
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 7e-12
Identities = 40/158 (25%), Positives = 67/158 (42%), Gaps = 9/158 (5%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTA--RCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL 80
+ + G+ G V D P A R + + + +R EIR+L+
Sbjct: 27 QRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF 86
Query: 81 SHPFLPKLLGSLETDEFLAWAVPYC----PGGDLN-VLRYKQNDRVFSPSVIRFYLSEII 135
HP + L E A Y DL V+ ++ SP I++++ I+
Sbjct: 87 HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIV--ISPQHIQYFMYHIL 144
Query: 136 CAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+ LH G+ +RDL P NIL+ + +T+ DF+L+R
Sbjct: 145 LGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR 182
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 7e-12
Identities = 51/218 (23%), Positives = 76/218 (34%), Gaps = 37/218 (16%)
Query: 3 ATPPPQPQTTPS----------LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFAL 52
T Q + +LK L+ LGKG G+V + A+
Sbjct: 16 TTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAV 75
Query: 53 KVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLG-SLETDEFLAWAVP-YCPGGDL 110
K + ST + ER EI +L L H + K G + Y P G L
Sbjct: 76 KKLQHSTEEHLRDFER----EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 131
Query: 111 NVLRY-KQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169
Y +++ + Y S+I +E+L +RDL NIL+ V + DF
Sbjct: 132 --RDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 189
Query: 170 DLSRNL----------------VKKTAFEKQSLNNNKF 191
L++ L + A E SL +KF
Sbjct: 190 GLTKVLPQDKEYYKVKEPGESPIFWYAPE--SLTESKF 225
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 8e-12
Identities = 49/196 (25%), Positives = 74/196 (37%), Gaps = 27/196 (13%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
+ +LK L+ LGKG G+V + A+K + ST + ER EI
Sbjct: 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER----EI 62
Query: 75 RVLSRLSHPFLPKLLG-SLETDEFLAWAVP-YCPGGDLNVLRY-KQNDRVFSPSVIRFYL 131
+L L H + K G + Y P G L Y +++ + Y
Sbjct: 63 EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL--RDYLQKHKERIDHIKLLQYT 120
Query: 132 SEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL---------------- 175
S+I +E+L +RDL NIL+ V + DF L++ L
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180
Query: 176 VKKTAFEKQSLNNNKF 191
+ A E SL +KF
Sbjct: 181 IFWYAPE--SLTESKF 194
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 75/388 (19%), Positives = 119/388 (30%), Gaps = 125/388 (32%)
Query: 7 PQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHE- 65
+ ++ + L +G+G G VF +A ALK K + + E
Sbjct: 6 DSVECPFCDEVSKYEKLAKIGQGTFGEVF----KARHRKTGQKVALK---KVLMENEKEG 58
Query: 66 ----AERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAV--------PYCPGGDLNVL 113
A R EI++L L H + L+ T +C DL L
Sbjct: 59 FPITALR----EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGL 113
Query: 114 RYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
F+ S I+ + ++ + ++H I +RD+K N+LI + G + L DF L+R
Sbjct: 114 -LSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172
Query: 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVS 233
AF T R++T W
Sbjct: 173 ------AFS----LAKNSQPNRYTN------RVVTLW----------------------- 193
Query: 234 RRQQSFDNGERSNSFVGTEEYVSPEVVRGDGH-EFAVDWWALGILTYEMLYGTTPFRGKN 292
Y PE++ G+ +D W G + EM + +G
Sbjct: 194 --------------------YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 233
Query: 293 ----------------------------------RKETFRNVLMKTPEFVGQRTALTDLI 318
K R V + +V AL DLI
Sbjct: 234 EQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYAL-DLI 292
Query: 319 QRLLEKDPVKRLGYLRGACEIKEHVFFK 346
+LL DP +R+ + + H FF
Sbjct: 293 DKLLVLDPAQRI----DSDDALNHDFFW 316
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 61/283 (21%), Positives = 105/283 (37%), Gaps = 95/283 (33%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDK---STLHAKHEAERRARWEIRVLSR 79
LK +G GA G V A D A+K + + + HAK RA E+ ++
Sbjct: 30 LKPIGSGAQGIV----CAAYDAILERNVAIKKLSRPFQNQTHAK-----RAYRELVLMKC 80
Query: 80 LSHPFLPKLLGSLETDEFLAWAVPYCPGGDLN----VLRYKQND--RV----FSPSVIRF 129
++H + LL + F P + V+ + +V + +
Sbjct: 81 VNHKNIIGLL-----NVFT----PQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY 131
Query: 130 YLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNN 189
L +++C I+HLH+ GI +RDLKP NI+++ + + DF L+R + +
Sbjct: 132 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTS 180
Query: 190 KFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249
+T ++TR+ A
Sbjct: 181 FM----MTPY------VVTRYYRA------------------------------------ 194
Query: 250 GTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKN 292
PEV+ G G++ VD W++G + EM+ G F G +
Sbjct: 195 -------PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 45/193 (23%), Positives = 78/193 (40%), Gaps = 19/193 (9%)
Query: 7 PQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEA 66
P L K +K+LG GA GTV+ + P A+K L +
Sbjct: 4 PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK-----EL--REAT 56
Query: 67 ERRARWEI----RVLSRLSHPFLPKLLGSLETDEFLAWAV-PYCPGGDLNVLRY-KQNDR 120
+A EI V++ + +P + +LLG T + P G L L Y +++
Sbjct: 57 SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTV--QLITQLMPFGCL--LDYVREHKD 112
Query: 121 VFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTA 180
+ + +I + +L + + +RDL N+L++ HV +TDF L++ L +
Sbjct: 113 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
Query: 181 FEKQSLNNNKFPV 193
K P+
Sbjct: 173 EYHAE--GGKVPI 183
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 68/422 (16%), Positives = 126/422 (29%), Gaps = 149/422 (35%)
Query: 21 KALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL 80
K LG G+ G V D + FALK K R E+ ++ L
Sbjct: 10 SLGKTLGTGSFGIVC----EVFDIESGKRFALK---KVLQDP-----RYKNRELDIMKVL 57
Query: 81 SHP--------FLPKLLGSLETDEFLAWAVPYCPGG------------------DLNVL- 113
H F + + LNV+
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 114 ------------RYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILI-RQ 160
+ ++ R ++I Y+ ++ A+ +H++GI +RD+KP+N+L+ +
Sbjct: 118 EYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSK 177
Query: 161 SGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTG 220
+ L DF ++ L+ P I +R+ A PE
Sbjct: 178 DNTLKLCDFGSAKKLIPSE---------------PSVA------YICSRFYRA-PEL--- 212
Query: 221 LKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYE 280
+G EY ++D W++G + E
Sbjct: 213 ---------------------------MLGATEYTP-----------SIDLWSIGCVFGE 234
Query: 281 MLYGTTPFRGKNR---------------KETFRNV-----LMKTPEFVGQR--------- 311
++ G F G+ KE + ++ P +
Sbjct: 235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGT 294
Query: 312 -TALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREENDL 370
+ DL++++L +P R+ E H FF +R ++V P ++
Sbjct: 295 PSLAIDLLEQILRYEPDLRI----NPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNI 350
Query: 371 TE 372
+
Sbjct: 351 PQ 352
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 75/383 (19%), Positives = 124/383 (32%), Gaps = 140/383 (36%)
Query: 21 KALKILGKGAMGTVFLVHDRAADPTARCPFALKVV--DKSTLHAKHEAERRARWEIRVLS 78
+ ++ G+G GTV L ++ T A+K V D R + ++ L+
Sbjct: 26 QVERMAGQGTFGTVQLGKEK---STGM-SVAIKKVIQDPRF------RNRELQ-IMQDLA 74
Query: 79 RLSHP-------FLPKLLGSLETDEFLAWAVPYCPGGDL-NVLR-YKQNDRVFSPSVIRF 129
L HP + L D +L + Y P L R Y + P +I+
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKV 133
Query: 130 YLSEIICAIEHLHN--MGIAYRDLKPENILI-RQSGHVTLTDFDLSRNLVKKTAFEKQSL 186
+L ++I +I LH + + +RD+KP N+L+ G + L DF ++ L
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS---------- 183
Query: 187 NNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSN 246
P P I +R+
Sbjct: 184 -----PSEPNVA------YICSRY------------------------------------ 196
Query: 247 SFVGTEEYVSPEVVRGDGH-EFAVDWWALGILTYEMLYGTTPFRGKN------------- 292
Y +PE++ G+ H AVD W++G + EM+ G FRG N
Sbjct: 197 -------YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG 249
Query: 293 --------------------------RKETFRNVLMKTPEFVGQRTALTDLIQRLLEKDP 326
F + +K + A DL+ LL+ P
Sbjct: 250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAK-----EAY-DLLSALLQYLP 303
Query: 327 VKRLGYLRGACEIKEHVFFKGVR 349
+R+ E H +F +
Sbjct: 304 EERM----KPYEALCHPYFDELH 322
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 5e-11
Identities = 45/177 (25%), Positives = 68/177 (38%), Gaps = 28/177 (15%)
Query: 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARW 72
S+ + + +G GA GTV+ +A DP + ALK V +
Sbjct: 4 GSMATSRYEPVAEIGVGAYGTVY----KARDPHSGHFVALKSV-------RVPNGGGGGG 52
Query: 73 --------EIRVLSRLS---HPFLPKLLGSLETDEFLAWAV-----PYCPGGDLNVLRYK 116
E+ +L RL HP + +L+ T + DL K
Sbjct: 53 GLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDK 111
Query: 117 QNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
I+ + + + ++ LH I +RDLKPENIL+ G V L DF L+R
Sbjct: 112 APPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 6e-11
Identities = 39/184 (21%), Positives = 73/184 (39%), Gaps = 17/184 (9%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARW-- 72
L+ LK+LG G GTV + + P +K + + ++ R++
Sbjct: 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIK-----VI--EDKSGRQSFQAV 62
Query: 73 --EIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRY-KQNDRVFSPSVIRF 129
+ + L H + +LLG L Y P G L L + +Q+ P ++
Sbjct: 63 TDHMLAIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSL--LDHVRQHRGALGPQLLLN 119
Query: 130 YLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNN 189
+ +I + +L G+ +R+L N+L++ V + DF ++ L S
Sbjct: 120 WGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS--EA 177
Query: 190 KFPV 193
K P+
Sbjct: 178 KTPI 181
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 6e-11
Identities = 50/197 (25%), Positives = 78/197 (39%), Gaps = 29/197 (14%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRA-RWE 73
+ +LK + LGKG G+V L A+K L ++R + E
Sbjct: 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVK-----QLQHSGPDQQRDFQRE 74
Query: 74 IRVLSRLSHPFLPKLLG-SLETDEFLAWAVP-YCPGGDLNVLRY-KQNDRVFSPSVIRFY 130
I++L L F+ K G S V Y P G L + +++ S + Y
Sbjct: 75 IQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCL--RDFLQRHRARLDASRLLLY 132
Query: 131 LSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL--------------- 175
S+I +E+L + +RDL NIL+ HV + DF L++ L
Sbjct: 133 SSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 192
Query: 176 -VKKTAFEKQSLNNNKF 191
+ A E SL++N F
Sbjct: 193 PIFWYAPE--SLSDNIF 207
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 7e-11
Identities = 48/191 (25%), Positives = 76/191 (39%), Gaps = 33/191 (17%)
Query: 1 MEATPPPQPQTTPSLDLDNL-------KALKILGKGAMGTVFLVHDRAADPTARCPFALK 53
M + PP + + L+ +G GA G V A D A+K
Sbjct: 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVC----SAVDGRTGAKVAIK 56
Query: 54 VVDK---STLHAKHEAERRARWEIRVLSRLSHP--------FLPKLLGSLETDEFLAWAV 102
+ + S L AK RA E+R+L + H F P TD +L V
Sbjct: 57 KLYRPFQSELFAK-----RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYL---V 108
Query: 103 PYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG 162
G DL L + I+F + +++ + ++H GI +RDLKP N+ + +
Sbjct: 109 MPFMGTDLGKLMKHEK---LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC 165
Query: 163 HVTLTDFDLSR 173
+ + DF L+R
Sbjct: 166 ELKILDFGLAR 176
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 37/194 (19%), Positives = 71/194 (36%), Gaps = 49/194 (25%)
Query: 248 FVGTEEYVSPEVVRGDGH-EFAVDWWALGILTYEMLYGTTPFRGKN-------------- 292
+V T Y +PEV+ VD W++G + EM+ G T F+G +
Sbjct: 185 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 244
Query: 293 ---------RKETFRNVLMKTPEFVGQ----------RTALTDLIQRLLEKDPVKRLGYL 333
+ + +N + PE + A+ +L++++L D +R+
Sbjct: 245 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAV-NLLEKMLVLDAEQRV--- 300
Query: 334 RGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREENDLTEKAMSGGGVDIRE--YFENLRA 391
A E H +F+ + D + + S ++ D T + + Y E L
Sbjct: 301 -TAGEALAHPYFESLH-DTEDEPQVQKYDDSFDDVDRTLD-------EWKRVTYKEVLSF 351
Query: 392 PPPSMPPSPLPSPS 405
PP + + +
Sbjct: 352 KPPRQLGARVSKET 365
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 8e-11
Identities = 43/160 (26%), Positives = 73/160 (45%), Gaps = 22/160 (13%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDK---STLHAKHEAERRARWEIRVLSR 79
L +G GA G+V A D A+K + + S +HAK R E+R+L
Sbjct: 34 LSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSIIHAK-----RTYRELRLLKH 84
Query: 80 LSHPFLPKLL------GSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSE 133
+ H + LL SLE + G DLN + Q + ++F + +
Sbjct: 85 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK---LTDDHVQFLIYQ 140
Query: 134 IICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
I+ ++++H+ I +RDLKP N+ + + + + DF L+R
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 180
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 9e-04
Identities = 40/192 (20%), Positives = 68/192 (35%), Gaps = 49/192 (25%)
Query: 248 FVGTEEYVSPEVVRGDGH-EFAVDWWALGILTYEMLYGTTPFRGKN-------------- 292
+V T Y +PE++ H VD W++G + E+L G T F G +
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 248
Query: 293 ---------RKETFRNVLMKTPEFVGQ----------RTALTDLIQRLLEKDPVKRLGYL 333
E+ RN + + A+ DL++++L D KR+
Sbjct: 249 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAV-DLLEKMLVLDSDKRI--- 304
Query: 334 RGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREENDLTEKAMSGGGVDIRE--YFENLRA 391
A + H +F D + + P+ S E DL + + Y E +
Sbjct: 305 -TAAQALAHAYFAQYH-DPDDEPVADPYDQSLESRDLLID-------EWKSLTYDEVISF 355
Query: 392 PPPSMPPSPLPS 403
PP + + S
Sbjct: 356 VPPPLDQEEMES 367
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 8e-11
Identities = 39/160 (24%), Positives = 71/160 (44%), Gaps = 23/160 (14%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDK---STLHAKHEAERRARWEIRVLSR 79
+G GA G+V A D + A+K + + S + AK RA E+ +L
Sbjct: 29 PTHVGSGAYGSVC----SAIDKRSGEKVAIKKLSRPFQSEIFAK-----RAYRELLLLKH 79
Query: 80 LSHPFLPKLL------GSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSE 133
+ H + LL SL + V DL + FS I++ + +
Sbjct: 80 MQHENVIGLLDVFTPASSLRNFYDF-YLVMPFMQTDLQKI-MGLK---FSEEKIQYLVYQ 134
Query: 134 IICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
++ ++++H+ G+ +RDLKP N+ + + + + DF L+R
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR 174
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 42/191 (21%), Positives = 71/191 (37%), Gaps = 25/191 (13%)
Query: 18 DNLKALKILGKGAMGTVF--LVHDRAADPTARCPFALKVVDKSTLHAKHEAERRAR---W 72
++LGKG G+V + A+K L A A
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFV---KVAVK-----MLKADIIASSDIEEFLR 74
Query: 73 EIRVLSRLSHPFLPKLLG-SLETDEFLAWA-----VPYCPGGDLN----VLRYKQNDRVF 122
E + HP + KL+G SL + +P+ GDL+ R +N
Sbjct: 75 EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 123 SPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFE 182
+ ++ +I C +E+L + +RDL N ++ + V + DF LSR + +
Sbjct: 135 PLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR 194
Query: 183 KQSLNNNKFPV 193
+ +K PV
Sbjct: 195 QGC--ASKLPV 203
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 38/189 (20%), Positives = 69/189 (36%), Gaps = 20/189 (10%)
Query: 13 PSLDLDNLKALKILGKGAMGTVF--LVHDRAADPTARCPFALKVVDKSTLHAKHEAERRA 70
+ +++G+G G V+ + D A+K +L +
Sbjct: 84 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKI---HCAVK-----SL--NRITDIGE 133
Query: 71 RW----EIRVLSRLSHPFLPKLLGSLETDEFLAWAV-PYCPGGDL-NVLRYKQNDRVFSP 124
E ++ SHP + LLG E V PY GDL N +R +
Sbjct: 134 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTV 191
Query: 125 SVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQ 184
+ + ++ ++ L + +RDL N ++ + V + DF L+R++ K
Sbjct: 192 KDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 251
Query: 185 SLNNNKFPV 193
+ K PV
Sbjct: 252 NKTGAKLPV 260
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 26/163 (15%), Positives = 51/163 (31%), Gaps = 14/163 (8%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDK-----STLHAKHEAERRA--RWEIRV 76
+ G ++ + P K K L + +RA ++
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 77 LSRLS---HPFLPKLLGS-LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLS 132
+L +P +G + D++ +P G L V S +
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVAC 166
Query: 133 EIICAIEHLHNMGIAYRDLKPENILI--RQSGHVTLTDFDLSR 173
++ A+E LH + ++ ENI + VTL + +
Sbjct: 167 RLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 3e-10
Identities = 29/159 (18%), Positives = 60/159 (37%), Gaps = 18/159 (11%)
Query: 21 KALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL 80
K + +G+G+ G +F + + A+K + + + R E R L
Sbjct: 13 KVGRRIGEGSFGVIFEGTNLLNNQ----QVAIKFEPRRSDA------PQLRDEYRTYKLL 62
Query: 81 SH-PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIE 139
+ +P + + + G L L R FS + +++ ++
Sbjct: 63 AGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLL-DLCGRKFSVKTVAMAAKQMLARVQ 120
Query: 140 HLHNMGIAYRDLKPENILIRQSGH-----VTLTDFDLSR 173
+H + YRD+KP+N LI + + + DF + +
Sbjct: 121 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 4e-10
Identities = 38/191 (19%), Positives = 78/191 (40%), Gaps = 20/191 (10%)
Query: 15 LDLDNLKALKILGKGAMGTVF---LVHDRAADPTARCPFALKVV-DKSTLHAKHEAERRA 70
+ + + + LG+G+ G V+ +P R A+K V + +++ + E
Sbjct: 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV--AIKTVNEAASMRERIEFLN-- 77
Query: 71 RWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRF 129
E V+ + + +LLG + + + GDL + LR + +P +
Sbjct: 78 --EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 135
Query: 130 YLSEII-CAI------EHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFE 182
LS++I A +L+ +RDL N ++ + V + DF ++R++ + +
Sbjct: 136 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 195
Query: 183 KQSLNNNKFPV 193
K PV
Sbjct: 196 KGG--KGLLPV 204
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 9e-10
Identities = 41/186 (22%), Positives = 82/186 (44%), Gaps = 20/186 (10%)
Query: 16 DLDNLKALKILGKGAMGTVF--LVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARW- 72
+ + +++GKG G V+ D+A + A+K +L E +
Sbjct: 19 ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRI---QCAIK-----SL--SRITEMQQVEA 68
Query: 73 ---EIRVLSRLSHPFLPKLLGSLETDEFLAWAV-PYCPGGDLNVLRY-KQNDRVFSPSVI 127
E ++ L+HP + L+G + E L + PY GDL L++ + R + +
Sbjct: 69 FLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDL--LQFIRSPQRNPTVKDL 126
Query: 128 RFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLN 187
+ ++ +E+L +RDL N ++ +S V + DF L+R+++ + + Q
Sbjct: 127 ISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHR 186
Query: 188 NNKFPV 193
+ + PV
Sbjct: 187 HARLPV 192
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 9e-10
Identities = 53/221 (23%), Positives = 84/221 (38%), Gaps = 42/221 (19%)
Query: 2 EATPPPQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLH 61
P P P LD +++K ++G+G G V R R A+K +
Sbjct: 9 HGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKA--RIKKDGLRMDAAIK-----RM- 60
Query: 62 AKHEAERRARW----EIRVLSRL-SHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRY 115
K A + E+ VL +L HP + LLG+ E +L A+ Y P G+L + LR
Sbjct: 61 -KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK 119
Query: 116 KQNDRVFSPSVIRFYLSEIICAI-------------EHLHNMGIAYRDLKPENILIRQSG 162
+ I + + + ++L +RDL NIL+ ++
Sbjct: 120 SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179
Query: 163 HVTLTDFDLSRNL------------VKKTAFEKQSLNNNKF 191
+ DF LSR V+ A E SLN + +
Sbjct: 180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIE--SLNYSVY 218
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 31/157 (19%), Positives = 58/157 (36%), Gaps = 16/157 (10%)
Query: 21 KALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL 80
+ + +G G+ G ++L D AA LH E ++ +
Sbjct: 12 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLH----------IESKIYKMM 61
Query: 81 SH-PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIE 139
+P + ++ + G L L R FS + ++I IE
Sbjct: 62 QGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLF-NFCSRKFSLKTVLLLADQMISRIE 119
Query: 140 HLHNMGIAYRDLKPENILIRQSGH---VTLTDFDLSR 173
++H+ +RD+KP+N L+ V + DF L++
Sbjct: 120 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 42/187 (22%), Positives = 70/187 (37%), Gaps = 35/187 (18%)
Query: 6 PPQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHE 65
+ DL + K+ G+G G V+ + D +ALK ++ + +
Sbjct: 10 KLSSERERVEDLFEYEGCKV-GRGTYGHVYKAKRK--DGKDDKDYALKQIEGTGIS--MS 64
Query: 66 AERRARWEIRVLSRLSHP--------FLPKLLGSL-------ETDEFLAWAVPYCPGGDL 110
A R EI +L L HP FL + E D L + +
Sbjct: 65 ACR----EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHD--LWHIIKFHRASKA 118
Query: 111 NVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILI----RQSGHVTL 166
N + +++ L +I+ I +LH + +RDLKP NIL+ + G V +
Sbjct: 119 N-----KKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 173
Query: 167 TDFDLSR 173
D +R
Sbjct: 174 ADMGFAR 180
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 21/65 (32%), Positives = 36/65 (55%)
Query: 109 DLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTD 168
DL K + I+ + +++ ++ LH+ + +RDLKP+NIL+ SG + L D
Sbjct: 104 DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD 163
Query: 169 FDLSR 173
F L+R
Sbjct: 164 FGLAR 168
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 44/192 (22%), Positives = 75/192 (39%), Gaps = 22/192 (11%)
Query: 15 LDLDNLKALKILGKGAMGTVF--LVHDRAADPTARCPFALKVV--DKSTLHAKHEAERRA 70
+D + L KILG+G G+V + A+K + D S+ E
Sbjct: 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSL---KVAVKTMKLDNSSQREIEEFLS-- 85
Query: 71 RWEIRVLSRLSHPFLPKLLG-SLETDEFLAWA----VPYCPGGDLN----VLRYKQNDRV 121
E + SHP + +LLG +E +P+ GDL+ R + +
Sbjct: 86 --EAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKH 143
Query: 122 FSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAF 181
+ ++ +I +E+L N +RDL N ++R V + DF LS+ + +
Sbjct: 144 IPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY 203
Query: 182 EKQSLNNNKFPV 193
+ K PV
Sbjct: 204 RQGR--IAKMPV 213
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 41/206 (19%), Positives = 78/206 (37%), Gaps = 30/206 (14%)
Query: 1 MEATPPPQPQTTPS-----LDLDNLKALKILGKGAMGTVF--LVHDRAADPTARCPFALK 53
E T PS + + ++ + +G+G G V + A+K
Sbjct: 368 AEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAM---AVAIK 424
Query: 54 VVDKSTLHAKHEAERRARW----EIRVLSRLSHPFLPKLLGSLETDEFLAWAV-PYCPGG 108
T K+ R E + + HP + KL+G + + W + C G
Sbjct: 425 -----TC--KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV--WIIMELCTLG 475
Query: 109 DLNVLRY-KQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLT 167
+L + + + + Y ++ A+ +L + +RD+ N+L+ + V L
Sbjct: 476 EL--RSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLG 533
Query: 168 DFDLSRNLVKKTAFEKQSLNNNKFPV 193
DF LSR ++ + + K S K P+
Sbjct: 534 DFGLSR-YMEDSTYYKAS--KGKLPI 556
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 44/176 (25%), Positives = 68/176 (38%), Gaps = 60/176 (34%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVV-DKSTLHAKHEAERRARWEIRVLSRLS 81
LK++GKG+ G V +A D ALK+V ++ H R+A EIR+L L
Sbjct: 102 LKVIGKGSFGQVV----KAYDHKVHQHVALKMVRNEKRFH------RQAAEEIRILEHLR 151
Query: 82 HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRY-------------------------- 115
+ D +NV+
Sbjct: 152 -----------KQD----------KDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIK 190
Query: 116 KQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGH--VTLTDF 169
K + FS ++R + I+ ++ LH I + DLKPENIL++Q G + + DF
Sbjct: 191 KNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 29/172 (16%), Positives = 60/172 (34%), Gaps = 32/172 (18%)
Query: 24 KILGKGAMGTVFLVHDRAADPTAR-CPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
+G+G G ++L +++ P +KV + + E++ R +
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVE-----PSDN---GPLFTELKFYQRAAK 92
Query: 83 PFLPKLLGSLETDEFLAWAVPYC--------PGGDLNVL-----------RYKQNDRVFS 123
P + ++L VP G + Y+ N + FS
Sbjct: 93 PEQIQKWIRTRKLKYLG--VPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFS 150
Query: 124 PSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILI--RQSGHVTLTDFDLSR 173
+ I+ +E++H + D+K N+L+ + V L D+ L+
Sbjct: 151 RKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 58/332 (17%), Positives = 104/332 (31%), Gaps = 100/332 (30%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARW-- 72
L+ ++L + +G+G G VF A+K + +
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVF----SGRLRADNTLVAVKSC-------RETLPPDLKAKF 159
Query: 73 --EIRVLSRLSHPFLPKLLGSLETDEFLAWAVP------YCPGGDL-NVLRYKQNDRVFS 123
E R+L + SHP + +L+G + P GGD LR
Sbjct: 160 LQEARILKQYSHPNIVRLIGVCTQKQ------PIYIVMELVQGGDFLTFLR--TEGARLR 211
Query: 124 PSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEK 183
+ + + +E+L + +RDL N L+ + + ++DF +SR
Sbjct: 212 VKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS 271
Query: 184 QSLNNNKFPVLPVTENPKRHRRILTRWLHALPEN-KTGLKKTKSARVSPVSRRQQSFDNG 242
+ PV +W A PE G ++S
Sbjct: 272 GG--LRQVPV---------------KWT-A-PEALNYGRYSSES---------------- 296
Query: 243 ERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEML-YGTTPFRGKNRKETFRNVL 301
D W+ GIL +E G +P+ + ++T V
Sbjct: 297 ---------------------------DVWSFGILLWETFSLGASPYPNLSNQQTREFVE 329
Query: 302 ----MKTPEFVGQRTALTDLIQRLLEKDPVKR 329
+ PE A+ L+++ +P +R
Sbjct: 330 KGGRLPCPE--LCPDAVFRLMEQCWAYEPGQR 359
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 5e-09
Identities = 40/193 (20%), Positives = 70/193 (36%), Gaps = 20/193 (10%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARC-PFALKVVDKSTLHAKHEAERRARWE 73
+ ++ LG+GA G VFL P A+K + +++ A+ + +R E
Sbjct: 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR----E 93
Query: 74 IRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLN-VLR------------YKQNDR 120
+L+ L H + + G L Y GDLN LR
Sbjct: 94 AELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPG 153
Query: 121 VFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTA 180
+ S++ + +L + +RDL N L+ Q V + DF +SR++
Sbjct: 154 PLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 213
Query: 181 FEKQSLNNNKFPV 193
+ P+
Sbjct: 214 YRVGG--RTMLPI 224
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 42/185 (22%), Positives = 75/185 (40%), Gaps = 17/185 (9%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARW-- 72
+ + K++G G G V+ + + P A+K TL K + R
Sbjct: 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIK-----TL--KAGYTEKQRVDF 93
Query: 73 --EIRVLSRLSHPFLPKLLGSLETDEFLAWAV-PYCPGGDLNVLRY-KQNDRVFSPSVIR 128
E ++ + SH + +L G + + + Y G L ++ ++ D FS +
Sbjct: 94 LGEAGIMGQFSHHNIIRLEGVI-SKYKPMMIITEYMENGAL--DKFLREKDGEFSVLQLV 150
Query: 129 FYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNN 188
L I +++L NM +RDL NIL+ + ++DF LSR L + +
Sbjct: 151 GMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT-SG 209
Query: 189 NKFPV 193
K P+
Sbjct: 210 GKIPI 214
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 7e-09
Identities = 44/192 (22%), Positives = 74/192 (38%), Gaps = 29/192 (15%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
+ ++LK K LG G G V++ A+K T+ + E
Sbjct: 185 IPRESLKLEKKLGAGQFGEVWMATYNK-----HTKVAVK-----TMKPGSMSVEAFLAEA 234
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYLSE 133
V+ L H L KL + T E + + G L + L+ + + P +I F ++
Sbjct: 235 NVMKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF-SAQ 292
Query: 134 IICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL--------------VKKT 179
I + + +RDL+ NIL+ S + DF L+R + +K T
Sbjct: 293 IAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT 352
Query: 180 AFEKQSLNNNKF 191
A E ++N F
Sbjct: 353 APE--AINFGSF 362
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 9e-09
Identities = 37/180 (20%), Positives = 74/180 (41%), Gaps = 16/180 (8%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
+ ++L+ LG+G G V++ +V K TL + E
Sbjct: 181 IPRESLRLEVKLGQGCFGEVWM---------GTWNGTTRVAIK-TLKPGTMSPEAFLQEA 230
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYLSE 133
+V+ +L H L +L + ++E + Y G L + L+ + + + ++
Sbjct: 231 QVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQ 288
Query: 134 IICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPV 193
I + ++ M +RDL+ NIL+ ++ + DF L+R + +Q KFP+
Sbjct: 289 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ---GAKFPI 345
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 35/159 (22%), Positives = 66/159 (41%), Gaps = 18/159 (11%)
Query: 21 KALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL 80
+ K +G G G + L + + A+K+ + + E R +L
Sbjct: 12 RVGKKIGCGNFGELRLGKNLYTNE----YVAIKLEPMKSRA------PQLHLEYRFYKQL 61
Query: 81 SH-PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIE 139
+P++ ++ A + G L L DR FS + ++I +E
Sbjct: 62 GSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLF-DLCDRTFSLKTVLMIAIQLISRME 119
Query: 140 HLHNMGIAYRDLKPENILIRQSGH-----VTLTDFDLSR 173
++H+ + YRD+KPEN LI + G+ + + DF L++
Sbjct: 120 YVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 27/171 (15%), Positives = 58/171 (33%), Gaps = 33/171 (19%)
Query: 24 KILGKGAMGTVFLVHD-RAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
K +G G G ++L + AR ++ + L + E++ R++
Sbjct: 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFS----------ELKFYQRVAK 92
Query: 83 PFLPKLLGSLETDEFLAWAVPYC--------PGGDLNVL----------RYKQNDRVFSP 124
K + ++L +P G + + + F
Sbjct: 93 KDCIKKWIERKQLDYLG--IPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKK 150
Query: 125 SVIRFYLSEIICAIEHLHNMGIAYRDLKPENILI--RQSGHVTLTDFDLSR 173
S + ++ +E++H + D+K N+L+ + V L D+ LS
Sbjct: 151 STVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 2e-08
Identities = 38/180 (21%), Positives = 71/180 (39%), Gaps = 16/180 (8%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
+D L ++ +G G G V L + A+K T+ +E E
Sbjct: 5 IDPSELTFVQEIGSGQFGLVHL-----GYWLNKDKVAIK-----TIREGAMSEEDFIEEA 54
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRY-KQNDRVFSPSVIRFYLSE 133
V+ +LSHP L +L G + + G L Y + +F+ + +
Sbjct: 55 EVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCL--SDYLRTQRGLFAAETLLGMCLD 112
Query: 134 IICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPV 193
+ + +L + +RDL N L+ ++ + ++DF ++R V + + KFPV
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSST--GTKFPV 169
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 43/199 (21%), Positives = 68/199 (34%), Gaps = 34/199 (17%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARW-- 72
+ +L+ L+ LG G+ G V A A+K L ++ A
Sbjct: 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGK-TVSVAVK-----CLKPDVLSQPEAMDDF 68
Query: 73 --EIRVLSRLSHPFLPKLLGSLETDEFLAWAV-PYCPGGDLNVLRY-KQNDRVFSPSVIR 128
E+ + L H L +L G + T V P G L L +++ F +
Sbjct: 69 IREVNAMHSLDHRNLIRLYGVVLTPPM--KMVTELAPLGSL--LDRLRKHQGHFLLGTLS 124
Query: 129 FYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL------------- 175
Y ++ + +L + +RDL N+L+ V + DF L R L
Sbjct: 125 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 184
Query: 176 ---VKKTAFEKQSLNNNKF 191
A E SL F
Sbjct: 185 KVPFAWCAPE--SLKTRTF 201
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 37/180 (20%), Positives = 74/180 (41%), Gaps = 16/180 (8%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
+ ++L+ LG+G G V++ +V K TL + E
Sbjct: 264 IPRESLRLEVKLGQGCFGEVWM---------GTWNGTTRVAIK-TLKPGTMSPEAFLQEA 313
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYLSE 133
+V+ +L H L +L + ++E + Y G L + L+ + + + ++
Sbjct: 314 QVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQ 371
Query: 134 IICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPV 193
I + ++ M +RDL+ NIL+ ++ + DF L+R + +Q KFP+
Sbjct: 372 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ---GAKFPI 428
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 29/157 (18%), Positives = 63/157 (40%), Gaps = 16/157 (10%)
Query: 21 KALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL 80
+ + +G G+ G ++L + + A+K+ + T H + +E ++ L
Sbjct: 10 RLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTKH------PQLLYESKIYRIL 59
Query: 81 S-HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIE 139
+P + ++ + G L L + R S + ++I +E
Sbjct: 60 QGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVE 117
Query: 140 HLHNMGIAYRDLKPENILIRQSGH---VTLTDFDLSR 173
+H+ +RD+KP+N L+ V + DF L++
Sbjct: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 3e-08
Identities = 45/198 (22%), Positives = 82/198 (41%), Gaps = 28/198 (14%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARC-PFALKVVDKSTLHAKHEAERRARW- 72
+ L ++ ++ LG+ G V+ H P + A+K TL K +AE R
Sbjct: 6 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIK-----TL--KDKAEGPLREE 58
Query: 73 ---EIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLN-VLR-------------Y 115
E + +RL HP + LLG + D+ L+ YC GDL+ L
Sbjct: 59 FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118
Query: 116 KQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
+ P +++I +E+L + + ++DL N+L+ +V ++D L R +
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV 178
Query: 176 VKKTAFEKQSLNNNKFPV 193
++ N+ P+
Sbjct: 179 YAADYYKLLG--NSLLPI 194
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 34/168 (20%), Positives = 64/168 (38%), Gaps = 30/168 (17%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
++ LG G TV+L D A+K+V ++ + A EI++L R++
Sbjct: 24 VRKLGWGHFSTVWLAKDM----VNNTHVAMKIVRGDKVYTEA-----AEDEIKLLQRVND 74
Query: 83 --PFLPKLLGSLE----TDEFL---AWAVPYC-----PGGDLNVLRYKQNDRVFSPSVIR 128
+G+ D F V G +L L K R ++
Sbjct: 75 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 134
Query: 129 FYLSEIICAIEHLH-NMGIAYRDLKPENILIRQSGH------VTLTDF 169
+++ ++++H GI + D+KPEN+L+ + + D
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADL 182
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 30/159 (18%), Positives = 50/159 (31%), Gaps = 53/159 (33%)
Query: 238 SFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPF--------- 288
+ E + + T EY SPEV+ G D W+ L +E++ G F
Sbjct: 185 ACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244
Query: 289 ----------------------RGKNRKETF-----------------RNVLMKTPEFVG 309
GK + F +VL + +F
Sbjct: 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK 304
Query: 310 -QRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347
+ ++D + +L+ DP KR A + H + K
Sbjct: 305 DEAKEISDFLSPMLQLDPRKRA----DAGGLVNHPWLKD 339
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 38/191 (19%), Positives = 77/191 (40%), Gaps = 20/191 (10%)
Query: 15 LDLDNLKALKILGKGAMGTVF--LVHDRAADPTARCPFALKVV-DKSTLHAKHEAERRAR 71
+ N+ ++ LG GA G V+ V DP+ A+K + + + + +
Sbjct: 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSP-LQVAVKTLPEVCSEQDELDFLM--- 82
Query: 72 WEIRVLSRLSHPFLPKLLG-SLETDEFLAWAVPYCPGGDL-NVLR----YKQNDRVFSPS 125
E ++S+ +H + + +G SL++ + GGDL + LR +
Sbjct: 83 -EALIISKFNHQNIVRCIGVSLQSLPRFI-LMELMAGGDLKSFLRETRPRPSQPSSLAML 140
Query: 126 VIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGH---VTLTDFDLSRNLVKKTAFE 182
+ +I C ++L +RD+ N L+ G + DF ++R++ + + +
Sbjct: 141 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 200
Query: 183 KQSLNNNKFPV 193
K PV
Sbjct: 201 KGG--CAMLPV 209
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 4e-08
Identities = 51/206 (24%), Positives = 85/206 (41%), Gaps = 30/206 (14%)
Query: 1 MEATPPPQPQTTPS---LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDK 57
M + Q + S L++ LK L+ +GKG G V L R A+K
Sbjct: 1 MGGSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRG------NKVAVK---- 50
Query: 58 STLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAV-PYCPGGDL-NVLRY 115
+ A+ E V+++L H L +LLG + ++ + V Y G L + LR
Sbjct: 51 -CIKNDATAQAFLA-EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR- 107
Query: 116 KQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
+ V + + ++ A+E+L +RDL N+L+ + ++DF L++
Sbjct: 108 SRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167
Query: 176 ----------VKKTAFEKQSLNNNKF 191
VK TA E +L KF
Sbjct: 168 SSTQDTGKLPVKWTAPE--ALREKKF 191
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 44/205 (21%), Positives = 82/205 (40%), Gaps = 34/205 (16%)
Query: 15 LDLDNLKALKILGKGAMGTVF---LVHDRAADPTARCPFALKVV-DKSTLHAKHEAERRA 70
+N++ ++ +G+GA G VF +P A+K++ ++++ + + +R
Sbjct: 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMV--AVKMLKEEASADMQADFQR-- 99
Query: 71 RWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLN-VLRYKQNDRVFSPSVIRF 129
E +++ +P + KLLG + + Y GDLN LR V S S
Sbjct: 100 --EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157
Query: 130 YLSEIICA-------IEHLHNM------GIAY--------RDLKPENILIRQSGHVTLTD 168
+ + + G+AY RDL N L+ ++ V + D
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIAD 217
Query: 169 FDLSRNLVKKTAFEKQSLNNNKFPV 193
F LSRN+ ++ N+ P+
Sbjct: 218 FGLSRNIYSADYYKADG--NDAIPI 240
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 4e-08
Identities = 44/195 (22%), Positives = 74/195 (37%), Gaps = 23/195 (11%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTAR-CPFALKVVDKSTLHAKHEAERRARWE 73
+ ++ + LG+GA G VFL PT A+K + TL A+ + +R E
Sbjct: 12 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR----E 67
Query: 74 IRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLN-VLRYKQNDRVFSPSVIRFYLS 132
+L+ L H + K G + L Y GDLN LR D +
Sbjct: 68 AELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 127
Query: 133 EIICAIEHLHNM------GIAY--------RDLKPENILIRQSGHVTLTDFDLSRNLVKK 178
+ + + ++ G+ Y RDL N L+ + V + DF +SR++
Sbjct: 128 GEL-GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 186
Query: 179 TAFEKQSLNNNKFPV 193
+ + P+
Sbjct: 187 DYYRVGG--HTMLPI 199
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 4e-08
Identities = 44/199 (22%), Positives = 81/199 (40%), Gaps = 38/199 (19%)
Query: 15 LDLDNLKALKILGKGAMGTVF--LVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARW 72
+ +++ +ILG+G G V+ + + + A+K K + +
Sbjct: 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKI---NVAVKTC-------KKDCTLDNKE 58
Query: 73 ----EIRVLSRLSHPFLPKLLGSLETDEFLAWAV-PYCPGGDLNVLRY-KQNDRVFSPSV 126
E ++ L HP + KL+G +E + W + P G+L Y ++N
Sbjct: 59 KFMSEAVIMKNLDHPHIVKLIGIIEEEPT--WIIMELYPYGEL--GHYLERNKNSLKVLT 114
Query: 127 IRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL----------- 175
+ Y +I A+ +L ++ +RD+ NIL+ V L DF LSR +
Sbjct: 115 LVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT 174
Query: 176 ---VKKTAFEKQSLNNNKF 191
+K + E S+N +F
Sbjct: 175 RLPIKWMSPE--SINFRRF 191
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 5e-08
Identities = 44/181 (24%), Positives = 73/181 (40%), Gaps = 18/181 (9%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
L + + LK LG G G V L + A+K + +E E
Sbjct: 5 LKREEITLLKELGSGQFGVVKL-----GKWKGQYDVAVK-----MIKEGSMSEDEFFQEA 54
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVP-YCPGGDLNVLRY-KQNDRVFSPSVIRFYLS 132
+ + +LSHP L K G + + E+ + V Y G L L Y + + + PS +
Sbjct: 55 QTMMKLSHPKLVKFYG-VCSKEYPIYIVTEYISNGCL--LNYLRSHGKGLEPSQLLEMCY 111
Query: 133 EIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFP 192
++ + L + +RDL N L+ + V ++DF ++R V + KFP
Sbjct: 112 DVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTR-YVLDDQYVSSV--GTKFP 168
Query: 193 V 193
V
Sbjct: 169 V 169
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 5e-08
Identities = 49/197 (24%), Positives = 77/197 (39%), Gaps = 29/197 (14%)
Query: 18 DNLKALKILGKGAMGTVF---LVHDRAADPTARCPFALKVVDKSTLHAKHEAERRA-RWE 73
+ L K LG GA G V +D A+K++ S H ER A E
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTV--AVKMLKPSA----HLTEREALMSE 76
Query: 74 IRVLSRL-SHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYL 131
++VLS L +H + LLG+ YC GDL N LR K++ + S +
Sbjct: 77 LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 132 SE---------IICAI------EHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176
+ + + L + +RDL NIL+ + DF L+R++
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 177 KKTAFEKQSLNNNKFPV 193
+ + + N + PV
Sbjct: 197 NDSNYVVKG--NARLPV 211
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 42/185 (22%), Positives = 75/185 (40%), Gaps = 18/185 (9%)
Query: 15 LDLDNLKALKILGKGAMGTVF--LVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARW 72
++ + KI+G G G V + P A+K L A + +R +
Sbjct: 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDV---PVAIK-----ALKAGYTERQRRDF 97
Query: 73 --EIRVLSRLSHPFLPKLLGSLETDEFLAWAV-PYCPGGDLNVLRY-KQNDRVFSPSVIR 128
E ++ + HP + +L G + T LA V Y G L + + +D F+ +
Sbjct: 98 LSEASIMGQFDHPNIIRLEGVV-TRGRLAMIVTEYMENGSL--DTFLRTHDGQFTIMQLV 154
Query: 129 FYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNN 188
L + + +L ++G +RDL N+L+ + ++DF LSR L +
Sbjct: 155 GMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT-TG 213
Query: 189 NKFPV 193
K P+
Sbjct: 214 GKIPI 218
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 6e-08
Identities = 36/190 (18%), Positives = 72/190 (37%), Gaps = 18/190 (9%)
Query: 15 LDLDNLKALKILGKGAMGTVF--LVHDRAADPTARCPFALKVV-DKSTLHAKHEAERRAR 71
+ N+ ++ LG GA G V+ V DP+ A+K + + + + +
Sbjct: 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSP-LQVAVKTLPEVCSEQDELDFLM--- 123
Query: 72 WEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLR----YKQNDRVFSPSV 126
E ++S+ +H + + +G + GGDL + LR +
Sbjct: 124 -EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182
Query: 127 IRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGH---VTLTDFDLSRNLVKKTAFEK 183
+ +I C ++L +RD+ N L+ G + DF ++R++ + + K
Sbjct: 183 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK 242
Query: 184 QSLNNNKFPV 193
PV
Sbjct: 243 GG--CAMLPV 250
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 7e-08
Identities = 30/176 (17%), Positives = 61/176 (34%), Gaps = 20/176 (11%)
Query: 15 LDLDNLKALKILGKGAMGTVF---LVHDRAADPTARCPFALKVVDKSTLHAKHEAERRAR 71
+ ++L + LG+G +F LKV+DK+ +
Sbjct: 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE--- 61
Query: 72 WEIRVLSRLSHPFLPKLLGSLETDEFLAWAVP-YCPGGDLNVLRY-KQNDRVFSPSVIRF 129
++S+LSH L G + V + G L Y K+N +
Sbjct: 62 -AASMMSKLSHKHLVLNYG-VCVCGDENILVQEFVKFGSL--DTYLKKNKNCINILWKLE 117
Query: 130 YLSEIICAIEHLHNMGIAYRDLKPENILIRQSGH--------VTLTDFDLSRNLVK 177
++ A+ L + + ++ +NIL+ + + L+D +S ++
Sbjct: 118 VAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP 173
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 7e-08
Identities = 46/199 (23%), Positives = 79/199 (39%), Gaps = 27/199 (13%)
Query: 15 LDLDNLKALKILGKGAMGTVF---LVHDRAADPTARCPFALKVV-DKSTLHAKHEAERRA 70
D L K LG+GA G V V P A+K++ D +T +
Sbjct: 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS-- 89
Query: 71 RWEIRVLSRL-SHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIR 128
E+ ++ + H + LLG+ D L V Y G+L LR ++ + I
Sbjct: 90 --EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 147
Query: 129 FYLSEIICAIEHLHNM------GIAY--------RDLKPENILIRQSGHVTLTDFDLSRN 174
E + + L + G+ Y RDL N+L+ ++ + + DF L+R+
Sbjct: 148 RVPEEQMT-FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 175 LVKKTAFEKQSLNNNKFPV 193
+ ++K + N + PV
Sbjct: 207 INNIDYYKKTT--NGRLPV 223
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 9e-08
Identities = 47/192 (24%), Positives = 77/192 (40%), Gaps = 27/192 (14%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
++ ++ LG G G V+ + A+K TL E
Sbjct: 217 MERTDITMKHKLGGGQYGEVYE--GVWKKYSLTV--AVK-----TLKEDTMEVEEFLKEA 267
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYLSE 133
V+ + HP L +LLG + + G+L + LR + N + S V+ + ++
Sbjct: 268 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQ 326
Query: 134 IICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL--------------VKKT 179
I A+E+L +R+L N L+ ++ V + DF LSR + +K T
Sbjct: 327 ISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 386
Query: 180 AFEKQSLNNNKF 191
A E SL NKF
Sbjct: 387 APE--SLAYNKF 396
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 9e-08
Identities = 37/184 (20%), Positives = 76/184 (41%), Gaps = 19/184 (10%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARW-- 72
+ + ++ + +G+G G V + + A+K T K+ R
Sbjct: 12 IQRERIELGRCIGEGQFGDVHQGIYMSPE-NPALAVAIK-----TC--KNCTSDSVREKF 63
Query: 73 --EIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRY-KQNDRVFSPSVIRF 129
E + + HP + KL+G + T+ + + C G+L + + + +
Sbjct: 64 LQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGEL--RSFLQVRKYSLDLASLIL 120
Query: 130 YLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNN 189
Y ++ A+ +L + +RD+ N+L+ + V L DF LSR ++ + + K S
Sbjct: 121 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKAS--KG 177
Query: 190 KFPV 193
K P+
Sbjct: 178 KLPI 181
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 9e-08
Identities = 43/180 (23%), Positives = 73/180 (40%), Gaps = 14/180 (7%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
++ ++ LG G G V+ A+K TL E
Sbjct: 10 MERTDITMKHKLGGGQYGEVY----EGVWKKYSLTVAVK-----TLKEDTMEVEEFLKEA 60
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYLSE 133
V+ + HP L +LLG + + G+L + LR + N + S V+ + ++
Sbjct: 61 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQ 119
Query: 134 IICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPV 193
I A+E+L +RDL N L+ ++ V + DF LSR L+ + + KFP+
Sbjct: 120 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHA--GAKFPI 176
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 1e-07
Identities = 48/198 (24%), Positives = 72/198 (36%), Gaps = 22/198 (11%)
Query: 3 ATPPPQPQTTPS------LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVD 56
P T +D +L LK LG G G V + A+K
Sbjct: 3 LGSKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKY-----GKWRGQYDVAIK--- 54
Query: 57 KSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRY- 115
+ +E E +V+ LSH L +L G + Y G L L Y
Sbjct: 55 --MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL--LNYL 110
Query: 116 KQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
++ F + ++ A+E+L + +RDL N L+ G V ++DF LSR
Sbjct: 111 REMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR-Y 169
Query: 176 VKKTAFEKQSLNNNKFPV 193
V + +KFPV
Sbjct: 170 VLDDEYTSSV--GSKFPV 185
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 2e-07
Identities = 38/192 (19%), Positives = 73/192 (38%), Gaps = 29/192 (15%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
+ + LK ++ LG G G V++ A+K +L + E
Sbjct: 10 VPRETLKLVERLGAGQFGEVWM-----GYYNGHTKVAVK-----SLKQGSMSPDAFLAEA 59
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYLSE 133
++ +L H L +L + T E + Y G L + L+ + + + + ++
Sbjct: 60 NLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQ 117
Query: 134 IICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL--------------VKKT 179
I + + +RDL+ NIL+ + + DF L+R + +K T
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 177
Query: 180 AFEKQSLNNNKF 191
A E ++N F
Sbjct: 178 APE--AINYGTF 187
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 30/178 (16%), Positives = 61/178 (34%), Gaps = 62/178 (34%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVV-DKSTLHAKHEAERRARWEIRVLSRLS 81
++GKG+ G V +A D + A+K++ +K +A+ E+R+L ++
Sbjct: 59 DSLIGKGSFGQVV----KAYDRVEQEWVAIKIIKNKKAFL------NQAQIEVRLLELMN 108
Query: 82 HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRY-------------------------K 116
+ D ++ +
Sbjct: 109 -----------KHD----------TEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLR 147
Query: 117 QNDRV-FSPSVIRFYLSEIICAIEHLHN--MGIAYRDLKPENILIRQSGH--VTLTDF 169
+ S ++ R + ++ A+ L + I + DLKPENIL+ + + DF
Sbjct: 148 NTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 45/185 (24%), Positives = 76/185 (41%), Gaps = 18/185 (9%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARC-PFALKVVDKSTLHAKHEAERRARW- 72
LD N+ K++G G G V R P+ + A+K TL K + R
Sbjct: 42 LDATNISIDKVVGAGEFGEVCS--GRLKLPSKKEISVAIK-----TL--KVGYTEKQRRD 92
Query: 73 ---EIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRY-KQNDRVFSPSVIR 128
E ++ + HP + +L G + + + Y G L + +++D F+ +
Sbjct: 93 FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL--DSFLRKHDAQFTVIQLV 150
Query: 129 FYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNN 188
L I +++L +MG +RDL NILI + ++DF L R L +
Sbjct: 151 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT-RG 209
Query: 189 NKFPV 193
K P+
Sbjct: 210 GKIPI 214
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 45/199 (22%), Positives = 78/199 (39%), Gaps = 27/199 (13%)
Query: 15 LDLDNLKALKILGKGAMGTVF---LVHDRAADPTARCPFALKVV-DKSTLHAKHEAERRA 70
D L K LG+G G V V P A+K++ D +T +
Sbjct: 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS-- 135
Query: 71 RWEIRVLSRL-SHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIR 128
E+ ++ + H + LLG+ D L V Y G+L LR ++ + I
Sbjct: 136 --EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 193
Query: 129 FYLSEIICAIEHLHNM------GIAY--------RDLKPENILIRQSGHVTLTDFDLSRN 174
E + + L + G+ Y RDL N+L+ ++ + + DF L+R+
Sbjct: 194 RVPEEQMT-FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 252
Query: 175 LVKKTAFEKQSLNNNKFPV 193
+ ++K + N + PV
Sbjct: 253 INNIDYYKKTT--NGRLPV 269
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 46/197 (23%), Positives = 79/197 (40%), Gaps = 30/197 (15%)
Query: 18 DNLKALKILGKGAMGTVF---LVHDRAADPTARCPFALKVV-DKSTLHAKHEAERRARWE 73
D LK K LG+GA G V A+K++ + +T E
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTV--AVKMLKEGATHSEHRALMS----E 80
Query: 74 IRVLSRL-SHPFLPKLLG-SLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFY 130
+++L + H + LLG + L V +C G+L LR K+N+ V
Sbjct: 81 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140
Query: 131 LSEIICAIEHLHNM------GIAY--------RDLKPENILIRQSGHVTLTDFDLSRNLV 176
+ + +EHL G+ + RDL NIL+ + V + DF L+R++
Sbjct: 141 YKDFLT-LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 177 KKTAFEKQSLNNNKFPV 193
K + ++ + + P+
Sbjct: 200 KDPDYVRKG--DARLPL 214
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 40/186 (21%), Positives = 75/186 (40%), Gaps = 21/186 (11%)
Query: 15 LDLDNLKALKI-LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARW- 72
L DNL I LG G G+V R + A+K L K E+
Sbjct: 6 LKRDNLLIADIELGCGNFGSVRQGVYRM--RKKQIDVAIK-----VL--KQGTEKADTEE 56
Query: 73 ---EIRVLSRLSHPFLPKLLGSLETDEFLAWAV-PYCPGGDLNVLRY-KQNDRVFSPSVI 127
E +++ +L +P++ +L+G + + V GG L ++ S +
Sbjct: 57 MMREAQIMHQLDNPYIVRLIGVCQAEAL--MLVMEMAGGGPL--HKFLVGKREEIPVSNV 112
Query: 128 RFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLN 187
L ++ +++L +RDL N+L+ + ++DF LS+ L ++ +
Sbjct: 113 AELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR-S 171
Query: 188 NNKFPV 193
K+P+
Sbjct: 172 AGKWPL 177
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 48/192 (25%), Positives = 77/192 (40%), Gaps = 33/192 (17%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARC---PFALKVVDKSTLHAKHEAERRAR 71
L++ LK L+ +GKG G V L A+K + A+
Sbjct: 190 LNMKELKLLQTIGKGEFGDVML---------GDYRGNKVAVK-----CIKNDATAQAFLA 235
Query: 72 WEIRVLSRLSHPFLPKLLG-SLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRF 129
E V+++L H L +LLG +E L Y G L + LR + V +
Sbjct: 236 -EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLK 293
Query: 130 YLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL----------VKKT 179
+ ++ A+E+L +RDL N+L+ + ++DF L++ VK T
Sbjct: 294 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT 353
Query: 180 AFEKQSLNNNKF 191
A E +L KF
Sbjct: 354 APE--ALREKKF 363
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 4e-07
Identities = 43/192 (22%), Positives = 77/192 (40%), Gaps = 23/192 (11%)
Query: 18 DNLKALKILGKGAMGTVF--LVHDRAADPTARCPFALKVVDKSTLHAKHEAERRA-RWEI 74
+NL+ K LG GA G V + A+K++ + H E+ A E+
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAV-LKVAVKMLKSTA----HADEKEALMSEL 100
Query: 75 RVLSRL-SHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYLS 132
+++S L H + LLG+ + YC GDL N LR K P+ +
Sbjct: 101 KIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160
Query: 133 -----------EIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAF 181
++ + L + +RD+ N+L+ + DF L+R+++ + +
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 220
Query: 182 EKQSLNNNKFPV 193
+ N + PV
Sbjct: 221 IVKG--NARLPV 230
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 5e-07
Identities = 44/210 (20%), Positives = 75/210 (35%), Gaps = 38/210 (18%)
Query: 5 PPPQPQTTPSLDLDNLKALKI-LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAK 63
P L DNL I LG G G+V + A+K L K
Sbjct: 322 PEELKDKKLFLKRDNLLIADIELGCGNFGSVRQ--GVYRMRKKQIDVAIK-----VL--K 372
Query: 64 HEAERRARW----EIRVLSRLSHPFLPKLLGSLETDEFLAWAV-PYCPGGDL-NVLRYKQ 117
E+ E +++ +L +P++ +L+G + + V GG L L
Sbjct: 373 QGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEAL--MLVMEMAGGGPLHKFLV--G 428
Query: 118 NDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL-- 175
S + L ++ +++L +R+L N+L+ + ++DF LS+ L
Sbjct: 429 KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488
Query: 176 --------------VKKTAFEKQSLNNNKF 191
+K A E +N KF
Sbjct: 489 DDSYYTARSAGKWPLKWYAPE--CINFRKF 516
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 7e-07
Identities = 41/173 (23%), Positives = 66/173 (38%), Gaps = 41/173 (23%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARW--EIR 75
+N ++G G G V+ D ALK + E + EI
Sbjct: 39 NNFDHKFLIGHGVFGKVY--KGVLRDGA---KVALKRRTPESSQGIEE------FETEIE 87
Query: 76 VLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYK--QN----DRVFSPSVIRF 129
LS HP L L+G +C + +L YK +N ++ +
Sbjct: 88 TLSFCRHPHLVSLIG-------------FCDERNEMILIYKYMENGNLKRHLYGSDLPTM 134
Query: 130 YLS-EI---ICA-----IEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+S E IC + +LH I +RD+K NIL+ ++ +TDF +S+
Sbjct: 135 SMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK 187
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 46/202 (22%), Positives = 80/202 (39%), Gaps = 34/202 (16%)
Query: 18 DNLKALKILGKGAMGTVF---LVHDRAADPTARCPFALKVV-DKSTLHAKHEAERRARWE 73
NL K LG+G G V H + A+K++ + ++ + E
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTV--AVKMLKENASPSELRDLLS----E 76
Query: 74 IRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYLS 132
VL +++HP + KL G+ D L V Y G L LR + S
Sbjct: 77 FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136
Query: 133 ---------------------EIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171
+I +++L M + +RDL NIL+ + + ++DF L
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 172 SRNLVKKTAFEKQSLNNNKFPV 193
SR++ ++ ++ K+S + PV
Sbjct: 197 SRDVYEEDSYVKRS--QGRIPV 216
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 42/181 (23%), Positives = 76/181 (41%), Gaps = 11/181 (6%)
Query: 15 LDLDNLK-ALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWE 73
LD L K LG G GTV + + A+K++ + E A E
Sbjct: 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVK--TVAVKILKNEANDPALKDELLA--E 68
Query: 74 IRVLSRLSHPFLPKLLGSLETDEFLAWAV-PYCPGGDLNVLRYKQNDRVFSPSVIRFYLS 132
V+ +L +P++ +++G E + + V G L +Y Q +R I +
Sbjct: 69 ANVMQQLDNPYIVRMIGICEAESW--MLVMEMAELGPL--NKYLQQNRHVKDKNIIELVH 124
Query: 133 EIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFP 192
++ +++L +RDL N+L+ + ++DF LS+ L + K + K+P
Sbjct: 125 QVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ-THGKWP 183
Query: 193 V 193
V
Sbjct: 184 V 184
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 46/202 (22%), Positives = 79/202 (39%), Gaps = 34/202 (16%)
Query: 18 DNLKALKILGKGAMGTVF---LVHDRAADPTARCPFALKVVDKSTLHAKHEAERRA-RWE 73
+NL+ K+LG GA G V + + A+K++ + +ER A E
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQV--AVKMLKEKA----DSSEREALMSE 98
Query: 74 IRVLSRL-SHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYL 131
++++++L SH + LLG+ + YC GDL N LR K+
Sbjct: 99 LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 158
Query: 132 SE--------------IICAI------EHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171
+ A E L +RDL N+L+ V + DF L
Sbjct: 159 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL 218
Query: 172 SRNLVKKTAFEKQSLNNNKFPV 193
+R+++ + + + N + PV
Sbjct: 219 ARDIMSDSNYVVRG--NARLPV 238
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 41/195 (21%), Positives = 76/195 (38%), Gaps = 25/195 (12%)
Query: 18 DNLKALKILGKGAMGTVF---LVHDRAADPTARCPFALKVV-DKSTLHAKHEAERRARWE 73
D L K LG+GA G V + P A+K++ +T + E
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLIS----E 124
Query: 74 IRVLSRL-SHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYL 131
+ ++ + H + LLG+ D L V Y G+L L+ ++ +
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184
Query: 132 SEIICAI-------------EHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178
E + + E+L + +RDL N+L+ + + + DF L+R++
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 244
Query: 179 TAFEKQSLNNNKFPV 193
++K + N + PV
Sbjct: 245 DYYKKTT--NGRLPV 257
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 1e-05
Identities = 29/199 (14%), Positives = 59/199 (29%), Gaps = 47/199 (23%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVV----DKSTLHAKHEAERRARWE 73
+ L+ + +G+G G VF P A+K++ + + E
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIAD------HTPVAIKIIAIEGPDLVNGSHQKTFEEILPE 73
Query: 74 IRVLSRL---------SHPFLPKLL------GSLETDEFLAWAVPYCPGGDLN------- 111
I + L L GS AW G N
Sbjct: 74 IIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFK 133
Query: 112 ------VLRY--------KQNDRVFSPSVIRFYLSEIICAIEHLHN-MGIAYRDLKPENI 156
VL + + ++ S + + L ++ ++ + +RDL N+
Sbjct: 134 DDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNV 193
Query: 157 LIRQSGHVTLTDFDLSRNL 175
L++++ L ++
Sbjct: 194 LLKKTSLKKLHYTLNGKSS 212
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 3e-05
Identities = 63/427 (14%), Positives = 127/427 (29%), Gaps = 138/427 (32%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPT----ARCPFALKVVDKSTLHAKHEAERR- 69
L L N++ K + L+ R T A + + S E +
Sbjct: 248 LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLL 307
Query: 70 ARW-EIRV--LSR---LSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFS 123
++ + R L R ++P ++ D W + ++ D+
Sbjct: 308 LKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATW----------DNWKHVNCDK--- 354
Query: 124 PSVIRFYLSEII-CAIEHL--HNMGIAYRDLK--PENILIRQSGHVTLT------DFDLS 172
L+ II ++ L + L P + I L+
Sbjct: 355 -------LTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTI---LLSLIWFDVIKSDV 404
Query: 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHAL-------PENKTGLKKTK 225
+V K K SL V + PK T + ++ EN+ L ++
Sbjct: 405 MVVVNK--LHKYSL---------VEKQPKES----TISIPSIYLELKVKLENEYALHRSI 449
Query: 226 SARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGT 285
++FD+ + + P + D + + +G + +
Sbjct: 450 VDHY----NIPKTFDS-----------DDLIPPYL--DQYFY----SHIG---HHL---- 481
Query: 286 TPFRGKNRKETFRNVLMKTPEFVGQR-----------TALTDLIQRLLEKDPVKRLGYLR 334
R FR V + F+ Q+ ++ + +Q+ L+ Y
Sbjct: 482 KNIEHPERMTLFRMVFLDF-RFLEQKIRHDSTAWNASGSILNTLQQ-LKF-------Y-- 530
Query: 335 GACEIKEHVFFKGVRWD-LLTDVLRPPFIPSREEN-------DLTEKAMS--GGGVDIRE 384
K ++ +++ L+ +L F+P EEN DL A+ +
Sbjct: 531 -----KPYICDNDPKYERLVNAILD--FLPKIEENLICSKYTDLLRIALMAEDEAI---- 579
Query: 385 YFENLRA 391
+ E +
Sbjct: 580 FEEAHKQ 586
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 6e-04
Identities = 59/435 (13%), Positives = 122/435 (28%), Gaps = 114/435 (26%)
Query: 17 LDNLKALKIL---GKGAMG-TVFLVHDRAADPTARCPFALKV-------VDKSTLHAKHE 65
L L+ K + G G T + D +C K+ + +
Sbjct: 144 LLELRPAKNVLIDGVLGSGKTW-VALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEML 202
Query: 66 AERRARWEIRVLSRLSHPFLPKLLGSLETDE----FLAWAVPYCPGGDLNVLRYKQNDRV 121
+ + + SR H KL E + C L VL V
Sbjct: 203 QKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENC----LLVL-----LNV 253
Query: 122 FSPSVIR-FYLSEIICAIEHLHNMGIAYRDLKPENILI-RQSGHVTLTDFDLSRNLVKKT 179
+ F + C I L + R + + L + H++L T
Sbjct: 254 QNAKAWNAF---NLSCKI--L----LTTRFKQVTDFLSAATTTHISLDHH-------SMT 297
Query: 180 AFEKQSLN------NNKFPVLP---VTENP----------KRHRRILTRWLHALPENKTG 220
+ + + + LP +T NP + W H + T
Sbjct: 298 LTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTT 357
Query: 221 LKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS-PEVVRGDGHEFAVDWWALGILTY 279
+ ++ + P R+ FD P ++ ++ W+ + +
Sbjct: 358 IIESSLNVLEPAEYRKM-FD------RLSVFPPSAHIPTIL------LSLIWFDV--IKS 402
Query: 280 EMLYGTTPFRG-----KNRKETFRNVLMKTPEFVGQRTALTDLIQRLLEKDPVKR----- 329
+++ K KE+ ++ E + L + +++ + +
Sbjct: 403 DVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSD 462
Query: 330 --------------LGY-LRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREENDLTEKA 374
+G+ L+ + F+ + D R F+ + +D T
Sbjct: 463 DLIPPYLDQYFYSHIGHHLKNIEHPERMTLFR----MVFLD-FR--FLEQKIRHDSTAWN 515
Query: 375 MSGGGV----DIREY 385
SG + ++ Y
Sbjct: 516 ASGSILNTLQQLKFY 530
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 43/162 (26%), Positives = 67/162 (41%), Gaps = 14/162 (8%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARC-PFALKVVDKSTLHAKHEAERRARWEIRV 76
D LK K LG+GA G V D TA C A+K++ + H++H A E+++
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS---ELKI 78
Query: 77 LSRL-SHPFLPKLLG-SLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYLSE 133
L + H + LLG + L V +C G+L LR K+N+ Y ++
Sbjct: 79 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE-------FVPYKTK 131
Query: 134 IICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
+ +G DLK I S + F ++L
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 2e-04
Identities = 40/158 (25%), Positives = 68/158 (43%), Gaps = 23/158 (14%)
Query: 25 ILGKGAMGTVF--LVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
+G+G G V+ V++ A+K + E +++ EI+V+++ H
Sbjct: 38 KMGEGGFGVVYKGYVNNT--------TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89
Query: 83 PFLPKLLG-SLETDEFLAWAV-PYCPGGDL-NVLRYKQNDRVFSPSVIRFYLSEIIC--- 136
L +LLG S + D+ V Y P G L + L S +R +I
Sbjct: 90 ENLVELLGFSSDGDDLC--LVYVYMPNGSLLDRLSCLDGTPPLSWH-MRC---KIAQGAA 143
Query: 137 -AIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
I LH +RD+K NIL+ ++ ++DF L+R
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLAR 181
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 412 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.8 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.46 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.24 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.16 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.95 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.71 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.61 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.48 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.36 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.27 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.23 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.18 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.82 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.66 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.66 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.6 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.22 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.17 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.15 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.14 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.05 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.01 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.0 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.97 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.64 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.63 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.57 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.73 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 84.02 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-71 Score=532.94 Aligned_cols=279 Identities=36% Similarity=0.590 Sum_probs=243.1
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
....++|+++++||+|+||+||+|+++.++. .||||++.+..+.. ....+.+.+|+++|++++|||||+++++|+
T Consensus 28 ~~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~----~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 102 (311)
T 4aw0_A 28 KKRPEDFKFGKILGEGSFSTVVLARELATSR----EYAIKILEKRHIIK-ENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102 (311)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CCCccccEEEEEEecccCeEEEEEEECCCCC----EEEEEEEEHHHCCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 3557899999999999999999999988654 49999998876533 234567888999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
+++.+|||||||.||+|.+++.... .++|.+++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+
T Consensus 103 ~~~~~yivmEy~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~ 180 (311)
T 4aw0_A 103 DDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAK 180 (311)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eCCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCce
Confidence 9999999999999999998887654 49999999999999999999999999999999999999999999999999998
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
.+... .......++|||+.
T Consensus 181 ~~~~~-------------------------------------------------------------~~~~~~~~~~GTp~ 199 (311)
T 4aw0_A 181 VLSPE-------------------------------------------------------------SKQARANSFVGTAQ 199 (311)
T ss_dssp ECCTT-------------------------------------------------------------TTCCCBCCCCSCGG
T ss_pred ecCCC-------------------------------------------------------------CCcccccCcccCcc
Confidence 65211 12234567899999
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCccCCC
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKRLGY 332 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R~~~ 332 (412)
|||||++.+..|+.++|||||||++|+|++|++||.+.+..+++.+|+...+.++ ..+++++|||.+||++||++|++.
T Consensus 200 YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~lL~~dp~~R~t~ 279 (311)
T 4aw0_A 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGC 279 (311)
T ss_dssp GCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHHHSCSSGGGSTTS
T ss_pred cCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHHHccCCHhHCcCh
Confidence 9999999999999999999999999999999999999999999999998776665 468999999999999999999953
Q ss_pred C--CChhhhhcCCCCCCCCchhhcccCCCCC
Q 042539 333 L--RGACEIKEHVFFKGVRWDLLTDVLRPPF 361 (412)
Q Consensus 333 ~--~~~~e~l~h~ff~~~~~~~~~~~~~pp~ 361 (412)
. ....++++||||++++|+.+... .||.
T Consensus 280 ~e~~~~~~i~~Hp~F~~idw~~l~~~-~pP~ 309 (311)
T 4aw0_A 280 EEMEGYGPLKAHPFFESVTWENLHQQ-TPPK 309 (311)
T ss_dssp GGGTCHHHHHTSGGGTTCCCTTGGGS-CCCC
T ss_pred HHHcCCHHHHCCCCcCCCCHHHhcCC-CCCC
Confidence 1 12234799999999999988664 3444
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-70 Score=523.69 Aligned_cols=283 Identities=40% Similarity=0.729 Sum_probs=241.0
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
..+..++|++++.||+|+||+||+|++... ..+++.||||++++....... ..++.+|+++|++++|||||+++++|
T Consensus 19 ~~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~-~~~~~~vAiK~i~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~l~~~~ 95 (304)
T 3ubd_A 19 EKADPSQFELLKVLGQGSFGKVFLVKKISG-SDARQLYAMKVLKKATLKVRD--RVRTKMERDILVEVNHPFIVKLHYAF 95 (304)
T ss_dssp CCCCGGGEEEEEEEECGGGCEEEEEEECSS-TTTTCEEEEEEEESEEEEEEE--CC------CCCCCCCCTTEECEEEEE
T ss_pred ccCCccccEEEEEEecCCCeEEEEEEEccC-CCCCEEEEEEEEehHHcChHH--HHHHHHHHHHHHHCCCCCCCeEEEEE
Confidence 345678999999999999999999997543 235677999999876543222 23566799999999999999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
++++.+|||||||.||+|..++.... .+++.+++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|
T Consensus 96 ~~~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla 173 (304)
T 3ubd_A 96 QTEGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS 173 (304)
T ss_dssp EETTEEEEEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEE
T ss_pred EECCEEEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccc
Confidence 99999999999999999998887654 4999999999999999999999999999999999999999999999999999
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+.... ......+++||+
T Consensus 174 ~~~~~---------------------------------------------------------------~~~~~~~~~GT~ 190 (304)
T 3ubd_A 174 KESID---------------------------------------------------------------HEKKAYSFCGTV 190 (304)
T ss_dssp EC--------------------------------------------------------------------CCCCSCCCCG
T ss_pred eeccC---------------------------------------------------------------CCccccccccCc
Confidence 75421 122345679999
Q ss_pred CCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCccCC
Q 042539 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKRLG 331 (412)
Q Consensus 253 ~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R~~ 331 (412)
.|||||++.+..|+.++|||||||++|||++|++||.+.+..+++.++....+.++ .+++++++||.+||++||++|++
T Consensus 191 ~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t 270 (304)
T 3ubd_A 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANRLG 270 (304)
T ss_dssp GGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTT
T ss_pred ccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcccCHHHCCC
Confidence 99999999999999999999999999999999999999999999999988776655 46899999999999999999997
Q ss_pred CC-CChhhhhcCCCCCCCCchhhcc-cCCCCCCC
Q 042539 332 YL-RGACEIKEHVFFKGVRWDLLTD-VLRPPFIP 363 (412)
Q Consensus 332 ~~-~~~~e~l~h~ff~~~~~~~~~~-~~~pp~~p 363 (412)
.. .+++|+++||||++++|+.+.. ...|||+|
T Consensus 271 a~~~~~~eil~Hp~f~~idw~~l~~~~~~pP~~P 304 (304)
T 3ubd_A 271 AGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP 304 (304)
T ss_dssp CSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSSCC
T ss_pred CCcCCHHHHHcCccccCCCHHHHHhCCCCcCcCC
Confidence 53 2478999999999999987654 56888887
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-67 Score=511.74 Aligned_cols=259 Identities=25% Similarity=0.436 Sum_probs=226.2
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
.+++|+++++||+|+||+||+|+++.++. .||||++.+..... .....+.+|+++|++|+|||||+++++|+++
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~----~vAiK~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~ 95 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGR----QYVIKEINISRMSS--KEREESRREVAVLANMKHPNIVQYRESFEEN 95 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCC----EEEEEEEECTTSCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCC----EEEEEEEehHHCCH--HHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence 46899999999999999999999987554 49999998776532 3466788999999999999999999999999
Q ss_pred CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchh
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
+.+|||||||.||+|.+++..+....+++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+
T Consensus 96 ~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 175 (350)
T 4b9d_A 96 GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175 (350)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceee
Confidence 99999999999999999988776667899999999999999999999999999999999999999999999999999865
Q ss_pred hchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCc
Q 042539 176 VKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYV 255 (412)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 255 (412)
..... ...+++||+.||
T Consensus 176 ~~~~~---------------------------------------------------------------~~~~~~GT~~Ym 192 (350)
T 4b9d_A 176 NSTVE---------------------------------------------------------------LARACIGTPYYL 192 (350)
T ss_dssp CHHHH---------------------------------------------------------------HHHHHHSCCTTC
T ss_pred cCCcc---------------------------------------------------------------cccccCCCcccc
Confidence 32211 123568999999
Q ss_pred cceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC--CCCCCChHHHHHHHHhhhhCCCccCCCC
Q 042539 256 SPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP--EFVGQRTALTDLIQRLLEKDPVKRLGYL 333 (412)
Q Consensus 256 APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~dli~~~L~~dP~~R~~~~ 333 (412)
|||++.+..|+.++|||||||++|||++|++||.+.+..+++.+++.... ....+++++++||.+||++||++||
T Consensus 193 APE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~--- 269 (350)
T 4b9d_A 193 SPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRP--- 269 (350)
T ss_dssp CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC---
T ss_pred CHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHccCChhHCc---
Confidence 99999999999999999999999999999999999999999999887653 2345789999999999999999999
Q ss_pred CChhhhhcCCCCCC
Q 042539 334 RGACEIKEHVFFKG 347 (412)
Q Consensus 334 ~~~~e~l~h~ff~~ 347 (412)
+++|+++||||+.
T Consensus 270 -s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 270 -SVNSILEKGFIAK 282 (350)
T ss_dssp -CHHHHHTSHHHHT
T ss_pred -CHHHHhcCHHhhc
Confidence 6999999999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-66 Score=490.16 Aligned_cols=257 Identities=29% Similarity=0.466 Sum_probs=211.8
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET 94 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 94 (412)
..+++|++++.||+|+||+||+|+++.++. .||||++.+..... .....++.+|+++|++++|||||+++++|++
T Consensus 10 ~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~----~vAiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~ 84 (275)
T 3hyh_A 10 AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQ----KVALKIINKKVLAK-SDMQGRIEREISYLRLLRHPHIIKLYDVIKS 84 (275)
T ss_dssp ----CCEEEEEEEC---CCEEEEECTTTCC----EEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CEeeCeEEEEEEecCcCeEEEEEEECCCCC----EEEEEEEeHHHcCC-HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 357899999999999999999999887554 49999998765532 3445678899999999999999999999999
Q ss_pred CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
++.+|+||||| +|+|.+++... +.+++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.
T Consensus 85 ~~~~~ivmEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~ 161 (275)
T 3hyh_A 85 KDEIIMVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNI 161 (275)
T ss_dssp SSEEEEEEECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--
T ss_pred CCEEEEEEeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCee
Confidence 99999999999 77888777654 4599999999999999999999999999999999999999999999999999975
Q ss_pred hhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCC
Q 042539 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254 (412)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 254 (412)
.. ......+.+||+.|
T Consensus 162 ~~----------------------------------------------------------------~~~~~~~~~GT~~Y 177 (275)
T 3hyh_A 162 MT----------------------------------------------------------------DGNFLKTSCGSPNY 177 (275)
T ss_dssp -----------------------------------------------------------------------------CTT
T ss_pred cC----------------------------------------------------------------CCCccCCeeECccc
Confidence 42 11223467999999
Q ss_pred ccceeecCCCC-CchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCccCCC
Q 042539 255 VSPEVVRGDGH-EFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKRLGY 332 (412)
Q Consensus 255 ~APE~l~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R~~~ 332 (412)
||||++.+..| +.++|||||||++|+|++|++||.+.+..+++.++....+.++ ..++++++||.+||++||++|+
T Consensus 178 ~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~-- 255 (275)
T 3hyh_A 178 AAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRI-- 255 (275)
T ss_dssp SCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCSSGGGSC--
T ss_pred CChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCChhHCc--
Confidence 99999999887 6899999999999999999999999999999999988776664 4689999999999999999999
Q ss_pred CCChhhhhcCCCCCC
Q 042539 333 LRGACEIKEHVFFKG 347 (412)
Q Consensus 333 ~~~~~e~l~h~ff~~ 347 (412)
+++|+++||||+.
T Consensus 256 --s~~eil~hpw~k~ 268 (275)
T 3hyh_A 256 --SIHEIMQDDWFKV 268 (275)
T ss_dssp --CHHHHHHCHHHHT
T ss_pred --CHHHHHcCccccc
Confidence 6999999999963
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-65 Score=499.34 Aligned_cols=253 Identities=24% Similarity=0.391 Sum_probs=224.6
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
+.|+++++||+|+||+||+|+++.++. .||||++++..... .+.+.+|+++|+.++|||||+++++|++++.
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~----~vAiK~i~~~~~~~----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~ 145 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGK----LVAVKKMDLRKQQR----RELLFNEVVIMRDYQHENVVEMYNSYLVGDE 145 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEEGGGCSS----GGGGHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCC----EEEEEEEecCchhH----HHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 569999999999999999999988654 49999997654322 3456779999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+|||||||.||+|..++.. +.+++.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+..
T Consensus 146 ~~ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 222 (346)
T 4fih_A 146 LWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 222 (346)
T ss_dssp EEEEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence 9999999999999988764 2499999999999999999999999999999999999999999999999999986521
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
......++|||+.||||
T Consensus 223 ---------------------------------------------------------------~~~~~~~~~GTp~YmAP 239 (346)
T 4fih_A 223 ---------------------------------------------------------------EVPRRKSLVGTPYWMAP 239 (346)
T ss_dssp ---------------------------------------------------------------SSCCBCCCCSCGGGCCH
T ss_pred ---------------------------------------------------------------CCCcccccccCcCcCCH
Confidence 12334578999999999
Q ss_pred eeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC----CCCCChHHHHHHHHhhhhCCCccCCCC
Q 042539 258 EVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE----FVGQRTALTDLIQRLLEKDPVKRLGYL 333 (412)
Q Consensus 258 E~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~dli~~~L~~dP~~R~~~~ 333 (412)
|++.+..|+.++|||||||++|||++|++||.+.+..+++..+....+. +..++++++|||.+||++||++|+
T Consensus 240 Evl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~--- 316 (346)
T 4fih_A 240 ELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRA--- 316 (346)
T ss_dssp HHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSC---
T ss_pred HHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCc---
Confidence 9999999999999999999999999999999999999988888765432 235689999999999999999999
Q ss_pred CChhhhhcCCCCCCC
Q 042539 334 RGACEIKEHVFFKGV 348 (412)
Q Consensus 334 ~~~~e~l~h~ff~~~ 348 (412)
+++|+++||||+..
T Consensus 317 -ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 317 -TAAELLKHPFLAKA 330 (346)
T ss_dssp -CHHHHTTCGGGGGC
T ss_pred -CHHHHhcCHhhcCC
Confidence 79999999999853
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-65 Score=528.40 Aligned_cols=287 Identities=32% Similarity=0.610 Sum_probs=243.5
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhH--HHHHHHHHHHHHHhhcCCCccceee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKH--EAERRARWEIRVLSRLSHPFLPKLL 89 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~--~~~~~~~~Ei~il~~l~hpnIv~l~ 89 (412)
...+++++|+++++||+|+||+||+|+++.++. .||||++++..+.... .......+++.+++.++|||||+++
T Consensus 183 ~~~~slddf~i~k~LG~G~fG~V~la~~~~tg~----~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~ 258 (689)
T 3v5w_A 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGK----MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 258 (689)
T ss_dssp TCCCCGGGEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred CCCCchHHeEEEEEEecccCeEEEEEEECCCCC----EEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEE
Confidence 346889999999999999999999999988654 4999999887653222 2223333456777788899999999
Q ss_pred eeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccc
Q 042539 90 GSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169 (412)
Q Consensus 90 ~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DF 169 (412)
++|++.+.+|||||||.||+|..++.... .|++..++.|++||+.||+|||++|||||||||+||||+.+|++||+||
T Consensus 259 ~~f~~~~~lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DF 336 (689)
T 3v5w_A 259 YAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDL 336 (689)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred EEEEECCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEeccc
Confidence 99999999999999999999998887654 5999999999999999999999999999999999999999999999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|+|+.+. .....++|
T Consensus 337 GlA~~~~-----------------------------------------------------------------~~~~~t~~ 351 (689)
T 3v5w_A 337 GLACDFS-----------------------------------------------------------------KKKPHASV 351 (689)
T ss_dssp TTCEECS-----------------------------------------------------------------SCCCCSCC
T ss_pred ceeeecC-----------------------------------------------------------------CCCCCCcc
Confidence 9997542 12234679
Q ss_pred cCCCCccceeec-CCCCCchhhHHHHHHHHHHHhhCCCCCCCC---CHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhh
Q 042539 250 GTEEYVSPEVVR-GDGHEFAVDWWALGILTYEMLYGTTPFRGK---NRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEK 324 (412)
Q Consensus 250 gt~~Y~APE~l~-~~~~~~~~DiwSlGvil~ell~g~~Pf~~~---~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~ 324 (412)
||+.|||||++. +..|+.++|||||||++|||++|++||.+. +..+++..+......++ .+++++++||.+||++
T Consensus 352 GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a~dLI~~lL~~ 431 (689)
T 3v5w_A 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 431 (689)
T ss_dssp SCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred CCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHHHHHHHHHHccC
Confidence 999999999996 468999999999999999999999999763 45566677776665554 5789999999999999
Q ss_pred CCCccCCCC-CChhhhhcCCCCCCCCchhhcc-cCCCCCCCCCCCch
Q 042539 325 DPVKRLGYL-RGACEIKEHVFFKGVRWDLLTD-VLRPPFIPSREEND 369 (412)
Q Consensus 325 dP~~R~~~~-~~~~e~l~h~ff~~~~~~~~~~-~~~pp~~p~~~~~~ 369 (412)
||.+|+++. .+++|+++||||++++|+.+.. ...|||+|......
T Consensus 432 dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~~~~~~ 478 (689)
T 3v5w_A 432 DVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVN 478 (689)
T ss_dssp CGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCCCTTCSS
T ss_pred CHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccCCCCCCC
Confidence 999999863 4699999999999999997754 67899999765543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-64 Score=501.33 Aligned_cols=253 Identities=24% Similarity=0.390 Sum_probs=224.9
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
+.|+++++||+|+||+||+|+++.++. .||||++.+..... .+.+.+|+.+|+.++|||||+++++|++++.
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~----~vAiK~i~~~~~~~----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~ 222 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGK----LVAVKKMDLRKQQR----RELLFNEVVIMRDYQHENVVEMYNSYLVGDE 222 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEESTTCSS----GGGHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCC----EEEEEEEeccchhH----HHHHHHHHHHHHhCCCCCCCceEEEEEECCE
Confidence 569999999999999999999988654 49999997654322 3456789999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+|||||||.||+|..++... .+++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+.
T Consensus 223 ~~iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~- 298 (423)
T 4fie_A 223 LWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS- 298 (423)
T ss_dssp EEEEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECC-
T ss_pred EEEEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECC-
Confidence 99999999999999887643 49999999999999999999999999999999999999999999999999998652
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
.......++|||+.||||
T Consensus 299 --------------------------------------------------------------~~~~~~~~~~GTp~YmAP 316 (423)
T 4fie_A 299 --------------------------------------------------------------KEVPRRKSLVGTPYWMAP 316 (423)
T ss_dssp --------------------------------------------------------------SSCCCBCCCEECTTTCCH
T ss_pred --------------------------------------------------------------CCCccccccccCcCcCCH
Confidence 122334578999999999
Q ss_pred eeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC----CCCCCChHHHHHHHHhhhhCCCccCCCC
Q 042539 258 EVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP----EFVGQRTALTDLIQRLLEKDPVKRLGYL 333 (412)
Q Consensus 258 E~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~----~~~~~~~~~~dli~~~L~~dP~~R~~~~ 333 (412)
|++.+..|+.++|||||||++|||++|++||.+.+..+.+..+....+ ....+++++++||.+||++||++|+
T Consensus 317 Evl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~--- 393 (423)
T 4fie_A 317 ELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRA--- 393 (423)
T ss_dssp HHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSC---
T ss_pred HHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCc---
Confidence 999999999999999999999999999999999999998888876542 2345789999999999999999999
Q ss_pred CChhhhhcCCCCCCC
Q 042539 334 RGACEIKEHVFFKGV 348 (412)
Q Consensus 334 ~~~~e~l~h~ff~~~ 348 (412)
+++|+++||||+..
T Consensus 394 -ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 394 -TAAELLKHPFLAKA 407 (423)
T ss_dssp -CHHHHTTCGGGGGC
T ss_pred -CHHHHhcCHHhcCC
Confidence 79999999999853
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-63 Score=469.70 Aligned_cols=251 Identities=22% Similarity=0.361 Sum_probs=212.3
Q ss_pred Cc-eeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe---
Q 042539 19 NL-KALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET--- 94 (412)
Q Consensus 19 ~y-~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--- 94 (412)
+| ++.++||+|+||+||+|+++.++. .||+|++.+.... ....+++.+|+++|++++|||||+++++|++
T Consensus 26 r~~~~~~~iG~G~fg~Vy~a~~~~~~~----~vAiK~i~~~~~~--~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~ 99 (290)
T 3fpq_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTV----EVAWCELQDRKLT--KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 99 (290)
T ss_dssp SEEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEGGGSC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEET
T ss_pred ceEEeeeEEecCcCcEEEEEEECCCCe----EEEEEEEchhhCC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccC
Confidence 44 788899999999999999987554 4999999776543 2345678899999999999999999999975
Q ss_pred -CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeeeCCCCceEEcc-CCCEEEcccc
Q 042539 95 -DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMG--IAYRDLKPENILIRQ-SGHVTLTDFD 170 (412)
Q Consensus 95 -~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~--iiHrDlKp~NiLl~~-~g~vkL~DFG 170 (412)
++.+|||||||.||+|..++.... .+++.+++.|+.||+.||+|||++| ||||||||+|||++. +|.+||+|||
T Consensus 100 ~~~~~~lvmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFG 177 (290)
T 3fpq_A 100 GKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp TEEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTT
T ss_pred CCcEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCc
Confidence 356999999999999999887654 4999999999999999999999999 999999999999985 7999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+|+.. ......+++|
T Consensus 178 la~~~-----------------------------------------------------------------~~~~~~~~~G 192 (290)
T 3fpq_A 178 LATLK-----------------------------------------------------------------RASFAKAVIG 192 (290)
T ss_dssp GGGGC-----------------------------------------------------------------CTTSBEESCS
T ss_pred CCEeC-----------------------------------------------------------------CCCccCCccc
Confidence 99642 1123346799
Q ss_pred CCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCC-HHHHHHHHhcCCCC--C-CCCChHHHHHHHHhhhhCC
Q 042539 251 TEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKN-RKETFRNVLMKTPE--F-VGQRTALTDLIQRLLEKDP 326 (412)
Q Consensus 251 t~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-~~~~~~~i~~~~~~--~-~~~~~~~~dli~~~L~~dP 326 (412)
|+.|||||++.+ .|+.++|||||||++|||+||++||.+.+ ...++..+...... + ...++++++||.+||++||
T Consensus 193 Tp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP 271 (290)
T 3fpq_A 193 TPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNK 271 (290)
T ss_dssp SCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSG
T ss_pred CccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCCh
Confidence 999999999876 59999999999999999999999998754 44555555544321 1 2457899999999999999
Q ss_pred CccCCCCCChhhhhcCCCCCC
Q 042539 327 VKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 327 ~~R~~~~~~~~e~l~h~ff~~ 347 (412)
++|| +++|+++||||++
T Consensus 272 ~~R~----s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 272 DERY----SIKDLLNHAFFQE 288 (290)
T ss_dssp GGSC----CHHHHHTSGGGC-
T ss_pred hHCc----CHHHHhcCccccC
Confidence 9999 6999999999974
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-63 Score=481.94 Aligned_cols=257 Identities=23% Similarity=0.310 Sum_probs=218.4
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET 94 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 94 (412)
...++|++.++||+|+||+||+|+++.++. .||||+++++... .+|+.+|+.++|||||+++++|++
T Consensus 55 ~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~----~vAiK~i~~~~~~---------~~E~~il~~l~HpnIV~l~~~~~~ 121 (336)
T 4g3f_A 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGF----QCAVKKVRLEVFR---------VEELVACAGLSSPRIVPLYGAVRE 121 (336)
T ss_dssp BTTTEEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEETTTCC---------THHHHTTTTCCCTTBCCEEEEEEE
T ss_pred cchhheEeCcEeccCCCeEEEEEEECCCCC----EEEEEEECHHHhH---------HHHHHHHHhCCCCCCCcEEEEEEE
Confidence 345789999999999999999999988654 4999999765432 249999999999999999999999
Q ss_pred CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCC-CEEEccccccc
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG-HVTLTDFDLSR 173 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g-~vkL~DFGla~ 173 (412)
++.+|||||||+||+|..++.... .+++.+++.|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+
T Consensus 122 ~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~ 199 (336)
T 4g3f_A 122 GPWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHAL 199 (336)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCE
T ss_pred CCEEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCe
Confidence 999999999999999999887654 499999999999999999999999999999999999999998 69999999998
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
.+...... .......+++||+.
T Consensus 200 ~~~~~~~~----------------------------------------------------------~~~~~~~~~~GT~~ 221 (336)
T 4g3f_A 200 CLQPDGLG----------------------------------------------------------KSLLTGDYIPGTET 221 (336)
T ss_dssp EC----------------------------------------------------------------------CCCCCCGG
T ss_pred EccCCCcc----------------------------------------------------------cceecCCccccCcc
Confidence 65321100 01112346789999
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC----CCCCChHHHHHHHHhhhhCCCcc
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE----FVGQRTALTDLIQRLLEKDPVKR 329 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~dli~~~L~~dP~~R 329 (412)
|||||++.+..|+.++|||||||++|||++|++||.+.+..+++.++....+. .+.+++++++||.+||++||.+|
T Consensus 222 YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 301 (336)
T 4g3f_A 222 HMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHR 301 (336)
T ss_dssp GCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred ccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHC
Confidence 99999999999999999999999999999999999998877777788776543 24678999999999999999999
Q ss_pred CCCCCChhhh-------------hcCCCCCCC
Q 042539 330 LGYLRGACEI-------------KEHVFFKGV 348 (412)
Q Consensus 330 ~~~~~~~~e~-------------l~h~ff~~~ 348 (412)
| ++.|+ ++|||+...
T Consensus 302 ~----sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 302 A----SAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp C----CHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred c----CHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 9 68887 567777643
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-62 Score=485.35 Aligned_cols=273 Identities=22% Similarity=0.367 Sum_probs=225.4
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe---
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET--- 94 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--- 94 (412)
++|+++++||+|+||+||+|+++.++. .||||++++... .....+++++|+++|+.++|||||++++++..
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~----~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 127 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQ----QVAIKKIPNAFD--VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVP 127 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEETTTTS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCC----EEEEEEECcccc--chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccc
Confidence 579999999999999999999988654 499999976543 23345678889999999999999999998764
Q ss_pred ---CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 95 ---DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 95 ---~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
.+.+|||||||. |+|..++.. .+.+++.+++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+
T Consensus 128 ~~~~~~~~ivmE~~~-g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 128 YGEFKSVYVVLDLME-SDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp TTTCCCEEEEEECCS-EEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred cccCCEEEEEEeCCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecce
Confidence 368999999996 568777654 34699999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
|+.+..... .......+++||
T Consensus 205 a~~~~~~~~-----------------------------------------------------------~~~~~~~~~~GT 225 (398)
T 4b99_A 205 ARGLCTSPA-----------------------------------------------------------EHQYFMTEYVAT 225 (398)
T ss_dssp CBCC------------------------------------------------------------------CCCCCSSCCC
T ss_pred eeecccCcc-----------------------------------------------------------ccccccccceeC
Confidence 986532110 122344578999
Q ss_pred CCCccceeecCCC-CCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--CC----------------------
Q 042539 252 EEYVSPEVVRGDG-HEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT--PE---------------------- 306 (412)
Q Consensus 252 ~~Y~APE~l~~~~-~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~~---------------------- 306 (412)
+.|||||++.+.. |+.++||||+|||+|||++|++||.+.+..+++..|+... +.
T Consensus 226 ~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (398)
T 4b99_A 226 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPR 305 (398)
T ss_dssp CTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCC
T ss_pred hHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCc
Confidence 9999999998864 5999999999999999999999999999988888775321 10
Q ss_pred --------CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCchhhcccCCCCCC
Q 042539 307 --------FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFI 362 (412)
Q Consensus 307 --------~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~~~~~~~~pp~~ 362 (412)
++..++++.|||.+||++||.+|+ |++|+|+||||+............++|.
T Consensus 306 ~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~----ta~e~L~Hp~f~~~~~p~~~p~~~~~~~ 365 (398)
T 4b99_A 306 QPVPWETVYPGADRQALSLLGRMLRFEPSARI----SAAAALRHPFLAKYHDPDDEPDCAPPFD 365 (398)
T ss_dssp CCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSC----CHHHHTTSGGGTTTCCGGGSCCCSSCCC
T ss_pred CCCCHHHhCCCCCHHHHHHHHHHCcCChhHCc----CHHHHhcCHhhCcCCCCccccCCCCCCC
Confidence 234678999999999999999999 7999999999998765444333444543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-61 Score=462.67 Aligned_cols=270 Identities=25% Similarity=0.433 Sum_probs=201.5
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
+++|++++.||+|+||+||+|+++.++. .||||++++.. .....+++.+|+++|++|+|||||+++++|.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~----~vAiK~i~~~~---~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~ 76 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDC----NYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLEKN 76 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCC----EEEEEEEEECS---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCC----EEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecC
Confidence 4689999999999999999999987554 49999997653 2344567889999999999999999999997654
Q ss_pred ------------eEEEEeeccCCCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCC
Q 042539 97 ------------FLAWAVPYCPGGDLNVLRYKQND-RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGH 163 (412)
Q Consensus 97 ------------~~~lv~e~~~gg~L~~~~~~~~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~ 163 (412)
.+|+|||||.||+|.+++..... ...++..++.++.||+.||+|||++|||||||||+|||++.+|.
T Consensus 77 ~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~ 156 (299)
T 4g31_A 77 TTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV 156 (299)
T ss_dssp ----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC
T ss_pred ccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCc
Confidence 47999999999999988865432 12345678999999999999999999999999999999999999
Q ss_pred EEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCC
Q 042539 164 VTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGE 243 (412)
Q Consensus 164 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (412)
+||+|||+|+.+......... ........
T Consensus 157 vKl~DFGla~~~~~~~~~~~~---------------------------------------------------~~~~~~~~ 185 (299)
T 4g31_A 157 VKVGDFGLVTAMDQDEEEQTV---------------------------------------------------LTPMPAYA 185 (299)
T ss_dssp EEECCCCCC-----------------------------------------------------------------------
T ss_pred EEEccCccceecCCCcccccc---------------------------------------------------cccccccc
Confidence 999999999876432110000 00001122
Q ss_pred CCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCH-HHHHHHHhcCC-C-CCCCCChHHHHHHHH
Q 042539 244 RSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNR-KETFRNVLMKT-P-EFVGQRTALTDLIQR 320 (412)
Q Consensus 244 ~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-~~~~~~i~~~~-~-~~~~~~~~~~dli~~ 320 (412)
...+.+||+.|||||++.+..|+.++|||||||++|||++ ||.+... ...+..+.... + .+...++.+.+||.+
T Consensus 186 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~ 262 (299)
T 4g31_A 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQD 262 (299)
T ss_dssp ------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHH
T ss_pred ccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcCCCCCCCcccCHHHHHHHHH
Confidence 3456799999999999999999999999999999999996 8865432 22333333222 1 112345678999999
Q ss_pred hhhhCCCccCCCCCChhhhhcCCCCCCCCch
Q 042539 321 LLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 321 ~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~ 351 (412)
||++||++|| ++.|+++||||++++|.
T Consensus 263 ~L~~dP~~Rp----s~~eil~h~~~~~~~~p 289 (299)
T 4g31_A 263 MLSPSPMERP----EAINIIENAVFEDLDFP 289 (299)
T ss_dssp HTCSSGGGSC----CHHHHHTSGGGCCC---
T ss_pred HcCCChhHCc----CHHHHhcCHhhCCCCCC
Confidence 9999999999 69999999999999884
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-60 Score=465.18 Aligned_cols=281 Identities=20% Similarity=0.332 Sum_probs=209.8
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeeeeEEeCC
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLGSLETDE 96 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 96 (412)
++|+++++||+|+||+||+|+++.. ..+++.||||++.+... ..++.+|+++|+.+ +|||||+++++|++++
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~-~~~~~~vAiK~i~~~~~------~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQ-VGPEEKIALKHLIPTSH------PIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBT-TSCEEEEEEEEECTTSC------HHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred CcEEEEEEEecccCcEEEEEEEccc-CCCCCEEEEEEEccccC------HHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 6799999999999999999987632 22456699999865431 23566799999999 5999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccC-CCEEEccccccchh
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQS-GHVTLTDFDLSRNL 175 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~-g~vkL~DFGla~~~ 175 (412)
++|+|||||.||+|.+++. .+++.+++.|+.||+.||+|||++|||||||||+|||++.+ |.+||+|||+|+..
T Consensus 94 ~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 9999999999999987762 39999999999999999999999999999999999999887 89999999999865
Q ss_pred hchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCc
Q 042539 176 VKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYV 255 (412)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 255 (412)
............. ...... .................+.+||+.||
T Consensus 169 ~~~~~~~~~~~~~----------------------------------~~~~~~-~~~~~~~~~~~~~~~~~~~~GT~~Y~ 213 (361)
T 4f9c_A 169 HDTKIELLKFVQS----------------------------------EAQQER-CSQNKCSICLSRRQQVAPRAGTPGFR 213 (361)
T ss_dssp TTCSCGGGGGC-------------------------------------------------------------CCCCGGGC
T ss_pred CCccccccccccc----------------------------------cccccc-cccccccccccccccccccccCcccc
Confidence 3221100000000 000000 00000000112233456789999999
Q ss_pred cceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCC-CCHHHHHHHHhcC------------------------------
Q 042539 256 SPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRG-KNRKETFRNVLMK------------------------------ 303 (412)
Q Consensus 256 APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~------------------------------ 303 (412)
|||++.+. .|+.++||||+|||+|||++|++||.+ .+..+++..|...
T Consensus 214 APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 293 (361)
T 4f9c_A 214 APEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRK 293 (361)
T ss_dssp CHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHH
T ss_pred CHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhH
Confidence 99999886 489999999999999999999999854 4555554443210
Q ss_pred -------------------------CCCCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCC
Q 042539 304 -------------------------TPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 304 -------------------------~~~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~ 349 (412)
...+...+++++|||.+||++||++|+ |++|+|+||||++++
T Consensus 294 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~----ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 294 LCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRI----TAEEALLHPFFKDMS 360 (361)
T ss_dssp HHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSC----CHHHHHTSGGGTTC-
T ss_pred HHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCc----CHHHHhcCcccCCCC
Confidence 011345678999999999999999999 799999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-58 Score=450.85 Aligned_cols=284 Identities=36% Similarity=0.665 Sum_probs=247.0
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET 94 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 94 (412)
+.+++|++++.||+|+||+||+|+++.++. .||||++++...... .....+.+|+++++.++||||++++++|++
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~----~vaiK~~~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 76 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGR----YYAMKILRKEVIIAK-DEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEHHHHHHT-TCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCC----EEEEEEEeHHHhhhh-hHHHHHHHHHHHHHhCCCCcCcceEEEEEe
Confidence 678999999999999999999999987554 499999987654222 234567789999999999999999999999
Q ss_pred CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
.+.+|+|||||.||+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.
T Consensus 77 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 154 (337)
T 1o6l_A 77 HDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE 154 (337)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhh
Confidence 999999999999999988876654 499999999999999999999999999999999999999999999999999974
Q ss_pred hhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCC
Q 042539 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254 (412)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 254 (412)
.. ..+....+.+||+.|
T Consensus 155 ~~---------------------------------------------------------------~~~~~~~~~~gt~~y 171 (337)
T 1o6l_A 155 GI---------------------------------------------------------------SDGATMKTFCGTPEY 171 (337)
T ss_dssp SC---------------------------------------------------------------CTTCCBCCCEECGGG
T ss_pred cc---------------------------------------------------------------cCCCcccccccChhh
Confidence 31 112234467899999
Q ss_pred ccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCccCCCC
Q 042539 255 VSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKRLGYL 333 (412)
Q Consensus 255 ~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R~~~~ 333 (412)
+|||++.+..++.++|||||||++|||++|.+||.+.+....+..+......++ ..++++.+||.+||+.||++|++..
T Consensus 172 ~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~ 251 (337)
T 1o6l_A 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGG 251 (337)
T ss_dssp CCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCS
T ss_pred CChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHHhcCCC
Confidence 999999999999999999999999999999999999999888888887766554 4689999999999999999999643
Q ss_pred -CChhhhhcCCCCCCCCchhhc-ccCCCCCCCCCCCc
Q 042539 334 -RGACEIKEHVFFKGVRWDLLT-DVLRPPFIPSREEN 368 (412)
Q Consensus 334 -~~~~e~l~h~ff~~~~~~~~~-~~~~pp~~p~~~~~ 368 (412)
.+++++++||||++++|+.+. ....|||.|...+.
T Consensus 252 ~~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p~~~~~ 288 (337)
T 1o6l_A 252 PSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSE 288 (337)
T ss_dssp TTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSST
T ss_pred CCCHHHHHcCCCcCCCCHHHHHhCCCCCCCCCCCCCc
Confidence 379999999999999998664 45689999886544
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-59 Score=458.55 Aligned_cols=288 Identities=34% Similarity=0.645 Sum_probs=241.1
Q ss_pred CCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceee
Q 042539 11 TTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLL 89 (412)
Q Consensus 11 ~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~ 89 (412)
....+.+++|+++++||+|+||+||+|+++.++. .||||++++..... ......+.+|+.+++.+ +||||++++
T Consensus 16 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~----~~AvK~~~~~~~~~-~~~~~~~~~E~~il~~~~~hp~Iv~l~ 90 (353)
T 3txo_A 16 SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGD----LYAVKVLKKDVILQ-DDDVECTMTEKRILSLARNHPFLTQLF 90 (353)
T ss_dssp -------CCEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEHHHHHH-HTTHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred CcCCCchhheEEEEEEeeCCCEEEEEEEEcCCCC----EEEEEEEEHHHhcc-hhHHHHHHHHHHHHHhccCCCceeeEE
Confidence 3456889999999999999999999999987554 49999998765432 23455677799999998 699999999
Q ss_pred eeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccc
Q 042539 90 GSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169 (412)
Q Consensus 90 ~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DF 169 (412)
++|++.+.+|+|||||.||+|..++.... .+++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+||
T Consensus 91 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DF 168 (353)
T 3txo_A 91 CCFQTPDRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADF 168 (353)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccc
Confidence 99999999999999999999988877654 4999999999999999999999999999999999999999999999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|+|+... .......+++
T Consensus 169 G~a~~~~---------------------------------------------------------------~~~~~~~~~~ 185 (353)
T 3txo_A 169 GMCKEGI---------------------------------------------------------------CNGVTTATFC 185 (353)
T ss_dssp TTCBCSC---------------------------------------------------------------C---------
T ss_pred cceeecc---------------------------------------------------------------cCCccccccC
Confidence 9997431 1122345678
Q ss_pred cCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC-CChHHHHHHHHhhhhCCCc
Q 042539 250 GTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVG-QRTALTDLIQRLLEKDPVK 328 (412)
Q Consensus 250 gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~dli~~~L~~dP~~ 328 (412)
||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+++.++......++. .++++.+||.+||++||++
T Consensus 186 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dP~~ 265 (353)
T 3txo_A 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTM 265 (353)
T ss_dssp CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred CCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhCHHH
Confidence 999999999999999999999999999999999999999999999999999887766654 6899999999999999999
Q ss_pred cCCC--CCChhhhhcCCCCCCCCchhhcc-cCCCCCCCCCCCc
Q 042539 329 RLGY--LRGACEIKEHVFFKGVRWDLLTD-VLRPPFIPSREEN 368 (412)
Q Consensus 329 R~~~--~~~~~e~l~h~ff~~~~~~~~~~-~~~pp~~p~~~~~ 368 (412)
|++. ..+++++++||||++++|+.+.. ...|||.|...+.
T Consensus 266 R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~~~~~ 308 (353)
T 3txo_A 266 RLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSR 308 (353)
T ss_dssp STTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCST
T ss_pred ccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccCCCCCc
Confidence 9974 12448999999999999997654 5689999886543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-59 Score=486.45 Aligned_cols=261 Identities=30% Similarity=0.439 Sum_probs=231.1
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
.+++|++++.||+|+||+||+|+++.++.. ||||++.+... .....+.+|+++|+.++|||||+++++|+++
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~----~AiK~i~~~~~----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 226 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNN----FAAKFVMTPHE----SDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 226 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCE----EEEEEEECCSH----HHHHHHHHHHHHHHHTCCTTBCCEEEEEECS
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCE----EEEEEEeccch----hhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 468999999999999999999999886554 99999976543 2345677899999999999999999999999
Q ss_pred CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccC--CCEEEccccccc
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQS--GHVTLTDFDLSR 173 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~--g~vkL~DFGla~ 173 (412)
+.+|||||||.||+|..++... .+.|++.+++.|+.||+.||+|||++||+||||||+|||++.+ |.+||+|||+|+
T Consensus 227 ~~~~iv~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~ 305 (573)
T 3uto_A 227 NEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA 305 (573)
T ss_dssp SEEEEEEECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCE
T ss_pred CEEEEEEeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeecccee
Confidence 9999999999999998877543 3469999999999999999999999999999999999999864 899999999998
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
.+. ......+.+||+.
T Consensus 306 ~~~----------------------------------------------------------------~~~~~~~~~GT~~ 321 (573)
T 3uto_A 306 HLD----------------------------------------------------------------PKQSVKVTTGTAE 321 (573)
T ss_dssp ECC----------------------------------------------------------------TTSEEEEECSSGG
T ss_pred Ecc----------------------------------------------------------------CCCceeeeEECcc
Confidence 652 1222346789999
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-----CCCChHHHHHHHHhhhhCCCc
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF-----VGQRTALTDLIQRLLEKDPVK 328 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~dli~~~L~~dP~~ 328 (412)
|||||++.+..|+.++|||||||++|||++|++||.+.+..+++.++......+ ..++++++|||.+||++||.+
T Consensus 322 y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~ 401 (573)
T 3uto_A 322 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNT 401 (573)
T ss_dssp GCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGG
T ss_pred ccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhH
Confidence 999999999999999999999999999999999999999999999998765433 457899999999999999999
Q ss_pred cCCCCCChhhhhcCCCCCCCCchhh
Q 042539 329 RLGYLRGACEIKEHVFFKGVRWDLL 353 (412)
Q Consensus 329 R~~~~~~~~e~l~h~ff~~~~~~~~ 353 (412)
|+ +++|+++||||+..+|...
T Consensus 402 R~----t~~e~l~Hpw~~~~~~~~~ 422 (573)
T 3uto_A 402 RM----TIHQALEHPWLTPGNAPGR 422 (573)
T ss_dssp SC----CHHHHHHSTTTSCCCCTTT
T ss_pred Cc----CHHHHhcCcCcCCCCCCCc
Confidence 99 6999999999999888643
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-59 Score=448.52 Aligned_cols=260 Identities=20% Similarity=0.285 Sum_probs=220.0
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCC-CCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAA-DPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLG 90 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~-~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 90 (412)
...+..++|.+.++||+|+||+||+|++... ...++..||||+++... ....+.+.+|+++|++++|||||++++
T Consensus 7 ~~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~----~~~~~~f~~E~~il~~l~HpnIV~l~g 82 (299)
T 4asz_A 7 VQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS----DNARKDFHREAELLTNLQHEHIVKFYG 82 (299)
T ss_dssp CCBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC----HHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred hcccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC----hHHHHHHHHHHHHHHhCCCCCCccEEE
Confidence 4578889999999999999999999998653 22356779999997543 334567889999999999999999999
Q ss_pred eEEeCCeEEEEeeccCCCCchhHHHhhC-----------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEc
Q 042539 91 SLETDEFLAWAVPYCPGGDLNVLRYKQN-----------DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIR 159 (412)
Q Consensus 91 ~~~~~~~~~lv~e~~~gg~L~~~~~~~~-----------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~ 159 (412)
++.+++.+|||||||.||+|.+++.... ...+++.++..++.||+.||+|||+++||||||||+|||++
T Consensus 83 ~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~ 162 (299)
T 4asz_A 83 VCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG 162 (299)
T ss_dssp EECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred EEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEEC
Confidence 9999999999999999999999987542 34699999999999999999999999999999999999999
Q ss_pred cCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCcccccccc
Q 042539 160 QSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSF 239 (412)
Q Consensus 160 ~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (412)
.++.+||+|||+|+.......
T Consensus 163 ~~~~~Ki~DFGla~~~~~~~~----------------------------------------------------------- 183 (299)
T 4asz_A 163 ENLLVKIGDFGMSRDVYSTDY----------------------------------------------------------- 183 (299)
T ss_dssp GGGCEEECCCSCHHHHTGGGC-----------------------------------------------------------
T ss_pred CCCcEEECCcccceecCCCCc-----------------------------------------------------------
Confidence 999999999999986532110
Q ss_pred CCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHH
Q 042539 240 DNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTD 316 (412)
Q Consensus 240 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~d 316 (412)
.......+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..+++..+..+. +....+++++.+
T Consensus 184 --~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~ 261 (299)
T 4asz_A 184 --YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPQEVYE 261 (299)
T ss_dssp --EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCCCCTTCCHHHHH
T ss_pred --eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHH
Confidence 011234579999999999999999999999999999999998 999999999999888887654 223457899999
Q ss_pred HHHHhhhhCCCccCCCCCChhhhh
Q 042539 317 LIQRLLEKDPVKRLGYLRGACEIK 340 (412)
Q Consensus 317 li~~~L~~dP~~R~~~~~~~~e~l 340 (412)
||.+||+.||++|| +++++.
T Consensus 262 li~~cl~~dP~~RP----s~~~i~ 281 (299)
T 4asz_A 262 LMLGCWQREPHMRK----NIKGIH 281 (299)
T ss_dssp HHHHHTCSSGGGSC----CHHHHH
T ss_pred HHHHHcCCChhHCc----CHHHHH
Confidence 99999999999999 578874
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-58 Score=459.49 Aligned_cols=287 Identities=34% Similarity=0.661 Sum_probs=241.3
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLG 90 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~ 90 (412)
...+.+++|+++++||+|+||+||+|+++.++ +.||||++++..... ......+.+|+.++.++ +|||||++++
T Consensus 46 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~----~~~AvK~~~k~~~~~-~~~~~~~~~E~~il~~~~~hp~Iv~l~~ 120 (396)
T 4dc2_A 46 SSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTD----RIYAMRVVKKELVND-DEDIDWVQTEKHVFEQASNHPFLVGLHS 120 (396)
T ss_dssp ---CCGGGEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEEEGGGTC-----CCHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred ccCCChhHcEEEEEEeeCCCeEEEEEEECCCC----CEEEEEEEEhhhccC-HHHHHHHHHHHHHHHhcCCCCCcCeeEE
Confidence 45678999999999999999999999998754 449999998765433 23445677799999888 7999999999
Q ss_pred eEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccc
Q 042539 91 SLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 91 ~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
+|++.+.+|+|||||.||+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||
T Consensus 121 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG 198 (396)
T 4dc2_A 121 CFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 198 (396)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EEEECCEEEEEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecc
Confidence 9999999999999999999988877654 49999999999999999999999999999999999999999999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+|+... .......+++|
T Consensus 199 la~~~~---------------------------------------------------------------~~~~~~~~~~g 215 (396)
T 4dc2_A 199 MCKEGL---------------------------------------------------------------RPGDTTSTFCG 215 (396)
T ss_dssp TCBCCC---------------------------------------------------------------CTTCCBCCCCB
T ss_pred eeeecc---------------------------------------------------------------cCCCccccccC
Confidence 997431 12233457799
Q ss_pred CCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCC---------CHHHHHHHHhcCCCCCC-CCChHHHHHHHH
Q 042539 251 TEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGK---------NRKETFRNVLMKTPEFV-GQRTALTDLIQR 320 (412)
Q Consensus 251 t~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~---------~~~~~~~~i~~~~~~~~-~~~~~~~dli~~ 320 (412)
|+.|+|||++.+..++.++|||||||++|||++|++||.+. .....+..+......++ ..+.++++||.+
T Consensus 216 t~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 295 (396)
T 4dc2_A 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKS 295 (396)
T ss_dssp CGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred CcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcCCHHHHHHHHH
Confidence 99999999999999999999999999999999999999642 33445666666665554 468999999999
Q ss_pred hhhhCCCccCCCC--CChhhhhcCCCCCCCCchhhcc-cCCCCCCCCCCCc
Q 042539 321 LLEKDPVKRLGYL--RGACEIKEHVFFKGVRWDLLTD-VLRPPFIPSREEN 368 (412)
Q Consensus 321 ~L~~dP~~R~~~~--~~~~e~l~h~ff~~~~~~~~~~-~~~pp~~p~~~~~ 368 (412)
||++||.+|++.. .+++++++||||++++|+.+.. ...|||.|.....
T Consensus 296 lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~p~~~~~ 346 (396)
T 4dc2_A 296 FLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGE 346 (396)
T ss_dssp HTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCCCCCCSS
T ss_pred HhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCcCCCCCc
Confidence 9999999999752 2468999999999999997754 5689999986654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-59 Score=445.85 Aligned_cols=254 Identities=21% Similarity=0.306 Sum_probs=207.1
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
.+++..++|++.++||+|+||+||+|+++. .||||+++.... .....+.+.+|+++|++++|||||+++++
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-------~vAvK~~~~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~ 100 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHG-------DVAVKILKVVDP--TPEQFQAFRNEVAVLRKTRHVNILLFMGY 100 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESSS-------EEEEEECCCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEECC-------cEEEEEEEecCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 468899999999999999999999998643 289999975443 23456778899999999999999999998
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
+. ++.+|||||||+||+|.+++.... +.+++.++..++.||+.||+|||++|||||||||+|||++.++.+||+|||+
T Consensus 101 ~~-~~~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 178 (307)
T 3omv_A 101 MT-KDNLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGL 178 (307)
T ss_dssp EC-SSSCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSS
T ss_pred EE-CCeEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccC
Confidence 75 457899999999999998886543 4699999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
|+..... .......+.+||
T Consensus 179 a~~~~~~-------------------------------------------------------------~~~~~~~~~~GT 197 (307)
T 3omv_A 179 ATVKSRW-------------------------------------------------------------SGSQQVEQPTGS 197 (307)
T ss_dssp CBC-------------------------------------------------------------------------CCCC
T ss_pred ceecccC-------------------------------------------------------------CcceeecccccC
Confidence 9764211 011223467899
Q ss_pred CCCccceeecCC---CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC---CC----CCCCChHHHHHHHHh
Q 042539 252 EEYVSPEVVRGD---GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT---PE----FVGQRTALTDLIQRL 321 (412)
Q Consensus 252 ~~Y~APE~l~~~---~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~---~~----~~~~~~~~~dli~~~ 321 (412)
+.|||||++.+. .|+.++|||||||++|||+||+.||.+.+.......++... +. ...+++++.+||.+|
T Consensus 198 ~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~c 277 (307)
T 3omv_A 198 VLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADC 277 (307)
T ss_dssp TTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHH
T ss_pred CCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHH
Confidence 999999999753 58999999999999999999999999876555544444322 21 235678999999999
Q ss_pred hhhCCCccCCCCCChhhhhc
Q 042539 322 LEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 322 L~~dP~~R~~~~~~~~e~l~ 341 (412)
|+.||++|| ++.++++
T Consensus 278 l~~dP~~RP----s~~ei~~ 293 (307)
T 3omv_A 278 VKKVKEERP----LFPQILS 293 (307)
T ss_dssp TCSSSTTSC----CHHHHHH
T ss_pred cCCCHhHCc----CHHHHHH
Confidence 999999999 4666543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-58 Score=448.40 Aligned_cols=261 Identities=18% Similarity=0.278 Sum_probs=215.8
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCC-CCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAA-DPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLG 90 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~-~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 90 (412)
...+..++|.+.++||+|+||+||+|+++.. +..+++.||||+++... ....+.+.+|+++|++++|||||++++
T Consensus 35 ~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~----~~~~~~f~~E~~il~~l~HpnIV~l~g 110 (329)
T 4aoj_A 35 VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS----ESARQDFQREAELLTMLQHQHIVRFFG 110 (329)
T ss_dssp SCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS----HHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred hcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC----HHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 3457788999999999999999999998653 33356779999997543 334567889999999999999999999
Q ss_pred eEEeCCeEEEEeeccCCCCchhHHHhhC-------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceE
Q 042539 91 SLETDEFLAWAVPYCPGGDLNVLRYKQN-------------DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENIL 157 (412)
Q Consensus 91 ~~~~~~~~~lv~e~~~gg~L~~~~~~~~-------------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiL 157 (412)
++.+++.+|||||||.||+|..++.... .+.+++.++..++.||+.||.|||+++||||||||+|||
T Consensus 111 ~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NIL 190 (329)
T 4aoj_A 111 VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCL 190 (329)
T ss_dssp EECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred EEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEE
Confidence 9999999999999999999999886542 245899999999999999999999999999999999999
Q ss_pred EccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCcccccc
Q 042539 158 IRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQ 237 (412)
Q Consensus 158 l~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (412)
++.++.+||+|||+|+.+....
T Consensus 191 l~~~~~~Ki~DFGla~~~~~~~---------------------------------------------------------- 212 (329)
T 4aoj_A 191 VGQGLVVKIGDFGMSRDIYSTD---------------------------------------------------------- 212 (329)
T ss_dssp EETTTEEEECCCC-------------------------------------------------------------------
T ss_pred ECCCCcEEEcccccceeccCCC----------------------------------------------------------
Confidence 9999999999999998653211
Q ss_pred ccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC-CC-CCCCChHH
Q 042539 238 SFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT-PE-FVGQRTAL 314 (412)
Q Consensus 238 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~-~~-~~~~~~~~ 314 (412)
........+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..+.+..+..+. +. ...+++++
T Consensus 213 ---~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~~~p~~~~~~~ 289 (329)
T 4aoj_A 213 ---YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEV 289 (329)
T ss_dssp ----------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCCCCCTTCCHHH
T ss_pred ---cceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCcccccHHH
Confidence 1112235689999999999999999999999999999999998 999999999988888887643 22 34578999
Q ss_pred HHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 315 TDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 315 ~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
.+||.+||+.||++|| ++.|+++
T Consensus 290 ~~li~~cl~~dP~~RP----s~~ei~~ 312 (329)
T 4aoj_A 290 YAIMRGCWQREPQQRH----SIKDVHA 312 (329)
T ss_dssp HHHHHHHCCSSTTTSC----CHHHHHH
T ss_pred HHHHHHHcCcChhHCc----CHHHHHH
Confidence 9999999999999999 5788875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-59 Score=446.56 Aligned_cols=264 Identities=19% Similarity=0.312 Sum_probs=221.6
Q ss_pred CCCCCCccCceeeeeeeccCceEEEEEEEcCCC-CCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceee
Q 042539 11 TTPSLDLDNLKALKILGKGAMGTVFLVHDRAAD-PTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLL 89 (412)
Q Consensus 11 ~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~ 89 (412)
...++..++++++++||+|+||+||+|+..... ..+++.||||+++... .....+.+.+|+.++++++|||||+++
T Consensus 19 ~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~---~~~~~~~f~~E~~il~~l~HpNIV~l~ 95 (308)
T 4gt4_A 19 KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA---EGPLREEFRHEAMLRARLQHPNVVCLL 95 (308)
T ss_dssp CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C---CC-CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc---ChHHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 355789999999999999999999999875422 2245679999996543 223456688899999999999999999
Q ss_pred eeEEeCCeEEEEeeccCCCCchhHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCc
Q 042539 90 GSLETDEFLAWAVPYCPGGDLNVLRYKQN--------------DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPEN 155 (412)
Q Consensus 90 ~~~~~~~~~~lv~e~~~gg~L~~~~~~~~--------------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~N 155 (412)
+++.+++.+|||||||.||+|.+++..+. ...+++.++..++.||+.||+|||+++||||||||+|
T Consensus 96 g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~N 175 (308)
T 4gt4_A 96 GVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRN 175 (308)
T ss_dssp EEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccc
Confidence 99999999999999999999999886542 2358999999999999999999999999999999999
Q ss_pred eEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCcccc
Q 042539 156 ILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRR 235 (412)
Q Consensus 156 iLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (412)
||++.++.+||+|||+|+......
T Consensus 176 ILl~~~~~~Ki~DFGlar~~~~~~-------------------------------------------------------- 199 (308)
T 4gt4_A 176 VLVYDKLNVKISDLGLFREVYAAD-------------------------------------------------------- 199 (308)
T ss_dssp EEECGGGCEEECCSCCBCGGGGGG--------------------------------------------------------
T ss_pred eEECCCCCEEECCcccceeccCCC--------------------------------------------------------
Confidence 999999999999999998653211
Q ss_pred ccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCCh
Q 042539 236 QQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRT 312 (412)
Q Consensus 236 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~ 312 (412)
......+.+||+.|||||++.+..|+.++|||||||++|||+| |..||.+.+..++...+..+. +....+++
T Consensus 200 -----~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~ 274 (308)
T 4gt4_A 200 -----YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPA 274 (308)
T ss_dssp -----CBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred -----ceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCcccchH
Confidence 1122345689999999999999999999999999999999998 899999999998888887654 33446789
Q ss_pred HHHHHHHHhhhhCCCccCCCCCChhhhhcC
Q 042539 313 ALTDLIQRLLEKDPVKRLGYLRGACEIKEH 342 (412)
Q Consensus 313 ~~~dli~~~L~~dP~~R~~~~~~~~e~l~h 342 (412)
++.+||.+||+.||++|| ++.+++++
T Consensus 275 ~~~~li~~C~~~dP~~RP----s~~ei~~~ 300 (308)
T 4gt4_A 275 WVYALMIECWNEFPSRRP----RFKDIHSR 300 (308)
T ss_dssp HHHHHHHHHTCSSGGGSC----CHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCc----CHHHHHHH
Confidence 999999999999999999 57777653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-58 Score=451.39 Aligned_cols=286 Identities=34% Similarity=0.676 Sum_probs=236.0
Q ss_pred CCCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccce
Q 042539 9 PQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPK 87 (412)
Q Consensus 9 ~~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~ 87 (412)
+.....+.+++|++++.||+|+||+||+|+++.++ +.||||++++...... .....+.+|+.++..+ +||||++
T Consensus 8 ~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~----~~vaiK~~~~~~~~~~-~~~~~~~~E~~il~~~~~hp~iv~ 82 (345)
T 1xjd_A 8 PSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTN----QFFAIKALKKDVVLMD-DDVECTMVEKRVLSLAWEHPFLTH 82 (345)
T ss_dssp --------CTTEEEEEEEEECSSSEEEEEEETTTT----EEEEEEEEEHHHHHHT-TCHHHHHHHHHHHHHHTTCTTBCC
T ss_pred CCccCCCChHHeEEEEEEeeCCCeEEEEEEECCCC----CEEEEEEEEhHHhhhh-hhHHHHHHHHHHHHhcCCCCCCCc
Confidence 44456788999999999999999999999998754 4599999987654222 2344566799999987 8999999
Q ss_pred eeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEc
Q 042539 88 LLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLT 167 (412)
Q Consensus 88 l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~ 167 (412)
++++|++.+.+|+|||||.||+|..++.... .+++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+
T Consensus 83 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~ 160 (345)
T 1xjd_A 83 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIA 160 (345)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred EEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEe
Confidence 9999999999999999999999988877654 49999999999999999999999999999999999999999999999
Q ss_pred cccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcc
Q 042539 168 DFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNS 247 (412)
Q Consensus 168 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (412)
|||+|+.... ......+
T Consensus 161 DFG~a~~~~~---------------------------------------------------------------~~~~~~~ 177 (345)
T 1xjd_A 161 DFGMCKENML---------------------------------------------------------------GDAKTNT 177 (345)
T ss_dssp CCTTCBCCCC---------------------------------------------------------------TTCCBCC
T ss_pred EChhhhhccc---------------------------------------------------------------CCCcccC
Confidence 9999974310 1123456
Q ss_pred cccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC-CChHHHHHHHHhhhhCC
Q 042539 248 FVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVG-QRTALTDLIQRLLEKDP 326 (412)
Q Consensus 248 ~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~dli~~~L~~dP 326 (412)
++||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+++..+....+.++. .++++++||.+||+.||
T Consensus 178 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dp 257 (345)
T 1xjd_A 178 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREP 257 (345)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSG
T ss_pred CCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHHHHHHhcCCH
Confidence 78999999999999999999999999999999999999999999999999998877766553 68999999999999999
Q ss_pred CccCCCCCChh-hhhcCCCCCCCCchhhcc-cCCCCCCCCCCCc
Q 042539 327 VKRLGYLRGAC-EIKEHVFFKGVRWDLLTD-VLRPPFIPSREEN 368 (412)
Q Consensus 327 ~~R~~~~~~~~-e~l~h~ff~~~~~~~~~~-~~~pp~~p~~~~~ 368 (412)
++|++ +. ++++||||++++|+.+.. ...|||.|...+.
T Consensus 258 ~~R~~----~~~~i~~hp~f~~~~w~~l~~~~~~~p~~p~~~~~ 297 (345)
T 1xjd_A 258 EKRLG----VRGDIRQHPLFREINWEELERKEIDPPFRPKVKSP 297 (345)
T ss_dssp GGSBT----TBSCGGGSGGGTTCCHHHHHTTCSCC---------
T ss_pred hHcCC----ChHHHHcCccccCCCHHHHhhCCCCCCcCCCCCCc
Confidence 99995 55 999999999999987754 5688999876543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-58 Score=454.58 Aligned_cols=288 Identities=38% Similarity=0.668 Sum_probs=241.0
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHH-HhhcCCCccceeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRV-LSRLSHPFLPKLLG 90 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~ 90 (412)
...+..++|++++.||+|+||+||+|+++.++. .||||++++...... .....+.+|..+ ++.++||||+++++
T Consensus 32 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~----~~AiK~~~~~~~~~~-~~~~~~~~e~~~ll~~~~hp~Iv~l~~ 106 (373)
T 2r5t_A 32 NPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEV----FYAVKVLQKKAILKK-KEEKHIMSERNVLLKNVKHPFLVGLHF 106 (373)
T ss_dssp CTTCCGGGEEEEEEEECCTTCEEEEEEETTTCC----EEEEEEEEGGGBC--------------CCBCCCCCTTBCCEEE
T ss_pred CCCCChhheEEEEEEeeCCCeEEEEEEEcCCCC----EEEEEEEEHHHhhhh-HHHHHHHHHHHHHHHhCCCCCCCCEEE
Confidence 345778999999999999999999999987554 499999988765332 334556667777 56789999999999
Q ss_pred eEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccc
Q 042539 91 SLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 91 ~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
+|++.+.+|+|||||.||+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||
T Consensus 107 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG 184 (373)
T 2r5t_A 107 SFQTADKLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFG 184 (373)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred EEEeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCc
Confidence 9999999999999999999988877654 49999999999999999999999999999999999999999999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+++... .......+++|
T Consensus 185 ~a~~~~---------------------------------------------------------------~~~~~~~~~~g 201 (373)
T 2r5t_A 185 LCKENI---------------------------------------------------------------EHNSTTSTFCG 201 (373)
T ss_dssp BCGGGB---------------------------------------------------------------CCCCCCCSBSC
T ss_pred cccccc---------------------------------------------------------------cCCCccccccC
Confidence 997532 11223456799
Q ss_pred CCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-CCCChHHHHHHHHhhhhCCCcc
Q 042539 251 TEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF-VGQRTALTDLIQRLLEKDPVKR 329 (412)
Q Consensus 251 t~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~dli~~~L~~dP~~R 329 (412)
|+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+++.+++.....+ ...+..+++||.+||+.||.+|
T Consensus 202 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~lL~~dp~~R 281 (373)
T 2r5t_A 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKR 281 (373)
T ss_dssp CCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHHHHHTCSSGGGS
T ss_pred CccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHcccCHHhC
Confidence 999999999999999999999999999999999999999999999999998766554 3578999999999999999999
Q ss_pred CCCCCChhhhhcCCCCCCCCchhhc-ccCCCCCCCCCCCch
Q 042539 330 LGYLRGACEIKEHVFFKGVRWDLLT-DVLRPPFIPSREEND 369 (412)
Q Consensus 330 ~~~~~~~~e~l~h~ff~~~~~~~~~-~~~~pp~~p~~~~~~ 369 (412)
++....++++++|+||++++|+.+. ....|||.|......
T Consensus 282 ~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~ 322 (373)
T 2r5t_A 282 LGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGPN 322 (373)
T ss_dssp TTTTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCCC--
T ss_pred CCCCCCHHHHhCCccccCCCHHHHHhCCCCCCCCCCCCCcc
Confidence 9876678999999999999998664 457899999865543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-58 Score=441.82 Aligned_cols=280 Identities=34% Similarity=0.642 Sum_probs=244.2
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
.+.+++|++++.||+|+||+||+|+++.++. .||+|++++..... ......+.+|+.+++.++||||++++++++
T Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 76 (318)
T 1fot_A 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGR----YYAMKVLKKEIVVR-LKQVEHTNDERLMLSIVTHPFIIRMWGTFQ 76 (318)
T ss_dssp -CCGGGEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred CCChHHcEEEEEEeeCCCEEEEEEEECCCCC----EEEEEEEEHHHhhh-hhHHHHHHHHHHHHhhCCCCCCceEeEEEE
Confidence 4678999999999999999999999987554 49999998765422 123456677999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
+.+.+|+|||||.||+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++
T Consensus 77 ~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~ 154 (318)
T 1fot_A 77 DAQQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK 154 (318)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred eCCEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcce
Confidence 9999999999999999998887643 49999999999999999999999999999999999999999999999999997
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
... ....+.+||+.
T Consensus 155 ~~~------------------------------------------------------------------~~~~~~~gt~~ 168 (318)
T 1fot_A 155 YVP------------------------------------------------------------------DVTYTLCGTPD 168 (318)
T ss_dssp ECS------------------------------------------------------------------SCBCCCCSCTT
T ss_pred ecC------------------------------------------------------------------CccccccCCcc
Confidence 531 11235689999
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCccCCC
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKRLGY 332 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R~~~ 332 (412)
|+|||++.+..++.++|||||||++|||++|++||.+.+..+.+.+++.....++ ..++++.+||.+||..||++|++.
T Consensus 169 y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~ 248 (318)
T 1fot_A 169 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGN 248 (318)
T ss_dssp TCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTS
T ss_pred ccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 9999999999999999999999999999999999999999999999887766554 467899999999999999999975
Q ss_pred CC-ChhhhhcCCCCCCCCchhhcc-cCCCCCCCCCC
Q 042539 333 LR-GACEIKEHVFFKGVRWDLLTD-VLRPPFIPSRE 366 (412)
Q Consensus 333 ~~-~~~e~l~h~ff~~~~~~~~~~-~~~pp~~p~~~ 366 (412)
.. +++++++||||++++|+.+.. ...|||.|...
T Consensus 249 ~~~~~~~i~~hp~f~~~~~~~~~~~~~~~p~~p~~~ 284 (318)
T 1fot_A 249 LQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQ 284 (318)
T ss_dssp STTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC-
T ss_pred cCCCHHHHhcCccccCCCHHHHHhCCCCCCCCCCcC
Confidence 43 799999999999999986644 56789988764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-58 Score=450.79 Aligned_cols=287 Identities=31% Similarity=0.603 Sum_probs=246.2
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLG 90 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~ 90 (412)
...+.+++|++++.||+|+||+||+|+++.++ +.||||++++...... .....+.+|+.++..+ +||||+++++
T Consensus 14 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~----~~~AiK~~~~~~~~~~-~~~~~~~~E~~~l~~~~~hp~iv~l~~ 88 (353)
T 2i0e_A 14 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTD----ELYAVKILKKDVVIQD-DDVECTMVEKRVLALPGKPPFLTQLHS 88 (353)
T ss_dssp -----CTTEEEEEEEEEETTEEEEEEEETTEE----EEEEEEEEEHHHHHHT-TCHHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred cCCCchHHcEEEEEEeeCCCEEEEEEEECCCC----CEEEEEEEEHHHhhcc-hHHHHHHHHHHHHHhcCCCCEEeeEEE
Confidence 44678899999999999999999999998744 4599999987654322 2345667799999988 6999999999
Q ss_pred eEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccc
Q 042539 91 SLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 91 ~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
+|++.+.+|+|||||.||+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||
T Consensus 89 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG 166 (353)
T 2i0e_A 89 CFQTMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG 166 (353)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EEEcCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCC
Confidence 9999999999999999999988877654 49999999999999999999999999999999999999999999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+|+... .......+++|
T Consensus 167 ~a~~~~---------------------------------------------------------------~~~~~~~~~~g 183 (353)
T 2i0e_A 167 MCKENI---------------------------------------------------------------WDGVTTKTFCG 183 (353)
T ss_dssp TCBCCC---------------------------------------------------------------CTTCCBCCCCS
T ss_pred cccccc---------------------------------------------------------------cCCcccccccC
Confidence 997431 11223456789
Q ss_pred CCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCcc
Q 042539 251 TEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKR 329 (412)
Q Consensus 251 t~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R 329 (412)
|+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+++.+++.....++ ..++++.+||.+||..||.+|
T Consensus 184 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R 263 (353)
T 2i0e_A 184 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 263 (353)
T ss_dssp CGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTSC
T ss_pred CccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhcCHHHc
Confidence 9999999999999999999999999999999999999999999999999988766554 468999999999999999999
Q ss_pred CCCC-CChhhhhcCCCCCCCCchhhc-ccCCCCCCCCCCCc
Q 042539 330 LGYL-RGACEIKEHVFFKGVRWDLLT-DVLRPPFIPSREEN 368 (412)
Q Consensus 330 ~~~~-~~~~e~l~h~ff~~~~~~~~~-~~~~pp~~p~~~~~ 368 (412)
+++. .+++++++||||++++|+.+. ....|||.|.....
T Consensus 264 ~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p~~~~~ 304 (353)
T 2i0e_A 264 LGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACGR 304 (353)
T ss_dssp TTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCCC
T ss_pred CCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCCCCCCc
Confidence 9753 358999999999999998764 45789999886543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-57 Score=443.48 Aligned_cols=286 Identities=34% Similarity=0.662 Sum_probs=242.7
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeeee
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLGS 91 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~ 91 (412)
..+.+++|++++.||+|+||+||+|+++.++ +.||||++++..... ......+.+|+.+++++ +||||++++++
T Consensus 4 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~----~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~l~~~ 78 (345)
T 3a8x_A 4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTD----RIYAMKVVKKELVND-DEDIDWVQTEKHVFEQASNHPFLVGLHSC 78 (345)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEEEGGGSCS-HHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred CCCchhheEEEEEEEecCCeEEEEEEECCCC----CEEEEEEEEhHHhcc-hHHHHHHHHHHHHHHhcCCCCccCeEEEE
Confidence 4578899999999999999999999998754 459999998765433 34456777899999998 79999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
|++.+.+|+|||||.||+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+
T Consensus 79 ~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~ 156 (345)
T 3a8x_A 79 FQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM 156 (345)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGG
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccc
Confidence 999999999999999999988877654 499999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
|+... .......+.+||
T Consensus 157 a~~~~---------------------------------------------------------------~~~~~~~~~~gt 173 (345)
T 3a8x_A 157 CKEGL---------------------------------------------------------------RPGDTTSTFCGT 173 (345)
T ss_dssp CBCSC---------------------------------------------------------------CTTCCBCCCCSC
T ss_pred ccccc---------------------------------------------------------------CCCCcccccCCC
Confidence 97431 111233467899
Q ss_pred CCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCC---------CCHHHHHHHHhcCCCCCC-CCChHHHHHHHHh
Q 042539 252 EEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRG---------KNRKETFRNVLMKTPEFV-GQRTALTDLIQRL 321 (412)
Q Consensus 252 ~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~---------~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~ 321 (412)
+.|+|||++.+..++.++|||||||++|||++|++||.. ......+..+......++ ..+.++++||.+|
T Consensus 174 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~l 253 (345)
T 3a8x_A 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSF 253 (345)
T ss_dssp GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 999999999999999999999999999999999999975 334455666666555544 4689999999999
Q ss_pred hhhCCCccCCCC--CChhhhhcCCCCCCCCchhhcc-cCCCCCCCCCCCc
Q 042539 322 LEKDPVKRLGYL--RGACEIKEHVFFKGVRWDLLTD-VLRPPFIPSREEN 368 (412)
Q Consensus 322 L~~dP~~R~~~~--~~~~e~l~h~ff~~~~~~~~~~-~~~pp~~p~~~~~ 368 (412)
|+.||.+|++.. .+++++++||||++++|+.+.. ...|||.|.....
T Consensus 254 L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~~~p~~p~~~~~ 303 (345)
T 3a8x_A 254 LNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGE 303 (345)
T ss_dssp TCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCTT
T ss_pred hcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCCCCCc
Confidence 999999999742 2368999999999999987654 5678999886543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-56 Score=439.35 Aligned_cols=284 Identities=33% Similarity=0.596 Sum_probs=248.1
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
.....+++|++++.||+|+||+||+|+++.++. .||||++.+..... ......+.+|+++++.++||||++++++
T Consensus 35 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 109 (350)
T 1rdq_E 35 QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGN----HYAMKILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKLEFS 109 (350)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccCCCHHHCEEEEEeecCcCcEEEEEEECCCCC----EEEEEEEEhHHhcc-HHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 345778999999999999999999999987554 49999997765422 2234567789999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
+.+++.+|+|||||.||+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+
T Consensus 110 ~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~ 187 (350)
T 1rdq_E 110 FKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEcCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEccccc
Confidence 999999999999999999988887654 499999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
++... ....+.+||
T Consensus 188 a~~~~------------------------------------------------------------------~~~~~~~gt 201 (350)
T 1rdq_E 188 AKRVK------------------------------------------------------------------GRTWTLCGT 201 (350)
T ss_dssp CEECS------------------------------------------------------------------SCBCCCEEC
T ss_pred ceecc------------------------------------------------------------------CCcccccCC
Confidence 97541 112356899
Q ss_pred CCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCccC
Q 042539 252 EEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKRL 330 (412)
Q Consensus 252 ~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R~ 330 (412)
+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+.++......++ ..+.++.+||.+||+.||.+|+
T Consensus 202 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~ 281 (350)
T 1rdq_E 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRF 281 (350)
T ss_dssp GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCT
T ss_pred ccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhcc
Confidence 999999999999999999999999999999999999999999999999887766554 4689999999999999999999
Q ss_pred CCC-CChhhhhcCCCCCCCCchhhc-ccCCCCCCCCCCCc
Q 042539 331 GYL-RGACEIKEHVFFKGVRWDLLT-DVLRPPFIPSREEN 368 (412)
Q Consensus 331 ~~~-~~~~e~l~h~ff~~~~~~~~~-~~~~pp~~p~~~~~ 368 (412)
+.. .+++++++||||++++|+.+. ....|||.|.....
T Consensus 282 ~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p~~~~~ 321 (350)
T 1rdq_E 282 GNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGP 321 (350)
T ss_dssp TSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCST
T ss_pred CCccCCHHHHHhCcCcCCCCHHHHhhccCCCCCCCCCCCc
Confidence 642 348999999999999998664 46789999986654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-57 Score=452.97 Aligned_cols=284 Identities=35% Similarity=0.609 Sum_probs=238.8
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
.+..++|+++++||+|+||+||+|+++.++. .||||++++..... ......+.+|+.++..++||||++++++|+
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~----~vAiK~l~k~~~~~-~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQ----VYAMKIMNKWDMLK-RGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEEHHHHHH-HGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCC----EEEEEEEeHHHhhh-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 4678999999999999999999999987554 49999997754322 223345677999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
+.+.+|+|||||.||+|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCL 210 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhhe
Confidence 9999999999999999998887643 359999999999999999999999999999999999999999999999999997
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
..... ......+.+||+.
T Consensus 211 ~~~~~--------------------------------------------------------------~~~~~~~~~Gt~~ 228 (412)
T 2vd5_A 211 KLRAD--------------------------------------------------------------GTVRSLVAVGTPD 228 (412)
T ss_dssp ECCTT--------------------------------------------------------------SCEECSSCCSCGG
T ss_pred eccCC--------------------------------------------------------------CccccceeccccC
Confidence 54210 0112235689999
Q ss_pred Cccceeec-------CCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--CCC----CCCChHHHHHHHH
Q 042539 254 YVSPEVVR-------GDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT--PEF----VGQRTALTDLIQR 320 (412)
Q Consensus 254 Y~APE~l~-------~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~----~~~~~~~~dli~~ 320 (412)
|+|||++. +..|+.++|||||||++|||++|++||.+.+..+++.+++... ..+ ...++++++||.+
T Consensus 229 Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~ 308 (412)
T 2vd5_A 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQR 308 (412)
T ss_dssp GCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHT
T ss_pred cCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHH
Confidence 99999997 3568999999999999999999999999999998888887521 222 3578999999999
Q ss_pred hhhhCCCccCCCCCChhhhhcCCCCCCCCchhhcccCCCCCCCCCCCc
Q 042539 321 LLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREEN 368 (412)
Q Consensus 321 ~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~~~~~~~~pp~~p~~~~~ 368 (412)
||. +|.+|++. .+++++++||||++++|+.+.. ..|||.|.....
T Consensus 309 lL~-~p~~Rlgr-~~~~ei~~Hpff~~i~w~~l~~-~~~p~~p~~~~~ 353 (412)
T 2vd5_A 309 LLC-PPETRLGR-GGAGDFRTHPFFFGLDWDGLRD-SVPPFTPDFEGA 353 (412)
T ss_dssp TSS-CGGGCTTT-TTHHHHHTSGGGTTCCSTTSTT-SCCSCCCC----
T ss_pred HcC-ChhhcCCC-CCHHHHhcCCCcCCCCHHHHhh-cCCCCCCcCCCc
Confidence 999 99999853 3799999999999999998864 578999987554
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-57 Score=451.77 Aligned_cols=282 Identities=30% Similarity=0.565 Sum_probs=240.0
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
.+..++|+++++||+|+||+||+|+++.++. .||+|++++...... .....+.+|+.+++.++|||||+++++|+
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~----~~AiK~~~k~~~~~~-~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRK----VYAMKLLSKFEMIKR-SDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEHHHHHHT-CCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCc----EEEEEEEehhhhhhh-HHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 4677899999999999999999999987554 499999977543221 12334667999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
+++.+|+|||||.||+|..++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence 999999999999999998887643 49999999999999999999999999999999999999999999999999997
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
.+... ......+.+||+.
T Consensus 217 ~~~~~--------------------------------------------------------------~~~~~~~~~gt~~ 234 (410)
T 3v8s_A 217 KMNKE--------------------------------------------------------------GMVRCDTAVGTPD 234 (410)
T ss_dssp ECCTT--------------------------------------------------------------SEEECCSCCSCGG
T ss_pred eeccC--------------------------------------------------------------CcccccCCcCCcc
Confidence 54211 0112346789999
Q ss_pred CccceeecCCC----CCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-----CCCCCCCChHHHHHHHHhhhh
Q 042539 254 YVSPEVVRGDG----HEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK-----TPEFVGQRTALTDLIQRLLEK 324 (412)
Q Consensus 254 Y~APE~l~~~~----~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~-----~~~~~~~~~~~~dli~~~L~~ 324 (412)
|+|||++.+.. ++.++|||||||++|||++|++||.+.+..+++.+++.. .+.....++++++||.+||+.
T Consensus 235 Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~ 314 (410)
T 3v8s_A 235 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTD 314 (410)
T ss_dssp GCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSC
T ss_pred ccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccC
Confidence 99999998765 789999999999999999999999999999998888753 244456889999999999998
Q ss_pred CCCc--cCCCCCChhhhhcCCCCCCCCchhh-cccCCCCCCCCCCCch
Q 042539 325 DPVK--RLGYLRGACEIKEHVFFKGVRWDLL-TDVLRPPFIPSREEND 369 (412)
Q Consensus 325 dP~~--R~~~~~~~~e~l~h~ff~~~~~~~~-~~~~~pp~~p~~~~~~ 369 (412)
+|.+ |+ +++|+++||||++++|+.+ .....|||+|...+..
T Consensus 315 ~~~rlgR~----~~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~~~~~~ 358 (410)
T 3v8s_A 315 REVRLGRN----GVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDI 358 (410)
T ss_dssp GGGCTTSS----CHHHHHTSGGGCCSSCCSTTGGGSCCSCCCCCSSTT
T ss_pred hhhhCCCC----CHHHHhcCccccCCCHHHHhhcccCCCCCCcCCCcc
Confidence 8877 77 7999999999999999744 3356899999876543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-57 Score=454.05 Aligned_cols=283 Identities=32% Similarity=0.575 Sum_probs=239.6
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
.+..++|+++++||+|+||+||+|+++.++ +.||||++++...... .....+.+|+.++..++||||++++++|+
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~----~~vAvK~~~~~~~~~~-~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNAD----KVFAMKILNKWEMLKR-AETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEEEHHHHHHT-TTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCC----cEEEEEEEEHHHhhhH-HHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 466789999999999999999999998754 4599999977543221 22334677999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
+++.+|+|||||.||+|..++... .+.+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~ 223 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL 223 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhh
Confidence 999999999999999999887653 3459999999999999999999999999999999999999999999999999997
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
..... ........+||+.
T Consensus 224 ~~~~~--------------------------------------------------------------~~~~~~~~~GT~~ 241 (437)
T 4aw2_A 224 KLMED--------------------------------------------------------------GTVQSSVAVGTPD 241 (437)
T ss_dssp ECCTT--------------------------------------------------------------SCEECCSCCSCGG
T ss_pred hcccC--------------------------------------------------------------CCcccccccCCcC
Confidence 54211 1112235689999
Q ss_pred Cccceeec-----CCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-----CCCC-CCCChHHHHHHHHhh
Q 042539 254 YVSPEVVR-----GDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK-----TPEF-VGQRTALTDLIQRLL 322 (412)
Q Consensus 254 Y~APE~l~-----~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~-----~~~~-~~~~~~~~dli~~~L 322 (412)
|+|||++. +..|+.++|||||||++|||++|++||.+.+..+.+.+++.. .+.. ...++++++||.+||
T Consensus 242 Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL 321 (437)
T 4aw2_A 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLI 321 (437)
T ss_dssp GCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTS
T ss_pred eeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHh
Confidence 99999997 456899999999999999999999999999999988888642 1222 457899999999999
Q ss_pred hhCCCc--cCCCCCChhhhhcCCCCCCCCchhhcccCCCCCCCCCCCch
Q 042539 323 EKDPVK--RLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREEND 369 (412)
Q Consensus 323 ~~dP~~--R~~~~~~~~e~l~h~ff~~~~~~~~~~~~~pp~~p~~~~~~ 369 (412)
..+|.+ |+ +++|+++||||++++|+.+. ...|||+|...+..
T Consensus 322 ~~~~~r~~r~----~~~eil~Hpff~~i~w~~l~-~~~~p~~P~~~~~~ 365 (437)
T 4aw2_A 322 CSREHRLGQN----GIEDFKKHPFFSGIDWDNIR-NCEAPYIPEVSSPT 365 (437)
T ss_dssp SCGGGCTTTT----TTHHHHTSGGGTTCCTTTGG-GSCCSCCCCCSSTT
T ss_pred cccccccCCC----CHHHHhCCCccCCCCHHHHh-hCCCCCCCcCCCcc
Confidence 988777 76 69999999999999999885 46889999876544
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-56 Score=431.88 Aligned_cols=292 Identities=35% Similarity=0.661 Sum_probs=235.7
Q ss_pred CCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeee
Q 042539 11 TTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLG 90 (412)
Q Consensus 11 ~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 90 (412)
....+..++|++++.||+|+||+||+|++... ..+++.||+|++++............+.+|+.+++.++||||+++++
T Consensus 10 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 88 (327)
T 3a62_A 10 GPEKIRPECFELLRVLGKGGYGKVFQVRKVTG-ANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIY 88 (327)
T ss_dssp ---CCCGGGEEEEEEEEEETTEEEEEEEECSS-TTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEE
T ss_pred CCCCCCHHHeEEEEEEEeCCCEEEEEEEEecc-CCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeE
Confidence 34568889999999999999999999998532 22556699999987654333344566778999999999999999999
Q ss_pred eEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccc
Q 042539 91 SLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 91 ~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
++.+++.+|+|||||.||+|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 166 (327)
T 3a62_A 89 AFQTGGKLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFG 166 (327)
T ss_dssp EEECSSCEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCS
T ss_pred EEEcCCEEEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCC
Confidence 9999999999999999999988877654 48999999999999999999999999999999999999999999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+++.... ........+|
T Consensus 167 ~~~~~~~---------------------------------------------------------------~~~~~~~~~g 183 (327)
T 3a62_A 167 LCKESIH---------------------------------------------------------------DGTVTHTFCG 183 (327)
T ss_dssp CC-------------------------------------------------------------------------CTTSS
T ss_pred ccccccc---------------------------------------------------------------CCccccccCC
Confidence 9875321 1122345689
Q ss_pred CCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCcc
Q 042539 251 TEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKR 329 (412)
Q Consensus 251 t~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R 329 (412)
|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+.++......++ ..++++.+||.+||..||.+|
T Consensus 184 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dp~~R 263 (327)
T 3a62_A 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASR 263 (327)
T ss_dssp CCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCSCGGGS
T ss_pred CcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHHhcCHhhc
Confidence 9999999999999999999999999999999999999999999888888887665543 467999999999999999999
Q ss_pred CCCC-CChhhhhcCCCCCCCCchhh-cccCCCCCCCCCCCc
Q 042539 330 LGYL-RGACEIKEHVFFKGVRWDLL-TDVLRPPFIPSREEN 368 (412)
Q Consensus 330 ~~~~-~~~~e~l~h~ff~~~~~~~~-~~~~~pp~~p~~~~~ 368 (412)
++.. .+++++++||||++++|+.+ .....|||.|.....
T Consensus 264 ~~~~~~~~~e~l~hp~f~~~~~~~~~~~~~~~p~~p~~~~~ 304 (327)
T 3a62_A 264 LGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSE 304 (327)
T ss_dssp TTSSTTTHHHHHHSGGGSSCCHHHHHTTCSCCSCCCC----
T ss_pred cCCCCCCHHHHHcCCcccCCCHHHHhhccCCCCCCCCcCCh
Confidence 9764 37999999999999999865 445678898876543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-56 Score=441.13 Aligned_cols=284 Identities=28% Similarity=0.581 Sum_probs=240.7
Q ss_pred CCCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCcccee
Q 042539 9 PQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKL 88 (412)
Q Consensus 9 ~~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l 88 (412)
......+.+++|++++.||+|+||+||+|+++.++. .||||++.+...... .....+.+|+++|+.++|||||++
T Consensus 6 ~~~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~----~~AiK~~~~~~~~~~-~~~~~~~~E~~il~~l~hp~Iv~l 80 (384)
T 4fr4_A 6 FDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKK----MYAMKYMNKQKCVER-NEVRNVFKELQIMQGLEHPFLVNL 80 (384)
T ss_dssp --CCCCCCGGGEEEEEEEECCTTCCEEEEEETTTCC----EEEEEEEEHHHHHHT-TCHHHHHHHHHHHHTCCCTTBCCE
T ss_pred cCCCCCCChHHeEEEEEEeeCCCeEEEEEEECCCCC----EEEEEEEehhhcccH-HHHHHHHHHHHHHHhCCCCCCCcE
Confidence 345678899999999999999999999999987554 499999977654322 234567789999999999999999
Q ss_pred eeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcc
Q 042539 89 LGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTD 168 (412)
Q Consensus 89 ~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~D 168 (412)
+++|.+.+.+|+|||||.||+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|
T Consensus 81 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~D 158 (384)
T 4fr4_A 81 WYSFQDEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITD 158 (384)
T ss_dssp EEEEECSSEEEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECC
T ss_pred EEEEEeCCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEec
Confidence 99999999999999999999998877653 4599999999999999999999999999999999999999999999999
Q ss_pred ccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccc
Q 042539 169 FDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248 (412)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (412)
||+|+.+. ......+.
T Consensus 159 FG~a~~~~----------------------------------------------------------------~~~~~~~~ 174 (384)
T 4fr4_A 159 FNIAAMLP----------------------------------------------------------------RETQITTM 174 (384)
T ss_dssp CTTCEECC----------------------------------------------------------------TTCCBCCC
T ss_pred cceeeecc----------------------------------------------------------------CCCceecc
Confidence 99997542 12233467
Q ss_pred ccCCCCccceeecC---CCCCchhhHHHHHHHHHHHhhCCCCCCC---CCHHHHHHHHhcCCCCCC-CCChHHHHHHHHh
Q 042539 249 VGTEEYVSPEVVRG---DGHEFAVDWWALGILTYEMLYGTTPFRG---KNRKETFRNVLMKTPEFV-GQRTALTDLIQRL 321 (412)
Q Consensus 249 ~gt~~Y~APE~l~~---~~~~~~~DiwSlGvil~ell~g~~Pf~~---~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~ 321 (412)
+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+ ....+....+......++ ..++++.+||.+|
T Consensus 175 ~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~~li~~l 254 (384)
T 4fr4_A 175 AGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKL 254 (384)
T ss_dssp CSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred CCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHHHHHHHH
Confidence 89999999999974 4589999999999999999999999975 344555555555544443 5689999999999
Q ss_pred hhhCCCccCCCCCChhhhhcCCCCCCCCchhh-cccCCCCCCCCCC
Q 042539 322 LEKDPVKRLGYLRGACEIKEHVFFKGVRWDLL-TDVLRPPFIPSRE 366 (412)
Q Consensus 322 L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~~~-~~~~~pp~~p~~~ 366 (412)
|+.||.+|++ +++++++||||++++|+.+ .....|||+|...
T Consensus 255 L~~dP~~R~s---~~~~l~~hp~f~~~~w~~~~~~~~~p~~~p~~~ 297 (384)
T 4fr4_A 255 LEPNPDQRFS---QLSDVQNFPYMNDINWDAVFQKRLIPGFIPNKG 297 (384)
T ss_dssp SCSSGGGSCC---SHHHHHTSGGGTTCCHHHHHTTCSCCCCCCSCC
T ss_pred hcCCHhHhcc---cHHHHHcChhhhcCCHHHHHhCCCCCCCCCCCC
Confidence 9999999996 5899999999999999855 4467899998753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-57 Score=442.82 Aligned_cols=262 Identities=23% Similarity=0.343 Sum_probs=216.9
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCC-CCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCC-Cccceeee
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADP-TARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH-PFLPKLLG 90 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~ 90 (412)
+++..++|+++++||+|+||+||+|++...+. .+.+.||||+++.... ....+.+.+|+++|+++.| ||||++++
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~---~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT---HSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC---HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC---hHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 46788999999999999999999999876543 3445699999976532 2345678889999999975 89999999
Q ss_pred eEEe-CCeEEEEeeccCCCCchhHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCc
Q 042539 91 SLET-DEFLAWAVPYCPGGDLNVLRYKQN--------------DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPEN 155 (412)
Q Consensus 91 ~~~~-~~~~~lv~e~~~gg~L~~~~~~~~--------------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~N 155 (412)
++.+ ++.+|||||||.||+|..++.... ...+++.++..++.||+.||+|||+++||||||||+|
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~N 215 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 215 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccc
Confidence 9865 467999999999999999987532 2348999999999999999999999999999999999
Q ss_pred eEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCcccc
Q 042539 156 ILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRR 235 (412)
Q Consensus 156 iLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (412)
||++.++.+||+|||+|+.+....
T Consensus 216 ILl~~~~~vKi~DFGlar~~~~~~-------------------------------------------------------- 239 (353)
T 4ase_A 216 ILLSEKNVVKICDFGLARDIYKDP-------------------------------------------------------- 239 (353)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCT--------------------------------------------------------
T ss_pred eeeCCCCCEEECcchhhhhcccCC--------------------------------------------------------
Confidence 999999999999999998653211
Q ss_pred ccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHH-HHHhcCC-CCC-CCCC
Q 042539 236 QQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETF-RNVLMKT-PEF-VGQR 311 (412)
Q Consensus 236 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~-~~i~~~~-~~~-~~~~ 311 (412)
......+.+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..+.+ ..+..+. +.. ..++
T Consensus 240 -----~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~ 314 (353)
T 4ase_A 240 -----DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTT 314 (353)
T ss_dssp -----TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCC
T ss_pred -----CceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCC
Confidence 1112345689999999999999999999999999999999998 99999987644444 3333322 222 3568
Q ss_pred hHHHHHHHHhhhhCCCccCCCCCChhhhhcC
Q 042539 312 TALTDLIQRLLEKDPVKRLGYLRGACEIKEH 342 (412)
Q Consensus 312 ~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h 342 (412)
+++.+||.+||+.||++|| ++.++++|
T Consensus 315 ~~~~~li~~c~~~dP~~RP----t~~eil~~ 341 (353)
T 4ase_A 315 PEMYQTMLDCWHGEPSQRP----TFSELVEH 341 (353)
T ss_dssp HHHHHHHHHHTCSSGGGSC----CHHHHHHH
T ss_pred HHHHHHHHHHcCcChhHCc----CHHHHHHH
Confidence 9999999999999999999 68999876
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-56 Score=471.19 Aligned_cols=285 Identities=31% Similarity=0.613 Sum_probs=246.4
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeeee
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLGS 91 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~ 91 (412)
..+.+++|+++++||+|+||+||+|+++.++. .||||++++...... .....+.+|+.++..+ +|+||++++++
T Consensus 336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~----~vAvK~l~~~~~~~~-~~~~~~~~E~~~l~~~~~~~~i~~l~~~ 410 (674)
T 3pfq_A 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDE----LYAVKILKKDVVIQD-DDVECTMVEKRVLALPGKPPFLTQLHSC 410 (674)
T ss_dssp ----CTTEEEEEESSBTTTBCEEEEEESSSCC----EEEEEEEEHHHHHHT-TTTHHHHHHHHHHTCTTCCTTBCCEEEE
T ss_pred ccccccceEEEEEEccCCCEEEEEEEECCCCc----EEEEEEEeccccccH-HHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence 35678999999999999999999999987554 499999987654322 2345667799999998 59999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
|++.+.+|||||||.||+|..++.... .+++.+++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+
T Consensus 411 ~~~~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGl 488 (674)
T 3pfq_A 411 FQTMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM 488 (674)
T ss_dssp CBCSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTT
T ss_pred EEeCCEEEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecce
Confidence 999999999999999999988887654 499999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
|+... .......+++||
T Consensus 489 a~~~~---------------------------------------------------------------~~~~~~~~~~GT 505 (674)
T 3pfq_A 489 CKENI---------------------------------------------------------------WDGVTTKTFCGT 505 (674)
T ss_dssp CEECC---------------------------------------------------------------CTTCCBCCCCSC
T ss_pred eeccc---------------------------------------------------------------cCCcccccccCC
Confidence 97531 112234567999
Q ss_pred CCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCccC
Q 042539 252 EEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKRL 330 (412)
Q Consensus 252 ~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R~ 330 (412)
+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+++..|+.....++ ..++++.+||.+||++||++|+
T Consensus 506 ~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~ 585 (674)
T 3pfq_A 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRL 585 (674)
T ss_dssp SSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHHHHSCSSSTTCT
T ss_pred CcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHccCCHHHCC
Confidence 999999999999999999999999999999999999999999999999998776665 4689999999999999999999
Q ss_pred CCC-CChhhhhcCCCCCCCCchhhcc-cCCCCCCCCCCC
Q 042539 331 GYL-RGACEIKEHVFFKGVRWDLLTD-VLRPPFIPSREE 367 (412)
Q Consensus 331 ~~~-~~~~e~l~h~ff~~~~~~~~~~-~~~pp~~p~~~~ 367 (412)
++. .+++++++||||++++|+.+.. ...|||.|....
T Consensus 586 ~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~~~ 624 (674)
T 3pfq_A 586 GCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKASG 624 (674)
T ss_dssp TCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBCCG
T ss_pred CCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcCCC
Confidence 752 3469999999999999997754 568999998654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-55 Score=450.19 Aligned_cols=286 Identities=31% Similarity=0.595 Sum_probs=245.1
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
..+..++|+++++||+|+||+||+|+++.++. .||||++.+...... .....+.+|+++++.++||||++++++|
T Consensus 180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~----~vAiK~l~k~~~~~~-~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 254 (543)
T 3c4z_A 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGK----LYACKKLNKKRLKKR-KGYQGAMVEKKILAKVHSRFIVSLAYAF 254 (543)
T ss_dssp SCCCGGGEEEEEEEEECSSSEEEEEEETTTCC----EEEEEEEEHHHHHHT-TCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCChhheEEEEEEeeCCCeEEEEEEECCCCc----EEEEEEEEhHHhhhh-HHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 45778999999999999999999999987554 499999987654322 2345677899999999999999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQN--DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~--~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
++.+.+|+|||||.||+|..++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||
T Consensus 255 ~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFG 334 (543)
T 3c4z_A 255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLG 334 (543)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred eeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecc
Confidence 99999999999999999988876543 3469999999999999999999999999999999999999999999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+++.+.. ......+++|
T Consensus 335 la~~~~~---------------------------------------------------------------~~~~~~~~~G 351 (543)
T 3c4z_A 335 LAVELKA---------------------------------------------------------------GQTKTKGYAG 351 (543)
T ss_dssp TCEECCT---------------------------------------------------------------TCCCBCCCCS
T ss_pred eeeeccC---------------------------------------------------------------CCcccccccC
Confidence 9975421 1112335689
Q ss_pred CCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCC----CHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhC
Q 042539 251 TEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGK----NRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKD 325 (412)
Q Consensus 251 t~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~----~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~d 325 (412)
|+.|+|||++.+..|+.++|||||||++|||++|++||.+. ...+....+......++ ..++++.+||.+||++|
T Consensus 352 T~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~d 431 (543)
T 3c4z_A 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKD 431 (543)
T ss_dssp CTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSS
T ss_pred CccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCHHHHHHHHHhccCC
Confidence 99999999999999999999999999999999999999875 45667777776655543 56899999999999999
Q ss_pred CCccCCCCC-ChhhhhcCCCCCCCCchhhcc-cCCCCCCCCCC
Q 042539 326 PVKRLGYLR-GACEIKEHVFFKGVRWDLLTD-VLRPPFIPSRE 366 (412)
Q Consensus 326 P~~R~~~~~-~~~e~l~h~ff~~~~~~~~~~-~~~pp~~p~~~ 366 (412)
|++|+++.. +++++++||||++++|+.+.. ...|||.|...
T Consensus 432 P~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~pp~~P~~~ 474 (543)
T 3c4z_A 432 PEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSR 474 (543)
T ss_dssp GGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSCCSCCCCSS
T ss_pred HhHCCCCcccCHHHHHcCccccCCCHHHHHcCCCCCCCCCCcc
Confidence 999998643 589999999999999997755 56899998754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-55 Score=443.90 Aligned_cols=287 Identities=36% Similarity=0.670 Sum_probs=237.8
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
...+..++|++++.||+|+||+||+|+++.++. .||||++++..... ......+.+|+.+++.++||||++++++
T Consensus 142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~l~~~ 216 (446)
T 4ejn_A 142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGR----YYAMKILKKEVIVA-KDEVAHTLTENRVLQNSRHPFLTALKYS 216 (446)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEHHHHC--------------CCCCCSCTTSCCEEEE
T ss_pred ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCC----EEEEEEEEhhhhhh-hHHHHHHHHHHHHHHhCCCCeEeeEEEE
Confidence 456788999999999999999999999987554 49999997764422 2344566779999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeeCCCCceEEccCCCEEEcccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN-MGIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
+.+.+.+|+|||||.||+|..++.... .+++..++.++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||
T Consensus 217 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG 294 (446)
T 4ejn_A 217 FQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFG 294 (446)
T ss_dssp EEETTEEEEEECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCC
T ss_pred EeeCCEEEEEEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCC
Confidence 999999999999999999988876654 49999999999999999999998 999999999999999999999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+|+.... ......+.+|
T Consensus 295 ~a~~~~~---------------------------------------------------------------~~~~~~~~~g 311 (446)
T 4ejn_A 295 LCKEGIK---------------------------------------------------------------DGATMKTFCG 311 (446)
T ss_dssp CCCTTCC--------------------------------------------------------------------CCSSS
T ss_pred CceeccC---------------------------------------------------------------CCcccccccC
Confidence 9975321 1122345789
Q ss_pred CCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCcc
Q 042539 251 TEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKR 329 (412)
Q Consensus 251 t~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R 329 (412)
|+.|+|||++.+..++.++|||||||++|||++|+.||.+.+....+..+......++ ..++++.+||.+||+.||.+|
T Consensus 312 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 391 (446)
T 4ejn_A 312 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQR 391 (446)
T ss_dssp CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTS
T ss_pred CccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccCHHHh
Confidence 9999999999999999999999999999999999999999999998888887666554 468999999999999999999
Q ss_pred CCCC-CChhhhhcCCCCCCCCchhh-cccCCCCCCCCCCCc
Q 042539 330 LGYL-RGACEIKEHVFFKGVRWDLL-TDVLRPPFIPSREEN 368 (412)
Q Consensus 330 ~~~~-~~~~e~l~h~ff~~~~~~~~-~~~~~pp~~p~~~~~ 368 (412)
++.. .+++++++||||++++|+.+ .....|||.|...+.
T Consensus 392 ~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p~~~~~ 432 (446)
T 4ejn_A 392 LGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSE 432 (446)
T ss_dssp TTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCSST
T ss_pred CCCCCCCHHHHHhCccccCCCHHHHhhCcCCCCccCCCCCc
Confidence 9543 37999999999999999865 446788999886554
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-55 Score=452.34 Aligned_cols=285 Identities=35% Similarity=0.606 Sum_probs=243.4
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
..+..++|+++++||+|+||+||+|+++.++. .||||++.+...... .....+.+|+++|+.++|||||++++++
T Consensus 179 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~----~vAvK~l~k~~~~~~-~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 253 (576)
T 2acx_A 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGK----MYACKKLEKKRIKKR-KGEAMALNEKQILEKVNSRFVVSLAYAY 253 (576)
T ss_dssp SCCCGGGEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEHHHHHHT-TCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCccccceEEEEEEeeCCCEEEEEEEECCCCC----EEEEEEEEhHhhhhh-HHHHHHHHHHHHHHHcCCCCEeeEEEEE
Confidence 34778999999999999999999999987554 499999987654322 2345677899999999999999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
++++.+|+|||||.||+|..++.......+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|
T Consensus 254 ~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla 333 (576)
T 2acx_A 254 ETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA 333 (576)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccc
Confidence 99999999999999999998887665556999999999999999999999999999999999999999999999999999
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+.+.. +....+.+||+
T Consensus 334 ~~~~~----------------------------------------------------------------~~~~~~~~GT~ 349 (576)
T 2acx_A 334 VHVPE----------------------------------------------------------------GQTIKGRVGTV 349 (576)
T ss_dssp EECCT----------------------------------------------------------------TCCEECCCSCG
T ss_pred eeccc----------------------------------------------------------------CccccccCCCc
Confidence 75421 11223458999
Q ss_pred CCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCC----CHHHHHHHHhcCCCCC-CCCChHHHHHHHHhhhhCCC
Q 042539 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGK----NRKETFRNVLMKTPEF-VGQRTALTDLIQRLLEKDPV 327 (412)
Q Consensus 253 ~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~----~~~~~~~~i~~~~~~~-~~~~~~~~dli~~~L~~dP~ 327 (412)
.|+|||++.+..++.++|||||||++|||++|++||.+. ....+...+......+ ...++++++||.+||+.||.
T Consensus 350 ~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~dLI~~lL~~dP~ 429 (576)
T 2acx_A 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPA 429 (576)
T ss_dssp GGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred cccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHHHHHHHhccCCHH
Confidence 999999999999999999999999999999999999875 3455566665544444 34689999999999999999
Q ss_pred ccCCCC-CChhhhhcCCCCCCCCchhhcc-cCCCCCCCCCC
Q 042539 328 KRLGYL-RGACEIKEHVFFKGVRWDLLTD-VLRPPFIPSRE 366 (412)
Q Consensus 328 ~R~~~~-~~~~e~l~h~ff~~~~~~~~~~-~~~pp~~p~~~ 366 (412)
+|+++. .+++|+++||||++++|+.+.. ...|||.|...
T Consensus 430 ~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~~pp~~p~~~ 470 (576)
T 2acx_A 430 ERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQ 470 (576)
T ss_dssp GSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred HcCCCCCCCHHHHHhChhhccCCHHHHhcCCCCCCCCCCcc
Confidence 999753 2689999999999999997754 56899998753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-54 Score=418.70 Aligned_cols=263 Identities=27% Similarity=0.450 Sum_probs=230.5
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
.....+++|++++.||+|+||+||+|++..++. .||||++.+.... ....+++.+|+++++.++||||++++++
T Consensus 9 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 82 (328)
T 3fe3_A 9 DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGR----EVAIKIIDKTQLN--PTSLQKLFREVRIMKILNHPNIVKLFEV 82 (328)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEGGGSC--HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCccCCEEEEEEEeeCCCEEEEEEEECCCCC----EEEEEEEEhhcCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 345678999999999999999999999987554 4999999776542 3445677889999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
+.+.+.+|+|||||.||+|..++.... .+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus 83 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 160 (328)
T 3fe3_A 83 IETEKTLYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGF 160 (328)
T ss_dssp EECSSEEEEEECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTC
T ss_pred EEECCEEEEEEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccC
Confidence 999999999999999999988877654 499999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
++... .+......+||
T Consensus 161 a~~~~----------------------------------------------------------------~~~~~~~~~gt 176 (328)
T 3fe3_A 161 SNEFT----------------------------------------------------------------VGGKLDAFCGA 176 (328)
T ss_dssp CGGGS----------------------------------------------------------------SSCGGGTTSSS
T ss_pred ceecC----------------------------------------------------------------CCCccccccCC
Confidence 97542 11223456899
Q ss_pred CCCccceeecCCCC-CchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCcc
Q 042539 252 EEYVSPEVVRGDGH-EFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKR 329 (412)
Q Consensus 252 ~~Y~APE~l~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R 329 (412)
+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+....+.......+ ..++++.+||.+||+.||.+|
T Consensus 177 ~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 256 (328)
T 3fe3_A 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKR 256 (328)
T ss_dssp GGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHCCSSTTTS
T ss_pred cceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHCCCChhHC
Confidence 99999999999887 4899999999999999999999999999998888887765554 468999999999999999999
Q ss_pred CCCCCChhhhhcCCCCCCCCc
Q 042539 330 LGYLRGACEIKEHVFFKGVRW 350 (412)
Q Consensus 330 ~~~~~~~~e~l~h~ff~~~~~ 350 (412)
| +++++++||||+...+
T Consensus 257 ~----t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 257 G----TLEQIMKDRWINAGHE 273 (328)
T ss_dssp C----CHHHHTTCTTTTTTCT
T ss_pred c----CHHHHhcCHhhcCCCc
Confidence 9 7999999999987554
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-54 Score=424.02 Aligned_cols=265 Identities=26% Similarity=0.416 Sum_probs=230.4
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhh--HHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAK--HEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
-..++|++++.||+|+||+||+|+++.++. .||+|++++...... ......+.+|+.+|+.++||||++++++|
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~----~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 84 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGL----EYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY 84 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCC----EEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE
Confidence 345689999999999999999999987554 499999987654221 11245677899999999999999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCC----CEEEcc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG----HVTLTD 168 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g----~vkL~D 168 (412)
.+.+.+|+|||||.||+|..++... +.+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 85 ENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EeCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 9999999999999999998887543 4599999999999999999999999999999999999998887 799999
Q ss_pred ccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccc
Q 042539 169 FDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248 (412)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (412)
||+++.+.. .......
T Consensus 163 FG~a~~~~~----------------------------------------------------------------~~~~~~~ 178 (361)
T 2yab_A 163 FGLAHEIED----------------------------------------------------------------GVEFKNI 178 (361)
T ss_dssp CSSCEECCT----------------------------------------------------------------TCCCCCC
T ss_pred cCCceEcCC----------------------------------------------------------------CCccccC
Confidence 999975421 1223456
Q ss_pred ccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-----CCCChHHHHHHHHhhh
Q 042539 249 VGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF-----VGQRTALTDLIQRLLE 323 (412)
Q Consensus 249 ~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~dli~~~L~ 323 (412)
+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+.++......+ ...++.+++||.+||.
T Consensus 179 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 258 (361)
T 2yab_A 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLV 258 (361)
T ss_dssp CSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSC
T ss_pred CCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCC
Confidence 89999999999999999999999999999999999999999999999998888766544 3578899999999999
Q ss_pred hCCCccCCCCCChhhhhcCCCCCCCCchhh
Q 042539 324 KDPVKRLGYLRGACEIKEHVFFKGVRWDLL 353 (412)
Q Consensus 324 ~dP~~R~~~~~~~~e~l~h~ff~~~~~~~~ 353 (412)
.||.+|| +++++++||||++++|...
T Consensus 259 ~dP~~R~----t~~e~l~hp~~~~~~~~~~ 284 (361)
T 2yab_A 259 KETRKRL----TIQEALRHPWITPVDTQQA 284 (361)
T ss_dssp SSTTTSC----CHHHHHTSTTTSCSSHHHH
T ss_pred CChhHCc----CHHHHhcCcCcCCCchhhh
Confidence 9999999 6999999999999998643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=412.37 Aligned_cols=293 Identities=41% Similarity=0.722 Sum_probs=237.3
Q ss_pred CCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceee
Q 042539 11 TTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLL 89 (412)
Q Consensus 11 ~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~ 89 (412)
....+.+++|++++.||+|+||+||+|++.. +..+++.||||++++............+.+|+++++.+ +||||++++
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 125 (355)
T 1vzo_A 47 HAEKVGIENFELLKVLGTGAYGKVFLVRKIS-GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH 125 (355)
T ss_dssp CCCCCCGGGEEEEEEEEETTTEEEEEEEECS-STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEE
T ss_pred ccccccccceEEEEEeccCCCEEEEEEEEcc-cCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEE
Confidence 4456778999999999999999999999853 22356679999997654322222234455699999999 699999999
Q ss_pred eeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccc
Q 042539 90 GSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169 (412)
Q Consensus 90 ~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DF 169 (412)
+++.+++.+|+|||||.||+|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+||
T Consensus 126 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Df 203 (355)
T 1vzo_A 126 YAFQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDF 203 (355)
T ss_dssp EEEEETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCS
T ss_pred EEEeeCceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeC
Confidence 99999999999999999999998887654 4999999999999999999999999999999999999999999999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|+++.+.... .......+
T Consensus 204 G~a~~~~~~~--------------------------------------------------------------~~~~~~~~ 221 (355)
T 1vzo_A 204 GLSKEFVADE--------------------------------------------------------------TERAYDFC 221 (355)
T ss_dssp SEEEECCGGG--------------------------------------------------------------GGGGCGGG
T ss_pred CCCeecccCC--------------------------------------------------------------CCcccCcc
Confidence 9997652111 11123568
Q ss_pred cCCCCccceeecCC--CCCchhhHHHHHHHHHHHhhCCCCCCCC----CHHHHHHHHhcCCCCC-CCCChHHHHHHHHhh
Q 042539 250 GTEEYVSPEVVRGD--GHEFAVDWWALGILTYEMLYGTTPFRGK----NRKETFRNVLMKTPEF-VGQRTALTDLIQRLL 322 (412)
Q Consensus 250 gt~~Y~APE~l~~~--~~~~~~DiwSlGvil~ell~g~~Pf~~~----~~~~~~~~i~~~~~~~-~~~~~~~~dli~~~L 322 (412)
||+.|+|||++.+. .++.++|||||||++|+|++|+.||... ........+....+.+ ...+..+.+||.+||
T Consensus 222 gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 301 (355)
T 1vzo_A 222 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLL 301 (355)
T ss_dssp SCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred cCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcccCHHHHHHHHHHh
Confidence 99999999999863 4689999999999999999999999753 3445555555544443 456789999999999
Q ss_pred hhCCCccCCCC-CChhhhhcCCCCCCCCchhhcc-cCCCCCCCCCCCc
Q 042539 323 EKDPVKRLGYL-RGACEIKEHVFFKGVRWDLLTD-VLRPPFIPSREEN 368 (412)
Q Consensus 323 ~~dP~~R~~~~-~~~~e~l~h~ff~~~~~~~~~~-~~~pp~~p~~~~~ 368 (412)
..||.+||++. .+++++++|+||++++|+.+.. ...+||.|...+.
T Consensus 302 ~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~~~~~p~~p~~~~~ 349 (355)
T 1vzo_A 302 MKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDE 349 (355)
T ss_dssp CSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC-
T ss_pred hhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhccCCCCCCCccccc
Confidence 99999999653 3799999999999999986655 4567888876543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=404.53 Aligned_cols=264 Identities=26% Similarity=0.423 Sum_probs=227.3
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhh--HHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAK--HEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
...++|++++.||+|+||+||+|+++.++. .||+|++++...... ......+.+|+.+++.++||||+++++++
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 83 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGL----QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY 83 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCC----EEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCc----EEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 345789999999999999999999987554 499999977543211 11245677899999999999999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCC----CEEEcc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG----HVTLTD 168 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g----~vkL~D 168 (412)
.+...+|+|||||.||+|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 84 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 84 ENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred EeCCEEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 9999999999999999998887543 4599999999999999999999999999999999999999888 799999
Q ss_pred ccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccc
Q 042539 169 FDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248 (412)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (412)
||+++.... .......
T Consensus 162 fg~a~~~~~----------------------------------------------------------------~~~~~~~ 177 (326)
T 2y0a_A 162 FGLAHKIDF----------------------------------------------------------------GNEFKNI 177 (326)
T ss_dssp CTTCEECCT----------------------------------------------------------------TSCCCCC
T ss_pred CCCCeECCC----------------------------------------------------------------CCccccc
Confidence 999975421 1122345
Q ss_pred ccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-----CCCChHHHHHHHHhhh
Q 042539 249 VGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF-----VGQRTALTDLIQRLLE 323 (412)
Q Consensus 249 ~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~dli~~~L~ 323 (412)
+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......+ ...+..+.+||.+||+
T Consensus 178 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 257 (326)
T 2y0a_A 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLV 257 (326)
T ss_dssp CSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSC
T ss_pred cCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHcc
Confidence 79999999999999999999999999999999999999999999888888777654443 3568899999999999
Q ss_pred hCCCccCCCCCChhhhhcCCCCCCCCchh
Q 042539 324 KDPVKRLGYLRGACEIKEHVFFKGVRWDL 352 (412)
Q Consensus 324 ~dP~~R~~~~~~~~e~l~h~ff~~~~~~~ 352 (412)
.||.+|| +++++++||||++.+|..
T Consensus 258 ~dP~~Rp----t~~e~l~hp~~~~~~~~~ 282 (326)
T 2y0a_A 258 KDPKKRM----TIQDSLQHPWIKPKDTQQ 282 (326)
T ss_dssp SSGGGSC----CHHHHHHSTTTSCCSHHH
T ss_pred CChhhCC----CHHHHhcCCCccCCcchh
Confidence 9999999 699999999999988753
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-53 Score=406.82 Aligned_cols=248 Identities=21% Similarity=0.237 Sum_probs=190.4
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
.++|.+.++||+|+||+||+|+++ ++.||||+++.... ......+|+..+.+++|||||++++++.+++
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~~------g~~VAvK~l~~~~~-----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~ 70 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKWR------GEEVAVKIFSSREE-----RSWFREAEIYQTVMLRHENILGFIAADNKDN 70 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET------TEEEEEEEECGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC------CEEEEEEEECccch-----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecC
Confidence 367999999999999999999874 24599999965432 1122334777778899999999999998654
Q ss_pred ----eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHc--------CceeeeCCCCceEEccCCCE
Q 042539 97 ----FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNM--------GIAYRDLKPENILIRQSGHV 164 (412)
Q Consensus 97 ----~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~--------~iiHrDlKp~NiLl~~~g~v 164 (412)
.+|||||||+||+|..++... .++++.+..++.|++.||+|||++ +||||||||+|||++.+|.+
T Consensus 71 ~~~~~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~ 147 (303)
T 3hmm_A 71 GTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 147 (303)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred CCceEEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCE
Confidence 689999999999999988653 389999999999999999999987 99999999999999999999
Q ss_pred EEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCC
Q 042539 165 TLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGER 244 (412)
Q Consensus 165 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (412)
||+|||+|+....... .....
T Consensus 148 Ki~DFGla~~~~~~~~-----------------------------------------------------------~~~~~ 168 (303)
T 3hmm_A 148 CIADLGLAVRHDSATD-----------------------------------------------------------TIDIA 168 (303)
T ss_dssp EECCCTTCEEEETTTT-----------------------------------------------------------EESCC
T ss_pred EEEeCCCCccccCCCC-----------------------------------------------------------ceeee
Confidence 9999999986532110 01112
Q ss_pred CcccccCCCCccceeecCC------CCCchhhHHHHHHHHHHHhhCCCCCCCC---------------CHHHHHHHHhcC
Q 042539 245 SNSFVGTEEYVSPEVVRGD------GHEFAVDWWALGILTYEMLYGTTPFRGK---------------NRKETFRNVLMK 303 (412)
Q Consensus 245 ~~~~~gt~~Y~APE~l~~~------~~~~~~DiwSlGvil~ell~g~~Pf~~~---------------~~~~~~~~i~~~ 303 (412)
..+.+||+.|||||++.+. .++.++|||||||++|||+||.+||... ...+....+...
T Consensus 169 ~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 248 (303)
T 3hmm_A 169 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ 248 (303)
T ss_dssp -----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTS
T ss_pred cccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcc
Confidence 3356899999999999765 3578999999999999999998766421 223333333332
Q ss_pred C--CCCCC------CChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 304 T--PEFVG------QRTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 304 ~--~~~~~------~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
. +..+. ..+.+.+||.+||+.||++|| |+.|+++
T Consensus 249 ~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RP----t~~ei~~ 290 (303)
T 3hmm_A 249 KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL----TALRIKK 290 (303)
T ss_dssp CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSC----CHHHHHH
T ss_pred cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCc----CHHHHHH
Confidence 2 22222 124688999999999999999 6788775
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=413.41 Aligned_cols=283 Identities=27% Similarity=0.390 Sum_probs=211.0
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEE
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLE 93 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~ 93 (412)
...++|++++.||+|+||+||+|.++.++. .||||++.+... .....+++.+|+.+++.+. ||||+++++++.
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~i~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~ 79 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGE----VVAVKKIFDAFQ--NSTDAQRTFREIMILTELSGHENIVNLLNVLR 79 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCC----EEEEEEECC--C--CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCC----EEEEEEeccccc--ChHHHHHHHHHHHHHHhccCCCCCCeeeeEEe
Confidence 346899999999999999999999987554 499999965432 2344567778999999997 999999999998
Q ss_pred eCC--eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 94 TDE--FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 94 ~~~--~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
..+ .+|+|||||. ++|..++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus 80 ~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 155 (388)
T 3oz6_A 80 ADNDRDVYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGL 155 (388)
T ss_dssp CTTSSCEEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred cCCCCEEEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcc
Confidence 654 7999999997 5787776542 499999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
|+.+....... . +.. ....................+||
T Consensus 156 a~~~~~~~~~~---------------~---------------------~~~------~~~~~~~~~~~~~~~~~~~~~gt 193 (388)
T 3oz6_A 156 SRSFVNIRRVT---------------N---------------------NIP------LSINENTENFDDDQPILTDYVAT 193 (388)
T ss_dssp CEESSSCCCCC---------------C---------------------CGG------GCCC---------------CCCG
T ss_pred ccccccccccc---------------c---------------------ccc------ccccccccccccccccccCCccc
Confidence 98653211000 0 000 00000000000112334567899
Q ss_pred CCCccceeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CC-----------------------
Q 042539 252 EEYVSPEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK--TP----------------------- 305 (412)
Q Consensus 252 ~~Y~APE~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~~----------------------- 305 (412)
+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+.+..++.. .+
T Consensus 194 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 273 (388)
T 3oz6_A 194 RWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEK 273 (388)
T ss_dssp GGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHH
T ss_pred CCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCccc
Confidence 99999999987 56899999999999999999999999999988877766521 11
Q ss_pred -----------------------CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCchhh
Q 042539 306 -----------------------EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLL 353 (412)
Q Consensus 306 -----------------------~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~~~ 353 (412)
.....++++.+||.+||+.||.+|+ +++|+++||||+.......
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~----t~~e~l~Hp~~~~~~~~~~ 340 (388)
T 3oz6_A 274 VEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI----SANDALKHPFVSIFHNPNE 340 (388)
T ss_dssp CC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSC----CHHHHTTSTTTTTTCCGGG
T ss_pred ccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCC----CHHHHhCCHHHHHhcCCcc
Confidence 0115678999999999999999999 7999999999987665433
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-53 Score=411.14 Aligned_cols=259 Identities=29% Similarity=0.450 Sum_probs=218.6
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
...+++|++++.||+|+||+||+|++..++. .||||++.+..... ......+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 79 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQ----KVALKFISRQLLKK-SDMHMRVEREISYLKLLRHPHIIKLYDVIT 79 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEHHHHHH-TTCSHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCC----EEEEEEEehHHccc-hhHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 4567899999999999999999999977554 49999997654322 223456778999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
+.+.+|+||||+ +|+|..++.... .+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++
T Consensus 80 ~~~~~~lv~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~ 156 (336)
T 3h4j_B 80 TPTDIVMVIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSN 156 (336)
T ss_dssp CSSEEEEEECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTB
T ss_pred eCCEEEEEEECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccce
Confidence 999999999999 778877766554 49999999999999999999999999999999999999999999999999997
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
... .+....+.+||+.
T Consensus 157 ~~~----------------------------------------------------------------~~~~~~~~~gt~~ 172 (336)
T 3h4j_B 157 IMT----------------------------------------------------------------DGNFLKTSCGSPN 172 (336)
T ss_dssp TTT----------------------------------------------------------------TSBTTCCCTTSTT
T ss_pred ecc----------------------------------------------------------------CCcccccccCCcC
Confidence 542 1122345689999
Q ss_pred CccceeecCCCC-CchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCccCC
Q 042539 254 YVSPEVVRGDGH-EFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKRLG 331 (412)
Q Consensus 254 Y~APE~l~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R~~ 331 (412)
|+|||++.+..+ +.++|||||||++|+|++|+.||.+......+..+.......+ ..++++.+||.+||+.||.+||
T Consensus 173 y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rp- 251 (336)
T 3h4j_B 173 YAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRI- 251 (336)
T ss_dssp TSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSC-
T ss_pred cCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCc-
Confidence 999999998876 7899999999999999999999988665444443333333333 3678999999999999999999
Q ss_pred CCCChhhhhcCCCCCCC
Q 042539 332 YLRGACEIKEHVFFKGV 348 (412)
Q Consensus 332 ~~~~~~e~l~h~ff~~~ 348 (412)
+++|+++||||+..
T Consensus 252 ---t~~eil~hp~~~~~ 265 (336)
T 3h4j_B 252 ---TIQEIRRDPWFNVN 265 (336)
T ss_dssp ---CHHHHTTCHHHHTT
T ss_pred ---CHHHHHhChhhccC
Confidence 79999999999853
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-52 Score=397.92 Aligned_cols=255 Identities=27% Similarity=0.396 Sum_probs=219.8
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
..++|++++.||+|+||+||+|++..++. .||||++....... ...+.+|+.+++.++||||+++++++.++
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQ----EVAIRQMNLQQQPK----KELIINEILVMRENKNPNIVNYLDSYLVG 89 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCC----EEEEEEEEGGGCSC----HHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCc----EEEEEEeecccccH----HHHHHHHHHHHhcCCCCCCCeEeEEEEEC
Confidence 45789999999999999999999877554 49999997654322 34567799999999999999999999999
Q ss_pred CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchh
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
+.+|+|||||.||+|..++... .+++.+++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (297)
T 3fxz_A 90 DELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (297)
T ss_dssp TEEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CEEEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceec
Confidence 9999999999999999887653 3999999999999999999999999999999999999999999999999998754
Q ss_pred hchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCc
Q 042539 176 VKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYV 255 (412)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 255 (412)
.. ........+||+.|+
T Consensus 167 ~~---------------------------------------------------------------~~~~~~~~~gt~~y~ 183 (297)
T 3fxz_A 167 TP---------------------------------------------------------------EQSKRSTMVGTPYWM 183 (297)
T ss_dssp CS---------------------------------------------------------------TTCCBCCCCSCGGGC
T ss_pred CC---------------------------------------------------------------cccccCCccCCcCcc
Confidence 21 111233568999999
Q ss_pred cceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-CC---CCCCChHHHHHHHHhhhhCCCccCC
Q 042539 256 SPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT-PE---FVGQRTALTDLIQRLLEKDPVKRLG 331 (412)
Q Consensus 256 APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-~~---~~~~~~~~~dli~~~L~~dP~~R~~ 331 (412)
|||++.+..++.++|||||||++|+|++|..||.+.+.......+.... +. ....++.+.+||.+||+.||++||
T Consensus 184 aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp- 262 (297)
T 3fxz_A 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRG- 262 (297)
T ss_dssp CHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSC-
T ss_pred ChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCc-
Confidence 9999999999999999999999999999999999988777666555332 22 234678999999999999999999
Q ss_pred CCCChhhhhcCCCCCCC
Q 042539 332 YLRGACEIKEHVFFKGV 348 (412)
Q Consensus 332 ~~~~~~e~l~h~ff~~~ 348 (412)
+++++++||||+..
T Consensus 263 ---s~~ell~h~~~~~~ 276 (297)
T 3fxz_A 263 ---SAKELLQHQFLKIA 276 (297)
T ss_dssp ---CHHHHTTCGGGGGC
T ss_pred ---CHHHHhhChhhccc
Confidence 69999999999854
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-52 Score=419.18 Aligned_cols=257 Identities=27% Similarity=0.439 Sum_probs=222.7
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
..++|++++.||+|+||+||+|.++.++. .||+|++.+.... ....+.+.+|+.+++.++|||||++++++.++
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~----~~a~K~i~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 82 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQ----EYAAMIINTKKLS--ARDHQKLEREARICRLLKHPNIVRLHDSISEE 82 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTE----EEEEEEEESCSCH--HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCc----EEEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC
Confidence 45789999999999999999999887554 4999999876543 23456678899999999999999999999999
Q ss_pred CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEc---cCCCEEEcccccc
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIR---QSGHVTLTDFDLS 172 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~---~~g~vkL~DFGla 172 (412)
+.+|+|||||.||+|...+.... .+++.++..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|
T Consensus 83 ~~~~lv~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 83 GHHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp SEEEEEECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred CEEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 99999999999999988776654 499999999999999999999999999999999999998 4578999999999
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+.... ........+||+
T Consensus 161 ~~~~~---------------------------------------------------------------~~~~~~~~~gt~ 177 (444)
T 3soa_A 161 IEVEG---------------------------------------------------------------EQQAWFGFAGTP 177 (444)
T ss_dssp BCCCT---------------------------------------------------------------TCCBCCCSCSCG
T ss_pred EEecC---------------------------------------------------------------CCceeecccCCc
Confidence 75421 111223568999
Q ss_pred CCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-----CCCChHHHHHHHHhhhhCCC
Q 042539 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF-----VGQRTALTDLIQRLLEKDPV 327 (412)
Q Consensus 253 ~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~dli~~~L~~dP~ 327 (412)
.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+......+ ...++++.+||.+||+.||.
T Consensus 178 ~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 257 (444)
T 3soa_A 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPS 257 (444)
T ss_dssp GGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTT
T ss_pred ccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChh
Confidence 9999999999999999999999999999999999999999999888887665433 45789999999999999999
Q ss_pred ccCCCCCChhhhhcCCCCCC
Q 042539 328 KRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 328 ~R~~~~~~~~e~l~h~ff~~ 347 (412)
+|| ++.++++||||+.
T Consensus 258 ~Rp----ta~e~L~hp~~~~ 273 (444)
T 3soa_A 258 KRI----TAAEALKHPWISH 273 (444)
T ss_dssp TSC----CHHHHHHSCTTHH
T ss_pred HCC----CHHHHhcCccccC
Confidence 999 7999999999964
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=402.51 Aligned_cols=267 Identities=25% Similarity=0.383 Sum_probs=215.4
Q ss_pred CCCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCcccee
Q 042539 9 PQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKL 88 (412)
Q Consensus 9 ~~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l 88 (412)
.....+--.++|++++.||+|+||+||+|++.. ++.||+|++..... .......+.+|+++++.++||||+++
T Consensus 12 ~~~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~ 84 (311)
T 3niz_A 12 ENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQ-----GRIVALKRIRLDAE--DEGIPSTAIREISLLKELHHPNIVSL 84 (311)
T ss_dssp ---CEECSSCEEEEEEEEEECSSCEEEEEEETT-----SCEEEEEEEC--------CHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cceeecchHhhhHhhhhccCCCCeEEEEEEECC-----CCEEEEEEEecccc--cchhhHHHHHHHHHHHHcCCCCEeee
Confidence 344566778999999999999999999999853 34599999976532 22345667789999999999999999
Q ss_pred eeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcc
Q 042539 89 LGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTD 168 (412)
Q Consensus 89 ~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~D 168 (412)
++++.+++.+|+|||||.| +|..++... ...+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~D 162 (311)
T 3niz_A 85 IDVIHSERCLTLVFEFMEK-DLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLAD 162 (311)
T ss_dssp EEEECCSSCEEEEEECCSE-EHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECC
T ss_pred eeEEccCCEEEEEEcCCCC-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEcc
Confidence 9999999999999999986 665555443 34599999999999999999999999999999999999999999999999
Q ss_pred ccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccc
Q 042539 169 FDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248 (412)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (412)
||+++..... .......
T Consensus 163 fg~a~~~~~~---------------------------------------------------------------~~~~~~~ 179 (311)
T 3niz_A 163 FGLARAFGIP---------------------------------------------------------------VRSYTHE 179 (311)
T ss_dssp CTTCEETTSC---------------------------------------------------------------CC---CC
T ss_pred CcCceecCCC---------------------------------------------------------------cccccCC
Confidence 9999754210 1112244
Q ss_pred ccCCCCccceeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhc---CCC-------------------
Q 042539 249 VGTEEYVSPEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLM---KTP------------------- 305 (412)
Q Consensus 249 ~gt~~Y~APE~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~---~~~------------------- 305 (412)
+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.. ...
T Consensus 180 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (311)
T 3niz_A 180 VVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQ 259 (311)
T ss_dssp CCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCC
T ss_pred cccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccc
Confidence 78999999999987 4579999999999999999999999998776665555432 110
Q ss_pred ---------CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCch
Q 042539 306 ---------EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 306 ---------~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~ 351 (412)
..+..++++.+||.+||+.||.+|| +++|+++||||++++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp----t~~ell~hp~f~~~~~~ 310 (311)
T 3niz_A 260 VFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRI----SARDAMNHPYFKDLDPQ 310 (311)
T ss_dssp CCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSC----CHHHHHTSGGGTTSCTT
T ss_pred cccCCcHHHhCcccCHHHHHHHHHHcCCChhHCC----CHHHHhcCcccccCCcc
Confidence 0123567899999999999999999 79999999999998764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-52 Score=409.54 Aligned_cols=255 Identities=27% Similarity=0.435 Sum_probs=222.1
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
.++|++++.||+|+||+||+|.++.++. .||+|++.+.... ....+.+.+|+.+++.++||||+++++++.+++
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~~avK~~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 101 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGL----EFAAKIINTKKLS--ARDFQKLEREARICRKLQHPNIVRLHDSIQEES 101 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEETTTCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCC----EEEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence 4689999999999999999999887554 4999999776542 234566788999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCC---CEEEccccccc
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG---HVTLTDFDLSR 173 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g---~vkL~DFGla~ 173 (412)
.+|+|||||.||+|..++... ..+++.++..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 102 FHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp EEEEEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 999999999999998776543 4599999999999999999999999999999999999998654 59999999997
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
... ........+||+.
T Consensus 180 ~~~----------------------------------------------------------------~~~~~~~~~gt~~ 195 (362)
T 2bdw_A 180 EVN----------------------------------------------------------------DSEAWHGFAGTPG 195 (362)
T ss_dssp CCT----------------------------------------------------------------TCCSCCCSCSCTT
T ss_pred Eec----------------------------------------------------------------CCcccccCCCCcc
Confidence 542 1112235689999
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-----CCCChHHHHHHHHhhhhCCCc
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF-----VGQRTALTDLIQRLLEKDPVK 328 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~dli~~~L~~dP~~ 328 (412)
|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+......+ ...++++.+||.+||+.||.+
T Consensus 196 y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 275 (362)
T 2bdw_A 196 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKK 275 (362)
T ss_dssp TCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGG
T ss_pred ccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhh
Confidence 999999999999999999999999999999999999999888888887665443 346889999999999999999
Q ss_pred cCCCCCChhhhhcCCCCCC
Q 042539 329 RLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 329 R~~~~~~~~e~l~h~ff~~ 347 (412)
|| ++.++++||||..
T Consensus 276 R~----t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 276 RI----TADQALKVPWICN 290 (362)
T ss_dssp SC----CHHHHTTSHHHHT
T ss_pred Cc----CHHHHhcCcccCC
Confidence 99 6999999999974
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-52 Score=395.93 Aligned_cols=257 Identities=26% Similarity=0.417 Sum_probs=212.6
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
+++|++++.||+|+||+||+|+++.++. .||+|++..... .......+.+|+.++++++||||+++++++.+++
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 74 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHE----IVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSDK 74 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCC----EEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCc----eEEEEeeeccCC--cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCC
Confidence 5799999999999999999999987554 499999976543 2234456778999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
.+|+|||||.|+.+. .+.. ..+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 75 ~~~lv~e~~~~~l~~-~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 152 (292)
T 3o0g_A 75 KLTLVFEFCDQDLKK-YFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG 152 (292)
T ss_dssp EEEEEEECCSEEHHH-HHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEecCCCCHHH-HHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecC
Confidence 999999999875444 3333 23469999999999999999999999999999999999999999999999999997542
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
. ........+||+.|+|
T Consensus 153 ~---------------------------------------------------------------~~~~~~~~~~t~~y~a 169 (292)
T 3o0g_A 153 I---------------------------------------------------------------PVRCYSAEVVTLWYRP 169 (292)
T ss_dssp S---------------------------------------------------------------CCSCCCSCCSCGGGCC
T ss_pred C---------------------------------------------------------------ccccccCCccccCCcC
Confidence 1 1112234578999999
Q ss_pred ceeecCCC-CCchhhHHHHHHHHHHHhhCCCC-CCCCCHHHHHHHHhcC--CC---------------------------
Q 042539 257 PEVVRGDG-HEFAVDWWALGILTYEMLYGTTP-FRGKNRKETFRNVLMK--TP--------------------------- 305 (412)
Q Consensus 257 PE~l~~~~-~~~~~DiwSlGvil~ell~g~~P-f~~~~~~~~~~~i~~~--~~--------------------------- 305 (412)
||++.+.. ++.++|||||||++|+|++|..| |.+.+..+.+..+... .+
T Consensus 170 PE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (292)
T 3o0g_A 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLV 249 (292)
T ss_dssp HHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCT
T ss_pred hHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchh
Confidence 99998766 79999999999999999987666 6777777766665431 00
Q ss_pred -CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCC
Q 042539 306 -EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 306 -~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~ 348 (412)
..+..++++++||.+||+.||++|| +++|+++||||+++
T Consensus 250 ~~~~~~~~~~~~li~~~L~~dP~~R~----t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 250 NVVPKLNATGRDLLQNLLKCNPVQRI----SAEEALQHPYFSDF 289 (292)
T ss_dssp TTSTTCCHHHHHHHHHHSCSSGGGSC----CHHHHHTSGGGTTC
T ss_pred hcccccChHHHHHHHHHhccChhhCC----CHHHHhcCcccccC
Confidence 0124568899999999999999999 79999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-52 Score=411.65 Aligned_cols=275 Identities=20% Similarity=0.279 Sum_probs=223.4
Q ss_pred CCCCCccCceeeeeeecc--CceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceee
Q 042539 12 TPSLDLDNLKALKILGKG--AMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLL 89 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G--~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~ 89 (412)
......++|++++.||+| +||+||+|+++.++. .||||++++... .......+.+|+.+++.++|||||+++
T Consensus 19 ~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~----~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~ 92 (389)
T 3gni_B 19 SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGE----YVTVRRINLEAC--SNEMVTFLQGELHVSKLFNHPNIVPYR 92 (389)
T ss_dssp CCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCC----EEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccCCCCcEEEEecccCCcCCceEEEEEEEcCCCC----EEEEEEeccccc--ChHHHHHHHHHHHHHHhCCCCCCCcEe
Confidence 445678899999999999 999999999987554 499999977653 234567788899999999999999999
Q ss_pred eeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccc
Q 042539 90 GSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169 (412)
Q Consensus 90 ~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DF 169 (412)
+++.+++.+|+|||||.||+|..++.......+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+||
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~df 172 (389)
T 3gni_B 93 ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGL 172 (389)
T ss_dssp EEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCG
T ss_pred EEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccc
Confidence 99999999999999999999999888765566999999999999999999999999999999999999999999999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|++......... ...........+
T Consensus 173 g~~~~~~~~~~~--------------------------------------------------------~~~~~~~~~~~~ 196 (389)
T 3gni_B 173 RSNLSMISHGQR--------------------------------------------------------QRVVHDFPKYSV 196 (389)
T ss_dssp GGCEECEETTEE--------------------------------------------------------CSCBCCCCTTCT
T ss_pred ccceeecccccc--------------------------------------------------------cccccccccccc
Confidence 998754321100 000111223457
Q ss_pred cCCCCccceeecC--CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-----------------------
Q 042539 250 GTEEYVSPEVVRG--DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT----------------------- 304 (412)
Q Consensus 250 gt~~Y~APE~l~~--~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~----------------------- 304 (412)
||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......++...
T Consensus 197 gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (389)
T 3gni_B 197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSV 276 (389)
T ss_dssp TTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------------------------
T ss_pred ccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccc
Confidence 9999999999988 578999999999999999999999998865544433322111
Q ss_pred ------------------------CCCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCchh
Q 042539 305 ------------------------PEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDL 352 (412)
Q Consensus 305 ------------------------~~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~~ 352 (412)
+.....++++.+||.+||+.||++|| +++|+++||||+++.|..
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp----ta~ell~hp~f~~~~~~~ 344 (389)
T 3gni_B 277 ANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP----SASTLLNHSFFKQIKRRA 344 (389)
T ss_dssp -----------------------------CCHHHHHHHHHHTCSCTTTSC----CHHHHTTSGGGGGC---C
T ss_pred cccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCC----CHHHHhcCHHHHHHhhcc
Confidence 01223568899999999999999999 699999999999888753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=404.14 Aligned_cols=254 Identities=25% Similarity=0.375 Sum_probs=222.9
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
.++|++++.||+|+||+||+|.++.++ +.||+|++.... .....+.+|+.+++.++||||+++++++.+.+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~~a~K~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 74 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSK----KTYMAKFVKVKG-----TDQVLVKKEISILNIARHRNILHLHESFESME 74 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEECCCT-----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCC----cEEEEEEEecCc-----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC
Confidence 579999999999999999999988754 449999996542 22345678999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEcc--CCCEEEccccccch
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQ--SGHVTLTDFDLSRN 174 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~--~g~vkL~DFGla~~ 174 (412)
.+|+|||||.||+|..++... ...+++.++..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~ 153 (321)
T 1tki_A 75 ELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEEEEEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence 999999999999998877543 245999999999999999999999999999999999999997 78999999999975
Q ss_pred hhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCC
Q 042539 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254 (412)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 254 (412)
+.. +......+||+.|
T Consensus 154 ~~~----------------------------------------------------------------~~~~~~~~gt~~y 169 (321)
T 1tki_A 154 LKP----------------------------------------------------------------GDNFRLLFTAPEY 169 (321)
T ss_dssp CCT----------------------------------------------------------------TCEEEEEESCGGG
T ss_pred CCC----------------------------------------------------------------CCccccccCChhh
Confidence 421 1122345799999
Q ss_pred ccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-----CCCChHHHHHHHHhhhhCCCcc
Q 042539 255 VSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF-----VGQRTALTDLIQRLLEKDPVKR 329 (412)
Q Consensus 255 ~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~dli~~~L~~dP~~R 329 (412)
+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+.++......+ ...+.++.+||.+||..||.+|
T Consensus 170 ~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R 249 (321)
T 1tki_A 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSR 249 (321)
T ss_dssp SCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGS
T ss_pred cCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHC
Confidence 99999999888999999999999999999999999999999888888766544 3678999999999999999999
Q ss_pred CCCCCChhhhhcCCCCCCC
Q 042539 330 LGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 330 ~~~~~~~~e~l~h~ff~~~ 348 (412)
| ++.|+++||||+..
T Consensus 250 p----t~~e~l~hp~~~~~ 264 (321)
T 1tki_A 250 M----TASEALQHPWLKQK 264 (321)
T ss_dssp C----CHHHHHHSHHHHSC
T ss_pred c----CHHHHhcChhhccC
Confidence 9 79999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-52 Score=418.79 Aligned_cols=292 Identities=23% Similarity=0.339 Sum_probs=203.9
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC-
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD- 95 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~- 95 (412)
.++|++++.||+|+||+||+|+++.++. .||||++.+... .....+++.+|+.+|+.++|||||++++++...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~i~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 125 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKR----VVAIKKILRVFE--DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD 125 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--C----EEEEEEECSTTS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCc----EEEEEEechhhc--CHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence 4789999999999999999999987554 499999966432 234466788899999999999999999999543
Q ss_pred ----CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 96 ----EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 96 ----~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
..+|+||||+ +++|..++... ..+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+
T Consensus 126 ~~~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 126 VEKFDELYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp TTTCCCEEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred cccCceEEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeeccccc
Confidence 5799999998 56887776543 4599999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
|+.......... ..+..+.... . ..................+||
T Consensus 203 a~~~~~~~~~~~------~~~~~~~~~~---------------------~---------~~~~~~~~~~~~~~~~~~~gt 246 (458)
T 3rp9_A 203 ARTVDYPENGNS------QLPISPREDD---------------------M---------NLVTFPHTKNLKRQLTGHVVT 246 (458)
T ss_dssp CBCTTSCTTCCC------CCC---------------------------------------------------------CC
T ss_pred chhccCcccccc------ccccCccccc---------------------c---------ccccccccccccccccCCccc
Confidence 987632211000 0000000000 0 000000000111234567899
Q ss_pred CCCccceee-cCCCCCchhhHHHHHHHHHHHhh-----------CCCCCCCCCH--------------------HHHHHH
Q 042539 252 EEYVSPEVV-RGDGHEFAVDWWALGILTYEMLY-----------GTTPFRGKNR--------------------KETFRN 299 (412)
Q Consensus 252 ~~Y~APE~l-~~~~~~~~~DiwSlGvil~ell~-----------g~~Pf~~~~~--------------------~~~~~~ 299 (412)
+.|+|||++ .+..|+.++||||||||+|||++ |+++|.+.+. .+.+..
T Consensus 247 ~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 326 (458)
T 3rp9_A 247 RWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNV 326 (458)
T ss_dssp CTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHH
T ss_pred ccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHH
Confidence 999999986 45678999999999999999998 8888877542 122222
Q ss_pred Hhc--CC------------------------------CCCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCC
Q 042539 300 VLM--KT------------------------------PEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 300 i~~--~~------------------------------~~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
+.. +. ..++..++++.+||.+||+.||++|+ +++|+++||||++
T Consensus 327 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~----t~~e~L~Hp~f~~ 402 (458)
T 3rp9_A 327 IFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRI----TINECLAHPFFKE 402 (458)
T ss_dssp HHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSC----CHHHHHHSGGGTT
T ss_pred HHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccC----CHHHHhcCHhhhh
Confidence 210 00 11345688999999999999999999 7999999999999
Q ss_pred CCchhhcccC
Q 042539 348 VRWDLLTDVL 357 (412)
Q Consensus 348 ~~~~~~~~~~ 357 (412)
++|.......
T Consensus 403 ~~~~~~e~~~ 412 (458)
T 3rp9_A 403 VRIAEVETNA 412 (458)
T ss_dssp TCCGGGCCCC
T ss_pred cCCCccCCCC
Confidence 9998765543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-52 Score=403.80 Aligned_cols=264 Identities=25% Similarity=0.368 Sum_probs=211.2
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
.....+++|++++.||+|+||+||+|++..++ +.||||+++.... .......+.+|+.+++.++||||++++++
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 101 (329)
T 3gbz_A 28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTN----ETVAIKRIRLEHE--EEGVPGTAIREVSLLKELQHRNIIELKSV 101 (329)
T ss_dssp ----CGGGEEEEEEEEECSSSEEEEEEETTTT----EEEEEEECCCCC----------CHHHHHHGGGCCCTTBCCEEEE
T ss_pred CcccchhhEEEEEEEEecCCeEEEEEEECCCC----ceEEEEEEccccc--ccccchhHHHHHHHHHHcCCCCcceEEEE
Confidence 45677899999999999999999999988754 4599999976542 23345566789999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEc-----cCCCEEE
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIR-----QSGHVTL 166 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~-----~~g~vkL 166 (412)
+.+++.+|+|||||.| +|..++.... .+++.+++.++.||+.||.|||++||+||||||+|||++ ..+.+||
T Consensus 102 ~~~~~~~~lv~e~~~~-~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl 178 (329)
T 3gbz_A 102 IHHNHRLHLIFEYAEN-DLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKI 178 (329)
T ss_dssp EEETTEEEEEEECCSE-EHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEE
T ss_pred EecCCEEEEEEecCCC-CHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEE
Confidence 9999999999999975 8877776543 499999999999999999999999999999999999995 4455999
Q ss_pred ccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCc
Q 042539 167 TDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSN 246 (412)
Q Consensus 167 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (412)
+|||+++..... .....
T Consensus 179 ~Dfg~a~~~~~~---------------------------------------------------------------~~~~~ 195 (329)
T 3gbz_A 179 GDFGLARAFGIP---------------------------------------------------------------IRQFT 195 (329)
T ss_dssp CCTTHHHHHC----------------------------------------------------------------------
T ss_pred CcCCCccccCCc---------------------------------------------------------------ccccC
Confidence 999999765211 11123
Q ss_pred ccccCCCCccceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CCC---C-------------
Q 042539 247 SFVGTEEYVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK--TPE---F------------- 307 (412)
Q Consensus 247 ~~~gt~~Y~APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~~~---~------------- 307 (412)
..+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+.++... .+. +
T Consensus 196 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (329)
T 3gbz_A 196 HEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSF 275 (329)
T ss_dssp ----CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred CCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhh
Confidence 44789999999999875 4799999999999999999999999999888777666531 110 0
Q ss_pred C-------------CCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCch
Q 042539 308 V-------------GQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 308 ~-------------~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~ 351 (412)
+ ..++++.+||.+||+.||.+|| +++|+++||||++.+|+
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~----t~~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 276 PKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRI----SAKNALEHPYFSHNDFD 328 (329)
T ss_dssp CCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSC----CHHHHHTSGGGSSSCSC
T ss_pred hhhccccHhhhcccccCHHHHHHHHHHccCChhhCC----CHHHHhCCcccCCCCCC
Confidence 0 1568899999999999999999 69999999999999985
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-52 Score=405.99 Aligned_cols=264 Identities=26% Similarity=0.438 Sum_probs=220.5
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhh-HHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAK-HEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
+..++|++++.||+|+||+||+|+++.++. .||||++.+...... ......+.+|+.+++.++||||+++++++.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 96 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQ----QFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS 96 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCC----EEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 334689999999999999999999987554 499999976543211 112456778999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCC---EEEcc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQ--NDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGH---VTLTD 168 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~---vkL~D 168 (412)
+++.+|+|||||.||+|..++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|
T Consensus 97 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~D 176 (351)
T 3c0i_A 97 SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGG 176 (351)
T ss_dssp ETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECC
T ss_pred eCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEec
Confidence 999999999999999997665543 2335899999999999999999999999999999999999987655 99999
Q ss_pred ccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccc
Q 042539 169 FDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248 (412)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (412)
||+++.... ........
T Consensus 177 fg~a~~~~~---------------------------------------------------------------~~~~~~~~ 193 (351)
T 3c0i_A 177 FGVAIQLGE---------------------------------------------------------------SGLVAGGR 193 (351)
T ss_dssp CTTCEECCT---------------------------------------------------------------TSCBCCCC
T ss_pred CcceeEecC---------------------------------------------------------------CCeeecCC
Confidence 999975421 11112355
Q ss_pred ccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-----CCCChHHHHHHHHhhh
Q 042539 249 VGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF-----VGQRTALTDLIQRLLE 323 (412)
Q Consensus 249 ~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~dli~~~L~ 323 (412)
+||+.|+|||++.+..++.++|||||||++|+|++|..||.+. ..+.+..+....... ...++++.+||.+||.
T Consensus 194 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 272 (351)
T 3c0i_A 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLM 272 (351)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTC
T ss_pred cCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCC
Confidence 7999999999999999999999999999999999999999885 455666666554333 4578999999999999
Q ss_pred hCCCccCCCCCChhhhhcCCCCCCCCc
Q 042539 324 KDPVKRLGYLRGACEIKEHVFFKGVRW 350 (412)
Q Consensus 324 ~dP~~R~~~~~~~~e~l~h~ff~~~~~ 350 (412)
.||++|| ++.++++||||++.++
T Consensus 273 ~dP~~R~----s~~e~l~hp~~~~~~~ 295 (351)
T 3c0i_A 273 LDPAERI----TVYEALNHPWLKERDR 295 (351)
T ss_dssp SSTTTSC----CHHHHHTSHHHHTHHH
T ss_pred CChhHCc----CHHHHhcChhhcCCcc
Confidence 9999999 6999999999987543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-52 Score=395.65 Aligned_cols=260 Identities=28% Similarity=0.456 Sum_probs=213.8
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhh----------------------HHHHHHH
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAK----------------------HEAERRA 70 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~----------------------~~~~~~~ 70 (412)
..+.+++|++++.||+|+||+||+|++..++ +.||||++.+...... ......+
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (298)
T 2zv2_A 8 DCVQLNQYTLKDEIGKGSYGVVKLAYNENDN----TYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQV 83 (298)
T ss_dssp --CEETTEEEEEEEEC--CCEEEEEEETTTT----EEEEEEEEECC-------------------------------CHH
T ss_pred CceeecceEEEeEEeecCCEEEEEEEECCCC----cEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHH
Confidence 4567899999999999999999999987754 4599999976543211 1123567
Q ss_pred HHHHHHHhhcCCCccceeeeeEEe--CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCcee
Q 042539 71 RWEIRVLSRLSHPFLPKLLGSLET--DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAY 148 (412)
Q Consensus 71 ~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiH 148 (412)
.+|+++++.++||||+++++++.+ ++.+|+|||||.|++|..+.. ...+++.+++.++.||+.||+|||++||+|
T Consensus 84 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH 160 (298)
T 2zv2_A 84 YQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQKIIH 160 (298)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 789999999999999999999987 568999999999999976543 345999999999999999999999999999
Q ss_pred eeCCCCceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccC
Q 042539 149 RDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSAR 228 (412)
Q Consensus 149 rDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (412)
|||||+|||++.+|.+||+|||+++.+...
T Consensus 161 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-------------------------------------------------- 190 (298)
T 2zv2_A 161 RDIKPSNLLVGEDGHIKIADFGVSNEFKGS-------------------------------------------------- 190 (298)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCEECSSS--------------------------------------------------
T ss_pred cCCCHHHEEECCCCCEEEecCCCccccccc--------------------------------------------------
Confidence 999999999999999999999999754210
Q ss_pred CCCccccccccCCCCCCcccccCCCCccceeecCCC---CCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC
Q 042539 229 VSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDG---HEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP 305 (412)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~---~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~ 305 (412)
.......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 191 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 257 (298)
T 2zv2_A 191 -------------DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQAL 257 (298)
T ss_dssp -------------SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred -------------cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccC
Confidence 11123457999999999998765 37899999999999999999999999887777777665443
Q ss_pred C---CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCC
Q 042539 306 E---FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346 (412)
Q Consensus 306 ~---~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~ 346 (412)
. ....++++.+||.+||..||.+|| ++.++++||||+
T Consensus 258 ~~~~~~~~~~~l~~li~~~l~~dp~~R~----s~~e~l~hp~~~ 297 (298)
T 2zv2_A 258 EFPDQPDIAEDLKDLITRMLDKNPESRI----VVPEIKLHPWVT 297 (298)
T ss_dssp CCCSSSCCCHHHHHHHHHHTCSCTTTSC----CHHHHTTCHHHH
T ss_pred CCCCccccCHHHHHHHHHHhhcChhhCC----CHHHHhcCcccc
Confidence 3 345789999999999999999999 699999999985
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-51 Score=405.98 Aligned_cols=260 Identities=29% Similarity=0.454 Sum_probs=223.5
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
....++|++++.||+|+||+||+|.++.++. .||+|++.+... .....+.+|+.+++.++||||+++++++.
T Consensus 47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~----~~a~K~~~~~~~----~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 118 (387)
T 1kob_A 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGR----VFVAKFINTPYP----LDKYTVKNEISIMNQLHHPKLINLHDAFE 118 (387)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEECCSH----HHHHHHHHHHHHHTTCCSTTBCCEEEEEE
T ss_pred CccccceEEEEEEecCCCEEEEEEEECCCCC----EEEEEEecccch----hhHHHHHHHHHHHHhCCCcCCCeEEEEEE
Confidence 3445899999999999999999999987554 499999976532 22346778999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEcc--CCCEEEccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQ--SGHVTLTDFDL 171 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~--~g~vkL~DFGl 171 (412)
+...+|+|||||.||+|..++... ...+++.+++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||+
T Consensus 119 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~ 197 (387)
T 1kob_A 119 DKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL 197 (387)
T ss_dssp CSSEEEEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEeccc
Confidence 999999999999999998776543 345999999999999999999999999999999999999974 47899999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
++.... .......+||
T Consensus 198 a~~~~~----------------------------------------------------------------~~~~~~~~gt 213 (387)
T 1kob_A 198 ATKLNP----------------------------------------------------------------DEIVKVTTAT 213 (387)
T ss_dssp CEECCT----------------------------------------------------------------TSCEEEECSS
T ss_pred ceecCC----------------------------------------------------------------CcceeeeccC
Confidence 975421 1112345799
Q ss_pred CCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC-----CCCCChHHHHHHHHhhhhCC
Q 042539 252 EEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE-----FVGQRTALTDLIQRLLEKDP 326 (412)
Q Consensus 252 ~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~-----~~~~~~~~~dli~~~L~~dP 326 (412)
+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+.++...... +...++++.+||.+||..||
T Consensus 214 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 293 (387)
T 1kob_A 214 AEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEP 293 (387)
T ss_dssp GGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSG
T ss_pred CCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCCh
Confidence 9999999999999999999999999999999999999999988888887765432 24568999999999999999
Q ss_pred CccCCCCCChhhhhcCCCCCCCCc
Q 042539 327 VKRLGYLRGACEIKEHVFFKGVRW 350 (412)
Q Consensus 327 ~~R~~~~~~~~e~l~h~ff~~~~~ 350 (412)
.+|| ++.++++||||++..+
T Consensus 294 ~~Rp----t~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 294 RKRL----TVHDALEHPWLKGDHS 313 (387)
T ss_dssp GGSC----CHHHHHTSTTTSSCCT
T ss_pred hHCc----CHHHHhhCccccCCcc
Confidence 9999 7999999999997654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=404.68 Aligned_cols=255 Identities=28% Similarity=0.441 Sum_probs=206.3
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
....++|++++.||+|+||+||+|+++.++. .||||++.+.... ...+.+|+.+++.++||||+++++++.
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~ 86 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKE----LVAVKYIERGAAI-----DENVQREIINHRSLRHPNIVRFKEVIL 86 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCC----EEEEEEEESSTTS-----CHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCc----EEEEEEEecCccc-----cHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 5567899999999999999999999987554 4999999765432 234567999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCC--EEEccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGH--VTLTDFDL 171 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~--vkL~DFGl 171 (412)
+.+.+|+|||||.||+|..++.... .+++.+++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+
T Consensus 87 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~ 164 (361)
T 3uc3_A 87 TPTHLAIIMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY 164 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCC
T ss_pred eCCEEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCc
Confidence 9999999999999999988876654 4999999999999999999999999999999999999988765 99999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
|+.... .......+||
T Consensus 165 a~~~~~----------------------------------------------------------------~~~~~~~~gt 180 (361)
T 3uc3_A 165 SKSSVL----------------------------------------------------------------HSQPKSTVGT 180 (361)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred cccccc----------------------------------------------------------------cCCCCCCcCC
Confidence 864311 1112345799
Q ss_pred CCCccceeecCCCCCc-hhhHHHHHHHHHHHhhCCCCCCCCCH----HHHHHHHhcCCCC---CCCCChHHHHHHHHhhh
Q 042539 252 EEYVSPEVVRGDGHEF-AVDWWALGILTYEMLYGTTPFRGKNR----KETFRNVLMKTPE---FVGQRTALTDLIQRLLE 323 (412)
Q Consensus 252 ~~Y~APE~l~~~~~~~-~~DiwSlGvil~ell~g~~Pf~~~~~----~~~~~~i~~~~~~---~~~~~~~~~dli~~~L~ 323 (412)
+.|+|||++.+..++. ++|||||||++|+|++|+.||.+.+. ......+...... ....++++++||.+||+
T Consensus 181 ~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~ 260 (361)
T 3uc3_A 181 PAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFV 260 (361)
T ss_dssp CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSC
T ss_pred CCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHcc
Confidence 9999999999888754 49999999999999999999987543 4445555544333 33568999999999999
Q ss_pred hCCCccCCCCCChhhhhcCCCCCC
Q 042539 324 KDPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 324 ~dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
.||.+|| ++.++++||||..
T Consensus 261 ~dP~~Rp----s~~ell~hp~f~~ 280 (361)
T 3uc3_A 261 ADPATRI----SIPEIKTHSWFLK 280 (361)
T ss_dssp SCTTTSC----CHHHHHTSHHHHT
T ss_pred CChhHCc----CHHHHHhCcchhc
Confidence 9999999 6999999999954
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=391.99 Aligned_cols=256 Identities=25% Similarity=0.402 Sum_probs=210.1
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
+++|++++.||+|+||+||+|++. + ++.||+|++...... ......+.+|+++++.++||||+++++++.+++
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~-~----~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQNN-Y----GETFALKKIRLEKED--EGIPSTTIREISILKELKHSNIVKLYDVIHTKK 73 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-T----SCEEEEEEECCSSGG--GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS
T ss_pred CccchhhhhcccCCCEEEEEEEcC-C----CCEEEEEEEeccccc--cccchhHHHHHHHHHhcCCCCEeeeeeEEccCC
Confidence 479999999999999999999883 2 345999999765422 222345667999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
.+|+||||+.| +|..++... .+.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 74 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 151 (288)
T 1ob3_A 74 RLVLVFEHLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFG 151 (288)
T ss_dssp CEEEEEECCSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred eEEEEEEecCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccC
Confidence 99999999976 777666543 3459999999999999999999999999999999999999999999999999997642
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
.. .......+||+.|+|
T Consensus 152 ~~---------------------------------------------------------------~~~~~~~~~t~~y~a 168 (288)
T 1ob3_A 152 IP---------------------------------------------------------------VRKYTHEIVTLWYRA 168 (288)
T ss_dssp C------------------------------------------------------------------------CCCTTCC
T ss_pred cc---------------------------------------------------------------ccccccccccccccC
Confidence 11 011223478999999
Q ss_pred ceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CC----------------------------
Q 042539 257 PEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK--TP---------------------------- 305 (412)
Q Consensus 257 PE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~~---------------------------- 305 (412)
||++.+. .++.++|||||||++|+|++|++||.+.+..+.+.++... .+
T Consensus 169 PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (288)
T 1ob3_A 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWES 248 (288)
T ss_dssp HHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGG
T ss_pred chheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHH
Confidence 9999875 5799999999999999999999999998887776665421 00
Q ss_pred CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCC
Q 042539 306 EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 306 ~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~ 348 (412)
.....++++.+||.+||+.||++|| +++++++||||++.
T Consensus 249 ~~~~~~~~~~~li~~~L~~dP~~Rp----t~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 249 FLKGLDESGIDLLSKMLKLDPNQRI----TAKQALEHAYFKEN 287 (288)
T ss_dssp TCCSCCHHHHHHHHHHTCSSTTTSC----CHHHHHTSGGGGC-
T ss_pred HhhhcCHHHHHHHHHHcCCCcccCC----CHHHHhcCcchhhc
Confidence 0123578899999999999999999 69999999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=419.36 Aligned_cols=262 Identities=25% Similarity=0.418 Sum_probs=228.8
Q ss_pred CCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeee
Q 042539 11 TTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLG 90 (412)
Q Consensus 11 ~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 90 (412)
....+.+++|++++.||+|+||+||+|++..++. .||||++.+..... ......+.+|+.+++.++||||+++++
T Consensus 9 ~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~----~vAvK~i~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~ 83 (476)
T 2y94_A 9 HDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGH----KVAVKILNRQKIRS-LDVVGKIRREIQNLKLFRHPHIIKLYQ 83 (476)
T ss_dssp CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCC----EEEEEEEEHHHHHH-TTTHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cCCCceecCEEEEEEEeeCCCeEEEEEEECCCCC----EEEEEEEEhhhccC-HHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 3457889999999999999999999999887554 49999997765422 223556788999999999999999999
Q ss_pred eEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccc
Q 042539 91 SLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 91 ~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
++.+.+.+|+|||||.||+|.+++... +.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||
T Consensus 84 ~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG 161 (476)
T 2y94_A 84 VISTPSDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFG 161 (476)
T ss_dssp EEECSSEEEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCS
T ss_pred EEEECCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEecc
Confidence 999999999999999999998877543 459999999999999999999999999999999999999999999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+++... .+....+.+|
T Consensus 162 ~a~~~~----------------------------------------------------------------~~~~~~~~~g 177 (476)
T 2y94_A 162 LSNMMS----------------------------------------------------------------DGEFLRTSCG 177 (476)
T ss_dssp SCEECC----------------------------------------------------------------TTCCBCCCCS
T ss_pred chhhcc----------------------------------------------------------------ccccccccCC
Confidence 997542 1122345689
Q ss_pred CCCCccceeecCCCC-CchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCc
Q 042539 251 TEEYVSPEVVRGDGH-EFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVK 328 (412)
Q Consensus 251 t~~Y~APE~l~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~ 328 (412)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+.++.......+ ..++++.+||.+||+.||.+
T Consensus 178 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 257 (476)
T 2y94_A 178 SPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMK 257 (476)
T ss_dssp CSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHHHHTCSSTTT
T ss_pred CcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHHHHcCCCchh
Confidence 999999999998876 7899999999999999999999999888888888887655444 46789999999999999999
Q ss_pred cCCCCCChhhhhcCCCCCC
Q 042539 329 RLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 329 R~~~~~~~~e~l~h~ff~~ 347 (412)
|| +++++++||||+.
T Consensus 258 Rp----t~~eil~hp~~~~ 272 (476)
T 2y94_A 258 RA----TIKDIREHEWFKQ 272 (476)
T ss_dssp SC----CHHHHHTCHHHHT
T ss_pred Cc----CHHHHHhCHHhhh
Confidence 99 7999999999975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-52 Score=403.91 Aligned_cols=257 Identities=28% Similarity=0.434 Sum_probs=216.4
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeeeeEEe
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLGSLET 94 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 94 (412)
..++|++++.||+|+||+||+|+++.++ +.||||++++.... ..+|++++.++ +||||+++++++.+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~~avK~~~~~~~~--------~~~E~~~l~~~~~hp~iv~~~~~~~~ 87 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATN----MEFAVKIIDKSKRD--------PTEEIEILLRYGQHPNIITLKDVYDD 87 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEEETTTCC--------CHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCC----CEEEEEEEEcccCC--------hHHHHHHHHHhcCCCCcCeEEEEEEc
Confidence 3578999999999999999999998754 44999999765432 22488888888 69999999999999
Q ss_pred CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccC----CCEEEcccc
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQS----GHVTLTDFD 170 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~----g~vkL~DFG 170 (412)
++.+|+|||||.||+|..++... +.+++.+++.++.||+.||+|||++||+||||||+|||+... +.+||+|||
T Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg 165 (342)
T 2qr7_A 88 GKYVYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFG 165 (342)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence 99999999999999998777654 459999999999999999999999999999999999998543 359999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+++.... ......+.+|
T Consensus 166 ~a~~~~~---------------------------------------------------------------~~~~~~~~~g 182 (342)
T 2qr7_A 166 FAKQLRA---------------------------------------------------------------ENGLLMTPCY 182 (342)
T ss_dssp TCEECBC---------------------------------------------------------------TTCCBCCSSC
T ss_pred CcccCcC---------------------------------------------------------------CCCceeccCC
Confidence 9975421 1122345689
Q ss_pred CCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCC---CCHHHHHHHHhcCCCCC-----CCCChHHHHHHHHhh
Q 042539 251 TEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRG---KNRKETFRNVLMKTPEF-----VGQRTALTDLIQRLL 322 (412)
Q Consensus 251 t~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~---~~~~~~~~~i~~~~~~~-----~~~~~~~~dli~~~L 322 (412)
|+.|+|||++.+..++.++|||||||++|+|++|..||.+ .+..+.+..+......+ ...++++++||.+||
T Consensus 183 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 262 (342)
T 2qr7_A 183 TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKML 262 (342)
T ss_dssp CSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHT
T ss_pred CccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHC
Confidence 9999999999988899999999999999999999999986 45666777776655433 457899999999999
Q ss_pred hhCCCccCCCCCChhhhhcCCCCCCCCchhhcc
Q 042539 323 EKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTD 355 (412)
Q Consensus 323 ~~dP~~R~~~~~~~~e~l~h~ff~~~~~~~~~~ 355 (412)
..||++|| ++.++++||||. +|+.+..
T Consensus 263 ~~dP~~R~----t~~~il~hp~~~--~~~~~~~ 289 (342)
T 2qr7_A 263 HVDPHQRL----TAALVLRHPWIV--HWDQLPQ 289 (342)
T ss_dssp CSSTTTSC----CHHHHTTSHHHH--TGGGSCC
T ss_pred CCChhHCc----CHHHHhcCCeec--Ccccccc
Confidence 99999999 699999999995 5765543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-51 Score=392.57 Aligned_cols=260 Identities=27% Similarity=0.399 Sum_probs=213.8
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
+++|++++.||+|+||+||+|++..++. .||+|++..... .....+.+.+|+.++++++||||+++++++.+++
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 75 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQ----IVAIKKFLESED--DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR 75 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCc----EEEEEEeecccc--chHHHHHHHHHHHHHHhCCCCCccchhheeecCC
Confidence 5799999999999999999999987544 499999866542 3345667778999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
.+++|||||.|++|..++... ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 153 (311)
T 4agu_A 76 RLHLVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLT 153 (311)
T ss_dssp EEEEEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred eEEEEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence 999999999999998776543 359999999999999999999999999999999999999999999999999997542
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
.. .......+||+.|+|
T Consensus 154 ~~---------------------------------------------------------------~~~~~~~~~~~~y~a 170 (311)
T 4agu_A 154 GP---------------------------------------------------------------SDYYDDEVATRWYRS 170 (311)
T ss_dssp ---------------------------------------------------------------------------GGGCC
T ss_pred Cc---------------------------------------------------------------ccccCCCcCCccccC
Confidence 11 111234578999999
Q ss_pred ceeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC----------------------C--------
Q 042539 257 PEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT----------------------P-------- 305 (412)
Q Consensus 257 PE~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~----------------------~-------- 305 (412)
||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.... +
T Consensus 171 PE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (311)
T 4agu_A 171 PELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPL 250 (311)
T ss_dssp HHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCH
T ss_pred hHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchh
Confidence 999987 567999999999999999999999999988776655443210 0
Q ss_pred --CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCch
Q 042539 306 --EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 306 --~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~ 351 (412)
.++..++++.+||.+||..||.+|| +++++++||||+++.+.
T Consensus 251 ~~~~~~~~~~~~~li~~~L~~dP~~Rp----t~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 251 ELKFPNISYPALGLLKGCLHMDPTERL----TCEQLLHHPYFENIREI 294 (311)
T ss_dssp HHHCTTCCHHHHHHHHHHCCSSTTTSC----CHHHHHTSGGGTTCC--
T ss_pred hhhcccccHHHHHHHHHHccCChhhcC----CHHHHhcChHHHhccCH
Confidence 1245678899999999999999999 69999999999998764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=398.94 Aligned_cols=259 Identities=24% Similarity=0.412 Sum_probs=214.3
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
.+++|++++.||+|+||+||+|+++.++. .||||++..... ......+.+|+.+++.++||||+++++++.++
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 77 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEE----AVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREG 77 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEECC----------CHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCc----EEEEEEEEcccc---cchHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 46899999999999999999999987554 499999965432 22335567899999999999999999999999
Q ss_pred CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchh
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
+..|+|||||.||+|..++... ..+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.+
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 155 (323)
T 3tki_A 78 NIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF 155 (323)
T ss_dssp SEEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CeEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeecccee
Confidence 9999999999999998876543 35999999999999999999999999999999999999999999999999999755
Q ss_pred hchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCc
Q 042539 176 VKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYV 255 (412)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 255 (412)
.... ........+||+.|+
T Consensus 156 ~~~~-------------------------------------------------------------~~~~~~~~~gt~~y~ 174 (323)
T 3tki_A 156 RYNN-------------------------------------------------------------RERLLNKMCGTLPYV 174 (323)
T ss_dssp EETT-------------------------------------------------------------EECCBCSCCSCGGGS
T ss_pred ccCC-------------------------------------------------------------cccccCCCccCcCcc
Confidence 2110 111223568999999
Q ss_pred cceeecCCCC-CchhhHHHHHHHHHHHhhCCCCCCCCCHH-HHHHHHhcCC---CCCCCCChHHHHHHHHhhhhCCCccC
Q 042539 256 SPEVVRGDGH-EFAVDWWALGILTYEMLYGTTPFRGKNRK-ETFRNVLMKT---PEFVGQRTALTDLIQRLLEKDPVKRL 330 (412)
Q Consensus 256 APE~l~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~~i~~~~---~~~~~~~~~~~dli~~~L~~dP~~R~ 330 (412)
|||++.+..+ +.++|||||||++|+|++|+.||.+.+.. ..+....... ..+...++.+.+||.+||..||.+||
T Consensus 175 aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 254 (323)
T 3tki_A 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI 254 (323)
T ss_dssp CHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSC
T ss_pred CcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHccCChhhCc
Confidence 9999988776 78999999999999999999999876543 2233333222 22345788999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCC
Q 042539 331 GYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 331 ~~~~~~~e~l~h~ff~~~ 348 (412)
+++|+++||||+..
T Consensus 255 ----t~~eil~h~~~~~~ 268 (323)
T 3tki_A 255 ----TIPDIKKDRWYNKP 268 (323)
T ss_dssp ----CHHHHTTCTTTTCC
T ss_pred ----CHHHHhhChhhccc
Confidence 69999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=393.92 Aligned_cols=263 Identities=25% Similarity=0.336 Sum_probs=210.2
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhh-hHHHHHHHHHHHHHHhhc---CCCcccee
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHA-KHEAERRARWEIRVLSRL---SHPFLPKL 88 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~~Ei~il~~l---~hpnIv~l 88 (412)
..+..++|++++.||+|+||+||+|++..++ +.||||++....... .........+|+.+++.+ +||||+++
T Consensus 4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~ 79 (308)
T 3g33_A 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSG----HFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRL 79 (308)
T ss_dssp ------CCEEEEEECCSSSCCEEEEECTTTC----CEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCE
T ss_pred CcccccceEEEEEEecCCCeEEEEEEECCCC----cEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEe
Confidence 4566789999999999999999999987754 449999997543211 111122334566666666 49999999
Q ss_pred eeeEEeCC-----eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCC
Q 042539 89 LGSLETDE-----FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGH 163 (412)
Q Consensus 89 ~~~~~~~~-----~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~ 163 (412)
++++.+.. .+++||||+. ++|..++.......+++.+++.++.||+.||+|||++||+||||||+|||++.+|.
T Consensus 80 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 80 MDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT 158 (308)
T ss_dssp EEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSC
T ss_pred eeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC
Confidence 99998765 5899999996 58888877666556999999999999999999999999999999999999999999
Q ss_pred EEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCC
Q 042539 164 VTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGE 243 (412)
Q Consensus 164 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (412)
+||+|||+|+... ...
T Consensus 159 ~kl~Dfg~a~~~~----------------------------------------------------------------~~~ 174 (308)
T 3g33_A 159 VKLADFGLARIYS----------------------------------------------------------------YQM 174 (308)
T ss_dssp EEECSCSCTTTST----------------------------------------------------------------TCC
T ss_pred EEEeeCccccccC----------------------------------------------------------------CCc
Confidence 9999999997542 111
Q ss_pred CCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--C---C------------
Q 042539 244 RSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT--P---E------------ 306 (412)
Q Consensus 244 ~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~---~------------ 306 (412)
.....+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+...++.... + .
T Consensus 175 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 254 (308)
T 3g33_A 175 ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAF 254 (308)
T ss_dssp CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGS
T ss_pred ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence 2235679999999999999999999999999999999999999999999888777765311 0 0
Q ss_pred -----------CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCC
Q 042539 307 -----------FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 307 -----------~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~ 348 (412)
.+..++.+.+||.+||+.||++|| ++.|+++||||++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~----t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 255 PPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRI----SAFRALQHSYLHKD 303 (308)
T ss_dssp CCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSC----CHHHHHTSTTC---
T ss_pred CCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCC----CHHHHhcCccccCC
Confidence 124578899999999999999999 79999999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=397.98 Aligned_cols=261 Identities=26% Similarity=0.384 Sum_probs=202.3
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
..++|++++.||+|+||+||+|+++.++ +.||+|+++..... .....+.+|+++++.++||||+++++++.++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 75 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTG----VYVALKEVKLDSEE---GTPSTAIREISLMKELKHENIVRLYDVIHTE 75 (317)
T ss_dssp ----------------CEEEEEECSSSC----CEEEEEEEECCSTT---CSCHHHHHHHHHHTTCCBTTBCCEEEEECCT
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCC----cEEEEEEeeccccc---ccHHHHHHHHHHHHhcCCCCcceEEEEEEEC
Confidence 4579999999999999999999987754 45999999765321 1234566799999999999999999999999
Q ss_pred CeEEEEeeccCCCCchhHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQN----DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~----~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
+.+|+|||||. |+|..++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+
T Consensus 76 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 154 (317)
T 2pmi_A 76 NKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGL 154 (317)
T ss_dssp TEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSS
T ss_pred CeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCcc
Confidence 99999999998 48877765542 13589999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
++.... ........+||
T Consensus 155 ~~~~~~---------------------------------------------------------------~~~~~~~~~~t 171 (317)
T 2pmi_A 155 ARAFGI---------------------------------------------------------------PVNTFSSEVVT 171 (317)
T ss_dssp CEETTS---------------------------------------------------------------CCCCCCCCCSC
T ss_pred ceecCC---------------------------------------------------------------CcccCCCCccc
Confidence 975421 01112345789
Q ss_pred CCCccceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CC-----------------------
Q 042539 252 EEYVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK--TP----------------------- 305 (412)
Q Consensus 252 ~~Y~APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~~----------------------- 305 (412)
+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+... .+
T Consensus 172 ~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (317)
T 2pmi_A 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPP 251 (317)
T ss_dssp CTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCC
T ss_pred ccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccc
Confidence 999999999874 5899999999999999999999999999888777666431 00
Q ss_pred ----------CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCch
Q 042539 306 ----------EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 306 ----------~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~ 351 (412)
.....+.++.+||.+||+.||.+|| +++++++||||++..|.
T Consensus 252 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp----t~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 252 RDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRL----SAKQALHHPWFAEYYHH 303 (317)
T ss_dssp CCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSC----CHHHHTTSGGGGGGCC-
T ss_pred hhHHHhhcccccccCCHHHHHHHHHHCCCCcccCC----CHHHHhCChhhhcccch
Confidence 0113567899999999999999999 69999999999987664
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=404.01 Aligned_cols=257 Identities=25% Similarity=0.410 Sum_probs=210.9
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
.++|++++.||+|+||+||+|.+..++. .||||++.+... .....+++.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 97 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGA----KVAIKKLYRPFQ--SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 97 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCC----EEEEEECSSTTS--SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCC----EEEEEEeCcccc--CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCC
Confidence 4689999999999999999999977554 499999966432 3345667888999999999999999999998653
Q ss_pred ------eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccc
Q 042539 97 ------FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 97 ------~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
.+|+||||+ |++|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 98 TLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred ccccCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeee
Confidence 569999999 8899888765 349999999999999999999999999999999999999999999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+++... ......+|
T Consensus 174 ~a~~~~------------------------------------------------------------------~~~~~~~~ 187 (367)
T 1cm8_A 174 LARQAD------------------------------------------------------------------SEMTGYVV 187 (367)
T ss_dssp TCEECC------------------------------------------------------------------SSCCSSCS
T ss_pred cccccc------------------------------------------------------------------cccCcCcC
Confidence 997531 11234578
Q ss_pred CCCCccceeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CC----------------------
Q 042539 251 TEEYVSPEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK--TP---------------------- 305 (412)
Q Consensus 251 t~~Y~APE~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~~---------------------- 305 (412)
|+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+.+..+... .+
T Consensus 188 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 267 (367)
T 1cm8_A 188 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPE 267 (367)
T ss_dssp CGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCC
T ss_pred CCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCC
Confidence 999999999987 67899999999999999999999999999887777666431 10
Q ss_pred --------CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCchhh
Q 042539 306 --------EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLL 353 (412)
Q Consensus 306 --------~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~~~ 353 (412)
.+...++.+.+||.+||+.||.+|+ +++++++||||+...+...
T Consensus 268 ~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~----t~~e~l~hp~f~~~~~~~~ 319 (367)
T 1cm8_A 268 LEKKDFASILTNASPLAVNLLEKMLVLDAEQRV----TAGEALAHPYFESLHDTED 319 (367)
T ss_dssp CCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSC----CHHHHHHSGGGTTTC----
T ss_pred CCCCCHHHHCCCCCHHHHHHHHHHccCChhHCC----CHHHHhcChHHHhhcCCcc
Confidence 1235578999999999999999999 7999999999998776543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-51 Score=410.40 Aligned_cols=291 Identities=23% Similarity=0.368 Sum_probs=214.4
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC-
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD- 95 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~- 95 (412)
.++|++++.||+|+||+||+|+++.++ +.||||++.+.. ......+++.+|+++|+.++|+||+++++++...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~----~~vAiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 98 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTE----KNVAIKKVNRMF--EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDD 98 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTT----EEEEEEEECSTT--TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCC----cEEEEEEeCchh--cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 478999999999999999999998754 459999997643 2334567788899999999999999999999876
Q ss_pred ----CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 96 ----EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 96 ----~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
..+|+||||+. |+|..++... ..+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus 99 ~~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 99 LLKFDELYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp TTTCCCEEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CCcCCeEEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCC
Confidence 57999999996 5887776543 4599999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
|+............ +..... .+ ............+.+||
T Consensus 176 a~~~~~~~~~~~~~----------------------------------~~~~~~----~~---~~~~~~~~~~~~~~~gt 214 (432)
T 3n9x_A 176 ARTINSEKDTNIVN----------------------------------DLEENE----EP---GPHNKNLKKQLTSHVVT 214 (432)
T ss_dssp CEEC------------------------------------------------------------------------CCCC
T ss_pred cccccccccccccc----------------------------------cccccc----cc---cccccchhccccCCCCC
Confidence 98763221100000 000000 00 00000111234577999
Q ss_pred CCCccceee-cCCCCCchhhHHHHHHHHHHHhh-----------CCCCCCCCC-----------------HHHHHHHHhc
Q 042539 252 EEYVSPEVV-RGDGHEFAVDWWALGILTYEMLY-----------GTTPFRGKN-----------------RKETFRNVLM 302 (412)
Q Consensus 252 ~~Y~APE~l-~~~~~~~~~DiwSlGvil~ell~-----------g~~Pf~~~~-----------------~~~~~~~i~~ 302 (412)
+.|+|||++ .+..++.++|||||||++|||++ |.++|.+.+ ..+.+..+..
T Consensus 215 ~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~ 294 (432)
T 3n9x_A 215 RWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFN 294 (432)
T ss_dssp CTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHH
T ss_pred ccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHH
Confidence 999999986 45668999999999999999998 566666643 1222222211
Q ss_pred --CCC------------------------------CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCc
Q 042539 303 --KTP------------------------------EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRW 350 (412)
Q Consensus 303 --~~~------------------------------~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~ 350 (412)
+.+ .++..++++.+||.+||+.||++|+ +++|+++||||++++|
T Consensus 295 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~----ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 295 IIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRI----TIDQALDHPYLKDVRK 370 (432)
T ss_dssp HHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSC----CHHHHHTCGGGTTTCC
T ss_pred hcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCC----CHHHHhcChhhhhccC
Confidence 000 1245789999999999999999999 7999999999999999
Q ss_pred hhhcccCCCCC
Q 042539 351 DLLTDVLRPPF 361 (412)
Q Consensus 351 ~~~~~~~~pp~ 361 (412)
.........++
T Consensus 371 ~~~e~~~~~~~ 381 (432)
T 3n9x_A 371 KKLENFSTKKI 381 (432)
T ss_dssp TTTC---CCCC
T ss_pred cccCcCCCCCC
Confidence 87665443333
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-51 Score=386.48 Aligned_cols=260 Identities=30% Similarity=0.510 Sum_probs=224.9
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
...+.+++|++++.||+|+||+||+|++..++. .||+|++.+..... ......+.+|+.+++.++||||++++++
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 77 (279)
T 3fdn_A 3 KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF----ILALKVLFKAQLEK-AGVEHQLRREVEIQSHLRHPNILRLYGY 77 (279)
T ss_dssp -CCCCGGGEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEHHHHHH-HTCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cceeecccEEEeeEEecCCCeEEEEEEEccCCc----EEEEEEEeccccch-hhHHHHHHHHHHHHHcCCCCCCcchhhe
Confidence 457789999999999999999999999887544 49999997655422 2335667889999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
+.+.+..|+||||+.||+|..++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+
T Consensus 78 ~~~~~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~ 155 (279)
T 3fdn_A 78 FHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 155 (279)
T ss_dssp EECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCE
T ss_pred EecCCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccc
Confidence 999999999999999999988876654 499999999999999999999999999999999999999999999999998
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
+..... ......+||
T Consensus 156 ~~~~~~-----------------------------------------------------------------~~~~~~~~~ 170 (279)
T 3fdn_A 156 SVHAPS-----------------------------------------------------------------SRRTDLCGT 170 (279)
T ss_dssp ESCC-------------------------------------------------------------------------CCC
T ss_pred cccCCc-----------------------------------------------------------------ccccccCCC
Confidence 854311 112245789
Q ss_pred CCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC-CChHHHHHHHHhhhhCCCccC
Q 042539 252 EEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVG-QRTALTDLIQRLLEKDPVKRL 330 (412)
Q Consensus 252 ~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~dli~~~L~~dP~~R~ 330 (412)
+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......++. .++.+.+||.+||..||.+||
T Consensus 171 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 250 (279)
T 3fdn_A 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRP 250 (279)
T ss_dssp CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHCCSSGGGSC
T ss_pred CCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHhccChhhCC
Confidence 9999999999998999999999999999999999999999988888887766555443 678999999999999999999
Q ss_pred CCCCChhhhhcCCCCCC
Q 042539 331 GYLRGACEIKEHVFFKG 347 (412)
Q Consensus 331 ~~~~~~~e~l~h~ff~~ 347 (412)
+++++++||||++
T Consensus 251 ----s~~e~l~h~~~~~ 263 (279)
T 3fdn_A 251 ----MLREVLEHPWITA 263 (279)
T ss_dssp ----CHHHHHHCHHHHH
T ss_pred ----CHHHHhhCccccC
Confidence 6999999999975
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=419.08 Aligned_cols=252 Identities=26% Similarity=0.443 Sum_probs=207.1
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC-
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD- 95 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~- 95 (412)
.++|++++.||+|+||+||+|++..++. .||||++.+... .....+++.+|+.+++.++|||||+++++|...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~----~vAiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 134 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDR----NVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 134 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTE----EEEEEEEESGGG--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCC----EEEEEEECcccc--ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCC
Confidence 5789999999999999999999987554 499999976532 334566788899999999999999999999654
Q ss_pred -----CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccc
Q 042539 96 -----EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 96 -----~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
..+|+|||||.|+ |...+. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||
T Consensus 135 ~~~~~~~~~lv~E~~~~~-l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 135 TLEEFQDVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp STTTCCEEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred ccccCCeEEEEEeCCCCC-HHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEE
Confidence 4679999999776 433332 238999999999999999999999999999999999999999999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+|+.... .......+|
T Consensus 210 ~a~~~~~----------------------------------------------------------------~~~~~~~~g 225 (464)
T 3ttj_A 210 LARTAGT----------------------------------------------------------------SFMMTPYVV 225 (464)
T ss_dssp CC---------------------------------------------------------------------CCCC----C
T ss_pred eeeecCC----------------------------------------------------------------CcccCCCcc
Confidence 9975421 112345689
Q ss_pred CCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC----------------------CCCC
Q 042539 251 TEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT----------------------PEFV 308 (412)
Q Consensus 251 t~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~----------------------~~~~ 308 (412)
|+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+++..++... +.+.
T Consensus 226 t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (464)
T 3ttj_A 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYA 305 (464)
T ss_dssp CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCC
T ss_pred cccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccC
Confidence 999999999999999999999999999999999999999998887776665311 1111
Q ss_pred CC---------------------ChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCC
Q 042539 309 GQ---------------------RTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 309 ~~---------------------~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
.. ++++++||.+||+.||++|+ +++|+++||||+.
T Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~----ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 306 GLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI----SVDDALQHPYINV 361 (464)
T ss_dssp CCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSC----CHHHHHTSTTTGG
T ss_pred CCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCC----CHHHHhcChhhhh
Confidence 10 35689999999999999999 7999999999985
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-51 Score=393.90 Aligned_cols=266 Identities=26% Similarity=0.401 Sum_probs=228.7
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhh--HHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAK--HEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
....++|++++.||+|+||.||+|+++.++. .||+|++++...... ......+.+|+.++++++||||++++++
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 83 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGL----EYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDV 83 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCe----EEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 3346789999999999999999999987554 499999976543211 1124567789999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCC----CEEEc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG----HVTLT 167 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g----~vkL~ 167 (412)
+.+.+.+|+|||||.|++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~ 161 (321)
T 2a2a_A 84 YENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLI 161 (321)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EecCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEc
Confidence 99999999999999999998887653 4599999999999999999999999999999999999999988 79999
Q ss_pred cccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcc
Q 042539 168 DFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNS 247 (412)
Q Consensus 168 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (412)
|||+++.... ......
T Consensus 162 Dfg~~~~~~~----------------------------------------------------------------~~~~~~ 177 (321)
T 2a2a_A 162 DFGLAHEIED----------------------------------------------------------------GVEFKN 177 (321)
T ss_dssp CCTTCEECCT----------------------------------------------------------------TCCCCC
T ss_pred cCccceecCc----------------------------------------------------------------cccccc
Confidence 9999975421 111234
Q ss_pred cccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-----CCCChHHHHHHHHhh
Q 042539 248 FVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF-----VGQRTALTDLIQRLL 322 (412)
Q Consensus 248 ~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~dli~~~L 322 (412)
.+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......+ ...+..+.+||.+||
T Consensus 178 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l 257 (321)
T 2a2a_A 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLL 257 (321)
T ss_dssp CCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTS
T ss_pred cCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHc
Confidence 579999999999999999999999999999999999999999999888888887655443 356789999999999
Q ss_pred hhCCCccCCCCCChhhhhcCCCCCCCCchhh
Q 042539 323 EKDPVKRLGYLRGACEIKEHVFFKGVRWDLL 353 (412)
Q Consensus 323 ~~dP~~R~~~~~~~~e~l~h~ff~~~~~~~~ 353 (412)
..||.+|| +++++++||||++++|...
T Consensus 258 ~~dp~~Rp----s~~e~l~hp~~~~~~~~~~ 284 (321)
T 2a2a_A 258 VKETRKRL----TIQEALRHPWITPVDNQQA 284 (321)
T ss_dssp CSSTTTSC----CHHHHHHSTTTSCSSHHHH
T ss_pred CCChhhCc----CHHHHhcCccccCCCcccc
Confidence 99999999 6999999999999988643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=380.65 Aligned_cols=260 Identities=26% Similarity=0.414 Sum_probs=224.8
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
..++|++++.||+|+||.||+|.++.++. .||+|++...... ......+.+|+.++++++||||+++++++.++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGL----EFAAKIINTKKLS--ARDFQKLEREARICRKLQHPNIVRLHDSIQEE 77 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEGGGCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCc----eEEEEEeecccCC--HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC
Confidence 35899999999999999999999887554 4999999766542 23456677899999999999999999999999
Q ss_pred CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCC---EEEcccccc
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGH---VTLTDFDLS 172 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~---vkL~DFGla 172 (412)
+..|+||||+.|++|...+.... .+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||++
T Consensus 78 ~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~ 155 (284)
T 3kk8_A 78 SFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 155 (284)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred CEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence 99999999999999987776654 4999999999999999999999999999999999999987665 999999998
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
..... ........||+
T Consensus 156 ~~~~~----------------------------------------------------------------~~~~~~~~~~~ 171 (284)
T 3kk8_A 156 IEVND----------------------------------------------------------------SEAWHGFAGTP 171 (284)
T ss_dssp EECCS----------------------------------------------------------------SCBCCCSCSCG
T ss_pred EEccc----------------------------------------------------------------CccccCCCCCc
Confidence 65421 11223457999
Q ss_pred CCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-----CCCChHHHHHHHHhhhhCCC
Q 042539 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF-----VGQRTALTDLIQRLLEKDPV 327 (412)
Q Consensus 253 ~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~dli~~~L~~dP~ 327 (412)
.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+ ...++++.+||.+||+.||+
T Consensus 172 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 251 (284)
T 3kk8_A 172 GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPK 251 (284)
T ss_dssp GGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTT
T ss_pred CCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChh
Confidence 9999999999999999999999999999999999999999888888776654332 35689999999999999999
Q ss_pred ccCCCCCChhhhhcCCCCCCCCch
Q 042539 328 KRLGYLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 328 ~R~~~~~~~~e~l~h~ff~~~~~~ 351 (412)
+|| +++++++||||++..+.
T Consensus 252 ~Rp----s~~~~l~h~~~~~~~~~ 271 (284)
T 3kk8_A 252 KRI----TADQALKVPWICNRERV 271 (284)
T ss_dssp TSC----CHHHHTTSHHHHSCCCG
T ss_pred hCC----CHHHHhcCccccCChhH
Confidence 999 69999999999876653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=395.46 Aligned_cols=255 Identities=24% Similarity=0.377 Sum_probs=215.6
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-----CCccc
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-----HPFLP 86 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-----hpnIv 86 (412)
...+..++|+++++||+|+||+||+|++..++ +.||||++++.. .......+|+.+++.+. ||||+
T Consensus 29 ~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 29 KGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNK----KYYAVKVVRNIK-----KYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETTTC----CEEEEEEECSCH-----HHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred cceEecCEEEEEEEEcccCCeEEEEEEECCCC----eEEEEEEeccch-----hhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 44556689999999999999999999997754 449999996432 23344566999999997 99999
Q ss_pred eeeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEcc------
Q 042539 87 KLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQ------ 160 (412)
Q Consensus 87 ~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~------ 160 (412)
++++++...+.+|+||||| |++|..++.......+++.+++.++.||+.||+|||++||+||||||+|||++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEE
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccc
Confidence 9999999999999999999 999998888766667999999999999999999999999999999999999975
Q ss_pred -------------------CCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCcccc
Q 042539 161 -------------------SGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGL 221 (412)
Q Consensus 161 -------------------~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (412)
++.+||+|||+|+...
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~--------------------------------------------- 213 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS--------------------------------------------- 213 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETT---------------------------------------------
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecC---------------------------------------------
Confidence 7899999999996431
Q ss_pred ccccccCCCCccccccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHh
Q 042539 222 KKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL 301 (412)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~ 301 (412)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.
T Consensus 214 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~ 272 (360)
T 3llt_A 214 ---------------------DYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMME 272 (360)
T ss_dssp ---------------------SCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ---------------------CCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHH
Confidence 11234579999999999999999999999999999999999999999988777665554
Q ss_pred cCCCCCC-----------------------------------------------CCChHHHHHHHHhhhhCCCccCCCCC
Q 042539 302 MKTPEFV-----------------------------------------------GQRTALTDLIQRLLEKDPVKRLGYLR 334 (412)
Q Consensus 302 ~~~~~~~-----------------------------------------------~~~~~~~dli~~~L~~dP~~R~~~~~ 334 (412)
......+ ..++.+.+||.+||+.||++||
T Consensus 273 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp---- 348 (360)
T 3llt_A 273 SIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRP---- 348 (360)
T ss_dssp HHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSC----
T ss_pred HhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCC----
Confidence 3211110 1136688999999999999999
Q ss_pred ChhhhhcCCCCC
Q 042539 335 GACEIKEHVFFK 346 (412)
Q Consensus 335 ~~~e~l~h~ff~ 346 (412)
+++|+++||||+
T Consensus 349 ta~elL~hp~f~ 360 (360)
T 3llt_A 349 SPAELLKHKFLE 360 (360)
T ss_dssp CHHHHTTSGGGC
T ss_pred CHHHHhcCcccC
Confidence 799999999995
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-51 Score=394.84 Aligned_cols=263 Identities=27% Similarity=0.400 Sum_probs=222.5
Q ss_pred cCceee-eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEEeC
Q 042539 18 DNLKAL-KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLETD 95 (412)
Q Consensus 18 ~~y~~~-~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~ 95 (412)
++|.+. +.||+|+||+||+|+++.++. .||+|++++..... .....+.+|+.+++.+. ||||+++++++.+.
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQ----EYAAKFLKKRRRGQ--DCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEESEETTE--ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCC----EEEEEEEehhhcch--HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 467777 899999999999999987554 49999997654322 23456777999999996 79999999999999
Q ss_pred CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEcc---CCCEEEcccccc
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQ---SGHVTLTDFDLS 172 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~---~g~vkL~DFGla 172 (412)
+.+|+|||||.||+|..++.......+++.+++.++.||+.||+|||++||+||||||+|||++. +|.+||+|||++
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a 181 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence 99999999999999988876555567999999999999999999999999999999999999998 789999999999
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+..... ......+||+
T Consensus 182 ~~~~~~----------------------------------------------------------------~~~~~~~gt~ 197 (327)
T 3lm5_A 182 RKIGHA----------------------------------------------------------------CELREIMGTP 197 (327)
T ss_dssp EEC-------------------------------------------------------------------------CCCG
T ss_pred cccCCc----------------------------------------------------------------cccccccCCc
Confidence 765211 1123457999
Q ss_pred CCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-----CCCCCChHHHHHHHHhhhhCCC
Q 042539 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP-----EFVGQRTALTDLIQRLLEKDPV 327 (412)
Q Consensus 253 ~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-----~~~~~~~~~~dli~~~L~~dP~ 327 (412)
.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+..... .+...++.+.+||.+||+.||.
T Consensus 198 ~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 277 (327)
T 3lm5_A 198 EYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPE 277 (327)
T ss_dssp GGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGG
T ss_pred CccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChh
Confidence 99999999999999999999999999999999999999998888777765432 2345678999999999999999
Q ss_pred ccCCCCCChhhhhcCCCCCCCCchhhc
Q 042539 328 KRLGYLRGACEIKEHVFFKGVRWDLLT 354 (412)
Q Consensus 328 ~R~~~~~~~~e~l~h~ff~~~~~~~~~ 354 (412)
+|| +++++++||||++.+|+.+.
T Consensus 278 ~Rp----t~~~ll~h~~~~~~~~~~~~ 300 (327)
T 3lm5_A 278 KRP----TAEICLSHSWLQQWDFENLF 300 (327)
T ss_dssp GSC----CHHHHTTCGGGCCCCTTCC-
T ss_pred hCc----CHHHHhCCHhhccccccccc
Confidence 999 69999999999999997553
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=398.65 Aligned_cols=267 Identities=26% Similarity=0.416 Sum_probs=220.3
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhh-hHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHA-KHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
++|++++.||+|+||+||+|+++.++. .||+|++.+..... .......+.+|+++++.++||||+++++++.+.+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRA----IRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hheeecceeeecCCeEEEEEEECCCCc----eEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 689999999999999999999877544 49999997765421 2234567888999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhh--------------------------------------CCCCCCHHHHHHHHHHHHHHH
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQ--------------------------------------NDRVFSPSVIRFYLSEIICAI 138 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~--------------------------------------~~~~l~~~~~~~~~~qi~~aL 138 (412)
.+|+|||||.||+|..++... ....+++..++.++.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 999999999999998776411 011246788999999999999
Q ss_pred HHHHHcCceeeeCCCCceEEccCC--CEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCC
Q 042539 139 EHLHNMGIAYRDLKPENILIRQSG--HVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPE 216 (412)
Q Consensus 139 ~yLH~~~iiHrDlKp~NiLl~~~g--~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (412)
+|||++||+||||||+|||++.++ .+||+|||+++.+.....
T Consensus 182 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~------------------------------------ 225 (345)
T 3hko_A 182 HYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN------------------------------------ 225 (345)
T ss_dssp HHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTC------------------------------------
T ss_pred HHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCc------------------------------------
Confidence 999999999999999999998777 899999999976532100
Q ss_pred CccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecC--CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHH
Q 042539 217 NKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRG--DGHEFAVDWWALGILTYEMLYGTTPFRGKNRK 294 (412)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~ 294 (412)
.........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..
T Consensus 226 -----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 282 (345)
T 3hko_A 226 -----------------------GEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA 282 (345)
T ss_dssp -----------------------C--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred -----------------------cccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChH
Confidence 00112235579999999999976 56789999999999999999999999999998
Q ss_pred HHHHHHhcCCCCCC-----CCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCch
Q 042539 295 ETFRNVLMKTPEFV-----GQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 295 ~~~~~i~~~~~~~~-----~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~ 351 (412)
+...++......+. ..++++.+||.+||+.||.+|| ++.++++||||++..|.
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----s~~~~l~hp~~~~~~~~ 340 (345)
T 3hko_A 283 DTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERF----DAMRALQHPWISQFSDK 340 (345)
T ss_dssp HHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSC----CHHHHHHSHHHHTTSSC
T ss_pred HHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCC----CHHHHhcChhhccChHh
Confidence 88888876654333 3678999999999999999999 69999999999987654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-51 Score=406.77 Aligned_cols=252 Identities=26% Similarity=0.430 Sum_probs=203.0
Q ss_pred CCccCceee-eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeeeeE
Q 042539 15 LDLDNLKAL-KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLGSL 92 (412)
Q Consensus 15 ~~~~~y~~~-~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 92 (412)
..+++|.++ +.||+|+||+||+|+++.++. .||||+++... .+.+|+.++.++ +||||++++++|
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~----~vAiK~~~~~~---------~~~~E~~~~~~~~~hp~iv~l~~~~ 124 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQE----KFALKMLQDCP---------KARREVELHWRASQCPHIVRIVDVY 124 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEECSH---------HHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCC----EEEEEEeCcch---------hHHHHHHHHHHhcCCCCcceEeEEE
Confidence 346788887 789999999999999987554 49999996421 234588887544 799999999998
Q ss_pred Ee----CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEcc---CCCEE
Q 042539 93 ET----DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQ---SGHVT 165 (412)
Q Consensus 93 ~~----~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~---~g~vk 165 (412)
.. ...+|+|||||.||+|..++.......+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+|
T Consensus 125 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~k 204 (400)
T 1nxk_A 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 204 (400)
T ss_dssp EEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEE
T ss_pred eecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEE
Confidence 76 568999999999999998887655556999999999999999999999999999999999999998 78999
Q ss_pred EccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCC
Q 042539 166 LTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERS 245 (412)
Q Consensus 166 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (412)
|+|||+++.... ....
T Consensus 205 l~DFG~a~~~~~----------------------------------------------------------------~~~~ 220 (400)
T 1nxk_A 205 LTDFGFAKETTS----------------------------------------------------------------HNSL 220 (400)
T ss_dssp ECCCTTCEECC---------------------------------------------------------------------
T ss_pred EEecccccccCC----------------------------------------------------------------CCcc
Confidence 999999975421 1122
Q ss_pred cccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHH----HHHHHhcCCC-----CCCCCChHHHH
Q 042539 246 NSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKE----TFRNVLMKTP-----EFVGQRTALTD 316 (412)
Q Consensus 246 ~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~----~~~~i~~~~~-----~~~~~~~~~~d 316 (412)
.+.+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+... ....+..... .+..+++++.+
T Consensus 221 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 300 (400)
T 1nxk_A 221 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 300 (400)
T ss_dssp ------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred ccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHH
Confidence 35689999999999999999999999999999999999999998754321 3334443332 23457899999
Q ss_pred HHHHhhhhCCCccCCCCCChhhhhcCCCCCC
Q 042539 317 LIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 317 li~~~L~~dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
||.+||+.||++|| ++.++++||||.+
T Consensus 301 li~~~L~~dP~~Rp----t~~eil~hp~~~~ 327 (400)
T 1nxk_A 301 LIRNLLKTEPTQRM----TITEFMNHPWIMQ 327 (400)
T ss_dssp HHHTTSCSSGGGSC----CHHHHHHSHHHHT
T ss_pred HHHHHCCCChhHCc----CHHHHhcCccccC
Confidence 99999999999999 6999999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=384.62 Aligned_cols=261 Identities=29% Similarity=0.494 Sum_probs=226.1
Q ss_pred CCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeee
Q 042539 11 TTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLG 90 (412)
Q Consensus 11 ~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 90 (412)
+...+.+++|++++.||+|+||.||+|++..++ ..||+|++.+..... ......+.+|+.+++.++||||+++++
T Consensus 7 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~ 81 (284)
T 2vgo_A 7 PKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNK----FIMALKVLFKSQLEK-EGVEHQLRREIEIQSHLRHPNILRMYN 81 (284)
T ss_dssp ---CCCGGGEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CccchhhhhceeeheecCCCCeEEEEEEEcCCC----cEEEEEEEcccccch-HHHHHHHHHHHHHHhcCCCCCEeeEEE
Confidence 356788999999999999999999999987644 459999997654322 223456778999999999999999999
Q ss_pred eEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccc
Q 042539 91 SLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 91 ~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
++.+++.+|+||||+.||+|..++.... .+++..+..++.||+.||.|||++||+||||||+||+++.+|.+||+|||
T Consensus 82 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg 159 (284)
T 2vgo_A 82 YFHDRKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFG 159 (284)
T ss_dssp EEECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred EEEcCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEeccc
Confidence 9999999999999999999988877654 49999999999999999999999999999999999999999999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
++..... ......+|
T Consensus 160 ~~~~~~~-----------------------------------------------------------------~~~~~~~~ 174 (284)
T 2vgo_A 160 WSVHAPS-----------------------------------------------------------------LRRRTMCG 174 (284)
T ss_dssp TCEECSS-----------------------------------------------------------------SCBCCCCS
T ss_pred ccccCcc-----------------------------------------------------------------cccccccC
Confidence 8864310 11234579
Q ss_pred CCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-CCCChHHHHHHHHhhhhCCCcc
Q 042539 251 TEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF-VGQRTALTDLIQRLLEKDPVKR 329 (412)
Q Consensus 251 t~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~dli~~~L~~dP~~R 329 (412)
|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......+ ...++++.+||.+||..||.+|
T Consensus 175 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 254 (284)
T 2vgo_A 175 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQR 254 (284)
T ss_dssp CGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred CCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHHHHhhcCHhhC
Confidence 999999999999999999999999999999999999999998888888877665544 3467899999999999999999
Q ss_pred CCCCCChhhhhcCCCCCC
Q 042539 330 LGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 330 ~~~~~~~~e~l~h~ff~~ 347 (412)
| +++++++||||+.
T Consensus 255 p----s~~~ll~h~~~~~ 268 (284)
T 2vgo_A 255 L----PLKGVMEHPWVKA 268 (284)
T ss_dssp C----CHHHHHTCHHHHH
T ss_pred C----CHHHHhhCHHHHh
Confidence 9 6999999999974
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-51 Score=415.47 Aligned_cols=261 Identities=28% Similarity=0.457 Sum_probs=222.8
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
......++|++++.||+|+||+||+|+++.++. .||||++.+..... .....+.+|+.++++++||||++++++
T Consensus 16 ~~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~ 89 (486)
T 3mwu_A 16 FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQ----EYAVKVINKASAKN--KDTSTILREVELLKKLDHPNIMKLFEI 89 (486)
T ss_dssp TCCHHHHHEEEEEEEECCSSSEEEEEEETTTCC----EEEEEEEEHHHHBC--SCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCChhcceEEeEEEeecCCEEEEEEEECCCCC----EEEEEEEecccccc--hHHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence 334456899999999999999999999987554 49999997654322 224567789999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEc---cCCCEEEcc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIR---QSGHVTLTD 168 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~---~~g~vkL~D 168 (412)
+.+...+|+|||||.||+|...+.... .+++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 167 (486)
T 3mwu_A 90 LEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIID 167 (486)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECS
T ss_pred EEcCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEE
Confidence 999999999999999999987776654 499999999999999999999999999999999999995 456799999
Q ss_pred ccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccc
Q 042539 169 FDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248 (412)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (412)
||+|+.... .......
T Consensus 168 fg~a~~~~~----------------------------------------------------------------~~~~~~~ 183 (486)
T 3mwu_A 168 FGLSTCFQQ----------------------------------------------------------------NTKMKDR 183 (486)
T ss_dssp CSCTTTBCC----------------------------------------------------------------C----CC
T ss_pred CCcCeECCC----------------------------------------------------------------CCccCCC
Confidence 999975421 1122345
Q ss_pred ccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC-----CCCCChHHHHHHHHhhh
Q 042539 249 VGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE-----FVGQRTALTDLIQRLLE 323 (412)
Q Consensus 249 ~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~-----~~~~~~~~~dli~~~L~ 323 (412)
+||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+.+..+.+..+...... +...++++++||.+||+
T Consensus 184 ~gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 262 (486)
T 3mwu_A 184 IGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLT 262 (486)
T ss_dssp TTGGGGCCGGGGGSC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTC
T ss_pred cCCCCCCCHHHhCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcC
Confidence 799999999999874 899999999999999999999999999999988888765433 34568999999999999
Q ss_pred hCCCccCCCCCChhhhhcCCCCCCCC
Q 042539 324 KDPVKRLGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 324 ~dP~~R~~~~~~~~e~l~h~ff~~~~ 349 (412)
.||.+|| ++.++++||||+...
T Consensus 263 ~dp~~R~----t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 263 FHPSLRI----TATQCLEHPWIQKYS 284 (486)
T ss_dssp SSTTTSC----CHHHHHHCHHHHHTC
T ss_pred CChhhCc----CHHHHhcCHhhccCc
Confidence 9999999 699999999998654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=390.98 Aligned_cols=252 Identities=26% Similarity=0.451 Sum_probs=195.3
Q ss_pred ccCceee---eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeE
Q 042539 17 LDNLKAL---KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSL 92 (412)
Q Consensus 17 ~~~y~~~---~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~ 92 (412)
.++|++. +.||+|+||+||+|.++.++. .||||++.+.. .....+|+.+++.+. ||||+++++++
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~-------~~~~~~e~~~l~~l~~h~niv~~~~~~ 75 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQ----AFAVKIISKRM-------EANTQKEITALKLCEGHPNIVKLHEVF 75 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCC----EEEEEEEEGGG-------HHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCC----EEEEEEEChhh-------hhhHHHHHHHHHHhcCCCCeeEEEEEE
Confidence 4677776 789999999999999987554 49999996542 234556999999997 99999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCC---CEEEccc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG---HVTLTDF 169 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g---~vkL~DF 169 (412)
.++..+|+|||||.||+|..++... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+||
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Df 153 (325)
T 3kn6_A 76 HDQLHTFLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDF 153 (325)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCC
T ss_pred EcCCEEEEEEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecc
Confidence 9999999999999999998887764 3599999999999999999999999999999999999998776 7999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|+++.... ......+.+
T Consensus 154 g~a~~~~~---------------------------------------------------------------~~~~~~~~~ 170 (325)
T 3kn6_A 154 GFARLKPP---------------------------------------------------------------DNQPLKTPC 170 (325)
T ss_dssp TTCEECCC------------------------------------------------------------------------
T ss_pred ccceecCC---------------------------------------------------------------CCCcccccC
Confidence 99975421 111223557
Q ss_pred cCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCH-------HHHHHHHhcCCCCCC-----CCChHHHHH
Q 042539 250 GTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNR-------KETFRNVLMKTPEFV-----GQRTALTDL 317 (412)
Q Consensus 250 gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-------~~~~~~i~~~~~~~~-----~~~~~~~dl 317 (412)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+. .+.+..+......+. ..++++++|
T Consensus 171 ~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 250 (325)
T 3kn6_A 171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDL 250 (325)
T ss_dssp -------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHH
T ss_pred CCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHH
Confidence 89999999999999999999999999999999999999987543 456666666554443 468999999
Q ss_pred HHHhhhhCCCccCCCCCChhhhhcCCCCCCC
Q 042539 318 IQRLLEKDPVKRLGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 318 i~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~ 348 (412)
|.+||+.||.+|| +++++++||||++.
T Consensus 251 i~~~L~~dP~~Rp----t~~ell~h~w~~~~ 277 (325)
T 3kn6_A 251 IQGLLTVDPNKRL----KMSGLRYNEWLQDG 277 (325)
T ss_dssp HHHHHCCCTTTCC----CTTTSTTCGGGCTT
T ss_pred HHHHCCCChhHCC----CHHHHhcChhhccC
Confidence 9999999999999 68999999999863
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=396.33 Aligned_cols=255 Identities=31% Similarity=0.455 Sum_probs=204.8
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
..++|++.+.||+|+||+||+|+++.++. .||||++++.. ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 120 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQK----PYALKVLKKTV------DKKIVRTEIGVLLRLSHPNIIKLKEIFETP 120 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEC----------------CHHHHHCCCTTBCCEEEEEECS
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCc----EEEEEEeccch------hHHHHHHHHHHHHhCCCCCCcceeeeEecC
Confidence 34679999999999999999999987544 49999997542 234566799999999999999999999999
Q ss_pred CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEcc---CCCEEEcccccc
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQ---SGHVTLTDFDLS 172 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~---~g~vkL~DFGla 172 (412)
+.+|+||||+.||+|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 121 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a 198 (349)
T 2w4o_A 121 TEISLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLS 198 (349)
T ss_dssp SEEEEEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred CeEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence 9999999999999998877543 45999999999999999999999999999999999999976 889999999999
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+.... .......+||+
T Consensus 199 ~~~~~----------------------------------------------------------------~~~~~~~~gt~ 214 (349)
T 2w4o_A 199 KIVEH----------------------------------------------------------------QVLMKTVCGTP 214 (349)
T ss_dssp ------------------------------------------------------------------------------CG
T ss_pred cccCc----------------------------------------------------------------ccccccccCCC
Confidence 75421 11123457999
Q ss_pred CCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHH-HHHHHHhcCCCC-----CCCCChHHHHHHHHhhhhCC
Q 042539 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRK-ETFRNVLMKTPE-----FVGQRTALTDLIQRLLEKDP 326 (412)
Q Consensus 253 ~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~~i~~~~~~-----~~~~~~~~~dli~~~L~~dP 326 (412)
.|+|||++.+..++.++|||||||++|+|++|..||.+.... ..+..+...... +...+.++.+||.+||..||
T Consensus 215 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 294 (349)
T 2w4o_A 215 GYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDP 294 (349)
T ss_dssp GGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSG
T ss_pred CccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCCh
Confidence 999999999999999999999999999999999999875544 466666654432 24568899999999999999
Q ss_pred CccCCCCCChhhhhcCCCCCCCCc
Q 042539 327 VKRLGYLRGACEIKEHVFFKGVRW 350 (412)
Q Consensus 327 ~~R~~~~~~~~e~l~h~ff~~~~~ 350 (412)
++|| ++.++++||||.+..+
T Consensus 295 ~~Rp----t~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 295 KKRL----TTFQALQHPWVTGKAA 314 (349)
T ss_dssp GGSC----CHHHHHHSTTTTSTTC
T ss_pred hhCc----CHHHHhcCcccCCCcc
Confidence 9999 6999999999997654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=394.37 Aligned_cols=274 Identities=23% Similarity=0.349 Sum_probs=220.5
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC--
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD-- 95 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-- 95 (412)
++|++++.||+|+||+||+|++..++ +.||||++.... .......+.+|++++++++||||+++++++...
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 99 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNK----VRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 99 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEECCTT---CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCC----eEEEEEEecccc---CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence 58999999999999999999987754 459999997533 233456778899999999999999999999765
Q ss_pred ---CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 96 ---EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 96 ---~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
..+|+||||+. |+|..++... .+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 100 ~~~~~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 100 EQMKDVYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred cccceEEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcce
Confidence 47999999997 4787776543 4999999999999999999999999999999999999999999999999999
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+...... .........+||+
T Consensus 176 ~~~~~~~------------------------------------------------------------~~~~~~~~~~gt~ 195 (364)
T 3qyz_A 176 RVADPDH------------------------------------------------------------DHTGFLTEYVATR 195 (364)
T ss_dssp EECCGGG------------------------------------------------------------CBCCTTCCCCSCG
T ss_pred EecCCCC------------------------------------------------------------Ccccccccccccc
Confidence 7653211 0111224568999
Q ss_pred CCccceeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CC------------------------
Q 042539 253 EYVSPEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK--TP------------------------ 305 (412)
Q Consensus 253 ~Y~APE~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~~------------------------ 305 (412)
.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+... .+
T Consensus 196 ~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (364)
T 3qyz_A 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKN 275 (364)
T ss_dssp GGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCC
T ss_pred CCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCcc
Confidence 9999998765 45899999999999999999999999998766665555421 00
Q ss_pred ------CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCchhhcccCCCCCCCCCC
Q 042539 306 ------EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSRE 366 (412)
Q Consensus 306 ------~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~~~~~~~~pp~~p~~~ 366 (412)
.++..++++.+||.+||+.||.+|| +++++++||||+...-........+||....+
T Consensus 276 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~----t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~ 338 (364)
T 3qyz_A 276 KVPWNRLFPNADSKALDLLDKMLTFNPHKRI----EVEQALAHPYLEQYYDPSDEPIAEAPFKFDME 338 (364)
T ss_dssp CCCHHHHCTTSCHHHHHHHHHHTCSSTTTSC----CHHHHHTSGGGTTTCCGGGSCCCSSCCCCC--
T ss_pred CCCHHHhCCCCCHHHHHHHHHHcCCChhhCC----CHHHHhcCcchhhccCcccccCCCCcCCcccc
Confidence 0135678999999999999999999 79999999999986444444445556655433
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=382.06 Aligned_cols=257 Identities=28% Similarity=0.467 Sum_probs=214.9
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET 94 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 94 (412)
...++|++.+.||+|+||+||+|+++.++. .||+|++.+..... ....+.+|+++++.++||||+++++++.+
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 91 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGL----ERVIKTINKDRSQV---PMEQIEAEIEVLKSLDHPNIIKIFEVFED 91 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEEGGGCCS---CHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCc----eEEEEEeeccccch---hHHHHHHHHHHHHhCCCchHHhHHHheec
Confidence 344899999999999999999999877544 49999997654321 24566779999999999999999999999
Q ss_pred CCeEEEEeeccCCCCchhHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEE---ccCCCEEEccc
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQ--NDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILI---RQSGHVTLTDF 169 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl---~~~g~vkL~DF 169 (412)
.+.+|+|||||.||+|..++... ....+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Df 171 (285)
T 3is5_A 92 YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDF 171 (285)
T ss_dssp SSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCC
T ss_pred CCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEee
Confidence 99999999999999998776543 23459999999999999999999999999999999999999 45688999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|+++.+.. .......+
T Consensus 172 g~a~~~~~----------------------------------------------------------------~~~~~~~~ 187 (285)
T 3is5_A 172 GLAELFKS----------------------------------------------------------------DEHSTNAA 187 (285)
T ss_dssp CCCCC--------------------------------------------------------------------------C
T ss_pred ecceecCC----------------------------------------------------------------cccCcCcc
Confidence 99975421 11123457
Q ss_pred cCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC----CCCChHHHHHHHHhhhhC
Q 042539 250 GTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF----VGQRTALTDLIQRLLEKD 325 (412)
Q Consensus 250 gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~dli~~~L~~d 325 (412)
||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+....+....+.+ ...++++.+||.+||+.|
T Consensus 188 ~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 266 (285)
T 3is5_A 188 GTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKD 266 (285)
T ss_dssp TTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSC
T ss_pred cccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHHHHHccCC
Confidence 999999999986 457899999999999999999999999998888777766544433 236789999999999999
Q ss_pred CCccCCCCCChhhhhcCCCCCC
Q 042539 326 PVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 326 P~~R~~~~~~~~e~l~h~ff~~ 347 (412)
|.+|| ++.|+++||||++
T Consensus 267 P~~Rp----s~~e~l~hp~f~~ 284 (285)
T 3is5_A 267 PERRP----SAAQVLHHEWFKQ 284 (285)
T ss_dssp TTTSC----CHHHHHTSGGGGC
T ss_pred hhhCc----CHHHHhcCHHhhc
Confidence 99999 6999999999985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=417.29 Aligned_cols=263 Identities=27% Similarity=0.463 Sum_probs=226.0
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
......++|++++.||+|+||+||+|+++.++. .||||++.+...... .....+.+|+.++++++||||++++++
T Consensus 20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~avK~~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~ 94 (484)
T 3nyv_A 20 STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQ----ECAVKVISKRQVKQK-TDKESLLREVQLLKQLDHPNIMKLYEF 94 (484)
T ss_dssp CCCCHHHHEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEETTTCCBS-SCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CCCcccCceEEeeEEecCCCEEEEEEEECCCCC----EEEEEEEEhhhcccc-hHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 345566899999999999999999999987554 499999977654322 234567789999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEE---ccCCCEEEcc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILI---RQSGHVTLTD 168 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl---~~~g~vkL~D 168 (412)
+.+.+.+|+|||||.||+|..++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 172 (484)
T 3nyv_A 95 FEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIID 172 (484)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred EEeCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEe
Confidence 99999999999999999998777654 459999999999999999999999999999999999999 5678999999
Q ss_pred ccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccc
Q 042539 169 FDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248 (412)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (412)
||+|+.+.. .......
T Consensus 173 fg~a~~~~~----------------------------------------------------------------~~~~~~~ 188 (484)
T 3nyv_A 173 FGLSTHFEA----------------------------------------------------------------SKKMKDK 188 (484)
T ss_dssp TTHHHHBCC----------------------------------------------------------------CCSHHHH
T ss_pred eeeeEEccc----------------------------------------------------------------ccccccC
Confidence 999976521 1122345
Q ss_pred ccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-----CCCChHHHHHHHHhhh
Q 042539 249 VGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF-----VGQRTALTDLIQRLLE 323 (412)
Q Consensus 249 ~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~dli~~~L~ 323 (412)
+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+......+ ...++++++||.+||+
T Consensus 189 ~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 267 (484)
T 3nyv_A 189 IGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLT 267 (484)
T ss_dssp TTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTC
T ss_pred CCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCC
Confidence 79999999999987 58999999999999999999999999999999888887765332 4578999999999999
Q ss_pred hCCCccCCCCCChhhhhcCCCCCCCCc
Q 042539 324 KDPVKRLGYLRGACEIKEHVFFKGVRW 350 (412)
Q Consensus 324 ~dP~~R~~~~~~~~e~l~h~ff~~~~~ 350 (412)
.||.+|| ++.++++||||+...+
T Consensus 268 ~dp~~R~----s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 268 YVPSMRI----SARDALDHEWIQTYTK 290 (484)
T ss_dssp SSGGGSC----CHHHHHTSHHHHHHTC
T ss_pred CChhHCc----CHHHHhhChhhccccc
Confidence 9999999 7999999999986544
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-51 Score=394.79 Aligned_cols=259 Identities=25% Similarity=0.375 Sum_probs=209.6
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
+++|++++.||+|+||+||+|+++.++. .||+|++..... ......+.+|+.+++.++||||+++++++.+++
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDN----LVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK 73 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEECC---------CCCCCCCHHHHSCCCCTTBCCEEEEEECSS
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCc----EEEEEEEecccc---cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCC
Confidence 5799999999999999999999987554 499999965432 112223446999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
.+|+|||||.| +|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 74 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 74 SLTLVFEYLDK-DLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKS 151 (324)
T ss_dssp CEEEEEECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred EEEEEeccccc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence 99999999975 777666553 3469999999999999999999999999999999999999999999999999997542
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
.. .......+||+.|+|
T Consensus 152 ~~---------------------------------------------------------------~~~~~~~~~t~~y~a 168 (324)
T 3mtl_A 152 IP---------------------------------------------------------------TKTYDNEVVTLWYRP 168 (324)
T ss_dssp --------------------------------------------------------------------------CGGGCC
T ss_pred CC---------------------------------------------------------------ccccccccCcccccC
Confidence 11 111224478999999
Q ss_pred ceeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CC----------------------------
Q 042539 257 PEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK--TP---------------------------- 305 (412)
Q Consensus 257 PE~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~~---------------------------- 305 (412)
||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+... .+
T Consensus 169 PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (324)
T 3mtl_A 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALL 248 (324)
T ss_dssp HHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHH
T ss_pred hhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhh
Confidence 999987 56799999999999999999999999999888776665431 11
Q ss_pred -CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCch
Q 042539 306 -EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 306 -~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~ 351 (412)
..+..++++.+||.+||+.||.+|| +++|+++||||.++...
T Consensus 249 ~~~~~~~~~~~~li~~~L~~dP~~R~----t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 249 SHAPRLDSDGADLLTKLLQFEGRNRI----SAEDAMKHPFFLSLGER 291 (324)
T ss_dssp HHCTTSCHHHHHHHHHHSCSSGGGSC----CHHHHTTSGGGGGGCST
T ss_pred hhcCCCCHHHHHHHHHHcCcCcccCC----CHHHHhcChhhhhcccc
Confidence 0124568899999999999999999 79999999999976643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-50 Score=387.83 Aligned_cols=261 Identities=28% Similarity=0.479 Sum_probs=226.2
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
....++|++++.||+|+||.||+|++..++. .||+|++.+.... .......+.+|+.+++.++|+||+++++++.
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~a~K~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 111 (335)
T 2owb_A 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKE----VFAGKIVPKSLLL-KPHQREKMSMEISIHRSLAHQHVVGFHGFFE 111 (335)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEGGGCC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cccCCceEEEEEEeeCCCeEEEEEEECCCCC----EEEEEEechhhhc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 3456799999999999999999999987544 4999999766542 2345567788999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
+++.+|+|||||.|++|..++.... .+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 189 (335)
T 2owb_A 112 DNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT 189 (335)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred cCCeEEEEEecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCce
Confidence 9999999999999999988876554 49999999999999999999999999999999999999999999999999997
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
.... ........+||+.
T Consensus 190 ~~~~---------------------------------------------------------------~~~~~~~~~gt~~ 206 (335)
T 2owb_A 190 KVEY---------------------------------------------------------------DGERKKVLCGTPN 206 (335)
T ss_dssp ECCS---------------------------------------------------------------TTCCBCCCCSCCS
T ss_pred eccc---------------------------------------------------------------CcccccccCCCcc
Confidence 5421 1112234579999
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCccCCC
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKRLGY 332 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R~~~ 332 (412)
|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+......++ ..++.+.+||.+||+.||++||
T Consensus 207 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-- 284 (335)
T 2owb_A 207 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARP-- 284 (335)
T ss_dssp SCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHTCSSGGGSC--
T ss_pred ccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHccCChhHCc--
Confidence 9999999999999999999999999999999999999888887777766554443 4678999999999999999999
Q ss_pred CCChhhhhcCCCCCCC
Q 042539 333 LRGACEIKEHVFFKGV 348 (412)
Q Consensus 333 ~~~~~e~l~h~ff~~~ 348 (412)
+++++++|+||...
T Consensus 285 --s~~ell~~~~~~~~ 298 (335)
T 2owb_A 285 --TINELLNDEFFTSG 298 (335)
T ss_dssp --CGGGGGGSHHHHTS
T ss_pred --CHHHHhcCccccCC
Confidence 69999999999753
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-50 Score=377.02 Aligned_cols=252 Identities=27% Similarity=0.438 Sum_probs=220.0
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
.++|++.+.||+|+||+||+|.++.++. .||+|++.+..... ...+.+|+++++.++||||+++++++.+++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~a~k~~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRI----RRAAKKIPKYFVED----VDRFKQEIEIMKSLDHPNIIRLYETFEDNT 79 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEGGGCSC----HHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCc----EEEEEeehhhccch----HHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 4689999999999999999999887544 49999997654322 345677999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEE---ccCCCEEEccccccc
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILI---RQSGHVTLTDFDLSR 173 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl---~~~g~vkL~DFGla~ 173 (412)
.+|+|||||.|++|..++.... .+++.+++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~ 157 (277)
T 3f3z_A 80 DIYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157 (277)
T ss_dssp EEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred eEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence 9999999999999988776654 49999999999999999999999999999999999999 788999999999987
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
.... .......+||+.
T Consensus 158 ~~~~----------------------------------------------------------------~~~~~~~~~t~~ 173 (277)
T 3f3z_A 158 RFKP----------------------------------------------------------------GKMMRTKVGTPY 173 (277)
T ss_dssp ECCT----------------------------------------------------------------TSCBCCCCSCTT
T ss_pred eccC----------------------------------------------------------------ccchhccCCCCC
Confidence 5421 112234579999
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-----CCChHHHHHHHHhhhhCCCc
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-----GQRTALTDLIQRLLEKDPVK 328 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-----~~~~~~~dli~~~L~~dP~~ 328 (412)
|+|||++.+. ++.++|||||||++|+|++|..||.+.+..+....+......++ ..++.+.+||.+||+.||.+
T Consensus 174 y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~ 252 (277)
T 3f3z_A 174 YVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQ 252 (277)
T ss_dssp TCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTT
T ss_pred ccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhh
Confidence 9999998765 89999999999999999999999999998888888877665443 57899999999999999999
Q ss_pred cCCCCCChhhhhcCCCCCC
Q 042539 329 RLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 329 R~~~~~~~~e~l~h~ff~~ 347 (412)
|| ++.++++||||++
T Consensus 253 R~----s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 253 RI----TSLQALEHEWFEK 267 (277)
T ss_dssp SC----CHHHHTTSHHHHH
T ss_pred Cc----CHHHHhcCHHHhc
Confidence 99 6999999999974
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=411.64 Aligned_cols=259 Identities=27% Similarity=0.420 Sum_probs=219.8
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhh---------HHHHHHHHHHHHHHhhcCCCccc
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAK---------HEAERRARWEIRVLSRLSHPFLP 86 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~---------~~~~~~~~~Ei~il~~l~hpnIv 86 (412)
..++|+++++||+|+||+||+|+++.++. .||||++.+...... ......+.+|+.++++++||||+
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv 109 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHS----EKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNII 109 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCC----EEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBC
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCc----EEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCC
Confidence 35789999999999999999999987554 499999987653211 12345678899999999999999
Q ss_pred eeeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCC---C
Q 042539 87 KLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG---H 163 (412)
Q Consensus 87 ~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g---~ 163 (412)
++++++.++..+|+|||||.||+|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .
T Consensus 110 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 110 KLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSS
T ss_pred eEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999999988776654 499999999999999999999999999999999999999876 6
Q ss_pred EEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCC
Q 042539 164 VTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGE 243 (412)
Q Consensus 164 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (412)
+||+|||+|+.... ..
T Consensus 188 ~kl~Dfg~a~~~~~----------------------------------------------------------------~~ 203 (504)
T 3q5i_A 188 IKIVDFGLSSFFSK----------------------------------------------------------------DY 203 (504)
T ss_dssp EEECCCTTCEECCT----------------------------------------------------------------TS
T ss_pred EEEEECCCCEEcCC----------------------------------------------------------------CC
Confidence 99999999975421 11
Q ss_pred CCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-----CCCChHHHHHH
Q 042539 244 RSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF-----VGQRTALTDLI 318 (412)
Q Consensus 244 ~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~dli 318 (412)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+......+ ...++++++||
T Consensus 204 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 282 (504)
T 3q5i_A 204 KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELI 282 (504)
T ss_dssp CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHH
T ss_pred ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHH
Confidence 2234579999999999875 58999999999999999999999999999999988888765443 46789999999
Q ss_pred HHhhhhCCCccCCCCCChhhhhcCCCCCCCC
Q 042539 319 QRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 319 ~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~ 349 (412)
.+||+.||.+|| +++++++||||+...
T Consensus 283 ~~~L~~dp~~R~----t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 283 KLMLTYDYNKRC----TAEEALNSRWIKKYA 309 (504)
T ss_dssp HHHTCSSTTTSC----CHHHHHTSHHHHHTC
T ss_pred HHHcCCChhHCC----CHHHHhcCHhhhhch
Confidence 999999999999 799999999997643
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=399.29 Aligned_cols=252 Identities=29% Similarity=0.475 Sum_probs=213.1
Q ss_pred eeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEEEe
Q 042539 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAV 102 (412)
Q Consensus 23 ~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 102 (412)
.+.||+|+||.||+|++..++. .||+|+++.... .....+.+|++++++++||||+++++++.+.+.+|+||
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~----~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 165 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGL----KLAAKIIKTRGM----KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVM 165 (373)
T ss_dssp EEECC-----CEEEEEETTTCC----EEEEEEEECCSH----HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ceEEecCcCEEEEEEEEcCCCc----EEEEEEEccccc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 6789999999999999887554 499999976543 23456778999999999999999999999999999999
Q ss_pred eccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEE--ccCCCEEEccccccchhhchhh
Q 042539 103 PYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILI--RQSGHVTLTDFDLSRNLVKKTA 180 (412)
Q Consensus 103 e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl--~~~g~vkL~DFGla~~~~~~~~ 180 (412)
|||.|++|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 166 E~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~--- 241 (373)
T 2x4f_A 166 EYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP--- 241 (373)
T ss_dssp ECCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT---
T ss_pred eCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC---
Confidence 9999999987775432 358999999999999999999999999999999999999 5667899999999975421
Q ss_pred hhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceee
Q 042539 181 FEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVV 260 (412)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l 260 (412)
.......+||+.|+|||++
T Consensus 242 -------------------------------------------------------------~~~~~~~~gt~~y~aPE~~ 260 (373)
T 2x4f_A 242 -------------------------------------------------------------REKLKVNFGTPEFLAPEVV 260 (373)
T ss_dssp -------------------------------------------------------------TCBCCCCCSSCTTCCHHHH
T ss_pred -------------------------------------------------------------ccccccccCCCcEeChhhc
Confidence 1122345799999999999
Q ss_pred cCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-----CCCChHHHHHHHHhhhhCCCccCCCCCC
Q 042539 261 RGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF-----VGQRTALTDLIQRLLEKDPVKRLGYLRG 335 (412)
Q Consensus 261 ~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~dli~~~L~~dP~~R~~~~~~ 335 (412)
.+..++.++|||||||++|+|++|..||.+.+..+.+.++......+ ...++++.+||.+||+.||.+|| +
T Consensus 261 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp----s 336 (373)
T 2x4f_A 261 NYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRI----S 336 (373)
T ss_dssp TTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSC----C
T ss_pred cCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCC----C
Confidence 98889999999999999999999999999999988888887654332 45789999999999999999999 6
Q ss_pred hhhhhcCCCCCCCCch
Q 042539 336 ACEIKEHVFFKGVRWD 351 (412)
Q Consensus 336 ~~e~l~h~ff~~~~~~ 351 (412)
++++++||||++..+.
T Consensus 337 ~~e~l~hp~~~~~~~~ 352 (373)
T 2x4f_A 337 ASEALKHPWLSDHKLH 352 (373)
T ss_dssp HHHHHHSHHHHCHHHH
T ss_pred HHHHhcCcCcCCCchh
Confidence 9999999999987654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=411.40 Aligned_cols=255 Identities=27% Similarity=0.449 Sum_probs=215.3
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
++|++++.||+|+||+||+|+++.++. .||+|++.+...... ....+.+|+.+++.++|||||++++++.+...
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 110 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHV----ERAIKIIRKTSVSTS--SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRN 110 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCC----EEEEEEEEC-----C--TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCc----EEEEEEEeccccCch--HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 479999999999999999999987554 499999987653222 24567789999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccC---CCEEEccccccch
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQS---GHVTLTDFDLSRN 174 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~---g~vkL~DFGla~~ 174 (412)
+|+|||||.||+|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||+|+.
T Consensus 111 ~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 999999999999987776654 49999999999999999999999999999999999999764 4599999999975
Q ss_pred hhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCC
Q 042539 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254 (412)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 254 (412)
... .......+||+.|
T Consensus 189 ~~~----------------------------------------------------------------~~~~~~~~gt~~y 204 (494)
T 3lij_A 189 FEN----------------------------------------------------------------QKKMKERLGTAYY 204 (494)
T ss_dssp CBT----------------------------------------------------------------TBCBCCCCSCTTT
T ss_pred CCC----------------------------------------------------------------CccccccCCCcCe
Confidence 421 1122355799999
Q ss_pred ccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC-----CCCCChHHHHHHHHhhhhCCCcc
Q 042539 255 VSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE-----FVGQRTALTDLIQRLLEKDPVKR 329 (412)
Q Consensus 255 ~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~-----~~~~~~~~~dli~~~L~~dP~~R 329 (412)
+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+...... +...++.+++||.+||+.||.+|
T Consensus 205 ~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R 283 (494)
T 3lij_A 205 IAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRR 283 (494)
T ss_dssp CCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTS
T ss_pred eCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhC
Confidence 99999864 5899999999999999999999999999999988888765543 34678999999999999999999
Q ss_pred CCCCCChhhhhcCCCCCCCC
Q 042539 330 LGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 330 ~~~~~~~~e~l~h~ff~~~~ 349 (412)
| ++.++++||||+...
T Consensus 284 ~----s~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 284 I----SAQQALEHPWIKEMC 299 (494)
T ss_dssp C----CHHHHHTCHHHHHHH
T ss_pred c----cHHHHhcCcccccCc
Confidence 9 699999999998643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=377.49 Aligned_cols=262 Identities=28% Similarity=0.476 Sum_probs=227.0
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
.....++|++++.||+|+||+||+|++..++. .||+|++.+.... .......+.+|+.+++.++|+||+++++++
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~a~K~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 84 (294)
T 2rku_A 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKE----VFAGKIVPKSLLL-KPHQREKMSMEISIHRSLAHQHVVGFHGFF 84 (294)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEGGGCC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCCcccceEEEEEEeecCCEEEEEEEECCCCc----eEEEEEechhhcc-CHHHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence 34667899999999999999999999987554 4999999766542 234456778899999999999999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
.+++.+|+||||+.|++|..++.... .+++.++..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 162 (294)
T 2rku_A 85 EDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 162 (294)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred ccCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCc
Confidence 99999999999999999988776554 4999999999999999999999999999999999999999999999999998
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+.... ........+||+
T Consensus 163 ~~~~~---------------------------------------------------------------~~~~~~~~~~~~ 179 (294)
T 2rku_A 163 TKVEY---------------------------------------------------------------DGERKKVLCGTP 179 (294)
T ss_dssp EECCS---------------------------------------------------------------TTCCBCCCCSCC
T ss_pred eeccc---------------------------------------------------------------CccccccccCCC
Confidence 75421 111223457999
Q ss_pred CCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-CCCChHHHHHHHHhhhhCCCccCC
Q 042539 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF-VGQRTALTDLIQRLLEKDPVKRLG 331 (412)
Q Consensus 253 ~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~dli~~~L~~dP~~R~~ 331 (412)
.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+....... ...++.+.+||.+||+.||++||
T Consensus 180 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp- 258 (294)
T 2rku_A 180 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARP- 258 (294)
T ss_dssp SSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSC-
T ss_pred CcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHHHcccChhhCc-
Confidence 9999999999889999999999999999999999999998888877777655444 34678999999999999999999
Q ss_pred CCCChhhhhcCCCCCCC
Q 042539 332 YLRGACEIKEHVFFKGV 348 (412)
Q Consensus 332 ~~~~~~e~l~h~ff~~~ 348 (412)
+++++++|+||...
T Consensus 259 ---s~~~ll~~~~~~~~ 272 (294)
T 2rku_A 259 ---TINELLNDEFFTSG 272 (294)
T ss_dssp ---CGGGGGGSHHHHTS
T ss_pred ---CHHHHhhChheecC
Confidence 69999999999753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-50 Score=385.47 Aligned_cols=266 Identities=27% Similarity=0.409 Sum_probs=209.7
Q ss_pred CccCceee-eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeeeeEE
Q 042539 16 DLDNLKAL-KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLGSLE 93 (412)
Q Consensus 16 ~~~~y~~~-~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 93 (412)
..++|++. +.||+|+||+||+|++..++ +.||||++.+... .....+.+|++++.++ +||||+++++++.
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~----~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~ 81 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITS----QEYAVKIIEKQPG----HIRSRVFREVEMLYQCQGHRNVLELIEFFE 81 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSC----CEEEEEEEECCSS----CCHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCC----cEEEEEEEeeCcc----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 45789996 78999999999999987654 4499999976532 2244567799999995 6999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCC---EEEcccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGH---VTLTDFD 170 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~---vkL~DFG 170 (412)
+++.+|+|||||.||+|..++.... .+++.+++.++.||+.||+|||++||+||||||+|||++.++. +||+|||
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg 159 (316)
T 2ac3_A 82 EEDRFYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFD 159 (316)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred eCCEEEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence 9999999999999999998887654 4999999999999999999999999999999999999998876 9999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+++.......... .........+|
T Consensus 160 ~~~~~~~~~~~~~--------------------------------------------------------~~~~~~~~~~g 183 (316)
T 2ac3_A 160 LGSGIKLNGDCSP--------------------------------------------------------ISTPELLTPCG 183 (316)
T ss_dssp CCC---------------------------------------------------------------------------CC
T ss_pred CccccccCCcccc--------------------------------------------------------ccccccccccC
Confidence 9976532110000 01112234579
Q ss_pred CCCCccceeecC-----CCCCchhhHHHHHHHHHHHhhCCCCCCCCC---------------HHHHHHHHhcCCCCCC--
Q 042539 251 TEEYVSPEVVRG-----DGHEFAVDWWALGILTYEMLYGTTPFRGKN---------------RKETFRNVLMKTPEFV-- 308 (412)
Q Consensus 251 t~~Y~APE~l~~-----~~~~~~~DiwSlGvil~ell~g~~Pf~~~~---------------~~~~~~~i~~~~~~~~-- 308 (412)
|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+ ....+..+......++
T Consensus 184 t~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 263 (316)
T 2ac3_A 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDK 263 (316)
T ss_dssp SGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHH
T ss_pred CcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCch
Confidence 999999999975 457889999999999999999999998754 2345555555544443
Q ss_pred ---CCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCch
Q 042539 309 ---GQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 309 ---~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~ 351 (412)
..++++.+||.+||..||.+|| +++++++||||++..+.
T Consensus 264 ~~~~~~~~~~~li~~~L~~dP~~Rp----s~~e~l~hp~~~~~~~~ 305 (316)
T 2ac3_A 264 DWAHISCAAKDLISKLLVRDAKQRL----SAAQVLQHPWVQGCAPE 305 (316)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSC----CHHHHHHSTTCC-----
T ss_pred hcccCCHHHHHHHHHHhhCChhhCC----CHHHHhcChhhcCCCCc
Confidence 5688999999999999999999 69999999999987654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=378.27 Aligned_cols=268 Identities=27% Similarity=0.425 Sum_probs=224.0
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhh-----hhhHHHHHHHHHHHHHHhhcC-CCccc
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTL-----HAKHEAERRARWEIRVLSRLS-HPFLP 86 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~-----~~~~~~~~~~~~Ei~il~~l~-hpnIv 86 (412)
..-..++|++++.||+|+||.||+|+++.++ +.||||+++.... .........+.+|+.+++++. ||||+
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~ 87 (298)
T 1phk_A 12 THGFYENYEPKEILGRGVSSVVRRCIHKPTC----KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 87 (298)
T ss_dssp ---CTTTEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBC
T ss_pred CcchhhccceeeeecCCCceEEEEEEEcCcC----ceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEe
Confidence 3456799999999999999999999997754 4499999975431 112334567788999999996 99999
Q ss_pred eeeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEE
Q 042539 87 KLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTL 166 (412)
Q Consensus 87 ~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL 166 (412)
++++++.+++.+|+||||+.|++|..++.... .+++..+..++.||+.||.|||++||+||||||+||+++.+|.+||
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl 165 (298)
T 1phk_A 88 QLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKL 165 (298)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEE
T ss_pred eeeeeeccCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEE
Confidence 99999999999999999999999998887654 4999999999999999999999999999999999999999999999
Q ss_pred ccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCc
Q 042539 167 TDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSN 246 (412)
Q Consensus 167 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (412)
+|||++..... .....
T Consensus 166 ~dfg~~~~~~~----------------------------------------------------------------~~~~~ 181 (298)
T 1phk_A 166 TDFGFSCQLDP----------------------------------------------------------------GEKLR 181 (298)
T ss_dssp CCCTTCEECCT----------------------------------------------------------------TCCBC
T ss_pred ecccchhhcCC----------------------------------------------------------------Ccccc
Confidence 99999875421 11223
Q ss_pred ccccCCCCccceeec------CCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-----CCCChHHH
Q 042539 247 SFVGTEEYVSPEVVR------GDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF-----VGQRTALT 315 (412)
Q Consensus 247 ~~~gt~~Y~APE~l~------~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~ 315 (412)
..+||+.|+|||++. ...++.++|||||||++|+|++|..||.+.+.......+......+ ...+..+.
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 261 (298)
T 1phk_A 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK 261 (298)
T ss_dssp CCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHH
T ss_pred cccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHHH
Confidence 457899999999985 4467899999999999999999999999988888877777654333 34678999
Q ss_pred HHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCchhhc
Q 042539 316 DLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLT 354 (412)
Q Consensus 316 dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~~~~ 354 (412)
+||.+||..||.+|| +++++++||||++..++.+.
T Consensus 262 ~li~~~l~~dp~~Rp----s~~~ll~h~~~~~~~~~~~~ 296 (298)
T 1phk_A 262 DLVSRFLVVQPQKRY----TAEEALAHPFFQQYVVEEVR 296 (298)
T ss_dssp HHHHHHCCSSGGGSC----CHHHHTTSGGGCTTC-----
T ss_pred HHHHHHccCCcccCC----CHHHHHhChHhhhccchhhc
Confidence 999999999999999 69999999999988876543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=392.33 Aligned_cols=267 Identities=27% Similarity=0.414 Sum_probs=212.1
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhh-hHHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHA-KHEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
....++|++++.||+|+||+||+|++..++ +.||||++....... .......+.+|+++++.++||||+++++++
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTN----QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF 81 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCC----SEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCC----cEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE
Confidence 345689999999999999999999987754 449999997654321 122234677899999999999999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
.+.+.+|+|||||.| +|..++.. ....+++.+++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 82 ~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 82 GHKSNISLVFDFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CCTTCCEEEEECCSE-EHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred eeCCceEEEEEcCCC-CHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccc
Confidence 999999999999986 67666544 3346899999999999999999999999999999999999999999999999999
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+.+.. ........+||+
T Consensus 160 ~~~~~---------------------------------------------------------------~~~~~~~~~~t~ 176 (346)
T 1ua2_A 160 KSFGS---------------------------------------------------------------PNRAYTHQVVTR 176 (346)
T ss_dssp STTTS---------------------------------------------------------------CCCCCCCSCCCC
T ss_pred eeccC---------------------------------------------------------------CcccCCcccccc
Confidence 75421 111223457999
Q ss_pred CCccceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CC---C--------------------
Q 042539 253 EYVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK--TP---E-------------------- 306 (412)
Q Consensus 253 ~Y~APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~~---~-------------------- 306 (412)
.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+.++... .+ .
T Consensus 177 ~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (346)
T 1ua2_A 177 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIP 256 (346)
T ss_dssp TTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCC
T ss_pred cccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCC
Confidence 99999999765 4799999999999999999999999999988877776531 10 0
Q ss_pred ----CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCchhh
Q 042539 307 ----FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLL 353 (412)
Q Consensus 307 ----~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~~~ 353 (412)
+...++++.+||.+||..||++|| +++|+++||||++..+...
T Consensus 257 ~~~~~~~~~~~~~~li~~~L~~dP~~Rp----t~~ell~h~~f~~~~~~~~ 303 (346)
T 1ua2_A 257 LHHIFSAAGDDLLDLIQGLFLFNPCARI----TATQALKMKYFSNRPGPTP 303 (346)
T ss_dssp HHHHCTTCCHHHHHHHHHHHCSSTTTSC----CHHHHHTSGGGTSSSCCCC
T ss_pred hHHhhccCCHHHHHHHHHHhccChhhCC----CHHHHhcChhhhcCCCCCC
Confidence 123468899999999999999999 7999999999998766544
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=396.73 Aligned_cols=255 Identities=25% Similarity=0.420 Sum_probs=200.8
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC--
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD-- 95 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-- 95 (412)
++|++++.||+|+||.||+|.+..++ +.||||++.+... .....+++.+|+.+++.++||||+++++++...
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~----~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 102 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTG----LRVAVKKLSRPFQ--SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 102 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTT----EEEEEEECSSTTS--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred CceEEeeEEeecCCeEEEEEEECCCC----CEEEEEEeCcccc--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCc
Confidence 79999999999999999999987754 4599999966432 234456778899999999999999999999754
Q ss_pred ----CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 96 ----EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 96 ----~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
..+|+|||++ |++|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus 103 ~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 103 LEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp GGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred cccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5689999999 7899877654 3599999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
++.... .....+||
T Consensus 179 a~~~~~------------------------------------------------------------------~~~~~~~t 192 (367)
T 2fst_X 179 ARHTAD------------------------------------------------------------------EMTGYVAT 192 (367)
T ss_dssp ------------------------------------------------------------------------------CC
T ss_pred cccccc------------------------------------------------------------------cCCCcCcC
Confidence 975321 11245799
Q ss_pred CCCccceeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CC---------------------C-
Q 042539 252 EEYVSPEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK--TP---------------------E- 306 (412)
Q Consensus 252 ~~Y~APE~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~~---------------------~- 306 (412)
+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+... .+ .
T Consensus 193 ~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~ 272 (367)
T 2fst_X 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 272 (367)
T ss_dssp CTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCC
T ss_pred cCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCC
Confidence 99999999987 67899999999999999999999999999887776665431 00 0
Q ss_pred --------CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCchh
Q 042539 307 --------FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDL 352 (412)
Q Consensus 307 --------~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~~ 352 (412)
++..++.+.+||.+||+.||.+|+ +++++++||||+......
T Consensus 273 ~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~----t~~e~L~hp~~~~~~~~~ 322 (367)
T 2fst_X 273 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRI----TAAQALAHAYFAQYHDPD 322 (367)
T ss_dssp CCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSC----CHHHHHTSGGGTTTCCGG
T ss_pred CCCCHHHHCCCCCHHHHHHHHHhCCCCcccCc----CHHHHhcChhhhhccCCC
Confidence 134578899999999999999999 799999999999876544
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=379.54 Aligned_cols=260 Identities=27% Similarity=0.505 Sum_probs=196.6
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
.+++|++++.||+|+||.||+|++..++ +.||||++.+..... ......+.+|+.+++.++||||+++++++.+.
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 83 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTG----LEVAIKMIDKKAMYK-AGMVQRVQNEVKIHCQLKHPSILELYNYFEDS 83 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTC----CEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS
T ss_pred ccccceeeeeecCCCceEEEEEEEccCC----ceEEEEEeehhhhhh-hhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC
Confidence 5689999999999999999999987654 449999997654322 22346678899999999999999999999999
Q ss_pred CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchh
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
+.+|+||||+.|++|..++... ...+++.+++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++...
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 84 NYVYLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQL 162 (278)
T ss_dssp SEEEEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred CeEEEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence 9999999999999998887653 245999999999999999999999999999999999999999999999999998754
Q ss_pred hchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCc
Q 042539 176 VKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYV 255 (412)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 255 (412)
... .......+||+.|+
T Consensus 163 ~~~---------------------------------------------------------------~~~~~~~~~~~~y~ 179 (278)
T 3cok_A 163 KMP---------------------------------------------------------------HEKHYTLCGTPNYI 179 (278)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred cCC---------------------------------------------------------------CCcceeccCCCCcC
Confidence 211 01122457899999
Q ss_pred cceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCccCCCCC
Q 042539 256 SPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKRLGYLR 334 (412)
Q Consensus 256 APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R~~~~~ 334 (412)
|||++.+..++.++|||||||++|+|++|+.||...+.......+.......+ ..+.++.+||.+||..||.+||
T Consensus 180 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---- 255 (278)
T 3cok_A 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADRL---- 255 (278)
T ss_dssp ------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHHHSCSSGGGSC----
T ss_pred CcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHHHcccCHhhCC----
Confidence 99999998899999999999999999999999988765555555544333333 4678999999999999999999
Q ss_pred ChhhhhcCCCCCCC
Q 042539 335 GACEIKEHVFFKGV 348 (412)
Q Consensus 335 ~~~e~l~h~ff~~~ 348 (412)
+++++++||||.+.
T Consensus 256 s~~~~l~h~~~~~~ 269 (278)
T 3cok_A 256 SLSSVLDHPFMSRN 269 (278)
T ss_dssp CHHHHTTSTTTC--
T ss_pred CHHHHhcCccccCC
Confidence 69999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=387.14 Aligned_cols=255 Identities=23% Similarity=0.322 Sum_probs=204.7
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeeee
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLGS 91 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~ 91 (412)
.++..++|+++++||+|+||+||+|+++.++. .||||++...... ........+|+..+..+ +|+||++++++
T Consensus 52 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~--~~~~~~~~~e~~~~~~~~~h~~iv~l~~~ 125 (311)
T 3p1a_A 52 ESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGR----LYAVKRSMSPFRG--PKDRARKLAEVGSHEKVGQHPCCVRLEQA 125 (311)
T ss_dssp SCHHHHHEEEEEEEEEETTEEEEEEEETTTSC----EEEEEEESSSCCS--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cchhhhheeeeheeccCCCeEEEEEEECCCCe----EEEEEEecccccC--hHHHHHHHHHHHHHHHhcCCCcEEEEEEE
Confidence 34445889999999999999999999987544 4999998654322 22233444466666655 89999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
+.+++.+|+||||| +++|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus 126 ~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~ 203 (311)
T 3p1a_A 126 WEEGGILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGL 203 (311)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTT
T ss_pred EEeCCEEEEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEcccee
Confidence 99999999999999 668877766543 4599999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
++.... .......+||
T Consensus 204 a~~~~~----------------------------------------------------------------~~~~~~~~gt 219 (311)
T 3p1a_A 204 LVELGT----------------------------------------------------------------AGAGEVQEGD 219 (311)
T ss_dssp CEECC----------------------------------------------------------------------CCCCC
T ss_pred eeeccc----------------------------------------------------------------CCCCcccCCC
Confidence 875421 1112345699
Q ss_pred CCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC---CCCCCChHHHHHHHHhhhhCCCc
Q 042539 252 EEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP---EFVGQRTALTDLIQRLLEKDPVK 328 (412)
Q Consensus 252 ~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~dli~~~L~~dP~~ 328 (412)
+.|+|||++.+ .++.++|||||||++|||++|..||.+... ...+..... .....++++.+||.+||+.||++
T Consensus 220 ~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 295 (311)
T 3p1a_A 220 PRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKL 295 (311)
T ss_dssp GGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTT
T ss_pred ccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHHHHHHcCCChhh
Confidence 99999999987 689999999999999999999777765332 223322221 12356889999999999999999
Q ss_pred cCCCCCChhhhhcCCCCCC
Q 042539 329 RLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 329 R~~~~~~~~e~l~h~ff~~ 347 (412)
|| +++++++||||+.
T Consensus 296 Rp----t~~ell~hp~~~~ 310 (311)
T 3p1a_A 296 RA----TAEALLALPVLRQ 310 (311)
T ss_dssp SC----CHHHHHTSGGGSC
T ss_pred Cc----CHHHHHhCccccC
Confidence 99 7999999999974
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=389.78 Aligned_cols=265 Identities=29% Similarity=0.413 Sum_probs=219.0
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
...-.+++|++++.||+|+||.||+|++..++. .||||++..... .......+.+|+.+++.++||||++++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 92 (331)
T 4aaa_A 19 LYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGR----IVAIKKFLESDD--DKMVKKIAMREIKLLKQLRHENLVNLLEV 92 (331)
T ss_dssp CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCC----EEEEEEEESCSS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhhhhhhheeeeEEeecCCEEEEEEEECCCCc----eEEEEEEecCCC--chHHHHHHHHHHHHHhhCCCCCEeeEEEE
Confidence 445578999999999999999999999987554 499999866542 33455667789999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
+.+.+.+|+||||+.|++|..+.... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+
T Consensus 93 ~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 170 (331)
T 4aaa_A 93 CKKKKRWYLVFEFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGF 170 (331)
T ss_dssp EEETTEEEEEEECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred eecCCEEEEEEecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCC
Confidence 99999999999999999987765443 3599999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
++.+... .......+||
T Consensus 171 ~~~~~~~---------------------------------------------------------------~~~~~~~~~t 187 (331)
T 4aaa_A 171 ARTLAAP---------------------------------------------------------------GEVYDDEVAT 187 (331)
T ss_dssp C---------------------------------------------------------------------------CCCC
T ss_pred ceeecCC---------------------------------------------------------------ccccCCCcCC
Confidence 9754211 1112345789
Q ss_pred CCCccceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC----------------------C---
Q 042539 252 EEYVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT----------------------P--- 305 (412)
Q Consensus 252 ~~Y~APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~----------------------~--- 305 (412)
+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+....+.... +
T Consensus 188 ~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
T 4aaa_A 188 RWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIK 267 (331)
T ss_dssp CTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCS
T ss_pred ccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCcccc
Confidence 999999999876 67999999999999999999999999988777665554210 0
Q ss_pred -------CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCch
Q 042539 306 -------EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 306 -------~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~ 351 (412)
.++..++.+.+||.+||+.||.+|| +++|+++||||+...+.
T Consensus 268 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp----t~~ell~hp~f~~~~~~ 316 (331)
T 4aaa_A 268 EREPLERRYPKLSEVVIDLAKKCLHIDPDKRP----FCAELLHHDFFQMDGFA 316 (331)
T ss_dssp SCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSC----CGGGGGGSHHHHGGGHH
T ss_pred ccchhhhcccchhHHHHHHHHHHhccCcccCC----CHHHHhcCchhccCChh
Confidence 0135678999999999999999999 69999999999876553
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-50 Score=381.67 Aligned_cols=264 Identities=25% Similarity=0.451 Sum_probs=220.1
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE--e
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE--T 94 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~ 94 (412)
+++|++++.||+|+||.||+|.+..++ +.||+|++++............+.+|+++++.++||||+++++++. +
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETL----CRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEE 79 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTC----CEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCC----cEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence 579999999999999999999987654 4499999987654333345667888999999999999999999984 4
Q ss_pred CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
...+|+|||||.++ |..++.......+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 80 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 80 KQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp --CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 56899999999887 55566655556799999999999999999999999999999999999999999999999999975
Q ss_pred hhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCC
Q 042539 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254 (412)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 254 (412)
.... ..........||+.|
T Consensus 159 ~~~~-------------------------------------------------------------~~~~~~~~~~~~~~y 177 (305)
T 2wtk_C 159 LHPF-------------------------------------------------------------AADDTCRTSQGSPAF 177 (305)
T ss_dssp CCTT-------------------------------------------------------------CSSCEECCCCSCGGG
T ss_pred cCcc-------------------------------------------------------------ccccccccCCCCCCC
Confidence 4210 011122345699999
Q ss_pred ccceeecCCCC--CchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCccCC
Q 042539 255 VSPEVVRGDGH--EFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKRLG 331 (412)
Q Consensus 255 ~APE~l~~~~~--~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R~~ 331 (412)
+|||++.+... +.++|||||||++|+|++|..||.+.+..+....+......++ ..++.+.+||.+||..||.+||
T Consensus 178 ~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp- 256 (305)
T 2wtk_C 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRF- 256 (305)
T ss_dssp CCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHHHHHHHHTCSSTTTSC-
T ss_pred cChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHHHHHHHHccCChhhCC-
Confidence 99999987543 7899999999999999999999999998888888776654443 5678999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCc
Q 042539 332 YLRGACEIKEHVFFKGVRW 350 (412)
Q Consensus 332 ~~~~~~e~l~h~ff~~~~~ 350 (412)
+++++++||||++...
T Consensus 257 ---s~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 257 ---SIRQIRQHSWFRKKHP 272 (305)
T ss_dssp ---CHHHHHHSHHHHSCCC
T ss_pred ---CHHHHhcCcccccCCC
Confidence 6999999999987554
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=391.84 Aligned_cols=268 Identities=23% Similarity=0.395 Sum_probs=206.6
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
+++|++++.||+|+||+||+|+++.++. .||||+++... .....+.+.+|++++++++||||++++++|.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~----~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 77 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDC----NYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLETP 77 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCC----EEEEEEEECCS---TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECC
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCc----EEEEEEeecCC---chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEec
Confidence 5789999999999999999999987554 49999997543 2234566788999999999999999999986543
Q ss_pred ---------------------------------------------------------eEEEEeeccCCCCchhHHHhhCC
Q 042539 97 ---------------------------------------------------------FLAWAVPYCPGGDLNVLRYKQND 119 (412)
Q Consensus 97 ---------------------------------------------------------~~~lv~e~~~gg~L~~~~~~~~~ 119 (412)
.+|+|||||.||+|..++.....
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 157 (332)
T 3qd2_B 78 PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157 (332)
T ss_dssp SCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS
T ss_pred cchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC
Confidence 38999999999999988765432
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCC
Q 042539 120 -RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTE 198 (412)
Q Consensus 120 -~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (412)
...++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++............
T Consensus 158 ~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~------------- 224 (332)
T 3qd2_B 158 LEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL------------- 224 (332)
T ss_dssp GGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------------
T ss_pred ccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccc-------------
Confidence 124556789999999999999999999999999999999999999999999998663221100000
Q ss_pred CcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHH
Q 042539 199 NPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILT 278 (412)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil 278 (412)
............+||+.|+|||++.+..++.++|||||||++
T Consensus 225 --------------------------------------~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 266 (332)
T 3qd2_B 225 --------------------------------------TPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLIL 266 (332)
T ss_dssp ---------------------------------------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHH
T ss_pred --------------------------------------ccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHH
Confidence 000011223456899999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCCHHHHHHHHhcCCCC--CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCC
Q 042539 279 YEMLYGTTPFRGKNRKETFRNVLMKTPE--FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 279 ~ell~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~ 348 (412)
|+|++|..|+.. .......+...... ....++++.+||.+||+.||.+|| +++++++||||+++
T Consensus 267 ~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----s~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 267 FELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERP----EATDIIENAIFENL 332 (332)
T ss_dssp HHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSC----CHHHHHHSTTCCCC
T ss_pred HHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCC----CHHHHhhchhhhcC
Confidence 999999877632 12222333222211 123457889999999999999999 69999999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=383.41 Aligned_cols=253 Identities=25% Similarity=0.394 Sum_probs=217.4
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeE
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFL 98 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 98 (412)
.|...+.||+|+||+||+|+++.++. .||||++...... ....+.+|+.+++.++||||+++++++...+.+
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~----~vavK~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGR----QVAVKMMDLRKQQ----RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL 117 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEETTTCC----SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCc----EEEEEEEeccchh----HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence 47888999999999999999876544 4999999754322 234566799999999999999999999999999
Q ss_pred EEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhch
Q 042539 99 AWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~ 178 (412)
|+||||+.|++|..++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 118 ~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~- 193 (321)
T 2c30_A 118 WVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK- 193 (321)
T ss_dssp EEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS-
T ss_pred EEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeeccc-
Confidence 999999999999887653 3499999999999999999999999999999999999999999999999999875421
Q ss_pred hhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccce
Q 042539 179 TAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPE 258 (412)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 258 (412)
........+||+.|+|||
T Consensus 194 --------------------------------------------------------------~~~~~~~~~gt~~y~aPE 211 (321)
T 2c30_A 194 --------------------------------------------------------------DVPKRKSLVGTPYWMAPE 211 (321)
T ss_dssp --------------------------------------------------------------SSCCBCCCCSCGGGCCHH
T ss_pred --------------------------------------------------------------CccccccccCCccccCHh
Confidence 111123567999999999
Q ss_pred eecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC----CCCChHHHHHHHHhhhhCCCccCCCCC
Q 042539 259 VVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF----VGQRTALTDLIQRLLEKDPVKRLGYLR 334 (412)
Q Consensus 259 ~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~dli~~~L~~dP~~R~~~~~ 334 (412)
++.+..++.++|||||||++|+|++|+.||.+.+..+....+....+.. ...++.+.+||.+||..||++||
T Consensus 212 ~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---- 287 (321)
T 2c30_A 212 VISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERA---- 287 (321)
T ss_dssp HHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSC----
T ss_pred hhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCc----
Confidence 9999999999999999999999999999999988888777776544322 24578999999999999999999
Q ss_pred ChhhhhcCCCCCCCC
Q 042539 335 GACEIKEHVFFKGVR 349 (412)
Q Consensus 335 ~~~e~l~h~ff~~~~ 349 (412)
+++++++||||....
T Consensus 288 s~~ell~hp~~~~~~ 302 (321)
T 2c30_A 288 TAQELLDHPFLLQTG 302 (321)
T ss_dssp CHHHHHTSGGGGGCC
T ss_pred CHHHHhcChhhccCC
Confidence 699999999997543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=393.16 Aligned_cols=263 Identities=24% Similarity=0.340 Sum_probs=212.9
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe-
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET- 94 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~- 94 (412)
.+++|++++.||+|+||+||+|+++.++. .||||++....... .....+.+|+.+++.++||||+++++++.+
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 88 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQ----KVALKKVLMENEKE--GFPITALREIKILQLLKHENVVNLIEICRTK 88 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCC----EEEEEECCCSSCSS--SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCC----EEEEEEEecccccc--cchHHHHHHHHHHHhccCCCcccHhheeecc
Confidence 57899999999999999999999987554 49999996654321 223455679999999999999999999987
Q ss_pred -------CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEc
Q 042539 95 -------DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLT 167 (412)
Q Consensus 95 -------~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~ 167 (412)
++.+|+|||||.| +|...+... ...+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~ 166 (351)
T 3mi9_A 89 ASPYNRCKGSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLA 166 (351)
T ss_dssp --------CEEEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEEC
T ss_pred ccccccCCceEEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEc
Confidence 4579999999976 555454433 2459999999999999999999999999999999999999999999999
Q ss_pred cccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcc
Q 042539 168 DFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNS 247 (412)
Q Consensus 168 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (412)
|||+|+.+..... ........
T Consensus 167 Dfg~a~~~~~~~~-----------------------------------------------------------~~~~~~~~ 187 (351)
T 3mi9_A 167 DFGLARAFSLAKN-----------------------------------------------------------SQPNRYTN 187 (351)
T ss_dssp CCTTCEECCCCSS-----------------------------------------------------------SSCCCCCS
T ss_pred cchhccccccccc-----------------------------------------------------------ccccccCC
Confidence 9999976521100 11122345
Q ss_pred cccCCCCccceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC---CC--CCCC------------
Q 042539 248 FVGTEEYVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK---TP--EFVG------------ 309 (412)
Q Consensus 248 ~~gt~~Y~APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~---~~--~~~~------------ 309 (412)
.+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+.......+... .+ .++.
T Consensus 188 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (351)
T 3mi9_A 188 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLEL 267 (351)
T ss_dssp SCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCC
T ss_pred cccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhccccc
Confidence 6799999999999874 5799999999999999999999999999888776665431 11 0111
Q ss_pred ----------------CChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCC
Q 042539 310 ----------------QRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 310 ----------------~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~ 349 (412)
.++.+.+||.+||+.||++|| +++|+++||||....
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~----t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 268 VKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI----DSDDALNHDFFWSDP 319 (351)
T ss_dssp CSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSC----CHHHHHTSGGGGSSS
T ss_pred ccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCC----CHHHHhCCCCcCCCC
Confidence 156799999999999999999 799999999998643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=374.90 Aligned_cols=261 Identities=25% Similarity=0.420 Sum_probs=216.8
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
...+..++|++++.||+|+||.||+|+++.++ +.||||++....... ......+.+|+.+++.++||||++++++
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 79 (276)
T 2h6d_A 5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTG----HKVAVKILNRQKIRS-LDVVGKIKREIQNLKLFRHPHIIKLYQV 79 (276)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTC----CEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cCcceeccEEEEeeecCCCCeEEEEEEECCCC----ceEEEEEeccccccc-hhHHHHHHHHHHHHhcCCCCCEeEEEEE
Confidence 45678899999999999999999999987654 449999997654322 2334567789999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
+.+.+.+|+||||+.|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+
T Consensus 80 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~ 157 (276)
T 2h6d_A 80 ISTPTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGL 157 (276)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCG
T ss_pred EecCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeeccc
Confidence 999999999999999999998887654 489999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
+..... .......+||
T Consensus 158 ~~~~~~----------------------------------------------------------------~~~~~~~~~~ 173 (276)
T 2h6d_A 158 SNMMSD----------------------------------------------------------------GEFLRTSCGS 173 (276)
T ss_dssp GGCCCC--------------------------------------------------------------------------
T ss_pred ccccCC----------------------------------------------------------------CcceecccCC
Confidence 865421 1112244789
Q ss_pred CCCccceeecCCCC-CchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCcc
Q 042539 252 EEYVSPEVVRGDGH-EFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKR 329 (412)
Q Consensus 252 ~~Y~APE~l~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R 329 (412)
+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......+ ..+..+.+||.+||+.||.+|
T Consensus 174 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 253 (276)
T 2h6d_A 174 PNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKR 253 (276)
T ss_dssp ---CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred ccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHHHHHccCChhhC
Confidence 99999999998776 6899999999999999999999999888888777776554443 457899999999999999999
Q ss_pred CCCCCChhhhhcCCCCCC
Q 042539 330 LGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 330 ~~~~~~~~e~l~h~ff~~ 347 (412)
| +++++++||||+.
T Consensus 254 p----s~~~~l~h~~~~~ 267 (276)
T 2h6d_A 254 A----TIKDIREHEWFKQ 267 (276)
T ss_dssp C----CHHHHHHSHHHHT
T ss_pred C----CHHHHHhChhhcc
Confidence 9 6999999999975
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-50 Score=391.57 Aligned_cols=263 Identities=25% Similarity=0.412 Sum_probs=221.3
Q ss_pred CCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeee
Q 042539 11 TTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLG 90 (412)
Q Consensus 11 ~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 90 (412)
...++..++|++++.||+|+||+||+|++..++. .||+|++.... .......+.+|+.+++.++||||+++++
T Consensus 26 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~va~K~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 98 (360)
T 3eqc_A 26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGL----VMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYG 98 (360)
T ss_dssp TCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEECCC---CHHHHHHHHHHHGGGGGCCCTTBCCEEE
T ss_pred cccccccccceeeeeecCCCCeEEEEEEECCCCc----EEEEEEecccc---CHHHHHHHHHHHHHHHHCCCCCEEEEeE
Confidence 3567888999999999999999999999987554 49999997653 2344567888999999999999999999
Q ss_pred eEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeeeCCCCceEEccCCCEEEccc
Q 042539 91 SLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNM-GIAYRDLKPENILIRQSGHVTLTDF 169 (412)
Q Consensus 91 ~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~-~iiHrDlKp~NiLl~~~g~vkL~DF 169 (412)
++.+++.+|+|||||.|++|..++.... .+++..+..++.|++.||.|||+. ||+||||||+|||++.+|.+||+||
T Consensus 99 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Df 176 (360)
T 3eqc_A 99 AFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDF 176 (360)
T ss_dssp EEEETTEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCC
T ss_pred EEEECCEEEEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEEC
Confidence 9999999999999999999998887654 499999999999999999999996 9999999999999999999999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|+++..... .....+
T Consensus 177 g~~~~~~~~-----------------------------------------------------------------~~~~~~ 191 (360)
T 3eqc_A 177 GVSGQLIDS-----------------------------------------------------------------MANSFV 191 (360)
T ss_dssp CCCHHHHHH-----------------------------------------------------------------C----C
T ss_pred CCCcccccc-----------------------------------------------------------------cccCCC
Confidence 999765321 112457
Q ss_pred cCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHH------------------------------
Q 042539 250 GTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRN------------------------------ 299 (412)
Q Consensus 250 gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~------------------------------ 299 (412)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....
T Consensus 192 gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (360)
T 3eqc_A 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDS 271 (360)
T ss_dssp CCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------------
T ss_pred CCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCC
Confidence 99999999999999999999999999999999999999988765543221
Q ss_pred ------------HhcCC-CCC--CCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCch
Q 042539 300 ------------VLMKT-PEF--VGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 300 ------------i~~~~-~~~--~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~ 351 (412)
+.... +.. ...+.++.+||.+||+.||++|| +++++++||||++.+|+
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp----t~~ell~hp~~~~~~~~ 334 (360)
T 3eqc_A 272 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA----DLKQLMVHAFIKRSDAE 334 (360)
T ss_dssp --CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSC----CHHHHHTSHHHHHHHHS
T ss_pred CCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCC----CHHHHhhChHhhcchHh
Confidence 11111 111 23578999999999999999999 79999999999876554
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-50 Score=394.05 Aligned_cols=269 Identities=25% Similarity=0.403 Sum_probs=210.5
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
..++|++++.||+|+||+||+|.+..++ +.||||++.+... .......+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 96 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILE----RNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQ 96 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEEECTTS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCC----ceEEEEEeccccC--ChHHHHHHHHHHHHHHhcCCCCccceEEeeccc
Confidence 3589999999999999999999987754 4499999976432 234456777899999999999999999999766
Q ss_pred C------eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccc
Q 042539 96 E------FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169 (412)
Q Consensus 96 ~------~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DF 169 (412)
+ .+|+|||||.| +|..++. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+||
T Consensus 97 ~~~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df 171 (371)
T 2xrw_A 97 KSLEEFQDVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 171 (371)
T ss_dssp CSTTTCCEEEEEEECCSE-EHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred cccccccceEEEEEcCCC-CHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEe
Confidence 4 78999999975 5655553 23899999999999999999999999999999999999999999999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|+++..... ......+
T Consensus 172 g~a~~~~~~----------------------------------------------------------------~~~~~~~ 187 (371)
T 2xrw_A 172 GLARTAGTS----------------------------------------------------------------FMMTPYV 187 (371)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred ecccccccc----------------------------------------------------------------cccCCce
Confidence 999754211 1123457
Q ss_pred cCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC----------------------CC
Q 042539 250 GTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP----------------------EF 307 (412)
Q Consensus 250 gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~----------------------~~ 307 (412)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..++.... .+
T Consensus 188 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (371)
T 2xrw_A 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKY 267 (371)
T ss_dssp --CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCC
T ss_pred ecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccc
Confidence 99999999999999999999999999999999999999999988877777654211 11
Q ss_pred CC---------------------CChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCchhhcccCCCCCCCC
Q 042539 308 VG---------------------QRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPS 364 (412)
Q Consensus 308 ~~---------------------~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~~~~~~~~pp~~p~ 364 (412)
.. .+.++++||.+||+.||++|| +++++++||||+....... ....+|..|.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~----t~~e~l~hp~~~~~~~~~~-~~~~~~~~~~ 340 (371)
T 2xrw_A 268 AGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI----SVDEALQHPYINVWYDPSE-AEAPPPKIPD 340 (371)
T ss_dssp CCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSC----CHHHHHHSHHHHTTCCHHH-HTCCCCCCCT
T ss_pred cccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCC----CHHHHhCCcchhhhcCccc-cCCCCCCCCC
Confidence 10 035789999999999999999 7999999999986433222 2234444444
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-50 Score=397.18 Aligned_cols=260 Identities=26% Similarity=0.441 Sum_probs=211.7
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
.+....+|++++.||+|+||+||+|++..++ . ||+|.+.+..... .+|+++++.++||||++++++|
T Consensus 35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~----~-~aikk~~~~~~~~--------~~E~~il~~l~h~niv~l~~~~ 101 (394)
T 4e7w_A 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESD----E-VAIKKVLQDKRFK--------NRELQIMRIVKHPNVVDLKAFF 101 (394)
T ss_dssp CCEEEEEEEEEEEEEEETTEEEEEEEETTTE----E-EEEEEEECCTTSC--------CHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCcccceEEEeEEEeeCCCeEEEEEEECCCC----e-EEEEEEecCcchH--------HHHHHHHHhCCCCCcceEEEEE
Confidence 3445678999999999999999999987543 2 7888775433211 2499999999999999999999
Q ss_pred EeCC------eEEEEeeccCCCCchhHHH-hhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEc-cCCCE
Q 042539 93 ETDE------FLAWAVPYCPGGDLNVLRY-KQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIR-QSGHV 164 (412)
Q Consensus 93 ~~~~------~~~lv~e~~~gg~L~~~~~-~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~-~~g~v 164 (412)
.... .+|+|||||.++.+..+.. ......+++..++.++.||+.||+|||++||+||||||+|||++ .+|.+
T Consensus 102 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~ 181 (394)
T 4e7w_A 102 YSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVL 181 (394)
T ss_dssp EEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEE
T ss_pred EecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcE
Confidence 6543 3899999998865544432 22345699999999999999999999999999999999999999 78999
Q ss_pred EEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCC
Q 042539 165 TLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGER 244 (412)
Q Consensus 165 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (412)
||+|||+|+... .+..
T Consensus 182 kL~DFG~a~~~~----------------------------------------------------------------~~~~ 197 (394)
T 4e7w_A 182 KLIDFGSAKILI----------------------------------------------------------------AGEP 197 (394)
T ss_dssp EECCCTTCEECC----------------------------------------------------------------TTCC
T ss_pred EEeeCCCccccc----------------------------------------------------------------CCCC
Confidence 999999997642 1122
Q ss_pred CcccccCCCCccceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CC---------------C
Q 042539 245 SNSFVGTEEYVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK--TP---------------E 306 (412)
Q Consensus 245 ~~~~~gt~~Y~APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~~---------------~ 306 (412)
..+.+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+..+... .+ .
T Consensus 198 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~ 277 (394)
T 4e7w_A 198 NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHK 277 (394)
T ss_dssp CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSC
T ss_pred CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhc
Confidence 2356789999999999875 4899999999999999999999999999887777666431 00 0
Q ss_pred -------------CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCchhh
Q 042539 307 -------------FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLL 353 (412)
Q Consensus 307 -------------~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~~~ 353 (412)
....++++.+||.+||+.||.+|| ++.++++||||+++.|...
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~----t~~e~l~hp~f~~~~~~~~ 333 (394)
T 4e7w_A 278 FPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARL----TAIEALCHPFFDELRTGEA 333 (394)
T ss_dssp CCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC----CHHHHHTSGGGSTTTSSCC
T ss_pred cccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCC----CHHHHhcChhhhhhccccc
Confidence 123678999999999999999999 6999999999999887543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=388.74 Aligned_cols=265 Identities=26% Similarity=0.376 Sum_probs=217.6
Q ss_pred CCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeee
Q 042539 11 TTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLG 90 (412)
Q Consensus 11 ~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 90 (412)
.++....++|++++.||+|+||+||+|++..++ +.||||+++..... .......+.+|+.++++++||||+++++
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 79 (311)
T 3ork_A 5 TTPSHLSDRYELGEILGFGGMSEVHLARDLRDH----RDVAVKVLRADLAR-DPSFYLRFRREAQNAAALNHPAIVAVYD 79 (311)
T ss_dssp CCCSEETTTEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEECTTTTT-SHHHHHHHHHHHTTCCCCCCTTBCCEEE
T ss_pred CCcceecCcEEEEEEEccCCCEEEEEEEECCCC----ceEEEEEeCccccC-CHHHHHHHHHHHHHHHcCCCCCcceEEE
Confidence 345666789999999999999999999987754 45999999765432 3445667888999999999999999999
Q ss_pred eEEeCC----eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEE
Q 042539 91 SLETDE----FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTL 166 (412)
Q Consensus 91 ~~~~~~----~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL 166 (412)
++.... ..|+|||||.|++|..++.... .+++.++..++.||+.||+|||++||+||||||+|||++.+|.+||
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl 157 (311)
T 3ork_A 80 TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKV 157 (311)
T ss_dssp EEEEEETTEEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEE
T ss_pred eeeccCCCCcccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEE
Confidence 997654 3599999999999998887654 4999999999999999999999999999999999999999999999
Q ss_pred ccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCc
Q 042539 167 TDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSN 246 (412)
Q Consensus 167 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (412)
+|||+++.+..... ......
T Consensus 158 ~Dfg~a~~~~~~~~------------------------------------------------------------~~~~~~ 177 (311)
T 3ork_A 158 MDFGIARAIADSGN------------------------------------------------------------SVTQTA 177 (311)
T ss_dssp CCCSCC--------------------------------------------------------------------------
T ss_pred eeccCccccccccc------------------------------------------------------------cccccc
Confidence 99999976532110 111223
Q ss_pred ccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-----CCCChHHHHHHHHh
Q 042539 247 SFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF-----VGQRTALTDLIQRL 321 (412)
Q Consensus 247 ~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~dli~~~ 321 (412)
..+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+...++....... ...+.++.+||.+|
T Consensus 178 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 257 (311)
T 3ork_A 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKA 257 (311)
T ss_dssp ----CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHH
T ss_pred ccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHH
Confidence 5679999999999999999999999999999999999999999998887776666554332 45789999999999
Q ss_pred hhhCCCccCCCCCChhhhhcCCCCC
Q 042539 322 LEKDPVKRLGYLRGACEIKEHVFFK 346 (412)
Q Consensus 322 L~~dP~~R~~~~~~~~e~l~h~ff~ 346 (412)
|..||.+|| ++.+++.|+|++
T Consensus 258 l~~dP~~R~----~~~~~l~~~l~~ 278 (311)
T 3ork_A 258 LAKNPENRY----QTAAEMRADLVR 278 (311)
T ss_dssp TCSSGGGSC----SSHHHHHHHHHH
T ss_pred HhcCHhhCh----hhHHHHHHHHHH
Confidence 999999999 578888899876
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=390.81 Aligned_cols=269 Identities=27% Similarity=0.411 Sum_probs=221.0
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
++|++++.||+|+||+||+|.++.++ +.||||++.+... .......+.+|+.+++.++||||+++++++...+.
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 115 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSG----EKVAIKKLSRPFQ--SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS 115 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEECSTTS--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCC----CEEEEEEeccccc--chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCC
Confidence 69999999999999999999998754 4599999976542 23456677889999999999999999999987765
Q ss_pred E------EEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 98 L------AWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 98 ~------~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
. |+||||+. ++|..++ ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus 116 ~~~~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 116 LRNFYDFYLVMPFMQ-TDLQKIM----GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp STTCCCCEEEEECCC-EEHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred cccceeEEEEEcccc-ccHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 4 99999997 5665544 23499999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
++.... .....+||
T Consensus 191 a~~~~~------------------------------------------------------------------~~~~~~~t 204 (371)
T 4exu_A 191 ARHADA------------------------------------------------------------------EMTGYVVT 204 (371)
T ss_dssp C--------------------------------------------------------------------------CTTCC
T ss_pred cccccc------------------------------------------------------------------CcCCcccC
Confidence 975321 12245789
Q ss_pred CCCccceeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--C-----------------------
Q 042539 252 EEYVSPEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT--P----------------------- 305 (412)
Q Consensus 252 ~~Y~APE~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~----------------------- 305 (412)
+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+.+++... +
T Consensus 205 ~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (371)
T 4exu_A 205 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQT 284 (371)
T ss_dssp CTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCC
T ss_pred ccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCC
Confidence 99999999987 678999999999999999999999999988877766664310 0
Q ss_pred -------CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCchhhcccCCCCCCCCCCC
Q 042539 306 -------EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREE 367 (412)
Q Consensus 306 -------~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~~~~~~~~pp~~p~~~~ 367 (412)
.++..++.+.+||.+||+.||.+|| +++++++||||+.............||....+.
T Consensus 285 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp----t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~ 349 (371)
T 4exu_A 285 PRKDFTQLFPRASPQAADLLEKMLELDVDKRL----TAAQALTHPFFEPFRDPEEETEAQQPFDDSLEH 349 (371)
T ss_dssp CCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSC----CHHHHHTSGGGTTTCCGGGCCCCSSCCCCTTSS
T ss_pred cchhHHHhccccChHHHHHHHHHCCCChhhcC----CHHHHhcCcccccCCCcccccccccCcCcchhh
Confidence 0234578999999999999999999 799999999999887765555555566655443
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=399.19 Aligned_cols=254 Identities=26% Similarity=0.395 Sum_probs=212.5
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc------CCCccce
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL------SHPFLPK 87 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l------~hpnIv~ 87 (412)
.....+|++++.||+|+||+||+|++..++ +.||||+++... .....+.+|+++++.+ .|+||++
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~----~~vAvK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~ 163 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVH----QHVALKMVRNEK-----RFHRQAAEEIRILEHLRKQDKDNTMNVIH 163 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTT----EEEEEEEECSCH-----HHHHHHHHHHHHHHHHHTTCTTSCSCBCC
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCC----cEEEEEEECCcc-----chHHHHHHHHHHHHHHhhccccCCcCEEE
Confidence 344568999999999999999999988754 459999996542 2334555688888777 4679999
Q ss_pred eeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCC--EE
Q 042539 88 LLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGH--VT 165 (412)
Q Consensus 88 l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~--vk 165 (412)
+++++...+.+|+||||+. ++|..++.......+++..++.++.||+.||+|||++||+||||||+|||++.+|. +|
T Consensus 164 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vk 242 (429)
T 3kvw_A 164 MLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIK 242 (429)
T ss_dssp EEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEE
T ss_pred EEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceE
Confidence 9999999999999999995 57877777766566999999999999999999999999999999999999999987 99
Q ss_pred EccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCC
Q 042539 166 LTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERS 245 (412)
Q Consensus 166 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (412)
|+|||+|+... ...
T Consensus 243 L~DFG~a~~~~------------------------------------------------------------------~~~ 256 (429)
T 3kvw_A 243 VIDFGSSCYEH------------------------------------------------------------------QRV 256 (429)
T ss_dssp ECCCTTCEETT------------------------------------------------------------------CCC
T ss_pred EeecccceecC------------------------------------------------------------------Ccc
Confidence 99999986431 122
Q ss_pred cccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CC------------------
Q 042539 246 NSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK--TP------------------ 305 (412)
Q Consensus 246 ~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~~------------------ 305 (412)
.+.+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+.+..++.. .+
T Consensus 257 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~ 336 (429)
T 3kvw_A 257 YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSK 336 (429)
T ss_dssp CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTT
T ss_pred cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCC
Confidence 3568999999999999999999999999999999999999999999887776655421 00
Q ss_pred ---C-------------------------------------CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCC
Q 042539 306 ---E-------------------------------------FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 306 ---~-------------------------------------~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff 345 (412)
. ....++.+.+||.+||+.||++|| +++|+++||||
T Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp----ta~e~L~Hpw~ 412 (429)
T 3kvw_A 337 GYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM----TPGQALRHPWL 412 (429)
T ss_dssp SCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC----CHHHHHTSTTT
T ss_pred CCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCC----CHHHHhCChhh
Confidence 0 001257799999999999999999 79999999999
Q ss_pred CC
Q 042539 346 KG 347 (412)
Q Consensus 346 ~~ 347 (412)
+.
T Consensus 413 ~~ 414 (429)
T 3kvw_A 413 RR 414 (429)
T ss_dssp C-
T ss_pred cc
Confidence 85
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=388.29 Aligned_cols=255 Identities=29% Similarity=0.495 Sum_probs=219.6
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhh----hhhHHHHHHHHHHHHHHhhc-CCCccceeeeeE
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTL----HAKHEAERRARWEIRVLSRL-SHPFLPKLLGSL 92 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~----~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 92 (412)
++|++++.||+|+||.||+|+++.++. .||||++..... .........+.+|+.+++.+ +||||+++++++
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~----~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGH----EFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhcccceEEecCCCEEEEEEEECCCCc----EEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 579999999999999999999976544 499999975431 12233456778899999999 799999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
......|+||||+.|++|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~ 247 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFS 247 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcc
Confidence 99999999999999999998877653 4999999999999999999999999999999999999999999999999998
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
..+.. .......+||+
T Consensus 248 ~~~~~----------------------------------------------------------------~~~~~~~~gt~ 263 (365)
T 2y7j_A 248 CHLEP----------------------------------------------------------------GEKLRELCGTP 263 (365)
T ss_dssp EECCT----------------------------------------------------------------TCCBCCCCSCG
T ss_pred cccCC----------------------------------------------------------------CcccccCCCCC
Confidence 75421 11223568999
Q ss_pred CCccceeecC------CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-----CCCChHHHHHHHHh
Q 042539 253 EYVSPEVVRG------DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF-----VGQRTALTDLIQRL 321 (412)
Q Consensus 253 ~Y~APE~l~~------~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~dli~~~ 321 (412)
.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+......+ ...+..+.+||.+|
T Consensus 264 ~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~ 343 (365)
T 2y7j_A 264 GYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRL 343 (365)
T ss_dssp GGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHH
T ss_pred CccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHH
Confidence 9999999864 357889999999999999999999999988888887777655433 35678899999999
Q ss_pred hhhCCCccCCCCCChhhhhcCCCCC
Q 042539 322 LEKDPVKRLGYLRGACEIKEHVFFK 346 (412)
Q Consensus 322 L~~dP~~R~~~~~~~~e~l~h~ff~ 346 (412)
|..||++|| +++++++||||+
T Consensus 344 L~~dP~~Rp----s~~ell~hp~f~ 364 (365)
T 2y7j_A 344 LQVDPEARL----TAEQALQHPFFE 364 (365)
T ss_dssp SCSSTTTSC----CHHHHHHSGGGC
T ss_pred cCCChhHCc----CHHHHhcCcccC
Confidence 999999999 699999999996
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-50 Score=396.23 Aligned_cols=256 Identities=26% Similarity=0.465 Sum_probs=208.4
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
+...++|++++.||+|+||+||+|++..++. .||||++...... ..+|+++++.++|||||+++++|.
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~----~vAiK~~~~~~~~--------~~~E~~il~~l~hpnIv~l~~~~~ 70 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGK----RFALKKVLQDPRY--------KNRELDIMKVLDHVNIIKLVDYFY 70 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCC----EEEEEEEECCTTS--------CCHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCC----EEEEEEEecCcch--------HHHHHHHHHHcCCCCccchhheee
Confidence 4566899999999999999999999987554 4999998654321 124999999999999999999984
Q ss_pred e--------------------------------------CCeEEEEeeccCCCCchhHHHh--hCCCCCCHHHHHHHHHH
Q 042539 94 T--------------------------------------DEFLAWAVPYCPGGDLNVLRYK--QNDRVFSPSVIRFYLSE 133 (412)
Q Consensus 94 ~--------------------------------------~~~~~lv~e~~~gg~L~~~~~~--~~~~~l~~~~~~~~~~q 133 (412)
. +..+++|||||.| +|...+.. .....+++..++.++.|
T Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~q 149 (383)
T 3eb0_A 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQ 149 (383)
T ss_dssp EC-------------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHH
T ss_pred ecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHH
Confidence 3 3458999999975 66555443 34456999999999999
Q ss_pred HHHHHHHHHHcCceeeeCCCCceEEc-cCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhc
Q 042539 134 IICAIEHLHNMGIAYRDLKPENILIR-QSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLH 212 (412)
Q Consensus 134 i~~aL~yLH~~~iiHrDlKp~NiLl~-~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (412)
|+.||.|||++||+||||||+|||++ .++.+||+|||+|+....
T Consensus 150 i~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~----------------------------------- 194 (383)
T 3eb0_A 150 LFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP----------------------------------- 194 (383)
T ss_dssp HHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT-----------------------------------
T ss_pred HHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC-----------------------------------
Confidence 99999999999999999999999998 678999999999975421
Q ss_pred cCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecCCC-CCchhhHHHHHHHHHHHhhCCCCCCCC
Q 042539 213 ALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDG-HEFAVDWWALGILTYEMLYGTTPFRGK 291 (412)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~DiwSlGvil~ell~g~~Pf~~~ 291 (412)
.......+||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.
T Consensus 195 -----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 245 (383)
T 3eb0_A 195 -----------------------------SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGE 245 (383)
T ss_dssp -----------------------------TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -----------------------------CCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCC
Confidence 12223557899999999998754 899999999999999999999999999
Q ss_pred CHHHHHHHHhcC--CC---------------C-------------CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 292 NRKETFRNVLMK--TP---------------E-------------FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 292 ~~~~~~~~i~~~--~~---------------~-------------~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
+..+.+..++.. .+ . ....++++.+||.+||+.||.+|+ ++.|+++
T Consensus 246 ~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~----t~~e~l~ 321 (383)
T 3eb0_A 246 TSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI----NPYEAMA 321 (383)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC----CHHHHHT
T ss_pred ChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC----CHHHHhc
Confidence 888877766531 00 0 123577899999999999999999 7999999
Q ss_pred CCCCCCCCc
Q 042539 342 HVFFKGVRW 350 (412)
Q Consensus 342 h~ff~~~~~ 350 (412)
||||+++.+
T Consensus 322 hp~f~~~~~ 330 (383)
T 3eb0_A 322 HPFFDHLRN 330 (383)
T ss_dssp SGGGHHHHH
T ss_pred CHHHHHHHh
Confidence 999987544
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=402.59 Aligned_cols=260 Identities=27% Similarity=0.432 Sum_probs=206.0
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhh----hHHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHA----KHEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
.++|++++.||+|+||+||+|.++.++. .||||++.+..... .......+.+|+.+|++++||||+++++++
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~ 209 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCK----KVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF 209 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCC----EEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCc----EEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 5789999999999999999999987554 49999998764321 112233567899999999999999999998
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCC---CEEEccc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG---HVTLTDF 169 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g---~vkL~DF 169 (412)
. .+.+|+|||||.||+|..++... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+||
T Consensus 210 ~-~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 210 D-AEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp E-SSEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred e-cCceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeec
Confidence 5 45689999999999997776543 4599999999999999999999999999999999999997655 4999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|+|+.... .....+.+
T Consensus 287 G~a~~~~~----------------------------------------------------------------~~~~~~~~ 302 (419)
T 3i6u_A 287 GHSKILGE----------------------------------------------------------------TSLMRTLC 302 (419)
T ss_dssp STTTSCC-------------------------------------------------------------------------
T ss_pred ccceecCC----------------------------------------------------------------CccccccC
Confidence 99975421 11223568
Q ss_pred cCCCCccceeecC---CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHH-HHHHHHhcCCCCC-----CCCChHHHHHHHH
Q 042539 250 GTEEYVSPEVVRG---DGHEFAVDWWALGILTYEMLYGTTPFRGKNRK-ETFRNVLMKTPEF-----VGQRTALTDLIQR 320 (412)
Q Consensus 250 gt~~Y~APE~l~~---~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~~i~~~~~~~-----~~~~~~~~dli~~ 320 (412)
||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.... .....+......+ ...++.+.+||.+
T Consensus 303 gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 382 (419)
T 3i6u_A 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKK 382 (419)
T ss_dssp --CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHH
T ss_pred CCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHH
Confidence 9999999999864 56789999999999999999999999875433 2333343333222 3568899999999
Q ss_pred hhhhCCCccCCCCCChhhhhcCCCCCCCCch
Q 042539 321 LLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 321 ~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~ 351 (412)
||+.||.+|| +++++++||||++.+|.
T Consensus 383 ~L~~dP~~Rp----s~~e~l~hp~~~~~~~~ 409 (419)
T 3i6u_A 383 LLVVDPKARF----TTEEALRHPWLQDEDMK 409 (419)
T ss_dssp HSCSSTTTSC----CHHHHHHSGGGCCHHHH
T ss_pred HccCChhHCc----CHHHHhCCcccCChhHH
Confidence 9999999999 69999999999987764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=375.68 Aligned_cols=257 Identities=27% Similarity=0.414 Sum_probs=212.9
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
...+..++|++++.||+|+||.||+|++..++. .||+|++..... ......+.+.+|+.++++++||||++++++
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~ 79 (294)
T 4eqm_A 5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNI----KVAIKAIFIPPR-EKEETLKRFEREVHNSSQLSHQNIVSMIDV 79 (294)
T ss_dssp CSSCEETTEEEEEEEEEETTEEEEEEEETTTCS----EEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCBTTBCCEEEE
T ss_pred hhhHhhccEEEEEEEccCCCEEEEEEEECCCCC----eEEEEEeccCcc-ccHHHHHHHHHHHHHHhcCCCCCCceEEEe
Confidence 345667899999999999999999999877544 499999865443 234556778889999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
+.+++.+|+|||||.|++|..++.... .+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+
T Consensus 80 ~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~ 157 (294)
T 4eqm_A 80 DEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGI 157 (294)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSS
T ss_pred eeeCCeEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCC
Confidence 999999999999999999998887654 499999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
++..... ........+||
T Consensus 158 ~~~~~~~--------------------------------------------------------------~~~~~~~~~gt 175 (294)
T 4eqm_A 158 AKALSET--------------------------------------------------------------SLTQTNHVLGT 175 (294)
T ss_dssp STTC---------------------------------------------------------------------------C
T ss_pred ccccccc--------------------------------------------------------------cccccCccccC
Confidence 9754211 01122346799
Q ss_pred CCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-C-----CCCCChHHHHHHHHhhhhC
Q 042539 252 EEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP-E-----FVGQRTALTDLIQRLLEKD 325 (412)
Q Consensus 252 ~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-~-----~~~~~~~~~dli~~~L~~d 325 (412)
+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+......+...... . ....++.+.++|.+||..|
T Consensus 176 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 255 (294)
T 4eqm_A 176 VQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKD 255 (294)
T ss_dssp CSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSS
T ss_pred ccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCC
Confidence 999999999999999999999999999999999999999887776655554332 1 2457889999999999999
Q ss_pred CCccCCCCCChhhhh
Q 042539 326 PVKRLGYLRGACEIK 340 (412)
Q Consensus 326 P~~R~~~~~~~~e~l 340 (412)
|.+||+ ++++++
T Consensus 256 p~~R~~---~~~~l~ 267 (294)
T 4eqm_A 256 KANRYK---TIQEMK 267 (294)
T ss_dssp GGGSCS---SHHHHH
T ss_pred HhHccc---cHHHHH
Confidence 999995 455444
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-50 Score=378.59 Aligned_cols=261 Identities=26% Similarity=0.467 Sum_probs=222.0
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhh--HHHHHHHHHHHHHHhhcCCCccceeeeeEEe
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAK--HEAERRARWEIRVLSRLSHPFLPKLLGSLET 94 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 94 (412)
.++|++++.||+|+||+||+|+++.++. .||+|++++...... ......+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 79 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGK----EYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN 79 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCC----eeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC
Confidence 4689999999999999999999987554 499999977643221 1124567789999999999999999999999
Q ss_pred CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCC----CEEEcccc
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG----HVTLTDFD 170 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g----~vkL~DFG 170 (412)
.+..|+||||+.|++|..++.... .+++.++..++.||+.||.|||++||+||||||+||+++.++ .+||+|||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred CCeEEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999998886654 499999999999999999999999999999999999999887 89999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
++...... .......|
T Consensus 158 ~~~~~~~~----------------------------------------------------------------~~~~~~~~ 173 (283)
T 3bhy_A 158 IAHKIEAG----------------------------------------------------------------NEFKNIFG 173 (283)
T ss_dssp TCEECC------------------------------------------------------------------------CC
T ss_pred cceeccCC----------------------------------------------------------------CcccccCC
Confidence 98754211 11224468
Q ss_pred CCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-----CCCChHHHHHHHHhhhhC
Q 042539 251 TEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF-----VGQRTALTDLIQRLLEKD 325 (412)
Q Consensus 251 t~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~dli~~~L~~d 325 (412)
|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......+ ...+..+.+||.+||..|
T Consensus 174 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 253 (283)
T 3bhy_A 174 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKD 253 (283)
T ss_dssp CGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSS
T ss_pred CcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCC
Confidence 999999999999999999999999999999999999999998888887776554433 356789999999999999
Q ss_pred CCccCCCCCChhhhhcCCCCCCCCch
Q 042539 326 PVKRLGYLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 326 P~~R~~~~~~~~e~l~h~ff~~~~~~ 351 (412)
|.+|| ++.++++||||+.+.+.
T Consensus 254 p~~Rp----s~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 254 PKRRM----TIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp GGGSC----CHHHHHHCHHHHHHHHC
T ss_pred HhHCc----CHHHHHhCHHHHHHHHH
Confidence 99999 69999999999876543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=384.98 Aligned_cols=252 Identities=25% Similarity=0.407 Sum_probs=206.9
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEEe
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLET 94 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~ 94 (412)
..++|++++.||+|+||+||+|++..++. .||||+++... ...+.+|+.+++.++ ||||+++++++.+
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~ 102 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNE----KVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADIVKD 102 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEECSCC-------HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCc----EEEEEEecccc-------hHHHHHHHHHHHHcCCCCCEEEeeeeecc
Confidence 45789999999999999999999877554 49999996432 244667999999997 9999999999988
Q ss_pred --CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCC-CEEEccccc
Q 042539 95 --DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG-HVTLTDFDL 171 (412)
Q Consensus 95 --~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g-~vkL~DFGl 171 (412)
....++||||+.|++|..++. .+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus 103 ~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~ 177 (330)
T 3nsz_A 103 PVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 177 (330)
T ss_dssp TTTCCEEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred CCCCceEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCC
Confidence 678999999999999977653 289999999999999999999999999999999999999777 899999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
|+.... .......+||
T Consensus 178 a~~~~~----------------------------------------------------------------~~~~~~~~~~ 193 (330)
T 3nsz_A 178 AEFYHP----------------------------------------------------------------GQEYNVRVAS 193 (330)
T ss_dssp CEECCT----------------------------------------------------------------TCCCCSCCSC
T ss_pred ceEcCC----------------------------------------------------------------CCcccccccc
Confidence 975421 1122345789
Q ss_pred CCCccceeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCC-CCHHHHHHHHhc-------------CCCC----------
Q 042539 252 EEYVSPEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRG-KNRKETFRNVLM-------------KTPE---------- 306 (412)
Q Consensus 252 ~~Y~APE~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~-------------~~~~---------- 306 (412)
+.|+|||++.+ ..++.++|||||||++|+|++|..||.. .+..+.+..+.. ....
T Consensus 194 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (330)
T 3nsz_A 194 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILG 273 (330)
T ss_dssp GGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHC
T ss_pred ccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhh
Confidence 99999999987 5689999999999999999999999944 333333322211 0000
Q ss_pred ---------------CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCch
Q 042539 307 ---------------FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 307 ---------------~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~ 351 (412)
....++++.+||.+||+.||++|| +++|+++||||+++.|+
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp----ta~e~l~hp~f~~~~~~ 329 (330)
T 3nsz_A 274 RHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL----TAREAMEHPYFYTVVKD 329 (330)
T ss_dssp CCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSC----CHHHHHTSGGGTTCC--
T ss_pred hccccchhhhccccccccCCHHHHHHHHHHhcCCcccCC----CHHHHhcCccHhhhccC
Confidence 011578999999999999999999 79999999999998765
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-50 Score=393.32 Aligned_cols=272 Identities=17% Similarity=0.244 Sum_probs=224.9
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCC-CCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAA-DPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLG 90 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~-~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 90 (412)
..++..++|++++.||+|+||+||+|++... +..+++.||||+++.... ......+.+|+.++++++||||+++++
T Consensus 65 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~ 141 (367)
T 3l9p_A 65 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS---EQDELDFLMEALIISKFNHQNIVRCIG 141 (367)
T ss_dssp SCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCC---HHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccC---hhhHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3467789999999999999999999997643 223566799999965422 233456778999999999999999999
Q ss_pred eEEeCCeEEEEeeccCCCCchhHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCC---
Q 042539 91 SLETDEFLAWAVPYCPGGDLNVLRYKQND-----RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG--- 162 (412)
Q Consensus 91 ~~~~~~~~~lv~e~~~gg~L~~~~~~~~~-----~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g--- 162 (412)
++.+....|+|||||.||+|..++..... ..+++.++..++.||+.||+|||++||+||||||+|||++.+|
T Consensus 142 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~ 221 (367)
T 3l9p_A 142 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 221 (367)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTC
T ss_pred EEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCc
Confidence 99999999999999999999988876542 3589999999999999999999999999999999999999665
Q ss_pred CEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCC
Q 042539 163 HVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNG 242 (412)
Q Consensus 163 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (412)
.+||+|||+|+.+.... ..
T Consensus 222 ~~kL~DFG~a~~~~~~~-------------------------------------------------------------~~ 240 (367)
T 3l9p_A 222 VAKIGDFGMARDIYRAG-------------------------------------------------------------YY 240 (367)
T ss_dssp CEEECCCHHHHHHHHHS-------------------------------------------------------------SC
T ss_pred eEEECCCcccccccccc-------------------------------------------------------------cc
Confidence 49999999998653221 11
Q ss_pred CCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCC--CCCCCChHHHHHHH
Q 042539 243 ERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTP--EFVGQRTALTDLIQ 319 (412)
Q Consensus 243 ~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~dli~ 319 (412)
......+||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+..... .....++.+.+||.
T Consensus 241 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 320 (367)
T 3l9p_A 241 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMT 320 (367)
T ss_dssp TTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred ccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence 12235578999999999999999999999999999999998 9999999998888887776442 23456789999999
Q ss_pred HhhhhCCCccCCCCCChhhhhcCCCCCCCCch
Q 042539 320 RLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 320 ~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~ 351 (412)
+||+.||.+|| ++.++++|.++-..+.+
T Consensus 321 ~~l~~dP~~Rp----s~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 321 QCWQHQPEDRP----NFAIILERIEYCTQDPD 348 (367)
T ss_dssp HHTCSSGGGSC----CHHHHHHHHHHHHHCHH
T ss_pred HHcCCCHhHCc----CHHHHHHHHHHHhhChh
Confidence 99999999999 68999998765433333
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=378.40 Aligned_cols=254 Identities=30% Similarity=0.462 Sum_probs=218.4
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
..++|++++.||+|+||+||+|+++.++. .||+|+++.... .....+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGK----LFALKCIKKSPA----FRDSSLENEIAVLKKIKHENIVTLEDIYEST 78 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEECC----------HHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCC----EEEEEEEecccc----cchHHHHHHHHHHHhCCCCCeeehhhhcccC
Confidence 35789999999999999999999877544 499999976432 1234567799999999999999999999999
Q ss_pred CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEE---ccCCCEEEcccccc
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILI---RQSGHVTLTDFDLS 172 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl---~~~g~vkL~DFGla 172 (412)
+.+|+|||||.|++|..++.... .+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~ 156 (304)
T 2jam_A 79 THYYLVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLS 156 (304)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTT
T ss_pred CEEEEEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcc
Confidence 99999999999999988876554 49999999999999999999999999999999999999 77899999999998
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+.... ......+||+
T Consensus 157 ~~~~~-----------------------------------------------------------------~~~~~~~~~~ 171 (304)
T 2jam_A 157 KMEQN-----------------------------------------------------------------GIMSTACGTP 171 (304)
T ss_dssp CCCCC-----------------------------------------------------------------BTTHHHHSCC
T ss_pred eecCC-----------------------------------------------------------------CccccccCCC
Confidence 64311 1122457999
Q ss_pred CCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC-----CCCCChHHHHHHHHhhhhCCC
Q 042539 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE-----FVGQRTALTDLIQRLLEKDPV 327 (412)
Q Consensus 253 ~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~-----~~~~~~~~~dli~~~L~~dP~ 327 (412)
.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+...... ....++++.+||.+||..||.
T Consensus 172 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 251 (304)
T 2jam_A 172 GYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPN 251 (304)
T ss_dssp CBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTT
T ss_pred CccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChh
Confidence 999999999999999999999999999999999999999888888887765433 245689999999999999999
Q ss_pred ccCCCCCChhhhhcCCCCCCC
Q 042539 328 KRLGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 328 ~R~~~~~~~~e~l~h~ff~~~ 348 (412)
+|| +++++++||||++.
T Consensus 252 ~Rp----s~~~~l~h~~~~~~ 268 (304)
T 2jam_A 252 ERY----TCEKALSHPWIDGN 268 (304)
T ss_dssp TSC----CHHHHHTSHHHHSS
T ss_pred HCc----CHHHHhcCccccCC
Confidence 999 69999999999763
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=387.85 Aligned_cols=263 Identities=19% Similarity=0.268 Sum_probs=220.4
Q ss_pred CCCCCCccCceeeeeeeccCceEEEEEEEcCCCC---CCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccc
Q 042539 11 TTPSLDLDNLKALKILGKGAMGTVFLVHDRAADP---TARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLP 86 (412)
Q Consensus 11 ~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv 86 (412)
....+..++|++++.||+|+||+||+|++...+. ..+..||||+++... .......+.+|+.+++.+ +||||+
T Consensus 74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpnIv 150 (370)
T 2psq_A 74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNII 150 (370)
T ss_dssp TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC---BHHHHHHHHHHHHHHHHSCCCTTBC
T ss_pred ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc---CHHHHHHHHHHHHHHHHhcCCCCEe
Confidence 3457788999999999999999999999864332 244569999997653 234456788899999999 799999
Q ss_pred eeeeeEEeCCeEEEEeeccCCCCchhHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCC
Q 042539 87 KLLGSLETDEFLAWAVPYCPGGDLNVLRYKQND--------------RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLK 152 (412)
Q Consensus 87 ~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~--------------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlK 152 (412)
++++++.+++.+|+|||||.||+|..++..... ..+++.++..++.||+.||+|||++||+|||||
T Consensus 151 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk 230 (370)
T 2psq_A 151 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA 230 (370)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred eEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence 999999999999999999999999988876431 348899999999999999999999999999999
Q ss_pred CCceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCc
Q 042539 153 PENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPV 232 (412)
Q Consensus 153 p~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (412)
|+|||++.+|.+||+|||+++.+....
T Consensus 231 p~NIll~~~~~~kl~DFG~a~~~~~~~----------------------------------------------------- 257 (370)
T 2psq_A 231 ARNVLVTENNVMKIADFGLARDINNID----------------------------------------------------- 257 (370)
T ss_dssp GGGEEECTTCCEEECCCSSCEETTCCC-----------------------------------------------------
T ss_pred hhhEEECCCCCEEEccccCCcccCccc-----------------------------------------------------
Confidence 999999999999999999997653110
Q ss_pred cccccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCC--CCCC
Q 042539 233 SRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTP--EFVG 309 (412)
Q Consensus 233 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~--~~~~ 309 (412)
.........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.+..+..... ....
T Consensus 258 --------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 329 (370)
T 2psq_A 258 --------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPAN 329 (370)
T ss_dssp --------TTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTT
T ss_pred --------ceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Confidence 0111223467889999999999999999999999999999998 9999999887777776665432 2345
Q ss_pred CChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 310 QRTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 310 ~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
++.++.+||.+||..||.+|| ++.++++
T Consensus 330 ~~~~l~~li~~~l~~dP~~Rp----t~~ell~ 357 (370)
T 2psq_A 330 CTNELYMMMRDCWHAVPSQRP----TFKQLVE 357 (370)
T ss_dssp SCHHHHHHHHHHTCSSGGGSC----CHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCc----CHHHHHH
Confidence 678999999999999999999 6888876
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-50 Score=381.56 Aligned_cols=271 Identities=25% Similarity=0.383 Sum_probs=198.3
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
...+..++|++++.||+|+||+||+|++..++. .||||++..... ......+.+|+.+++.++||||++++++
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 81 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKE----KVAIKRINLEKC---QTSMDELLKEIQAMSQCHHPNIVSYYTS 81 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----C----EEEEECCC-------------------CCCCCCCTTBCCEEEE
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCc----EEEEEEEEhhhc---chhHHHHHHHHHHHhhcCCCCEeeEEEE
Confidence 457888999999999999999999998876544 499999965432 2334567789999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhh------CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEE
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQ------NDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVT 165 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~------~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vk 165 (412)
+...+..|+||||+.|++|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~k 161 (303)
T 2vwi_A 82 FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQ 161 (303)
T ss_dssp EESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEE
T ss_pred EeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEE
Confidence 99999999999999999998887641 234589999999999999999999999999999999999999999999
Q ss_pred EccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCC
Q 042539 166 LTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERS 245 (412)
Q Consensus 166 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (412)
|+|||+++........ ......
T Consensus 162 l~dfg~~~~~~~~~~~----------------------------------------------------------~~~~~~ 183 (303)
T 2vwi_A 162 IADFGVSAFLATGGDI----------------------------------------------------------TRNKVR 183 (303)
T ss_dssp ECCCHHHHHCC---------------------------------------------------------------------
T ss_pred EEeccchheeccCCCc----------------------------------------------------------cchhhh
Confidence 9999998765321100 011122
Q ss_pred cccccCCCCccceeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC-----------CCCCChH
Q 042539 246 NSFVGTEEYVSPEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE-----------FVGQRTA 313 (412)
Q Consensus 246 ~~~~gt~~Y~APE~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~-----------~~~~~~~ 313 (412)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+............+. ....+.+
T Consensus 184 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (303)
T 2vwi_A 184 KTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKS 263 (303)
T ss_dssp ----CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHH
T ss_pred cccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHH
Confidence 35679999999999976 56889999999999999999999999987766555444433211 1345688
Q ss_pred HHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCch
Q 042539 314 LTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 314 ~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~ 351 (412)
+.+||.+||..||.+|| ++.++++||||++..++
T Consensus 264 ~~~li~~~l~~dp~~Rp----s~~~ll~h~~~~~~~~~ 297 (303)
T 2vwi_A 264 FRKMISLCLQKDPEKRP----TAAELLRHKFFQKAKNK 297 (303)
T ss_dssp HHHHHHHHCCSSGGGSC----CHHHHHTSTTC------
T ss_pred HHHHHHHHccCChhhCc----CHHHHhhChhhhcCCCC
Confidence 99999999999999999 69999999999987654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=390.86 Aligned_cols=251 Identities=23% Similarity=0.376 Sum_probs=209.7
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhh----HHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAK----HEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
.++|++++.||+|+||+||+|+++.++ +.||||++++...... ......+.+|+.+++.++||||+++++++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 98 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKN----KEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF 98 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTT----EEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCC----cEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 468999999999999999999988754 4499999977643211 11223455699999999999999999999
Q ss_pred EeCCeEEEEeeccCCC-CchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 93 ETDEFLAWAVPYCPGG-DLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg-~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
.+.+.+++||||+.+| +|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+
T Consensus 99 ~~~~~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 99 ENQGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp ECSSEEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred eeCCEEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 9999999999999776 887776543 3599999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
++... ......+.+||
T Consensus 177 a~~~~----------------------------------------------------------------~~~~~~~~~gt 192 (335)
T 3dls_A 177 AAYLE----------------------------------------------------------------RGKLFYTFCGT 192 (335)
T ss_dssp CEECC----------------------------------------------------------------TTCCBCEECSC
T ss_pred ceECC----------------------------------------------------------------CCCceeccCCC
Confidence 97542 11223356799
Q ss_pred CCCccceeecCCCC-CchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-CCCCCCCChHHHHHHHHhhhhCCCcc
Q 042539 252 EEYVSPEVVRGDGH-EFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK-TPEFVGQRTALTDLIQRLLEKDPVKR 329 (412)
Q Consensus 252 ~~Y~APE~l~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~dli~~~L~~dP~~R 329 (412)
+.|+|||++.+..+ +.++|||||||++|+|++|..||..... .... .......++++.+||.+||..||.+|
T Consensus 193 ~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 266 (335)
T 3dls_A 193 IEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIHPPYLVSKELMSLVSGLLQPVPERR 266 (335)
T ss_dssp GGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCCCSSCCCHHHHHHHHHHTCSSGGGS
T ss_pred ccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccCCCcccCHHHHHHHHHHccCChhhC
Confidence 99999999998887 8899999999999999999999976321 1111 12233468999999999999999999
Q ss_pred CCCCCChhhhhcCCCCCC
Q 042539 330 LGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 330 ~~~~~~~~e~l~h~ff~~ 347 (412)
| +++++++||||+.
T Consensus 267 p----s~~ell~hp~~~~ 280 (335)
T 3dls_A 267 T----TLEKLVTDPWVTQ 280 (335)
T ss_dssp C----CHHHHHHCTTTTC
T ss_pred c----CHHHHhcCccccC
Confidence 9 6999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=397.75 Aligned_cols=255 Identities=24% Similarity=0.418 Sum_probs=207.1
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
...+|++++.||+|+||+||+|+++.++ +.||||++.+... ...+|+++|+.++|||||+++++|...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~----~~vaiK~~~~~~~--------~~~~E~~il~~l~hpniv~l~~~~~~~ 119 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSG----ELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSS 119 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTC----CEEEEEEEECCTT--------SCCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCC----cEEEEEEecccch--------hHHHHHHHHHHcCCCCccceeeEEecc
Confidence 3457999999999999999999998754 4499999865432 122599999999999999999998542
Q ss_pred ------CeEEEEeeccCCCCchhHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccC-CCEEE
Q 042539 96 ------EFLAWAVPYCPGGDLNVLRYK--QNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQS-GHVTL 166 (412)
Q Consensus 96 ------~~~~lv~e~~~gg~L~~~~~~--~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~-g~vkL 166 (412)
..+++||||+.++ |..++.. .....+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||
T Consensus 120 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl 198 (420)
T 1j1b_A 120 GEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKL 198 (420)
T ss_dssp ETTTTEEEEEEEEECCCEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEE
T ss_pred CCCCcceeEEeehhccccc-HHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEe
Confidence 2478999999764 4333322 334569999999999999999999999999999999999999965 56899
Q ss_pred ccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCc
Q 042539 167 TDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSN 246 (412)
Q Consensus 167 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (412)
+|||+++.+.. +....
T Consensus 199 ~DFG~a~~~~~----------------------------------------------------------------~~~~~ 214 (420)
T 1j1b_A 199 CDFGSAKQLVR----------------------------------------------------------------GEPNV 214 (420)
T ss_dssp CCCTTCEECCT----------------------------------------------------------------TCCCC
T ss_pred ccchhhhhccc----------------------------------------------------------------CCCce
Confidence 99999975421 11223
Q ss_pred ccccCCCCccceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--C---------------CCC-
Q 042539 247 SFVGTEEYVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK--T---------------PEF- 307 (412)
Q Consensus 247 ~~~gt~~Y~APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~---------------~~~- 307 (412)
..+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+.+++.. . ..+
T Consensus 215 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p 294 (420)
T 1j1b_A 215 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 294 (420)
T ss_dssp SCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCC
T ss_pred eeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccC
Confidence 46799999999999875 6899999999999999999999999998887776665431 0 011
Q ss_pred ------------CCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCch
Q 042539 308 ------------VGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 308 ------------~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~ 351 (412)
...++++.+||.+||++||.+|+ ++.|+++||||+++.+.
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~----t~~e~l~hp~f~~~~~~ 346 (420)
T 1j1b_A 295 QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL----TPLEACAHSFFDELRDP 346 (420)
T ss_dssp CCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSC----CHHHHHTSGGGGGGGCT
T ss_pred ccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCC----CHHHHhCCHhhcccccc
Confidence 23468999999999999999999 79999999999887654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-49 Score=369.71 Aligned_cols=259 Identities=24% Similarity=0.412 Sum_probs=215.4
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
..++|++++.||+|+||.||+|+++.++. .||+|++...... .....+.+|+.+++.++||||+++++++.++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEE----AVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFYGHRREG 77 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCC----EEEEEEEEGGGCT---THHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCc----EEEEEEeeeccch---hhhHHHHHHHHHHHhcCCCCceeeeeEEEcC
Confidence 35789999999999999999999876544 4999999755432 2345677899999999999999999999999
Q ss_pred CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchh
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
+..|+||||+.|++|..++... ..+++.++..++.|++.||.|||++||+||||||+||+++.+|.+||+|||++..+
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 155 (276)
T 2yex_A 78 NIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF 155 (276)
T ss_dssp TEEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CEEEEEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence 9999999999999998876543 35999999999999999999999999999999999999999999999999999754
Q ss_pred hchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCc
Q 042539 176 VKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYV 255 (412)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 255 (412)
.... ........+||+.|+
T Consensus 156 ~~~~-------------------------------------------------------------~~~~~~~~~~~~~y~ 174 (276)
T 2yex_A 156 RYNN-------------------------------------------------------------RERLLNKMCGTLPYV 174 (276)
T ss_dssp EETT-------------------------------------------------------------EECCBCCCCSCGGGC
T ss_pred CCCc-------------------------------------------------------------chhcccCCccccCcc
Confidence 2110 001123457999999
Q ss_pred cceeecCCCC-CchhhHHHHHHHHHHHhhCCCCCCCCCHH-HHHHHHhcCC---CCCCCCChHHHHHHHHhhhhCCCccC
Q 042539 256 SPEVVRGDGH-EFAVDWWALGILTYEMLYGTTPFRGKNRK-ETFRNVLMKT---PEFVGQRTALTDLIQRLLEKDPVKRL 330 (412)
Q Consensus 256 APE~l~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~~i~~~~---~~~~~~~~~~~dli~~~L~~dP~~R~ 330 (412)
|||++.+..+ +.++|||||||++|+|++|..||.+.+.. ..+..+.... ......++.+.+||.+||..||.+||
T Consensus 175 aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 254 (276)
T 2yex_A 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI 254 (276)
T ss_dssp CGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSC
T ss_pred ChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCC
Confidence 9999988775 78999999999999999999999876543 2333333322 22345688999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCC
Q 042539 331 GYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 331 ~~~~~~~e~l~h~ff~~~ 348 (412)
+++++++||||++.
T Consensus 255 ----s~~~il~~~~~~~~ 268 (276)
T 2yex_A 255 ----TIPDIKKDRWYNKP 268 (276)
T ss_dssp ----CHHHHTTCTTTTCC
T ss_pred ----CHHHHhcCccccCh
Confidence 69999999999864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-49 Score=383.85 Aligned_cols=254 Identities=24% Similarity=0.329 Sum_probs=214.9
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
+.|++++.||+|+||+||+|++..++ +.||||++...... .....+.+.+|++++++++||||+++++++.+++.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~----~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNS----EVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEEESCSSC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCC----eEEEEEEEcccccc-chHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCe
Confidence 45999999999999999999987644 45999999765332 23445677889999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
.|+|||||.| +|..++.... ..+++.++..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 129 ~~lv~e~~~g-~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~- 205 (348)
T 1u5q_A 129 AWLVMEYCLG-SASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA- 205 (348)
T ss_dssp EEEEEECCSE-EHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS-
T ss_pred EEEEEecCCC-CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecC-
Confidence 9999999975 6655554432 459999999999999999999999999999999999999999999999999986431
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
.....+||+.|+||
T Consensus 206 ------------------------------------------------------------------~~~~~~gt~~y~aP 219 (348)
T 1u5q_A 206 ------------------------------------------------------------------PANSFVGTPYWMAP 219 (348)
T ss_dssp ------------------------------------------------------------------SBCCCCSCGGGCCH
T ss_pred ------------------------------------------------------------------CCCcccCCcceeCH
Confidence 11245799999999
Q ss_pred eeec---CCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC---CCCCChHHHHHHHHhhhhCCCccCC
Q 042539 258 EVVR---GDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE---FVGQRTALTDLIQRLLEKDPVKRLG 331 (412)
Q Consensus 258 E~l~---~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~dli~~~L~~dP~~R~~ 331 (412)
|++. +..++.++|||||||++|||++|++||.+.+.......+...... ....++.+.+||.+||+.||.+||
T Consensus 220 E~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp- 298 (348)
T 1u5q_A 220 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRP- 298 (348)
T ss_dssp HHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSC-
T ss_pred hhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCc-
Confidence 9985 456899999999999999999999999998877776666654322 235678999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCC
Q 042539 332 YLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 332 ~~~~~~e~l~h~ff~~~~ 349 (412)
+++++++|+||....
T Consensus 299 ---s~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 299 ---TSEVLLKHRFVLRER 313 (348)
T ss_dssp ---CHHHHTTCHHHHSCC
T ss_pred ---CHHHHhhChhhhccC
Confidence 699999999997543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=382.13 Aligned_cols=269 Identities=26% Similarity=0.390 Sum_probs=219.1
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
.++|.+.+.||+|+||.||+|+++.++ +.||||++.+... .......+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 96 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSG----EKVAIKKLSRPFQ--SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS 96 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEESSTTS--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCC----CEEEEEEeccccc--chHHHHHHHHHHHHHHhcCCCCcccHhheEeccc
Confidence 378999999999999999999987754 4599999976532 3345667788999999999999999999998765
Q ss_pred e------EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccc
Q 042539 97 F------LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 97 ~------~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
. +|+||||+. ++|..++. ..+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||
T Consensus 97 ~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg 171 (353)
T 3coi_A 97 SLRNFYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFG 171 (353)
T ss_dssp SGGGCCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred ccccceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecc
Confidence 4 599999997 57765542 249999999999999999999999999999999999999999999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+++.... .....+|
T Consensus 172 ~~~~~~~------------------------------------------------------------------~~~~~~~ 185 (353)
T 3coi_A 172 LARHADA------------------------------------------------------------------EMTGYVV 185 (353)
T ss_dssp CTTC--------------------------------------------------------------------------CC
T ss_pred cccCCCC------------------------------------------------------------------Ccccccc
Confidence 9864311 1123578
Q ss_pred CCCCccceeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-------------------------
Q 042539 251 TEEYVSPEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT------------------------- 304 (412)
Q Consensus 251 t~~Y~APE~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~------------------------- 304 (412)
|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 186 t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (353)
T 3coi_A 186 TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQ 265 (353)
T ss_dssp SBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCB
T ss_pred CcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcC
Confidence 999999999987 678999999999999999999999999988777665554210
Q ss_pred -------CCCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCchhhcccCCCCCCCCCC
Q 042539 305 -------PEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSRE 366 (412)
Q Consensus 305 -------~~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~~~~~~~~pp~~p~~~ 366 (412)
...+..++++.+||.+||..||.+|| +++++++||||+.............+|.+..+
T Consensus 266 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp----t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~ 330 (353)
T 3coi_A 266 TPRKDFTQLFPRASPQAADLLEKMLELDVDKRL----TAAQALTHPFFEPFRDPEEETEAQQPFDDSLE 330 (353)
T ss_dssp CSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSC----CHHHHHTSGGGTTTCCGGGCCCCSSCCCCTTT
T ss_pred CCCccHHHhcCCcCHHHHHHHHHHcCCCcccCC----CHHHHhcCcchhhccCccccccCCCCCccchh
Confidence 01235678999999999999999999 69999999999988766554444455655443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=371.18 Aligned_cols=259 Identities=23% Similarity=0.356 Sum_probs=201.1
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
++..++|++++.||+|+||+||+|++..++ +.||+|+++.... .......+..+...++.++||||+++++++.
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~ 76 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSG----QIMAVKRIRATVN--SQEQKRLLMDLDISMRTVDCPFTVTFYGALF 76 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEEC---C--HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCC----eEEEEEEeecccC--cHHHHHHHHHHHHHHHhCCCCeEEEEeeeee
Confidence 577899999999999999999999997754 4499999976532 2233344444556688889999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeeeCCCCceEEccCCCEEEcccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYK--QNDRVFSPSVIRFYLSEIICAIEHLHNM-GIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~--~~~~~l~~~~~~~~~~qi~~aL~yLH~~-~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
+++..|+|||||.| +|..++.. .....+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus 77 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T 3fme_A 77 REGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFG 155 (290)
T ss_dssp CSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-
T ss_pred ccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecC
Confidence 99999999999975 66555443 2345699999999999999999999998 99999999999999999999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+++..... .......|
T Consensus 156 ~~~~~~~~----------------------------------------------------------------~~~~~~~~ 171 (290)
T 3fme_A 156 ISGYLVDD----------------------------------------------------------------VAKDIDAG 171 (290)
T ss_dssp ------------------------------------------------------------------------------CC
T ss_pred Cccccccc----------------------------------------------------------------ccccccCC
Confidence 99765211 11223469
Q ss_pred CCCCccceee----cCCCCCchhhHHHHHHHHHHHhhCCCCCCC-CCHHHHHHHHhcC-CCCC--CCCChHHHHHHHHhh
Q 042539 251 TEEYVSPEVV----RGDGHEFAVDWWALGILTYEMLYGTTPFRG-KNRKETFRNVLMK-TPEF--VGQRTALTDLIQRLL 322 (412)
Q Consensus 251 t~~Y~APE~l----~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~-~~~~--~~~~~~~~dli~~~L 322 (412)
|+.|+|||++ .+..++.++|||||||++|+|++|+.||.. ............. .+.. ...++++.+||.+||
T Consensus 172 t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 251 (290)
T 3fme_A 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCL 251 (290)
T ss_dssp CCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHT
T ss_pred CccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHHHHHHHHHh
Confidence 9999999996 455689999999999999999999999986 3444444444433 2222 356889999999999
Q ss_pred hhCCCccCCCCCChhhhhcCCCCCC
Q 042539 323 EKDPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 323 ~~dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
+.||.+|| ++.++++||||+.
T Consensus 252 ~~~p~~Rp----t~~e~l~hp~f~~ 272 (290)
T 3fme_A 252 KKNSKERP----TYPELMQHPFFTL 272 (290)
T ss_dssp CSSGGGSC----CHHHHTTSHHHHH
T ss_pred hcChhhCc----CHHHHHhCccccc
Confidence 99999999 6999999999974
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=368.45 Aligned_cols=255 Identities=22% Similarity=0.333 Sum_probs=211.4
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET 94 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 94 (412)
..-+.|++.+.||+|+||+||+|.+..++. .||+|++...... ....+.+.+|+.+++.++||||+++++++..
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~va~k~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 96 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTV----EVAWCELQDRKLT--KSERQRFKEEAEMLKGLQHPNIVRFYDSWES 96 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEGGGSC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred cCceeEEeeeeccCCCCeEEEEeEecCCce----EEEEEEecchhhC--HHHHHHHHHHHHHHHhCCCCCeeeeeeeecc
Confidence 344569999999999999999999887544 4999999765542 3346678889999999999999999999875
Q ss_pred ----CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeeeCCCCceEEc-cCCCEEEc
Q 042539 95 ----DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMG--IAYRDLKPENILIR-QSGHVTLT 167 (412)
Q Consensus 95 ----~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~--iiHrDlKp~NiLl~-~~g~vkL~ 167 (412)
+..+|+||||+.||+|..++.... .+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~ 174 (290)
T 1t4h_A 97 TVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIG 174 (290)
T ss_dssp ESSSCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred ccCCCceEEEEEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEe
Confidence 356999999999999998887654 4999999999999999999999999 99999999999998 78999999
Q ss_pred cccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcc
Q 042539 168 DFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNS 247 (412)
Q Consensus 168 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (412)
|||++.... ......
T Consensus 175 Dfg~~~~~~-----------------------------------------------------------------~~~~~~ 189 (290)
T 1t4h_A 175 DLGLATLKR-----------------------------------------------------------------ASFAKA 189 (290)
T ss_dssp CTTGGGGCC-----------------------------------------------------------------TTSBEE
T ss_pred eCCCccccc-----------------------------------------------------------------cccccc
Confidence 999986431 112234
Q ss_pred cccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCH-HHHHHHHhcCCCC---CCCCChHHHHHHHHhhh
Q 042539 248 FVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNR-KETFRNVLMKTPE---FVGQRTALTDLIQRLLE 323 (412)
Q Consensus 248 ~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-~~~~~~i~~~~~~---~~~~~~~~~dli~~~L~ 323 (412)
.+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+... ......+...... ....++++.+||.+||.
T Consensus 190 ~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 268 (290)
T 1t4h_A 190 VIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIR 268 (290)
T ss_dssp SCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSC
T ss_pred ccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHcc
Confidence 579999999998875 489999999999999999999999988544 4444444433221 12356889999999999
Q ss_pred hCCCccCCCCCChhhhhcCCCCCC
Q 042539 324 KDPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 324 ~dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
.||.+|| +++++++||||++
T Consensus 269 ~dp~~Rp----s~~ell~h~~f~~ 288 (290)
T 1t4h_A 269 QNKDERY----SIKDLLNHAFFQE 288 (290)
T ss_dssp SSGGGSC----CHHHHHTSGGGC-
T ss_pred CChhhCC----CHHHHhhCccccc
Confidence 9999999 6999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=385.85 Aligned_cols=269 Identities=23% Similarity=0.385 Sum_probs=226.3
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhH-------------HHHHHHHHHHHHHh
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKH-------------EAERRARWEIRVLS 78 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~-------------~~~~~~~~Ei~il~ 78 (412)
...+..++|++++.||+|+||.||+|++ + ++.||||++......... .....+.+|+.+++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 98 (348)
T 2pml_X 25 EKDKYINDYRIIRTLNQGKFNKIILCEK--D----NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98 (348)
T ss_dssp SSCEEETTEEEEEEEECCSSCCEEEEEE--T----TEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHT
T ss_pred hcccccCceEEEEEEcCCCCeEEEEEEc--C----CceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHH
Confidence 3456678999999999999999999988 2 345999999765432110 01156778999999
Q ss_pred hcCCCccceeeeeEEeCCeEEEEeeccCCCCchhH------HHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeeC
Q 042539 79 RLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVL------RYKQNDRVFSPSVIRFYLSEIICAIEHLHN-MGIAYRDL 151 (412)
Q Consensus 79 ~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~------~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDl 151 (412)
.++||||+++++++.+.+.+|+|||||.||+|..+ +.......+++..++.++.||+.||.|||+ +||+||||
T Consensus 99 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl 178 (348)
T 2pml_X 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDV 178 (348)
T ss_dssp TCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCC
T ss_pred hCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCC
Confidence 99999999999999999999999999999999887 554335679999999999999999999999 99999999
Q ss_pred CCCceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCC
Q 042539 152 KPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSP 231 (412)
Q Consensus 152 Kp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (412)
||+|||++.+|.+||+|||+++.....
T Consensus 179 ~p~Nil~~~~~~~kl~dfg~~~~~~~~----------------------------------------------------- 205 (348)
T 2pml_X 179 KPSNILMDKNGRVKLSDFGESEYMVDK----------------------------------------------------- 205 (348)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECBTT-----------------------------------------------------
T ss_pred ChHhEEEcCCCcEEEeccccccccccc-----------------------------------------------------
Confidence 999999999999999999999754211
Q ss_pred ccccccccCCCCCCcccccCCCCccceeecCC-CCCc-hhhHHHHHHHHHHHhhCCCCCCCCCH-HHHHHHHhcCCCCC-
Q 042539 232 VSRRQQSFDNGERSNSFVGTEEYVSPEVVRGD-GHEF-AVDWWALGILTYEMLYGTTPFRGKNR-KETFRNVLMKTPEF- 307 (412)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~-~~DiwSlGvil~ell~g~~Pf~~~~~-~~~~~~i~~~~~~~- 307 (412)
......||+.|+|||++.+. .++. ++|||||||++|+|++|..||.+.+. .+....+......+
T Consensus 206 ------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~ 273 (348)
T 2pml_X 206 ------------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYP 273 (348)
T ss_dssp ------------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCC
T ss_pred ------------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCc
Confidence 12245689999999999987 5665 99999999999999999999998776 66777776554433
Q ss_pred -------------------CCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCchhhcc
Q 042539 308 -------------------VGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTD 355 (412)
Q Consensus 308 -------------------~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~~~~~ 355 (412)
...+.++.+||.+||+.||.+|| +++++++||||++.+|..+..
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp----s~~e~l~hp~f~~~~~~~~~~ 336 (348)
T 2pml_X 274 LDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI----TSEDALKHEWLADTNIEDLRE 336 (348)
T ss_dssp CSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSC----CHHHHHTSGGGTTCCHHHHHH
T ss_pred cchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCC----CHHHHhcCccccCCCHHHHHH
Confidence 34678999999999999999999 699999999999999876543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=369.75 Aligned_cols=253 Identities=19% Similarity=0.305 Sum_probs=207.1
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeeeeEEe
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLGSLET 94 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 94 (412)
..++|++++.||+|+||+||+|++..++. .||||++++.... ......+.+|+.++..+ +||||+++++++.+
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~--~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~ 82 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGC----IYAIKRSKKPLAG--SVDEQNALREVYAHAVLGQHSHVVRYFSAWAE 82 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEECCCTT--SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCc----eEEEEEecccccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec
Confidence 35789999999999999999999987544 4999999765432 22345677799999999 89999999999999
Q ss_pred CCeEEEEeeccCCCCchhHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCC----------
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQN--DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG---------- 162 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~--~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g---------- 162 (412)
++.+|+|||||.|++|..++.... ...+++.+++.++.||+.||.|||++||+||||||+|||++.+|
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~ 162 (289)
T 1x8b_A 83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGD 162 (289)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------
T ss_pred CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccc
Confidence 999999999999999998876542 24589999999999999999999999999999999999998544
Q ss_pred ---------CEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCcc
Q 042539 163 ---------HVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVS 233 (412)
Q Consensus 163 ---------~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (412)
.+||+|||++.....
T Consensus 163 ~~~~~~~~~~~kl~Dfg~~~~~~~-------------------------------------------------------- 186 (289)
T 1x8b_A 163 EDDWASNKVMFKIGDLGHVTRISS-------------------------------------------------------- 186 (289)
T ss_dssp -------CCCEEECCCTTCEETTC--------------------------------------------------------
T ss_pred cccccCCceEEEEcccccccccCC--------------------------------------------------------
Confidence 799999999875421
Q ss_pred ccccccCCCCCCcccccCCCCccceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-CCC-CCC
Q 042539 234 RRQQSFDNGERSNSFVGTEEYVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT-PEF-VGQ 310 (412)
Q Consensus 234 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~-~~~ 310 (412)
.....||+.|+|||++.+. .++.++|||||||++|+|++|.+++..... ...+.... +.. ...
T Consensus 187 -----------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 252 (289)
T 1x8b_A 187 -----------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEIRQGRLPRIPQVL 252 (289)
T ss_dssp -----------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHHHTTCCCCCSSCC
T ss_pred -----------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHHHcCCCCCCCccc
Confidence 1123589999999999876 567899999999999999999988766433 23333322 222 356
Q ss_pred ChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCC
Q 042539 311 RTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 311 ~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~ 348 (412)
++++.+||.+||..||++|| ++.++++||||.+.
T Consensus 253 ~~~~~~li~~~l~~dp~~Rp----s~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 253 SQEFTELLKVMIHPDPERRP----SAMALVKHSVLLSA 286 (289)
T ss_dssp CHHHHHHHHHHTCSSGGGSC----CHHHHHTCTTC---
T ss_pred CHHHHHHHHHHhCCCcccCC----CHHHHhhChHhhhh
Confidence 89999999999999999999 69999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=376.37 Aligned_cols=258 Identities=22% Similarity=0.300 Sum_probs=208.6
Q ss_pred CCCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCcccee
Q 042539 9 PQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKL 88 (412)
Q Consensus 9 ~~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l 88 (412)
.....++..++|++++.||+|+||+||+|++. +..||||++.+.... ......+.+|++++++++||||+++
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~------~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~ 99 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH------GSDVAVKILMEQDFH--AERVNEFLREVAIMKRLRHPNIVLF 99 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEET------TEEEEEEEECCCCCS--HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEEC------CCcEEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 34466788899999999999999999999874 234999999765532 2345667889999999999999999
Q ss_pred eeeEEeCCeEEEEeeccCCCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHcC--ceeeeCCCCceEEccCCCEE
Q 042539 89 LGSLETDEFLAWAVPYCPGGDLNVLRYKQND-RVFSPSVIRFYLSEIICAIEHLHNMG--IAYRDLKPENILIRQSGHVT 165 (412)
Q Consensus 89 ~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~-~~l~~~~~~~~~~qi~~aL~yLH~~~--iiHrDlKp~NiLl~~~g~vk 165 (412)
++++.+.+.+|+|||||.||+|..++..... ..+++..+..++.||+.||+|||++| |+||||||+|||++.+|.+|
T Consensus 100 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~k 179 (309)
T 3p86_A 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVK 179 (309)
T ss_dssp EEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEE
T ss_pred EEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEE
Confidence 9999999999999999999999888765321 13899999999999999999999999 99999999999999999999
Q ss_pred EccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCC
Q 042539 166 LTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERS 245 (412)
Q Consensus 166 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (412)
|+|||+++..... ....
T Consensus 180 L~Dfg~a~~~~~~---------------------------------------------------------------~~~~ 196 (309)
T 3p86_A 180 VCDFGLSRLKAST---------------------------------------------------------------FLSS 196 (309)
T ss_dssp ECCCC---------------------------------------------------------------------------
T ss_pred ECCCCCCcccccc---------------------------------------------------------------cccc
Confidence 9999999743211 1112
Q ss_pred cccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--C-CCCCCChHHHHHHHHhh
Q 042539 246 NSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT--P-EFVGQRTALTDLIQRLL 322 (412)
Q Consensus 246 ~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~-~~~~~~~~~~dli~~~L 322 (412)
...+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.... . .....++++.+||.+||
T Consensus 197 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 276 (309)
T 3p86_A 197 KSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCW 276 (309)
T ss_dssp -----CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHT
T ss_pred ccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHc
Confidence 34579999999999999999999999999999999999999999998888777664322 2 22356899999999999
Q ss_pred hhCCCccCCCCCChhhhhc
Q 042539 323 EKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 323 ~~dP~~R~~~~~~~~e~l~ 341 (412)
..||.+|| +++++++
T Consensus 277 ~~dP~~Rp----s~~~ll~ 291 (309)
T 3p86_A 277 TNEPWKRP----SFATIMD 291 (309)
T ss_dssp CSSGGGSC----CHHHHHH
T ss_pred cCChhhCc----CHHHHHH
Confidence 99999999 6888875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=377.04 Aligned_cols=261 Identities=21% Similarity=0.328 Sum_probs=219.2
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
..++..++|++++.||+|+||+||+|++..++. .+..||||+++... .....+.+.+|+.+++.++||||++++++
T Consensus 43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 118 (325)
T 3kul_A 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQ-RDVPVAIKALKAGY---TERQRRDFLSEASIMGQFDHPNIIRLEGV 118 (325)
T ss_dssp CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTS-CCEEEEEEEECTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccccChhHeEEeeEEEeCCCcEEEEEEEecCCC-CCceEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 557888999999999999999999999976543 34559999997543 23345677889999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
+.+++.+|+|||||.||+|..++... .+.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 197 (325)
T 3kul_A 119 VTRGRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGL 197 (325)
T ss_dssp ECGGGCCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred EEeCCccEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCc
Confidence 99999999999999999999887654 34699999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
++....... .........+|
T Consensus 198 a~~~~~~~~------------------------------------------------------------~~~~~~~~~~t 217 (325)
T 3kul_A 198 SRVLEDDPD------------------------------------------------------------AAYTTTGGKIP 217 (325)
T ss_dssp CEECC----------------------------------------------------------------CCEECC---CC
T ss_pred ccccccCcc------------------------------------------------------------ceeeccCCCCc
Confidence 976532110 00111233568
Q ss_pred CCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCc
Q 042539 252 EEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVK 328 (412)
Q Consensus 252 ~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~ 328 (412)
+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.... +....+++.+.+||.+||..||.+
T Consensus 218 ~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 297 (325)
T 3kul_A 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQ 297 (325)
T ss_dssp GGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred ccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhh
Confidence 89999999999899999999999999999998 999999999888887776543 334467899999999999999999
Q ss_pred cCCCCCChhhhhc
Q 042539 329 RLGYLRGACEIKE 341 (412)
Q Consensus 329 R~~~~~~~~e~l~ 341 (412)
|| ++.++++
T Consensus 298 Rp----s~~eil~ 306 (325)
T 3kul_A 298 RP----RFSQIVS 306 (325)
T ss_dssp SC----CHHHHHH
T ss_pred Cc----CHHHHHH
Confidence 99 5788775
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=388.01 Aligned_cols=265 Identities=25% Similarity=0.414 Sum_probs=202.5
Q ss_pred CCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceee
Q 042539 10 QTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLL 89 (412)
Q Consensus 10 ~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~ 89 (412)
.......+++|++++.||+|+||+||+|+++.++. .||||++....... ....+|++.++.++||||++++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~-----~~~~~~~~~l~~l~h~niv~~~ 85 (360)
T 3e3p_A 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGM----SVAIKKVIQDPRFR-----NRELQIMQDLAVLHHPNIVQLQ 85 (360)
T ss_dssp SHHHHHHHTTEEEC----------CEEEEETTTCC----EEEEEEEECCTTCC-----CHHHHHHHHHHHHCCTTBCCEE
T ss_pred hhhchhhccceEEEEEEecCCCeEEEEEEECCCCC----EEEEEEEecCcccc-----HHHHHHHHHHHhcCCCCcccHH
Confidence 33456778999999999999999999999987554 49999986543221 2334577888999999999999
Q ss_pred eeEEeCCe-------EEEEeeccCCCCchhHHH-hhCCCCCCHHHHHHHHHHHHHHHHHHH--HcCceeeeCCCCceEEc
Q 042539 90 GSLETDEF-------LAWAVPYCPGGDLNVLRY-KQNDRVFSPSVIRFYLSEIICAIEHLH--NMGIAYRDLKPENILIR 159 (412)
Q Consensus 90 ~~~~~~~~-------~~lv~e~~~gg~L~~~~~-~~~~~~l~~~~~~~~~~qi~~aL~yLH--~~~iiHrDlKp~NiLl~ 159 (412)
++|..... +++|||||.|+.+..+.. ......+++..++.++.|++.||.||| ++||+||||||+|||++
T Consensus 86 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~ 165 (360)
T 3e3p_A 86 SYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN 165 (360)
T ss_dssp EEEEEECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEE
T ss_pred HhhhccccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEe
Confidence 99976433 899999998764433322 223456899999999999999999999 99999999999999999
Q ss_pred c-CCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccc
Q 042539 160 Q-SGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQS 238 (412)
Q Consensus 160 ~-~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (412)
. +|.+||+|||+++....
T Consensus 166 ~~~~~~kl~Dfg~a~~~~~------------------------------------------------------------- 184 (360)
T 3e3p_A 166 EADGTLKLCDFGSAKKLSP------------------------------------------------------------- 184 (360)
T ss_dssp TTTTEEEECCCTTCBCCCT-------------------------------------------------------------
T ss_pred CCCCcEEEeeCCCceecCC-------------------------------------------------------------
Confidence 7 89999999999975421
Q ss_pred cCCCCCCcccccCCCCccceeecCCC-CCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--C----------
Q 042539 239 FDNGERSNSFVGTEEYVSPEVVRGDG-HEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT--P---------- 305 (412)
Q Consensus 239 ~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~---------- 305 (412)
.......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+....+..+.... +
T Consensus 185 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3e3p_A 185 ---SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNP 261 (360)
T ss_dssp ---TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCT
T ss_pred ---CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhccc
Confidence 11223457899999999997755 7999999999999999999999999998887776665310 0
Q ss_pred ---------------------CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCch
Q 042539 306 ---------------------EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 306 ---------------------~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~ 351 (412)
.....++++.+||.+||+.||.+|| ++.|+++||||+++.+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp----t~~e~l~hp~f~~~~~~ 324 (360)
T 3e3p_A 262 SHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERM----KPYEALCHPYFDELHDP 324 (360)
T ss_dssp TCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSC----CHHHHTTSGGGGGGGCT
T ss_pred chhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccC----CHHHHhcCccccccCCc
Confidence 0011357899999999999999999 79999999999976543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=381.52 Aligned_cols=261 Identities=26% Similarity=0.435 Sum_probs=208.8
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhh----hhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLH----AKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~----~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
..++|++++.||+|+||.||+|+++.++ +.||||++.+.... ........+.+|+++++.++||||++++++
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 83 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTC----KKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF 83 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCC----cEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeE
Confidence 3578999999999999999999998754 44999999765432 112233457789999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCC---EEEcc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGH---VTLTD 168 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~---vkL~D 168 (412)
+..++ +|+||||+.|++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|
T Consensus 84 ~~~~~-~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 84 FDAED-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp EESSS-EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred EcCCc-eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 97665 89999999999998776543 45999999999999999999999999999999999999987765 99999
Q ss_pred ccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccc
Q 042539 169 FDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248 (412)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (412)
||+++..... ......
T Consensus 161 fg~~~~~~~~----------------------------------------------------------------~~~~~~ 176 (322)
T 2ycf_A 161 FGHSKILGET----------------------------------------------------------------SLMRTL 176 (322)
T ss_dssp CTTCEECCCC----------------------------------------------------------------HHHHHH
T ss_pred Cccceecccc----------------------------------------------------------------cccccc
Confidence 9999754211 111245
Q ss_pred ccCCCCccceeec---CCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHH-HHHHHHhcCCCCC-----CCCChHHHHHHH
Q 042539 249 VGTEEYVSPEVVR---GDGHEFAVDWWALGILTYEMLYGTTPFRGKNRK-ETFRNVLMKTPEF-----VGQRTALTDLIQ 319 (412)
Q Consensus 249 ~gt~~Y~APE~l~---~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~~i~~~~~~~-----~~~~~~~~dli~ 319 (412)
+||+.|+|||++. +..++.++|||||||++|+|++|..||.+.... .....+......+ ...++.+.+||.
T Consensus 177 ~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 256 (322)
T 2ycf_A 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVK 256 (322)
T ss_dssp HSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHH
T ss_pred cCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHH
Confidence 7999999999974 456789999999999999999999999875433 2333333332222 356889999999
Q ss_pred HhhhhCCCccCCCCCChhhhhcCCCCCCCCch
Q 042539 320 RLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 320 ~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~ 351 (412)
+||..||.+|| +++++++||||++.+|.
T Consensus 257 ~~l~~dP~~Rp----s~~~~l~h~~~~~~~~~ 284 (322)
T 2ycf_A 257 KLLVVDPKARF----TTEEALRHPWLQDEDMK 284 (322)
T ss_dssp HHSCSSTTTSC----CHHHHHTSGGGCCHHHH
T ss_pred HHcccCHhhCC----CHHHHhhCcCcCCHHHH
Confidence 99999999999 69999999999986653
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=378.83 Aligned_cols=259 Identities=27% Similarity=0.349 Sum_probs=213.6
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCC------cc
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP------FL 85 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hp------nI 85 (412)
..++..++|++++.||+|+||+||+|.+... +++.||||+++... .....+.+|+++++.++|+ +|
T Consensus 8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~i 79 (339)
T 1z57_A 8 SGDVLSARYEIVDTLGEGAFGKVVECIDHKA---GGRHVAVKIVKNVD-----RYCEAARSEIQVLEHLNTTDPNSTFRC 79 (339)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTT---TTEEEEEEEECSSH-----HHHHHHHHHHHHHHHHHHHCTTCTTCB
T ss_pred cCCCccCceEEEEEEecCCCeEEEEEEecCC---CCcEEEEEEEecCC-----chhHHHHHHHHHHHHhhhcCCCCceee
Confidence 4456678999999999999999999988432 34559999996532 2345566799999988755 49
Q ss_pred ceeeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEcc-----
Q 042539 86 PKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQ----- 160 (412)
Q Consensus 86 v~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~----- 160 (412)
+++++++.+++.+|+||||| +++|..++.......+++.+++.++.||+.||+|||++||+||||||+|||++.
T Consensus 80 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~ 158 (339)
T 1z57_A 80 VQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTE 158 (339)
T ss_dssp CCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEE
T ss_pred EeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecccccc
Confidence 99999999999999999999 888988887766556999999999999999999999999999999999999987
Q ss_pred --------------CCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccc
Q 042539 161 --------------SGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKS 226 (412)
Q Consensus 161 --------------~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (412)
++.+||+|||+++...
T Consensus 159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~-------------------------------------------------- 188 (339)
T 1z57_A 159 AYNPKIKRDERTLINPDIKVVDFGSATYDD-------------------------------------------------- 188 (339)
T ss_dssp EEC----CEEEEESCCCEEECCCSSCEETT--------------------------------------------------
T ss_pred ccCCccccccccccCCCceEeeCcccccCc--------------------------------------------------
Confidence 6789999999986431
Q ss_pred cCCCCccccccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhc---C
Q 042539 227 ARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLM---K 303 (412)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~---~ 303 (412)
......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+.. .
T Consensus 189 ----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 252 (339)
T 1z57_A 189 ----------------EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGP 252 (339)
T ss_dssp ----------------SCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCS
T ss_pred ----------------cccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 112345799999999999999999999999999999999999999999887665443321 1
Q ss_pred CCC------------------------------------------CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 304 TPE------------------------------------------FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 304 ~~~------------------------------------------~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
.+. ....++++.+||.+||..||.+|| +++|+++
T Consensus 253 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp----t~~ell~ 328 (339)
T 1z57_A 253 LPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI----TLREALK 328 (339)
T ss_dssp CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC----CHHHHTT
T ss_pred CCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc----CHHHHhc
Confidence 110 001135788999999999999999 6999999
Q ss_pred CCCCCCCC
Q 042539 342 HVFFKGVR 349 (412)
Q Consensus 342 h~ff~~~~ 349 (412)
||||+.+.
T Consensus 329 hp~f~~~~ 336 (339)
T 1z57_A 329 HPFFDLLK 336 (339)
T ss_dssp SGGGGGGG
T ss_pred CHHHHHHh
Confidence 99998643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=373.02 Aligned_cols=262 Identities=27% Similarity=0.447 Sum_probs=217.7
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
.-..++|++++.||+|+||.||+|++..++. .||+|++..... .....+.+|+++++.++||||+++++++.
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 86 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGA----LAAAKVIETKSE----EELEDYIVEIEILATCDHPYIVKLLGAYY 86 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEETTTCC----EEEEEEEC--------CCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCCccceeecceeccCCCeEEEEEEEcCCCc----EEEEEEecCCCH----HHHHHHHHHHHHHhcCCCCCEeeeeeeee
Confidence 3445789999999999999999999987544 499999965432 22456677999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
+++.+|+|||||.|++|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 87 ~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 165 (302)
T 2j7t_A 87 HDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSA 165 (302)
T ss_dssp CC-CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHH
T ss_pred eCCeEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCc
Confidence 9999999999999999988776533 459999999999999999999999999999999999999999999999999886
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
....... .....+||+.
T Consensus 166 ~~~~~~~---------------------------------------------------------------~~~~~~~~~~ 182 (302)
T 2j7t_A 166 KNLKTLQ---------------------------------------------------------------KRDSFIGTPY 182 (302)
T ss_dssp HHHHHHH---------------------------------------------------------------C-----CCGG
T ss_pred ccccccc---------------------------------------------------------------ccccccCChh
Confidence 5421110 1124578999
Q ss_pred Cccceeec-----CCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC----CCCCChHHHHHHHHhhhh
Q 042539 254 YVSPEVVR-----GDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE----FVGQRTALTDLIQRLLEK 324 (412)
Q Consensus 254 Y~APE~l~-----~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~dli~~~L~~ 324 (412)
|+|||++. +..++.++|||||||++|+|++|..||...+.......+...... ....+..+.+||.+||..
T Consensus 183 y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 262 (302)
T 2j7t_A 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDK 262 (302)
T ss_dssp GCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCS
T ss_pred hcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHHHHHHHccc
Confidence 99999984 567889999999999999999999999998888777776654432 234578999999999999
Q ss_pred CCCccCCCCCChhhhhcCCCCCCCCch
Q 042539 325 DPVKRLGYLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 325 dP~~R~~~~~~~~e~l~h~ff~~~~~~ 351 (412)
||.+|| ++.++++||||+++.|.
T Consensus 263 dp~~Rp----s~~~ll~h~~~~~~~~~ 285 (302)
T 2j7t_A 263 NPETRP----SAAQLLEHPFVSSITSN 285 (302)
T ss_dssp CTTTSC----CHHHHTTSTTTTTCCCC
T ss_pred ChhhCC----CHHHHhcChHHhhhccc
Confidence 999999 69999999999998875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=379.64 Aligned_cols=258 Identities=27% Similarity=0.429 Sum_probs=208.0
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCC--Cccceeeee
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH--PFLPKLLGS 91 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~ 91 (412)
++.-++|++++.||+|+||+||+|.+. +++.||||++..... .......+.+|+.+++.++| +||++++++
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 77 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNE-----KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 77 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECT-----TSCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeC-----CCCEEEEEEeecccc--chHHHHHHHHHHHHHHhhhhcCCceEEEeee
Confidence 456678999999999999999999874 244599999976543 23445677889999999986 999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
+.+++.+|+||| +.+++|..++... ..+++.+++.++.||+.||.|||++||+||||||+|||++ +|.+||+|||+
T Consensus 78 ~~~~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~ 153 (343)
T 3dbq_A 78 EITDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGI 153 (343)
T ss_dssp EECSSEEEEEEC-CCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSS
T ss_pred EeeCCEEEEEEe-CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeeccc
Confidence 999999999999 5688998887764 3599999999999999999999999999999999999996 68899999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
++.+.... ........+||
T Consensus 154 a~~~~~~~-------------------------------------------------------------~~~~~~~~~gt 172 (343)
T 3dbq_A 154 ANQMQPDT-------------------------------------------------------------TSVVKDSQVGT 172 (343)
T ss_dssp SCCC-------------------------------------------------------------------------CCC
T ss_pred ccccCccc-------------------------------------------------------------ccccCCCCcCC
Confidence 97653110 01122356899
Q ss_pred CCCccceeecC-----------CCCCchhhHHHHHHHHHHHhhCCCCCCCCC-HHHHHHHHhcCC--CCCC-CCChHHHH
Q 042539 252 EEYVSPEVVRG-----------DGHEFAVDWWALGILTYEMLYGTTPFRGKN-RKETFRNVLMKT--PEFV-GQRTALTD 316 (412)
Q Consensus 252 ~~Y~APE~l~~-----------~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-~~~~~~~i~~~~--~~~~-~~~~~~~d 316 (412)
+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.. ....+..+.... ..++ ..+.++.+
T Consensus 173 ~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 252 (343)
T 3dbq_A 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQD 252 (343)
T ss_dssp CSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHH
T ss_pred cCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHH
Confidence 99999999875 567899999999999999999999998743 334445554332 2233 34578999
Q ss_pred HHHHhhhhCCCccCCCCCChhhhhcCCCCCC
Q 042539 317 LIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 317 li~~~L~~dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
||.+||+.||.+|| ++.++++||||+.
T Consensus 253 li~~~L~~dp~~Rp----t~~e~l~hp~~~~ 279 (343)
T 3dbq_A 253 VLKCCLKRDPKQRI----SIPELLAHPYVQI 279 (343)
T ss_dssp HHHHHTCSSTTTSC----CHHHHHTSHHHHS
T ss_pred HHHHHcCCChhHCC----CHHHHHhCccccc
Confidence 99999999999999 7999999999974
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=380.80 Aligned_cols=265 Identities=24% Similarity=0.346 Sum_probs=216.2
Q ss_pred CCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCc-----
Q 042539 10 QTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPF----- 84 (412)
Q Consensus 10 ~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpn----- 84 (412)
.....+..++|++++.||+|+||+||+|.+..++ ++.||+|++++.. .....+.+|+.+++.++|++
T Consensus 11 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~ 82 (355)
T 2eu9_A 11 CRIGDWLQERYEIVGNLGEGTFGKVVECLDHARG---KSQVALKIIRNVG-----KYREAARLEINVLKKIKEKDKENKF 82 (355)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTT---TEEEEEEEECSCH-----HHHHHHHHHHHHHHHHHHHCTTSCS
T ss_pred cccCceecccEEEEEEeeccCCeEEEEEEecCCC---ceEEEEEEEcccc-----cchhHHHHHHHHHHHHhhcCCCCce
Confidence 3445666789999999999999999999987653 2459999996532 23455667999999997655
Q ss_pred -cceeeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEE-----
Q 042539 85 -LPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILI----- 158 (412)
Q Consensus 85 -Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl----- 158 (412)
|+.+++++...+.+|+||||+ +++|..++.......+++.+++.++.||+.||+|||++||+||||||+|||+
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~ 161 (355)
T 2eu9_A 83 LCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEF 161 (355)
T ss_dssp CBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCE
T ss_pred eEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccc
Confidence 999999999999999999999 5556556555554569999999999999999999999999999999999999
Q ss_pred --------------ccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccc
Q 042539 159 --------------RQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKT 224 (412)
Q Consensus 159 --------------~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (412)
+.++.+||+|||+++...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~------------------------------------------------ 193 (355)
T 2eu9_A 162 ETLYNEHKSCEEKSVKNTSIRVADFGSATFDH------------------------------------------------ 193 (355)
T ss_dssp EEEECCC-CCCEEEESCCCEEECCCTTCEETT------------------------------------------------
T ss_pred cccccccccccccccCCCcEEEeecCcccccc------------------------------------------------
Confidence 667899999999986431
Q ss_pred cccCCCCccccccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhc--
Q 042539 225 KSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLM-- 302 (412)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~-- 302 (412)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 194 ------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 255 (355)
T 2eu9_A 194 ------------------EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKIL 255 (355)
T ss_dssp ------------------SCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred ------------------ccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 112345799999999999999999999999999999999999999999887665443322
Q ss_pred -CCCC------------------C------------------------CCCChHHHHHHHHhhhhCCCccCCCCCChhhh
Q 042539 303 -KTPE------------------F------------------------VGQRTALTDLIQRLLEKDPVKRLGYLRGACEI 339 (412)
Q Consensus 303 -~~~~------------------~------------------------~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~ 339 (412)
..+. + ...+.++.+||.+||..||++|| ++.++
T Consensus 256 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp----t~~e~ 331 (355)
T 2eu9_A 256 GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI----TLAEA 331 (355)
T ss_dssp CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC----CHHHH
T ss_pred CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc----CHHHH
Confidence 1110 0 00124788999999999999999 79999
Q ss_pred hcCCCCCCCCchhh
Q 042539 340 KEHVFFKGVRWDLL 353 (412)
Q Consensus 340 l~h~ff~~~~~~~~ 353 (412)
++||||++++|+..
T Consensus 332 l~hp~f~~~~~~~~ 345 (355)
T 2eu9_A 332 LLHPFFAGLTPEER 345 (355)
T ss_dssp TTSGGGGGCCHHHH
T ss_pred hcChhhcCCChhhc
Confidence 99999999887644
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=387.44 Aligned_cols=259 Identities=27% Similarity=0.426 Sum_probs=210.2
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC--CCccceeeeeE
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS--HPFLPKLLGSL 92 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~ 92 (412)
+.-++|++++.||+|+||+||+|.+.. ++.||||++.+... .......+.+|+.+|+.++ |+||+++++++
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-----~~~vaiK~~~~~~~--~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~ 125 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEK-----KQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTT-----CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCC-----CCEEEEEEEecccc--cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEE
Confidence 344569999999999999999998753 34599999976543 2345567888999999997 59999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
..++.+|+||| +.+++|..++.... .+++.+++.++.||+.||.|||++||+||||||+|||++ +|.+||+|||++
T Consensus 126 ~~~~~~~lv~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a 201 (390)
T 2zmd_A 126 ITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIA 201 (390)
T ss_dssp ECSSEEEEEEE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSS
T ss_pred ecCCEEEEEEe-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCcc
Confidence 99999999999 66889988877644 589999999999999999999999999999999999995 689999999999
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+.+.... ......+.+||+
T Consensus 202 ~~~~~~~-------------------------------------------------------------~~~~~~~~~gt~ 220 (390)
T 2zmd_A 202 NQMQPDT-------------------------------------------------------------TSVVKDSQVGAV 220 (390)
T ss_dssp CCC----------------------------------------------------------------------CCSCCCG
T ss_pred ccccCCC-------------------------------------------------------------ccccCCCCCcCC
Confidence 7652110 011123568999
Q ss_pred CCccceeecC-----------CCCCchhhHHHHHHHHHHHhhCCCCCCCC-CHHHHHHHHhcCCC--CCC-CCChHHHHH
Q 042539 253 EYVSPEVVRG-----------DGHEFAVDWWALGILTYEMLYGTTPFRGK-NRKETFRNVLMKTP--EFV-GQRTALTDL 317 (412)
Q Consensus 253 ~Y~APE~l~~-----------~~~~~~~DiwSlGvil~ell~g~~Pf~~~-~~~~~~~~i~~~~~--~~~-~~~~~~~dl 317 (412)
.|+|||++.+ ..++.++|||||||++|+|++|+.||.+. +....+..++.... .++ ..+.++.+|
T Consensus 221 ~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 300 (390)
T 2zmd_A 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDV 300 (390)
T ss_dssp GGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHH
T ss_pred CccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCccchHHHHHH
Confidence 9999999976 35789999999999999999999999875 34455566654332 222 346789999
Q ss_pred HHHhhhhCCCccCCCCCChhhhhcCCCCCCCC
Q 042539 318 IQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 318 i~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~ 349 (412)
|.+||..||.+|| ++.++++||||+...
T Consensus 301 i~~~L~~dP~~Rp----s~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 301 LKCCLKRDPKQRI----SIPELLAHPYVQIQT 328 (390)
T ss_dssp HHHHTCSSTTTSC----CHHHHHTSHHHHSCC
T ss_pred HHHHcccChhhCC----CHHHHhhCcCccccC
Confidence 9999999999999 699999999997543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=375.18 Aligned_cols=262 Identities=23% Similarity=0.387 Sum_probs=214.2
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeeeeE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLGSL 92 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 92 (412)
....++|++++.||+|+||.||+|++..++ +.||||++..... ....+.+|+.+++++ +||||+++++++
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTG----QLAAIKVMDVTGD-----EEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTC----CEEEEEEEECCSS-----TTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCC----CeEEEEEEecCcc-----cHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 344678999999999999999999987654 4499999965432 123566799999999 799999999999
Q ss_pred Ee------CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEE
Q 042539 93 ET------DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTL 166 (412)
Q Consensus 93 ~~------~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL 166 (412)
.. .+.+|+|||||.||+|..++.......+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl 170 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKL 170 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEE
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEE
Confidence 87 468999999999999999887655456999999999999999999999999999999999999999999999
Q ss_pred ccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCc
Q 042539 167 TDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSN 246 (412)
Q Consensus 167 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (412)
+|||++...... .....
T Consensus 171 ~Dfg~~~~~~~~---------------------------------------------------------------~~~~~ 187 (326)
T 2x7f_A 171 VDFGVSAQLDRT---------------------------------------------------------------VGRRN 187 (326)
T ss_dssp CCCTTTC-------------------------------------------------------------------------
T ss_pred eeCcCceecCcC---------------------------------------------------------------ccccc
Confidence 999998754211 01123
Q ss_pred ccccCCCCccceeec-----CCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC---CCCCCChHHHHHH
Q 042539 247 SFVGTEEYVSPEVVR-----GDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP---EFVGQRTALTDLI 318 (412)
Q Consensus 247 ~~~gt~~Y~APE~l~-----~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~dli 318 (412)
..+||+.|+|||++. +..++.++|||||||++|+|++|..||.+.+.......+..... .....++.+.+||
T Consensus 188 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 267 (326)
T 2x7f_A 188 TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFI 267 (326)
T ss_dssp ---CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSCSCHHHHHHH
T ss_pred cccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCccccCHHHHHHH
Confidence 457999999999987 45678999999999999999999999999887776665554322 2245678999999
Q ss_pred HHhhhhCCCccCCCCCChhhhhcCCCCCCCCch
Q 042539 319 QRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 319 ~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~ 351 (412)
.+||..||.+|| +++++++||||++..+.
T Consensus 268 ~~~l~~dp~~Rp----s~~~ll~hp~~~~~~~~ 296 (326)
T 2x7f_A 268 ESCLVKNHSQRP----ATEQLMKHPFIRDQPNE 296 (326)
T ss_dssp HHHCCSSGGGSC----CHHHHHTSHHHHCCTTH
T ss_pred HHHhccChhhCC----CHHHHhhChHHhhCccc
Confidence 999999999999 69999999999987654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=377.57 Aligned_cols=271 Identities=24% Similarity=0.332 Sum_probs=216.0
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
....++|++++.||+|+||+||+|++..++ +.||||++.... .......+.+|+++++.++||||+++++++.
T Consensus 7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 79 (353)
T 2b9h_A 7 YNISSDFQLKSLLGEGAYGVVCSATHKPTG----EIVAIKKIEPFD---KPLFALRTLREIKILKHFKHENIITIFNIQR 79 (353)
T ss_dssp CCSCTTEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEECCCS---SHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred cccccceEEeeEEcCCCCeEEEEEEECCCC----cEEEEEeecccc---cchHHHHHHHHHHHHHhCcCCCcCCeeeeec
Confidence 344689999999999999999999987654 459999996532 2344556778999999999999999999886
Q ss_pred eC-----CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcc
Q 042539 94 TD-----EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTD 168 (412)
Q Consensus 94 ~~-----~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~D 168 (412)
.. ..+|+||||+. ++|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|
T Consensus 80 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~D 155 (353)
T 2b9h_A 80 PDSFENFNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCD 155 (353)
T ss_dssp CSCSTTCCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECC
T ss_pred ccccCccceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEe
Confidence 54 67999999996 578777654 3499999999999999999999999999999999999999999999999
Q ss_pred ccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccc
Q 042539 169 FDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248 (412)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (412)
||+++........... ...........
T Consensus 156 fg~a~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~ 182 (353)
T 2b9h_A 156 FGLARIIDESAADNSE-----------------------------------------------------PTGQQSGMVEF 182 (353)
T ss_dssp CTTCEECC---------------------------------------------------------------------CCC
T ss_pred cccccccccccccccC-----------------------------------------------------ccccccchhhc
Confidence 9999865322110000 00011122356
Q ss_pred ccCCCCccceeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhc--CC---------------------
Q 042539 249 VGTEEYVSPEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLM--KT--------------------- 304 (412)
Q Consensus 249 ~gt~~Y~APE~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~--~~--------------------- 304 (412)
+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.. +.
T Consensus 183 ~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (353)
T 2b9h_A 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKS 262 (353)
T ss_dssp CCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHT
T ss_pred cccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhc
Confidence 89999999998865 6689999999999999999999999999887665544431 00
Q ss_pred -CC---------CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCchh
Q 042539 305 -PE---------FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDL 352 (412)
Q Consensus 305 -~~---------~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~~ 352 (412)
+. ++..++++.+||.+||..||++|| +++++++||||+...+..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp----t~~ell~hp~~~~~~~~~ 316 (353)
T 2b9h_A 263 LPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRI----TAKEALEHPYLQTYHDPN 316 (353)
T ss_dssp SCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSC----CHHHHHTSGGGTTTCCTT
T ss_pred ccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCC----CHHHHhcCccccccCCcc
Confidence 00 135678999999999999999999 699999999999887654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-49 Score=388.59 Aligned_cols=256 Identities=23% Similarity=0.331 Sum_probs=205.5
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC--------CC
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS--------HP 83 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~--------hp 83 (412)
...+..++|++++.||+|+||+||+|++..++ +.||||++++.. .....+.+|+.+++.++ |+
T Consensus 31 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~ 101 (397)
T 1wak_A 31 IGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGK----KFVAMKVVKSAE-----HYTETALDEIRLLKSVRNSDPNDPNRE 101 (397)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEECSCH-----HHHHHHHHHHHHHHHHHHSCTTCGGGG
T ss_pred hhhhcCCeEEEEEEeeecCCeeEEEEEecCCC----eEEEEEEEecCC-----cchHHHHHHHHHHHHHhhcCCCCCCcc
Confidence 34555689999999999999999999987744 459999996542 23456677999999996 78
Q ss_pred ccceeeeeEE----eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeeeCCCCceEE
Q 042539 84 FLPKLLGSLE----TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNM-GIAYRDLKPENILI 158 (412)
Q Consensus 84 nIv~l~~~~~----~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~-~iiHrDlKp~NiLl 158 (412)
||++++++|. +...+|+||||| +++|...+.......+++.+++.++.||+.||.|||++ ||+||||||+|||+
T Consensus 102 ~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll 180 (397)
T 1wak_A 102 MVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILL 180 (397)
T ss_dssp GBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEE
T ss_pred eeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeE
Confidence 8999999998 556899999999 55555555555445699999999999999999999998 99999999999999
Q ss_pred ccCC-------------------------------------------------CEEEccccccchhhchhhhhhhcccCC
Q 042539 159 RQSG-------------------------------------------------HVTLTDFDLSRNLVKKTAFEKQSLNNN 189 (412)
Q Consensus 159 ~~~g-------------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~~~~ 189 (412)
+.+| .+||+|||+|+....
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~------------ 248 (397)
T 1wak_A 181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK------------ 248 (397)
T ss_dssp CCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB------------
T ss_pred eccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc------------
Confidence 9776 799999999975421
Q ss_pred CCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecCCCCCchh
Q 042539 190 KFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAV 269 (412)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~ 269 (412)
.....+||+.|+|||++.+..++.++
T Consensus 249 ------------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~ 274 (397)
T 1wak_A 249 ------------------------------------------------------HFTEDIQTRQYRSLEVLIGSGYNTPA 274 (397)
T ss_dssp ------------------------------------------------------CSCSCCSCGGGCCHHHHHTSCCCTHH
T ss_pred ------------------------------------------------------cCccCCCCCcccCChhhcCCCCCcHH
Confidence 12234789999999999999999999
Q ss_pred hHHHHHHHHHHHhhCCCCCCCCC------HHHHHHHHh---cCCCC----------------------------------
Q 042539 270 DWWALGILTYEMLYGTTPFRGKN------RKETFRNVL---MKTPE---------------------------------- 306 (412)
Q Consensus 270 DiwSlGvil~ell~g~~Pf~~~~------~~~~~~~i~---~~~~~---------------------------------- 306 (412)
|||||||++|+|++|+.||.+.+ .......+. ...+.
T Consensus 275 DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (397)
T 1wak_A 275 DIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVL 354 (397)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHH
T ss_pred HHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhh
Confidence 99999999999999999998754 222222221 11100
Q ss_pred ------CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCC
Q 042539 307 ------FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 307 ------~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
....++.+.+||.+||+.||++|| +++|+++||||++
T Consensus 355 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp----t~~e~l~hp~~~~ 397 (397)
T 1wak_A 355 VEKYEWSQEEAAGFTDFLLPMLELIPEKRA----TAAECLRHPWLNS 397 (397)
T ss_dssp HHTSCCCHHHHHHHHHHHGGGGCSSGGGSC----CHHHHHTSGGGGC
T ss_pred hhhcccchhhHHHHHHHHHHHhccChhhcC----CHHHHhhCccccC
Confidence 001125688999999999999999 7999999999973
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=381.03 Aligned_cols=266 Identities=20% Similarity=0.267 Sum_probs=223.6
Q ss_pred CCCCCCCCccCceeeeeeeccCceEEEEEEEcCCCC---CCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCc
Q 042539 9 PQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADP---TARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPF 84 (412)
Q Consensus 9 ~~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpn 84 (412)
+...+++..++|++++.||+|+||+||+|++..++. .....||||+++... .......+.+|+++++.+ +|||
T Consensus 60 ~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpn 136 (382)
T 3tt0_A 60 EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKN 136 (382)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTT
T ss_pred cCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc---CHHHHHHHHHHHHHHHHhcCCch
Confidence 344567888999999999999999999999865443 234569999997653 234456778899999999 8999
Q ss_pred cceeeeeEEeCCeEEEEeeccCCCCchhHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeee
Q 042539 85 LPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQND--------------RVFSPSVIRFYLSEIICAIEHLHNMGIAYRD 150 (412)
Q Consensus 85 Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~--------------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrD 150 (412)
|+++++++.+++.+|+|||||.||+|..++..... ..+++.+++.++.||+.||.|||++||+|||
T Consensus 137 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 216 (382)
T 3tt0_A 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRD 216 (382)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred hhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCC
Confidence 99999999999999999999999999998876542 3599999999999999999999999999999
Q ss_pred CCCCceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCC
Q 042539 151 LKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVS 230 (412)
Q Consensus 151 lKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (412)
|||+|||++.+|.+||+|||+|+......
T Consensus 217 lkp~NIll~~~~~~kL~DFG~a~~~~~~~--------------------------------------------------- 245 (382)
T 3tt0_A 217 LAARNVLVTEDNVMKIADFGLARDIHHID--------------------------------------------------- 245 (382)
T ss_dssp CCGGGEEECTTCCEEECSCSCCCCSSCCC---------------------------------------------------
T ss_pred CCcceEEEcCCCcEEEcccCccccccccc---------------------------------------------------
Confidence 99999999999999999999997542110
Q ss_pred CccccccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCC
Q 042539 231 PVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEF 307 (412)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~ 307 (412)
.........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.... ...
T Consensus 246 ----------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~ 315 (382)
T 3tt0_A 246 ----------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKP 315 (382)
T ss_dssp ----------TTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred ----------ccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 0112233467889999999999999999999999999999999 999999999888877776543 223
Q ss_pred CCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcC
Q 042539 308 VGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEH 342 (412)
Q Consensus 308 ~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h 342 (412)
...++++.+||.+||..||++|| ++.+++++
T Consensus 316 ~~~~~~l~~li~~~l~~dP~~Rp----s~~ell~~ 346 (382)
T 3tt0_A 316 SNCTNELYMMMRDCWHAVPSQRP----TFKQLVED 346 (382)
T ss_dssp SSCCHHHHHHHHHHTCSSGGGSC----CHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCc----CHHHHHHH
Confidence 45689999999999999999999 68888873
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=377.01 Aligned_cols=262 Identities=26% Similarity=0.349 Sum_probs=215.2
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc---CCCccceeeeeE
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL---SHPFLPKLLGSL 92 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~ 92 (412)
..++|++++.||+|+||+||+|++... +++.||+|+++...... .....+.+|+.+++.+ +||||+++++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~ 83 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKN---GGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVC 83 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTT---TTEEEEEEEEEEEBCTT--SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCC---CCEEEEEEEeccCcccc--cCCchhhHHHHHHHhhhccCCCCeEeeeeee
Confidence 348999999999999999999998532 34459999997543211 1112334577777666 899999999998
Q ss_pred E-----eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEc
Q 042539 93 E-----TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLT 167 (412)
Q Consensus 93 ~-----~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~ 167 (412)
. ....+++||||+. |+|..++.......+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 84 TVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp EEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred eecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEe
Confidence 7 4568999999997 588888877665669999999999999999999999999999999999999999999999
Q ss_pred cccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcc
Q 042539 168 DFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNS 247 (412)
Q Consensus 168 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (412)
|||+++..... .....
T Consensus 163 Dfg~~~~~~~~----------------------------------------------------------------~~~~~ 178 (326)
T 1blx_A 163 DFGLARIYSFQ----------------------------------------------------------------MALTS 178 (326)
T ss_dssp SCCSCCCCCGG----------------------------------------------------------------GGGCC
T ss_pred cCcccccccCC----------------------------------------------------------------CCccc
Confidence 99998754211 11224
Q ss_pred cccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CC--------------------
Q 042539 248 FVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK--TP-------------------- 305 (412)
Q Consensus 248 ~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~~-------------------- 305 (412)
.+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+..++.. .+
T Consensus 179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (326)
T 1blx_A 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKS 258 (326)
T ss_dssp CCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCC
T ss_pred cccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccC
Confidence 57899999999999999999999999999999999999999999888777666531 00
Q ss_pred ------CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCch
Q 042539 306 ------EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 306 ------~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~ 351 (412)
.....+..+.+||.+||..||.+|| ++.++++||||+++++.
T Consensus 259 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp----t~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 259 AQPIEKFVTDIDELGKDLLLKCLTFNPAKRI----SAYSALSHPYFQDLERC 306 (326)
T ss_dssp CCCGGGTCCSCCHHHHHHHHHHSCSSTTTSC----CHHHHHTSGGGTTCCCC
T ss_pred cchhhhccccCCHHHHHHHHHHcCCCcccCC----CHHHHhcCccccccchh
Confidence 0134678899999999999999999 69999999999987764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=376.37 Aligned_cols=279 Identities=19% Similarity=0.283 Sum_probs=203.8
Q ss_pred CCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeee
Q 042539 11 TTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLG 90 (412)
Q Consensus 11 ~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 90 (412)
....+..++|++++.||+|+||+||+|++...+. ....||||+++...... ...+.+.+|++++++++||||+++++
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~ 92 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDG-SFVKVAVKMLKADIIAS--SDIEEFLREAACMKEFDHPHVAKLVG 92 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC--------CEEEEEEC------C--HHHHHHHHHHHHHTTCCCTTBCCCCE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCC-cceeEEEEEecccccCH--HHHHHHHHHHHHHHHCCCCceehhhc
Confidence 3456777899999999999999999999876543 22359999997654322 33567788999999999999999999
Q ss_pred eEEeCCeE------EEEeeccCCCCchhHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEcc
Q 042539 91 SLETDEFL------AWAVPYCPGGDLNVLRYKQND----RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQ 160 (412)
Q Consensus 91 ~~~~~~~~------~lv~e~~~gg~L~~~~~~~~~----~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~ 160 (412)
++...... ++|||||.||+|..++..... ..+++.++..++.||+.||.|||++||+||||||+|||++.
T Consensus 93 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~ 172 (323)
T 3qup_A 93 VSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAE 172 (323)
T ss_dssp EEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred eeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcC
Confidence 99877654 999999999999888765431 24899999999999999999999999999999999999999
Q ss_pred CCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccC
Q 042539 161 SGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFD 240 (412)
Q Consensus 161 ~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (412)
+|.+||+|||+++.......
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~------------------------------------------------------------ 192 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDY------------------------------------------------------------ 192 (323)
T ss_dssp TSCEEECCCCC---------------------------------------------------------------------
T ss_pred CCCEEEeecccccccccccc------------------------------------------------------------
Confidence 99999999999976532110
Q ss_pred CCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHH
Q 042539 241 NGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDL 317 (412)
Q Consensus 241 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dl 317 (412)
........+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.... ......++++.+|
T Consensus 193 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 271 (323)
T 3qup_A 193 -YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDL 271 (323)
T ss_dssp ---------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred -ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCCCCCccCHHHHHH
Confidence 011123356889999999999999999999999999999999 999999988888877776543 3345678999999
Q ss_pred HHHhhhhCCCccCCCC---CChhhhhcCCCCCCCCchhh
Q 042539 318 IQRLLEKDPVKRLGYL---RGACEIKEHVFFKGVRWDLL 353 (412)
Q Consensus 318 i~~~L~~dP~~R~~~~---~~~~e~l~h~ff~~~~~~~~ 353 (412)
|.+||..||.+||++. ...++++.|+|+....++-+
T Consensus 272 i~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl 310 (323)
T 3qup_A 272 MYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPL 310 (323)
T ss_dssp HHHTTCSSGGGSCCHHHHHHHHHHHHHC-----------
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCC
Confidence 9999999999999320 11788999999987655433
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=371.38 Aligned_cols=261 Identities=28% Similarity=0.455 Sum_probs=221.2
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
.....++|++++.||+|+||.||+|+++.++. .||+|++.+..... .....+.+|++++++++||||+++++++
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~----~valK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 90 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQ----EYAVKVINKASAKN--KDTSTILREVELLKKLDHPNIMKLFEIL 90 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEGGGBSS--SCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCc----EEEEEEecccccch--HHHHHHHHHHHHHHhccCCCccEEEEEE
Confidence 34456899999999999999999999876544 49999997654322 2345677899999999999999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCC---CEEEccc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG---HVTLTDF 169 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g---~vkL~DF 169 (412)
.+.+.+|+||||+.|++|..++.... .+++.++..++.||+.||.|||++||+||||||+||+++.++ .+||+||
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Df 168 (287)
T 2wei_A 91 EDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF 168 (287)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECST
T ss_pred eCCCeEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEecc
Confidence 99999999999999999987776554 499999999999999999999999999999999999997654 6999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|+++.... ........
T Consensus 169 g~~~~~~~----------------------------------------------------------------~~~~~~~~ 184 (287)
T 2wei_A 169 GLSTCFQQ----------------------------------------------------------------NTKMKDRI 184 (287)
T ss_dssp TGGGTBCC----------------------------------------------------------------CSSCSCHH
T ss_pred CcceeecC----------------------------------------------------------------CCcccccc
Confidence 99875421 11122446
Q ss_pred cCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC-----CCCCChHHHHHHHHhhhh
Q 042539 250 GTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE-----FVGQRTALTDLIQRLLEK 324 (412)
Q Consensus 250 gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~-----~~~~~~~~~dli~~~L~~ 324 (412)
||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..+....+...... +...++++.+||.+||..
T Consensus 185 ~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 263 (287)
T 2wei_A 185 GTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTF 263 (287)
T ss_dssp HHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCS
T ss_pred CcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHccc
Confidence 89999999998765 889999999999999999999999999888887777665432 245789999999999999
Q ss_pred CCCccCCCCCChhhhhcCCCCCCCCc
Q 042539 325 DPVKRLGYLRGACEIKEHVFFKGVRW 350 (412)
Q Consensus 325 dP~~R~~~~~~~~e~l~h~ff~~~~~ 350 (412)
||.+|| ++.++++||||++..+
T Consensus 264 dp~~Rp----s~~ell~hp~~~~~~~ 285 (287)
T 2wei_A 264 HPSLRI----TATQCLEHPWIQKYSS 285 (287)
T ss_dssp SGGGSC----CHHHHHHSHHHHHHCC
T ss_pred ChhhCc----CHHHHhcCHHHhcccc
Confidence 999999 6999999999986554
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=385.54 Aligned_cols=257 Identities=27% Similarity=0.384 Sum_probs=210.9
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CC-----ccce
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HP-----FLPK 87 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hp-----nIv~ 87 (412)
+...++|++++.||+|+||+||+|++..++ +.||||+++... .....+.+|+.+++.+. |+ +|++
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~ 120 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQ----EWVAIKIIKNKK-----AFLNQAQIEVRLLELMNKHDTEMKYYIVH 120 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTT----EEEEEEEECSSH-----HHHHHHHHHHHHHHHHHHCSSGGGGGBCC
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCC----cEEEEEEEeccH-----HHHHHHHHHHHHHHHHHhcccccceeEEE
Confidence 444689999999999999999999987754 459999997542 23445666888888885 55 4999
Q ss_pred eeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH--HcCceeeeCCCCceEEc--cCCC
Q 042539 88 LLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLH--NMGIAYRDLKPENILIR--QSGH 163 (412)
Q Consensus 88 l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH--~~~iiHrDlKp~NiLl~--~~g~ 163 (412)
+++++...+.+|+||||+.| +|..++.......+++..++.++.||+.||.||| +.||+||||||+|||++ .++.
T Consensus 121 ~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~ 199 (382)
T 2vx3_A 121 LKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSA 199 (382)
T ss_dssp EEEEEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCC
T ss_pred eeeeeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCc
Confidence 99999999999999999964 8888877765556999999999999999999999 57999999999999995 4788
Q ss_pred EEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCC
Q 042539 164 VTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGE 243 (412)
Q Consensus 164 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (412)
+||+|||+|+... .
T Consensus 200 ~kL~DFG~a~~~~------------------------------------------------------------------~ 213 (382)
T 2vx3_A 200 IKIVDFGSSCQLG------------------------------------------------------------------Q 213 (382)
T ss_dssp EEECCCTTCEETT------------------------------------------------------------------C
T ss_pred EEEEeccCceecc------------------------------------------------------------------c
Confidence 9999999997542 1
Q ss_pred CCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC----------------
Q 042539 244 RSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF---------------- 307 (412)
Q Consensus 244 ~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~---------------- 307 (412)
.....+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+.+..+.......
T Consensus 214 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 293 (382)
T 2vx3_A 214 RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFE 293 (382)
T ss_dssp CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEE
T ss_pred ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHH
Confidence 1234579999999999999999999999999999999999999999998887776665311000
Q ss_pred --C-------------------C----------------------------CChHHHHHHHHhhhhCCCccCCCCCChhh
Q 042539 308 --V-------------------G----------------------------QRTALTDLIQRLLEKDPVKRLGYLRGACE 338 (412)
Q Consensus 308 --~-------------------~----------------------------~~~~~~dli~~~L~~dP~~R~~~~~~~~e 338 (412)
+ . .++++.+||.+||+.||++|| +++|
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rp----ta~e 369 (382)
T 2vx3_A 294 KLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRI----QPYY 369 (382)
T ss_dssp ECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSC----CHHH
T ss_pred hccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCC----CHHH
Confidence 0 0 003789999999999999999 7999
Q ss_pred hhcCCCCCCCCc
Q 042539 339 IKEHVFFKGVRW 350 (412)
Q Consensus 339 ~l~h~ff~~~~~ 350 (412)
+++||||++..+
T Consensus 370 ~L~hp~f~~~~~ 381 (382)
T 2vx3_A 370 ALQHSFFKKTAD 381 (382)
T ss_dssp HTTSGGGCC---
T ss_pred HhcCcccccCCC
Confidence 999999987554
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=397.54 Aligned_cols=250 Identities=18% Similarity=0.191 Sum_probs=199.7
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHH---HHhhcCCCccceee----
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIR---VLSRLSHPFLPKLL---- 89 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~---il~~l~hpnIv~l~---- 89 (412)
.++|++++.||+|+||+||+|+++.++ +.||||++.+..... ....+.+.+|+. +++.++|||||+++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~----~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~ 146 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETG----ESFEVHVPYFTERPP-SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 146 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCC----CEEEEEEEEECC-CC-TTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBC
T ss_pred CceEEEcceeecCCCEEEEEEEECCCC----cEEEEEEEeeccccc-hHHHHHHHHHHHHHHhccccCCHHHHHHHhhhh
Confidence 578999999999999999999987644 459999997654322 234566778994 55555799999998
Q ss_pred ---eeEEeCC-----------------eEEEEeeccCCCCchhHHHhhCCCCCCH-------HHHHHHHHHHHHHHHHHH
Q 042539 90 ---GSLETDE-----------------FLAWAVPYCPGGDLNVLRYKQNDRVFSP-------SVIRFYLSEIICAIEHLH 142 (412)
Q Consensus 90 ---~~~~~~~-----------------~~~lv~e~~~gg~L~~~~~~~~~~~l~~-------~~~~~~~~qi~~aL~yLH 142 (412)
+++.+.+ ..|+||||| +|+|..++..... +++ ..+..++.||+.||+|||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~--~~~~~~~l~~~~~~~i~~qi~~aL~~LH 223 (377)
T 3byv_A 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLS--HSSTHKSLVHHARLQLTLQVIRLLASLH 223 (377)
T ss_dssp CCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHH--TTTTTHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccc--cccccccccHHHHHHHHHHHHHHHHHHH
Confidence 6666553 389999999 6899888776432 444 788889999999999999
Q ss_pred HcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccc
Q 042539 143 NMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLK 222 (412)
Q Consensus 143 ~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (412)
++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 224 ~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~---------------------------------------------- 257 (377)
T 3byv_A 224 HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG---------------------------------------------- 257 (377)
T ss_dssp HTTEECSCCCGGGEEECTTCCEEECCGGGCEETT----------------------------------------------
T ss_pred hCCeecCCCCHHHEEEcCCCCEEEEechhheecC----------------------------------------------
Confidence 9999999999999999999999999999997431
Q ss_pred cccccCCCCccccccccCCCCCCcccccCCCCccceeecCC-----------CCCchhhHHHHHHHHHHHhhCCCCCCCC
Q 042539 223 KTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGD-----------GHEFAVDWWALGILTYEMLYGTTPFRGK 291 (412)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-----------~~~~~~DiwSlGvil~ell~g~~Pf~~~ 291 (412)
....+.+| +.|+|||++.+. .++.++|||||||++|||++|+.||.+.
T Consensus 258 --------------------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~ 316 (377)
T 3byv_A 258 --------------------ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKD 316 (377)
T ss_dssp --------------------CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred --------------------CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCccc
Confidence 11234578 999999999987 7899999999999999999999999886
Q ss_pred CHHHHHHHHhcCCCCCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCC
Q 042539 292 NRKETFRNVLMKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 292 ~~~~~~~~i~~~~~~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~ 348 (412)
+.......+.. .....++++.+||.+||+.||++|| ++.++++||||+++
T Consensus 317 ~~~~~~~~~~~---~~~~~~~~~~~li~~~L~~dp~~Rp----t~~e~l~hp~f~~~ 366 (377)
T 3byv_A 317 AALGGSEWIFR---SCKNIPQPVRALLEGFLRYPKEDRL----LPLQAMETPEYEQL 366 (377)
T ss_dssp ---CCSGGGGS---SCCCCCHHHHHHHHHHTCSSGGGCC----CHHHHHTSHHHHHH
T ss_pred ccccchhhhhh---hccCCCHHHHHHHHHHcCCCchhCC----CHHHHhhChHHHHH
Confidence 65444433332 2356789999999999999999999 69999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=367.20 Aligned_cols=259 Identities=24% Similarity=0.378 Sum_probs=219.0
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe-
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET- 94 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~- 94 (412)
..++|++++.||+|+||.||+|+++.++ +.||+|++...... ....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDG----KILVWKELDYGSMT--EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR 77 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTC----CEEEEEEEECTTCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG
T ss_pred chhheeeehhccCCCCcEEEEEEECCCC----cEEEEEEEEcccCC--HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC
Confidence 5789999999999999999999998754 44999999765532 3345678889999999999999999998854
Q ss_pred -CCeEEEEeeccCCCCchhHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHcC-----ceeeeCCCCceEEccCCCEEE
Q 042539 95 -DEFLAWAVPYCPGGDLNVLRYKQN--DRVFSPSVIRFYLSEIICAIEHLHNMG-----IAYRDLKPENILIRQSGHVTL 166 (412)
Q Consensus 95 -~~~~~lv~e~~~gg~L~~~~~~~~--~~~l~~~~~~~~~~qi~~aL~yLH~~~-----iiHrDlKp~NiLl~~~g~vkL 166 (412)
+..+|+|||||.|++|..++.... ...+++..+..++.|++.||+|||++| |+||||||+|||++.+|.+||
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl 157 (279)
T 2w5a_A 78 TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL 157 (279)
T ss_dssp GGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEE
T ss_pred CCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEE
Confidence 578999999999999988876532 334899999999999999999999999 999999999999999999999
Q ss_pred ccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCc
Q 042539 167 TDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSN 246 (412)
Q Consensus 167 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (412)
+|||+++....... ...
T Consensus 158 ~dfg~~~~~~~~~~---------------------------------------------------------------~~~ 174 (279)
T 2w5a_A 158 GDFGLARILNHDTS---------------------------------------------------------------FAK 174 (279)
T ss_dssp CCCCHHHHC---CH---------------------------------------------------------------HHH
T ss_pred ecCchheeeccccc---------------------------------------------------------------ccc
Confidence 99999876532110 112
Q ss_pred ccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-CC-CCCChHHHHHHHHhhhh
Q 042539 247 SFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP-EF-VGQRTALTDLIQRLLEK 324 (412)
Q Consensus 247 ~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~-~~~~~~~~dli~~~L~~ 324 (412)
...||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..... .. ...+.++.++|.+||..
T Consensus 175 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~ 254 (279)
T 2w5a_A 175 TFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNL 254 (279)
T ss_dssp HHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred ccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcccCHHHHHHHHHHcCC
Confidence 34689999999999999999999999999999999999999999888877777765443 22 35678999999999999
Q ss_pred CCCccCCCCCChhhhhcCCCCCC
Q 042539 325 DPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 325 dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
||.+|| ++.++++|+|+.+
T Consensus 255 ~p~~Rp----s~~~ll~~~~~~~ 273 (279)
T 2w5a_A 255 KDYHRP----SVEEILENPLILE 273 (279)
T ss_dssp SGGGSC----CHHHHHTSTTCCG
T ss_pred CcccCC----CHHHHHhChhhhh
Confidence 999999 6999999999975
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=377.40 Aligned_cols=255 Identities=27% Similarity=0.408 Sum_probs=208.4
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
.+.-++|++++.||+|+||+||+|++..++. .||||++....... ....+.+|+++++.++||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 77 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGD----LFAIKVFNNISFLR---PVDVQMREFEVLKKLNHKNIVKLFAIEE 77 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEECGGGGGS---CHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCc----EEEEEEeccccccc---hHHHHHHHHHHHHhcCCCCcceEEEEee
Confidence 3456899999999999999999999987544 49999997654322 2345567999999999999999999998
Q ss_pred eCC--eEEEEeeccCCCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEE----ccCCCEEE
Q 042539 94 TDE--FLAWAVPYCPGGDLNVLRYKQND-RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILI----RQSGHVTL 166 (412)
Q Consensus 94 ~~~--~~~lv~e~~~gg~L~~~~~~~~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl----~~~g~vkL 166 (412)
... .+|+|||||.|++|..++..... ..+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL 157 (319)
T 4euu_A 78 ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKL 157 (319)
T ss_dssp CTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEE
T ss_pred cCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEE
Confidence 765 88999999999999988775432 238999999999999999999999999999999999999 77788999
Q ss_pred ccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCc
Q 042539 167 TDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSN 246 (412)
Q Consensus 167 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (412)
+|||+++.... .....
T Consensus 158 ~Dfg~a~~~~~----------------------------------------------------------------~~~~~ 173 (319)
T 4euu_A 158 TDFGAARELED----------------------------------------------------------------DEQFV 173 (319)
T ss_dssp CCCTTCEECCT----------------------------------------------------------------TCCBC
T ss_pred ccCCCceecCC----------------------------------------------------------------CCcee
Confidence 99999975421 11223
Q ss_pred ccccCCCCccceeec--------CCCCCchhhHHHHHHHHHHHhhCCCCCCCCC----HHHHHHHHhcCCCC--------
Q 042539 247 SFVGTEEYVSPEVVR--------GDGHEFAVDWWALGILTYEMLYGTTPFRGKN----RKETFRNVLMKTPE-------- 306 (412)
Q Consensus 247 ~~~gt~~Y~APE~l~--------~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~----~~~~~~~i~~~~~~-------- 306 (412)
+.+||+.|+|||++. +..++.++|||||||++|||++|+.||.... ..+.+.+++...+.
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 253 (319)
T 4euu_A 174 SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQK 253 (319)
T ss_dssp CCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEEC
T ss_pred ecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhc
Confidence 457999999999986 5678999999999999999999999997432 34455555543321
Q ss_pred -----------CC---C----CChHHHHHHHHhhhhCCCccCCCCCChhhhhcCC
Q 042539 307 -----------FV---G----QRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHV 343 (412)
Q Consensus 307 -----------~~---~----~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ 343 (412)
++ . .+..+.+||.+||+.||++|+ +++|+++||
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~----s~~ell~h~ 304 (319)
T 4euu_A 254 AENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW----GFDQFFAET 304 (319)
T ss_dssp STTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSC----CHHHHHHHH
T ss_pred ccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhc----cHHHhhhcc
Confidence 11 1 135788999999999999999 699999987
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=373.68 Aligned_cols=261 Identities=25% Similarity=0.350 Sum_probs=208.6
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE--
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE-- 93 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-- 93 (412)
..++|++++.||+|+||.||+|.+..++ +.||+|++.... ....+.+.+|+++++.++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 80 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCD----KRVAIKKIVLTD----PQSVKHALREIKIIRRLDHDNIVKVFEILGPS 80 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTT----EEEEEEEEECCS----HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTT
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCC----eEEEEEEEecCC----hHHHHHHHHHHHHHHhcCCCCeeEEEEecccc
Confidence 3579999999999999999999998754 459999986543 234566778999999999999999999873
Q ss_pred ------------eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEc-c
Q 042539 94 ------------TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIR-Q 160 (412)
Q Consensus 94 ------------~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~-~ 160 (412)
+...+|+||||+. |+|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++ .
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 156 (320)
T 2i6l_A 81 GSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTE 156 (320)
T ss_dssp SCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT
T ss_pred ccccccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC
Confidence 3468999999997 588777643 4599999999999999999999999999999999999997 5
Q ss_pred CCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccC
Q 042539 161 SGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFD 240 (412)
Q Consensus 161 ~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (412)
++.+||+|||+++...... .
T Consensus 157 ~~~~kl~Dfg~~~~~~~~~------------------------------------------------------------~ 176 (320)
T 2i6l_A 157 DLVLKIGDFGLARIMDPHY------------------------------------------------------------S 176 (320)
T ss_dssp TTEEEECCCTTCBCC-----------------------------------------------------------------
T ss_pred CCeEEEccCccccccCCCc------------------------------------------------------------c
Confidence 6799999999997642110 0
Q ss_pred CCCCCcccccCCCCccceeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC-------------
Q 042539 241 NGERSNSFVGTEEYVSPEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE------------- 306 (412)
Q Consensus 241 ~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~------------- 306 (412)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....+.
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (320)
T 2i6l_A 177 HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVI 256 (320)
T ss_dssp ---CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTS
T ss_pred cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcC
Confidence 1112234568999999999876 66899999999999999999999999998887776666543211
Q ss_pred ------------------CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCchh
Q 042539 307 ------------------FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDL 352 (412)
Q Consensus 307 ------------------~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~~ 352 (412)
.+..+.++.+||.+||+.||.+|| +++++++||||+..+|..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp----t~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 257 PVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRL----TAEEALSHPYMSIYSFPM 316 (320)
T ss_dssp CHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSC----CHHHHHTSHHHHTTCC--
T ss_pred cccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccC----CHHHHhCCcccccccCcc
Confidence 135688999999999999999999 799999999999887754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=389.72 Aligned_cols=263 Identities=24% Similarity=0.329 Sum_probs=193.5
Q ss_pred cCcee-eeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe--
Q 042539 18 DNLKA-LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET-- 94 (412)
Q Consensus 18 ~~y~~-~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-- 94 (412)
+.|.+ .++||+|+||+||+|+++... +++.||||++...... ..+.+|+.+|+.++||||+++++++..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~--~~~~vaiK~~~~~~~~------~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGK--DDKDYALKQIEGTGIS------MSACREIALLRELKHPNVISLQKVFLSHA 91 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSS--CCCCEEEEECSSSSCC------HHHHHHHHHHHHCCCTTBCCCCEEEEETT
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCC--CCeEEEEEEECCCCCC------HHHHHHHHHHHhcCCCCeeeEeeEEecCC
Confidence 45776 458999999999999976432 3455999999765331 245679999999999999999999954
Q ss_pred CCeEEEEeeccCCCCchhHHHhhC-------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEE----ccCCC
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQN-------DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILI----RQSGH 163 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~-------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl----~~~g~ 163 (412)
+..+|+|||||.| +|..++.... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 92 DRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred CCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCc
Confidence 6789999999975 6655544221 1249999999999999999999999999999999999999 67799
Q ss_pred EEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCC
Q 042539 164 VTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGE 243 (412)
Q Consensus 164 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (412)
+||+|||+|+.+.... ....
T Consensus 171 ~kl~Dfg~a~~~~~~~------------------------------------------------------------~~~~ 190 (405)
T 3rgf_A 171 VKIADMGFARLFNSPL------------------------------------------------------------KPLA 190 (405)
T ss_dssp EEECCTTCCC----------------------------------------------------------------------
T ss_pred EEEEECCCceecCCCC------------------------------------------------------------cccc
Confidence 9999999997653210 0112
Q ss_pred CCcccccCCCCccceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHH---------HHHHHHhc--CCCC-----
Q 042539 244 RSNSFVGTEEYVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRK---------ETFRNVLM--KTPE----- 306 (412)
Q Consensus 244 ~~~~~~gt~~Y~APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---------~~~~~i~~--~~~~----- 306 (412)
.....+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+.. +.+..+.. +.+.
T Consensus 191 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~ 270 (405)
T 3rgf_A 191 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWE 270 (405)
T ss_dssp ------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCG
T ss_pred cCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcc
Confidence 23356899999999999885 4899999999999999999999999876542 33333321 1110
Q ss_pred --------------------------------CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCchhh
Q 042539 307 --------------------------------FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLL 353 (412)
Q Consensus 307 --------------------------------~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~~~ 353 (412)
....++.+.+||.+||+.||.+|| +++|+++||||.+..+...
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~----ta~e~L~hp~f~~~~~~~~ 345 (405)
T 3rgf_A 271 DIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI----TSEQAMQDPYFLEDPLPTS 345 (405)
T ss_dssp GGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSC----CHHHHHTSGGGTSSSCCCS
T ss_pred hhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCC----CHHHHhcChhhccCCCCcc
Confidence 011267899999999999999999 7999999999998776543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-48 Score=368.35 Aligned_cols=254 Identities=27% Similarity=0.406 Sum_probs=218.3
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
-+.|++++.||+|+||.||+|.+..++ +.||||++...... .....+.+|+.+++.++||||+++++++.++.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 93 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQ----KVVAIKIIDLEEAE---DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT 93 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTC----CEEEEEEEETTTCS---TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCC----cEEEEEEecccccH---HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 367999999999999999999987654 44999999765432 23456778999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
.+|+||||+.|++|..++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 94 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 170 (303)
T 3a7i_A 94 KLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170 (303)
T ss_dssp EEEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred eEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecC
Confidence 99999999999999887653 359999999999999999999999999999999999999999999999999997542
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
.. .......+||+.|+|
T Consensus 171 ~~---------------------------------------------------------------~~~~~~~~~~~~y~a 187 (303)
T 3a7i_A 171 DT---------------------------------------------------------------QIKRNTFVGTPFWMA 187 (303)
T ss_dssp TT---------------------------------------------------------------BCCBCCCCSCGGGCC
T ss_pred cc---------------------------------------------------------------ccccCccCCCcCccC
Confidence 11 111234579999999
Q ss_pred ceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC--CCCCChHHHHHHHHhhhhCCCccCCCCC
Q 042539 257 PEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE--FVGQRTALTDLIQRLLEKDPVKRLGYLR 334 (412)
Q Consensus 257 PE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~dli~~~L~~dP~~R~~~~~ 334 (412)
||++.+..++.++|||||||++|+|++|..||...+.......+....+. ....+..+.+||.+||..||.+||
T Consensus 188 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---- 263 (303)
T 3a7i_A 188 PEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRP---- 263 (303)
T ss_dssp HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSC----
T ss_pred HHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHcCCChhhCc----
Confidence 99999999999999999999999999999999998877776666544322 235678999999999999999999
Q ss_pred ChhhhhcCCCCCC
Q 042539 335 GACEIKEHVFFKG 347 (412)
Q Consensus 335 ~~~e~l~h~ff~~ 347 (412)
++.++++|+||..
T Consensus 264 s~~~ll~~~~~~~ 276 (303)
T 3a7i_A 264 TAKELLKHKFILR 276 (303)
T ss_dssp CHHHHTTCHHHHH
T ss_pred CHHHHhhChhhhc
Confidence 6999999999964
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=370.95 Aligned_cols=260 Identities=25% Similarity=0.385 Sum_probs=214.2
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
....++|++++.||+|+||.||+|.+..++. .||||++..... ...+.+|+.+++.++||||+++++++.
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQ----IVAIKQVPVESD------LQEIIKEISIMQQCDSPHVVKYYGSYF 94 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCC----EEEEEEEETTSC------CHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCC----EEEEEecCchHH------HHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence 4456789999999999999999999876544 499999965431 234667999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
+++.+|+|||||.|++|..++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.+|.+||+|||++.
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 173 (314)
T 3com_A 95 KNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAG 173 (314)
T ss_dssp ETTEEEEEEECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred eCCEEEEEeecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccch
Confidence 9999999999999999998876433 459999999999999999999999999999999999999999999999999997
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
..... ........||+.
T Consensus 174 ~~~~~---------------------------------------------------------------~~~~~~~~~~~~ 190 (314)
T 3com_A 174 QLTDT---------------------------------------------------------------MAKRNTVIGTPF 190 (314)
T ss_dssp ECBTT---------------------------------------------------------------BSCBCCCCSCGG
T ss_pred hhhhh---------------------------------------------------------------ccccCccCCCCC
Confidence 54211 011234578999
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC----CCCCChHHHHHHHHhhhhCCCcc
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE----FVGQRTALTDLIQRLLEKDPVKR 329 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~dli~~~L~~dP~~R 329 (412)
|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+...... ....++.+.+||.+||..||.+|
T Consensus 191 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 270 (314)
T 3com_A 191 WMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQR 270 (314)
T ss_dssp GCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTS
T ss_pred ccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhC
Confidence 99999999999999999999999999999999999988876665555443322 12357899999999999999999
Q ss_pred CCCCCChhhhhcCCCCCCCCch
Q 042539 330 LGYLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 330 ~~~~~~~~e~l~h~ff~~~~~~ 351 (412)
| ++.++++||||++..+.
T Consensus 271 p----t~~~ll~~~~~~~~~~~ 288 (314)
T 3com_A 271 A----TATQLLQHPFVRSAKGV 288 (314)
T ss_dssp C----CHHHHTTSHHHHTCCCG
T ss_pred c----CHHHHHhCHHHhcCCcc
Confidence 9 69999999999987764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=371.70 Aligned_cols=267 Identities=21% Similarity=0.281 Sum_probs=221.8
Q ss_pred CCCCCCCCCccCceeeeeeeccCceEEEEEEEcCCC-CCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccc
Q 042539 8 QPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAAD-PTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLP 86 (412)
Q Consensus 8 ~~~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv 86 (412)
...+..++..++|++.+.||+|+||.||+|.+.... ..++..||+|++.... .....+.+.+|+++++.++||||+
T Consensus 13 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv 89 (314)
T 2ivs_A 13 LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA---SPSELRDLLSEFNVLKQVNHPHVI 89 (314)
T ss_dssp -CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHTTCCCTTBC
T ss_pred cCCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC---CHHHHHHHHHHHHHHhhCCCCcee
Confidence 345677888999999999999999999999885432 2244669999997543 234456778899999999999999
Q ss_pred eeeeeEEeCCeEEEEeeccCCCCchhHHHhhCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHc
Q 042539 87 KLLGSLETDEFLAWAVPYCPGGDLNVLRYKQND----------------------RVFSPSVIRFYLSEIICAIEHLHNM 144 (412)
Q Consensus 87 ~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~----------------------~~l~~~~~~~~~~qi~~aL~yLH~~ 144 (412)
++++++.+++.+|+|||||.||+|..++..... ..+++.++..++.||+.||.|||++
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 169 (314)
T 2ivs_A 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM 169 (314)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT
T ss_pred eEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC
Confidence 999999999999999999999999988876432 2489999999999999999999999
Q ss_pred CceeeeCCCCceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccc
Q 042539 145 GIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKT 224 (412)
Q Consensus 145 ~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (412)
||+||||||+|||++.++.+||+|||+++.......
T Consensus 170 ~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~-------------------------------------------- 205 (314)
T 2ivs_A 170 KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS-------------------------------------------- 205 (314)
T ss_dssp TEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSC--------------------------------------------
T ss_pred CCcccccchheEEEcCCCCEEEcccccccccccccc--------------------------------------------
Confidence 999999999999999999999999999975521100
Q ss_pred cccCCCCccccccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcC
Q 042539 225 KSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMK 303 (412)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~ 303 (412)
........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+...
T Consensus 206 -----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 268 (314)
T 2ivs_A 206 -----------------YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTG 268 (314)
T ss_dssp -----------------EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred -----------------ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcC
Confidence 011223457889999999999889999999999999999999 99999998877776666544
Q ss_pred C--CCCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcC
Q 042539 304 T--PEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEH 342 (412)
Q Consensus 304 ~--~~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h 342 (412)
. ......++++.+||.+||..||.+|| ++.+++++
T Consensus 269 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rp----s~~~l~~~ 305 (314)
T 2ivs_A 269 HRMERPDNCSEEMYRLMLQCWKQEPDKRP----VFADISKD 305 (314)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSC----CHHHHHHH
T ss_pred CcCCCCccCCHHHHHHHHHHccCChhhCc----CHHHHHHH
Confidence 3 22345689999999999999999999 68888763
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=375.00 Aligned_cols=261 Identities=18% Similarity=0.240 Sum_probs=211.8
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
...+..++|++++.||+|+||+||+|++..++......||+|++...... .....+.+|+.+++.++||||++++++
T Consensus 7 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~ 83 (325)
T 3kex_A 7 ARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR---QSFQAVTDHMLAIGSLDHAHIVRLLGL 83 (325)
T ss_dssp CCBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC---SCBCSCCHHHHHHHTCCCTTBCCEEEE
T ss_pred HhhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH---HHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 45678899999999999999999999998876655555777777543211 122345569999999999999999998
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
+. ++..++||||+.||+|..++... .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+
T Consensus 84 ~~-~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 161 (325)
T 3kex_A 84 CP-GSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGV 161 (325)
T ss_dssp EC-BSSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSG
T ss_pred Ec-CCccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCc
Confidence 86 56789999999999998887653 24599999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
++.+.... .........||
T Consensus 162 a~~~~~~~-------------------------------------------------------------~~~~~~~~~~~ 180 (325)
T 3kex_A 162 ADLLPPDD-------------------------------------------------------------KQLLYSEAKTP 180 (325)
T ss_dssp GGGSCCCT-------------------------------------------------------------TCCC-----CC
T ss_pred ccccCccc-------------------------------------------------------------ccccccCCCCc
Confidence 97652110 11122345688
Q ss_pred CCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCc
Q 042539 252 EEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVK 328 (412)
Q Consensus 252 ~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~ 328 (412)
+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.... ......+.++.+||.+||..||.+
T Consensus 181 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~ 260 (325)
T 3kex_A 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENI 260 (325)
T ss_dssp TTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTT
T ss_pred ccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhh
Confidence 89999999999999999999999999999999 999999987777666665432 222345678999999999999999
Q ss_pred cCCCCCChhhhhcC
Q 042539 329 RLGYLRGACEIKEH 342 (412)
Q Consensus 329 R~~~~~~~~e~l~h 342 (412)
|| ++.++++|
T Consensus 261 Rp----s~~el~~~ 270 (325)
T 3kex_A 261 RP----TFKELANE 270 (325)
T ss_dssp SC----CHHHHHHH
T ss_pred Cc----CHHHHHHH
Confidence 99 57888765
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=360.88 Aligned_cols=255 Identities=19% Similarity=0.266 Sum_probs=216.4
Q ss_pred CCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeee
Q 042539 11 TTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLG 90 (412)
Q Consensus 11 ~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 90 (412)
..+.+..++|++++.||+|+||+||+|++.. +..||+|++...... ...+.+|++++++++||||+++++
T Consensus 3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~ 72 (269)
T 4hcu_A 3 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLN-----KDKVAIKTIREGAMS-----EEDFIEEAEVMMKLSHPKLVQLYG 72 (269)
T ss_dssp --CBCCGGGEEEEEEEEECSSCEEEEEEETT-----TEEEEEEEECTTSBC-----HHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ccEEeChhhceeeheecCCCccEEEEEEecC-----CCeEEEEEecccccC-----HHHHHHHHHHHHhCCCCCEeeEEE
Confidence 3467888999999999999999999999863 234999999765432 234677999999999999999999
Q ss_pred eEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccc
Q 042539 91 SLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 91 ~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
++.+++.+|+||||+.|++|..++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 73 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg 151 (269)
T 4hcu_A 73 VCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFG 151 (269)
T ss_dssp EECSSSSEEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTT
T ss_pred EEecCCceEEEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccc
Confidence 9999999999999999999998876533 468999999999999999999999999999999999999999999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+++........ ......|
T Consensus 152 ~~~~~~~~~~~--------------------------------------------------------------~~~~~~~ 169 (269)
T 4hcu_A 152 MTRFVLDDQYT--------------------------------------------------------------SSTGTKF 169 (269)
T ss_dssp GGGGBCCHHHH--------------------------------------------------------------STTSTTC
T ss_pred ccccccccccc--------------------------------------------------------------cccCccc
Confidence 99765322110 1123356
Q ss_pred CCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCC--CCCCCChHHHHHHHHhhhhCCC
Q 042539 251 TEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTP--EFVGQRTALTDLIQRLLEKDPV 327 (412)
Q Consensus 251 t~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~dli~~~L~~dP~ 327 (412)
|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+..... .....++.+.++|.+||+.||+
T Consensus 170 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 249 (269)
T 4hcu_A 170 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPE 249 (269)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred ccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHHHccCCcc
Confidence 888999999999999999999999999999999 9999999998888888776432 2234578999999999999999
Q ss_pred ccCCCCCChhhhhcC
Q 042539 328 KRLGYLRGACEIKEH 342 (412)
Q Consensus 328 ~R~~~~~~~~e~l~h 342 (412)
+|| ++.++++|
T Consensus 250 ~Rp----s~~~ll~~ 260 (269)
T 4hcu_A 250 DRP----AFSRLLRQ 260 (269)
T ss_dssp GSC----CHHHHHHH
T ss_pred cCc----CHHHHHHH
Confidence 999 68888864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=378.22 Aligned_cols=260 Identities=25% Similarity=0.385 Sum_probs=206.9
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhh-------hhHHHHHHHHHHHHHHhhcCCCcccee
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLH-------AKHEAERRARWEIRVLSRLSHPFLPKL 88 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~-------~~~~~~~~~~~Ei~il~~l~hpnIv~l 88 (412)
..++|++++.||+|+||.||+|.+.. +..||||++...... ......+.+.+|++++++++||||+++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 94 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-----GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGL 94 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-----SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-----CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccce
Confidence 35799999999999999999998753 345999999654321 223445778889999999999999999
Q ss_pred eeeEEe-----CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCC
Q 042539 89 LGSLET-----DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGH 163 (412)
Q Consensus 89 ~~~~~~-----~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~ 163 (412)
++++.. ...+|+|||||. |+|..++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.+|.
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~ 172 (362)
T 3pg1_A 95 RDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND 172 (362)
T ss_dssp SEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC
T ss_pred eeeEEeccCCCcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC
Confidence 999854 347899999997 466666553 3346999999999999999999999999999999999999999999
Q ss_pred EEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCC
Q 042539 164 VTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGE 243 (412)
Q Consensus 164 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (412)
+||+|||+++.... ..
T Consensus 173 ~kl~Dfg~~~~~~~----------------------------------------------------------------~~ 188 (362)
T 3pg1_A 173 ITICDFNLAREDTA----------------------------------------------------------------DA 188 (362)
T ss_dssp EEECCTTC------------------------------------------------------------------------
T ss_pred EEEEecCccccccc----------------------------------------------------------------cc
Confidence 99999999974321 11
Q ss_pred CCcccccCCCCccceeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CC---------------
Q 042539 244 RSNSFVGTEEYVSPEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK--TP--------------- 305 (412)
Q Consensus 244 ~~~~~~gt~~Y~APE~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~~--------------- 305 (412)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+... .+
T Consensus 189 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 268 (362)
T 3pg1_A 189 NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARD 268 (362)
T ss_dssp -------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHH
T ss_pred ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhH
Confidence 1234578999999999987 66899999999999999999999999998877776665421 00
Q ss_pred ----------------CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCc
Q 042539 306 ----------------EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRW 350 (412)
Q Consensus 306 ----------------~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~ 350 (412)
..+..++.+.+||.+||+.||.+|| +++++++||||+++..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp----t~~ell~hp~f~~~~~ 325 (362)
T 3pg1_A 269 YLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRI----STEQALRHPYFESLFD 325 (362)
T ss_dssp HTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSC----CHHHHHTSGGGTTTCC
T ss_pred HHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCC----CHHHHHcCchhhhccC
Confidence 0124567899999999999999999 6999999999998743
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=373.33 Aligned_cols=263 Identities=20% Similarity=0.247 Sum_probs=211.3
Q ss_pred CCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceee
Q 042539 10 QTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLL 89 (412)
Q Consensus 10 ~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~ 89 (412)
.....+..++|++++.||+|+||+||+|++..++......||+|.+.... .....+.+.+|+.++++++||||++++
T Consensus 7 ~~~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~ 83 (327)
T 3poz_A 7 ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLL 83 (327)
T ss_dssp CSSEECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC----------CHHHHHHHHHHHHHCCBTTBCCEE
T ss_pred HHHhhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc---CHHHHHHHHHHHHHHHhCCCCCEeEEE
Confidence 34556788999999999999999999999987766655557888875432 223456678899999999999999999
Q ss_pred eeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccc
Q 042539 90 GSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169 (412)
Q Consensus 90 ~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DF 169 (412)
+++.++. .++|+||+.+|+|..++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+||
T Consensus 84 ~~~~~~~-~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Df 161 (327)
T 3poz_A 84 GICLTST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDF 161 (327)
T ss_dssp EEEESSS-EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCT
T ss_pred EEEecCC-eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccC
Confidence 9998765 789999999999988876543 45999999999999999999999999999999999999999999999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|+|+...... .........
T Consensus 162 g~a~~~~~~~-------------------------------------------------------------~~~~~~~~~ 180 (327)
T 3poz_A 162 GLAKLLGAEE-------------------------------------------------------------KEYHAEGGK 180 (327)
T ss_dssp THHHHHTTTC-------------------------------------------------------------C-------C
T ss_pred cceeEccCCc-------------------------------------------------------------ccccccCCC
Confidence 9998653210 011122345
Q ss_pred cCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCC
Q 042539 250 GTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDP 326 (412)
Q Consensus 250 gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP 326 (412)
||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+.... +.....+.++.++|.+||+.||
T Consensus 181 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 260 (327)
T 3poz_A 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDA 260 (327)
T ss_dssp CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCG
T ss_pred ccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCh
Confidence 7889999999999999999999999999999999 999999987776665555432 3344567899999999999999
Q ss_pred CccCCCCCChhhhhcC
Q 042539 327 VKRLGYLRGACEIKEH 342 (412)
Q Consensus 327 ~~R~~~~~~~~e~l~h 342 (412)
.+|| ++.+++++
T Consensus 261 ~~Rp----s~~ell~~ 272 (327)
T 3poz_A 261 DSRP----KFRELIIE 272 (327)
T ss_dssp GGSC----CHHHHHHH
T ss_pred hhCC----CHHHHHHH
Confidence 9999 68888864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=372.19 Aligned_cols=261 Identities=21% Similarity=0.283 Sum_probs=219.4
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCC-CCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADP-TARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
..+..++|++++.||+|+||.||+|++..... .+++.||||++++.. .......+.+|+.+++.++||||++++++
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 36677899999999999999999999875321 244669999997653 23445678889999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceee
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQN----------------------DRVFSPSVIRFYLSEIICAIEHLHNMGIAYR 149 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~----------------------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHr 149 (412)
+.+++.+|+|||||.||+|..++.... ...+++.+++.++.||+.||.|||++||+||
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 999999999999999999998887642 1468999999999999999999999999999
Q ss_pred eCCCCceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCC
Q 042539 150 DLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARV 229 (412)
Q Consensus 150 DlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (412)
||||+|||++.+|.+||+|||+++.......
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~------------------------------------------------- 229 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADY------------------------------------------------- 229 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGC-------------------------------------------------
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCcc-------------------------------------------------
Confidence 9999999999999999999999976532110
Q ss_pred CCccccccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCC--C
Q 042539 230 SPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTP--E 306 (412)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~--~ 306 (412)
........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+..... .
T Consensus 230 ------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 297 (343)
T 1luf_A 230 ------------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILAC 297 (343)
T ss_dssp ------------BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC
T ss_pred ------------ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcCCC
Confidence 011223468899999999999999999999999999999998 9999999998888877766542 2
Q ss_pred CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 307 FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 307 ~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
...+++++.+||.+||..||.+|| ++.++++
T Consensus 298 ~~~~~~~l~~li~~~l~~~p~~Rp----s~~~~~~ 328 (343)
T 1luf_A 298 PENCPLELYNLMRLCWSKLPADRP----SFCSIHR 328 (343)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSC----CHHHHHH
T ss_pred CCCCCHHHHHHHHHHcccCcccCC----CHHHHHH
Confidence 345678999999999999999999 5788775
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=377.49 Aligned_cols=263 Identities=26% Similarity=0.386 Sum_probs=187.8
Q ss_pred CCCCCCCCCCCCCccCceeee-eeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCC
Q 042539 4 TPPPQPQTTPSLDLDNLKALK-ILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82 (412)
Q Consensus 4 ~~~~~~~~~~~~~~~~y~~~~-~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~h 82 (412)
++.+.|........++|++++ .||+|+||+||+|+++.++. .||||++..... ..+. ....++.+.|
T Consensus 14 ~~~~~p~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~-----~~~e---~~~~~~~~~h 81 (336)
T 3fhr_A 14 VLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQ----KCALKLLYDSPK-----ARQE---VDHHWQASGG 81 (336)
T ss_dssp ------CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEESSHH-----HHHH---HHHHHHHTTS
T ss_pred ccccCCCCCCccccceeEecceeeeeCCCeEEEEEEECCCCC----EEEEEEecCcHH-----HHHH---HHHHHHhcCC
Confidence 344556666777889999976 69999999999999987554 499999965321 1111 2234566789
Q ss_pred CccceeeeeEEe----CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEE
Q 042539 83 PFLPKLLGSLET----DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILI 158 (412)
Q Consensus 83 pnIv~l~~~~~~----~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl 158 (412)
|||+++++++.. +..+|+|||||.||+|..++.......+++.+++.++.||+.||.|||++||+||||||+|||+
T Consensus 82 ~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll 161 (336)
T 3fhr_A 82 PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLY 161 (336)
T ss_dssp TTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred CChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 999999999976 4569999999999999988877665679999999999999999999999999999999999999
Q ss_pred ccC---CCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCcccc
Q 042539 159 RQS---GHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRR 235 (412)
Q Consensus 159 ~~~---g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (412)
+.+ +.+||+|||+++....
T Consensus 162 ~~~~~~~~~kl~Dfg~~~~~~~---------------------------------------------------------- 183 (336)
T 3fhr_A 162 TSKEKDAVLKLTDFGFAKETTQ---------------------------------------------------------- 183 (336)
T ss_dssp SCSSTTCCEEECCCTTCEEC------------------------------------------------------------
T ss_pred EecCCCceEEEeccccceeccc----------------------------------------------------------
Confidence 864 5599999999975421
Q ss_pred ccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHH----HHHhcC-----CCC
Q 042539 236 QQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETF----RNVLMK-----TPE 306 (412)
Q Consensus 236 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~----~~i~~~-----~~~ 306 (412)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+....... ..+... .+.
T Consensus 184 -------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (336)
T 3fhr_A 184 -------NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE 256 (336)
T ss_dssp ---------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTT
T ss_pred -------cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchh
Confidence 1122457899999999998888999999999999999999999999876544332 122211 123
Q ss_pred CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCC
Q 042539 307 FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 307 ~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
+...++++.+||.+||..||.+|| +++++++||||++
T Consensus 257 ~~~~~~~~~~li~~~L~~dP~~Rp----t~~ell~hp~~~~ 293 (336)
T 3fhr_A 257 WSEVSEDAKQLIRLLLKTDPTERL----TITQFMNHPWINQ 293 (336)
T ss_dssp STTCCHHHHHHHHHHSCSSGGGSC----CHHHHHHSHHHHT
T ss_pred hccCCHHHHHHHHHHCCCChhHCc----CHHHHhcCccccc
Confidence 346789999999999999999999 6999999999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=390.99 Aligned_cols=260 Identities=20% Similarity=0.218 Sum_probs=194.7
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc--CCCccceee----
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL--SHPFLPKLL---- 89 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l--~hpnIv~l~---- 89 (412)
...+|++++.||+|+||+||+|++..++ +.||||++.+.... .......+.+|+.+++.+ +||||++++
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~ 134 (371)
T 3q60_A 60 GERKLKLVEPLRVGDRSVVFLVRDVERL----EDFALKVFTMGAEN-SRSELERLHEATFAAARLLGESPEEARDRRRLL 134 (371)
T ss_dssp CEEEEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEEECCSTT-HHHHHHHHHHHHHHHHHHHC----------CBC
T ss_pred CceeeeeeeeccCCCCEEEEEEEECCCC----ceeEEEEEEecccc-cccHHHHHHHHHHHHHHhcccChhhhhhceeEE
Confidence 3456999999999999999999987754 45999999876542 234455677786555555 599988765
Q ss_pred ---eeEEeC-----------------CeEEEEeeccCCCCchhHHHhhCCCCCCHHHH------HHHHHHHHHHHHHHHH
Q 042539 90 ---GSLETD-----------------EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVI------RFYLSEIICAIEHLHN 143 (412)
Q Consensus 90 ---~~~~~~-----------------~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~------~~~~~qi~~aL~yLH~ 143 (412)
+++... ..+|+|||||. |+|..++..... .+++... ..++.||+.||+|||+
T Consensus 135 ~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~ 212 (371)
T 3q60_A 135 LPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQS 212 (371)
T ss_dssp CCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred eeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHH
Confidence 444432 34899999998 899988876432 2444544 5667999999999999
Q ss_pred cCceeeeCCCCceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCcccccc
Q 042539 144 MGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKK 223 (412)
Q Consensus 144 ~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (412)
+||+||||||+|||++.+|.+||+|||+|+....
T Consensus 213 ~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---------------------------------------------- 246 (371)
T 3q60_A 213 KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT---------------------------------------------- 246 (371)
T ss_dssp TTEEETTCSGGGEEECTTSCEEECCGGGEEETTC----------------------------------------------
T ss_pred CCCccCcCCHHHEEECCCCCEEEEecceeeecCC----------------------------------------------
Confidence 9999999999999999999999999999975421
Q ss_pred ccccCCCCccccccccCCCCCCcccccCCCCccceeecC--CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHH--HHH
Q 042539 224 TKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRG--DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKET--FRN 299 (412)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~--~~~ 299 (412)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...... +..
T Consensus 247 --------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~ 306 (371)
T 3q60_A 247 --------------------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKR 306 (371)
T ss_dssp --------------------EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCB
T ss_pred --------------------CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhh
Confidence 1113357799999999987 6789999999999999999999999988642211 100
Q ss_pred H---h--cC---CCCCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCchh
Q 042539 300 V---L--MK---TPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDL 352 (412)
Q Consensus 300 i---~--~~---~~~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~~ 352 (412)
+ . .. .+.....++.+.+||.+||+.||++|| ++.++++||||+++.|..
T Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp----t~~e~l~hp~f~~~~~~~ 363 (371)
T 3q60_A 307 PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRL----LPLEAMETPEFLQLQNEI 363 (371)
T ss_dssp CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCC----CHHHHTTSHHHHHHHHHH
T ss_pred hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCC----CHHHHhcCHHHHHHHHHH
Confidence 0 0 01 122246789999999999999999999 699999999999887753
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-48 Score=371.42 Aligned_cols=263 Identities=17% Similarity=0.242 Sum_probs=219.2
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCC-CCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAA-DPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLG 90 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~-~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 90 (412)
.+++..++|++.+.||+|+||.||+|.++.. ...++..||+|++..... ......+.+|+.+++.++||||+++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS---MRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC---HHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC---HHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 4567778999999999999999999987631 112345699999975432 233456778999999999999999999
Q ss_pred eEEeCCeEEEEeeccCCCCchhHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCC
Q 042539 91 SLETDEFLAWAVPYCPGGDLNVLRYKQN--------DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG 162 (412)
Q Consensus 91 ~~~~~~~~~lv~e~~~gg~L~~~~~~~~--------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g 162 (412)
++.+++..|+|||||.||+|..++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.+|
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence 9999999999999999999998876532 13478999999999999999999999999999999999999999
Q ss_pred CEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCC
Q 042539 163 HVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNG 242 (412)
Q Consensus 163 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (412)
.+||+|||+++........
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~------------------------------------------------------------- 194 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYY------------------------------------------------------------- 194 (322)
T ss_dssp CEEECCTTCCCGGGGGGCE-------------------------------------------------------------
T ss_pred eEEECcCcccccccccccc-------------------------------------------------------------
Confidence 9999999999765321100
Q ss_pred CCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHH
Q 042539 243 ERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQ 319 (412)
Q Consensus 243 ~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~ 319 (412)
.......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.... ......++.+.+||.
T Consensus 195 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 274 (322)
T 1p4o_A 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMR 274 (322)
T ss_dssp EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred ccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHH
Confidence 01123467899999999999999999999999999999999 999999998888877776543 233456889999999
Q ss_pred HhhhhCCCccCCCCCChhhhhcC
Q 042539 320 RLLEKDPVKRLGYLRGACEIKEH 342 (412)
Q Consensus 320 ~~L~~dP~~R~~~~~~~~e~l~h 342 (412)
+||..||.+|| ++.++++|
T Consensus 275 ~~l~~dp~~Rp----s~~e~l~~ 293 (322)
T 1p4o_A 275 MCWQYNPKMRP----SFLEIISS 293 (322)
T ss_dssp HHTCSSGGGSC----CHHHHHHH
T ss_pred HHcCCCcccCc----CHHHHHHH
Confidence 99999999999 68888875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=360.95 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=203.1
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
.++..++|++.+.||+|+||.||+|++. +..||||+++...........+.+.+|+.+++.++||||+++++++
T Consensus 2 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 75 (271)
T 3dtc_A 2 LEIDFAELTLEEIIGIGGFGKVYRAFWI------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC 75 (271)
T ss_dssp CBCCTTSEEEEEEEEEETTEEEEEEEET------TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CccchhheeeeeeeccCCCeEEEEEEEc------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 3678899999999999999999999874 2349999997654433334456778899999999999999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcC---ceeeeCCCCceEEcc--------C
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMG---IAYRDLKPENILIRQ--------S 161 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~---iiHrDlKp~NiLl~~--------~ 161 (412)
.+++.+|+||||+.|++|..++.. ..+++..+..++.|++.||.|||++| |+||||||+|||++. +
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~ 152 (271)
T 3dtc_A 76 LKEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSN 152 (271)
T ss_dssp CCC--CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred ecCCceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccC
Confidence 999999999999999999877642 35999999999999999999999999 999999999999986 7
Q ss_pred CCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCC
Q 042539 162 GHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDN 241 (412)
Q Consensus 162 g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (412)
+.+||+|||+++.....
T Consensus 153 ~~~kl~Dfg~~~~~~~~--------------------------------------------------------------- 169 (271)
T 3dtc_A 153 KILKITDFGLAREWHRT--------------------------------------------------------------- 169 (271)
T ss_dssp CCEEECCCCC----------------------------------------------------------------------
T ss_pred cceEEccCCcccccccc---------------------------------------------------------------
Confidence 78999999999754211
Q ss_pred CCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC---CCCCChHHHHHH
Q 042539 242 GERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE---FVGQRTALTDLI 318 (412)
Q Consensus 242 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~dli 318 (412)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+...... ....++.+.+||
T Consensus 170 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 247 (271)
T 3dtc_A 170 --TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLM 247 (271)
T ss_dssp --------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCHHHHHHH
T ss_pred --cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccCHHHHHHH
Confidence 111346899999999999999999999999999999999999999998888777666654422 245678999999
Q ss_pred HHhhhhCCCccCCCCCChhhhhcC
Q 042539 319 QRLLEKDPVKRLGYLRGACEIKEH 342 (412)
Q Consensus 319 ~~~L~~dP~~R~~~~~~~~e~l~h 342 (412)
.+||..||.+|| ++.+++++
T Consensus 248 ~~~l~~~p~~Rp----s~~e~l~~ 267 (271)
T 3dtc_A 248 EDCWNPDPHSRP----SFTNILDQ 267 (271)
T ss_dssp HHHTCSSGGGSC----CHHHHHHH
T ss_pred HHHhcCCcccCc----CHHHHHHH
Confidence 999999999999 68888763
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=360.43 Aligned_cols=256 Identities=21% Similarity=0.249 Sum_probs=214.6
Q ss_pred CCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceee
Q 042539 10 QTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLL 89 (412)
Q Consensus 10 ~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~ 89 (412)
...+++..++|++++.||+|+||+||++.+.. +..||+|+++..... ...+.+|+++++.++|+||++++
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~ 85 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRG-----QYDVAIKMIKEGSMS-----EDEFIEEAKVMMNLSHEKLVQLY 85 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEETT-----TEEEEEEEECTTSBC-----HHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEcC-----CCeEEEEEecCCCCC-----HHHHHHHHHHHhcCCCCCEeeEE
Confidence 34668889999999999999999999998763 334999999765432 23466799999999999999999
Q ss_pred eeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccc
Q 042539 90 GSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169 (412)
Q Consensus 90 ~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DF 169 (412)
+++.+++.+|+|||||.|++|..++.... ..+++.++..++.|++.||.|||++||+||||||+|||++.+|.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Df 164 (283)
T 3gen_A 86 GVCTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDF 164 (283)
T ss_dssp EEECSSSSEEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECST
T ss_pred EEEecCCCeEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccc
Confidence 99999999999999999999998876532 35999999999999999999999999999999999999999999999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|+++........ ......
T Consensus 165 g~~~~~~~~~~~--------------------------------------------------------------~~~~~~ 182 (283)
T 3gen_A 165 GLSRYVLDDEYT--------------------------------------------------------------SSVGSK 182 (283)
T ss_dssp TGGGGBCCHHHH--------------------------------------------------------------STTSTT
T ss_pred cccccccccccc--------------------------------------------------------------cccCCc
Confidence 999765322110 011234
Q ss_pred cCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCC--CCCCCChHHHHHHHHhhhhCC
Q 042539 250 GTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTP--EFVGQRTALTDLIQRLLEKDP 326 (412)
Q Consensus 250 gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~dli~~~L~~dP 326 (412)
||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..+....+..... .....++.+.+||.+||..||
T Consensus 183 ~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 262 (283)
T 3gen_A 183 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKA 262 (283)
T ss_dssp SCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSG
T ss_pred cCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHHHHHccCCh
Confidence 6888999999999999999999999999999998 9999999998888887776532 223457899999999999999
Q ss_pred CccCCCCCChhhhhcC
Q 042539 327 VKRLGYLRGACEIKEH 342 (412)
Q Consensus 327 ~~R~~~~~~~~e~l~h 342 (412)
.+|| +++++++|
T Consensus 263 ~~Rp----s~~~ll~~ 274 (283)
T 3gen_A 263 DERP----TFKILLSN 274 (283)
T ss_dssp GGSC----CHHHHHHH
T ss_pred hHCc----CHHHHHHH
Confidence 9999 68888864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=362.25 Aligned_cols=259 Identities=20% Similarity=0.323 Sum_probs=207.3
Q ss_pred CCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeee
Q 042539 11 TTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLG 90 (412)
Q Consensus 11 ~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 90 (412)
...++..++|++++.||+|+||.||+|++...+. .+..||+|+++... .......+.+|+.++++++||||+++++
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 83 (281)
T 1mp8_A 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPEN-PALAVAIKTCKNCT---SDSVREKFLQEALTMRQFDHPHIVKLIG 83 (281)
T ss_dssp -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC---CCEEEEEEECTTTT---SHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cceEEehHHeEEEeEeeecCCeeEEEEEEecCCC-CceEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCccceEEE
Confidence 4567888999999999999999999999876443 34569999986542 2345567888999999999999999999
Q ss_pred eEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccc
Q 042539 91 SLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 91 ~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
++. ++..|+||||+.|++|..++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||
T Consensus 84 ~~~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 161 (281)
T 1mp8_A 84 VIT-ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 161 (281)
T ss_dssp EEC-SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred EEc-cCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccc
Confidence 984 567899999999999998876543 459999999999999999999999999999999999999999999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+++....... .......+
T Consensus 162 ~~~~~~~~~~--------------------------------------------------------------~~~~~~~~ 179 (281)
T 1mp8_A 162 LSRYMEDSTY--------------------------------------------------------------YKASKGKL 179 (281)
T ss_dssp -------------------------------------------------------------------------------C
T ss_pred cccccCcccc--------------------------------------------------------------cccccCCC
Confidence 9976532110 01123357
Q ss_pred CCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCC
Q 042539 251 TEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPV 327 (412)
Q Consensus 251 t~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~ 327 (412)
|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.... +.....++.+.+||.+||..||+
T Consensus 180 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 259 (281)
T 1mp8_A 180 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPS 259 (281)
T ss_dssp CGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred cccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChh
Confidence 889999999999999999999999999999996 999999988777777776543 23356789999999999999999
Q ss_pred ccCCCCCChhhhhc
Q 042539 328 KRLGYLRGACEIKE 341 (412)
Q Consensus 328 ~R~~~~~~~~e~l~ 341 (412)
+|| ++.++++
T Consensus 260 ~Rp----s~~~l~~ 269 (281)
T 1mp8_A 260 RRP----RFTELKA 269 (281)
T ss_dssp GSC----CHHHHHH
T ss_pred hCc----CHHHHHH
Confidence 999 6888875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=366.92 Aligned_cols=266 Identities=23% Similarity=0.336 Sum_probs=210.0
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
..+..++|++.+.||+|+||+||+|.+..++. .||+|++... .....+.+.+|++++++++||||+++++++
T Consensus 5 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~----~va~K~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 76 (310)
T 3s95_A 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGE----VMVMKELIRF----DEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76 (310)
T ss_dssp EEECGGGEEEEEEEECCSSEEEEEEEETTTCC----EEEEEEESCC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred eeeChhHeeccceecCCCCEEEEEEEECCCCc----EEEEEEeccC----CHHHHHHHHHHHHHHHhCCCcCcccEEEEE
Confidence 35678999999999999999999999987554 4999998553 234556788899999999999999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
.+++.+|+|||||.||+|..++... ...+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 155 (310)
T 3s95_A 77 YKDKRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLA 155 (310)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTC
T ss_pred ecCCeeEEEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccc
Confidence 9999999999999999999888763 345999999999999999999999999999999999999999999999999999
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+........... .............+.+||+
T Consensus 156 ~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~~~~~~gt~ 186 (310)
T 3s95_A 156 RLMVDEKTQPEG-------------------------------------------------LRSLKKPDRKKRYTVVGNP 186 (310)
T ss_dssp EECC---------------------------------------------------------------------CCCCSCG
T ss_pred eecccccccccc-------------------------------------------------cccccccccccccccCCCc
Confidence 866322110000 0000001122334678999
Q ss_pred CCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHH-----HHHHHhcCCCCCCCCChHHHHHHHHhhhhCCC
Q 042539 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKE-----TFRNVLMKTPEFVGQRTALTDLIQRLLEKDPV 327 (412)
Q Consensus 253 ~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-----~~~~i~~~~~~~~~~~~~~~dli~~~L~~dP~ 327 (412)
.|+|||++.+..++.++|||||||++|+|++|..||....... ....... ......+++.+.+||.+||..||+
T Consensus 187 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~ 265 (310)
T 3s95_A 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD-RYCPPNCPPSFFPITVRCCDLDPE 265 (310)
T ss_dssp GGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH-HTCCTTCCTTHHHHHHHHTCSSGG
T ss_pred ceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc-ccCCCCCCHHHHHHHHHHccCChh
Confidence 9999999999999999999999999999999999987632111 0111111 112345678899999999999999
Q ss_pred ccCCCCCChhhhhc
Q 042539 328 KRLGYLRGACEIKE 341 (412)
Q Consensus 328 ~R~~~~~~~~e~l~ 341 (412)
+|| ++.++++
T Consensus 266 ~Rp----s~~~l~~ 275 (310)
T 3s95_A 266 KRP----SFVKLEH 275 (310)
T ss_dssp GSC----CHHHHHH
T ss_pred hCc----CHHHHHH
Confidence 999 6888876
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=370.88 Aligned_cols=254 Identities=21% Similarity=0.272 Sum_probs=204.0
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeeeeEEe
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLGSLET 94 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 94 (412)
.-++|++++.||+|+||+||+|++..++ +.||||++..... ...+.+|+++++.+ +|+||+++++++.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 76 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTN----EYVAIKLEPMKSR------APQLHLEYRFYKQLGSGDGIPQVYYFGPC 76 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTT----EEEEEEEEETTCS------SCCHHHHHHHHHHHCSCTTSCCEEEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCC----cEEEEEEeccccc------hHHHHHHHHHHHHhhCCCCCCEEEEEEec
Confidence 3478999999999999999999987654 4599999865432 12355699999999 89999999999999
Q ss_pred CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCC-----EEEccc
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGH-----VTLTDF 169 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~-----vkL~DF 169 (412)
++..|+||||+ |++|.+++... .+.+++.++..++.||+.||+|||++||+||||||+|||++.+|. +||+||
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DF 154 (330)
T 2izr_A 77 GKYNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDF 154 (330)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCC
T ss_pred CCccEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEc
Confidence 99999999999 99999887754 346999999999999999999999999999999999999999887 999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|+|+.+...... ...........+
T Consensus 155 g~a~~~~~~~~~--------------------------------------------------------~~~~~~~~~~~~ 178 (330)
T 2izr_A 155 ALAKEYIDPETK--------------------------------------------------------KHIPYREHKSLT 178 (330)
T ss_dssp TTCEESBCTTTC--------------------------------------------------------CBCCCCCCCCCC
T ss_pred ccceeeecCCCC--------------------------------------------------------ccccccccCCcC
Confidence 999865321100 000111234678
Q ss_pred cCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCC---CHHHHHHHHhcCCCCC-----CCCChHHHHHHHHh
Q 042539 250 GTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGK---NRKETFRNVLMKTPEF-----VGQRTALTDLIQRL 321 (412)
Q Consensus 250 gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~---~~~~~~~~i~~~~~~~-----~~~~~~~~dli~~~ 321 (412)
||+.|+|||++.+..++.++|||||||++|||++|+.||.+. +..+.+..+....... ....+++.+||.+|
T Consensus 179 gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~~~li~~~ 258 (330)
T 2izr_A 179 GTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFPEMATYLRYV 258 (330)
T ss_dssp SCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCHHHHHHHHHH
T ss_pred CCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccChHHHHHHHHH
Confidence 999999999999999999999999999999999999999884 3444444443221111 12223899999999
Q ss_pred hhhCCCccCCCCCChhhhhc
Q 042539 322 LEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 322 L~~dP~~R~~~~~~~~e~l~ 341 (412)
|..||.+|| +++++++
T Consensus 259 l~~~p~~RP----~~~~l~~ 274 (330)
T 2izr_A 259 RRLDFFEKP----DYDYLRK 274 (330)
T ss_dssp HHCCTTCCC----CHHHHHH
T ss_pred HhCCCCCCC----CHHHHHH
Confidence 999999999 4666554
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=377.36 Aligned_cols=263 Identities=23% Similarity=0.338 Sum_probs=213.8
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCC-CCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAAD-PTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLL 89 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~ 89 (412)
.+++..++|++++.||+|+||.||+|++...+ ..+++.||||++++... ....+.+.+|+++++++ +||||++++
T Consensus 16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT---HSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC---HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC---HHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 45678899999999999999999999865432 23556799999976532 23356678899999999 689999999
Q ss_pred eeEEeCC-eEEEEeeccCCCCchhHHHhhCC-------------------------------------------------
Q 042539 90 GSLETDE-FLAWAVPYCPGGDLNVLRYKQND------------------------------------------------- 119 (412)
Q Consensus 90 ~~~~~~~-~~~lv~e~~~gg~L~~~~~~~~~------------------------------------------------- 119 (412)
+++.+.+ .+++|||||.||+|..++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 9998755 59999999999999988876432
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhhhh
Q 042539 120 ---------------RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQ 184 (412)
Q Consensus 120 ---------------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~ 184 (412)
..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~----- 247 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP----- 247 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT-----
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccc-----
Confidence 128999999999999999999999999999999999999999999999999997542110
Q ss_pred cccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecCCC
Q 042539 185 SLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDG 264 (412)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~ 264 (412)
.........||+.|+|||++.+..
T Consensus 248 --------------------------------------------------------~~~~~~~~~~t~~y~aPE~~~~~~ 271 (359)
T 3vhe_A 248 --------------------------------------------------------DYVRKGDARLPLKWMAPETIFDRV 271 (359)
T ss_dssp --------------------------------------------------------TCEEC--CEECGGGCCHHHHHHCC
T ss_pred --------------------------------------------------------cchhccccCCCceeEChhhhcCCC
Confidence 111223457899999999999999
Q ss_pred CCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhc-CC--CCCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhh
Q 042539 265 HEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLM-KT--PEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIK 340 (412)
Q Consensus 265 ~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~-~~--~~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l 340 (412)
++.++|||||||++|+|++ |..||.+....+.+...+. .. ......++++.++|.+||..||.+|| ++.+++
T Consensus 272 ~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp----s~~ell 347 (359)
T 3vhe_A 272 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP----TFSELV 347 (359)
T ss_dssp CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC----CHHHHH
T ss_pred CCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCC----CHHHHH
Confidence 9999999999999999998 9999998764444333332 21 22334678999999999999999999 688888
Q ss_pred cC
Q 042539 341 EH 342 (412)
Q Consensus 341 ~h 342 (412)
+|
T Consensus 348 ~~ 349 (359)
T 3vhe_A 348 EH 349 (359)
T ss_dssp HH
T ss_pred HH
Confidence 74
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=357.38 Aligned_cols=253 Identities=21% Similarity=0.249 Sum_probs=214.9
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
.++..++|++++.||+|+||.||+|+++. +..||+|+++..... ...+.+|++++++++||||+++++++
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~ 72 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWKG-----QYDVAVKMIKEGSMS-----EDEFFQEAQTMMKLSHPKLVKFYGVC 72 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETT-----TEEEEEEEECBTTBC-----HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred eEechhheeeeeeeccCCCceEEEEEecC-----ceeEEEEEeccCCCc-----HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 46788999999999999999999998763 234999999765432 23466799999999999999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
.++..+|+|||||.|++|..++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 73 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~ 151 (268)
T 3sxs_A 73 SKEYPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMT 151 (268)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCE
T ss_pred ccCCceEEEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccc
Confidence 99999999999999999998876643 34899999999999999999999999999999999999999999999999999
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+...... ........||+
T Consensus 152 ~~~~~~~--------------------------------------------------------------~~~~~~~~~~~ 169 (268)
T 3sxs_A 152 RYVLDDQ--------------------------------------------------------------YVSSVGTKFPV 169 (268)
T ss_dssp EECCTTC--------------------------------------------------------------EEECCSCCCCG
T ss_pred eecchhh--------------------------------------------------------------hhcccCCCcCc
Confidence 7542110 00112335678
Q ss_pred CCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCCC--CCCCChHHHHHHHHhhhhCCCcc
Q 042539 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTPE--FVGQRTALTDLIQRLLEKDPVKR 329 (412)
Q Consensus 253 ~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~dli~~~L~~dP~~R 329 (412)
.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+...... ....++.+.++|.+||+.||.+|
T Consensus 170 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 249 (268)
T 3sxs_A 170 KWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKR 249 (268)
T ss_dssp GGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGS
T ss_pred ccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHHHHcCCChhhC
Confidence 8999999999889999999999999999998 99999999888887777655432 23457899999999999999999
Q ss_pred CCCCCChhhhhcC
Q 042539 330 LGYLRGACEIKEH 342 (412)
Q Consensus 330 ~~~~~~~~e~l~h 342 (412)
| ++.+++++
T Consensus 250 p----s~~~ll~~ 258 (268)
T 3sxs_A 250 P----TFQQLLSS 258 (268)
T ss_dssp C----CHHHHHHH
T ss_pred c----CHHHHHHH
Confidence 9 68888864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=379.54 Aligned_cols=259 Identities=20% Similarity=0.273 Sum_probs=216.2
Q ss_pred CCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceee
Q 042539 10 QTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLL 89 (412)
Q Consensus 10 ~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~ 89 (412)
...+.+..++|++++.||+|+||.||+|+++.++ +.||||+++... .......+.+|++++++++||||++++
T Consensus 106 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~----~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~ 178 (377)
T 3cbl_A 106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADN----TLVAVKSCRETL---PPDLKAKFLQEARILKQYSHPNIVRLI 178 (377)
T ss_dssp CCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTC----CEEEEEECCTTS---CHHHHTTTTHHHHHHTTCCCTTBCCEE
T ss_pred ccccEEchHHeEEeeEeccCCCCeEEEEEEecCC----eEEEEEEccccC---CHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 4456788899999999999999999999997644 449999996542 233455677899999999999999999
Q ss_pred eeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccc
Q 042539 90 GSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169 (412)
Q Consensus 90 ~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DF 169 (412)
+++.+++.+|+|||||.||+|..++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+||
T Consensus 179 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~Df 257 (377)
T 3cbl_A 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDF 257 (377)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCG
T ss_pred EEEecCCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcC
Confidence 99999999999999999999998877543 34899999999999999999999999999999999999999999999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|+++....... ........
T Consensus 258 G~s~~~~~~~~-------------------------------------------------------------~~~~~~~~ 276 (377)
T 3cbl_A 258 GMSREEADGVY-------------------------------------------------------------AASGGLRQ 276 (377)
T ss_dssp GGCEECTTSEE-------------------------------------------------------------ECCSSCCE
T ss_pred CCceecCCCce-------------------------------------------------------------eecCCCCC
Confidence 99975321100 00011224
Q ss_pred cCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCC
Q 042539 250 GTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDP 326 (412)
Q Consensus 250 gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP 326 (412)
+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+.... +....+++++.+||.+||..||
T Consensus 277 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 356 (377)
T 3cbl_A 277 VPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEP 356 (377)
T ss_dssp EEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred CCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCc
Confidence 5778999999998889999999999999999998 999999988887776665432 2233467899999999999999
Q ss_pred CccCCCCCChhhhhc
Q 042539 327 VKRLGYLRGACEIKE 341 (412)
Q Consensus 327 ~~R~~~~~~~~e~l~ 341 (412)
++|| +++++++
T Consensus 357 ~~Rp----s~~~i~~ 367 (377)
T 3cbl_A 357 GQRP----SFSTIYQ 367 (377)
T ss_dssp GGSC----CHHHHHH
T ss_pred hhCc----CHHHHHH
Confidence 9999 5777764
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=375.83 Aligned_cols=256 Identities=23% Similarity=0.373 Sum_probs=205.7
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-----------
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS----------- 81 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~----------- 81 (412)
..+..++|++++.||+|+||+||+|++..++ +.||||++.+... ....+.+|+.+++.+.
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~~~ 84 (373)
T 1q8y_A 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNN----THVAMKIVRGDKV-----YTEAAEDEIKLLQRVNDADNTKEDSMG 84 (373)
T ss_dssp CEETTTTEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEECSCHH-----HHHHHHHHHHHHHHHHHTCCSHHHHHH
T ss_pred CcccCCeEEEEEeeeecCCeEEEEEEecCCC----cEEEEEEecCCcc-----chhhhhHHHHHHHHhhcccccchhccc
Confidence 4566789999999999999999999987654 4599999975432 2345667899988886
Q ss_pred CCccceeeeeEEeCC----eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeeeCCCCce
Q 042539 82 HPFLPKLLGSLETDE----FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNM-GIAYRDLKPENI 156 (412)
Q Consensus 82 hpnIv~l~~~~~~~~----~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~-~iiHrDlKp~Ni 156 (412)
|+||+++++++...+ .+++|||++ |++|..++.......+++..++.++.||+.||+|||++ ||+||||||+||
T Consensus 85 ~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NI 163 (373)
T 1q8y_A 85 ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENV 163 (373)
T ss_dssp HTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGE
T ss_pred cchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHe
Confidence 789999999998654 799999999 99998888776556699999999999999999999998 999999999999
Q ss_pred EEcc------CCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCC
Q 042539 157 LIRQ------SGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVS 230 (412)
Q Consensus 157 Ll~~------~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (412)
|++. .+.+||+|||+++....
T Consensus 164 ll~~~~~~~~~~~~kl~Dfg~a~~~~~----------------------------------------------------- 190 (373)
T 1q8y_A 164 LMEIVDSPENLIQIKIADLGNACWYDE----------------------------------------------------- 190 (373)
T ss_dssp EEEEEETTTTEEEEEECCCTTCEETTB-----------------------------------------------------
T ss_pred EEeccCCCcCcceEEEcccccccccCC-----------------------------------------------------
Confidence 9954 34799999999975421
Q ss_pred CccccccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCC------HHHHHHHHhc--
Q 042539 231 PVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKN------RKETFRNVLM-- 302 (412)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~------~~~~~~~i~~-- 302 (412)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+ ....+..+..
T Consensus 191 -------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 257 (373)
T 1q8y_A 191 -------------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 257 (373)
T ss_dssp -------------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHH
T ss_pred -------------CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhc
Confidence 1123478999999999999999999999999999999999999998754 2222222221
Q ss_pred -CCC---------------------------------------CC-CCCChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 303 -KTP---------------------------------------EF-VGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 303 -~~~---------------------------------------~~-~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
..+ .+ ...++++.+||.+||+.||.+|| +++|+++
T Consensus 258 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp----t~~ell~ 333 (373)
T 1q8y_A 258 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA----DAGGLVN 333 (373)
T ss_dssp CSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB----CHHHHHT
T ss_pred CCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC----CHHHHhh
Confidence 100 00 11236788999999999999999 6999999
Q ss_pred CCCCCCC
Q 042539 342 HVFFKGV 348 (412)
Q Consensus 342 h~ff~~~ 348 (412)
||||++.
T Consensus 334 hp~f~~~ 340 (373)
T 1q8y_A 334 HPWLKDT 340 (373)
T ss_dssp CGGGTTC
T ss_pred Chhhhcc
Confidence 9999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=362.43 Aligned_cols=258 Identities=24% Similarity=0.352 Sum_probs=203.3
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
.....+++|++++.||+|+||.||+|++..++ +.||+|++.+... ........+.+|+.+++.++||||++++++
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~ 102 (309)
T 2h34_A 28 REGTQFGPYRLRRLVGRGGMGDVYEAEDTVRE----RIVALKLMSETLS-SDPVFRTRMQREARTAGRLQEPHVVPIHDF 102 (309)
T ss_dssp ------CCEEEEEEEEECSSSEEEEEEETTTT----EEEEEEECGGGGG-GSHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CCCcEeccEEEEEEEcCCCCeeEEEEEEcCCC----eEEEEEecCcccc-cCHHHHHHHHHHHHHHhhcCCCCeeEEEEE
Confidence 34566899999999999999999999987654 4599999976543 234456778889999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
+.+++.+|+||||+.|++|..++.... .+++.++..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+
T Consensus 103 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~ 180 (309)
T 2h34_A 103 GEIDGQLYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGI 180 (309)
T ss_dssp EEETTEEEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC
T ss_pred EeeCCeEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCcc
Confidence 999999999999999999998887654 499999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
+...... .........||
T Consensus 181 ~~~~~~~--------------------------------------------------------------~~~~~~~~~~~ 198 (309)
T 2h34_A 181 ASATTDE--------------------------------------------------------------KLTQLGNTVGT 198 (309)
T ss_dssp ------------------------------------------------------------------------------CC
T ss_pred Ccccccc--------------------------------------------------------------ccccccccCCC
Confidence 8754211 01112345799
Q ss_pred CCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC----CCCCChHHHHHHHHhhhhCCC
Q 042539 252 EEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE----FVGQRTALTDLIQRLLEKDPV 327 (412)
Q Consensus 252 ~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~dli~~~L~~dP~ 327 (412)
+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+....+. ....+.++.++|.+||..||+
T Consensus 199 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~ 278 (309)
T 2h34_A 199 LYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPE 278 (309)
T ss_dssp GGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGG
T ss_pred cCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHH
Confidence 9999999999988999999999999999999999999987765444444333221 245788999999999999999
Q ss_pred ccCCCCCChhhhhc
Q 042539 328 KRLGYLRGACEIKE 341 (412)
Q Consensus 328 ~R~~~~~~~~e~l~ 341 (412)
+||+ +++++++
T Consensus 279 ~Rp~---s~~~l~~ 289 (309)
T 2h34_A 279 DRYV---TCGDLSA 289 (309)
T ss_dssp GSCS---SHHHHHH
T ss_pred HHHH---hHHHHHH
Confidence 9995 5666664
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=364.17 Aligned_cols=264 Identities=21% Similarity=0.296 Sum_probs=217.5
Q ss_pred CCCCCCCccCceeeeeeeccCceEEEEEEEcCC-CCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccce
Q 042539 10 QTTPSLDLDNLKALKILGKGAMGTVFLVHDRAA-DPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPK 87 (412)
Q Consensus 10 ~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~-~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~ 87 (412)
....++..++|++++.||+|+||+||+|++... +..+++.||+|+++.... ......+.+|+.+++++ +||||++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~i~~ 91 (313)
T 1t46_A 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH---LTEREALMSELKVLSYLGNHMNIVN 91 (313)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC---HHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh---HHHHHHHHHHHHHHhhcccCCCeee
Confidence 445678889999999999999999999986432 233556799999976532 23456778899999999 8999999
Q ss_pred eeeeEEeCCeEEEEeeccCCCCchhHHHhhCCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeeC
Q 042539 88 LLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDR----------------VFSPSVIRFYLSEIICAIEHLHNMGIAYRDL 151 (412)
Q Consensus 88 l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~----------------~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDl 151 (412)
+++++.+++..++|||||.||+|..++...... .+++.++..++.||+.||.|||++||+||||
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl 171 (313)
T 1t46_A 92 LLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDL 171 (313)
T ss_dssp EEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 999999999999999999999999888765422 4899999999999999999999999999999
Q ss_pred CCCceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCC
Q 042539 152 KPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSP 231 (412)
Q Consensus 152 Kp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (412)
||+|||++.++.+||+|||+++.......
T Consensus 172 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--------------------------------------------------- 200 (313)
T 1t46_A 172 AARNILLTHGRITKICDFGLARDIKNDSN--------------------------------------------------- 200 (313)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCTTSCTT---------------------------------------------------
T ss_pred ccceEEEcCCCCEEEcccccccccccccc---------------------------------------------------
Confidence 99999999999999999999975521100
Q ss_pred ccccccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC---CCC
Q 042539 232 VSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT---PEF 307 (412)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~---~~~ 307 (412)
........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+..........+... ...
T Consensus 201 ----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 270 (313)
T 1t46_A 201 ----------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP 270 (313)
T ss_dssp ----------SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCC
T ss_pred ----------ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCCCc
Confidence 011223467889999999999999999999999999999998 999998876554444443322 223
Q ss_pred CCCChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 308 VGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 308 ~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
...+.++.+||.+||..||.+|| ++.++++
T Consensus 271 ~~~~~~l~~li~~~l~~dp~~Rp----s~~ell~ 300 (313)
T 1t46_A 271 EHAPAEMYDIMKTCWDADPLKRP----TFKQIVQ 300 (313)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSC----CHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCCchhCc----CHHHHHH
Confidence 45678999999999999999999 6888886
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=366.26 Aligned_cols=264 Identities=19% Similarity=0.270 Sum_probs=219.2
Q ss_pred CCCCCCCccCceeeeeeeccCceEEEEEEEcCCCC---CCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCcc
Q 042539 10 QTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADP---TARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFL 85 (412)
Q Consensus 10 ~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnI 85 (412)
.+.+++..++|++++.||+|+||+||+|++...+. ..+..||||+++... .......+.+|+.+++.+ +||||
T Consensus 27 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~i 103 (334)
T 2pvf_A 27 DPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNI 103 (334)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC---CHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred CccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC---cHHHHHHHHHHHHHHHHhhcCCCE
Confidence 34567888999999999999999999999864332 345679999997543 233456678899999999 89999
Q ss_pred ceeeeeEEeCCeEEEEeeccCCCCchhHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeeC
Q 042539 86 PKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQND--------------RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDL 151 (412)
Q Consensus 86 v~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~--------------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDl 151 (412)
+++++++.+++.+|+|||||.||+|..++..... ..+++.++..++.||+.||.|||++||+||||
T Consensus 104 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl 183 (334)
T 2pvf_A 104 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDL 183 (334)
T ss_dssp CCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred eeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence 9999999999999999999999999988875432 24899999999999999999999999999999
Q ss_pred CCCceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCC
Q 042539 152 KPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSP 231 (412)
Q Consensus 152 Kp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (412)
||+|||++.+|.+||+|||+++.......
T Consensus 184 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~--------------------------------------------------- 212 (334)
T 2pvf_A 184 AARNVLVTENNVMKIADFGLARDINNIDY--------------------------------------------------- 212 (334)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECTTTSS---------------------------------------------------
T ss_pred ccceEEEcCCCCEEEcccccccccccccc---------------------------------------------------
Confidence 99999999999999999999975421100
Q ss_pred ccccccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCC
Q 042539 232 VSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFV 308 (412)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~ 308 (412)
........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.... ....
T Consensus 213 ----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 282 (334)
T 2pvf_A 213 ----------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPA 282 (334)
T ss_dssp ----------EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCT
T ss_pred ----------ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCCCCCc
Confidence 011123457889999999998889999999999999999999 999999998888777666543 2234
Q ss_pred CCChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 309 GQRTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 309 ~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
..+.++.+||.+||..||.+|| ++.++++
T Consensus 283 ~~~~~l~~li~~~l~~dp~~Rp----s~~ell~ 311 (334)
T 2pvf_A 283 NCTNELYMMMRDCWHAVPSQRP----TFKQLVE 311 (334)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSC----CHHHHHH
T ss_pred cCCHHHHHHHHHHccCChhhCc----CHHHHHH
Confidence 5678999999999999999999 6888886
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=371.25 Aligned_cols=263 Identities=20% Similarity=0.296 Sum_probs=214.1
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCC-CCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAAD-PTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLL 89 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~ 89 (412)
.+++..++|++++.||+|+||+||+|++.... ..++..||||++.... .......+.+|+.+++++ +||||++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 115 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLL 115 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc---CHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 45677889999999999999999999975432 2245569999997543 223456677899999999 899999999
Q ss_pred eeEEeCCeEEEEeeccCCCCchhHHHhhCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHcCcee
Q 042539 90 GSLETDEFLAWAVPYCPGGDLNVLRYKQND---------------------RVFSPSVIRFYLSEIICAIEHLHNMGIAY 148 (412)
Q Consensus 90 ~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~---------------------~~l~~~~~~~~~~qi~~aL~yLH~~~iiH 148 (412)
+++.+.+.+|+|||||.||+|..++..... ..+++..+..++.||+.||+|||++||+|
T Consensus 116 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 195 (344)
T 1rjb_A 116 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 195 (344)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred EEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 999999999999999999999988876432 23789999999999999999999999999
Q ss_pred eeCCCCceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccC
Q 042539 149 RDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSAR 228 (412)
Q Consensus 149 rDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (412)
|||||+|||++.+|.+||+|||+++......
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~------------------------------------------------- 226 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDS------------------------------------------------- 226 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCT-------------------------------------------------
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCc-------------------------------------------------
Confidence 9999999999999999999999997653210
Q ss_pred CCCccccccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC---
Q 042539 229 VSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--- 304 (412)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--- 304 (412)
.........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+......+..++...
T Consensus 227 ------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 294 (344)
T 1rjb_A 227 ------------NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM 294 (344)
T ss_dssp ------------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCC
T ss_pred ------------cceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCC
Confidence 0011234567899999999999999999999999999999998 999999876555555544432
Q ss_pred CCCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcC
Q 042539 305 PEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEH 342 (412)
Q Consensus 305 ~~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h 342 (412)
......++++.+||.+||..||.+|| ++.++++|
T Consensus 295 ~~~~~~~~~l~~li~~~l~~dp~~Rp----s~~~l~~~ 328 (344)
T 1rjb_A 295 DQPFYATEEIYIIMQSCWAFDSRKRP----SFPNLTSF 328 (344)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSC----CHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCc----CHHHHHHH
Confidence 22334678999999999999999999 68888874
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=361.15 Aligned_cols=260 Identities=22% Similarity=0.266 Sum_probs=207.8
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
.++..++|++++.||+|+||+||+|+....+..+++.||||++.... ....+.+.+|++++++++||||+++++++
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 80 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEHLRDFEREIEILKSLQHDNIVKYKGVC 80 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC----HHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC----HHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 57888999999999999999999999766566677789999997543 33456678899999999999999999998
Q ss_pred Ee--CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccc
Q 042539 93 ET--DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 93 ~~--~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
.. ...+++|||||.||+|..++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg 159 (295)
T 3ugc_A 81 YSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 159 (295)
T ss_dssp CHHHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred ecCCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCc
Confidence 64 457999999999999998876543 358999999999999999999999999999999999999999999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+++........ ........|
T Consensus 160 ~~~~~~~~~~~------------------------------------------------------------~~~~~~~~~ 179 (295)
T 3ugc_A 160 LTKVLPQDKEF------------------------------------------------------------FKVKEPGES 179 (295)
T ss_dssp SCC-------------------------------------------------------------------------CTTC
T ss_pred ccccccCCcce------------------------------------------------------------eeeccCCCC
Confidence 99765321110 011123457
Q ss_pred CCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHH----------------HHHHHHhcC--CCCCCCCCh
Q 042539 251 TEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRK----------------ETFRNVLMK--TPEFVGQRT 312 (412)
Q Consensus 251 t~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~----------------~~~~~i~~~--~~~~~~~~~ 312 (412)
|..|+|||++.+..++.++|||||||++|+|++|..||...... .....+... .+....+++
T Consensus 180 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (295)
T 3ugc_A 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD 259 (295)
T ss_dssp GGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCH
T ss_pred ccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCH
Confidence 88899999999999999999999999999999999998753221 111122211 123345789
Q ss_pred HHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 313 ALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 313 ~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
++.+||.+||..||++|| ++.++++
T Consensus 260 ~l~~li~~~l~~dp~~Rp----s~~el~~ 284 (295)
T 3ugc_A 260 EIYMIMTECWNNNVNQRP----SFRDLAL 284 (295)
T ss_dssp HHHHHHHHHSCSSGGGSC----CHHHHHH
T ss_pred HHHHHHHHHcCCChhhCC----CHHHHHH
Confidence 999999999999999999 6788775
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=369.39 Aligned_cols=267 Identities=16% Similarity=0.248 Sum_probs=217.1
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCC-CCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAA-DPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLG 90 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~-~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 90 (412)
..++..++|++++.||+|+||.||+|++... +..++..||||++.... .......+.+|+.+++.++||||+++++
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 100 (327)
T 2yfx_A 24 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC---SEQDELDFLMEALIISKFNHQNIVRCIG 100 (327)
T ss_dssp SCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc---chhhHHHHHHHHHHHhhCCCCCCCeEEE
Confidence 4567889999999999999999999986432 22355679999996442 2234556778999999999999999999
Q ss_pred eEEeCCeEEEEeeccCCCCchhHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccC---C
Q 042539 91 SLETDEFLAWAVPYCPGGDLNVLRYKQND-----RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQS---G 162 (412)
Q Consensus 91 ~~~~~~~~~lv~e~~~gg~L~~~~~~~~~-----~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~---g 162 (412)
++.+....|+|||||.|++|..++..... ..+++.++..++.||+.||.|||++||+||||||+|||++.+ +
T Consensus 101 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~ 180 (327)
T 2yfx_A 101 VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 180 (327)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTC
T ss_pred EEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcc
Confidence 99999999999999999999998876532 348999999999999999999999999999999999999954 4
Q ss_pred CEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCC
Q 042539 163 HVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNG 242 (412)
Q Consensus 163 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (412)
.+||+|||+++....... .
T Consensus 181 ~~kl~Dfg~~~~~~~~~~-------------------------------------------------------------~ 199 (327)
T 2yfx_A 181 VAKIGDFGMARDIYRASY-------------------------------------------------------------Y 199 (327)
T ss_dssp CEEECCCHHHHHHHC-----------------------------------------------------------------
T ss_pred eEEECccccccccccccc-------------------------------------------------------------c
Confidence 699999999976532110 1
Q ss_pred CCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHH
Q 042539 243 ERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQ 319 (412)
Q Consensus 243 ~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~ 319 (412)
.......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.... ......+..+.+||.
T Consensus 200 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 279 (327)
T 2yfx_A 200 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMT 279 (327)
T ss_dssp --CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 11234568999999999999899999999999999999998 999999988888777776543 223456789999999
Q ss_pred HhhhhCCCccCCCCCChhhhhcCCCCC
Q 042539 320 RLLEKDPVKRLGYLRGACEIKEHVFFK 346 (412)
Q Consensus 320 ~~L~~dP~~R~~~~~~~~e~l~h~ff~ 346 (412)
+||..||.+|| ++.++++|.|+-
T Consensus 280 ~~l~~dp~~Rp----s~~~ll~~l~~~ 302 (327)
T 2yfx_A 280 QCWQHQPEDRP----NFAIILERIEYC 302 (327)
T ss_dssp HHTCSSGGGSC----CHHHHHHHHHHH
T ss_pred HHhcCChhhCc----CHHHHHHHHHHH
Confidence 99999999999 699999987754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=366.98 Aligned_cols=261 Identities=22% Similarity=0.345 Sum_probs=215.3
Q ss_pred CCCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccce
Q 042539 9 PQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPK 87 (412)
Q Consensus 9 ~~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~ 87 (412)
....+.+..++|++.+.||+|+||.||+|+++.++.. ..+|+|+++... .......+.+|+.+++++ +||||++
T Consensus 16 ~~~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~ 90 (327)
T 1fvr_A 16 PTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLR--MDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIIN 90 (327)
T ss_dssp CCCSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEE--EEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCC
T ss_pred CcccccccHHHccceeeeecCCCceEEEEEEccCCcc--cceeeeeecccc---chHHHHHHHHHHHHHHhccCCCchhh
Confidence 4456778899999999999999999999998775432 125999986532 223445677899999999 8999999
Q ss_pred eeeeEEeCCeEEEEeeccCCCCchhHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCC
Q 042539 88 LLGSLETDEFLAWAVPYCPGGDLNVLRYKQN--------------DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKP 153 (412)
Q Consensus 88 l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~--------------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp 153 (412)
+++++.+.+.+|+|||||.||+|..++.... ...+++.+++.++.||+.||.|||++||+||||||
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp 170 (327)
T 1fvr_A 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAA 170 (327)
T ss_dssp EEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred hceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCcc
Confidence 9999999999999999999999998876542 23599999999999999999999999999999999
Q ss_pred CceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCcc
Q 042539 154 ENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVS 233 (412)
Q Consensus 154 ~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (412)
+|||++.+|.+||+|||+++....
T Consensus 171 ~NIl~~~~~~~kL~Dfg~~~~~~~-------------------------------------------------------- 194 (327)
T 1fvr_A 171 RNILVGENYVAKIADFGLSRGQEV-------------------------------------------------------- 194 (327)
T ss_dssp GGEEECGGGCEEECCTTCEESSCE--------------------------------------------------------
T ss_pred ceEEEcCCCeEEEcccCcCccccc--------------------------------------------------------
Confidence 999999999999999999864311
Q ss_pred ccccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCC
Q 042539 234 RRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQ 310 (412)
Q Consensus 234 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~ 310 (412)
........+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.... ......
T Consensus 195 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 266 (327)
T 1fvr_A 195 --------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNC 266 (327)
T ss_dssp --------ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCTTB
T ss_pred --------cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCCCCCCCC
Confidence 011123357889999999998889999999999999999998 999999998888777766542 223456
Q ss_pred ChHHHHHHHHhhhhCCCccCCCCCChhhhhcC
Q 042539 311 RTALTDLIQRLLEKDPVKRLGYLRGACEIKEH 342 (412)
Q Consensus 311 ~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h 342 (412)
++++.+||.+||..||.+|| ++++++++
T Consensus 267 ~~~l~~li~~~l~~dp~~Rp----s~~ell~~ 294 (327)
T 1fvr_A 267 DDEVYDLMRQCWREKPYERP----SFAQILVS 294 (327)
T ss_dssp CHHHHHHHHHHTCSSGGGSC----CHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCc----CHHHHHHH
Confidence 78999999999999999999 68888864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=359.98 Aligned_cols=263 Identities=27% Similarity=0.405 Sum_probs=211.6
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
......++|.....||+|+||.||+|++..++ +.||||++..... ...+.+.+|+.+++.++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~ 87 (295)
T 2clq_A 16 EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQ----VRIAIKEIPERDS----RYSQPLHEEIALHKHLKHKNIVQYLGS 87 (295)
T ss_dssp CEEECBCTTSSBCEEEECSSSEEEEEEETTTC----CEEEEEEEECCCC-------HHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cccccccCCCCcEEEeecCcEEEEEEEECCCC----eEEEEEEccCCch----HHHHHHHHHHHHHHhCCCCCEeeEeeE
Confidence 34566677777889999999999999987754 4499999976432 234567789999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEcc-CCCEEEccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQN-DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQ-SGHVTLTDF 169 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~-~g~vkL~DF 169 (412)
+.+.+.+++||||+.|++|..++.... ...+++..++.++.||+.||.|||++||+||||||+|||++. +|.+||+||
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Df 167 (295)
T 2clq_A 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDF 167 (295)
T ss_dssp EEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCT
T ss_pred EEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeec
Confidence 999999999999999999998887643 234678999999999999999999999999999999999998 899999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|+++..... ........
T Consensus 168 g~~~~~~~~---------------------------------------------------------------~~~~~~~~ 184 (295)
T 2clq_A 168 GTSKRLAGI---------------------------------------------------------------NPCTETFT 184 (295)
T ss_dssp TTCEESCC--------------------------------------------------------------------CCCC
T ss_pred ccccccCCC---------------------------------------------------------------CCcccccC
Confidence 999754211 01123457
Q ss_pred cCCCCccceeecCCC--CCchhhHHHHHHHHHHHhhCCCCCCCCCHH-HH-HHHHh-cCCCCC-CCCChHHHHHHHHhhh
Q 042539 250 GTEEYVSPEVVRGDG--HEFAVDWWALGILTYEMLYGTTPFRGKNRK-ET-FRNVL-MKTPEF-VGQRTALTDLIQRLLE 323 (412)
Q Consensus 250 gt~~Y~APE~l~~~~--~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~-~~~i~-~~~~~~-~~~~~~~~dli~~~L~ 323 (412)
||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...... .. ..... ...+.. ...++++.+||.+||.
T Consensus 185 ~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 264 (295)
T 2clq_A 185 GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFE 264 (295)
T ss_dssp CCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTC
T ss_pred CCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHHHcc
Confidence 999999999997653 789999999999999999999999764322 22 22211 222232 3568899999999999
Q ss_pred hCCCccCCCCCChhhhhcCCCCCCCC
Q 042539 324 KDPVKRLGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 324 ~dP~~R~~~~~~~~e~l~h~ff~~~~ 349 (412)
.||++|| +++++++|+||+...
T Consensus 265 ~dp~~Rp----s~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 265 PDPDKRA----CANDLLVDEFLKVSS 286 (295)
T ss_dssp SSTTTSC----CHHHHHTSGGGCC--
T ss_pred CChhhCC----CHHHHhcChhhhhcc
Confidence 9999999 699999999998543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=362.95 Aligned_cols=259 Identities=25% Similarity=0.394 Sum_probs=198.9
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
..+.+++|++++.||+|+||.||+|+++.++. .||||++..... .....+.+..+..+++.++||||+++++++
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~ 93 (318)
T 2dyl_A 20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGH----VIAVKQMRRSGN--KEENKRILMDLDVVLKSHDCPYIVQCFGTF 93 (318)
T ss_dssp EECCGGGEEEEEEC------CEEEEEETTTCC----EEEEEEEETTSC--HHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred hhhhhccccccceeeecCCeeEEEEEEecCCe----EEEEEEeccccc--chHHHHHHHHHHHHHHhcCCCceeeEEEEE
Confidence 45678999999999999999999999987544 499999976542 222334444455678888999999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeeeCCCCceEEccCCCEEEccccc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNM-GIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~-~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
.+++.+|+||||+ |+.+..+... ....+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+
T Consensus 94 ~~~~~~~lv~e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 171 (318)
T 2dyl_A 94 ITNTDVFIAMELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGI 171 (318)
T ss_dssp ECSSEEEEEECCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred ecCCcEEEEEecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCC
Confidence 9999999999999 5555544433 235699999999999999999999995 999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
++..... .......||
T Consensus 172 ~~~~~~~----------------------------------------------------------------~~~~~~~~~ 187 (318)
T 2dyl_A 172 SGRLVDD----------------------------------------------------------------KAKDRSAGC 187 (318)
T ss_dssp C------------------------------------------------------------------------------C
T ss_pred chhccCC----------------------------------------------------------------ccccccCCC
Confidence 8754211 111234689
Q ss_pred CCCccceeec-----CCCCCchhhHHHHHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCCC----CCCCChHHHHHHHHh
Q 042539 252 EEYVSPEVVR-----GDGHEFAVDWWALGILTYEMLYGTTPFRG-KNRKETFRNVLMKTPE----FVGQRTALTDLIQRL 321 (412)
Q Consensus 252 ~~Y~APE~l~-----~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~----~~~~~~~~~dli~~~ 321 (412)
+.|+|||++. +..++.++|||||||++|+|++|+.||.. ....+.+..+....+. ....++++.+||.+|
T Consensus 188 ~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 267 (318)
T 2dyl_A 188 AAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDC 267 (318)
T ss_dssp CTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHH
T ss_pred ccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHH
Confidence 9999999995 45678999999999999999999999987 4555666666654432 234689999999999
Q ss_pred hhhCCCccCCCCCChhhhhcCCCCCC
Q 042539 322 LEKDPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 322 L~~dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
|..||.+|| +++++++||||++
T Consensus 268 l~~dp~~Rp----s~~~ll~h~~~~~ 289 (318)
T 2dyl_A 268 LTKDHRKRP----KYNKLLEHSFIKR 289 (318)
T ss_dssp TCSCTTTSC----CHHHHTTSHHHHH
T ss_pred ccCChhHCc----CHHHHhhCHHHHh
Confidence 999999999 6999999999974
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=360.07 Aligned_cols=257 Identities=21% Similarity=0.286 Sum_probs=219.6
Q ss_pred CCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceee
Q 042539 10 QTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLL 89 (412)
Q Consensus 10 ~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~ 89 (412)
-..+++..++|++.+.||+|+||+||+|.++.++ ..||+|++..... ....+.+|++++++++||||++++
T Consensus 5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~ 75 (288)
T 3kfa_A 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYS----LTVAVKTLKEDTM-----EVEEFLKEAAVMKEIKHPNLVQLL 75 (288)
T ss_dssp CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGT----EEEEEEEECSCST-----HHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhcccccccceeEEeecCCCCceeEEEeEecCCC----EEEEEEecCcCHH-----HHHHHHHHHHHHHhCCCCCEeeEE
Confidence 3577889999999999999999999999998754 4499999975432 245567799999999999999999
Q ss_pred eeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccc
Q 042539 90 GSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169 (412)
Q Consensus 90 ~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DF 169 (412)
+++.+++.+|+||||+.|++|..++.......+++..+..++.||+.||.|||++||+||||||+||+++.+|.+||+||
T Consensus 76 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Df 155 (288)
T 3kfa_A 76 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF 155 (288)
T ss_dssp EEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred EEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccC
Confidence 99999999999999999999999887766667999999999999999999999999999999999999999999999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|+++..... .........
T Consensus 156 g~~~~~~~~--------------------------------------------------------------~~~~~~~~~ 173 (288)
T 3kfa_A 156 GLSRLMTGD--------------------------------------------------------------TYTAHAGAK 173 (288)
T ss_dssp CGGGTSCSS--------------------------------------------------------------SSEEETTEE
T ss_pred ccceeccCC--------------------------------------------------------------ccccccCCc
Confidence 999754211 001122345
Q ss_pred cCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCC
Q 042539 250 GTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDP 326 (412)
Q Consensus 250 gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP 326 (412)
||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+.... ......++.+.+||.+||..||
T Consensus 174 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 253 (288)
T 3kfa_A 174 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 253 (288)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred cccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHhCCCh
Confidence 7889999999999999999999999999999999 999999988777666655432 2334578999999999999999
Q ss_pred CccCCCCCChhhhhc
Q 042539 327 VKRLGYLRGACEIKE 341 (412)
Q Consensus 327 ~~R~~~~~~~~e~l~ 341 (412)
.+|| +++++++
T Consensus 254 ~~Rp----s~~~~~~ 264 (288)
T 3kfa_A 254 SDRP----SFAEIHQ 264 (288)
T ss_dssp GGSC----CHHHHHH
T ss_pred hhCc----CHHHHHH
Confidence 9999 6888875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=359.35 Aligned_cols=253 Identities=18% Similarity=0.226 Sum_probs=210.7
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCC---CCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceee
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPT---ARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLL 89 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~ 89 (412)
.++..++|++++.||+|+||+||+|+++.++.. .+..||+|++.+... ...+.+.+|+.++++++||||++++
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~ 78 (289)
T 4fvq_A 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR----NYSESFFEAASMMSKLSHKHLVLNY 78 (289)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG----GGHHHHHHHHHHHHTSCCTTBCCEE
T ss_pred EEechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH----HHHHHHHHHHHHHHhCCCCCEeEEE
Confidence 467889999999999999999999998765421 123599999966432 2345677899999999999999999
Q ss_pred eeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCC------
Q 042539 90 GSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGH------ 163 (412)
Q Consensus 90 ~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~------ 163 (412)
+++.+++..|+|||||.||+|..++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 79 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 79 GVCVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp EEECCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred EEEEeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccc
Confidence 99999999999999999999998887543 34899999999999999999999999999999999999999987
Q ss_pred --EEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCC
Q 042539 164 --VTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDN 241 (412)
Q Consensus 164 --vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (412)
+||+|||+++.....
T Consensus 158 ~~~kl~Dfg~~~~~~~~--------------------------------------------------------------- 174 (289)
T 4fvq_A 158 PFIKLSDPGISITVLPK--------------------------------------------------------------- 174 (289)
T ss_dssp CEEEECCCCSCTTTSCH---------------------------------------------------------------
T ss_pred ceeeeccCcccccccCc---------------------------------------------------------------
Confidence 999999998654211
Q ss_pred CCCCcccccCCCCccceeecC-CCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCCCCCCCChHHHHHHH
Q 042539 242 GERSNSFVGTEEYVSPEVVRG-DGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTPEFVGQRTALTDLIQ 319 (412)
Q Consensus 242 ~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~dli~ 319 (412)
....||+.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..................++++.+||.
T Consensus 175 ----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 250 (289)
T 4fvq_A 175 ----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLIN 250 (289)
T ss_dssp ----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCSSCTTHHHHH
T ss_pred ----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCCCCCCCHHHHHHHH
Confidence 13358889999999988 668999999999999999999 566777766665554444433334455788999999
Q ss_pred HhhhhCCCccCCCCCChhhhhc
Q 042539 320 RLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 320 ~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
+||+.||.+|| ++.++++
T Consensus 251 ~~l~~dp~~Rp----s~~~ll~ 268 (289)
T 4fvq_A 251 NCMDYEPDHRP----SFRAIIR 268 (289)
T ss_dssp HHSCSSGGGSC----CHHHHHH
T ss_pred HHcCCChhHCc----CHHHHHH
Confidence 99999999999 6888886
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=358.14 Aligned_cols=272 Identities=18% Similarity=0.206 Sum_probs=216.8
Q ss_pred CCCCCCCCCCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC
Q 042539 2 EATPPPQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS 81 (412)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~ 81 (412)
+.++++.+.....+..++|++++.||+|+||.||+|++...+..+++.||+|++..... ......+.+|+++++.++
T Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~ 81 (302)
T 4e5w_A 5 SEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG---GNHIADLKKEIEILRNLY 81 (302)
T ss_dssp CCCCCCCCCCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--------CCHHHHHHHHHHHHTCC
T ss_pred cccCcceecChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc---chhHHHHHHHHHHHHhCC
Confidence 45666666777788899999999999999999999997665666778899999975532 123456778999999999
Q ss_pred CCccceeeeeEEeC--CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEc
Q 042539 82 HPFLPKLLGSLETD--EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIR 159 (412)
Q Consensus 82 hpnIv~l~~~~~~~--~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~ 159 (412)
||||+++++++.+. ..+|+|||||.||+|..++.... ..+++.++..++.|++.||+|||++||+||||||+|||++
T Consensus 82 h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~ 160 (302)
T 4e5w_A 82 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE 160 (302)
T ss_dssp CTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred CCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEc
Confidence 99999999999876 67999999999999998885543 4599999999999999999999999999999999999999
Q ss_pred cCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCcccccccc
Q 042539 160 QSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSF 239 (412)
Q Consensus 160 ~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (412)
.+|.+||+|||+++.......
T Consensus 161 ~~~~~kl~Dfg~~~~~~~~~~----------------------------------------------------------- 181 (302)
T 4e5w_A 161 SEHQVKIGDFGLTKAIETDKE----------------------------------------------------------- 181 (302)
T ss_dssp ETTEEEECCCTTCEECCTTCC-----------------------------------------------------------
T ss_pred CCCCEEECcccccccccCCCc-----------------------------------------------------------
Confidence 999999999999976532110
Q ss_pred CCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCC--------------CHHH-HHHHHhcC-
Q 042539 240 DNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGK--------------NRKE-TFRNVLMK- 303 (412)
Q Consensus 240 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~--------------~~~~-~~~~i~~~- 303 (412)
.........||..|+|||++.+..++.++|||||||++|+|++|..|+... .... ....+...
T Consensus 182 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (302)
T 4e5w_A 182 -YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGK 260 (302)
T ss_dssp -EEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTC
T ss_pred -ceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccC
Confidence 001123446888999999999999999999999999999999999876432 1122 22222221
Q ss_pred -CCCCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 304 -TPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 304 -~~~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
.+.....++++.+||.+||..||.+|| ++.++++
T Consensus 261 ~~~~~~~~~~~l~~li~~~l~~dp~~Rp----s~~~ll~ 295 (302)
T 4e5w_A 261 RLPCPPNCPDEVYQLMRKCWEFQPSNRT----SFQNLIE 295 (302)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSC----CHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCCCCCC----CHHHHHH
Confidence 122346789999999999999999999 6888775
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=366.76 Aligned_cols=262 Identities=19% Similarity=0.281 Sum_probs=216.8
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCC-CCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADP-TARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLL 89 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~ 89 (412)
..++..++|++++.||+|+||+||+|.+..++. .....||+|++.... .......+.+|+.+++.+ +||||++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 116 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA---HADEKEALMSELKIMSHLGQHENIVNLL 116 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc---ChHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 567788999999999999999999999877654 234569999996543 223456678899999999 799999999
Q ss_pred eeEEeCCeEEEEeeccCCCCchhHHHhhC------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceE
Q 042539 90 GSLETDEFLAWAVPYCPGGDLNVLRYKQN------------DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENIL 157 (412)
Q Consensus 90 ~~~~~~~~~~lv~e~~~gg~L~~~~~~~~------------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiL 157 (412)
+++.+++.+|+|||||.||+|..++.... ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL 196 (333)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCE
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEE
Confidence 99999999999999999999998876542 235899999999999999999999999999999999999
Q ss_pred EccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCcccccc
Q 042539 158 IRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQ 237 (412)
Q Consensus 158 l~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (412)
++.++.+||+|||+++.......
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~--------------------------------------------------------- 219 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSN--------------------------------------------------------- 219 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTT---------------------------------------------------------
T ss_pred ECCCCeEEECccccccccccccc---------------------------------------------------------
Confidence 99999999999999975532110
Q ss_pred ccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC---CCCCCCChH
Q 042539 238 SFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT---PEFVGQRTA 313 (412)
Q Consensus 238 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~~ 313 (412)
........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+......+..+.... ......++.
T Consensus 220 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (333)
T 2i1m_A 220 ----YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKN 295 (333)
T ss_dssp ----SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHH
T ss_pred ----eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCCCCCCHH
Confidence 011223467889999999999999999999999999999998 999999876555544444322 223346789
Q ss_pred HHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 314 LTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 314 ~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
+.+||.+||+.||.+|| ++.++++
T Consensus 296 l~~li~~~l~~~p~~Rp----s~~~l~~ 319 (333)
T 2i1m_A 296 IYSIMQACWALEPTHRP----TFQQICS 319 (333)
T ss_dssp HHHHHHHHTCSSGGGSC----CHHHHHH
T ss_pred HHHHHHHHhccChhhCc----CHHHHHH
Confidence 99999999999999999 6888876
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=371.64 Aligned_cols=261 Identities=23% Similarity=0.305 Sum_probs=206.8
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
..++..++|++.+.||+|+||+||+|+++..+. .+..||||+++... .....+.+.+|+.++++++||||++++++
T Consensus 39 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 114 (373)
T 2qol_A 39 AKELDATNISIDKVVGAGEFGEVCSGRLKLPSK-KEISVAIKTLKVGY---TEKQRRDFLGEASIMGQFDHPNIIRLEGV 114 (373)
T ss_dssp SCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTS-CBCCEEEEECCTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred HhhcCHhhceeeeEEeeCCCeEEEEEEEecCCC-CceeEEEEEecCcc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 446778899999999999999999998763322 34559999997543 23345678889999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
+.+++.+|+|||||.||+|..++... ...+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 115 ~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 193 (373)
T 2qol_A 115 VTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGL 193 (373)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred EeeCCceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcc
Confidence 99999999999999999999888654 34599999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
++........ ........+|
T Consensus 194 a~~~~~~~~~------------------------------------------------------------~~~~~~~~~~ 213 (373)
T 2qol_A 194 GRVLEDDPEA------------------------------------------------------------AYTTRGGKIP 213 (373)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccccccCCcc------------------------------------------------------------ceeccCCCcC
Confidence 9765321100 0011123467
Q ss_pred CCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCChHHHHHHHHhhhhCCCc
Q 042539 252 EEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMK--TPEFVGQRTALTDLIQRLLEKDPVK 328 (412)
Q Consensus 252 ~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~dli~~~L~~dP~~ 328 (412)
+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+... .+.....+..+.+||.+||+.||.+
T Consensus 214 ~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 293 (373)
T 2qol_A 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNN 293 (373)
T ss_dssp CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGG
T ss_pred CCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhh
Confidence 89999999999999999999999999999997 99999998888877776543 2334467789999999999999999
Q ss_pred cCCCCCChhhhhc
Q 042539 329 RLGYLRGACEIKE 341 (412)
Q Consensus 329 R~~~~~~~~e~l~ 341 (412)
|| ++.++++
T Consensus 294 RP----s~~~i~~ 302 (373)
T 2qol_A 294 RP----KFEQIVS 302 (373)
T ss_dssp SC----CHHHHHH
T ss_pred Cc----CHHHHHH
Confidence 99 5777764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=354.93 Aligned_cols=250 Identities=18% Similarity=0.251 Sum_probs=213.3
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
...+..++|++++.||+|+||+||+|++. +..||+|+++..... ....+.+.+|+.++++++||||++++++
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~avK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 75 (271)
T 3kmu_A 4 HSGIDFKQLNFLTKLNENHSGELWKGRWQ------GNDIVVKVLKVRDWS--TRKSRDFNEECPRLRIFSHPNVLPVLGA 75 (271)
T ss_dssp CCCCCGGGCEEEEEEEEETTEEEEEEEET------TEEEEEEEECCTTCC--HHHHHHHHHHGGGGCCCSCTTEECEEEE
T ss_pred cCCCCHHHhHHHHHhcCCCcceEEEEEEC------CeeEEEEEecccccC--HHHHHHHHHHHHHHHhcCCCchhheEEE
Confidence 46789999999999999999999999985 234999999775432 2345668889999999999999999999
Q ss_pred EEeC--CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeeeCCCCceEEccCCCEEEc
Q 042539 92 LETD--EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMG--IAYRDLKPENILIRQSGHVTLT 167 (412)
Q Consensus 92 ~~~~--~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~--iiHrDlKp~NiLl~~~g~vkL~ 167 (412)
+.+. ..+++|||||.||+|..++.......+++.++..++.||+.||.|||++| |+||||||+|||++.+|.++|+
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~ 155 (271)
T 3kmu_A 76 CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARIS 155 (271)
T ss_dssp ECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEE
T ss_pred EccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEE
Confidence 9877 78999999999999999987765556999999999999999999999999 9999999999999999999999
Q ss_pred cccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcc
Q 042539 168 DFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNS 247 (412)
Q Consensus 168 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (412)
|||++.... ...
T Consensus 156 ~~~~~~~~~--------------------------------------------------------------------~~~ 167 (271)
T 3kmu_A 156 MADVKFSFQ--------------------------------------------------------------------SPG 167 (271)
T ss_dssp GGGSCCTTS--------------------------------------------------------------------CTT
T ss_pred eccceeeec--------------------------------------------------------------------ccC
Confidence 998764321 113
Q ss_pred cccCCCCccceeecCCCCC---chhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC---CCCCCChHHHHHHHHh
Q 042539 248 FVGTEEYVSPEVVRGDGHE---FAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP---EFVGQRTALTDLIQRL 321 (412)
Q Consensus 248 ~~gt~~Y~APE~l~~~~~~---~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~dli~~~ 321 (412)
.+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+....+..... .....++++.+||.+|
T Consensus 168 ~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 247 (271)
T 3kmu_A 168 RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKIC 247 (271)
T ss_dssp CBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHHHHHHH
T ss_pred ccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence 4689999999999886554 489999999999999999999999888887766664432 2245689999999999
Q ss_pred hhhCCCccCCCCCChhhhhc
Q 042539 322 LEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 322 L~~dP~~R~~~~~~~~e~l~ 341 (412)
|+.||.+|| +++++++
T Consensus 248 l~~~p~~Rp----s~~~il~ 263 (271)
T 3kmu_A 248 MNEDPAKRP----KFDMIVP 263 (271)
T ss_dssp TCSSGGGSC----CHHHHHH
T ss_pred cCCChhhCc----CHHHHHH
Confidence 999999999 6888875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=357.99 Aligned_cols=269 Identities=26% Similarity=0.413 Sum_probs=204.8
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe--
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET-- 94 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-- 94 (412)
.++|++++.||+|+||.||+|++..++ +.||||++... ......+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 75 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDS----RYYAIKKIRHT-----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERR 75 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTC----CEEEEEEEEEE-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECC
T ss_pred cccchhhheeccCCcEEEEEEEEcCCC----eEEEEEEEecc-----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhc
Confidence 368999999999999999999987654 44999999653 2334567789999999999999999998865
Q ss_pred -----------CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCC
Q 042539 95 -----------DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGH 163 (412)
Q Consensus 95 -----------~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~ 163 (412)
...+|+|||||.||+|..++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.+|.
T Consensus 76 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~ 154 (303)
T 1zy4_A 76 NFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN 154 (303)
T ss_dssp CCCC------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC
T ss_pred chhhhhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCC
Confidence 457899999999999998887533 45888999999999999999999999999999999999999999
Q ss_pred EEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCC
Q 042539 164 VTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGE 243 (412)
Q Consensus 164 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (412)
+||+|||+++............ . ........
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~--~-----------------------------------------------~~~~~~~~ 185 (303)
T 1zy4_A 155 VKIGDFGLAKNVHRSLDILKLD--S-----------------------------------------------QNLPGSSD 185 (303)
T ss_dssp EEECCCCCCSCTTC------------------------------------------------------------------
T ss_pred EEEeeCcchhhcccccchhccc--c-----------------------------------------------cccccccc
Confidence 9999999997653221100000 0 00000112
Q ss_pred CCcccccCCCCccceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCCCC-----CCCChHHHH
Q 042539 244 RSNSFVGTEEYVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRG-KNRKETFRNVLMKTPEF-----VGQRTALTD 316 (412)
Q Consensus 244 ~~~~~~gt~~Y~APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~-----~~~~~~~~d 316 (412)
.....+||+.|+|||++.+. .++.++|||||||++|+|++ ||.. .+.......+......+ ...+..+.+
T Consensus 186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (303)
T 1zy4_A 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKK 262 (303)
T ss_dssp --------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHH
T ss_pred ccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccchHHHHH
Confidence 23456799999999999875 57999999999999999998 5543 33344455554433222 234577999
Q ss_pred HHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCch
Q 042539 317 LIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 317 li~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~ 351 (412)
||.+||..||.+|| ++.++++||||+...++
T Consensus 263 li~~~l~~dp~~Rp----s~~~ll~h~~~~~~~~~ 293 (303)
T 1zy4_A 263 IIRLLIDHDPNKRP----GARTLLNSGWLPVKHQD 293 (303)
T ss_dssp HHHHHTCSSGGGSC----CHHHHHHSSCSCCCCHH
T ss_pred HHHHHHhcCcccCc----CHHHHhCCCCcCCCChH
Confidence 99999999999999 69999999999987665
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=364.68 Aligned_cols=256 Identities=27% Similarity=0.404 Sum_probs=200.8
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhH--HHHHHHHHHHHHHhhc----CCCccc
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKH--EAERRARWEIRVLSRL----SHPFLP 86 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~--~~~~~~~~Ei~il~~l----~hpnIv 86 (412)
.+...++|++++.||+|+||.||+|++..++ +.||||++......... .....+.+|+.++.++ +|+||+
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~ 101 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDR----LQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVI 101 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTC----CEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBC
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCC----eEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCee
Confidence 3556789999999999999999999887654 44999999765432211 1233455699999999 899999
Q ss_pred eeeeeEEeCCeEEEEeec-cCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEc-cCCCE
Q 042539 87 KLLGSLETDEFLAWAVPY-CPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIR-QSGHV 164 (412)
Q Consensus 87 ~l~~~~~~~~~~~lv~e~-~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~-~~g~v 164 (412)
++++++.+.+..++|||+ +.|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .+|.+
T Consensus 102 ~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 102 RLLDWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp CEEEEC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEE
T ss_pred eEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeE
Confidence 999999999999999999 78999998887654 499999999999999999999999999999999999999 78999
Q ss_pred EEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCC
Q 042539 165 TLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGER 244 (412)
Q Consensus 165 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (412)
||+|||+++.... ..
T Consensus 180 kl~dfg~~~~~~~-----------------------------------------------------------------~~ 194 (312)
T 2iwi_A 180 KLIDFGSGALLHD-----------------------------------------------------------------EP 194 (312)
T ss_dssp EECCCSSCEECCS-----------------------------------------------------------------SC
T ss_pred EEEEcchhhhccc-----------------------------------------------------------------Cc
Confidence 9999999875421 11
Q ss_pred CcccccCCCCccceeecCCCC-CchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-CCCChHHHHHHHHhh
Q 042539 245 SNSFVGTEEYVSPEVVRGDGH-EFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF-VGQRTALTDLIQRLL 322 (412)
Q Consensus 245 ~~~~~gt~~Y~APE~l~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~dli~~~L 322 (412)
.....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.. .+......+ ...+.++.+||.+||
T Consensus 195 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~li~~~l 268 (312)
T 2iwi_A 195 YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFPAHVSPDCCALIRRCL 268 (312)
T ss_dssp BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCCTTSCHHHHHHHHHHT
T ss_pred ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCcccCCHHHHHHHHHHc
Confidence 224569999999999987766 569999999999999999999997632 222222222 456889999999999
Q ss_pred hhCCCccCCCCCChhhhhcCCCCCCCC
Q 042539 323 EKDPVKRLGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 323 ~~dP~~R~~~~~~~~e~l~h~ff~~~~ 349 (412)
..||++|| +++++++|+||+...
T Consensus 269 ~~~p~~Rp----s~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 269 APKPSSRP----SLEEILLDPWMQTPA 291 (312)
T ss_dssp CSSTTTSC----CHHHHHHSTTTCC--
T ss_pred cCChhhCc----CHHHHhcChhhcCch
Confidence 99999999 699999999998654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=363.88 Aligned_cols=262 Identities=20% Similarity=0.297 Sum_probs=214.1
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
..++..++|++.+.||+|+||+||+|.++..+...+..||||+++... .......+.+|+.+++.++||||++++++
T Consensus 38 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 114 (333)
T 1mqb_A 38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNIIRLEGV 114 (333)
T ss_dssp CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 457788999999999999999999999877655555679999997543 22345567889999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
+.+.+.+|+|||||.||+|..++... ...+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 115 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 193 (333)
T 1mqb_A 115 ISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGL 193 (333)
T ss_dssp ECSSSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred EecCCCcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCc
Confidence 99999999999999999999887654 34699999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
++....... .........+|
T Consensus 194 ~~~~~~~~~------------------------------------------------------------~~~~~~~~~~~ 213 (333)
T 1mqb_A 194 SRVLEDDPE------------------------------------------------------------ATYTTSGGKIP 213 (333)
T ss_dssp -----------------------------------------------------------------------------CCC
T ss_pred chhhccccc------------------------------------------------------------cccccCCCCcc
Confidence 976532110 00011123468
Q ss_pred CCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCc
Q 042539 252 EEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVK 328 (412)
Q Consensus 252 ~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~ 328 (412)
+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.... +.....++.+.++|.+||..||.+
T Consensus 214 ~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 293 (333)
T 1mqb_A 214 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERAR 293 (333)
T ss_dssp GGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTT
T ss_pred ccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhh
Confidence 89999999999999999999999999999998 999999988888877776542 333456789999999999999999
Q ss_pred cCCCCCChhhhhc
Q 042539 329 RLGYLRGACEIKE 341 (412)
Q Consensus 329 R~~~~~~~~e~l~ 341 (412)
|| ++.++++
T Consensus 294 Rp----s~~~l~~ 302 (333)
T 1mqb_A 294 RP----KFADIVS 302 (333)
T ss_dssp SC----CHHHHHH
T ss_pred Cc----CHHHHHH
Confidence 99 5788775
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=365.02 Aligned_cols=260 Identities=20% Similarity=0.251 Sum_probs=209.7
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
...+..++|++++.||+|+||+||+|++..++......||+|.+..... ......+.+|+.+++.++||||++++++
T Consensus 9 ~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 85 (327)
T 3lzb_A 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS---PKANKEILDEAYVMASVDNPHVCRLLGI 85 (327)
T ss_dssp CEECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSS---CCCHHHHHHHHHHHTTCCBTTBCCCCEE
T ss_pred hcccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccC---HHHHHHHHHHHHHHHhCCCCCeeEEEEE
Confidence 4457789999999999999999999999887766444567777654321 2234567789999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
+.++. .++|++|+.+|+|..++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+
T Consensus 86 ~~~~~-~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~ 163 (327)
T 3lzb_A 86 CLTST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp EESSS-EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC
T ss_pred EecCC-ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcc
Confidence 98765 889999999999988876543 4599999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
++....... ........||
T Consensus 164 a~~~~~~~~-------------------------------------------------------------~~~~~~~~~t 182 (327)
T 3lzb_A 164 AKLLGAEEK-------------------------------------------------------------EYHAEGGKVP 182 (327)
T ss_dssp -----------------------------------------------------------------------------CCC
T ss_pred eeEccCccc-------------------------------------------------------------cccccCCCcc
Confidence 976532110 0111234578
Q ss_pred CCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCc
Q 042539 252 EEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVK 328 (412)
Q Consensus 252 ~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~ 328 (412)
+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.... +.....+.++.+||.+||..||.+
T Consensus 183 ~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 262 (327)
T 3lzb_A 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADS 262 (327)
T ss_dssp GGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGG
T ss_pred ccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhH
Confidence 89999999999999999999999999999999 999999988777666655433 333456789999999999999999
Q ss_pred cCCCCCChhhhhc
Q 042539 329 RLGYLRGACEIKE 341 (412)
Q Consensus 329 R~~~~~~~~e~l~ 341 (412)
|| ++.++++
T Consensus 263 Rp----s~~ell~ 271 (327)
T 3lzb_A 263 RP----KFRELII 271 (327)
T ss_dssp SC----CHHHHHH
T ss_pred Cc----CHHHHHH
Confidence 99 6888886
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=357.95 Aligned_cols=261 Identities=20% Similarity=0.316 Sum_probs=199.1
Q ss_pred CCCCCCCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCc
Q 042539 5 PPPQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPF 84 (412)
Q Consensus 5 ~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpn 84 (412)
+++......++.-++|++.+.||+|+||+||++++.. .||+|+++.... .....+.+.+|+.++++++|+|
T Consensus 11 ~~~~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-------~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ 81 (289)
T 3og7_A 11 GSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-------DVAVKMLNVTAP--TPQQLQAFKNEVGVLRKTRHVN 81 (289)
T ss_dssp -------CCBCCTTSCEEEEEEEECSSEEEEEEESSS-------EEEEEEESCSSC--CHHHHHHHHHHHHHHTTCCCTT
T ss_pred CCCCCCCCCccCccceeeeeEecCCCCeEEEEEEEcC-------ceEEEEEeccCC--CHHHHHHHHHHHHHHHhCCCCc
Confidence 3444455679999999999999999999999997643 299999976543 2344567888999999999999
Q ss_pred cceeeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCE
Q 042539 85 LPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHV 164 (412)
Q Consensus 85 Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~v 164 (412)
|++++++. ....+++|||||.|++|..++... ...+++..+..++.|++.||.|||++||+||||||+|||++.+|.+
T Consensus 82 iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~ 159 (289)
T 3og7_A 82 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTV 159 (289)
T ss_dssp BCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEEEeec-cCCccEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCE
Confidence 99999954 566789999999999998877543 3469999999999999999999999999999999999999999999
Q ss_pred EEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCC
Q 042539 165 TLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGER 244 (412)
Q Consensus 165 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (412)
||+|||+++..... .....
T Consensus 160 kl~Dfg~~~~~~~~-------------------------------------------------------------~~~~~ 178 (289)
T 3og7_A 160 KIGDFGLATEKSRW-------------------------------------------------------------SGSHQ 178 (289)
T ss_dssp EECCCC--------------------------------------------------------------------------
T ss_pred EEccceeccccccc-------------------------------------------------------------ccccc
Confidence 99999999754211 01112
Q ss_pred CcccccCCCCccceeec---CCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHh-cCC--CC----CCCCChHH
Q 042539 245 SNSFVGTEEYVSPEVVR---GDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL-MKT--PE----FVGQRTAL 314 (412)
Q Consensus 245 ~~~~~gt~~Y~APE~l~---~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~-~~~--~~----~~~~~~~~ 314 (412)
.....||+.|+|||++. +..++.++|||||||++|+|++|+.||.+.+..+...... ... +. ...+++++
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (289)
T 3og7_A 179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM 258 (289)
T ss_dssp -----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHH
T ss_pred ccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHH
Confidence 23457999999999987 5668899999999999999999999998865554444443 222 11 12567899
Q ss_pred HHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 315 TDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 315 ~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
.+||.+||..||.+|| ++.++++
T Consensus 259 ~~li~~~l~~~p~~Rp----s~~ell~ 281 (289)
T 3og7_A 259 KRLMAECLKKKRDERP----SFPRILA 281 (289)
T ss_dssp HHHHHHHTCSSGGGSC----CHHHHHH
T ss_pred HHHHHHHccCChhhCC----CHHHHHH
Confidence 9999999999999999 5788775
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=355.09 Aligned_cols=256 Identities=22% Similarity=0.302 Sum_probs=207.0
Q ss_pred CCCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHH---HHHHHHHHHHhhcCCCcc
Q 042539 9 PQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAE---RRARWEIRVLSRLSHPFL 85 (412)
Q Consensus 9 ~~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~---~~~~~Ei~il~~l~hpnI 85 (412)
....+.+..++|++++.||+|+||+||+|++..++. .||+|++............ +.+.+|+.+++.++||||
T Consensus 10 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 85 (287)
T 4f0f_A 10 KSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKS----VVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85 (287)
T ss_dssp --CCCBCCSTTEEEEEECCCCSSSCEEEEEETTTCC----EEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTB
T ss_pred chhhhhhhhccceehhccccCCceeEEEEEEcCCce----EEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCc
Confidence 345667888999999999999999999999987544 4999999765443322222 567889999999999999
Q ss_pred ceeeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeeeCCCCceEEccCCC
Q 042539 86 PKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMG--IAYRDLKPENILIRQSGH 163 (412)
Q Consensus 86 v~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~--iiHrDlKp~NiLl~~~g~ 163 (412)
+++++++.+.. ++||||+.||+|..++... ...+++..+..++.|++.||+|||++| |+||||||+|||++.++.
T Consensus 86 ~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~ 162 (287)
T 4f0f_A 86 VKLYGLMHNPP--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDE 162 (287)
T ss_dssp CCEEEEETTTT--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCT
T ss_pred hhhheeecCCC--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCC
Confidence 99999997665 6999999999997776543 346999999999999999999999999 999999999999998886
Q ss_pred -----EEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccc
Q 042539 164 -----VTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQS 238 (412)
Q Consensus 164 -----vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (412)
+||+|||+++...
T Consensus 163 ~~~~~~kl~Dfg~~~~~~-------------------------------------------------------------- 180 (287)
T 4f0f_A 163 NAPVCAKVADFGLSQQSV-------------------------------------------------------------- 180 (287)
T ss_dssp TCSCCEEECCCTTCBCCS--------------------------------------------------------------
T ss_pred CCceeEEeCCCCcccccc--------------------------------------------------------------
Confidence 9999999986431
Q ss_pred cCCCCCCcccccCCCCccceeec--CCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHH--HHHHHhcCC---CCCCCCC
Q 042539 239 FDNGERSNSFVGTEEYVSPEVVR--GDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKE--TFRNVLMKT---PEFVGQR 311 (412)
Q Consensus 239 ~~~~~~~~~~~gt~~Y~APE~l~--~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--~~~~i~~~~---~~~~~~~ 311 (412)
......+||+.|+|||++. +..++.++|||||||++|+|++|+.||.+.+... ....+.... ......+
T Consensus 181 ----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (287)
T 4f0f_A 181 ----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCP 256 (287)
T ss_dssp ----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTSC
T ss_pred ----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCcccC
Confidence 1122457999999999994 4456899999999999999999999998754332 233333222 1224567
Q ss_pred hHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 312 TALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 312 ~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
+++.+||.+||..||.+|| +++++++
T Consensus 257 ~~l~~li~~~l~~dp~~Rp----s~~~ll~ 282 (287)
T 4f0f_A 257 PRLRNVIELCWSGDPKKRP----HFSYIVK 282 (287)
T ss_dssp HHHHHHHHHHTCSSGGGSC----CHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCc----CHHHHHH
Confidence 8999999999999999999 6888775
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=350.06 Aligned_cols=253 Identities=19% Similarity=0.271 Sum_probs=215.0
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
++.+..++|++++.||+|+||.||+|.+.. +..||+|++...... .+.+.+|+++++.++||||++++++
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~vaiK~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~ 71 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLN-----KDKVAIKTIREGAMS-----EEDFIEEAEVMMKLSHPKLVQLYGV 71 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETT-----TEEEEEEEECTTTBC-----HHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecC-----CCeEEEEEccccCCC-----HHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 356788999999999999999999999863 234999999765432 2356779999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
+.+++.+|+||||+.|++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 72 ~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~ 150 (267)
T 3t9t_A 72 CLEQAPICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGM 150 (267)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTG
T ss_pred EccCCCeEEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccc
Confidence 999999999999999999998876543 4589999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
++....... .......||
T Consensus 151 ~~~~~~~~~--------------------------------------------------------------~~~~~~~~~ 168 (267)
T 3t9t_A 151 TRFVLDDQY--------------------------------------------------------------TSSTGTKFP 168 (267)
T ss_dssp GGGBCCHHH--------------------------------------------------------------HSTTSTTCC
T ss_pred ccccccccc--------------------------------------------------------------ccccccccc
Confidence 976532111 011133578
Q ss_pred CCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCC--CCCCCChHHHHHHHHhhhhCCCc
Q 042539 252 EEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTP--EFVGQRTALTDLIQRLLEKDPVK 328 (412)
Q Consensus 252 ~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~dli~~~L~~dP~~ 328 (412)
+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+..... .....+..+.++|.+||..||.+
T Consensus 169 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 248 (267)
T 3t9t_A 169 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPED 248 (267)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred ccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHHHccCChhh
Confidence 89999999999889999999999999999999 9999999988888877766532 22345789999999999999999
Q ss_pred cCCCCCChhhhhc
Q 042539 329 RLGYLRGACEIKE 341 (412)
Q Consensus 329 R~~~~~~~~e~l~ 341 (412)
|| ++.++++
T Consensus 249 Rp----s~~~ll~ 257 (267)
T 3t9t_A 249 RP----AFSRLLR 257 (267)
T ss_dssp SC----CHHHHHH
T ss_pred Cc----CHHHHHH
Confidence 99 6888875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=379.72 Aligned_cols=254 Identities=20% Similarity=0.264 Sum_probs=214.1
Q ss_pred CCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeee
Q 042539 11 TTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLG 90 (412)
Q Consensus 11 ~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 90 (412)
..+++..++|++.+.||+|+||+||+|.++. +..||||+++.... ..+.+.+|+++|++++|||||++++
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-----~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~l~~ 250 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNK-----HTKVAVKTMKPGSM-----SVEAFLAEANVMKTLQHDKLVKLHA 250 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETT-----TEEEEEEEECTTSB-----CHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECC-----ccEEEEEEecCCCc-----cHHHHHHHHHHHhhCCCCCEeeEEE
Confidence 4567888999999999999999999998853 33499999976542 2345778999999999999999999
Q ss_pred eEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccc
Q 042539 91 SLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 91 ~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
++. ++.+|+|||||.||+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 251 ~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG 329 (454)
T 1qcf_A 251 VVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFG 329 (454)
T ss_dssp EEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTT
T ss_pred EEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCC
Confidence 986 6679999999999999988875543358999999999999999999999999999999999999999999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+++........ ......+
T Consensus 330 ~a~~~~~~~~~--------------------------------------------------------------~~~~~~~ 347 (454)
T 1qcf_A 330 LARVIEDNEYT--------------------------------------------------------------AREGAKF 347 (454)
T ss_dssp GGGGBCCHHHH--------------------------------------------------------------TTCSSSS
T ss_pred CceEcCCCcee--------------------------------------------------------------ccCCCcc
Confidence 99865321110 0112346
Q ss_pred CCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCC
Q 042539 251 TEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPV 327 (412)
Q Consensus 251 t~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~ 327 (412)
|..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+.... +....+++++.+||.+||..||+
T Consensus 348 ~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 427 (454)
T 1qcf_A 348 PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPE 427 (454)
T ss_dssp CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred cccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChh
Confidence 788999999998899999999999999999999 999999999888877776543 33346789999999999999999
Q ss_pred ccCCCCCChhhhhc
Q 042539 328 KRLGYLRGACEIKE 341 (412)
Q Consensus 328 ~R~~~~~~~~e~l~ 341 (412)
+|| +++++++
T Consensus 428 ~RP----t~~~i~~ 437 (454)
T 1qcf_A 428 ERP----TFEYIQS 437 (454)
T ss_dssp GSC----CHHHHHH
T ss_pred HCc----CHHHHHH
Confidence 999 5777764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=354.56 Aligned_cols=258 Identities=17% Similarity=0.211 Sum_probs=207.9
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLG 90 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~ 90 (412)
...+..++|++++.||+|+||+||+|++..++ +.||||++..... ...+.+|+.+++.+ +|+||+++++
T Consensus 4 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~ 73 (298)
T 1csn_A 4 QNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNN----QQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYY 73 (298)
T ss_dssp --CEETTTEEEEEEEEECSSCEEEEEEETTTT----EEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEE
T ss_pred cCcccccceEEEEEEeecCCEEEEEEEECCCC----cEEEEEEeccCCc------cHHHHHHHHHHHHHhcCCCCCeEEe
Confidence 34566789999999999999999999987644 4599999865432 12355699999999 6999999999
Q ss_pred eEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCC-----EE
Q 042539 91 SLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGH-----VT 165 (412)
Q Consensus 91 ~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~-----vk 165 (412)
++.++...|+||||+ |++|..++.... ..+++.++..++.||+.||.|||++||+||||||+|||++.+|. +|
T Consensus 74 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~k 151 (298)
T 1csn_A 74 FGQEGLHNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIY 151 (298)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEE
T ss_pred ecCCCceeEEEEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEE
Confidence 999999999999999 999998887543 45999999999999999999999999999999999999988776 99
Q ss_pred EccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCC
Q 042539 166 LTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERS 245 (412)
Q Consensus 166 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (412)
|+|||+++........ ........
T Consensus 152 l~Dfg~~~~~~~~~~~--------------------------------------------------------~~~~~~~~ 175 (298)
T 1csn_A 152 VVDFGMVKFYRDPVTK--------------------------------------------------------QHIPYREK 175 (298)
T ss_dssp ECCCTTCEESBCTTTC--------------------------------------------------------CBCCCCCC
T ss_pred EEECcccccccccccc--------------------------------------------------------ccccccCc
Confidence 9999999865321100 00011223
Q ss_pred cccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCC---CHHHHHHHHhcCCC------CCCCCChHHHH
Q 042539 246 NSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGK---NRKETFRNVLMKTP------EFVGQRTALTD 316 (412)
Q Consensus 246 ~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~---~~~~~~~~i~~~~~------~~~~~~~~~~d 316 (412)
...+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+. +..+.+..+..... .....++++.+
T Consensus 176 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 255 (298)
T 1csn_A 176 KNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYK 255 (298)
T ss_dssp CCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHH
T ss_pred cCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHH
Confidence 4668999999999999999999999999999999999999999884 34444444432211 12367899999
Q ss_pred HHHHhhhhCCCccCCCCCChhhhhc
Q 042539 317 LIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 317 li~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
||.+||..||.+|| +++++++
T Consensus 256 li~~~l~~dp~~RP----~~~~l~~ 276 (298)
T 1csn_A 256 YMHYARNLAFDATP----DYDYLQG 276 (298)
T ss_dssp HHHHHHHCCTTCCC----CHHHHHH
T ss_pred HHHHHhcCCcccCC----CHHHHHH
Confidence 99999999999999 5666654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=378.76 Aligned_cols=248 Identities=23% Similarity=0.334 Sum_probs=211.3
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
.+.+..++|++++.||+|+||+||++.+.. +.||||+++... ..+.+.+|+++|++++|||||+++++
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~------~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~ 254 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDYRG------NKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGV 254 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEETT------EEEEEEEESSCT------TSHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEecC------CeEEEEEeCCch------HHHHHHHHHHHHHhccCCCEEEEEEE
Confidence 457889999999999999999999998752 349999997643 23456779999999999999999999
Q ss_pred EEeCC-eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccc
Q 042539 92 LETDE-FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 92 ~~~~~-~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
+...+ .+|+|||||.||+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||
T Consensus 255 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG 334 (450)
T 1k9a_A 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG 334 (450)
T ss_dssp EECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCC
Confidence 87665 79999999999999999887765568999999999999999999999999999999999999999999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+++.... ......+
T Consensus 335 ~a~~~~~------------------------------------------------------------------~~~~~~~ 348 (450)
T 1k9a_A 335 LTKEASS------------------------------------------------------------------TQDTGKL 348 (450)
T ss_dssp TCEECC------------------------------------------------------------------------CC
T ss_pred Ccccccc------------------------------------------------------------------cccCCCC
Confidence 9974311 0112257
Q ss_pred CCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCC
Q 042539 251 TEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPV 327 (412)
Q Consensus 251 t~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~ 327 (412)
|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+..+. +....+++++.+||.+||..||.
T Consensus 349 ~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~ 428 (450)
T 1k9a_A 349 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAA 428 (450)
T ss_dssp CTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred CcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChh
Confidence 889999999999999999999999999999998 999999987777777666542 23345789999999999999999
Q ss_pred ccCCCCCChhhhhc
Q 042539 328 KRLGYLRGACEIKE 341 (412)
Q Consensus 328 ~R~~~~~~~~e~l~ 341 (412)
+|| ++.++++
T Consensus 429 ~Rp----t~~~l~~ 438 (450)
T 1k9a_A 429 TRP----TFLQLRE 438 (450)
T ss_dssp GSC----CHHHHHH
T ss_pred HCc----CHHHHHH
Confidence 999 5777764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=353.80 Aligned_cols=261 Identities=21% Similarity=0.280 Sum_probs=214.2
Q ss_pred CCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceee
Q 042539 10 QTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLL 89 (412)
Q Consensus 10 ~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~ 89 (412)
.+...+..++|++.+.||+|+||+||+|++..... .+..||+|++.+.. .......+.+|+.+++.++||||++++
T Consensus 4 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~ 79 (281)
T 3cc6_A 4 GPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKG-EKINVAVKTCKKDC---TLDNKEKFMSEAVIMKNLDHPHIVKLI 79 (281)
T ss_dssp CCCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTC-CEEEEEEEECCTTS---CHHHHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred CccceecccceEEEEEEEecCCeeEEEeEEcCCCC-CcceEEEEeccccc---CchHHHHHHHHHHHHHhCCCCCcceEE
Confidence 35668889999999999999999999998765332 34569999997653 223456788899999999999999999
Q ss_pred eeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccc
Q 042539 90 GSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169 (412)
Q Consensus 90 ~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DF 169 (412)
+++.++ ..|+||||+.|++|..++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+||
T Consensus 80 ~~~~~~-~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df 157 (281)
T 3cc6_A 80 GIIEEE-PTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDF 157 (281)
T ss_dssp EEECSS-SCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCC
T ss_pred EEEcCC-CCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCcc
Confidence 998754 5689999999999998886543 45899999999999999999999999999999999999999999999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|+++...... ........
T Consensus 158 g~~~~~~~~~--------------------------------------------------------------~~~~~~~~ 175 (281)
T 3cc6_A 158 GLSRYIEDED--------------------------------------------------------------YYKASVTR 175 (281)
T ss_dssp CGGGCC-----------------------------------------------------------------------CCC
T ss_pred CCCccccccc--------------------------------------------------------------ccccccCC
Confidence 9997542210 01112345
Q ss_pred cCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCC
Q 042539 250 GTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDP 326 (412)
Q Consensus 250 gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP 326 (412)
||+.|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+.... +.....++.+.++|.+||..||
T Consensus 176 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 255 (281)
T 3cc6_A 176 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDP 255 (281)
T ss_dssp CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred CCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCc
Confidence 7889999999999899999999999999999998 999998877666665554432 2334567899999999999999
Q ss_pred CccCCCCCChhhhhcC
Q 042539 327 VKRLGYLRGACEIKEH 342 (412)
Q Consensus 327 ~~R~~~~~~~~e~l~h 342 (412)
.+|| ++.+++++
T Consensus 256 ~~Rp----s~~ell~~ 267 (281)
T 3cc6_A 256 SDRP----RFTELVCS 267 (281)
T ss_dssp GGSC----CHHHHHHH
T ss_pred hhCc----CHHHHHHH
Confidence 9999 68888763
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=354.84 Aligned_cols=260 Identities=19% Similarity=0.244 Sum_probs=215.2
Q ss_pred CCCCCccCceeee-eeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeee
Q 042539 12 TPSLDLDNLKALK-ILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLG 90 (412)
Q Consensus 12 ~~~~~~~~y~~~~-~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 90 (412)
...+..++|.+++ .||+|+||.||+|.+.... .+..||+|+++... .....+.+.+|+++++.++||||+++++
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 77 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRK--KQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIG 77 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC-----CCEEEEEEEECSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCC--CcceEEEEecCCcc---chhHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence 4567789999998 9999999999999875432 34569999997653 2344567788999999999999999999
Q ss_pred eEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccc
Q 042539 91 SLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 91 ~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
++ ..+.+|+||||+.|++|..++... ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||
T Consensus 78 ~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg 155 (287)
T 1u59_A 78 VC-QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFG 155 (287)
T ss_dssp EE-ESSSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCT
T ss_pred Ee-cCCCcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECccc
Confidence 99 556799999999999998887543 3459999999999999999999999999999999999999999999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+++....... .........|
T Consensus 156 ~~~~~~~~~~------------------------------------------------------------~~~~~~~~~~ 175 (287)
T 1u59_A 156 LSKALGADDS------------------------------------------------------------YYTARSAGKW 175 (287)
T ss_dssp TCEECTTCSC------------------------------------------------------------EECCCCSSCC
T ss_pred ceeeeccCcc------------------------------------------------------------eeeccccccc
Confidence 9976521100 0011123457
Q ss_pred CCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCC
Q 042539 251 TEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPV 327 (412)
Q Consensus 251 t~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~ 327 (412)
|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..+....+.... ......++++.++|.+||..||.
T Consensus 176 ~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 255 (287)
T 1u59_A 176 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWE 255 (287)
T ss_dssp CGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGG
T ss_pred cccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChh
Confidence 899999999998889999999999999999998 999999988777777766543 22346789999999999999999
Q ss_pred ccCCCCCChhhhhcC
Q 042539 328 KRLGYLRGACEIKEH 342 (412)
Q Consensus 328 ~R~~~~~~~~e~l~h 342 (412)
+|| ++.++++|
T Consensus 256 ~Rp----s~~~l~~~ 266 (287)
T 1u59_A 256 DRP----DFLTVEQR 266 (287)
T ss_dssp GSC----CHHHHHHH
T ss_pred hCc----CHHHHHHH
Confidence 999 68888875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=365.12 Aligned_cols=250 Identities=20% Similarity=0.302 Sum_probs=198.4
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
..+..++|+++++||+|+||+||+|++. ++.||||++..... ......+|+.++++++|||||++++++
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~ 87 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLL------NEYVAVKIFPIQDK-----QSWQNEYEVYSLPGMKHENILQFIGAE 87 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEET------TEEEEEEEECGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred cccchhhchhhheecccCceEEEEEEEC------CCEEEEEEeecCch-----HHHHHHHHHHHHhcCCCCCchhhccee
Confidence 3567789999999999999999999875 24599999965432 223345599999999999999999999
Q ss_pred EeCC----eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHc----------CceeeeCCCCceEE
Q 042539 93 ETDE----FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNM----------GIAYRDLKPENILI 158 (412)
Q Consensus 93 ~~~~----~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~----------~iiHrDlKp~NiLl 158 (412)
.+.. .+|+|||||.||+|..++... .+++..+..++.|++.||.|||++ ||+||||||+|||+
T Consensus 88 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill 164 (322)
T 3soc_A 88 KRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL 164 (322)
T ss_dssp EEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE
T ss_pred ccCCCCCceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE
Confidence 8754 479999999999999888653 399999999999999999999999 99999999999999
Q ss_pred ccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccc
Q 042539 159 RQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQS 238 (412)
Q Consensus 159 ~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (412)
+.++.+||+|||+|+.+....
T Consensus 165 ~~~~~~kL~DFg~a~~~~~~~----------------------------------------------------------- 185 (322)
T 3soc_A 165 KNNLTACIADFGLALKFEAGK----------------------------------------------------------- 185 (322)
T ss_dssp CTTCCEEECCCTTCEEECTTS-----------------------------------------------------------
T ss_pred CCCCeEEEccCCccccccccc-----------------------------------------------------------
Confidence 999999999999997652110
Q ss_pred cCCCCCCcccccCCCCccceeecCC-----CCCchhhHHHHHHHHHHHhhCCCCCCCCC----------------HHHHH
Q 042539 239 FDNGERSNSFVGTEEYVSPEVVRGD-----GHEFAVDWWALGILTYEMLYGTTPFRGKN----------------RKETF 297 (412)
Q Consensus 239 ~~~~~~~~~~~gt~~Y~APE~l~~~-----~~~~~~DiwSlGvil~ell~g~~Pf~~~~----------------~~~~~ 297 (412)
........+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.. .....
T Consensus 186 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (322)
T 3soc_A 186 --SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQ 263 (322)
T ss_dssp --CCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHH
T ss_pred --CccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhh
Confidence 11122345799999999999873 45678999999999999999999997642 22222
Q ss_pred HHHhcCC--CCCCC------CChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 298 RNVLMKT--PEFVG------QRTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 298 ~~i~~~~--~~~~~------~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
..+.... +.... .++++.+||.+||+.||++|| ++.++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp----s~~ell~ 311 (322)
T 3soc_A 264 EVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL----SAGCVGE 311 (322)
T ss_dssp HHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSC----CHHHHHH
T ss_pred hhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCc----CHHHHHH
Confidence 2222221 11111 124599999999999999999 5888875
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=366.03 Aligned_cols=260 Identities=25% Similarity=0.344 Sum_probs=212.2
Q ss_pred CCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhH--HHHHHHHHHHHHHhhcC--CCccc
Q 042539 11 TTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKH--EAERRARWEIRVLSRLS--HPFLP 86 (412)
Q Consensus 11 ~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~--~~~~~~~~Ei~il~~l~--hpnIv 86 (412)
...+...++|++++.||+|+||+||+|++..++ +.||||++.+....... .....+.+|+.+++.+. |+||+
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~ 111 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDN----LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI 111 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTT----EEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCC----cEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCce
Confidence 344666789999999999999999999987654 45999999766432100 11234456999999996 59999
Q ss_pred eeeeeEEeCCeEEEEeeccCC-CCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEc-cCCCE
Q 042539 87 KLLGSLETDEFLAWAVPYCPG-GDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIR-QSGHV 164 (412)
Q Consensus 87 ~l~~~~~~~~~~~lv~e~~~g-g~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~-~~g~v 164 (412)
++++++.+.+.+++|||++.+ ++|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++ .++.+
T Consensus 112 ~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~ 189 (320)
T 3a99_A 112 RLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL 189 (320)
T ss_dssp CEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEE
T ss_pred EEEEEEecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCE
Confidence 999999999999999999986 89988876654 499999999999999999999999999999999999999 77999
Q ss_pred EEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCC
Q 042539 165 TLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGER 244 (412)
Q Consensus 165 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (412)
||+|||+++.... ..
T Consensus 190 kL~Dfg~~~~~~~-----------------------------------------------------------------~~ 204 (320)
T 3a99_A 190 KLIDFGSGALLKD-----------------------------------------------------------------TV 204 (320)
T ss_dssp EECCCTTCEECCS-----------------------------------------------------------------SC
T ss_pred EEeeCcccccccc-----------------------------------------------------------------cc
Confidence 9999999875421 11
Q ss_pred CcccccCCCCccceeecCCCC-CchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-CCCCCCChHHHHHHHHhh
Q 042539 245 SNSFVGTEEYVSPEVVRGDGH-EFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT-PEFVGQRTALTDLIQRLL 322 (412)
Q Consensus 245 ~~~~~gt~~Y~APE~l~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~dli~~~L 322 (412)
.....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+ .+.... ......++++.+||.+||
T Consensus 205 ~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~li~~~l 278 (320)
T 3a99_A 205 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQHLIRWCL 278 (320)
T ss_dssp BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHHHHHHHHHHT
T ss_pred ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccccccCCHHHHHHHHHHc
Confidence 224569999999999988776 789999999999999999999997632 122222 223457899999999999
Q ss_pred hhCCCccCCCCCChhhhhcCCCCCCCCch
Q 042539 323 EKDPVKRLGYLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 323 ~~dP~~R~~~~~~~~e~l~h~ff~~~~~~ 351 (412)
..||.+|| +++++++||||+++.+.
T Consensus 279 ~~dp~~Rp----s~~~ll~hp~~~~~~~~ 303 (320)
T 3a99_A 279 ALRPSDRP----TFEEIQNHPWMQDVLLP 303 (320)
T ss_dssp CSSGGGSC----CHHHHHTSGGGSSCCCH
T ss_pred cCChhhCc----CHHHHhcCHhhcCccCc
Confidence 99999999 69999999999976543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=365.16 Aligned_cols=266 Identities=23% Similarity=0.372 Sum_probs=193.3
Q ss_pred CCCCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHH-HHhhcCCCccc
Q 042539 8 QPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIR-VLSRLSHPFLP 86 (412)
Q Consensus 8 ~~~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv 86 (412)
.+.....+..++|++++.||+|+||.||+|.++.++ +.||||+++.... ......+.+|+. +++.++||||+
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv 84 (327)
T 3aln_A 12 SPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSG----QIMAVKRIRSTVD---EKEQKQLLMDLDVVMRSSDCPYIV 84 (327)
T ss_dssp CCCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTT----EEEEEEEEECCCC---HHHHHHHHHHHHHHHSSCCCTTBC
T ss_pred ChHHhcccCHHHhhehheeccCCCEEEEEEEEcCCC----CEEEEEEeecccC---chHHHHHHHHHHHHHHcCCCCcEe
Confidence 345566888999999999999999999999987654 4599999976532 122334444555 77778999999
Q ss_pred eeeeeEEeCCeEEEEeeccCCCCchhHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeeeCCCCceEEccCC
Q 042539 87 KLLGSLETDEFLAWAVPYCPGGDLNVLRYK---QNDRVFSPSVIRFYLSEIICAIEHLHNM-GIAYRDLKPENILIRQSG 162 (412)
Q Consensus 87 ~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~---~~~~~l~~~~~~~~~~qi~~aL~yLH~~-~iiHrDlKp~NiLl~~~g 162 (412)
++++++.+++..|+||||+.| +|..++.. .....+++..+..++.|++.||.|||++ ||+||||||+|||++.+|
T Consensus 85 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~ 163 (327)
T 3aln_A 85 QFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG 163 (327)
T ss_dssp CEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT
T ss_pred eeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC
Confidence 999999999999999999986 66555442 2245699999999999999999999999 999999999999999999
Q ss_pred CEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCC
Q 042539 163 HVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNG 242 (412)
Q Consensus 163 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (412)
.+||+|||+++.....
T Consensus 164 ~~kl~Dfg~~~~~~~~---------------------------------------------------------------- 179 (327)
T 3aln_A 164 NIKLCDFGISGQLVDS---------------------------------------------------------------- 179 (327)
T ss_dssp EEEECCCSSSCC--------------------------------------------------------------------
T ss_pred CEEEccCCCceecccc----------------------------------------------------------------
Confidence 9999999999754211
Q ss_pred CCCcccccCCCCccceee----cCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHH-HHHHHHhcCC-CCC-----CCCC
Q 042539 243 ERSNSFVGTEEYVSPEVV----RGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRK-ETFRNVLMKT-PEF-----VGQR 311 (412)
Q Consensus 243 ~~~~~~~gt~~Y~APE~l----~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~~i~~~~-~~~-----~~~~ 311 (412)
.......||+.|+|||++ .+..++.++|||||||++|+|++|+.||.+.+.. +.+..+.... +.+ ...+
T Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (327)
T 3aln_A 180 IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFS 259 (327)
T ss_dssp --------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCC
T ss_pred cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCC
Confidence 111233689999999999 4566899999999999999999999999875432 2222222222 122 2467
Q ss_pred hHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCC
Q 042539 312 TALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 312 ~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~ 349 (412)
+.+.+||.+||..||.+|| ++.++++||||....
T Consensus 260 ~~l~~li~~~l~~dp~~Rp----s~~ell~hp~~~~~~ 293 (327)
T 3aln_A 260 PSFINFVNLCLTKDESKRP----KYKELLKHPFILMYE 293 (327)
T ss_dssp HHHHHHHHHHTCSSGGGSC----CHHHHTTSHHHHHHH
T ss_pred HHHHHHHHHHhhCChhhCc----CHHHHHhChHHHHhH
Confidence 8999999999999999999 699999999997543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=368.11 Aligned_cols=265 Identities=17% Similarity=0.200 Sum_probs=203.1
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCC-CCCceEEeeecchhhhhhHH-------HHHHHHHHHHHHhhcCCCccc
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPT-ARCPFALKVVDKSTLHAKHE-------AERRARWEIRVLSRLSHPFLP 86 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~-~~~~vAiK~i~~~~~~~~~~-------~~~~~~~Ei~il~~l~hpnIv 86 (412)
+..++|++++.||+|+||+||+|.++.++.. .++.||||++.........+ .......|+..+..++|+||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 4456999999999999999999998765422 35669999987654211111 111234467778888999999
Q ss_pred eeeeeEEeC----CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEc--c
Q 042539 87 KLLGSLETD----EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIR--Q 160 (412)
Q Consensus 87 ~l~~~~~~~----~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~--~ 160 (412)
++++++... ..+|+||||| |++|..++... ...+++.+++.++.||+.||+|||++||+||||||+|||++ .
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence 999998765 4689999999 99999887654 34699999999999999999999999999999999999999 8
Q ss_pred CCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccC
Q 042539 161 SGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFD 240 (412)
Q Consensus 161 ~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (412)
++.+||+|||+|+.+...... ...
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~--------------------------------------------------------~~~ 213 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVH--------------------------------------------------------KAY 213 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCC--------------------------------------------------------CCS
T ss_pred CCeEEEEECCcceecccCCcc--------------------------------------------------------ccc
Confidence 899999999999866322110 001
Q ss_pred CCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHH------------HhcCCCCCC
Q 042539 241 NGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRN------------VLMKTPEFV 308 (412)
Q Consensus 241 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~------------i~~~~~~~~ 308 (412)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+......... ++.......
T Consensus 214 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (364)
T 3op5_A 214 AADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAA 293 (364)
T ss_dssp SCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTT
T ss_pred ccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccc
Confidence 11223456799999999999999999999999999999999999999986322211111 111111124
Q ss_pred CCChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 309 GQRTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 309 ~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
..++++.+||..||..||.+|| ++.++++
T Consensus 294 ~~~~~~~~li~~cl~~~p~~RP----~~~~l~~ 322 (364)
T 3op5_A 294 NAPGEIAKYMETVKLLDYTEKP----LYENLRD 322 (364)
T ss_dssp CCCHHHHHHHHHHHTCCTTCCC----CHHHHHH
T ss_pred cCHHHHHHHHHHHhcCCCCCCC----CHHHHHH
Confidence 6789999999999999999999 4666654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=384.80 Aligned_cols=255 Identities=21% Similarity=0.290 Sum_probs=216.6
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
.+++..++|++.+.||+|+||.||+|.++.++ ..||||+++.... ....+.+|+.+|++++|||||+++++
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~----~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~ 284 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYS----LTVAVKTLKEDTM-----EVEEFLKEAAVMKEIKHPNLVQLLGV 284 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGT----EEEEEEECCSSSS-----CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCC----eEEEEEEecCccc-----chHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 45778899999999999999999999998644 4499999976532 13456779999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
+.+.+.+|+|||||.||+|..++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 285 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 364 (495)
T 1opk_A 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGL 364 (495)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTC
T ss_pred EecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeeccc
Confidence 99999999999999999999998776556699999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
++...... ........+|
T Consensus 365 a~~~~~~~--------------------------------------------------------------~~~~~~~~~~ 382 (495)
T 1opk_A 365 SRLMTGDT--------------------------------------------------------------YTAHAGAKFP 382 (495)
T ss_dssp EECCTTCC--------------------------------------------------------------EECCTTCCCC
T ss_pred ceeccCCc--------------------------------------------------------------eeecCCCcCC
Confidence 97642110 0011233467
Q ss_pred CCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCc
Q 042539 252 EEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVK 328 (412)
Q Consensus 252 ~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~ 328 (412)
..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+.... .....+++++.+||.+||+.||.+
T Consensus 383 ~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 462 (495)
T 1opk_A 383 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 462 (495)
T ss_dssp GGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred cceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhH
Confidence 88999999999889999999999999999998 999999988777766655432 223457899999999999999999
Q ss_pred cCCCCCChhhhhc
Q 042539 329 RLGYLRGACEIKE 341 (412)
Q Consensus 329 R~~~~~~~~e~l~ 341 (412)
|| ++.++++
T Consensus 463 RP----s~~el~~ 471 (495)
T 1opk_A 463 RP----SFAEIHQ 471 (495)
T ss_dssp SC----CHHHHHH
T ss_pred Cc----CHHHHHH
Confidence 99 5777764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=353.45 Aligned_cols=256 Identities=29% Similarity=0.436 Sum_probs=201.2
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
...+++|++++.||+|+||.||+|.+..++ ..||||++....... ......+.+|+.+++.++||||+++++++.
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 102 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDG----VPVALKKVQIFDLMD-AKARADCIKEIDLLKQLNHPNVIKYYASFI 102 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTC----CEEEEEEECTTSSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCC----ceEEEEeeehhhccC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 446789999999999999999999987654 449999997644322 344567788999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYK--QNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~--~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
+++.+++||||+.|++|..++.. .....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~ 182 (310)
T 2wqm_A 103 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL 182 (310)
T ss_dssp ETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--
T ss_pred cCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccc
Confidence 99999999999999999888754 2345689999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
++..... ........||
T Consensus 183 ~~~~~~~---------------------------------------------------------------~~~~~~~~~~ 199 (310)
T 2wqm_A 183 GRFFSSK---------------------------------------------------------------TTAAHSLVGT 199 (310)
T ss_dssp -------------------------------------------------------------------------------C
T ss_pred eeeecCC---------------------------------------------------------------CccccccCCC
Confidence 8754211 1112245789
Q ss_pred CCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCC--CHHHHHHHHhcCC-CC--CCCCChHHHHHHHHhhhhCC
Q 042539 252 EEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGK--NRKETFRNVLMKT-PE--FVGQRTALTDLIQRLLEKDP 326 (412)
Q Consensus 252 ~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~--~~~~~~~~i~~~~-~~--~~~~~~~~~dli~~~L~~dP 326 (412)
+.|+|||++.+..++.++|||||||++|+|++|..||.+. +.......+.... +. ....++++.+||.+||..||
T Consensus 200 ~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 279 (310)
T 2wqm_A 200 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDP 279 (310)
T ss_dssp CSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSG
T ss_pred eeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCCh
Confidence 9999999999999999999999999999999999999764 3334444444322 21 23567899999999999999
Q ss_pred CccCCCCCChhhhhc
Q 042539 327 VKRLGYLRGACEIKE 341 (412)
Q Consensus 327 ~~R~~~~~~~~e~l~ 341 (412)
.+|| ++.++++
T Consensus 280 ~~Rp----s~~~il~ 290 (310)
T 2wqm_A 280 EKRP----DVTYVYD 290 (310)
T ss_dssp GGSC----CHHHHHH
T ss_pred hhCC----CHHHHHH
Confidence 9999 6888875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=353.31 Aligned_cols=260 Identities=20% Similarity=0.246 Sum_probs=211.0
Q ss_pred CCCCCCccCceeee-eeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceee
Q 042539 11 TTPSLDLDNLKALK-ILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLL 89 (412)
Q Consensus 11 ~~~~~~~~~y~~~~-~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~ 89 (412)
....+..++|++.+ .||+|+||+||+|.+.... ++..||||+++.... .....+.+.+|+++++.++||||++++
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~--~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~ 84 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKK--VVKTVAVKILKNEAN--DPALKDELLAEANVMQQLDNPYIVRMI 84 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSS--SEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCC--ceeeEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 45677889999999 9999999999999654322 445699999976532 233456788899999999999999999
Q ss_pred eeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccc
Q 042539 90 GSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169 (412)
Q Consensus 90 ~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DF 169 (412)
+++ ..+.+|+||||+.|++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 85 ~~~-~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Df 161 (291)
T 1xbb_A 85 GIC-EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDF 161 (291)
T ss_dssp EEE-ESSSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCC
T ss_pred EEE-CCCCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccC
Confidence 999 567889999999999999888764 34999999999999999999999999999999999999999999999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|+++........ ........
T Consensus 162 g~~~~~~~~~~~------------------------------------------------------------~~~~~~~~ 181 (291)
T 1xbb_A 162 GLSKALRADENY------------------------------------------------------------YKAQTHGK 181 (291)
T ss_dssp TTCEECCTTCSE------------------------------------------------------------EEC----C
T ss_pred CcceeeccCCCc------------------------------------------------------------ccccccCC
Confidence 999765211100 00112234
Q ss_pred cCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC-C-CCCCCChHHHHHHHHhhhhCC
Q 042539 250 GTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT-P-EFVGQRTALTDLIQRLLEKDP 326 (412)
Q Consensus 250 gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~-~-~~~~~~~~~~dli~~~L~~dP 326 (412)
||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..+....+.... + .....++.+.++|.+||..||
T Consensus 182 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 261 (291)
T 1xbb_A 182 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDV 261 (291)
T ss_dssp CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSST
T ss_pred CCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCh
Confidence 6789999999998889999999999999999999 999999988888777666543 2 224568999999999999999
Q ss_pred CccCCCCCChhhhhc
Q 042539 327 VKRLGYLRGACEIKE 341 (412)
Q Consensus 327 ~~R~~~~~~~~e~l~ 341 (412)
.+|| ++.++++
T Consensus 262 ~~Rp----s~~~l~~ 272 (291)
T 1xbb_A 262 ENRP----GFAAVEL 272 (291)
T ss_dssp TTSC----CHHHHHH
T ss_pred hhCc----CHHHHHH
Confidence 9999 5777774
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=360.16 Aligned_cols=262 Identities=23% Similarity=0.344 Sum_probs=212.6
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCC-CCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeee
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAAD-PTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLG 90 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~ 90 (412)
.++..++|++++.||+|+||+||+|++.... ..+++.||||++++... ......+.+|+.+++++ +||||+++++
T Consensus 22 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 22 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT---HSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC---HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred eecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC---cHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 3677789999999999999999999875432 23566799999976532 23455678899999999 6999999999
Q ss_pred eEEeCC-eEEEEeeccCCCCchhHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCc
Q 042539 91 SLETDE-FLAWAVPYCPGGDLNVLRYKQND--------------RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPEN 155 (412)
Q Consensus 91 ~~~~~~-~~~lv~e~~~gg~L~~~~~~~~~--------------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~N 155 (412)
++...+ .+|+|||||.||+|..++..... ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N 178 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 178 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence 987754 59999999999999988876432 128899999999999999999999999999999999
Q ss_pred eEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCcccc
Q 042539 156 ILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRR 235 (412)
Q Consensus 156 iLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (412)
||++.+|.+||+|||+++......
T Consensus 179 il~~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------------------- 202 (316)
T 2xir_A 179 ILLSEKNVVKICDFGLARDIYKDP-------------------------------------------------------- 202 (316)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCT--------------------------------------------------------
T ss_pred EEECCCCCEEECCCccccccccCc--------------------------------------------------------
Confidence 999999999999999997542110
Q ss_pred ccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHH-HHHhcCC--CCCCCCC
Q 042539 236 QQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETF-RNVLMKT--PEFVGQR 311 (412)
Q Consensus 236 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~-~~i~~~~--~~~~~~~ 311 (412)
.........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+.+ ..+.... ......+
T Consensus 203 -----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (316)
T 2xir_A 203 -----DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTT 277 (316)
T ss_dssp -----TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCC
T ss_pred -----cceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCCCCCC
Confidence 0111234568899999999999999999999999999999998 99999886644333 3333222 2223467
Q ss_pred hHHHHHHHHhhhhCCCccCCCCCChhhhhcC
Q 042539 312 TALTDLIQRLLEKDPVKRLGYLRGACEIKEH 342 (412)
Q Consensus 312 ~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h 342 (412)
+++.++|.+||..||.+|| ++.++++|
T Consensus 278 ~~l~~li~~~l~~dp~~Rp----s~~ell~~ 304 (316)
T 2xir_A 278 PEMYQTMLDCWHGEPSQRP----TFSELVEH 304 (316)
T ss_dssp HHHHHHHHHHTCSSGGGSC----CHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCc----CHHHHHHH
Confidence 8999999999999999999 68988875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=365.49 Aligned_cols=264 Identities=17% Similarity=0.171 Sum_probs=200.4
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHH-------HHHHHHHHHHHHhhcCCCccc
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHE-------AERRARWEIRVLSRLSHPFLP 86 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~-------~~~~~~~Ei~il~~l~hpnIv 86 (412)
.+..++|++++.||+|+||+||+|++...+. ++..||||++.+.......+ ....+.+|+.+++.++||||+
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~ 111 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPE-KDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP 111 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCG-GGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCC-ccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence 4556799999999999999999999976322 34459999997653211111 112356789999999999999
Q ss_pred eeeeeEEe----CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCC
Q 042539 87 KLLGSLET----DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG 162 (412)
Q Consensus 87 ~l~~~~~~----~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g 162 (412)
++++++.+ +..+|+||||| |++|..++.... .+++.+++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSS
T ss_pred eeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCC
Confidence 99999987 67899999999 999988876544 599999999999999999999999999999999999999887
Q ss_pred --CEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccC
Q 042539 163 --HVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFD 240 (412)
Q Consensus 163 --~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (412)
.+||+|||+|+.+...... ...
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~--------------------------------------------------------~~~ 212 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNH--------------------------------------------------------KQY 212 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCC--------------------------------------------------------CCC
T ss_pred CCcEEEEeCCCceeccccccc--------------------------------------------------------ccc
Confidence 9999999999876322110 001
Q ss_pred CCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCC--CCHHHHHH---HHhcCCCC-------CC
Q 042539 241 NGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRG--KNRKETFR---NVLMKTPE-------FV 308 (412)
Q Consensus 241 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~--~~~~~~~~---~i~~~~~~-------~~ 308 (412)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+ .+...... ......+. ..
T Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (345)
T 2v62_A 213 QENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSG 292 (345)
T ss_dssp CCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTT
T ss_pred hhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhcccc
Confidence 11222456899999999999999999999999999999999999999965 23222211 11111111 11
Q ss_pred CCChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 309 GQRTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 309 ~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
..+.++.+||.+||..||.+|| +++++++
T Consensus 293 ~~~~~l~~li~~~l~~dp~~Rp----s~~~l~~ 321 (345)
T 2v62_A 293 SSCCEIAQFLVCAHSLAYDEKP----NYQALKK 321 (345)
T ss_dssp SCCHHHHHHHHHHHTCCTTCCC----CHHHHHH
T ss_pred ccHHHHHHHHHHHhhcCcccCC----CHHHHHH
Confidence 6788999999999999999999 5777775
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=356.14 Aligned_cols=262 Identities=20% Similarity=0.268 Sum_probs=207.8
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
...+..++|++.+.||+|+||+||+|.+...+. ++..||+|+++.... .......+.+|+.++++++||||++++++
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDG-TSLKVAVKTMKLDNS--SQREIEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTS-CEEEEEEEEC---CC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCC-ceeEEEEEEEecccc--chhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 445677899999999999999999998765332 445699999976543 22345667889999999999999999999
Q ss_pred EEeCC-----eEEEEeeccCCCCchhHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCC
Q 042539 92 LETDE-----FLAWAVPYCPGGDLNVLRYKQ----NDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG 162 (412)
Q Consensus 92 ~~~~~-----~~~lv~e~~~gg~L~~~~~~~----~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g 162 (412)
+.+.+ ..|+||||+.||+|..++... ....+++..++.++.||+.||.|||++||+||||||+|||++.+|
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC
Confidence 98654 459999999999998887432 334699999999999999999999999999999999999999999
Q ss_pred CEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCC
Q 042539 163 HVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNG 242 (412)
Q Consensus 163 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (412)
.+||+|||+++.+..... .
T Consensus 185 ~~kl~Dfg~~~~~~~~~~-------------------------------------------------------------~ 203 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDY-------------------------------------------------------------Y 203 (313)
T ss_dssp CEEECSCSCC----------------------------------------------------------------------
T ss_pred cEEEeecCcceecccccc-------------------------------------------------------------c
Confidence 999999999976532110 0
Q ss_pred CCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHH
Q 042539 243 ERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQ 319 (412)
Q Consensus 243 ~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~ 319 (412)
.......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.... ......++++.+||.
T Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 283 (313)
T 3brb_A 204 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMY 283 (313)
T ss_dssp -------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCBTTCCHHHHHHHH
T ss_pred CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCCCccccHHHHHHHH
Confidence 11123457889999999999999999999999999999999 999999988777777766543 233457789999999
Q ss_pred HhhhhCCCccCCCCCChhhhhc
Q 042539 320 RLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 320 ~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
+||..||.+|| ++.++++
T Consensus 284 ~~l~~dp~~Rp----s~~~l~~ 301 (313)
T 3brb_A 284 SCWRTDPLDRP----TFSVLRL 301 (313)
T ss_dssp HTTCSSGGGSC----CHHHHHH
T ss_pred HHcCCChhhCc----CHHHHHH
Confidence 99999999999 6888876
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=375.90 Aligned_cols=254 Identities=20% Similarity=0.264 Sum_probs=210.9
Q ss_pred CCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeee
Q 042539 11 TTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLG 90 (412)
Q Consensus 11 ~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 90 (412)
..+++..++|++.+.||+|+||+||+|.++.+ ..||||+++..... ...+.+|+++|++++||||+++++
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-----~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~ 246 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-----TRVAIKTLKPGTMS-----PEAFLQEAQVMKKLRHEKLVQLYA 246 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-----EEEEEEECCTTSSC-----HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCC-----ceEEEEEeccCCCC-----HHHHHHHHHHHHhCCCCCEeeEEE
Confidence 35678889999999999999999999998642 34999999765421 235677999999999999999999
Q ss_pred eEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccc
Q 042539 91 SLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 91 ~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
++.+ +.+|+|||||.||+|.+++.......+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 247 ~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG 325 (452)
T 1fmk_A 247 VVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG 325 (452)
T ss_dssp EECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred EEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCc
Confidence 9876 678999999999999988875444458999999999999999999999999999999999999999999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+++...... ........+
T Consensus 326 ~a~~~~~~~--------------------------------------------------------------~~~~~~~~~ 343 (452)
T 1fmk_A 326 LARLIEDNE--------------------------------------------------------------YTARQGAKF 343 (452)
T ss_dssp TTC----------------------------------------------------------------------------C
T ss_pred cceecCCCc--------------------------------------------------------------eecccCCcc
Confidence 997652110 001122356
Q ss_pred CCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCC
Q 042539 251 TEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPV 327 (412)
Q Consensus 251 t~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~ 327 (412)
|..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+..+. +....+++.+.+||.+||..||+
T Consensus 344 ~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 423 (452)
T 1fmk_A 344 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPE 423 (452)
T ss_dssp CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred cccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChh
Confidence 789999999999899999999999999999999 999999999888887776543 23346788999999999999999
Q ss_pred ccCCCCCChhhhhc
Q 042539 328 KRLGYLRGACEIKE 341 (412)
Q Consensus 328 ~R~~~~~~~~e~l~ 341 (412)
+|| +++++++
T Consensus 424 ~Rp----t~~~l~~ 433 (452)
T 1fmk_A 424 ERP----TFEYLQA 433 (452)
T ss_dssp GSC----CHHHHHH
T ss_pred hCc----CHHHHHH
Confidence 999 5777775
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=367.19 Aligned_cols=257 Identities=16% Similarity=0.206 Sum_probs=200.3
Q ss_pred CCCCCCCccCceeeeeeeccCceEEEEEEEcCC-CCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC---CCcc
Q 042539 10 QTTPSLDLDNLKALKILGKGAMGTVFLVHDRAA-DPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS---HPFL 85 (412)
Q Consensus 10 ~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~-~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~---hpnI 85 (412)
....++.-++|++++.||+|+||+||+|.+... ...+++.||||+++... ...+.+|+++++.+. |+||
T Consensus 57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~e~~~~~~l~~~~~~~i 129 (365)
T 3e7e_A 57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-------PWEFYIGTQLMERLKPSMQHMF 129 (365)
T ss_dssp SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-------HHHHHHHHHHHHHSCGGGGGGB
T ss_pred ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-------hhHHHHHHHHHHHhhhhhhhhh
Confidence 334456678899999999999999999964331 22345669999997643 223455777888887 8999
Q ss_pred ceeeeeEEeCCeEEEEeeccCCCCchhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEcc--
Q 042539 86 PKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQ---NDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQ-- 160 (412)
Q Consensus 86 v~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~---~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~-- 160 (412)
+++++++..++..|+|||||.||+|..++... ....+++.+++.++.||+.||+|||++|||||||||+|||++.
T Consensus 130 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~ 209 (365)
T 3e7e_A 130 MKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGF 209 (365)
T ss_dssp CCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGG
T ss_pred hhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccc
Confidence 99999999999999999999999999887653 2346999999999999999999999999999999999999998
Q ss_pred ---------CCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCC
Q 042539 161 ---------SGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSP 231 (412)
Q Consensus 161 ---------~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (412)
++.+||+|||+|+.+...
T Consensus 210 ~~~~~~~~~~~~~kl~DFG~a~~~~~~----------------------------------------------------- 236 (365)
T 3e7e_A 210 LEQDDEDDLSAGLALIDLGQSIDMKLF----------------------------------------------------- 236 (365)
T ss_dssp TCC------CTTEEECCCTTCEEGGGS-----------------------------------------------------
T ss_pred cCccccccccCCEEEeeCchhhhhhcc-----------------------------------------------------
Confidence 899999999999754211
Q ss_pred ccccccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 042539 232 VSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVGQR 311 (412)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 311 (412)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..........+
T Consensus 237 --------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~~~~~~~~~ 305 (365)
T 3e7e_A 237 --------PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK---PEGLFRRLPHL 305 (365)
T ss_dssp --------CTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE---ECSCCTTCSSH
T ss_pred --------CCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee---echhccccCcH
Confidence 1112234568999999999999999999999999999999999999999654321100 00111111235
Q ss_pred hHHHHHHHHhhhhCCCccCCCCCChhhhh
Q 042539 312 TALTDLIQRLLEKDPVKRLGYLRGACEIK 340 (412)
Q Consensus 312 ~~~~dli~~~L~~dP~~R~~~~~~~~e~l 340 (412)
+.+.+++.+||+.+|.+|++ ++.++.
T Consensus 306 ~~~~~~~~~~l~~~p~~r~~---~~~~l~ 331 (365)
T 3e7e_A 306 DMWNEFFHVMLNIPDCHHLP---SLDLLR 331 (365)
T ss_dssp HHHHHHHHHHHCCCCTTCCC---CHHHHH
T ss_pred HHHHHHHHHHcCCCCCCcch---HHHHHH
Confidence 67889999999999999985 444443
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=353.50 Aligned_cols=251 Identities=23% Similarity=0.331 Sum_probs=207.6
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
......++|++++.||+|+||.||+|++..++ +.||+|++.... ..+.+|+++++.++||||++++++
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~ 72 (284)
T 2a19_B 5 VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDG----KTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVHYNGC 72 (284)
T ss_dssp CCHHHHHHEEEEEEEECSSSCCEEEEEETTTC----CEEEEEEEECCS--------GGGHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccchhccccceeeeeccCCceEEEEEEEcCCC----eEEEEEEecccc--------HHHHHHHHHHHhCCCCCEEEEeee
Confidence 33444578999999999999999999987654 449999996543 124469999999999999999999
Q ss_pred EEe----------------CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCc
Q 042539 92 LET----------------DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPEN 155 (412)
Q Consensus 92 ~~~----------------~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~N 155 (412)
+.. ...+|+|||||.|++|..++.......+++..+..++.||+.||.|||++||+||||||+|
T Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~N 152 (284)
T 2a19_B 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSN 152 (284)
T ss_dssp EEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred EeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHH
Confidence 864 4568999999999999998876655569999999999999999999999999999999999
Q ss_pred eEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCcccc
Q 042539 156 ILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRR 235 (412)
Q Consensus 156 iLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (412)
||++.++.+||+|||+++....
T Consensus 153 il~~~~~~~kl~Dfg~~~~~~~---------------------------------------------------------- 174 (284)
T 2a19_B 153 IFLVDTKQVKIGDFGLVTSLKN---------------------------------------------------------- 174 (284)
T ss_dssp EEEEETTEEEECCCTTCEESSC----------------------------------------------------------
T ss_pred EEEcCCCCEEECcchhheeccc----------------------------------------------------------
Confidence 9999999999999999875421
Q ss_pred ccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCChHHH
Q 042539 236 QQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVGQRTALT 315 (412)
Q Consensus 236 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 315 (412)
........||+.|+|||++.+..++.++|||||||++|+|++|..||... ......+... ......+..+.
T Consensus 175 ------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~ 245 (284)
T 2a19_B 175 ------DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG-IISDIFDKKEK 245 (284)
T ss_dssp ------CSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT-CCCTTSCHHHH
T ss_pred ------cccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc-cccccCCHHHH
Confidence 11122446999999999999999999999999999999999999988532 2233333322 22345678999
Q ss_pred HHHHHhhhhCCCccCCCCCChhhhhcCCCC
Q 042539 316 DLIQRLLEKDPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 316 dli~~~L~~dP~~R~~~~~~~~e~l~h~ff 345 (412)
+||.+||..||.+|| ++.++++|.+.
T Consensus 246 ~li~~~l~~dp~~Rp----s~~e~l~~l~~ 271 (284)
T 2a19_B 246 TLLQKLLSKKPEDRP----NTSEILRTLTV 271 (284)
T ss_dssp HHHHHHTCSSGGGSC----CHHHHHHHHHH
T ss_pred HHHHHHccCChhhCc----CHHHHHHHHHH
Confidence 999999999999999 69999987653
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=360.27 Aligned_cols=262 Identities=21% Similarity=0.267 Sum_probs=213.0
Q ss_pred CCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeee
Q 042539 11 TTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLG 90 (412)
Q Consensus 11 ~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 90 (412)
...-++.++|++++.||+|+||.||+|++...+..+++.||||++.... ....+.+.+|++++++++|+||+++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~ 91 (327)
T 3lxl_A 16 DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG----PDQQRDFQREIQILKALHSDFIVKYRG 91 (327)
T ss_dssp -CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC----HHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred hhhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC----HHHHHHHHHHHHHHHhcCCCceeEEEE
Confidence 3456788999999999999999999999766666677789999997653 234566788999999999999999999
Q ss_pred eEE--eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcc
Q 042539 91 SLE--TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTD 168 (412)
Q Consensus 91 ~~~--~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~D 168 (412)
++. +...+|+|||||.|++|..++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~D 170 (327)
T 3lxl_A 92 VSYGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIAD 170 (327)
T ss_dssp EEECSSSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECC
T ss_pred EEecCCCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcc
Confidence 886 4567999999999999998877643 3489999999999999999999999999999999999999999999999
Q ss_pred ccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccc
Q 042539 169 FDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248 (412)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (412)
||+++....... ........
T Consensus 171 fg~~~~~~~~~~------------------------------------------------------------~~~~~~~~ 190 (327)
T 3lxl_A 171 FGLAKLLPLDKD------------------------------------------------------------YYVVREPG 190 (327)
T ss_dssp GGGCEECCTTCS------------------------------------------------------------EEECSSCC
T ss_pred cccceecccCCc------------------------------------------------------------cceeeccC
Confidence 999976521100 00112234
Q ss_pred ccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHH---------------HHHHHHhcC--CCCCCCCC
Q 042539 249 VGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRK---------------ETFRNVLMK--TPEFVGQR 311 (412)
Q Consensus 249 ~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---------------~~~~~i~~~--~~~~~~~~ 311 (412)
.||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+... .+.....+
T Consensus 191 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (327)
T 3lxl_A 191 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACP 270 (327)
T ss_dssp CSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCCCTTCC
T ss_pred CccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCCCCCccc
Confidence 6888999999999998999999999999999999999999764322 112222221 12334568
Q ss_pred hHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 312 TALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 312 ~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
+.+.+||.+||..||.+|| ++.++++
T Consensus 271 ~~l~~li~~~l~~dP~~Rp----s~~ell~ 296 (327)
T 3lxl_A 271 AEVHELMKLCWAPSPQDRP----SFSALGP 296 (327)
T ss_dssp HHHHHHHHHHTCSSGGGSC----CHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCc----CHHHHHH
Confidence 9999999999999999999 6888865
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=356.81 Aligned_cols=259 Identities=27% Similarity=0.422 Sum_probs=207.0
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC--CCccceeeee
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS--HPFLPKLLGS 91 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~ 91 (412)
.+.-++|++++.||+|+||.||+|.+.. ++.||||++..... .......+.+|+.++++++ |+||++++++
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNEK-----KQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTT-----CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcCC-----CcEEEEEEeccccc--cccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 4455689999999999999999998753 34599999976543 2334567788999999997 5999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
+.+++.+|+||| +.+++|..++.... .+++.+++.++.||+.||.|||++||+||||||+|||++ +|.+||+|||+
T Consensus 97 ~~~~~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~ 172 (313)
T 3cek_A 97 EITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGI 172 (313)
T ss_dssp EECSSEEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSS
T ss_pred eecCCEEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccc
Confidence 999999999999 56889988877543 589999999999999999999999999999999999996 58999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
++....... .......+||
T Consensus 173 ~~~~~~~~~-------------------------------------------------------------~~~~~~~~gt 191 (313)
T 3cek_A 173 ANQMQPDTT-------------------------------------------------------------SVVKDSQVGT 191 (313)
T ss_dssp SCC---------------------------------------------------------------------------CC
T ss_pred cccccCccc-------------------------------------------------------------cccccCCCCC
Confidence 976532110 0112345799
Q ss_pred CCCccceeecC-----------CCCCchhhHHHHHHHHHHHhhCCCCCCCCC-HHHHHHHHhcCCC--CC-CCCChHHHH
Q 042539 252 EEYVSPEVVRG-----------DGHEFAVDWWALGILTYEMLYGTTPFRGKN-RKETFRNVLMKTP--EF-VGQRTALTD 316 (412)
Q Consensus 252 ~~Y~APE~l~~-----------~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-~~~~~~~i~~~~~--~~-~~~~~~~~d 316 (412)
+.|+|||++.+ ..++.++|||||||++|+|++|..||.... ....+..+..... .+ ...+.++.+
T Consensus 192 ~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (313)
T 3cek_A 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQD 271 (313)
T ss_dssp GGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHH
T ss_pred CCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcccchHHHHH
Confidence 99999999876 467889999999999999999999998753 3344455544322 22 234688999
Q ss_pred HHHHhhhhCCCccCCCCCChhhhhcCCCCCCC
Q 042539 317 LIQRLLEKDPVKRLGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 317 li~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~ 348 (412)
||.+||..||.+|| ++.++++||||+..
T Consensus 272 li~~~l~~dp~~Rp----s~~ell~h~~~~~~ 299 (313)
T 3cek_A 272 VLKCCLKRDPKQRI----SIPELLAHPYVQIQ 299 (313)
T ss_dssp HHHHHTCSSTTTSC----CHHHHHTSHHHHCC
T ss_pred HHHHHccCCcccCc----CHHHHhcCccccCC
Confidence 99999999999999 69999999999753
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=349.83 Aligned_cols=254 Identities=18% Similarity=0.247 Sum_probs=212.0
Q ss_pred CCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeee
Q 042539 11 TTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLG 90 (412)
Q Consensus 11 ~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 90 (412)
..+++..++|++++.||+|+||.||+|++.. +..||+|++...... ...+.+|+++++.++||||+++++
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~ 75 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNG-----HTKVAVKSLKQGSMS-----PDAFLAEANLMKQLQHQRLVRLYA 75 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETT-----TEEEEEEEECTTSSC-----HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEcC-----CcEEEEEEecCCccc-----HHHHHHHHHHHHhCCCcCcceEEE
Confidence 3567788999999999999999999998753 334999999765421 345677999999999999999999
Q ss_pred eEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccc
Q 042539 91 SLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 91 ~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
++. ++..|+||||+.|++|.+++.......+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 76 ~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg 154 (279)
T 1qpc_A 76 VVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFG 154 (279)
T ss_dssp EEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEc-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCc
Confidence 986 4568999999999999888765433359999999999999999999999999999999999999999999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+++...... ........|
T Consensus 155 ~~~~~~~~~--------------------------------------------------------------~~~~~~~~~ 172 (279)
T 1qpc_A 155 LARLIEDNE--------------------------------------------------------------YTAREGAKF 172 (279)
T ss_dssp TCEECSSSC--------------------------------------------------------------EECCTTCCC
T ss_pred ccccccCcc--------------------------------------------------------------cccccCCCC
Confidence 997542110 001123357
Q ss_pred CCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCC
Q 042539 251 TEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPV 327 (412)
Q Consensus 251 t~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~ 327 (412)
|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..+....+.... ......++++.+||.+||..||+
T Consensus 173 ~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 252 (279)
T 1qpc_A 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPE 252 (279)
T ss_dssp CTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred ccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHHHHHHhccChh
Confidence 889999999998889999999999999999999 999999998888877776543 22345678999999999999999
Q ss_pred ccCCCCCChhhhhc
Q 042539 328 KRLGYLRGACEIKE 341 (412)
Q Consensus 328 ~R~~~~~~~~e~l~ 341 (412)
+|| +++++++
T Consensus 253 ~Rp----s~~~l~~ 262 (279)
T 1qpc_A 253 DRP----TFDYLRS 262 (279)
T ss_dssp GSC----CHHHHHH
T ss_pred hCC----CHHHHHH
Confidence 999 5777775
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=356.77 Aligned_cols=257 Identities=19% Similarity=0.251 Sum_probs=207.0
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET 94 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 94 (412)
+.-+.|++++.||+|+||+||++..+..+..+++.||||++++.. .......+.+|+++++.++||||+++++++.+
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA---GPQHRSGWKQEIDILRTLYHEHIIKYKGCCED 104 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc---ChHHHHHHHHHHHHHHhCCCcchhhEEEEEec
Confidence 444445999999999999999998877777788889999997653 23445678889999999999999999999987
Q ss_pred C--CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 95 D--EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 95 ~--~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
. ..+|+|||||.||+|..++... .+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 181 (318)
T 3lxp_A 105 AGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181 (318)
T ss_dssp TTTTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred CCCceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccc
Confidence 4 6899999999999998887543 3999999999999999999999999999999999999999999999999999
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+....... .........||+
T Consensus 182 ~~~~~~~~------------------------------------------------------------~~~~~~~~~~~~ 201 (318)
T 3lxp_A 182 KAVPEGHE------------------------------------------------------------YYRVREDGDSPV 201 (318)
T ss_dssp EECCTTCS------------------------------------------------------------EEEC---CCCCG
T ss_pred cccccccc------------------------------------------------------------ccccccCCCCCc
Confidence 76532100 001122446888
Q ss_pred CCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHH--------------HHHHHhcC---CCCCCCCChHHH
Q 042539 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKE--------------TFRNVLMK---TPEFVGQRTALT 315 (412)
Q Consensus 253 ~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--------------~~~~i~~~---~~~~~~~~~~~~ 315 (412)
.|+|||++.+..++.++|||||||++|+|++|..||....... .....+.. .+.....+.++.
T Consensus 202 ~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 281 (318)
T 3lxp_A 202 FWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVY 281 (318)
T ss_dssp GGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred eeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHH
Confidence 9999999999889999999999999999999999997643211 11112211 123345688999
Q ss_pred HHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 316 DLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 316 dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
+||.+||..||.+|| ++.++++
T Consensus 282 ~li~~~l~~dP~~Rp----s~~ell~ 303 (318)
T 3lxp_A 282 HLMKNCWETEASFRP----TFENLIP 303 (318)
T ss_dssp HHHHHHTCSSGGGSC----CHHHHHH
T ss_pred HHHHHHcCCCcccCc----CHHHHHH
Confidence 999999999999999 6888874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=352.46 Aligned_cols=259 Identities=17% Similarity=0.203 Sum_probs=208.1
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeE-E
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSL-E 93 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~ 93 (412)
....+|++.+.||+|+||+||+|++...+. ....||+|++.... .......+.+|+.++++++||||+++++++ .
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~avk~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 97 (298)
T 3f66_A 22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDG-KKIHCAVKSLNRIT---DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 97 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEC------CEEEEEEEETTCC---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred ccceehhhcceeeecCCceEEEEEEecCCC-ceeEEEEEecccCC---CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc
Confidence 345689999999999999999998765432 34458999986532 233456678899999999999999999985 5
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
.++..|+|||||.||+|..++... ...+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++
T Consensus 98 ~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 98 SEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred CCCceEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccc
Confidence 567889999999999999887653 3458999999999999999999999999999999999999999999999999997
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
....... ..........||+.
T Consensus 177 ~~~~~~~-----------------------------------------------------------~~~~~~~~~~~~~~ 197 (298)
T 3f66_A 177 DMYDKEY-----------------------------------------------------------YSVHNKTGAKLPVK 197 (298)
T ss_dssp CCSCGGG-----------------------------------------------------------CBC-----CCBCGG
T ss_pred cccccch-----------------------------------------------------------hccccccCCCCCcc
Confidence 6532111 01112234468899
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCCC--CCCCChHHHHHHHHhhhhCCCccC
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTPE--FVGQRTALTDLIQRLLEKDPVKRL 330 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~dli~~~L~~dP~~R~ 330 (412)
|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+...... ....++.+.++|.+||..||.+||
T Consensus 198 y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 277 (298)
T 3f66_A 198 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRP 277 (298)
T ss_dssp GSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred ccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCc
Confidence 999999999999999999999999999999 78888887766666666554322 334678999999999999999999
Q ss_pred CCCCChhhhhc
Q 042539 331 GYLRGACEIKE 341 (412)
Q Consensus 331 ~~~~~~~e~l~ 341 (412)
++.++++
T Consensus 278 ----s~~ell~ 284 (298)
T 3f66_A 278 ----SFSELVS 284 (298)
T ss_dssp ----CHHHHHH
T ss_pred ----CHHHHHH
Confidence 6888775
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=373.67 Aligned_cols=253 Identities=27% Similarity=0.412 Sum_probs=204.3
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
.+.-++|++.+.||+|+||+||+|+++.++. .||||++.+..... ....+.+|+++++.++||||+++++++.
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 77 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGD----LFAIKVFNNISFLR---PVDVQMREFEVLKKLNHKNIVKLFAIEE 77 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEECGGGGGS---CHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCc----EEEEEEeccccccc---hHHHHHHHHHHHHhcCCCCCCeEEEeec
Confidence 3456799999999999999999999987554 49999997654322 2345567999999999999999999998
Q ss_pred eCC--eEEEEeeccCCCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEE----ccCCCEEE
Q 042539 94 TDE--FLAWAVPYCPGGDLNVLRYKQND-RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILI----RQSGHVTL 166 (412)
Q Consensus 94 ~~~--~~~lv~e~~~gg~L~~~~~~~~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl----~~~g~vkL 166 (412)
..+ ..|+|||||.||+|..++..... ..+++.+++.++.||+.||+|||++||+||||||+|||+ +.++.+||
T Consensus 78 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL 157 (396)
T 4eut_A 78 ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKL 157 (396)
T ss_dssp CTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEE
T ss_pred cCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEE
Confidence 765 78999999999999888765432 239999999999999999999999999999999999999 77788999
Q ss_pred ccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCc
Q 042539 167 TDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSN 246 (412)
Q Consensus 167 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (412)
+|||+++..... ....
T Consensus 158 ~DFG~a~~~~~~----------------------------------------------------------------~~~~ 173 (396)
T 4eut_A 158 TDFGAARELEDD----------------------------------------------------------------EQFV 173 (396)
T ss_dssp CCGGGCEECCCG----------------------------------------------------------------GGSS
T ss_pred ecCCCceEccCC----------------------------------------------------------------Cccc
Confidence 999999765211 1123
Q ss_pred ccccCCCCccceeecC--------CCCCchhhHHHHHHHHHHHhhCCCCCCC----CCHHHHHHHHhcCCCCC-------
Q 042539 247 SFVGTEEYVSPEVVRG--------DGHEFAVDWWALGILTYEMLYGTTPFRG----KNRKETFRNVLMKTPEF------- 307 (412)
Q Consensus 247 ~~~gt~~Y~APE~l~~--------~~~~~~~DiwSlGvil~ell~g~~Pf~~----~~~~~~~~~i~~~~~~~------- 307 (412)
+.+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.. ....+.+.+++.+.+..
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 253 (396)
T 4eut_A 174 SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQK 253 (396)
T ss_dssp CSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEEC
T ss_pred cccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhhee
Confidence 4579999999999875 4568899999999999999999999964 23345555665544321
Q ss_pred ---------------CC----CChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 308 ---------------VG----QRTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 308 ---------------~~----~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
.. .+..+.+||.+||..||++|+ +++++++
T Consensus 254 ~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~----s~~e~l~ 302 (396)
T 4eut_A 254 AENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW----GFDQFFA 302 (396)
T ss_dssp STTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSC----CHHHHHH
T ss_pred ccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhc----cHHHHHH
Confidence 01 225788999999999999999 5777754
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=354.42 Aligned_cols=264 Identities=20% Similarity=0.262 Sum_probs=208.1
Q ss_pred CCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceee
Q 042539 10 QTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLL 89 (412)
Q Consensus 10 ~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~ 89 (412)
.....+..++|++++.||+|+||+||+|++..... ....||+|+++...... ....+.+.+|+++++.++||||++++
T Consensus 10 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~ 87 (291)
T 1u46_A 10 SLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSG-KTVSVAVKCLKPDVLSQ-PEAMDDFIREVNAMHSLDHRNLIRLY 87 (291)
T ss_dssp -CCEECCGGGEEEEEECC----CCCEEEEEECTTS-CEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccchhHeeeeeeecCCCceeEEEEEeccCCC-ceeEEEEEEEccCccCC-HHHHHHHHHHHHHHHhCCCCCcccEE
Confidence 34557778999999999999999999998754322 22358999997654322 34566788899999999999999999
Q ss_pred eeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccc
Q 042539 90 GSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169 (412)
Q Consensus 90 ~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DF 169 (412)
+++.++. .++||||+.+++|..++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 88 ~~~~~~~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Df 165 (291)
T 1u46_A 88 GVVLTPP-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDF 165 (291)
T ss_dssp EEECSSS-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred EEEccCC-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccc
Confidence 9998765 899999999999988876643 35899999999999999999999999999999999999999999999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|+++....... .........
T Consensus 166 g~~~~~~~~~~------------------------------------------------------------~~~~~~~~~ 185 (291)
T 1u46_A 166 GLMRALPQNDD------------------------------------------------------------HYVMQEHRK 185 (291)
T ss_dssp TTCEECCC-CC------------------------------------------------------------EEEC-----
T ss_pred ccccccccccc------------------------------------------------------------chhhhccCC
Confidence 99976521100 001122346
Q ss_pred cCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCC---CCCCCChHHHHHHHHhhhhC
Q 042539 250 GTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTP---EFVGQRTALTDLIQRLLEKD 325 (412)
Q Consensus 250 gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~dli~~~L~~d 325 (412)
||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..+....+..... .....+.++.++|.+||..|
T Consensus 186 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 265 (291)
T 1u46_A 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHK 265 (291)
T ss_dssp CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCC
Confidence 7889999999999889999999999999999999 9999999998888887765432 23456789999999999999
Q ss_pred CCccCCCCCChhhhhc
Q 042539 326 PVKRLGYLRGACEIKE 341 (412)
Q Consensus 326 P~~R~~~~~~~~e~l~ 341 (412)
|.+|| ++.++++
T Consensus 266 p~~Rp----s~~~l~~ 277 (291)
T 1u46_A 266 PEDRP----TFVALRD 277 (291)
T ss_dssp GGGSC----CHHHHHH
T ss_pred cccCc----CHHHHHH
Confidence 99999 6888886
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=351.40 Aligned_cols=249 Identities=22% Similarity=0.328 Sum_probs=204.5
Q ss_pred CCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeee
Q 042539 11 TTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLG 90 (412)
Q Consensus 11 ~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 90 (412)
....+..++|++++.||+|+||+||++++. +..||+|+++... ..+.+.+|+++++.++||||+++++
T Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~ 81 (278)
T 1byg_A 14 SGWALNMKELKLLQTIGKGEFGDVMLGDYR------GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLG 81 (278)
T ss_dssp -CCBCCGGGEEEEEEEEECSSCEEEEEEET------TEEEEEEECCCCC--------HHHHHTHHHHTTCCCTTBCCEEE
T ss_pred ccccCChhhceEEeEEecCCCceEEEEEEc------CCEEEEEEecchh------HHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 345788999999999999999999999874 2359999996542 2345777999999999999999999
Q ss_pred eEEeC-CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccc
Q 042539 91 SLETD-EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169 (412)
Q Consensus 91 ~~~~~-~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DF 169 (412)
++.+. +.+|+||||+.|++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Df 161 (278)
T 1byg_A 82 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDF 161 (278)
T ss_dssp EECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred EEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeec
Confidence 87544 57999999999999998887654334889999999999999999999999999999999999999999999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|+++..... .....
T Consensus 162 g~~~~~~~~------------------------------------------------------------------~~~~~ 175 (278)
T 1byg_A 162 GLTKEASST------------------------------------------------------------------QDTGK 175 (278)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred ccccccccc------------------------------------------------------------------ccCCC
Confidence 998643210 11235
Q ss_pred cCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCC
Q 042539 250 GTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDP 326 (412)
Q Consensus 250 gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP 326 (412)
+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.... ......++.+.++|.+||..||
T Consensus 176 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 255 (278)
T 1byg_A 176 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDA 255 (278)
T ss_dssp CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred ccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhcCCh
Confidence 7889999999999999999999999999999998 999999988777776665442 2234568899999999999999
Q ss_pred CccCCCCCChhhhhc
Q 042539 327 VKRLGYLRGACEIKE 341 (412)
Q Consensus 327 ~~R~~~~~~~~e~l~ 341 (412)
.+|| ++.++++
T Consensus 256 ~~Rp----s~~~l~~ 266 (278)
T 1byg_A 256 AMRP----SFLQLRE 266 (278)
T ss_dssp GGSC----CHHHHHH
T ss_pred hhCC----CHHHHHH
Confidence 9999 5777764
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=348.45 Aligned_cols=256 Identities=20% Similarity=0.252 Sum_probs=208.4
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
-.|++.+.||+|+||+||+|++...+. .+..||+|++.+.. .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQ-NRIQCAIKSLSRIT---EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG 96 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSS-CEEEEEEEEETTCC---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred eEEccCceeccCCCceEEEEEEecCCC-ceeeeeeeeccccc---cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCC
Confidence 356677999999999999998765433 33459999986533 23345677789999999999999999999987765
Q ss_pred E-EEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 98 L-AWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 98 ~-~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
. ++||||+.||+|..++... ...+++.++..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.+.
T Consensus 97 ~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 97 LPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp CCEEEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred CcEEEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 5 9999999999998887653 3468999999999999999999999999999999999999999999999999997653
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
.... ..........||+.|+|
T Consensus 176 ~~~~-----------------------------------------------------------~~~~~~~~~~~~~~y~a 196 (298)
T 3pls_A 176 DREY-----------------------------------------------------------YSVQQHRHARLPVKWTA 196 (298)
T ss_dssp TGGG-----------------------------------------------------------GCSCCSSCTTCGGGGSC
T ss_pred CCcc-----------------------------------------------------------cccccCcCCCCCccccC
Confidence 2211 01122234568899999
Q ss_pred ceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCccCCCC
Q 042539 257 PEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVKRLGYL 333 (412)
Q Consensus 257 PE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~R~~~~ 333 (412)
||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+.... +.....++.+.+||.+||..||.+||
T Consensus 197 PE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp--- 273 (298)
T 3pls_A 197 LESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRP--- 273 (298)
T ss_dssp HHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC---
T ss_pred hhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCc---
Confidence 999999999999999999999999999 666677777666666555433 23345678999999999999999999
Q ss_pred CChhhhhc
Q 042539 334 RGACEIKE 341 (412)
Q Consensus 334 ~~~~e~l~ 341 (412)
++.++++
T Consensus 274 -s~~~ll~ 280 (298)
T 3pls_A 274 -TFRVLVG 280 (298)
T ss_dssp -CHHHHHH
T ss_pred -CHHHHHH
Confidence 5788775
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=361.27 Aligned_cols=257 Identities=16% Similarity=0.211 Sum_probs=202.8
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCC----CCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccce---
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPT----ARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPK--- 87 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~----~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~--- 87 (412)
..-++|++++.||+|+||+||+|++..+... .++.||||++.+. ..+.+|++++++++||||++
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~~~~~E~~~l~~l~h~niv~~~~ 109 (352)
T 2jii_A 39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------GRLFNEQNFFQRAAKPLQVNKWK 109 (352)
T ss_dssp TTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------STHHHHHHHHHHHCCHHHHHHHH
T ss_pred ccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------chHHHHHHHHHHhcccchhhhhh
Confidence 3458999999999999999999998864210 2445999999654 23556999999999999988
Q ss_pred ------------eeeeEEe-CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCC
Q 042539 88 ------------LLGSLET-DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPE 154 (412)
Q Consensus 88 ------------l~~~~~~-~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~ 154 (412)
+++++.. +..+|+||||| |++|..++.......+++.++..++.||+.||.|||++||+||||||+
T Consensus 110 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~ 188 (352)
T 2jii_A 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAE 188 (352)
T ss_dssp HHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGG
T ss_pred hhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHH
Confidence 5667765 67899999999 999999988654456999999999999999999999999999999999
Q ss_pred ceEEccCC--CEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCc
Q 042539 155 NILIRQSG--HVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPV 232 (412)
Q Consensus 155 NiLl~~~g--~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (412)
|||++.++ .+||+|||+++.+.......
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~-------------------------------------------------- 218 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHV-------------------------------------------------- 218 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCC--------------------------------------------------
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccc--------------------------------------------------
Confidence 99999998 89999999998653221100
Q ss_pred cccccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCC--HHHHHHHH---hcCCCCC
Q 042539 233 SRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKN--RKETFRNV---LMKTPEF 307 (412)
Q Consensus 233 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~--~~~~~~~i---~~~~~~~ 307 (412)
...........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.. ........ ......+
T Consensus 219 ------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 292 (352)
T 2jii_A 219 ------AYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPF 292 (352)
T ss_dssp ------CCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCE
T ss_pred ------cccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhh
Confidence 001122335589999999999999999999999999999999999999998753 33332222 2222222
Q ss_pred -------CCCChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 308 -------VGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 308 -------~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
...+.++.+||.+||..||.+|| +++++++
T Consensus 293 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp----s~~~l~~ 329 (352)
T 2jii_A 293 VGPCGHWIRPSETLQKYLKVVMALTYEEKP----PYAMLRN 329 (352)
T ss_dssp ECTTSCEECCCHHHHHHHHHHHTCCTTCCC----CHHHHHH
T ss_pred hhhccccCCCcHHHHHHHHHHHhCChhhCC----CHHHHHH
Confidence 24579999999999999999999 5777765
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=372.48 Aligned_cols=268 Identities=18% Similarity=0.271 Sum_probs=213.0
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCC-CccceeeeeEEe
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH-PFLPKLLGSLET 94 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~ 94 (412)
..++|+++++||+|+||.||+|++..++. .||||++...... ..+.+|+++++.+.| ++|+.+..++..
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~----~vAvK~~~~~~~~------~~~~~E~~il~~L~~~~~i~~i~~~~~~ 74 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTKH------PQLLYESKIYRILQGGTGIPNVRWFGVE 74 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCC----EEEEEEEETTCSS------CCHHHHHHHHHHTTTSTTCCCEEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCc----EEEEEEecccccc------HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 45799999999999999999999877544 4999998654432 235569999999986 667777777788
Q ss_pred CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEE---ccCCCEEEccccc
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILI---RQSGHVTLTDFDL 171 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl---~~~g~vkL~DFGl 171 (412)
.+..||||||| |++|.+++.... ..+++.+++.++.||+.||+|||++|||||||||+|||| +.++.+||+|||+
T Consensus 75 ~~~~~lvme~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 152 (483)
T 3sv0_A 75 GDYNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (483)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred CCEEEEEEECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCc
Confidence 88999999999 999998876433 459999999999999999999999999999999999999 6889999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
++.+....... ..........+||
T Consensus 153 a~~~~~~~~~~--------------------------------------------------------~~~~~~~~~~~gt 176 (483)
T 3sv0_A 153 AKKYRDTSTHQ--------------------------------------------------------HIPYRENKNLTGT 176 (483)
T ss_dssp CEECBCTTTCC--------------------------------------------------------BCCCCCCCCCCSC
T ss_pred ceeccCCcccc--------------------------------------------------------ccccccccccCCC
Confidence 98653211000 0001223367899
Q ss_pred CCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCC---HHHHHHHHhcCC------CCCCCCChHHHHHHHHhh
Q 042539 252 EEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKN---RKETFRNVLMKT------PEFVGQRTALTDLIQRLL 322 (412)
Q Consensus 252 ~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~---~~~~~~~i~~~~------~~~~~~~~~~~dli~~~L 322 (412)
+.|+|||++.+..++.++|||||||++|||++|+.||.+.. ..+.+..+.... .....+++++.+||.+||
T Consensus 177 ~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl 256 (483)
T 3sv0_A 177 ARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCR 256 (483)
T ss_dssp TTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHH
T ss_pred ccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHh
Confidence 99999999999999999999999999999999999998743 333333332211 011466889999999999
Q ss_pred hhCCCccCCCCCChhhh----------hcCCCCCCCCchhhcc
Q 042539 323 EKDPVKRLGYLRGACEI----------KEHVFFKGVRWDLLTD 355 (412)
Q Consensus 323 ~~dP~~R~~~~~~~~e~----------l~h~ff~~~~~~~~~~ 355 (412)
..||.+||+ ++++ ..++|+..++|+.+..
T Consensus 257 ~~dP~~RPs----~~el~~~L~~l~~~~~~~~~~~~dW~~~~~ 295 (483)
T 3sv0_A 257 SLRFDDKPD----YSYLKRLFRDLFIREGFQFDYVFDWTILKY 295 (483)
T ss_dssp TCCTTCCCC----HHHHHHHHHHHHHHTTCCCSSCCHHHHHTC
T ss_pred cCChhhCcC----HHHHHHHHHHHHHHcCCCccCCcCchhhcc
Confidence 999999995 4433 3579999999987754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=361.44 Aligned_cols=255 Identities=20% Similarity=0.216 Sum_probs=203.6
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
.-..++|++.+.||+|+||+||+|+++ +++.||||++..... .....+.+|+.+++.++||||+++++++.
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 105 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLR-----DGAKVALKRRTPESS----QGIEEFETEIETLSFCRHPHLVSLIGFCD 105 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECT-----TCCEEEEEECCSCCS----SHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred HHHHhccCccceeecCCCeeEEEEEEC-----CCCEEEEEEecccCh----HHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 345589999999999999999999864 234599999865432 23456778999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQND--RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
+++.+|+|||||.||+|..++..... ..+++.++..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999888754432 2489999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
++..... ..........||
T Consensus 186 ~~~~~~~-------------------------------------------------------------~~~~~~~~~~gt 204 (321)
T 2qkw_B 186 SKKGTEL-------------------------------------------------------------DQTHLSTVVKGT 204 (321)
T ss_dssp CEECSSS-------------------------------------------------------------SCCCCBCCCEEE
T ss_pred ccccccc-------------------------------------------------------------cccccccccCCC
Confidence 8753210 011122345799
Q ss_pred CCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHH-------HHHHhcCC------CCC-----CCCChH
Q 042539 252 EEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKET-------FRNVLMKT------PEF-----VGQRTA 313 (412)
Q Consensus 252 ~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-------~~~i~~~~------~~~-----~~~~~~ 313 (412)
+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+. ........ +.. +..+..
T Consensus 205 ~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (321)
T 2qkw_B 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRK 284 (321)
T ss_dssp TTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHH
T ss_pred ccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHH
Confidence 999999999988899999999999999999999999976432211 01111110 111 112357
Q ss_pred HHHHHHHhhhhCCCccCCCCCChhhhhcC
Q 042539 314 LTDLIQRLLEKDPVKRLGYLRGACEIKEH 342 (412)
Q Consensus 314 ~~dli~~~L~~dP~~R~~~~~~~~e~l~h 342 (412)
+.++|.+||..||++|| ++.+++++
T Consensus 285 l~~li~~~l~~dP~~Rp----s~~ell~~ 309 (321)
T 2qkw_B 285 FGDTAVKCLALSSEDRP----SMGDVLWK 309 (321)
T ss_dssp HHHHHHHHTCSSGGGSC----CHHHHHHH
T ss_pred HHHHHHHHcCCCcccCc----CHHHHHHH
Confidence 88999999999999999 68888864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=372.59 Aligned_cols=259 Identities=22% Similarity=0.345 Sum_probs=196.3
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeeeeEE
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLGSLE 93 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 93 (412)
+.-.+|.+.+.||+|+||+||... .. +++.||||++.+.... .+.+|+++|+.+ +|||||++++++.
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~-~~----~~~~vAvK~~~~~~~~-------~~~~E~~~l~~l~~HpnIv~l~~~~~ 88 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRG-MF----DNRDVAVKRILPECFS-------FADREVQLLRESDEHPNVIRYFCTEK 88 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEE-ES----SSSEEEEEEECTTTEE-------ECHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEE-Ee----CCeEEEEEEECHHHHH-------HHHHHHHHHHhccCCCCcCeEEEEEe
Confidence 344569999999999999976432 23 3455999999665432 134599999999 7999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccC-----CCEEEcc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQS-----GHVTLTD 168 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~-----g~vkL~D 168 (412)
+...+|+|||||. |+|..++.... ..+.+..+..++.||+.||.|||++||+||||||+|||++.+ ..+||+|
T Consensus 89 ~~~~~~lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~D 166 (432)
T 3p23_A 89 DRQFQYIAIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISD 166 (432)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECC
T ss_pred cCCEEEEEEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEec
Confidence 9999999999996 58887776543 346666778999999999999999999999999999999532 3578999
Q ss_pred ccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccc
Q 042539 169 FDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248 (412)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (412)
||+|+....... ........
T Consensus 167 FG~a~~~~~~~~------------------------------------------------------------~~~~~~~~ 186 (432)
T 3p23_A 167 FGLCKKLAVGRH------------------------------------------------------------SFSRRSGV 186 (432)
T ss_dssp TTEEECC------------------------------------------------------------------------C
T ss_pred ccceeeccCCCc------------------------------------------------------------ceeecccc
Confidence 999976532100 01122356
Q ss_pred ccCCCCccceeecC---CCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCCCCC----CCChHHHHHHHH
Q 042539 249 VGTEEYVSPEVVRG---DGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTPEFV----GQRTALTDLIQR 320 (412)
Q Consensus 249 ~gt~~Y~APE~l~~---~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~dli~~ 320 (412)
+||+.|+|||++.+ ..++.++|||||||++|||++ |..||...........+........ ..+..+.+||.+
T Consensus 187 ~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 266 (432)
T 3p23_A 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEK 266 (432)
T ss_dssp CSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHH
T ss_pred CCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccccHHHHHHHHH
Confidence 79999999999984 556889999999999999999 9999976554443222211111111 123568899999
Q ss_pred hhhhCCCccCCCCCChhhhhcCCCCCCCCch
Q 042539 321 LLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 321 ~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~ 351 (412)
||+.||.+|| +++++++||||.++.|.
T Consensus 267 ~L~~dP~~Rp----s~~evl~hp~f~~~~~~ 293 (432)
T 3p23_A 267 MIAMDPQKRP----SAKHVLKHPFFWSLEKQ 293 (432)
T ss_dssp HSCSSGGGSC----CHHHHHTSTTTCCHHHH
T ss_pred HHhCCHhhCC----CHHHHHhCccccChHHH
Confidence 9999999999 69999999999988873
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=350.76 Aligned_cols=250 Identities=25% Similarity=0.317 Sum_probs=193.8
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhh--cCCCccceeee
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSR--LSHPFLPKLLG 90 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~ 90 (412)
..+..++|++++.||+|+||+||+|++. ++.||||++..... ....+|.+++.. ++||||+++++
T Consensus 3 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~vavK~~~~~~~-------~~~~~e~~~~~~~~l~h~niv~~~~ 69 (301)
T 3q4u_A 3 QRTVARDITLLECVGKGRYGEVWRGSWQ------GENVAVKIFSSRDE-------KSWFRETELYNTVMLRHENILGFIA 69 (301)
T ss_dssp -CCCGGGCEEEEEEEECSSEEEEEEEET------TEEEEEEEECGGGH-------HHHHHHHHHHHHTCCCCTTBCCEEE
T ss_pred cccccCcEEEEEeeccCCCcEEEEEEEC------CEEEEEEEeccccc-------hhhHHHHHHHHHhhccCcCeeeEEE
Confidence 3566789999999999999999999873 34499999965421 223346666666 78999999999
Q ss_pred eEEe----CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH--------HcCceeeeCCCCceEE
Q 042539 91 SLET----DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLH--------NMGIAYRDLKPENILI 158 (412)
Q Consensus 91 ~~~~----~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH--------~~~iiHrDlKp~NiLl 158 (412)
++.+ ...+|+|||||.||+|..++.. ..+++..+..++.||+.||+||| ++||+||||||+|||+
T Consensus 70 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill 146 (301)
T 3q4u_A 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV 146 (301)
T ss_dssp EEEEEETTEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE
T ss_pred eeccccCCCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE
Confidence 8654 3468999999999999888743 35999999999999999999999 9999999999999999
Q ss_pred ccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccc
Q 042539 159 RQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQS 238 (412)
Q Consensus 159 ~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (412)
+.++.+||+|||+|+.......
T Consensus 147 ~~~~~~kl~Dfg~a~~~~~~~~---------------------------------------------------------- 168 (301)
T 3q4u_A 147 KKNGQCCIADLGLAVMHSQSTN---------------------------------------------------------- 168 (301)
T ss_dssp CTTSCEEECCCTTCEEEETTTT----------------------------------------------------------
T ss_pred cCCCCEEEeeCCCeeecccccc----------------------------------------------------------
Confidence 9999999999999976532110
Q ss_pred cCCCCCCcccccCCCCccceeecCC------CCCchhhHHHHHHHHHHHhhC----------CCCCCCC----CHHHHHH
Q 042539 239 FDNGERSNSFVGTEEYVSPEVVRGD------GHEFAVDWWALGILTYEMLYG----------TTPFRGK----NRKETFR 298 (412)
Q Consensus 239 ~~~~~~~~~~~gt~~Y~APE~l~~~------~~~~~~DiwSlGvil~ell~g----------~~Pf~~~----~~~~~~~ 298 (412)
.........+||+.|+|||++.+. .++.++|||||||++|||++| ..||... .......
T Consensus 169 -~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~ 247 (301)
T 3q4u_A 169 -QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247 (301)
T ss_dssp -EEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHH
T ss_pred -cccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhh
Confidence 000112345799999999999876 445799999999999999999 8898653 2223333
Q ss_pred HHhcCCCCCCC---------CChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 299 NVLMKTPEFVG---------QRTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 299 ~i~~~~~~~~~---------~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
.........+. .++++.+||.+||+.||.+|| ++.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp----s~~~i~~ 295 (301)
T 3q4u_A 248 KVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARL----TALRIKK 295 (301)
T ss_dssp HHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSC----CHHHHHH
T ss_pred HHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCC----CHHHHHH
Confidence 33322211111 236799999999999999999 6888875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=378.39 Aligned_cols=254 Identities=20% Similarity=0.264 Sum_probs=214.6
Q ss_pred CCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeee
Q 042539 11 TTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLG 90 (412)
Q Consensus 11 ~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 90 (412)
..+++..++|++.+.||+|+||+||++.++.. ..||||+++..... ...+.+|+++|++++|+||+++++
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-----~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~ 329 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-----TRVAIKTLKPGTMS-----PEAFLQEAQVMKKLRHEKLVQLYA 329 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTT-----EEEEEEEECTTSSC-----HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCC-----ceEEEEEeCCCCCC-----HHHHHHHHHHHHhCCCCCEeeEEE
Confidence 35678889999999999999999999998642 34999999765431 235677999999999999999999
Q ss_pred eEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccc
Q 042539 91 SLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 91 ~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
++.+ +.+|||||||.||+|.+++.......+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 330 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG 408 (535)
T 2h8h_A 330 VVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG 408 (535)
T ss_dssp EECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTT
T ss_pred EEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccc
Confidence 9876 679999999999999988875444458999999999999999999999999999999999999999999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+++.+...... ......+
T Consensus 409 ~a~~~~~~~~~--------------------------------------------------------------~~~~~~~ 426 (535)
T 2h8h_A 409 LARLIEDNEYT--------------------------------------------------------------ARQGAKF 426 (535)
T ss_dssp STTTCCCHHHH--------------------------------------------------------------TTCSTTS
T ss_pred cceecCCCcee--------------------------------------------------------------cccCCcC
Confidence 99765321100 0112346
Q ss_pred CCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCC
Q 042539 251 TEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPV 327 (412)
Q Consensus 251 t~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~ 327 (412)
|..|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+.... +....++..+.+||.+||..||+
T Consensus 427 ~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 506 (535)
T 2h8h_A 427 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPE 506 (535)
T ss_dssp CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred cccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChh
Confidence 788999999999899999999999999999999 999999999888887776543 23346788999999999999999
Q ss_pred ccCCCCCChhhhhc
Q 042539 328 KRLGYLRGACEIKE 341 (412)
Q Consensus 328 ~R~~~~~~~~e~l~ 341 (412)
+|| +++++++
T Consensus 507 ~RP----t~~~l~~ 516 (535)
T 2h8h_A 507 ERP----TFEYLQA 516 (535)
T ss_dssp GSC----CHHHHHH
T ss_pred HCc----CHHHHHH
Confidence 999 5777775
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=346.54 Aligned_cols=253 Identities=19% Similarity=0.246 Sum_probs=195.9
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee-EEeC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS-LETD 95 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~-~~~~ 95 (412)
-++|++++.||+|+||+||+|++..++ +.||||++...... ..+.+|+.+++.++|++++..+.. +..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~ 77 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAG----EEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCGAEG 77 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTT----EEEEEEEEEC---C------CCHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCC----ceEEEEeecccccc------hHHHHHHHHHHHhcCCCCCCeeeeecCCC
Confidence 478999999999999999999987754 45999987554322 235569999999998776655554 4677
Q ss_pred CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEE---ccCCCEEEcccccc
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILI---RQSGHVTLTDFDLS 172 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl---~~~g~vkL~DFGla 172 (412)
+..++||||+ |++|..++.... ..+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a 155 (296)
T 4hgt_A 78 DYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred CceEEEEEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence 8899999999 999988876433 459999999999999999999999999999999999999 78899999999999
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+......... ...........||+
T Consensus 156 ~~~~~~~~~~--------------------------------------------------------~~~~~~~~~~~gt~ 179 (296)
T 4hgt_A 156 KKYRDARTHQ--------------------------------------------------------HIPYRENKNLTGTA 179 (296)
T ss_dssp EECBCTTTCC--------------------------------------------------------BCCCCCSCCCCSCG
T ss_pred eeccCcccCc--------------------------------------------------------cCCCCcccccCCCc
Confidence 8653211000 00112234568999
Q ss_pred CCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHH---HHHHHHhcC---CC---CCCCCChHHHHHHHHhhh
Q 042539 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRK---ETFRNVLMK---TP---EFVGQRTALTDLIQRLLE 323 (412)
Q Consensus 253 ~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~~~i~~~---~~---~~~~~~~~~~dli~~~L~ 323 (412)
.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.. ..+..+... .+ .....++++.+||.+||+
T Consensus 180 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 259 (296)
T 4hgt_A 180 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRS 259 (296)
T ss_dssp GGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHT
T ss_pred cccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHh
Confidence 999999999999999999999999999999999999874321 122222111 11 124568899999999999
Q ss_pred hCCCccCCCCCChhhhhc
Q 042539 324 KDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 324 ~dP~~R~~~~~~~~e~l~ 341 (412)
.||++|| +++++++
T Consensus 260 ~~p~~Rp----t~~~l~~ 273 (296)
T 4hgt_A 260 LRFDDKP----DYSYLRQ 273 (296)
T ss_dssp SCTTCCC----CHHHHHH
T ss_pred cCCCCCC----CHHHHHH
Confidence 9999999 5777765
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=353.16 Aligned_cols=263 Identities=22% Similarity=0.275 Sum_probs=203.1
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
.+..++|++++.||+|+||.||+|++..++ +.||||++.... ......+.+|+.+++.++||||+++++++.
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 96 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDG----HFYALKRILCHE----QQDREEAQREADMHRLFNHPNILRLVAYCL 96 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTC----CEEEEEEEEESS----HHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCC----cEEEEEEEecCC----HHHHHHHHHHHHHHhhcCCCCeeeEEEEEE
Confidence 456688999999999999999999987754 459999986542 234566778999999999999999999987
Q ss_pred e----CCeEEEEeeccCCCCchhHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEc
Q 042539 94 T----DEFLAWAVPYCPGGDLNVLRYKQ--NDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLT 167 (412)
Q Consensus 94 ~----~~~~~lv~e~~~gg~L~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~ 167 (412)
. ...+|+|||||.||+|..++... ....+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+
T Consensus 97 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~ 176 (317)
T 2buj_A 97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLM 176 (317)
T ss_dssp EEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEEC
T ss_pred eccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEE
Confidence 3 34789999999999998887653 23569999999999999999999999999999999999999999999999
Q ss_pred cccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcc
Q 042539 168 DFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNS 247 (412)
Q Consensus 168 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (412)
|||+++............ ........
T Consensus 177 dfg~~~~~~~~~~~~~~~------------------------------------------------------~~~~~~~~ 202 (317)
T 2buj_A 177 DLGSMNQACIHVEGSRQA------------------------------------------------------LTLQDWAA 202 (317)
T ss_dssp CCSSCEESCEEEESHHHH------------------------------------------------------HHHHHHHH
T ss_pred ecCcchhccccccccccc------------------------------------------------------cccccccc
Confidence 999987642211000000 00000123
Q ss_pred cccCCCCccceeecCCC---CCchhhHHHHHHHHHHHhhCCCCCCCCCHH--HHHHHHhc--CCCCCCCCChHHHHHHHH
Q 042539 248 FVGTEEYVSPEVVRGDG---HEFAVDWWALGILTYEMLYGTTPFRGKNRK--ETFRNVLM--KTPEFVGQRTALTDLIQR 320 (412)
Q Consensus 248 ~~gt~~Y~APE~l~~~~---~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--~~~~~i~~--~~~~~~~~~~~~~dli~~ 320 (412)
..||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...... .....+.. ..+.....+.++.+||.+
T Consensus 203 ~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 282 (317)
T 2buj_A 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNS 282 (317)
T ss_dssp HHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHH
T ss_pred ccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCCCCccccCCHHHHHHHHH
Confidence 46899999999998664 588999999999999999999999542110 11111111 223345678999999999
Q ss_pred hhhhCCCccCCCCCChhhhhcC
Q 042539 321 LLEKDPVKRLGYLRGACEIKEH 342 (412)
Q Consensus 321 ~L~~dP~~R~~~~~~~~e~l~h 342 (412)
||..||.+|| ++.+++++
T Consensus 283 ~l~~dp~~Rp----s~~~ll~~ 300 (317)
T 2buj_A 283 MMTVDPHQRP----HIPLLLSQ 300 (317)
T ss_dssp HTCSSGGGSC----CHHHHHHH
T ss_pred HhhcChhhCC----CHHHHHHH
Confidence 9999999999 68888874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=367.98 Aligned_cols=253 Identities=28% Similarity=0.377 Sum_probs=189.4
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceeeeeEEeCC
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLLGSLETDE 96 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 96 (412)
+.|.+.+.||+|+||+||.+.. . +++.||||++.... ...+.+|+.+++++ +|||||++++++.+++
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~-~----~g~~vAvK~~~~~~-------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 82 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGS-F----QGRPVAVKRMLIDF-------CDIALMEIKLLTESDDHPNVIRYYCSETTDR 82 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEE-S----SSSEEEEEEEEGGG-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred heeeccCeEeeCCCeEEEEEEE-E----CCeEEEEEEEcHHH-------HHHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence 4456678899999999987543 2 34569999986542 22456799999987 7999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCC-----CCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccC----------
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRV-----FSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQS---------- 161 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~-----l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~---------- 161 (412)
.+|+|||||. |+|.+++....... .++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 83 ~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~ 161 (434)
T 2rio_A 83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTG 161 (434)
T ss_dssp EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccC
Confidence 9999999995 59988876543211 1333467799999999999999999999999999999764
Q ss_pred ---CCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccc
Q 042539 162 ---GHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQS 238 (412)
Q Consensus 162 ---g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (412)
+.+||+|||+|+.......
T Consensus 162 ~~~~~~kL~DFG~a~~~~~~~~---------------------------------------------------------- 183 (434)
T 2rio_A 162 AENLRILISDFGLCKKLDSGQS---------------------------------------------------------- 183 (434)
T ss_dssp CCSCEEEECCCTTCEECCC-------------------------------------------------------------
T ss_pred CCceEEEEcccccceecCCCCc----------------------------------------------------------
Confidence 4899999999986532110
Q ss_pred cCCCCCCcccccCCCCccceeecC-------CCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCCCCCC-
Q 042539 239 FDNGERSNSFVGTEEYVSPEVVRG-------DGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTPEFVG- 309 (412)
Q Consensus 239 ~~~~~~~~~~~gt~~Y~APE~l~~-------~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~- 309 (412)
.........+||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+....+ .+++........
T Consensus 184 -~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~ 260 (434)
T 2rio_A 184 -SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEM 260 (434)
T ss_dssp ------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCC
T ss_pred -cceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccc
Confidence 00011234579999999999976 567999999999999999998 999998754433 233333222211
Q ss_pred -------CChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCC
Q 042539 310 -------QRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 310 -------~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~ 348 (412)
.++++.+||.+||+.||.+|| ++.++++||||...
T Consensus 261 ~~~~~~~~~~~~~~li~~~L~~dP~~Rp----s~~eil~hp~f~~~ 302 (434)
T 2rio_A 261 KCLHDRSLIAEATDLISQMIDHDPLKRP----TAMKVLRHPLFWPK 302 (434)
T ss_dssp TTCCCHHHHHHHHHHHHHHTCSSGGGSC----CHHHHHTSGGGSCH
T ss_pred cccccccchHHHHHHHHHHhhCChhhCC----CHHHHHhCCccCCc
Confidence 236899999999999999999 69999999999754
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=349.81 Aligned_cols=245 Identities=24% Similarity=0.379 Sum_probs=197.6
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
..+..++|++.+.||+|+||+||++++.. ..||+|++.... ..+.+.+|++++++++||||+++++++
T Consensus 3 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~------~~vavK~~~~~~------~~~~~~~E~~~l~~l~hp~iv~~~~~~ 70 (307)
T 2eva_A 3 HMIDYKEIEVEEVVGRGAFGVVCKAKWRA------KDVAIKQIESES------ERKAFIVELRQLSRVNHPNIVKLYGAC 70 (307)
T ss_dssp CBCCGGGEEEEEEEECCSSSEEEEEEETT------EEEEEEECSSTT------HHHHHHHHHHHHHHCCCTTBCCEEEBC
T ss_pred CcCCHhHeeeeeEeecCCCceEEEEEECC------eeEEEEEecChh------HHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence 45788999999999999999999998752 349999986432 245677799999999999999999988
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHH---cCceeeeCCCCceEEccCCC-EEEc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQND-RVFSPSVIRFYLSEIICAIEHLHN---MGIAYRDLKPENILIRQSGH-VTLT 167 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~-~~l~~~~~~~~~~qi~~aL~yLH~---~~iiHrDlKp~NiLl~~~g~-vkL~ 167 (412)
.+ ..|+||||+.||+|..++..... ..+++..+..++.|++.||.|||+ +||+||||||+|||++.+|. +||+
T Consensus 71 ~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~ 148 (307)
T 2eva_A 71 LN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKIC 148 (307)
T ss_dssp TT--TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEEC
T ss_pred cC--CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEc
Confidence 74 48999999999999988765432 237889999999999999999999 89999999999999999887 7999
Q ss_pred cccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcc
Q 042539 168 DFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNS 247 (412)
Q Consensus 168 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (412)
|||+++.... ....
T Consensus 149 Dfg~~~~~~~------------------------------------------------------------------~~~~ 162 (307)
T 2eva_A 149 DFGTACDIQT------------------------------------------------------------------HMTN 162 (307)
T ss_dssp CCCC----------------------------------------------------------------------------
T ss_pred cccccccccc------------------------------------------------------------------cccc
Confidence 9999864421 0112
Q ss_pred cccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCC--HHHHHHHHhcCC--CCCCCCChHHHHHHHHhhh
Q 042539 248 FVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKN--RKETFRNVLMKT--PEFVGQRTALTDLIQRLLE 323 (412)
Q Consensus 248 ~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~--~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~ 323 (412)
..||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .......+.... +.....++.+.+||.+||+
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 242 (307)
T 2eva_A 163 NKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWS 242 (307)
T ss_dssp --CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHTC
T ss_pred CCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHHHHHhc
Confidence 358999999999999999999999999999999999999998643 333333333322 2334678999999999999
Q ss_pred hCCCccCCCCCChhhhhc
Q 042539 324 KDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 324 ~dP~~R~~~~~~~~e~l~ 341 (412)
.||.+|| +++++++
T Consensus 243 ~dp~~Rp----s~~ell~ 256 (307)
T 2eva_A 243 KDPSQRP----SMEEIVK 256 (307)
T ss_dssp SSGGGSC----CHHHHHH
T ss_pred CChhhCc----CHHHHHH
Confidence 9999999 6888876
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=381.36 Aligned_cols=255 Identities=20% Similarity=0.261 Sum_probs=205.2
Q ss_pred CccCceee-eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe
Q 042539 16 DLDNLKAL-KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET 94 (412)
Q Consensus 16 ~~~~y~~~-~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 94 (412)
..+.+.+. ++||+|+||+||+|.+.... ++..||||+++.... .......+.+|+++|++++|||||++++++..
T Consensus 366 ~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~--~~~~vAvK~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 441 (635)
T 4fl3_A 366 DRKLLTLEDKELGSGNFGTVKKGYYQMKK--VVKTVAVKILKNEAN--DPALKDELLAEANVMQQLDNPYIVRMIGICEA 441 (635)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSS--CEEEEEEEEECGGGG--CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred cchhccccCCEeccCCCEEEEEEEEcCCC--cceEEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 33444443 48999999999999664322 345699999976543 22335667889999999999999999999964
Q ss_pred CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
+.+++|||||.||+|..++... ..+++.++..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.
T Consensus 442 -~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 518 (635)
T 4fl3_A 442 -ESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 518 (635)
T ss_dssp -SSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHH
T ss_pred -CCEEEEEEccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccc
Confidence 5689999999999999888654 3599999999999999999999999999999999999999999999999999986
Q ss_pred hhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCC
Q 042539 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254 (412)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 254 (412)
+...... ........||+.|
T Consensus 519 ~~~~~~~------------------------------------------------------------~~~~~~~~~t~~y 538 (635)
T 4fl3_A 519 LRADENY------------------------------------------------------------YKAQTHGKWPVKW 538 (635)
T ss_dssp TTC-------------------------------------------------------------------------CGGG
T ss_pred cccCccc------------------------------------------------------------cccccCCCCceee
Confidence 5321110 0111233578899
Q ss_pred ccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCccCC
Q 042539 255 VSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVKRLG 331 (412)
Q Consensus 255 ~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~R~~ 331 (412)
+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+.... .....+++++.+||.+||..||++||
T Consensus 539 ~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RP- 617 (635)
T 4fl3_A 539 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRP- 617 (635)
T ss_dssp SCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSC-
T ss_pred eChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCc-
Confidence 99999999999999999999999999998 999999999888887776543 22345789999999999999999999
Q ss_pred CCCChhhhhc
Q 042539 332 YLRGACEIKE 341 (412)
Q Consensus 332 ~~~~~~e~l~ 341 (412)
+++++++
T Consensus 618 ---s~~~l~~ 624 (635)
T 4fl3_A 618 ---GFAAVEL 624 (635)
T ss_dssp ---CHHHHHH
T ss_pred ---CHHHHHH
Confidence 5777764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=365.19 Aligned_cols=256 Identities=18% Similarity=0.225 Sum_probs=199.2
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE-eCC
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE-TDE 96 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~ 96 (412)
..|++.+.||+|+||+||+|++...+. ....||+|+++... .......+.+|+.++++++||||+++++++. .++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 164 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDG-KKIHCAVKSLNRIT---DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 164 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTT-EEEEEEEEECCSCS---CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSS
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCC-cEEEEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCC
Confidence 457889999999999999998764332 23458999986532 2234567788999999999999999999864 556
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
..|+|||||.||+|..++.... ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 165 SPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp CCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccc
Confidence 8899999999999998876533 458899999999999999999999999999999999999999999999999997653
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
.... ..........||+.|+|
T Consensus 244 ~~~~-----------------------------------------------------------~~~~~~~~~~~~~~y~a 264 (373)
T 3c1x_A 244 DKEF-----------------------------------------------------------DSVHNKTGAKLPVKWMA 264 (373)
T ss_dssp -------------------------------------------------------------------------CCGGGSC
T ss_pred cccc-----------------------------------------------------------ccccccCCCCCcccccC
Confidence 2110 00011123457889999
Q ss_pred ceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCC--CCCCCChHHHHHHHHhhhhCCCccCCCC
Q 042539 257 PEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTP--EFVGQRTALTDLIQRLLEKDPVKRLGYL 333 (412)
Q Consensus 257 PE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~dli~~~L~~dP~~R~~~~ 333 (412)
||++.+..++.++|||||||++|||++ |.+||.+.+..+....+..... ....+++.+.++|.+||..||++||
T Consensus 265 PE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RP--- 341 (373)
T 3c1x_A 265 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRP--- 341 (373)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC---
T ss_pred hHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCc---
Confidence 999999999999999999999999999 8899988766665555554432 2345678999999999999999999
Q ss_pred CChhhhhc
Q 042539 334 RGACEIKE 341 (412)
Q Consensus 334 ~~~~e~l~ 341 (412)
++.++++
T Consensus 342 -s~~ell~ 348 (373)
T 3c1x_A 342 -SFSELVS 348 (373)
T ss_dssp -CHHHHHH
T ss_pred -CHHHHHH
Confidence 5788876
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=353.34 Aligned_cols=264 Identities=23% Similarity=0.337 Sum_probs=185.6
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSL 92 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~ 92 (412)
++.-.+|+++++||+|+||.||+|++..++. .||||++.... ......+.+|+.+++++. ||||+++++++
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~----~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 95 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGR----EYALKRLLSNE----EEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCC----EEEEEEEEESS----HHHHHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCc----EEEEEEecCCc----hHHHHHHHHHHHHHHHhccCCChhhccccc
Confidence 4455699999999999999999999977554 49999985543 234456778999999996 99999999998
Q ss_pred E--------eCCeEEEEeeccCCCCchhHHHh-hCCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeeeCCCCceEEccC
Q 042539 93 E--------TDEFLAWAVPYCPGGDLNVLRYK-QNDRVFSPSVIRFYLSEIICAIEHLHNMG--IAYRDLKPENILIRQS 161 (412)
Q Consensus 93 ~--------~~~~~~lv~e~~~gg~L~~~~~~-~~~~~l~~~~~~~~~~qi~~aL~yLH~~~--iiHrDlKp~NiLl~~~ 161 (412)
. ....+++|||||. |+|.+++.. ...+.+++.++..++.||+.||.|||++| |+||||||+|||++.+
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~ 174 (337)
T 3ll6_A 96 SIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ 174 (337)
T ss_dssp EECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTT
T ss_pred cccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCC
Confidence 4 3346899999996 577666554 34456999999999999999999999999 9999999999999999
Q ss_pred CCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCC
Q 042539 162 GHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDN 241 (412)
Q Consensus 162 g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (412)
|.+||+|||+++........... ......
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~---------------------------------------------------~~~~~~ 203 (337)
T 3ll6_A 175 GTIKLCDFGSATTISHYPDYSWS---------------------------------------------------AQRRAL 203 (337)
T ss_dssp SCEEBCCCTTCBCCSSCC--------------------------------------------------------------
T ss_pred CCEEEecCccceeccccCccccc---------------------------------------------------cccccc
Confidence 99999999999865322110000 000001
Q ss_pred CCCCcccccCCCCccceee---cCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCChHHHHHH
Q 042539 242 GERSNSFVGTEEYVSPEVV---RGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVGQRTALTDLI 318 (412)
Q Consensus 242 ~~~~~~~~gt~~Y~APE~l---~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~dli 318 (412)
.......+||+.|+|||++ .+..++.++|||||||++|+|++|..||.+........... ..+.....+..+.+||
T Consensus 204 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li 282 (337)
T 3ll6_A 204 VEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKY-SIPPHDTQYTVFHSLI 282 (337)
T ss_dssp --------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------C-CCCTTCCSSGGGHHHH
T ss_pred chhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCcc-cCCcccccchHHHHHH
Confidence 1122356799999999998 56678999999999999999999999998765544333222 2233345567899999
Q ss_pred HHhhhhCCCccCCCCCChhhhhcC
Q 042539 319 QRLLEKDPVKRLGYLRGACEIKEH 342 (412)
Q Consensus 319 ~~~L~~dP~~R~~~~~~~~e~l~h 342 (412)
.+||+.||.+|| ++.++++|
T Consensus 283 ~~~l~~~p~~Rp----s~~e~l~~ 302 (337)
T 3ll6_A 283 RAMLQVNPEERL----SIAEVVHQ 302 (337)
T ss_dssp HHHSCSSGGGSC----CHHHHHHH
T ss_pred HHHccCChhhCc----CHHHHHHH
Confidence 999999999999 68999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=355.96 Aligned_cols=257 Identities=19% Similarity=0.230 Sum_probs=201.9
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
.+..++|++.+.||+|+||+||+|++. +++.||||++...... .....+.+|+.+++.++||||+++++++.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRLA-----DGTLVAVKRLKEERTQ---GGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECCS-----SSCCEEEEECCC--------CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred HHHhhccccceeEecCCCcEEEEEEec-----CCCEEEEEEeccccCc---hHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 345679999999999999999999753 2345999999765422 12235677999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHc---CceeeeCCCCceEEccCCCEEEcc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQND--RVFSPSVIRFYLSEIICAIEHLHNM---GIAYRDLKPENILIRQSGHVTLTD 168 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~--~~l~~~~~~~~~~qi~~aL~yLH~~---~iiHrDlKp~NiLl~~~g~vkL~D 168 (412)
+.+..++|||||.||+|..++..... ..+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 99999999999999999988776432 3489999999999999999999999 999999999999999999999999
Q ss_pred ccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccc
Q 042539 169 FDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248 (412)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (412)
||+++..... ........
T Consensus 178 fg~~~~~~~~--------------------------------------------------------------~~~~~~~~ 195 (326)
T 3uim_A 178 FGLAKLMDYK--------------------------------------------------------------DTHVTTAV 195 (326)
T ss_dssp CSSCEECCSS--------------------------------------------------------------SSCEECCC
T ss_pred CccccccCcc--------------------------------------------------------------cccccccc
Confidence 9999754211 11122345
Q ss_pred ccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCC--------HHHHHHHHhcCC--CCC------CC---
Q 042539 249 VGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKN--------RKETFRNVLMKT--PEF------VG--- 309 (412)
Q Consensus 249 ~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~--------~~~~~~~i~~~~--~~~------~~--- 309 (412)
+||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ............ ... ..
T Consensus 196 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (326)
T 3uim_A 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKD 275 (326)
T ss_dssp CSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCH
T ss_pred cCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCH
Confidence 69999999999998889999999999999999999999996211 111111111110 000 01
Q ss_pred -CChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCC
Q 042539 310 -QRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVF 344 (412)
Q Consensus 310 -~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~f 344 (412)
.+..+.+||.+||+.||.+|| ++.++++|-.
T Consensus 276 ~~~~~l~~li~~cl~~dP~~Rp----s~~ell~~L~ 307 (326)
T 3uim_A 276 EEVEQLIQVALLCTQSSPMERP----KMSEVVRMLE 307 (326)
T ss_dssp HHHHHHHHHHHHHTCSCGGGSC----CHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCcCCccCC----CHHHHHHHhc
Confidence 125799999999999999999 6899988643
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=379.66 Aligned_cols=256 Identities=19% Similarity=0.242 Sum_probs=206.9
Q ss_pred CCCccCceeee-eeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 14 SLDLDNLKALK-ILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 14 ~~~~~~y~~~~-~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
.+..+++.+.+ .||+|+||+||+|.++..+ .+..||||++++... ......+.+|+++|++++|||||++++++
T Consensus 331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~--~~~~vAvK~~~~~~~---~~~~~~~~~E~~il~~l~hpniv~l~~~~ 405 (613)
T 2ozo_A 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRK--KQIDVAIKVLKQGTE---KADTEEMMREAQIMHQLDNPYIVRLIGVC 405 (613)
T ss_dssp BCCTTSEEEEEEEEEECSSSEEEEEEEECSS--CEEEEEEEECCCCCS---STTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred eccccceeEcCcEEecCCCcEEEEEEEecCC--CcEEEEEEEcCCCCC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEe
Confidence 34456667777 8999999999999876433 345599999976532 12345677899999999999999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
.+ +.+|+|||||.||+|..++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 406 ~~-~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla 483 (613)
T 2ozo_A 406 QA-EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLS 483 (613)
T ss_dssp ES-SSEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTT
T ss_pred cc-CCeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCc
Confidence 76 5699999999999998887543 346999999999999999999999999999999999999999999999999999
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+.+..... .........+|+
T Consensus 484 ~~~~~~~~------------------------------------------------------------~~~~~~~~~~~~ 503 (613)
T 2ozo_A 484 KALGADDS------------------------------------------------------------YYTARSAGKWPL 503 (613)
T ss_dssp TTCC--------------------------------------------------------------------------CC
T ss_pred ccccCCCc------------------------------------------------------------eeeeccCCCCcc
Confidence 76521110 000112234678
Q ss_pred CCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCcc
Q 042539 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVKR 329 (412)
Q Consensus 253 ~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~R 329 (412)
.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+..+. .....+++++.+||.+||..||++|
T Consensus 504 ~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~R 583 (613)
T 2ozo_A 504 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDR 583 (613)
T ss_dssp TTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTS
T ss_pred ceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHC
Confidence 9999999999999999999999999999998 999999988888877776543 2234578999999999999999999
Q ss_pred CCCCCChhhhh
Q 042539 330 LGYLRGACEIK 340 (412)
Q Consensus 330 ~~~~~~~~e~l 340 (412)
| ++.+++
T Consensus 584 P----s~~~l~ 590 (613)
T 2ozo_A 584 P----DFLTVE 590 (613)
T ss_dssp C----CHHHHH
T ss_pred c----CHHHHH
Confidence 9 566665
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=344.35 Aligned_cols=253 Identities=19% Similarity=0.250 Sum_probs=199.2
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee-EEeC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS-LETD 95 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~-~~~~ 95 (412)
.++|++++.||+|+||+||+|++..++ +.||||++...... ..+.+|+.+++.++|++++..+.. +..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~ 77 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAG----EEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCGAEG 77 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTT----EEEEEEEEESCSSC------CHHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCC----cEEEEEEecCCcch------hHHHHHHHHHHHhhcCCCCCccccccCCC
Confidence 478999999999999999999987644 45999998654321 235669999999998776555554 4677
Q ss_pred CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEE---ccCCCEEEcccccc
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILI---RQSGHVTLTDFDLS 172 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl---~~~g~vkL~DFGla 172 (412)
+..++||||+ |++|.+++.... ..+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 155 (296)
T 3uzp_A 78 DYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred CceEEEEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence 8899999999 999988876433 459999999999999999999999999999999999999 48899999999999
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+......... ..........+||+
T Consensus 156 ~~~~~~~~~~--------------------------------------------------------~~~~~~~~~~~gt~ 179 (296)
T 3uzp_A 156 KKYRDARTHQ--------------------------------------------------------HIPYRENKNLTGTA 179 (296)
T ss_dssp EECBCTTTCC--------------------------------------------------------BCCCCCSCCCCSCT
T ss_pred cccccccccc--------------------------------------------------------cccccccccccccc
Confidence 7653211000 00112234568999
Q ss_pred CCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCH---HHHHHHHhcC---CC---CCCCCChHHHHHHHHhhh
Q 042539 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNR---KETFRNVLMK---TP---EFVGQRTALTDLIQRLLE 323 (412)
Q Consensus 253 ~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---~~~~~~i~~~---~~---~~~~~~~~~~dli~~~L~ 323 (412)
.|+|||++.+..++.++|||||||++|+|++|+.||.+.+. .+.+..+... .+ .....++++.+||.+||+
T Consensus 180 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 259 (296)
T 3uzp_A 180 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRS 259 (296)
T ss_dssp TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHT
T ss_pred ccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHh
Confidence 99999999999999999999999999999999999987431 1222222211 11 124578899999999999
Q ss_pred hCCCccCCCCCChhhhhc
Q 042539 324 KDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 324 ~dP~~R~~~~~~~~e~l~ 341 (412)
.||.+|| +++++++
T Consensus 260 ~dp~~Rp----s~~~l~~ 273 (296)
T 3uzp_A 260 LRFDDKP----DYSYLRQ 273 (296)
T ss_dssp SCTTCCC----CHHHHHH
T ss_pred cCcCcCC----CHHHHHH
Confidence 9999999 5777765
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=344.77 Aligned_cols=237 Identities=26% Similarity=0.435 Sum_probs=192.5
Q ss_pred CCCCCCCCccCceee-eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHH-hhcCCCccc
Q 042539 9 PQTTPSLDLDNLKAL-KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVL-SRLSHPFLP 86 (412)
Q Consensus 9 ~~~~~~~~~~~y~~~-~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv 86 (412)
.+......+++|.++ +.||+|+||.||+|.++.++. .||+|+++... ...+|+.++ +.++||||+
T Consensus 8 ~~~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~---------~~~~e~~~~~~~~~h~~i~ 74 (299)
T 3m2w_A 8 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQE----KFALKMLQDCP---------KARREVELHWRASQCPHIV 74 (299)
T ss_dssp CCCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEECSH---------HHHHHHHHHHHHTTSTTBC
T ss_pred ccCcccccccchhhcCcccccCCCeEEEEEEEcCCCc----EEEEEEecccH---------HHHHHHHHHHHhccCCCch
Confidence 344556677899998 789999999999999987544 49999996421 234588887 555899999
Q ss_pred eeeeeEEe----CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEcc--
Q 042539 87 KLLGSLET----DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQ-- 160 (412)
Q Consensus 87 ~l~~~~~~----~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~-- 160 (412)
++++++.+ +..+|+|||||.||+|..++.......+++.+++.++.||+.||.|||++||+||||||+|||++.
T Consensus 75 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 154 (299)
T 3m2w_A 75 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR 154 (299)
T ss_dssp CEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS
T ss_pred hHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCC
Confidence 99999987 678999999999999999888766567999999999999999999999999999999999999998
Q ss_pred -CCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCcccccccc
Q 042539 161 -SGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSF 239 (412)
Q Consensus 161 -~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (412)
++.+||+|||+++...
T Consensus 155 ~~~~~kl~Dfg~a~~~~--------------------------------------------------------------- 171 (299)
T 3m2w_A 155 PNAILKLTDFGFAKETT--------------------------------------------------------------- 171 (299)
T ss_dssp TTCCEEECCCTTCEECT---------------------------------------------------------------
T ss_pred CCCcEEEeccccccccc---------------------------------------------------------------
Confidence 7899999999886431
Q ss_pred CCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhc----CCCCC-----CCC
Q 042539 240 DNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLM----KTPEF-----VGQ 310 (412)
Q Consensus 240 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~----~~~~~-----~~~ 310 (412)
+..++.++|||||||++|+|++|+.||.+.+.......+.. ....+ ...
T Consensus 172 ----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (299)
T 3m2w_A 172 ----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 229 (299)
T ss_dssp ----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTS
T ss_pred ----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccC
Confidence 13467899999999999999999999987655443221111 11111 356
Q ss_pred ChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCC
Q 042539 311 RTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 311 ~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
++++.+||.+||..||.+|| +++++++||||.+
T Consensus 230 ~~~~~~li~~~l~~dP~~Rp----s~~e~l~hp~~~~ 262 (299)
T 3m2w_A 230 SEEVKMLIRNLLKTEPTQRM----TITEFMNHPWIMQ 262 (299)
T ss_dssp CHHHHHHHHHHTCSSTTTSC----CHHHHHTSHHHHT
T ss_pred CHHHHHHHHHHcccChhhCC----CHHHHhcChhhcc
Confidence 88999999999999999999 6999999999975
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=354.67 Aligned_cols=257 Identities=26% Similarity=0.376 Sum_probs=188.6
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
.+.+.+++|++++.||+|+||+||+|++. ++.||||++..... .. .....|+..+..++|+||+++++.
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~---~~--~~~e~~~~~~~~~~h~~i~~~~~~ 75 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGSLD------ERPVAVKVFSFANR---QN--FINEKNIYRVPLMEHDNIARFIVG 75 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEEET------TEEEEEEEEEGGGH---HH--HHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred CCCcChHHhheeeecccCCCeEEEEEEEC------CeEEEEEEeeccch---hh--HHHHHHHHHHHhccCcchhhheec
Confidence 45788999999999999999999999763 34599999965432 11 111234455556899999999986
Q ss_pred EEe-----CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHc---------CceeeeCCCCceE
Q 042539 92 LET-----DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNM---------GIAYRDLKPENIL 157 (412)
Q Consensus 92 ~~~-----~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~---------~iiHrDlKp~NiL 157 (412)
+.. ...+|+|||||.||+|..++.... +++..+..++.||+.||.|||++ ||+||||||+|||
T Consensus 76 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nil 152 (336)
T 3g2f_A 76 DERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVL 152 (336)
T ss_dssp EEEECTTSCEEEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEE
T ss_pred ccccccCCCceEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEE
Confidence 542 336899999999999998886543 68999999999999999999999 9999999999999
Q ss_pred EccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCcccccc
Q 042539 158 IRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQ 237 (412)
Q Consensus 158 l~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (412)
++.+|.+||+|||+++.+.......
T Consensus 153 l~~~~~~kL~DFG~a~~~~~~~~~~------------------------------------------------------- 177 (336)
T 3g2f_A 153 VKNDGTCVISDFGLSMRLTGNRLVR------------------------------------------------------- 177 (336)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCC--------------------------------------------------------
T ss_pred EcCCCcEEEeeccceeecccccccC-------------------------------------------------------
Confidence 9999999999999998653211000
Q ss_pred ccCCCCCCcccccCCCCccceeecC-------CCCCchhhHHHHHHHHHHHhhCCCCCC-CCC----------------H
Q 042539 238 SFDNGERSNSFVGTEEYVSPEVVRG-------DGHEFAVDWWALGILTYEMLYGTTPFR-GKN----------------R 293 (412)
Q Consensus 238 ~~~~~~~~~~~~gt~~Y~APE~l~~-------~~~~~~~DiwSlGvil~ell~g~~Pf~-~~~----------------~ 293 (412)
...........+||+.|+|||++.+ ..++.++|||||||++|||++|..||. +.. .
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 257 (336)
T 3g2f_A 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPT 257 (336)
T ss_dssp --------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCC
T ss_pred ccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCch
Confidence 0001122335679999999999987 345678999999999999999966653 221 0
Q ss_pred HHHHHHHhcCC---CCCCC-------CChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 294 KETFRNVLMKT---PEFVG-------QRTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 294 ~~~~~~i~~~~---~~~~~-------~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
.+......... +.++. .++++.+||.+||..||++|| ++.++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp----s~~e~l~ 311 (336)
T 3g2f_A 258 FEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARL----TAQXAEE 311 (336)
T ss_dssp HHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSC----CHHHHHH
T ss_pred HHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCc----chHHHHH
Confidence 11112222211 22221 124799999999999999999 6888854
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=353.32 Aligned_cols=258 Identities=19% Similarity=0.258 Sum_probs=208.3
Q ss_pred CCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeee
Q 042539 11 TTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLG 90 (412)
Q Consensus 11 ~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 90 (412)
...++..++|++++.||+|+||.||+|++.. .||+|+++...... ...+.+.+|+.++++++|+||+++++
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~avk~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~ 96 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-------EVAIRLIDIERDNE--DQLKAFKREVMAYRQTRHENVVLFMG 96 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS-------SEEEEECCCCSCCC--CCCCCCCTTGGGGTTCCCTTBCCCCE
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC-------eEEEEEeecCCCCH--HHHHHHHHHHHHHhcCCCCCEeEEEE
Confidence 4567888999999999999999999998754 29999997653211 12234556999999999999999999
Q ss_pred eEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccc
Q 042539 91 SLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 91 ~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
++.+.+.+++|||||.|++|..++... ...+++..+..++.||+.||.|||++||+||||||+|||++ +|.+||+|||
T Consensus 97 ~~~~~~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg 174 (319)
T 2y4i_B 97 ACMSPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFG 174 (319)
T ss_dssp EEECSSCEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCS
T ss_pred EEecCCceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecC
Confidence 999999999999999999998887543 34599999999999999999999999999999999999998 7899999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+++........ ..........|
T Consensus 175 ~~~~~~~~~~~----------------------------------------------------------~~~~~~~~~~g 196 (319)
T 2y4i_B 175 LFSISGVLQAG----------------------------------------------------------RREDKLRIQNG 196 (319)
T ss_dssp CCC--------------------------------------------------------------------CCSCBCCSG
T ss_pred Ccccccccccc----------------------------------------------------------ccccccccCCC
Confidence 98754211000 11122334569
Q ss_pred CCCCccceeecC---------CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC---CCCCChHHHHHH
Q 042539 251 TEEYVSPEVVRG---------DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE---FVGQRTALTDLI 318 (412)
Q Consensus 251 t~~Y~APE~l~~---------~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~dli 318 (412)
|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...... ....+.++.++|
T Consensus 197 ~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 276 (319)
T 2y4i_B 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDIL 276 (319)
T ss_dssp GGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHHHH
T ss_pred cccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHHHH
Confidence 999999999875 34788999999999999999999999999888877776654322 224678999999
Q ss_pred HHhhhhCCCccCCCCCChhhhhc
Q 042539 319 QRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 319 ~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
.+||..||.+|| ++.++++
T Consensus 277 ~~~l~~~p~~Rp----t~~~l~~ 295 (319)
T 2y4i_B 277 LFCWAFEQEERP----TFTKLMD 295 (319)
T ss_dssp HHHHCSSTTTSC----CHHHHHH
T ss_pred HHHhcCChhhCc----CHHHHHH
Confidence 999999999999 6888875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=376.59 Aligned_cols=258 Identities=20% Similarity=0.323 Sum_probs=213.8
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
..++..++|++++.||+|+||+||+|.+...+. ....||||+++... .......+.+|+.++++++||||++++++
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 459 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPEN-PAMAVAIKTCKNCT---SDSVREKFLQEALTMRQFDHPHIVKLIGV 459 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSS-CCEEEEEEECSSTT---CHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCC-ccEEEEEEEecccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 346677899999999999999999999875443 34569999986542 23445678889999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
+. ++.+|+|||||.||+|..++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+
T Consensus 460 ~~-~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 460 IT-ENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp EC-SSSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred Ee-cCceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCC
Confidence 85 467899999999999998876543 4589999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
++....... .......||
T Consensus 538 a~~~~~~~~--------------------------------------------------------------~~~~~~~~t 555 (656)
T 2j0j_A 538 SRYMEDSTY--------------------------------------------------------------YKASKGKLP 555 (656)
T ss_dssp CCSCCC------------------------------------------------------------------------CC
T ss_pred CeecCCCcc--------------------------------------------------------------eeccCCCCC
Confidence 976521110 111234578
Q ss_pred CCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCc
Q 042539 252 EEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVK 328 (412)
Q Consensus 252 ~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~ 328 (412)
+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+.... +....+++.+.+||.+||..||.+
T Consensus 556 ~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 635 (656)
T 2j0j_A 556 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSR 635 (656)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred cceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhH
Confidence 89999999999999999999999999999997 999999999888887776543 233467899999999999999999
Q ss_pred cCCCCCChhhhhc
Q 042539 329 RLGYLRGACEIKE 341 (412)
Q Consensus 329 R~~~~~~~~e~l~ 341 (412)
|| ++.++++
T Consensus 636 RP----s~~el~~ 644 (656)
T 2j0j_A 636 RP----RFTELKA 644 (656)
T ss_dssp SC----CHHHHHH
T ss_pred Cc----CHHHHHH
Confidence 99 5788775
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=363.08 Aligned_cols=246 Identities=18% Similarity=0.244 Sum_probs=189.7
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhh----hhHHHHHHHHHHHHHHhhcC--------
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLH----AKHEAERRARWEIRVLSRLS-------- 81 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~----~~~~~~~~~~~Ei~il~~l~-------- 81 (412)
.+..++|++++.||+|+||+||+|++. ++.||||++.+.... ......+.+.+|+.+++.++
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~ 89 (336)
T 2vuw_A 16 CLPTEKLQRCEKIGEGVFGEVFQTIAD------HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCN 89 (336)
T ss_dssp HSCHHHHHTCEEEEEETTEEEEEEEET------TEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSS
T ss_pred hcccccchheeeecccCceEEEEEEeC------CceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccc
Confidence 466789999999999999999999872 245999999876421 11122355667888888886
Q ss_pred -CCccceee-----------------eeEEe-------------CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHH
Q 042539 82 -HPFLPKLL-----------------GSLET-------------DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFY 130 (412)
Q Consensus 82 -hpnIv~l~-----------------~~~~~-------------~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~ 130 (412)
|+|||+++ ++|.+ ++.+|+|||||.||++...+.. ..+++.+++.+
T Consensus 90 ~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i 166 (336)
T 2vuw_A 90 RTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSI 166 (336)
T ss_dssp BCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHH
T ss_pred cCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHH
Confidence 55555554 44443 6799999999999976554432 45899999999
Q ss_pred HHHHHHHHHHHH-HcCceeeeCCCCceEEccCC--------------------CEEEccccccchhhchhhhhhhcccCC
Q 042539 131 LSEIICAIEHLH-NMGIAYRDLKPENILIRQSG--------------------HVTLTDFDLSRNLVKKTAFEKQSLNNN 189 (412)
Q Consensus 131 ~~qi~~aL~yLH-~~~iiHrDlKp~NiLl~~~g--------------------~vkL~DFGla~~~~~~~~~~~~~~~~~ 189 (412)
+.||+.||.||| ++||+||||||+|||++.+| .+||+|||+|+....
T Consensus 167 ~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------------ 234 (336)
T 2vuw_A 167 LHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------------ 234 (336)
T ss_dssp HHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------------
T ss_pred HHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------------
Confidence 999999999999 99999999999999999988 899999999975421
Q ss_pred CCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecCCCCCchh
Q 042539 190 KFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAV 269 (412)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~ 269 (412)
...+||+.|||||++.+.. +.++
T Consensus 235 --------------------------------------------------------~~~~gt~~y~aPE~~~g~~-~~~~ 257 (336)
T 2vuw_A 235 --------------------------------------------------------GIVVFCDVSMDEDLFTGDG-DYQF 257 (336)
T ss_dssp --------------------------------------------------------TEEECCCCTTCSGGGCCCS-SHHH
T ss_pred --------------------------------------------------------CcEEEeecccChhhhcCCC-ccce
Confidence 1347999999999999876 8899
Q ss_pred hHHHHHHH-HHHHhhCCCCCCCCCH-HHHHHHHhcCC----CC----CCCCChHHHHHHHHhhhhCCCccCCCCCChhhh
Q 042539 270 DWWALGIL-TYEMLYGTTPFRGKNR-KETFRNVLMKT----PE----FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEI 339 (412)
Q Consensus 270 DiwSlGvi-l~ell~g~~Pf~~~~~-~~~~~~i~~~~----~~----~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~ 339 (412)
||||||++ .++++.|..||.+... ......+.... .. ....++++++||.+||++| +++|+
T Consensus 258 Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d---------sa~e~ 328 (336)
T 2vuw_A 258 DIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS---------SATDL 328 (336)
T ss_dssp HHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS---------SHHHH
T ss_pred ehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC---------CHHHH
Confidence 99998887 7778899999965321 11222333111 11 1124578999999999977 59999
Q ss_pred h-cCCCCC
Q 042539 340 K-EHVFFK 346 (412)
Q Consensus 340 l-~h~ff~ 346 (412)
+ +||||+
T Consensus 329 l~~Hp~f~ 336 (336)
T 2vuw_A 329 LCQHSLFK 336 (336)
T ss_dssp HHHCGGGC
T ss_pred HhcCCCcC
Confidence 9 999995
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=349.33 Aligned_cols=251 Identities=20% Similarity=0.251 Sum_probs=198.8
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeE
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFL 98 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 98 (412)
.|...+.||+|+||+||+|.+. +..||+|++............+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 105 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYVN------NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDL 105 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEESS------SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred ccccCCccccCCCeEEEEEEEC------CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCce
Confidence 3455689999999999999863 2349999997644323344566788899999999999999999999999999
Q ss_pred EEEeeccCCCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 99 AWAVPYCPGGDLNVLRYKQN-DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~~~~~~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
|+||||+.|++|..++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 185 (307)
T 2nru_A 106 CLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEK 185 (307)
T ss_dssp EEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccc
Confidence 99999999999988876432 34589999999999999999999999999999999999999999999999999875421
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
. .........+||+.|+||
T Consensus 186 ~-------------------------------------------------------------~~~~~~~~~~g~~~y~aP 204 (307)
T 2nru_A 186 F-------------------------------------------------------------AQTVMTSRIVGTTAYMAP 204 (307)
T ss_dssp C-------------------------------------------------------------SSCEECSSCCSCGGGCCH
T ss_pred c-------------------------------------------------------------cccccccccCCCcCcCCh
Confidence 0 011112345799999999
Q ss_pred eeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHH----HHHHHhcCC--------CCCCC----CChHHHHHHHHh
Q 042539 258 EVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKE----TFRNVLMKT--------PEFVG----QRTALTDLIQRL 321 (412)
Q Consensus 258 E~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~----~~~~i~~~~--------~~~~~----~~~~~~dli~~~ 321 (412)
|++.+. ++.++|||||||++|+|++|.+||.+..... ....+.... ..... .+..+.++|.+|
T Consensus 205 E~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 283 (307)
T 2nru_A 205 EALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQC 283 (307)
T ss_dssp HHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHH
T ss_pred HHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHH
Confidence 998764 7889999999999999999999998754322 111111111 11111 235789999999
Q ss_pred hhhCCCccCCCCCChhhhhc
Q 042539 322 LEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 322 L~~dP~~R~~~~~~~~e~l~ 341 (412)
|..||.+|| ++.++++
T Consensus 284 l~~~p~~Rp----s~~~l~~ 299 (307)
T 2nru_A 284 LHEKKNKRP----DIKKVQQ 299 (307)
T ss_dssp TCSSTTTSC----CHHHHHH
T ss_pred cCCCcccCc----CHHHHHH
Confidence 999999999 6888875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=346.97 Aligned_cols=261 Identities=21% Similarity=0.272 Sum_probs=208.0
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
...+..++|++++.||+|+||.||+|+....+..+++.||||++.... ....+.+.+|+++++.++||||++++++
T Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 110 (326)
T 2w1i_A 35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEHLRDFEREIEILKSLQHDNIVKYKGV 110 (326)
T ss_dssp --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC----SHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC----HHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 446778899999999999999999999765555567789999997642 2345667889999999999999999999
Q ss_pred EEeCC--eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccc
Q 042539 92 LETDE--FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169 (412)
Q Consensus 92 ~~~~~--~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DF 169 (412)
+...+ .+++||||+.|++|..++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+||
T Consensus 111 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Df 189 (326)
T 2w1i_A 111 CYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 189 (326)
T ss_dssp ECC----CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred EEecCCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecC
Confidence 87543 7899999999999998887643 45999999999999999999999999999999999999999999999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|+++........ ........
T Consensus 190 g~~~~~~~~~~~------------------------------------------------------------~~~~~~~~ 209 (326)
T 2w1i_A 190 GLTKVLPQDKEY------------------------------------------------------------YKVKEPGE 209 (326)
T ss_dssp TTCEECCSSCSE------------------------------------------------------------EECSSCCS
T ss_pred cchhhccccccc------------------------------------------------------------cccccCCC
Confidence 999765211000 00112345
Q ss_pred cCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHH------------H---HHHHHhcC---CCCCCCCC
Q 042539 250 GTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRK------------E---TFRNVLMK---TPEFVGQR 311 (412)
Q Consensus 250 gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------------~---~~~~i~~~---~~~~~~~~ 311 (412)
+|..|+|||++.+..++.++|||||||++|+|++|..||...... . .+...+.. .+....++
T Consensus 210 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (326)
T 2w1i_A 210 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCP 289 (326)
T ss_dssp CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCC
T ss_pred CceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCccc
Confidence 788899999999988999999999999999999999998643111 0 11112211 22334578
Q ss_pred hHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 312 TALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 312 ~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
+++.+||.+||..||.+|| ++.++++
T Consensus 290 ~~l~~li~~cl~~dP~~Rp----s~~el~~ 315 (326)
T 2w1i_A 290 DEIYMIMTECWNNNVNQRP----SFRDLAL 315 (326)
T ss_dssp HHHHHHHHHHSCSSGGGSC----CHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCc----CHHHHHH
Confidence 9999999999999999999 5788774
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=345.47 Aligned_cols=250 Identities=22% Similarity=0.330 Sum_probs=192.6
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc--CCCccceeeee
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL--SHPFLPKLLGS 91 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l--~hpnIv~l~~~ 91 (412)
....++|++++.||+|+||.||+|++. ++.||||++..... ....+|.+++..+ +||||++++++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~vavK~~~~~~~-------~~~~~e~~~~~~~~~~h~~i~~~~~~ 99 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR------GEKVAVKVFFTTEE-------ASWFRETEIYQTVLMRHENILGFIAA 99 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET------TEEEEEEEEEGGGH-------HHHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC------CceEEEEEEecccc-------chhhhHHHHHHHHhhcCCCeeeEEEE
Confidence 444579999999999999999999875 34599999854321 1223355555554 89999999999
Q ss_pred EEeC----CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHc--------CceeeeCCCCceEEc
Q 042539 92 LETD----EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNM--------GIAYRDLKPENILIR 159 (412)
Q Consensus 92 ~~~~----~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~--------~iiHrDlKp~NiLl~ 159 (412)
+... ..+|+|||||.||+|..++... .+++..+..++.|++.||.|||++ ||+||||||+|||++
T Consensus 100 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~ 176 (337)
T 3mdy_A 100 DIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK 176 (337)
T ss_dssp EEESCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred EccCCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC
Confidence 9887 7899999999999999888653 499999999999999999999999 999999999999999
Q ss_pred cCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCcccccccc
Q 042539 160 QSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSF 239 (412)
Q Consensus 160 ~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (412)
.+|.+||+|||+++.+.....
T Consensus 177 ~~~~~kl~Dfg~a~~~~~~~~----------------------------------------------------------- 197 (337)
T 3mdy_A 177 KNGTCCIADLGLAVKFISDTN----------------------------------------------------------- 197 (337)
T ss_dssp TTSCEEECCCTTCEECC---------------------------------------------------------------
T ss_pred CCCCEEEEeCCCceeeccccc-----------------------------------------------------------
Confidence 999999999999976532111
Q ss_pred CCCCCCcccccCCCCccceeecCCCCCch------hhHHHHHHHHHHHhhC----------CCCCCCCC----HHHHHHH
Q 042539 240 DNGERSNSFVGTEEYVSPEVVRGDGHEFA------VDWWALGILTYEMLYG----------TTPFRGKN----RKETFRN 299 (412)
Q Consensus 240 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~------~DiwSlGvil~ell~g----------~~Pf~~~~----~~~~~~~ 299 (412)
.......+.+||+.|+|||++.+..++.. +|||||||++|||++| ..||.... .......
T Consensus 198 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 277 (337)
T 3mdy_A 198 EVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMRE 277 (337)
T ss_dssp -----CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHH
T ss_pred cccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHH
Confidence 00111235689999999999988766544 9999999999999999 77776531 1222233
Q ss_pred Hhc-C--CCCCC------CCChHHHHHHHHhhhhCCCccCCCCCChhhhhcC
Q 042539 300 VLM-K--TPEFV------GQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEH 342 (412)
Q Consensus 300 i~~-~--~~~~~------~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h 342 (412)
... . .+.++ .+++++.+||.+||..||.+|| ++.++++|
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp----s~~ell~~ 325 (337)
T 3mdy_A 278 IVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRL----TALRVKKT 325 (337)
T ss_dssp HHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSC----CHHHHHHH
T ss_pred HHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCC----CHHHHHHH
Confidence 222 1 12222 2346799999999999999999 68888863
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=382.09 Aligned_cols=261 Identities=24% Similarity=0.365 Sum_probs=204.4
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
....++|++++.||+|+||+||+|.+..++. .||||++.... .......+.+|+++++.++||||+++++++.
T Consensus 10 g~~~grY~i~~~LG~G~fG~Vyla~~~~tg~----~VAVKvi~~~~---~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~ 82 (676)
T 3qa8_A 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGE----QVAIKQCRQEL---SPKNRERWCLEIQIMKKLNHPNVVSAREVPD 82 (676)
T ss_dssp -------CCCCCCCBCSSSBCCCCCCTTTTC----CEEECCCCSCC---CHHHHHHHHHHHHHHHHCCBTTBCCEEECCT
T ss_pred CCCCCCeEEEEEEeeCCCeEEEEEEECCCCc----EEEEEEecccC---CHHHHHHHHHHHHHHHhCCCCCCCceeeeec
Confidence 4456999999999999999999988776544 49999997642 2334567788999999999999999999876
Q ss_pred e------CCeEEEEeeccCCCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCC---
Q 042539 94 T------DEFLAWAVPYCPGGDLNVLRYKQN-DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGH--- 163 (412)
Q Consensus 94 ~------~~~~~lv~e~~~gg~L~~~~~~~~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~--- 163 (412)
. ++..|+|||||.||+|..++.... ...+++..++.++.|++.||.|||++||+||||||+|||++.+|.
T Consensus 83 ~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~ 162 (676)
T 3qa8_A 83 GLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLI 162 (676)
T ss_dssp TTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCE
T ss_pred ccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCcee
Confidence 5 678899999999999998877543 235999999999999999999999999999999999999998775
Q ss_pred EEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCC
Q 042539 164 VTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGE 243 (412)
Q Consensus 164 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (412)
+||+|||+++... ...
T Consensus 163 vKL~DFG~a~~~~----------------------------------------------------------------~~~ 178 (676)
T 3qa8_A 163 HKIIDLGYAKELD----------------------------------------------------------------QGE 178 (676)
T ss_dssp EEECSCCCCCBTT----------------------------------------------------------------SCC
T ss_pred EEEcccccccccc----------------------------------------------------------------ccc
Confidence 9999999997542 112
Q ss_pred CCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH---------h-----cCCCCC--
Q 042539 244 RSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNV---------L-----MKTPEF-- 307 (412)
Q Consensus 244 ~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i---------~-----~~~~~~-- 307 (412)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......... . .+...+
T Consensus 179 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~ 258 (676)
T 3qa8_A 179 LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSS 258 (676)
T ss_dssp CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCS
T ss_pred ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhcccccccc
Confidence 223567999999999999999999999999999999999999999875433221100 0 000011
Q ss_pred ---------CCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCC
Q 042539 308 ---------VGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 308 ---------~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~ 349 (412)
...++.+.+||.+||..||++|| ++.++++||||+.++
T Consensus 259 ~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRP----Ta~elL~hp~F~~l~ 305 (676)
T 3qa8_A 259 VLPTPNHLSGILAGKLERWLQCMLMWHQRQRG----TDPQNPNVGCFQALD 305 (676)
T ss_dssp SSCCSCCCCGGGHHHHHHHHHHHSCSSCC-------CCTTCCCCTTHHHHH
T ss_pred ccCCchhhchhhhHHHHHHHHHHccCCHhhCc----CHHHHhcCHHHHHHH
Confidence 01347899999999999999999 689999999998643
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=341.88 Aligned_cols=247 Identities=22% Similarity=0.282 Sum_probs=196.3
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhh--cCCCccceeeeeEEe
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSR--LSHPFLPKLLGSLET 94 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~ 94 (412)
.++|++++.||+|+||+||+|++. ++.||||++.... ...+.+|+++++. ++||||+++++++..
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~-------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWR------GEEVAVKIFSSRE-------ERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET------TEEEEEEEECGGG-------HHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred cccEEEEeeecCCCCcEEEEEEEc------CccEEEEEeCchh-------HHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 479999999999999999999873 3459999996542 2345568888887 689999999999987
Q ss_pred CC----eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH--------HcCceeeeCCCCceEEccCC
Q 042539 95 DE----FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLH--------NMGIAYRDLKPENILIRQSG 162 (412)
Q Consensus 95 ~~----~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH--------~~~iiHrDlKp~NiLl~~~g 162 (412)
.. .+|+||||+.||+|..++... .+++.++..++.|++.||.||| ++||+||||||+|||++.+|
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 184 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS
T ss_pred cCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC
Confidence 76 899999999999999888653 4999999999999999999999 89999999999999999999
Q ss_pred CEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCC
Q 042539 163 HVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNG 242 (412)
Q Consensus 163 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (412)
.+||+|||+++........ ..
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~-----------------------------------------------------------~~ 205 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDT-----------------------------------------------------------ID 205 (342)
T ss_dssp CEEECCCTTCEEEETTTTE-----------------------------------------------------------EE
T ss_pred CEEEEECCCceeccccccc-----------------------------------------------------------cc
Confidence 9999999999765321100 00
Q ss_pred CCCcccccCCCCccceeecCCC------CCchhhHHHHHHHHHHHhhC----------CCCCCCC-----CHHHHHHHHh
Q 042539 243 ERSNSFVGTEEYVSPEVVRGDG------HEFAVDWWALGILTYEMLYG----------TTPFRGK-----NRKETFRNVL 301 (412)
Q Consensus 243 ~~~~~~~gt~~Y~APE~l~~~~------~~~~~DiwSlGvil~ell~g----------~~Pf~~~-----~~~~~~~~i~ 301 (412)
......+||+.|+|||++.+.. ++.++|||||||++|+|++| ..||... ........+.
T Consensus 206 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 285 (342)
T 1b6c_B 206 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 285 (342)
T ss_dssp ECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHT
T ss_pred cccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHH
Confidence 0123457999999999998762 34789999999999999999 7898764 2333444443
Q ss_pred cCC--CCCCC------CChHHHHHHHHhhhhCCCccCCCCCChhhhhcC
Q 042539 302 MKT--PEFVG------QRTALTDLIQRLLEKDPVKRLGYLRGACEIKEH 342 (412)
Q Consensus 302 ~~~--~~~~~------~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h 342 (412)
... +..+. .++.+.+||.+||..||++|| ++.++++|
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp----s~~~i~~~ 330 (342)
T 1b6c_B 286 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL----TALRIKKT 330 (342)
T ss_dssp TSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSC----CHHHHHHH
T ss_pred HHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCC----CHHHHHHH
Confidence 322 22221 125789999999999999999 68888864
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=361.55 Aligned_cols=254 Identities=17% Similarity=0.173 Sum_probs=194.7
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCC-Ccccee------
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH-PFLPKL------ 88 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l------ 88 (412)
...+|++.+.||+|+||+||+|++..++. .||||++...... .....+.+.+|+.+++.+.| .|+..+
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~----~vAvK~~~~~~~~-~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~ 150 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGE----SFEVHVPYFTERP-PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 150 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEECCSCC-----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCB
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCC----ceEEEEEecCCCc-cHHHHHHHHHHHHHHHhhccCCCHHHHHHhccc
Confidence 34568899999999999999999987554 4999999744322 22335567789999999986 322111
Q ss_pred ---------------eeeEEe-----CCeEEEEeeccCCCCchhHHH-----hhCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 042539 89 ---------------LGSLET-----DEFLAWAVPYCPGGDLNVLRY-----KQNDRVFSPSVIRFYLSEIICAIEHLHN 143 (412)
Q Consensus 89 ---------------~~~~~~-----~~~~~lv~e~~~gg~L~~~~~-----~~~~~~l~~~~~~~~~~qi~~aL~yLH~ 143 (412)
..++.. ...++++|+++ +++|.+++. ......+++..+..++.||+.||+|||+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 229 (413)
T 3dzo_A 151 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 229 (413)
T ss_dssp CCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 111111 22467778776 678887764 2223347788899999999999999999
Q ss_pred cCceeeeCCCCceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCcccccc
Q 042539 144 MGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKK 223 (412)
Q Consensus 144 ~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (412)
+||+||||||+|||++.+|.+||+|||+++....
T Consensus 230 ~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~---------------------------------------------- 263 (413)
T 3dzo_A 230 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---------------------------------------------- 263 (413)
T ss_dssp TTEECSCCCGGGEEECTTCCEEECCGGGCEETTE----------------------------------------------
T ss_pred CCcccCCcccceEEEecCCeEEEEeccceeecCC----------------------------------------------
Confidence 9999999999999999999999999999875421
Q ss_pred ccccCCCCccccccccCCCCCCcccccCCCCccceee----------cCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCH
Q 042539 224 TKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVV----------RGDGHEFAVDWWALGILTYEMLYGTTPFRGKNR 293 (412)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l----------~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~ 293 (412)
...+.+| +.|+|||++ .+..++.++|||||||++|||++|+.||.+.+.
T Consensus 264 --------------------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~ 322 (413)
T 3dzo_A 264 --------------------SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAA 322 (413)
T ss_dssp --------------------EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGG
T ss_pred --------------------ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcch
Confidence 1234578 999999999 455578899999999999999999999988765
Q ss_pred HHHHHHHhcCCCCCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCC
Q 042539 294 KETFRNVLMKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 294 ~~~~~~i~~~~~~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~ 349 (412)
.+....+.. .....++++.+||.+||+.||.+|| ++.++++||||+.+.
T Consensus 323 ~~~~~~~~~---~~~~~~~~~~~li~~~l~~dP~~Rp----t~~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 323 LGGSEWIFR---SCKNIPQPVRALLEGFLRYPKEDRL----LPLQAMETPEYEQLR 371 (413)
T ss_dssp GSCSGGGGS---SCCCCCHHHHHHHHHHTCSSGGGSC----CHHHHTTSHHHHHHH
T ss_pred hhhHHHHHh---hcccCCHHHHHHHHHHccCChhhCc----CHHHHHhCHHHHHHH
Confidence 544443333 2246689999999999999999999 699999999998654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=329.78 Aligned_cols=223 Identities=17% Similarity=0.152 Sum_probs=183.2
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET 94 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 94 (412)
+..++|++++.||+|+||.||+|++..++ +.||||++...... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~----~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 102 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALD----RQVALTFVDPQGVL-PDDVLQETLSRTLRLSRIDKPGVARVLDVVHT 102 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTT----EEEEEEESCTTCCS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCC----ceEEEEEECccccc-CHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE
Confidence 44477999999999999999999997644 45999999765432 23455677889999999999999999999999
Q ss_pred CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
++..|+|||||.|++|..++.. + ..+.++..++.||+.||+|||++||+||||||+|||++.+|.+||+++|
T Consensus 103 ~~~~~lv~e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~---- 174 (286)
T 3uqc_A 103 RAGGLVVAEWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA---- 174 (286)
T ss_dssp TTEEEEEEECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC----
T ss_pred CCcEEEEEEecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc----
Confidence 9999999999999999888742 2 4666788899999999999999999999999999999999999998654
Q ss_pred hhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCC
Q 042539 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254 (412)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 254 (412)
|
T Consensus 175 -------------------------------------------------------------------------------~ 175 (286)
T 3uqc_A 175 -------------------------------------------------------------------------------T 175 (286)
T ss_dssp -------------------------------------------------------------------------------C
T ss_pred -------------------------------------------------------------------------------c
Confidence 3
Q ss_pred ccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH---HHhcCCCC-----CCCCChHHHHHHHHhhhhCC
Q 042539 255 VSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFR---NVLMKTPE-----FVGQRTALTDLIQRLLEKDP 326 (412)
Q Consensus 255 ~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~---~i~~~~~~-----~~~~~~~~~dli~~~L~~dP 326 (412)
++ .++.++|||||||++|+|++|+.||.+.+..+.+. +.....+. ....++++.+||.+||+.||
T Consensus 176 ~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 248 (286)
T 3uqc_A 176 MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDG 248 (286)
T ss_dssp CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTS
T ss_pred cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCC
Confidence 33 26889999999999999999999998865432110 11111111 24578899999999999999
Q ss_pred CccCCCCCChhhhhc
Q 042539 327 VKRLGYLRGACEIKE 341 (412)
Q Consensus 327 ~~R~~~~~~~~e~l~ 341 (412)
.+| + +.++++
T Consensus 249 ~~R-s----~~el~~ 258 (286)
T 3uqc_A 249 GIR-S----ASTLLN 258 (286)
T ss_dssp SCC-C----HHHHHH
T ss_pred ccC-C----HHHHHH
Confidence 999 5 777775
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=372.59 Aligned_cols=245 Identities=22% Similarity=0.333 Sum_probs=195.7
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
++..++|++++.||+|+||+||+|.+... +++.||||++.... .......+.+|++++++++|||||++++++.
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~---~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 149 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNV---NGRPVVLKGLVHSG---DAEAQAMAMAERQFLAEVVHPSIVQIFNFVE 149 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGG---TTEEEEEEESCSSC---CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCC---CCcEEEEEEeCccC---CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEe
Confidence 34458999999999999999999998752 23459999986542 2344566778999999999999999999998
Q ss_pred eCCe-----EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcc
Q 042539 94 TDEF-----LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTD 168 (412)
Q Consensus 94 ~~~~-----~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~D 168 (412)
..+. .|+|||||.|++|..++.. .+++.+++.++.||+.||.|||++|||||||||+|||++.+ .+||+|
T Consensus 150 ~~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~D 224 (681)
T 2pzi_A 150 HTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLID 224 (681)
T ss_dssp EECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECC
T ss_pred ecCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEe
Confidence 7665 7999999999999876532 49999999999999999999999999999999999999875 999999
Q ss_pred ccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccc
Q 042539 169 FDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248 (412)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (412)
||+++.... ....
T Consensus 225 FG~a~~~~~-------------------------------------------------------------------~~~~ 237 (681)
T 2pzi_A 225 LGAVSRINS-------------------------------------------------------------------FGYL 237 (681)
T ss_dssp CTTCEETTC-------------------------------------------------------------------CSCC
T ss_pred cccchhccc-------------------------------------------------------------------CCcc
Confidence 999975421 1345
Q ss_pred ccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCChHHHHHHHHhhhhCCCc
Q 042539 249 VGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVGQRTALTDLIQRLLEKDPVK 328 (412)
Q Consensus 249 ~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~dli~~~L~~dP~~ 328 (412)
+||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+...... .........++.+.+||.+||..||.+
T Consensus 238 ~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~dP~~ 311 (681)
T 2pzi_A 238 YGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL-----PEDDPVLKTYDSYGRLLRRAIDPDPRQ 311 (681)
T ss_dssp CCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC-----CTTCHHHHHCHHHHHHHHHHTCSSGGG
T ss_pred CCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc-----cccccccccCHHHHHHHhhhccCChhh
Confidence 799999999999775 48899999999999999999999876321000 000001113467999999999999999
Q ss_pred cCCCCCChhhhhcCCCCC
Q 042539 329 RLGYLRGACEIKEHVFFK 346 (412)
Q Consensus 329 R~~~~~~~~e~l~h~ff~ 346 (412)
|++ ..+.+.|+|+.
T Consensus 312 R~~----~~~~l~~~l~~ 325 (681)
T 2pzi_A 312 RFT----TAEEMSAQLTG 325 (681)
T ss_dssp SCS----SHHHHHHHHHH
T ss_pred CCC----HHHHHHHHHHH
Confidence 994 56777777764
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=322.14 Aligned_cols=190 Identities=13% Similarity=0.089 Sum_probs=132.6
Q ss_pred eeeccCceEEEEEEEcCCCCCCCCceEEeeecchhh------hhhHHHHHHHHHHHHHHhhc-CCCccceeeeeEEeCCe
Q 042539 25 ILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTL------HAKHEAERRARWEIRVLSRL-SHPFLPKLLGSLETDEF 97 (412)
Q Consensus 25 ~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~------~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 97 (412)
.++.|++|.+..++..-.+. .||+|++.+... ...+...+.+.+|+++|+++ .|+||+++++++++++.
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~----~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~ 316 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGE----DYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQS 316 (569)
T ss_dssp C-C--------CCEEEEECS----SEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSE
T ss_pred ccccCCcccccccccccccc----eeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCE
Confidence 45667777776655554444 499999976532 12334456788999999999 59999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+|||||||+|++|.+++... +.+++. .|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+....
T Consensus 317 ~yLVMEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 317 GWLVMEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EEEEEECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EEEEEecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999999988654 347664 4789999999999999999999999999999999999999999975421
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
......+.+||+.||||
T Consensus 392 ---------------------------------------------------------------~~~~~~t~vGTp~YmAP 408 (569)
T 4azs_A 392 ---------------------------------------------------------------DCSWPTNLVQSFFVFVN 408 (569)
T ss_dssp -----------------------------------------------------------------CCSHHHHHHHHHHHH
T ss_pred ---------------------------------------------------------------CCccccCceechhhccH
Confidence 12234567999999999
Q ss_pred eeecCCCCCchhhHHHHHHHHHHHhhCCCC
Q 042539 258 EVVRGDGHEFAVDWWALGILTYEMLYGTTP 287 (412)
Q Consensus 258 E~l~~~~~~~~~DiwSlGvil~ell~g~~P 287 (412)
|++.+. +..++|+||+|+++|++.++..+
T Consensus 409 E~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 409 ELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp HHC------------------CCCCTTHHH
T ss_pred HHhCCC-CCCcccccccccchhhhccccch
Confidence 999875 56789999999999888766443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.6e-31 Score=270.05 Aligned_cols=195 Identities=14% Similarity=0.064 Sum_probs=145.3
Q ss_pred eeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhh----hhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 21 KALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLH----AKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 21 ~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~----~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
...+.||+|+||+||++.... ..+|+|........ ......+++.+|++++++++||||+++..++...+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 412 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLD------FDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD 412 (540)
T ss_dssp ---------CCEEEEEEECSS------CEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT
T ss_pred CCCCEEeeCCCEEEEEEEECC------CeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC
Confidence 446789999999999994432 33899986543322 12223566889999999999999996666666777
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
..|+|||||+|++|.+++.. +..++.|++.||+|||++||+||||||+|||++. .+||+|||+|+...
T Consensus 413 ~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 413 NKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp TTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred ccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 88999999999999877643 5689999999999999999999999999999998 99999999998764
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
....... +......+++||+.|||
T Consensus 481 ~~~~~~~--------------------------------------------------------~~~~~~~~~~GT~~y~A 504 (540)
T 3en9_A 481 LDEDKAV--------------------------------------------------------DLIVFKKAVLSTHHEKF 504 (540)
T ss_dssp CHHHHHH--------------------------------------------------------HHHHHHHHHHHHCGGGH
T ss_pred Ccccccc--------------------------------------------------------chhhhhhhhcCCCCcCC
Confidence 3211000 00001235789999999
Q ss_pred ceeecC--CCCCchhhHHHHHHHHHHHhhCCCCCC
Q 042539 257 PEVVRG--DGHEFAVDWWALGILTYEMLYGTTPFR 289 (412)
Q Consensus 257 PE~l~~--~~~~~~~DiwSlGvil~ell~g~~Pf~ 289 (412)
||++.+ ..|+..+|+||..+-..+.+.++.+|.
T Consensus 505 PEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 505 DEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred HHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 999987 678888999999999888887776663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-27 Score=225.32 Aligned_cols=131 Identities=22% Similarity=0.161 Sum_probs=105.0
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhh-----H---------HHHHHHHHHHHHHhhcCCCccceee
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAK-----H---------EAERRARWEIRVLSRLSHPFLPKLL 89 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~-----~---------~~~~~~~~Ei~il~~l~hpnIv~l~ 89 (412)
+.||+|+||.||+|++ .+ ++.||||+++....... . .....+.+|+.+++.++ | ++++
T Consensus 96 ~~iG~G~~g~Vy~~~~-~~----g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 96 KLMGEGKESAVFNCYS-EK----FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp EEEEECSSEEEEEEEE-TT----TEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred CEeccCCCceEEEEEe-CC----CCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 9999999999999998 43 44599999965432110 0 23556788999999999 5 7777
Q ss_pred eeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccc
Q 042539 90 GSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169 (412)
Q Consensus 90 ~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DF 169 (412)
+++.. +..|+|||||.||+|.. +. . ..+..++.|++.||.|||++||+||||||+|||++ +|.+||+||
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~------~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DF 236 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VR------V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDF 236 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCC
T ss_pred eEEec-cceEEEEEecCCCcHHH-cc------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEEC
Confidence 76654 45699999999999976 21 1 33557999999999999999999999999999999 999999999
Q ss_pred cccc
Q 042539 170 DLSR 173 (412)
Q Consensus 170 Gla~ 173 (412)
|+|+
T Consensus 237 G~a~ 240 (282)
T 1zar_A 237 PQSV 240 (282)
T ss_dssp TTCE
T ss_pred CCCe
Confidence 9985
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-22 Score=189.77 Aligned_cols=141 Identities=16% Similarity=0.145 Sum_probs=107.0
Q ss_pred ceeeeeeeccCceEEEEEEEcCCCCCCCCc--eEEeeecchhhhh--------------------hHHHHHHHHHHHHHH
Q 042539 20 LKALKILGKGAMGTVFLVHDRAADPTARCP--FALKVVDKSTLHA--------------------KHEAERRARWEIRVL 77 (412)
Q Consensus 20 y~~~~~LG~G~fg~V~la~~~~~~~~~~~~--vAiK~i~~~~~~~--------------------~~~~~~~~~~Ei~il 77 (412)
|++.+.||+|+||.||+|.+.. +++. ||||+++...... .......+.+|+.+|
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~----~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 124 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVF----DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNL 124 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEE----TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcC----CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHH
Confidence 6789999999999999998854 3456 9999976542111 112334677899999
Q ss_pred hhcCCCcc--ceeeeeEEeCCeEEEEeeccCC-C----CchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH-HcCceee
Q 042539 78 SRLSHPFL--PKLLGSLETDEFLAWAVPYCPG-G----DLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLH-NMGIAYR 149 (412)
Q Consensus 78 ~~l~hpnI--v~l~~~~~~~~~~~lv~e~~~g-g----~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH-~~~iiHr 149 (412)
+.+.|++| +.+++. +..+||||||.+ | +|..+... .++..+..++.|++.||.||| ++||+||
T Consensus 125 ~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHr 195 (258)
T 1zth_A 125 ERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHA 195 (258)
T ss_dssp HHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECS
T ss_pred HHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 99988754 444432 356899999942 3 44433211 345678899999999999999 9999999
Q ss_pred eCCCCceEEccCCCEEEccccccchh
Q 042539 150 DLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 150 DlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
||||+|||++. .++|+|||+|...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999988 9999999999765
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.7e-19 Score=176.46 Aligned_cols=141 Identities=16% Similarity=0.138 Sum_probs=100.4
Q ss_pred ceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhh------------------hhHHHHHHHHHHHHHHhhcC
Q 042539 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLH------------------AKHEAERRARWEIRVLSRLS 81 (412)
Q Consensus 20 y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~------------------~~~~~~~~~~~Ei~il~~l~ 81 (412)
|.+.+.||+|+||.||+|.+. .++.||||+++..... ..........+|...|.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-----~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~ 171 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-----KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY 171 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-----TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEecCEeeeCCceEEEEEECC-----CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH
Confidence 889999999999999999874 2445999998643211 00111122345777777775
Q ss_pred CCccceeeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccC
Q 042539 82 HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQS 161 (412)
Q Consensus 82 hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~ 161 (412)
+.++. +...+... ..+|||||+.|+.|..+. ....+..++.||+.+|.|||++|||||||||.|||++.+
T Consensus 172 ~~gv~-vp~p~~~~-~~~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 172 EEGFP-VPEPIAQS-RHTIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREE 241 (397)
T ss_dssp HTTCS-CCCEEEEE-TTEEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEE
T ss_pred hcCCC-CCeeeecc-CceEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCC
Confidence 44332 22222222 237999999999885432 223456788999999999999999999999999999988
Q ss_pred C----------CEEEccccccchh
Q 042539 162 G----------HVTLTDFDLSRNL 175 (412)
Q Consensus 162 g----------~vkL~DFGla~~~ 175 (412)
| .+.|+||+-+...
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCcccccccccceEEEEeCCcccC
Confidence 7 3899999987543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=3.1e-13 Score=125.61 Aligned_cols=142 Identities=14% Similarity=0.086 Sum_probs=111.6
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEEe
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLET 94 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~ 94 (412)
.++.|++...+|.|+.+.||++... +..+++|+........ ...+.+|+.+++.+. +..+.++++++.+
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~------~~~~vlK~~~~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~ 81 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE------NENLYLKMTDSRYKGT----TYDVEREKDMMLWLEGKLPVPKVLHFERH 81 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS------SCEEEEEEECGGGTTS----TTCHHHHHHHHHHHTTTSCCCCEEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC------CCcEEEEeCCcccCCC----HHHHHHHHHHHHHHhcCCCCCeEEEEEec
Confidence 3578999999999999999998643 2349999986532111 123566999999995 6778899999999
Q ss_pred CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN------------------------------- 143 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~------------------------------- 143 (412)
.+..|+|||+++|.+|.... .+......++.++..+|..||+
T Consensus 82 ~~~~~lv~e~i~G~~l~~~~-------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (263)
T 3tm0_A 82 DGWSNLLMSEADGVLCSEEY-------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD 154 (263)
T ss_dssp TTEEEEEEECCSSEEHHHHC-------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCS
T ss_pred CCceEEEEEecCCeehhhcc-------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccc
Confidence 99999999999999886542 1223345678899999999999
Q ss_pred ----------------------------cCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 144 ----------------------------MGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 144 ----------------------------~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
.+++|+|++|.|||++.++.+.|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4589999999999998765567999998864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.29 E-value=9.8e-12 Score=114.65 Aligned_cols=138 Identities=15% Similarity=0.038 Sum_probs=99.6
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCc--cceeeeeEE
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPF--LPKLLGSLE 93 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~ 93 (412)
.+.+|.+....+.|+.+.||++... .+ ..+++|+..... ...+.+|+.+++.+.+.+ +.+++++..
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~~-~g----~~~vlK~~~~~~-------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~ 85 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSAQ-GR----PVLFVKTDLSGA-------LNELQDEAARLSWLATTGVPCAAVLDVVT 85 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEECT-TS----CCEEEEEECSCT-------TSCHHHHHHHHHHHHTTTCCBCCEEEEEE
T ss_pred hcCCCceEecccCCCCceEEEEecC-CC----CeEEEEeCCccc-------chhhhHHHHHHHHHHhCCCCCCeEEEecc
Confidence 3456777655556777999998642 22 339999875431 123456889999886433 667999888
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcC----------------------------
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMG---------------------------- 145 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~---------------------------- 145 (412)
.++..++||||++|.+|. .. . .+ ...++.++...|..||+..
T Consensus 86 ~~~~~~~v~e~i~G~~l~--~~--~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (264)
T 1nd4_A 86 EAGRDWLLLGEVPGQDLL--SS--H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQ 155 (264)
T ss_dssp CSSCEEEEEECCSSEETT--TS--C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCT
T ss_pred CCCCCEEEEEecCCcccC--cC--c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccc
Confidence 888899999999999884 11 1 12 1245677777788887643
Q ss_pred ------------------------------ceeeeCCCCceEEccCCCEEEccccccchh
Q 042539 146 ------------------------------IAYRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 146 ------------------------------iiHrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
++|+|++|.|||++.++.+.|+|||.+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 156 DDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp TSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred hhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 999999999999987666779999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.24 E-value=2.2e-11 Score=118.48 Aligned_cols=143 Identities=17% Similarity=0.207 Sum_probs=106.7
Q ss_pred ceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeec--chhhhhhHHHHHHHHHHHHHHhhcC--CCccceeeeeEEeC
Q 042539 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVD--KSTLHAKHEAERRARWEIRVLSRLS--HPFLPKLLGSLETD 95 (412)
Q Consensus 20 y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~--~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~ 95 (412)
..-++.|+.|.++.||++.... ..+++|+.. ..... .....+.+|+.+++.+. +..+++++.++.+.
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~~------~~~vlr~~~~p~~~~~---~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~ 110 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTPG------QTYVMRAKPGPKSKLL---PSAHAIEREYRVMDALAGTDVPVAKMYALCEDE 110 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECSS------CEEEEECCCC-------------CHHHHHHHHHHHTTSSSCCCCEEEEECCT
T ss_pred CceEEEcCCcccceEEEEEECC------ceEEEEeCCCCCCCCC---CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC
Confidence 3457889999999999987542 238888875 33211 12335667999999997 45688999888776
Q ss_pred ---CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------
Q 042539 96 ---EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN----------------------------- 143 (412)
Q Consensus 96 ---~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~----------------------------- 143 (412)
+..|+||||+.|..+.... ...+++.+...++.++..+|..||+
T Consensus 111 ~~~g~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (359)
T 3dxp_A 111 SVIGRAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQY 186 (359)
T ss_dssp TTTSSCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHH
T ss_pred CccCCeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHH
Confidence 4589999999998874311 1237788889999999999999997
Q ss_pred -----------------------------cCceeeeCCCCceEEccCCC--EEEccccccchh
Q 042539 144 -----------------------------MGIAYRDLKPENILIRQSGH--VTLTDFDLSRNL 175 (412)
Q Consensus 144 -----------------------------~~iiHrDlKp~NiLl~~~g~--vkL~DFGla~~~ 175 (412)
.++||+|+++.|||++.++. +.|+||+.+...
T Consensus 187 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 187 KLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 36999999999999998763 699999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.16 E-value=4e-11 Score=113.97 Aligned_cols=134 Identities=16% Similarity=0.180 Sum_probs=99.2
Q ss_pred eeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCc--cceeeeeEEeCC---
Q 042539 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPF--LPKLLGSLETDE--- 96 (412)
Q Consensus 23 ~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpn--Iv~l~~~~~~~~--- 96 (412)
++.++.|....||++. ..+++|+-... .....+.+|+.+|+.+. +.. +.+++......+
T Consensus 25 i~~~~~G~~n~v~~v~---------~~~vlR~~~~~------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~ 89 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN---------RDFIFKFPKHS------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQ 89 (304)
T ss_dssp CCEEEECSSEEEEEST---------TSEEEEEESSH------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCS
T ss_pred eEecCCCCcceEEEEC---------CEEEEEecCCc------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCC
Confidence 4569999999999753 12899986432 23455677999999884 332 455555544333
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN--------------------------------- 143 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~--------------------------------- 143 (412)
..|+||++++|..+...... .++..+...++.|+...|..||+
T Consensus 90 ~~~~vm~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (304)
T 3sg8_A 90 MSFAGFTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSREL 165 (304)
T ss_dssp CSCEEEECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTS
T ss_pred cceEEEcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccC
Confidence 35899999999988653321 27888888899999999999996
Q ss_pred -------------------------cCceeeeCCCCceEEcc--CCCEEEccccccchh
Q 042539 144 -------------------------MGIAYRDLKPENILIRQ--SGHVTLTDFDLSRNL 175 (412)
Q Consensus 144 -------------------------~~iiHrDlKp~NiLl~~--~g~vkL~DFGla~~~ 175 (412)
..++|+|++|.||+++. .+.+.|+||+.+...
T Consensus 166 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 166 KGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp CHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred CcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 13799999999999998 456799999988654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.71 E-value=3e-07 Score=87.32 Aligned_cols=135 Identities=16% Similarity=0.157 Sum_probs=94.8
Q ss_pred eeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCC---ccceeeeeEE-eCCe
Q 042539 22 ALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP---FLPKLLGSLE-TDEF 97 (412)
Q Consensus 22 ~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hp---nIv~l~~~~~-~~~~ 97 (412)
-++.++.|....||++ +. .+++|+-.. ......+.+|+.+|+.+.+. .|.+.+.+.. ..+.
T Consensus 23 ~v~~l~~G~~n~v~~v-----g~----~~VlR~~~~------~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~ 87 (306)
T 3tdw_A 23 SVESLGEGFRNYAILV-----NG----DWVFRFPKS------QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGN 87 (306)
T ss_dssp CEEEEEECSSEEEEEE-----TT----TEEEEEESS------HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSC
T ss_pred eeeecCCCcceeEEEE-----CC----EEEEEecCC------chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCc
Confidence 3566899999999987 22 289998532 12345677799999999742 3566666664 3456
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHc---------------------------------
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNM--------------------------------- 144 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~--------------------------------- 144 (412)
.|+||++++|..+...... .++..+...++.++...|..||+.
T Consensus 88 ~~~v~e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~ 163 (306)
T 3tdw_A 88 PFVGYRKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPL 163 (306)
T ss_dssp EEEEEECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGG
T ss_pred eEEEEeccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccc
Confidence 7899999999888653211 145555566666666666666642
Q ss_pred ---------------------------CceeeeCCCCceEEcc---CCCE-EEccccccchh
Q 042539 145 ---------------------------GIAYRDLKPENILIRQ---SGHV-TLTDFDLSRNL 175 (412)
Q Consensus 145 ---------------------------~iiHrDlKp~NiLl~~---~g~v-kL~DFGla~~~ 175 (412)
.++|+|++|.|||++. ++.+ .|+||+.+...
T Consensus 164 l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 164 LDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp SCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred cchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3599999999999987 4565 89999988654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.61 E-value=7.5e-07 Score=82.48 Aligned_cols=139 Identities=14% Similarity=0.097 Sum_probs=94.4
Q ss_pred CceeeeeeeccCc-eEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEEeCC
Q 042539 19 NLKALKILGKGAM-GTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLETDE 96 (412)
Q Consensus 19 ~y~~~~~LG~G~f-g~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 96 (412)
.|+.. .+..|.. +.||+......+ ..+.+|+-... ....+.+|..+|+.+. +--|.+++.+..+.+
T Consensus 26 g~~~~-~~~~G~S~~~v~rl~~~~~~----~~~~lk~~~~~-------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~ 93 (272)
T 4gkh_A 26 GYRWA-RDNVGQSGATIYRLYGKPNA----PELFLKHGKGS-------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPD 93 (272)
T ss_dssp TCEEE-EEECSSSSCEEEEEECCTTC----CCEEEEEEETH-------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred CCeEE-EccCCCcCCeEEEEEecCCC----eEEEEEECCCC-------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECC
Confidence 34433 3344544 479987665433 33899986433 2334566999998886 434788899999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHc--------------------------------
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNM-------------------------------- 144 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~-------------------------------- 144 (412)
..|+|||+++|.++....... ......+..++...|.-||+.
T Consensus 94 ~~~lvme~l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (272)
T 4gkh_A 94 DAWLLTTAIPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDF 167 (272)
T ss_dssp EEEEEEECCCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGC
T ss_pred eEEEEEEeeCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhc
Confidence 999999999998876543321 122234455555556655531
Q ss_pred --------------------------CceeeeCCCCceEEccCCCEEEccccccchh
Q 042539 145 --------------------------GIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 145 --------------------------~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
.++|+|+.+.|||++..+.+-|+||+.+...
T Consensus 168 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 168 DDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp CGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred cccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 2799999999999988777789999998743
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.36 E-value=3.8e-06 Score=80.16 Aligned_cols=139 Identities=15% Similarity=0.198 Sum_probs=79.0
Q ss_pred eeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC--CCccceeee------eEE
Q 042539 22 ALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS--HPFLPKLLG------SLE 93 (412)
Q Consensus 22 ~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~------~~~ 93 (412)
-++.|+.|..+.||++.... + .+++|+..... ..+..|+.+++.|. .-.|.+++. +..
T Consensus 36 ~~~~l~gG~~n~~~~v~~~~-----~-~~vlk~~~~~~--------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~ 101 (346)
T 2q83_A 36 KIDVIQGNQMALVWKVHTDS-----G-AVCLKRIHRPE--------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSK 101 (346)
T ss_dssp EEEECC----CEEEEEEETT-----E-EEEEEEECSCH--------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEE
T ss_pred EeeeccccccCcEEEEEeCC-----C-CEEEEecCCCH--------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEE
Confidence 34567777899999987532 1 28999986521 11223455555553 113444443 224
Q ss_pred eCCeEEEEeeccCCCCchh--------------HHHhhCCC---C--------C-CHH--------H-------------
Q 042539 94 TDEFLAWAVPYCPGGDLNV--------------LRYKQNDR---V--------F-SPS--------V------------- 126 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~--------------~~~~~~~~---~--------l-~~~--------~------------- 126 (412)
..+..++||+|++|..+.. .++..... . + ... .
T Consensus 102 ~~~~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 181 (346)
T 2q83_A 102 HGSFLFVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKE 181 (346)
T ss_dssp ETTEEEEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSS
T ss_pred ECCEEEEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccC
Confidence 5678899999999975520 11111100 0 0 000 0
Q ss_pred ----------HHHHHHHHHHHHHHHHH-------------cCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 127 ----------IRFYLSEIICAIEHLHN-------------MGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 127 ----------~~~~~~qi~~aL~yLH~-------------~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
+..+..++..++++|++ .++||+|+++.|||++.++.+.|+||+.+..
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 182 DPFSQLYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CcHHHHHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 11122234445666653 5799999999999998888999999998864
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=2.3e-06 Score=83.96 Aligned_cols=81 Identities=21% Similarity=0.235 Sum_probs=49.2
Q ss_pred eeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhh-hhh--HHHHHHHHHHHHHHhhcCC--Cc-cceeeeeEEeC
Q 042539 22 ALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTL-HAK--HEAERRARWEIRVLSRLSH--PF-LPKLLGSLETD 95 (412)
Q Consensus 22 ~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~-~~~--~~~~~~~~~Ei~il~~l~h--pn-Iv~l~~~~~~~ 95 (412)
-++.||.|..+.||++.....+ ..|++|......- ... .....+..+|+++++.+.. +. +.+++.+ +.
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~----~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~ 107 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHD----RALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT 107 (397)
T ss_dssp EEEECCSSSSEEEEEEEC--------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET
T ss_pred EEEECCCCceEEEEEEEECCCC----cEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cC
Confidence 4678999999999999654322 3499998643210 000 0112345568889888742 33 4456543 44
Q ss_pred CeEEEEeeccCCC
Q 042539 96 EFLAWAVPYCPGG 108 (412)
Q Consensus 96 ~~~~lv~e~~~gg 108 (412)
+..++|||++.|.
T Consensus 108 ~~~~lvmE~l~g~ 120 (397)
T 2olc_A 108 EMAVTVMEDLSHL 120 (397)
T ss_dssp TTTEEEECCCTTS
T ss_pred CccEEEEEeCCCc
Confidence 5568999999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=3.1e-06 Score=81.68 Aligned_cols=88 Identities=10% Similarity=0.089 Sum_probs=54.9
Q ss_pred ceeeeee-eccCceEEEEEEEcC--CCCCCCCceEEeeecchh---hhhhHHHHHHHHHHHHHHhhcC-C--Cccceeee
Q 042539 20 LKALKIL-GKGAMGTVFLVHDRA--ADPTARCPFALKVVDKST---LHAKHEAERRARWEIRVLSRLS-H--PFLPKLLG 90 (412)
Q Consensus 20 y~~~~~L-G~G~fg~V~la~~~~--~~~~~~~~vAiK~i~~~~---~~~~~~~~~~~~~Ei~il~~l~-h--pnIv~l~~ 90 (412)
...++.| +.|....+|++.... .+...+..+++|+-.... ... ...+.+|+.+++.+. + -.+.+++.
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~----~~~~~~E~~~l~~L~~~~~vpvP~v~~ 97 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP----TYRLDHQFEVIRLVGELTDVPVPRVRW 97 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS----CCCHHHHHHHHHHHHHHCCSCCCCEEE
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc----hhHHHHHHHHHHHHhhcCCCCCCcEEE
Confidence 3445778 889999999886530 000002338888765432 100 123445888888885 3 35778888
Q ss_pred eEEeC---CeEEEEeeccCCCCch
Q 042539 91 SLETD---EFLAWAVPYCPGGDLN 111 (412)
Q Consensus 91 ~~~~~---~~~~lv~e~~~gg~L~ 111 (412)
+..+. ...|+|||+++|..+.
T Consensus 98 ~~~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 98 IETTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp EECSSTTTSSCEEEEECCCCBCCC
T ss_pred EccCCCccCCceEEEEecCCCChh
Confidence 77655 3568999999997654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.82 E-value=0.00018 Score=68.24 Aligned_cols=77 Identities=18% Similarity=0.155 Sum_probs=58.4
Q ss_pred eeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC---CCccceeeeeEEeCCe
Q 042539 21 KALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS---HPFLPKLLGSLETDEF 97 (412)
Q Consensus 21 ~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~ 97 (412)
.-++.|+.|....+|++... +..+++|+-.... ...+.+|+..|+.|. ...+++++.+....+.
T Consensus 39 ~~~~~l~gG~~n~~y~v~~~------~~~~vlK~~~~~~-------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~ 105 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLINDE------VQTVFVKINERSY-------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGH 105 (312)
T ss_dssp CEEEEECCSSSSEEEEEESS------SCEEEEEEEEGGG-------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSE
T ss_pred eeeEEeCCccceeeeEEEEC------CCeEEEEeCCccc-------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCc
Confidence 34678999999999998742 2238899875321 334566888888884 3568889988888889
Q ss_pred EEEEeeccCCCCc
Q 042539 98 LAWAVPYCPGGDL 110 (412)
Q Consensus 98 ~~lv~e~~~gg~L 110 (412)
.++|||+++|..+
T Consensus 106 ~~lvme~l~G~~~ 118 (312)
T 3jr1_A 106 SFLLLEALNKSKN 118 (312)
T ss_dssp EEEEEECCCCCCC
T ss_pred eEEEEEeccCCCC
Confidence 9999999999765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.0002 Score=70.77 Aligned_cols=32 Identities=16% Similarity=0.209 Sum_probs=28.3
Q ss_pred HcCceeeeCCCCceEEccCCCEEEccccccchh
Q 042539 143 NMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 143 ~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
...++|+|++|.|||++.++ ++|+||+.+..-
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 45799999999999998877 999999988764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00026 Score=66.45 Aligned_cols=138 Identities=16% Similarity=0.121 Sum_probs=76.8
Q ss_pred ceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEEeCCeE
Q 042539 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLETDEFL 98 (412)
Q Consensus 20 y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 98 (412)
+.-++.|+.|....+|++ . .+.+|+........ ....+|+.+++.+. +.-..+++... .+.-
T Consensus 20 ~~~i~~l~gG~tN~~~~~------~----~~vlR~~~~~~~~~-----~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~ 82 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA------G----DLCLRIPGKGTEEY-----INRANEAVAAREAAKAGVSPEVLHVD--PATG 82 (301)
T ss_dssp CCSCEEEESCSSEEEEEE------T----TEEEEEECC----C-----CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTC
T ss_pred ccceeEcCCcccccccee------e----eEEEECCCCCccce-----eCHHHHHHHHHHHHHcCCCCceEEEE--CCCC
Confidence 333889999999999998 1 28999875432110 01123777777775 32225666543 3345
Q ss_pred EEEeecc-CCCCchhHHHh----------------hC-CCCCC-----HHHHHHHHHH--------------HHHHHHHH
Q 042539 99 AWAVPYC-PGGDLNVLRYK----------------QN-DRVFS-----PSVIRFYLSE--------------IICAIEHL 141 (412)
Q Consensus 99 ~lv~e~~-~gg~L~~~~~~----------------~~-~~~l~-----~~~~~~~~~q--------------i~~aL~yL 141 (412)
++++||+ .|..+...... +. ...+. ...+..+..+ +...+..+
T Consensus 83 ~~v~e~i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l 162 (301)
T 3dxq_A 83 VMVTRYIAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGV 162 (301)
T ss_dssp CEEEECCTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHH
T ss_pred EEEEeecCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHH
Confidence 7899999 77665321000 00 00010 0111111111 11112222
Q ss_pred H----H----cCceeeeCCCCceEEccCCCEEEccccccchh
Q 042539 142 H----N----MGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 142 H----~----~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
. . ..++|+|+.+.||+ ..+|.+.|+||..+..-
T Consensus 163 ~~~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 163 RSALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp HHHHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred HHHHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 1 1 13899999999999 56778999999988654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00029 Score=66.63 Aligned_cols=144 Identities=21% Similarity=0.229 Sum_probs=79.7
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CC-ccceeeee-----
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HP-FLPKLLGS----- 91 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hp-nIv~l~~~----- 91 (412)
+..-++.|+.|....||++.... + .+++|+..... . ...+..|+.+++.|. +. .+.+++..
T Consensus 23 ~~~~~~~i~~G~~n~~~~v~~~~-g-----~~vlk~~~~~~--~----~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~ 90 (322)
T 2ppq_A 23 SLTSYKGIAEGVENSNFLLHTTK-D-----PLILTLYEKRV--E----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGEL 90 (322)
T ss_dssp CEEEEEEECC---EEEEEEEESS-C-----CEEEEEECC---------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCS
T ss_pred cceEeeccCCCcccceEEEEeCC-c-----cEEEEEeCCCC--C----HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCE
Confidence 34456778889999999987532 1 28999886521 1 112334677777664 21 13344321
Q ss_pred -EEeCCeEEEEeeccCCCCchh--------------HHHhhCCC---C----CCHHHHHH---------------HHHHH
Q 042539 92 -LETDEFLAWAVPYCPGGDLNV--------------LRYKQNDR---V----FSPSVIRF---------------YLSEI 134 (412)
Q Consensus 92 -~~~~~~~~lv~e~~~gg~L~~--------------~~~~~~~~---~----l~~~~~~~---------------~~~qi 134 (412)
....+..+++|++++|..+.. .++..... . .....-.. +...+
T Consensus 91 ~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l 170 (322)
T 2ppq_A 91 LGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEI 170 (322)
T ss_dssp CEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHH
T ss_pred EEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHH
Confidence 233467799999999865421 01111100 0 00000000 00113
Q ss_pred HHHHHHHHH-------cCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 135 ICAIEHLHN-------MGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 135 ~~aL~yLH~-------~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
...++.+++ .++||+|+.+.|||++.++.+.|+||+.+..
T Consensus 171 ~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 171 RPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 344555553 3699999999999998776668999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0011 Score=65.80 Aligned_cols=79 Identities=22% Similarity=0.250 Sum_probs=49.5
Q ss_pred eeeeeeccCceEEEEEEEcCCCC---CCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEEeCCe
Q 042539 22 ALKILGKGAMGTVFLVHDRAADP---TARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLETDEF 97 (412)
Q Consensus 22 ~~~~LG~G~fg~V~la~~~~~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 97 (412)
-++.|+.|-...||++....... ..+..+.+|+..... . ...+.+|..+++.|. +.-..++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~----~~~li~E~~~l~~L~~~g~~P~l~~~~~~--- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T----ESHLVAESVIFTLLSERHLGPKLYGIFSG--- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C----HHHHHHHHHHHHHHHHTTSSSCEEEEETT---
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c----HHHHHHHHHHHHHHHhCCCCCcEEEEeCC---
Confidence 45678889999999997642110 013458899873311 1 012235888888885 4334677776643
Q ss_pred EEEEeeccCCCCc
Q 042539 98 LAWAVPYCPGGDL 110 (412)
Q Consensus 98 ~~lv~e~~~gg~L 110 (412)
.+|++|++|..+
T Consensus 148 -g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 -GRLEEYIPSRPL 159 (429)
T ss_dssp -EEEECCCCEEEC
T ss_pred -CEEEEEeCCccc
Confidence 289999987554
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0029 Score=58.80 Aligned_cols=79 Identities=15% Similarity=0.088 Sum_probs=52.0
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-C--CccceeeeeEEeC
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-H--PFLPKLLGSLETD 95 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-h--pnIv~l~~~~~~~ 95 (412)
...-++.+|.|..+.||++... .++.|.+|+-....... ...+.+|+..|+.|. . --+++++.+.
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~-----DG~~~~vK~~~~~~~~~----~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--- 83 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA-----DGTPLFVKALPDDAPAL----DGLFRAEALGLDWLGRSFGSPVPQVAGWD--- 83 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET-----TSCEEEEEECCTTCCCC----TTHHHHHHHHHHHHTCSTTCCSCCEEEEE---
T ss_pred CeEEEEecCCCCCeEEEEEEEC-----CCCEEEEEEeCCCCcch----hhHHHHHHHHHHHHHhhCCCCcceEEecc---
Confidence 4566788999999999998764 23448999764332211 123456899999885 2 2355555542
Q ss_pred CeEEEEeeccCCCCc
Q 042539 96 EFLAWAVPYCPGGDL 110 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L 110 (412)
.-++|||++.++..
T Consensus 84 -~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 84 -DRTLAMEWVDERPP 97 (288)
T ss_dssp -TTEEEEECCCCCCC
T ss_pred -CceEEEEeecccCC
Confidence 23789999987654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0009 Score=63.61 Aligned_cols=32 Identities=25% Similarity=0.315 Sum_probs=27.8
Q ss_pred cCceeeeCCCCceEEccC----CCEEEccccccchh
Q 042539 144 MGIAYRDLKPENILIRQS----GHVTLTDFDLSRNL 175 (412)
Q Consensus 144 ~~iiHrDlKp~NiLl~~~----g~vkL~DFGla~~~ 175 (412)
..++|+|+.+.|||++.+ +.+.|+||+.+..-
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 469999999999999874 67999999988754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0021 Score=60.79 Aligned_cols=140 Identities=18% Similarity=0.152 Sum_probs=77.0
Q ss_pred eeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-C-Cccceeeee-----EEeC
Q 042539 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-H-PFLPKLLGS-----LETD 95 (412)
Q Consensus 23 ~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-h-pnIv~l~~~-----~~~~ 95 (412)
+..|+ |....||++.... +..+++|+...... . ...+..|..+++.+. + -.+++++.. ...+
T Consensus 31 ~~~l~-g~~n~~y~v~~~~-----g~~~vlK~~~~~~~-~----~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~ 99 (328)
T 1zyl_A 31 LTPLN-SYENRVYQFQDED-----RRRFVVKFYRPERW-T----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQ 99 (328)
T ss_dssp CEEEC-CSSSEEEEECCTT-----CCCEEEEEECTTTS-C----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEET
T ss_pred EEeec-CcccceEEEEcCC-----CCEEEEEEcCCCCC-C----HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEEC
Confidence 34566 8888999875421 22389999853321 1 123344777777774 2 124445443 2235
Q ss_pred CeEEEEeeccCCCCchh-----H---------HHhh-CC------CCCCHHH----------------------HHHHHH
Q 042539 96 EFLAWAVPYCPGGDLNV-----L---------RYKQ-ND------RVFSPSV----------------------IRFYLS 132 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~-----~---------~~~~-~~------~~l~~~~----------------------~~~~~~ 132 (412)
+..++||++++|..+.. + ++.. .. ..++... ....+.
T Consensus 100 g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 179 (328)
T 1zyl_A 100 GFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATD 179 (328)
T ss_dssp TEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHH
T ss_pred CEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHH
Confidence 56788999998865421 0 1110 00 0111110 011111
Q ss_pred HHHHHHHHH----HHcCceeeeCCCCceEEccCCCEEEccccccchh
Q 042539 133 EIICAIEHL----HNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 133 qi~~aL~yL----H~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
+++..++-+ ....++|+|+++.|||++ + .+.|+||+.+...
T Consensus 180 ~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 180 ELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp HHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred HHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 222222221 123589999999999998 4 8999999988643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0012 Score=64.26 Aligned_cols=148 Identities=17% Similarity=0.188 Sum_probs=84.9
Q ss_pred cCceeeeeeeccCceEEEEEEEcCC---CCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEE
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAA---DPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLE 93 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~---~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~ 93 (412)
+++. ++.|..|-...+|++..... .......|.+|+.-.. . .. .....+|.++++.|. +.-..++++++.
T Consensus 51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~-~~---~~~~~rE~~vl~~L~~~gv~P~ll~~~~ 124 (379)
T 3feg_A 51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-L-QG---VDSLVLESVMFAILAERSLGPQLYGVFP 124 (379)
T ss_dssp GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CC---HHHHHHHHHHHHHHHHTTSSCCEEEEET
T ss_pred CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-c-ch---HHHHHHHHHHHHHHHhcCCCCeEEEEcC
Confidence 4454 45677788899999876321 0112345888875221 1 11 122336999998885 444577777765
Q ss_pred eCCeEEEEeeccCCCCchhH-----------------HHhhC---CCCC--CHHHHHHHHHHHHH---------------
Q 042539 94 TDEFLAWAVPYCPGGDLNVL-----------------RYKQN---DRVF--SPSVIRFYLSEIIC--------------- 136 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~-----------------~~~~~---~~~l--~~~~~~~~~~qi~~--------------- 136 (412)
++ +||||++|..|..- ++... .... -..++..|..++-.
T Consensus 125 ~g----~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~ 200 (379)
T 3feg_A 125 EG----RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMY 200 (379)
T ss_dssp TE----EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHT
T ss_pred Cc----cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhH
Confidence 42 89999998665311 01110 0011 13455666554422
Q ss_pred ----HHHHHHH--------cCceeeeCCCCceEEccC----CCEEEccccccchh
Q 042539 137 ----AIEHLHN--------MGIAYRDLKPENILIRQS----GHVTLTDFDLSRNL 175 (412)
Q Consensus 137 ----aL~yLH~--------~~iiHrDlKp~NiLl~~~----g~vkL~DFGla~~~ 175 (412)
.++.|.+ ..++|+|+.+.|||++.+ +.+.|+||..|..-
T Consensus 201 ~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~ 255 (379)
T 3feg_A 201 SLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN 255 (379)
T ss_dssp THHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred HHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence 2333332 259999999999999876 78999999988743
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0029 Score=61.07 Aligned_cols=80 Identities=18% Similarity=0.196 Sum_probs=44.4
Q ss_pred eeeeeeccCceEEEEEEEcCCC----CCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEEeCC
Q 042539 22 ALKILGKGAMGTVFLVHDRAAD----PTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLETDE 96 (412)
Q Consensus 22 ~~~~LG~G~fg~V~la~~~~~~----~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 96 (412)
-++.|+.|....+|++.....+ ......+.+|+........ . ...+|..+++.+. +.-+.++++.+ .
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~----~-~~~~E~~~l~~L~~~g~~P~~~~~~--~- 108 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL----Y-NTISEFEVYKTMSKYKIAPQLLNTF--N- 108 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT----S-CHHHHHHHHHHHHHTTSSCCEEEEE--T-
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce----e-cHHHHHHHHHHHHhcCCCCceEEec--C-
Confidence 4567888888999998764310 0011348888764422110 0 1234888888885 33355777654 2
Q ss_pred eEEEEeeccCCCCc
Q 042539 97 FLAWAVPYCPGGDL 110 (412)
Q Consensus 97 ~~~lv~e~~~gg~L 110 (412)
-++||+|++|..+
T Consensus 109 -~~~v~e~i~G~~l 121 (369)
T 3c5i_A 109 -GGRIEEWLYGDPL 121 (369)
T ss_dssp -TEEEEECCCSEEC
T ss_pred -CcEEEEEecCCcC
Confidence 2689999998654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0074 Score=53.63 Aligned_cols=122 Identities=16% Similarity=0.051 Sum_probs=78.4
Q ss_pred CchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeeCCCCceEEccCCCEEEccccccchhhchhhhhhhccc
Q 042539 109 DLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN-MGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLN 187 (412)
Q Consensus 109 ~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 187 (412)
+|.+.+...+ .+++|++++.++.|.+.+|.-+-. ..-..+=+.|..|++..+|+|.+.+ +.+.
T Consensus 34 SL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------- 97 (229)
T 2yle_A 34 SLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------- 97 (229)
T ss_dssp EHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred cHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------
Confidence 5666666654 579999999999999999877621 1222334457899999999987774 2110
Q ss_pred CCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecCCCCCc
Q 042539 188 NNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEF 267 (412)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~ 267 (412)
.....+.|||... ...+.
T Consensus 98 -------------------------------------------------------------~~~~~~~~pe~~~-~~~te 115 (229)
T 2yle_A 98 -------------------------------------------------------------AGEPPPVAGKLGY-SQCME 115 (229)
T ss_dssp ----------------------------------------------------------------------CCSS-SSSCH
T ss_pred -------------------------------------------------------------ccccCCCChhhcc-ccchH
Confidence 0122466777763 34467
Q ss_pred hhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCChHHHHHHHHhhhh
Q 042539 268 AVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVGQRTALTDLIQRLLEK 324 (412)
Q Consensus 268 ~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~dli~~~L~~ 324 (412)
+.=|||||+++|.-+--..|= ..-..+++++..||..|..-
T Consensus 116 ~~~IysLG~tLY~ALDygL~e----------------~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 116 TEVIESLGIIIYKALDYGLKE----------------NEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp HHHHHHHHHHHHHHHTTTCCT----------------TEEECCCHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHHhhcCCCc----------------ccchhhCHHHHHHHHHHHhc
Confidence 889999999999888422211 11235688899999988765
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0041 Score=59.45 Aligned_cols=32 Identities=16% Similarity=0.272 Sum_probs=28.4
Q ss_pred cCceeeeCCCCceEEccCCCEEEccccccchh
Q 042539 144 MGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 144 ~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
.+++|+|+.+.||+++.++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 36999999999999998889999999988654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0068 Score=60.47 Aligned_cols=76 Identities=13% Similarity=0.182 Sum_probs=46.9
Q ss_pred eeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCC-ccceeeeeEEeCCeEEE
Q 042539 22 ALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP-FLPKLLGSLETDEFLAW 100 (412)
Q Consensus 22 ~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~l 100 (412)
-++.|+.|-...+|++.... .+..|.+|+....... ... -.+|..+++.|... -..++++++. + .+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~----~~~~~vLRi~g~~~~~----~id-R~~E~~vl~~L~~~gl~P~ll~~~~--~--G~ 178 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMS----KQAKYLIRLYGPKTDE----IIN-REREKKISCILYNKNIAKKIYVFFT--N--GR 178 (458)
T ss_dssp EEEEECC--CEEEEEEEETT----TTEEEEEEEECC-CCS----CSC-HHHHHHHHHHHTTSSSBCCEEEEET--T--EE
T ss_pred EEEEcCCCeEeEEEEEEECC----CCceEEEEECCCChhh----hcC-HHHHHHHHHHHHhcCCCCCEEEEeC--C--eE
Confidence 45678889999999987643 1234889987432110 000 13488899999743 3467777773 2 25
Q ss_pred EeeccCCCCc
Q 042539 101 AVPYCPGGDL 110 (412)
Q Consensus 101 v~e~~~gg~L 110 (412)
||||++|..|
T Consensus 179 v~e~I~G~~l 188 (458)
T 2qg7_A 179 IEEFMDGYAL 188 (458)
T ss_dssp EEECCCSEEC
T ss_pred EEEeeCCccC
Confidence 9999998555
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.57 E-value=0.064 Score=52.81 Aligned_cols=81 Identities=15% Similarity=0.169 Sum_probs=48.5
Q ss_pred eeeeeeeccCceEEEEEEEcCCCC---CCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEEeCC
Q 042539 21 KALKILGKGAMGTVFLVHDRAADP---TARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLETDE 96 (412)
Q Consensus 21 ~~~~~LG~G~fg~V~la~~~~~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 96 (412)
.-++.|..|-...+|++....... .....|.+++....... ... ..+|..+++.+. +.-..++++.+.
T Consensus 73 ~~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~----~id-R~~E~~~l~~L~~~gi~P~l~~~~~--- 144 (424)
T 3mes_A 73 IEVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK----FYD-SKVELDVFRYLSNINIAPNIIADFP--- 144 (424)
T ss_dssp EEEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C----CCC-HHHHHHHHHHHHHTTSSCCEEEEET---
T ss_pred eEEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch----hcC-HHHHHHHHHHHHhcCCCCCEEEEcC---
Confidence 345677778899999987642111 01345888886432110 011 124888888885 444566776443
Q ss_pred eEEEEeeccCCCCc
Q 042539 97 FLAWAVPYCPGGDL 110 (412)
Q Consensus 97 ~~~lv~e~~~gg~L 110 (412)
-++||+|++|..|
T Consensus 145 -~~~I~efI~G~~l 157 (424)
T 3mes_A 145 -EGRIEEFIDGEPL 157 (424)
T ss_dssp -TEEEEECCCSEEC
T ss_pred -CCEEEEEeCCccC
Confidence 2789999999764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.73 E-value=0.17 Score=49.31 Aligned_cols=30 Identities=27% Similarity=0.394 Sum_probs=25.8
Q ss_pred ceeeeCCCCceEE------ccCCCEEEccccccchh
Q 042539 146 IAYRDLKPENILI------RQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 146 iiHrDlKp~NiLl------~~~g~vkL~DFGla~~~ 175 (412)
++|+|+.+.|||+ +..+.+.++||..|..-
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 6899999999999 44577999999998754
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=84.02 E-value=0.12 Score=51.52 Aligned_cols=64 Identities=8% Similarity=-0.031 Sum_probs=17.9
Q ss_pred eeeeeeeccCceEEEEEEEcCCCCCCCCceEE------eeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 21 KALKILGKGAMGTVFLVHDRAADPTARCPFAL------KVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 21 ~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAi------K~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
.+.+.|| ||.||++..... ..+||+ |..+.... ..+....+.+|..+++.++|+|+++.+.+-.
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~----~~~Vav~~~~~~K~~~~~~~--~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKK----HMPVLKETHDERDSTGQDGV--SEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC-------------CCBGGGC-------------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhccccccc----CCchhhhhccCccccccccc--cccccccccccccccccccccccCCCcceEE
Confidence 4556676 999999877542 234888 65543222 2233445677999999999999999988654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 412 | ||||
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-56 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-47 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-40 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-37 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-23 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-36 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-19 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-35 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-34 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-29 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-34 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-34 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-22 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-34 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-33 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-18 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-33 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-19 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-33 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-23 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-32 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-32 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-32 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-27 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-32 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-32 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-08 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-32 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-32 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-32 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-21 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-31 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-23 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-31 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-28 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-31 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-31 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-31 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-12 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-30 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-30 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-30 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-13 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-30 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-25 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-30 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-11 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-30 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-12 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-30 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-21 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-30 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-18 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-30 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-30 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-15 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-29 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-29 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-29 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-29 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-18 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-29 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-28 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-28 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-28 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-15 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-28 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-10 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-27 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-27 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-20 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-27 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-24 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-27 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-11 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-26 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-25 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-26 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-26 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-17 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-25 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-25 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-24 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-09 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-24 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-23 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-21 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-16 |
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 6e-56
Identities = 93/358 (25%), Positives = 149/358 (41%), Gaps = 74/358 (20%)
Query: 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRV 76
+++ K+LGKG+ G VFL + + FA+K + K + + E + +
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTN----QFFAIKALKKDVVLMDDDVECTMVEKRVL 56
Query: 77 LSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIIC 136
HPFL + + +T E L + + Y GGDL + + Q+ F S FY +EII
Sbjct: 57 SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAEIIL 114
Query: 137 AIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPV 196
++ LH+ GI YRDLK +NIL+ + GH+ + DF + + +
Sbjct: 115 GLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN--------------------M 154
Query: 197 TENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256
+ K + T A PE G K S
Sbjct: 155 LGDAKTNTFCGTPDYIA-PEILLGQKYNHS------------------------------ 183
Query: 257 PEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVGQ-RTALT 315
VDWW+ G+L YEML G +PF G++ +E F ++ M P +
Sbjct: 184 ------------VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAK 231
Query: 316 DLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD-LLTDVLRPPFIPSREENDLTE 372
DL+ +L ++P KRLG +I++H F+ + W+ L + PPF P +
Sbjct: 232 DLLVKLFVREPEKRLGV---RGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCS 286
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 184 bits (467), Expect = 4e-55
Identities = 92/366 (25%), Positives = 151/366 (41%), Gaps = 78/366 (21%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAE--RRARW 72
L +++ +I+G+G G V+ +A+K +DK + K R
Sbjct: 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTG----KMYAMKCLDKKRIKMKQGETLALNERI 56
Query: 73 EIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLS 132
+ ++S PF+ + + T + L++ + GGDL+ + VFS + +RFY +
Sbjct: 57 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGVFSEADMRFYAA 114
Query: 133 EIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFP 192
EII +EH+HN + YRDLKP NIL+ + GHV ++D L+ +
Sbjct: 115 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF----------------- 157
Query: 193 VLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252
K H + T A + G+ SA
Sbjct: 158 -----SKKKPHASVGTHGYMAPEVLQKGVAYDSSA------------------------- 187
Query: 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKET---FRNVLMKTPEFVG 309
DW++LG + +++L G +PFR K+ R L E
Sbjct: 188 -----------------DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 230
Query: 310 QRT-ALTDLIQRLLEKDPVKRLGYL-RGACEIKEHVFFKGVRWDLLTD-VLRPPFIPSRE 366
+ L L++ LL++D +RLG L RGA E+KE FF+ + W ++ PP IP R
Sbjct: 231 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRG 290
Query: 367 ENDLTE 372
E + +
Sbjct: 291 EVNAAD 296
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 5e-47
Identities = 73/348 (20%), Positives = 113/348 (32%), Gaps = 85/348 (24%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
+ +G+GA GTV+ D A A++ ++ K EI V+ +
Sbjct: 25 FEKIGQGASGTVYTAMDVATG----QEVAIRQMNLQQQPKKELIIN----EILVMRENKN 76
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLH 142
P + L S + L + Y GG L + + I E + A+E LH
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLH 133
Query: 143 NMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKR 202
+ + +RD+K +NIL+ G V LTDF + E KR
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--------------------EQSKR 173
Query: 203 HRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRG 262
+ T + A PE T +
Sbjct: 174 STMVGTPYWMA-PEVVTRKAYGPKVDI--------------------------------- 199
Query: 263 DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK-TPEFVGQRT---ALTDLI 318
W+LGI+ EM+ G P+ +N + TPE D +
Sbjct: 200 ---------WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 250
Query: 319 QRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSRE 366
R L+ D KR A E+ +H F K + L P ++E
Sbjct: 251 NRCLDMDVEKRG----SAKELLQHQFLKIAKP---LSSLTPLIAAAKE 291
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 7e-40
Identities = 59/348 (16%), Positives = 111/348 (31%), Gaps = 54/348 (15%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
L D+ + + LG G G VF V + + A K++ K + E+
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSG----LVMARKLIHLEI---KPAIRNQIIREL 55
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEI 134
+VL + P++ G+ +D ++ + + GG L+ + K ++ +
Sbjct: 56 QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAV 113
Query: 135 ICAIEHLHNM-GIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPV 193
I + +L I +RD+KP NIL+ G + L DF +S L
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL------------------ 155
Query: 194 LPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSF-------DNGERSN 246
+ + + TR + PE G + + + S G
Sbjct: 156 ----IDSMANSFVGTRSYMS-PERLQGTHYSVQSDIW-------SMGLSLVEMAVGRYPI 203
Query: 247 SFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE 306
+E + +G YG E ++ + P
Sbjct: 204 PPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPP 263
Query: 307 FVGQRT---ALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351
+ D + + L K+P +R ++ H F K +
Sbjct: 264 KLPSGVFSLEFQDFVNKCLIKNPAERA----DLKQLMVHAFIKRSDAE 307
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 1e-37
Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 7/159 (4%)
Query: 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRV 76
L++ + + LGKG G V+L ++ + ALKV+ K+ L K E + R E+ +
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSK----FILALKVLFKAQLE-KAGVEHQLRREVEI 59
Query: 77 LSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIIC 136
S L HP + +L G + + Y P G + R Q F Y++E+
Sbjct: 60 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV--YRELQKLSKFDEQRTATYITELAN 117
Query: 137 AIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
A+ + H+ + +RD+KPEN+L+ +G + + DF S +
Sbjct: 118 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 156
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.2 bits (239), Expect = 3e-23
Identities = 35/110 (31%), Positives = 52/110 (47%), Gaps = 5/110 (4%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFR 298
R + GT +Y+ PE++ G H+ VD W+LG+L YE L G PF +ET++
Sbjct: 155 HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK 214
Query: 299 NVLMKTPEFVGQRT-ALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347
+ F T DLI RLL+ +P +R E+ EH +
Sbjct: 215 RISRVEFTFPDFVTEGARDLISRLLKHNPSQRP----MLREVLEHPWITA 260
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 4e-36
Identities = 43/160 (26%), Positives = 71/160 (44%), Gaps = 9/160 (5%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVL 77
D + + LG GA G V+ ++ A KV+D E EI +L
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETS----VLAAAKVIDTK----SEEELEDYMVEIDIL 63
Query: 78 SRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICA 137
+ HP + KLL + + L + +C GG ++ + + R + S I+ + + A
Sbjct: 64 ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDA 122
Query: 138 IEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177
+ +LH+ I +RDLK NIL G + L DF +S +
Sbjct: 123 LNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.9 bits (207), Expect = 8e-19
Identities = 27/117 (23%), Positives = 48/117 (41%), Gaps = 13/117 (11%)
Query: 240 DNGERSNSFVGTEEYVSPEVVRGD-----GHEFAVDWWALGILTYEMLYGTTPFRGKNRK 294
+R +SF+GT +++PEVV + +++ D W+LGI EM P N
Sbjct: 162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM 221
Query: 295 ETFRNVLMKTPEFVGQR----TALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347
+ P + Q + D +++ LEK+ R ++ +H F
Sbjct: 222 RVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARW----TTSQLLQHPFVTV 274
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 8e-36
Identities = 66/373 (17%), Positives = 114/373 (30%), Gaps = 113/373 (30%)
Query: 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIR 75
++ + L +G+G G VF R ALK V + K A EI+
Sbjct: 8 EVSKYEKLAKIGQGTFGEVFKARHRKTG----QKVALKKVLME--NEKEGFPITALREIK 61
Query: 76 VLSRLSHPFLPKLLGSLETDEFLAWAV--------PYCPGGDLNVLRYKQNDRVFSPSVI 127
+L L H + L+ T +C F+ S I
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNVLVKFTLSEI 119
Query: 128 RFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLN 187
+ + ++ + ++H I +RD+K N+LI + G + L DF L+R
Sbjct: 120 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR-------------- 165
Query: 188 NNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNS 247
F + ++ + R++T W
Sbjct: 166 --AFSLAKNSQPNRYTNRVVTLW------------------------------------- 186
Query: 248 FVGTEEYVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNV------ 300
Y PE++ G+ + +D W G + EM + +G + +
Sbjct: 187 ------YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240
Query: 301 -------------LMKTPEFVGQRT--------------ALTDLIQRLLEKDPVKRLGYL 333
L + E V + DLI +LL DP +R+
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI--- 297
Query: 334 RGACEIKEHVFFK 346
+ + H FF
Sbjct: 298 -DSDDALNHDFFW 309
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 130 bits (327), Expect = 3e-35
Identities = 59/340 (17%), Positives = 116/340 (34%), Gaps = 48/340 (14%)
Query: 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIR 75
+ D+ + ++ LG+G VF + T +K++ +++ + EI+
Sbjct: 33 NQDDYQLVRKLGRGKYSEVFEAINI----TNNEKVVVKILKP-------VKKKKIKREIK 81
Query: 76 VLSRLS-HPFLPKLLGSLE--TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLS 132
+L L P + L ++ A + D KQ + + IRFY+
Sbjct: 82 ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF-----KQLYQTLTDYDIRFYMY 136
Query: 133 EIICAIEHLHNMGIAYRDLKPENILI-RQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKF 191
EI+ A+++ H+MGI +RD+KP N++I + + L D+ L+
Sbjct: 137 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY---------------- 180
Query: 192 PVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251
+ + R+ +R+ S + + S +
Sbjct: 181 -----HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235
Query: 252 EEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVGQR 311
+ + G E D+ + + + R ++ + +
Sbjct: 236 NYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKR---WERFVHSENQHLVS 292
Query: 312 TALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351
D + +LL D RL A E EH +F V D
Sbjct: 293 PEALDFLDKLLRYDHQSRL----TAREAMEHPYFYTVVKD 328
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 1e-34
Identities = 57/156 (36%), Positives = 88/156 (56%), Gaps = 7/156 (4%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVL 77
++ K KILG+G+ TV L + A +A+K+++K + K E V+
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATS----REYAIKILEKRHII-KENKVPYVTRERDVM 62
Query: 78 SRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICA 137
SRL HPF KL + + DE L + + Y G+L L+Y + F + RFY +EI+ A
Sbjct: 63 SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTRFYTAEIVSA 120
Query: 138 IEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+E+LH GI +RDLKPENIL+ + H+ +TDF ++
Sbjct: 121 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAK 156
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (285), Expect = 1e-29
Identities = 44/136 (32%), Positives = 69/136 (50%), Gaps = 4/136 (2%)
Query: 232 VSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGK 291
++ R+NSFVGT +YVSPE++ + D WALG + Y+++ G PFR
Sbjct: 154 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 213
Query: 292 NRKETFRNVLMKTPEFVGQRT-ALTDLIQRLLEKDPVKRLGY--LRGACEIKEHVFFKGV 348
N F+ ++ +F + DL+++LL D KRLG + G +K H FF+ V
Sbjct: 214 NEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273
Query: 349 RWDLLTDVLRPPFIPS 364
W+ L PP + +
Sbjct: 274 TWENLHQ-QTPPKLTA 288
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 4e-34
Identities = 59/344 (17%), Positives = 107/344 (31%), Gaps = 95/344 (27%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARC-PFALKVVDKSTLHAKHEAERRARWE 73
+NL+ K+LG GA G V T A+K++ + A E
Sbjct: 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK---ADSSEREALMSE 90
Query: 74 IRVLSRL-SHPFLPKLLGSLETDEFLAWAVPYCPGGDL---------------------N 111
++++++L SH + LLG+ + YC GDL
Sbjct: 91 LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150
Query: 112 VLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171
L +++ V + + + ++ +E L +RDL N+L+ V + DF L
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL 210
Query: 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSP 231
+R+++ + + + L A PE+ T + V
Sbjct: 211 ARDIMSDSNYVVR------------------GNARLPVKWMA-PESLFEGIYTIKSDVWS 251
Query: 232 VSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEML-YGTTPFRG 290
GIL +E+ G P+ G
Sbjct: 252 ------------------------------------------YGILLWEIFSLGVNPYPG 269
Query: 291 KNRKETFRNVL-----MKTPEFVGQRTALTDLIQRLLEKDPVKR 329
F ++ M P + + + ++Q D KR
Sbjct: 270 IPVDANFYKLIQNGFKMDQPFYATEE--IYIIMQSCWAFDSRKR 311
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 127 bits (320), Expect = 6e-34
Identities = 49/172 (28%), Positives = 75/172 (43%), Gaps = 12/172 (6%)
Query: 7 PQPQTTPSLD-LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHE 65
PQP LD+ + LG GA G V V +RA FA K V K
Sbjct: 14 PQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATG----NNFAAKFVMTPHESDKET 69
Query: 66 AERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPS 125
+ EI+ +S L HP L L + E D + + GG+L ++++ S
Sbjct: 70 VRK----EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSED 124
Query: 126 VIRFYLSEIICAIEHLHNMGIAYRDLKPENILI--RQSGHVTLTDFDLSRNL 175
Y+ ++ + H+H + DLKPENI+ ++S + L DF L+ +L
Sbjct: 125 EAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 95.9 bits (238), Expect = 1e-22
Identities = 37/176 (21%), Positives = 61/176 (34%), Gaps = 22/176 (12%)
Query: 238 SFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETF 297
D + GT E+ +PEV G + D W++G+L+Y +L G +PF G+N ET
Sbjct: 175 HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL 234
Query: 298 RNVLMKTPEFVGQR-----TALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDL 352
RNV D I++LL DP R+ + EH +
Sbjct: 235 RNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM----TIHQALEHPWLTPGNAPG 290
Query: 353 LTDVLRPPFIPSREENDLTEKAMSGGGVDIREYFENLRAPPPSMPPSPLPSPSHRS 408
+ ++ I+ ++ P P + S +
Sbjct: 291 RDSQIPSSRYTKIRDS-------------IKTKYDAWPEPLPPLGRISNYSSLRKH 333
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 7e-34
Identities = 62/319 (19%), Positives = 104/319 (32%), Gaps = 78/319 (24%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
+D +L LK LG G G V R + A+K++ + ++ +E E
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRG-----QYDVAIKMIKEGSM-----SEDEFIEEA 50
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEI 134
+V+ LSH L +L G + Y G L + R F + ++
Sbjct: 51 KVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDV 109
Query: 135 ICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVL 194
A+E+L + +RDL N L+ G V ++DF LSR ++ E S +KFPV
Sbjct: 110 CEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD---EYTSSVGSKFPV- 165
Query: 195 PVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254
RW PE K + +
Sbjct: 166 --------------RWSP--PEVLMYSKFSSKS--------------------------- 182
Query: 255 VSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL----MKTPEFVGQ 310
D F V W + G P+ ET ++ + P +
Sbjct: 183 --------DIWAFGVLMWEI------YSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE 228
Query: 311 RTALTDLIQRLLEKDPVKR 329
+ + ++ + +R
Sbjct: 229 K--VYTIMYSCWHEKADER 245
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 2e-33
Identities = 37/157 (23%), Positives = 74/157 (47%), Gaps = 9/157 (5%)
Query: 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRV 76
+++ ++ LG+GA G V L +R + A+K+VD + + EI +
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTE----EAVAVKIVDMKR---AVDCPENIKKEICI 56
Query: 77 LSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIIC 136
L+H + K G + YC GG+ + + D + + +++
Sbjct: 57 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE--LFDRIEPDIGMPEPDAQRFFHQLMA 114
Query: 137 AIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
+ +LH +GI +RD+KPEN+L+ + ++ ++DF L+
Sbjct: 115 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT 151
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.0 bits (202), Expect = 3e-18
Identities = 23/120 (19%), Positives = 50/120 (41%), Gaps = 9/120 (7%)
Query: 232 VSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDG-HEFAVDWWALGILTYEMLYGTTPFRG 290
++ + + N GT YV+PE+++ H VD W+ GI+ ML G P+
Sbjct: 149 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 208
Query: 291 KNRKETFRNVLMKTPEFVGQRTALT----DLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
+ + + ++ + L+ ++L ++P R+ +IK+ ++
Sbjct: 209 PSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI----TIPDIKKDRWYN 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 125 bits (314), Expect = 2e-33
Identities = 35/159 (22%), Positives = 65/159 (40%), Gaps = 7/159 (4%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
L+ +G G+ G V+ D + A+K + S +E + E+R L +L H
Sbjct: 20 LREIGHGSFGAVYFARDV---RNSE-VVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQKLRH 74
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLH 142
P + G + + YC G + + + + I + + +LH
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 143 NMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAF 181
+ + +RD+K NIL+ + G V L DF + + +F
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF 171
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 86.2 bits (213), Expect = 1e-19
Identities = 30/140 (21%), Positives = 54/140 (38%), Gaps = 11/140 (7%)
Query: 243 ERSNSFVGTEEYVSPEVVRGDGHE---FAVDWWALGILTYEMLYGTTPFRGKNRKETFRN 299
+NSFVGT +++PEV+ VD W+LGI E+ P N +
Sbjct: 166 APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 225
Query: 300 VLMKTPEFVGQRT---ALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR-WDLLTD 355
+ + + + L+K P R + + +H F R ++ D
Sbjct: 226 IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRP----TSEVLLKHRFVLRERPPTVIMD 281
Query: 356 VLRPPFIPSREENDLTEKAM 375
+++ RE ++L + M
Sbjct: 282 LIQRTKDAVRELDNLQYRKM 301
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 125 bits (315), Expect = 3e-33
Identities = 44/176 (25%), Positives = 76/176 (43%), Gaps = 12/176 (6%)
Query: 2 EATPPPQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLH 61
+ P P S+ D L+ LG GA G V ++A F K ++
Sbjct: 14 KYVPQPVEVKQGSV-YDYYDILEELGSGAFGVVHRCVEKATG----RVFVAKFINTPYPL 68
Query: 62 AKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRV 121
K+ + EI ++++L HP L L + E + + + GG+L R D
Sbjct: 69 DKYTVKN----EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF-DRIAAEDYK 123
Query: 122 FSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIR--QSGHVTLTDFDLSRNL 175
S + + Y+ + ++H+H I + D+KPENI+ ++ V + DF L+ L
Sbjct: 124 MSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 98.6 bits (245), Expect = 1e-23
Identities = 49/171 (28%), Positives = 74/171 (43%), Gaps = 23/171 (13%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFR 298
+ E T E+ +PE+V + F D WA+G+L Y +L G +PF G++ ET +
Sbjct: 179 LNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ 238
Query: 299 NVLMKTPEFVGQR-----TALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLL 353
NV EF D I+ LL+K+P KRL + EH + KG +L
Sbjct: 239 NVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL----TVHDALEHPWLKGDHSNL- 293
Query: 354 TDVLRPPFIPSREENDLTEKAMSGGGVDIREYFENLRAPPPSMPPSPLPSP 404
IPS N + +K I+E + + AP P++ S
Sbjct: 294 -----TSRIPSSRYNKIRQK--------IKEKYADWPAPQPAIGRIANFSS 331
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 1e-32
Identities = 64/354 (18%), Positives = 107/354 (30%), Gaps = 102/354 (28%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTL-HAKHEAERRARWEIRVLSRLS 81
L LG+G TV+ D+ + A+K + AK R A EI++L LS
Sbjct: 3 LDFLGEGQFATVYKARDKNTN----QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 58
Query: 82 HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHL 141
HP + LL + ++ + + K N V +PS I+ Y+ + +E+L
Sbjct: 59 HPNIIGLLDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGLEYL 116
Query: 142 HNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPK 201
H I +RDLKP N+L+ ++G + L DF L+++ N
Sbjct: 117 HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--------------------PNRA 156
Query: 202 RHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVR 261
+++TRW A
Sbjct: 157 YTHQVVTRWYRAPELLFGARMYGVGV---------------------------------- 182
Query: 262 GDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVGQR---------- 311
D E+L G + + + ++
Sbjct: 183 -DMWAVGCILA-------ELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 312 -------------------TALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
L DLIQ L +P R+ A + + +F
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI----TATQALKMKYFS 284
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 1e-32
Identities = 62/358 (17%), Positives = 119/358 (33%), Gaps = 47/358 (13%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
L +G+GA G V +D A+K + +R EI++L R H
Sbjct: 13 LSYIGEGAYGMVCSAYDNVNK----VRVAIKKISPF---EHQTYCQRTLREIKILLRFRH 65
Query: 83 PFLPKLLGSLETDEF----LAWAVPYCPGGD-LNVLRYKQNDRVFSPSVIRFYLSEIICA 137
+ + + + V + G D +L+ + S I ++L +I+
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH----LSNDHICYFLYQILRG 121
Query: 138 IEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVT 197
++++H+ + +RDLKP N+L+ + + + DF L+R
Sbjct: 122 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-----------------D 164
Query: 198 ENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257
+ TRW A TKS + V + F G
Sbjct: 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP--IFPGKHYLDQL 222
Query: 258 EVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVGQRTALTDL 317
+ G + + I+ + KN+ R + + DL
Sbjct: 223 NHILGILGSPSQEDLN-CIINLKARNYLLSLPHKNKVPWNRLFPNADSKAL-------DL 274
Query: 318 IQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREENDLTEKAM 375
+ ++L +P KR+ + H + + + PF E +DL ++ +
Sbjct: 275 LDKMLTFNPHKRI----EVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKL 328
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 122 bits (307), Expect = 2e-32
Identities = 49/159 (30%), Positives = 88/159 (55%), Gaps = 7/159 (4%)
Query: 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRV 76
L + + L+ LG G+ G V L+ R +A+KV+ K + + + E +
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNG----RYYAMKVLKKEIV-VRLKQVEHTNDERLM 57
Query: 77 LSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIIC 136
LS ++HPF+ ++ G+ + + + + Y GG+L + + F V +FY +E+
Sbjct: 58 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYAAEVCL 115
Query: 137 AIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
A+E+LH+ I YRDLKPENIL+ ++GH+ +TDF ++ +
Sbjct: 116 ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV 154
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 107 bits (267), Expect = 7e-27
Identities = 45/131 (34%), Positives = 73/131 (55%), Gaps = 3/131 (2%)
Query: 242 GERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL 301
+ + + GT +Y++PEVV + ++DWW+ GIL YEML G TPF N +T+ +L
Sbjct: 155 PDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL 214
Query: 302 MKTPEFVGQRT-ALTDLIQRLLEKDPVKRLGYLR-GACEIKEHVFFKGVRWD-LLTDVLR 358
F + DL+ RL+ +D +RLG L+ G ++K H +FK V W+ LL+ +
Sbjct: 215 NAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIE 274
Query: 359 PPFIPSREEND 369
P+ P ++
Sbjct: 275 TPYEPPIQQGQ 285
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 2e-32
Identities = 56/321 (17%), Positives = 94/321 (29%), Gaps = 66/321 (20%)
Query: 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRAR 71
T + +L+ L+ LG G+ G V A A+K + L ++ EA
Sbjct: 2 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTV-SVAVKCLKPDVL-SQPEAMDDFI 59
Query: 72 WEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYL 131
E+ + L H L +L G + T + P G L K F + Y
Sbjct: 60 REVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYA 117
Query: 132 SEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKF 191
++ + +L + +RDL N+L+ V + DF L R
Sbjct: 118 VQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR------------------ 159
Query: 192 PVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251
ALP+N + +V +S S
Sbjct: 160 ---------------------ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFS------ 192
Query: 252 EEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVGQR 311
D F V W + YG P+ G N + + +
Sbjct: 193 --------HASDTWMFGVTLWEM------FTYGQEPWIGLNGSQILHKIDKEGERLPRPE 238
Query: 312 T---ALTDLIQRLLEKDPVKR 329
+ +++ + P R
Sbjct: 239 DCPQDIYNVMVQCWAHKPEDR 259
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 120 bits (303), Expect = 3e-32
Identities = 40/178 (22%), Positives = 71/178 (39%), Gaps = 10/178 (5%)
Query: 3 ATPPPQPQTTP-SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLH 61
A P P ++ ++ LG G G V+ + A+K + + T+
Sbjct: 1 AMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYS----LTVAVKTLKEDTME 56
Query: 62 AKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRV 121
+ E V+ + HP L +LLG + + G+L + N +
Sbjct: 57 VE-----EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 111
Query: 122 FSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKT 179
S V+ + ++I A+E+L +RDL N L+ ++ V + DF LSR + T
Sbjct: 112 VSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 53.2 bits (127), Expect = 2e-08
Identities = 20/100 (20%), Positives = 44/100 (44%), Gaps = 7/100 (7%)
Query: 235 RQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEML-YGTTPFRGKNR 293
R + D ++ +PE + + D WA G+L +E+ YG +P+ G +
Sbjct: 163 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 222
Query: 294 KETFRNVL----MKTPEFVGQRTALTDLIQRLLEKDPVKR 329
+ + + M+ PE ++ + +L++ + +P R
Sbjct: 223 SQVYELLEKDYRMERPEGCPEK--VYELMRACWQWNPSDR 260
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 5e-32
Identities = 59/355 (16%), Positives = 120/355 (33%), Gaps = 46/355 (12%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
L+ +G GA G V D A+K + + +RA E+R+L + H
Sbjct: 23 LQPVGSGAYGAVCSAVDGRTG----AKVAIKKLYRP--FQSELFAKRAYRELRLLKHMRH 76
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDL--NVLRYKQNDRVFSPSVIRFYLSEIICAIEH 140
+ LL DE L + L I+F + +++ + +
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 136
Query: 141 LHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENP 200
+H GI +RDLKP N+ + + + + DF L+R +
Sbjct: 137 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA-----------------------DS 173
Query: 201 KRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVV 260
+ ++TRW A ++ T++ + V + F G++ + +
Sbjct: 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGC--IMAEMITGKTLFKGSDHLDQLKEI 231
Query: 261 RGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVGQRTALTDLIQR 320
++ L + + K+ F ++L +L+++
Sbjct: 232 MKVTGTPPAEFVQ--RLQSDEAKNYMKGLPELEKKDFASILTNASP------LAVNLLEK 283
Query: 321 LLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREENDLTEKAM 375
+L D +R+ A E H +F+ + + + S ++ D T
Sbjct: 284 MLVLDAEQRV----TAGEALAHPYFESLHDTEDEPQV-QKYDDSFDDVDRTLDEW 333
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 6e-32
Identities = 72/389 (18%), Positives = 130/389 (33%), Gaps = 85/389 (21%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-H 82
++LG G G V + ++ FALK++ +AR E+ + R S
Sbjct: 18 QVLGLGINGKVLQIFNKRTQ----EKFALKMLQDC---------PKARREVELHWRASQC 64
Query: 83 PFLPKLLGSLET----DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAI 138
P + +++ E + L + GG+L + D+ F+ + I AI
Sbjct: 65 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 124
Query: 139 EHLHNMGIAYRDLKPENILI---RQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLP 195
++LH++ IA+RD+KPEN+L R + + LTDF ++
Sbjct: 125 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-------------------- 164
Query: 196 VTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYV 255
T + T + A PE K KS
Sbjct: 165 -TSHNSLTTPCYTPYYVA-PEVLGPEKYDKSC---------------------------- 194
Query: 256 SPEVVRGDGHEFAVDWWAL--GILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVGQRTA 313
D V + L G + +G G + PE+
Sbjct: 195 -------DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 247
Query: 314 LTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREEN-DLTE 372
+ LI+ LL+ +P +R+ E H + T + + +E + +
Sbjct: 248 VKMLIRNLLKTEPTQRM----TITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVK 303
Query: 373 KAMSGGGVDIREYFENLRAPPPSMPPSPL 401
+ M+ +R +E ++ +PL
Sbjct: 304 EEMTSALATMRVDYEQIKIKKIEDASNPL 332
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 120 bits (301), Expect = 7e-32
Identities = 43/164 (26%), Positives = 71/164 (43%), Gaps = 12/164 (7%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKH-----EAERRARW 72
+N + +ILG+G V + +A+K++D + + E
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTC----KEYAVKIIDVTGGGSFSAEEVQELREATLK 58
Query: 73 EIRVLSRLS-HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYL 131
E+ +L ++S HP + +L + ET+ F G+L Y S R +
Sbjct: 59 EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL--FDYLTEKVTLSEKETRKIM 116
Query: 132 SEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
++ I LH + I +RDLKPENIL+ ++ LTDF S L
Sbjct: 117 RALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 89.7 bits (222), Expect = 6e-21
Identities = 33/120 (27%), Positives = 53/120 (44%), Gaps = 15/120 (12%)
Query: 238 SFDNGERSNSFVGTEEYVSPEVVRG------DGHEFAVDWWALGILTYEMLYGTTPFRGK 291
D GE+ GT Y++PE++ G+ VD W+ G++ Y +L G+ PF +
Sbjct: 159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 218
Query: 292 NRKETFRNVL-----MKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
+ R ++ +PE+ + DL+ R L P KR A E H FF+
Sbjct: 219 KQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY----TAEEALAHPFFQ 274
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 1e-31
Identities = 47/317 (14%), Positives = 90/317 (28%), Gaps = 74/317 (23%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
+ + LK ++ LG G G V++ + A+K + + + E
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNG-----HTKVAVKSLKQG-----SMSPDAFLAEA 59
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEI 134
++ +L H L +L T E + Y G L + + + + ++I
Sbjct: 60 NLMKQLQHQRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 135 ICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVL 194
+ + +RDL+ NIL+ + + DF L+R ++
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR-------------------LI 159
Query: 195 PVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254
E R A G KS
Sbjct: 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKS---------------------------- 191
Query: 255 VSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVGQRT-- 312
D F + + + +G P+ G E +N+
Sbjct: 192 --------DVWSFGILLTEI------VTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 237
Query: 313 ALTDLIQRLLEKDPVKR 329
L L++ ++ P R
Sbjct: 238 ELYQLMRLCWKERPEDR 254
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 1e-31
Identities = 50/319 (15%), Positives = 98/319 (30%), Gaps = 73/319 (22%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
+ + ++ + +G+G G V + + A A+K T + E
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALA-VAIKTCKNCT---SDSVREKFLQEA 59
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEI 134
+ + HP + KL+G + T+ + + C G+L + + + Y ++
Sbjct: 60 LTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQL 117
Query: 135 ICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVL 194
A+ +L + +RD+ N+L+ + V L DF LSR +
Sbjct: 118 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-------------------YM 158
Query: 195 PVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254
+ K + L A + S
Sbjct: 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSAS---------------------------- 190
Query: 255 VSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL----MKTPEFVGQ 310
D F V W + +++G PF+G + + + P
Sbjct: 191 --------DVWMFGVCMWEI------LMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 236
Query: 311 RTALTDLIQRLLEKDPVKR 329
L L+ + DP +R
Sbjct: 237 --TLYSLMTKCWAYDPSRR 253
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 2e-31
Identities = 62/163 (38%), Positives = 94/163 (57%), Gaps = 4/163 (2%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
+ ++N + LK+LG GA G VFLV + T + +A+KV+ K+T+ K + R E
Sbjct: 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGK-LYAMKVLKKATIVQKAKTTEHTRTER 79
Query: 75 RVLSRLSH-PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSE 133
+VL + PFL L + +T+ L + Y GG+L + F+ ++ Y+ E
Sbjct: 80 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQIYVGE 137
Query: 134 IICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176
I+ A+EHLH +GI YRD+K ENIL+ +GHV LTDF LS+ V
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.6 bits (242), Expect = 2e-23
Identities = 59/140 (42%), Positives = 79/140 (56%), Gaps = 10/140 (7%)
Query: 241 NGERSNSFVGTEEYVSPEVVRGD--GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFR 298
ER+ F GT EY++P++VRG GH+ AVDWW+LG+L YE+L G +PF K +
Sbjct: 183 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA 242
Query: 299 NVLMKTPEFVGQR-----TALTDLIQRLLEKDPVKRLGYLR-GACEIKEHVFFKGVRWD- 351
+ + + DLIQRLL KDP KRLG A EIKEH+FF+ + WD
Sbjct: 243 EISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDD 302
Query: 352 LLTDVLRPPFIPS-REENDL 370
L + PF P R+E D+
Sbjct: 303 LAAKKVPAPFKPVIRDELDV 322
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 2e-31
Identities = 56/161 (34%), Positives = 91/161 (56%), Gaps = 7/161 (4%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
+ +++ LK+LGKG G V LV ++A +A+K++ K + AK E E
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATG----RYYAMKILRKEVIIAKDEVAHTVT-ES 56
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEI 134
RVL HPFL L + +T + L + + Y GG+L + +RVF+ RFY +EI
Sbjct: 57 RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEI 114
Query: 135 ICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
+ A+E+LH+ + YRD+K EN+++ + GH+ +TDF L +
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 7e-28
Identities = 47/131 (35%), Positives = 70/131 (53%), Gaps = 3/131 (2%)
Query: 237 QSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKET 296
+ +G +F GT EY++PEV+ + + AVDWW LG++ YEM+ G PF ++ +
Sbjct: 154 EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213
Query: 297 FRNVLMKTPEFVGQ-RTALTDLIQRLLEKDPVKRLGYLR-GACEIKEHVFFKGVRWD-LL 353
F +LM+ F L+ LL+KDP +RLG A E+ EH FF + W ++
Sbjct: 214 FELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVV 273
Query: 354 TDVLRPPFIPS 364
L PPF P
Sbjct: 274 QKKLLPPFKPQ 284
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 118 bits (297), Expect = 3e-31
Identities = 52/346 (15%), Positives = 93/346 (26%), Gaps = 77/346 (22%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
+ +G+G+ G +F + + A+K + + R E R L+
Sbjct: 10 GRRIGEGSFGVIFEGTNLLNN----QQVAIKFEPR------RSDAPQLRDEYRTYKLLAG 59
Query: 83 PFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLH 142
+ + V G L L R FS + +++ ++ +H
Sbjct: 60 CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDL-LDLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 143 NMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKR 202
+ YRD+KP+N LI + + N++ F
Sbjct: 119 EKSLVYRDIKPDNFLIGR-------PNSKNANMIYVVDF--------------------- 150
Query: 203 HRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRG 262
G+ K V+ + + GT Y+S G
Sbjct: 151 -----------------GMVKFYRDPVT------KQHIPYREKKNLSGTARYMSINTHLG 187
Query: 263 DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKET----FRNVLMKTPEFVGQRTA----- 313
D ALG + L G+ P++G R K + + A
Sbjct: 188 REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEE 247
Query: 314 LTDLIQRLLEKDPVKRLGY------LRGACEIKEHVFFKGVRWDLL 353
+ Y E + W+LL
Sbjct: 248 FYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 293
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 5e-31
Identities = 62/340 (18%), Positives = 111/340 (32%), Gaps = 89/340 (26%)
Query: 9 PQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAER 68
P P LD +++K ++G+G G V + R A+K + + +A + R
Sbjct: 1 PTIYPVLDWNDIKFQDVIGEGNFGQVLKARIK--KDGLRMDAAIKRMKE---YASKDDHR 55
Query: 69 RARWEIRVLSRLS-HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYK----------- 116
E+ VL +L HP + LLG+ E +L A+ Y P G+L K
Sbjct: 56 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 115
Query: 117 ---QNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
S + + +++ +++L +RDL NIL+ ++ + DF LSR
Sbjct: 116 IANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 175
Query: 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVS 233
K+ L A+ + T S
Sbjct: 176 G---------------------QEVYVKKTMGRLPVRWMAIESLNYSVYTTNS------- 207
Query: 234 RRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNR 293
D + V W + + G TP+ G
Sbjct: 208 -----------------------------DVWSYGVLLWEI------VSLGGTPYCGMTC 232
Query: 294 KETFRNVL----MKTPEFVGQRTALTDLIQRLLEKDPVKR 329
E + + ++ P + DL+++ + P +R
Sbjct: 233 AELYEKLPQGYRLEKPLNCDDE--VYDLMRQCWREKPYER 270
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 117 bits (295), Expect = 7e-31
Identities = 37/164 (22%), Positives = 67/164 (40%), Gaps = 5/164 (3%)
Query: 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRAR 71
+D+ +K +++G G G V H + A+K + + R
Sbjct: 20 AKEIDISCVKIEQVIGAGEFGEVCSGHLKL-PGKREIFVAIKTLKSG---YTEKQRRDFL 75
Query: 72 WEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYL 131
E ++ + HP + L G + + + G L+ +QND F+ + L
Sbjct: 76 SEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF-LRQNDGQFTVIQLVGML 134
Query: 132 SEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
I +++L +M +RDL NIL+ + ++DF LSR L
Sbjct: 135 RGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 64.4 bits (156), Expect = 4e-12
Identities = 20/104 (19%), Positives = 40/104 (38%), Gaps = 3/104 (2%)
Query: 229 VSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEML-YGTTP 287
+S S + + +PE ++ A D W+ GI+ +E++ YG P
Sbjct: 174 LSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 233
Query: 288 FRGKNRKETFRNVLM--KTPEFVGQRTALTDLIQRLLEKDPVKR 329
+ ++ + + P + +AL L+ +KD R
Sbjct: 234 YWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHR 277
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 1e-30
Identities = 70/371 (18%), Positives = 132/371 (35%), Gaps = 53/371 (14%)
Query: 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRV 76
L + LK +G GA G V +D D A+K + + +RA E+ +
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLD----RNVAIKKLSRP--FQNQTHAKRAYRELVL 69
Query: 77 LSRLSHPFLPKLLG------SLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFY 130
+ ++H + LL +LE + + + V++ + + +
Sbjct: 70 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME-----LDHERMSYL 124
Query: 131 LSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNK 190
L +++C I+HLH+ GI +RDLKP NI+++ + + DF L+R
Sbjct: 125 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART---------------- 168
Query: 191 FPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250
+ ++TR+ A PE G+ ++ + V + F G
Sbjct: 169 -----AGTSFMMTPYVVTRYYRA-PEVILGMGYKENVDIWSVGCIMGEMVRHKI--LFPG 220
Query: 251 -TEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVG 309
+V+ G L + + G + F + L
Sbjct: 221 RDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 280
Query: 310 QRTA--LTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPP---FIPS 364
+ A DL+ ++L DP KR+ + +H + W +V PP +
Sbjct: 281 KLKASQARDLLSKMLVIDPAKRI----SVDDALQHPYIN--VWYDPAEVEAPPPQIYDKQ 334
Query: 365 REENDLTEKAM 375
+E + T +
Sbjct: 335 LDEREHTIEEW 345
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 117 bits (293), Expect = 1e-30
Identities = 45/351 (12%), Positives = 100/351 (28%), Gaps = 81/351 (23%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVL 77
+ + + +G G+ G ++L D AA A+K+ T H + E ++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAG----EEVAIKLECVKTKH------PQLHIESKIY 56
Query: 78 SRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICA 137
+ + + V G L + R FS + ++I
Sbjct: 57 KMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLE-DLFNFCSRKFSLKTVLLLADQMISR 115
Query: 138 IEHLHNMGIAYRDLKPENILIRQSGH---VTLTDFDLSRNLVKKTAFEKQSLNNNKFPVL 194
IE++H+ +RD+KP+N L+ V + DF L++ +
Sbjct: 116 IEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH----------- 164
Query: 195 PVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254
+ T + G+++++
Sbjct: 165 --IPYRENKNLTGTARYAS-INTHLGIEQSRRD--------------------------- 194
Query: 255 VSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVGQRT-- 312
D +LG + G+ P++G + + + +
Sbjct: 195 ---------------DLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 313 -------ALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK-GVRWDLLTD 355
+ + Y ++ ++F + G +D + D
Sbjct: 240 LCKGYPSEFATYLNFCRSLRFDDKPDY-SYLRQLFRNLFHRQGFSYDYVFD 289
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (290), Expect = 1e-30
Identities = 38/162 (23%), Positives = 65/162 (40%), Gaps = 13/162 (8%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
L++ LK L+ +GKG G V L R A+K + + E
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDYRGN------KVAVKCIKND------ATAQAFLAEA 51
Query: 75 RVLSRLSHPFLPKLLGS-LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSE 133
V+++L H L +LLG +E L Y G L + V + + +
Sbjct: 52 SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 111
Query: 134 IICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
+ A+E+L +RDL N+L+ + ++DF L++
Sbjct: 112 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.8 bits (160), Expect = 7e-13
Identities = 18/98 (18%), Positives = 38/98 (38%), Gaps = 7/98 (7%)
Query: 237 QSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEML-YGTTPFRGKNRKE 295
+ + ++ ++ +PE +R D W+ GIL +E+ +G P+ K+
Sbjct: 149 LTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 208
Query: 296 TFRNVL----MKTPEFVGQRTALTDLIQRLLEKDPVKR 329
V M P+ A+ ++++ D R
Sbjct: 209 VVPRVEKGYKMDAPDGCPP--AVYEVMKNCWHLDAAMR 244
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 117 bits (295), Expect = 2e-30
Identities = 52/160 (32%), Positives = 86/160 (53%), Gaps = 7/160 (4%)
Query: 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWE 73
+ LD +K LG G+ G V LV + + +A+K++DK + K + E
Sbjct: 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESG----NHYAMKILDKQKV-VKLKQIEHTLNE 91
Query: 74 IRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSE 133
R+L ++ PFL KL S + + L + Y GG++ + + FS RFY ++
Sbjct: 92 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHARFYAAQ 149
Query: 134 IICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173
I+ E+LH++ + YRDLKPEN+LI Q G++ +TDF ++
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 102 bits (255), Expect = 5e-25
Identities = 44/133 (33%), Positives = 67/133 (50%), Gaps = 3/133 (2%)
Query: 243 ERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLM 302
R+ + GT E ++PE++ G+ AVDWWALG+L YEM G PF + + ++
Sbjct: 193 GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252
Query: 303 KTPEFVGQRTA-LTDLIQRLLEKDPVKRLGYLR-GACEIKEHVFFKGVRWD-LLTDVLRP 359
F ++ L DL++ LL+ D KR G L+ G +IK H +F W + +
Sbjct: 253 GKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEA 312
Query: 360 PFIPSREENDLTE 372
PFIP + T
Sbjct: 313 PFIPKFKGPGDTS 325
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 2e-30
Identities = 33/161 (20%), Positives = 65/161 (40%), Gaps = 11/161 (6%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
+D L ++ +G G G V L + D A+K + + +E E
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDK-----VAIKTIREG-----AMSEEDFIEEA 51
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEI 134
V+ +LSHP L +L G + + G L+ Q F+ + ++
Sbjct: 52 EVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDV 110
Query: 135 ICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
+ +L + +RDL N L+ ++ + ++DF ++R +
Sbjct: 111 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 151
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.0 bits (150), Expect = 1e-11
Identities = 17/95 (17%), Positives = 35/95 (36%), Gaps = 7/95 (7%)
Query: 240 DNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEML-YGTTPFRGKNRKETFR 298
D S ++ SPEV + D W+ G+L +E+ G P+ ++ E
Sbjct: 154 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 213
Query: 299 NVL----MKTPEFVGQRTALTDLIQRLLEKDPVKR 329
++ + P + ++ ++ P R
Sbjct: 214 DISTGFRLYKPRLASTH--VYQIMNHCWKERPEDR 246
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (290), Expect = 2e-30
Identities = 36/162 (22%), Positives = 71/162 (43%), Gaps = 8/162 (4%)
Query: 15 LDLDNLKALKI-LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWE 73
L DNL I LG G G+V R + A+KV+ + T + E
Sbjct: 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKK--QIDVAIKVLKQGT---EKADTEEMMRE 59
Query: 74 IRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSE 133
+++ +L +P++ +L+G + + + + GG L+ + + S + L +
Sbjct: 60 AQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQ 117
Query: 134 IICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
+ +++L +RDL N+L+ + ++DF LS+ L
Sbjct: 118 VSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.7 bits (157), Expect = 2e-12
Identities = 16/95 (16%), Positives = 30/95 (31%), Gaps = 7/95 (7%)
Query: 240 DNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEML-YGTTPFRGKNRKETFR 298
++ ++ +PE + D W+ G+ +E L YG P++ E
Sbjct: 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA 223
Query: 299 NVL----MKTPEFVGQRTALTDLIQRLLEKDPVKR 329
+ M+ P L L+ R
Sbjct: 224 FIEQGKRMECPPECPP--ELYALMSDCWIYKWEDR 256
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 3e-30
Identities = 37/160 (23%), Positives = 69/160 (43%), Gaps = 12/160 (7%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVL 77
+ + LG+G G V + ++ T + K V K + + EI +L
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKT----YMAKFVKV-----KGTDQVLVKKEISIL 55
Query: 78 SRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICA 137
+ H + L S E+ E L + G D+ R + + I Y+ ++ A
Sbjct: 56 NIARHRNILHLHESFESMEELVMIFEFISGLDIFE-RINTSAFELNEREIVSYVHQVCEA 114
Query: 138 IEHLHNMGIAYRDLKPENILI--RQSGHVTLTDFDLSRNL 175
++ LH+ I + D++PENI+ R+S + + +F +R L
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.6 bits (227), Expect = 2e-21
Identities = 39/179 (21%), Positives = 66/179 (36%), Gaps = 26/179 (14%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFR 298
G+ EY +PEV + D A D W+LG L Y +L G PF + ++
Sbjct: 154 LKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE 213
Query: 299 NVLMKTPEFVGQR-----TALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKG----VR 349
N++ F + D + RLL K+ R+ A E +H + K V
Sbjct: 214 NIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM----TASEALQHPWLKQKIERVS 269
Query: 350 WDLLTDVLRPPFIPSREENDLT----EKAMSGGGVDIREYFENLRAPP-PSMPPSPLPS 403
++ + + + + DL +S GG +R+ S+ + S
Sbjct: 270 TKVIRTLKHRRYYHTLIKKDLNMVVSAARISCGG--------AIRSQKGVSVAKVKVAS 320
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 3e-30
Identities = 37/175 (21%), Positives = 75/175 (42%), Gaps = 15/175 (8%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVL 77
++ + L +G G+ G + ++ K +D ++ ++ E+ +L
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDG----KILVWKELDYGSM--TEAEKQMLVSEVNLL 57
Query: 78 SRLSHPFLPKLLGSL--ETDEFLAWAVPYCPGGDLN--VLRYKQNDRVFSPSVIRFYLSE 133
L HP + + + T+ L + YC GGDL + + + + + +++
Sbjct: 58 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 117
Query: 134 IICAIEHLHNMG-----IAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEK 183
+ A++ H + +RDLKP N+ + +V L DF L+R L T+F K
Sbjct: 118 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK 172
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.7 bits (204), Expect = 1e-18
Identities = 28/107 (26%), Positives = 44/107 (41%), Gaps = 6/107 (5%)
Query: 240 DNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRN 299
+ + +FVGT Y+SPE + + D W+LG L YE+ PF ++KE
Sbjct: 166 HDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK 225
Query: 300 VLMKTPEFVGQR--TALTDLIQRLLEKDPVKRLGYLRGACEIKEHVF 344
+ + R L ++I R+L R EI E+
Sbjct: 226 IREGKFRRIPYRYSDELNEIITRMLNLKDYHRP----SVEEILENPL 268
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 115 bits (288), Expect = 5e-30
Identities = 60/330 (18%), Positives = 110/330 (33%), Gaps = 45/330 (13%)
Query: 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRV 76
++ L+ +G+G G V+ + + FALK + EI +
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNNYGET-----FALKKIRLE--KEDEGIPSTTIREISI 53
Query: 77 LSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIIC 136
L L H + KL + T + L + +L + + +L +++
Sbjct: 54 LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLN 111
Query: 137 AIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPV 196
I + H+ + +RDLKP+N+LI + G + + DF L+R
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI------------------- 152
Query: 197 TENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256
K I+T W A K + + + V NG F G E
Sbjct: 153 -PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTP--LFPGVSEADQ 209
Query: 257 PEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVGQRTALTD 316
+ W + T + + + + + D
Sbjct: 210 LMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGL---DESGI-------D 259
Query: 317 LIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
L+ ++L+ DP +R+ A + EH +FK
Sbjct: 260 LLSKMLKLDPNQRI----TAKQALEHAYFK 285
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 5e-30
Identities = 32/161 (19%), Positives = 63/161 (39%), Gaps = 11/161 (6%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
+ + + +G G+ GTV+ A+K+++ + + + + E+
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGKWHG-------DVAVKMLNVT--APTPQQLQAFKNEV 55
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEI 134
VL + H + +G T LA +C G L + + F + +
Sbjct: 56 GVLRKTRHVNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQT 113
Query: 135 ICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
+++LH I +RDLK NI + + V + DF L+
Sbjct: 114 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.9 bits (176), Expect = 9e-15
Identities = 20/108 (18%), Positives = 46/108 (42%), Gaps = 10/108 (9%)
Query: 232 VSRRQQSFDNGERSNSFVGTEEYVSPEVVRG---DGHEFAVDWWALGILTYEMLYGTTPF 288
++ + + + G+ +++PEV+R + + F D +A GI+ YE++ G P+
Sbjct: 150 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 209
Query: 289 RGKNRKETFRNVLMKTPEFVGQRT-------ALTDLIQRLLEKDPVKR 329
N ++ ++ + A+ L+ L+K +R
Sbjct: 210 SNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDER 257
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 1e-29
Identities = 71/384 (18%), Positives = 127/384 (33%), Gaps = 63/384 (16%)
Query: 1 MEATPPPQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTL 60
+ ATP P + + K ++G G+ G V+ + A+K V +
Sbjct: 6 VVATPGQGPDRPQEVSYTDTK---VIGNGSFGVVYQAKLCDSG----ELVAIKKVLQD-- 56
Query: 61 HAKHEAERRARWEIRVLSRLSHPFLPKLL------GSLETDEFLAWAVPYCPGGDLNVLR 114
+R E++++ +L H + +L G + + +L + Y P V R
Sbjct: 57 ------KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 110
Query: 115 -YKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVT-LTDFDLS 172
Y + + ++ Y+ ++ ++ ++H+ GI +RD+KP+N+L+ V L DF +
Sbjct: 111 HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 170
Query: 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPV 232
+ LV+ I +R+ A T S V
Sbjct: 171 KQLVRGE---------------------PNVSYICSRYYRAPELIFGATDYTSSIDVWSA 209
Query: 233 SRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKN 292
G+ F G + LG T E + P +
Sbjct: 210 GCVLAELLLGQP--IFPGDSGV----------DQLVEIIKVLGTPTREQIREMNPNYTEF 257
Query: 293 RKETFRNVLMKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDL 352
+ + L RLLE P RL E H FF +R
Sbjct: 258 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL----TPLEACAHSFFDELRDP- 312
Query: 353 LTDVLRPPFIPSREENDLTEKAMS 376
+V P + + T + +S
Sbjct: 313 --NVKLPNGRDTPALFNFTTQELS 334
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 4e-29
Identities = 68/334 (20%), Positives = 114/334 (34%), Gaps = 45/334 (13%)
Query: 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRV 76
++N + ++ +G+G G V+ ++ ALK + T A EI +
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTG----EVVALKKIRLDTE--TEGVPSTAIREISL 54
Query: 77 LSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIIC 136
L L+HP + KLL + T+ L + V DL +I+ YL +++
Sbjct: 55 LKELNHPNIVKLLDVIHTENKL-YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 137 AIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPV 196
+ H+ + +RDLKP+N+LI G + L DF L+R
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--------------------G 153
Query: 197 TENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY-V 255
++T W A + + + + F G E
Sbjct: 154 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQ 211
Query: 256 SPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVGQRTALT 315
+ R G V W + P K ++ F V+ E
Sbjct: 212 LFRIFRTLGTPDEVVWPG-----VTSMPDYKPSFPKWARQDFSKVVPPLDE------DGR 260
Query: 316 DLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349
L+ ++L DP KR+ A H FF+ V
Sbjct: 261 SLLSQMLHYDPNKRI----SAKAALAHPFFQDVT 290
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 4e-29
Identities = 64/330 (19%), Positives = 114/330 (34%), Gaps = 43/330 (13%)
Query: 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRV 76
+ + L+ +G+G GTVF +R ALK V A EI +
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETH----EIVALKRVRLD--DDDEGVPSSALREICL 54
Query: 77 LSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIIC 136
L L H + +L L +D+ L +C + + P +++ +L +++
Sbjct: 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKK--YFDSCNGDLDPEIVKSFLFQLLK 112
Query: 137 AIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPV 196
+ H+ + +RDLKP+N+LI ++G + L +F L+R
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF--------------------G 152
Query: 197 TENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256
++T W + S + N R +
Sbjct: 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 212
Query: 257 PEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVGQRTALTD 316
+ R G W ++ L P+ + NV+ K D
Sbjct: 213 KRIFRLLGTPTEEQWPSMTKLPDYK-----PYPMYPATTSLVNVVPKLNA------TGRD 261
Query: 317 LIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
L+Q LL+ +PV+R+ A E +H +F
Sbjct: 262 LLQNLLKCNPVQRI----SAEEALQHPYFS 287
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 112 bits (280), Expect = 5e-29
Identities = 41/168 (24%), Positives = 66/168 (39%), Gaps = 11/168 (6%)
Query: 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRAR 71
TPS D + +ILG G M V L D A+KV+ R R
Sbjct: 1 TPSHLSDRYELGEILGFGGMSEVHLARDLRLH----RDVAVKVLRADLAR-DPSFYLRFR 55
Query: 72 WEIRVLSRLSHPFLPKLLGSLETDEFLAWAV----PYCPGGDLNVLRYKQNDRVFSPSVI 127
E + + L+HP + + + E + Y G L + +P
Sbjct: 56 REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL--RDIVHTEGPMTPKRA 113
Query: 128 RFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
+++ A+ H GI +RD+KP NI+I + V + DF ++R +
Sbjct: 114 IEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 83.3 bits (205), Expect = 1e-18
Identities = 27/99 (27%), Positives = 47/99 (47%), Gaps = 5/99 (5%)
Query: 236 QQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKE 295
S ++ ++ + +GT +Y+SPE RGD + D ++LG + YE+L G PF G +
Sbjct: 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 221
Query: 296 TFRNVLMKTPEFVGQR-----TALTDLIQRLLEKDPVKR 329
+ + P R L ++ + L K+P R
Sbjct: 222 VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 260
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 8e-29
Identities = 66/361 (18%), Positives = 127/361 (35%), Gaps = 52/361 (14%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVL 77
+ + L +G GA G+V D A+K + + H +R E+R+L
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTG----LRVAVKKLSRPFQSIIHA--KRTYRELRLL 71
Query: 78 SRLSHPFLPKLLGSLETDEFLA-----WAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLS 132
+ H + LL L + V + G DLN + Q + ++F +
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIY 128
Query: 133 EIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFP 192
+I+ ++++H+ I +RDLKP N+ + + + + DF L+R+
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT----------------- 171
Query: 193 VLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252
+ + + TRW A + ++ + S + F GT+
Sbjct: 172 ------DDEMTGYVATRWYRAPEIMLNWMHYNQTVDI--WSVGCIMAELLTGRTLFPGTD 223
Query: 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVGQRT 312
+++ + ++ E + K F NV +
Sbjct: 224 HIDQLKLILRLVGTPGAELLK--KISSESARNYIQSLTQMPKMNFANVFIGANP------ 275
Query: 313 ALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPPFIPSREENDLTE 372
DL++++L D KR+ A + H +F D + + P+ S E DL
Sbjct: 276 LAVDLLEKMLVLDSDKRI----TAAQALAHAYFAQYH-DPDDEPVADPYDQSFESRDLLI 330
Query: 373 K 373
Sbjct: 331 D 331
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (277), Expect = 2e-28
Identities = 52/319 (16%), Positives = 94/319 (29%), Gaps = 78/319 (24%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
+ ++L+ LG+G G V++ A+K + T+ + E
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTR-----VAIKTLKPGTM-----SPEAFLQEA 63
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEI 134
+V+ +L H L +L + + Y G L + + + ++I
Sbjct: 64 QVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 122
Query: 135 ICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVL 194
+ ++ M +RDL+ NIL+ ++ + DF L+R ++
Sbjct: 123 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR-------------------LI 163
Query: 195 PVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254
E R A G KS
Sbjct: 164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS---------------------------- 195
Query: 255 VSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL----MKTPEFVGQ 310
D F + L G P+ G +E V M P +
Sbjct: 196 --------DVWSFGILLTEL------TTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE 241
Query: 311 RTALTDLIQRLLEKDPVKR 329
L DL+ + K+P +R
Sbjct: 242 S--LHDLMCQCWRKEPEER 258
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 2e-28
Identities = 40/179 (22%), Positives = 63/179 (35%), Gaps = 21/179 (11%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAA-DPTARCPFALKVVDKSTLHAKHEAERRARWE 73
+ L K LG GA G V A A+K++ S + EA E
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS---E 76
Query: 74 IRVLSRLS-HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDR------------ 120
++VLS L H + LLG+ YC GDL ++ D
Sbjct: 77 LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 121 ----VFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
+ + ++ + L + +RDL NIL+ + DF L+R++
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI 195
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 4e-28
Identities = 33/152 (21%), Positives = 66/152 (43%), Gaps = 7/152 (4%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP 83
K LG G GTV + + A+K++ + E V+ +L +P
Sbjct: 13 KELGSGNFGTVKKGYYQ--MKKVVKTVAVKILKNEAN--DPALKDELLAEANVMQQLDNP 68
Query: 84 FLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN 143
++ +++G E + ++ + G LN +Y Q +R I + ++ +++L
Sbjct: 69 YIVRMIGICEAESWM-LVMEMAELGPLN--KYLQQNRHVKDKNIIELVHQVSMGMKYLEE 125
Query: 144 MGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
+RDL N+L+ + ++DF LS+ L
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 157
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.4 bits (182), Expect = 1e-15
Identities = 21/121 (17%), Positives = 40/121 (33%), Gaps = 8/121 (6%)
Query: 236 QQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEML-YGTTPFRGKNRK 294
+ + + ++ +PE + D W+ G+L +E YG P+RG
Sbjct: 158 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 217
Query: 295 ETFRNVL----MKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRW 350
E + M P + + DL+ D R G+ + ++ V
Sbjct: 218 EVTAMLEKGERMGCPAGCPRE--MYDLMNLCWTYDVENRPGF-AAVELRLRNYYYDVVNE 274
Query: 351 D 351
Sbjct: 275 G 275
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 4e-28
Identities = 37/164 (22%), Positives = 67/164 (40%), Gaps = 4/164 (2%)
Query: 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRAR 71
T + + K++G G G V+ + + P A+K + +
Sbjct: 1 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG---YTEKQRVDFL 57
Query: 72 WEIRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYL 131
E ++ + SH + +L G + + + Y G L+ ++ D FS + L
Sbjct: 58 GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF-LREKDGEFSVLQLVGML 116
Query: 132 SEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
I +++L NM +RDL NIL+ + ++DF LSR L
Sbjct: 117 RGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.3 bits (140), Expect = 3e-10
Identities = 16/97 (16%), Positives = 42/97 (43%), Gaps = 3/97 (3%)
Query: 236 QQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEML-YGTTPFRGKNRK 294
+ + ++ + +PE + A D W+ GI+ +E++ YG P+ +
Sbjct: 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH 220
Query: 295 ETFRNVL--MKTPEFVGQRTALTDLIQRLLEKDPVKR 329
E + + + P + +A+ L+ + +++ +R
Sbjct: 221 EVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARR 257
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 109 bits (272), Expect = 1e-27
Identities = 55/339 (16%), Positives = 100/339 (29%), Gaps = 92/339 (27%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAA-DPTARCPFALKVVDKSTLHAKHEAERRARWEIRV 76
+N++ ++ +G+GA G VF A+K++ + A + + + E +
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE---EASADMQADFQREAAL 69
Query: 77 LSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLN----------------------VLR 114
++ +P + KLLG + + Y GDLN
Sbjct: 70 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129
Query: 115 YKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174
S + ++ + +L +RDL N L+ ++ V + DF LSRN
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSR 234
+ + K PE+ + T +
Sbjct: 190 -------------------IYSADYYKADGNDAIPIRWMPPESIFYNRYTTES------- 223
Query: 235 RQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRK 294
D + V W + YG P+ G +
Sbjct: 224 ----------------------------DVWAYGVVLWEI------FSYGLQPYYGMAHE 249
Query: 295 ETFRNV----LMKTPEFVGQRTALTDLIQRLLEKDPVKR 329
E V ++ PE L +L++ K P R
Sbjct: 250 EVIYYVRDGNILACPENCPLE--LYNLMRLCWSKLPADR 286
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (267), Expect = 3e-27
Identities = 40/167 (23%), Positives = 66/167 (39%), Gaps = 15/167 (8%)
Query: 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWE 73
S D LK +G+G+ TV+ D A + L +R + E
Sbjct: 5 SNDGRFLKFDIEIGRGSFKTVYKGLDTETT----VEVAWCELQDRKL--TKSERQRFKEE 58
Query: 74 IRVLSRLSHPFLPKLLGSLET----DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRF 129
+L L HP + + S E+ + + G L Y + +V V+R
Sbjct: 59 AEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTL--KTYLKRFKVMKIKVLRS 116
Query: 130 YLSEIICAIEHLHNMG--IAYRDLKPENILIR-QSGHVTLTDFDLSR 173
+ +I+ ++ LH I +RDLK +NI I +G V + D L+
Sbjct: 117 WCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.4 bits (216), Expect = 4e-20
Identities = 21/112 (18%), Positives = 48/112 (42%), Gaps = 9/112 (8%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGK-NRKETF 297
+ + +GT E+++PE+ ++ +VD +A G+ EM P+ N + +
Sbjct: 164 LKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY 222
Query: 298 RNVLMKTPEFVGQRTA---LTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFK 346
R V + A + ++I+ + ++ +R ++ H FF+
Sbjct: 223 RRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERY----SIKDLLNHAFFQ 270
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 107 bits (269), Expect = 3e-27
Identities = 43/159 (27%), Positives = 71/159 (44%), Gaps = 12/159 (7%)
Query: 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVL 77
D +LG GA V L D+ A+K + K L K E EI VL
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQ----KLVAIKCIAKKALEGK---EGSMENEIAVL 61
Query: 78 SRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICA 137
++ HP + L E+ L + GG+L ++ + +++ A
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL--FDRIVEKGFYTERDASRLIFQVLDA 119
Query: 138 IEHLHNMGIAYRDLKPENILIR---QSGHVTLTDFDLSR 173
+++LH++GI +RDLKPEN+L + + ++DF LS+
Sbjct: 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 98.6 bits (245), Expect = 7e-24
Identities = 38/150 (25%), Positives = 66/150 (44%), Gaps = 15/150 (10%)
Query: 237 QSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKET 296
+ D G ++ GT YV+PEV+ + AVD W++G++ Y +L G PF +N +
Sbjct: 158 KMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL 217
Query: 297 FRNVLMKTPEFVGQR-----TALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRW- 350
F +L EF + D I+ L+EKDP KR + +H + G
Sbjct: 218 FEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF----TCEQALQHPWIAGDTAL 273
Query: 351 -----DLLTDVLRPPFIPSREENDLTEKAM 375
+++ ++ F S+ + A+
Sbjct: 274 DKNIHQSVSEQIKKNFAKSKWKQAFNATAV 303
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 6e-27
Identities = 40/161 (24%), Positives = 71/161 (44%), Gaps = 5/161 (3%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEI 74
L K +K+LG GA GTV+ + P A+K + ++T +A + E
Sbjct: 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEA 62
Query: 75 RVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEI 134
V++ + +P + +LLG T P G L + D + + +I
Sbjct: 63 YVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQI 120
Query: 135 ICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175
+ +L + + +RDL N+L++ HV +TDF L++ L
Sbjct: 121 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.0 bits (147), Expect = 5e-11
Identities = 12/103 (11%), Positives = 38/103 (36%), Gaps = 7/103 (6%)
Query: 232 VSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEML-YGTTPFRG 290
+++ + + + ++++ E + + D W+ G+ +E++ +G+ P+ G
Sbjct: 157 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 216
Query: 291 KNRKETFRNVL----MKTPEFVGQRTALTDLIQRLLEKDPVKR 329
E + + P + ++ + D R
Sbjct: 217 IPASEISSILEKGERLPQPPICTID--VYMIMVKCWMIDADSR 257
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 3e-26
Identities = 33/159 (20%), Positives = 63/159 (39%), Gaps = 12/159 (7%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARW--EIRVLSRL 80
+ LG G V +++ +A K + K + R E+ +L +
Sbjct: 15 GEELGSGQFAVVKKCREKSTG----LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 81 SHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEH 140
HP + L E + + GG+L + + +L +I+ + +
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGEL--FDFLAEKESLTEEEATEFLKQILNGVYY 128
Query: 141 LHNMGIAYRDLKPENILIRQSG----HVTLTDFDLSRNL 175
LH++ IA+ DLKPENI++ + + DF L+ +
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 4e-25
Identities = 39/130 (30%), Positives = 59/130 (45%), Gaps = 10/130 (7%)
Query: 237 QSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKET 296
D G + GT E+V+PE+V + D W++G++TY +L G +PF G ++ET
Sbjct: 165 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 224
Query: 297 FRNVLMKTPEFVGQR-----TALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351
NV EF + D I+RLL KDP KR+ + +H + K
Sbjct: 225 LANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM----TIQDSLQHPWIKPKDTQ 280
Query: 352 -LLTDVLRPP 360
L+ P
Sbjct: 281 QALSSAWSHP 290
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 3e-26
Identities = 63/337 (18%), Positives = 109/337 (32%), Gaps = 56/337 (16%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS- 81
+ +G+GA G VF D ALK V T + E+ VL L
Sbjct: 12 VAEIGEGAYGKVFKARDL---KNGGRFVALKRVRVQT--GEEGMPLSTIREVAVLRHLET 66
Query: 82 --HPFLPKLLG-----SLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEI 134
HP + +L + + L + L I+ + ++
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG-VPTETIKDMMFQL 125
Query: 135 ICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVL 194
+ ++ LH+ + +RDLKP+NIL+ SG + L DF L+R
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY------------------- 166
Query: 195 PVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254
+ ++T W A + + V S + R F G+ +
Sbjct: 167 --SFQMALTSVVVTLWYRAPEVLLQS---SYATPVDLWSVGCIFAEMFRRKPLFRGSSDV 221
Query: 255 -VSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVGQRTA 313
+++ G DW L + F K+ + + V
Sbjct: 222 DQLGKILDVIGLPGEEDWPRDVALPRQA------FHSKSAQPIEKFVTDIDELGK----- 270
Query: 314 LTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRW 350
DL+ + L +P KR+ A H +F+ +
Sbjct: 271 --DLLLKCLTFNPAKRI----SAYSALSHPYFQDLER 301
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 5e-26
Identities = 37/158 (23%), Positives = 65/158 (41%), Gaps = 10/158 (6%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARW--EIRVLSRL 80
+LG G G+V+ + + P A+K V+K + E R E+ +L ++
Sbjct: 9 GPLLGSGGFGSVYSGIRVSDN----LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 81 S--HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAI 138
S + +LL E + + + + R + +++ A+
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAV 123
Query: 139 EHLHNMGIAYRDLKPENILIRQS-GHVTLTDFDLSRNL 175
H HN G+ +RD+K ENILI + G + L DF L
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.7 bits (196), Expect = 2e-17
Identities = 28/112 (25%), Positives = 40/112 (35%), Gaps = 10/112 (8%)
Query: 239 FDNGERSNSFVGTEEYVSPEVVRGDGHE-FAVDWWALGILTYEMLYGTTPFRGKNRKETF 297
F GT Y PE +R + + W+LGIL Y+M+ G PF E
Sbjct: 160 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--EII 217
Query: 298 RNVLMKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349
R + + LI+ L P R EI+ H + + V
Sbjct: 218 RGQVFFRQRV---SSECQHLIRWCLALRPSDRP----TFEEIQNHPWMQDVL 262
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 4e-25
Identities = 51/343 (14%), Positives = 91/343 (26%), Gaps = 102/343 (29%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
+ +GKG G V+ R A+K+ + E EI L H
Sbjct: 8 QESIGKGRFGEVWRGKWRGE------EVAVKIFSS-----REERSWFREAEIYQTVMLRH 56
Query: 83 PFLPKLLGSLETDEFLAWAV----PYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAI 138
+ + + D + Y G L Y V +I+ L +
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSL--FDYLNRYTVTVEGMIKLAL-STASGL 113
Query: 139 EHLH--------NMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNK 190
HLH IA+RDLK +NIL++++G + D L+ T
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD---------- 163
Query: 191 FPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250
T + + R+ T+ A PE K
Sbjct: 164 ------TIDIAPNHRVGTKRYMA-PEVLDDSINMKHFESFK------------------- 197
Query: 251 TEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKET-------------- 296
D +A+G++ +E+ + +
Sbjct: 198 -----------------RADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 297 ---------FRNVLMKTPEFVGQRTALTDLIQRLLEKDPVKRL 330
R + + + +++ + RL
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 283
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 5e-25
Identities = 52/311 (16%), Positives = 98/311 (31%), Gaps = 70/311 (22%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHP 83
+++G+G G V+ D + A+K +++ T + E ++ SHP
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGK-KIHCAVKSLNRIT---DIGEVSQFLTEGIIMKDFSHP 88
Query: 84 FLPKLLGSLETDEFLAWAV-PYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLH 142
+ LLG E V PY GDL + +I F L ++ ++ L
Sbjct: 89 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAKGMKFLA 147
Query: 143 NMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKR 202
+ +RDL N ++ + V + DF L+R++ K + K PV +
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA----- 202
Query: 203 HRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRG 262
E+ K T + V
Sbjct: 203 ------------LESLQTQKFTTKSDV--------------------------------- 217
Query: 263 DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL----MKTPEFVGQRTALTDLI 318
++ ++T G P+ N + +L + PE+ L +++
Sbjct: 218 ----WSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP--LYEVM 267
Query: 319 QRLLEKDPVKR 329
+ R
Sbjct: 268 LKCWHPKAEMR 278
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 2e-24
Identities = 43/188 (22%), Positives = 76/188 (40%), Gaps = 20/188 (10%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARC-PFALKVVDKSTLHAKHEAERRARWE 73
D LK K LG+GA G V D TA C A+K++ + H++H A E
Sbjct: 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS---E 66
Query: 74 IRVLSRLSHPFLPKLLG--SLETDEFLAWAVPYCPGGDLNVLRYKQND------------ 119
+++L + H L + L V +C G+L+ + +
Sbjct: 67 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 120 --RVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177
+ + Y ++ +E L + +RDL NIL+ + V + DF L+R++ K
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 178 KTAFEKQS 185
+ ++
Sbjct: 187 DPDYVRKG 194
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.1 bits (129), Expect = 8e-09
Identities = 21/116 (18%), Positives = 43/116 (37%), Gaps = 12/116 (10%)
Query: 233 SRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGT-TPFRGK 291
+R + R ++++PE + + D W+ G+L +E+ +P+ G
Sbjct: 181 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240
Query: 292 NRKETFRNVL-----MKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEH 342
E F L M+ P++ + + +P +R E+ EH
Sbjct: 241 KIDEEFCRRLKEGTRMRAPDYTTPE--MYQTMLDCWHGEPSQRP----TFSELVEH 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 2e-24
Identities = 46/322 (14%), Positives = 103/322 (31%), Gaps = 66/322 (20%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAA-DPTARCPFALKVVDKSTLHAKHEAERRARWE 73
+ + + + LG+G+ G V+ + A+K V+++ A E
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA---ASMRERIEFLNE 73
Query: 74 IRVLSRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYLS 132
V+ + + +LLG + + + GDL + LR + +P + LS
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 133 EIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFP 192
++I + + L + R + + ++ + K
Sbjct: 134 KMIQMAGEIAD---GMAYLNANKFVHR---DLAARNCMVAEDFTVK-------------- 173
Query: 193 VLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252
I + R D + +
Sbjct: 174 -------------IGDFGMT---------------------RDIYETDYYRKGGKGLLPV 199
Query: 253 EYVSPEVVRGDGHEFAVDWWALGILTYEML-YGTTPFRGKNRKETFRNV----LMKTPEF 307
++SPE ++ D W+ G++ +E+ P++G + ++ R V L+ P+
Sbjct: 200 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDN 259
Query: 308 VGQRTALTDLIQRLLEKDPVKR 329
L +L++ + +P R
Sbjct: 260 CPDM--LFELMRMCWQYNPKMR 279
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.5 bits (239), Expect = 4e-23
Identities = 58/324 (17%), Positives = 104/324 (32%), Gaps = 61/324 (18%)
Query: 15 LDLDNLKALKILGKGAMGTVFLVHDRAAD---PTARCPFALKVVDKSTLHAKHEAERRAR 71
L D L K LG+GA G V L D P A+K++ A +
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS---DATEKDLSDLI 66
Query: 72 WEIRVLSRLS-HPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFY 130
E+ ++ + H + LLG+ D L V Y G+
Sbjct: 67 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN--------------------- 105
Query: 131 LSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNK 190
L E + A PE L + + A + L + K
Sbjct: 106 LREYLQARRPPGLEYSYNPSHNPEEQL----------SSKDLVSCAYQVARGMEYLASKK 155
Query: 191 FPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250
HR + R + +N + ++R D +++ +
Sbjct: 156 CI----------HRDLAARNVLVTEDNVMKIADF------GLARDIHHIDYYKKTTNGRL 199
Query: 251 TEEYVSPEVVRGDGHEFAVDWWALGILTYEML-YGTTPFRGKNRKETFRNVL----MKTP 305
++++PE + + D W+ G+L +E+ G +P+ G +E F+ + M P
Sbjct: 200 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKP 259
Query: 306 EFVGQRTALTDLIQRLLEKDPVKR 329
L +++ P +R
Sbjct: 260 SNCTNE--LYMMMRDCWHAVPSQR 281
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 92.8 bits (229), Expect = 1e-21
Identities = 59/390 (15%), Positives = 116/390 (29%), Gaps = 67/390 (17%)
Query: 23 LKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH 82
++ LG G TV+L D + A+K+V ++ + A EI++L R++
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNN----THVAMKIVRGDKVYTE-----AAEDEIKLLQRVND 68
Query: 83 PFLPKLLGSLE--------------TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIR 128
K + V G +L L K R ++
Sbjct: 69 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 128
Query: 129 FYLSEIICAIEHLH-NMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLN 187
+++ ++++H GI + D+KPEN+L+ +K
Sbjct: 129 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ------IKIADLGNA--- 179
Query: 188 NNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVS-------RRQQSFD 240
+ + + + PE G A + + F+
Sbjct: 180 ---------CWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230
Query: 241 NGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNV 300
E + + + G+ + + + +
Sbjct: 231 PDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVL 290
Query: 301 LMKTPEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWDLLTDVLRPP 360
K + ++D + +L+ DP KR A + H + K L + +R P
Sbjct: 291 TEKYKFSKDEAKEISDFLSPMLQLDPRKRA----DAGGLVNHPWLKDT---LGMEEIRVP 343
Query: 361 FIPSREENDLTEKAMSGGGVDIREYFENLR 390
+ G G DI +FE +R
Sbjct: 344 DRE-----------LYGSGSDIPGWFEEVR 362
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 74.4 bits (182), Expect = 3e-16
Identities = 27/165 (16%), Positives = 49/165 (29%), Gaps = 17/165 (10%)
Query: 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAK------HEAERRARWEIRVL 77
K++G+G VF + +K K +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGE-----CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 78 SRLSHPFLPKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICA 137
+R L KL G + + L L + L I+
Sbjct: 61 ARNEFRALQKLQG-----LAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEE 115
Query: 138 IEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFE 182
+ ++ GI + DL N+L+ + G + DF S + ++ E
Sbjct: 116 VAKFYHRGIVHGDLSQYNVLVSEEGIW-IIDFPQSVEVGEEGWRE 159
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 412 | |||
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.61 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.98 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.9 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.18 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.63 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.62 |
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-67 Score=505.48 Aligned_cols=283 Identities=36% Similarity=0.666 Sum_probs=249.8
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET 94 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 94 (412)
+++++|+++++||+|+||+||+|+++.++. .||||++++...... .....+.+|+.+|++++|||||+++++|++
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~----~~AiK~i~k~~~~~~-~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 76 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGR----YYAMKILRKEVIIAK-DEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEHHHHHHT-TCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCC----EEEEEEEchhhccCH-HHHHHHHHHHHHHHhCCCCCEEEEEeeecc
Confidence 689999999999999999999999987554 499999988765332 335667789999999999999999999999
Q ss_pred CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
++.+|+|||||.||+|..++.... .+++.+++.+++||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.
T Consensus 77 ~~~~~iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~ 154 (337)
T d1o6la_ 77 HDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE 154 (337)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred ccccccceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccc
Confidence 999999999999999988877654 499999999999999999999999999999999999999999999999999975
Q ss_pred hhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCC
Q 042539 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254 (412)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 254 (412)
... ......+++||+.|
T Consensus 155 ~~~---------------------------------------------------------------~~~~~~~~~GT~~Y 171 (337)
T d1o6la_ 155 GIS---------------------------------------------------------------DGATMKTFCGTPEY 171 (337)
T ss_dssp SCC---------------------------------------------------------------TTCCBCCCEECGGG
T ss_pred ccc---------------------------------------------------------------CCcccccceeCHHH
Confidence 421 12334567999999
Q ss_pred ccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC-CChHHHHHHHHhhhhCCCccCCCC
Q 042539 255 VSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVG-QRTALTDLIQRLLEKDPVKRLGYL 333 (412)
Q Consensus 255 ~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~dli~~~L~~dP~~R~~~~ 333 (412)
||||++.+.+|+.++|||||||++|||++|++||.+.+..+++..+....+.++. .++++++||++||++||.+|+++.
T Consensus 172 ~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~ 251 (337)
T d1o6la_ 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGG 251 (337)
T ss_dssp CCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCS
T ss_pred hhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHhhccCCchhhcccc
Confidence 9999999999999999999999999999999999999999999999887766654 689999999999999999999753
Q ss_pred C-ChhhhhcCCCCCCCCchhhcc-cCCCCCCCCCCC
Q 042539 334 R-GACEIKEHVFFKGVRWDLLTD-VLRPPFIPSREE 367 (412)
Q Consensus 334 ~-~~~e~l~h~ff~~~~~~~~~~-~~~pp~~p~~~~ 367 (412)
. +++++++||||++++|+.+.. ...|||.|....
T Consensus 252 ~~~~~eil~Hp~f~~i~~~~l~~~~~~~p~~P~~~~ 287 (337)
T d1o6la_ 252 PSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTS 287 (337)
T ss_dssp TTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSS
T ss_pred cccHHHHHcCcccccCCHHHHHhCCCCCCCCCCCCC
Confidence 3 589999999999999986644 567888886543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-66 Score=490.45 Aligned_cols=279 Identities=36% Similarity=0.597 Sum_probs=237.2
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
..++|++++.||+|+||+||+|+++.++. .||||++++..... ......+.+|+++|++++|||||+++++|+++
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~----~vAvK~i~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 80 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSR----EYAIKILEKRHIIK-ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD 80 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCC----EEEEEEEehHHccC-HHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC
Confidence 45899999999999999999999987554 49999998765432 23456788899999999999999999999999
Q ss_pred CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchh
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
+.+|+|||||.||+|..++.... .+++.+++.++.|++.||+|||++|||||||||+|||++.+|.+||+|||+|+.+
T Consensus 81 ~~~~ivmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 158 (288)
T d1uu3a_ 81 EKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 158 (288)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CEEEEEEEccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceec
Confidence 99999999999999988877654 4999999999999999999999999999999999999999999999999999865
Q ss_pred hchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCc
Q 042539 176 VKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYV 255 (412)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 255 (412)
... .......+.+||+.||
T Consensus 159 ~~~-------------------------------------------------------------~~~~~~~~~~GT~~Y~ 177 (288)
T d1uu3a_ 159 SPE-------------------------------------------------------------SKQARANSFVGTAQYV 177 (288)
T ss_dssp C-----------------------------------------------------------------------CCCCGGGC
T ss_pred ccC-------------------------------------------------------------CcccccccccCCcccc
Confidence 321 1122334678999999
Q ss_pred cceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-CCChHHHHHHHHhhhhCCCccCCCCC
Q 042539 256 SPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-GQRTALTDLIQRLLEKDPVKRLGYLR 334 (412)
Q Consensus 256 APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~dli~~~L~~dP~~R~~~~~ 334 (412)
|||++.+..|+.++|||||||++|||++|++||.+.+..+++.++....+.++ ..++++++||.+||++||.+|++...
T Consensus 178 APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e 257 (288)
T d1uu3a_ 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEE 257 (288)
T ss_dssp CHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGG
T ss_pred CceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHH
Confidence 99999999999999999999999999999999999999999999988776665 57899999999999999999995310
Q ss_pred --ChhhhhcCCCCCCCCchhhcccCCCCCCC
Q 042539 335 --GACEIKEHVFFKGVRWDLLTDVLRPPFIP 363 (412)
Q Consensus 335 --~~~e~l~h~ff~~~~~~~~~~~~~pp~~p 363 (412)
....+++||||++++|+.+... .||-+|
T Consensus 258 ~~~~~~i~~Hpff~~i~w~~l~~~-~pP~l~ 287 (288)
T d1uu3a_ 258 MEGYGPLKAHPFFESVTWENLHQQ-TPPKLT 287 (288)
T ss_dssp GTCHHHHHTSGGGTTCCCTTGGGS-CCCCCC
T ss_pred HcCCHHHHcCCccCCCCHHHhhcC-CCCCCC
Confidence 1223689999999999988664 444444
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.8e-65 Score=487.81 Aligned_cols=278 Identities=34% Similarity=0.644 Sum_probs=244.4
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
++++|+++++||+|+||+||+|+++.++. .||||++++..... ....+.+.+|+.+|+.++|||||++++++.++
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~----~vAvK~i~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 76 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGR----YYAMKVLKKEIVVR-LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA 76 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCC----EEEEEEEchHHccC-HHHHHHHHHHHHHHHhccCcChhheeeeEeeC
Confidence 67899999999999999999999987554 49999998765432 23456778899999999999999999999999
Q ss_pred CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchh
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
+.+|+|||||.||+|..++.... .+++.+++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+..
T Consensus 77 ~~~~ivmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~ 154 (316)
T d1fota_ 77 QQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV 154 (316)
T ss_dssp SEEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred CeeeeEeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEe
Confidence 99999999999999987776554 4899999999999999999999999999999999999999999999999999754
Q ss_pred hchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCc
Q 042539 176 VKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYV 255 (412)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 255 (412)
. ....+.+||+.||
T Consensus 155 ~------------------------------------------------------------------~~~~~~~Gt~~Y~ 168 (316)
T d1fota_ 155 P------------------------------------------------------------------DVTYTLCGTPDYI 168 (316)
T ss_dssp S------------------------------------------------------------------SCBCCCCSCTTTC
T ss_pred c------------------------------------------------------------------cccccccCccccc
Confidence 2 1123568999999
Q ss_pred cceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-CCCChHHHHHHHHhhhhCCCccCCCC-
Q 042539 256 SPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF-VGQRTALTDLIQRLLEKDPVKRLGYL- 333 (412)
Q Consensus 256 APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~dli~~~L~~dP~~R~~~~- 333 (412)
|||++.+..|+.++|||||||++|+|++|+.||.+.+..+.+.+++.....+ ...++++.++|.+||++||.+|++..
T Consensus 169 APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r 248 (316)
T d1fota_ 169 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQ 248 (316)
T ss_dssp CHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSST
T ss_pred CHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhCHHhccccch
Confidence 9999999999999999999999999999999999999999999998877665 45789999999999999999998654
Q ss_pred CChhhhhcCCCCCCCCchhhc-ccCCCCCCCCCC
Q 042539 334 RGACEIKEHVFFKGVRWDLLT-DVLRPPFIPSRE 366 (412)
Q Consensus 334 ~~~~e~l~h~ff~~~~~~~~~-~~~~pp~~p~~~ 366 (412)
++++++++||||++++|+.+. ....+||.|...
T Consensus 249 ~t~~~il~Hp~f~~i~~~~l~~~~~~~p~~p~~~ 282 (316)
T d1fota_ 249 NGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQ 282 (316)
T ss_dssp TTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC-
T ss_pred hhHHHHHcCcccccCCHHHHHhCCCCcCCCCCcC
Confidence 379999999999999999664 456788887643
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-63 Score=486.21 Aligned_cols=282 Identities=33% Similarity=0.596 Sum_probs=247.0
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
...+++|++++.||+|+||+||+|+++.++. .||||++.+..... ....+.+.+|+++|+.++|||||+++++|.
T Consensus 37 ~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~----~~AvK~i~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 111 (350)
T d1rdqe_ 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGN----HYAMKILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CCCccCeEEEEEeecCcCcEEEEEEECCCCC----EEEEEEEchHHccC-HHHHHHHHHHHHHHHHcCCCcEeecccccc
Confidence 4567999999999999999999999987554 49999998765432 233456788999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
+.+.+|+|||||.||+|..++.... .+++.+++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+|+
T Consensus 112 ~~~~~~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~ 189 (350)
T d1rdqe_ 112 DNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189 (350)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cccccccccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeee
Confidence 9999999999999999988877654 49999999999999999999999999999999999999999999999999997
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
.+. ....+.+||+.
T Consensus 190 ~~~------------------------------------------------------------------~~~~~~~Gt~~ 203 (350)
T d1rdqe_ 190 RVK------------------------------------------------------------------GRTWTLCGTPE 203 (350)
T ss_dssp ECS------------------------------------------------------------------SCBCCCEECGG
T ss_pred ecc------------------------------------------------------------------cccccccCccc
Confidence 642 11235689999
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-CCCChHHHHHHHHhhhhCCCccCCC
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF-VGQRTALTDLIQRLLEKDPVKRLGY 332 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~dli~~~L~~dP~~R~~~ 332 (412)
|||||++.+..|+.++|||||||++|||++|++||.+.+....+.++....+.+ ..+++++.+||.+||++||.+|+..
T Consensus 204 Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~kR~~~ 283 (350)
T d1rdqe_ 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGN 283 (350)
T ss_dssp GCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTS
T ss_pred cCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHhhhCHHhcccc
Confidence 999999999999999999999999999999999999999999999988776555 4578999999999999999999743
Q ss_pred -CCChhhhhcCCCCCCCCchhhcc-cCCCCCCCCCCCc
Q 042539 333 -LRGACEIKEHVFFKGVRWDLLTD-VLRPPFIPSREEN 368 (412)
Q Consensus 333 -~~~~~e~l~h~ff~~~~~~~~~~-~~~pp~~p~~~~~ 368 (412)
.++++++++||||++++|..+.. ...|||+|....+
T Consensus 284 ~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~~~~~ 321 (350)
T d1rdqe_ 284 LKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGP 321 (350)
T ss_dssp STTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCST
T ss_pred ccccHHHHHcCccccCCCHHHHHhcCCCcCccCCCCCc
Confidence 34799999999999999986644 5688999876543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-64 Score=472.88 Aligned_cols=257 Identities=30% Similarity=0.519 Sum_probs=229.6
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET 94 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 94 (412)
.++++|++++.||+|+||+||+|+++.++. .||+|++.+..... ......+.+|+++++.++|||||++++++.+
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~----~vAiK~i~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 77 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKF----ILALKVLFKAQLEK-AGVEHQLRREVEIQSHLRHPNILRLYGYFHD 77 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred cchhHeEEEEEEecCCCcEEEEEEECCCCc----EEEEEEEchHHccC-hHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE
Confidence 468999999999999999999999987554 49999998765432 2345677889999999999999999999999
Q ss_pred CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
++.+|+|||||.||+|..++.... .+++.+++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.
T Consensus 78 ~~~~~ivmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~ 155 (263)
T d2j4za1 78 ATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH 155 (263)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSC
T ss_pred CCEEEEEEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeee
Confidence 999999999999999988887654 499999999999999999999999999999999999999999999999999965
Q ss_pred hhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCC
Q 042539 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254 (412)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 254 (412)
.. .......+||+.|
T Consensus 156 ~~-----------------------------------------------------------------~~~~~~~~Gt~~Y 170 (263)
T d2j4za1 156 AP-----------------------------------------------------------------SSRRTTLCGTLDY 170 (263)
T ss_dssp CC-----------------------------------------------------------------CCCCEETTEEGGG
T ss_pred cC-----------------------------------------------------------------CCcccccCCCCcc
Confidence 31 1123356899999
Q ss_pred ccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC-CChHHHHHHHHhhhhCCCccCCCC
Q 042539 255 VSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVG-QRTALTDLIQRLLEKDPVKRLGYL 333 (412)
Q Consensus 255 ~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~dli~~~L~~dP~~R~~~~ 333 (412)
||||++.+..|+.++|||||||++|||++|++||.+.+..+.+.++....+.++. .++++++||.+||++||++||
T Consensus 171 ~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~--- 247 (263)
T d2j4za1 171 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRP--- 247 (263)
T ss_dssp CCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSC---
T ss_pred cCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHccCCHhHCc---
Confidence 9999999999999999999999999999999999999999999998887766654 689999999999999999999
Q ss_pred CChhhhhcCCCCCC
Q 042539 334 RGACEIKEHVFFKG 347 (412)
Q Consensus 334 ~~~~e~l~h~ff~~ 347 (412)
+++|+++||||++
T Consensus 248 -t~~eil~hp~~~~ 260 (263)
T d2j4za1 248 -MLREVLEHPWITA 260 (263)
T ss_dssp -CHHHHHTCHHHHH
T ss_pred -CHHHHHcCcCcCC
Confidence 6999999999963
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-63 Score=479.96 Aligned_cols=277 Identities=35% Similarity=0.689 Sum_probs=233.9
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHh-hcCCCccceeeeeEEeC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLS-RLSHPFLPKLLGSLETD 95 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~-~l~hpnIv~l~~~~~~~ 95 (412)
+++|+++++||+|+||+||+|+++.++ +.||||++++....... ....+.+|+.++. .++|||||+++++++++
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~----~~vAvK~i~k~~~~~~~-~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~ 75 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTN----QFFAIKALKKDVVLMDD-DVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 75 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTT----EEEEEEEEEHHHHHHTT-CHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCC----CEEEEEEEchhhccChH-HHHHHHHHHHHHHHhCCCCcEEEEEEEEccC
Confidence 589999999999999999999998754 45999999876543332 2344555777665 68999999999999999
Q ss_pred CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchh
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
+.+|+|||||.||+|..++.... .+++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+..
T Consensus 76 ~~~yivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 76 ENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 153 (320)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred CceeEEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhc
Confidence 99999999999999998887654 4999999999999999999999999999999999999999999999999999754
Q ss_pred hchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCc
Q 042539 176 VKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYV 255 (412)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 255 (412)
.. ........+||+.|+
T Consensus 154 ~~---------------------------------------------------------------~~~~~~~~~gt~~y~ 170 (320)
T d1xjda_ 154 ML---------------------------------------------------------------GDAKTNTFCGTPDYI 170 (320)
T ss_dssp CC---------------------------------------------------------------TTCCBCCCCSCGGGC
T ss_pred cc---------------------------------------------------------------ccccccccCCCCCcC
Confidence 21 112233568999999
Q ss_pred cceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC-CChHHHHHHHHhhhhCCCccCCCCC
Q 042539 256 SPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFVG-QRTALTDLIQRLLEKDPVKRLGYLR 334 (412)
Q Consensus 256 APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~dli~~~L~~dP~~R~~~~~ 334 (412)
|||++.+..|+.++|||||||++|+|++|+.||.+.+..+++.++....+.++. +++++.+||++||++||++||+
T Consensus 171 aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~s--- 247 (320)
T d1xjda_ 171 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLG--- 247 (320)
T ss_dssp CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBT---
T ss_pred CHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHhcccCCCCCcC---
Confidence 999999999999999999999999999999999999999999999888777654 6899999999999999999994
Q ss_pred Ch-hhhhcCCCCCCCCchhhcc-cCCCCCCCCCCC
Q 042539 335 GA-CEIKEHVFFKGVRWDLLTD-VLRPPFIPSREE 367 (412)
Q Consensus 335 ~~-~e~l~h~ff~~~~~~~~~~-~~~pp~~p~~~~ 367 (412)
+ .++++||||++++|+.+.. ...||+.|...+
T Consensus 248 -~~~~l~~hpff~~~~~~~l~~~~~~pp~~p~~~~ 281 (320)
T d1xjda_ 248 -VRGDIRQHPLFREINWEELERKEIDPPFRPKVKS 281 (320)
T ss_dssp -TBSCGGGSGGGTTCCHHHHHTTCSCC--------
T ss_pred -HHHHHHhCchhccCCHHHHHhcCCCCCCCCCCCC
Confidence 5 4899999999999986644 557888876544
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-63 Score=469.42 Aligned_cols=258 Identities=24% Similarity=0.410 Sum_probs=215.7
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
.+++|++++.||+|+||+||+|+++.++. .||||++.+... .+..+.+.+|+++|++++|||||++++++.++
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~----~vAiK~i~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~ 75 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEE----AVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREG 75 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCC----EEEEEEEehhhc---chHHHHHHHHHHHHHhCCCCCEeeEeeeeccC
Confidence 36899999999999999999999987554 499999976543 22345678899999999999999999999999
Q ss_pred CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchh
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNL 175 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~ 175 (412)
+.+|+|||||.||+|.+++... +.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+
T Consensus 76 ~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~ 153 (271)
T d1nvra_ 76 NIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF 153 (271)
T ss_dssp TEEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceeEEEEeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheee
Confidence 9999999999999998877543 45999999999999999999999999999999999999999999999999999865
Q ss_pred hchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCc
Q 042539 176 VKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYV 255 (412)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 255 (412)
.... ......+.+||+.||
T Consensus 154 ~~~~-------------------------------------------------------------~~~~~~~~~GT~~Y~ 172 (271)
T d1nvra_ 154 RYNN-------------------------------------------------------------RERLLNKMCGTLPYV 172 (271)
T ss_dssp EETT-------------------------------------------------------------EECCBCCCCSCGGGS
T ss_pred ccCC-------------------------------------------------------------ccccccceeeCcCcc
Confidence 3211 112234678999999
Q ss_pred cceeecCCCC-CchhhHHHHHHHHHHHhhCCCCCCCCCHHH-HHHHHhcCC---CCCCCCChHHHHHHHHhhhhCCCccC
Q 042539 256 SPEVVRGDGH-EFAVDWWALGILTYEMLYGTTPFRGKNRKE-TFRNVLMKT---PEFVGQRTALTDLIQRLLEKDPVKRL 330 (412)
Q Consensus 256 APE~l~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-~~~~i~~~~---~~~~~~~~~~~dli~~~L~~dP~~R~ 330 (412)
|||++.+..+ +.++|||||||++|||++|++||.+.+... .+..+.... ..+...++++.+||.+||+.||++||
T Consensus 173 APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 252 (271)
T d1nvra_ 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI 252 (271)
T ss_dssp CTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSC
T ss_pred CHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCc
Confidence 9999998886 688999999999999999999998765433 333333322 22345689999999999999999999
Q ss_pred CCCCChhhhhcCCCCCC
Q 042539 331 GYLRGACEIKEHVFFKG 347 (412)
Q Consensus 331 ~~~~~~~e~l~h~ff~~ 347 (412)
+++|+++||||+.
T Consensus 253 ----t~~eil~hpwf~~ 265 (271)
T d1nvra_ 253 ----TIPDIKKDRWYNK 265 (271)
T ss_dssp ----CHHHHTTCTTTTC
T ss_pred ----CHHHHhcCHhhCc
Confidence 6999999999974
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.5e-62 Score=478.41 Aligned_cols=283 Identities=33% Similarity=0.608 Sum_probs=232.7
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhH--HHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKH--EAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~--~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
+++++|+++++||+|+||+||+|+++.++. .||||++.+..+.... ....+..+|+++++.++|||||+++++|
T Consensus 1 lslddy~i~~~lG~G~fg~Vy~~~~~~t~~----~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~ 76 (364)
T d1omwa3 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGK----MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF 76 (364)
T ss_dssp CCSTTEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE
T ss_pred CCHHhCeeeeEEecCCCeEEEEEEECCCCC----EEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE
Confidence 578999999999999999999999987654 4999999876543221 2222333457777888899999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
.+++.+|+|||||.||+|..++.... .+++.+++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|
T Consensus 77 ~~~~~~~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla 154 (364)
T d1omwa3 77 HTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 154 (364)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTC
T ss_pred EECCEEEEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeecee
Confidence 99999999999999999998887654 4899999999999999999999999999999999999999999999999999
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+.+.. ......+||+
T Consensus 155 ~~~~~-----------------------------------------------------------------~~~~~~~GT~ 169 (364)
T d1omwa3 155 CDFSK-----------------------------------------------------------------KKPHASVGTH 169 (364)
T ss_dssp EECSS-----------------------------------------------------------------SCCCSCCSCG
T ss_pred eecCC-----------------------------------------------------------------Cccccccccc
Confidence 75421 1223568999
Q ss_pred CCccceeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCCH---HHHHHHHhcCCCCC-CCCChHHHHHHHHhhhhCCC
Q 042539 253 EYVSPEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNR---KETFRNVLMKTPEF-VGQRTALTDLIQRLLEKDPV 327 (412)
Q Consensus 253 ~Y~APE~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---~~~~~~i~~~~~~~-~~~~~~~~dli~~~L~~dP~ 327 (412)
.|||||++.+ ..|+.++|||||||++|||++|+.||.+.+. .+....+....+.+ ..+++++++||.+||++||.
T Consensus 170 ~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 249 (364)
T d1omwa3 170 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVN 249 (364)
T ss_dssp GGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTT
T ss_pred ccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHHHHcccCHH
Confidence 9999999974 5789999999999999999999999987543 33344433433433 35789999999999999999
Q ss_pred ccCCCC-CChhhhhcCCCCCCCCchhhcc-cCCCCCCCCCCCc
Q 042539 328 KRLGYL-RGACEIKEHVFFKGVRWDLLTD-VLRPPFIPSREEN 368 (412)
Q Consensus 328 ~R~~~~-~~~~e~l~h~ff~~~~~~~~~~-~~~pp~~p~~~~~ 368 (412)
+|+++. .+++|+++||||++++|..+.. ...||++|.....
T Consensus 250 ~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~~~p~~p~~~~~ 292 (364)
T d1omwa3 250 RRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEV 292 (364)
T ss_dssp TSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC--
T ss_pred HhCCCcccCHHHHHcCccccCCCHHHHhcCCCCcCcCCCCCCC
Confidence 999753 3489999999999999986644 5578888866543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-62 Score=466.37 Aligned_cols=252 Identities=27% Similarity=0.404 Sum_probs=220.4
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
++|++++.||+|+||+||+|+++.++. .||||++++..... .+.+.+|+++|++++|||||+++++|.+++.
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~----~vAvK~~~~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 91 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQ----EVAIRQMNLQQQPK----KELIINEILVMRENKNPNIVNYLDSYLVGDE 91 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCC----EEEEEEEEGGGCSC----HHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCC----EEEEEEEecccChH----HHHHHHHHHHHHhCCCCCEeeEeEEEEECCE
Confidence 579999999999999999999887554 49999997654322 3567789999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+|+|||||.||+|..++... .+++.+++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.+..
T Consensus 92 ~~ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 92 LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp EEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 99999999999998876542 499999999999999999999999999999999999999999999999999976521
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
........+||+.||||
T Consensus 169 ---------------------------------------------------------------~~~~~~~~~gt~~Y~aP 185 (293)
T d1yhwa1 169 ---------------------------------------------------------------EQSKRSTMVGTPYWMAP 185 (293)
T ss_dssp ---------------------------------------------------------------TTCCBCCCCSCGGGCCH
T ss_pred ---------------------------------------------------------------ccccccccccCCCccCh
Confidence 11233456899999999
Q ss_pred eeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-CC---CCCCChHHHHHHHHhhhhCCCccCCCC
Q 042539 258 EVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT-PE---FVGQRTALTDLIQRLLEKDPVKRLGYL 333 (412)
Q Consensus 258 E~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-~~---~~~~~~~~~dli~~~L~~dP~~R~~~~ 333 (412)
|++.+..|+.++|||||||++|+|++|++||.+.+..+.+..+.... +. ...+++++++||.+||++||.+||
T Consensus 186 E~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~--- 262 (293)
T d1yhwa1 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRG--- 262 (293)
T ss_dssp HHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSC---
T ss_pred hhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCc---
Confidence 99999999999999999999999999999999988887777666432 22 234689999999999999999999
Q ss_pred CChhhhhcCCCCCC
Q 042539 334 RGACEIKEHVFFKG 347 (412)
Q Consensus 334 ~~~~e~l~h~ff~~ 347 (412)
+++|+++||||+.
T Consensus 263 -s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 263 -SAKELLQHQFLKI 275 (293)
T ss_dssp -CHHHHTTCGGGGG
T ss_pred -CHHHHhcCHhhCC
Confidence 6999999999973
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=9.8e-62 Score=472.61 Aligned_cols=261 Identities=30% Similarity=0.439 Sum_probs=229.1
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET 94 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 94 (412)
--+++|++++.||+|+||+||+|+++.++ +.||||++.+... ...+.+.+|+++|++++|||||+++++|.+
T Consensus 23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g----~~vAvK~i~~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 94 (350)
T d1koaa2 23 HVLDHYDIHEELGTGAFGVVHRVTERATG----NNFAAKFVMTPHE----SDKETVRKEIQTMSVLRHPTLVNLHDAFED 94 (350)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTT----EEEEEEEECCCSH----HHHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred CCccCeEEEEEEecCcCeEEEEEEECCCC----CEEEEEEEcccch----hhHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 34789999999999999999999998754 4499999976543 234567889999999999999999999999
Q ss_pred CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEcc--CCCEEEcccccc
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQ--SGHVTLTDFDLS 172 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~--~g~vkL~DFGla 172 (412)
++.+|+|||||.||+|..++... .+.+++.+++.++.||+.||+|||++|||||||||+|||++. +|.+||+|||+|
T Consensus 95 ~~~~~ivmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a 173 (350)
T d1koaa2 95 DNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT 173 (350)
T ss_dssp TTEEEEEECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchh
Confidence 99999999999999998877543 346999999999999999999999999999999999999964 588999999999
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+.+. ......+.+||+
T Consensus 174 ~~~~----------------------------------------------------------------~~~~~~~~~gT~ 189 (350)
T d1koaa2 174 AHLD----------------------------------------------------------------PKQSVKVTTGTA 189 (350)
T ss_dssp EECC----------------------------------------------------------------TTSCEEEECSCT
T ss_pred eecc----------------------------------------------------------------cccccceecCcc
Confidence 7652 112234678999
Q ss_pred CCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-----CCCChHHHHHHHHhhhhCCC
Q 042539 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF-----VGQRTALTDLIQRLLEKDPV 327 (412)
Q Consensus 253 ~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~dli~~~L~~dP~ 327 (412)
.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+++.++......+ ..+++++++||.+||++||+
T Consensus 190 ~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 269 (350)
T d1koaa2 190 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPN 269 (350)
T ss_dssp TTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGG
T ss_pred cccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChh
Confidence 9999999999999999999999999999999999999999999999988765443 34789999999999999999
Q ss_pred ccCCCCCChhhhhcCCCCCCCCchh
Q 042539 328 KRLGYLRGACEIKEHVFFKGVRWDL 352 (412)
Q Consensus 328 ~R~~~~~~~~e~l~h~ff~~~~~~~ 352 (412)
+|| +++|+++||||+..+|..
T Consensus 270 ~R~----t~~eil~hp~~~~~~~~~ 290 (350)
T d1koaa2 270 TRM----TIHQALEHPWLTPGNAPG 290 (350)
T ss_dssp GSC----CHHHHHHSTTTSCTTCCS
T ss_pred HCc----CHHHHhcCcccCCCCCCC
Confidence 999 799999999999877643
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-62 Score=468.01 Aligned_cols=254 Identities=30% Similarity=0.484 Sum_probs=208.9
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
.+.|++++.||+|+||+||+|+++.++. .||||++.+..... ....+.+|+.+|++++|||||+++++|++++
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~----~vAvK~i~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 80 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQK----LVAIKCIAKKALEG---KEGSMENEIAVLHKIKHPNIVALDDIYESGG 80 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCC----EEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCC----EEEEEEEchHHhhh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 3669999999999999999999987554 49999998765432 2456778999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEc---cCCCEEEccccccc
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIR---QSGHVTLTDFDLSR 173 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~---~~g~vkL~DFGla~ 173 (412)
.+|+|||||.||+|..++... +.+++.+++.++.||+.||+|||++||+||||||+|||+. .+|.+||+|||+|+
T Consensus 81 ~~~lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~ 158 (307)
T d1a06a_ 81 HLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158 (307)
T ss_dssp EEEEEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred EEEEEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeE
Confidence 999999999999998887654 4599999999999999999999999999999999999995 47899999999997
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
... ......+.+||+.
T Consensus 159 ~~~----------------------------------------------------------------~~~~~~~~~GT~~ 174 (307)
T d1a06a_ 159 MED----------------------------------------------------------------PGSVLSTACGTPG 174 (307)
T ss_dssp ------------------------------------------------------------------------------CT
T ss_pred Ecc----------------------------------------------------------------CCCeeeeeeeCcc
Confidence 542 1122346689999
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-----CCCChHHHHHHHHhhhhCCCc
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF-----VGQRTALTDLIQRLLEKDPVK 328 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~dli~~~L~~dP~~ 328 (412)
|||||++.+..|+.++|||||||++|||++|++||.+.+..++..++......+ ..+++++.+||.+||++||++
T Consensus 175 y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 254 (307)
T d1a06a_ 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEK 254 (307)
T ss_dssp TSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGG
T ss_pred ccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhH
Confidence 999999999999999999999999999999999999999999988888765433 457899999999999999999
Q ss_pred cCCCCCChhhhhcCCCCCC
Q 042539 329 RLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 329 R~~~~~~~~e~l~h~ff~~ 347 (412)
|| +++|+++||||++
T Consensus 255 R~----s~~eil~hp~~~~ 269 (307)
T d1a06a_ 255 RF----TCEQALQHPWIAG 269 (307)
T ss_dssp SC----CHHHHHHSTTTTS
T ss_pred Cc----CHHHHhcCHhhCC
Confidence 99 6999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-62 Score=462.77 Aligned_cols=262 Identities=26% Similarity=0.438 Sum_probs=226.3
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhh--HHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAK--HEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
++|+++++||+|+||+||+|+++.++. .||||++++...... ....+.+.+|+++|++++|||||+++++|+++
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~----~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGL----QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 85 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCC----EEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 569999999999999999999987554 499999987654321 12356678899999999999999999999999
Q ss_pred CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCC----CEEEccccc
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG----HVTLTDFDL 171 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g----~vkL~DFGl 171 (412)
+.+|+|||||.||+|..++.... .+++.+++.++.||+.||+|||++||+||||||+|||++.+| .+||+|||+
T Consensus 86 ~~~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 86 TDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred CEEEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhh
Confidence 99999999999999998887654 499999999999999999999999999999999999999877 499999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
|+... .+....+.+||
T Consensus 164 a~~~~----------------------------------------------------------------~~~~~~~~~~t 179 (293)
T d1jksa_ 164 AHKID----------------------------------------------------------------FGNEFKNIFGT 179 (293)
T ss_dssp CEECT----------------------------------------------------------------TSCBCSCCCCC
T ss_pred hhhcC----------------------------------------------------------------CCccccccCCC
Confidence 97652 12233456899
Q ss_pred CCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-----CCCChHHHHHHHHhhhhCC
Q 042539 252 EEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF-----VGQRTALTDLIQRLLEKDP 326 (412)
Q Consensus 252 ~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~dli~~~L~~dP 326 (412)
+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+.++......+ ...++++++||.+||+.||
T Consensus 180 ~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 259 (293)
T d1jksa_ 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDP 259 (293)
T ss_dssp GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSG
T ss_pred CcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCCh
Confidence 99999999999999999999999999999999999999999999999888766543 3578999999999999999
Q ss_pred CccCCCCCChhhhhcCCCCCCCCchhh
Q 042539 327 VKRLGYLRGACEIKEHVFFKGVRWDLL 353 (412)
Q Consensus 327 ~~R~~~~~~~~e~l~h~ff~~~~~~~~ 353 (412)
++|| +++|+++||||++.+|...
T Consensus 260 ~~R~----s~~eil~hp~~~~~~~~~~ 282 (293)
T d1jksa_ 260 KKRM----TIQDSLQHPWIKPKDTQQA 282 (293)
T ss_dssp GGSC----CHHHHHHSTTTCC------
T ss_pred hHCc----CHHHHhcCcccCCCChhHh
Confidence 9999 6999999999999888643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-62 Score=456.65 Aligned_cols=257 Identities=24% Similarity=0.382 Sum_probs=213.7
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe-
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET- 94 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~- 94 (412)
..++|++++.||+|+||+||+|+++.++. .||||++++.... +...+.+.+|+++|++++|||||++++++.+
T Consensus 2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~----~vAvK~i~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 75 (269)
T d2java1 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGK----ILVWKELDYGSMT--EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR 75 (269)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEECCTTSC--HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-
T ss_pred CchhCEEeEEEecCCCeEEEEEEECCCCC----EEEEEEEChhhCC--HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC
Confidence 36899999999999999999999987554 4999999877543 3345678889999999999999999999865
Q ss_pred -CCeEEEEeeccCCCCchhHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHcC-----ceeeeCCCCceEEccCCCEEE
Q 042539 95 -DEFLAWAVPYCPGGDLNVLRYKQ--NDRVFSPSVIRFYLSEIICAIEHLHNMG-----IAYRDLKPENILIRQSGHVTL 166 (412)
Q Consensus 95 -~~~~~lv~e~~~gg~L~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~yLH~~~-----iiHrDlKp~NiLl~~~g~vkL 166 (412)
++.+|+|||||+||+|.+++... ....+++.+++.++.||+.||+|||++| ||||||||+|||++.+|.+||
T Consensus 76 ~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl 155 (269)
T d2java1 76 TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL 155 (269)
T ss_dssp ---CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEE
T ss_pred CCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEE
Confidence 46799999999999999887542 3456999999999999999999999976 999999999999999999999
Q ss_pred ccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCc
Q 042539 167 TDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSN 246 (412)
Q Consensus 167 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (412)
+|||+|+.+... .....
T Consensus 156 ~DFG~a~~~~~~---------------------------------------------------------------~~~~~ 172 (269)
T d2java1 156 GDFGLARILNHD---------------------------------------------------------------TSFAK 172 (269)
T ss_dssp CCHHHHHHC-----------------------------------------------------------------------
T ss_pred eeccceeecccC---------------------------------------------------------------CCccc
Confidence 999999865311 11233
Q ss_pred ccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC-C-CCCChHHHHHHHHhhhh
Q 042539 247 SFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE-F-VGQRTALTDLIQRLLEK 324 (412)
Q Consensus 247 ~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~-~-~~~~~~~~dli~~~L~~ 324 (412)
+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..++..++...... . ...++++.+||.+||+.
T Consensus 173 ~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~ 252 (269)
T d2java1 173 AFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNL 252 (269)
T ss_dssp ---CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred cCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCC
Confidence 568999999999999999999999999999999999999999999999988888765532 2 35789999999999999
Q ss_pred CCCccCCCCCChhhhhcCCCC
Q 042539 325 DPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 325 dP~~R~~~~~~~~e~l~h~ff 345 (412)
||.+|| +++|+++|||+
T Consensus 253 dp~~Rp----s~~ell~hp~i 269 (269)
T d2java1 253 KDYHRP----SVEEILENPLI 269 (269)
T ss_dssp SGGGSC----CHHHHHTSTTC
T ss_pred ChhHCc----CHHHHHhCCcC
Confidence 999999 69999999995
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.6e-61 Score=469.97 Aligned_cols=256 Identities=30% Similarity=0.468 Sum_probs=225.2
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD 95 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 95 (412)
..++|++++.||+|+||+||+|+++.++. .||||++++... .....+.+|+.+|++++|||||+++++|.++
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~----~vAiK~i~~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 98 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGR----VFVAKFINTPYP----LDKYTVKNEISIMNQLHHPKLINLHDAFEDK 98 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEECCSH----HHHHHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCC----EEEEEEECCcch----hHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 35889999999999999999999987554 499999976542 2345677899999999999999999999999
Q ss_pred CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEc--cCCCEEEccccccc
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIR--QSGHVTLTDFDLSR 173 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~--~~g~vkL~DFGla~ 173 (412)
+.+|+|||||.||+|.+++... ...+++.+++.++.||+.||+|||++|||||||||+|||++ .+|.+||+|||+|+
T Consensus 99 ~~~~ivmE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~ 177 (352)
T d1koba_ 99 YEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT 177 (352)
T ss_dssp SEEEEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccce
Confidence 9999999999999997665433 34599999999999999999999999999999999999998 56899999999997
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
.+. ......+.+||+.
T Consensus 178 ~~~----------------------------------------------------------------~~~~~~~~~gt~~ 193 (352)
T d1koba_ 178 KLN----------------------------------------------------------------PDEIVKVTTATAE 193 (352)
T ss_dssp ECC----------------------------------------------------------------TTSCEEEECSSGG
T ss_pred ecC----------------------------------------------------------------CCCceeeccCccc
Confidence 652 1223346689999
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-----CCCChHHHHHHHHhhhhCCCc
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF-----VGQRTALTDLIQRLLEKDPVK 328 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~dli~~~L~~dP~~ 328 (412)
|||||++.+..|+.++|||||||++|+|++|++||.+.+..+.+.++......+ ...++++++||.+||++||.+
T Consensus 194 y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 273 (352)
T d1koba_ 194 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRK 273 (352)
T ss_dssp GCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGG
T ss_pred ccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhH
Confidence 999999999999999999999999999999999999999999988888765433 357899999999999999999
Q ss_pred cCCCCCChhhhhcCCCCCCC
Q 042539 329 RLGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 329 R~~~~~~~~e~l~h~ff~~~ 348 (412)
|| +++|+++||||++.
T Consensus 274 R~----s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 274 RL----TVHDALEHPWLKGD 289 (352)
T ss_dssp SC----CHHHHHTSTTTSSC
T ss_pred Cc----CHHHHhcCHhhCCC
Confidence 99 69999999999874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-62 Score=471.53 Aligned_cols=260 Identities=25% Similarity=0.424 Sum_probs=217.7
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLE 93 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 93 (412)
++.-++|++++.||+|+||+||+|+++.++ +.||+|++++... ......+.+|+.+|++++|||||+++++|.
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~----~~vAiK~i~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 74 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSG----LVMARKLIHLEIK---PAIRNQIIRELQVLHECNSPYIVGFYGAFY 74 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTT----EEEEEEEEECCCC---TTHHHHHHHHGGGGGGCCCTTBCCEEEEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCC----cEEEEEEEChhhC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 567899999999999999999999998754 4599999976532 234567788999999999999999999999
Q ss_pred eCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 94 TDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN-MGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 94 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
+++++|+|||||.||+|..++.... .+++.+++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|
T Consensus 75 ~~~~~~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla 152 (322)
T d1s9ja_ 75 SDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 152 (322)
T ss_dssp CSSEEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred ECCEEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCc
Confidence 9999999999999999998887654 49999999999999999999997 59999999999999999999999999999
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+.+... ...+++||+
T Consensus 153 ~~~~~~-----------------------------------------------------------------~~~~~~GT~ 167 (322)
T d1s9ja_ 153 GQLIDS-----------------------------------------------------------------MANSFVGTR 167 (322)
T ss_dssp HHHHHH-----------------------------------------------------------------TC---CCSS
T ss_pred cccCCC-----------------------------------------------------------------ccccccCCc
Confidence 865321 123568999
Q ss_pred CCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHH------------------------------------
Q 042539 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKET------------------------------------ 296 (412)
Q Consensus 253 ~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------------------------------------ 296 (412)
.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+.
T Consensus 168 ~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (322)
T d1s9ja_ 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPP 247 (322)
T ss_dssp CCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CC
T ss_pred cccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccc
Confidence 99999999999999999999999999999999999987543221
Q ss_pred ------HHHHhcCC-CCC--CCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCch
Q 042539 297 ------FRNVLMKT-PEF--VGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 297 ------~~~i~~~~-~~~--~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~ 351 (412)
...+.... +.. ...+.+++|||.+||++||++|| |++|+++||||+..+|+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~----ta~e~L~Hpf~~~~~~~ 307 (322)
T d1s9ja_ 248 MAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA----DLKQLMVHAFIKRSDAE 307 (322)
T ss_dssp CCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSC----CHHHHHTSHHHHHHHHS
T ss_pred hhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCc----CHHHHhhCHhhCcCCcc
Confidence 01111111 111 12468899999999999999999 79999999999876553
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-61 Score=456.53 Aligned_cols=254 Identities=27% Similarity=0.422 Sum_probs=220.4
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCe
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEF 97 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 97 (412)
+.|++++.||+|+||+||+|+++.++. .||||++++.... ..+.+.+|+++|++++|||||++++++.+++.
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~----~vAvK~i~~~~~~----~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 83 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSV----LAAAKVIDTKSEE----ELEDYMVEIDILASCDHPNIVKLLDAFYYENN 83 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEECSSSG----GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCe----EEEEEEECcCCHH----HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCe
Confidence 468999999999999999999987554 4999999765322 23456779999999999999999999999999
Q ss_pred EEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhc
Q 042539 98 LAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVK 177 (412)
Q Consensus 98 ~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~ 177 (412)
+|+|||||.||+|..++.... +.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 84 ~~lvmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 84 LWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred EEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 999999999999988765543 4599999999999999999999999999999999999999999999999999976532
Q ss_pred hhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccc
Q 042539 178 KTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSP 257 (412)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 257 (412)
... ...+.+||+.||||
T Consensus 163 ~~~---------------------------------------------------------------~~~~~~Gt~~y~AP 179 (288)
T d2jfla1 163 TIQ---------------------------------------------------------------RRDSFIGTPYWMAP 179 (288)
T ss_dssp HHH---------------------------------------------------------------HHTCCCSCCTTCCH
T ss_pred Ccc---------------------------------------------------------------cccccccccccCCH
Confidence 211 12256899999999
Q ss_pred eeec-----CCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC----CCCChHHHHHHHHhhhhCCCc
Q 042539 258 EVVR-----GDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF----VGQRTALTDLIQRLLEKDPVK 328 (412)
Q Consensus 258 E~l~-----~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~dli~~~L~~dP~~ 328 (412)
|++. +..|+.++|||||||++|||++|++||.+.+..+.+.++....+.. ...++++++||.+||+.||.+
T Consensus 180 E~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 259 (288)
T d2jfla1 180 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDA 259 (288)
T ss_dssp HHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTT
T ss_pred HHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhH
Confidence 9984 4567899999999999999999999999998888888888765332 346899999999999999999
Q ss_pred cCCCCCChhhhhcCCCCCC
Q 042539 329 RLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 329 R~~~~~~~~e~l~h~ff~~ 347 (412)
|| +++|+++||||+.
T Consensus 260 R~----t~~ell~hp~~~~ 274 (288)
T d2jfla1 260 RW----TTSQLLQHPFVTV 274 (288)
T ss_dssp SC----CHHHHTTSGGGCC
T ss_pred Cc----CHHHHhcCcccCC
Confidence 99 6999999999975
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-60 Score=457.10 Aligned_cols=251 Identities=24% Similarity=0.346 Sum_probs=219.0
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeE
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFL 98 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 98 (412)
.|+++++||+|+||+||+|+++.++ +.||||++.+..... ....+.+.+|+++|++++|||||++++++.+++.+
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~----~~vAvK~i~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 90 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNS----EVVAIKKMSYSGKQS-NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA 90 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTT----EEEEEEEEECCSSCH-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCC----cEEEEEEEchhhccC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEE
Confidence 4999999999999999999998754 459999998765432 34556788899999999999999999999999999
Q ss_pred EEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhch
Q 042539 99 AWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKK 178 (412)
Q Consensus 99 ~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~ 178 (412)
|+|||||.||+|..++... +.+++.+++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+...
T Consensus 91 ~iv~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~-- 166 (309)
T d1u5ra_ 91 WLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-- 166 (309)
T ss_dssp EEEEECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS--
T ss_pred EEEEEecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccC--
Confidence 9999999999997655443 459999999999999999999999999999999999999999999999999996431
Q ss_pred hhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccce
Q 042539 179 TAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPE 258 (412)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 258 (412)
...+.+||+.|||||
T Consensus 167 -----------------------------------------------------------------~~~~~~GT~~Y~APE 181 (309)
T d1u5ra_ 167 -----------------------------------------------------------------PANSFVGTPYWMAPE 181 (309)
T ss_dssp -----------------------------------------------------------------SBCCCCSCGGGCCHH
T ss_pred -----------------------------------------------------------------CCCccccCccccCHH
Confidence 123457999999999
Q ss_pred eecC---CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC---CCCCChHHHHHHHHhhhhCCCccCCC
Q 042539 259 VVRG---DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE---FVGQRTALTDLIQRLLEKDPVKRLGY 332 (412)
Q Consensus 259 ~l~~---~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~dli~~~L~~dP~~R~~~ 332 (412)
++.+ ..|+.++|||||||++|||++|..||.+.+..+.+.++...... ....++++++||.+||+.||.+||
T Consensus 182 ~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-- 259 (309)
T d1u5ra_ 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRP-- 259 (309)
T ss_dssp HHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSC--
T ss_pred HHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCc--
Confidence 9975 35899999999999999999999999999888888777765432 234689999999999999999999
Q ss_pred CCChhhhhcCCCCCC
Q 042539 333 LRGACEIKEHVFFKG 347 (412)
Q Consensus 333 ~~~~~e~l~h~ff~~ 347 (412)
+++|+++||||..
T Consensus 260 --t~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 260 --TSEVLLKHRFVLR 272 (309)
T ss_dssp --CHHHHTTCHHHHS
T ss_pred --CHHHHHhCHHhcC
Confidence 6999999999964
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-60 Score=443.97 Aligned_cols=249 Identities=23% Similarity=0.365 Sum_probs=210.7
Q ss_pred ceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe----C
Q 042539 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET----D 95 (412)
Q Consensus 20 y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~ 95 (412)
|++.++||+|+||+||+|+++.++. .||+|++.+.... ....+.+.+|+++|++++|||||+++++|++ +
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~----~va~K~i~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 84 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTV----EVAWCELQDRKLT--KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 84 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEGGGSC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred EEeeeEEecCcCcEEEEEEECCCCe----EEEEEEEchhhCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccC
Confidence 4788899999999999999987554 4999999776542 2345678889999999999999999999975 3
Q ss_pred CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeeeCCCCceEEc-cCCCEEEcccccc
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMG--IAYRDLKPENILIR-QSGHVTLTDFDLS 172 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~--iiHrDlKp~NiLl~-~~g~vkL~DFGla 172 (412)
..+|+|||||.||+|..++.... .+++.+++.++.||+.||+|||++| |+||||||+|||++ .+|.+||+|||+|
T Consensus 85 ~~~~ivmE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 85 KCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162 (270)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred CEEEEEEeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence 56899999999999998887654 4999999999999999999999999 99999999999997 4799999999999
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+... .....+.+||+
T Consensus 163 ~~~~-----------------------------------------------------------------~~~~~~~~GT~ 177 (270)
T d1t4ha_ 163 TLKR-----------------------------------------------------------------ASFAKAVIGTP 177 (270)
T ss_dssp GGCC-----------------------------------------------------------------TTSBEESCSSC
T ss_pred eecc-----------------------------------------------------------------CCccCCcccCc
Confidence 6421 12234668999
Q ss_pred CCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCC-HHHHHHHHhcCCCC--C-CCCChHHHHHHHHhhhhCCCc
Q 042539 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKN-RKETFRNVLMKTPE--F-VGQRTALTDLIQRLLEKDPVK 328 (412)
Q Consensus 253 ~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-~~~~~~~i~~~~~~--~-~~~~~~~~dli~~~L~~dP~~ 328 (412)
.|||||++.+ .|+.++|||||||++|||++|+.||.+.. ..+++.++...... + ...++++++||.+||++||++
T Consensus 178 ~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~ 256 (270)
T d1t4ha_ 178 EFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDE 256 (270)
T ss_dssp CCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGG
T ss_pred cccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhH
Confidence 9999999876 59999999999999999999999998754 45555666544322 1 245789999999999999999
Q ss_pred cCCCCCChhhhhcCCCCC
Q 042539 329 RLGYLRGACEIKEHVFFK 346 (412)
Q Consensus 329 R~~~~~~~~e~l~h~ff~ 346 (412)
|| +++|+++||||+
T Consensus 257 R~----s~~ell~Hp~fk 270 (270)
T d1t4ha_ 257 RY----SIKDLLNHAFFQ 270 (270)
T ss_dssp SC----CHHHHHTSGGGC
T ss_pred Cc----CHHHHhCCcccC
Confidence 99 699999999995
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.9e-59 Score=442.28 Aligned_cols=257 Identities=28% Similarity=0.453 Sum_probs=224.7
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhh-----hhHHHHHHHHHHHHHHhhcC-CCccceeee
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLH-----AKHEAERRARWEIRVLSRLS-HPFLPKLLG 90 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~ 90 (412)
.++|++++.||+|+||+||+|+++.++ +.||||++++.... ........+.+|+.++++++ |||||++++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~----~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 77 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTC----KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 77 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred cccCEEceEEecCcCeEEEEEEECCCC----CEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEe
Confidence 589999999999999999999987754 45999999775432 12335567889999999997 999999999
Q ss_pred eEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccc
Q 042539 91 SLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 91 ~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
+|.+++++|||||||+||+|.+++..+. .+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||
T Consensus 78 ~~~~~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 78 TYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred ecccCcceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccch
Confidence 9999999999999999999999987654 49999999999999999999999999999999999999999999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+|+.+.. .......+|
T Consensus 156 ~a~~~~~----------------------------------------------------------------~~~~~~~~g 171 (277)
T d1phka_ 156 FSCQLDP----------------------------------------------------------------GEKLREVCG 171 (277)
T ss_dssp TCEECCT----------------------------------------------------------------TCCBCCCCS
T ss_pred heeEccC----------------------------------------------------------------CCceeeeec
Confidence 9976521 122335689
Q ss_pred CCCCccceeecC------CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC-----CCCCChHHHHHHH
Q 042539 251 TEEYVSPEVVRG------DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE-----FVGQRTALTDLIQ 319 (412)
Q Consensus 251 t~~Y~APE~l~~------~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~-----~~~~~~~~~dli~ 319 (412)
|+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+...++...... ....++++++||.
T Consensus 172 t~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 251 (277)
T d1phka_ 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVS 251 (277)
T ss_dssp CGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHH
T ss_pred cCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHH
Confidence 999999999864 34688999999999999999999999999999988888866543 2357899999999
Q ss_pred HhhhhCCCccCCCCCChhhhhcCCCCCC
Q 042539 320 RLLEKDPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 320 ~~L~~dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
+||++||++|| +++|+++||||+.
T Consensus 252 ~~L~~~p~~R~----s~~eil~h~~~~~ 275 (277)
T d1phka_ 252 RFLVVQPQKRY----TAEEALAHPFFQQ 275 (277)
T ss_dssp HHCCSSGGGSC----CHHHHTTSGGGCT
T ss_pred HHccCChhHCc----CHHHHHcCHHHHH
Confidence 99999999999 6999999999985
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-59 Score=452.37 Aligned_cols=253 Identities=25% Similarity=0.375 Sum_probs=223.5
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
.++|++++.||+|+||+||+|.++.++. .||||++++... ....+.+|+++|+.++|||||+++++|++++
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~----~~AiK~i~~~~~-----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 74 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKK----TYMAKFVKVKGT-----DQVLVKKEISILNIARHRNILHLHESFESME 74 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEECCCTH-----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCc----EEEEEEEcCCcc-----cHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 5789999999999999999999987554 499999977542 2345678999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccC--CCEEEccccccch
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQS--GHVTLTDFDLSRN 174 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~--g~vkL~DFGla~~ 174 (412)
.+|+|||||.||+|..++.... ..+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus 75 ~~~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~ 153 (321)
T d1tkia_ 75 ELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhc
Confidence 9999999999999988775432 359999999999999999999999999999999999999855 4899999999975
Q ss_pred hhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCC
Q 042539 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254 (412)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 254 (412)
.. ......+.+||+.|
T Consensus 154 ~~----------------------------------------------------------------~~~~~~~~~~t~~y 169 (321)
T d1tkia_ 154 LK----------------------------------------------------------------PGDNFRLLFTAPEY 169 (321)
T ss_dssp CC----------------------------------------------------------------TTCEEEEEESCGGG
T ss_pred cc----------------------------------------------------------------cCCccccccccccc
Confidence 42 11223456899999
Q ss_pred ccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC-----CCChHHHHHHHHhhhhCCCcc
Q 042539 255 VSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEFV-----GQRTALTDLIQRLLEKDPVKR 329 (412)
Q Consensus 255 ~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-----~~~~~~~dli~~~L~~dP~~R 329 (412)
+|||.+.+..|+.++|||||||++|+|++|.+||.+.+..+.+.++......++ .+++++++||.+||++||.+|
T Consensus 170 ~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R 249 (321)
T d1tkia_ 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSR 249 (321)
T ss_dssp SCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGS
T ss_pred ccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHC
Confidence 999999999999999999999999999999999999999999999988765543 578999999999999999999
Q ss_pred CCCCCChhhhhcCCCCCC
Q 042539 330 LGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 330 ~~~~~~~~e~l~h~ff~~ 347 (412)
| +++|+++||||+.
T Consensus 250 ~----s~~eil~hp~~~~ 263 (321)
T d1tkia_ 250 M----TASEALQHPWLKQ 263 (321)
T ss_dssp C----CHHHHHHSHHHHS
T ss_pred c----CHHHHhcCHhhcc
Confidence 9 6999999999974
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-59 Score=446.00 Aligned_cols=255 Identities=27% Similarity=0.427 Sum_probs=209.9
Q ss_pred eeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhh-hHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEE
Q 042539 21 KALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHA-KHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLA 99 (412)
Q Consensus 21 ~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 99 (412)
+.+++||+|+||+||+|+++.++ +.||||++++..... .....+.+.+|+++|++++|||||+++++|.+++++|
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ 76 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTN----QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 76 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCC----SEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred CcceEeccCcCeEEEEEEECCCC----cEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCcee
Confidence 35789999999999999988754 459999997765422 2233456888999999999999999999999999999
Q ss_pred EEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchh
Q 042539 100 WAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKT 179 (412)
Q Consensus 100 lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~ 179 (412)
+|||||.|+++..+.. ....+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 77 ivmE~~~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~-- 152 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-- 152 (299)
T ss_dssp EEEECCSEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS--
T ss_pred ehhhhhcchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCC--
Confidence 9999999987754433 345699999999999999999999999999999999999999999999999999975421
Q ss_pred hhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcccee
Q 042539 180 AFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEV 259 (412)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 259 (412)
......+.+||+.|||||+
T Consensus 153 -------------------------------------------------------------~~~~~~~~~gt~~y~aPE~ 171 (299)
T d1ua2a_ 153 -------------------------------------------------------------PNRAYTHQVVTRWYRAPEL 171 (299)
T ss_dssp -------------------------------------------------------------CCCCCCCSCCCCTTCCHHH
T ss_pred -------------------------------------------------------------CcccccceecChhhccHHH
Confidence 1122345689999999999
Q ss_pred ecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CCC---------------------------CCC
Q 042539 260 VRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK--TPE---------------------------FVG 309 (412)
Q Consensus 260 l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~~~---------------------------~~~ 309 (412)
+.+. .|+.++|||||||++|||++|.+||.+.+..+++.++... .+. +..
T Consensus 172 ~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (299)
T d1ua2a_ 172 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSA 251 (299)
T ss_dssp HTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTT
T ss_pred HccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhccc
Confidence 8754 5799999999999999999999999999988887776531 000 124
Q ss_pred CChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCC
Q 042539 310 QRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 310 ~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~ 348 (412)
.++++.|||.+||++||++|+ |++|+++||||++.
T Consensus 252 ~s~~~~dll~~~L~~dP~~R~----sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 252 AGDDLLDLIQGLFLFNPCARI----TATQALKMKYFSNR 286 (299)
T ss_dssp CCHHHHHHHHHHHCSSTTTSC----CHHHHHTSGGGTSS
T ss_pred CCHHHHHHHHHHccCChhhCc----CHHHHhCCHhhCCC
Confidence 568999999999999999999 79999999999864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-59 Score=447.56 Aligned_cols=290 Identities=41% Similarity=0.717 Sum_probs=239.5
Q ss_pred CCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCC-CccceeeeeE
Q 042539 14 SLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH-PFLPKLLGSL 92 (412)
Q Consensus 14 ~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~ 92 (412)
.+.+++|+++++||+|+||+||+|++... ..+++.||||++++..........+.+.+|+++|++++| |||+++++++
T Consensus 20 ~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~-~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~ 98 (322)
T d1vzoa_ 20 KVGIENFELLKVLGTGAYGKVFLVRKISG-HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 98 (322)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSS-TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred ccchhceEEEEEEecCCCeEEEEEEECcc-CCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee
Confidence 46789999999999999999999988543 235667999999876543333345567779999999976 8999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
.+...+|++||||.||+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|
T Consensus 99 ~~~~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 99 QTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred ccCCceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccch
Confidence 99999999999999999988877655 4889999999999999999999999999999999999999999999999999
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+.+.... .....+..||+
T Consensus 177 ~~~~~~~--------------------------------------------------------------~~~~~~~~g~~ 194 (322)
T d1vzoa_ 177 KEFVADE--------------------------------------------------------------TERAYDFCGTI 194 (322)
T ss_dssp EECCGGG--------------------------------------------------------------GGGGCGGGSCC
T ss_pred hhhcccc--------------------------------------------------------------ccccccccccc
Confidence 7653211 11233567999
Q ss_pred CCccceeecCCC--CCchhhHHHHHHHHHHHhhCCCCCCCCCHHH----HHHHHhcCCCCC-CCCChHHHHHHHHhhhhC
Q 042539 253 EYVSPEVVRGDG--HEFAVDWWALGILTYEMLYGTTPFRGKNRKE----TFRNVLMKTPEF-VGQRTALTDLIQRLLEKD 325 (412)
Q Consensus 253 ~Y~APE~l~~~~--~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~----~~~~i~~~~~~~-~~~~~~~~dli~~~L~~d 325 (412)
.|+|||.+.+.. ++.++|||||||+||+|++|..||.+.+..+ .........+.+ ...++++.+||.+||++|
T Consensus 195 ~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~d 274 (322)
T d1vzoa_ 195 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKD 274 (322)
T ss_dssp TTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred ccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccC
Confidence 999999998754 5889999999999999999999998754333 333333344443 357899999999999999
Q ss_pred CCccCCCCC-ChhhhhcCCCCCCCCchhhcc-cCCCCCCCCCCCc
Q 042539 326 PVKRLGYLR-GACEIKEHVFFKGVRWDLLTD-VLRPPFIPSREEN 368 (412)
Q Consensus 326 P~~R~~~~~-~~~e~l~h~ff~~~~~~~~~~-~~~pp~~p~~~~~ 368 (412)
|.+|+++.. |++|+++||||++++|+.+.. ...+|++|..+++
T Consensus 275 P~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p~~~~~ 319 (322)
T d1vzoa_ 275 PKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDE 319 (322)
T ss_dssp GGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC-
T ss_pred HHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCCCCCCC
Confidence 999998643 699999999999999986655 6788999986654
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-58 Score=441.25 Aligned_cols=259 Identities=26% Similarity=0.378 Sum_probs=216.0
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
+|+|+++++||+|+||+||+|+++.++. .||||++++... .+.....+.+|+++|++++|||||+++++|++++
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~----~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~ 74 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGE----VVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 74 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCC----EEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCC----EEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEEecccccccc
Confidence 5899999999999999999999987554 499999976543 2233567788999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
++|+|||||.|+.+. ++.......+++.+++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+...
T Consensus 75 ~~~iv~e~~~~~~~~-~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~ 153 (298)
T d1gz8a_ 75 KLYLVFEFLHQDLKK-FMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153 (298)
T ss_dssp EEEEEEECCSEEHHH-HHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred ceeEEEeecCCchhh-hhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceecc
Confidence 999999999766544 4444555679999999999999999999999999999999999999999999999999997542
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
. ........+||+.|+|
T Consensus 154 ~---------------------------------------------------------------~~~~~~~~~gt~~y~a 170 (298)
T d1gz8a_ 154 V---------------------------------------------------------------PVRTYTHEVVTLWYRA 170 (298)
T ss_dssp C---------------------------------------------------------------CSBCTTCCBCCCTTCC
T ss_pred C---------------------------------------------------------------Ccccceeecccceeee
Confidence 1 1122345689999999
Q ss_pred ceeecCCCC-CchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--C----------------------------
Q 042539 257 PEVVRGDGH-EFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT--P---------------------------- 305 (412)
Q Consensus 257 PE~l~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~---------------------------- 305 (412)
||++....+ +.++|||||||++|+|++|+.||.+.+..+.+.++.... +
T Consensus 171 pE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T d1gz8a_ 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSK 250 (298)
T ss_dssp HHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHH
T ss_pred hhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhh
Confidence 999887765 889999999999999999999999998888776654210 0
Q ss_pred CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCC
Q 042539 306 EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 306 ~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~ 349 (412)
..+..+++++|||.+||++||++|| +++|+++||||+++.
T Consensus 251 ~~~~~s~~~~dll~~mL~~dP~~R~----t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 251 VVPPLDEDGRSLLSQMLHYDPNKRI----SAKAALAHPFFQDVT 290 (298)
T ss_dssp HSTTCCHHHHHHHHHHTCSSTTTSC----CHHHHHTSGGGTTCC
T ss_pred hccCCCHHHHHHHHHHccCChhHCc----CHHHHhCCHhhccCC
Confidence 0124568899999999999999999 799999999998764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-59 Score=449.46 Aligned_cols=255 Identities=26% Similarity=0.426 Sum_probs=210.5
Q ss_pred CCCCCccCceeee-eeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceee
Q 042539 12 TPSLDLDNLKALK-ILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLL 89 (412)
Q Consensus 12 ~~~~~~~~y~~~~-~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~ 89 (412)
....-+++|++++ +||+|+||+||+|+++.++. .||||++++.. .+.+|+.++.++ +|||||+++
T Consensus 5 ~~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~----~vAiK~i~~~~---------~~~~E~~~~~~~~~hpnIv~l~ 71 (335)
T d2ozaa1 5 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQE----KFALKMLQDCP---------KARREVELHWRASQCPHIVRIV 71 (335)
T ss_dssp BCSCGGGTEEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEECSH---------HHHHHHHHHHHHTTSTTBCCEE
T ss_pred CCCCcccCEEEeeEEeeeccCeEEEEEEECCCCC----EEEEEEECCcH---------HHHHHHHHHHHhcCCCCCCeEE
Confidence 3444578999986 59999999999999987554 49999996532 344689887655 799999999
Q ss_pred eeEEe----CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEcc---CC
Q 042539 90 GSLET----DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQ---SG 162 (412)
Q Consensus 90 ~~~~~----~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~---~g 162 (412)
++|++ +..+|+|||||+||+|.+++.......|++.+++.++.||+.||+|||++||+||||||+|||++. .+
T Consensus 72 ~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~ 151 (335)
T d2ozaa1 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA 151 (335)
T ss_dssp EEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTC
T ss_pred EEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccc
Confidence 99976 467999999999999999887665567999999999999999999999999999999999999986 46
Q ss_pred CEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCC
Q 042539 163 HVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNG 242 (412)
Q Consensus 163 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (412)
.+||+|||+|+... ..
T Consensus 152 ~~Kl~DFG~a~~~~----------------------------------------------------------------~~ 167 (335)
T d2ozaa1 152 ILKLTDFGFAKETT----------------------------------------------------------------SH 167 (335)
T ss_dssp CEEECCCTTCEECC----------------------------------------------------------------CC
T ss_pred cccccccceeeecc----------------------------------------------------------------CC
Confidence 79999999997542 11
Q ss_pred CCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH----hcCCCCCC-----CCChH
Q 042539 243 ERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNV----LMKTPEFV-----GQRTA 313 (412)
Q Consensus 243 ~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i----~~~~~~~~-----~~~~~ 313 (412)
....+.+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+..+....+ ......++ .++++
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 247 (335)
T d2ozaa1 168 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 247 (335)
T ss_dssp CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHH
T ss_pred CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHH
Confidence 2234568999999999999999999999999999999999999999886644443333 22333333 46789
Q ss_pred HHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCC
Q 042539 314 LTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 314 ~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
+++||.+||++||++|| ++.|+++||||..
T Consensus 248 ~~~li~~~L~~dP~~R~----s~~eil~hp~~~~ 277 (335)
T d2ozaa1 248 VKMLIRNLLKTEPTQRM----TITEFMNHPWIMQ 277 (335)
T ss_dssp HHHHHHHHSCSSTTTSC----CHHHHHHSHHHHT
T ss_pred HHHHHHHHccCChhHCc----CHHHHHcCHHhhC
Confidence 99999999999999999 6999999999964
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-58 Score=438.22 Aligned_cols=260 Identities=26% Similarity=0.342 Sum_probs=213.9
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc---CCCccceeeeeEE
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL---SHPFLPKLLGSLE 93 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~ 93 (412)
-++|+++++||+|+||+||+|++..++ ++.||||++++..... .....+.+|+.+|+.| +||||++++++|.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~---~~~vAiK~i~~~~~~~--~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~ 80 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNG---GRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 80 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTT---TEEEEEEEEEEEBCTT--SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCC---CEEEEEEEEehhhccc--hHHHHHHHHHHHHHHHhhcCCCCcceeeeeec
Confidence 479999999999999999999986542 3459999997654321 1122344577777666 7999999999986
Q ss_pred e-----CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcc
Q 042539 94 T-----DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTD 168 (412)
Q Consensus 94 ~-----~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~D 168 (412)
. ...+|++||||.|+++... .......+++..++.++.|++.||+|||++|||||||||+|||++.+|.+||+|
T Consensus 81 ~~~~~~~~~~~~~~e~~~~~~~~~~-~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 81 VSRTDRETKLTLVFEHVDQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp EEECSSEEEEEEEEECCSCBHHHHH-HHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred ccccccCceEEEEEEeccCCchhhh-hhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecc
Confidence 3 3478999999998877544 334445699999999999999999999999999999999999999999999999
Q ss_pred ccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccc
Q 042539 169 FDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248 (412)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (412)
||+++.... .....+.
T Consensus 160 fg~~~~~~~----------------------------------------------------------------~~~~~~~ 175 (305)
T d1blxa_ 160 FGLARIYSF----------------------------------------------------------------QMALTSV 175 (305)
T ss_dssp CCSCCCCCG----------------------------------------------------------------GGGGCCC
T ss_pred hhhhhhhcc----------------------------------------------------------------cccCCCc
Confidence 999875421 1123456
Q ss_pred ccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CC---------------------
Q 042539 249 VGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK--TP--------------------- 305 (412)
Q Consensus 249 ~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~~--------------------- 305 (412)
+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+++.+++.. .+
T Consensus 176 ~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (305)
T d1blxa_ 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSA 255 (305)
T ss_dssp CCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCC
T ss_pred ccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccc
Confidence 8999999999999999999999999999999999999999999988887776531 00
Q ss_pred -----CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCc
Q 042539 306 -----EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRW 350 (412)
Q Consensus 306 -----~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~ 350 (412)
.....++.++|||.+||++||++|| +++|+++||||+++++
T Consensus 256 ~~~~~~~~~~s~~~~dli~~mL~~dP~~R~----sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 256 QPIEKFVTDIDELGKDLLLKCLTFNPAKRI----SAYSALSHPYFQDLER 301 (305)
T ss_dssp CCGGGTCCSCCHHHHHHHHHHSCSSTTTSC----CHHHHHTSGGGTTCCC
T ss_pred cchhhccccCCHHHHHHHHHHCcCChhHCc----CHHHHhcChhhcCchh
Confidence 0124568899999999999999999 6999999999998865
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-58 Score=430.98 Aligned_cols=252 Identities=26% Similarity=0.379 Sum_probs=209.2
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhH--HHHHHHHHHHHHHhhcC--CCccceeeeeE
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKH--EAERRARWEIRVLSRLS--HPFLPKLLGSL 92 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~--~~~~~~~~Ei~il~~l~--hpnIv~l~~~~ 92 (412)
-++|++.++||+|+||+||+|+++.++. .||||++++....... ....++.+|+.+|++++ |||||+++++|
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~ 78 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNL----PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 78 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCC----EEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE
Confidence 3689999999999999999999987554 4999999876542211 11233556999999997 89999999999
Q ss_pred EeCCeEEEEeeccCC-CCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccC-CCEEEcccc
Q 042539 93 ETDEFLAWAVPYCPG-GDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQS-GHVTLTDFD 170 (412)
Q Consensus 93 ~~~~~~~lv~e~~~g-g~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~-g~vkL~DFG 170 (412)
.+++.+|+||||+.| +++..++.... .+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||
T Consensus 79 ~~~~~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 79 ERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eeCCeEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccc
Confidence 999999999999987 56666655543 59999999999999999999999999999999999999855 799999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+|+... .....+.+|
T Consensus 157 ~a~~~~-----------------------------------------------------------------~~~~~~~~G 171 (273)
T d1xwsa_ 157 SGALLK-----------------------------------------------------------------DTVYTDFDG 171 (273)
T ss_dssp TCEECC-----------------------------------------------------------------SSCBCCCCS
T ss_pred cceecc-----------------------------------------------------------------ccccccccc
Confidence 996431 112345689
Q ss_pred CCCCccceeecCCCC-CchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-CCCChHHHHHHHHhhhhCCCc
Q 042539 251 TEEYVSPEVVRGDGH-EFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF-VGQRTALTDLIQRLLEKDPVK 328 (412)
Q Consensus 251 t~~Y~APE~l~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~dli~~~L~~dP~~ 328 (412)
|+.|||||++.+..+ +.++|||||||++|||++|+.||.+.+ ++......+ ..+++++++||.+||++||++
T Consensus 172 T~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 245 (273)
T d1xwsa_ 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQHLIRWCLALRPSD 245 (273)
T ss_dssp CGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHHHHHHHHHHTCSSGGG
T ss_pred CCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCCCCCCHHHHHHHHHHccCCHhH
Confidence 999999999988775 678999999999999999999998632 233333333 457899999999999999999
Q ss_pred cCCCCCChhhhhcCCCCCCCC
Q 042539 329 RLGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 329 R~~~~~~~~e~l~h~ff~~~~ 349 (412)
|| +++|+++||||+++.
T Consensus 246 R~----s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 246 RP----TFEEIQNHPWMQDVL 262 (273)
T ss_dssp SC----CHHHHHTSGGGSSCC
T ss_pred Cc----CHHHHhcCHhhCCCC
Confidence 99 699999999998754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.1e-57 Score=428.61 Aligned_cols=256 Identities=20% Similarity=0.272 Sum_probs=217.0
Q ss_pred CCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeee
Q 042539 11 TTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLG 90 (412)
Q Consensus 11 ~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 90 (412)
..+++..++|++++.||+|+||+||+|+++.++. .||||+++++... .+.+.+|+++|++++|||||++++
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~----~vAvK~i~~~~~~-----~~~~~~E~~il~~l~HpnIv~~~~ 80 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSL----TVAVKTLKEDTME-----VEEFLKEAAVMKEIKHPNLVQLLG 80 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTE----EEEEEECCTTCSC-----HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCe----EEEEEEECCccch-----HHHHHHHHHHHHhCCCCCEecCCc
Confidence 4578999999999999999999999999987544 4999999765432 345778999999999999999999
Q ss_pred eEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccc
Q 042539 91 SLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 91 ~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
++.+++.+|+|||||.+|+|..++.......+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||
T Consensus 81 ~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG 160 (287)
T d1opja_ 81 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 160 (287)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred cEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEcccc
Confidence 99999999999999999999988877666779999999999999999999999999999999999999999999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+|+..... .........|
T Consensus 161 ~a~~~~~~--------------------------------------------------------------~~~~~~~~~g 178 (287)
T d1opja_ 161 LSRLMTGD--------------------------------------------------------------TYTAHAGAKF 178 (287)
T ss_dssp CTTTCCSS--------------------------------------------------------------SSEEETTEEE
T ss_pred ceeecCCC--------------------------------------------------------------Cceeeccccc
Confidence 99764211 0011123458
Q ss_pred CCCCccceeecCCCCCchhhHHHHHHHHHHHhhC-CCCCCCCCHHHHHHHHhcCC-C-CCCCCChHHHHHHHHhhhhCCC
Q 042539 251 TEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYG-TTPFRGKNRKETFRNVLMKT-P-EFVGQRTALTDLIQRLLEKDPV 327 (412)
Q Consensus 251 t~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g-~~Pf~~~~~~~~~~~i~~~~-~-~~~~~~~~~~dli~~~L~~dP~ 327 (412)
|+.|||||++.+..|+.++|||||||++|||++| .+||.+.+..+.+..+.... + ....+++++.+||.+||+.||+
T Consensus 179 ~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 258 (287)
T d1opja_ 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPS 258 (287)
T ss_dssp CGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred cccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHh
Confidence 9999999999999999999999999999999995 55566677666665554432 2 2345789999999999999999
Q ss_pred ccCCCCCChhhhhc
Q 042539 328 KRLGYLRGACEIKE 341 (412)
Q Consensus 328 ~R~~~~~~~~e~l~ 341 (412)
+|| +++++++
T Consensus 259 ~Rp----s~~ei~~ 268 (287)
T d1opja_ 259 DRP----SFAEIHQ 268 (287)
T ss_dssp GSC----CHHHHHH
T ss_pred HCc----CHHHHHH
Confidence 999 6888865
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-56 Score=423.40 Aligned_cols=254 Identities=26% Similarity=0.405 Sum_probs=210.5
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
-++|++++.||+|+||+||+|+++.++. .||||++++.... ......++.+|+++++.++|||||++++++.+.+
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~----~vAiK~i~~~~~~-~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~ 80 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHR----DVAVKVLRADLAR-DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 80 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEECSTTTT-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCC----EEEEEEEchhhcc-CHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc
Confidence 4679999999999999999999987554 4999999876543 3445667889999999999999999999998654
Q ss_pred ----eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 97 ----FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 97 ----~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
.+|+|||||.||+|..++.... .+++.+++.++.||+.||+|||++|||||||||+|||++.++.++|+|||.+
T Consensus 81 ~~~~~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 81 PAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp SSSEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred CCCceEEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhh
Confidence 4899999999999988776654 4999999999999999999999999999999999999999999999999998
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+...... .......+.+||+
T Consensus 159 ~~~~~~~------------------------------------------------------------~~~~~~~~~~Gt~ 178 (277)
T d1o6ya_ 159 RAIADSG------------------------------------------------------------NSVTQTAAVIGTA 178 (277)
T ss_dssp EECC----------------------------------------------------------------------------
T ss_pred hhhcccc------------------------------------------------------------ccccccccccCcc
Confidence 7542111 1122344678999
Q ss_pred CCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC-----CCCCChHHHHHHHHhhhhCCC
Q 042539 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPE-----FVGQRTALTDLIQRLLEKDPV 327 (412)
Q Consensus 253 ~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~-----~~~~~~~~~dli~~~L~~dP~ 327 (412)
.|||||++.+..++.++|||||||++|||++|++||.+.+..+.+.+++...+. ...+++++.+||.+||++||.
T Consensus 179 ~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~ 258 (277)
T d1o6ya_ 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPE 258 (277)
T ss_dssp TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGG
T ss_pred cccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHh
Confidence 999999999999999999999999999999999999999988888887766543 246789999999999999999
Q ss_pred ccCCCCCChhhhh
Q 042539 328 KRLGYLRGACEIK 340 (412)
Q Consensus 328 ~R~~~~~~~~e~l 340 (412)
+||+ ++++++
T Consensus 259 ~R~~---sa~~l~ 268 (277)
T d1o6ya_ 259 NRYQ---TAAEMR 268 (277)
T ss_dssp GSCS---SHHHHH
T ss_pred HCHh---HHHHHH
Confidence 9995 566665
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4e-57 Score=428.46 Aligned_cols=255 Identities=25% Similarity=0.400 Sum_probs=212.3
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
+++|+++++||+|+||+||+|+++ +++.||||++++.... ....+++.+|+.+|++++|||||+++++|.+++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-----~~~~vAvK~i~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 73 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-----YGETFALKKIRLEKED--EGIPSTTIREISILKELKHSNIVKLYDVIHTKK 73 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-----TSCEEEEEEECCSSGG--GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS
T ss_pred CCCceeccEEecCCCcEEEEEEeC-----CCCEEEEEEEehhhcC--hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC
Confidence 589999999999999999999985 3345999999776432 233567778999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
.+|++||++.|+++..+.. ..+.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|....
T Consensus 74 ~~~i~~e~~~~~~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~ 151 (286)
T d1ob3a_ 74 RLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFG 151 (286)
T ss_dssp CEEEEEECCSEEHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred ceeEEEEeehhhhHHHHHh--hcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecc
Confidence 9999999998887765543 34569999999999999999999999999999999999999999999999999997652
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
.. .......+||+.|+|
T Consensus 152 ~~---------------------------------------------------------------~~~~~~~~~~~~y~~ 168 (286)
T d1ob3a_ 152 IP---------------------------------------------------------------VRKYTHEIVTLWYRA 168 (286)
T ss_dssp C------------------------------------------------------------------------CCCTTCC
T ss_pred cC---------------------------------------------------------------ccccceecccchhhh
Confidence 11 112234578999999
Q ss_pred ceeecCCC-CCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CC----------------------------
Q 042539 257 PEVVRGDG-HEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK--TP---------------------------- 305 (412)
Q Consensus 257 PE~l~~~~-~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~~---------------------------- 305 (412)
||.+.+.. ++.++|||||||++|||++|++||.+.+..+++.++... .+
T Consensus 169 pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (286)
T d1ob3a_ 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWES 248 (286)
T ss_dssp HHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGG
T ss_pred HHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhh
Confidence 99997654 589999999999999999999999998888777665421 00
Q ss_pred CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCC
Q 042539 306 EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 306 ~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
.....+++++|||.+||++||++|+ +++|+++||||++
T Consensus 249 ~~~~~s~~~~dli~~~L~~dP~~R~----s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 249 FLKGLDESGIDLLSKMLKLDPNQRI----TAKQALEHAYFKE 286 (286)
T ss_dssp TCCSCCHHHHHHHHHHTCSSTTTSC----CHHHHHTSGGGGC
T ss_pred hcccCCHHHHHHHHHHccCChhHCc----CHHHHhcCcccCc
Confidence 0234568899999999999999999 6999999999974
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-57 Score=434.36 Aligned_cols=263 Identities=21% Similarity=0.290 Sum_probs=217.2
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCC-CCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPT-ARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLL 89 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~ 89 (412)
.+++..++|+++++||+|+||+||+|+++..+.. ....||+|++.+... ......+.+|+.+|.++ +|||||+++
T Consensus 31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~HpnIv~l~ 107 (325)
T d1rjba_ 31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD---SSEREALMSELKMMTQLGSHENIVNLL 107 (325)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC---HHHHHHHHHHHHHHHHhcCCCcEeEEE
Confidence 3567789999999999999999999998765432 334589999865432 23445677899999998 799999999
Q ss_pred eeEEeCCeEEEEeeccCCCCchhHHHhhCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHcCcee
Q 042539 90 GSLETDEFLAWAVPYCPGGDLNVLRYKQND---------------------RVFSPSVIRFYLSEIICAIEHLHNMGIAY 148 (412)
Q Consensus 90 ~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~---------------------~~l~~~~~~~~~~qi~~aL~yLH~~~iiH 148 (412)
+++.+.+.+|+|||||+||+|..++..... ..+++.+++.++.||+.||+|||++||||
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiH 187 (325)
T d1rjba_ 108 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 187 (325)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred EEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 999999999999999999999998865432 35899999999999999999999999999
Q ss_pred eeCCCCceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccC
Q 042539 149 RDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSAR 228 (412)
Q Consensus 149 rDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (412)
|||||+|||++.+|++||+|||+|+......
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~------------------------------------------------- 218 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDS------------------------------------------------- 218 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCT-------------------------------------------------
T ss_pred ccCchhccccccCCeEEEeeccccccccCCC-------------------------------------------------
Confidence 9999999999999999999999997653211
Q ss_pred CCCccccccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCC--
Q 042539 229 VSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTP-- 305 (412)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~-- 305 (412)
......+.+||+.|||||++.+..|+.++|||||||++|||++ |++||.+.+..+.+.+++....
T Consensus 219 ------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~ 286 (325)
T d1rjba_ 219 ------------NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM 286 (325)
T ss_dssp ------------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCC
T ss_pred ------------ceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 1112235678999999999999999999999999999999997 8999999776666666665432
Q ss_pred -CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcC
Q 042539 306 -EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEH 342 (412)
Q Consensus 306 -~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h 342 (412)
....+++++++||.+||+.||++|| +++|+++|
T Consensus 287 ~~p~~~~~~l~~li~~cl~~dP~~RP----t~~ei~~~ 320 (325)
T d1rjba_ 287 DQPFYATEEIYIIMQSCWAFDSRKRP----SFPNLTSF 320 (325)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSC----CHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCc----CHHHHHHH
Confidence 2245689999999999999999999 68998875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-57 Score=424.46 Aligned_cols=255 Identities=21% Similarity=0.290 Sum_probs=207.0
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
.+++..++|++++.||+|+||+||+|+.+. .||||+++...... ...+.+.+|+.+|++++|||||+++++
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-------~vAvK~~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~ 72 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-------DVAVKMLNVTAPTP--QQLQAFKNEVGVLRKTRHVNILLFMGY 72 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESSS-------EEEEEECCCSSCCT--THHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEECC-------EEEEEEEEcccCCH--HHHHHHHHHHHHHHhCCCCCEeeeeEE
Confidence 357888999999999999999999997542 29999997654322 345678889999999999999999997
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
.. ++.+|+|||||.||+|.+++.... ..+++.++..++.||+.||+|||++|||||||||+|||++.++.+||+|||+
T Consensus 73 ~~-~~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGl 150 (276)
T d1uwha_ 73 ST-APQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGL 150 (276)
T ss_dssp EC-SSSCEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCC
T ss_pred Ee-ccEEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccc
Confidence 64 457899999999999988876543 4699999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
|+...... ......+.+||
T Consensus 151 a~~~~~~~-------------------------------------------------------------~~~~~~~~~gt 169 (276)
T d1uwha_ 151 ATVKSRWS-------------------------------------------------------------GSHQFEQLSGS 169 (276)
T ss_dssp SCC-------------------------------------------------------------------------CCCC
T ss_pred eeeccccC-------------------------------------------------------------CcccccccccC
Confidence 97652110 11223456899
Q ss_pred CCCccceeecCC---CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC---CC----CCCCChHHHHHHHHh
Q 042539 252 EEYVSPEVVRGD---GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT---PE----FVGQRTALTDLIQRL 321 (412)
Q Consensus 252 ~~Y~APE~l~~~---~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~---~~----~~~~~~~~~dli~~~ 321 (412)
+.|||||++.+. .|+.++|||||||++|||+||+.||.+.+.......++... +. ...+++++.+||.+|
T Consensus 170 ~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~c 249 (276)
T d1uwha_ 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAEC 249 (276)
T ss_dssp GGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHH
T ss_pred cccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHH
Confidence 999999999753 47999999999999999999999999876555444443322 11 235678999999999
Q ss_pred hhhCCCccCCCCCChhhhhcC
Q 042539 322 LEKDPVKRLGYLRGACEIKEH 342 (412)
Q Consensus 322 L~~dP~~R~~~~~~~~e~l~h 342 (412)
|..||++|| ++++++++
T Consensus 250 l~~dp~~RP----t~~~il~~ 266 (276)
T d1uwha_ 250 LKKKRDERP----LFPQILAS 266 (276)
T ss_dssp TCSSGGGSC----CHHHHHHH
T ss_pred cCCCHhHCc----CHHHHHHH
Confidence 999999999 68888864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.1e-56 Score=424.16 Aligned_cols=262 Identities=21% Similarity=0.287 Sum_probs=209.2
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
.++..++|++.+.||+|+||+||+|+++.++. ....||||.+..... ....+.+.+|+++|++++|||||++++++
T Consensus 21 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~ 96 (299)
T d1jpaa_ 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGK-REIFVAIKTLKSGYT---EKQRRDFLSEASIMGQFDHPNVIHLEGVV 96 (299)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECC----CCEEEEEEECCSSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhhChhhcEEeeEEeeCCCeEEEEEEEeCCCC-EEEEEEEEEECcccC---HHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 45778999999999999999999999876543 234588998865432 33456788999999999999999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
.+++.+|+|||||.||+|..++... .+.+++.++..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|
T Consensus 97 ~~~~~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla 175 (299)
T d1jpaa_ 97 TKSTPVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLS 175 (299)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred eeCCEEEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccc
Confidence 9999999999999999998876653 346999999999999999999999999999999999999999999999999999
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+.+...... ..........||+
T Consensus 176 ~~~~~~~~~----------------------------------------------------------~~~~~~~~~~~t~ 197 (299)
T d1jpaa_ 176 RFLEDDTSD----------------------------------------------------------PTYTSALGGKIPI 197 (299)
T ss_dssp ------------------------------------------------------------------------------CG
T ss_pred eEccCCCCc----------------------------------------------------------ceeeecccccCCc
Confidence 866322110 0011112346899
Q ss_pred CCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCcc
Q 042539 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVKR 329 (412)
Q Consensus 253 ~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~R 329 (412)
.|||||++.+..++.++|||||||++|||+| |++||.+.+..+....+..+. +....+++++.+||.+||+.||++|
T Consensus 198 ~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R 277 (299)
T d1jpaa_ 198 RWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHR 277 (299)
T ss_dssp GGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTS
T ss_pred cccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHC
Confidence 9999999999999999999999999999998 899999999888888776543 3344678999999999999999999
Q ss_pred CCCCCChhhhhc
Q 042539 330 LGYLRGACEIKE 341 (412)
Q Consensus 330 ~~~~~~~~e~l~ 341 (412)
| ++.++++
T Consensus 278 P----s~~ei~~ 285 (299)
T d1jpaa_ 278 P----KFGQIVN 285 (299)
T ss_dssp C----CHHHHHH
T ss_pred c----CHHHHHH
Confidence 9 5777765
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-56 Score=421.32 Aligned_cols=263 Identities=19% Similarity=0.255 Sum_probs=219.7
Q ss_pred CCCCCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccc
Q 042539 7 PQPQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLP 86 (412)
Q Consensus 7 ~~~~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv 86 (412)
|.....+++..++|++++.||+|+||+||+|+++. +..||||++++.... .+.+.+|++++++++|||||
T Consensus 2 p~~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~-----~~~vAvK~~~~~~~~-----~~~~~~E~~~l~~l~HpnIv 71 (272)
T d1qpca_ 2 PWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNG-----HTKVAVKSLKQGSMS-----PDAFLAEANLMKQLQHQRLV 71 (272)
T ss_dssp CTTTCTTBCCGGGEEEEEEEEEETTEEEEEEEETT-----TEEEEEEEECTTSSC-----HHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCCCeecCHHHeEEeEEEecCCCcEEEEEEECC-----CCEEEEEEEccCcCC-----HHHHHHHHHHHHhCCCCCEe
Confidence 33455677888999999999999999999999752 345999999765432 24577899999999999999
Q ss_pred eeeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEE
Q 042539 87 KLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTL 166 (412)
Q Consensus 87 ~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL 166 (412)
++++++. ++.+|+|||||.+|+|..++.......+++.++..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 72 ~~~g~~~-~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl 150 (272)
T d1qpca_ 72 RLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKI 150 (272)
T ss_dssp CEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEE
T ss_pred EEEeeec-cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceee
Confidence 9999875 456799999999999987766555446999999999999999999999999999999999999999999999
Q ss_pred ccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCc
Q 042539 167 TDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSN 246 (412)
Q Consensus 167 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (412)
+|||+|+.+.... .....
T Consensus 151 ~DFGla~~~~~~~--------------------------------------------------------------~~~~~ 168 (272)
T d1qpca_ 151 ADFGLARLIEDNE--------------------------------------------------------------YTARE 168 (272)
T ss_dssp CCCTTCEECSSSC--------------------------------------------------------------EECCT
T ss_pred ccccceEEccCCc--------------------------------------------------------------ccccc
Confidence 9999998652110 01123
Q ss_pred ccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhh
Q 042539 247 SFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLE 323 (412)
Q Consensus 247 ~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~ 323 (412)
...||+.|||||++.+..++.++|||||||++|||+| |.+||...+..+.+..+.... .....+++++.+||.+||+
T Consensus 169 ~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~ 248 (272)
T d1qpca_ 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWK 248 (272)
T ss_dssp TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred ccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHHHHcC
Confidence 4578999999999999889999999999999999998 577788888888888877643 2234578999999999999
Q ss_pred hCCCccCCCCCChhhhhc--CCCCC
Q 042539 324 KDPVKRLGYLRGACEIKE--HVFFK 346 (412)
Q Consensus 324 ~dP~~R~~~~~~~~e~l~--h~ff~ 346 (412)
.||++|| +++++++ |+||.
T Consensus 249 ~~P~~Rp----t~~ei~~~L~~~ft 269 (272)
T d1qpca_ 249 ERPEDRP----TFDYLRSVLEDFFT 269 (272)
T ss_dssp SSGGGSC----CHHHHHHHHHHHHH
T ss_pred CCHhHCc----CHHHHHHHhhhhhh
Confidence 9999999 6889887 66664
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=413.66 Aligned_cols=251 Identities=19% Similarity=0.280 Sum_probs=206.0
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET 94 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 94 (412)
+..++|++++.||+|+||+||+|+++. +..||||++++.... .+.+.+|++++++++|||||++++++.+
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~-----~~~vAvK~i~~~~~~-----~~~~~~E~~~l~~l~HpnIv~~~g~~~~ 71 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLN-----KDKVAIKTIREGAMS-----EEDFIEEAEVMMKLSHPKLVQLYGVCLE 71 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETT-----TEEEEEEECCSSSSC-----HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECC-----CCEEEEEEECCCcCc-----HHHHHHHHHHHHhcCCCCcccccceecc
Confidence 456799999999999999999999863 234999999765432 2356789999999999999999999999
Q ss_pred CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
++.+|+|||||.+|+|..++... ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.
T Consensus 72 ~~~~~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 150 (263)
T d1sm2a_ 72 QAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF 150 (263)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----
T ss_pred CCceEEEEEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchhee
Confidence 99999999999999998877654 34589999999999999999999999999999999999999999999999999976
Q ss_pred hhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCC
Q 042539 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254 (412)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 254 (412)
..... ........||+.|
T Consensus 151 ~~~~~--------------------------------------------------------------~~~~~~~~gt~~y 168 (263)
T d1sm2a_ 151 VLDDQ--------------------------------------------------------------YTSSTGTKFPVKW 168 (263)
T ss_dssp ----------------------------------------------------------------------------CTTS
T ss_pred ccCCC--------------------------------------------------------------ceeecceecCccc
Confidence 53211 1112245799999
Q ss_pred ccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCC--CCCCCChHHHHHHHHhhhhCCCccCC
Q 042539 255 VSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTP--EFVGQRTALTDLIQRLLEKDPVKRLG 331 (412)
Q Consensus 255 ~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~dli~~~L~~dP~~R~~ 331 (412)
||||++.+..|+.++|||||||++|||+| |.+||...+..+.+..+..+.. .....++++.+||.+||+.||++||
T Consensus 169 ~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rp- 247 (263)
T d1sm2a_ 169 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRP- 247 (263)
T ss_dssp CCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC-
T ss_pred CChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCc-
Confidence 99999999999999999999999999998 6888888888888887776532 2234678999999999999999999
Q ss_pred CCCChhhhhcC
Q 042539 332 YLRGACEIKEH 342 (412)
Q Consensus 332 ~~~~~~e~l~h 342 (412)
+++++++|
T Consensus 248 ---s~~~il~~ 255 (263)
T d1sm2a_ 248 ---AFSRLLRQ 255 (263)
T ss_dssp ---CHHHHHHH
T ss_pred ---CHHHHHHH
Confidence 68898874
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-56 Score=432.00 Aligned_cols=251 Identities=25% Similarity=0.443 Sum_probs=208.3
Q ss_pred CceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe----
Q 042539 19 NLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET---- 94 (412)
Q Consensus 19 ~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~---- 94 (412)
+|+.+++||+|+||+||+|+++.++. .||||+++++... ..+|+++|++++|+|||+++++|..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~----~vAiK~i~~~~~~--------~~~Ei~il~~l~h~niv~~~~~~~~~~~~ 88 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGE----LVAIKKVLQDKRF--------KNRELQIMRKLDHCNIVRLRYFFYSSGEK 88 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEECCSSS--------CCHHHHHHHHCCCTTBCCEEEEEEEC--C
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCC----EEEEEEECccchH--------HHHHHHHHHhcCCCCCCcEEEEEEecCcc
Confidence 79999999999999999999987554 4999999765422 2259999999999999999999853
Q ss_pred --CCeEEEEeeccCCCCchhHHH-hhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCC-CEEEcccc
Q 042539 95 --DEFLAWAVPYCPGGDLNVLRY-KQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG-HVTLTDFD 170 (412)
Q Consensus 95 --~~~~~lv~e~~~gg~L~~~~~-~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g-~vkL~DFG 170 (412)
..++|+|||||.++.+..+.. ......+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 89 ~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG 168 (350)
T d1q5ka_ 89 KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG 168 (350)
T ss_dssp CSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCT
T ss_pred CCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEeccc
Confidence 236899999998776554433 23445699999999999999999999999999999999999999875 89999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+|+.+. ......+.+|
T Consensus 169 ~a~~~~----------------------------------------------------------------~~~~~~~~~g 184 (350)
T d1q5ka_ 169 SAKQLV----------------------------------------------------------------RGEPNVSYIC 184 (350)
T ss_dssp TCEECC----------------------------------------------------------------TTSCCCSCCS
T ss_pred chhhcc----------------------------------------------------------------CCcccccccc
Confidence 997542 1223345689
Q ss_pred CCCCccceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--C------------------C----
Q 042539 251 TEEYVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK--T------------------P---- 305 (412)
Q Consensus 251 t~~Y~APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~------------------~---- 305 (412)
|+.|+|||.+.+. .|+.++|||||||++|||++|++||.+.+..+.+.++... . +
T Consensus 185 t~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 264 (350)
T d1q5ka_ 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKA 264 (350)
T ss_dssp CTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCC
T ss_pred cccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhcccccccc
Confidence 9999999998764 6899999999999999999999999998887776665421 0 0
Q ss_pred ------CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCC
Q 042539 306 ------EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 306 ------~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~ 349 (412)
.....++++.|||.+||++||++|+ |+.|+++||||+++.
T Consensus 265 ~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~----ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 265 HPWTKVFRPRTPPEAIALCSRLLEYTPTARL----TPLEACAHSFFDELR 310 (350)
T ss_dssp CCGGGTSCTTSCHHHHHHHHHHSCSSGGGSC----CHHHHHTSGGGGGGG
T ss_pred CchhhhcccCCCHHHHHHHHHHccCChhHCc----CHHHHhcCHhhcccc
Confidence 1134578999999999999999999 699999999998653
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-56 Score=430.32 Aligned_cols=255 Identities=25% Similarity=0.419 Sum_probs=208.6
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
-++|+++++||+|+||+||+|.++.++. .||||++++... .....+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~----~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~ 90 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGA----KVAIKKLYRPFQ--SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 90 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCC----EEEEEECSSTTS--SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCC----EEEEEEEchhhc--ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCc
Confidence 5799999999999999999999987554 499999976543 3345677889999999999999999999997654
Q ss_pred ------eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccc
Q 042539 97 ------FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 97 ------~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
.+|+||||| |++|..+... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 91 ~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 91 TLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred cccccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccccccccccc
Confidence 579999999 6677665543 349999999999999999999999999999999999999999999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+|+... ......+|
T Consensus 167 ~a~~~~------------------------------------------------------------------~~~~~~~~ 180 (346)
T d1cm8a_ 167 LARQAD------------------------------------------------------------------SEMTGYVV 180 (346)
T ss_dssp TCEECC------------------------------------------------------------------SSCCSSCS
T ss_pred ceeccC------------------------------------------------------------------Cccccccc
Confidence 997542 11235679
Q ss_pred CCCCccceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-----------------------C-
Q 042539 251 TEEYVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKT-----------------------P- 305 (412)
Q Consensus 251 t~~Y~APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-----------------------~- 305 (412)
|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+....+..+.... +
T Consensus 181 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (346)
T d1cm8a_ 181 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPE 260 (346)
T ss_dssp CGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCC
T ss_pred cccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCc
Confidence 9999999999875 46899999999999999999999999988776654443210 0
Q ss_pred --------CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCch
Q 042539 306 --------EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 306 --------~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~ 351 (412)
.+...++++.|||.+||+.||.+|| |++|+++||||+++.+.
T Consensus 261 ~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~----ta~eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 261 LEKKDFASILTNASPLAVNLLEKMLVLDAEQRV----TAGEALAHPYFESLHDT 310 (346)
T ss_dssp CCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSC----CHHHHHHSGGGTTTC--
T ss_pred ccccchHHhccCCCHHHHHHHHHHCcCChhHCc----CHHHHhcChhhCcCCCc
Confidence 1235678999999999999999999 79999999999987654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.3e-55 Score=426.08 Aligned_cols=252 Identities=24% Similarity=0.396 Sum_probs=207.4
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEEe
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLET 94 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~ 94 (412)
..++|+++++||+|+||+||+|+++.++ +.||||++++.. .+++.+|+++|++++ ||||++++++|..
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~----~~vAiK~i~~~~-------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~ 101 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNN----EKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADIVKD 101 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEECSSC-------HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCC----CEEEEEEECHHH-------HHHHHHHHHHHHhccCCCCCcEEEEEEEe
Confidence 5689999999999999999999998754 459999997543 235677999999996 9999999999985
Q ss_pred C--CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCC-CEEEccccc
Q 042539 95 D--EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG-HVTLTDFDL 171 (412)
Q Consensus 95 ~--~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g-~vkL~DFGl 171 (412)
. ..+|+|||||.+++|..+. +.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus 102 ~~~~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~ 176 (328)
T d3bqca1 102 PVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 176 (328)
T ss_dssp TTTCSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGG
T ss_pred cCCCceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeeccccc
Confidence 4 5799999999999986542 3499999999999999999999999999999999999999765 589999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
|+... ........+||
T Consensus 177 a~~~~----------------------------------------------------------------~~~~~~~~~~t 192 (328)
T d3bqca1 177 AEFYH----------------------------------------------------------------PGQEYNVRVAS 192 (328)
T ss_dssp CEECC----------------------------------------------------------------TTCCCCSCCSC
T ss_pred ceecc----------------------------------------------------------------CCCcccccccC
Confidence 97542 11233456899
Q ss_pred CCCccceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCC-HHHHHHHHhc-------------C----C--------
Q 042539 252 EEYVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKN-RKETFRNVLM-------------K----T-------- 304 (412)
Q Consensus 252 ~~Y~APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~-~~~~~~~i~~-------------~----~-------- 304 (412)
+.|+|||.+.+. .++.++|||||||++|+|++|+.||.... .......+.. . .
T Consensus 193 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 272 (328)
T d3bqca1 193 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILG 272 (328)
T ss_dssp GGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCC
T ss_pred ccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcc
Confidence 999999998875 47999999999999999999999997643 2222222110 0 0
Q ss_pred -------------CCCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCch
Q 042539 305 -------------PEFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRWD 351 (412)
Q Consensus 305 -------------~~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~~ 351 (412)
......+++++|||++||++||++|+ |++|+|+||||+.+.|+
T Consensus 273 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~----ta~e~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 273 RHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL----TAREAMEHPYFYTVVKD 328 (328)
T ss_dssp CCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSC----CHHHHHTSGGGTTSCCC
T ss_pred cccccchhhcccccccccCCHHHHHHHHHHccCChhHCc----CHHHHhcCcccCCCCCC
Confidence 01123568899999999999999999 79999999999999985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-56 Score=417.09 Aligned_cols=252 Identities=19% Similarity=0.265 Sum_probs=205.5
Q ss_pred eeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCCeEEEEee
Q 042539 24 KILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDEFLAWAVP 103 (412)
Q Consensus 24 ~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~e 103 (412)
++||+|+||+||+|.++..+ +++.||||+++.... .....+.+.+|+++|++++|||||++++++.+ +..|+|||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~--~~~~vAvK~~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE 87 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKK--VVKTVAVKILKNEAN--DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVME 87 (277)
T ss_dssp EEEEECSSEEEEEEEEECSS--SEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred CCcccCCCeEEEEEEEccCC--cCeEEEEEEEChhhC--CHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEE
Confidence 47999999999999875433 445699999976542 23445678899999999999999999999865 46789999
Q ss_pred ccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhhhhh
Q 042539 104 YCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEK 183 (412)
Q Consensus 104 ~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~ 183 (412)
||+||+|..++.... .+++.++..++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.+.....
T Consensus 88 ~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~--- 162 (277)
T d1xbba_ 88 MAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--- 162 (277)
T ss_dssp CCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS---
T ss_pred cCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccc---
Confidence 999999998876543 499999999999999999999999999999999999999999999999999986521100
Q ss_pred hcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceeecCC
Q 042539 184 QSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGD 263 (412)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~ 263 (412)
.........||+.|||||++.+.
T Consensus 163 ---------------------------------------------------------~~~~~~~~~gt~~y~APE~l~~~ 185 (277)
T d1xbba_ 163 ---------------------------------------------------------YYKAQTHGKWPVKWYAPECINYY 185 (277)
T ss_dssp ---------------------------------------------------------EEEC----CCCGGGCCHHHHHHC
T ss_pred ---------------------------------------------------------ccccccccCCCceecCchhhcCC
Confidence 00112345789999999999999
Q ss_pred CCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC-CC-CCCCChHHHHHHHHhhhhCCCccCCCCCChhhh-
Q 042539 264 GHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT-PE-FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEI- 339 (412)
Q Consensus 264 ~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~-~~-~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~- 339 (412)
.++.++|||||||++|||++ |++||.+.+..++...+..+. +. ...+++++.+||.+||+.||++|| +++++
T Consensus 186 ~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RP----s~~~i~ 261 (277)
T d1xbba_ 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRP----GFAAVE 261 (277)
T ss_dssp EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSC----CHHHHH
T ss_pred CCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCc----CHHHHH
Confidence 99999999999999999997 999999999888887776543 22 345789999999999999999999 46666
Q ss_pred --hcCCCCC
Q 042539 340 --KEHVFFK 346 (412)
Q Consensus 340 --l~h~ff~ 346 (412)
|+|+|++
T Consensus 262 ~~L~~~~~~ 270 (277)
T d1xbba_ 262 LRLRNYYYD 270 (277)
T ss_dssp HHHHHHHHH
T ss_pred HHhhCHHhh
Confidence 5666653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-55 Score=415.25 Aligned_cols=265 Identities=20% Similarity=0.264 Sum_probs=216.4
Q ss_pred CCCCccCceeeee-eeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 13 PSLDLDNLKALKI-LGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 13 ~~~~~~~y~~~~~-LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
.-+..++|.+.+. ||+|+||+||+|.++.++ .+..||||++++.. .....+.+.+|+++|++++|||||+++++
T Consensus 3 l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~--~~~~vAvK~l~~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~ 77 (285)
T d1u59a_ 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRK--KQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGV 77 (285)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC-----CCEEEEEEEECSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred eeecccCeEECCcEEecccCeEEEEEEEecCC--CcEEEEEEEEChhc---CHHHHHHHHHHHHHHHhCCCCCEeeEeee
Confidence 4567788999985 999999999999876543 34569999997653 23345678889999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
+.+ +.+|+|||||+||+|..++... ...+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 78 ~~~-~~~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGl 155 (285)
T d1u59a_ 78 CQA-EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGL 155 (285)
T ss_dssp EES-SSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred ecc-CeEEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchh
Confidence 875 4689999999999998876543 34599999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
|+.+..... ........+||
T Consensus 156 a~~~~~~~~------------------------------------------------------------~~~~~~~~~gt 175 (285)
T d1u59a_ 156 SKALGADDS------------------------------------------------------------YYTARSAGKWP 175 (285)
T ss_dssp CEECTTCSC------------------------------------------------------------EECCCCSSCCC
T ss_pred hhccccccc------------------------------------------------------------ccccccccccC
Confidence 986532100 01122345789
Q ss_pred CCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCc
Q 042539 252 EEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVK 328 (412)
Q Consensus 252 ~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~ 328 (412)
+.|||||++.+..++.++|||||||++|||+| |+.||.+.+..++...+..+. +....+++++.+||.+||..||++
T Consensus 176 ~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~ 255 (285)
T d1u59a_ 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWED 255 (285)
T ss_dssp GGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGG
T ss_pred ccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhH
Confidence 99999999999999999999999999999997 999999988888887776543 223467899999999999999999
Q ss_pred cCCCCCChhhhhcCCCC
Q 042539 329 RLGYLRGACEIKEHVFF 345 (412)
Q Consensus 329 R~~~~~~~~e~l~h~ff 345 (412)
||++. ++.+.|+|+|+
T Consensus 256 RPs~~-~i~~~L~~~~~ 271 (285)
T d1u59a_ 256 RPDFL-TVEQRMRACYY 271 (285)
T ss_dssp SCCHH-HHHHHHHHHHH
T ss_pred CcCHH-HHHHHHHHHHH
Confidence 99531 24444667765
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=424.47 Aligned_cols=260 Identities=24% Similarity=0.332 Sum_probs=208.8
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe--
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET-- 94 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-- 94 (412)
+++|+++++||+|+||+||+|+++.++. .||||++.+.... ......+.+|+++|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~----~vAvK~i~~~~~~--~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~ 82 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQ----KVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLIEICRTKA 82 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCC----EEEEEEC----CT--TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCC----EEEEEEEehhhcc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeccc
Confidence 7999999999999999999999987554 4999999766432 2344567789999999999999999998854
Q ss_pred ------CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcc
Q 042539 95 ------DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTD 168 (412)
Q Consensus 95 ------~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~D 168 (412)
+.++|+|||||.++++.... .....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|
T Consensus 83 ~~~~~~~~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~d 160 (318)
T d3blha1 83 SPYNRCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLAD 160 (318)
T ss_dssp --------CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECC
T ss_pred ccccccCceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeee
Confidence 35689999999888765433 3344699999999999999999999999999999999999999999999999
Q ss_pred ccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccc
Q 042539 169 FDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSF 248 (412)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (412)
||+|+.+..... .......+.
T Consensus 161 fg~~~~~~~~~~-----------------------------------------------------------~~~~~~~~~ 181 (318)
T d3blha1 161 FGLARAFSLAKN-----------------------------------------------------------SQPNRYTNR 181 (318)
T ss_dssp CTTCEECCC----------------------------------------------------------------CCCCCSC
T ss_pred cceeeecccccc-----------------------------------------------------------cccccccce
Confidence 999976531110 112233456
Q ss_pred ccCCCCccceeecCC-CCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-----C--------------
Q 042539 249 VGTEEYVSPEVVRGD-GHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTPEF-----V-------------- 308 (412)
Q Consensus 249 ~gt~~Y~APE~l~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-----~-------------- 308 (412)
+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+....+......+ .
T Consensus 182 ~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (318)
T d3blha1 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELV 261 (318)
T ss_dssp CSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CC
T ss_pred ecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhccc
Confidence 899999999999875 68999999999999999999999999988877666554211000 0
Q ss_pred --------------CCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCC
Q 042539 309 --------------GQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 309 --------------~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
..++.+.|||.+||++||++|+ +++|+++||||+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~----sa~elL~Hpff~~ 310 (318)
T d3blha1 262 KGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI----DSDDALNHDFFWS 310 (318)
T ss_dssp SSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSC----CHHHHHHSGGGSS
T ss_pred ccccccchhhhccccCCHHHHHHHHHHCcCChhHCc----CHHHHHcChhhcc
Confidence 1245788999999999999999 7999999999974
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-55 Score=409.12 Aligned_cols=251 Identities=22% Similarity=0.261 Sum_probs=215.6
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET 94 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 94 (412)
+..++|+++++||+|+||+||+|+++ +++.||||+++++... ...+++|+.++++++|||||++++++.+
T Consensus 1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~-----~~~~vAvK~l~~~~~~-----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~ 70 (258)
T d1k2pa_ 1 IDPKDLTFLKELGTGQFGVVKYGKWR-----GQYDVAIKMIKEGSMS-----EDEFIEEAKVMMNLSHEKLVQLYGVCTK 70 (258)
T ss_dssp CCCCCCCCCCCCCEETTEEEEEEEET-----TTEEEEEEEEESSSSC-----HHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred CChHHCEEeEEEecCCCeEEEEEEEC-----CCCEEEEEEECcCcCC-----HHHHHHHHHHHHhcCCCceeeEEEEEee
Confidence 35689999999999999999999975 3345999999876542 2346789999999999999999999999
Q ss_pred CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
++.+++|||||.+|+|..++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 71 ~~~~~iv~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~ 149 (258)
T d1k2pa_ 71 QRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 149 (258)
T ss_dssp SSSEEEEEECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCB
T ss_pred CCceEEEEEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhhee
Confidence 999999999999999987765543 4589999999999999999999999999999999999999999999999999975
Q ss_pred hhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCC
Q 042539 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254 (412)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 254 (412)
+... .........||+.|
T Consensus 150 ~~~~--------------------------------------------------------------~~~~~~~~~~t~~y 167 (258)
T d1k2pa_ 150 VLDD--------------------------------------------------------------EYTSSVGSKFPVRW 167 (258)
T ss_dssp CSSS--------------------------------------------------------------SCCCCCCSCCCGGG
T ss_pred ccCC--------------------------------------------------------------CceeecccCCCCCc
Confidence 5211 11112235799999
Q ss_pred ccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCccCC
Q 042539 255 VSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVKRLG 331 (412)
Q Consensus 255 ~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~R~~ 331 (412)
+|||++.+..++.++|||||||++|||+| |+.||.+.+..++..++.... +.....++++.+||.+||+.||++||
T Consensus 168 ~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RP- 246 (258)
T d1k2pa_ 168 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERP- 246 (258)
T ss_dssp CCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSC-
T ss_pred CCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCc-
Confidence 99999999999999999999999999998 899999999999888887643 22234578999999999999999999
Q ss_pred CCCChhhhhcC
Q 042539 332 YLRGACEIKEH 342 (412)
Q Consensus 332 ~~~~~~e~l~h 342 (412)
+++++++|
T Consensus 247 ---t~~eil~~ 254 (258)
T d1k2pa_ 247 ---TFKILLSN 254 (258)
T ss_dssp ---CHHHHHHH
T ss_pred ---CHHHHHHH
Confidence 68999876
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-55 Score=413.19 Aligned_cols=258 Identities=19% Similarity=0.321 Sum_probs=209.3
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
+++..++|++++.||+|+||+||+|++..++. ....||||+++... .......+.+|+++|++++|||||++++++
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~-~~~~vaik~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 77 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPEN-PALAVAIKTCKNCT---SDSVREKFLQEALTMRQFDHPHIVKLIGVI 77 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC---CCEEEEEEECTTTT---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCc-eeEEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 56778999999999999999999999876543 34458899886543 234456788899999999999999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
. ++.+|+|||||.||+|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 78 ~-~~~~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a 155 (273)
T d1mp8a_ 78 T-ENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 155 (273)
T ss_dssp C-SSSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred e-cCeEEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhh
Confidence 6 56789999999999998776543 356999999999999999999999999999999999999999999999999999
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+.+... ........+||+
T Consensus 156 ~~~~~~--------------------------------------------------------------~~~~~~~~~gt~ 173 (273)
T d1mp8a_ 156 RYMEDS--------------------------------------------------------------TYYKASKGKLPI 173 (273)
T ss_dssp -----------------------------------------------------------------------------CCG
T ss_pred eeccCC--------------------------------------------------------------cceeccceecCc
Confidence 765311 111223457899
Q ss_pred CCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCcc
Q 042539 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVKR 329 (412)
Q Consensus 253 ~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~R 329 (412)
.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+++.++..+. +....+++++.+||.+||..||++|
T Consensus 174 ~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R 253 (273)
T d1mp8a_ 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRR 253 (273)
T ss_dssp GGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred ccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHC
Confidence 9999999999999999999999999999997 999999998888888887654 3345678999999999999999999
Q ss_pred CCCCCChhhhhcC
Q 042539 330 LGYLRGACEIKEH 342 (412)
Q Consensus 330 ~~~~~~~~e~l~h 342 (412)
| +++++++|
T Consensus 254 p----s~~ei~~~ 262 (273)
T d1mp8a_ 254 P----RFTELKAQ 262 (273)
T ss_dssp C----CHHHHHHH
T ss_pred c----CHHHHHHH
Confidence 9 68888864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-54 Score=410.48 Aligned_cols=262 Identities=20% Similarity=0.295 Sum_probs=211.5
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
+.++..++|++.++||+|+||+||+|.++.++......||||+++.... ......+++|++++++++|||||+++++
T Consensus 1 ~~ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~~E~~il~~l~H~nIv~~~g~ 77 (283)
T d1mqba_ 1 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT---EKQRVDFLGEAGIMGQFSHHNIIRLEGV 77 (283)
T ss_dssp CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CCcCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC---hHHHHHHHHHHHHHHhcCCCCEeeeeEE
Confidence 3577888999999999999999999998876655556799999965432 2334567889999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
+.+.+.+++|||||.+|++..++... ...+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 78 ~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGl 156 (283)
T d1mqba_ 78 ISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGL 156 (283)
T ss_dssp ECSSSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred EecCCceEEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccch
Confidence 99999999999999999998766543 35699999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
|+.+..... .........||
T Consensus 157 a~~~~~~~~------------------------------------------------------------~~~~~~~~~gt 176 (283)
T d1mqba_ 157 SRVLEDDPE------------------------------------------------------------ATYTTSGGKIP 176 (283)
T ss_dssp -----------------------------------------------------------------------------CCC
T ss_pred hhcccCCCc------------------------------------------------------------cceEeccCCCC
Confidence 986532111 01112234689
Q ss_pred CCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCc
Q 042539 252 EEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVK 328 (412)
Q Consensus 252 ~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~ 328 (412)
+.|||||++.+..++.++|||||||++|||++ |.+||.+.+..+.+..+..+. +....+++++.+||.+||+.||++
T Consensus 177 ~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~ 256 (283)
T d1mqba_ 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERAR 256 (283)
T ss_dssp GGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTT
T ss_pred ccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhH
Confidence 99999999999999999999999999999998 566677778777777776543 233456789999999999999999
Q ss_pred cCCCCCChhhhhc
Q 042539 329 RLGYLRGACEIKE 341 (412)
Q Consensus 329 R~~~~~~~~e~l~ 341 (412)
|| ++.++++
T Consensus 257 RP----t~~eil~ 265 (283)
T d1mqba_ 257 RP----KFADIVS 265 (283)
T ss_dssp SC----CHHHHHH
T ss_pred Cc----CHHHHHH
Confidence 99 5788875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-55 Score=411.99 Aligned_cols=261 Identities=20% Similarity=0.272 Sum_probs=216.5
Q ss_pred CCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceee
Q 042539 10 QTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLL 89 (412)
Q Consensus 10 ~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~ 89 (412)
...+++..++|++++.||+|+||+||+|+++.+ ..||||+++..... .+.+.+|+.++++++|||||+++
T Consensus 9 ~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-----~~vAiK~l~~~~~~-----~~~~~~E~~~l~~l~h~nIv~~~ 78 (285)
T d1fmka3 9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-----TRVAIKTLKPGTMS-----PEAFLQEAQVMKKLRHEKLVQLY 78 (285)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-----EEEEEEECCTTSSC-----HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-----CEEEEEEECcccCC-----HHHHHHHHHHHHhcccCCEeEEE
Confidence 345788899999999999999999999998653 24999999765432 24567899999999999999999
Q ss_pred eeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccc
Q 042539 90 GSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDF 169 (412)
Q Consensus 90 ~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DF 169 (412)
+++.+ +.+|+|||||.+|+|..++.......+++.++..++.||+.||+|||++||+||||||+||||+.+|.+||+||
T Consensus 79 g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~Df 157 (285)
T d1fmka3 79 AVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADF 157 (285)
T ss_dssp EEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred EEEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEccc
Confidence 99854 56899999999999988877665556999999999999999999999999999999999999999999999999
Q ss_pred cccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccc
Q 042539 170 DLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFV 249 (412)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (412)
|+|+...... ........
T Consensus 158 Gla~~~~~~~--------------------------------------------------------------~~~~~~~~ 175 (285)
T d1fmka3 158 GLARLIEDNE--------------------------------------------------------------YTARQGAK 175 (285)
T ss_dssp CTTC----------------------------------------------------------------------------
T ss_pred chhhhccCCC--------------------------------------------------------------ceeecccc
Confidence 9997652111 01122356
Q ss_pred cCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCC
Q 042539 250 GTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDP 326 (412)
Q Consensus 250 gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP 326 (412)
||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+.+..+.... +....+++++++||.+||+.||
T Consensus 176 gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP 255 (285)
T d1fmka3 176 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 255 (285)
T ss_dssp CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSG
T ss_pred ccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHHHcccCH
Confidence 8999999999999999999999999999999998 567778888888887776543 3345678999999999999999
Q ss_pred CccCCCCCChhhhhc--CCCCCC
Q 042539 327 VKRLGYLRGACEIKE--HVFFKG 347 (412)
Q Consensus 327 ~~R~~~~~~~~e~l~--h~ff~~ 347 (412)
++|| +++++++ ++||..
T Consensus 256 ~~Rp----s~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 256 EERP----TFEYLQAFLEDYFTS 274 (285)
T ss_dssp GGSC----CHHHHHHHHHTTTSC
T ss_pred hHCc----CHHHHHHHHhhhhcC
Confidence 9999 6899887 788864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=420.82 Aligned_cols=259 Identities=24% Similarity=0.374 Sum_probs=208.5
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC-
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE- 96 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~- 96 (412)
++|++++.||+|+||+||+|+++.++. .||||++++.. .....+.+++|+.+|++++||||+++++++....
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~----~vAvK~i~~~~---~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~ 80 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKV----RVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 80 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCS----EEEEEEECCTT---CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCc----EEEEEEEehhc---ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence 469999999999999999999987554 49999997654 2344567888999999999999999999997653
Q ss_pred ---eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccc
Q 042539 97 ---FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSR 173 (412)
Q Consensus 97 ---~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~ 173 (412)
..+++++++.||+|..++... .+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+
T Consensus 81 ~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 81 EQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp TTCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred cccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence 234445566699999887643 49999999999999999999999999999999999999999999999999997
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
...... .........+||+.
T Consensus 158 ~~~~~~------------------------------------------------------------~~~~~~~~~~gt~~ 177 (345)
T d1pmea_ 158 VADPDH------------------------------------------------------------DHTGFLTEYVATRW 177 (345)
T ss_dssp ECCGGG------------------------------------------------------------CBCCTTCCCCSCGG
T ss_pred eccCCC------------------------------------------------------------ccceeeccccccce
Confidence 653211 11122345689999
Q ss_pred CccceeecC-CCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--C---------------------C----
Q 042539 254 YVSPEVVRG-DGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMK--T---------------------P---- 305 (412)
Q Consensus 254 Y~APE~l~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~---------------------~---- 305 (412)
|+|||++.. ..++.++||||+||++|+|++|++||.+.+..+........ . +
T Consensus 178 y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (345)
T d1pmea_ 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNK 257 (345)
T ss_dssp GCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCC
T ss_pred echHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCC
Confidence 999999854 56789999999999999999999999998766554443210 0 0
Q ss_pred -----CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCc
Q 042539 306 -----EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRW 350 (412)
Q Consensus 306 -----~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~ 350 (412)
.++..++++++||.+||++||.+|| +++|+++||||+...-
T Consensus 258 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~----ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 258 VPWNRLFPNADSKALDLLDKMLTFNPHKRI----EVEQALAHPYLEQYYD 303 (345)
T ss_dssp CCHHHHCTTSCHHHHHHHHHHSCSSTTTSC----CHHHHHTSGGGTTTCC
T ss_pred CCHHHhCCCCCHHHHHHHHHHccCChhHCc----CHHHHhcCHhhccCCC
Confidence 1235678899999999999999999 7999999999986543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-54 Score=409.62 Aligned_cols=257 Identities=26% Similarity=0.422 Sum_probs=215.0
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
+++|+++++||+|+||+||+|+++.++. .||||++++... ......++.+|+.+|+.++|||||++++++.+.+
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~----~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 74 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHE----IVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSDK 74 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCC----EEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCc----EEEEEEEehhhC--ChHHHHHHHHHHHHHHhcCcCCEEeecccccccc
Confidence 5799999999999999999999987554 499999976543 2345677888999999999999999999999999
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhh
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLV 176 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~ 176 (412)
.+++||+++.|++|..++.. .+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|+...
T Consensus 75 ~~~iv~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~ 152 (292)
T d1unla_ 75 KLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG 152 (292)
T ss_dssp EEEEEEECCSEEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred ceeEEeeecccccccccccc--ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhccc
Confidence 99999999999998776554 3459999999999999999999999999999999999999999999999999997652
Q ss_pred chhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCcc
Q 042539 177 KKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVS 256 (412)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 256 (412)
.. ........+++.|+|
T Consensus 153 ~~---------------------------------------------------------------~~~~~~~~~~~~~~~ 169 (292)
T d1unla_ 153 IP---------------------------------------------------------------VRCYSAEVVTLWYRP 169 (292)
T ss_dssp SC---------------------------------------------------------------CSCCCSCCSCGGGCC
T ss_pred CC---------------------------------------------------------------Cccceeeccccchhh
Confidence 11 112223467889999
Q ss_pred ceeecCCC-CCchhhHHHHHHHHHHHhhCCCC-CCCCCHHHHHHHHhcC--CC---------------------------
Q 042539 257 PEVVRGDG-HEFAVDWWALGILTYEMLYGTTP-FRGKNRKETFRNVLMK--TP--------------------------- 305 (412)
Q Consensus 257 PE~l~~~~-~~~~~DiwSlGvil~ell~g~~P-f~~~~~~~~~~~i~~~--~~--------------------------- 305 (412)
||++.+.. ++.++|||||||++|||++|+.| |.+.+..+.+..+... .+
T Consensus 170 pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (292)
T d1unla_ 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLV 249 (292)
T ss_dssp HHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCT
T ss_pred hhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhh
Confidence 99998765 58999999999999999999888 5566666666655321 00
Q ss_pred -CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCC
Q 042539 306 -EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGV 348 (412)
Q Consensus 306 -~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~ 348 (412)
.....++.++|||++||++||.+|| +++|+|+||||++.
T Consensus 250 ~~~~~~s~~~~dll~~mL~~dP~~R~----sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 250 NVVPKLNATGRDLLQNLLKCNPVQRI----SAEEALQHPYFSDF 289 (292)
T ss_dssp TTSTTCCHHHHHHHHHHSCSSGGGSC----CHHHHTTSGGGSSC
T ss_pred hccccCCHHHHHHHHHHccCChhHCc----CHHHHhcChhhcCC
Confidence 1123467899999999999999999 69999999999863
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-54 Score=414.68 Aligned_cols=258 Identities=20% Similarity=0.253 Sum_probs=209.8
Q ss_pred CCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe
Q 042539 15 LDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET 94 (412)
Q Consensus 15 ~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 94 (412)
+.-++|+++++||+|+||+||+|++..++......||+|.++.... ....+.+.+|+.++++++|||||++++++.+
T Consensus 6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~ 82 (317)
T d1xkka_ 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS---PKANKEILDEAYVMASVDNPHVCRLLGICLT 82 (317)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred CCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3457899999999999999999999887766666789998865432 2235667889999999999999999999986
Q ss_pred CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 95 DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 95 ~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
+ ..+++||+|.+|+|...+... ...+++..++.++.||+.||+|||++|||||||||+|||++.++++||+|||+|+.
T Consensus 83 ~-~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 83 S-TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp S-SEEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred C-CeeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeecccccee
Confidence 5 567888999999998776654 35699999999999999999999999999999999999999999999999999986
Q ss_pred hhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCC
Q 042539 175 LVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEY 254 (412)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 254 (412)
..... .........||+.|
T Consensus 161 ~~~~~-------------------------------------------------------------~~~~~~~~~gt~~y 179 (317)
T d1xkka_ 161 LGAEE-------------------------------------------------------------KEYHAEGGKVPIKW 179 (317)
T ss_dssp TTTTC-------------------------------------------------------------C--------CCTTT
T ss_pred ccccc-------------------------------------------------------------ccccccccccCccc
Confidence 53210 01112345689999
Q ss_pred ccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCChHHHHHHHHhhhhCCCccCC
Q 042539 255 VSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PEFVGQRTALTDLIQRLLEKDPVKRLG 331 (412)
Q Consensus 255 ~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~dli~~~L~~dP~~R~~ 331 (412)
||||++.+..|+.++|||||||++|||+| |.+||.+.+..+....+..+. +....+++++.+||.+||..||++||
T Consensus 180 ~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RP- 258 (317)
T d1xkka_ 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRP- 258 (317)
T ss_dssp SCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSC-
T ss_pred cChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCc-
Confidence 99999999999999999999999999998 899999988777776665543 23345789999999999999999999
Q ss_pred CCCChhhhhcC
Q 042539 332 YLRGACEIKEH 342 (412)
Q Consensus 332 ~~~~~~e~l~h 342 (412)
++.++++|
T Consensus 259 ---s~~eil~~ 266 (317)
T d1xkka_ 259 ---KFRELIIE 266 (317)
T ss_dssp ---CHHHHHHH
T ss_pred ---CHHHHHHH
Confidence 68999887
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-54 Score=422.07 Aligned_cols=255 Identities=25% Similarity=0.415 Sum_probs=203.9
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe--
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET-- 94 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-- 94 (412)
+++|+++++||+|+||+||+|+++.++ +.||||++.+.... .....++.+|+.+|++++|||||+++++|..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~----~~vAvK~i~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~ 89 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLD----RNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 89 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTT----EEEEEEEEESTTSS--HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCC----CEEEEEEEChhhcC--HHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccc
Confidence 478999999999999999999998755 44999999776532 3445678899999999999999999999964
Q ss_pred ----CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccc
Q 042539 95 ----DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFD 170 (412)
Q Consensus 95 ----~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFG 170 (412)
..++|+|||||.|+.+..+ . ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+|++|||
T Consensus 90 ~~~~~~~~~iv~Ey~~~~l~~~~---~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~ 164 (355)
T d2b1pa1 90 TLEEFQDVYLVMELMDANLCQVI---Q--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_dssp STTTCCEEEEEEECCSEEHHHHH---T--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred ccccCceeEEEEeccchHHHHhh---h--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechh
Confidence 3689999999987765432 1 349999999999999999999999999999999999999999999999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+++... ........+|
T Consensus 165 ~~~~~~----------------------------------------------------------------~~~~~~~~~~ 180 (355)
T d2b1pa1 165 LARTAG----------------------------------------------------------------TSFMMTPYVV 180 (355)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred hhhccc----------------------------------------------------------------cccccccccc
Confidence 987542 1122345689
Q ss_pred CCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhc----------------------CCCCCC
Q 042539 251 TEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLM----------------------KTPEFV 308 (412)
Q Consensus 251 t~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~----------------------~~~~~~ 308 (412)
|+.|+|||++.+..++.++||||+||++|+|++|++||.+.+......+++. ..+...
T Consensus 181 t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (355)
T d2b1pa1 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYA 260 (355)
T ss_dssp CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCC
T ss_pred cccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCcccc
Confidence 9999999999999999999999999999999999999999887776655432 111110
Q ss_pred ---------------------CCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCCc
Q 042539 309 ---------------------GQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVRW 350 (412)
Q Consensus 309 ---------------------~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~~ 350 (412)
..+++++|||++||..||++|| ||+|+|+||||+...+
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~----ta~elL~Hpw~~~~~~ 319 (355)
T d2b1pa1 261 GLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI----SVDDALQHPYINVWYD 319 (355)
T ss_dssp CCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSC----CHHHHHTSTTTGGGCC
T ss_pred ccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCc----CHHHHhcCcccCCCCC
Confidence 1135789999999999999999 7999999999997544
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=421.71 Aligned_cols=254 Identities=24% Similarity=0.399 Sum_probs=210.2
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeC-
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETD- 95 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~- 95 (412)
.++|+++++||+|+||+||+|+++.++ +.||||++++... .....+++.+|+++|++++|||||+++++|...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~----~~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~ 90 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTG----LRVAVKKLSRPFQ--SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 90 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTT----EEEEEEECSCTTS--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCC----CEEEEEEECchhc--ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecc
Confidence 378999999999999999999998754 4599999987643 223456788899999999999999999999643
Q ss_pred ----CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 96 ----EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 96 ----~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
...+++|+++.||+|..++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||+
T Consensus 91 ~~~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 91 SLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp STTTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred ccccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccch
Confidence 344666777889999887743 3599999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
|.... ....+.+||
T Consensus 168 a~~~~------------------------------------------------------------------~~~~~~~g~ 181 (348)
T d2gfsa1 168 ARHTD------------------------------------------------------------------DEMTGYVAT 181 (348)
T ss_dssp --CCT------------------------------------------------------------------GGGSSSCHH
T ss_pred hcccC------------------------------------------------------------------ccccccccc
Confidence 86432 112345799
Q ss_pred CCCccceeecCCC-CCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-------------------------
Q 042539 252 EEYVSPEVVRGDG-HEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVLMKTP------------------------- 305 (412)
Q Consensus 252 ~~Y~APE~l~~~~-~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~------------------------- 305 (412)
+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+.......+.....
T Consensus 182 ~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (348)
T d2gfsa1 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 261 (348)
T ss_dssp HHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCC
T ss_pred ccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccC
Confidence 9999999987765 58999999999999999999999999988777666542111
Q ss_pred -------CCCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCCCC
Q 042539 306 -------EFVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKGVR 349 (412)
Q Consensus 306 -------~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~~~ 349 (412)
.+...+++++|||.+||+.||++|+ |++|+++||||++..
T Consensus 262 ~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~----ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 262 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRI----TAAQALAHAYFAQYH 308 (348)
T ss_dssp CCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSC----CHHHHHTSGGGTTTC
T ss_pred CCcchhhhcCCCCHHHHHHHHHHCcCChhhCc----CHHHHhcCHhhCCCC
Confidence 0235678999999999999999999 799999999998753
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-54 Score=410.36 Aligned_cols=263 Identities=22% Similarity=0.319 Sum_probs=206.1
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCC-CCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccceee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADP-TARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKLL 89 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~ 89 (412)
.+++..++|+++++||+|+||+||+|++...+. .+++.||||+++.... ....+.+.+|..++.++ +|+|||.++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~---~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT---HSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C---HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC---cHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 346788999999999999999999999876543 3456799999975432 23345666788888887 589999999
Q ss_pred eeEEeC-CeEEEEeeccCCCCchhHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCC
Q 042539 90 GSLETD-EFLAWAVPYCPGGDLNVLRYKQN--------------DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPE 154 (412)
Q Consensus 90 ~~~~~~-~~~~lv~e~~~gg~L~~~~~~~~--------------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~ 154 (412)
+++... ..+++|||||+||+|..++.... ...+++.++..++.||+.||+|||++|||||||||+
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~ 163 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 163 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcc
Confidence 987654 57999999999999999886542 234899999999999999999999999999999999
Q ss_pred ceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccc
Q 042539 155 NILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSR 234 (412)
Q Consensus 155 NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (412)
|||++.+|++||+|||+|+.....
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~-------------------------------------------------------- 187 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKD-------------------------------------------------------- 187 (299)
T ss_dssp GEEECGGGCEEECC------CCSC--------------------------------------------------------
T ss_pred ceeECCCCcEEEccCcchhhcccc--------------------------------------------------------
Confidence 999999999999999999754211
Q ss_pred cccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhC-CCCCCCCCHHHHHHHHhcCC--CCC-CCC
Q 042539 235 RQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYG-TTPFRGKNRKETFRNVLMKT--PEF-VGQ 310 (412)
Q Consensus 235 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g-~~Pf~~~~~~~~~~~i~~~~--~~~-~~~ 310 (412)
.......+.+||+.|||||++.+..++.++|||||||++|||++| .+||.+.+..+.+..++... +.. ...
T Consensus 188 -----~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (299)
T d1ywna1 188 -----PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYT 262 (299)
T ss_dssp -----TTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTC
T ss_pred -----ccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCccC
Confidence 111223456899999999999999999999999999999999986 67898876555444444322 222 346
Q ss_pred ChHHHHHHHHhhhhCCCccCCCCCChhhhhcC
Q 042539 311 RTALTDLIQRLLEKDPVKRLGYLRGACEIKEH 342 (412)
Q Consensus 311 ~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h 342 (412)
++++.+||.+||+.||++|| +++|+++|
T Consensus 263 ~~~l~~li~~cl~~dP~~Rp----t~~eil~~ 290 (299)
T d1ywna1 263 TPEMYQTMLDCWHGEPSQRP----TFSELVEH 290 (299)
T ss_dssp CHHHHHHHHHHTCSSGGGSC----CHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCc----CHHHHHHH
Confidence 79999999999999999999 68999875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-54 Score=404.75 Aligned_cols=261 Identities=20% Similarity=0.259 Sum_probs=207.5
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
.-+..+||++++.||+|+||+||+|+.+.... ....||||++++..... .+..+.+.+|+++|++++|||||++++++
T Consensus 3 ~~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~-~~~~vAiK~l~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~ 80 (273)
T d1u46a_ 3 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSG-KTVSVAVKCLKPDVLSQ-PEAMDDFIREVNAMHSLDHRNLIRLYGVV 80 (273)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTS-CEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred eEEchHHeEEEEEEecCCCeEEEEEEEECCCC-cEEEEEEEEEChhhcCC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 34677899999999999999999998765432 23458999997765533 34556788999999999999999999999
Q ss_pred EeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEcccccc
Q 042539 93 ETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLS 172 (412)
Q Consensus 93 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla 172 (412)
.+ ..+++|||||.+|++..++.... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~-~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~ 158 (273)
T d1u46a_ 81 LT-PPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 158 (273)
T ss_dssp CS-SSCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred ee-cchheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhh
Confidence 75 47789999999999987766543 35999999999999999999999999999999999999999999999999999
Q ss_pred chhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCC
Q 042539 173 RNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTE 252 (412)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 252 (412)
+.+..... .........||.
T Consensus 159 ~~~~~~~~------------------------------------------------------------~~~~~~~~~~~~ 178 (273)
T d1u46a_ 159 RALPQNDD------------------------------------------------------------HYVMQEHRKVPF 178 (273)
T ss_dssp EECCC-CC------------------------------------------------------------EEEC-----CCG
T ss_pred hhcccCCC------------------------------------------------------------cceecCccccCc
Confidence 86532110 111223456888
Q ss_pred CCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCCC---CCCCChHHHHHHHHhhhhCCCc
Q 042539 253 EYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKTPE---FVGQRTALTDLIQRLLEKDPVK 328 (412)
Q Consensus 253 ~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~dli~~~L~~dP~~ 328 (412)
.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+...++...... ...+++++.+||.+||..||++
T Consensus 179 ~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 258 (273)
T d1u46a_ 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPED 258 (273)
T ss_dssp GGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred ccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhH
Confidence 9999999999999999999999999999998 89999999999998888765432 3457899999999999999999
Q ss_pred cCCCCCChhhhhc
Q 042539 329 RLGYLRGACEIKE 341 (412)
Q Consensus 329 R~~~~~~~~e~l~ 341 (412)
|| +++++.+
T Consensus 259 RP----t~~ei~~ 267 (273)
T d1u46a_ 259 RP----TFVALRD 267 (273)
T ss_dssp SC----CHHHHHH
T ss_pred Cc----CHHHHHH
Confidence 99 5777753
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=409.10 Aligned_cols=261 Identities=22% Similarity=0.329 Sum_probs=217.1
Q ss_pred CCCCCCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccce
Q 042539 9 PQTTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPK 87 (412)
Q Consensus 9 ~~~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~ 87 (412)
|...+.+..++|++.++||+|+||+||+|+++.++.. ..||||.+++... .+..+.+.+|+++|.++ +|||||+
T Consensus 1 ~~~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~--~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~~HpnIv~ 75 (309)
T d1fvra_ 1 PTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLR--MDAAIKRMKEYAS---KDDHRDFAGELEVLCKLGHHPNIIN 75 (309)
T ss_dssp CCCSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEE--EEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCC
T ss_pred CCCCCccCHHHcEEEEEEeeCCCcEEEEEEECCCCeE--EEEEEEEECcccC---hHHHHHHHHHHHHHHhccCCCCEee
Confidence 4566778999999999999999999999998775432 2377888754322 23355678899999999 6999999
Q ss_pred eeeeEEeCCeEEEEeeccCCCCchhHHHhh--------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCC
Q 042539 88 LLGSLETDEFLAWAVPYCPGGDLNVLRYKQ--------------NDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKP 153 (412)
Q Consensus 88 l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~--------------~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp 153 (412)
+++++.+++.+|+|||||+||+|.+++... ....+++.++..++.||+.||.|||++||+||||||
T Consensus 76 ~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp 155 (309)
T d1fvra_ 76 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAA 155 (309)
T ss_dssp EEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCcccccccc
Confidence 999999999999999999999999988653 235699999999999999999999999999999999
Q ss_pred CceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCcc
Q 042539 154 ENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVS 233 (412)
Q Consensus 154 ~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (412)
+|||++.++.+||+|||+|+....
T Consensus 156 ~NIL~~~~~~~kl~DfG~a~~~~~-------------------------------------------------------- 179 (309)
T d1fvra_ 156 RNILVGENYVAKIADFGLSRGQEV-------------------------------------------------------- 179 (309)
T ss_dssp GGEEECGGGCEEECCTTCEESSCE--------------------------------------------------------
T ss_pred ceEEEcCCCceEEccccccccccc--------------------------------------------------------
Confidence 999999999999999999975421
Q ss_pred ccccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhC-CCCCCCCCHHHHHHHHhcCC-CC-CCCC
Q 042539 234 RRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYG-TTPFRGKNRKETFRNVLMKT-PE-FVGQ 310 (412)
Q Consensus 234 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g-~~Pf~~~~~~~~~~~i~~~~-~~-~~~~ 310 (412)
........||..|+|||.+.+..++.++|||||||++|||++| .+||.+.+..++...+..+. +. ...+
T Consensus 180 --------~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 251 (309)
T d1fvra_ 180 --------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNC 251 (309)
T ss_dssp --------ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCTTB
T ss_pred --------cccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCccC
Confidence 1112345789999999999999999999999999999999996 56899999888888876543 22 3456
Q ss_pred ChHHHHHHHHhhhhCCCccCCCCCChhhhhcC
Q 042539 311 RTALTDLIQRLLEKDPVKRLGYLRGACEIKEH 342 (412)
Q Consensus 311 ~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h 342 (412)
++++++||.+||+.||++|| +++++++|
T Consensus 252 ~~~~~~li~~cl~~dP~~RP----s~~eil~~ 279 (309)
T d1fvra_ 252 DDEVYDLMRQCWREKPYERP----SFAQILVS 279 (309)
T ss_dssp CHHHHHHHHHHTCSSGGGSC----CHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCc----CHHHHHHH
Confidence 89999999999999999999 68999976
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-53 Score=402.74 Aligned_cols=263 Identities=20% Similarity=0.270 Sum_probs=216.6
Q ss_pred CCCCCCccCceeeeeeeccCceEEEEEEEcCCCCC---CCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCccc
Q 042539 11 TTPSLDLDNLKALKILGKGAMGTVFLVHDRAADPT---ARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLP 86 (412)
Q Consensus 11 ~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv 86 (412)
+++++..++|++++.||+|+||.||+|++..++.. ....||||++++... ......+.+|...+.++ +|||||
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~~e~~~l~~~~~HpnIv 82 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT---EKDLSDLISEMEMMKMIGKHKNII 82 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC---HHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC---hHHHHHHHHHHHHHHHhcCCCeEE
Confidence 45788999999999999999999999998766532 234699999976542 23345677798999888 699999
Q ss_pred eeeeeEEeCCeEEEEeeccCCCCchhHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCC
Q 042539 87 KLLGSLETDEFLAWAVPYCPGGDLNVLRYKQN--------------DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLK 152 (412)
Q Consensus 87 ~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~--------------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlK 152 (412)
++++++.+++.+|+|||||.||+|..++.... ...+++.++..++.||+.||+|||++||||||||
T Consensus 83 ~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiK 162 (299)
T d1fgka_ 83 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA 162 (299)
T ss_dssp CEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred ecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeec
Confidence 99999999999999999999999999887553 2358999999999999999999999999999999
Q ss_pred CCceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCc
Q 042539 153 PENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPV 232 (412)
Q Consensus 153 p~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (412)
|+|||++.+|.+||+|||+++......
T Consensus 163 p~NiLl~~~~~~kl~dfg~~~~~~~~~----------------------------------------------------- 189 (299)
T d1fgka_ 163 ARNVLVTEDNVMKIADFGLARDIHHID----------------------------------------------------- 189 (299)
T ss_dssp GGGEEECTTCCEEECSTTCCCCGGGCC-----------------------------------------------------
T ss_pred ccceeecCCCCeEeccchhhccccccc-----------------------------------------------------
Confidence 999999999999999999998653211
Q ss_pred cccccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC-CC-CCC
Q 042539 233 SRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT-PE-FVG 309 (412)
Q Consensus 233 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~-~~-~~~ 309 (412)
........+||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+..+++..+..+. +. ...
T Consensus 190 --------~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~p~~ 261 (299)
T d1fgka_ 190 --------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSN 261 (299)
T ss_dssp --------TTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSS
T ss_pred --------cccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 1122345679999999999999999999999999999999997 799999999888877776543 22 235
Q ss_pred CChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 310 QRTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 310 ~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
.++++.+||.+||+.||.+|| ++.|+++
T Consensus 262 ~~~~l~~li~~cl~~dP~~Rp----s~~eil~ 289 (299)
T d1fgka_ 262 CTNELYMMMRDCWHAVPSQRP----TFKQLVE 289 (299)
T ss_dssp CCHHHHHHHHHHTCSSGGGSC----CHHHHHH
T ss_pred chHHHHHHHHHHccCCHhHCc----CHHHHHH
Confidence 679999999999999999999 6888875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.9e-53 Score=403.29 Aligned_cols=261 Identities=20% Similarity=0.261 Sum_probs=219.6
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCC-CCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeee
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAAD-PTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGS 91 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 91 (412)
.++..++|++++.||+|+||+||+|+++... ..+++.||||++++.. .....+.+.+|+++|++++||||++++++
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc---ChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 4566789999999999999999999987532 3355679999997543 23456678889999999999999999999
Q ss_pred EEeCCeEEEEeeccCCCCchhHHHhhC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceee
Q 042539 92 LETDEFLAWAVPYCPGGDLNVLRYKQN----------------------DRVFSPSVIRFYLSEIICAIEHLHNMGIAYR 149 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L~~~~~~~~----------------------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHr 149 (412)
+.+.+.++++||||.+|+|..++.... ...+++..+..++.|++.||+|||++|||||
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHr 164 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 164 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEee
Confidence 999999999999999999998886532 1248899999999999999999999999999
Q ss_pred eCCCCceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCC
Q 042539 150 DLKPENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARV 229 (412)
Q Consensus 150 DlKp~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (412)
||||+|||++.++.+||+|||+|+.+....
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~-------------------------------------------------- 194 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSAD-------------------------------------------------- 194 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGG--------------------------------------------------
T ss_pred EEcccceEECCCCcEEEccchhheeccCCc--------------------------------------------------
Confidence 999999999999999999999998653221
Q ss_pred CCccccccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhC-CCCCCCCCHHHHHHHHhcCCC-C-
Q 042539 230 SPVSRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYG-TTPFRGKNRKETFRNVLMKTP-E- 306 (412)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g-~~Pf~~~~~~~~~~~i~~~~~-~- 306 (412)
......+.+||+.|+|||++.+..|+.++|||||||++|||++| .+||.+.+..+....+..+.. .
T Consensus 195 -----------~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~~ 263 (301)
T d1lufa_ 195 -----------YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILAC 263 (301)
T ss_dssp -----------CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC
T ss_pred -----------cccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 11122356789999999999999999999999999999999988 578999999998888876542 2
Q ss_pred CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 307 FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 307 ~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
...+++++.+||.+||+.||++|| ++.|+++
T Consensus 264 p~~~~~~~~~li~~cl~~~P~~RP----t~~ev~~ 294 (301)
T d1lufa_ 264 PENCPLELYNLMRLCWSKLPADRP----SFCSIHR 294 (301)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSC----CHHHHHH
T ss_pred CccchHHHHHHHHHHcCCChhHCc----CHHHHHH
Confidence 335789999999999999999999 5788754
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-54 Score=400.77 Aligned_cols=247 Identities=22% Similarity=0.332 Sum_probs=206.4
Q ss_pred CCCCccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeE
Q 042539 13 PSLDLDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSL 92 (412)
Q Consensus 13 ~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 92 (412)
+++.+++|++++.||+|+||.||+|++++ ..||||+++++. ..+.+.+|++++++++|||||++++++
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~vAvK~i~~~~------~~~~~~~E~~~l~~l~HpnIv~~~g~~ 69 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRG------NKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVI 69 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETT------EEEEEEECCCCC--------HHHHHTHHHHTTCCCTTBCCEEEEE
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECC------eEEEEEEECcHH------HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 68899999999999999999999998853 249999997643 234577899999999999999999988
Q ss_pred Ee-CCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccc
Q 042539 93 ET-DEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDL 171 (412)
Q Consensus 93 ~~-~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGl 171 (412)
.+ ++.+|+|||||.+|+|.+++.......+++..++.++.||+.||.|||+++|+||||||+|||++.+|.+||+|||+
T Consensus 70 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~ 149 (262)
T d1byga_ 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 149 (262)
T ss_dssp CCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred EecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeeccccc
Confidence 54 56799999999999999988765444589999999999999999999999999999999999999999999999999
Q ss_pred cchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccC
Q 042539 172 SRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGT 251 (412)
Q Consensus 172 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 251 (412)
++.... ...+..+|
T Consensus 150 s~~~~~------------------------------------------------------------------~~~~~~~~ 163 (262)
T d1byga_ 150 TKEASS------------------------------------------------------------------TQDTGKLP 163 (262)
T ss_dssp ------------------------------------------------------------------------------CC
T ss_pred ceecCC------------------------------------------------------------------CCcccccc
Confidence 975421 11234688
Q ss_pred CCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC-CCC-CCCChHHHHHHHHhhhhCCCc
Q 042539 252 EEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT-PEF-VGQRTALTDLIQRLLEKDPVK 328 (412)
Q Consensus 252 ~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~-~~~-~~~~~~~~dli~~~L~~dP~~ 328 (412)
..|+|||++.+..++.++|||||||++|||++ |++||.+.+..+....+..+. ++. ...++++.+||.+||..||.+
T Consensus 164 ~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~ 243 (262)
T d1byga_ 164 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAM 243 (262)
T ss_dssp TTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred ccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhH
Confidence 99999999999999999999999999999998 899999988888888876532 333 346799999999999999999
Q ss_pred cCCCCCChhhhhc
Q 042539 329 RLGYLRGACEIKE 341 (412)
Q Consensus 329 R~~~~~~~~e~l~ 341 (412)
|| ++.++++
T Consensus 244 Rp----s~~~l~~ 252 (262)
T d1byga_ 244 RP----SFLQLRE 252 (262)
T ss_dssp SC----CHHHHHH
T ss_pred Cc----CHHHHHH
Confidence 99 5788775
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=401.98 Aligned_cols=262 Identities=18% Similarity=0.219 Sum_probs=220.9
Q ss_pred CCCCCccCceeeeeeeccCceEEEEEEEcCCCC-CCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeee
Q 042539 12 TPSLDLDNLKALKILGKGAMGTVFLVHDRAADP-TARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLG 90 (412)
Q Consensus 12 ~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 90 (412)
.+++..++|++++.||+|+||+||+|.++.... ..++.||||++++... ......+.+|++++++++|||||++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~ 90 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS---MRERIEFLNEASVMKEFNCHHVVRLLG 90 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC---HHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccC---hHHHHHHHHHHHHHHHcCCCCEeeeee
Confidence 478889999999999999999999998864321 1345699999976432 234556788999999999999999999
Q ss_pred eEEeCCeEEEEeeccCCCCchhHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCC
Q 042539 91 SLETDEFLAWAVPYCPGGDLNVLRYKQN--------DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSG 162 (412)
Q Consensus 91 ~~~~~~~~~lv~e~~~gg~L~~~~~~~~--------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g 162 (412)
++..++.+++|||||.+|+|..++.... ...++...+..++.|++.||.|||+++|+||||||+|||++.++
T Consensus 91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc
Confidence 9999999999999999999988766432 12368899999999999999999999999999999999999999
Q ss_pred CEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCC
Q 042539 163 HVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNG 242 (412)
Q Consensus 163 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (412)
++||+|||+|+....... .
T Consensus 171 ~~Kl~DFGla~~~~~~~~-------------------------------------------------------------~ 189 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDY-------------------------------------------------------------Y 189 (308)
T ss_dssp CEEECCTTCCCGGGGGGC-------------------------------------------------------------E
T ss_pred eEEEeecccceeccCCcc-------------------------------------------------------------e
Confidence 999999999986532211 1
Q ss_pred CCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhC-CCCCCCCCHHHHHHHHhcCCC--CCCCCChHHHHHHH
Q 042539 243 ERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYG-TTPFRGKNRKETFRNVLMKTP--EFVGQRTALTDLIQ 319 (412)
Q Consensus 243 ~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g-~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~dli~ 319 (412)
......+||+.|+|||.+.+..++.++|||||||++|||+|| .+||.+.+..+.+..+..+.. ....+++.+.+||.
T Consensus 190 ~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~ 269 (308)
T d1p4oa_ 190 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMR 269 (308)
T ss_dssp EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCCCcccchHHHHHHHH
Confidence 112345789999999999999999999999999999999997 689999999999888876442 23456789999999
Q ss_pred HhhhhCCCccCCCCCChhhhhc
Q 042539 320 RLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 320 ~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
+||+.||.+|| +++++++
T Consensus 270 ~cl~~~P~~RP----s~~~il~ 287 (308)
T d1p4oa_ 270 MCWQYNPKMRP----SFLEIIS 287 (308)
T ss_dssp HHTCSSGGGSC----CHHHHHH
T ss_pred HHcCCChhHCc----CHHHHHH
Confidence 99999999999 5788876
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-52 Score=398.88 Aligned_cols=263 Identities=21% Similarity=0.293 Sum_probs=218.8
Q ss_pred CCCCCCccCceeeeeeeccCceEEEEEEEcCC-CCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhc-CCCcccee
Q 042539 11 TTPSLDLDNLKALKILGKGAMGTVFLVHDRAA-DPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRL-SHPFLPKL 88 (412)
Q Consensus 11 ~~~~~~~~~y~~~~~LG~G~fg~V~la~~~~~-~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l 88 (412)
..+++..++|++.++||+|+||.||+|+++.. +..++..||||++++... ......+.+|+.+++++ +|||||++
T Consensus 16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~E~~~~~~l~~HpnIv~~ 92 (311)
T d1t46a_ 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH---LTEREALMSELKVLSYLGNHMNIVNL 92 (311)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC---HHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC---HHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 35678889999999999999999999987642 344667799999976542 33455678899999999 59999999
Q ss_pred eeeEEeCCeEEEEeeccCCCCchhHHHhhC----------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCC
Q 042539 89 LGSLETDEFLAWAVPYCPGGDLNVLRYKQN----------------DRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLK 152 (412)
Q Consensus 89 ~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~----------------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlK 152 (412)
++++.+++.+|+|||||.||+|..++.... ...+++..+..++.||+.||+|||++||||||||
T Consensus 93 ~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLK 172 (311)
T d1t46a_ 93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA 172 (311)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccc
Confidence 999999999999999999999998877543 2258999999999999999999999999999999
Q ss_pred CCceEEccCCCEEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCc
Q 042539 153 PENILIRQSGHVTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPV 232 (412)
Q Consensus 153 p~NiLl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (412)
|+|||++.++.+||+|||+++......
T Consensus 173 p~NIl~~~~~~~ki~DfG~~~~~~~~~----------------------------------------------------- 199 (311)
T d1t46a_ 173 ARNILLTHGRITKICDFGLARDIKNDS----------------------------------------------------- 199 (311)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCT-----------------------------------------------------
T ss_pred cccccccccCcccccccchheeccCCC-----------------------------------------------------
Confidence 999999999999999999997653211
Q ss_pred cccccccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC--CC-CC
Q 042539 233 SRRQQSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLY-GTTPFRGKNRKETFRNVLMKT--PE-FV 308 (412)
Q Consensus 233 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~--~~-~~ 308 (412)
........+||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+..+.+.+++... +. ..
T Consensus 200 --------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~ 271 (311)
T d1t46a_ 200 --------NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPE 271 (311)
T ss_dssp --------TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCT
T ss_pred --------cceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcc
Confidence 1112234689999999999999999999999999999999998 788888877666666655432 22 23
Q ss_pred CCChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 309 GQRTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 309 ~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
..++++.+||.+||+.||++|| +++++++
T Consensus 272 ~~~~~l~~Li~~cl~~dP~~RP----s~~~il~ 300 (311)
T d1t46a_ 272 HAPAEMYDIMKTCWDADPLKRP----TFKQIVQ 300 (311)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSC----CHHHHHH
T ss_pred cccHHHHHHHHHHcCCChhHCc----CHHHHHH
Confidence 4679999999999999999999 5888875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=381.34 Aligned_cols=253 Identities=17% Similarity=0.204 Sum_probs=200.0
Q ss_pred eeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEe-CCeEEE
Q 042539 22 ALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLET-DEFLAW 100 (412)
Q Consensus 22 ~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~l 100 (412)
+-++||+|+||+||+|++..++. +...||||++++.. .......+.+|+++|++++|||||++++++.. +..+++
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l 106 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDG-KKIHCAVKSLNRIT---DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 106 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC-----CEEEEEEEECCCC---CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCC-EEEEEEEEEECccc---CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEE
Confidence 36789999999999999876432 34458999996532 23445778899999999999999999999765 568999
Q ss_pred EeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEEEccccccchhhchhh
Q 042539 101 AVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVTLTDFDLSRNLVKKTA 180 (412)
Q Consensus 101 v~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~~~~~~~ 180 (412)
|||||.+|+|..++.... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 107 v~E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 107 VLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp EEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred EEEEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 999999999988766443 4577888999999999999999999999999999999999999999999999986532110
Q ss_pred hhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCCCccceee
Q 042539 181 FEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEEYVSPEVV 260 (412)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~l 260 (412)
..........||+.|+|||.+
T Consensus 186 -----------------------------------------------------------~~~~~~~~~~gt~~y~aPE~~ 206 (311)
T d1r0pa_ 186 -----------------------------------------------------------DSVHNKTGAKLPVKWMALESL 206 (311)
T ss_dssp -----------------------------------------------------------CCTTCTTCSSCCGGGSCHHHH
T ss_pred -----------------------------------------------------------ccceecccccccccccChHHH
Confidence 111122345789999999999
Q ss_pred cCCCCCchhhHHHHHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCC-C-CCCCCChHHHHHHHHhhhhCCCccCCCCCChh
Q 042539 261 RGDGHEFAVDWWALGILTYEMLYGTTPFRG-KNRKETFRNVLMKT-P-EFVGQRTALTDLIQRLLEKDPVKRLGYLRGAC 337 (412)
Q Consensus 261 ~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~-~-~~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~ 337 (412)
.+..++.++|||||||++|||++|..||.. .+..+....+..+. + ....+++++.+||.+||+.||++|| ++.
T Consensus 207 ~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RP----s~~ 282 (311)
T d1r0pa_ 207 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRP----SFS 282 (311)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC----CHH
T ss_pred hcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCc----CHH
Confidence 999999999999999999999996666654 44444555555432 2 2234678999999999999999999 688
Q ss_pred hhhcC
Q 042539 338 EIKEH 342 (412)
Q Consensus 338 e~l~h 342 (412)
|+++|
T Consensus 283 ei~~~ 287 (311)
T d1r0pa_ 283 ELVSR 287 (311)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 88876
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-49 Score=377.36 Aligned_cols=259 Identities=19% Similarity=0.236 Sum_probs=196.4
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCc-cceeeeeEEeCC
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPF-LPKLLGSLETDE 96 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~ 96 (412)
++|++++.||+|+||+||+|+++.++ +.||||++...... ..+.+|+++++.++|+| |+.+++++.+++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~----~~vAvK~~~~~~~~------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~ 76 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAG----EEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCGAEGD 76 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTT----EEEEEEEEESCTTS------CCHHHHHHHHHHSTTSTTCCCEEEEEEETT
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCC----CEEEEEEEchhccC------HHHHHHHHHHHHccCCCcccEEEEEEecCC
Confidence 46999999999999999999998754 45999998765322 23556999999998665 566667778888
Q ss_pred eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEcc---CCCEEEccccccc
Q 042539 97 FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQ---SGHVTLTDFDLSR 173 (412)
Q Consensus 97 ~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~---~g~vkL~DFGla~ 173 (412)
..++|||||. +++...+.. ..+.+++..+..++.|++.||+|||++|||||||||+|||++. ++.+||+|||+|+
T Consensus 77 ~~~ivme~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~ 154 (299)
T d1ckia_ 77 YNVMVMELLG-PSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154 (299)
T ss_dssp EEEEEEECCC-CBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred EEEEEEEEcC-Cchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcce
Confidence 9999999995 455444433 3356999999999999999999999999999999999999864 4579999999998
Q ss_pred hhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCcccccCCC
Q 042539 174 NLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVGTEE 253 (412)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 253 (412)
.+...... .........+.+||+.
T Consensus 155 ~~~~~~~~--------------------------------------------------------~~~~~~~~~~~~gt~~ 178 (299)
T d1ckia_ 155 KYRDARTH--------------------------------------------------------QHIPYRENKNLTGTAR 178 (299)
T ss_dssp ECBCTTTC--------------------------------------------------------CBCCCCBCCSCCCCSS
T ss_pred eccccccc--------------------------------------------------------cceeccccCCcCCCcc
Confidence 76321110 0011223456789999
Q ss_pred CccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHh---c---CCC---CCCCCChHHHHHHHHhhhh
Q 042539 254 YVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRKETFRNVL---M---KTP---EFVGQRTALTDLIQRLLEK 324 (412)
Q Consensus 254 Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~---~---~~~---~~~~~~~~~~dli~~~L~~ 324 (412)
|||||++.+..++.++|||||||++|||++|..||.+.........+. . ..+ ....+++++.+||.+||..
T Consensus 179 y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~ 258 (299)
T d1ckia_ 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSL 258 (299)
T ss_dssp SCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHS
T ss_pred ccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccC
Confidence 999999999999999999999999999999999998865443322221 1 111 1346789999999999999
Q ss_pred CCCccCCCCCChhhhhcCCCC
Q 042539 325 DPVKRLGYLRGACEIKEHVFF 345 (412)
Q Consensus 325 dP~~R~~~~~~~~e~l~h~ff 345 (412)
||++||++. .+.++++|+|.
T Consensus 259 ~p~~RP~~~-~i~~~l~~~~~ 278 (299)
T d1ckia_ 259 RFDDKPDYS-YLRQLFRNLFH 278 (299)
T ss_dssp CTTCCCCHH-HHHHHHHHHHH
T ss_pred ChhHCcCHH-HHHHHHHHHHH
Confidence 999999531 23455666654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=9.6e-49 Score=372.03 Aligned_cols=247 Identities=19% Similarity=0.242 Sum_probs=198.9
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCC-CccceeeeeEEeC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSH-PFLPKLLGSLETD 95 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~ 95 (412)
-++|+++++||+|+||+||+|++..++ +.||||++.+... ...+.+|+++++.++| +||+.+++++.++
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~----~~vAvK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~ 73 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNN----QQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQEG 73 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTT----EEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCC----CEEEEEEEccccC------cHHHHHHHHHHHHhcCCCCCCEEEEEeecC
Confidence 368999999999999999999998754 4599999865432 1234568899999975 8999999999999
Q ss_pred CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEcc-----CCCEEEcccc
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQ-----SGHVTLTDFD 170 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~-----~g~vkL~DFG 170 (412)
...|+||||| |++|..++... ...+++.++..++.|++.||+|||++|||||||||+|||++. .+.+||+|||
T Consensus 74 ~~~~~vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG 151 (293)
T d1csna_ 74 LHNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 151 (293)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred CccEEEEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccc
Confidence 9999999999 78887776543 346999999999999999999999999999999999999975 5789999999
Q ss_pred ccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCCCccccc
Q 042539 171 LSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGERSNSFVG 250 (412)
Q Consensus 171 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 250 (412)
+|+........ .........+++|
T Consensus 152 ~a~~~~~~~~~--------------------------------------------------------~~~~~~~~~~~~G 175 (293)
T d1csna_ 152 MVKFYRDPVTK--------------------------------------------------------QHIPYREKKNLSG 175 (293)
T ss_dssp TCEESBCTTTC--------------------------------------------------------CBCCCCCCCCCCS
T ss_pred eeEEcccCccc--------------------------------------------------------cceeecccCceEE
Confidence 99876322110 0011123446789
Q ss_pred CCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCC---HHHHHHHHhcC---CC---CCCCCChHHHHHHHHh
Q 042539 251 TEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKN---RKETFRNVLMK---TP---EFVGQRTALTDLIQRL 321 (412)
Q Consensus 251 t~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~---~~~~~~~i~~~---~~---~~~~~~~~~~dli~~~ 321 (412)
|+.|||||++.+..++.++|||||||++|||++|..||.+.. ......++... .+ ....+++++.++|..|
T Consensus 176 T~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~ 255 (293)
T d1csna_ 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYA 255 (293)
T ss_dssp CTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHH
T ss_pred chhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHH
Confidence 999999999999999999999999999999999999998643 33333333221 11 1245788999999999
Q ss_pred hhhCCCccCC
Q 042539 322 LEKDPVKRLG 331 (412)
Q Consensus 322 L~~dP~~R~~ 331 (412)
+..+|.+||+
T Consensus 256 ~~~~~~~rP~ 265 (293)
T d1csna_ 256 RNLAFDATPD 265 (293)
T ss_dssp HHCCTTCCCC
T ss_pred hcCCcccCcC
Confidence 9999999994
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=373.60 Aligned_cols=248 Identities=21% Similarity=0.233 Sum_probs=189.1
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCccceeeeeEEeCC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPFLPKLLGSLETDE 96 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 96 (412)
.++|.+.+.||+|+||+||+|+.. ++.||||+++.+.. ......+|+..+.+++|||||++++++.+++
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~~------g~~vAvK~~~~~~~-----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~ 70 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKWR------GEEVAVKIFSSREE-----RSWFREAEIYQTVMLRHENILGFIAADNKDN 70 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET------TEEEEEEEECGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC------CEEEEEEEECccch-----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCC
Confidence 468999999999999999999863 34599999965431 1122234666667889999999999997654
Q ss_pred ----eEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH--------cCceeeeCCCCceEEccCCCE
Q 042539 97 ----FLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN--------MGIAYRDLKPENILIRQSGHV 164 (412)
Q Consensus 97 ----~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~--------~~iiHrDlKp~NiLl~~~g~v 164 (412)
.+|+|||||.+|+|..++... .++..+...++.|++.||.|||+ +|||||||||+|||++.+|.+
T Consensus 71 ~~~~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~ 147 (303)
T d1vjya_ 71 GTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 147 (303)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCE
T ss_pred CcceEEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCe
Confidence 689999999999999988754 38999999999999999999996 599999999999999999999
Q ss_pred EEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccccccCCCCC
Q 042539 165 TLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQQSFDNGER 244 (412)
Q Consensus 165 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (412)
||+|||+++....... .....
T Consensus 148 Kl~DFGl~~~~~~~~~-----------------------------------------------------------~~~~~ 168 (303)
T d1vjya_ 148 CIADLGLAVRHDSATD-----------------------------------------------------------TIDIA 168 (303)
T ss_dssp EECCCTTCEEEETTTT-----------------------------------------------------------EECC-
T ss_pred EEEecCccccccCCCc-----------------------------------------------------------ceecc
Confidence 9999999986532110 01122
Q ss_pred CcccccCCCCccceeecCCC------CCchhhHHHHHHHHHHHhhCCCCCCCC---------------CHHHHHHHHhcC
Q 042539 245 SNSFVGTEEYVSPEVVRGDG------HEFAVDWWALGILTYEMLYGTTPFRGK---------------NRKETFRNVLMK 303 (412)
Q Consensus 245 ~~~~~gt~~Y~APE~l~~~~------~~~~~DiwSlGvil~ell~g~~Pf~~~---------------~~~~~~~~i~~~ 303 (412)
....+||+.|||||++.+.. ++.++|||||||++|||+||.+||... ........+...
T Consensus 169 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (303)
T d1vjya_ 169 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ 248 (303)
T ss_dssp ---CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTS
T ss_pred ccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhcc
Confidence 33568999999999987653 577899999999999999999887431 122222222221
Q ss_pred C--CCCCCC------ChHHHHHHHHhhhhCCCccCCCCCChhhhhc
Q 042539 304 T--PEFVGQ------RTALTDLIQRLLEKDPVKRLGYLRGACEIKE 341 (412)
Q Consensus 304 ~--~~~~~~------~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~ 341 (412)
. +.++.. ...+.+||.+||+.||++|| ++.|+++
T Consensus 249 ~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp----s~~ei~~ 290 (303)
T d1vjya_ 249 KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL----TALRIKK 290 (303)
T ss_dssp CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSC----CHHHHHH
T ss_pred ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCc----CHHHHHH
Confidence 1 222111 13588999999999999999 5788775
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.8e-47 Score=370.21 Aligned_cols=253 Identities=23% Similarity=0.348 Sum_probs=194.7
Q ss_pred cCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-----------CCccc
Q 042539 18 DNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-----------HPFLP 86 (412)
Q Consensus 18 ~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-----------hpnIv 86 (412)
++|+++++||+|+||+||+|+++.++. .||||++++... ....+.+|+++++.++ |+|||
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~----~vAvKvi~~~~~-----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv 83 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNT----HVAMKIVRGDKV-----YTEAAEDEIKLLQRVNDADNTKEDSMGANHIL 83 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEECSCHH-----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCC----EEEEEEEecccc-----chHHHHHHHHHHHHhcchhhhhhhhcCcCceE
Confidence 569999999999999999999987554 499999976542 2234566888888775 57899
Q ss_pred eeeeeEEe--CCeEEEEeeccCCCCc-hhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeeCCCCceEEccCC
Q 042539 87 KLLGSLET--DEFLAWAVPYCPGGDL-NVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHN-MGIAYRDLKPENILIRQSG 162 (412)
Q Consensus 87 ~l~~~~~~--~~~~~lv~e~~~gg~L-~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDlKp~NiLl~~~g 162 (412)
++++++.. ....+++|+++.++.. ...........+++..++.++.||+.||.|||+ .||+||||||+|||++.+|
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~ 163 (362)
T d1q8ya_ 84 KLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 163 (362)
T ss_dssp CCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred EEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccC
Confidence 99998864 3567777777665543 333444455679999999999999999999998 8999999999999998776
Q ss_pred C------EEEccccccchhhchhhhhhhcccCCCCCCCCCCCCcchhhhhhhhhhccCCCCccccccccccCCCCccccc
Q 042539 163 H------VTLTDFDLSRNLVKKTAFEKQSLNNNKFPVLPVTENPKRHRRILTRWLHALPENKTGLKKTKSARVSPVSRRQ 236 (412)
Q Consensus 163 ~------vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (412)
. +|++|||.|....
T Consensus 164 ~~~~~~~~kl~dfg~s~~~~------------------------------------------------------------ 183 (362)
T d1q8ya_ 164 SPENLIQIKIADLGNACWYD------------------------------------------------------------ 183 (362)
T ss_dssp TTTTEEEEEECCCTTCEETT------------------------------------------------------------
T ss_pred cccccceeeEeecccccccc------------------------------------------------------------
Confidence 4 9999999986431
Q ss_pred cccCCCCCCcccccCCCCccceeecCCCCCchhhHHHHHHHHHHHhhCCCCCCCCCHH------HHHHHH---hcCC---
Q 042539 237 QSFDNGERSNSFVGTEEYVSPEVVRGDGHEFAVDWWALGILTYEMLYGTTPFRGKNRK------ETFRNV---LMKT--- 304 (412)
Q Consensus 237 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~i---~~~~--- 304 (412)
......+||+.|+|||++.+..++.++|+||+||++++|++|+.||...+.. +..... +...
T Consensus 184 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~ 257 (362)
T d1q8ya_ 184 ------EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSY 257 (362)
T ss_dssp ------BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHH
T ss_pred ------cccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHH
Confidence 1223568999999999999999999999999999999999999999764321 111111 1000
Q ss_pred ---------------------CC----------------CCCCChHHHHHHHHhhhhCCCccCCCCCChhhhhcCCCCCC
Q 042539 305 ---------------------PE----------------FVGQRTALTDLIQRLLEKDPVKRLGYLRGACEIKEHVFFKG 347 (412)
Q Consensus 305 ---------------------~~----------------~~~~~~~~~dli~~~L~~dP~~R~~~~~~~~e~l~h~ff~~ 347 (412)
.. ....++++.|||.+||.+||.+|| |++|+|+||||++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp----ta~e~L~Hp~f~~ 333 (362)
T d1q8ya_ 258 LLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA----DAGGLVNHPWLKD 333 (362)
T ss_dssp HHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB----CHHHHHTCGGGTT
T ss_pred HhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc----CHHHHhcCcccCC
Confidence 00 001236799999999999999999 7999999999996
Q ss_pred CC
Q 042539 348 VR 349 (412)
Q Consensus 348 ~~ 349 (412)
+.
T Consensus 334 ~~ 335 (362)
T d1q8ya_ 334 TL 335 (362)
T ss_dssp CT
T ss_pred CC
Confidence 54
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=8.8e-27 Score=205.97 Aligned_cols=137 Identities=22% Similarity=0.197 Sum_probs=107.0
Q ss_pred ceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhh--------------hhHHHHHHHHHHHHHHhhcCCCcc
Q 042539 20 LKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLH--------------AKHEAERRARWEIRVLSRLSHPFL 85 (412)
Q Consensus 20 y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~--------------~~~~~~~~~~~Ei~il~~l~hpnI 85 (412)
+.+.++||+|+||+||+|++. +++.||||+++..... ..........+|...+.++.|.++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-----~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v 76 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-----KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAV 76 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-----TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSS
T ss_pred chhCCEeeeCcceEEEEEECC-----CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCc
Confidence 457899999999999999874 2345999987643211 112233455678999999999999
Q ss_pred ceeeeeEEeCCeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeeeCCCCceEEccCCCEE
Q 042539 86 PKLLGSLETDEFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLHNMGIAYRDLKPENILIRQSGHVT 165 (412)
Q Consensus 86 v~l~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDlKp~NiLl~~~g~vk 165 (412)
+..+++.. .+++|||+.+..+.. +++..+..++.|++.+|+|||++||+||||||+|||++.++ ++
T Consensus 77 ~~~~~~~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~ 142 (191)
T d1zara2 77 PKVYAWEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IW 142 (191)
T ss_dssp CCEEEEET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EE
T ss_pred ceEEEecC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EE
Confidence 98886632 379999998876532 45566788999999999999999999999999999998654 89
Q ss_pred Eccccccchh
Q 042539 166 LTDFDLSRNL 175 (412)
Q Consensus 166 L~DFGla~~~ 175 (412)
|+|||+|+..
T Consensus 143 liDFG~a~~~ 152 (191)
T d1zara2 143 IIDFPQSVEV 152 (191)
T ss_dssp ECCCTTCEET
T ss_pred EEECCCcccC
Confidence 9999999765
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.61 E-value=1.3e-07 Score=84.95 Aligned_cols=141 Identities=14% Similarity=0.096 Sum_probs=92.7
Q ss_pred ccCceeeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeeeEEeC
Q 042539 17 LDNLKALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGSLETD 95 (412)
Q Consensus 17 ~~~y~~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~ 95 (412)
++.|++.+..+.++.+.||++.... ..+.+|......... ...+.+|..++..+. +--+.+++.+..++
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~~~------~~~vlk~~~~~~~~~----~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~ 82 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVGEN------ENLYLKMTDSRYKGT----TYDVEREKDMMLWLEGKLPVPKVLHFERHD 82 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEECSS------CEEEEEEECGGGTTS----TTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred hhceEEEEcCCCCCCCcEEEEEeCC------CeEEEEEcCCCcccc----hhhHHHHHHHHHHHhccCCCCcEEEEEecC
Confidence 4678888887777778999875321 227888875543222 123445888888775 44477888888888
Q ss_pred CeEEEEeeccCCCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---------------------------------
Q 042539 96 EFLAWAVPYCPGGDLNVLRYKQNDRVFSPSVIRFYLSEIICAIEHLH--------------------------------- 142 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L~~~~~~~~~~~l~~~~~~~~~~qi~~aL~yLH--------------------------------- 142 (412)
+..|+||++++|..+...... ......++.++...+..||
T Consensus 83 ~~~~lv~~~l~G~~~~~~~~~-------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T d1j7la_ 83 GWSNLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp TEEEEEEECCSSEEHHHHTTT-------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred CceEEEEEecccccccccccc-------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence 999999999999876433211 1111112223333333333
Q ss_pred --------------------H------cCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 143 --------------------N------MGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 143 --------------------~------~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
+ ..++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1 1379999999999998766667999998864
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.98 E-value=9.7e-06 Score=77.28 Aligned_cols=83 Identities=20% Similarity=0.260 Sum_probs=48.8
Q ss_pred eeeeeeccCceEEEEEEEcCCCCCCCCceEEeeecchh-hhhh--HHHHHHHHHHHHHHhhcC-C--CccceeeeeEEeC
Q 042539 22 ALKILGKGAMGTVFLVHDRAADPTARCPFALKVVDKST-LHAK--HEAERRARWEIRVLSRLS-H--PFLPKLLGSLETD 95 (412)
Q Consensus 22 ~~~~LG~G~fg~V~la~~~~~~~~~~~~vAiK~i~~~~-~~~~--~~~~~~~~~Ei~il~~l~-h--pnIv~l~~~~~~~ 95 (412)
-.+.||.|....||++.+...+. .|++|.-.... .... .....+..+|+.+|+.+. + ..+++++.+ +.
T Consensus 30 ~~~eig~G~~N~vfrV~~~~~~~----svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~ 103 (392)
T d2pula1 30 TCQEIGDGNLNYVFHIYDQEHDR----ALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT 103 (392)
T ss_dssp EEEECCSSSSEEEEEEEC----C----EEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET
T ss_pred eEEEeCCCceEeEEEEEeCCCCe----EEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cC
Confidence 35679999999999998655333 38888543210 0000 011234456888888774 3 345666544 44
Q ss_pred CeEEEEeeccCCCCc
Q 042539 96 EFLAWAVPYCPGGDL 110 (412)
Q Consensus 96 ~~~~lv~e~~~gg~L 110 (412)
+..++|||++.+..+
T Consensus 104 ~~~~lvmE~L~~~~~ 118 (392)
T d2pula1 104 EMAVTVMEDLSHLKI 118 (392)
T ss_dssp TTTEEEECCCTTSEE
T ss_pred CCCEEEEeccCCccc
Confidence 556789999977544
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.90 E-value=3.2e-05 Score=68.32 Aligned_cols=137 Identities=15% Similarity=0.038 Sum_probs=79.9
Q ss_pred eeccC-ceEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC--CCccceeeeeEEeCCeEEEEe
Q 042539 26 LGKGA-MGTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS--HPFLPKLLGSLETDEFLAWAV 102 (412)
Q Consensus 26 LG~G~-fg~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~lv~ 102 (412)
+..|. -+.||++.... +..+.+|.-...... .+.+|+.+++.+. .--+.+++.+..+++..++||
T Consensus 18 ~~~G~s~~~v~r~~~~~-----~~~~vlK~~~~~~~~-------~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~ 85 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQG-----RPVLFVKTDLSGALN-------ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 85 (255)
T ss_dssp CSCTTSSCEEEEEECTT-----SCCEEEEEECSCTTS-------CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred cCCcccCCeEEEEEeCC-----CCEEEEEeCCccCHh-------HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEE
Confidence 34444 47899887542 223788976544321 2344777777774 233678888888888899999
Q ss_pred eccCCCCchhHH--------------Hh-hC----CCCCCHHHHHH-------H---------------HHHHHHHHHHH
Q 042539 103 PYCPGGDLNVLR--------------YK-QN----DRVFSPSVIRF-------Y---------------LSEIICAIEHL 141 (412)
Q Consensus 103 e~~~gg~L~~~~--------------~~-~~----~~~l~~~~~~~-------~---------------~~qi~~aL~yL 141 (412)
++++|.++.... .. +. ...+....... + .......+..+
T Consensus 86 ~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 165 (255)
T d1nd4a_ 86 GEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 165 (255)
T ss_dssp ECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred EeeeccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHH
Confidence 999987653210 00 00 00000000000 0 00011123333
Q ss_pred HHc-------CceeeeCCCCceEEccCCCEEEccccccch
Q 042539 142 HNM-------GIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 142 H~~-------~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
.+. .+||+|+.|.|||++.++.+-|+||+.+..
T Consensus 166 ~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 166 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 332 389999999999998776678999998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.18 E-value=0.0005 Score=64.90 Aligned_cols=84 Identities=21% Similarity=0.258 Sum_probs=52.9
Q ss_pred CccCceeeeeeeccCceEEEEEEEcCCCC---CCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcC-CCccceeeee
Q 042539 16 DLDNLKALKILGKGAMGTVFLVHDRAADP---TARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLS-HPFLPKLLGS 91 (412)
Q Consensus 16 ~~~~y~~~~~LG~G~fg~V~la~~~~~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~ 91 (412)
..+++++ +.|+.|---.+|++....... .....|.+++.-.... .. ...+|..+++.+. +.-..+++++
T Consensus 41 ~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~-----~i-dr~~E~~i~~~ls~~gl~Pkll~~ 113 (395)
T d1nw1a_ 41 PLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET-----ES-HLVAESVIFTLLSERHLGPKLYGI 113 (395)
T ss_dssp CGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC-----HH-HHHHHHHHHHHHHHTTSSSCEEEE
T ss_pred CccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch-----hh-HHHHHHHHHHHHHhCCCCCeEEEE
Confidence 3445544 678889999999998654321 1223366666532211 11 2235888888886 5556688887
Q ss_pred EEeCCeEEEEeeccCCCCc
Q 042539 92 LETDEFLAWAVPYCPGGDL 110 (412)
Q Consensus 92 ~~~~~~~~lv~e~~~gg~L 110 (412)
+.+ .+||||++|..+
T Consensus 114 ~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 114 FSG----GRLEEYIPSRPL 128 (395)
T ss_dssp ETT----EEEECCCCEEEC
T ss_pred cCC----ceEEEEeccccC
Confidence 754 689999988655
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.63 E-value=0.0029 Score=57.75 Aligned_cols=131 Identities=18% Similarity=0.176 Sum_probs=72.0
Q ss_pred eEEEEEEEcCCCCCCCCceEEeeecchhhhhhHHHHHHHHHHHHHHhhcCCCc--cceee-----eeEEeCCeEEEEeec
Q 042539 32 GTVFLVHDRAADPTARCPFALKVVDKSTLHAKHEAERRARWEIRVLSRLSHPF--LPKLL-----GSLETDEFLAWAVPY 104 (412)
Q Consensus 32 g~V~la~~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~-----~~~~~~~~~~lv~e~ 104 (412)
-.||++... .+..|++|+....... ...+..|+..+..|.... ++..+ ..+..+...+.++++
T Consensus 36 N~vy~v~~~-----dg~~~VlK~~rp~~~s-----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~ 105 (325)
T d1zyla1 36 NRVYQFQDE-----DRRRFVVKFYRPERWT-----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 105 (325)
T ss_dssp SEEEEECCT-----TCCCEEEEEECTTTSC-----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred ceeEEEEcC-----CCCEEEEEEeCCCCCC-----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEee
Confidence 589988654 2344999998654321 122334777777775211 11111 134556778899999
Q ss_pred cCCCCchh----HHHh----------h--C------------------------CCCCCHHHHHHHHHHHHHHHHHHHH-
Q 042539 105 CPGGDLNV----LRYK----------Q--N------------------------DRVFSPSVIRFYLSEIICAIEHLHN- 143 (412)
Q Consensus 105 ~~gg~L~~----~~~~----------~--~------------------------~~~l~~~~~~~~~~qi~~aL~yLH~- 143 (412)
+.|..+.. .... . . ...++......+...+-..++.+..
T Consensus 106 ~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~ 185 (325)
T d1zyla1 106 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 185 (325)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHh
Confidence 98754321 0000 0 0 0011222222222223333333332
Q ss_pred ------cCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 144 ------MGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 144 ------~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
.++||+|+.+.|||++. | ..++||+-+..
T Consensus 186 ~~~~~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 186 WREDFTVLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp CCSCSCCEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred ccccCCceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 36899999999999964 4 45899998865
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.62 E-value=0.0041 Score=56.21 Aligned_cols=31 Identities=26% Similarity=0.353 Sum_probs=27.6
Q ss_pred cCceeeeCCCCceEEccCCCEEEccccccch
Q 042539 144 MGIAYRDLKPENILIRQSGHVTLTDFDLSRN 174 (412)
Q Consensus 144 ~~iiHrDlKp~NiLl~~~g~vkL~DFGla~~ 174 (412)
.|+||+|+.++|++++.++..-|+||+.|..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 4799999999999999887778999999864
|